PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Hale, RC; La Guardia, MJ; Harvey, EP; Gaylor, MO; Mainor, TM; Duff, WH				Hale, RC; La Guardia, MJ; Harvey, EP; Gaylor, MO; Mainor, TM; Duff, WH			Flame retardants - Persistent pollutants in land-applied sludges	NATURE			English	Article									Virginia Inst Marine Sci, Dept Environm Sci, Gloucester Point, VA 23062 USA	William & Mary; Virginia Institute of Marine Science	Hale, RC (corresponding author), Virginia Inst Marine Sci, Dept Environm Sci, POB 1346, Gloucester Point, VA 23062 USA.	hale@vims.edu	Hale, Robert C/D-7601-2013	La Guardia, Mark/0000-0003-4866-4992				de Boer J, 1998, NATURE, V394, P28, DOI 10.1038/27798; DICARLO FJ, 1978, ENVIRON HEALTH PERSP, V23, P351, DOI 10.1289/ehp.7823351; *NAT AC SCI, 1996, US RECL WAT SLUD FOO; Renner R, 2000, ENVIRON SCI TECHNOL, V34, p452A, DOI 10.1021/es003482n; Renner R, 2000, ENVIRON SCI TECHNOL, V34, p222A, DOI 10.1021/es003269r; Sellstrom U, 1999, ORGANOHALOGEN COMPD, V40, P383; Strandberg B, 2001, ENVIRON SCI TECHNOL, V35, P1078, DOI 10.1021/es001819f; *US EPA, 1999, EPA530R99009; World Health Organization: Brominated diphenylethers, 1994, ENV HLTH CRIT	9	200	209	7	75	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 12	2001	412	6843					140	141		10.1038/35084130	http://dx.doi.org/10.1038/35084130			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	451AJ	11449259				2022-12-24	WOS:000169778700037
J	Sharma, L; Song, J; Felson, DT; Cahue, S; Shamiyeh, E; Dunlop, DD				Sharma, L; Song, J; Felson, DT; Cahue, S; Shamiyeh, E; Dunlop, DD			The role of knee alignment in disease progression and functional decline in knee osteoarthritis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RADIOGRAPHIC ASSESSMENT; MEDICAL CONDITIONS; CLINICAL-TRIALS; JOINT LOAD; MALALIGNMENT; ARTHRITIS; LAXITY; MENISCECTOMY; STABILITY; DYNAMICS	Context Knee osteoarthritis (OA) is a leading cause of disability in older persons. Few risk factors for disease progression or functional decline have been identified. Hip-knee-ankle align ment influences load distribution at the knee; varus and valgus alignment increase medial and lateral load, respectively. Objective To test the hypotheses that (1) varus alignment increases risk of medial knee OA progression during the subsequent 18 months, (2) valgus alignment increases risk of subsequent lateral knee OA progression, (3) greater severity of malalignment is associated with greater subsequent loss of joint space, and (4) greater burden of malalignment is associated with greater subsequent decline in physical function. Design and Setting Prospective longitudinal cohort study conducted March 1997 to March 2000 at an academic medical center in Chicago, ill. Participants A total of 237 persons recruited from the community with primary knee OA, defined by presence of definite tibiofemoral osteophytes and at least some difficulty with knee-requiring activity; 230 (97%) completed the study. Main Outcome Measures Progression of OA, defined as al-grade increase in severity of joint space narrowing on semiflexed, fluoroscopically confirmed knee radiographs; change in narrowest joint space width; and change in physical function between baseline and 18 months, compared by knee alignment at baseline. Results Varus alignment at baseline was associated with a 4-fold increase in the odds of medial progression, adjusting for age, sex, and body mass index (adjusted odds ratio [OR], 4.09; 95% confidence interval [CI], 2.20-7.62). Valgus alignment at baseline was associated with a nearly 5-fold increase in the odds of lateral progression (adjusted OR, 4.89; 95% CI, 2.13-11.20). Severity of varus correlated with greater medial joint space loss during the subsequent 18 months (R=0.52; 95% CI, 0.40-0.62 in dominant knees), and severity of valgus correlated with greater subsequent lateral joint space loss (R=0.35; 95% CI, 0.21-0.47 in dominant knees). Having alignment of more than 5 degrees (in either direction) in both knees at baseline was associated with significantly greater functional deterioration during the 18 months than having alignment of 5 degrees or less in both knees, after adjusting for age, sex, body mass index, and pain. Conclusion This is, to our knowledge, the first demonstration that in primary knee OA varus alignment increases risk of medial OA progression, that valgus alignment increases risk of lateral OA progression, that burden of malalignment predicts decline in physical function, and that these effects can be detected after as little as 18 months of observation.	Northwestern Univ, Sch Med, Chicago, IL 60611 USA; Boston Univ, Boston, MA 02215 USA	Northwestern University; Boston University	Sharma, L (corresponding author), Northwestern Univ, Sch Med, 303 E Chicago Ave,Ward Bldg 3-315, Chicago, IL 60611 USA.			Felson, David/0000-0002-2668-2447; Sharma, Leena/0000-0002-5571-1622	NCRR NIH HHS [RR-00048] Funding Source: Medline; NIAMS NIH HHS [AR-30692] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P60AR030692] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ALLEN PR, 1984, J BONE JOINT SURG BR, V66, P666, DOI 10.1302/0301-620X.66B5.6548755; Altman R, 1996, OSTEOARTHR CARTILAGE, V4, P217, DOI 10.1016/S1063-4584(05)80101-3; ALTMAN RD, 1987, ARTHRITIS RHEUM-US, V30, P1214, DOI 10.1002/art.1780301103; ANDRIACCHI TP, 1994, ORTHOP CLIN N AM, V25, P395; BOE S, 1986, J BONE JOINT SURG BR, V68, P707, DOI 10.1302/0301-620X.68B5.3782228; BRAGE ME, 1994, CLIN ORTHOP RELAT R, P184; Bruns J, 1993, ARCH ORTHOP TRAUMA S, V133, P12; Buckland-Wright JC, 1999, J RHEUMATOL, V26, P2664; BUCKLANDWRIGHT C, 1995, OSTEOARTHR CARTILAGE, V3, P71; BUCKLANDWRIGHT JC, 1995, ANN RHEUM DIS, V54, P872, DOI 10.1136/ard.54.11.872; BUCKLANDWRIGHT JC, 1994, ANN RHEUM DIS, V53, P268, DOI 10.1136/ard.53.4.268; BUCKLANDWRIGHT JC, 1995, ANN RHEUM DIS, V54, P263, DOI 10.1136/ard.54.4.263; BUCKLANDWRIGHT JC, 1995, OSTEOARTHRITIC DISOR, P51; CHAO EYS, 1994, ORTHOP CLIN N AM, V25, P379; COOKE TDV, 1994, ORTHOP CLIN N AM, V25, P387; CUSHNAGHAN J, 1990, ANN RHEUM DIS, V49, P768, DOI 10.1136/ard.49.10.768; Dieppe P, 1995, OSTEOARTHRITIC DISOR, P481; DIEPPE P, 2001, STEPP OA SCI C PREV; DIEPPE P, 1995, OSTEOARTHRITIC DISOR, P7; DOUGADOS M, 1992, J RHEUMATOL, V19, P378; ETTINGER WH, 1994, J CLIN EPIDEMIOL, V47, P809, DOI 10.1016/0895-4356(94)90178-3; FLECKENSTEIN SJ, 1988, J BIOMECH, V21, P915, DOI 10.1016/0021-9290(88)90129-7; GOLDBERG VM, 1992, OSTEOARTHRITIS DIAGN, P599; GUCCIONE AA, 1994, AM J PUBLIC HEALTH, V84, P351, DOI 10.2105/AJPH.84.3.351; GURALNIK JM, 1995, NEW ENGL J MED, V332, P556, DOI 10.1056/NEJM199503023320902; HARRINGTON IJ, 1983, J BONE JOINT SURG AM, V65, P247, DOI 10.2106/00004623-198365020-00016; HILDING MB, 1995, ACTA ORTHOP SCAND, V66, P317, DOI 10.3109/17453679508995552; HSU RWW, 1990, CLIN ORTHOP RELAT R, P215; JOHNSON F, 1980, J BONE JOINT SURG BR, V62, P346, DOI 10.1302/0301-620X.62B3.7410467; KUETTNER KE, 1995, OSTEOARTHRITIC DISOR, pR21; Lawrence RC, 1998, ARTHRITIS RHEUM-US, V41, P778, DOI 10.1002/1529-0131(199805)41:5<778::AID-ART4>3.0.CO;2-V; LEDINGHAM J, 1995, ANN RHEUM DIS, V54, P53, DOI 10.1136/ard.54.1.53; Lequesne M., 1995, OSTEOARTHRITIC DISOR, P427; MARKOLF KL, 1981, J BONE JOINT SURG AM, V63, P570, DOI 10.2106/00004623-198163040-00007; MARKOLF KL, 1978, J BONE JOINT SURG AM, V60, P664, DOI 10.2106/00004623-197860050-00014; Mazzuca SA, 1997, OSTEOARTHR CARTILAGE, V5, P217, DOI 10.1016/S1063-4584(97)80017-9; Mazzuca SA, 1999, RHEUM DIS CLIN N AM, V25, P467, DOI 10.1016/S0889-857X(05)70079-X; MCKELLOP HA, 1994, ORTHOP CLIN N AM, V25, P415; MESSIEH SS, 1990, J BONE JOINT SURG BR, V72, P639, DOI 10.1302/0301-620X.72B4.2380220; MILLER R, 1973, J BONE JOINT SURG AM, VA 55, P956, DOI 10.2106/00004623-197355050-00004; MORELAND JR, 1987, J BONE JOINT SURG AM, V69A, P745, DOI 10.2106/00004623-198769050-00016; MORRISON JB, 1970, J BIOMECH, V3, P51, DOI 10.1016/0021-9290(70)90050-3; *NAT I ARTHR MUSC, 2001, OST IN; NEYRET P, 1993, J BONE JOINT SURG BR, V75, P36, DOI 10.1302/0301-620X.75B1.8421030; NOYES FR, 1991, AM J SPORT MED, V19, P163, DOI 10.1177/036354659101900212; OGILVIE-HARRIS D J, 1991, Arthroscopy, V7, P151, DOI 10.1016/0749-8063(91)90101-3; PAI YC, 1991, ARCH PHYS MED REHAB, V72, P881, DOI 10.1016/0003-9993(91)90004-3; PAI YC, 1994, ARTHRITIS RHEUM-US, V37, P1297, DOI 10.1002/art.1780370905; PELLETIER JP, 1997, ARTHRITIS ALLIED CON, P1969; POTTENGER LA, 1990, ARTHRITIS RHEUM-US, V33, P853, DOI 10.1002/art.1780330612; Ravaud P, 1996, J RHEUMATOL, V23, P1756; RITTER MA, 1994, CLIN ORTHOP RELAT R, P153; SCHIPPLEIN OD, 1991, J ORTHOPAED RES, V9, P113, DOI 10.1002/jor.1100090114; SCHOUTEN JSAG, 1992, ANN RHEUM DIS, V51, P932, DOI 10.1136/ard.51.8.932; SCHULTZ AB, 1992, J BIOMECH, V25, P1383, DOI 10.1016/0021-9290(92)90052-3; SEEMAN TE, 1994, J GERONTOL MED SCI, V49, P97; Sharma L, 1999, ARTHRITIS RHEUM, V42, P861, DOI 10.1002/1529-0131(199905)42:5<861::AID-ANR4>3.0.CO;2-N; Sharma L, 1999, ARTHRITIS RHEUM-US, V42, P25, DOI 10.1002/1529-0131(199901)42:1<25::AID-ANR3>3.0.CO;2-G; TETSWORTH K, 1994, ORTHOP CLIN N AM, V25, P367; Wada M, 1996, BRIT J RHEUMATOL, V35, P560; YASUDA K, 1992, CLIN ORTHOP RELAT R, P186	61	961	1043	1	73	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 11	2001	286	2					188	195		10.1001/jama.286.2.188	http://dx.doi.org/10.1001/jama.286.2.188			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	451JJ	11448282				2022-12-24	WOS:000169798700024
J	Verlinsky, Y; Rechitsky, S; Schoolcraft, W; Strom, C; Kuliev, A				Verlinsky, Y; Rechitsky, S; Schoolcraft, W; Strom, C; Kuliev, A			Preimplantation diagnosis for fanconi anemia combined with HLA matching	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SINGLE-GENE DISORDERS; POLAR BODY ANALYSIS; AMPLIFICATION; POLYMORPHISM; FACC	Context The advent of single-cell polymerase chain reaction (PCR) has presented the opportunity for combined preimplantation genetic diagnosis (PCD) and HLA antigen testing, This is a novel and useful way to preselect a potential donor for an affected sibling requiring stem cell transplantation. Objective To perform in vitro fertilization (IVF) and preimplantation HLA matching combined with PGD for Fanconi anemia (FA), Design DNA analysis for the IVS 4+4 A -->T (adenine to thymine) mutation in the FA complement C (FANCC) gene in single blastomeres, obtained by biopsy of embryos, to identify genetic status and HLA markers of each embryo before intrauterine transfer. Setting In vitro fertilization programs at large medical centers in Chicago, ill, and Denver, Colo. Participants A couple, both carriers of the IVS 4+4 A -->T mutation in the FANCC gene with an affected child requiring an HLA-compatible donor for cord blood transplantation. Main Outcome Measures DNA analysis of single blastomeres to preselect unaffected embryos representing an HLA match for the affected sibling. Results Of 30 embryos tested in 4 IVF attempts, 6 were homozygous affected and 24 were unaffected. Five of these embryos were also found to be HLA-compatible, of which 2 were transferred in the first and 1 in each of the other 3 cycles, resulting in a pregnancy and birth of an unaffected child in the last cycle. Conclusion To our knowledge, this is the first PGD with HLA matching, demonstrating feasibility of preselecting unaffected embryos that can also be an HLA-compatible source for stem cell transplantation for a sibling.	Inst Reprod Genet, Chicago, IL USA; Colorado Ctr Reprod Med, Denver, CO USA		Verlinsky, Y (corresponding author), 2825 N Halsted St, Chicago, IL 60657 USA.		Kuliev, Anver/P-5666-2018	Kuliev, Anver/0000-0002-2486-9339				BLASCZYK R, 1995, TISSUE ANTIGENS, V46, P86, DOI 10.1111/j.1399-0039.1995.tb02483.x; Foissac A, 1998, TISSUE ANTIGENS, V52, P318, DOI 10.1111/j.1399-0039.1998.tb03054.x; Gibson RA, 1996, HUM MUTAT, V8, P140, DOI 10.1002/(SICI)1098-1004(1996)8:2<140::AID-HUMU6>3.0.CO;2-F; GLUCKMAN E, 1989, NEW ENGL J MED, V321, P1174, DOI 10.1056/NEJM198910263211707; GLUCKMAN E, 1980, BRIT J HAEMATOL, V45, P557, DOI 10.1111/j.1365-2141.1980.tb07178.x; HANDYSIDE AH, 1990, NATURE, V344, P768, DOI 10.1038/344768a0; HANDYSIDE AH, 1992, NEW ENGL J MED, V327, P905, DOI 10.1056/NEJM199209243271301; *INT WORK GROUP PR, 2001, J ASSIST REPROD GEN, V18, P66; *INT WORK GROUP PR, 2000, J ASSIST REPROD GEN, V17, P75; Mitsunaga S, 1998, EUR J IMMUNOGENET, V25, P15, DOI 10.1046/j.1365-2370.1998.00093.x; Munne S, 1998, J ASSIST REPROD GEN, V15, P290, DOI 10.1023/A:1022544511198; Rechitsky S, 1999, J ASSIST REPROD GEN, V16, P192, DOI 10.1023/A:1020312823155; Sermon K, 1997, PRENATAL DIAG, V17, P925, DOI 10.1002/(SICI)1097-0223(199710)17:10<925::AID-PD178>3.0.CO;2-4; STRATHDEE CA, 1992, NAT GENET, V1, P196, DOI 10.1038/ng0692-196; STRATHDEE CA, 1992, NATURE, V356, P763, DOI 10.1038/356763a0; VELRINSKY Y, 2000, ATLAS PREIMPLANTATIO; Verlinsky Y, 1999, GENET TEST, V3, P185, DOI 10.1089/gte.1999.3.185; VERLINSKY Y, 1990, HUM REPROD, V5, P826, DOI 10.1093/oxfordjournals.humrep.a137192; Verlinsky Y, 1999, J ASSIST REPROD GEN, V16, P161, DOI 10.1023/A:1020327804500; Verlinsky Yury, 2001, Reprod Biomed Online, V2, P102; WAGNER JE, 1999, HEMATOPOIETIC CELL T, P1204; WHITNEY MA, 1993, NAT GENET, V4, P202, DOI 10.1038/ng0693-202; Xu KP, 1999, JAMA-J AM MED ASSOC, V281, P1701, DOI 10.1001/jama.281.18.1701; YOSHIDA M, 1992, HUM IMMUNOL, V34, P257, DOI 10.1016/0198-8859(92)90025-I	24	244	271	0	15	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 27	2001	285	24					3130	3133		10.1001/jama.285.24.3130	http://dx.doi.org/10.1001/jama.285.24.3130			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	444FF	11427142	Bronze			2022-12-24	WOS:000169388900027
J	Smith, GCS; Pell, JP; Walsh, D				Smith, GCS; Pell, JP; Walsh, D			Pregnancy complications and maternal risk of ischaemic heart disease: a retrospective cohort study of 129,290 births	LANCET			English	Article							MYOCARDIAL-INFARCTION; YOUNG-WOMEN; CIGARETTE-SMOKING; WEIGHT; HYPERTENSION; ASSOCIATION; MORTALITY; SCOTLAND; PREECLAMPSIA; PROGNOSIS	Background Individuals who are small at birth are at increased risk of ischaemic heart disease (IHD) in later life. One hypothesis to explain this association is fetal adaptation to a suboptimum intrauterine environment. We investigated whether pregnancy complications associated with low birthweight are related to risk of subsequent IHD in the mother. Methods Routine discharge data were used to identify all singleton first births in Scotland between 1981 and 1985. Linkage to the mothers' subsequent admissions and deaths provided 15-19 years of follow-up. The mothers' risks of death from any cause or from IHD and admission for or death from IHD were related to adverse obstetric outcomes in the first pregnancy. Hazard ratios were adjusted for socioeconomic deprivation, maternal height and age, and essential hypertension. Findings Complete data were available on 129 920 (95.6%) eligible deliveries. Maternal risk of IHD admission or death was associated with delivering a baby in the lowest birthweight quintile for gestational age (adjusted hazard ratio 1.9 [95% CI 1.5-2.4]), preterm delivery (1.8 [1.3-2.5]), and pre-eclampsia (2.0 [1.5-2.5]). The associations were additive; women with all three characteristics had a risk of IHD admission or death seven times (95% CI 3.3-14.5) greater than the reference category. Interpretation Complications of pregnancy linked to low birthweight are associated with an increased risk of subsequent IHD in the mother. Common genetic risk factors might explain the link between birthweight and risk of IHD in both the individual and the mother.	Univ Glasgow, Dept Obstet & Gynaecol, Glasgow, Lanark, Scotland; Univ Glasgow, Dept Med Cardiol, Glasgow, Lanark, Scotland; Common Serv Agcy, Informat & Stat Div, Edinburgh, Midlothian, Scotland	University of Glasgow; University of Glasgow	Smith, GCS (corresponding author), Queen Mothers Hosp, Dept Obstet & Gynaecol, Glasgow G3 8SJ, Lanark, Scotland.		Smith, Gordon/A-8070-2008	Smith, Gordon/0000-0003-2124-0997; Pell, Jill/0000-0002-8898-7035; Walsh, David/0000-0002-3390-5039				Barker D. J. P., 1994, MOTHERS BABIES DIS L; CHESLEY LC, 1980, KIDNEY INT, V18, P234, DOI 10.1038/ki.1980.131; Conde-Agudelo A, 1999, AM J OBSTET GYNECOL, V181, P1026, DOI 10.1016/S0002-9378(99)70341-8; Dunn NR, 2000, J EPIDEMIOL COMMUN H, V54, P293, DOI 10.1136/jech.54.4.293; Erhardt E, 2000, BIOL NEONATE, V78, P145, DOI 10.1159/000014263; Gurevitz O, 2000, AM J CARDIOL, V85, P806, DOI 10.1016/S0002-9149(99)00871-1; Hattersley AT, 1998, NAT GENET, V19, P268, DOI 10.1038/953; Hocher B, 2000, LANCET, V355, P1241, DOI 10.1016/S0140-6736(00)02094-8; Hosmer D. W., 1999, APPL SURVIVAL ANAL; Jonsdottir LS, 1995, ACTA OBSTET GYN SCAN, V74, P772; KRAMER MS, 1987, B WORLD HEALTH ORGAN, V65, P663; Kupferminc MJ, 1999, NEW ENGL J MED, V340, P9, DOI 10.1056/NEJM199901073400102; Lindsay RS, 2000, DIABETES, V49, P445, DOI 10.2337/diabetes.49.3.445; MARMOT MG, 1984, INT J EPIDEMIOL, V13, P160, DOI 10.1093/ije/13.2.160; MCLOONE P, 1994, BRIT MED J, V309, P1465, DOI 10.1136/bmj.309.6967.1465; Melander O, 1999, J HYPERTENS, V17, P1557, DOI 10.1097/00004872-199917110-00008; Morris JA, 1998, MED HYPOTHESES, V51, P285, DOI 10.1016/S0306-9877(98)90048-2; Rosendaal FR, 1997, BLOOD, V89, P2817, DOI 10.1182/blood.V89.8.2817; Rosendaal FR, 1997, BLOOD, V90, P1747, DOI 10.1182/blood.V90.5.1747; Shah NR, 2000, AM J OBSTET GYNECOL, V182, P465, DOI 10.1016/S0002-9378(00)70240-7; Smith GCS, 2000, AM J EPIDEMIOL, V151, P614, DOI 10.1093/oxfordjournals.aje.a010249; Smith GCS, 1998, NEW ENGL J MED, V339, P1817, DOI 10.1056/NEJM199812173392504; Smith GD, 1997, BRIT MED J, V315, P1189, DOI 10.1136/bmj.315.7117.1189; Smith GD, 2000, BRIT MED J, V320, P839, DOI 10.1136/bmj.320.7238.839; SUSSER M, 1991, AM J CLIN NUTR, V53, P1384, DOI 10.1093/ajcn/53.6.1384; vandenElzen HJ, 1996, BRIT J OBSTET GYNAEC, V103, P117; ZHANG XQ, 2001, J SOC GYNECOL INVEST, V8	27	704	717	2	29	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 23	2001	357	9273					2002	2006		10.1016/S0140-6736(00)05112-6	http://dx.doi.org/10.1016/S0140-6736(00)05112-6			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	446JB	11438131				2022-12-24	WOS:000169509200008
J	Karnath, HO; Ferber, S; Himmelbach, M				Karnath, HO; Ferber, S; Himmelbach, M			Spatial awareness is a function of the temporal not the posterior parietal lobe	NATURE			English	Article							RIGHT-HEMISPHERE STROKE; SUNNYBROOK STROKE; VISUAL NEGLECT; LESIONS; MONKEYS; CORTEX; SULCUS; REPRESENTATION; ATTENTION; BEHAVIOR	Our current understanding of spatial behaviour and parietal lobe function is largely based on the belief that spatial neglect in humans (a lack of awareness of space on the side of the body contralateral to a brain injury) is typically associated with lesions of the posterior parietal lobe. However, in monkeys, this disorder is observed after lesions of the superior temporal cortex(1), a puzzling discrepancy between the species. Here we show that, contrary to the widely accepted view, the superior temporal cortex is the neural substrate of spatial neglect in humans, as it is in monkeys. Unlike the monkey brain, spatial awareness in humans is a function largely confined to the right superior temporal cortex, a location topographically reminiscent of that for language on the left(2). Hence, the decisive phylogenetic transition from monkey to human brain seems to be a restriction of a formerly bilateral function to the right side, rather than a shift from the temporal to the parietal lobe. One may speculate that this lateralization of spatial awareness parallels the emergence of an elaborate representation for language on the left side.	Univ Tubingen, Dept Cognit Neurol, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen	Karnath, HO (corresponding author), Univ Tubingen, Dept Cognit Neurol, Hoppe Seyler Str 3, D-72076 Tubingen, Germany.			Himmelbach, Marc/0000-0002-7771-2968				Binder J, 2000, BRAIN, V123, P2371, DOI 10.1093/brain/123.12.2371; BRUCE C, 1981, J NEUROPHYSIOL, V46, P369, DOI 10.1152/jn.1981.46.2.369; DAMASIO AR, 1980, NEUROPSYCHOLOGIA, V18, P123, DOI 10.1016/0028-3932(80)90058-5; Darling WG, 2001, NEUROPSYCHOLOGIA, V39, P237, DOI 10.1016/S0028-3932(00)00113-5; ETTLINGER G, 1962, J NEUROL NEUROSUR PS, V25, P256, DOI 10.1136/jnnp.25.3.256; FAUGIERGRIMAUD S, 1978, NEUROPSYCHOLOGIA, V16, P151, DOI 10.1016/0028-3932(78)90103-3; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Gaffan D, 1997, BRAIN, V120, P1647, DOI 10.1093/brain/120.9.1647; GAUTHIER L, 1989, INT J CLIN NEUROPSYC, V11, P49; Heilman K. M, 1983, LOCALIZATION NEUROPS, P471; JONES E G, 1970, Brain Behavior and Evolution, V93, P793, DOI 10.1093/brain/93.4.793; LAMOTTE RH, 1978, BRAIN RES, V139, P309, DOI 10.1016/0006-8993(78)90931-9; Leibovitch FS, 1998, NEUROLOGY, V50, P901, DOI 10.1212/WNL.50.4.901; Leibovitch FS, 1999, HUM BRAIN MAPP, V7, P244, DOI 10.1002/(SICI)1097-0193(1999)7:4<244::AID-HBM3>3.0.CO;2-K; LUH KE, 1986, NEUROPSYCHOLOGIA, V24, P461, DOI 10.1016/0028-3932(86)90091-6; LYNCH JC, 1989, J NEUROPHYSIOL, V61, P74, DOI 10.1152/jn.1989.61.1.74; Mesulam MM, 1999, PHILOS T R SOC B, V354, P1325, DOI 10.1098/rstb.1999.0482; MOTOMURA N, 1986, ACTA NEUROL SCAND, V74, P190, DOI 10.1111/j.1600-0404.1986.tb07854.x; Perenin M.-T., 1997, PARIETAL LOBE CONTRI, P289; RORDEN C, IN PRESS BEHAV NEURO; Samuelsson H, 1997, CORTEX, V33, P271, DOI 10.1016/S0010-9452(08)70004-2; SELTZER B, 1978, BRAIN RES, V149, P1, DOI 10.1016/0006-8993(78)90584-X; Talairach J., 1988, COPLANAR STEREOTAXIC; Tham K, 1996, NEUROPSYCHOL REHABIL, V6, P19, DOI 10.1080/713755496; Ungerleider LG., 1982, ANAL VISUAL BEHAV, P549; VALLAR G, 1986, NEUROPSYCHOLOGIA, V24, P609, DOI 10.1016/0028-3932(86)90001-1; WATSON RT, 1994, ARCH NEUROL-CHICAGO, V51, P1014, DOI 10.1001/archneur.1994.00540220060015; Weintraub S., 1985, PRINCIPLES BEHAV NEU, P71	28	597	609	2	23	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 21	2001	411	6840					950	953		10.1038/35082075	http://dx.doi.org/10.1038/35082075			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	444EN	11418859				2022-12-24	WOS:000169386200045
J	Baker, AC				Baker, AC			Ecosystems - Reef corals bleach to survive change	NATURE			English	Article							ZOOXANTHELLAE; DIVERSITY; ECOLOGY; FUTURE		Wildlife Conservat Soc, Osborn Labs Marine Sci, New York Aquarium, Brooklyn, NY 11224 USA	Wildlife Conservation Society	Baker, AC (corresponding author), Wildlife Conservat Soc, Osborn Labs Marine Sci, New York Aquarium, Surf Ave & W 8th St, Brooklyn, NY 11224 USA.			Baker, Andrew/0000-0002-7866-2587				Baker AC., 1999, SYMBIOSIS ECOLOGY RE; Brown BE, 1997, CORAL REEFS, V16, P129; Buddemeier RW, 1999, AM ZOOL, V39, P1; BUDDEMEIER RW, 1993, BIOSCIENCE, V43, P320, DOI 10.2307/1312064; GLYNN PW, 1992, AM ZOOL, V32, P707; GLYNN PW, 1993, CORAL REEFS, V12, P1, DOI 10.1007/BF00303779; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Kinzie RA, 2001, BIOL BULL, V200, P51, DOI 10.2307/1543084; ROWAN R, 1991, SCIENCE, V251, P1348, DOI 10.1126/science.251.4999.1348; ROWAN R, 1995, P NATL ACAD SCI USA, V92, P2850, DOI 10.1073/pnas.92.7.2850; Rowan R, 1997, NATURE, V388, P265, DOI 10.1038/40843; Rowan R, 1998, J PHYCOL, V34, P407, DOI 10.1046/j.1529-8817.1998.340407.x; TOLLER WW, IN PRESS BIOL B MAR; Wilkinson C, 1999, AMBIO, V28, P188	14	362	381	3	161	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 14	2001	411	6839					765	766		10.1038/35081151	http://dx.doi.org/10.1038/35081151			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	441TV	11459046				2022-12-24	WOS:000169246400036
J	Bellwood, DR; Hughes, TP				Bellwood, DR; Hughes, TP			Regional-scale assembly rules and biodiversity of coral reefs	SCIENCE			English	Article							LONG-TERM; DIVERSITY; CONSEQUENCES; RECOVERY; PATTERNS; DISTURBANCE; LEVEL	Tropical reef fishes and corals exhibit highly predictable patterns of taxonomic composition across the Indian and Pacific Oceans. Despite steep Longitudinal and Latitudinal gradients in total species richness, the composition of these key taxa is constrained within a remarkably narrow range of values. Regional-scale variation in reef biodiversity is best explained by Large-scale patterns in the availability of shallow-water habitat. Once habitat area is accounted for, there is surprisingly little residual effect of Latitude or Longitude. Low-diversity regions are most vulnerable to human impacts such as global warming, underscoring the urgent need for integrated management at multinational scales.	James Cook Univ N Queensland, Dept Marine Biol, Ctr Coral Reef Biodivers, Townsville, Qld 4811, Australia	James Cook University	Bellwood, DR (corresponding author), James Cook Univ N Queensland, Dept Marine Biol, Ctr Coral Reef Biodivers, Townsville, Qld 4811, Australia.	david.bellwood@jcu.edu.au	Bellwood, David/E-2497-2011; Hughes, Terry P/L-4721-2013	Hughes, Terry P/0000-0002-5257-5063				Ayre DJ, 2000, EVOLUTION, V54, P1590; Bellwood D. R., 1997, P 8 INT COR REEF S, V1, P379; Briggs JC, 1999, EVOLUTION, V53, P326, DOI 10.1111/j.1558-5646.1999.tb03769.x; BROWN BE, 1990, CORAL REEFS, V8, P163, DOI 10.1007/BF00265007; BROWN BE, 1985, ADV MAR BIOL, V22, P1, DOI 10.1016/S0065-2881(08)60049-8; Bryant D., 1998, REEFS RISK MAP BASED; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; Colwell RK, 2000, TRENDS ECOL EVOL, V15, P70, DOI 10.1016/S0169-5347(99)01767-X; Connell JH, 1997, CORAL REEFS, V16, pS101, DOI 10.1007/s003380050246; DOLLAR SJ, 1993, CORAL REEFS, V12, P223, DOI 10.1007/BF00334481; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; Glynn PW, 2000, CORAL REEFS, V19, P1, DOI 10.1007/s003380050220; Hastie TJ., 1990, GEN ADDITIVE MODELS; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Hughes TP, 1999, LIMNOL OCEANOGR, V44, P932, DOI 10.4319/lo.1999.44.3_part_2.0932; JABLONSKI D, 1986, SCIENCE, V231, P129, DOI 10.1126/science.231.4734.129; JABLONSKI D, 1987, SCIENCE, V238, P360, DOI 10.1126/science.238.4825.360; JACKSON JBC, 1974, AM NAT, V108, P541, DOI 10.1086/282933; JACKSON JBC, 1993, SCIENCE, V260, P1624, DOI 10.1126/science.260.5114.1624; JACKSON JBC, IN PRESS SCIENCE; JEN Veron, 1995, CORALS SPACE TIME BI; Leis J.M., 1991, P183; LESSIOS HA, 1988, ANNU REV ECOL SYST, V19, P371, DOI 10.1146/annurev.es.19.110188.002103; McCann KS, 2000, NATURE, V405, P228, DOI 10.1038/35012234; Palumbi SR, 1997, CORAL REEFS, V16, pS47, DOI 10.1007/s003380050241; PAULAY G, 1990, PALEOBIOLOGY, V16, P415, DOI 10.1017/S0094837300010162; Purvis A, 2000, NATURE, V405, P212, DOI 10.1038/35012221; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Rosenzweig ML, 1999, SCIENCE, V284, P276, DOI 10.1126/science.284.5412.276; Russ GR, 1998, CORAL REEFS, V17, P399, DOI 10.1007/s003380050146; STEHLI FG, 1971, SYST ZOOL, V20, P115, DOI 10.2307/2412052; Tilman D, 2000, NATURE, V405, P208, DOI 10.1038/35012217; Wilson Moyra E. J., 1998, P165	33	420	445	2	154	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 25	2001	292	5521					1532	1534		10.1126/science.1058635	http://dx.doi.org/10.1126/science.1058635			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YQ	11375488				2022-12-24	WOS:000168963800041
J	Silagy, C; Formica, N				Silagy, C; Formica, N			Place of bupropion in smoking-cessation therapy	LANCET			English	Editorial Material									Monash Med Ctr, Monash Inst Hlth Serv Res, Melbourne, Vic 3168, Australia	Monash University	Silagy, C (corresponding author), Monash Med Ctr, Monash Inst Hlth Serv Res, Melbourne, Vic 3168, Australia.							FIORE MC, 2000, TREATING TOBACCO USE; HUGHES JR, 2000, COCHRANE DATABASE SY, V2; Jorenby DE, 1999, NEW ENGL J MED, V340, P685, DOI 10.1056/NEJM199903043400903; Lancaster T, 2000, BRIT MED J, V321, P355, DOI 10.1136/bmj.321.7257.355; Peto R., 2000, CRITICAL ISSUES GLOB, P154; West R, 2000, THORAX, V55, P987, DOI 10.1136/thorax.55.12.987	6	6	6	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 19	2001	357	9268					1550	1550		10.1016/S0140-6736(00)04781-4	http://dx.doi.org/10.1016/S0140-6736(00)04781-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	434RR	11377641				2022-12-24	WOS:000168830100007
J	Baker, DA; Mille-Baker, B; Wainwright, SM; Ish-Horowicz, D; Dibb, NJ				Baker, DA; Mille-Baker, B; Wainwright, SM; Ish-Horowicz, D; Dibb, NJ			Mae mediates MAP kinase phosphorylation of Ets transcription factors in Drosophila	NATURE			English	Article							EMBRYONIC VENTRAL ECTODERM; EGF RECEPTOR PATHWAY; SIGNALING PATHWAY; DOMAIN PROTEIN; FEEDBACK LOOP; DNA-BINDING; YAN GENE; MIDLINE; MOTIF; DIFFERENTIATION	The evolutionarily conserved Ras/mitogen-activated protein kinase (MAPK) cascade is an integral part of the processes of cell division, differentiation, movement and death. Signals received at the cell surface are relayed into the nucleus, where MAPK phosphorylates and thereby modulates the activities of a subset of transcription factors(1,2). Here we report the cloning and characterization of a new component of this signal transduction pathway called Mae (for modulator of the activity of Ets). Mae is a signalling intermediate that directly links the MAPK signalling pathway to its downstream transcription factor targets. Phosphorylation by MAPK of the critical serine residue (Ser 127) of the Drosophila transcription factor Yan depends on Mae, and is mediated by the binding of Yan to Mae through their Pointed domains. This phosphorylation is both necessary and sufficient to abrogate transcriptional repression by Yan. Mae also regulates the activity of the transcriptional activator Pointed-P2 by a similar mechanism. Mae is essential for the normal development and viability of Drosophila, and is required in vivo for normal signalling of the epidermal growth factor receptor. Our study indicates that MAPK signalling specificity may depend on proteins that couple specific substrates to the kinase.	Hammersmith Hosp, Imperial Coll Sch Med, Inst Reprod & Dev Biol, Cell Signalling Unit, London W12 0NN, England; Imperial Canc Res Fund, Dev Genet Lab, London WC2A 3PX, England	Imperial College London; Cancer Research UK	Baker, DA (corresponding author), Hammersmith Hosp, Imperial Coll Sch Med, Inst Reprod & Dev Biol, Cell Signalling Unit, Du Cane Rd, London W12 0NN, England.			Ish-Horowicz, David/0000-0001-5684-7129				BRUNNER D, 1994, NATURE, V370, P386, DOI 10.1038/370386a0; Dumstrei K, 1998, DEVELOPMENT, V125, P3417; Gabay L, 1996, DEVELOPMENT, V122, P3355; Gabay L, 1997, SCIENCE, V277, P1103, DOI 10.1126/science.277.5329.1103; Golembo M, 1999, GENE DEV, V13, P158, DOI 10.1101/gad.13.2.158; Golembo M, 1996, DEVELOPMENT, V122, P3363; Golembo M, 1996, DEVELOPMENT, V122, P223; HILL CS, 1995, CELL, V80, P199, DOI 10.1016/0092-8674(95)90403-4; Jousset C, 1997, EMBO J, V16, P69, DOI 10.1093/emboj/16.1.69; JURGENS G, 1984, ROUX ARCH DEV BIOL, V193, P283, DOI 10.1007/BF00848157; KLAMBT C, 1993, DEVELOPMENT, V117, P163; LAI ZC, 1992, CELL, V70, P609, DOI 10.1016/0092-8674(92)90430-K; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; MAYER U, 1988, GENE DEV, V2, P1496, DOI 10.1101/gad.2.11.1496; NYE JA, 1992, GENE DEV, V6, P975, DOI 10.1101/gad.6.6.975; ONEILL EM, 1994, CELL, V78, P137, DOI 10.1016/0092-8674(94)90580-0; PONTING CP, 1995, PROTEIN SCI, V4, P1928, DOI 10.1002/pro.5560040927; Rebay I, 2000, GENETICS, V154, P695; REBAY I, 1995, CELL, V81, P857, DOI 10.1016/0092-8674(95)90006-3; Roch F, 1998, MOL GEN GENET, V257, P103, DOI 10.1007/PL00008620; Rogge R, 1995, DEVELOPMENT, V121, P3947; Scholz H, 1997, MECH DEVELOP, V64, P137; SOUDANT N, 1994, NUCLEIC ACIDS RES, V22, P3871, DOI 10.1093/nar/22.19.3871; Spradling AC, 1999, GENETICS, V153, P135; TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Treisman R, 1996, CURR OPIN CELL BIOL, V8, P205, DOI 10.1016/S0955-0674(96)80067-6; Wasserman JD, 2000, GENE DEV, V14, P1651; Wasylyk B, 1998, TRENDS BIOCHEM SCI, V23, P213, DOI 10.1016/S0968-0004(98)01211-0; Wieschaus E., 1986, P199; Yagi Y, 1998, DEVELOPMENT, V125, P3625	31	58	59	1	5	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 17	2001	411	6835					330	334		10.1038/35077122	http://dx.doi.org/10.1038/35077122			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432RT	11357138				2022-12-24	WOS:000168710000053
J	Hughes, RAC				Hughes, RAC			Sensory form of Guillain-Barre syndrome	LANCET			English	Editorial Material									Guys Kings & St Thomas Sch Med, Dept Neuroimmunol, London SE1 9RT, England	University of London; King's College London	Hughes, RAC (corresponding author), Guys Kings & St Thomas Sch Med, Dept Neuroimmunol, Guys Campus, London SE1 9RT, England.							Chiba A, 1997, BRAIN RES, V745, P32, DOI 10.1016/S0006-8993(96)01123-7; FISHER M, 1956, NEW ENGL J MED, V255, P57, DOI 10.1056/NEJM195607122550201; Ho TW, 1999, ANN NEUROL, V45, P168, DOI 10.1002/1531-8249(199902)45:2<168::AID-ANA6>3.0.CO;2-6; Hughes RAC, 1999, J NEUROIMMUNOL, V100, P74, DOI 10.1016/S0165-5728(99)00195-2; Oh SJ, 2001, NEUROLOGY, V56, P82, DOI 10.1212/WNL.56.1.82; Wilmshurst J M, 1999, Eur J Paediatr Neurol, V3, P277, DOI 10.1016/S1090-3798(99)90983-2; WINDEBANK AJ, 1990, NEUROLOGY, V40, P584, DOI 10.1212/WNL.40.4.584	7	5	5	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 12	2001	357	9267					1465	1465		10.1016/S0140-6736(00)04672-9	http://dx.doi.org/10.1016/S0140-6736(00)04672-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	431CL	11377594				2022-12-24	WOS:000168614300006
J	Melino, G				Melino, G			The Sirens' song	NATURE			English	Editorial Material							CELL-DEATH		Univ Roma Tor Vergata, IDI IRCCS, Biochem Lab, I-00133 Rome, Italy	IRCCS Istituto Dermopatico dell'Immacolata (IDI); University of Rome Tor Vergata	Melino, G (corresponding author), Univ Roma Tor Vergata, IDI IRCCS, Biochem Lab, I-00133 Rome, Italy.			MELINO, GERRY/0000-0001-9428-5972				Aravind L, 2001, SCIENCE, V291, P1279, DOI 10.1126/science.291.5507.1279; ARNEISEN JC, 1999, SCULPTURE VIVANT; Heemels MT, 2000, NATURE, V407, P769; Metzstein MM, 1998, TRENDS GENET, V14, P410, DOI 10.1016/S0168-9525(98)01573-X; RAFF MC, 1992, NATURE, V356, P397, DOI 10.1038/356397a0	5	45	49	0	3	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 5	2001	412	6842					23	23		10.1038/35083653	http://dx.doi.org/10.1038/35083653			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448TB	11452281				2022-12-24	WOS:000169644900020
J	Mack, V; Burnashev, N; Kaiser, KMM; Rozov, A; Jensen, V; Hvalby, O; Sakmann, B; Seeburg, PH; Sprengel, R				Mack, V; Burnashev, N; Kaiser, KMM; Rozov, A; Jensen, V; Hvalby, O; Sakmann, B; Seeburg, PH; Sprengel, R			Conditional restoration of hippocampal synaptic potentiation in GluR-A-deficient mice	SCIENCE			English	Article							GLUTAMATE RECEPTORS; AMPA RECEPTORS; EXPRESSION; CELLS; LTP; CAMKII	Plasticity of mature hippocampal CA1 synapses is dependent on L-alpha -amino-3-hydroxy-5-methylisoxazole-4-propionate (AMPA) receptors containing the glutamate receptor A (GLuR-A) subunit. In GLuR-A-deficient mice, plasticity could be restored by controlled expression of green fluorescent protein (GFP)-tagged GluRA, which contributes to channel formation and displayed the developmental redistribution of AMPA receptors in CA1 pyramidal neurons. Long-term potentiation (LTP) induced by pairing or tetanic stimulation was rescued in adult GluR-A(-/-) mice when (GFP)GluR-A expression was constitutive or induced in already fully developed pyramidal cells. This shows that GluR-A-independent forms of synaptic plasticity can mediate the establishment of mature hippocampal circuits that are prebuilt to express GluR-A-dependent LTP.	Max Planck Inst Med Res, Dept Mol Neurobiol, D-69120 Heidelberg, Germany; Max Planck Inst Med Res, Dept Cell Physiol, D-69120 Heidelberg, Germany; Univ Oslo, Inst Basic Med Sci, Dept Physiol, N-0462 Oslo, Norway	Max Planck Society; Max Planck Society; University of Oslo	Sprengel, R (corresponding author), Max Planck Inst Med Res, Dept Mol Neurobiol, Jahnstr 29, D-69120 Heidelberg, Germany.		Burnashev, Nail/G-4056-2013; Rozov, Andrei/C-1997-2015					BARON U, 1995, NUCLEIC ACIDS RES, V23, P3605, DOI 10.1093/nar/23.17.3605; Chen HX, 1999, J NEUROPHYSIOL, V82, P526, DOI 10.1152/jn.1999.82.2.526; Dingledine R, 1999, PHARMACOL REV, V51, P7; Gossen Manfred, 1994, Current Opinion in Biotechnology, V5, P516, DOI 10.1016/0958-1669(94)90067-1; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; JENSEN V, UNPUB; KEINANEN K, 1990, SCIENCE, V249, P556, DOI 10.1126/science.2166337; Krestel HE, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.7.e39; Malinow R, 2000, CURR OPIN NEUROBIOL, V10, P352, DOI 10.1016/S0959-4388(00)00099-4; Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678; Petersen SA, 1997, NEURON, V19, P1237, DOI 10.1016/S0896-6273(00)80415-8; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Zamanillo D, 1999, SCIENCE, V284, P1805, DOI 10.1126/science.284.5421.1805; Zhu JJ, 2000, NAT NEUROSCI, V3, P1098, DOI 10.1038/80614; Zolotukhin S, 1996, J VIROL, V70, P4646, DOI 10.1128/JVI.70.7.4646-4654.1996	16	94	96	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 29	2001	292	5526					2501	2504		10.1126/science.1059365	http://dx.doi.org/10.1126/science.1059365			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448YU	11431570				2022-12-24	WOS:000169658200045
J	Sun, ZYJ; Kim, HS; Wagner, G; Reinherz, EL				Sun, ZYJ; Kim, HS; Wagner, G; Reinherz, EL			Mechanisms contributing to T cell receptor signaling and assembly revealed by the solution structure of an ectodomain fragment of the CD3 epsilon gamma heterodimer	CELL			English	Article							CD3 GAMMA-CHAIN; TCR-ALPHA-BETA; MHC CLASS-II; ANTIGEN RECEPTOR; CRYSTAL-STRUCTURE; TCR/CD3 COMPLEX; SURFACE EXPRESSION; ZETA-CHAIN; T3-MOLECULAR COMPLEX; ACTIVATION MOTIFS	The T cell receptor (TCR) consists of genetically diverse disulfide-linked ru and beta chains in noncovalent association with the invariant CD3 subunits. CD3 epsilon and CD3 gamma are integral components of both the TCR and pre-TCR. Here, we present the solution structure of a heterodimeric CD3 epsilon gamma ectodomain complex. A unique side-to-side hydrophobic interface between the two C2-set immunoglobulin-like domains and parallel pairing of their respective C-terminal beta strands are revealed. Mutational analysis confirms the importance of the distinctive linkage as well as the membrane proximal stalk motif (RxCxxCxE) for domain-domain association. These biochemical and structural analyses offer insights into the modular pairwise association of CD3 invariant chains. More importantly, the findings suggest how the rigidified CD3 elements participate in TCR-based signal transduction.	Harvard Univ, Sch Med, Dana Farber Canc Inst, Immunobiol Lab, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Wagner, G (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Immunobiol Lab, 44 Binney St, Boston, MA 02115 USA.	wagner@wagner.med.harvard.edu; ellis_reinherz@dfci.harvard.edu			NIAID NIH HHS [AI37581, AI19807] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI019807, R56AI019807, R01AI037581, R01AI019807] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alam SM, 1996, NATURE, V381, P616, DOI 10.1038/381616a0; ALARCON B, 1988, J BIOL CHEM, V263, P2953; ASHWELL JD, 1990, ANNU REV IMMUNOL, V8, P139, DOI 10.1146/annurev.immunol.8.1.139; BARTELS C, 1995, J BIOMOL NMR, V6, P1, DOI 10.1007/BF00417486; Borroto A, 1998, J BIOL CHEM, V273, P12807, DOI 10.1074/jbc.273.21.12807; Brunger A. T., 1992, XPLOR VERSION 3 1 SY; Casasnovas JM, 1998, P NATL ACAD SCI USA, V95, P4134, DOI 10.1073/pnas.95.8.4134; CHOTHIA C, 1985, J MOL BIOL, V186, P651, DOI 10.1016/0022-2836(85)90137-8; CLEVERS H, 1988, ANNU REV IMMUNOL, V6, P629, DOI 10.1146/annurev.iy.06.040188.003213; CONNOLLY ML, 1983, J APPL CRYSTALLOGR, V16, P548, DOI 10.1107/S0021889883010985; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Dave VP, 1997, EMBO J, V16, P1360, DOI 10.1093/emboj/16.6.1360; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; Degano M, 2000, IMMUNITY, V12, P251, DOI 10.1016/S1074-7613(00)80178-8; DELAHERA A, 1991, J EXP MED, V173, P7, DOI 10.1084/jem.173.1.7; Diethrich EB, 1996, J ENDOVASC SURG, V3, P132, DOI 10.1583/1074-6218(1996)003<0132:IFCASA>2.0.CO;2; Ding YH, 1999, IMMUNITY, V11, P45, DOI 10.1016/S1074-7613(00)80080-1; Ding YH, 1998, IMMUNITY, V8, P403, DOI 10.1016/S1074-7613(00)80546-4; EXLEY M, 1994, J BIOL CHEM, V269, P15140; Garboczi DN, 1996, J IMMUNOL, V157, P5403; Garcia KC, 1998, SCIENCE, V279, P1166, DOI 10.1126/science.279.5354.1166; Garcia KC, 1999, ANNU REV IMMUNOL, V17, P369, DOI 10.1146/annurev.immunol.17.1.369; Garcia KC, 1996, SCIENCE, V274, P209, DOI 10.1126/science.274.5285.209; Ghendler Y, 1998, J EXP MED, V187, P1529, DOI 10.1084/jem.187.9.1529; Ghendler Y, 1998, P NATL ACAD SCI USA, V95, P10061, DOI 10.1073/pnas.95.17.10061; Gobel TWF, 2000, J IMMUNOL, V164, P879, DOI 10.4049/jimmunol.164.2.879; GUNTERT P, 1992, J BIOMOL NMR, V2, P619, DOI 10.1007/BF02192850; Haks MC, 1998, EMBO J, V17, P1871, DOI 10.1093/emboj/17.7.1871; HALL C, 1991, INT IMMUNOL, V3, P359, DOI 10.1093/intimm/3.4.359; Harrison PT, 1996, MOL MEMBR BIOL, V13, P67, DOI 10.3109/09687689609160579; Hennecke J, 2000, EMBO J, V19, P5611, DOI 10.1093/emboj/19.21.5611; HERMANSON GG, 1988, P NATL ACAD SCI USA, V85, P6890, DOI 10.1073/pnas.85.18.6890; IRVING BA, 1991, CELL, V64, P891, DOI 10.1016/0092-8674(91)90314-O; ISAKOV N, 1995, J EXP MED, V181, P375, DOI 10.1084/jem.181.1.375; KAPPES DJ, 1991, P NATL ACAD SCI USA, V88, P10619, DOI 10.1073/pnas.88.23.10619; Kersh GJ, 1998, IMMUNITY, V9, P817, DOI 10.1016/S1074-7613(00)80647-0; Kim KS, 2000, J MOL BIOL, V302, P899, DOI 10.1006/jmbi.2000.4098; Klimov DK, 2000, P NATL ACAD SCI USA, V97, P7254, DOI 10.1073/pnas.97.13.7254; KONING F, 1990, EUR J IMMUNOL, V20, P299, DOI 10.1002/eji.1830200211; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LETOURNEUR F, 1992, SCIENCE, V255, P79, DOI 10.1126/science.1532456; LEVELT CN, 1993, P NATL ACAD SCI USA, V90, P11401, DOI 10.1073/pnas.90.23.11401; Lin YX, 1999, J BIOMOL NMR, V15, P227, DOI 10.1023/A:1008343915382; LIU CP, 1993, EMBO J, V12, P4863, DOI 10.1002/j.1460-2075.1993.tb06176.x; LOVE PE, 1993, SCIENCE, V261, P918, DOI 10.1126/science.7688481; Lu H, 2000, BIOPHYS J, V79, P51, DOI 10.1016/S0006-3495(00)76273-4; MALISSEN M, 1993, EMBO J, V12, P4347, DOI 10.1002/j.1460-2075.1993.tb06119.x; MALISSEN M, 1995, EMBO J, V14, P4641, DOI 10.1002/j.1460-2075.1995.tb00146.x; MANOLIOS N, 1991, EMBO J, V10, P1643, DOI 10.1002/j.1460-2075.1991.tb07687.x; Marrack P, 1986, Adv Immunol, V38, P1, DOI 10.1016/S0065-2776(08)60005-X; Matsuo H, 1997, NAT STRUCT BIOL, V4, P717, DOI 10.1038/nsb0997-717; MEUER SC, 1983, NATURE, V303, P808, DOI 10.1038/303808a0; MEUER SC, 1983, J EXP MED, V157, P705, DOI 10.1084/jem.157.2.705; MEUER SC, 1983, J EXP MED, V158, P988, DOI 10.1084/jem.158.3.988; MYERS LC, 1993, BIOCHEMISTRY-US, V32, P14089, DOI 10.1021/bi00214a003; Nagata K, 1997, IMMUNITY, V7, P559, DOI 10.1016/S1074-7613(00)80377-5; OHNO H, 1993, INT IMMUNOL, V5, P1403, DOI 10.1093/intimm/5.11.1403; Osman N, 1996, EUR J IMMUNOL, V26, P1063, DOI 10.1002/eji.1830260516; Ottemann KM, 1999, SCIENCE, V285, P1751, DOI 10.1126/science.285.5434.1751; PUNT JA, 1994, J EXP MED, V180, P587, DOI 10.1084/jem.180.2.587; RAVICHANDRAN KS, 1993, SCIENCE, V262, P902, DOI 10.1126/science.8235613; REINHERZ EL, 1982, CELL, V30, P735, DOI 10.1016/0092-8674(82)90278-1; Reinherz EL, 1999, SCIENCE, V286, P1913, DOI 10.1126/science.286.5446.1913; REINHERZ EL, 1983, IMMUNOL REV, V74, P83, DOI 10.1111/j.1600-065X.1983.tb01085.x; Reiser JB, 2000, NAT IMMUNOL, V1, P291, DOI 10.1038/79728; RETH M, 1989, NATURE, V338, P383, DOI 10.1038/338383b0; Rudd PM, 1999, J MOL BIOL, V293, P351, DOI 10.1006/jmbi.1999.3104; SAINTRUF C, 1994, SCIENCE, V266, P1208, DOI 10.1126/science.7973703; SAITO H, 1987, P NATL ACAD SCI USA, V84, P9131, DOI 10.1073/pnas.84.24.9131; SAKAGUCHI N, 1988, EMBO J, V7, P3457, DOI 10.1002/j.1460-2075.1988.tb03220.x; Sasada T, 2000, EUR J IMMUNOL, V30, P1281, DOI 10.1002/(SICI)1521-4141(200005)30:5<1281::AID-IMMU1281>3.3.CO;2-4; SCHWABE JWR, 1990, NATURE, V348, P458, DOI 10.1038/348458a0; SHINKAI Y, 1994, INT IMMUNOL, V6, P995, DOI 10.1093/intimm/6.7.995; Sondermann P, 1999, EMBO J, V18, P1095, DOI 10.1093/emboj/18.5.1095; SunderPlassmann R, 1997, EUR J IMMUNOL, V27, P2001, DOI 10.1002/eji.1830270826; SUSSMAN JJ, 1988, CELL, V52, P85, DOI 10.1016/0092-8674(88)90533-8; Teng MK, 1998, CURR BIOL, V8, P409, DOI 10.1016/S0960-9822(98)70160-5; TUNNACLIFFE A, 1988, EUR J IMMUNOL, V18, P1639, DOI 10.1002/eji.1830181027; VANWAUWE JP, 1980, J IMMUNOL, V124, P2708; von Boehmer H, 1998, IMMUNOL REV, V165, P111; von Boehmer H, 1999, CURR OPIN IMMUNOL, V11, P135, DOI 10.1016/S0952-7915(99)80024-7; Wang JH, 1998, EMBO J, V17, P10, DOI 10.1093/emboj/17.1.10; Zidovetzki R, 1998, IMMUNOL LETT, V64, P97, DOI 10.1016/S0165-2478(98)00100-X	84	142	154	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 29	2001	105	7					913	923		10.1016/S0092-8674(01)00395-6	http://dx.doi.org/10.1016/S0092-8674(01)00395-6			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	449BK	11439187	Bronze			2022-12-24	WOS:000169664300011
J	Buchbinder, R; Forbes, A; Hall, S; Dennett, X; Giles, G				Buchbinder, R; Forbes, A; Hall, S; Dennett, X; Giles, G			Incidence of malignant disease in biopsy-proven inflammatory myopathy - A population-based cohort study	ANNALS OF INTERNAL MEDICINE			English	Article							INCLUSION-BODY MYOSITIS; POLYMYOSITIS-DERMATOMYOSITIS; ADULT DERMATOMYOSITIS; TEMPORAL ASSOCIATION; CELL CARCINOMA; CANCER; RISK; CLASSIFICATION	Background: The validity and magnitude of an association between myositis and malignant disease continue to be debated. Such issues as the legitimacy of a myositis diagnosis and distinction among myositis subgroups in previous population-based studies remain unresolved. Objective: To determine the risk for malignant disease in patients with biopsy-proven inflammatory myopathies. Design: Population-based, retrospective cohort study. Setting: Victoria, Australia. Patients: 537 patients in whom a biopsy-positive idiopathic inflammatory myopathy was first diagnosed from 1981 through 1995. Measurements: standardized incidence ratios were calculated to compare the incidence of malignant disease in patients with inflammatory myopathy and the general population. Results: A total of 116 cases of malignant disease were found in 104 patients. Seventy-four cases were identified concurrently with (within 7 days) or after diagnosis of myositis. The highest risk for malignant disease was associated with dermatomyositis (standardized incidence ratio, 6.2 [95% CI, 3.9 to 10.0]). The risk was also increased in polymyositis (standardized incidence ratio, 2.0 [CI, 1.4 to 2.7]), although the relative risk for malignant disease in dermatomyositis compared with polymyositis was 2.4 (CI, 1.3 to 4.2). An increased risk for malignant disease was also found in inclusion-body myositis (standardized incidence ratio, 2.4 [CI, 1.2 to 4.9]). The excess risk for malignant disease diminished with time (standardized incidence ratio, 4.4 [CI, 2.7 to 7.1] in the first year; 3.4 [Cl, 2.3 to 5.1] between 1 and 3 years; 2.2 [Cl, 1.3 to 3.9] between 3 and 5 years; and 1.6 [Cl, 1.0 to 2.6] beyond 5 years [P for trend, 0.002]). Conclusion: The risk for malignant disease is increased in biopsy-proven dermatomyositis and polymyositis and also appears to be increased in inclusion-body myositis.	Cabrini Med Ctr, Dept Clin Epidemiol, Malvern, Vic 3144, Australia; Monash Univ, Dept Epidemiol & Prevent Med, Prahran, Vic 3181, Australia; Anti Canc Council Victoria, Canc Epidemiol Ctr, Canc Control Res Inst, Melbourne, Vic 3053, Australia	Cabrini Health; Monash University; Cancer Council Victoria	Buchbinder, R (corresponding author), Cabrini Med Ctr, Dept Clin Epidemiol, 183 Wattletree Rd,Suite 41, Malvern, Vic 3144, Australia.	rachelle.buchbinder@med.monash.edu.au	Buchbinder, Rachelle/G-2952-2011	Buchbinder, Rachelle/0000-0002-0597-0933; Forbes, Andrew/0000-0003-4269-914X; Giles, Graham/0000-0003-4946-9099				AIRIO A, 1995, J RHEUMATOL, V22, P1300; *ANT COUNC VICT CA, 1996, CANST CANC VICT 1993; BANKER BQ, 1986, MYOLOGY, P1385; BARNES BE, 1976, ANN INTERN MED, V84, P68, DOI 10.7326/0003-4819-84-1-68; BASSETSEGUIN N, 1990, ARCH DERMATOL, V126, P633, DOI 10.1001/archderm.126.5.633; BOHAN A, 1975, NEW ENGL J MED, V292, P344, DOI 10.1056/NEJM197502132920706; BONNETBLANC JM, 1990, DERMATOLOGICA, V180, P212, DOI 10.1159/000248032; Buchbinder R, 1996, AM J IND MED, V29, P171, DOI 10.1002/(SICI)1097-0274(199602)29:2<171::AID-AJIM7>3.0.CO;2-V; CALLEN JP, 1980, ARCH DERMATOL, V116, P295, DOI 10.1001/archderm.116.3.295; CHERKIN DC, 1992, SPINE, V17, P817, DOI 10.1097/00007632-199207000-00015; CHOW WH, 1995, CANCER CAUSE CONTROL, V6, P9, DOI 10.1007/BF00051675; COTE RA, 1980, SYSTEMATIZED NONENCL; COX NH, 1990, ARCH DERMATOL, V126, P61, DOI 10.1001/archderm.126.1.61; DAVIS W, 1987, STAT METHODS CANC RE, V2; DUNCAN AG, 1991, ACTA DERM-VENEREOL, V71, P312; HIDANO A, 1986, Journal of Dermatology (Tokyo), V13, P233; HILTONJONES D, 1992, NEW ENGL J MED, V327, P207; HOFFMAN GS, 1983, AM J MED, V75, P433, DOI 10.1016/0002-9343(83)90344-3; HSIA DC, 1988, NEW ENGL J MED, V318, P352, DOI 10.1056/NEJM198802113180604; Jensen ML, 1997, ARCH PHYS MED REHAB, V78, P327, DOI 10.1016/S0003-9993(97)90043-5; Kankeleit H., 1916, DTSCH ARCH KLIN MED, V120, P335; LAKHANPAL S, 1986, MAYO CLIN PROC, V61, P645, DOI 10.1016/S0025-6196(12)62030-8; Lipskie T L, 1998, Chronic Dis Can, V19, P112; LOTZ BP, 1989, BRAIN, V112, P727, DOI 10.1093/brain/112.3.727; LYON MG, 1989, J RHEUMATOL, V16, P1218; MANCHUL LA, 1985, ARCH INTERN MED, V145, P1835, DOI 10.1001/archinte.145.10.1835; Maoz CR, 1998, SEMIN ARTHRITIS RHEU, V27, P319, DOI 10.1016/S0049-0172(98)80052-8; MASI AT, 1988, MT SINAI J MED, V55, P471; Mautner GH, 1998, CUTIS, V61, P190; MEDSGER TA, 1970, AM J MED, V48, P715, DOI 10.1016/S0002-9343(70)80006-7; *NAT AC SCI, 1980, REL NAT HOSP DISCH S; O'Gradaigh D, 1998, BRIT J RHEUMATOL, V37, P914; ODDIS CV, 1990, J RHEUMATOL, V17, P1329; Patrick M, 1999, J RHEUMATOL, V26, P1094; Pautas E, 1999, AM J MED, V106, P122; SCHULMAN P, 1991, J RHEUMATOL, V18, P1689; SIGURGEIRSSON B, 1992, NEW ENGL J MED, V326, P363, DOI 10.1056/NEJM199202063260602; STERTZ G, 1916, BERL KLIN WOCHENSCHR, V53, P488; WHITMORE SE, 1994, MEDICINE, V73, P153, DOI 10.1097/00005792-199405000-00004; World Health Organization, 1977, INT CLASS DIS; World Health Organization, 1976, INT CLASS DIS ONC; YTTERBERG SR, 1993, ARTHRITIS RHEUM, V36, P416, DOI 10.1002/art.1780360319; ZANTOS D, 1994, J RHEUMATOL, V21, P1855	43	276	294	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 19	2001	134	12					1087	1095		10.7326/0003-4819-134-12-200106190-00008	http://dx.doi.org/10.7326/0003-4819-134-12-200106190-00008			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	442YU	11412048				2022-12-24	WOS:000169313200001
J	Chadwick, D				Chadwick, D			Vagal-nerve stimulation for epilepsy	LANCET			English	Editorial Material							VAGUS NERVE; SEIZURES; CHILDREN; TRIAL		Univ Liverpool, Walton Ctr Neurol & Neurosurg, Dept Neurol Sci, Liverpool L9 7IJ, Merseyside, England	University of Liverpool; Walton Centre	Chadwick, D (corresponding author), Univ Liverpool, Walton Ctr Neurol & Neurosurg, Dept Neurol Sci, Liverpool L9 7IJ, Merseyside, England.							Annegers JF, 2000, EPILEPSIA, V41, P549, DOI 10.1111/j.1528-1157.2000.tb00208.x; DeGiorgio CM, 2000, EPILEPSIA, V41, P1195, DOI 10.1111/j.1528-1157.2000.tb00325.x; GEORGE R, 1995, NEUROLOGY, V45, P224, DOI 10.1212/wnl.45.2.224; Handforth A, 1998, NEUROLOGY, V51, P48, DOI 10.1212/WNL.51.1.48; Labar D, 2000, DEV MED CHILD NEUROL, V42, P496, DOI 10.1017/S001216220000092X; Marson AG, 2001, J NEUROL NEUROSUR PS, V70, P143, DOI 10.1136/jnnp.70.2.143; MCLACHLAN RS, 1993, EPILEPSIA, V34, P918, DOI 10.1111/j.1528-1157.1993.tb02112.x; Patwardhan RV, 2000, NEUROSURGERY, V47, P1353, DOI 10.1097/00006123-200012000-00016; Salinsky MC, 1996, ARCH NEUROL-CHICAGO, V53, P1176, DOI 10.1001/archneur.1996.00550110128021; Tatum WO, 1999, NEUROLOGY, V52, P1267, DOI 10.1212/WNL.52.6.1267; WOODBURY DM, 1990, EPILEPSIA, V31, pS7, DOI 10.1111/j.1528-1157.1990.tb05852.x; ZABARA J, 1992, EPILEPSIA, V33, P1005, DOI 10.1111/j.1528-1157.1992.tb01751.x	12	20	20	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 2	2001	357	9270					1726	1727		10.1016/S0140-6736(00)04933-3	http://dx.doi.org/10.1016/S0140-6736(00)04933-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	440BN	11403805				2022-12-24	WOS:000169156200006
J	Agrawal, AF; Brodie, ED; Brown, J				Agrawal, AF; Brodie, ED; Brown, J			Parent-offspring coadaptation and the dual genetic control of maternal care	SCIENCE			English	Article							BURROWER BUG; SOLICITATION; SIGNALS; NEED	In many animal species, the amount of care provided by parents is determined through a complex interaction of offspring signals and responses by parents to those signals. As predicted by honest signaling theory, we show that in the burrower bug, Sehirus cinctus, maternal provisioning responds to experimental manipulations of offspring condition. Despite this predicted environmental influence, we find evidence from two cross-foster experiments that variation in maternal care also stems from two distinct genetic sources: variation among offspring in their ability to elicit care and variation among parents in their response to offspring signals, Furthermore, as predicted by maternal-offspring coadaptation theory, offspring signaling is negatively genetically correlated with maternal provisioning.	Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; Indiana Univ, Ctr Integrat Study Anim Behav, Bloomington, IN 47405 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Agrawal, AF (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN 47405 USA.	aagrawal@bio.indiana.edu	Brodie, Edmund D/B-2335-2013; Brown, Jeremy/B-4544-2010	Brown, Jeremy/0000-0002-1447-8633				AGRAWAL AF, UNPUB; Bergstrom CT, 1998, P NATL ACAD SCI USA, V95, P5100, DOI 10.1073/pnas.95.9.5100; CHEVERUD JM, 1984, QUANTITATIVE GENETIC, P67; GODFRAY HCJ, 1995, NATURE, V376, P133, DOI 10.1038/376133a0; GODFRAY HCJ, 1991, NATURE, V352, P328, DOI 10.1038/352328a0; GRAFEN A, 1990, J THEOR BIOL, V144, P517, DOI 10.1016/S0022-5193(05)80088-8; Johnstone RA, 1999, P NATL ACAD SCI USA, V96, P12644, DOI 10.1073/pnas.96.22.12644; Kight SL, 1997, ANIM BEHAV, V53, P105, DOI 10.1006/anbe.1996.0282; Kight SL, 1998, PHYSIOL ENTOMOL, V23, P38, DOI 10.1046/j.1365-3032.1998.2310038.x; Kilner R, 1997, TRENDS ECOL EVOL, V12, P11, DOI 10.1016/S0169-5347(96)10061-6; Kolliker M, 2000, P ROY SOC B-BIOL SCI, V267, P2127, DOI 10.1098/rspb.2000.1259; Lynch M., 1998, AM J HUM GENET; Mock D. W., 1997, EVOLUTION SIBLING RI; Moore AJ, 1997, EVOLUTION, V51, P1352, DOI 10.1111/j.1558-5646.1997.tb01458.x; Rauter CM, 1999, P ROY SOC B-BIOL SCI, V266, P1691, DOI 10.1098/rspb.1999.0833; SITES RW, 1982, ANN ENTOMOL SOC AM, V75, P210, DOI 10.1093/aesa/75.2.210; TALFAMY DW, 1999, ANIM BEHAV, V57, P727; TRIVERS RL, 1974, AM ZOOL, V14, P249; Wade MJ, 1998, MATERNAL EFFECTS AS ADAPTATIONS, P5; Wolf JB, 2000, EVOLUTION, V54, P1882, DOI 10.1111/j.0014-3820.2000.tb01235.x; Wolf JB, 1998, EVOLUTION, V52, P299, DOI [10.1111/j.1558-5646.1998.tb01632.x, 10.2307/2411068]	21	144	146	1	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 1	2001	292	5522					1710	1712		10.1126/science.1059910	http://dx.doi.org/10.1126/science.1059910			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	438AP	11387474				2022-12-24	WOS:000169031800043
J	Reisz, RR; Smith, MM				Reisz, RR; Smith, MM			Developmental biology - Lungfish dental pattern conserved for 360 Myr	NATURE			English	Article									Kings Coll London, Inst Dent, London SE1 9RT, England; Univ Toronto, Mississauga, ON L5L 1C6, Canada	University of London; King's College London; University of Toronto; University Toronto Mississauga	Reisz, RR (corresponding author), Univ Toronto, 3359 Mississauga Rd, Mississauga, ON L5L 1C6, Canada.	moya.smith@kcl.ac.uk		Meredith Smith, Moya/0000-0002-3397-873X				KEMP A, 1995, J MORPHOL, V225, P345, DOI 10.1002/jmor.1052250306; Krupina Natasha I., 1999, Modern Geology, V24, P99; KRUPINA NI, IN PRESS CAN J EARTH; Smith M.M., 1988, Memoires du Museum National d'Histoire Naturelle Serie C Sciences de la Terre, V53, P179; SMITH MM, IN PRESS J ANAT	5	22	25	0	3	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 31	2001	411	6837					548	548		10.1038/35079187	http://dx.doi.org/10.1038/35079187			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437GE	11385561	Bronze			2022-12-24	WOS:000168982500040
J	Kikkawa, M; Sablin, EP; Okada, Y; Yajima, H; Fletterick, RJ; Hirokawa, N				Kikkawa, M; Sablin, EP; Okada, Y; Yajima, H; Fletterick, RJ; Hirokawa, N			Switch-based mechanism of kinesin motors	NATURE			English	Article							X-RAY STRUCTURE; FACTOR EF-TU; CRYSTAL-STRUCTURE; ANGSTROM RESOLUTION; MOLECULAR MOTOR; NUCLEOTIDE-BINDING; MICROTUBULE; PROTEIN; DOMAIN; NCD	Kinesin motors are specialized enzymes that use hydrolysis of ATP to generate force and movement along their cellular tracks, the microtubules. Although numerous biochemical and biophysical studies have accumulated much data that link microtubule-assisted ATP hydrolysis to kinesin motion, the structural view of kinesin movement remains unclear. This study of the monomeric kinesin motor KIF1A combines X-ray crystallography and cryo-electron microscopy, and allows analysis of force-generating conformational changes at atomic resolution. The motor is revealed in its two functionally critical states-complexed with ADP and with a non-hydrolysable analogue of ATP. The conformational change observed between the ADP-bound and the ATP-like structures of the KIF1A catalytic core is modular, extends to all kinesins and is similar to the conformational change used by myosin motors and G proteins. Docking of the ADP-bound and ATP-like crystallographic models of KIF1A into the corresponding cryo-electron microscopy maps suggests a rationale for the plus-end directional bias associated with the kinesin catalytic core.	Univ Tokyo, Grad Sch Med, Dept Cell Biol & Anat, Bunkyo Ku, Tokyo 1130033, Japan; Univ Calif San Francisco, Dept Biochem Biophys, San Francisco, CA 94143 USA	University of Tokyo; University of California System; University of California San Francisco	Hirokawa, N (corresponding author), Univ Tokyo, Grad Sch Med, Dept Cell Biol & Anat, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	hirokawa@m.u-tokyo.ac.jp	Yajima, Hiroaki/AAS-6021-2020; Okada, Yasushi/N-5067-2015; Kikkawa, Masahide/I-7958-2015	Okada, Yasushi/0000-0003-2601-3689; Kikkawa, Masahide/0000-0001-7656-8194				Alonso MC, 1998, EMBO J, V17, P945, DOI 10.1093/emboj/17.4.945; Arnal I, 1998, STRUCTURE, V6, P33, DOI 10.1016/S0969-2126(98)00005-7; Bohm A, 1997, CURR OPIN BIOTECH, V8, P480, DOI 10.1016/S0958-1669(97)80072-9; Boriack-Sjodin PA, 1998, NATURE, V394, P337, DOI 10.1038/28548; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Case RB, 2000, CURR BIOL, V10, P157, DOI 10.1016/S0960-9822(00)00316-X; Case RB, 1997, CELL, V90, P959, DOI 10.1016/S0092-8674(00)80360-8; Dominguez R, 1998, CELL, V94, P559, DOI 10.1016/S0092-8674(00)81598-6; Endow SA, 1998, SCIENCE, V281, P1200, DOI 10.1126/science.281.5380.1200; Geeves MA, 1999, ANNU REV BIOCHEM, V68, P687, DOI 10.1146/annurev.biochem.68.1.687; Gilbert SP, 1998, BIOCHEMISTRY-US, V37, P792, DOI 10.1021/bi971117b; Gulick AM, 1998, BIOCHEMISTRY-US, V37, P1769, DOI 10.1021/bi972504o; Henningsen U, 1997, NATURE, V389, P93, DOI 10.1038/38022; Hirokawa N, 1998, SCIENCE, V279, P519, DOI 10.1126/science.279.5350.519; Hirose K, 2000, EMBO J, V19, P5308, DOI 10.1093/emboj/19.20.5308; HIROSE K, 1995, NATURE, V376, P277, DOI 10.1038/376277a0; Hirose K, 1998, J MOL BIOL, V278, P389, DOI 10.1006/jmbi.1998.1709; Hoenger A, 1998, J CELL BIOL, V141, P419, DOI 10.1083/jcb.141.2.419; Houdusse A, 1999, CELL, V97, P459, DOI 10.1016/S0092-8674(00)80756-4; Kawashima T, 1996, NATURE, V379, P511, DOI 10.1038/379511a0; Kikkawa M, 2000, CELL, V100, P241, DOI 10.1016/S0092-8674(00)81562-7; Kjeldgaard M, 1996, FASEB J, V10, P1347, DOI 10.1096/fasebj.10.12.8903506; KJELDGAARD M, 1993, STRUCTURE, V1, P35, DOI 10.1016/0969-2126(93)90007-4; Kozielski F, 1999, STRUCTURE, V7, P1407, DOI 10.1016/S0969-2126(00)80030-1; Kozielski F, 1997, CELL, V91, P985, DOI 10.1016/S0092-8674(00)80489-4; Kull FJ, 1996, NATURE, V380, P550, DOI 10.1038/380550a0; Ma YZ, 1997, J BIOL CHEM, V272, P724, DOI 10.1074/jbc.272.2.724; MILBURN MV, 1990, SCIENCE, V247, P939, DOI 10.1126/science.2406906; Nogales E, 1999, CELL, V96, P79, DOI 10.1016/S0092-8674(00)80961-7; Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465; Okada Y, 2000, P NATL ACAD SCI USA, V97, P640, DOI 10.1073/pnas.97.2.640; OKADA Y, 1995, CELL, V81, P769, DOI 10.1016/0092-8674(95)90538-3; Okada Y, 1999, SCIENCE, V283, P1152, DOI 10.1126/science.283.5405.1152; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Polekhina G, 1996, STRUCTURE, V4, P1141, DOI 10.1016/S0969-2126(96)00122-0; RAYMENT I, 1993, SCIENCE, V261, P50, DOI 10.1126/science.8316857; Rice S, 1999, NATURE, V402, P778, DOI 10.1038/45483; Sablin EP, 1996, NATURE, V380, P555, DOI 10.1038/380555a0; Sablin EP, 1998, NATURE, V395, P813, DOI 10.1038/27463; Sack S, 1997, BIOCHEMISTRY-US, V36, P16155, DOI 10.1021/bi9722498; Sack S, 1999, EUR J BIOCHEM, V262, P1, DOI 10.1046/j.1432-1327.1999.00341.x; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; Song HB, 1998, NATURE, V396, P587, DOI 10.1038/25153; Sosa H, 1997, CELL, V90, P217, DOI 10.1016/S0092-8674(00)80330-X; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; Thorn KS, 2000, J CELL BIOL, V151, P1093, DOI 10.1083/jcb.151.5.1093; Vale RD, 2000, SCIENCE, V288, P88, DOI 10.1126/science.288.5463.88; Vale RD, 1996, J CELL BIOL, V135, P291, DOI 10.1083/jcb.135.2.291; Vale RD, 2000, PHILOS T ROY SOC B, V355, P449, DOI 10.1098/rstb.2000.0586; Woehlke G, 1997, CELL, V90, P207, DOI 10.1016/S0092-8674(00)80329-3	50	286	299	1	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 24	2001	411	6836					439	445		10.1038/35078000	http://dx.doi.org/10.1038/35078000			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	435CB	11373668				2022-12-24	WOS:000168858700037
J	Olsen, SJ; DeBess, EE; McGivern, TE; Marano, N; Eby, T; Mauvais, S; Balan, VK; Zirnstein, G; Cieslak, PR; Angulo, FJ				Olsen, SJ; DeBess, EE; McGivern, TE; Marano, N; Eby, T; Mauvais, S; Balan, VK; Zirnstein, G; Cieslak, PR; Angulo, FJ			A nosocomial outbreak of fluoroquinolone-resistant salmonella infection.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							UNITED-STATES	Background: Infection with fluoroquinolone-resistant strains of salmonella is rare, as is nosocomial salmonella infection. We describe the first recognized outbreak of fluoroquinolone-resistant salmonella infection in the United States, which occurred in two nursing homes and one hospital in Oregon. Methods: We interviewed medical staff and reviewed patients' charts and death certificates. In Nursing Home A we conducted a case-control study. Patients were defined as residents of the nursing home from whom fluoroquinolone-resistant Salmonella enterica serotype Schwarzengrund was isolated between February 1996 and December 1998. Controls were residents with similar medical conditions whose cultures did not yield salmonella. Results: Eleven patients with fluoroquinolone-resistant salmonellosis were identified at two nursing homes. In nine patients a urine culture was positive, in one a stool culture, and in one a wound culture. The index patient had been hospitalized in the Philippines and had probably acquired the infection there. Transmission was probably direct (from patient to patient) or through contact with contaminated surfaces. Treatment with fluoroquinolones during the six months before a culture was obtained was associated with a significant risk of salmonella infection. More fluoroquinolones were used at Nursing Home A than at similar nursing homes in Oregon. The isolates from the outbreak had similar patterns on pulsed-field gel electrophoresis and the same gyrA mutations. The isolates from the outbreak were also similar to the only previous isolate of fluoroquinolone-resistant salmonella in the United States, which came from a patient in New York who had been transferred from a hospital in the Philippines. Conclusions: We describe a prolonged nosocomial outbreak of infection with fluoroquinolone-resistant S. enterica serotype Schwarzengrund. More such outbreaks are likely in institutional settings, particularly those in which there is heavy use of antimicrobial agents. (N Engl J Med 2001;344:1572-9.) Copyright (C) 2001 Massachusetts Medical Society.	CDCP, Foodborne Diarrheal Dis Branch, Div Bacterial Mycot Dis, Natl Ctr Infect Dis, Atlanta, GA 30333 USA; CDCP, Epidem Intelligence Serv, Div Appl Publ Hlth Training, Epidemiol Program Off, Atlanta, GA 30333 USA; Oregon Dept Human Serv, Hlth Div, Portland, OR USA; Oregon Dept Human Serv, Hlth Div, Portland, OR USA; Multnomah Cty Dept Hlth, Portland, OR USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Olsen, SJ (corresponding author), CDCP, Foodborne Diarrheal Dis Branch, Div Bacterial Mycot Dis, Natl Ctr Infect Dis, 1600 Clifton Rd,Mailstop A-38, Atlanta, GA 30333 USA.	sco2@cdc.gov						Acar JF, 1997, CLIN INFECT DIS, V24, pS67, DOI 10.1093/clinids/24.Supplement_1.S67; Angulo FJ, 2000, MICROB DRUG RESIST, V6, P77, DOI 10.1089/mdr.2000.6.77; *CDCP, 1998, STAND MOL SUBT FOODB; COHEN ML, 1986, SCIENCE, V234, P964, DOI 10.1126/science.3535069; Griggs DJ, 1996, ANTIMICROB AGENTS CH, V40, P1009, DOI 10.1128/AAC.40.4.1009; Herikstad H, 1997, EMERG INFECT DIS, V3, P371, DOI 10.3201/eid0303.970316; Kumar A, 1995, Indian Pediatr, V32, P881; LEE LA, 1994, J INFECT DIS, V170, P128, DOI 10.1093/infdis/170.1.128; LEPAGE P, 1987, LANCET, V1, P1458; Li JH, 1996, AM J EPIDEMIOL, V143, P1042; Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; Miller S.I., 2000, PRINCIPLES PRACTICE, V2, P2344; OLSEN S, 2000, INT C EM INF DIS ATL, P144; PAVIA AT, 1990, J INFECT DIS, V161, P255, DOI 10.1093/infdis/161.2.255; Pers C, 1996, SCAND J INFECT DIS, V28, P529, DOI 10.3109/00365549609037954; Piddock L J, 1995, Drugs, V49 Suppl 2, P29; PIDDOCK LJV, 1993, ANTIMICROB AGENTS CH, V37, P662, DOI 10.1128/AAC.37.4.662; RILEY LW, 1984, J INFECT DIS, V150, P236, DOI 10.1093/infdis/150.2.236; TAUXE RV, 1991, J FOOD PROTECT, V54, P563, DOI 10.4315/0362-028X-54.7.563; Turnidge J, 1995, Drugs, V49 Suppl 2, P43; Vasallo FJ, 1998, CLIN INFECT DIS, V26, P535, DOI 10.1086/517087; *WHO, 1998, WHOEMCZDI9812	22	107	116	1	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 24	2001	344	21					1572	1579		10.1056/NEJM200105243442102	http://dx.doi.org/10.1056/NEJM200105243442102			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	434RM	11372008				2022-12-24	WOS:000168829700002
J	Carding, P; Welch, A; Owen, S; Stafford, F				Carding, P; Welch, A; Owen, S; Stafford, F			Surgical voice restoration	LANCET			English	Editorial Material							QUALITY-OF-LIFE; TOTAL LARYNGECTOMY; NECK-CANCER; HEAD		Freeman Hosp, No Head & Neck Canc Ctr, Newcastle Upon Tyne NE7 7DN, Tyne & Wear, England	Newcastle Freeman Hospital	Carding, P (corresponding author), Freeman Hosp, No Head & Neck Canc Ctr, Newcastle Upon Tyne NE7 7DN, Tyne & Wear, England.			Carding, Paul/0000-0002-4206-1827				BLOM ED, 1998, TRACHEOESOPHAGEAL VO; BLOM ED, 1998, TRACHEOESOPHAGEAL VO, pCH10; *BRIT ASS HEAD NEC, 2000, EFF HEAD NECK CANC M; Deleyiannis FWB, 1999, HEAD NECK-J SCI SPEC, V21, P319, DOI 10.1002/(SICI)1097-0347(199907)21:4<319::AID-HED5>3.0.CO;2-H; Hoffman HT, 1997, HEAD NECK-J SCI SPEC, V19, P92, DOI 10.1002/(SICI)1097-0347(199703)19:2<92::AID-HED2>3.0.CO;2-P; JOHNS MME, 1998, TRACHEOESOPHAGEAL VO; Jones AS, 2000, CLIN OTOLARYNGOL, V25, P396, DOI 10.1046/j.1365-2273.2000.00387.x; KAO WW, 1994, ARCH OTOLARYNGOL, V120, P301; LEWIN JS, 1998, TRACHEOESOPHAGEAL VO, pCH9; MORRIS HL, 1992, ANN OTO RHINOL LARYN, V101, P503, DOI 10.1177/000348949210100611; SINGER MI, 1981, ARCH OTOLARYNGOL, V107, P670; STGUILY JL, 1990, ANN OTOLARYNGOL, V107, P205; Weymuller EA, 2000, ARCH OTOLARYNGOL, V126, P329, DOI 10.1001/archotol.126.3.329	13	3	3	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 12	2001	357	9267					1463	1464		10.1016/S0140-6736(00)04671-7	http://dx.doi.org/10.1016/S0140-6736(00)04671-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	431CL	11377593				2022-12-24	WOS:000168614300005
J	Dann, CE; Hsieh, JC; Rattner, A; Sharma, D; Nathans, J; Leahy, DJ				Dann, CE; Hsieh, JC; Rattner, A; Sharma, D; Nathans, J; Leahy, DJ			Insights into Wnt binding and signalling from the structures of two Frizzled cysteine-rich domains	NATURE			English	Article							PROTEIN-PROTEIN INTERFACES; RECEPTOR TYROSINE KINASES; SECRETED PROTEINS; CRD DOMAIN; CLASSIFICATION; PURIFICATION; DIFFRACTION; ANTAGONIST; FAMILY	Members of the Frizzled family of seven-pass transmembrane proteins serve as receptors for Wnt signalling proteins(1). Wnt proteins have important roles in the differentiation and patterning of diverse tissues during animal development(2,3), and inappropriate activation of Wnt signalling pathways is a key feature of many cancers(4). An extracellular cysteine-rich domain (CRD) at the amino terminus of Frizzled proteins binds Wnt proteins(1), as do homologous domains in soluble proteins-termed secreted Frizzled-related proteins(5) - that function as antagonists of Wnt signalling(6-8). Recently, an LDL-receptor-related protein has been shown to function as a co-receptor for Wnt proteins and to bind to a Frizzled CRD in a Wnt-dependent manner(9-11). To investigate the molecular nature of the Wnt signalling complex, we determined the crystal structures of the CRDs from mouse Frizzled 8 and secreted Frizzled-related protein 3. Here we show a previously unknown protein fold, and the design and interpretation of CRD mutations that identify a Wnt-binding site. CRDs exhibit a conserved dimer interface that may be a feature of Wnt signalling. This work provides a framework for studies of homologous CRDs in proteins including muscle-specific kinase and Smoothened, a component of the Hedgehog signalling pathway(12,13).	Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Leahy, DJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA.	leahy@groucho.med.jhmi.edu	Dann, Charles E/C-2747-2018	Nathans, Jeremy/0000-0001-8106-5460; Rattner, Amir/0000-0001-9542-6212				Bhanot P, 1996, NATURE, V382, P225, DOI 10.1038/382225a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CARSON M, 1991, J APPL CRYSTALLOGR, V24, P958, DOI 10.1107/S0021889891007240; Dauter Z, 2000, ACTA CRYSTALLOGR D, V56, P232, DOI 10.1107/S0907444999016352; Finch PW, 1997, P NATL ACAD SCI USA, V94, P6770, DOI 10.1073/pnas.94.13.6770; HENDRICKSON WA, 1991, SCIENCE, V254, P51, DOI 10.1126/science.1925561; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Hsieh JC, 1999, P NATL ACAD SCI USA, V96, P3546, DOI 10.1073/pnas.96.7.3546; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Leahy DJ, 2000, PROTEIN EXPRES PURIF, V20, P500, DOI 10.1006/prep.2000.1331; Leyns L, 1997, CELL, V88, P747, DOI 10.1016/S0092-8674(00)81921-2; Masiakowski P, 1998, CURR BIOL, V8, pR407, DOI 10.1016/S0960-9822(98)70263-5; Moon RT, 1997, CELL, V88, P725, DOI 10.1016/S0092-8674(00)81915-7; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; NUSSE R, 1992, CELL, V69, P1073, DOI 10.1016/0092-8674(92)90630-U; Orengo CA, 1997, STRUCTURE, V5, P1093, DOI 10.1016/S0969-2126(97)00260-8; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pinson KI, 2000, NATURE, V407, P535, DOI 10.1038/35035124; Rattner A, 1997, P NATL ACAD SCI USA, V94, P2859, DOI 10.1073/pnas.94.7.2859; Sparks AB, 1998, CANCER RES, V58, P1130; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Wehrli M, 2000, NATURE, V407, P527, DOI 10.1038/35035110; WELLS JA, 1991, METHOD ENZYMOL, V202, P390; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Xu YK, 1998, CURR BIOL, V8, pR405, DOI 10.1016/S0960-9822(98)70262-3; YONG K, 1990, ACTA CRYSTALLOGR A, V46, P41	30	362	419	0	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 5	2001	412	6842					86	90		10.1038/35083601	http://dx.doi.org/10.1038/35083601			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448TB	11452312				2022-12-24	WOS:000169644900049
J	Cardinal, RN; Pennicott, DR; Sugathapala, CL; Robbins, TW; Everitt, BJ				Cardinal, RN; Pennicott, DR; Sugathapala, CL; Robbins, TW; Everitt, BJ			Impulsive choice induced in rats by lesions of the nucleus accumbens core	SCIENCE			English	Article							DEFICIT HYPERACTIVITY DISORDER; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; REACTION-TIME-TASK; PREFRONTAL CORTEX; D-AMPHETAMINE; REWARD; BEHAVIOR; REINFORCEMENT; CINGULATE; DISSOCIATION	Impulsive choice is exemplified by choosing a small or poor reward that is available immediately, in preference to a Larger but delayed reward. Impulsive choice contributes to drug addiction, attention-deficit/hyperactivity disorder, mania, and personality disorders, but its neuroanatomical basis is unclear. Here, we show that selective Lesions of the nucleus accumbens core induce persistent impulsive choice in rats. In contrast, damage to two of its afferents, the anterior cingulate cortex and medial prefrontal cortex, had no effect on this capacity. Thus, dysfunction of the nucleus accumbens core may be a key element in the neuropathology of impulsivity.	Univ Cambridge, Dept Expt Psychol, Cambridge CB2 3EB, England	University of Cambridge	Cardinal, RN (corresponding author), Univ Cambridge, Dept Expt Psychol, Downing St, Cambridge CB2 3EB, England.		Cardinal, Rudolf/AAG-2597-2020; Robbins, Trevor W/A-7551-2008	Cardinal, Rudolf/0000-0002-8751-5167; Robbins, Trevor/0000-0003-0642-5977; Everitt, Barry/0000-0003-4431-6536	MRC [G9537855] Funding Source: UKRI; Medical Research Council [G9537855] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Aberman JE, 1999, NEUROSCIENCE, V92, P545, DOI 10.1016/S0306-4522(99)00004-4; AINSLIE G, 1975, PSYCHOL BULL, V82, P463, DOI 10.1037/h0076860; ALEXANDER MC, 1985, J COMPUT ASSIST TOMO, V9, P357, DOI 10.1097/00004728-198503000-00024; American Psychological Association, 1994, DIAGN STAT MAN MENT, V4th; [Anonymous], [No title captured]; Balleine BW, 1998, NEUROPHARMACOLOGY, V37, P407, DOI 10.1016/S0028-3908(98)00033-1; Bechara A, 1999, J NEUROSCI, V19, P5473; Bizot JC, 1999, PSYCHOPHARMACOLOGY, V146, P400, DOI 10.1007/PL00005485; Bowman EM, 1998, EXP BRAIN RES, V123, P439, DOI 10.1007/s002210050588; Bush G, 1999, BIOL PSYCHIAT, V45, P1542, DOI 10.1016/S0006-3223(99)00083-9; Bussey TJ, 1997, BEHAV NEUROSCI, V111, P908, DOI 10.1037/0735-7044.111.5.908; Cardinal RN, 2000, PSYCHOPHARMACOLOGY, V152, P362, DOI 10.1007/s002130000536; CHRISTAKOU A, UNPUB; COLE BJ, 1989, BEHAV BRAIN RES, V33, P165, DOI 10.1016/S0166-4328(89)80048-8; Dietrich A, 1998, BEHAV NEUROSCI, V112, P1043, DOI 10.1037/0735-7044.112.5.1043; Ernst M, 1998, J NEUROSCI, V18, P5901; Evenden JL, 1996, PSYCHOPHARMACOLOGY, V128, P161, DOI 10.1007/s002130050121; Evenden JL, 1999, PSYCHOPHARMACOLOGY, V146, P348, DOI 10.1007/PL00005481; Everitt BJ, 1999, ANN NY ACAD SCI, V877, P412, DOI 10.1111/j.1749-6632.1999.tb09280.x; Ho MY, 1999, PSYCHOPHARMACOLOGY, V146, P362, DOI 10.1007/PL00005482; HOK JC, 1995, MODELS INFORMATION P, P249; Muir JL, 1996, CEREB CORTEX, V6, P470, DOI 10.1093/cercor/6.3.470; Parkinson JA, 2000, PROG BRAIN RES, V126, P263; Parkinson JA, 1999, J NEUROSCI, V19, P2401; Rogers RD, 1999, J NEUROSCI, V19, P9029, DOI 10.1523/JNEUROSCI.19-20-09029.1999; Rubia K, 1999, AM J PSYCHIAT, V156, P891, DOI 10.1176/ajp.156.6.891; RUSSELL V, 1995, BRAIN RES, V676, P343, DOI 10.1016/0006-8993(95)00135-D; Sadile AG, 2000, NEUROSCI BIOBEHAV R, V24, P161, DOI 10.1016/S0149-7634(99)00057-3; Sagvolden T, 1998, BEHAV BRAIN RES, V94, P1; SALAMONE JD, 1994, BEHAV BRAIN RES, V65, P221, DOI 10.1016/0166-4328(94)90108-2; Schultz W, 2000, CEREB CORTEX, V10, P272, DOI 10.1093/cercor/10.3.272; Wade TR, 2000, PSYCHOPHARMACOLOGY, V150, P90	32	669	683	3	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 29	2001	292	5526					2499	2501		10.1126/science.1060818	http://dx.doi.org/10.1126/science.1060818			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448YU	11375482				2022-12-24	WOS:000169658200044
J	Nguyen, VQ; Co, C; Li, JJ				Nguyen, VQ; Co, C; Li, JJ			Cyclin-dependent kinases prevent DNA re-replication through multiple mechanisms	NATURE			English	Article							CELL-CYCLE; S-PHASE; SACCHAROMYCES-CEREVISIAE; SUBCELLULAR-LOCALIZATION; CHROMOSOME-REPLICATION; CDK PHOSPHORYLATION; DISTINCT MODES; NUCLEAR EXPORT; MAMMALIAN CDC6; BUDDING YEAST	The stable propagation of genetic information requires that the entire genome of an organism be faithfully replicated once and only once each cell cycle. In eukaryotes, this replication is initiated at hundreds to thousands of replication origins distributed over the genome, each of which must be prohibited from re-initiating DNA replication within every cell cycle. How cells prevent reinitiation has been a long-standing question in cell biology. In several eukaryotes, cyclin-dependent kinases (CDKs) have been implicated in promoting the block to re-initiation(1), but exactly how they perform this function is unclear. Here we show that B-type CDKs in Saccharomyces cerevisiae prevent re-initiation through multiple overlapping mechanisms, including phosphorylation of the origin recognition complex (ORC), downregulation of Cdc6 activity, and nuclear exclusion of the Mcm2-7 complex. Only when all three inhibitory pathways are disrupted do origins re-initiate DNA replication in G2/M cells. These studies show that each of these three independent mechanisms of regulation is functionally important.	Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Li, JJ (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA.							BELL SP, 1992, NATURE, V357, P128, DOI 10.1038/357128a0; BREWER BJ, 1993, COLD SPRING HARB SYM, V58, P425, DOI 10.1101/SQB.1993.058.01.049; BROEK D, 1991, NATURE, V349, P388, DOI 10.1038/349388a0; DAHMANN C, 1995, CURR BIOL, V5, P1257, DOI 10.1016/S0960-9822(95)00252-1; Drury LS, 2000, CURR BIOL, V10, P231, DOI 10.1016/S0960-9822(00)00355-9; Drury LS, 1997, EMBO J, V16, P5966, DOI 10.1093/emboj/16.19.5966; Elsasser S, 1996, MOL BIOL CELL, V7, P1723, DOI 10.1091/mbc.7.11.1723; Elsasser S, 1999, MOL BIOL CELL, V10, P3263, DOI 10.1091/mbc.10.10.3263; Fujita M, 1999, J BIOL CHEM, V274, P25927, DOI 10.1074/jbc.274.36.25927; HENNESSY KM, 1990, GENE DEV, V4, P2252, DOI 10.1101/gad.4.12b.2252; Jallepalli PV, 1997, GENE DEV, V11, P2767, DOI 10.1101/gad.11.21.2767; Jiang W, 1999, P NATL ACAD SCI USA, V96, P6193, DOI 10.1073/pnas.96.11.6193; Kelly TJ, 2000, ANNU REV BIOCHEM, V69, P829, DOI 10.1146/annurev.biochem.69.1.829; Labib K, 1999, NAT CELL BIOL, V1, P415, DOI 10.1038/15649; Liang C, 1997, GENE DEV, V11, P3375, DOI 10.1101/gad.11.24.3375; MOLL T, 1991, CELL, V66, P743, DOI 10.1016/0092-8674(91)90118-I; MUZIFALCONI M, 1996, P NATL ACAD SCI USA, V93, P1666; NEWLON CS, 1993, COLD SPRING HARB SYM, V58, P415, DOI 10.1101/SQB.1993.058.01.048; Nguyen VQ, 2000, CURR BIOL, V10, P195, DOI 10.1016/S0960-9822(00)00337-7; Nishitani H, 2000, NATURE, V404, P625, DOI 10.1038/35007110; NISHITANI H, 1995, CELL, V83, P397, DOI 10.1016/0092-8674(95)90117-5; Noton E, 2000, MOL CELL, V5, P85, DOI 10.1016/S1097-2765(00)80405-0; Pelizon C, 2000, GENE DEV, V14, P2526, DOI 10.1101/gad.176300; Petersen BO, 2000, GENE DEV, V14, P2330, DOI 10.1101/gad.832500; Petersen BO, 1999, EMBO J, V18, P396, DOI 10.1093/emboj/18.2.396; Saha P, 1998, MOL CELL BIOL, V18, P2758, DOI 10.1128/MCB.18.5.2758; SAUER K, 1995, GENE DEV, V9, P1327, DOI 10.1101/gad.9.11.1327; SCHWOB E, 1994, CELL, V79, P233, DOI 10.1016/0092-8674(94)90193-7; VAS A, 2001, IN PRESS MOL CELL BI; Visintin R, 1997, SCIENCE, V278, P460, DOI 10.1126/science.278.5337.460	30	353	357	0	9	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 28	2001	411	6841					1068	1073		10.1038/35082600	http://dx.doi.org/10.1038/35082600			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	446TF	11429609				2022-12-24	WOS:000169528500052
J	Bao, SD; Tibbetts, RS; Brumbaugh, KM; Fang, YN; Richardson, DA; Ali, A; Chen, SM; Abraham, RT; Wang, XF				Bao, SD; Tibbetts, RS; Brumbaugh, KM; Fang, YN; Richardson, DA; Ali, A; Chen, SM; Abraham, RT; Wang, XF			ATR/ATM-mediated phosphorylation of human Rad17 is required for genotoxic stress responses	NATURE			English	Article							SLIDING CLAMP; DNA; ATR; FAMILY	Genotoxic stress triggers the activation of checkpoints that delay cell-cycle progression to allow for DNA repair(1). Studies in fission yeast implicate members of the Rad family of checkpoint proteins, which includes Rad17, Rad1, Rad9 and Hus1, as key early-response elements during the activation of both the DNA damage and replication checkpoints(2-5). Here we demonstrate a direct regulatory linkage between the human Rad17 homologue (hRad17) and the checkpoint kinases, ATM and ATR. Treatment of human cells with genotoxic agents induced ATM/ATR-dependent phosphorylation of hRad17 at Ser 635 and Ser 645. Overexpression of a hRad17 mutant (hRad17(AA)) bearing Ala substitutions at both phosphorylation sites abrogated the DNA-damage-induced G(2) checkpoint, and sensitized human fibroblasts to genotoxic stress. In contrast to wild-type hRad17, the hRad17(AA) mutant showed no ionizing-radiation-inducible association with hRad1, a component of the hRad1-hRad9-hHus1 checkpoint complex. These findings demonstrate that ATR/ATM-dependent phosphorylation of hRad17 is a critical early event during checkpoint signalling in DNA-damaged cells.	Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA	Duke University	Wang, XF (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA.	wang0011@mc.duke.edu		Tibbetts, Randal/0000-0003-2245-2297; Fang, Yanan/0000-0002-1112-9569				Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Bao SD, 1998, CELL GROWTH DIFFER, V9, P961; Burtelow MA, 2000, J BIOL CHEM, V275, P26343, DOI 10.1074/jbc.M001244200; Caspari T, 1999, BIOCHIMIE, V81, P173, DOI 10.1016/S0300-9084(99)80050-9; Cliby WA, 1998, EMBO J, V17, P159, DOI 10.1093/emboj/17.1.159; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Kim ST, 1999, J BIOL CHEM, V274, P37538, DOI 10.1074/jbc.274.53.37538; Lowndes NF, 2000, CURR OPIN GENET DEV, V10, P17, DOI 10.1016/S0959-437X(99)00050-7; O'Connell MJ, 2000, TRENDS CELL BIOL, V10, P296, DOI 10.1016/S0962-8924(00)01773-6; Parker AE, 1999, J BIOL CHEM, V274, P24438; Rauen M, 2000, J BIOL CHEM, V275, P29767, DOI 10.1074/jbc.M005782200; Sekulic A, 2000, CANCER RES, V60, P3504; Shiloh Y, 2001, CURR OPIN GENET DEV, V11, P71, DOI 10.1016/S0959-437X(00)00159-3; Thelen MP, 1999, CELL, V96, P769, DOI 10.1016/S0092-8674(00)80587-5; Tibbetts RS, 1999, GENE DEV, V13, P152, DOI 10.1101/gad.13.2.152; Tibbetts RS, 2000, GENE DEV, V14, P2989, DOI 10.1101/gad.851000; Venclovas C, 2000, NUCLEIC ACIDS RES, V28, P2481, DOI 10.1093/nar/28.13.2481; Weinert T, 1997, CANCER SURV, V29, P109; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	19	220	233	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 21	2001	411	6840					969	974		10.1038/35082110	http://dx.doi.org/10.1038/35082110			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	444EN	11418864				2022-12-24	WOS:000169386200050
J	Kane, B				Kane, B			Medical marijuana: The continuing story	ANNALS OF INTERNAL MEDICINE			English	Article																			0	6	6	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 19	2001	134	12					1159	1162		10.7326/0003-4819-134-12-200106190-00035	http://dx.doi.org/10.7326/0003-4819-134-12-200106190-00035			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	442YU	11412075				2022-12-24	WOS:000169313200025
J	Farmer, A				Farmer, A			10-minute consultation - Prostatic symptoms	BRITISH MEDICAL JOURNAL			English	Article									Inst Hlth Sci, Oxford OX3 7LF, England	University of Oxford	Farmer, A (corresponding author), Inst Hlth Sci, Oxford OX3 7LF, England.								0	8	8	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 16	2001	322	7300					1468	1468		10.1136/bmj.322.7300.1468	http://dx.doi.org/10.1136/bmj.322.7300.1468			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	444FJ	11408305	Bronze, Green Published, Green Submitted			2022-12-24	WOS:000169389200032
J	Prior, P				Prior, P			A tale of seven surgeons	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	2	2	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 9	2001	322	7299					1433	1433		10.1136/bmj.322.7299.1433	http://dx.doi.org/10.1136/bmj.322.7299.1433			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	442KN	11397766	Green Published			2022-12-24	WOS:000169284600058
J	Calfee, JE				Calfee, JE			Pharmaceutical price controls and patient welfare	ANNALS OF INTERNAL MEDICINE			English	Article							INHALED INSULIN; SEVERE SEPSIS; DEPRESSION; REALITY	Price controls could have a substantial negative effect on pharmaceutical research and development. Extensive research is required before the development costs of a new drug or its benefits are known; most new drug development projects fail, sometimes after substantial financial and time costs. These conditions pose intractable practical problems for the operation of price controls, which cannot rest on objective, predictable standards such as the benefits or costs of individual drugs. In the absence of objective standards, pressure from health care providers and others would create powerful incentives for price regulators to decrease drug prices toward marginal costs of production and distribution, well below levels sufficient to reward innovative research. This downwardly biased price-setting mechanism would apply with particular force to the few successful projects that yield innovative drugs, whose prices would not be set by regulatory authorities until after research expenditures have been incurred and the new drugs are ready to enter the market. Manufacturers will expect price controls to reduce the potential payoffs from breakthrough drugs. This expectation would substantially reduce the incentives to pursue innovative research, as is evident in advanced economies in which price controls are now in force. Once established, price controls for pharmaceuticals, like those for medical services in the Medicare system, would also tend toward complexity and entrenchment of vested interests and could easily become permanent regardless of the harm they cause to patients.	Amer Enterprise Inst Publ Policy Res, Washington, DC 20036 USA	American Enterprise Institute for Public Policy Research	Calfee, JE (corresponding author), Amer Enterprise Inst Publ Policy Res, 1150 17th St NW, Washington, DC 20036 USA.	calfeej@aei.org						Andress G, 2001, BRIT MED J, V322, P419, DOI 10.1136/bmj.322.7283.419; [Anonymous], 1997, PHARM PRICE REGULATI; Ball BG, 2000, JAMA-J AM MED ASSOC, V284, P2788, DOI 10.1001/jama.284.21.2788; Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; BERNDT ER, 2000, US DEP HLTH HUM SERV; BOOTH B, 1999, AM MED NEWS     1227; BURTON TM, 2000, WALL STREET J   0630; BUTLER L, 1999, AM MED NEWS     1227; Calfee JE, 2000, PHARMACOECONOMICS, V18, P47, DOI 10.2165/00019053-200018001-00007; CALFEE JE, 2000, PRICES MARKETS PHARM; CALFEE JE, 1997, FEAR PERSUASION NEEW; CALFEE JE, 2001, FRASER FORUM     FEB, P4; CLARKSON KW, 1996, COMPETITIVE STRATEGI, P238; DANZON PM, 1999, REV US CROSS NATL ST; DIMASI JA, 2001, US DEP HLTH HUM SERV; Dubois RW, 2000, HEALTH AFFAIR, V19, P231, DOI 10.1377/hlthaff.19.2.231; *FOOD DRUG ADM, 1999, FED REGISTER, V64, P43197; Gale EAM, 2001, LANCET, V357, P324, DOI 10.1016/S0140-6736(00)03631-X; GLENNERSTER R, 2000, WORLD BANK VACCINE C; Glick ID, 2001, ANN INTERN MED, V134, P47, DOI 10.7326/0003-4819-134-1-200101020-00013; GRABOWSKI HG, 1994, J HEALTH ECON, V13, P383, DOI 10.1016/0167-6296(94)90010-8; Grabowski HG, 2000, PHARMACOECONOMICS, V18, P21, DOI 10.2165/00019053-200018001-00005; GRABOWSKI HG, 1994, HLTH REFORM PHARM IN; GROOPMAN J, 2000, WALL STREE J    0502; *IMS HLTH, 2000, DRUG MON; Kettler H. E., 1998, COMPETITION INNOVATI; KING RT, 1999, WALL STREE J    0219; LANGRETH R, 2001, FORBES MAGAZINE 0222; LANGRETH R, 1999, WALL STREEJ J   0813; LEWERS DT, 2001, AM MED NEWS     0305; Matthay MA, 2001, NEW ENGL J MED, V344, P759, DOI 10.1056/NEJM200103083441009; Mintz M, 2001, WASHINGTON POST 1102, pB1; Monkman D, 2000, BMJ-BRIT MED J, V321, P1299, DOI 10.1136/bmj.321.7272.1299; MOORE SD, 1998, WALL STREET J   1207; Nathan DM, 2001, ANN INTERN MED, V134, P242, DOI 10.7326/0003-4819-134-3-200102060-00016; OLSON E, 1999, NY TIMES        1118; *PAT MED PRIC REV, 2000, ANN REP YEAR END DEC; Pickering TG, 2001, ANN INTERN MED, V134, P72, DOI 10.7326/0003-4819-134-1-200101020-00016; SAGER A, 1999, AFFORDABLE MED AM PR; SEIDEN C, 2001, POTENTIAL BLOCKBUSTE; Spilker B., 1994, MULTINATIONAL PHARM, V2nd; Thomas L. G., 1994, IND CORP CHANGE, V3, P451; Triplett JE, 1999, MEASURING PRICES MED; *US FOOD DRUG ADM, 2001, TEST TUB PAT NEW DRU, P67; WINSLOW R, 2000, WALL STREET J   1214; WINSLOW R, 2000, WALL STREET J   0420, P20; 1999, ECONOMIST       0814; 2000, WORLDS TOP 50 BEST S	48	11	11	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 5	2001	134	11					1060	1064		10.7326/0003-4819-134-11-200106050-00012	http://dx.doi.org/10.7326/0003-4819-134-11-200106050-00012			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	436YL	11388819				2022-12-24	WOS:000168963400006
J	Olesen, AB; Juul, S; Birkebaek, N; Thestrup-Pedersen, K				Olesen, AB; Juul, S; Birkebaek, N; Thestrup-Pedersen, K			Association between atopic dermatitis and insulin-dependent diabetes mellitus: a case-control study	LANCET			English	Article							PARTY DIAGNOSTIC-CRITERIA; INTERFERON-GAMMA; CLINICAL ASPECTS; NATURAL-HISTORY; TRANSGENIC MICE; EXPRESSION; CHILDREN; ECZEMA; IL-4	Background Up to two-thirds of children with atopic dermatitis have IgE-mediated allergic reactions and a Th2 immune reactivity pattern with low production of interferon gamma and high production of interleukin 4 after allergen stimulation of T lymphocytes. Insulin-dependent diabetes mellitus (IDDM) seems to be associated with a Th1 immune reactivity pattern. We therefore postulated that these diseases may be inversely associated. Methods We designed a case-control study including 920 children with IDDM, registered in the Danish Registry for Childhood Diabetes, and a sample of 9732 non-diabetic children registered in the Danish Medical Birth Registry. The children were aged 3-15 years. Information on atopic dermatitis was obtained by questionnaires. Findings The cumulative incidence of atopic dermatitis up to age 15 years was 13.1% among children with IDDM and 19.8% in non-diabetic children (p<0.0001). Among children who developed IDDM, the incidence of atopic dermatitis was significantly lower than in the controls before onset of IDDM (73 cases in 5314 person-months vs 1375 in 57 432 person-months; odds ratio 0.49 [0.39-0.63]). After onset of IDDM, diabetic and non-diabetic groups did not differ in incidence of atopic dermatitis (1.36 [0.89-2.07]). Interpretation Our findings may be explained by different acquired or inherited reactivity patterns associated with atopic dermatitis (Th2) and IDDM (Th1). The results do not allow us to find out whether early development of atopic dermatitis reduces the risk of IDDM, or a propensity for IDDM reduces the risk of early-onset atopic dermatitis.	Aarhus Univ Hosp, Dept Dermatol, DK-8000 Aarhus C, Denmark; Aarhus Univ Hosp, Dept Parasitol, DK-8000 Aarhus C, Denmark; Univ Aarhus, Dept Epidemiol & Social Med, Aarhus, Denmark	Aarhus University; Aarhus University; Aarhus University	Olesen, AB (corresponding author), Aarhus Univ Hosp, Dept Dermatol, DK-8000 Aarhus C, Denmark.	Annebraae@dadlnet.dk		Birkebaek, Niels/0000-0001-6268-6464				Cameron MJ, 1997, J IMMUNOL, V159, P4686; Dahlquist G, 2000, J PEDIATR-US, V137, P470, DOI 10.1067/mpd.2000.109109; de Longueville M, 1997, PEDIATR ALLERGY IMMU, V8, P177; DELPRETE G, 1992, ALLERGY, V47, P450; DELPRETE G, 1988, J IMMUNOL, V140, P4193; DOTTERUD LK, 1995, ACTA DERM-VENEREOL, V75, P50; GREWE M, 1994, LANCET, V343, P25, DOI 10.1016/S0140-6736(94)90879-6; Knudsen LB, 1998, DAN MED BULL, V45, P320; Mandrup-Poulsen T, 1998, BMJ-BRIT MED J, V316, P1221, DOI 10.1136/bmj.316.7139.1221; MEERWALD R, 1998, HORM RES, V50, P125; Prescott SL, 1999, LANCET, V353, P196, DOI 10.1016/S0140-6736(98)05104-6; RAJKA G, 1986, CLIN REV ALLERG, V4, P3; SARVETNICK N, 1988, CELL, V52, P773, DOI 10.1016/0092-8674(88)90414-X; SARVETNICK N, 1990, NATURE, V346, P844, DOI 10.1038/346844a0; STROMBERG LGE, 1995, J ALLERGY CLIN IMMUN, V96, P188, DOI 10.1016/S0091-6749(95)70007-2; Thepen T, 1996, J ALLERGY CLIN IMMUN, V97, P828, DOI 10.1016/S0091-6749(96)80161-8; WILLIAMS HC, 1994, BRIT J DERMATOL, V131, P397, DOI 10.1111/j.1365-2133.1994.tb08531.x; WILLIAMS HC, 1994, BRIT J DERMATOL, V131, P406, DOI 10.1111/j.1365-2133.1994.tb08532.x; WILLIAMS HC, 1994, BRIT J DERMATOL, V131, P383, DOI 10.1111/j.1365-2133.1994.tb08530.x; Williams HC, 1998, BRIT J DERMATOL, V139, P834; WILLIAMS HC, 1996, SO I DEFINE ATOPIC E; WOGENSEN L, 1993, J EXP MED, V178, P175, DOI 10.1084/jem.178.1.175; Wuthrich B, 1999, ANN ALLERG ASTHMA IM, V83, P464, DOI 10.1016/S1081-1206(10)62852-9	23	82	84	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 2	2001	357	9270					1749	1752		10.1016/S0140-6736(00)04896-0	http://dx.doi.org/10.1016/S0140-6736(00)04896-0			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	440BN	11403811				2022-12-24	WOS:000169156200012
J	Both, C; Visser, ME				Both, C; Visser, ME			Adjustment to climate change is constrained by arrival date in a long-distance migrant bird	NATURE			English	Article							EGG-LAYING TRENDS; REPRODUCTION; TEMPERATURE; POPULATION; PHENOLOGY; EARLIER; BRITAIN; TITS	Spring temperatures in temperate regions have increased over the past 20 years(1), and many organisms have responded to this increase by advancing the date of their growth and reproduction(2-7). Here we show that adaptation to climate change in a long-distance migrant is constrained by the timing of its migratory journey. For long-distance migrants climate change may advance the phenology of their breeding areas, but the timing of some species' spring migration relies on endogenous rhythms that are not affected by climate change(8). Thus, the spring migration of these species will not advance even though they need to arrive earlier on their breeding grounds to breed at the appropriate time. We show that the migratory pied flycatcher Ficedula hypoleuca has advanced its laying date over the past 20 years. This temporal shift has been insufficient, however, as indicated by increased selection for earlier breeding over the same period. The shift is hampered by its spring arrival date, which has not advanced. Some of the numerous long-distance migrants will suffer from climate change, because either their migration strategy is unaffected by climate change, or the climate in breeding and wintering areas are changing at different speeds, preventing adequate adaptation.	Inst Ecol Res, NL-6666 ZG Heteren, Netherlands; Univ Groningen, Zool Lab, NL-9750 AA Haren, Netherlands	University of Groningen	Visser, ME (corresponding author), Inst Ecol Res, POB 40, NL-6666 ZG Heteren, Netherlands.		Visser, Marcel E/A-9151-2009; Both, Christiaan/E-6459-2011	Visser, Marcel E/0000-0002-1456-1939; Both, Christiaan/0000-0001-7099-9831				ALATALO RV, 1986, NATURE, V323, P152, DOI 10.1038/323152a0; Arrow Kenneth J., 1996, CLIMATE CHANGE 1995; BEEBEE TJC, 1995, NATURE, V374, P219, DOI 10.1038/374219a0; BERTHOLD P, 1992, NATURE, V360, P668, DOI 10.1038/360668a0; Berthold P, 1998, NATURWISSENSCHAFTEN, V85, P350, DOI 10.1007/s001140050514; BERTHOLD P, 1990, 20 C INT ORN, P780; BILZECKER J, 1998, 982 VOG ARNH EO; Both C, 2000, J AVIAN BIOL, V31, P412, DOI 10.1034/j.1600-048X.2000.310317.x; Brown JL, 1999, P NATL ACAD SCI USA, V96, P5565, DOI 10.1073/pnas.96.10.5565; Buse A, 1999, FUNCT ECOL, V13, P74, DOI 10.1046/j.1365-2435.1999.00010.x; Crick HQP, 1999, NATURE, V399, P423, DOI 10.1038/20839; Crick HQP, 1997, NATURE, V388, P526, DOI 10.1038/41453; Falconer D. S., 1996, INTRO QUANTATIVE GEN; Forchhammer MC, 1998, NATURE, V391, P29, DOI 10.1038/34070; Gwinner E, 1996, IBIS, V138, P47, DOI 10.1111/j.1474-919X.1996.tb04312.x; Harrington R, 1999, TRENDS ECOL EVOL, V14, P146, DOI 10.1016/S0169-5347(99)01604-3; Huin N, 1998, BIRD STUDY, V45, P361, DOI 10.1080/00063659809461108; Huin N, 2000, BIRD STUDY, V47, P22, DOI 10.1080/00063650009461157; Lundberg A., 1992, PIED FLYCATCHER; MASON CF, 1995, BIRD STUDY, V42, P182, DOI 10.1080/00063659509477167; McCleery RH, 1998, NATURE, V391, P30, DOI 10.1038/34073; Myers J.P., 1992, P193; Przybylo R, 2000, J ANIM ECOL, V69, P395, DOI 10.1046/j.1365-2656.2000.00401.x; Pulido F, 1996, P NATL ACAD SCI USA, V93, P14642, DOI 10.1073/pnas.93.25.14642; Stevenson IR, 2000, NATURE, V406, P366, DOI 10.1038/35019151; Visser ME, 1998, P ROY SOC B-BIOL SCI, V265, P1867, DOI 10.1098/rspb.1998.0514; Visser ME, 2001, P ROY SOC B-BIOL SCI, V268, P289, DOI 10.1098/rspb.2000.1363	27	717	758	9	555	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 17	2001	411	6835					296	298		10.1038/35077063	http://dx.doi.org/10.1038/35077063			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432RT	11357129	Green Published			2022-12-24	WOS:000168710000044
J	Said, G				Said, G			Value of nerve biopsy?	LANCET			English	Editorial Material							NEUROPATHY		Hop Bicetre, Serv Neurol, F-94275 Le Kremlin Bicetre, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay	Said, G (corresponding author), Hop Bicetre, Serv Neurol, F-94275 Le Kremlin Bicetre, France.							ARGOV Z, 1989, ACTA NEUROL SCAND, V79, P243, DOI 10.1111/j.1600-0404.1989.tb03745.x; Collins MP, 2000, NEUROLOGY, V55, P636, DOI 10.1212/WNL.55.5.636; De Freitas MRG, 1998, ARQ NEURO-PSIQUIAT, V56, P585, DOI 10.1590/S0004-282X1998000400011; Dyck PJ GC, 1993, PERIPHERAL NEUROPATH, P514; Gabriel CM, 2000, J NEUROL NEUROSUR PS, V69, P442, DOI 10.1136/jnnp.69.4.442; HELLMANN DB, 1988, MEDICINE, V67, P145, DOI 10.1097/00005792-198805000-00001; RAPPAPORT WD, 1993, AM J SURG, V166, P252, DOI 10.1016/S0002-9610(05)80968-7; Said G, 1999, MUSCLE NERVE, V22, P1617, DOI 10.1002/(SICI)1097-4598(199912)22:12<1617::AID-MUS1>3.0.CO;2-L; SAID G, 1988, ANN NEUROL, V23, P461, DOI 10.1002/ana.410230506; THOMAS PK, 1995, PERIPHERAL NERVE DIS, V2, P281	10	17	17	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 21	2001	357	9264					1220	1221		10.1016/S0140-6736(00)04449-4	http://dx.doi.org/10.1016/S0140-6736(00)04449-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	425YY	11418142				2022-12-24	WOS:000168323300004
J	Lu, QX; Lemke, G				Lu, QX; Lemke, G			Homeostatic regulation of the immune system by receptor tyrosine kinases of the Tyro 3 family	SCIENCE			English	Article							EXPRESSION ANALYSIS; PROTEIN-S; C-MER; LIGANDS; AXL; ANTIBODIES; SELECTION; CLONING; GAS6	Receptor tyrosine kinases and their Ligands mediate cell-cell communication and interaction in many organ systems, but have not been known to actin this capacity in the mature immune system. We now provide genetic evidence that three closely related receptor tyrosine kinases, Tyro 3, Axl, and Mer, play an essential immunoregulatory role. Mutant mice that lack these receptors develop a severe Lymphoproliferative disorder accompanied by broad-spectrum autoimmunity. These phenotypes are cell nonautonomous with respect to Lymphocytes and result from the hyperactivation of antigen-presenting cells in which the three receptors are normally expressed.	Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA	Salk Institute	Lemke, G (corresponding author), Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA.							Bokarewa MI, 1997, SEMIN HEMATOL, V34, P235; Camenisch TD, 1999, J IMMUNOL, V162, P3498; Daeron M, 1999, CURR TOP MICROBIOL, V244, P1; Ernst B, 1999, IMMUNITY, V11, P173, DOI 10.1016/S1074-7613(00)80092-8; GODOWSKI PJ, 1995, CELL, V82, P355, DOI 10.1016/0092-8674(95)90424-7; GRAHAM DK, 1994, CELL GROWTH DIFFER, V5, P647; GRAHAM DK, 1995, ONCOGENE, V10, P2349; GREVES M, 1999, HAEMATOLOGICA, V84, P32; Hahn BH, 1997, DUBOIS LUPUS ERYTHEM, P69; HESS DC, 1993, J RHEUMATOL, V20, P610; LAI C, 1994, ONCOGENE, V9, P2567; LAI C, 1991, NEURON, V6, P691, DOI 10.1016/0896-6273(91)90167-X; Lenardo M, 1999, ANNU REV IMMUNOL, V17, P221, DOI 10.1146/annurev.immunol.17.1.221; LU Q, UNPUB; Lu QX, 1999, NATURE, V398, P723, DOI 10.1038/19554; LYONS AB, 1994, J IMMUNOL METHODS, V171, P131, DOI 10.1016/0022-1759(94)90236-4; MIYAJIMA A, 1992, ANNU REV IMMUNOL, V10, P295, DOI 10.1146/annurev.immunol.10.1.295; NEUBAUER A, 1994, BLOOD, V84, P1931; Neubauer A, 1997, LEUKEMIA LYMPHOMA, V25, P91, DOI 10.3109/10428199709042499; Nousari HC, 1999, LANCET, V354, P667, DOI 10.1016/S0140-6736(99)03007-X; OBRYAN JP, 1991, MOL CELL BIOL, V11, P5016, DOI 10.1128/MCB.11.10.5016; RADIC MZ, 1994, ANNU REV IMMUNOL, V12, P487, DOI 10.1146/annurev.iy.12.040194.002415; Scott RS, 2001, NATURE, V411, P207, DOI 10.1038/35075603; STITT TN, 1995, CELL, V80, P661, DOI 10.1016/0092-8674(95)90520-0; STUART JM, 1984, ANNU REV IMMUNOL, V2, P199, DOI 10.1146/annurev.iy.02.040184.001215	25	506	554	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 13	2001	293	5528					306	311		10.1126/science.1061663	http://dx.doi.org/10.1126/science.1061663			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	452TK	11452127				2022-12-24	WOS:000169875200061
J	Kelley, DS; Karson, JA; Blackman, DK; Fruh-Green, GL; Butterfield, DA; Lilley, MD; Olson, EJ; Schrenk, MO; Roe, KK; Lebon, GT; Rivizzigno, P				Kelley, DS; Karson, JA; Blackman, DK; Fruh-Green, GL; Butterfield, DA; Lilley, MD; Olson, EJ; Schrenk, MO; Roe, KK; Lebon, GT; Rivizzigno, P		AT3-60 Shipboard Party	An off-axis hydrothermal vent field near the Mid-Atlantic Ridge at 30 degrees N	NATURE			English	Article							FRACTURE-ZONE; ULTRAMAFIC ROCKS; ENDEAVOR SEGMENT; SERPENTINIZATION; SYSTEMS; CH4; INTERSECTION; CHEMISTRY; HYDROGEN; OFFSETS	Evidence is growing that hydrothermal venting occurs not only along mid-ocean ridges but also on old regions of the oceanic crust away from spreading centres. Here we report the discovery of an extensive hydrothermal field at 30 degrees N near the eastern intersection of the Mid-Atlantic Ridge and the Atlantis fracture zone. The vent field-named 'Lost City'-is distinctly different from all other known sea-floor hydrothermal fields in that it is located on 1.5-Myr-old crust, nearly 15 km from the spreading axis, and may be driven by the heat of exothermic serpentinization reactions between sea water and mantle rocks. It is located on a dome-like massif and is dominated by steep-sided carbonate chimneys, rather than the sulphide structures typical of 'black smoker' hydrothermal fields. We found that vent fluids are relatively cool (40-75 degrees C) and alkaline (pH 9.0-9.8), supporting dense microbial communities that include anaerobic thermophiles. Because the geological characteristics of the Atlantis massif are similar to numerous areas of old crust along the Mid-Atlantic, Indian and Arctic ridges, these results indicate that a much larger portion of the oceanic crust may support hydrothermal activity and microbial life than previously thought.	Univ Washington, Sch Oceanog, Seattle, WA 98195 USA; Duke Univ, Div Earth & Ocean Sci, Durham, NC 27708 USA; Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; ETH Zentrum, Inst Mineral & Petrol, CH-8092 Zurich, Switzerland; Univ Washington, NOAA, Pacific Marine Environm Lab, Joint Inst Study Atmosphere & Oceans, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Duke University; University of California System; University of California San Diego; Scripps Institution of Oceanography; Swiss Federal Institutes of Technology Domain; ETH Zurich; National Oceanic Atmospheric Admin (NOAA) - USA; University of Washington; University of Washington Seattle	Kelley, DS (corresponding author), Univ Washington, Sch Oceanog, Seattle, WA 98195 USA.		Butterfield, David/H-3815-2016; Matthew, Schrenk/AAH-5682-2020	Butterfield, David/0000-0002-1595-9279; Schrenk, Matthew/0000-0002-5623-8558				ALLEN DA, 1998, EOS T AM GEOPHYS UN, V79, P58; BARNES I, 1972, CONTRIB MINERAL PETR, V35, P263, DOI 10.1007/BF00371220; BARRIGA FJA, 1998, EOS, V79, P67; Berndt ME, 1996, GEOLOGY, V24, P351, DOI 10.1130/0091-7613(1996)024<0351:ROCDSO>2.3.CO;2; Blackman DK, 1998, J GEOPHYS RES-SOL EA, V103, P21315, DOI 10.1029/98JB01756; BONATTI E, 1980, GEOCHIM COSMOCHIM AC, V44, P1207, DOI 10.1016/0016-7037(80)90074-5; Bougault H, 1998, EARTH PLANET SC LETT, V161, P1, DOI 10.1016/S0012-821X(98)00094-6; BUTTERFIELD DA, 1994, J GEOPHYS RES-SOL EA, V99, P9561, DOI 10.1029/93JB03132; Cann JR, 1997, NATURE, V385, P329, DOI 10.1038/385329a0; Charlou JL, 2000, CHEM GEOL, V171, P49, DOI 10.1016/S0009-2541(00)00244-8; Charlou JL, 1998, GEOCHIM COSMOCHIM AC, V62, P2323, DOI 10.1016/S0016-7037(98)00138-0; COLEMAN RG, 1971, GEOL SOC AM BULL, V82, P897, DOI 10.1130/0016-7606(1971)82[897:PAGNOS]2.0.CO;2; Donval J. P., 1997, EOS T AM GEOPHYS UN, V78, P832; DOUVILLE E, 1997, EOS T AM GEOPHYS UN, V78, P832; FORNARI DJ, 1995, AM GEOPHYSICAL UNION, V91, P1; FOUQUET Y, 1977, EOS, V78, P832; Fruh-Green G. L., 1996, P ODP SCI RESULTS, V147, P255, DOI DOI 10.2973/0DP.PR0C.SR.147.016.1996; Fryer P, 1990, P OCEAN DRILLING PRO, V125, P69, DOI DOI 10.2973/ODP.PROC.IR.125.1990; German CR, 1996, EARTH PLANET SC LETT, V138, P93, DOI 10.1016/0012-821X(95)00224-Z; Gracia E, 2000, EARTH PLANET SC LETT, V177, P89, DOI 10.1016/S0012-821X(00)00034-0; HAGGERTY JA, 1987, AM GEOPHYSICAL MONOG, V47, P175; HANNINGTON MD, 1995, AM GEOPHYSICAL UNION, V91, P115; JAMES RH, 1995, GEOCHIM COSMOCHIM AC, V59, P651, DOI 10.1016/0016-7037(95)00003-I; JANECKY DR, 1986, GEOCHIM COSMOCHIM AC, V50, P1357, DOI 10.1016/0016-7037(86)90311-X; Karson J. A., 1997, P OCEAN DRILLING PRO, V153, P5; Krasnov S.G., 1995, GEOL SOC LOND SPEC P, V87, P43, DOI 10.1144/GSL.SP.1995.087.01.05; Lagabrielle Y, 1998, GEOPH MONOG SERIES, V106, P153; LILLEY MD, 1993, NATURE, V364, P45, DOI 10.1038/364045a0; MACLEOD G, 1994, ORIGINS LIFE EVOL B, V24, P19, DOI 10.1007/BF01582037; NEAL C, 1983, EARTH PLANET SC LETT, V66, P315, DOI 10.1016/0012-821X(83)90144-9; NEAL C, 1984, MINERAL MAG, V48, P237, DOI 10.1180/minmag.1984.048.347.07; Pace NR, 1997, SCIENCE, V276, P734, DOI 10.1126/science.276.5313.734; RONA PA, 1992, GEOLOGY, V20, P783, DOI 10.1130/0091-7613(1992)020<0783:HCSADA>2.3.CO;2; RUSSELL MJ, 1996, J GEOL SOC LONDON, V153, P1; SAKAI R, 1990, EARTH PLANET SC LETT, V100, P291, DOI 10.1016/0012-821X(90)90192-Z; SCHOPF JW, 1983, EARTHS EARLIEST BIOS, P1; SEEWALD JS, 1990, EARTH PLANET SC LETT, V101, P388, DOI 10.1016/0012-821X(90)90168-W; Shock EL, 1998, J GEOPHYS RES-PLANET, V103, P28513, DOI 10.1029/98JE02142; Tivey MK, 1999, J GEOPHYS RES-SOL EA, V104, P22859, DOI 10.1029/1999JB900107; VANDOVER CL, 2000, ECOLOGY DEEP SEA HYD, P63; VONDAMM KL, 1995, AM GEOPHYSICAL UNION, V91, P222; Wetzel LR, 2000, J GEOPHYS RES-SOL EA, V105, P8319, DOI 10.1029/1999JB900382	42	821	880	7	263	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 12	2001	412	6843					145	149		10.1038/35084000	http://dx.doi.org/10.1038/35084000			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	451AJ	11449263				2022-12-24	WOS:000169778700041
J	Davare, MA; Avdonin, V; Hall, DD; Peden, EM; Burette, A; Weinberg, RJ; Horne, MC; Hoshi, T; Hell, JW				Davare, MA; Avdonin, V; Hall, DD; Peden, EM; Burette, A; Weinberg, RJ; Horne, MC; Hoshi, T; Hell, JW			A beta(2) adrenergic receptor signaling complex assembled with the Ca2+ channel Ca(v)1.2	SCIENCE			English	Article							DEPENDENT PROTEIN-KINASE; NEURONAL CLASS-C; CALCIUM CHANNELS; HIPPOCAMPAL-NEURONS; ADENYLYL-CYCLASE; ALPHA-1 SUBUNIT; GAMMA-SUBUNITS; ION CHANNELS; PHOSPHORYLATION; LOCALIZATION	The existence of a large number of receptors coupled to heterotrimeric guanine nucleotide binding proteins (G proteins) raises the question of how a particular receptor selectively regulates specific targets. We provide insight into this question by identifying a prototypical macromolecular signaling complex. The beta (2) adrenergic receptor was found to be directly associated with one of its ultimate effecters, the class C L-type calcium channel Ca(v)1.2. This complex also contained a C protein, an adenylyl cyclase, cyclic adenosine monophosphate-dependent protein kinase, and the counterbalancing phosphatase PP2A. Our electrophysiological recordings from hippocampal neurons demonstrate highly localized signal transduction from the receptor to the channel. The assembly of this signaling complex provides a mechanism that ensures specific and rapid signaling by a G protein-coupled receptor.	Univ Wisconsin, Dept Pharmacol, Madison, WI 53706 USA; Univ Iowa, Dept Physiol & Biophys, Iowa City, IA 52242 USA; Univ N Carolina, Dept Cell Biol & Anat, Chapel Hill, NC 27599 USA	University of Wisconsin System; University of Wisconsin Madison; University of Iowa; University of North Carolina; University of North Carolina Chapel Hill	Hell, JW (corresponding author), Univ Wisconsin, Dept Pharmacol, Madison, WI 53706 USA.		Hell, Johannes W./P-5085-2019; Hall, Duane/ACD-6815-2022; Weinberg, Richard/AAC-1898-2020	Hall, Duane/0000-0003-2228-0966; Horne, Mary/0000-0002-2799-3212; Davare, Monika/0000-0003-1802-7597; Peden, Erik/0000-0002-8436-3217	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061645] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008688, R01GM056900] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035563, R01NS039444] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R56AG017502, R01AG017502] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL61645] Funding Source: Medline; NIA NIH HHS [AG17502, AG00213] Funding Source: Medline; NIGMS NIH HHS [GM08688, GM56900] Funding Source: Medline; NINDS NIH HHS [NS39444, NS35563] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BARSINAI A, 1992, EUR J BIOCHEM, V207, P703, DOI 10.1111/j.1432-1033.1992.tb17098.x; BEAN BP, 1984, NATURE, V307, P371, DOI 10.1038/307371a0; Bunemann M, 1999, J BIOL CHEM, V274, P33851, DOI 10.1074/jbc.274.48.33851; CATTERALL WA, 1995, ANNU REV BIOCHEM, V64, P493, DOI 10.1146/annurev.biochem.64.1.493; Clapham DE, 1997, ANNU REV PHARMACOL, V37, P167, DOI 10.1146/annurev.pharmtox.37.1.167; Davare MA, 1999, J BIOL CHEM, V274, P30280, DOI 10.1074/jbc.274.42.30280; Davare MA, 2000, J BIOL CHEM, V275, P39710, DOI 10.1074/jbc.M005462200; DeJongh KS, 1996, BIOCHEMISTRY-US, V35, P10392, DOI 10.1021/bi953023c; Edwards SW, 2000, TRENDS PHARMACOL SCI, V21, P304, DOI 10.1016/S0165-6147(00)01513-3; Gao TY, 1997, NEURON, V19, P185, DOI 10.1016/S0896-6273(00)80358-X; Gao TY, 1997, J BIOL CHEM, V272, P19401, DOI 10.1074/jbc.272.31.19401; Gerhardstein BL, 2000, J BIOL CHEM, V275, P8556, DOI 10.1074/jbc.275.12.8556; Gray PC, 1998, CURR OPIN NEUROBIOL, V8, P330, DOI 10.1016/S0959-4388(98)80057-3; GRAY R, 1987, NATURE, V327, P620, DOI 10.1038/327620a0; HELL JW, 1993, J CELL BIOL, V123, P949, DOI 10.1083/jcb.123.4.949; Hell JW, 1996, P NATL ACAD SCI USA, V93, P3362, DOI 10.1073/pnas.93.8.3362; HELL JW, 1993, J BIOL CHEM, V268, P19451; Horne MC, 1996, IMMUNITY, V4, P145, DOI 10.1016/S1074-7613(00)80679-2; MONS N, 1995, P NATL ACAD SCI USA, V92, P8473, DOI 10.1073/pnas.92.18.8473; Porter NM, 1997, J NEUROSCI, V17, P5629; Seibold A, 1998, J BIOL CHEM, V273, P7637, DOI 10.1074/jbc.273.13.7637; STRADER CD, 1983, P NATL ACAD SCI-BIOL, V80, P1840, DOI 10.1073/pnas.80.7.1840; Taylor JM, 1996, J BIOL CHEM, V271, P3336; Valtschanoff JG, 2000, EUR J NEUROSCI, V12, P3605, DOI 10.1046/j.1460-9568.2000.00256.x; Wu GY, 2000, J BIOL CHEM, V275, P9026, DOI 10.1074/jbc.275.12.9026; Xiao RP, 1999, CIRC RES, V85, P1092; Ye CI, 2000, BIOPHYS J, V79, P2547, DOI 10.1016/S0006-3495(00)76495-2	27	414	425	1	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 6	2001	293	5527					98	101		10.1126/science.293.5527.98	http://dx.doi.org/10.1126/science.293.5527.98			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	451BB	11441182				2022-12-24	WOS:000169780300037
J	Waelti, P; Dickinson, A; Schultz, W				Waelti, P; Dickinson, A; Schultz, W			Dopamine responses comply with basic assumptions of formal learning theory	NATURE			English	Article							LONG-TERM DEPRESSION; RAT PREFRONTAL CORTEX; BEHAVIORAL REACTIONS; CONDITIONED-STIMULI; MONKEY MIDBRAIN; NEURONS; REWARD; PREDICTION; MECHANISMS; MODEL	According to contemporary learning theories, the discrepancy, or error, between the actual and predicted reward determines whether learning occurs when a stimulus is paired with a reward. The role of prediction errors is directly demonstrated by the observation that learning is blocked when the stimulus is paired with a fully predicted reward. By using this blocking procedure, we show that the responses of dopamine neurons to conditioned stimuli was governed differentially by the occurrence of reward prediction errors rather than stimulus-reward associations alone, as was the learning of behavioural reactions. Both behavioural and neuronal learning occurred predominantly when dopamine neurons registered a reward prediction error at the time of the reward. Our data indicate that the use of analytical tests derived from formal behavioural learning theory provides a powerful approach for studying the role of single neurons in learning.	Univ Fribourg, Inst Physiol, CH-1700 Fribourg, Switzerland; Univ Fribourg, Program Neurosci, CH-1700 Fribourg, Switzerland; Univ Cambridge, Dept Expt Psychol, Cambridge CB2 3EB, England	University of Fribourg; University of Fribourg; University of Cambridge	Schultz, W (corresponding author), Univ Fribourg, Inst Physiol, CH-1700 Fribourg, Switzerland.		schultz, wolfram/H-8958-2016	schultz, wolfram/0000-0002-8530-4518				CALABRESI P, 1992, J NEUROSCI, V12, P4224; Calabresi P, 1997, J NEUROSCI, V17, P4536; Centonze D, 1999, J NEUROPHYSIOL, V82, P3575, DOI 10.1152/jn.1999.82.6.3575; Dickinson A, 2001, Q J EXP PSYCHOL-B, V54, P3, DOI 10.1080/02724990042000010; Dickinson A., 1980, CONT ANIMAL LEARNING; FRISTON KJ, 1994, NEUROSCIENCE, V59, P229, DOI 10.1016/0306-4522(94)90592-4; GARCIAMUNOZ M, 1992, NEUROREPORT, V3, P357, DOI 10.1097/00001756-199204000-00017; Holland PC, 1997, ANIM LEARN BEHAV, V25, P373, DOI 10.3758/BF03209846; Hollerman JR, 1998, NAT NEUROSCI, V1, P304, DOI 10.1038/1124; Horvitz JC, 2000, NEUROSCIENCE, V96, P651, DOI 10.1016/S0306-4522(00)00019-1; Houk JC, 1995, MODELS INFORM PROCES, P249; ITO M, 1989, ANNU REV NEUROSCI, V12, P85, DOI 10.1146/annurev.ne.12.030189.000505; Kalman R.E., 1960, T ASME J BASIC ENG, V82, P35, DOI [DOI 10.1115/1.3662552, 10.1115/1.3662552]; Kamin L. J., 1969, FUNDAMENTAL ISSUES A, P42; KAWATO M, 1992, TRENDS NEUROSCI, V15, P445, DOI 10.1016/0166-2236(92)90008-V; Kim JJ, 1998, SCIENCE, V279, P570, DOI 10.1126/science.279.5350.570; LJUNGBERG T, 1992, J NEUROPHYSIOL, V67, P145, DOI 10.1152/jn.1992.67.1.145; Mackintosh N. J, 1983, CONDITIONING ASS LEA; MACKINTOSH NJ, 1975, PSYCHOL REV, V82, P276, DOI 10.1037/h0076778; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; MARTIN I, 1991, Q J EXP PSYCHOL-B, V43, P233; MINSKY M, 1961, P IRE, V49, P8, DOI 10.1109/JRPROC.1961.287775; Montague PR, 1996, J NEUROSCI, V16, P1936, DOI 10.1523/jneurosci.16-05-01936.1996; Otani S, 1998, NEUROSCIENCE, V85, P669, DOI 10.1016/S0306-4522(97)00677-5; Otani S, 1999, J NEUROSCI, V19, P9788; Pavlov IP, 1927, CONDITIONAL REFLEXES; PEARCE JM, 1980, PSYCHOL REV, V87, P532, DOI 10.1037/0033-295X.87.6.532; Rauhut AS, 1999, J EXP PSYCHOL ANIM B, V25, P45, DOI 10.1037/0097-7403.25.1.45; Rescorla RA, 1972, CLASSICAL CONDITION, P64, DOI DOI 10.1101/GR.110528.110; Robbins TW, 1996, CURR OPIN NEUROBIOL, V6, P228, DOI 10.1016/S0959-4388(96)80077-8; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; ROMO R, 1990, J NEUROPHYSIOL, V63, P592, DOI 10.1152/jn.1990.63.3.592; SALAMONE JD, 1994, BEHAV BRAIN RES, V61, P117, DOI 10.1016/0166-4328(94)90153-8; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; SCHULTZ W, 1990, J NEUROPHYSIOL, V63, P607, DOI 10.1152/jn.1990.63.3.607; Schultz W, 2000, ANNU REV NEUROSCI, V23, P473, DOI 10.1146/annurev.neuro.23.1.473; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; SCHULTZ W, 1993, J NEUROSCI, V13, P900; SCHULTZ W, 1987, J NEUROPHYSIOL, V57, P201, DOI 10.1152/jn.1987.57.1.201; Suri RE, 1999, NEUROSCIENCE, V91, P871, DOI 10.1016/S0306-4522(98)00697-6; Sutton R.S., 1990, LEARNING COMPUTATION, P497; Sutton Richard S., 1998, REINFORCEMENT LEARNI; SUTTON RS, 1981, PSYCHOL REV, V88, P135, DOI 10.1037/0033-295X.88.2.135; THOMPSON RF, 1991, PERSPECTIVES COGNITI, P25; Thorndike EL., 1911, ANIMAL INTELLIGENCE, DOI DOI 10.4324/9781351321044; Wickens JR, 1996, NEUROSCIENCE, V70, P1, DOI 10.1016/0306-4522(95)00436-M; WIDROW G, 1985, ADAPTIVE SIGNAL PROC; WIDROW G, 1960, I RADIO ENG W ELEC 4, P96; WISE RA, 1992, SYNAPSE, V10, P247, DOI 10.1002/syn.890100307; [No title captured]	50	693	701	2	55	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 5	2001	412	6842					43	48		10.1038/35083500	http://dx.doi.org/10.1038/35083500			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	448TB	11452299	Green Submitted			2022-12-24	WOS:000169644900036
J	Kirkham, FJ; Hewes, DKM; Prengler, M; Wade, A; Lane, R; Evans, JPM				Kirkham, FJ; Hewes, DKM; Prengler, M; Wade, A; Lane, R; Evans, JPM			Nocturnal hypoxaemia and central-nervous-system events in sickle-cell disease	LANCET			English	Article							OBSTRUCTIVE SLEEP-APNEA; CHILDREN; STROKE; ABNORMALITIES; ANEMIA; RISK; ERYTHROPOIETIN; HEMOGLOBIN; ACTIVATION; PLATELET	Background Central-nervous-system (CNS) events, including strokes, transient ischaemic attacks, and seizures are common in sickle-cell disease. Stroke can be predicted by high velocities in the internal-carotid or middle-cerebral arteries on transcranial doppler ultrasonography. We tested the hypothesis that nocturnal hypoxaemia can predict CNS events better than clinical or haematological features, or transcranial doppler sonography. Methods We screened 95 hospital-based patients with sickle-cell disease (median age 7.7 years [range 1.0-23.1]), but without previous stroke, with transcranial doppler and overnight pulse oximetry. Follow-up continued for a median of 6.01(0.11-8.54) years. Findings 19 patients had CNS events (six ischaemic and one haemorrhagic stroke, eight transient ischaemic attacks, and four seizures). Mean overnight oxygen saturation ([SaO(2)] hazard ratio 0.82 per 1% increase [95% CI 0.71-0.93]; p=0.003) and higher internat-carotid or middle-cerebral artery velocity (1.02 for every increase of 1 cm/s [1.004-1.03]; p=0.009) were independently associated with time to CNS event. After accounting for mean SaO(2), artery velocity, and haemoglobinopathy, high haemoglobin concentration was also associated with an increased risk of CNS event (1.7 per g/dL, [1.18-2.43]; p=0.004). Dips suggestive of obstructive sleep apnoea did not predict CNS events, and adenotonsillectomy seemed to have no effect, although the CI were wide and clinically important effects cannot be excluded. Interpretation Screening for, and appropriate management of, nocturnal hypoxaemia might be a safe and effective alternative to prophylactic blood transfusion for primary prevention of CNS events in sickle-cell disease.	UCL, Inst Child Hlth, Neurosci Unit, London, England; UCL, Inst Child Hlth, Paediat Epidemiol & Biostat Unit, London, England; UCL, Inst Child Hlth, Portex Unit Anaesthesia Intens Care & Resp Med, London, England; UCL, Inst Child Hlth, Dept Haematol, London, England; Great Ormond St Hosp Sick Children, London WC1N 3JH, England	University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust	Kirkham, FJ (corresponding author), Wolfson Ctr Magnet Technol, Mecklenburgh Sq, London WC1N 2AP, England.	F.Kirkham@ich.ucl.ac.uk	Kirkham, Fenella/C-2442-2009	Kirkham, Fenella/0000-0002-2443-7958				Adams RJ, 1997, ANN NEUROL, V42, P699, DOI 10.1002/ana.410420505; Adams RJ, 1998, NEW ENGL J MED, V339, P5, DOI 10.1056/NEJM199807023390102; Appenzeller O, 1998, ARCH NEUROL-CHICAGO, V55, P1007, DOI 10.1001/archneur.55.7.1007; Armstrong FD, 1996, PEDIATRICS, V97, P864; BALKARAN B, 1992, J PEDIATR-US, V120, P360, DOI 10.1016/S0022-3476(05)80897-2; Britton TC, 1997, J NEUROL NEUROSUR PS, V63, P808, DOI 10.1136/jnnp.63.6.808; Collett D, 1994, MODELLING SURVIVAL D; Dale GL, 1998, LANCET, V352, P566, DOI 10.1016/S0140-6736(97)11506-9; DAVIES SC, 1989, LANCET, V2, P283; Earley CJ, 1998, NEUROLOGY, V51, P169, DOI 10.1212/WNL.51.1.169; Eisensehr I, 1998, NEUROLOGY, V51, P188, DOI 10.1212/WNL.51.1.188; EMBURY SH, 1984, NEW ENGL J MED, V311, P291, DOI 10.1056/NEJM198408023110504; Gadian DG, 2000, J CHILD NEUROL, V15, P279, DOI 10.1177/088307380001500502; GILLARD JH, 1986, J NEUROL NEUROSUR PS, V49, P1025, DOI 10.1136/jnnp.49.9.1025; Inwald DP, 2000, BRIT J HAEMATOL, V111, P474, DOI 10.1046/j.1365-2141.2000.02353.x; Kinney TR, 1999, PEDIATRICS, V103, P640, DOI 10.1542/peds.103.3.640; Kirkham FJ, 2001, ANN NEUROL, V49, P477; LIU JE, 1994, J NEUROL SCI, V123, P6, DOI 10.1016/0022-510X(94)90196-1; Miller ST, 2000, NEW ENGL J MED, V342, P83, DOI 10.1056/NEJM200001133420203; Miyamoto O, 2000, NEUROLOGY, V54, P362, DOI 10.1212/WNL.54.2.362; Ohene-Frempong K, 1998, BLOOD, V91, P288; PARTINEN M, 1985, LANCET, V2, P1325; POWARS DR, 1984, BLOOD, V63, P921, DOI 10.1182/blood.V63.4.921.921; RACKOFF WR, 1993, BLOOD, V81, P3422; ROBERTSON PL, 1988, ANN NEUROL, V23, P614, DOI 10.1002/ana.410230615; ROTHMAN SM, 1986, ANN NEUROL, V20, P684, DOI 10.1002/ana.410200606; SAMUELS MP, 1992, ARCH DIS CHILD, V67, P925, DOI 10.1136/adc.67.7.925; Setty BNY, 1996, BLOOD, V88, P2311, DOI 10.1182/blood.V88.6.2311.bloodjournal8862311; Steen RG, 1999, ANN NEUROL, V45, P279, DOI 10.1002/1531-8249(199903)45:3<279::AID-ANA2>3.0.CO;2-7; Wang WC, 1998, J PEDIATR-US, V132, P994, DOI 10.1016/S0022-3476(98)70397-X	30	183	189	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 26	2001	357	9269					1656	1659		10.1016/S0140-6736(00)04821-2	http://dx.doi.org/10.1016/S0140-6736(00)04821-2			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	435UY	11425370				2022-12-24	WOS:000168901600011
J	McCord, TB; Hansen, GB; Hibbitts, CA				McCord, TB; Hansen, GB; Hibbitts, CA			Hydrated salt minerals on Ganymede's surface: Evidence of an ocean below	SCIENCE			English	Article							ICY GALILEAN SATELLITES; WATER-ICE; MU-M; EUROPA	Reflectance spectra from Galileo's near-infrared mapping spectrometer (NIMS) suggests that the surface of Ganymede, the Largest satellite of Jupiter, contains hydrated materials. These materials are interpreted to be similar to those found on Europa, that is, mostly frozen magnesium sulfate brines that are derived from a subsurface briny Layer of fluid.	Univ Hawaii, Hawaii Inst Geophys & Planetol, Honolulu, HI 96822 USA	University of Hawaii System	McCord, TB (corresponding author), Univ Hawaii, Hawaii Inst Geophys & Planetol, Honolulu, HI 96822 USA.	tom@higp.hawaii.edu	Hibbitts, Charles/B-7787-2016	Hibbitts, Charles/0000-0001-9089-4391				Anderson JD, 1997, SCIENCE, V276, P1236, DOI 10.1126/science.276.5316.1236; CALVIN WM, 1995, J GEOPHYS RES-PLANET, V100, P19041, DOI 10.1029/94JE03349; Carlson RW, 1999, SCIENCE, V286, P97, DOI 10.1126/science.286.5437.97; CLARK RN, 1980, ICARUS, V41, P323, DOI 10.1016/0019-1035(80)90217-1; Collins G. C, 2000, LUNAR PLANET SCI, P1034; DUFRESNE ER, 1962, GEOCHIM COSMOCHIM AC, V26, P1058; FANALE FP, 1989, ICARUS, V82, P97, DOI 10.1016/0019-1035(89)90026-2; FANALE FP, 1998, LUNAR PLANET SCI, V29, P1248; FANALE FP, 1977, PLANETARY SATELLITES, P379; HANSEN GB, 2000, EOS, V81, pF792; KARGEL JS, 1991, ICARUS, V94, P368, DOI 10.1016/0019-1035(91)90235-L; KIVELSON MG, 2000, EOS, V81, pF789; McCord TB, 1998, J GEOPHYS RES-PLANET, V103, P8603, DOI 10.1029/98JE00788; McCord TB, 1998, SCIENCE, V280, P1242, DOI 10.1126/science.280.5367.1242; McCord TB, 1999, J GEOPHYS RES-PLANET, V104, P11827, DOI 10.1029/1999JE900005; McCord TB, 2001, J GEOPHYS RES-PLANET, V106, P3311, DOI 10.1029/2000JE001282; MCCORD TB, IN PRESS J GEOPHYS R; MCCORD TB, 2000, EOS, V81, P209; Moore JM, 1999, ICARUS, V140, P294, DOI 10.1006/icar.1999.6132; PAPPALARDO RT, 2000, EOS, V81, pF791; PILCHER CB, 1972, SCIENCE, V178, P1087, DOI 10.1126/science.178.4065.1087; SHOEMAKER G, 1982, SATELLITES JUPITER, P435; SPENCER JR, 1987, ICARUS, V69, P297, DOI 10.1016/0019-1035(87)90107-2; VANKEULEN L, 2000, LUNAR PLANET SCI, V31, P1539; ZOLOTOV MY, IN PRESS J GEOPHYS R	25	110	115	0	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 25	2001	292	5521					1523	1525		10.1126/science.1059916	http://dx.doi.org/10.1126/science.1059916			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YQ	11375486				2022-12-24	WOS:000168963800038
J	Cronin, DC; Millis, JM; Siegler, M				Cronin, DC; Millis, JM; Siegler, M			Transplantation of liver grafts from living donors into adults - Too much, too soon.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							RIGHT LOBE GRAFT; SURGICAL TECHNIQUES; WAITING TIME; MORTALITY; CHILDREN; SIZE; FAILURE; ETHICS		Univ Chicago, Chicago, IL 60637 USA	University of Chicago	Cronin, DC (corresponding author), Univ Chicago, Chicago, IL 60637 USA.		Millis, Michael/K-5346-2019					Amersi F, 1998, Clin Transpl, P255; Ben-Haim M, 2000, TRANSPLANTATION, V69, pS290; BROELSCH C, 2000, WORKSH LIV DON LIV T; BROELSCH CE, 1991, ANN SURG, V214, P428, DOI 10.1097/00000658-199110000-00007; BROWN R, 2000, WORKSH LIV DON LIV T; Edwards EB, 1999, NEW ENGL J MED, V341, P2049, DOI 10.1056/NEJM199912303412703; EMOND JC, 1989, HEPATOLOGY, V10, P867, DOI 10.1002/hep.1840100520; EMOND JC, 1990, ANN SURG, V212, P14, DOI 10.1097/00000658-199007000-00003; Emre S, 1999, LIVER TRANSPLANT SUR, V5, P161, DOI 10.1002/lt.500050315; Everhart JE, 1997, TRANSPLANTATION, V64, P1300, DOI 10.1097/00007890-199711150-00012; Fan ST, 1996, HEPATO-GASTROENTEROL, V43, P893; Fan ST, 2000, ANN SURG, V231, P126, DOI 10.1097/00000658-200001000-00018; FREEDMAN B, 1987, NEW ENGL J MED, V317, P141, DOI 10.1056/NEJM198707163170304; Freeman RB, 2000, LIVER TRANSPLANT, V6, P543, DOI 10.1053/jlts.2000.9744; Goss JA, 1997, TRANSPLANTATION, V64, P871, DOI 10.1097/00007890-199709270-00014; Grewal HP, 1998, ANN SURG, V228, P214, DOI 10.1097/00000658-199808000-00011; Hirano I, 2000, LIVER TRANSPLANT, V6, P250, DOI 10.1016/S1527-6465(00)80023-4; Inomata Y, 2000, TRANSPLANTATION, V69, P258, DOI 10.1097/00007890-200001270-00011; Kim WR, 1998, HEPATOLOGY, V28, P33, DOI 10.1002/hep.510280106; Kiuchi T, 1999, TRANSPLANTATION, V67, P321, DOI 10.1097/00007890-199901270-00024; Llovet JM, 1999, HEPATOLOGY, V30, P1434, DOI 10.1002/hep.510300629; Lo CM, 1997, TRANSPLANTATION, V63, P1524, DOI 10.1097/00007890-199705270-00027; Lo CM, 1997, ANN SURG, V226, P261, DOI 10.1097/00000658-199709000-00005; MALAGO M, 1994, TRANSPLANT P, V26, P3620; Marcos A, 1999, TRANSPLANTATION, V68, P798, DOI 10.1097/00007890-199909270-00012; MARCOS A, 2000, 1 JOINT ANN M AM SOC; Millis J M, 1995, Clin Transpl, P187; Millis JM, 2000, ANN SURG, V232, P104, DOI 10.1097/00000658-200007000-00015; Miwa S, 1999, HEPATOLOGY, V30, P1521, DOI 10.1002/hep.510300621; MOORE FD, 1988, TRANSPLANT P, V20, P1061; MORI K, 1992, TRANSPLANTATION, V54, P263, DOI 10.1097/00007890-199208000-00014; Piper J B, 1992, Clin Transpl, P179; Pomposelli JJ, 2000, TRANSPLANTATION, V69, pS291; ROGIERS X, 1994, BRIT J SURG, V81, P1251, DOI 10.1002/bjs.1800810903; SINGER PA, 1989, NEW ENGL J MED, V321, P620, DOI 10.1056/NEJM198908313210919; STRONG RW, 1990, NEW ENGL J MED, V322, P1505, DOI 10.1056/NEJM199005243222106; Strong RW, 1999, LIVER TRANSPLANT SUR, V5, P536, DOI 10.1002/lt.500050613; TANAKA K, 1993, ANN SURG, V217, P82, DOI 10.1097/00000658-199301000-00014; Testa G, 1999, LANGENBECK ARCH SURG, V384, P536, DOI 10.1007/s004230050240; *US SCI REG TRANSP, 2000, 2000 ANN REP US SCI; Wachs ME, 1998, TRANSPLANTATION, V66, P1313, DOI 10.1097/00007890-199811270-00008; YAMAOKA Y, 1995, TRANSPLANTATION, V59, P224	42	161	161	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 24	2001	344	21					1633	1637		10.1056/NEJM200105243442112	http://dx.doi.org/10.1056/NEJM200105243442112			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	434RM	11372018				2022-12-24	WOS:000168829700012
J	Ku, NO; Gish, R; Wright, TL; Omary, MB				Ku, NO; Gish, R; Wright, TL; Omary, MB			Keratin 8 mutations in patients with cryptogenic liver disease.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							EPIDERMOLYSIS-BULLOSA SIMPLEX; GENETIC SKIN DISEASES; ENCODING LAMIN A/C; INTERMEDIATE FILAMENTS; TRANSGENIC MICE; PARTIAL LIPODYSTROPHY; HEPATOCYTE INTEGRITY; MISSENSE MUTATIONS; SKELETAL MYOPATHY; RAT HEPATOCYTES	Background: About 10 percent of patients who undergo liver transplantation have cryptogenic liver disease. In animal models, the absence of heteropolymeric keratins 8 and 18 or the presence of mutant keratins in hepatocytes causes or promotes liver disease. We have previously described a mutation in the keratin 18 gene in a patient with cryptogenic cirrhosis, but the importance of mutations in the keratin 8 and keratin 18 genes in such patients is unclear. Methods: We tested for mutations in the keratin 8 and keratin 18 genes in purified genomic DNA isolated from 150 explanted livers and 89 peripheral-blood specimens from three groups of patients: 55 patients with cryptogenic liver disease; 98 patients with noncryptogenic liver disease, with causes that included alcohol use, autoimmunity, drug use, and viral infections; and 86 randomly selected inpatients and outpatients who provided blood to the hematology laboratory. Results: Of the 55 patients with cryptogenic liver disease, 3 had glycine-to-cysteine mutations at position 61 (a highly conserved glycine) of keratin 8, and 2 had tyrosine-to-histidine mutations at position 53 of keratin 8. These mutations were not detected in the patients with other liver diseases or in the randomly selected patients. In transfected cells, the glycine-to-cysteine mutation limited keratin-filament reorganization when the cells were exposed to oxidative stress. In contrast, the tyrosine-to-histidine mutation destabilized keratin filaments when transfected cells were exposed to heat or okadaic acid stress. Conclusions: Mutations in the keratin 8 gene may predispose people to liver disease and may account for cryptogenic liver disease in some patients. (N Engl J Med 2001;344:1580-7.) Copyright (C) 2001 Massachusetts Medical Society.	Vet Affairs Med Ctr, Gastroenterol Sect, Palo Alto, CA 94304 USA; Stanford Univ, Sch Med, Palo Alto, CA 94304 USA; Calif Pacific Med Ctr, Dept Transplantat, San Francisco, CA USA; Vet Affairs Med Ctr, Gastroenterol Sect, San Francisco, CA 94121 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Stanford University; California Pacific Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Ku, NO (corresponding author), Vet Affairs Med Ctr, Gastroenterol Sect, Mail Code 154J,3801 Miranda Ave, Palo Alto, CA 94304 USA.		Wilson, Matthew H/K-3193-2013; Gish, Robert/B-3605-2018	Gish, Robert/0000-0001-6306-3189; Omary, Bishr/0000-0002-8624-2347	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052951] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK52951] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BARIBAULT H, 1994, GENE DEV, V8, P2964, DOI 10.1101/gad.8.24.2964; BARIBAULT H, 1993, GENE DEV, V7, P1191, DOI 10.1101/gad.7.7a.1191; Bonne G, 1999, NAT GENET, V21, P285, DOI 10.1038/6799; Caldwell SH, 1999, HEPATOLOGY, V29, P664, DOI 10.1002/hep.510290347; Cao H, 2000, HUM MOL GENET, V9, P109, DOI 10.1093/hmg/9.1.109; CHAN YM, 1993, P NATL ACAD SCI USA, V90, P7414, DOI 10.1073/pnas.90.15.7414; Charlton M R, 1997, Liver Transpl Surg, V3, P359, DOI 10.1002/lt.500030402; CHIPEV CC, 1992, CELL, V70, P821, DOI 10.1016/0092-8674(92)90315-4; Covello SP, 1998, BRIT J DERMATOL, V139, P475; Dalakas MC, 2000, NEW ENGL J MED, V342, P770, DOI 10.1056/NEJM200003163421104; Fatkin D, 1999, NEW ENGL J MED, V341, P1715, DOI 10.1056/NEJM199912023412302; FUCHS E, 1992, CELL, V69, P899, DOI 10.1016/0092-8674(92)90607-E; Fuchs E, 1998, SCIENCE, V279, P514, DOI 10.1126/science.279.5350.514; FUCHS E, 1994, ANNU REV BIOCHEM, V63, P345, DOI 10.1146/annurev.biochem.63.1.345; Goldfarb LG, 1998, NAT GENET, V19, P402, DOI 10.1038/1300; Hoet P, 1997, LANCET, V350, P556, DOI 10.1016/S0140-6736(97)03094-8; Irvine AD, 1999, BRIT J DERMATOL, V140, P815, DOI 10.1046/j.1365-2133.1999.02810.x; Jochimsen EM, 1998, NEW ENGL J MED, V338, P873, DOI 10.1056/NEJM199803263381304; Jochimsen EM, 1998, NEW ENGL J MED, V339, P139; Kingham JGC, 2000, GUT, V47, P328, DOI 10.1136/gut.47.3.328; Ku NO, 2000, J CELL BIOL, V149, P547, DOI 10.1083/jcb.149.3.547; Ku NO, 1999, AM J PHYSIOL-GASTR L, V277, pG1108, DOI 10.1152/ajpgi.1999.277.6.G1108; Ku NO, 1996, J CLIN INVEST, V98, P1034, DOI 10.1172/JCI118864; KU NO, 1995, J CELL BIOL, V131, P1303, DOI 10.1083/jcb.131.5.1303; Ku NO, 1998, J CELL BIOL, V143, P2023, DOI 10.1083/jcb.143.7.2023; Ku NO, 1997, J CLIN INVEST, V99, P19, DOI 10.1172/JCI119127; KULESH DA, 1989, MOL CELL BIOL, V9, P1553, DOI 10.1128/MCB.9.4.1553; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIAO J, 1995, EXP CELL RES, V219, P348, DOI 10.1006/excr.1995.1238; Liao J, 1996, ELECTROPHORESIS, V17, P1671, DOI 10.1002/elps.1150171104; Loranger A, 1997, AM J PATHOL, V151, P1673; Magin T M, 1998, Subcell Biochem, V31, P141; MCLEAN WHI, 1995, CURR OPIN CELL BIOL, V7, P118; MOLL R, 1982, CELL, V31, P11, DOI 10.1016/0092-8674(82)90400-7; Muller FB, 1998, J INVEST DERMATOL, V111, P900, DOI 10.1046/j.1523-1747.1998.00374.x; Muller T, 1999, J PEDIATR-US, V135, P189, DOI 10.1016/S0022-3476(99)70021-1; Munoz-Marmol AM, 1998, P NATL ACAD SCI USA, V95, P11312, DOI 10.1073/pnas.95.19.11312; OHTA T, 1992, CARCINOGENESIS, V13, P2443, DOI 10.1093/carcin/13.12.2443; Omary MB, 1997, HEPATOLOGY, V25, P1043, DOI 10.1002/hep.510250537; Ponsoda X, 1999, BIOCHEM PHARMACOL, V58, P1579, DOI 10.1016/S0006-2952(99)00249-X; Poonawala A, 2000, HEPATOLOGY, V32, P689, DOI 10.1053/jhep.2000.17894; QUINLAN RA, 1984, J MOL BIOL, V178, P365, DOI 10.1016/0022-2836(84)90149-9; RAGHU G, 1986, BRIT J EXP PATHOL, V67, P105; *SAS I, 1995, JMP STAT GRAPH GUID; Shackleton S, 2000, NAT GENET, V24, P153, DOI 10.1038/72807; STEINERT PM, 1993, J BIOL CHEM, V268, P2878; STEINERT PM, 1993, TRENDS GENET, V9, P280, DOI 10.1016/0168-9525(93)90014-9; Struben VMD, 2000, AM J MED, V108, P9, DOI 10.1016/S0002-9343(99)00315-0; Toivola DM, 1998, HEPATOLOGY, V28, P116, DOI 10.1002/hep.510280117; Toivola DM, 1997, J CELL SCI, V110, P23; YANG JM, 1994, J INVEST DERMATOL, V102, P17, DOI 10.1111/1523-1747.ep12371725; Yang JM, 1996, J INVEST DERMATOL, V107, P439, DOI 10.1111/1523-1747.ep12365483; Zatloukal K, 2000, AM J PATHOL, V156, P1263, DOI 10.1016/S0002-9440(10)64997-8	53	136	142	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 24	2001	344	21					1580	1587		10.1056/NEJM200105243442103	http://dx.doi.org/10.1056/NEJM200105243442103			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	434RM	11372009				2022-12-24	WOS:000168829700003
J	Perrier, A; Howarth, N; Didier, D; Loubeyre, P; Unger, PF; de Moerloose, P; Slosman, D; Junod, A; Bounameaux, H				Perrier, A; Howarth, N; Didier, D; Loubeyre, P; Unger, PF; de Moerloose, P; Slosman, D; Junod, A; Bounameaux, H			Performance of helical computed tomography in unselected outpatients with suspected pulmonary embolism	ANNALS OF INTERNAL MEDICINE			English	Article							DEEP VENOUS THROMBOSIS; VENTILATION-PERFUSION SCINTIGRAPHY; SPIRAL CT; D-DIMER; MEDICAL LITERATURE; VEIN THROMBOSIS; DIAGNOSTIC-TEST; USERS GUIDES; LUNG-SCAN; ANGIOGRAPHY	Background: Helical computed tomography (CT) is commonly used to diagnose pulmonary embolism, although its operating characteristics have been insufficiently evaluated. Objective: To assess the sensitivity and specificity of helical CT in suspected pulmonary embolism. Design: observational study. Setting: Emergency department of a teaching and community hospital. Patients: 299 patients with clinically suspected pulmonary embolism and a plasma D-dimer level greater than 500 mug/L. Intervention: Pulmonary embolism was established by using a validated algorithm that included clinical assessment, lower-limb compression ultrasonography, lung scanning, and pulmonary angiography. Measurements: Sensitivity, specificity, and likelihood ratios of helical CT and interobserver agreement. Helical CT scans were withheld from clinicians and were read 3 months after acquisition by radiologists blinded to all clinical data. Results: 118 patients (39%) had pulmonary embolism, In 12 patients (4%), 2 of whom had pulmonary embolism, results of helical CT were inconclusive, For patients with conclusive results, sensitivity of helical CT was 70% (95% CI, 62% to 78%) and specificity was 91% (CI, 86% to 95%), Interobserver agreement was high (kappa = 0.823 to 0,902). The false-negative rate was lower for helical CT used after initial negative results on ultrasonography than for helical CT alone (21% vs, 30%). Use of helical CT after normal results on initial ultrasonography and nondiagnostic results on lung scanning had a false-negative rate of only 5% and a false-positive rate of only 7%. Conclusion: Helical CT should not be used alone for suspected pulmonary embolism but could replace angiography in combined strategies that include ultrasonography and lung scanning.	Univ Hosp Geneva, Dept Internal Med, Med Clin 1, CH-1211 Geneva 14, Switzerland	University of Geneva	Perrier, A (corresponding author), Univ Hosp Geneva, Dept Internal Med, Med Clin 1, Rue Micheli Du Crest 24, CH-1211 Geneva 14, Switzerland.	Arnaud.Perrier@medecine.unige.ch	Perrier, Arnaud/M-2263-2014					BECKER DM, 1989, ARCH INTERN MED, V149, P1731, DOI 10.1001/archinte.149.8.1731; Becker DM, 1996, ARCH INTERN MED, V156, P939, DOI 10.1001/archinte.156.9.939; BOUNAMEAUX H, 1991, LANCET, V337, P196, DOI 10.1016/0140-6736(91)92158-X; Bounameaux H, 1997, QJM-INT J MED, V90, P437, DOI 10.1093/qjmed/90.7.437; Cham MD, 2000, RADIOLOGY, V216, P744, DOI 10.1148/radiology.216.3.r00se44744; deMoerloose P, 1996, THROMB HAEMOSTASIS, V75, P11; Drucker EA, 1998, RADIOLOGY, V209, P235, DOI 10.1148/radiology.209.1.9769837; Garg K, 1998, RADIOLOGY, V208, P201, DOI 10.1148/radiology.208.1.9646814; GOODMAN LR, 1995, AM J ROENTGENOL, V164, P1369, DOI 10.2214/ajr.164.6.7754875; HULL RD, 1994, ARCH INTERN MED, V154, P289, DOI 10.1001/archinte.154.3.289; JAESCHKE R, 1994, JAMA-J AM MED ASSOC, V271, P389, DOI 10.1001/jama.271.5.389; JAESCHKE R, 1994, JAMA-J AM MED ASSOC, V271, P703, DOI 10.1001/jama.271.9.703; Kearon C, 1998, ANN INTERN MED, V129, P1044, DOI 10.7326/0003-4819-129-12-199812150-00009; Kim KI, 1999, RADIOLOGY, V210, P693, DOI 10.1148/radiology.210.3.r99mr01693; LENSING AWA, 1989, NEW ENGL J MED, V320, P342, DOI 10.1056/NEJM198902093200602; Loud PA, 2000, AM J ROENTGENOL, V174, P61, DOI 10.2214/ajr.174.1.1740061; Mayo JR, 1997, RADIOLOGY, V205, P447, DOI 10.1148/radiology.205.2.9356627; Mullins MD, 2000, ARCH INTERN MED, V160, P293, DOI 10.1001/archinte.160.3.293; Perrier A, 2000, ARCH INTERN MED, V160, P512, DOI 10.1001/archinte.160.4.512; Perrier A, 1996, ARCH INTERN MED, V156, P531, DOI 10.1001/archinte.156.5.531; Perrier A, 1999, LANCET, V353, P190, DOI 10.1016/S0140-6736(98)05248-9; Rathbun SW, 2000, ANN INTERN MED, V132, P227, DOI 10.7326/0003-4819-132-3-200002010-00009; RemyJardin M, 1996, RADIOLOGY, V200, P699, DOI 10.1148/radiology.200.3.8756918; RemyJardin M, 1997, RADIOLOGY, V204, P157, DOI 10.1148/radiology.204.1.9205239; REMYJARDIN M, 1992, RADIOLOGY, V185, P381, DOI 10.1148/radiology.185.2.1410342; Silverstein MD, 1998, ARCH INTERN MED, V158, P585, DOI 10.1001/archinte.158.6.585; Sostman HD, 1996, JMRI-J MAGN RESON IM, V6, P275, DOI 10.1002/jmri.1880060203; SOSTMAN HD, 1994, RADIOLOGY, V193, P103, DOI 10.1148/radiology.193.1.8090877; Turkstra F, 1997, ANN INTERN MED, V126, P775, DOI 10.7326/0003-4819-126-10-199705150-00005; vanRossum AB, 1996, THORAX, V51, P23, DOI 10.1136/thx.51.1.23; vanRossum AB, 1996, RADIOLOGY, V201, P467, DOI 10.1148/radiology.201.2.8888242; Wells PS, 1998, ANN INTERN MED, V129, P997, DOI 10.7326/0003-4819-129-12-199812150-00002; Woodard PK, 2000, RADIOLOGY, V215, P325, DOI 10.1148/radiology.215.2.r00ma48325; 1990, JAMA, V263, P2753	34	232	238	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 17	2001	135	2					88	97		10.7326/0003-4819-135-2-200107170-00008	http://dx.doi.org/10.7326/0003-4819-135-2-200107170-00008			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	452DR	11453707				2022-12-24	WOS:000169842300002
J	Wells, PS; Anderson, DR; Rodger, M; Stiell, I; Dreyer, JF; Barnes, D; Forgie, M; Kovacs, G; Ward, J; Kovacs, MJ				Wells, PS; Anderson, DR; Rodger, M; Stiell, I; Dreyer, JF; Barnes, D; Forgie, M; Kovacs, G; Ward, J; Kovacs, MJ			Excluding pulmonary embolism at the bedside without diagnostic imaging: Management of patients with suspected pulmonary embolism presenting to the emergency department by using a simple clinical model and D-dimer	ANNALS OF INTERNAL MEDICINE			English	Article							DEEP-VEIN THROMBOSIS; VENOUS THROMBOEMBOLISM; ANGIOGRAPHY; ULTRASONOGRAPHY; SCINTIGRAPHY; PROBABILITY; UTILITY; SCAN; CT	Background: The limitations of the current diagnostic standard, ventilation-perfusion lung scanning, complicate the management of patients with suspected pulmonary embolism. We previously demonstrated that determining the pretest probability can assist with management and that the high negative predictive value of certain D-dimer assays may simplify the diagnostic process. Objective: To determine the safety of using a simple clinical model combined with D-dimer assay to manage patients presenting to the emergency department with suspected pulmonary embolism. Design: Prospective cohort study. Setting: Emergency departments at four tertiary care hospitals in Canada. Patients: 930 consecutive patients with suspected pulmonary embolism. Interventions: Physicians first used a clinical model to determine patients' pretest probability of pulmonary embolism and then performed a D-dimer test. Patients with low pretest probability and a negative D-dimer result had no further tests and were considered to have a diagnosis of pulmonary embolism excluded. All other patients underwent ventilation-perfusion lung scanning. If the scan was nondiagnostic, bilateral deep venous ultrasonography was done. Whether further testing (by serial ultrasonography or angiography) was done depended on the patients' pretest probability and the lung scanning results. Measurements: Patients received a diagnosis of pulmonary embolism if they had a high-probability ventilation-perfusion scan, an abnormal result on ultrasonography or pulmonary angiography, or a venous thromboembolic event during follow-up. Patients for whom the diagnosis was considered excluded were followed up for 3 months for the development of thromboembolic events. Results: The pretest probability of pulmonary embolism was low, moderate, and high in 527, 339, and 64 patients (1.3%, 16.2%, and 37.5% had pulmonary embolism), respectively. Of 849 patients in whom a diagnosis of pulmonary-embolism had initially been excluded, 5 (0.6% [95% CI, 0.2% to 1.4%]) developed pulmonary embolism or deep venous thrombosis during followup. However, 4 of these patients had not undergone the proper diagnostic testing protocol. In 7 of the patients who received a diagnosis of pulmonary embolism, the physician had performed more diagnostic tests than were called for by the algorithm. In 759 of the 849 patients in whom pulmonary embolism was not found on initial evaluation, the diagnostic protocol was followed correctly. Only 1 (0.1% [CI, 0.0% to 0.7%]) of these 759 patients developed thromboembolic events during follow-up. Of the 437 patients with a negative D-dimer result and low clinical probability, only 1 developed pulmonary embolism during follow-up; thus, the negative predictive value for the combined strategy of using the clinical model with D-dimer testing in these patients was 99.5% (CI, 99.1% to 100%). Conclusion: Managing patients for suspected pulmonary embolism on the basis of pretest probability and sigma -dimer result is safe and decreases the need for diagnostic imaging.	Univ Ottawa, Ottawa, ON K1N 6N5, Canada; Univ Western Ontario, London, ON N6A 3K7, Canada; Dalhousie Univ, Halifax, NS B3H 3J5, Canada; Univ British Columbia, Vancouver, BC V5Z 1M9, Canada	University of Ottawa; Western University (University of Western Ontario); Dalhousie University; University of British Columbia	Wells, PS (corresponding author), Suite 452,737 Parkdale Ave, Ottawa, ON K1Y 1J8, Canada.		Kovacs, Michael/G-3315-2011	Anderson, David/0000-0003-0845-1722; Stiell, Ian/0000-0002-2583-6408; Rodger, Marc/0000-0001-8166-3487				Anderson DR, 1999, ARCH INTERN MED, V159, P477, DOI 10.1001/archinte.159.5.477; ANDERSON FA, 1991, ARCH INTERN MED, V151, P933, DOI 10.1001/archinte.151.5.933; Bauld DL, 1999, AM J EMERG MED, V17, P11, DOI 10.1016/S0735-6757(99)90004-9; CARSON JL, 1992, NEW ENGL J MED, V326, P1240, DOI 10.1056/NEJM199205073261902; de Groot MR, 1999, THROMB HAEMOSTASIS, V82, P1588; Farrell S, 2000, ANN EMERG MED, V35, P121, DOI 10.1016/S0196-0644(00)70130-2; Ferretti GR, 1997, RADIOLOGY, V205, P453, DOI 10.1148/radiology.205.2.9356628; FRANKEL N, 1986, J NUCL MED, V27, P366; Gupta A, 1999, RADIOLOGY, V210, P353, DOI 10.1148/radiology.210.2.r99fe53353; HEIJBOER H, 1992, ACTA RADIOL, V33, P297; HULL RD, 1983, ANN INTERN MED, V98, P891, DOI 10.7326/0003-4819-98-6-891; Kember PG, 1997, BRIT J RADIOL, V70, P1109, DOI 10.1259/bjr.70.839.9536900; LENSING AWA, 1992, THROMB HAEMOSTASIS, V68, P245; LENSING AWA, 1989, NEW ENGL J MED, V320, P342, DOI 10.1056/NEJM198902093200602; Perrier A, 1999, LANCET, V353, P190, DOI 10.1016/S0140-6736(98)05248-9; RemyJardin M, 1996, RADIOLOGY, V200, P699, DOI 10.1148/radiology.200.3.8756918; Schluger N, 1994, J Thorac Imaging, V9, P180, DOI 10.1097/00005382-199422000-00013; STEIN PD, 1992, CIRCULATION, V85, P462, DOI 10.1161/01.CIR.85.2.462; Wells PS, 1998, ANN INTERN MED, V129, P997, DOI 10.7326/0003-4819-129-12-199812150-00002; Wells PS, 2000, THROMB HAEMOSTASIS, V83, P416; 1990, JAMA, V263, P2753	21	932	971	0	27	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 17	2001	135	2					98	107		10.7326/0003-4819-135-2-200107170-00010	http://dx.doi.org/10.7326/0003-4819-135-2-200107170-00010			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	452DR	11453709				2022-12-24	WOS:000169842300003
J	Eggenschwiler, JT; Espinoza, E; Anderson, KV				Eggenschwiler, JT; Espinoza, E; Anderson, KV			Rab23 is an essential negative regulator of the mouse Sonic hedgehog signalling pathway	NATURE			English	Article							NEURAL-TUBE; OPEN BRAIN; GENE; MICE; CHOLESTEROL; SPECIFICITY; MUTATION; DEFECTS; FAMILY; DORSAL	The mouse open brain (opb) and Sonic hedgehog (Shh) genes have opposing roles in neural patterning: opb is required for dorsal cell types and Shh is required for ventral cell types in the spinal cord(1-3). Here we show that opb acts downstream of Shh. Ventral cell types that are absent in Shh mutants, including the floor plate, are present in Shh opb double mutants. The organization of ventral cell types in Shh opb double mutants reveals that Shh-independent mechanisms can pattern the neural tube along its dorsal-ventral axis. We cloned opb by a map-based approach and found that it encodes Rab23, a member of the Rab family of vesicle transport proteins. The data indicate that dorsalizing signals activate transcription of Rab23 in order to silence the Shh pathway in dorsal neural cells.	Sloan Kettering Inst, Program Mol Biol, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Anderson, KV (corresponding author), Sloan Kettering Inst, Program Mol Biol, 1275 York Ave, New York, NY 10021 USA.	k-anderson@ski.mskcc.org		Anderson, Kathryn/0000-0003-1657-2161				Bock JB, 2001, NATURE, V409, P839, DOI 10.1038/35057024; CAPDEVILA J, 1994, DEVELOPMENT, V120, P987; Carstea ED, 1997, SCIENCE, V277, P228, DOI 10.1126/science.277.5323.228; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Denef N, 2000, CELL, V102, P521, DOI 10.1016/S0092-8674(00)00056-8; ECHELARD Y, 1993, CELL, V75, P1417, DOI 10.1016/0092-8674(93)90627-3; Eggenschwiler JT, 2000, DEV BIOL, V227, P648, DOI 10.1006/dbio.2000.9918; FORBES AJ, 1993, DEVELOPMENT, P115; Goodrich LV, 1996, GENE DEV, V10, P301, DOI 10.1101/gad.10.3.301; Goodrich LV, 1998, NEURON, V21, P1243, DOI 10.1016/S0896-6273(00)80645-5; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; GUNTHER T, 1994, DEVELOPMENT, V120, P3119; Holtta-Vuori M, 2000, CURR BIOL, V10, P95, DOI 10.1016/S0960-9822(99)99991-8; HUI CC, 1993, NAT GENET, V3, P241, DOI 10.1038/ng0393-241; Incardona JP, 2000, P NATL ACAD SCI USA, V97, P12044, DOI 10.1073/pnas.220251997; Ingham PW, 1998, EMBO J, V17, P3505, DOI 10.1093/emboj/17.13.3505; Kasarskis A, 1998, P NATL ACAD SCI USA, V95, P7485, DOI 10.1073/pnas.95.13.7485; Lee KJ, 2000, NATURE, V403, P734, DOI 10.1038/35001507; Liem KF, 2000, DEVELOPMENT, V127, P4855; LITINGTUNG Y, 2000, NAT NEUROSCI, V10, P979; Matise MP, 1999, ONCOGENE, V18, P7852, DOI 10.1038/sj.onc.1203243; McMahon JA, 1998, GENE DEV, V12, P1438, DOI 10.1101/gad.12.10.1438; Methot N, 2001, DEVELOPMENT, V128, P733; Milenkovic L, 1999, DEVELOPMENT, V126, P4431; Mo R, 1997, DEVELOPMENT, V124, P113; OLKKONEN VM, 1994, GENE, V138, P207, DOI 10.1016/0378-1119(94)90809-5; Ostermeier C, 1999, CELL, V96, P363, DOI 10.1016/S0092-8674(00)80549-8; Pereira-Leal JB, 2000, J MOL BIOL, V301, P1077, DOI 10.1006/jmbi.2000.4010; Sonnichsen B, 2000, J CELL BIOL, V149, P901, DOI 10.1083/jcb.149.4.901; Wilson SM, 2000, P NATL ACAD SCI USA, V97, P7933, DOI 10.1073/pnas.140212797	30	284	296	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 12	2001	412	6843					194	198		10.1038/35084089	http://dx.doi.org/10.1038/35084089			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	451AJ	11449277				2022-12-24	WOS:000169778700055
J	Melnick, GJ; Neufeld, DA; Ford, KES; Hollenbach, DJ; Ashby, MLN				Melnick, GJ; Neufeld, DA; Ford, KES; Hollenbach, DJ; Ashby, MLN			Discovery of water vapour around IRC+10216 as evidence for comets orbiting another star	NATURE			English	Article							WAVE-ASTRONOMY-SATELLITE; SUBMILLIMETER; MILLIMETER; MOLECULES; SPECTRUM; LINES; HCN	Since 1995, planets with masses comparable to that of Jupiter have been discovered around approximately 60 stars(1). These planets have not been seen directly, but their presence has been inferred from the small reflex motions that they gravitationally induce on the star they orbit; these motions result in small periodic wavelength shifts in the stellar spectrum. The presence of analogues of the smaller bodies in our Solar System cannot, however, be determined using this technique, because the induced reflex motions are too small-so an alternative approach is needed. Here we report the observation of circumstellar water vapour around the ageing carbon star IRC+10216; water is not expected in measurable quantities around such a star. The only plausible explanation for this water is that the recent evolution of IRC+10216, which has been accompanied by a prodigious increase in its luminosity, is causing the vaporization of a collection of orbiting icy bodies-a process considered in an earlier theoretical study(2).	Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; Johns Hopkins Univ, Dept Phys & Astron, Baltimore, MD 21218 USA; NASA, Ames Res Ctr, Moffett Field, CA 94035 USA	Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; Johns Hopkins University; National Aeronautics & Space Administration (NASA); NASA Ames Research Center	Melnick, GJ (corresponding author), Harvard Smithsonian Ctr Astrophys, 60 Garden St, Cambridge, MA 02138 USA.							Ashby MLN, 2000, ASTROPHYS J, V539, pL115, DOI 10.1086/312842; Cernicharo J, 1999, ASTROPHYS J, V526, pL41, DOI 10.1086/312360; Cernicharo J, 1996, ASTRON ASTROPHYS, V315, pL201; DELUCIA FC, 1977, J CHEM PHYS, V67, P4262, DOI 10.1063/1.435363; Glassgold AE, 1996, ANNU REV ASTRON ASTR, V34, P241, DOI 10.1146/annurev.astro.34.1.241; Herpin F, 2000, ASTROPHYS J, V530, pL129, DOI 10.1086/312507; Hogerheijde MR, 2000, ASTRON ASTROPHYS, V362, P697; Jewitt D. C., 2000, Protostars and planets 4, P1201; Marcy GW, 2000, PUBL ASTRON SOC PAC, V112, P137, DOI 10.1086/316516; Melnick GJ, 2000, ASTROPHYS J, V539, pL77, DOI 10.1086/312856; Millar TJ, 2000, MON NOT R ASTRON SOC, V316, P195, DOI 10.1046/j.1365-8711.2000.03560.x; Neufeld DA, 1999, ASTROPHYS J, V517, pL147, DOI 10.1086/312036; Pickett HM, 1998, J QUANT SPECTROSC RA, V60, P883, DOI 10.1016/S0022-4073(98)00091-0; Skinner CJ, 1999, MON NOT R ASTRON SOC, V302, P293, DOI 10.1046/j.1365-8711.1999.02113.x; STERN SA, 1990, NATURE, V345, P305, DOI 10.1038/345305a0; Willacy K, 1998, ASTRON ASTROPHYS, V330, P676; WILLIAMS PG, 1992, ASTRON ASTROPHYS, V266, P365; WOOLF NJ, 1964, ASTROPHYS J, V140, P833, DOI 10.1086/147989	18	109	110	0	4	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 12	2001	412	6843					160	163		10.1038/35084024	http://dx.doi.org/10.1038/35084024			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	451AJ	11449266				2022-12-24	WOS:000169778700044
J	Facinelli, B; Spinaci, C; Magi, G; Giovanetti, E; Varaldo, PE				Facinelli, B; Spinaci, C; Magi, G; Giovanetti, E; Varaldo, PE			Association between erythromycin resistance and ability to enter human respiratory cells in group A streptococci	LANCET			English	Article							GROUP-A STREPTOCOCCI; FIBRONECTIN-BINDING-PROTEIN; EPITHELIAL-CELLS; PYOGENES; INVASION; INTERNALIZATION; PHENOTYPES; STRAINS; GENE	Background An increase in erythromycin resistance rates among group A streptococci has been reported in some European countries. These bacteria, long thought to be extracellular pathogens, can be efficiently internalised by, and survive within, human cells of respiratory-tract origin. Macrolide antibiotics enter eukaryotic cells, whereas beta -lactams are essentially confined to the extracellular fluid. A protein encoded by gene prtF1 is required for efficient entry of group A streptococci into epithelial cells. We investigated isolates of group A streptococci from children with pharyngitis in Italy for the presence of prtF1 and cell-invasion efficiency. Methods We investigated 74 erythromycin-resistant and 52 erythromycin-susceptible isolates collected throughout Italy in 1997-98 from children with pharyngitis. Erythromycin-resistance phenotypes (constitutive, inducible, and M) were assessed by the triple-disc test and resistance determinants (ermB, ermTR, and mefA) by PCR. All strains were examined for the presence of prtF1 by PCR and for their ability to enter cultured human respiratory cells. Findings The proportion of prtF1-positive strains was significantly higher among erythromycin-resistant than susceptible strains (66 [89%] vs 11 [21%]; difference 68% [95% CI 52-84]). All erythromycin-resistant strains without prtF1 were of the M phenotype. The proportion of highly cell-invasive isolates (invasion efficiency >10%) was significantly higher among erythromycin-resistant than among susceptible strains (59 [80%] vs five [10%]; difference 70% [57-83]). Interpretations The unsuspected association between erythromycin resistance and cell invasiveness in group A streptococci raises serious concern. Strains combining erythromycin resistance and ability to enter human respiratory-tract cells may be able to escape both p-lactams by virtue of intracellular location and macrolides by virtue of resistance.	Univ Ancona, Sch Med, Inst Microbiol, I-60131 Ancona, Italy	Marche Polytechnic University	Facinelli, B (corresponding author), Univ Ancona, Sch Med, Inst Microbiol, Via Ranieri, I-60131 Ancona, Italy.			GIOVANETTI, Eleonora/0000-0002-9427-8091; VARALDO, Pietro/0000-0002-4131-487X				Cue DR, 1997, INFECT IMMUN, V65, P2759, DOI 10.1128/IAI.65.7.2759-2764.1997; Gillespie SH, 1998, LANCET, V352, P1954, DOI 10.1016/S0140-6736(05)61327-X; Giovanetti E, 1999, ANTIMICROB AGENTS CH, V43, P1935, DOI 10.1128/AAC.43.8.1935; HSUEH PR, 1995, ANTIMICROB AGENTS CH, V39, P2239, DOI 10.1128/AAC.39.10.2239; KAPLAN EL, 1997, CLIN INFECT DIS    S, V24, P89; LAPENTA D, 1994, P NATL ACAD SCI USA, V91, P12115, DOI 10.1073/pnas.91.25.12115; Medina E, 1999, J IMMUNOL, V163, P3396; MITSUHASHI S, 1982, MICROBIOLOGY 1982, P151; Molinari G, 1998, J INFECT DIS, V177, P1600, DOI 10.1086/515310; Molinari G, 1999, CURR OPIN MICROBIOL, V2, P56, DOI 10.1016/S1369-5274(99)80010-1; Molinari G, 1997, INFECT IMMUN, V65, P1357, DOI 10.1128/IAI.65.4.1357-1363.1997; NATANSON S, 1995, J INFECT DIS, V171, P871, DOI 10.1093/infdis/171.4.871; National Committee for Clinical Laboratory Standards, 1997, METH DIL ANT SUSC TE; Neeman R, 1998, LANCET, V352, P1974, DOI 10.1016/S0140-6736(97)12452-7; Osterlund A, 1997, LARYNGOSCOPE, V107, P640; Ozeri V, 1998, MOL MICROBIOL, V30, P625, DOI 10.1046/j.1365-2958.1998.01097.x; SCHITO GC, 1998, 39 INT C ANT AG CHEM; SEPPALA H, 1993, J ANTIMICROB CHEMOTH, V32, P885, DOI 10.1093/jac/32.6.885; SEPPALA H, 1992, NEW ENGL J MED, V326, P292, DOI 10.1056/NEJM199201303260503; Seppala H, 1998, ANTIMICROB AGENTS CH, V42, P257; Sutcliffe J, 1996, ANTIMICROB AGENTS CH, V40, P2562, DOI 10.1128/AAC.40.11.2562; Sutcliffe J, 1996, ANTIMICROB AGENTS CH, V40, P1817, DOI 10.1128/AAC.40.8.1817; Varaldo PE, 1999, CLIN INFECT DIS, V29, P869, DOI 10.1086/520451; WEISBLUM B, 1995, ANTIMICROB AGENTS CH, V39, P577, DOI 10.1128/AAC.39.3.577	24	78	78	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 7	2001	358	9275					30	33		10.1016/S0140-6736(00)05253-3	http://dx.doi.org/10.1016/S0140-6736(00)05253-3			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	449WV	11454374				2022-12-24	WOS:000169710900013
J	Ducros, A; Denier, C; Joutel, A; Cecillon, M; Lescoat, C; Vahedi, K; Darcel, F; Vicaut, E; Bousser, M; Tournier-Lasserve, E				Ducros, A; Denier, C; Joutel, A; Cecillon, M; Lescoat, C; Vahedi, K; Darcel, F; Vicaut, E; Bousser, M; Tournier-Lasserve, E			The clinical spectrum of familial hemiplegic migraine associated with mutations in a neuronal calcium channel.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CACNA1A GENE MUTATION; DE-NOVO MUTATION; HETEROGENEITY; PREVALENCE; NYSTAGMUS; LOCUS; COMA; AURA; MAPS	Background: Familial hemiplegic migraine, an autosomal dominant disorder characterized by attacks of transient hemiparesis followed by a migraine headache, is divided into pure familial hemiplegic migraine (affecting 80 percent of families) and familial hemiplegic migraine with permanent cerebellar signs (affecting 20 percent of families). Mutations in CACNA1A, which encodes a neuronal calcium channel, are present in 50 percent of families with hemiplegic migraine, including all those with cerebellar signs. We studied the various clinical manifestations associated with mutations in CACNA1A in 28 families with hemiplegic migraine with and without cerebellar signs. Methods: CACNA1A was analyzed and nine mutations were detected in 15 of 16 probands of families affected by hemiplegic migraine and cerebellar signs, in 2 of 3 subjects with sporadic hemiplegic migraine and cerebellar signs, and in 4 of 12 probands of families affected by pure hemiplegic migraine. Genotyping of probands and relatives identified a total of 117 subjects with mutations whose clinical manifestations were assessed in detail. Results: Eighty-nine percent of the subjects with mutations had attacks of hemiplegic migraine. One third had severe attacks with coma, prolonged hemiplegia, or both, with full recovery. All nine mutations, including five newly identified ones, were missense mutations. Six mutations were associated with hemiplegic migraine and cerebellar signs, and 83 percent of the subjects with these six mutations had nystagmus, ataxia, or both. Three mutations were associated with pure hemiplegic migraine. Conclusions: Hemiplegic migraine in subjects with mutations in CACNA1A has a broad clinical spectrum. This clinical variability is partially associated with the various types of mutations. (N Engl J Med 2001;345:17-24.) Copyright (C) 2001 Massachusetts Medical Society.	Fac Med Lariboisiere, INSERM, E9921, Paris, France; Hop Lariboisiere, Dept Neurol, F-75475 Paris 10, France; Hop Lariboisiere, Genet Lab, F-75475 Paris 10, France; CHU, Dept Neurol, Rennes, France; Hop Fernand Widal, Biophys Lab, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; CHU Rennes; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite	Ducros, A (corresponding author), Hop Lariboisiere, Dept Neurol, 2 Rue Ambroise Pare, F-75475 Paris 10, France.	anne.ducros@lrb.ap-hop-paris.fr	Joutel, Anne/K-5601-2017; Tournier-Lasserve, Elisabeth/N-7134-2017; DUCROS, Anne/D-1899-2010	Joutel, Anne/0000-0003-3963-3860; Tournier-Lasserve, Elisabeth/0000-0002-3039-1677; DUCROS, Anne/0000-0001-5560-5013				Battistini S, 1999, NEUROLOGY, V53, P38, DOI 10.1212/WNL.53.1.38; BLAU JN, 1955, LANCET, V2, P1115; Carrera P, 1999, NEUROLOGY, V53, P26, DOI 10.1212/WNL.53.1.26; Clarke JM, 1910, BMJ-BRIT MED J, V1910, P1534; Denier C, 1999, NEUROLOGY, V52, P1816, DOI 10.1212/WNL.52.9.1816; Ducros A, 1997, ANN NEUROL, V42, P885, DOI 10.1002/ana.410420610; Ducros A, 1999, AM J HUM GENET, V64, P89, DOI 10.1086/302192; Elliott MA, 1996, ANN NEUROL, V39, P100, DOI 10.1002/ana.410390115; FITZSIMONS RB, 1985, BRAIN, V108, P555, DOI 10.1093/brain/108.3.555-a; FREEMAN GH, 1951, BIOMETRIKA, V38, P141, DOI 10.2307/2332323; Friend KL, 1999, HUM GENET, V105, P261, DOI 10.1007/s004390051099; Gardner K, 1997, NEUROLOGY, V49, P1231, DOI 10.1212/WNL.49.5.1231; Gervil M, 1999, NEUROLOGY, V53, P995, DOI 10.1212/WNL.53.5.995; Geschwind DH, 1997, NEUROLOGY, V49, P1247, DOI 10.1212/WNL.49.5.1247; Hans M, 1999, J NEUROSCI, V19, P1610; HENRY S, 1990, IEEE SOFTWARE, V7, P36, DOI 10.1109/52.50772; Hollander M., 1973, NONPARAMETRIC STAT M; JOUTEL A, 1994, AM J HUM GENET, V55, P1166; JOUTEL A, 1993, NAT GENET, V5, P40, DOI 10.1038/ng0993-40; Kraus RL, 1998, J BIOL CHEM, V273, P5586, DOI 10.1074/jbc.273.10.5586; Kraus RL, 2000, J BIOL CHEM, V275, P9239, DOI 10.1074/jbc.275.13.9239; LANCE JW, 1982, MECH MANAGEMENT HEAD; OHTA M, 1967, NEUROLOGY, V17, P813, DOI 10.1212/WNL.17.8.813; OPHOFF RA, 1994, GENOMICS, V22, P21, DOI 10.1006/geno.1994.1340; Ophoff RA, 1996, CELL, V87, P543, DOI 10.1016/S0092-8674(00)81373-2; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; Russell MB, 1996, BRAIN, V119, P355, DOI 10.1093/brain/119.2.355; SORGE F, 1988, CEPHALALGIA, V8, P1, DOI 10.1046/j.1468-2982.1988.0801001.x; STEWART WF, 1992, JAMA-J AM MED ASSOC, V267, P64, DOI 10.1001/jama.267.1.64; Terwindt GM, 1998, NEUROLOGY, V50, P1105, DOI 10.1212/WNL.50.4.1105; Ulrich V, 1999, ANN NEUROL, V45, P242, DOI 10.1002/1531-8249(199902)45:2<242::AID-ANA15>3.0.CO;2-1; Vahedi K, 2000, NEUROLOGY, V55, P1040, DOI 10.1212/WNL.55.7.1040; WHITTY CWM, 1953, J NEUROL NEUROSUR PS, V16, P172, DOI 10.1136/jnnp.16.3.172; Yue Q, 1998, AM J MED GENET, V77, P298, DOI 10.1002/(SICI)1096-8628(19980526)77:4<298::AID-AJMG9>3.0.CO;2-J; Zhuchenko O, 1997, NAT GENET, V15, P62, DOI 10.1038/ng0197-62; ZIFKIN B, 1980, ANN NEUROL, V8, P329, DOI 10.1002/ana.410080319	36	373	387	0	21	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 1	2001	345	1					17	U5		10.1056/NEJM200107053450103	http://dx.doi.org/10.1056/NEJM200107053450103			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	449QJ	11439943				2022-12-24	WOS:000169697600003
J	Clover, BP; McHenry, CS				Clover, BP; McHenry, CS			The DNA polymerase III holoenzyme: An asymmetric dimeric replicative complex with leading and lagging strand polymerases	CELL			English	Article							ESCHERICHIA-COLI; INITIATION COMPLEX; EPSILON-SUBUNIT; GENE-PRODUCT; CLAMP LOADER; TAU-SUBUNIT; PURIFICATION; PROTEIN; GAMMA; TEMPLATE	The DNA Polymerase III holoenzyme forms initiation complexes on primed DNA in an ATP-dependent reaction. We demonstrate that the nonhydrolyzable ATP analog, ATP gammaS, supports the formation of an isolable leading strand complex that loads and replicates the lagging strand only in the presence of ATP, beta, and the single-stranded DNA binding protein. The single endogenous DnaX complex within DNA polymerase III holoenzyme assembles beta onto both the leading and lagging strand polymerases by an ordered mechanism. The dimeric replication complex disassembles in the opposite order from which it assembled. Upon ATP gammaS-induced dissociation, the leading strand polymerase is refractory to disassembly allowing cycling to occur exclusively on the lagging strand. These results establish holoenzyme as an intrinsic asymmetric dimer with distinguishable leading and lagging strand polymerases.	Univ Colorado, Hlth Sci Ctr, Dept Biochem & Mol Genet, Denver, CO 80262 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	McHenry, CS (corresponding author), Univ Colorado, Hlth Sci Ctr, Dept Biochem & Mol Genet, 4200 E 9th Ave, Denver, CO 80262 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035695, R01GM036255] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM35695, GM36255] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALBERTS BM, 1982, COLD SPRING HARB SYM, V47, P655, DOI 10.1101/SQB.1983.047.01.077; BURGERS PMJ, 1982, J BIOL CHEM, V257, P1468; DALLMANN HG, 1995, J BIOL CHEM, V270, P29555, DOI 10.1074/jbc.270.49.29555; Glover BP, 2000, J BIOL CHEM, V275, P3017, DOI 10.1074/jbc.275.5.3017; Glover BP, 1998, J BIOL CHEM, V273, P23476, DOI 10.1074/jbc.273.36.23476; GRIEP MA, 1989, J BIOL CHEM, V264, P11294; HAWKER JR, 1987, J BIOL CHEM, V262, P12722; Hingorani MM, 1998, J BIOL CHEM, V273, P24550, DOI 10.1074/jbc.273.38.24550; JOHANSON KO, 1986, J BIOL CHEM, V261, P1460; JOHANSON KO, 1984, J BIOL CHEM, V259, P4589; Kelman Z, 1998, EMBO J, V17, P2436, DOI 10.1093/emboj/17.8.2436; Kim DR, 1996, J BIOL CHEM, V271, P20681, DOI 10.1074/jbc.271.34.20681; Kim S, 1996, J BIOL CHEM, V271, P21406, DOI 10.1074/jbc.271.35.21406; Kim S, 1996, J BIOL CHEM, V271, P4315; Kim SS, 1996, CELL, V84, P643, DOI 10.1016/S0092-8674(00)81039-9; KODAIRA M, 1983, MOL GEN GENET, V192, P80, DOI 10.1007/BF00327650; Kornberg A., 1992, DNA REPLICATION; LEBOWITZ JH, 1986, J BIOL CHEM, V261, P4738; Li XJ, 2000, J BIOL CHEM, V275, P34757, DOI 10.1074/jbc.M006556200; MAKI H, 1988, J BIOL CHEM, V263, P6570; MCHENRY CS, 1982, J BIOL CHEM, V257, P2657; MCHENRY CS, 1988, ANNU REV BIOCHEM, V57, P519; MCHENRY CS, 1988, BIOCHIM BIOPHYS ACTA, V951, P240, DOI 10.1016/0167-4781(88)90092-9; MINDEN JS, 1985, J BIOL CHEM, V260, P9316; MULLIN DA, 1983, MOL GEN GENET, V192, P73, DOI 10.1007/BF00327649; OGAWA T, 1980, ANNU REV BIOCHEM, V49, P421, DOI 10.1146/annurev.bi.49.070180.002225; ONRUST R, 1993, J BIOL CHEM, V268, P11766; ONRUST R, 1995, J BIOL CHEM, V270, P13366, DOI 10.1074/jbc.270.22.13366; Pritchard AE, 2000, EMBO J, V19, P6536, DOI 10.1093/emboj/19.23.6536; REEMS JA, 1994, J BIOL CHEM, V269, P33091; Schulenberg B, 1999, J BIOL CHEM, V274, P34233, DOI 10.1074/jbc.274.48.34233; SHRIMANKAR P, 1992, J BACTERIOL, V174, P7689, DOI 10.1128/JB.174.23.7689-7696.1992; SINHA NK, 1980, J BIOL CHEM, V255, P4290; Stock D, 2000, CURR OPIN STRUC BIOL, V10, P672, DOI 10.1016/S0959-440X(00)00147-0; STUDWELLVAUGHAN PS, 1991, J BIOL CHEM, V266, P19833; WICKNER S, 1976, P NATL ACAD SCI USA, V73, P3511, DOI 10.1073/pnas.73.10.3511; Yuzhakov A, 1999, CELL, V96, P153, DOI 10.1016/S0092-8674(00)80968-X; Yuzhakov A, 1996, CELL, V86, P877, DOI 10.1016/S0092-8674(00)80163-4	38	52	65	1	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 29	2001	105	7					925	934		10.1016/S0092-8674(01)00400-7	http://dx.doi.org/10.1016/S0092-8674(01)00400-7			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	449BK	11439188	Bronze			2022-12-24	WOS:000169664300012
J	Lilburn, TC; Kim, KS; Ostrom, NE; Byzek, KR; Leadbetter, JR; Breznak, JA				Lilburn, TC; Kim, KS; Ostrom, NE; Byzek, KR; Leadbetter, JR; Breznak, JA			Nitrogen fixation by symbiotic and free-living spirochetes	SCIENCE			English	Article							RETICULITERMES FLAVIPES; PHYLOGENETIC DIVERSITY; MICROBIAL COMMUNITY; LOWER TERMITE; GUT; GENES; ACETOGENESIS; DEPENDENCE; INHIBITION; MICROFLORA	Spirochetes from termite hindguts and freshwater sediments possessed homologs of a nitrogenase gene (nifH) and exhibited nitrogenase activity, a previously unrecognized metabolic capability in spirochetes. Fixation of 15-dinitrogen was demonstrated with termite gut Treponema ZAS-9 and free-living Spirochaeta aurantia. Homologs of nifH were also present in human oral and bovine ruminal treponemes. Results implicate spirochetes in the nitrogen nutrition of termites, whose food is typically Low in nitrogen, and in global nitrogen cycling. These results also proffer spirochetes as a Likely origin of certain nifHs observed in termite guts and other environments that were not previously attributable to known microbes.	Michigan State Univ, Ctr Microbial Ecol, E Lansing, MI 48824 USA; Michigan State Univ, Ribosomal Database Project, E Lansing, MI 48824 USA; Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA; Michigan State Univ, Dept Geol Sci, E Lansing, MI 48824 USA; CALTECH, Pasadena, CA 91125 USA	Michigan State University; Michigan State University; Michigan State University; Michigan State University; California Institute of Technology	Breznak, JA (corresponding author), Michigan State Univ, Ctr Microbial Ecol, E Lansing, MI 48824 USA.			Leadbetter, Jared/0000-0002-7033-0844				BOLLAG DM, 1991, PROTEIN METHODS, P45; Breznak JA, 2000, TERMITES: EVOLUTION, SOCIALITY, SYMBIOSES, ECOLOGY, P209; BROWN RE, 1989, ANAL BIOCHEM, V180, P136, DOI 10.1016/0003-2697(89)90101-2; Bruno WJ, 2000, MOL BIOL EVOL, V17, P189, DOI 10.1093/oxfordjournals.molbev.a026231; CANALEPAROLA E, 1992, PROKARYOTES HDB BIOL, V4, P3524; Chien YT, 2000, J BACTERIOL, V182, P3247, DOI 10.1128/JB.182.11.3247-3253.2000; Dean D.R., 1992, BIOL NITROGEN FIXATI, P763; DILWORTH MJ, 1987, NATURE, V327, P167, DOI 10.1038/327167a0; Ebert A, 1997, APPL ENVIRON MICROB, V63, P4039, DOI 10.1128/AEM.63.10.4039-4046.1997; EUTICK ML, 1978, J INSECT PHYSIOL, V24, P363, DOI 10.1016/0022-1910(78)90076-8; Felsenstein J., 1993, PHYLIP PHYLOGENY INF; GARRITY GM, 2000, BERGEYS MANUAL SYSTE, P1; GRABER JR, 2000, AM SOC MICR ABSTR, P475; GUTH JH, 1983, BIOCHEMISTRY-US, V22, P5111, DOI 10.1021/bi00291a010; Kessler PS, 1997, J BACTERIOL, V179, P541, DOI 10.1128/jb.179.2.541-543.1997; Leadbetter JR, 1999, SCIENCE, V283, P686, DOI 10.1126/science.283.5402.686; Lilburn TG, 1999, ENVIRON MICROBIOL, V1, P331; MADDEN MS, 1991, J BACTERIOL, V173, P5403, DOI 10.1128/jb.173.17.5403-5405.1991; MILLER JN, 1992, PROKARYOTES, V4, P3537; MINIGAWA M, 1985, ANAL CHEM, V56, P1859; Neidhardt FC, 1990, PHYSL BACTERIAL CELL; Noda S, 1999, APPL ENVIRON MICROB, V65, P4935; Ohkuma M, 1999, APPL ENVIRON MICROB, V65, P4926; Ohkuma M, 1996, APPL ENVIRON MICROB, V62, P2747, DOI 10.1128/AEM.62.8.2747-2752.1996; Paster BJ, 1996, APPL ENVIRON MICROB, V62, P347, DOI 10.1128/AEM.62.2.347-352.1996; Postgate J.R., 1972, METHODS MICROBIOLOGY, P343, DOI [10.1016/s0580-9517(08)70604-4, DOI 10.1016/S0580-9517(08)70604-4]; RASCHE ME, 1989, PLANT PHYSIOL, V91, P663, DOI 10.1104/pp.91.2.663; SCHULTZ JE, 1978, APPL ENVIRON MICROB, V35, P930, DOI 10.1128/AEM.35.5.930-936.1978; STANTON TB, 1980, ARCH MICROBIOL, V127, P145, DOI 10.1007/BF00428018; Strimmer K, 1996, MOL BIOL EVOL, V13, P964, DOI 10.1093/oxfordjournals.molbev.a025664; Sugimoto A, 2000, TERMITES: EVOLUTION, SOCIALITY, SYMBIOSES, ECOLOGY, P409; TAYASU I, 1994, NATURWISSENSCHAFTEN, V81, P229, DOI 10.1007/s001140050063; Tholen A, 1997, FEMS MICROBIOL ECOL, V24, P137, DOI 10.1016/S0168-6496(97)00053-6; Weinbauer MG, 1998, APPL ENVIRON MICROB, V64, P5000; Young J. P. W., 1992, BIOL NITROGEN FIXATI, V1544, P43	35	176	189	4	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 29	2001	292	5526					2495	2498		10.1126/science.1060281	http://dx.doi.org/10.1126/science.1060281			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448YU	11431569				2022-12-24	WOS:000169658200043
J	Veasy, LG				Veasy, LG			Time to take soundings in acute rheumatic fever	LANCET			English	Editorial Material							DOPPLER-ECHOCARDIOGRAPHIC FINDINGS; VALVULAR REGURGITATION; MITRAL REGURGITATION; INTERMOUNTAIN AREA; UNITED-STATES; CARDITIS; DIAGNOSIS		Univ Utah, Sch Med, Dept Pediat, Salt Lake City, UT 84113 USA	Utah System of Higher Education; University of Utah	Veasy, LG (corresponding author), Univ Utah, Sch Med, Dept Pediat, Salt Lake City, UT 84113 USA.							ABERNETHY M, 1994, AUST NZ J MED, V24, P530, DOI 10.1111/j.1445-5994.1994.tb01753.x; DAJANI AS, 1992, JAMA-J AM MED ASSOC, V268, P2069, DOI 10.1001/jama.1992.03490150121036; DASILVA CH, 1999, REV HOSP CLIN FAC ME, V54, P85; Elevli M, 1999, ACTA PAEDIATR, V88, P1074, DOI 10.1080/08035259950168117; Figueroa FE, 2001, HEART, V85, P407, DOI 10.1136/heart.85.4.407; FOLGER GM, 1992, BRIT HEART J, V67, P434; FOLGER GM, 1989, AM J CARDIOL, V63, P1278, DOI 10.1016/0002-9149(89)90192-6; Minich LD, 1997, CLIN CARDIOL, V20, P924, DOI 10.1002/clc.4960201105; MORSI MR, 1994, ALEXANDRIA J PEDIAT, V3, P341; STEINFELD L, 1986, CIRCULATION, V74, P385; VEASY LG, 1994, J PEDIATR-US, V124, P9, DOI 10.1016/S0022-3476(94)70247-0; VEASY LG, 1987, NEW ENGL J MED, V316, P421, DOI 10.1056/NEJM198702193160801; WILSON NJ, 1995, INT J CARDIOL, V50, P1, DOI 10.1016/0167-5273(95)02325-Q; YOSHIDA K, 1988, CIRCULATION, V78, P840, DOI 10.1161/01.CIR.78.4.840	14	28	28	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 23	2001	357	9273					1994	1995		10.1016/S0140-6736(00)05134-5	http://dx.doi.org/10.1016/S0140-6736(00)05134-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	446JB	11438128				2022-12-24	WOS:000169509200005
J	Di Cristo, G; Berardi, N; Cancedda, L; Pizzorusso, T; Putignano, E; Ratto, GM; Maffei, L				Di Cristo, G; Berardi, N; Cancedda, L; Pizzorusso, T; Putignano, E; Ratto, GM; Maffei, L			Requirement of ERK activation for visual cortical plasticity	SCIENCE			English	Article							CRITICAL-PERIOD; MAP KINASE; EXPERIENCE; CORTEX; PHOSPHORYLATION; NEUROTROPHINS; CASCADE	Experience-dependent plasticity in the developing visual cortex depends on electrical activity and molecular signals involved in stabilization or removal of inputs. Extracellular signal-regulated kinase 1,2 (also called p42/44 mitogen-activated protein kinase) activation in the cortex is regulated by both factors. We show that two different inhibitors of the ERK pathway suppress the induction of two forms of long-term potentiation (LTP) in rat cortical slices and that their intracortical administration to monocularly deprived rats prevents the shift in ocular dominance towards the nondeprived eye. These results demonstrate that the ERK pathway is necessary for experience-dependent plasticity and for LTP of synaptic transmission in the developing visual cortex.	CNR, Ist Neurofisiol, I-56100 Pisa, Italy; Scuola Normale Super Pisa, I-56126 Pisa, Italy; Univ Florence, Dipartimento Psicol, I-50123 Florence, Italy	Consiglio Nazionale delle Ricerche (CNR); Scuola Normale Superiore di Pisa; University of Florence	Berardi, N (corresponding author), CNR, Ist Neurofisiol, Via Moruzzi 1, I-56100 Pisa, Italy.	berardi@in.pi.cnr.it	Ratto, Gian Michele/AAX-8514-2020; Ratto, Gian Michele/AAB-8719-2021; Pizzorusso, Tommaso/D-1399-2013	Ratto, Gian Michele/0000-0001-9632-7769; Pizzorusso, Tommaso/0000-0001-5614-0668; Cancedda, Laura/0000-0003-0566-057X; Putignano, Elena/0000-0002-4313-408X	Telethon [934] Funding Source: Medline	Telethon(Fondazione Telethon)		Adams JP, 2000, J NEUROCHEM, V75, P2277, DOI 10.1046/j.1471-4159.2000.0752277.x; Atkins CM, 1998, NAT NEUROSCI, V1, P602, DOI 10.1038/2836; Bailey CH, 1997, NEURON, V18, P913, DOI 10.1016/S0896-6273(00)80331-1; Berardi N, 2000, CURR OPIN NEUROBIOL, V10, P138, DOI 10.1016/S0959-4388(99)00047-1; Berman DE, 1998, J NEUROSCI, V18, P10037; BIRCH D, 1979, VISION RES, V19, P933, DOI 10.1016/0042-6989(79)90029-4; Blum S, 1999, J NEUROSCI, V19, P3535; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; FAGIOLINI M, 1994, VISION RES, V34, P709, DOI 10.1016/0042-6989(94)90210-0; Fagiolini M, 2000, NATURE, V404, P183, DOI 10.1038/35004582; Glazewski S, 2000, NAT NEUROSCI, V3, P911, DOI 10.1038/78820; Grewal SS, 1999, CURR OPIN NEUROBIOL, V9, P544, DOI 10.1016/S0959-4388(99)00010-0; Hensch TK, 1998, SCIENCE, V282, P1504, DOI 10.1126/science.282.5393.1504; Huang ZJ, 1999, CELL, V98, P739, DOI 10.1016/S0092-8674(00)81509-3; Jovanovic JN, 1996, P NATL ACAD SCI USA, V93, P3679, DOI 10.1073/pnas.93.8.3679; KIRKWOOD A, 1994, J NEUROSCI, V14, P1634, DOI 10.1523/JNEUROSCI.14-03-01634.1994; KIRKWOOD A, 1995, NATURE, V375, P328, DOI 10.1038/375328a0; Lodovichi C, 2000, J NEUROSCI, V20, P2155; McAllister AK, 1999, ANNU REV NEUROSCI, V22, P295, DOI 10.1146/annurev.neuro.22.1.295; Pham TA, 1999, NEURON, V22, P63, DOI 10.1016/S0896-6273(00)80679-0; Pizzorusso T, 2000, J NEUROSCI, V20, P2809; Quinlan EM, 1999, NAT NEUROSCI, V2, P352, DOI 10.1038/7263; Schafe GE, 2000, J NEUROSCI, V20, P8177; Silva AJ, 1998, ANNU REV NEUROSCI, V21, P127, DOI 10.1146/annurev.neuro.21.1.127	24	161	164	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 22	2001	292	5525					2337	2340						4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	445KD	11423664				2022-12-24	WOS:000169455900060
J	Georgellis, D; Kwon, O; Lin, ECC				Georgellis, D; Kwon, O; Lin, ECC			Quinones as the redox signal for the Arc two-component system of bacteria	SCIENCE			English	Article							SENSOR-REGULATOR PROTEIN; ESCHERICHIA-COLI; ANAEROBIC REPRESSION; IN-VITRO; TRANSDUCTION; BINDING; GENE; PHOSPHORELAY; REQUIREMENT; PROMOTER	The Arc two-component signal transduction system mediates adaptive responses of Escherichia coli to changing respiratory conditions of growth. Under anaerobic conditions, the ArcB sensor kinase autophosphorylates and then transphosphorylates ArcA, a global transcriptional regulator that controls the expression of numerous operons involved in respiratory or fermentative metabolism. We show that oxidized forms of quinone electron carriers act as direct negative signals that inhibit autophosphorylation of ArcB during aerobiosis. Thus, the Arc signal transduction system provides a link between the electron transport chain and gene expression.	Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Lin, ECC (corresponding author), Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, 200 Longwood Ave, Boston, MA 02115 USA.	elin@hms.harvard.edu	Georgellis, Dimitris/U-2517-2017	Georgellis, Dimitris/0000-0002-6114-795X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040993] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM40993] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bibikov SI, 1997, J BACTERIOL, V179, P4075, DOI 10.1128/jb.179.12.4075-4079.1997; BRONDSTED L, 1994, J BACTERIOL, V176, P5423; Gennis R. B., 1996, ESCHERICHIA COLI SAL, P217; Georgellis D, 1999, J BIOL CHEM, V274, P35950, DOI 10.1074/jbc.274.50.35950; Georgellis D, 1998, J BIOL CHEM, V273, P32864, DOI 10.1074/jbc.273.49.32864; Georgellis D, 1997, J BACTERIOL, V179, P5429, DOI 10.1128/jb.179.17.5429-5435.1997; GEORGELLIS D, UNPUB; Hoch JA, 1995, 2 COMPONENT SIGNAL T; ISHIGE K, 1994, EMBO J, V13, P5195, DOI 10.1002/j.1460-2075.1994.tb06850.x; IUCHI S, 1992, J BACTERIOL, V174, P3972, DOI 10.1128/jb.174.12.3972-3980.1992; IUCHI S, 1993, J BIOL CHEM, V268, P23972; IUCHI S, 1990, J BACTERIOL, V172, P6020, DOI 10.1128/jb.172.10.6020-6025.1990; IUCHI S, 1990, MOL MICROBIOL, V4, P715, DOI 10.1111/j.1365-2958.1990.tb00642.x; IUCHI S, 1988, P NATL ACAD SCI USA, V85, P1888, DOI 10.1073/pnas.85.6.1888; Kwon O, 2000, J BACTERIOL, V182, P3858, DOI 10.1128/JB.182.13.3858-3862.2000; Kwon O, 2000, J BACTERIOL, V182, P2960, DOI 10.1128/JB.182.10.2960-2966.2000; Lynch A. Simon, 1996, P361; Lynch AS, 1996, J BACTERIOL, V178, P6238, DOI 10.1128/JB.178.21.6238-6249.1996; LYNCH AS, 1996, ESCHERICHIA COLI SAL, V1, P1526; Magasanik B., 1996, ESCHERICHIA COLI SAL, P1344; McGuire AM, 1999, MOL MICROBIOL, V32, P219, DOI 10.1046/j.1365-2958.1999.01347.x; NAGASAWA S, 1992, MOL MICROBIOL, V6, P799, DOI 10.1111/j.1365-2958.1992.tb01530.x; PARKINSON JS, 1992, ANNU REV GENET, V26, P71, DOI 10.1146/annurev.ge.26.120192.000443; Pellicer MT, 1999, MOL GEN GENET, V261, P170, DOI 10.1007/s004380050954; Pernestig AK, 2001, J BIOL CHEM, V276, P225, DOI 10.1074/jbc.M001550200; Rebbapragada A, 1997, P NATL ACAD SCI USA, V94, P10541, DOI 10.1073/pnas.94.20.10541; SAWERS G, 1992, J BACTERIOL, V174, P3474, DOI 10.1128/JB.174.11.3474-3478.1992; SILVERMAN PM, 1991, J MOL BIOL, V220, P271, DOI 10.1016/0022-2836(91)90012-U; Soballe B, 1998, MICROBIOL-UK, V144, P361, DOI 10.1099/00221287-144-2-361	29	365	375	0	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 22	2001	292	5525					2314	2316		10.1126/science.1059361	http://dx.doi.org/10.1126/science.1059361			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	445KD	11423658				2022-12-24	WOS:000169455900053
J	Royer, DL; Wing, SL; Beerling, DJ; Jolley, DW; Koch, PL; Hickey, LJ; Berner, RA				Royer, DL; Wing, SL; Beerling, DJ; Jolley, DW; Koch, PL; Hickey, LJ; Berner, RA			Paleobotanical evidence for near present-day levels of atmospheric CO2 during part of the tertiary	SCIENCE			English	Article							CARBON-DIOXIDE; CLIMATE; MARINE; RECORD; END; RESPONSES; PCO(2); L.	Understanding the Link between the greenhouse gas carbon dioxide (CO2) and Earth's temperature underpins much of paleoclimatology and our predictions of future global warming. Here, we use the inverse relationship between Leaf stomatal indices and the partial pressure of CO2 in modern Ginkgo biloba and Metasequoia glyptostroboides to develop a CO2 reconstruction based on fossil Ginkgo and Metaseguoia cuticles for the middle Paleocene to early Eocene and middle Miocene. Our reconstruction indicates that CO2 remained between 300 and 450 parts per million by volume for these intervals with the exception of a single high estimate near the Paleocene/Eocene boundary. These results suggest that factors in addition to CO2 are required to explain these past intervals of global warmth.	Yale Univ, Dept Geol & Geophys, New Haven, CT 06520 USA; Smithsonian Inst, Dept Paleobiol, Washington, DC 20560 USA; Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England; Univ Sheffield, Ctr Palynol, Sheffield S3 7HF, S Yorkshire, England; Univ Calif Santa Cruz, Dept Earth Sci, Santa Cruz, CA 95064 USA	Yale University; Smithsonian Institution; Smithsonian National Museum of Natural History; University of Sheffield; University of Sheffield; University of California System; University of California Santa Cruz	Royer, DL (corresponding author), Yale Univ, Dept Geol & Geophys, POB 208109, New Haven, CT 06520 USA.	dana.royer@yale.edu	Beerling, David J/C-2840-2009	Beerling, David J/0000-0003-1869-4314; Royer, Dana/0000-0003-0976-953X; Wing, Scott/0000-0002-2954-8905				Beerling DJ, 1998, J EXP BOT, V49, P1603, DOI 10.1093/jexbot/49.326.1603; Beerling DJ, 2000, PALAEOGEOGR PALAEOCL, V161, P395, DOI 10.1016/S0031-0182(00)00095-X; Berner RA, 2001, AM J SCI, V301, P182, DOI 10.2475/ajs.301.2.182; CHANEY RALPH W., 1951, TRANS AMER PHIL SOC, V40, P171; Crowley TJ, 2001, SCIENCE, V292, P870, DOI 10.1126/science.1061664; DICKENS GR, 1995, PALEOCEANOGRAPHY, V10, P965, DOI 10.1029/95PA02087; DICKENS GR, IN PRESS GEOPHYS MON, V124; Ekart DD, 1999, AM J SCI, V299, P805, DOI 10.2475/ajs.299.10.805; FRIEDLI H, 1986, NATURE, V324, P237, DOI 10.1038/324237a0; Huber M, 1999, J GEOPHYS RES-ATMOS, V104, P16633, DOI 10.1029/1999JD900272; KENNETT JP, 1991, NATURE, V353, P225, DOI 10.1038/353225a0; KOCH PL, 1992, NATURE, V358, P319, DOI 10.1038/358319a0; Kothavala Z, 1999, GEOPHYS RES LETT, V26, P209, DOI 10.1029/1998GL900275; Lemarchand D, 2000, NATURE, V408, P951, DOI 10.1038/35050058; Norris RD, 1999, NATURE, V401, P775, DOI 10.1038/44545; Pagani M, 1999, PALEOCEANOGRAPHY, V14, P273, DOI 10.1029/1999PA900006; Pearson PN, 2000, NATURE, V406, P695, DOI 10.1038/35021000; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; Retallack GJ, 2001, NATURE, V411, P287, DOI 10.1038/35077041; Royer DL, 2001, REV PALAEOBOT PALYNO, V114, P1, DOI 10.1016/S0034-6667(00)00074-9; ROYER DL, IN PRESS EARTH SCI R; Rundgren M, 1999, HOLOCENE, V9, P509, DOI 10.1191/095968399677717287; SAVIN SM, 1975, GEOL SOC AM BULL, V86, P1499, DOI 10.1130/0016-7606(1975)86<1499:TMP>2.0.CO;2; SINHA A, 1994, GLOBAL PLANET CHANGE, V9, P297, DOI 10.1016/0921-8181(94)00010-7; Sloan LC, 1996, PALAEOGEOGR PALAEOCL, V119, P275, DOI 10.1016/0031-0182(95)00012-7; Stott LD, 1992, PALEOCEANOGRAPHY, V7, P395, DOI 10.1029/92PA01183; Tajika E, 1998, EARTH PLANET SC LETT, V160, P695, DOI 10.1016/S0012-821X(98)00121-6; THIRY M, 1998, MEM SCI TERRE, V34, P21; TRALAU H, 1968, LETHAIA, V1, P63, DOI 10.1111/j.1502-3931.1968.tb01728.x; VANDERBURGH J, 1993, SCIENCE, V260, P1788, DOI 10.1126/science.260.5115.1788; WALLMANN K, IN PRESS GEOCHIM COS; Wing S., 2000, WARM CLIMATES EARTH, V7, P197; WOODWARD FI, 1987, NATURE, V327, P617, DOI 10.1038/327617a0; WOODWARD FI, 1988, J EXP BOT, V39, P1771, DOI 10.1093/jxb/39.12.1771	34	263	292	1	116	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 22	2001	292	5525					2310	2313		10.1126/science.292.5525.2310	http://dx.doi.org/10.1126/science.292.5525.2310			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	445KD	11423657				2022-12-24	WOS:000169455900052
J	Teasley, S; Wolinsky, S				Teasley, S; Wolinsky, S			Policy forum: Communication - Scientific collaborations at a distance	SCIENCE			English	Article									Univ Michigan, Sch Informat, Collab Res Elect Work, Ann Arbor, MI 48109 USA; Northwestern Univ, Dept Med, Chicago, IL 60611 USA	University of Michigan System; University of Michigan; Northwestern University	Teasley, S (corresponding author), Univ Michigan, Sch Informat, Collab Res Elect Work, Ann Arbor, MI 48109 USA.	steasley@umich.edu	Wolinsky, Steven/B-2893-2012	Wolinsky, Steven/0000-0002-9625-6697	NATIONAL CANCER INSTITUTE [P30CA079458] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA79458-03] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Finholt TA, 1997, PSYCHOL SCI, V8, P28, DOI 10.1111/j.1467-9280.1997.tb00540.x; FINHOLT TA, 2001, ANN REV INF SCI TECH, V36; HESSE BW, 1993, COMMUN ACM, V36, P90, DOI 10.1145/163381.163409; National Research Council, 1993, NAT COLL APPL INF TE; Schatz B. R., 1991, Journal of Management Information Systems, V8, P87; STAR SL, 1994, P C COMP SUPP COOP W, P253; Uncapher K., 1989, NATL COLLABORATORY R; WEINBERG AM, 1961, SCIENCE, V134, P161, DOI 10.1126/science.134.3473.161; WULF WA, 1993, SCIENCE, V261, P854, DOI 10.1126/science.8346438	9	53	56	2	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 22	2001	292	5525					2254	2255		10.1126/science.1061619	http://dx.doi.org/10.1126/science.1061619			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	445KD	11423638				2022-12-24	WOS:000169455900029
J	Istre, GR; McCoy, MA; Osborn, L; Barnard, JJ; Bolton, A				Istre, GR; McCoy, MA; Osborn, L; Barnard, JJ; Bolton, A			Deaths and injuries from house fires.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Proceedings Paper	Annual Meeting of the American-Public-Health-Association	NOV 15-16, 2000	BOSTON, MASSACHUSETTS	Amer Public Hlth Assoc			FATAL RESIDENTIAL FIRES; HOMES	Background: We sought to define the factors associated with house fires and related injuries by analyzing the data from population-based surveillance. Methods: For 1991 through 1997, we linked the following data for Dallas: records from the fire department of all house fires (excluding fires in apartments and mobile homes), records of patients transported by ambulance, hospital admissions, and reports from the medical examiner of fatal injuries. Results: There were 223 injuries (91 fatal and 132 nonfatal) from 7190 house fires, for a rate of 5.2 injured persons per 100,000 population per year. Rates of injury related to house fires were highest among blacks (relative risk, 2.8; 95 percent confidence interval, 2.1 to 3.6) and in people 65 years of age or older (relative risk, 2.6; 95 percent confidence interval, 1.9 to 3.5). Census tracts with low median incomes had the highest rates of injury related to house fires (relative risk as compared with census tracts with high median incomes, 8.1; 95 percent confidence interval, 2.5 to 32.0). The rate of injuries was higher for fires that began in bedrooms or living areas (relative risk, 3.7); that were started by heating equipment, smoking, or children playing with fire (relative risk, 2.6); or that occurred in houses built before 1980 (relative risk, 6.6). Injuries occurred more often in houses without functioning smoke detectors (relative risk, 1.5; 95 percent confidence interval, 1.0 to 2.4). The prevalence of functioning smoke detectors was lowest in houses in the census tracts with the lowest median incomes (P<0.001). Conclusions: Rates of injuries related to house fires are highest in elderly, minority, and low-income populations and in houses without functioning smoke detectors. Efforts to prevent injuries and deaths from house fires should target these populations. (N Engl J Med 2001;344:1911-6.) Copyright (C) 2001 Massachusetts Medical Society.	Injury Prevent Ctr Greater Dallas, Dallas, TX 75235 USA; PID Associates, Dallas, TX USA; Dallas Fire Dept, Dallas, TX USA; Dallas Fir, Off Chief Med Examiner Dallas Cty, Dallas, TX USA; Univ Alabama, Ctr Comprehens Canc, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Istre, GR (corresponding author), Injury Prevent Ctr Greater Dallas, POB 36067, Dallas, TX 75235 USA.							Bonnie RJ, 1999, REDUCING BURDEN INJU; Dean A.G., 1994, EPI INFO VERSION 6 W; Douglas MR, 1999, AM J PUBLIC HEALTH, V89, P1112, DOI 10.2105/AJPH.89.7.1112; *FED EM MAN AG, 1997, SOC FACT INC FIR; *FIR ADM, 1999, FIR US 1987 1996; GORMAN RL, 1985, PEDIATRICS, V75, P14; GREENLAND S, 1985, BIOMETRICS, V41, P55, DOI 10.2307/2530643; HEMENWAY D, 1990, Q J ECON, V105, P1063, DOI 10.2307/2937886; ISTRE GR, 1992, PUBLIC HEALTH SURVEILLANCE, P42; Johnson S. W., 1996, 808338 NHTSA DOT HS; Mallonee S, 1996, NEW ENGL J MED, V335, P27, DOI 10.1056/NEJM199607043350106; Marshall SW, 1998, JAMA-J AM MED ASSOC, V279, P1633, DOI 10.1001/jama.279.20.1633; MCLOUGHLIN E, 1985, AM J PUBLIC HEALTH, V75, P858, DOI 10.2105/AJPH.75.8.858; MEHTA CR, 1985, J AM STAT ASSOC, V80, P969, DOI 10.2307/2288562; MIERLEY MC, 1983, JAMA-J AM MED ASSOC, V249, P1466, DOI 10.1001/jama.249.11.1466; PICKENS S, 2000, DALLAS MED J, V86, P251; ROBERTS I, 1995, BRIT MED J, V311, P1381, DOI 10.1136/bmj.311.7017.1381; RUNYAN CW, 1992, NEW ENGL J MED, V327, P859, DOI 10.1056/NEJM199209173271207; Selvin S., 1996, STAT ANAL EPIDEMIOLO; SHULTS R, 1996, EFFORTS INCREASE SMO; Thacker SB, 1996, FIELD EPIDEMIOLOGY, P16; WOODWARD M, 1999, EPIDEMIOLOGY STUDY D, P476	22	121	123	0	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 21	2001	344	25					1911	1916		10.1056/NEJM200106213442506	http://dx.doi.org/10.1056/NEJM200106213442506			6	Medicine, General & Internal	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	443VJ	11419429				2022-12-24	WOS:000169362100006
J	Lutzoni, F; Pagel, M; Reeb, V				Lutzoni, F; Pagel, M; Reeb, V			Major fungal lineages are derived from lichen symbiotic ancestors	NATURE			English	Article							DISCRETE CHARACTERS; PHYLOGENY; EVOLUTIONARY; ORIGINS	About one-fifth of all known extant fungal species form obligate symbiotic associations with green algae, cyanobacteria or with both photobionts. These symbioses, known as lichens, are one way for fungi to meet their requirement for carbohydrates(1,2). Lichens are widely believed to have arisen independently on several occasions, accounting for the high diversity and mixed occurrence of lichenized and non-lichenized (42 and 58%, respectively) fungal species within the Ascomycota(3,4). Depending on the taxonomic classification chosen(2,5,6), 15-18 orders of the Ascomycota include lichen-forming taxa, and 8-11 of these orders (representing about 60% of the Ascomycota species) contain both lichenized and non-lichenized species. Here we report a phylogenetic comparative analysis of the Ascomycota, a phylum that includes greater than 98% of known lichenized fungal species 5. Using a Bayesian phylogenetic tree sampling methodology(7,8) combined with a statistical model of trait evolution(9), we take into account uncertainty about the phylogenetic tree and ancestral state reconstructions. Our results show that lichens evolved earlier than believed, and that gains of lichenization have been infrequent during Ascomycota evolution, but have been followed by multiple independent losses of the lichen symbiosis. As a consequence, major Ascomycota lineages of exclusively non-lichen-forming species are derived from lichen-forming ancestors. These species include taxa with important benefits and detriments to humans, such as Penicillium and Aspergillus(10-12).	Field Museum Nat Hist, Dept Bot, Chicago, IL 60605 USA; Univ Reading, Sch Anim & Microbial Sci, Reading RG6 6AJ, Berks, England; Univ Illinois, Dept Biol Sci, Chicago, IL 60607 USA	Field Museum of Natural History (Chicago); University of Reading; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Lutzoni, F (corresponding author), Duke Univ, Dept Biol, Durham, NC 27708 USA.							Alexopoulos C. J., 1996; BARINAGA M, 1995, SCIENCE, V268, P1437, DOI 10.1126/science.7770768; BERBEE ML, 1995, MYCOLOGIA, V87, P210, DOI 10.2307/3760907; BERBEE ML, 1995, CAN J BOT, V73, pS677; Berbee ML, 2000, MOL PHYLOGENET EVOL, V17, P337, DOI 10.1006/mpev.2000.0835; Bhattacharya D, 2000, MOL BIOL EVOL, V17, P1971, DOI 10.1093/oxfordjournals.molbev.a026298; COLLINS TM, 1994, SYST BIOL, V43, P482, DOI 10.2307/2413547; Elix J. A., 1996, P154; GARGAS A, 1995, SCIENCE, V268, P1492, DOI 10.1126/science.7770775; Hafellner J., 1988, HDB LICHENOLOGY, P41; Hawksworth D.L., 1995, DICT FUNGI, V8th; HAWKSWORTH DL, 1991, MYCOL RES, V95, P641, DOI 10.1016/S0953-7562(09)80810-1; Hibbett DS, 2000, NATURE, V407, P506, DOI 10.1038/35035065; Hillis DM, 1996, MOL SYSTEMATICS; Honegger R., 1996, P24; Huelsenbeck JP, 2000, SCIENCE, V288, P2349, DOI 10.1126/science.288.5475.2349; Kranner I., 1999, PLANT RESPONSES ENV, P591; Larget B, 1999, MOL BIOL EVOL, V16, P750, DOI 10.1093/oxfordjournals.molbev.a026160; Liu YJJ, 1999, MOL BIOL EVOL, V16, P1799, DOI 10.1093/oxfordjournals.molbev.a026092; Lutzoni F, 1997, P NATL ACAD SCI USA, V94, P11422, DOI 10.1073/pnas.94.21.11422; LUTZONI F, 1995, CRYPTOG BOT, V5, P82; Lutzoni FM, 1997, SYST BIOL, V46, P373, DOI 10.1093/sysbio/46.3.373; MADDISON DR, 1994, ANNU REV ENTOMOL, V39, P267, DOI 10.1146/annurev.en.39.010194.001411; Pagel M, 1999, SYST BIOL, V48, P612, DOI 10.1080/106351599260184; PAGEL M, 1994, P ROY SOC B-BIOL SCI, V255, P37, DOI 10.1098/rspb.1994.0006; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Rambold G., 1992, BIBLIOTHECA LICHENOL, V48, P1; SPATAFORA JW, 1995, CAN J BOT, V73, pS811, DOI 10.1139/b95-326; Suh SO, 1999, MYCOLOGIA, V91, P836, DOI 10.2307/3761537; Wilson IJ, 1998, GENETICS, V150, P499	30	378	402	12	132	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 21	2001	411	6840					937	940		10.1038/35082053	http://dx.doi.org/10.1038/35082053			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	444EN	11418855				2022-12-24	WOS:000169386200041
J	Charatan, F				Charatan, F			Fake prescription drugs are flooding the United States	BRITISH MEDICAL JOURNAL			English	News Item																			0	6	6	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 16	2001	322	7300					1443	1443						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	444FJ	11408295				2022-12-24	WOS:000169389200011
J	Osterwalder, J				Osterwalder, J			Portal hypertension - Where is evidence for 5% dextrose and pulmonary artery catheter?	BRITISH MEDICAL JOURNAL			English	Letter									Kantonsspital, CH-9007 St Gallen, Switzerland	Kantonsspital Aarau AG (KSA); Kantonsspital St. Gallen	Osterwalder, J (corresponding author), Kantonsspital, CH-9007 St Gallen, Switzerland.							Connors AF, 1996, JAMA-J AM MED ASSOC, V276, P889, DOI 10.1001/jama.276.11.889; DEREK A, 2001, BRIT MED J, V322, P446; Krige JEJ, 2001, BRIT MED J, V322, P348, DOI 10.1136/bmj.322.7282.348	3	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 16	2001	322	7300					1492	1492		10.1136/bmj.322.7300.1492	http://dx.doi.org/10.1136/bmj.322.7300.1492			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	444FJ	11430380	Green Published			2022-12-24	WOS:000169389200065
J	Baur, JA; Zou, Y; Shay, JW; Wright, WE				Baur, JA; Zou, Y; Shay, JW; Wright, WE			Telomere position effect in human cells	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; HISTONE DEACETYLASE; CELLULAR SENESCENCE; EXPRESSION; GENE; FIBROBLASTS; REPRESSION; SEQUENCE; RB	In yeast, telomere position effect (TPE) results in the reversible silencing of genes near telomeres. Here we demonstrate the presence of TPE in human cells. HeLa clones containing a luciferase reporter adjacent to a newly formed telomere express 10 times less luciferase than do control clones generated by random integration. Luciferase expression is restored by trichostatin A, a histone deacetylase inhibitor. Overexpression of a human telomerase reverse transcriptase complementary DNA results in telomere elongation and an additional 2- to 10-fold decrease in expression in telomeric clones but not control clones. The dependence of TPE on telomere length provides a mechanism for the modification of gene expression throughout the replicative life-span of human cells.	Univ Texas, SW Med Ctr, Dept Cell Biol, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Shay, JW (corresponding author), Univ Texas, SW Med Ctr, Dept Cell Biol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.		Baur, Joseph A/D-8163-2011; Shay, Jerry W/F-7878-2011	Baur, Joseph/0000-0001-8262-6549	NIA NIH HHS [AG07792] Funding Source: Medline	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BAUR J, UNPUB; BAYNE RAL, 1994, HUM MOL GENET, V3, P539; Bryan TM, 1997, HUM MOL GENET, V6, P921, DOI 10.1093/hmg/6.6.921; COOKE H, 1995, TELOMERES, P238; GOTTSCHLING DE, 1990, CELL, V63, P751, DOI 10.1016/0092-8674(90)90141-Z; HANISH JP, 1994, P NATL ACAD SCI USA, V91, P8861, DOI 10.1073/pnas.91.19.8861; HARA E, 1991, BIOCHEM BIOPH RES CO, V179, P528, DOI 10.1016/0006-291X(91)91403-Y; HARLEY CB, 1991, MUTAT RES, V256, P271, DOI 10.1016/0921-8734(91)90018-7; HAYFLICK L, 1980, ANN REV GERONTOLOGY, V1, P26; Kilburn AE, 2001, MOL CELL BIOL, V21, P126, DOI 10.1128/MCB.21.1.126-135.2001; KYRION G, 1993, GENE DEV, V7, P1146, DOI 10.1101/gad.7.7a.1146; Marks PA, 2000, JNCI-J NATL CANCER I, V92, P1210, DOI 10.1093/jnci/92.15.1210; McChesney Patricia A., 2000, Molecular Cell Biology Research Communications, V3, P312, DOI 10.1006/mcbr.2000.0229; Ofir R, 1999, P NATL ACAD SCI USA, V96, P11434, DOI 10.1073/pnas.96.20.11434; RENAULD H, 1993, GENE DEV, V7, P1133, DOI 10.1101/gad.7.7a.1133; SHAY JW, 1991, EXP CELL RES, V196, P33, DOI 10.1016/0014-4827(91)90453-2; Sprung CN, 1996, NUCLEIC ACIDS RES, V24, P4336, DOI 10.1093/nar/24.21.4336; Tresini M, 1999, J CELL PHYSIOL, V179, P11, DOI 10.1002/(SICI)1097-4652(199904)179:1<11::AID-JCP2>3.3.CO;2-Z; WILEY EA, 1995, GENETICS, V139, P67; Wright WE, 1997, GENE DEV, V11, P2801, DOI 10.1101/gad.11.21.2801; WRIGHT WE, 1992, TRENDS GENET, V8, P193, DOI 10.1016/0168-9525(92)90232-S; Yamano T, 2000, MOL THER, V1, P574, DOI 10.1006/mthe.2000.0074	22	351	365	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 15	2001	292	5524					2075	2077		10.1126/science.1062329	http://dx.doi.org/10.1126/science.1062329			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442KP	11408657				2022-12-24	WOS:000169284700047
J	Lohmann, JU; Hong, RL; Hobe, M; Busch, MA; Parcy, F; Simon, R; Weigel, D				Lohmann, JU; Hong, RL; Hobe, M; Busch, MA; Parcy, F; Simon, R; Weigel, D			A molecular link between stem cell regulation and floral patterning in Arabidopsis	CELL			English	Article							HOMEOTIC GENE; FLOWER DEVELOPMENT; ORGAN IDENTITY; SYNERGISTIC ACTIVATION; NEGATIVE REGULATION; ECTOPIC EXPRESSION; SHOOT MERISTEMS; LEAFY; PLANTS; TRANSCRIPTION	The homeotic gene AGAMOUS (AG) has dual roles in specifying organ fate and limiting stem cell proliferation in Arabidopsis flowers. We show that the floral identity protein LEAFY (LPI), a transcription factor expressed throughout the flower, cooperates with the homeodomain protein WUSCHEL (WUS) to activateAG in the center of flowers. WUS was previously identified because of its role in maintaining stem cell populations in both shoot and floral meristems. The unsuspected additional role of WUS in regulating floral homeotic gene expression supports the hypothesis that floral patterning uses a general meristem patterning system that was present before flowers evolved. We also show that AG represses WUS at later stages of floral development, thus creating a negative feedback loop that is required for the determinate growth of floral meristems.	Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA; Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA; Univ Cologne, Inst Entwicklungsbiol, D-50923 Cologne, Germany; Max Planck Inst Dev Biol, Dept Mol Biol, D-72076 Tubingen, Germany	Salk Institute; University of California System; University of California San Diego; University of Cologne; Max Planck Society	Weigel, D (corresponding author), Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA.		Lohmann, Jan/T-3776-2019; Parcy, François/G-9177-2011; parcy, francois/A-6031-2009; Weigel, Detlef/AAR-3312-2021; Weigel, Detlef/GSJ-0799-2022; Weigel, Detlef/C-1418-2008; Simon, Rudiger/T-6755-2018	Lohmann, Jan/0000-0003-3667-187X; Parcy, François/0000-0003-2191-500X; Weigel, Detlef/0000-0002-2114-7963; Weigel, Detlef/0000-0002-2114-7963; Simon, Rudiger/0000-0002-1317-7716	NIGMS NIH HHS [GM07240-24] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bechtold N, 1998, METH MOL B, V82, P259; Blazquez MA, 1997, DEVELOPMENT, V124, P3835; BOWMAN JL, 1991, DEVELOPMENT, V112, P1; BOWMAN JL, 1989, PLANT CELL, V1, P37, DOI 10.1105/tpc.1.1.37; Brand U, 2000, SCIENCE, V289, P617, DOI 10.1126/science.289.5479.617; Busch MA, 1999, SCIENCE, V285, P585, DOI 10.1126/science.285.5427.585; Byzova MV, 1999, GENE DEV, V13, P1002, DOI 10.1101/gad.13.8.1002; CAREY M, 1990, NATURE, V345, P361, DOI 10.1038/345361a0; CARROLL SB, 1994, SCIENCE, V265, P109, DOI 10.1126/science.7912449; CLARK SE, 1993, DEVELOPMENT, V119, P397; COEN ES, 1991, NATURE, V353, P31, DOI 10.1038/353031a0; Conner J, 2000, P NATL ACAD SCI USA, V97, P12902, DOI 10.1073/pnas.230352397; Deyholos MK, 2000, PLANT CELL, V12, P1799, DOI 10.1105/tpc.12.10.1799; DREWS GN, 1991, CELL, V65, P991, DOI 10.1016/0092-8674(91)90551-9; Fletcher LC, 1999, SCIENCE, V283, P1911, DOI 10.1126/science.283.5409.1911; GEHRING WJ, 1994, CELL, V78, P211, DOI 10.1016/0092-8674(94)90292-5; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; GLEAVE AP, 1992, PLANT MOL BIOL, V20, P1203, DOI 10.1007/BF00028910; GOLEMIS EA, 1996, CURRENT PROTOCOLS MO; Goodrich J, 1997, NATURE, V386, P44, DOI 10.1038/386044a0; GUARENTE L, 1983, CELL, V32, P1279, DOI 10.1016/0092-8674(83)90309-4; Honma T, 2001, NATURE, V409, P525, DOI 10.1038/35054083; HUALA E, 1992, PLANT CELL, V4, P901, DOI 10.1105/tpc.4.8.901; Irish VF, 1999, DEV BIOL, V209, P211, DOI 10.1006/dbio.1999.9226; JACK T, 1994, CELL, V76, P703, DOI 10.1016/0092-8674(94)90509-6; JOFUKU KD, 1994, PLANT CELL, V6, P1211, DOI 10.1105/tpc.6.9.1211; Keys DN, 1999, SCIENCE, V283, P532, DOI 10.1126/science.283.5401.532; Laux T, 1996, DEVELOPMENT, V122, P87; Lee I, 1997, CURR BIOL, V7, P95, DOI 10.1016/S0960-9822(06)00053-4; LIN YS, 1990, NATURE, V345, P359, DOI 10.1038/345359a0; Mayer KFX, 1998, CELL, V95, P805, DOI 10.1016/S0092-8674(00)81703-1; MIZUKAMI Y, 1992, CELL, V71, P119, DOI 10.1016/0092-8674(92)90271-D; MIZUKAMI Y, 1995, PLANT MOL BIOL, V28, P767, DOI 10.1007/BF00042064; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; Ng M, 2001, NAT REV GENET, V2, P186, DOI 10.1038/35056041; OLIVIERO S, 1991, P NATL ACAD SCI USA, V88, P224, DOI 10.1073/pnas.88.1.224; Parcy F, 1998, NATURE, V395, P561, DOI 10.1038/26903; Pelaz S, 2001, CURR BIOL, V11, P182, DOI 10.1016/S0960-9822(01)00024-0; SAUER F, 1995, SCIENCE, V270, P1783, DOI 10.1126/science.270.5243.1783; Schoof H, 2000, CELL, V100, P635, DOI 10.1016/S0092-8674(00)80700-X; SCHULTZ EA, 1991, PLANT CELL, V3, P771, DOI 10.1105/tpc.3.8.771; Sessions A, 1999, PLANT J, V20, P259, DOI 10.1046/j.1365-313x.1999.00594.x; Sieburth LE, 1997, PLANT CELL, V9, P355, DOI 10.1105/tpc.9.3.355; Sieburth LE, 1998, DEVELOPMENT, V125, P4303; SIEBURTH LE, 1995, PLANT CELL, V7, P1249, DOI 10.1105/tpc.7.8.1249; SMYTH DR, 1990, PLANT CELL, V2, P755, DOI 10.1105/tpc.2.8.755; Theissen G, 2000, PLANT MOL BIOL, V42, P115, DOI 10.1023/A:1006332105728; Trotochaud AE, 2000, SCIENCE, V289, P613, DOI 10.1126/science.289.5479.613; von Goethe J. W., 1790, VERSUCH METAMORPHOSE; Wagner D, 1999, SCIENCE, V285, P582, DOI 10.1126/science.285.5427.582; WEIGEL D, 1994, CELL, V78, P203, DOI 10.1016/0092-8674(94)90291-7; WEIGEL D, 1992, CELL, V69, P843, DOI 10.1016/0092-8674(92)90295-N; WEIGEL D, 1995, NATURE, V377, P495, DOI 10.1038/377495a0; YANOFSKY MF, 1990, NATURE, V346, P35, DOI 10.1038/346035a0	54	500	556	8	76	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 15	2001	105	6					793	803		10.1016/S0092-8674(01)00384-1	http://dx.doi.org/10.1016/S0092-8674(01)00384-1			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	444AE	11440721	Bronze, Green Published			2022-12-24	WOS:000169375100012
J	Heames, RM; Sado, D; Deakin, CD				Heames, RM; Sado, D; Deakin, CD			Do doctors position defibrillation paddles correctly? Observational study	BRITISH MEDICAL JOURNAL			English	Article									Southampton Gen Hosp NHS Trust, Shackleton Dept Anaesthet, Southampton SO16 6YD, Hants, England		Deakin, CD (corresponding author), Southampton Gen Hosp NHS Trust, Shackleton Dept Anaesthet, Southampton SO16 6YD, Hants, England.							[Anonymous], 2000, RESUSCITATION, V46, P109; [Anonymous], 2000, RESUSCITATION, V46, P73; *EM CARD CAR COMM, 1992, JAMA-J AM MED ASSOC, V268, P2199; LAROSE D, 1993, ANN EMERG MED, V22, P1925, DOI 10.1016/S0196-0644(05)80429-9; Robertson C, 1998, RESUSCITATION, V37, P81, DOI 10.1016/S0300-9572(98)00035-5	5	27	28	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 9	2001	322	7299					1393	1394		10.1136/bmj.322.7299.1393	http://dx.doi.org/10.1136/bmj.322.7299.1393			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	442KN	11397743	Green Published, Green Submitted, Bronze			2022-12-24	WOS:000169284600016
J	Alroy, J				Alroy, J			A multispecies overkill simulation of the end-Pleistocene megafaunal mass extinction	SCIENCE			English	Article							MAMMALS; HUNTER	A computer simulation of North American end-Pleistocene human and Large herbivore population dynamics correctly predicts the extinction or survival of 32 out of 41 prey species. Slow human population growth rates, random hunting, and Low maximum hunting effort are assumed; additional parameters are based on published values. Predictions are close to observed values for overall extinction rates, human population densities, game consumption rates, and the temporal overlap of humans and extinct species. Results are robust to variation in unconstrained parameters. This fully mechanistic model accounts for megafaunal extinction without invoking climate change and secondary ecological effects.	Univ Calif Santa Barbara, Natl Ctr Ecol Anal & Synth, Santa Barbara, CA 93101 USA	National Center for Ecological Analysis & Synthesis; University of California System; University of California Santa Barbara	Alroy, J (corresponding author), Univ Calif Santa Barbara, Natl Ctr Ecol Anal & Synth, 735 State St,Suite 300, Santa Barbara, CA 93101 USA.	alroy@nceas.ucsb.edu	Alroy, John/B-4585-2009	Alroy, John/0000-0002-9882-2111				ADAMS RHM, 1986, HUM TOXICOL, V5, P5, DOI 10.1177/096032718600500102; ALBERDI MT, 1995, BIOL J LINN SOC, V54, P349, DOI 10.1111/j.1095-8312.1995.tb01042.x; Alroy John, 1999, P105; Beck MW, 1996, PALEOBIOLOGY, V22, P91, DOI 10.1017/S0094837300016043; BELOVSKY GE, 1987, J ANTHROPOL ARCHAEOL, V6, P29, DOI 10.1016/0278-4165(87)90016-X; BELOVSKY GE, 1988, J ANTHROPOL ARCHAEOL, V7, P329, DOI 10.1016/0278-4165(88)90002-5; BROWN JH, 1991, AM NAT, V138, P1478, DOI 10.1086/285297; BUDYKO MI, 1967, SOV GEOGR, V8, P783, DOI 10.1080/00385417.1967.10770945; Choquenot D, 1998, GLOBAL ECOL BIOGEOGR, V7, P167, DOI 10.2307/2997372; Damuth J., 1990, BODY SIZE MAMMALIAN; Diamond J.M., 1984, QUATERNARY EXTINCTIO, P354; Fiedel SJ, 1999, AM ANTIQUITY, V64, P95, DOI 10.2307/2694348; Graham R.W., 1984, P223; Graham RW, 1996, SCIENCE, V272, P1601; Guthrie R.D., 1984, P259; HARVEY PH, 1991, AM NAT, V137, P556, DOI 10.1086/285183; HASSAN FA, 1981, DEMOGRAPHIC ARCHAEOL; Haynes Gary, 1999, P71; HENNEMANN WW, 1983, OECOLOGIA, V56, P104, DOI 10.1007/BF00378224; HOLLING C. S., 1959, CANADIAN ENT, V91, P293; Keesing F, 1998, OECOLOGIA, V116, P381, DOI 10.1007/s004420050601; MacPhee Ross D.E., 1997, P169; Martin P.S., 1999, EXTINCTIONS NEAR TIM, P17, DOI DOI 10.1007/978-1-4757-5202-1_2; MARTIN PS, 1973, SCIENCE, V179, P969, DOI 10.1126/science.179.4077.969; Martin PS, 1967, PREHISTORIC EXTINCTI; MOSIMANN JE, 1975, AM SCI, V63, P304; OWENSMITH N, 1987, PALEOBIOLOGY, V13, P351; Post E, 1999, ECOLOGY, V80, P1322, DOI 10.1890/0012-9658(1999)080[1322:CVPPAN]2.0.CO;2; Silva M, 1997, J ANIM ECOL, V66, P327, DOI 10.2307/5979; Webster D., 1981, P556; WHITLEY DS, 1993, AM ANTIQUITY, V58, P626, DOI 10.2307/282199; Whittington S.L., 1984, P451; Wilkie DS, 1998, CONSERV BIOL, V12, P137, DOI 10.1046/j.1523-1739.1998.96156.x; WINTERHALDER B, 1988, J ANTHROPOL ARCHAEOL, V7, P289, DOI 10.1016/0278-4165(88)90001-3	34	349	367	16	399	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 8	2001	292	5523					1893	1896		10.1126/science.1059342	http://dx.doi.org/10.1126/science.1059342			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	440WY	11397940				2022-12-24	WOS:000169200700043
J	Mullen, AC; High, FA; Hutchins, AS; Lee, HW; Villarino, AV; Livingston, DM; Kung, AL; Cereb, N; Yao, TP; Yang, SY; Reiner, SL				Mullen, AC; High, FA; Hutchins, AS; Lee, HW; Villarino, AV; Livingston, DM; Kung, AL; Cereb, N; Yao, TP; Yang, SY; Reiner, SL			Role of T-bet in commitment of T(H)1 cells before IL-12-dependent selection	SCIENCE			English	Article							CYTOKINE GENE-EXPRESSION; TRANSCRIPTION FACTOR; SIGNAL TRANSDUCER; TH2 CELLS; ACTIVATION; RESPONSES; STAT6; IL-4; DIFFERENTIATION; INTERLEUKIN-4	How cytokines control differentiation of helper T (T-H) cells is controversial. We show that T-bet, without apparent assistance from interleukin 12 (IL-12)/ STAT4, specifies T(H)1 effector fate by targeting chromatin remodeling to individual interferon-gamma (IFN-gamma) alleles and by inducing IL-12 receptor beta2 expression. Subsequently, it appears that IL-12/STAT4 serves two essential functions in the development of T(H)1 cells: as growth signal, inducing survival and cell division; and as trans-activator, prolonging IFN-gamma synthesis through a genetic interaction with the coactivator, CREB-binding protein. These results suggest that a cytokine does not simply induce T-H fate choice but instead may act as an essential secondary stimulus that mediates selective survival of a lineage.	Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; Univ Penn, Dept Med, Philadelphia, PA 19104 USA; Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Histogenet Inc, Hawthorne, NY 10532 USA; Ctr Genet Polymorphism, Hawthorne, NY 10532 USA; Duke Univ, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Duke University	Reiner, SL (corresponding author), Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA.		Kung, Andrew L/AEU-0826-2022; Kung, Andrew/AAL-2384-2020	Kung, Andrew L/0000-0002-9091-488X; Villarino, Alejandro/0000-0001-8068-2176; Mullen, Alan/0000-0002-4096-3106	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042370] Funding Source: NIH RePORTER; NEI NIH HHS [EY-07131] Funding Source: Medline; NIAID NIH HHS [AI-42370] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Agarwal S, 1998, IMMUNITY, V9, P765, DOI 10.1016/S1074-7613(00)80642-1; Bird JJ, 1998, IMMUNITY, V9, P229, DOI 10.1016/S1074-7613(00)80605-6; Bix M, 1998, SCIENCE, V281, P1352, DOI 10.1126/science.281.5381.1352; Coffman RL, 1999, SCIENCE, V284, P1283, DOI 10.1126/science.284.5418.1283; Farrar JD, 2001, J EXP MED, V193, P643, DOI 10.1084/jem.193.5.643; Finkelman FD, 2000, J IMMUNOL, V164, P2303, DOI 10.4049/jimmunol.164.5.2303; Grogan JL, 2001, IMMUNITY, V14, P205, DOI 10.1016/S1074-7613(01)00103-0; Hollander GA, 1998, SCIENCE, V279, P2118, DOI 10.1126/science.279.5359.2118; Kaplan MH, 1998, J EXP MED, V188, P1191, DOI 10.1084/jem.188.6.1191; Kaplan MH, 1996, IMMUNITY, V4, P313, DOI 10.1016/S1074-7613(00)80439-2; Kaplan MH, 1996, NATURE, V382, P174, DOI 10.1038/382174a0; Korzus E, 1998, SCIENCE, V279, P703, DOI 10.1126/science.279.5351.703; Kung AL, 2000, GENE DEV, V14, P272; Kurata H, 1999, IMMUNITY, V11, P677, DOI 10.1016/S1074-7613(00)80142-9; Langenkamp A, 2000, NAT IMMUNOL, V1, P311, DOI 10.1038/79758; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; MULLEN AC, UNPUB; Murphy KM, 2000, ANNU REV IMMUNOL, V18, P451, DOI 10.1146/annurev.immunol.18.1.451; Ouyang W, 1998, IMMUNITY, V9, P745, DOI 10.1016/S1074-7613(00)80671-8; Ouyang WJ, 2000, IMMUNITY, V12, P27, DOI 10.1016/S1074-7613(00)80156-9; Riviere I, 1998, IMMUNITY, V9, P217, DOI 10.1016/S1074-7613(00)80604-4; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; SEDER RA, 1992, J EXP MED, V176, P1091, DOI 10.1084/jem.176.4.1091; Simpson SJ, 1998, J EXP MED, V187, P1225, DOI 10.1084/jem.187.8.1225; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Yang JF, 1999, EUR J IMMUNOL, V29, P548, DOI 10.1002/(SICI)1521-4141(199902)29:02<548::AID-IMMU548>3.0.CO;2-Z; Zhang WX, 2000, GENOMICS, V70, P41, DOI 10.1006/geno.2000.6361; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8	28	645	692	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 8	2001	292	5523					1907	1910		10.1126/science.1059835	http://dx.doi.org/10.1126/science.1059835			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	440WY	11397944				2022-12-24	WOS:000169200700048
J	Agrawal, AF				Agrawal, AF			Sexual selection and the maintenance of sexual reproduction	NATURE			English	Article							DELETERIOUS MUTATIONS; EVOLUTION; LOAD; ADVANTAGE; DOMINANCE; BALANCE	The maintenance of sexual reproduction is a problem in evolutionary theory because, all else being equal, asexual populations have a twofold fitness advantage over their sexual counterparts(1,2) and should rapidly outnumber a sexual population because every individual has the potential to reproduce. The twofold cost of sex exists because of anisogamy or gamete dimorphism(2)-egg-producing females make a larger contribution to the zygote compared with the small contribution made by the sperm of males, but both males and females contribute 50% of the genes. Anisogamy also generates the conditions for sexual selection(3), a powerful evolutionary force that does not exist in asexual populations. The continued prevalence of sexual reproduction indicates that the 'all else being equal' assumption is incorrect. Here I show that sexual selection can mitigate or even eliminate the cost of sex. If sexual selection causes deleterious mutations to be more deleterious in males than females, then deleterious mutations are maintained at lower equilibrium frequency in sexual populations relative to asexual populations. The fitness of sexual females is higher than asexuals because there is no difference in the fecundity of sexual females and asexuals of the same genotype, but the equilibrium frequency of deleterious mutations is lower in sexual populations. The results are not altered by synergistic epistasis in males.	Indiana Univ, Dept Biol, Bloomington, IN 47405 USA	Indiana University System; Indiana University Bloomington	Agrawal, AF (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN 47405 USA.	aagrawal@bio.indiana.edu						Andersson Malte, 1994; ARNOLD SJ, 1984, EVOLUTION, V38, P720, DOI 10.1111/j.1558-5646.1984.tb00345.x; Bell G, 1982, MASTERPIECE NATURE E; CHARLESWORTH B, 1990, GENET RES, V55, P199, DOI 10.1017/S0016672300025532; Chasnov JR, 2000, GENETICS, V156, P1419; CROW J. F., 1970, Biomathematics. Volume 1. Mathematical topics in population genetics., P128; Drickamer LC, 2000, ANIM BEHAV, V59, P371, DOI 10.1006/anbe.1999.1316; Elena SF, 1997, NATURE, V390, P395, DOI 10.1038/37108; Evans JP, 2000, P NATL ACAD SCI USA, V97, P10074, DOI 10.1073/pnas.180207297; Garcia-Dorado A, 2000, GENETICS, V155, P1991; HOWARD RS, 1994, NATURE, V367, P554, DOI 10.1038/367554a0; Hurst Laurence D., 1996, Trends in Ecology and Evolution, V11, P46, DOI 10.1016/0169-5347(96)81041-X; Keightley PD, 2000, SCIENCE, V290, P331, DOI 10.1126/science.290.5490.331; Keightley PD, 1999, GENETICS, V153, P515; KIMURA M, 1966, GENETICS, V54, P1337; Kingsolver JG, 2001, AM NAT, V157, P245, DOI 10.1086/319193; Kodric-Brown A, 1987, EVOL ECOL, V1, P95, DOI 10.1007/BF02067393; KOESLAG JH, 1993, J HERED, V84, P396, DOI 10.1093/oxfordjournals.jhered.a111360; KONDRASHOV AS, 1988, NATURE, V336, P435, DOI 10.1038/336435a0; KONDRASHOV AS, 1982, GENET RES, V40, P325, DOI 10.1017/S0016672300019194; Lynch M, 1999, EVOLUTION, V53, P645, DOI 10.1111/j.1558-5646.1999.tb05361.x; Lynch M., 1998, AM J HUM GENET; MANNING JT, 1984, J THEOR BIOL, V108, P215, DOI 10.1016/S0022-5193(84)80067-3; Maynard Smith J., 1978, EVOLUTION SEX, DOI DOI 10.1093/bioinformatics/btg412; MULCAHY DL, 1979, SCIENCE, V206, P20, DOI 10.1126/science.206.4414.20; Peck JR, 2000, NATURE, V406, P399, DOI 10.1038/35019055; TRIVERS RL, 1972, SEXUAL SELECTION DES, P141; Welch AM, 1998, SCIENCE, V280, P1928, DOI 10.1126/science.280.5371.1928; Whitlock MC, 2000, EVOLUTION, V54, P1654, DOI 10.1111/j.0014-3820.2000.tb00709.x; Whitlock MC, 2000, EVOLUTION, V54, P1855, DOI 10.1111/j.0014-3820.2000.tb01232.x	30	227	229	0	139	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN	2001	411	6838					692	695		10.1038/35079590	http://dx.doi.org/10.1038/35079590			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439JC	11395771				2022-12-24	WOS:000169112500045
J	Hellberg, ME; Balch, DP; Roy, K				Hellberg, ME; Balch, DP; Roy, K			Climate-driven range expansion and morphological evolution in a marine gastropod	SCIENCE			English	Article							GENE FLOW; DNA-SEQUENCES; ICE AGES; SPECIATION; PLEISTOCENE; POPULATIONS; GRADIENTS; RECORD; SIZE	Little is known about the phenotypic consequences of global climate change, despite the excellent Pleistocene fossil record of many taxa. We used morphological measurements from extant and Pleistocene populations of a marine gastropod (Acanthinucella spirata) in conjunction with mitochondrial DNA sequence variation from Living populations to determine how populations responded phenotypically to Pleistocene climatic changes. Northern populations show Little sequence variation as compared to southern populations, a pattern consistent with a recent northward range expansion. These recently recolonized northern populations also contain shell morphologies that are absent in extant southern populations and throughout the Pleistocene fossil record, Thus, contrary to traditional expectations that morphological evolution should occur Largely within Pleistocene refugia, our data show that geographical range shifts in response to climatic change can Lead to significant morphological evolution.	Univ Calif San Diego, Div Biol, Sect Ecol Behav & Evolut, La Jolla, CA 92093 USA; Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA	University of California System; University of California San Diego; Louisiana State University System; Louisiana State University	Roy, K (corresponding author), Univ Calif San Diego, Div Biol, Sect Ecol Behav & Evolut, 9500 Gilman Dr, La Jolla, CA 92093 USA.							Avise JC, 2000, PHYLOGEOGRAPHY HIST, DOI 10.2307/j.ctv1nzfgj7; Bell M. A., 1997, V82, P323; Bernardi G, 2000, EVOLUTION, V54, P226, DOI 10.1111/j.0014-3820.2000.tb00023.x; Burton RS, 1998, EVOLUTION, V52, P734, DOI 10.1111/j.1558-5646.1998.tb03698.x; Case TJ, 2000, AM NAT, V155, P583, DOI 10.1086/303351; Chiba S, 1998, PALEOBIOLOGY, V24, P99, DOI 10.1017/S0094837300019990; EXCOFFIER L, 1992, GENETICS, V131, P479; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Gaylord B, 2000, AM NAT, V155, P769, DOI 10.1086/303357; GIANNINY GL, 1992, VELIGER, V35, P195; Graham RW, 1996, SCIENCE, V272, P1601; Hadly EA, 1998, P NATL ACAD SCI USA, V95, P6893, DOI 10.1073/pnas.95.12.6893; HAFFER J, 1969, SCIENCE, V165, P131, DOI 10.1126/science.165.3889.131; HELLBERG ME, 1994, EVOLUTION, V48, P1829, DOI 10.1111/j.1558-5646.1994.tb02218.x; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Huey RB, 2000, SCIENCE, V287, P308, DOI 10.1126/science.287.5451.308; Kennedy G.L., 1978, THESIS U CALIFORNIA, pvii; Klicka J, 1997, SCIENCE, V277, P1666, DOI 10.1126/science.277.5332.1666; Lindberg David R., 1996, P161; Losos JB, 1997, NATURE, V387, P70, DOI 10.1038/387070a0; Marko PB, 1998, EVOLUTION, V52, P757, DOI 10.1111/j.1558-5646.1998.tb03700.x; Marko PB, 1999, MOL PHYLOGENET EVOL, V13, P275, DOI 10.1006/mpev.1999.0655; Nei M, 1987, MOL EVOLUTIONARY GEN; PEASE CM, 1989, ECOLOGY, V70, P1657, DOI 10.2307/1938100; Price TD, 1997, EVOLUTION, V51, P552, DOI 10.1111/j.1558-5646.1997.tb02442.x; Roy K, 1997, TRENDS ECOL EVOL, V12, P277, DOI 10.1016/S0169-5347(97)81026-9; Roy K, 1998, P NATL ACAD SCI USA, V95, P3699, DOI 10.1073/pnas.95.7.3699; Roy K, 1996, TRENDS ECOL EVOL, V11, P458, DOI 10.1016/0169-5347(96)10054-9; ROY K, 1995, GEOLOGY, V23, P1071, DOI 10.1130/0091-7613(1995)023<1071:TAARPI>2.3.CO;2; Rundle HD, 2000, SCIENCE, V287, P306, DOI 10.1126/science.287.5451.306; Schneider S., 2000, ARLEQUIN SOFTWARE PO, V2, P2496; SLATKIN M, 1991, GENETICS, V129, P555; SMITH FA, 1995, SCIENCE, V270, P2012, DOI 10.1126/science.270.5244.2012; SPIGHT T M, 1977, Nautilus, V91, P67; SWOFFORD DL, 1998, PAUP STAR PHYLOGENET; TAJIMA F, 1983, GENETICS, V105, P437; VALENTINE JW, 1966, LIMNOL OCEANOGR, V11, P198, DOI 10.4319/lo.1966.11.2.0198; VALENTINE JW, 1989, PALEOBIOLOGY, V15, P83, DOI 10.1017/S0094837300009295; Zink RM, 2000, CONSERV BIOL, V14, P1394, DOI 10.1046/j.1523-1739.2000.99082.x	39	136	141	2	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 1	2001	292	5522					1707	1710		10.1126/science.1060102	http://dx.doi.org/10.1126/science.1060102			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	438AP	11387473				2022-12-24	WOS:000169031800042
J	Zhou, M; Morais-Cabral, JH; Mann, S; MacKinnon, R				Zhou, M; Morais-Cabral, JH; Mann, S; MacKinnon, R			Potassium channel receptor site for the inactivation gate and quaternary amine inhibitors	NATURE			English	Article							SHAKER K-CHANNELS; PORE; MECHANISMS; BLOCKADE	Many voltage-dependent K+ channels open when the membrane is depolarized and then rapidly close by a process called inactivation. Neurons use inactivating K+ channels to modulate their firing frequency. In Shaker-type K+ channels, the inactivation gate, which is responsible for the closing of the channel, is formed by the channel's cytoplasmic amino terminus. Here we show that the central cavity and inner pore of the K+ channel form the receptor site for both the inactivation gate and small-molecule inhibitors. We propose that inactivation occurs by a sequential reaction in which the gate binds initially to the cytoplasmic channel surface and then enters the pore as an extended peptide. This mechanism accounts for the functional properties of K+ channel inactivation and indicates that the cavity may be the site of action for certain drugs that alter cation channel function.	Rockefeller Univ, Howard Hughes Med Inst, Lab Mol Neurobiol & Biophys, New York, NY 10021 USA	Howard Hughes Medical Institute; Rockefeller University	MacKinnon, R (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab Mol Neurobiol & Biophys, 1230 York Ave, New York, NY 10021 USA.	mackinn@rockvax.rockefeller.edu	Morais-Cabral, Joao H/J-4914-2013	Morais-Cabral, Joao H/0000-0002-4461-9716				Antz C, 1997, NATURE, V385, P272, DOI 10.1038/385272a0; Antz C, 1998, NEWS PHYSIOL SCI, V13, P177; ARMSTRONG CM, 1971, J GEN PHYSIOL, V58, P413, DOI 10.1085/jgp.58.4.413; ARMSTRONG CM, 1972, J GEN PHYSIOL, V59, P388, DOI 10.1085/jgp.59.4.388; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; CHOI KL, 1991, P NATL ACAD SCI USA, V88, P5092, DOI 10.1073/pnas.88.12.5092; DEMO SD, 1991, NEURON, V7, P743, DOI 10.1016/0896-6273(91)90277-7; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; GOMEZLAGUNAS F, 1995, BIOPHYS J, V68, P89, DOI 10.1016/S0006-3495(95)80162-1; Gulbis JM, 2000, SCIENCE, V289, P123, DOI 10.1126/science.289.5476.123; Heinemann SH, 1996, J PHYSIOL-LONDON, V493, P625, DOI 10.1113/jphysiol.1996.sp021409; HIDALGO P, 1995, SCIENCE, V268, P307, DOI 10.1126/science.7716527; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; ISACOFF EY, 1991, NATURE, V353, P86, DOI 10.1038/353086a0; Kobertz WR, 2000, BIOCHEMISTRY-US, V39, P10347, DOI 10.1021/bi001292j; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LU Z, 1994, J GEN PHYSIOL, V104, P477, DOI 10.1085/jgp.104.3.477; MACKINNON R, 1993, SCIENCE, V262, P757, DOI 10.1126/science.7694359; MACKINNON R, 1990, SCIENCE, V250, P276, DOI 10.1126/science.2218530; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Mitcheson JS, 2000, P NATL ACAD SCI USA, V97, P12329, DOI 10.1073/pnas.210244497; MURRELLLAGNADO RD, 1993, J GEN PHYSIOL, V102, P977, DOI 10.1085/jgp.102.6.977; MURRELLLAGNADO RD, 1993, J GEN PHYSIOL, V102, P949, DOI 10.1085/jgp.102.6.949; OTWINOWSKI Z, 1993, P CCP4 STUD WEEK SER; Rasmusson RL, 1995, J PHYSIOL-LONDON, V489, P709, DOI 10.1113/jphysiol.1995.sp021085; RETTIG J, 1994, NATURE, V369, P289, DOI 10.1038/369289a0; Schott MK, 1998, EUR BIOPHYS J BIOPHY, V27, P99, DOI 10.1007/s002490050115; Sokolova O, 2001, STRUCTURE, V9, P215, DOI 10.1016/S0969-2126(01)00578-0; Yarov-Yarovoy V, 2001, J BIOL CHEM, V276, P20, DOI 10.1074/jbc.M006992200; ZAGOTTA WN, 1990, J GEN PHYSIOL, V95, P29, DOI 10.1085/jgp.95.1.29; ZAGOTTA WN, 1990, SCIENCE, V250, P568, DOI 10.1126/science.2122520	31	484	494	1	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN	2001	411	6838					657	661		10.1038/35079500	http://dx.doi.org/10.1038/35079500			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439JC	11395760				2022-12-24	WOS:000169112500034
J	Young, D				Young, D			Leprosy and the genome - not yet a burnt-out case	LANCET			English	Editorial Material									Univ London Imperial Coll Sci Technol & Med, Ctr Mol Microbiol & Infect, London SW7 2AZ, England	Imperial College London	Young, D (corresponding author), Univ London Imperial Coll Sci Technol & Med, Ctr Mol Microbiol & Infect, London SW7 2AZ, England.							Cole ST, 2001, NATURE, V409, P1007, DOI 10.1038/35059006; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Ng V, 2000, CELL, V103, P511, DOI 10.1016/S0092-8674(00)00142-2; Perna NT, 2001, NATURE, V409, P529, DOI 10.1038/35054089; Siddiqui MR, 2001, NAT GENET, V27, P439, DOI 10.1038/86958; van Soolingen D, 2001, J INTERN MED, V249, P1, DOI 10.1046/j.1365-2796.2001.00772.x; *WHO, 2000, GLOB TUB CONTR; *WHO, 2000, WKLY EPIDEMIOL REC, V75, P226	8	5	5	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 26	2001	357	9269					1639	1640		10.1016/S0140-6736(00)04861-3	http://dx.doi.org/10.1016/S0140-6736(00)04861-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	435UY	11425365				2022-12-24	WOS:000168901600006
J	Daily, GC				Daily, GC			Ecological forecasts	NATURE			English	Editorial Material									Stanford Univ, Dept Biol Sci, Ctr Conservat Biol, Stanford, CA 94305 USA	Stanford University	Daily, GC (corresponding author), Stanford Univ, Dept Biol Sci, Ctr Conservat Biol, 371 Serra Mall, Stanford, CA 94305 USA.							[Anonymous], 1997, NATURES SERVICES; Daily GC, 2001, ECOL APPL, V11, P1, DOI 10.1890/1051-0761(2001)011[0001:CBUOHD]2.0.CO;2; MYERS N, IN PRESS FUTURE COUR; SALZMAN J, IN PRESS STANFORD EN	4	126	134	0	37	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 17	2001	411	6835					245	245		10.1038/35077178	http://dx.doi.org/10.1038/35077178			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432RT	11357107				2022-12-24	WOS:000168710000024
J	Retallack, GJ				Retallack, GJ			A 300-million-year record of atmospheric carbon dioxide from fossil plant cuticles	NATURE			English	Article							CO2 CONCENTRATIONS; BOUNDARY; PALEOCLIMATE; AUSTRALIA; GERMANY; CLIMATE	To understand better the link between atmospheric CO2 concentrations and climate over geological time, records of past CO2 are reconstructed from geochemical proxies(1-4). Although these records have provided us with a broad picture of CO2 variation throughout the Phanerozoic eon (the past 544 Myr), inconsistencies and gaps remain that still need to be resolved. Here I present a continuous 300-Myr record of stomatal abundance from fossil leaves of four genera of plants that are closely related to the present-day Ginkgo tree. Using the known relationship between leaf stomatal abundance and growing season CO2 concentrations(5,6), I reconstruct past atmospheric CO2 concentrations. For the past 300 Myr, only two intervals of low CO2 (<1,000 p.p.m.v.) are inferred, both of which coincide with known ice ages in Neogene (1-8 Myr) and early Permian (275- 290 Myr) times. But for most of the Mesozoic era (65-250 Myr), CO2 levels were high (1,000-2,000 p.p.m.v.), with transient excursions to even higher CO2 (>2,000 p.p.m.v.) concentrations. These results are consistent with some reconstructions of past CO2 (refs 1, 2) and palaeotemperature records(7), but suggest that CO2 reconstructions based on carbon isotope proxies(3,4) may be compromised by episodic outbursts of isotopically light methane(8,9). These results support the role of water vapour, methane and CO2 in greenhouse climate warming over the past 300 Myr.	Univ Oregon, Dept Geol Sci, Eugene, OR 97403 USA	University of Oregon	Retallack, GJ (corresponding author), Univ Oregon, Dept Geol Sci, Eugene, OR 97403 USA.							[Anonymous], PALAEOFLORA SO AFRIC; Arens NC, 2000, PALAIOS, V15, P314, DOI 10.2307/3515539; Beerling DJ, 1998, J EXP BOT, V49, P1603, DOI 10.1093/jexbot/49.326.1603; BERNER RA, 1997, SCIENCE, V276, P543; Cowling SA, 1999, SCIENCE, V285, P1500, DOI 10.1126/science.285.5433.1500; Ekart DD, 1999, AM J SCI, V299, P805, DOI 10.2475/ajs.299.10.805; FLORIN R., 1931, KUNGLIGA SVENSKA VET, V10, P1; Gomankov A.V., 1986, TATARINOVAYA FLORA S, P401; GRADSTEIN FM, 1995, SEPM SPEC PUBL, V54, P95; Jahren AH, 2001, GEOLOGY, V29, P159, DOI 10.1130/0091-7613(2001)029<0159:TROMHD>2.0.CO;2; Khalil MAK, 2000, ATMOSPHERIC METHANE, P86; Krull ES, 2000, NEW ZEAL J GEOL GEOP, V43, P21, DOI 10.1080/00288306.2000.9514868; Kurschner WM, 1996, MAR MICROPALEONTOL, V27, P299, DOI 10.1016/0377-8398(95)00067-4; Lemarchand D, 2000, NATURE, V408, P951, DOI 10.1038/35050058; McElwain JC, 1996, PALAIOS, V11, P376, DOI 10.2307/3515247; McElwain JC, 1999, SCIENCE, V285, P1386, DOI 10.1126/science.285.5432.1386; McGowran B, 1997, MICROPALEONTOLOGY, V43, P129, DOI 10.2307/1485778; Meyen S.V., 1987, FUNDAMENTALS PALAEOB; Pagani M, 1999, SCIENCE, V285, P876, DOI 10.1126/science.285.5429.876; Palfy J, 2000, GEOLOGY, V28, P39, DOI 10.1130/0091-7613(2000)28<39:TTEMEF>2.0.CO;2; Pearson PN, 2000, NATURE, V406, P695, DOI 10.1038/35021000; Retallack GJ, 1999, GEOL SOC AM BULL, V111, P52, DOI 10.1130/0016-7606(1999)111<0052:PGPRBE>2.3.CO;2; RETALLACK GJ, 2000, GEOL SOC AM SPEC PAP, V344, P1, DOI DOI 10.1130/0-8137-2344-21; RETALLACK GJ, 1997, COLOUR GUIDE PALEOSO, P117; ROYER DL, 2000, GEOL SOC AM ABSTR, V32, pA196; Schwarz T, 1997, PALAEOGEOGR PALAEOCL, V129, P37, DOI 10.1016/S0031-0182(96)00065-X; Thomas Ellen, 2000, P132; Utescher T, 2000, PALAIOS, V15, P430, DOI 10.2307/3515514; VAKRAMEEV VA, 1991, JURASSIC CRETACEOUS, P53; Veizer J, 2000, NATURE, V408, P698, DOI 10.1038/35047044	30	302	346	3	130	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 17	2001	411	6835					287	290		10.1038/35077041	http://dx.doi.org/10.1038/35077041			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432RT	11357126				2022-12-24	WOS:000168710000041
J	Shirali, GS; Ni, JY; Chinnock, RE; Johnston, JK; Rosenthal, GL; Bowles, NE; Towbin, JA				Shirali, GS; Ni, JY; Chinnock, RE; Johnston, JK; Rosenthal, GL; Bowles, NE; Towbin, JA			Association of viral genome with graft loss in children after cardiac transplantation.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							POLYMERASE-CHAIN-REACTION; IDIOPATHIC DILATED CARDIOMYOPATHY; INFANT HEART-TRANSPLANTATION; NUCLEIC-ACID HYBRIDIZATION; CORONARY-ARTERY DISEASE; COXSACKIEVIRUS B3 RNA; ENDOMYOCARDIAL BIOPSY; CYTOMEGALOVIRUS-INFECTION; ENTEROVIRUS RNA; ENDOCARDIAL FIBROELASTOSIS	Background: The survival of recipients of cardiac allografts is limited by rejection and coronary vasculopathy. The purpose of this study in children who had received heart transplants was to evaluate the cardiac allografts for myocardial viral infections and to determine whether the presence of viral genome in the myocardium correlates with rejection, coronary vasculopathy, or graft loss. Methods: We enrolled heart-transplant recipients 1 day to 18 years old who were undergoing evaluation for possible rejection and coronary vasculopathy. Endomyocardial-biopsy specimens were evaluated for evidence of rejection with the use of standard criteria and were analyzed for the presence of virus by the polymerase chain reaction (PCR). Results: PCR analyses were performed on 553 consecutive biopsy samples from 149 transplant recipients. Viral genome was amplified from 48 samples (8.7 percent) from 34 patients (23 percent); adenovirus was found in 30 samples, enterovirus in 9 samples, parvovirus in 5 samples, cytomegalovirus in 2 samples, herpes simplex virus in 1 sample, and Epstein-Barr virus in 1 sample. In 29 of the 34 patients with positive results on PCR (85 percent), an adverse cardiac event occurred within three months after the positive biopsy, and 9 of the 34 patients had graft loss due to coronary vasculopathy, chronic graft failure, or acute rejection. In 39 of the 115 patients with negative results on PCR (34 percent), an adverse cardiac event occurred within three months of the negative PCR finding; graft loss did not occur in any of the patients in this group. The odds of graft loss were 6.5 times as great among those with positive results on PCR (P = 0.006). The detection of adenovirus was associated with considerably reduced graft survival (P = 0.002). Conclusions: Identification of viral genome, particularly adenovirus, in the myocardium of pediatric transplant recipients is predictive of adverse clinical events, including coronary vasculopathy and graft loss. (N Engl J Med 2001;344:1498-503.) Copyright (C) 2001 Massachusetts Medical Society.	Baylor Coll Med, Dept Pediat Cardiol, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Dept Cardiovasc Sci, Houston, TX 77030 USA; Med Univ S Carolina, Dept Pediat, Charleston, SC 29425 USA; Loma Linda Univ, Childrens Hosp, Dept Ambulatory Pediat, Loma Linda, CA 92350 USA; Loma Linda Univ, Childrens Hosp, Dept Nursing, Loma Linda, CA 92350 USA; Univ Washington, Dept Pediat Cardiol, Seattle, WA 98195 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Medical University of South Carolina; Children's Hospital Los Angeles; Loma Linda University; Children's Hospital Los Angeles; Loma Linda University; University of Washington; University of Washington Seattle	Towbin, JA (corresponding author), Baylor Coll Med, Dept Pediat Cardiol, Rm 333E,1 Baylor Plaza, Houston, TX 77030 USA.		Towbin, Jeffrey A./J-5595-2019	Towbin, Jeffrey A./0000-0002-6585-714X; Chinnock, Richard/0000-0002-9814-1762				Akhtar N, 1999, CIRCULATION, V99, P2011, DOI 10.1161/01.CIR.99.15.2011; Billingham M E, 1990, J Heart Transplant, V9, P587; BOUCEK MM, 1993, J HEART LUNG TRANSPL, V12, P824; BOUCEK MM, 1994, J HEART LUNG TRANSPL, V13, P66; BOWLES NE, 1989, CIRCULATION, V80, P1128, DOI 10.1161/01.CIR.80.5.1128; BOWLES NE, 1986, LANCET, V1, P1120; Bridges ND, 1998, J THORAC CARDIOV SUR, V116, P617, DOI 10.1016/S0022-5223(98)70168-0; CHAPMAN NM, 1990, J CLIN MICROBIOL, V28, P843, DOI 10.1128/JCM.28.5.843-850.1990; CHOW LH, 1989, J AM COLL CARDIOL, V14, P915, DOI 10.1016/0735-1097(89)90465-8; EISENSTEIN BI, 1990, NEW ENGL J MED, V322, P178; EVERETT JP, 1992, J HEART LUNG TRANS S, V11, P133; FABRICANT CG, 1978, J EXP MED, V148, P335, DOI 10.1084/jem.148.1.335; GRASSO M, 1992, AM J CARDIOL, V69, P658, DOI 10.1016/0002-9149(92)90160-Z; GRATTAN MT, 1989, JAMA-J AM MED ASSOC, V261, P3561, DOI 10.1001/jama.261.24.3561; GRIFFIN LD, 1995, CARDIOVASC PATHOL, V4, P3, DOI 10.1016/1054-8807(94)00025-M; HAUCK AJ, 1989, MAYO CLIN PROC, V64, P1235, DOI 10.1016/S0025-6196(12)61286-5; HILTON DA, 1993, J PATHOL, V170, P45, DOI 10.1002/path.1711700108; JIN O, 1990, CIRCULATION, V82, P8, DOI 10.1161/01.CIR.82.1.8; KANDOLF R, 1987, P NATL ACAD SCI USA, V84, P6272, DOI 10.1073/pnas.84.17.6272; KOSKINEN PK, 1993, J HEART LUNG TRANSPL, V12, P724; LIE JT, 1988, ANN INTERN MED, V109, P525, DOI 10.7326/0003-4819-109-7-525; LOEBE M, 1990, J HEART TRANSPLANT, V9, P707; MARTIN AB, 1994, CIRCULATION, V90, P330, DOI 10.1161/01.CIR.90.1.330; MCDONALD K, 1989, AM J CARDIOL, V64, P359, DOI 10.1016/0002-9149(89)90535-3; MELNICK JL, 1990, JAMA-J AM MED ASSOC, V263, P2204, DOI 10.1001/jama.263.16.2204; MORGANCAPNER P, 1984, VIRAL HEART DISEASE, P99; MUIR P, 1993, J CLIN MICROBIOL, V31, P31, DOI 10.1128/JCM.31.1.31-38.1993; Ni JY, 1997, CIRCULATION, V95, P133, DOI 10.1161/01.CIR.95.1.133; Pauschinger M, 1999, CIRCULATION, V99, P1348, DOI 10.1161/01.CIR.99.10.1348; PETITJEAN J, 1992, J MED VIROL, V37, P76, DOI 10.1002/jmv.1890370114; PETITJEAN J, 1993, J MED VIROL, V41, P260; REDLINE RW, 1991, AM J CLIN PATHOL, V96, P568; Schowengerdt KO, 1997, CIRCULATION, V96, P3549; Schowengerdt KO, 1996, J HEART LUNG TRANSPL, V15, P111; WEISS LM, 1991, AM J PATHOL, V138, P497; WEISS LM, 1992, J CLIN INVEST, V90, P156, DOI 10.1172/JCI115830; Winters GL, 1998, J HEART LUNG TRANSPL, V17, P754	37	135	146	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 17	2001	344	20					1498	1503		10.1056/NEJM200105173442002	http://dx.doi.org/10.1056/NEJM200105173442002			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	432DP	11357152				2022-12-24	WOS:000168677200002
J	Woolhouse, M; Chase-Topping, M; Haydon, D; Friar, J; Matthews, L; Hughes, G; Shaw, D; Wilesmith, J; Donaldson, A; Cornell, S; Keeling, M; Grenfell, B				Woolhouse, M; Chase-Topping, M; Haydon, D; Friar, J; Matthews, L; Hughes, G; Shaw, D; Wilesmith, J; Donaldson, A; Cornell, S; Keeling, M; Grenfell, B			Epidemiology - Foot-and-mouth disease under control in the UK	NATURE			English	Article									Univ Edinburgh, Ctr Trop Vet Med, Roslin EH25 9RG, Midlothian, Scotland; Univ Guelph, Dept Zool, Guelph, ON N1G 2W1, Canada; Eoscene Corp, Seattle, WA 98104 USA; AFRC, Inst Anim Hlth, Pirbright Lab, Woking GU24 0NF, Surrey, England; Vet Labs Agcy, Addlestone KT15 3NB, Surrey, England; Univ London London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1E 7HT, England; Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England	University of Edinburgh; University of Guelph; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; Pirbright Institute; Veterinary Laboratories Agency; University of London; London School of Hygiene & Tropical Medicine; University of Cambridge	Woolhouse, M (corresponding author), Univ Edinburgh, Ctr Trop Vet Med, Roslin EH25 9RG, Midlothian, Scotland.		Matthews, Louise/E-2913-2013; Cornell, Stephen J/D-3955-2009; Keeling, Matt J/J-9280-2012	Matthews, Louise/0000-0003-4420-8367; Keeling, Matt J/0000-0003-4639-4765; Shaw, Darren/0000-0003-2016-1541; Haydon, Daniel/0000-0002-1240-1886				ANDERSON R M, 1991; FERGUSON N, 2001, SCIENCE         0413; Haydon DT, 1997, IMA J MATH APPL MED, V14, P1; PATIL GP, 1971, STAT ECOLOGY, V2; SELLERS RF, 1981, BRIT VET J, V137, P608, DOI 10.1016/S0007-1935(17)31539-7; Woolhouse M, 2001, NATURE, V410, P515, DOI 10.1038/35069250; 2001, VET REC, V148, P390; 2001, VET REC, V148, P286	8	76	76	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 17	2001	411	6835					258	259		10.1038/35077149	http://dx.doi.org/10.1038/35077149			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432RT	11357118				2022-12-24	WOS:000168710000033
J	Tolfvenstam, T; Papadogiannakis, N; Norbeck, O; Petersson, K; Broliden, K				Tolfvenstam, T; Papadogiannakis, N; Norbeck, O; Petersson, K; Broliden, K			Frequency of human parvovirus B19 infection in intrauterine fetal death	LANCET			English	Article							ANTIGEN	Background Parvovirus B19 is known to cause fetal death in the second trimester, mainly in combination with hydrops fetalis. However, the frequency of parvovirus-B19-associated non-hydropic fetal loss in the late second and third trimester has not been thoroughly investigated. We aimed to investigate the frequency of parvovirus B19 infection in unselected cases of intrauterine fetal death and to assess the sensitivity of different diagnostic procedures. Methods Of 14 147 deliveries in three hospitals in the major Stockholm area of Sweden. all cases of intrauterine fetal death (greater than or equal to 22 gestational weeks) that occurred between January, 1998, and May, 1999 (n=47), referred cases of miscarriage (<22 gestational weeks, n=37), and induced abortions (n=29), were included in the study. Placental and fetal tissues were examined by means of parvovirus-B19-specific PCR, histopathology, and immunohistochemistry. Placental tissues from 53 normal pregnancies at term were also examined. Findings Significantly more cases of intrauterine fetal death were positive for parvovirus B19 DNA (seven [15%]) than were normal pregnancies at term (zero, p=0.049). Furthermore. parvovirus B19 DNA was found in two (5%) of the miscarriages but not in any of the cases of induced abortion. Only three of nine DNA-positive cases had parvovirus-B19-associated inclusions and stained positive for viral proteins. All but one of the DNA-positive cases of intrauterine fetal death were non-hydropic. Interpretation The presence of parvovirus B19 DNA in cases of late second-trimester and third-trimester fetal death is common, and most are non-hydropic. The sensitivity of conventional diagnostic procedures for intrauterine fetal death could be greatly improved by addition of parvovirus B19 PCR.	Huddinge Univ Hosp, Karolinska Inst, Dept Clin Virol, SE-14186 Stockholm, Sweden; Huddinge Univ Hosp, Karolinska Inst, Dept Pathol, SE-14186 Stockholm, Sweden; Huddinge Univ Hosp, Karolinska Inst, Dept Obstet & Gynecol, SE-14186 Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet	Tolfvenstam, T (corresponding author), Huddinge Univ Hosp, Karolinska Inst, Dept Clin Virol, SE-14186 Stockholm, Sweden.	Thomas.Tolfvenstam@impi.ki.se		Tolfvenstam, Thomas/0000-0003-3549-8083				ANAND A, 1987, NEW ENGL J MED, V316, P183, DOI 10.1056/NEJM198701223160403; ANDERSON MJ, 1983, LANCET, V1, P1378; ANDERSON MJ, 1987, LANCET, V1, P738; Broliden K, 1998, MED PEDIATR ONCOL, V31, P66; BROWN KE, 1993, SCIENCE, V262, P114, DOI 10.1126/science.8211117; BROWN KE, 1989, BRIT J OBSTET GYNAEC, V96, P764, DOI 10.1111/j.1471-0528.1989.tb03313.x; BROWN T, 1984, LANCET, V2, P1033; Centers for Disease Control (CDC), 1989, MMWR Morb Mortal Wkly Rep, V38, P81; Centers for Disease Control (CDC), 1989, MMWR-MORBID MORTAL W, V38, p[81, 93]; CLEWLEY JP, 1987, J MED VIROL, V23, P367, DOI 10.1002/jmv.1890230409; COHEN BJ, 1988, J MED MICROBIOL, V25, P151, DOI 10.1099/00222615-25-2-151; EHRLICH HA, 1989, PCR TECHNOLOGY PRINC, P193; ENDERS G, 1990, Behring Institute Mitteilungen, P74; FRICKHOFEN N, 1990, ANN INTERN MED, V113, P926, DOI 10.7326/0003-4819-113-12-926; HALL SM, 1990, BMJ-BRIT MED J, V300, P1166; Miller E, 1998, BRIT J OBSTET GYNAEC, V105, P174, DOI 10.1111/j.1471-0528.1998.tb10048.x; MOREY AL, 1992, BRIT J OBSTET GYNAEC, V99, P566, DOI 10.1111/j.1471-0528.1992.tb13822.x; PATTISON JR, 1981, LANCET, V1, P664; RODIS JF, 1988, OBSTET GYNECOL, V72, P733; Rogers BB, 1999, PEDIATR DEVEL PATHOL, V2, P296, DOI 10.1007/s100249900128; SERJEANT GR, 1993, LANCET, V341, P1237, DOI 10.1016/0140-6736(93)91145-C; Skjoldebrand-Sparre K, 2000, BRIT J OBSTET GYNAEC, V107, P476, DOI 10.1111/j.1471-0528.2000.tb13265.x; TOROK TJ, 1990, PEDIATR INFECT DIS J, V9, P772; WOOLF AD, 1989, ARCH INTERN MED, V149, P1153, DOI 10.1001/archinte.149.5.1153	24	103	114	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 12	2001	357	9267					1494	1497		10.1016/S0140-6736(00)04647-X	http://dx.doi.org/10.1016/S0140-6736(00)04647-X			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	431CL	11377602				2022-12-24	WOS:000168614300014
J	Boers, M				Boers, M			NSAIDS and selective COX-2 inhibitors: competition between gastroprotection and cardioprotection	LANCET			English	Editorial Material							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; RHEUMATOID-ARTHRITIS; GASTROINTESTINAL TOXICITY; COMPLICATIONS; MISOPROSTOL; MORTALITY; ASPIRIN; RISK		Free Univ Amsterdam Hosp, Dept Clin Epidemiol & Biostat, NL-1007 MB Amsterdam, Netherlands	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Boers, M (corresponding author), Free Univ Amsterdam Hosp, Dept Clin Epidemiol & Biostat, NL-1007 MB Amsterdam, Netherlands.	j.wildbret@azvu.nl						Aranow C, 2000, LUPUS, V9, P166, DOI 10.1191/096120300678828208; Bombardier C, 2000, NEW ENGL J MED, V343, P1520, DOI 10.1056/NEJM200011233432103; Chan FKL, 1998, NEW ENGL J MED, V339, P349; CLELAND JGF, 1995, BRIT HEART J, V74, P215; Dickinson JP, 1998, QJM-INT J MED, V91, P523, DOI 10.1093/qjmed/91.8.523; Hawkey CJ, 2000, BMJ-BRIT MED J, V321, P291, DOI 10.1136/bmj.321.7256.291; Hawkey CJ, 1998, NEW ENGL J MED, V338, P727, DOI 10.1056/NEJM199803123381105; Hawkey CJ, 1999, LANCET, V353, P307, DOI 10.1016/S0140-6736(98)12154-2; Isles C, 1999, LANCET, V353, P148, DOI 10.1016/S0140-6736(05)76185-7; MUTRU O, 1989, CARDIOLOGY, V76, P71, DOI 10.1159/000174474; SILVERSTEIN FE, 1995, ANN INTERN MED, V123, P241, DOI 10.7326/0003-4819-123-4-199508150-00001; Silverstein FE, 2000, JAMA-J AM MED ASSOC, V284, P1247, DOI 10.1001/jama.284.10.1247; WallbergJonsson S, 1997, J RHEUMATOL, V24, P445	13	45	47	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 21	2001	357	9264					1222	1223		10.1016/S0140-6736(00)04451-2	http://dx.doi.org/10.1016/S0140-6736(00)04451-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	425YY	11418144				2022-12-24	WOS:000168323300006
J	Reddien, PW; Cameron, S; Horvitz, HR				Reddien, PW; Cameron, S; Horvitz, HR			Phagocytosis promotes programmed cell death in C-elegans	NATURE			English	Article							CAENORHABDITIS-ELEGANS; APOPTOTIC CELLS; PROTEIN CED-9; GENE; ENGULFMENT; ENCODES; NEMATODE; MACROPHAGES; ACTIVATION; MIGRATION	In the nematode Caenorhabditis elegans programmed cell death requires the killer genes egl-1, ced-4 and ced-3 (refs 1 and 2), and the engulfment of dying cells requires the genes ced-1, ced-2, ced-5, ced-6, ced-7, ced-10 and ced-12 (refs 3-5). Here we show that engulfment promotes programmed cell death. Mutations that cause partial loss of function of killer genes allow the survival of some cells that are programmed to die, and mutations in engulfment genes enhance the frequency of this cell survival. Furthermore, mutations in engulfment genes alone allow the survival and differentiation of some cells that would normally die. Engulfment genes probably act in engulfing cells to promote death, as the expression in engulfing cells of ced-1, which encodes a receptor that recognizes cell corpses(6), rescues the cell-killing defects of ced-1 mutants. We propose that engulfing cells act to ensure that cells triggered to undergo programmed cell death by the CED-3 caspase(7) die rather than recover after the initial stages of death.	MIT, Howard Hughes Med Inst, Dept Biol, Cambridge, MA 02139 USA; Childrens Hosp, Dana Farber Canc Inst, Div Pediat Hematol Oncol, Boston, MA 02115 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Harvard University; Boston Children's Hospital; Dana-Farber Cancer Institute	Horvitz, HR (corresponding author), MIT, Howard Hughes Med Inst, Dept Biol, 68-425,77 Massachusetts Ave, Cambridge, MA 02139 USA.							Albert ML, 2000, NAT CELL BIOL, V2, P899, DOI 10.1038/35046549; Chung SB, 2000, NAT CELL BIOL, V2, P931, DOI 10.1038/35046585; CLARK SG, 1994, GENETICS, V137, P987; Conradt B, 1998, CELL, V93, P519, DOI 10.1016/S0092-8674(00)81182-4; Conradt B, 1999, CELL, V98, P317, DOI 10.1016/S0092-8674(00)81961-3; DiezRoux G, 1997, DEVELOPMENT, V124, P3633; ELLIS HM, 1986, CELL, V44, P817, DOI 10.1016/0092-8674(86)90004-8; ELLIS RE, 1991, GENETICS, V129, P79; FREYD G, 1990, NATURE, V344, P876, DOI 10.1038/344876a0; HEDGECOCK EM, 1983, SCIENCE, V220, P1277, DOI 10.1126/science.6857247; HENGARTNER MO, 1994, CELL, V76, P665, DOI 10.1016/0092-8674(94)90506-1; HENGARTNER MO, 1994, NATURE, V369, P318, DOI 10.1038/369318a0; Hobert O, 1997, NEURON, V19, P345, DOI 10.1016/S0896-6273(00)80944-7; LANG RA, 1993, CELL, V74, P453, DOI 10.1016/0092-8674(93)80047-I; LITTLE GH, 1993, COMP BIOCHEM PHYS A, V105, P79, DOI 10.1016/0300-9629(93)90176-5; Liu QA, 1998, CELL, V93, P961, DOI 10.1016/S0092-8674(00)81202-7; Metzstein MM, 1998, TRENDS GENET, V14, P410, DOI 10.1016/S0168-9525(98)01573-X; Reddien PW, 2000, NAT CELL BIOL, V2, P131, DOI 10.1038/35004000; ROBERTSON AMG, 1982, J EMBRYOL EXP MORPH, V67, P89; Shah A, 1999, AGING MENT HEALTH, V3, P153, DOI 10.1080/13607869956316; Stanfield GM, 2000, MOL CELL, V5, P423, DOI 10.1016/S1097-2765(00)80437-2; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; SULSTON JE, 1980, DEV BIOL, V78, P542, DOI 10.1016/0012-1606(80)90352-8; Vaux DL, 1999, CELL, V96, P245, DOI 10.1016/S0092-8674(00)80564-4; Wu YC, 2000, GENE DEV, V14, P536; Wu YC, 1998, NATURE, V392, P501, DOI 10.1038/33163; Wu YC, 1998, CELL, V93, P951, DOI 10.1016/S0092-8674(00)81201-5; WYLLIE AH, 1980, NATURE, V284, P555, DOI 10.1038/284555a0; YUAN JY, 1993, CELL, V75, P641, DOI 10.1016/0092-8674(93)90485-9; Zhou Z, 2001, CELL, V104, P43, DOI 10.1016/S0092-8674(01)00190-8	30	268	285	1	15	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 12	2001	412	6843					198	202		10.1038/35084096	http://dx.doi.org/10.1038/35084096			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	451AJ	11449278				2022-12-24	WOS:000169778700056
J	Herbert, TD; Schuffert, JD; Andreasen, D; Heusser, L; Lyle, M; Mix, A; Ravelo, AC; Stott, LD; Herguera, JC				Herbert, TD; Schuffert, JD; Andreasen, D; Heusser, L; Lyle, M; Mix, A; Ravelo, AC; Stott, LD; Herguera, JC			Collapse of the California Current during glacial maxima linked to climate change on land	SCIENCE			English	Article							SEA-SURFACE TEMPERATURE; DEVILS-HOLE; PACIFIC-OCEAN; ATLANTIC; RECORD; CALIBRATION; INDICATORS; BARBADOS; CALCITE; MARGIN	Time series of alkenone unsaturation indices gathered along the California margin reveal Large (4 degrees to 8 degreesC) glacial-interglacial changes in sea surface temperature (SST) over the past 550,000 years. Interglacial times with SSTs equal to or exceeding that of the Holocene contain peak abundances in the pollen of redwood, the distinctive component of the temperate rainforest of the northwest coast of California. In the region now dominated by the California Current, SSTs warmed 10,000 to 15,000 years in advance of deglaciation at each of the past five glacial maxima. SSTs did not rise in advance of deglaciation south of the modern California Current front. Glacial warming along the California margin therefore is a regional signal of the weakening of the California Current during times when large ice sheets reorganized wind systems over the North Pacific. Both the timing and magnitude of the SST estimates suggest that the Devils Hole (Nevada) calcite record represents regional but not global paleotemperatures, and hence does not pose a fundamental challenge to the orbital ("Milankovitch") theory of the Ice Ages.	Brown Univ, Dept Geol Sci, Providence, RI 02912 USA; Univ Calif Santa Cruz, Santa Cruz, CA 95064 USA; Lamont Doherty Earth Observ, Palisades, NY 10964 USA; Boise State Univ, Ctr Geophys Invest Shallow Subsurface, Boise, ID 83725 USA; Oregon State Univ, Corvallis, OR 97331 USA; Univ So Calif, Los Angeles, CA 90089 USA; Ctr Invest Cient & Educ Super Ensenada, Ensenada 22860, Baja California, Mexico	Brown University; University of California System; University of California Santa Cruz; Columbia University; Idaho; Boise State University; Oregon State University; University of Southern California; CICESE - Centro de Investigacion Cientifica y de Educacion Superior de Ensenada	Herbert, TD (corresponding author), Brown Univ, Dept Geol Sci, Providence, RI 02912 USA.		Herguera, Juan Carlos/B-7812-2016	Herguera, Juan Carlos/0000-0001-8335-2607; Ravelo, Ana Christina/0000-0003-3929-677X				BARD E, 1990, NATURE, V346, P456, DOI 10.1038/346456a0; BENSON LV, 1990, PALAEOGEOGR PALAEOCL, V78, P241, DOI 10.1016/0031-0182(90)90217-U; CROWLEY TJ, 1994, PALEOCEANOGRAPHY, V9, P1, DOI 10.1029/93PA02558; Dean WE, 1997, GEOCHIM COSMOCHIM AC, V61, P4507, DOI 10.1016/S0016-7037(97)00237-8; Doose H, 1997, PALEOCEANOGRAPHY, V12, P615, DOI 10.1029/97PA00821; ELY LL, 1994, J CLIMATE, V7, P977, DOI 10.1175/1520-0442(1994)007<0977:ANPACA>2.0.CO;2; EMERY WJ, 1985, J GEOPHYS RES-OCEANS, V90, P857, DOI 10.1029/JC090iC01p00857; FAIRBANKS RG, 1978, QUATERNARY RES, V10, P181, DOI 10.1016/0033-5894(78)90100-X; GRIGGS GB, 1969, J SEDIMENT PETROL, V39, P1142; Grootes P. M., 1993, CLIMATE CHANGE CONTI, V78, P37; Henderson GM, 2000, NATURE, V404, P61, DOI 10.1038/35003541; Herbert T.D., 1995, PROC OCEAN DRILL SCI, V146, P257; Herbert TD, 1998, PALEOCEANOGRAPHY, V13, P263, DOI 10.1029/98PA00069; Heusser L.E., 1995, PROC OCEAN DRILL SCI, V146, P265; HEUSSER LE, 1979, SCIENCE, V204, P837, DOI 10.1126/science.204.4395.837; HEUSSER LE, 2000, P OC DRILL PROGR SCI, V167, P217; Hickey B. M., 1979, Progress in Oceanography, V8, P191, DOI 10.1016/0079-6611(79)90002-8; IMBRIE J, 1993, NATURE, V363, P531, DOI 10.1038/363531a0; Imbrie J., 1984, MILANKOVITCH CLIMA 1, P269; Kennett James P., 1995, Proceedings of the Ocean Drilling Program Scientific Results, V146, P281; KENT D, 1971, GEOL SOC AM BULL, V82, P2741, DOI 10.1130/0016-7606(1971)82[2741:CCITNP]2.0.CO;2; KUTZBACH JE, 1985, QUATERNARY SCI REV, V4, P147, DOI 10.1016/0277-3791(85)90024-1; Lea DW, 2000, SCIENCE, V289, P1719, DOI 10.1126/science.289.5485.1719; LUDWIG KR, 1992, SCIENCE, V258, P284, DOI 10.1126/science.258.5080.284; LYLE M, UNPUB; MANABE S, 1985, J GEOPHYS RES-ATMOS, V90, P2167, DOI 10.1029/JD090iD01p02167; MARTINSON DG, 1987, QUATERNARY RES, V27, P1, DOI 10.1016/0033-5894(87)90046-9; Mortyn PG, 1996, PALEOCEANOGRAPHY, V11, P415, DOI 10.1029/96PA01236; Muller PJ, 1998, GEOCHIM COSMOCHIM AC, V62, P1757, DOI 10.1016/S0016-7037(98)00097-0; Ortiz J, 1997, PALEOCEANOGRAPHY, V12, P191, DOI 10.1029/96PA03165; PISIAS NG, IN PRESS QUAT SCI RE; PRAHL FG, 1995, PALEOCEANOGRAPHY, V10, P763, DOI 10.1029/95PA01394; PRAHL FG, 1988, GEOCHIM COSMOCHIM AC, V52, P2303, DOI 10.1016/0016-7037(88)90132-9; Reimers CE, 1992, GLOBAL BIOGEOCHEM CY, V6, P199, DOI 10.1029/92GB00105; ROSANSKI KL, 1993, CLIMAT CHANGE CONTIN, P1; RUDDIMAN WF, 1984, GEOL SOC AM BULL, V95, P381, DOI 10.1130/0016-7606(1984)95<381:ITRACR>2.0.CO;2; Sabin AL, 1996, QUATERNARY RES, V46, P48, DOI 10.1006/qres.1996.0043; SANCETTA C, 1992, QUATERNARY RES, V38, P359, DOI 10.1016/0033-5894(92)90044-J; Schneider R.R., 1995, S ATLANTIC PRESENT P, P527; Schrag DP, 1996, SCIENCE, V272, P1930, DOI 10.1126/science.272.5270.1930; Schuffert JD, 1998, MAR GEOL, V146, P21, DOI 10.1016/S0025-3227(97)00122-9; Shackleton NJ, 2000, SCIENCE, V289, P1897, DOI 10.1126/science.289.5486.1897; SHACKLETON NJ, 1990, T ROY SOC EDIN-EARTH, V81, P251, DOI 10.1017/S0263593300020782; SIMPSON JJ, 1983, GEOPHYS RES LETT, V10, P937, DOI 10.1029/GL010i010p00937; Stott LD, 2000, PALEOCEANOGRAPHY, V15, P161, DOI 10.1029/1999PA000375; THOMPSON PR, 1980, NATURE, V287, P829, DOI 10.1038/287829a0; Villanueva J, 1998, GEOCHIM COSMOCHIM AC, V62, P2421, DOI 10.1016/S0016-7037(98)00180-X; WINOGRAD IJ, 1992, SCIENCE, V258, P255, DOI 10.1126/science.258.5080.255; WINOGRAD IJ, 1996, EOS T AM GEOPHYS UN, V77, pS169	49	217	224	1	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 6	2001	293	5527					71	76		10.1126/science.1059209	http://dx.doi.org/10.1126/science.1059209			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	451BB	11441174				2022-12-24	WOS:000169780300029
J	Lydon-Rochelle, M; Holt, VL; Easterling, TR; Martin, DP				Lydon-Rochelle, M; Holt, VL; Easterling, TR; Martin, DP			Risk of uterine rupture during labor among women with a prior cesarean delivery.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							VAGINAL BIRTH; TRIAL; MISOPROSTOL; SECTION	Background: Each year in the United States, approximately 60 percent of women with a prior cesarean delivery who become pregnant again attempt labor. Concern persists that a trial of labor may increase the risk of uterine rupture, an uncommon but serious obstetrical complication. Methods: We conducted a population-based, retrospective cohort analysis using data from all primiparous women who gave birth to live singleton infants by cesarean section in civilian hospitals in Washington State from 1987 through 1996 and who delivered a second singleton child during the same period (a total of 20,095 women). We assessed the risk of uterine rupture for deliveries with spontaneous onset of labor, those with labor induced by prostaglandins, and those in which labor was induced by other means; these three groups of deliveries were compared with repeated cesarean delivery without labor. Results: Uterine rupture occurred at a rate of 1.6 per 1000 among women with repeated cesarean delivery without labor (11 women), 5.2 per 1000 among women with spontaneous onset of labor (56 women), 7.7 per 1000 among women whose labor was induced without prostaglandins (15 women), and 24.5 per 1000 among women with prostaglandin-induced labor (9 women). As compared with the risk in women with repeated cesarean delivery without labor, uterine rupture was more likely among women with spontaneous onset of labor (relative risk, 3.3; 95 percent confidence interval, 1.8 to 6.0), induction of labor without prostaglandins (relative risk, 4.9; 95 percent confidence interval, 2.4 to 9.7), and induction with prostaglandins (relative risk, 15.6; 95 percent confidence interval, 8.1 to 30.0). Conclusions: For women with one prior cesarean delivery, the risk of uterine rupture is higher among those whose labor is induced than among those with repeated cesarean delivery without labor. Labor induced with a prostaglandin confers the highest risk. (N Engl J Med 2001;345:3-8.) Copyright (C) 2001 Massachusetts Medical Society.	Univ Washington, Ctr Womens Hlth Res, Dept Family & Child Nursing, Sch Nursing, Seattle, WA 98195 USA; Univ Washington, Sch Publ Hlth & Community Med, Dept Epidemiol, Seattle, WA 98195 USA; Univ Washington, Sch Med, Dept Obstet & Gynecol, Seattle, WA 98195 USA; Univ Washington, Sch Publ Hlth & Community Med, Dept Hlth Serv, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Lydon-Rochelle, M (corresponding author), Univ Washington, Ctr Womens Hlth Res, Dept Family & Child Nursing, Sch Nursing, Mailstop 357262, Seattle, WA 98195 USA.				AHRQ HHS [5 T32 HS00034] Funding Source: Medline; NINR NIH HHS [T32 NR07039] Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [T32HS000034] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [T32NR007039] Funding Source: NIH RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NINR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))		*AM COLL OBST GYN, 1999, 228 ACOG, P1; Caughey AB, 1999, AM J OBSTET GYNECOL, V181, P872, DOI 10.1016/S0002-9378(99)70317-0; FLAMM BL, 1994, OBSTET GYNECOL, V83, P927, DOI 10.1097/00006250-199406000-00005; Gregory KD, 1999, OBSTET GYNECOL, V94, P985, DOI 10.1016/S0029-7844(99)00422-6; LEUNG AS, 1993, AM J OBSTET GYNECOL, V169, P945, DOI 10.1016/0002-9378(93)90032-E; McMahon MJ, 1996, NEW ENGL J MED, V335, P689, DOI 10.1056/NEJM199609053351001; PARRISH KM, 1993, AM J EPIDEMIOL, V138, P119, DOI 10.1093/oxfordjournals.aje.a116834; Plaut MM, 1999, AM J OBSTET GYNECOL, V180, P1535, DOI 10.1016/S0002-9378(99)70049-9; Rageth JC, 1999, OBSTET GYNECOL, V93, P332, DOI 10.1016/S0029-7844(98)00446-3; Raskin KS, 1999, J REPROD MED, V44, P571; SAS Institute, 1990, SAS STAT US GUID VER; Stalnaker BL, 1997, AM J OBSTET GYNECOL, V177, P268, DOI 10.1016/S0002-9378(97)70186-8; VENTURA SJ, 2000, NATL VITAL STAT REP, V48, P13; Wing DA, 1998, OBSTET GYNECOL, V91, P828, DOI 10.1016/S0029-7844(97)00553-X; 1998, ICD 9 CM, V1	15	566	593	1	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 1	2001	345	1					3	8		10.1056/NEJM200107053450101	http://dx.doi.org/10.1056/NEJM200107053450101			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	449QJ	11439945	Bronze			2022-12-24	WOS:000169697600001
J	Imai, Y; Soda, M; Inoue, H; Hattori, N; Mizuno, Y; Takahashi, R				Imai, Y; Soda, M; Inoue, H; Hattori, N; Mizuno, Y; Takahashi, R			An unfolded putative transmembrane polypeptide, which can lead to endoplasmic reticulum stress, is a substrate of parkin	CELL			English	Article							UBIQUITIN-PROTEIN LIGASE; RECESSIVE JUVENILE PARKINSONISM; ALPHA-SYNUCLEIN; LEWY BODIES; DEGRADATION; DISEASE; ER; RECEPTOR; AGGREGATION; PROTEASOME	A putative G protein-coupled transmembrane polypeptide, named Pael receptor, was identified as an interacting protein with Parkin, a gene product responsible for autosomal recessive juvenile Parkinsonism (AR-JP). When overexpressed in cells, this receptor tends to become unfolded, insoluble, and ubiquitinated in vivo. The insoluble Pael receptor leads to unfolded protein-induced cell death. Parkin specifically ubiquitinates this receptor in the presence of ubiquitin-conjugating enzymes resident in the endoplasmic reticulum and promotes the degradation of insoluble Pael receptor, resulting in suppression of the cell death induced by Pael receptor overexpression. Moreover, the insoluble form of Pael receptor accumulates in the brains of AR-JP patients. Here, we show that the unfolded Pael receptor is a substrate of Parkin, the accumulation of which may cause selective neuronal death in AR-JP.	RIKEN, BSI, Lab Motor Syst Neurodegenerat, Saitama 3510198, Japan; Juntendo Univ, Sch Med, Dept Neurol, Bunkyo Ku, Tokyo 1130033, Japan	RIKEN; Juntendo University	Takahashi, R (corresponding author), RIKEN, BSI, Lab Motor Syst Neurodegenerat, Saitama 3510198, Japan.		Hattori, Nobutaka/ACR-0069-2022; Imai, Yuzuru/AAA-6472-2019	Imai, Yuzuru/0000-0003-2924-5231; Inoue, Haruhisa/0000-0003-4736-9537				Baba M, 1998, AM J PATHOL, V152, P879; Biederer T, 1997, SCIENCE, V278, P1806, DOI 10.1126/science.278.5344.1806; Bordallo J, 1998, MOL BIOL CELL, V9, P209, DOI 10.1091/mbc.9.1.209; Casagrande R, 2000, MOL CELL, V5, P729, DOI 10.1016/S1097-2765(00)80251-8; Donohue PJ, 1998, MOL BRAIN RES, V54, P152, DOI 10.1016/S0169-328X(97)00336-7; Friedlander R, 2000, NAT CELL BIOL, V2, P379, DOI 10.1038/35017001; Gilon T, 2000, MOL CELL BIOL, V20, P7214, DOI 10.1128/MCB.20.19.7214-7219.2000; Goldberg MS, 2000, NAT CELL BIOL, V2, pE115, DOI 10.1038/35017124; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; Imai Y, 2000, J BIOL CHEM, V275, P35661, DOI 10.1074/jbc.C000447200; Jackson PK, 2000, TRENDS CELL BIOL, V10, P429, DOI 10.1016/S0962-8924(00)01834-1; JENSEN TJ, 1995, CELL, V83, P129, DOI 10.1016/0092-8674(95)90241-4; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; Julien JP, 2001, CELL, V104, P581, DOI 10.1016/S0092-8674(01)00244-6; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; KOZUTSUMI Y, 1988, NATURE, V332, P462, DOI 10.1038/332462a0; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Mayer TU, 1998, EMBO J, V17, P3251, DOI 10.1093/emboj/17.12.3251; Mizuno Y, 1998, J NEUROCHEM, V71, P893; Morett E, 1999, TRENDS BIOCHEM SCI, V24, P229, DOI 10.1016/S0968-0004(99)01381-X; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Petaja-Repo UE, 2001, J BIOL CHEM, V276, P4416, DOI 10.1074/jbc.M007151200; Plemper RK, 1999, TRENDS BIOCHEM SCI, V24, P266, DOI 10.1016/S0968-0004(99)01420-6; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Sherman MY, 2001, NEURON, V29, P15, DOI 10.1016/S0896-6273(01)00177-5; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Shimura H, 1999, ANN NEUROL, V45, P668, DOI 10.1002/1531-8249(199905)45:5<668::AID-ANA19>3.0.CO;2-Z; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Trojanowski JQ, 1998, CELL DEATH DIFFER, V5, P832, DOI 10.1038/sj.cdd.4400432; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Valdenaire O, 1998, FEBS LETT, V424, P193, DOI 10.1016/S0014-5793(98)00170-7; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; Wilhovsky S, 2000, MOL BIOL CELL, V11, P1697, DOI 10.1091/mbc.11.5.1697; Yu H, 1999, J BIOL CHEM, V274, P36852, DOI 10.1074/jbc.274.52.36852; Zeng ZZ, 1997, BIOCHEM BIOPH RES CO, V233, P559, DOI 10.1006/bbrc.1997.6408; Zhang Y, 2000, P NATL ACAD SCI USA, V97, P13354, DOI 10.1073/pnas.240347797; Zuscik MJ, 2000, NAT MED, V6, P1388, DOI 10.1038/82207	40	852	900	0	27	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 29	2001	105	7					891	902		10.1016/S0092-8674(01)00407-X	http://dx.doi.org/10.1016/S0092-8674(01)00407-X			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	449BK	11439185	Bronze			2022-12-24	WOS:000169664300009
J	Lee, SH; Oe, T; Blair, IA				Lee, SH; Oe, T; Blair, IA			Vitamin C-induced decomposition of lipid hydroperoxides to endogenous genotoxins	SCIENCE			English	Article							DNA-ADDUCTS; IN-VIVO; PEROXIDATION; PRODUCT; DAMAGE; ACID; SUBSTRATE; ASCORBATE; APOPTOSIS; RADICALS	Epidemiological data suggest that dietary antioxidants play a protective role against cancer. This has led to the proposal that dietary supplementation with antioxidants such as vitamin C (vit C) may be useful in disease prevention. However, vit C has proved to be ineffective in cancer chemoprevention studies. In addition, concerns have been raised over potentially deleterious transition metal ion-mediated pro-oxidant effects. We have now determined that vit C induces lipid hydroperoxide decomposition to the DNA-reactive bifunctional electrophiles 4-oxo-2-nonenal, 4,5-epoxy-2(E)-decenal, and 4-hydroxy-2-non-enal, The compound 4,5-Epoxy-2(E)-decenal is a precursor of etheno-2'-deoxyadenosine, a highly mutagenic lesion found in human DNA. Vitamin C-mediated formation of genotoxins from lipid hydroperoxides in the absence of transition metal ions could help explain its lack of efficacy as a cancer chemoprevention agent.	Univ Penn, Ctr Canc Pharmacol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Blair, IA (corresponding author), Univ Penn, Ctr Canc Pharmacol, 1254 BRB 2-3,421 Curie Blvd, Philadelphia, PA 19104 USA.		Blair, Ian A/B-3320-2010; Oe, Tomoyuki/AAE-1514-2019	Oe, Tomoyuki/0000-0002-3893-0815; Lee, Seon Hwa/0000-0003-1095-5516	NATIONAL CANCER INSTITUTE [P30CA016520, R01CA065878] Funding Source: NIH RePORTER; NCI NIH HHS [CA65878, CA16520] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915; Beckman KB, 1997, J BIOL CHEM, V272, P19633, DOI 10.1074/jbc.272.32.19633; Brash AR, 1999, J BIOL CHEM, V274, P23679, DOI 10.1074/jbc.274.34.23679; Buettner GR, 1996, RADIAT RES, V145, P532, DOI 10.2307/3579271; Burcham PC, 1998, MUTAGENESIS, V13, P287, DOI 10.1093/mutage/13.3.287; Burczynski ME, 2001, J BIOL CHEM, V276, P2890, DOI 10.1074/jbc.M006655200; Cadet J, 1999, MUTAT RES-FUND MOL M, V424, P9, DOI 10.1016/S0027-5107(99)00004-4; CHAUDHARY AK, 1994, SCIENCE, V265, P1580, DOI 10.1126/science.8079172; Chung FL, 1996, CARCINOGENESIS, V17, P2105, DOI 10.1093/carcin/17.10.2105; Doerge DR, 2000, CHEM RES TOXICOL, V13, P1259, DOI 10.1021/tx0001575; Gardner HW, 1998, PLANT PHYSIOL, V116, P1359, DOI 10.1104/pp.116.4.1359; HAMBERG M, 1967, J BIOL CHEM, V242, P5336; Hamberg M, 1998, ARCH BIOCHEM BIOPHYS, V349, P376, DOI 10.1006/abbi.1997.0443; Johnson TM, 1996, P NATL ACAD SCI USA, V93, P11848, DOI 10.1073/pnas.93.21.11848; Kamitani H, 1998, J BIOL CHEM, V273, P21569, DOI 10.1074/jbc.273.34.21569; KURNAGAI T, 2000, BIOCHEM BIOPH RES CO, V273, P437; LANEUVILLE O, 1995, J BIOL CHEM, V270, P19330, DOI 10.1074/jbc.270.33.19330; LAUDICINA DC, 1990, ARCH BIOCHEM BIOPHYS, V278, P73, DOI 10.1016/0003-9861(90)90233-O; Lee SH, 2000, CHEM RES TOXICOL, V13, P698, DOI 10.1021/tx000101a; Lee SH, 2000, CHEM RES TOXICOL, V13, P565, DOI 10.1021/tx000057z; Levine M, 1996, P NATL ACAD SCI USA, V93, P3704, DOI 10.1073/pnas.93.8.3704; Levine RL, 2000, CANCER RES, V60, P4098; Lin JM, 1999, LIPIDS, V34, P1117, DOI 10.1007/s11745-999-0463-8; Linn S, 1998, DRUG METAB REV, V30, P313, DOI 10.3109/03602539808996315; Lippman SM, 1998, JNCI-J NATL CANCER I, V90, P1514, DOI 10.1093/jnci/90.20.1514; Marnett LJ, 2000, CARCINOGENESIS, V21, P361, DOI 10.1093/carcin/21.3.361; Proteggente AR, 2000, BIOCHEM BIOPH RES CO, V277, P535, DOI 10.1006/bbrc.2000.3711; PRYOR WA, 1990, FREE RADICAL BIO MED, V8, P541, DOI 10.1016/0891-5849(90)90153-A; Rindgen D, 1999, CHEM RES TOXICOL, V12, P1195, DOI 10.1021/tx990034o; Williams C, 1999, ANN NY ACAD SCI, V889, P72, DOI 10.1111/j.1749-6632.1999.tb08725.x	30	358	389	1	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 15	2001	292	5524					2083	2086		10.1126/science.1059501	http://dx.doi.org/10.1126/science.1059501			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442KP	11408659				2022-12-24	WOS:000169284700050
J	Balter, M				Balter, M			Canser research - Transatlantic war over BRCA1 patent	SCIENCE			English	News Item																			0	6	6	1	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 8	2001	292	5523					1818	1818		10.1126/science.292.5523.1818	http://dx.doi.org/10.1126/science.292.5523.1818			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	440WY	11397923				2022-12-24	WOS:000169200700010
J	Puertollano, R; Aguilar, RC; Gorshkova, I; Crouch, RJ; Bonifacino, JS				Puertollano, R; Aguilar, RC; Gorshkova, I; Crouch, RJ; Bonifacino, JS			Sorting of mannose 6-phosphate receptors mediated by the GGAs	SCIENCE			English	Article							FACTOR-II RECEPTOR; CYTOPLASMIC DOMAIN; GAMMA-ADAPTIN; TRANS-GOLGI; SIGNALS; PROTEINS; BINDING; FAMILY; RECOGNITION; TRAFFICKING	The delivery of soluble hydrolases to lysosomes is mediated by the cation-independent and cation-dependent mannose 6-phosphate receptors. The cytosolic tails of both receptors contain acidic-cluster-dileucine signals that direct sorting from the trans-Golgi network to the endosomal-lysosomal system. We found that these signals bind to the VHS domain of the Golgi-localized, gamma -ear-containing, ARF-binding proteins (GGAs). The receptors and the GGAs left the trans-Golgi network on the same tubulo-vesicular carriers. A dominant-negative GGA mutant blocked exit of the receptors from the trans-Golgi, network. Thus, the GGAs appear to mediate sorting of the mannose 6-phosphate receptors at the trans-Golgi network.	NICHHD, Cell Biol & Metab Branch, NIH, Bethesda, MD 20892 USA; NICHHD, Genet Mol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Bonifacino, JS (corresponding author), NICHHD, Cell Biol & Metab Branch, NIH, Bethesda, MD 20892 USA.			Bonifacino, Juan S./0000-0002-5673-6370	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001607, ZIAHD000068] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD001607, Z01HD000068] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Aguilar RC, 2001, J BIOL CHEM, V276, P13145, DOI 10.1074/jbc.M010591200; Boll W, 1996, EMBO J, V15, P5789, DOI 10.1002/j.1460-2075.1996.tb00965.x; Boman AL, 2000, MOL BIOL CELL, V11, P1241, DOI 10.1091/mbc.11.4.1241; Chen HJ, 1997, J BIOL CHEM, V272, P7003, DOI 10.1074/jbc.272.11.7003; Dell'Angelica EC, 2000, J CELL BIOL, V149, P81, DOI 10.1083/jcb.149.1.81; GLICKMAN JN, 1989, EMBO J, V8, P1041, DOI 10.1002/j.1460-2075.1989.tb03471.x; Heilker R, 1999, BIOESSAYS, V21, P558, DOI 10.1002/(SICI)1521-1878(199907)21:7<558::AID-BIES4>3.0.CO;2-R; Hirst J, 2000, J CELL BIOL, V149, P67, DOI 10.1083/jcb.149.1.67; HONING S, 1997, J BIOL CHEM, V272, P1984; JOHNSON KF, 1992, J CELL BIOL, V119, P249, DOI 10.1083/jcb.119.2.249; KOMFELD S, 1992, ANNU REV BIOCHEM, V61, P307; Liu SH, 1998, J CELL BIOL, V140, P1023, DOI 10.1083/jcb.140.5.1023; Mauxion F, 1996, J BIOL CHEM, V271, P2171, DOI 10.1074/jbc.271.4.2171; Meyer C, 2000, EMBO J, V19, P2193, DOI 10.1093/emboj/19.10.2193; Poussu A, 2000, J BIOL CHEM, V275, P7176, DOI 10.1074/jbc.275.10.7176; Puertollano R, 2001, CELL, V105, P93, DOI 10.1016/S0092-8674(01)00299-9; Zhu YX, 2001, SCIENCE, V292, P1716, DOI 10.1126/science.1060896	17	317	330	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 1	2001	292	5522					1712	1716		10.1126/science.1060750	http://dx.doi.org/10.1126/science.1060750			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	438AP	11387475				2022-12-24	WOS:000169031800044
J	Chen, Y; Schier, AF				Chen, Y; Schier, AF			The zebrafish Nodal signal Squint functions as a morphogen	NATURE			English	Article							LONG-RANGE ACTION; ONE-EYED PINHEAD; TGF-BETA FAMILY; ACTIVIN; INDUCTION; MESODERM; GRADIENT; GASTRULATION; ORGANIZER; ENDODERM	Secreted morphogens induce distinct cellular responses in a concentration-dependent manner and act directly at a distance(1-7). The existence of morphogens during mesoderm induction and patterning in vertebrates has been highly controversial, and it remains unknown whether endogenous mesoderm inducers act directly as morphogens(8-10), function locally(9) or act through relay mechanisms(11-12). Here we test the morphogen properties of Cyclops and Squint-two Nodal-related transforming growth factor-beta signals required for mesoderm formation and patterning in zebrafish(13-16). Whereas different levels of both Squint and Cyclops can induce different downstream genes(14,17-19), we rnd that only Squint can function directly at a distance. These results indicate that Squint acts as a secreted morphogen that does not require a relay mechanism.	NYU, Sch Med, Skirball Inst Biomol Med, Dev Genet Program, New York, NY 10016 USA; NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA	New York University; New York University	Schier, AF (corresponding author), NYU, Sch Med, Skirball Inst Biomol Med, Dev Genet Program, New York, NY 10016 USA.			Schier, Alexander Franz/0000-0001-7645-5325				Agius E, 2000, DEVELOPMENT, V127, P1173; Erter CE, 1998, DEV BIOL, V204, P361, DOI 10.1006/dbio.1998.9097; Feldman B, 1998, NATURE, V395, P181, DOI 10.1038/26013; Gritsman K, 2000, DEVELOPMENT, V127, P921; Gritsman K, 1999, CELL, V97, P121, DOI 10.1016/S0092-8674(00)80720-5; GURDON JB, 1994, NATURE, V371, P487, DOI 10.1038/371487a0; Jones CM, 1996, CURR BIOL, V6, P1468, DOI 10.1016/S0960-9822(96)00751-8; JONES CM, 1995, DEVELOPMENT, V121, P3651; Lecuit T, 1996, NATURE, V381, P387, DOI 10.1038/381387a0; McDowell N, 1997, CURR BIOL, V7, P671, DOI 10.1016/S0960-9822(06)00294-6; Nellen D, 1996, CELL, V85, P357, DOI 10.1016/S0092-8674(00)81114-9; Neumann C, 1997, BIOESSAYS, V19, P721, DOI 10.1002/bies.950190813; Neumann CJ, 1997, DEVELOPMENT, V124, P871; Pfeiffer S, 2000, CURR BIOL, V10, P321, DOI 10.1016/S0960-9822(00)00381-X; Rebagliati MR, 1998, P NATL ACAD SCI USA, V95, P9932, DOI 10.1073/pnas.95.17.9932; Reilly KM, 1996, CELL, V86, P743, DOI 10.1016/S0092-8674(00)80149-X; Rodaway A, 1999, DEVELOPMENT, V126, P3067; Ruppert R, 1996, EUR J BIOCHEM, V237, P295, DOI 10.1111/j.1432-1033.1996.0295n.x; Sampath K, 1998, NATURE, V395, P185, DOI 10.1038/26020; Schier AF, 2000, NATURE, V403, P385, DOI 10.1038/35000126; Schier AF, 1997, DEVELOPMENT, V124, P327; Strahle U, 1997, Genes Funct, V1, P131; Thisse B, 2000, NATURE, V403, P425, DOI 10.1038/35000200; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; Vogel AM, 1999, MECH DEVELOP, V85, P133, DOI 10.1016/S0925-4773(99)00104-5; WOLPERT L, 1969, J THEOR BIOL, V25, P1, DOI 10.1016/S0022-5193(69)80016-0; Zecca M, 1996, CELL, V87, P833, DOI 10.1016/S0092-8674(00)81991-1; Zhang JJ, 1998, CELL, V92, P241, DOI 10.1016/S0092-8674(00)80918-6	28	238	245	1	9	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 31	2001	411	6837					607	610		10.1038/35079121	http://dx.doi.org/10.1038/35079121			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437GE	11385578				2022-12-24	WOS:000168982500057
J	Ungless, MA; Whistler, JL; Malenka, RC; Bonci, A				Ungless, MA; Whistler, JL; Malenka, RC; Bonci, A			Single cocaine exposure in vivo induces long-term potentiation in dopamine neurons	NATURE			English	Article							VENTRAL TEGMENTAL AREA; EXCITATORY AMINO-ACIDS; BEHAVIORAL SENSITIZATION; AMPA RECEPTORS; SILENT SYNAPSES; GLUTAMATE; AMPHETAMINE; ADDICTION; LTP; RAT	How do drugs of abuse modify neural circuitry and thereby lead to addictive behaviour? As for many forms of experience-dependent plasticity, modifications in glutamatergic synaptic transmission have been suggested to be particularly important(1-4). Evidence of such changes in response to in vivo administration of drugs of abuse is lacking, however. Here we show that a single in vivo exposure to cocaine induces long-term potentiation of AMPA (alpha -amino-3-hydroxy-5-methyl-isoxazole propionic acid)-receptor-mediated currents at excitatory synapses onto dopamine cells in the ventral tegmental area. Potentiation is still observed 5 but not 10 days after cocaine exposure and is blocked when an NMDA (N-methyl-D-aspartate) receptor antagonist is administered with cocaine. Furthermore, long-term potentiation at these synapses is occluded and long-term depression is enhanced by in vivo cocaine exposure. These results show that a prominent form of synaptic plasticity can be elicited by a single in vivo exposure to cocaine and therefore may be involved in the early stages of the development of drug addiction.	Univ Calif San Francisco, Dept Neurol, Ernest Gallo Clin & Res Ctr, San Francisco, CA 94110 USA; Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Nancy Pritzker Lab, Palo Alto, CA 94134 USA	University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center; Stanford University	Bonci, A (corresponding author), Univ Calif San Francisco, Dept Neurol, Ernest Gallo Clin & Res Ctr, San Francisco, CA 94110 USA.		Ungless, Mark/A-1985-2009; Jansen, Heiko T./A-5770-2008	Jansen, Heiko T./0000-0003-0178-396X; Ungless, Mark/0000-0002-1730-3353				Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; Berke JD, 2000, NEURON, V25, P515, DOI 10.1016/S0896-6273(00)81056-9; Bonci A, 1999, J NEUROSCI, V19, P3723; Carlezon WA, 1997, SCIENCE, V277, P812, DOI 10.1126/science.277.5327.812; Choi S, 2000, NAT NEUROSCI, V3, P330, DOI 10.1038/73895; Clark D, 1998, ADDICT BIOL, V3, P109, DOI 10.1080/13556219872191; DEWIT H, 1981, PSYCHOPHARMACOLOGY, V75, P134, DOI 10.1007/BF00432175; Dobrunz LE, 1997, NEURON, V18, P995, DOI 10.1016/S0896-6273(00)80338-4; Fitzgerald LW, 1996, J NEUROSCI, V16, P274; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; JACKSON HC, 1993, PHARMACOL BIOCHEM BE, V45, P733, DOI 10.1016/0091-3057(93)90533-Y; JOHNSON SW, 1992, J PHYSIOL-LONDON, V450, P455, DOI 10.1113/jphysiol.1992.sp019136; Jones S, 2000, J NEUROSCI, V20, P5575, DOI 10.1523/JNEUROSCI.20-15-05575.2000; KALIVAS PW, 1995, J NEUROSCI, V15, P5379, DOI 10.1523/jneurosci.15-07-05379.1995; KALIVAS PW, 1995, DRUG ALCOHOL DEPEN, V37, P95, DOI 10.1016/0376-8716(94)01063-Q; KALIVAS PW, 1993, J PHARMACOL EXP THER, V267, P486; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; Liu GS, 1999, NEURON, V22, P395, DOI 10.1016/S0896-6273(00)81099-5; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Mansvelder HD, 2000, NEURON, V27, P349, DOI 10.1016/S0896-6273(00)00042-8; Overton PG, 1999, NEUROREPORT, V10, P221, DOI 10.1097/00001756-199902050-00004; PERKEL DJ, 1993, J PHYSIOL-LONDON, V471, P481, DOI 10.1113/jphysiol.1993.sp019911; Rioult-Pedotti MS, 2000, SCIENCE, V290, P533, DOI 10.1126/science.290.5491.533; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Thomas MJ, 2000, J NEUROSCI, V20, P5581, DOI 10.1523/JNEUROSCI.20-15-05581.2000; THOMAS MJ, 2000, SOC NEUR ABSTR; WHITE FJ, 1984, BRAIN RES, V309, P283; Wolf ME, 1998, PROG NEUROBIOL, V54, P679, DOI 10.1016/S0301-0082(97)00090-7; Zhang XF, 1997, J PHARMACOL EXP THER, V281, P699	30	871	897	2	114	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 31	2001	411	6837					583	587		10.1038/35079077	http://dx.doi.org/10.1038/35079077			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437GE	11385572				2022-12-24	WOS:000168982500051
J	Mack, TM				Mack, TM			The new pan-asian paan problem	LANCET			English	Editorial Material							RISK-FACTOR; BETEL QUID; TOBACCO		Univ So Calif, Dept Prevent Med, Los Angeles, CA 90089 USA	University of Southern California	Mack, TM (corresponding author), Univ So Calif, Dept Prevent Med, Los Angeles, CA 90089 USA.	tmack@hsc.usc.edu						Chen CL, 1999, CARCINOGENESIS, V20, P2331, DOI 10.1093/carcin/20.12.2331; Chen JW, 1996, J ORAL PATHOL MED, V25, P140, DOI 10.1111/j.1600-0714.1996.tb00209.x; GUPTA P, 1990, 7 WORLD C TOB HLTH P; Gupta PC, 2000, B WORLD HEALTH ORGAN, V78, P877; HUANG WT, 1990, EC STUDY BETEL NUTS; *IARC, 1972, MON EV CARC RISK CHE, V1, P169; *IARC, 1985, MON EV CARC RISK CHE, V37, P141; Liu CJ, 2000, CAN MED ASSOC J, V162, P359; Merchant A, 2000, INT J CANCER, V86, P128, DOI 10.1002/(SICI)1097-0215(20000401)86:1&lt;128::AID-IJC20&gt;3.0.CO;2-M; Norton SA, 1998, J AM ACAD DERMATOL, V38, P81, DOI 10.1016/S0190-9622(98)70543-2; PINDBORG JJ, 1984, COMMUNITY DENT ORAL, V12, P195, DOI 10.1111/j.1600-0528.1984.tb01438.x; Reichart P A, 1999, Eur J Dent Educ, V3, P126, DOI 10.1111/j.1600-0579.1999.tb00078.x; SARMA AB, 1992, FOOD CHEM TOXICOL, V30, P161, DOI 10.1016/0278-6915(92)90152-B; Tang JG, 1997, COMMUNITY DENT ORAL, V25, P177, DOI 10.1111/j.1600-0528.1997.tb00918.x; Tsai JF, 2001, BRIT J CANCER, V84, P709, DOI 10.1054/bjoc.1999.1597	15	30	31	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 26	2001	357	9269					1638	1639		10.1016/S0140-6736(00)04860-1	http://dx.doi.org/10.1016/S0140-6736(00)04860-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	435UY	11425364				2022-12-24	WOS:000168901600005
J	Batista, FD; Iber, D; Neuberger, MS				Batista, FD; Iber, D; Neuberger, MS			B cells acquire antigen from target cells after synapse formation	NATURE			English	Article							FOLLICULAR DENDRITIC CELLS; REACTIVE LYMPHOCYTES-B; PEPTIDE-MHC COMPLEXES; T-CELLS; SURFACE MOLECULES; PRESENTING CELLS; CLASS-II; RECEPTOR; AFFINITY; INTERNALIZATION	Soluble antigen binds to the B-cell antigen receptor and is internalized for subsequent processing and the presentation of antigen-derived peptides to T cells(1). Many antigens are not soluble, however, but are integral components of membrane; furthermore, soluble antigens will usually be encountered in vivo in a membrane-anchored form, tethered by Fc or complement receptors(2-4). Here we show that B-cell interaction with antigens that are immobilized on the surface of a target cell leads to the formation of a synapse and the acquisition, even, of membrane-integral antigens from the target. B-cell antigen receptor accumulates at the synapse, segregated from the CD45 co-receptor which is excluded from the synapse, and there is a corresponding polarization of cytoplasmic effectors in the B cell. B-cell antigen receptor mediates the gathering of antigen into the synapse and its subsequent acquisition, thereby potentiating antigen processing and presentation to T cells with high efficacy. Synapse formation and antigen acquisition will probably enhance the activation of B cells at low antigen concentration, allow context-dependent antigen recognition and enhance the linking of B- and T-cell epitopes.	Med Res Lab Mol Biol, Cambridge CB2 2QH, England	MRC Laboratory Molecular Biology	Batista, FD (corresponding author), Med Res Lab Mol Biol, Hills Rd, Cambridge CB2 2QH, England.		Iber, Dagmar/V-2846-2019	Iber, Dagmar/0000-0001-8051-1035				Aluvihare VR, 1997, EMBO J, V16, P3553, DOI 10.1093/emboj/16.12.3553; Batista FD, 2000, EMBO J, V19, P513, DOI 10.1093/emboj/19.4.513; Batista FD, 1998, IMMUNITY, V8, P751, DOI 10.1016/S1074-7613(00)80580-4; CAGAN RL, 1992, CELL, V69, P393, DOI 10.1016/0092-8674(92)90442-F; CASTEN LA, 1985, P NATL ACAD SCI USA, V82, P5890, DOI 10.1073/pnas.82.17.5890; Cheng PC, 1999, J EXP MED, V190, P1549, DOI 10.1084/jem.190.11.1549; Dustin ML, 1997, J BIOL CHEM, V272, P30889, DOI 10.1074/jbc.272.49.30889; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; GREEN SM, 1989, ONCOGENE, V4, P737; HARTLEY SB, 1991, NATURE, V353, P765, DOI 10.1038/353765a0; Huang JF, 1999, SCIENCE, V286, P952, DOI 10.1126/science.286.5441.952; Hwang I, 2000, J EXP MED, V191, P1137, DOI 10.1084/jem.191.7.1137; KLAUS GGB, 1980, IMMUNOL REV, V53, P3, DOI 10.1111/j.1600-065X.1980.tb01038.x; KOSCOVILBOIS MH, 1993, J EXP MED, V178, P2055, DOI 10.1084/jem.178.6.2055; Lang J, 1996, J EXP MED, V184, P1685, DOI 10.1084/jem.184.5.1685; LANZAVECCHIA A, 1985, NATURE, V314, P537, DOI 10.1038/314537a0; Leupin O, 2000, CURR BIOL, V10, P277, DOI 10.1016/S0960-9822(00)00362-6; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; NEMAZEE DA, 1989, NATURE, V337, P562, DOI 10.1038/337562a0; RUSSELL DM, 1991, NATURE, V354, P308, DOI 10.1038/354308a0; Schamel WWA, 2000, IMMUNITY, V13, P5, DOI 10.1016/S1074-7613(00)00003-0; SCHREINER GF, 1977, J IMMUNOL, V119, P1549; Serre K, 1998, J IMMUNOL, V161, P6059; Siemasko K, 1998, J IMMUNOL, V160, P5203; TAYLOR RB, 1971, NATURE-NEW BIOL, V233, P225, DOI 10.1038/newbio233225a0; TEW JG, 1990, IMMUNOL REV, V117, P185, DOI 10.1111/j.1600-065X.1990.tb00573.x; VALITUTTI S, 1995, NATURE, V375, P148, DOI 10.1038/375148a0; Weintraub BC, 2000, J EXP MED, V191, P1443, DOI 10.1084/jem.191.8.1443; Wulfing C, 1998, SCIENCE, V282, P2266, DOI 10.1126/science.282.5397.2266	30	468	482	0	22	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 24	2001	411	6836					489	494		10.1038/35078099	http://dx.doi.org/10.1038/35078099			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	435CB	11373683				2022-12-24	WOS:000168858700052
J	Milkereit, P; Gadal, O; Podtelejnikov, A; Trumtel, S; Gas, N; Petfalski, E; Tollervey, D; Mann, M; Hurt, E; Tschochner, H				Milkereit, P; Gadal, O; Podtelejnikov, A; Trumtel, S; Gas, N; Petfalski, E; Tollervey, D; Mann, M; Hurt, E; Tschochner, H			Maturation and intranuclear transport of pre-ribosomes requires Noc proteins	CELL			English	Article							MESSENGER-RNA EXPORT; NUCLEAR EXPORT; SACCHAROMYCES-CEREVISIAE; COMPLEX-FORMATION; BINDING PROTEIN; POLYMERASE I; MEX67P; NUCLEOPORINS; BIOGENESIS; NUCLEOLUS	How pre-ribosomes temporally and spatially mature during intranuclear biogenesis is not known. Here, we report three nucleolar proteins, Noc1p to Noc3p, that are required for ribosome maturation and transport. They can be isolated in two distinct complexes: Noc1p/Noc2p associates with 90S and 66S pre-ribosomes and is enriched in the nucleolus, and Noc2p/Noc3p associates with 66S pre-ribosomes and is mainly nucleoplasmic. Mutation of each Noc protein impairs intranuclear transport of 60S subunits at different stages and inhibits pre-rRNA processing. Overexpression of a conserved domain common to Noc1p and Noc3p is dominant-negative for cell growth, with a defect int nuclear 60S subunit transport, but no inhibition of pre-RNA processing. We propose that the dynamic interaction of Noc proteins is crucial for intranuclear movement of ribosomal precursor particles, and, thereby represent a prerequisite for proper maturation.	Biochem Zentrum Heidelberg, D-69120 Heidelberg, Germany; Odense Univ, Prot Interact Lab, DK-5230 Odense M, Denmark; Lab Biol Mol Eucaryote, F-32062 Toulouse, France; Univ Edinburgh, Inst Cell & Mol Biol, Edinburgh EH9 3JR, Midlothian, Scotland	Ruprecht Karls University Heidelberg; University of Southern Denmark; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); University of Edinburgh	Tschochner, H (corresponding author), Biochem Zentrum Heidelberg, Neuenheimer Feld 328, D-69120 Heidelberg, Germany.	cg5@ix.urz.uni-heidelberg.de; IM4@ix.urz.uni-heidelberg.de	Mann, Matthias/A-3454-2013; Gadal, Olivier/A-4731-2008; Ed Hurt, Dr./AAE-8874-2019; Tollervey, David/AAR-6662-2020; Podtelejnikov, Alexandre/B-6120-2017	Mann, Matthias/0000-0003-1292-4799; Gadal, Olivier/0000-0001-9421-0831; Ed Hurt, Dr./0000-0002-4535-8255; Tollervey, David/0000-0003-2894-2772; Podtelejnikov, Alexandre/0000-0002-8124-6584				AMBERG DC, 1992, GENE DEV, V6, P1173, DOI 10.1101/gad.6.7.1173; BORER RA, 1989, CELL, V56, P379, DOI 10.1016/0092-8674(89)90241-9; DOYE V, 1995, TRENDS GENET, V11, P235, DOI 10.1016/S0168-9525(00)89057-5; Edskes HK, 1998, J BIOL CHEM, V273, P28912, DOI 10.1074/jbc.273.44.28912; Fath S, 2000, J CELL BIOL, V149, P575, DOI 10.1083/jcb.149.3.575; Gadal O, 2001, MOL CELL BIOL, V21, P3405, DOI 10.1128/MCB.21.10.3405-3415.2001; GRANDI P, 1993, EMBO J, V12, P3061, DOI 10.1002/j.1460-2075.1993.tb05975.x; Hellmuth K, 1998, MOL CELL BIOL, V18, P6374, DOI 10.1128/MCB.18.11.6374; Hurt E, 1999, J CELL BIOL, V144, P389, DOI 10.1083/jcb.144.3.389; KADOWAKI T, 1992, P NATL ACAD SCI USA, V89, P2312, DOI 10.1073/pnas.89.6.2312; Kressler D, 1999, MOL CELL BIOL, V19, P7897; Leger-Silvestre I, 1999, CHROMOSOMA, V108, P103, DOI 10.1007/s004120050357; LegerSilvestre I, 1997, EUR J CELL BIOL, V72, P13; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.0.CO;2-U; Milkereit P, 1997, BIOL CHEM, V378, P1433, DOI 10.1515/bchm.1997.378.12.1433; Moy TI, 1999, GENE DEV, V13, P2118, DOI 10.1101/gad.13.16.2118; Sambrook J., 1982, MOL CLONING; Santos-Rosa H, 1998, MOL CELL BIOL, V18, P6826, DOI 10.1128/MCB.18.11.6826; Sarkar S, 1999, P NATL ACAD SCI USA, V96, P14366, DOI 10.1073/pnas.96.25.14366; Scheer U, 1999, CURR OPIN CELL BIOL, V11, P385, DOI 10.1016/S0955-0674(99)80054-4; Segref A, 1997, EMBO J, V16, P3256, DOI 10.1093/emboj/16.11.3256; Shevchenko A, 1996, P NATL ACAD SCI USA, V93, P14440, DOI 10.1073/pnas.93.25.14440; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Siniossoglou S, 1996, CELL, V84, P265, DOI 10.1016/S0092-8674(00)80981-2; Stade K, 1997, CELL, V90, P1041, DOI 10.1016/S0092-8674(00)80370-0; Strasser K, 2000, EMBO J, V19, P410, DOI 10.1093/emboj/19.3.410; TOLLERVEY D, 1987, EMBO J, V6, P4169, DOI 10.1002/j.1460-2075.1987.tb02763.x; TOLLERVEY D, 1993, CELL, V72, P443, DOI 10.1016/0092-8674(93)90120-F; TRAPMAN J, 1975, EXP CELL RES, V90, P95, DOI 10.1016/0014-4827(75)90361-4; Trumtel S, 2000, MOL BIOL CELL, V11, P2175, DOI 10.1091/mbc.11.6.2175; Venema J, 1999, ANNU REV GENET, V33, P261, DOI 10.1146/annurev.genet.33.1.261; Williams M., 1977, QUANTITATIVE METHODS; WOOLFORD JL, 1991, ADV GENET, V29, P63, DOI 10.1016/S0065-2660(08)60107-8	33	156	160	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 18	2001	105	4					499	509		10.1016/S0092-8674(01)00358-0	http://dx.doi.org/10.1016/S0092-8674(01)00358-0			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	434XG	11371346	Bronze			2022-12-24	WOS:000168840700009
J	Hediger, ML; Overpeck, MD; Kuczmarski, RJ; Ruan, WJ				Hediger, ML; Overpeck, MD; Kuczmarski, RJ; Ruan, WJ			Association between infant breastfeeding and overweight in young children	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GESTATIONAL-AGE; PRESCHOOL-CHILDREN; UNITED-STATES; BIRTH-WEIGHT; BORN SMALL; OBESITY; GROWTH; ADIPOSITY; PREVALENCE; CHILDHOOD	Context it has been suggested that breastfeeding is protective against children becoming overweight, and that there is a dose-dependent effect of its duration. Objective To determine whether breastfeeding and its duration are associated with a reduced risk of being overweight among young children in the United States. Design and Setting Data on infant feeding and child overweight status were taken from the third National Health and Nutrition Examination Survey (NHANES iii), a cross-sectional health examination survey conducted from 1988-1994. Subjects Sample of 2685 US-born children between the ages of 3 and 5 years, with birth certificates, height and weight measures, and information on infant feeding. Main Outcome Measures A body mass index (BMI) between the 85th and 94th percentile was considered at risk of overweight and a BMI in the 95th percentile or higher was considered being overweight. Results After adjusting for potential confounders, there was a reduced risk of being at risk of overweight for ever breastfed children (adjusted odds ratio [AOR], 0.63; 95% confidence interval [CI], 0.41-0.96) compared with those never breastfed. There was no reduced risk of being overweight (AOR, 0.84; 95% CI, 0.62-1.13), There was no clear dose-dependent effect of the duration of full breastfeeding on being at risk of overweight or overweight and no threshold effect. The strongest predictor of child overweight status was the mother's concurrent weight. The rate of children being overweight nearly tripled with maternal overweight status (BMI, 25.0-29.9 kg/m(2); AOR, 2.95; 95% CI, 1.35-6.42) and more than quadrupled with maternal obesity status (BMI greater than or equal to 30.0 kg/m(2); AOR, 4.34; 95% CI, 2.50-7.54). Conclusions There are inconsistent associations among breastfeeding, its duration, and the risk of being overweight in young children, Breastfeeding continues to be strongly recommended, but may not be as effective as moderating familial factors, such as dietary habits and physical activity, in preventing children from becoming overweight.	NICHD, Div Epidemiol Stat & Prevent Res, NIH, Bethesda, MD 20892 USA; US Hlth Resources & Serv Adm, Maternal & Child Hlth Bur, Rockville, MD 20857 USA; Ctr Dis Control & Prevent, Div Hlth Examinat Stat, Natl Ctr Hlth Stat, Hyattsville, MD 20782 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); United States Health Resources & Service Administration (HRSA); Centers for Disease Control & Prevention - USA; CDC National Center for Health Statistics (NCHS)	Hediger, ML (corresponding author), NICHD, Div Epidemiol Stat & Prevent Res, NIH, Bldg 6100,Room 7B03,9000 Rockville Pike, Bethesda, MD 20892 USA.	hedigerm@exchange.nih.gov			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD002512] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Anderson JW, 1999, AM J CLIN NUTR, V70, P525; [Anonymous], 2000, ADV DATA VITAL HLTH; BARANOWSKI T, 1990, J DEV BEHAV PEDIATR, V11, P234; Barlow SE, 1998, PEDIATRICS, V102, DOI 10.1542/peds.102.3.e29; Butte NF, 2000, PEDIATRICS, V106, P1355, DOI 10.1542/peds.106.6.1355; Gartner LM, 1997, PEDIATRICS, V100, P1035, DOI 10.1542/peds.100.6.1035; GREENLAND S, 1989, AM J PUBLIC HEALTH, V79, P340, DOI 10.2105/AJPH.79.3.340; Hediger ML, 1998, ARCH PEDIAT ADOL MED, V152, P1225; Hediger ML, 1999, PEDIATRICS, V104, part. no., DOI 10.1542/peds.104.3.e33; Hediger ML, 2000, AM J CLIN NUTR, V72, P159; HIMES JH, 1994, AM J CLIN NUTR, V59, P307, DOI 10.1093/ajcn/59.2.307; HUTTLY SRA, 1990, AM J EPIDEMIOL, V132, P572, DOI 10.1093/oxfordjournals.aje.a115693; Lohman TG, 1988, ANTHROPOMETRIC STAND; Mehta KC, 1998, PEDIATRICS, V102, P569, DOI 10.1542/peds.102.3.569; Mei ZG, 1998, PEDIATRICS, V101, DOI 10.1542/peds.101.1.e12; *NAT CTR HLTH STAT, 1997, 1994 NAT DAT SET 21, V4; National Center for Health Statistics, 1996, NHANES 3 REF MAN REP; National Center for Health Statistics, 1994, PLAN OP 3 NAT HLTH N; OCallaghan MJ, 1997, J PAEDIATR CHILD H, V33, P311, DOI 10.1111/j.1440-1754.1997.tb01607.x; Oddy WH, 1999, BMJ-BRIT MED J, V319, P815, DOI 10.1136/bmj.319.7213.815; Ogden CL, 1997, PEDIATRICS, V99, part. no., DOI 10.1542/peds.99.4.e1; Overpeck MD, 2000, J PEDIATR-US, V137, P205, DOI 10.1067/mpd.2000.107163; Overpeck MD, 1999, OBSTET GYNECOL, V93, P943, DOI 10.1016/S0029-7844(98)00553-5; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; Raisler J, 1999, AM J PUBLIC HEALTH, V89, P25, DOI 10.2105/AJPH.89.1.25; ROLLANDCACHERA MF, 1987, ANN HUM BIOL, V14, P219, DOI 10.1080/03014468700008991; Ryan AS, 1997, PEDIATRICS, V99, part. no., DOI 10.1542/peds.99.4.e12; RYAN AS, 1991, PEDIATRICS, V88, P719; RYAN AS, 1991, AM J PUBLIC HEALTH, V81, P1049, DOI 10.2105/AJPH.81.8.1049; Shah BV, 1997, SUDAAN USERS MANUAL; Tulldahl J, 1999, OBES RES, V7, P431, DOI 10.1002/j.1550-8528.1999.tb00430.x; *US DEPT HHS, 1996, NHANES 3 ANTHR PROC; von Kries R, 1999, BRIT MED J, V319, P147, DOI 10.1136/bmj.319.7203.147; Wadsworth M, 1999, BRIT MED J, V319, P1576, DOI 10.1136/bmj.319.7224.1576; Whitaker RC, 1997, NEW ENGL J MED, V337, P869, DOI 10.1056/NEJM199709253371301; Whitaker RC, 1998, PEDIATRICS, V101, DOI 10.1542/peds.101.3.e5; ZHANG J, 1995, OBSTET GYNECOL, V86, P200, DOI 10.1016/0029-7844(95)00142-E; ZIVE MM, 1992, AM J CLIN NUTR, V55, P1104, DOI 10.1093/ajcn/55.6.1104	38	262	277	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 16	2001	285	19					2453	2460		10.1001/jama.285.19.2453	http://dx.doi.org/10.1001/jama.285.19.2453			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	429ZC	11368697	Bronze			2022-12-24	WOS:000168547600026
J	Perutz, MF; Windle, AH				Perutz, MF; Windle, AH			Cause of neural death in neurodegenerative diseases attributable to expansion of glutamine repeats	NATURE			English	Article							HUNTINGTONS-DISEASE; INTRANUCLEAR INCLUSIONS; CELL-DEATH; DYSFUNCTION; MODEL	Neurodegenerative diseases resulting from expanded repeat sequences of glutamine residues are associated with the formation of protein aggregates in the cell nuclei of the affected neurons, but whether these are pathogenic is controversial. Recent observations indicate that the ages of onset of these diseases are exponential functions of the repeat lengths and that the probability of neural death is constant with time. The only process known to us that could give rise to such behaviour is nucleation of the aggregates.	MRC, Mol Biol Lab, Cambridge CB2 2QH, England; Univ Cambridge, Dept Mat Sci & Met, Cambridge CB2 3QZ, England	MRC Laboratory Molecular Biology; University of Cambridge	Perutz, MF (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.							Carmichael J, 2000, P NATL ACAD SCI USA, V97, P9701, DOI 10.1073/pnas.170280697; Clarke G, 2000, NATURE, V406, P195, DOI 10.1038/35018098; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Gusella JF, 2000, NAT REV NEUROSCI, V1, P109, DOI 10.1038/35039051; Huang CC, 1998, SOMAT CELL MOLEC GEN, V24, P217, DOI 10.1023/B:SCAM.0000007124.19463.e5; KAZANTSEV A, UNPUB CELL; Kuemmerle S, 1999, ANN NEUROL, V46, P842; Mullins J. W., 1972, CRYSTALLISATION; Narain Y, 1999, J MED GENET, V36, P739, DOI 10.1136/jmg.36.10.739; Nucifora FC, 2001, SCIENCE, V291, P2423, DOI 10.1126/science.1056784; Perutz MF, 1999, TRENDS BIOCHEM SCI, V24, P58, DOI 10.1016/S0968-0004(98)01350-4; PERUTZ MF, 1994, P NATL ACAD SCI USA, V91, P5355, DOI 10.1073/pnas.91.12.5355; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; Skinner PJ, 1997, NATURE, V389, P971, DOI 10.1038/40153; Yamamoto A, 2000, CELL, V101, P57, DOI 10.1016/S0092-8674(00)80623-6	17	161	167	0	8	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 12	2001	412	6843					143	144		10.1038/35084141	http://dx.doi.org/10.1038/35084141			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	451AJ	11449262				2022-12-24	WOS:000169778700040
J	Grimes, DA				Grimes, DA			Intrauterine devices and infertility: sifting through the evidence	LANCET			English	Editorial Material							PELVIC INFLAMMATORY DISEASE		Family Hlth Int, Res Triangle Pk, NC 27709 USA		Grimes, DA (corresponding author), Family Hlth Int, POB 13950, Res Triangle Pk, NC 27709 USA.							Bastianelli C, 1998, Minerva Ginecol, V50, P231; BUCHAN H, 1990, BRIT J OBSTET GYNAEC, V97, P780, DOI 10.1111/j.1471-0528.1990.tb02571.x; CATES W, 2000, WOMEN HLTH, P381; Doll H, 2001, BRIT J OBSTET GYNAEC, V108, P304, DOI 10.1111/j.1471-0528.2001.00075.x; Grimes DA, 2000, LANCET, V356, P1013, DOI 10.1016/S0140-6736(00)02699-4; HUBACHER D, 2000, INT J GYNECOL OBSTET; *ROYAL COLL OBST G, INT INV MAN INF COUP; VESSEY MP, 1981, BRIT MED J, V282, P855, DOI 10.1136/bmj.282.6267.855; *WHO, 2001, IMPR ACC QUAL CAR FA; World Health Organization (Who), 1987, 753 WHO	10	16	16	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 7	2001	358	9275					6	7		10.1016/S0140-6736(00)05299-5	http://dx.doi.org/10.1016/S0140-6736(00)05299-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	449WV	11454367				2022-12-24	WOS:000169710900006
J	Merila, J; Kruuk, LEB; Sheldon, BC				Merila, J; Kruuk, LEB; Sheldon, BC			Cryptic evolution in a wild bird population	NATURE			English	Article							NESTLING COLLARED FLYCATCHERS; DIRECTIONAL SELECTION; NATURAL-SELECTION; BODY-SIZE; VARIANCE; MASS	Microevolution is expected to be commonplace, yet there are few thoroughly documented cases of microevolution in wild populations(1,2). In contrast, it is often observed that apparently heritable traits under strong and consistent directional selection fail to show the expected evolutionary response(3,4). One explanation proposed for this paradox is that a genetic response to selection may be masked by opposing changes in the environment(5,6). We used data from a 20-year study of collared flycatchers (Ficedula albicollis) to explore selection on, and evolution of, a heritable trait: relative body weight at fledging ('condition'). Despite consistent positive directional selection, on both the phenotypic and the additive genetic component (breeding values, estimated from an animal model) of condition, the mean phenotypic value of this trait in the population has declined, rather than increased, over time. Here we show that, despite this decline, the mean breeding value for condition has increased over time. The mismatch between response to selection at the levels of genotype and phenotype can be explained by environmental deterioration, concealing underlying evolution. This form of cryptic evolution may be common in natural environments.	Uppsala Univ, Evolutionary Biol Ctr, Dept Populat Biol, SE-75236 Uppsala, Sweden; Univ Edinburgh, Inst Cell Anim & Populat Biol, Edinburgh EH9 3JT, Midlothian, Scotland; Univ Oxford, Dept Zool, Oxford OX1 3PS, England; Uppsala Univ, Evolutionary Biol Ctr, Dept Anim Ecol, SE-75236 Uppsala, Sweden	Uppsala University; University of Edinburgh; University of Oxford; Uppsala University	Merila, J (corresponding author), Uppsala Univ, Evolutionary Biol Ctr, Dept Populat Biol, Norbyvagen 18d, SE-75236 Uppsala, Sweden.		Merila, Juha/A-4061-2008; Sheldon, Ben C/A-8056-2010; Kruuk, Loeske/AAB-8714-2019; Kruuk, Loeske E. B./J-3295-2012	Merila, Juha/0000-0001-9614-0072; Sheldon, Ben C/0000-0002-5240-7828; Kruuk, Loeske/0000-0001-8588-1123; Kruuk, Loeske E. B./0000-0001-8588-1123				ALATALO RV, 1990, AM NAT, V135, P464, DOI 10.1086/285056; ALATALO RV, 1984, J ANIM ECOL, V53, P969, DOI 10.2307/4671; BLAIR HT, 1984, J ANIM SCI, V58, P878, DOI 10.2527/jas1984.584878x; Boltnev AI, 1998, CAN J ZOOL, V76, P843, DOI 10.1139/cjz-76-5-843; Both C, 1999, P ROY SOC B-BIOL SCI, V266, P465, DOI 10.1098/rspb.1999.0660; CONOVER DO, 1995, TRENDS ECOL EVOL, V10, P248, DOI 10.1016/S0169-5347(00)89081-3; COOKE F, 1990, AM NAT, V136, P261, DOI 10.1086/285095; Doligez B, 1999, J ANIM ECOL, V68, P1193, DOI 10.1046/j.1365-2656.1999.00362.x; FRANK SA, 1992, TRENDS ECOL EVOL, V7, P92, DOI 10.1016/0169-5347(92)90248-A; *GENST, 1998, GENST 5 REL 4 1; Gilchrist AS, 1999, GENETICS, V153, P1775; GRANT PR, 1995, EVOLUTION, V49, P241, DOI 10.1111/j.1558-5646.1995.tb02236.x; GROENEVELD E, 1992, ARCH ANIM BREED, V15, P399; GROENEVELD E, 1995, REML VCE MULTIVARIAT; GUSTAFSSON L, 1988, IBIS, V130, P11, DOI 10.1111/j.1474-919X.1988.tb00951.x; HOCHACHKA W, 1991, J ANIM ECOL, V60, P995, DOI 10.2307/5427; LEWONTIN RC, 1978, SCI AM, V239, P212, DOI 10.1038/scientificamerican0978-212; LINDEN M, 1992, ECOLOGY, V73, P336, DOI 10.2307/1938745; Lynch M., 1998, AM J HUM GENET; Merila J, 1996, FUNCT ECOL, V10, P465, DOI 10.2307/2389939; Merila J, 1997, MOL ECOL, V6, P1167, DOI 10.1046/j.1365-294X.1997.00295.x; MERILA J, UNPUB J EVOL BIOL; MEYER K, 1989, GENET SEL EVOL, V21, P317, DOI 10.1051/gse:19890308; PRICE T, 1988, SCIENCE, V240, P798, DOI 10.1126/science.3363360; Reznick DN, 1997, SCIENCE, V275, P1934, DOI 10.1126/science.275.5308.1934; Roff D.A., 1997, EVOLUTIONARY QUANTIT; Sheldon BC, 1998, ECOLOGY, V79, P1939, DOI 10.1890/0012-9658(1998)079[1939:GAESIN]2.0.CO;2; Sorci G, 1999, EVOL ECOL RES, V1, P303; SOUTHWOOD OI, 1991, J ANIM SCI, V69, P3177; Visser ME, 2001, P ROY SOC B-BIOL SCI, V268, P289, DOI 10.1098/rspb.2000.1363	30	169	172	0	61	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 5	2001	412	6842					76	79		10.1038/35083580	http://dx.doi.org/10.1038/35083580			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448TB	11452309				2022-12-24	WOS:000169644900046
J	Parrish, J; Li, LL; Klotz, K; Ledwich, D; Wang, XD; Xue, D				Parrish, J; Li, LL; Klotz, K; Ledwich, D; Wang, XD; Xue, D			Mitochondrial endonuclease G is important for apoptosis in C-elegans	NATURE			English	Article							PROGRAMMED CELL DEATHS; DNA FRAGMENTATION; PROTEIN; INTERFERENCE; GENE; RNA	Programmed cell death (apoptosis) is a tightly regulated process of cell disassembly in which dying cells and their nuclei shrink and fragment and the chromosomal DNA is degraded into internucleosomal repeats(1-3). Here we report the characterization of the cps-6 gene, which appears to function downstream of, or in parallel to, the cell-death protease CED-3 of Caenorhabditis elegans in the DNA degradation process during apoptosis. cps-6 encodes a homologue of human mitochondrial endonuclease G(4,5), and its protein product similarly localizes to mitochondria in C. elegans. Reduction of cps-6 activity caused by a genetic mutation or RNA-mediated interference (RNAi) affects normal DNA degradation, as revealed by increased staining in a TUNEL assay, and results in delayed appearance of cell corpses during development in C. elegans. This observation provides in vivo evidence that the DNA degradation process is important for proper progression of apoptosis. CPS-6 is the first mitochondrial protein identified to be involved in programmed cell death in C. elegans, underscoring the conserved and important role of mitochondria in the execution of apoptosis.	Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA; Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75390 USA	University of Colorado System; University of Colorado Boulder; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Xue, D (corresponding author), Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA.	ding.xue@colorado.edu		XUE, DING/0000-0002-8429-8136; Wang, Xiaodong/0000-0001-9885-356X				BRENNER S, 1974, GENETICS, V77, P71; Chalfie M, 1995, PROG BRAIN RES, V105, P179; Chen FL, 2000, SCIENCE, V287, P1485, DOI 10.1126/science.287.5457.1485; CLARK SG, 1994, GENETICS, V137, P987; COTE J, 1993, SCIENCE, V261, P765, DOI 10.1126/science.7688144; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Enari M, 1998, NATURE, V391, P43, DOI 10.1038/34112; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Gu T, 1998, MOL CELL BIOL, V18, P4556, DOI 10.1128/MCB.18.8.4556; HEDGECOCK EM, 1983, SCIENCE, V220, P1277, DOI 10.1126/science.6857247; Horvitz HR, 1999, CANCER RES, V59, p1701S; HSU DR, 1995, DEVELOPMENT, V121, P3323; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Li LY, 2001, NATURE, V412, P95, DOI 10.1038/35083620; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Liu XS, 1997, CELL, V89, P175, DOI 10.1016/S0092-8674(00)80197-X; McIlroy D, 2000, GENE DEV, V14, P549; Nagata S, 2000, EXP CELL RES, V256, P12, DOI 10.1006/excr.2000.4834; Riddle DL, 1997, C ELEGANS; RUIZCARRILLO A, 1987, EMBO J, V6, P401, DOI 10.1002/j.1460-2075.1987.tb04769.x; Shah A, 1999, AGING MENT HEALTH, V3, P153, DOI 10.1080/13607869956316; Stanfield GM, 2000, MOL CELL, V5, P423, DOI 10.1016/S1097-2765(00)80437-2; STELLER H, 1995, SCIENCE, V267, P1445, DOI 10.1126/science.7878463; SULSTON JE, 1976, PHILOS T ROY SOC B, V275, P287, DOI 10.1098/rstb.1976.0084; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Wu YC, 2000, GENE DEV, V14, P536; Zhang JH, 1998, P NATL ACAD SCI USA, V95, P12480, DOI 10.1073/pnas.95.21.12480	30	331	345	10	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 5	2001	412	6842					90	94		10.1038/35083608	http://dx.doi.org/10.1038/35083608			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448TB	11452313				2022-12-24	WOS:000169644900050
J	Outten, CE; O'Halloran, TV				Outten, CE; O'Halloran, TV			Femtomolar sensitivity of metalloregulatory proteins controlling zinc homeostasis	SCIENCE			English	Article							ESCHERICHIA-COLI; REGULATOR ZUR; UPTAKE SYSTEM; HIGH-AFFINITY; METALLOTHIONEIN; IONS; ZNTR; SMTB; FLUORESCENCE; TRANSPORTER	Intracellular zinc is thought to be available in a cytosolic pool of free or Loosely bound Zn(II) ions in the micromolar to picomolar range. To test this, we determined the mechanism of zinc sensors that control metal uptake or export in Escherichia coli and calibrated their response against the thermodynamically defined free line concentration. Whereas the cellular line quota is millimolar, free Zn(II) concentrations that trigger transcription of zinc uptake or efflux machinery are femtomolar, or six orders of magnitude Less than one atom per cell. This is not consistent with a cytosolic pool of free Zn(II) and suggests an extraordinary intracellular zinc-binding capacity. Thus, cells exert tight control over cytosolic metal concentrations, even for relatively Low-toxicity metals such as zinc.	Northwestern Univ, Dept Chem, Evanston, IL 60208 USA; Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA	Northwestern University; Northwestern University	O'Halloran, TV (corresponding author), Northwestern Univ, Dept Chem, 2145 Sheridan Rd, Evanston, IL 60208 USA.		Outten, Caryn E./I-9433-2019; O'Halloran, Thomas/ABE-6125-2021	Outten, Caryn E./0000-0003-0335-6531; O'Halloran, Thomas/0000-0001-8732-5059	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052627] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038784, T32GM008382] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK52627] Funding Source: Medline; NIGMS NIH HHS [R01 GM38784, T32 GM08382, R01 GM038784] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AKERLUND T, 1995, J BACTERIOL, V177, P6791, DOI 10.1128/jb.177.23.6791-6797.1995; Ausubel FM, 1995, CURRENT PROTOCOLS MO, V1; Azam TA, 1999, J BACTERIOL, V181, P6361, DOI 10.1128/JB.181.20.6361-6370.1999; Berg JM, 1996, SCIENCE, V271, P1081, DOI 10.1126/science.271.5252.1081; Binet MRB, 2000, FEBS LETT, V473, P67, DOI 10.1016/S0014-5793(00)01509-X; Bremer H., 1996, E COLI SALMONELLA CE, V2, P1553; Brocklehurst KR, 1999, MOL MICROBIOL, V31, P893, DOI 10.1046/j.1365-2958.1999.01229.x; Coleman JE, 1998, CURR OPIN CHEM BIOL, V2, P222, DOI 10.1016/S1367-5931(98)80064-1; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Fahrni CJ, 1999, J AM CHEM SOC, V121, P11448, DOI 10.1021/ja992709f; Gaballa A, 1998, J BACTERIOL, V180, P5815, DOI 10.1128/JB.180.22.5815-5821.1998; Granger J, 1999, LIMNOL OCEANOGR, V44, P541, DOI 10.4319/lo.1999.44.3.0541; HEUCHEL R, 1994, EMBO J, V13, P2870, DOI 10.1002/j.1460-2075.1994.tb06581.x; HITOMI Y, UNPUB; HUCKLE JW, 1993, MOL MICROBIOL, V7, P177, DOI 10.1111/j.1365-2958.1993.tb01109.x; Huffman DL, 2000, J BIOL CHEM, V275, P18611, DOI 10.1074/jbc.C000172200; Kar SR, 1997, BIOCHEMISTRY-US, V36, P15343, DOI 10.1021/bi971690v; Martell A.E., 1998, NIST STANDARD REFERE, V46; Nasir MS, 1999, J BIOL INORG CHEM, V4, P775, DOI 10.1007/s007750050350; Neidhardt FC, 1990, PHYSL BACTERIAL CELL; OUTTEN C, UNPUB; Outten CE, 1999, J BIOL CHEM, V274, P37517, DOI 10.1074/jbc.274.53.37517; OUTTEN FW, UNPUB; PALMITER RD, 1995, EMBO J, V14, P639, DOI 10.1002/j.1460-2075.1995.tb07042.x; Patzer SI, 2000, J BIOL CHEM, V275, P24321, DOI 10.1074/jbc.M001775200; Patzer SI, 1998, MOL MICROBIOL, V28, P1199, DOI 10.1046/j.1365-2958.1998.00883.x; Rae TD, 1999, SCIENCE, V284, P805, DOI 10.1126/science.284.5415.805; Rensing C, 1999, J BACTERIOL, V181, P5891, DOI 10.1128/JB.181.19.5891-5897.1999; Sensi SL, 1997, J NEUROSCI, V17, P9554; Singh VK, 1999, MOL MICROBIOL, V33, P200, DOI 10.1046/j.1365-2958.1999.01466.x; Suhy DA, 1999, J BIOL CHEM, V274, P9183, DOI 10.1074/jbc.274.14.9183; Thelwell C, 1998, P NATL ACAD SCI USA, V95, P10728, DOI 10.1073/pnas.95.18.10728; VALLEE B L, 1988, Biofactors, V1, P31; VanZile ML, 2000, BIOCHEMISTRY-US, V39, P11818, DOI 10.1021/bi001140o; Williams RJP, 2000, COORDIN CHEM REV, V200, P247, DOI 10.1016/S0010-8545(00)00324-6; Zhao H, 1997, MOL CELL BIOL, V17, P5044, DOI 10.1128/MCB.17.9.5044	36	1112	1135	2	127	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 29	2001	292	5526					2488	2492		10.1126/science.1060331	http://dx.doi.org/10.1126/science.1060331			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448YU	11397910				2022-12-24	WOS:000169658200041
J	Orr, A; McVean, RJ; Webb, AK; Dodd, ME				Orr, A; McVean, RJ; Webb, AK; Dodd, ME			Questionnaire survey of urinary incontinence in women with cystic fibrosis	BRITISH MEDICAL JOURNAL			English	Article							PREVALENCE		S Manchester Univ Hosp Trust, NW Lung Ctr, Adult Cyst Fibrosis Unit, Manchester M23 9LT, Lancs, England		Orr, A (corresponding author), S Manchester Univ Hosp Trust, NW Lung Ctr, Adult Cyst Fibrosis Unit, Manchester M23 9LT, Lancs, England.							Chiarelli P, 1999, NEUROUROL URODYNAM, V18, P567, DOI 10.1002/(SICI)1520-6777(1999)18:6<567::AID-NAU7>3.0.CO;2-F; Dolan LR, 1999, BJU INT, V83, P760; Gunnarsson M, 1999, NEUROUROL URODYNAM, V18, P613, DOI 10.1002/(SICI)1520-6777(1999)18:6<613::AID-NAU11>3.0.CO;2-B; THOMAS TM, 1980, BRIT MED J, V281, P1243, DOI 10.1136/bmj.281.6250.1243	4	41	41	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 23	2001	322	7301					1521	1521		10.1136/bmj.322.7301.1521	http://dx.doi.org/10.1136/bmj.322.7301.1521			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	446UF	11420273	Bronze, Green Published, Green Submitted			2022-12-24	WOS:000169532000018
J	Wallis, JD; Anderson, KC; Miller, EK				Wallis, JD; Anderson, KC; Miller, EK			Single neurons in prefrontal cortex encode abstract rules	NATURE			English	Article							ORBITOFRONTAL CORTEX; NEURAL ACTIVITY; FRONTAL-CORTEX; WORKING-MEMORY; UNIT-ACTIVITY; PRIMATE; REWARD; MACAQUE; MONKEY	The ability to abstract principles or rules from direct experience allows behaviour to extend beyond specific circumstances to general situations. For example, we learn the 'rules' for restaurant dining from specific experiences and can then apply them in new restaurants. The use of such rules is thought to depend on the prefrontal cortex (PFC) because its damage often results in difficulty in following rules(1). Here we explore its neural basis by recording from single neurons in the PFC of monkeys trained to use two abstract rules. They were required to indicate whether two successively presented pictures were the same or different depending on which rule was currently in effect. The monkeys performed this task with new pictures, thus showing that they had learned two general principles that could be applied to stimuli that they had not yet experienced. The most prevalent neuronal activity observed in the PFC reflected the coding of these abstract rules.	MIT, Ctr Learning & Memory, RIKEN, Neurosci Res Ctr, Cambridge, MA 02139 USA; MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); RIKEN; Massachusetts Institute of Technology (MIT)	Miller, EK (corresponding author), MIT, Ctr Learning & Memory, RIKEN, Neurosci Res Ctr, Cambridge, MA 02139 USA.		Miller, Earl K./AAE-8187-2019	Miller, Earl K./0000-0002-0582-6958; Wallis, Joni/0000-0001-7262-7417				Asaad WF, 2000, J NEUROPHYSIOL, V84, P451, DOI 10.1152/jn.2000.84.1.451; Asaad WF, 1998, NEURON, V21, P1399, DOI 10.1016/S0896-6273(00)80658-3; DIPELLEGRINO G, 1993, J NEUROSCI, V13, P1227; Freedman DJ, 2001, SCIENCE, V291, P312, DOI 10.1126/science.291.5502.312; FUNAHASHI S, 1989, J NEUROPHYSIOL, V61, P331, DOI 10.1152/jn.1989.61.2.331; Fuster JM, 2000, NATURE, V405, P347, DOI 10.1038/35012613; FUSTER JM, 1971, SCIENCE, V173, P652, DOI 10.1126/science.173.3997.652; FUSTER JM, 1973, J NEUROPHYSIOL, V36, P61, DOI 10.1152/jn.1973.36.1.61; FUSTER JM, 1997, PREFRONTAL CORTEX; GOLDMANRAKIC PS, 1995, NEURON, V14, P477, DOI 10.1016/0896-6273(95)90304-6; Hoshi E, 1998, J NEUROPHYSIOL, V80, P3392, DOI 10.1152/jn.1998.80.6.3392; Leon MI, 1999, NEURON, V24, P415, DOI 10.1016/S0896-6273(00)80854-5; Miller EK, 1999, NEURON, V22, P15, DOI 10.1016/S0896-6273(00)80673-X; Miller EK, 1996, J NEUROSCI, V16, P5154; Milner B., 1963, ARCH NEUROL-CHICAGO, V9, P90, DOI DOI 10.1001/ARCHNEUR.1963.00460070100010; NIKI H, 1974, BRAIN RES, V68, P197, DOI 10.1016/0006-8993(74)90389-8; Rainer G, 1998, NATURE, V393, P577, DOI 10.1038/31235; Rainer G, 1999, J NEUROSCI, V19, P5493; Rao SC, 1997, SCIENCE, V276, P821, DOI 10.1126/science.276.5313.821; Roberts AC, 2000, CEREB CORTEX, V10, P252, DOI 10.1093/cercor/10.3.252; Rolls ET, 2000, CEREB CORTEX, V10, P284, DOI 10.1093/cercor/10.3.284; ROLLS ET, 1990, J NEUROPHYSIOL, V64, P1055, DOI 10.1152/jn.1990.64.4.1055; Tremblay L, 1999, NATURE, V398, P704, DOI 10.1038/19525; Watanabe M, 1996, NATURE, V382, P629, DOI 10.1038/382629a0; White IM, 1999, EXP BRAIN RES, V126, P315, DOI 10.1007/s002210050740; Wise SP, 1996, CRIT REV NEUROBIOL, V10, P317, DOI 10.1615/CritRevNeurobiol.v10.i3-4.30	26	686	696	0	65	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 21	2001	411	6840					953	956		10.1038/35082081	http://dx.doi.org/10.1038/35082081			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	444EN	11418860				2022-12-24	WOS:000169386200046
J	Moscicki, AB; Hills, N; Shiboski, S; Powell, K; Jay, N; Hanson, E; Miller, S; Clayton, L; Farhat, S; Broering, J; Darragh, T; Palefsky, J				Moscicki, AB; Hills, N; Shiboski, S; Powell, K; Jay, N; Hanson, E; Miller, S; Clayton, L; Farhat, S; Broering, J; Darragh, T; Palefsky, J			Risks for incident human papillomavirus infection and low-grade squamous intraepithelial lesion development in young females	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SEXUALLY-TRANSMITTED-DISEASE; NATURAL-HISTORY; CIGARETTE-SMOKING; HPV INFECTION; TYPE-16; ASSOCIATION; BEHAVIOR; CANCER; E6; PREVALENCE	Context Low-grade squamous intraepithelial lesions (LSILs) have been described as a benign cytological consequence of active human papillomavirus (HPV) replication. Several studies have reported that certain behavioral and biological risks exist for LSIL, suggesting that HPV alone is not sufficient for the development of LSIL. However, because most of these studies have been cross-sectional, it is not known whether behavioral and biological risks are simply risks for HPV infection itself. Objective To prospectively examine risks of incident HPV infection in HPV-negative females and of incident LSIL development in females with HPV infection. Design Prospective cohort study conducted between 1990-2000, with a median follow-up of 50 months. Setting and Participants Females aged 13 to 21 years who attended 2 family planning clinics in the San francisco bay area; 496 had prevalent HPV infection and 105 were HPV-negative. Main Outcome Measure Incident development of HPV infection and LSIL, analyzed by various demographic, behavioral, and clinical risk factors. Results Fifty-four incident HPV infections occurred in the 105 females who were HPV-negative at study entry (median duration of follow-up for those who remained HPV-negative was 26 months). Multivariable analysis showed that risks of HPV included sexual behavior (relative hazard [RH], 10.10; 95% confidence interval [CI], 3.24-31.50 per new partner per month), history of herpes simplex virus (RH, 3.54; 95% CI, 1.37-9.10), and history of vulvar warts (RH, 2.73; 95% CI, 1.27-5.87). Current use of oral contraceptives had a significantly protective effect (RH, 0.49; 95% CI, 0.28-0.86). Among the 496 individuals who were HPV-positive at baseline or in follow-up, there were 109 incident cases of LSIL during the follow-up interval, with a median follow-up time of 60 months for those who never developed LSIL. Human papillomavirus infection was the most significant risk factor for development of LSIL, The multivariable model showed the following risks for LSIL: HPV infection for less than 1 year(RH, 7.40; 95% CI, 4.74-11.57); HPV infection for 1 to 2 years (RH, 10.27; 95% CI, 5.64-18.69); HPV infection for 2 to 3 years (RH, 6.11; 95% CI, 1.86-20.06); and daily cigarette smoking (RH, 1.67; 95% CI, 1.12-2.48). Conclusion Our results indicate distinct risks for HPV and LSIL. In addition, most women with HPV infection in our study did not develop LSIL within a median follow-up period of 60 months. These findings underscore the hypothesis that certain biological risks thought to be associated with LSIL are, in fact, risks for acquisition of HPV. Cigarette smoking was a risk specific to LSIL, supporting the role of tobacco in neoplastic development.	Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Anat Pathol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Stomatol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Moscicki, AB (corresponding author), 3333 Calif St,Suite 245, San Francisco, CA 94118 USA.	annam@itsa.ucsf.edu	Moscicki, Anna-Barbara/AAP-3806-2021	Broering, Jeanette/0000-0002-7580-8931	NCI NIH HHS [R37 CA051323, R01CA54053, R01CA51323] Funding Source: Medline; NCRR NIH HHS [M01 RR01271] Funding Source: Medline; PHS HHS [MCJ000978, P01A121912] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA054053, R01CA051323, R37CA051323] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR001271] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		AMBROS RA, 1990, SEMIN DIAGN PATHOL, V7, P158; Arany I, 1996, J INTERF CYTOK RES, V16, P453, DOI 10.1089/jir.1996.16.453; ASHLEY RL, 1988, J CLIN MICROBIOL, V26, P662, DOI 10.1128/JCM.26.4.662-667.1988; BARTON SE, 1988, LANCET, V2, P652; BAUER HM, 1991, JAMA-J AM MED ASSOC, V265, P472, DOI 10.1001/jama.265.4.472; CLARKE EA, 1985, AM J OBSTET GYNECOL, V151, P612, DOI 10.1016/0002-9378(85)90149-8; COPPLESON M, 1979, COLPOSCOPY SCI PRACT; COX JT, 1992, OBSTET GYNECOL, V80, P389; Daling JR, 1996, CANCER EPIDEM BIOMAR, V5, P541; DEVET HCW, 1993, INT J EPIDEMIOL, V22, P798, DOI 10.1093/ije/22.5.798; Ferenczy A, 1996, OBSTET GYN CLIN N AM, V23, P759, DOI 10.1016/S0889-8545(05)70276-X; Gravitt PE, 1998, J CLIN MICROBIOL, V36, P3020, DOI 10.1128/JCM.36.10.3020-3027.1998; HARAHAP RE, 1986, CANCER DETECT PREV, V9, P237; Ho GYF, 1998, NEW ENGL J MED, V338, P423, DOI 10.1056/NEJM199802123380703; HOLMES KK, 1981, SCAND J INFECT DIS, P110; IRWIN KL, 1988, JAMA-J AM MED ASSOC, V259, P59, DOI 10.1001/jama.259.1.59; Kadish AS, 1997, J NATL CANCER I, V89, P1285, DOI 10.1093/jnci/89.17.1285; Kurman RJ, 1994, BETHESDA SYSTEM REPO; LAVECCHIA C, 1986, CANCER, V58, P935, DOI 10.1002/1097-0142(19860815)58:4<935::AID-CNCR2820580422>3.0.CO;2-O; LORINCZ A, 1996, HUMAN PAPILLOMAVIRUS, V1; MOSCICKI AB, 1993, OBSTET GYNECOL, V82, P578; MOSCICKI AB, 1993, J ADOLESCENT HEALTH, V14, P74, DOI 10.1016/1054-139X(93)90088-7; MOSCICKI AB, 1989, J PEDIATR-US, V115, P487, DOI 10.1016/S0022-3476(89)80863-7; MOSCICKI AB, 1990, PEDIATR RES, V28, P507, DOI 10.1203/00006450-199011000-00018; Moscicki AB, 1998, J PEDIATR-US, V132, P277, DOI 10.1016/S0022-3476(98)70445-7; Nakagawa M, 2000, J INFECT DIS, V182, P595, DOI 10.1086/315706; Nakagawa M, 1996, CLIN DIAGN LAB IMMUN, V3, P205, DOI 10.1128/CDLI.3.2.205-210.1996; NASH JD, 1987, OBSTET GYNECOL, V69, P160; NEVINS JR, 1992, SCIENCE, V258, P424; Roberts S, 1997, J VIROL, V71, P3554, DOI 10.1128/JVI.71.5.3554-3562.1997; ROSENFELD WD, 1989, AM J DIS CHILD, V143, P1443, DOI 10.1001/archpedi.1989.02150240065018; SCHACHTER J, 1982, JAMA-J AM MED ASSOC, V248, P2134, DOI 10.1001/jama.248.17.2134; SCHIFFMAN MH, 1987, CANCER RES, V47, P3886; Scott M, 1999, CLIN DIAGN LAB IMMUN, V6, P751, DOI 10.1128/CDLI.6.5.751-755.1999; Smith PJ, 1997, STAT MED, V16, P485, DOI 10.1002/(SICI)1097-0258(19970315)16:5&lt;485::AID-SIM422&gt;3.0.CO;2-#; STONE KM, 1995, EPIDEMIOLOGY, V6, P409, DOI 10.1097/00001648-199507000-00014; Svare EI, 1998, INT J CANCER, V75, P1, DOI 10.1002/(SICI)1097-0215(19980105)75:1&lt;1::AID-IJC1&gt;3.0.CO;2-1; SYRJANEN K, 1992, OBSTET GYNECOL, V79, P675; Tibbetts TA, 1999, BIOL REPROD, V60, P1158, DOI 10.1095/biolreprod60.5.1158; WERNESS BA, 1990, SCIENCE, V248, P76, DOI 10.1126/science.2157286; WINKELSTEIN W, 1984, AM J EPIDEMIOL, V119, P1	41	402	419	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 20	2001	285	23					2995	3002		10.1001/jama.285.23.2995	http://dx.doi.org/10.1001/jama.285.23.2995			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	442AR	11410098	Bronze			2022-12-24	WOS:000169263200022
J	Premawardhena, A; Fisher, CA; Fathiu, F; de Silva, S; Perera, W; Peto, TEA; Olivieri, NF; Weatherall, DJ				Premawardhena, A; Fisher, CA; Fathiu, F; de Silva, S; Perera, W; Peto, TEA; Olivieri, NF; Weatherall, DJ			Genetic determinants of jaundice and gallstones in haemoglobin E beta thalassaemia	LANCET			English	Article							UDP-GLUCURONOSYLTRANSFERASE-1	Chronic hyperbilirubinaemia, gallstone formation, and bladder disease are unusually common in people with haemoglobin E beta thalassaemia in Sri Lanka. To determine whether this has a genetic basis we compared the bilirubin levels and frequency of gallstones in patients with different alleles of the UGT*1 gene. There was a significantly higher bilirubin level in those with the 7/7 genotypes compared with 6/6 and 6/7 genotype (p=0.032 and 0.0015 respectively), who also appeared more prone to gallstone formation. These results suggest that the UGT*1 genotpe is of importance in the genesis of gallstones in this population of patients.	Univ Oxford, Weatherall Inst Mol Med, Oxford, England; Gen Hosp, Thalassaemia Unit, Kurunegala, Sri Lanka; Hosp Sick Children, Toronto, ON M5G 1X8, Canada; Toronto Gen Hosp, Toronto, ON, Canada	University of Oxford; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital	Weatherall, DJ (corresponding author), Univ Oxford, Weatherall Inst Mol Med, Oxford, England.		Premawardhena, Anuja/GLN-5388-2022; Olivieri, Nancy/AAI-2250-2020	Premawardhena, Anuja/0000-0003-0605-9081; 				Beutler E, 1998, P NATL ACAD SCI USA, V95, P8170, DOI 10.1073/pnas.95.14.8170; BOSMA PJ, 1995, NEW ENGL J MED, V333, P1171, DOI 10.1056/NEJM199511023331802; de Silva S, 2000, LANCET, V355, P786, DOI 10.1016/S0140-6736(99)08246-X; del Giudice EM, 1999, BLOOD, V94, P2259, DOI 10.1182/blood.V94.7.2259.419k42_2259_2262; Sampietro M, 1999, HAEMATOLOGICA, V84, P150	5	57	58	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 16	2001	357	9272					1945	1946		10.1016/S0140-6736(00)05082-0	http://dx.doi.org/10.1016/S0140-6736(00)05082-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	444YZ	11425418				2022-12-24	WOS:000169431000016
J	Zaslavskaia, LA; Lippmeier, JC; Shih, C; Ehrhardt, D; Grossman, AR; Apt, KE				Zaslavskaia, LA; Lippmeier, JC; Shih, C; Ehrhardt, D; Grossman, AR; Apt, KE			Trophic obligate conversion of an photoautotrophic organism through metabolic engineering	SCIENCE			English	Article							SELECTABLE MARKER; TRANSFORMATION; REPORTER; OCEANOGRAPHY; MICROALGAE; CHLORELLA; GLUCOSE; GLUT1; IRON	Most microalgae are obligate photoautotrophs and their growth is strictly dependent on the generation of photosynthetically derived energy. We show that the microalga Phaeodactylum tricornutum can be genetically engineered to thrive on exogenous glucose in the absence of light through the introduction of a gene encoding a glucose transporter (glut1 or hup1). This demonstrates that a fundamental change in the metabolism of an organism can be accomplished through the introduction of a single gene. This also represents progress toward the use of fermentation technology for large-scale commercial exploitation of algae by reducing limitations associated with light-dependent growth.	Martek Biosci Corp, Columbia, MD 21045 USA; Carnegie Inst Sci, Dept Plant Biol, Stanford, CA 94305 USA	Carnegie Institution for Science	Apt, KE (corresponding author), Martek Biosci Corp, 6480 Dobbin Rd, Columbia, MD 21045 USA.	kirkapt@martekbio.com		Lippmeier, J./0000-0002-8157-1491				Apt KE, 1999, J PHYCOL, V35, P215, DOI 10.1046/j.1529-8817.1999.3520215.x; Apt KE, 1996, MOL GEN GENET, V252, P572, DOI 10.1007/s004380050264; ASANO T, 1991, J BIOL CHEM, V266, P24632; Borowitzka MA, 1999, J BIOTECHNOL, V70, P313, DOI 10.1016/S0168-1656(99)00083-8; Boyle E, 1998, NATURE, V393, P733, DOI 10.1038/31585; Chen F, 1996, TRENDS BIOTECHNOL, V14, P421, DOI 10.1016/0167-7799(96)10060-3; Chisholm SW, 2000, NATURE, V407, P685, DOI 10.1038/35037696; Chiu WL, 1996, CURR BIOL, V6, P325, DOI 10.1016/S0960-9822(02)00483-9; COOKSEY KE, 1974, J PHYCOL, V10, P253, DOI 10.1111/j.0022-3646.1974.00253.x; Droop M.R., 1974, ALGAL PHYSL BIOCH, P530; Falciatore A, 1999, MAR BIOTECHNOL, V1, P239, DOI 10.1007/PL00011773; Fischer H, 1999, J PHYCOL, V35, P113, DOI 10.1046/j.1529-8817.1999.3510113.x; Hallmann A, 1996, P NATL ACAD SCI USA, V93, P669, DOI 10.1073/pnas.93.2.669; Haseloff J, 1997, P NATL ACAD SCI USA, V94, P2122, DOI 10.1073/pnas.94.6.2122; Hellebust J.A., 1977, BIOL DIATOMS, V13, P169; Kruckeberg AL, 1996, ARCH MICROBIOL, V166, P283, DOI 10.1007/s002030050385; Landry MR, 2000, MAR ECOL PROG SER, V201, P57, DOI 10.3354/meps201057; Lu LL, 1997, J CHROMATOGR A, V776, P81, DOI 10.1016/S0021-9673(97)00151-9; Mueckler M, 1997, BIOCHEM SOC T, V25, P951, DOI 10.1042/bst0250951; RADMER RJ, 1994, J APPL PHYCOL, V6, P93, DOI 10.1007/BF02186062; Raven JA, 1999, PLANT CELL ENVIRON, V22, P741, DOI 10.1046/j.1365-3040.1999.00419.x; ROESSLER PG, 1987, J PHYCOL, V23, P494, DOI 10.1111/j.1529-8817.1987.tb02536.x; RUNNING JA, 1994, J APPL PHYCOL, V6, P99, DOI 10.1007/BF02186063; SAUER N, 1989, FEBS LETT, V259, P43, DOI 10.1016/0014-5793(89)81489-9; Takeda S, 1998, NATURE, V393, P774, DOI 10.1038/31674; TREGUER P, 1995, SCIENCE, V268, P375, DOI 10.1126/science.268.5209.375; Zaslavskaia LA, 2000, J PHYCOL, V36, P379, DOI 10.1046/j.1529-8817.2000.99164.x; ZASLAVSKAIA LA, UNPUB	28	212	260	3	100	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 15	2001	292	5524					2073	2075		10.1126/science.160015	http://dx.doi.org/10.1126/science.160015			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442KP	11408656				2022-12-24	WOS:000169284700046
J	Dubois, L; Lecourtois, M; Alexandre, C; Hirst, E; Vincent, JP				Dubois, L; Lecourtois, M; Alexandre, C; Hirst, E; Vincent, JP			Regulated endocytic routing modulates wingless signaling in Drosophila embryos	CELL			English	Article							PROTEIN-COUPLED RECEPTORS; EGF RECEPTOR; GRADIENT FORMATION; SPEMANN ORGANIZER; HORSERADISH-PEROXIDASE; MORPHOGEN GRADIENT; VENTRAL ECTODERM; TYROSINE KINASE; CELL-SURFACE; EPIDERMIS	Embryos have evolved various strategies to confine the action of secreted signals. Using an HRP-Wingless fusion protein to track the fate of endocytosed Wingless, we show that degradation by targeting to lysosomes is one such strategy. Wingless protein is specifically degraded at the posterior of each stripe of wingless transcription, even under conditions of over-expression. If lysosomal degradation is compromised genetically or chemically, excess Wingless accumulates and ectopic signaling ensues. In the wild-type, Wingless degradation is slower at the anterior than at the posterior. This follows in part from the segmental activation of signaling by the epidermal growth factor receptor, which accelerates Wingless degradation at the posterior, thus leading to asymmetrical Wingless signaling along the anterior-posterior axis.	Natl Inst Med Res, London NW7 1AA, England	MRC National Institute for Medical Research	Vincent, JP (corresponding author), Natl Inst Med Res, Mill Hill, London NW7 1AA, England.		LECOURTOIS, Magalie/AAL-2531-2020	LECOURTOIS, Magalie/0000-0002-4257-1974				Alexandre C, 1999, DEVELOPMENT, V126, P5689; ARIAS AM, 1993, DEV DROSOPHILA MELAN, P517; ASTROMOFF A, 1995, P NATL ACAD SCI USA, V92, P8110, DOI 10.1073/pnas.92.18.8110; BAZINET C, 1993, GENETICS, V134, P1119; BEJSOVEC A, 1995, GENETICS, V139, P309; BEJSOVEC A, 1991, DEVELOPMENT, V113, P471; Bergeron JJM, 1995, BIOSCIENCE REP, V15, P411, DOI 10.1007/BF01204345; Bohm SK, 1997, BIOCHEM J, V322, P1; Cadigan KM, 1998, CELL, V93, P767, DOI 10.1016/S0092-8674(00)81438-5; Carpenter G, 2000, BIOESSAYS, V22, P697, DOI 10.1002/1521-1878(200008)22:8<697::AID-BIES3>3.3.CO;2-T; Ceresa BP, 2000, CURR OPIN CELL BIOL, V12, P204, DOI 10.1016/S0955-0674(99)00077-0; CLIFFORD R, 1992, DEVELOPMENT, V115, P853; CONNOLLY CN, 1994, J CELL BIOL, V127, P641, DOI 10.1083/jcb.127.3.641; Denef N, 2000, CELL, V102, P521, DOI 10.1016/S0092-8674(00)00056-8; Dickinson WJ, 1997, CELL MOTIL CYTOSKEL, V38, P9; Entchev EV, 2000, CELL, V103, P981, DOI 10.1016/S0092-8674(00)00200-2; Freeman M, 2000, NATURE, V408, P313, DOI 10.1038/35042500; Gabay L, 1996, DEVELOPMENT, V122, P3355; GONZALEZ F, 1991, MECH DEVELOP, V35, P43, DOI 10.1016/0925-4773(91)90040-D; Incardona JP, 2000, P NATL ACAD SCI USA, V97, P12044, DOI 10.1073/pnas.220251997; Kirchhausen T, 1999, ANNU REV CELL DEV BI, V15, P705, DOI 10.1146/annurev.cellbio.15.1.705; Kurz DJ, 2000, J CELL SCI, V113, P3613; Lawrence PA, 1996, DEVELOPMENT, V122, P4095; LECOURTOIS M, 2001, IN PRESS DEV BIOL; Levkowitz G, 1999, MOL CELL, V4, P1029, DOI 10.1016/S1097-2765(00)80231-2; Leyns L, 1997, CELL, V88, P747, DOI 10.1016/S0092-8674(00)81921-2; Lin XH, 1999, NATURE, V400, P281, DOI 10.1038/22343; Moline MM, 1999, DEVELOPMENT, V126, P4375; Payre F, 1999, NATURE, V400, P271, DOI 10.1038/22330; Pfeiffer S, 2000, CURR BIOL, V10, P321, DOI 10.1016/S0960-9822(00)00381-X; REINKE R, 1988, CELL, V55, P321, DOI 10.1016/0092-8674(88)90055-4; Sanson B, 1996, NATURE, V383, P627, DOI 10.1038/383627a0; Sanson B, 1999, CELL, V98, P207, DOI 10.1016/S0092-8674(00)81015-6; SCHWEITZER R, 1995, NATURE, V376, P699, DOI 10.1038/376699a0; SCHWEITZER R, 1995, GENE DEV, V9, P1518, DOI 10.1101/gad.9.12.1518; Sevrioukov EA, 1999, MOL CELL, V4, P479, DOI 10.1016/S1097-2765(00)80199-9; Strigini M, 2000, CURR BIOL, V10, P293, DOI 10.1016/S0960-9822(00)00378-X; Sunio A, 1999, MOL BIOL CELL, V10, P847, DOI 10.1091/mbc.10.4.847; Teleman AA, 2000, CELL, V103, P971, DOI 10.1016/S0092-8674(00)00199-9; Tsao P, 2000, CURR OPIN NEUROBIOL, V10, P365, DOI 10.1016/S0959-4388(00)00096-9; Tsuda M, 1999, NATURE, V400, P276, DOI 10.1038/22336; VANDENHEUVEL M, 1989, CELL, V59, P739, DOI 10.1016/0092-8674(89)90020-2; VANVACTOR DL, 1991, CELL, V67, P1145, DOI 10.1016/0092-8674(91)90291-6; VINCENT JP, 1992, CELL, V68, P923, DOI 10.1016/0092-8674(92)90035-B; Wang SW, 1997, CELL, V88, P757, DOI 10.1016/S0092-8674(00)81922-4; Wasserman JD, 2000, GENE DEV, V14, P1651; Wasylyk C, 1997, ONCOGENE, V14, P899, DOI 10.1038/sj.onc.1200914; Zecca M, 1996, CELL, V87, P833, DOI 10.1016/S0092-8674(00)81991-1; Zhang J, 1998, DEVELOPMENT, V125, P3075; Zimmerman LB, 1996, CELL, V86, P599, DOI 10.1016/S0092-8674(00)80133-6	50	175	175	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 1	2001	105	5					613	624		10.1016/S0092-8674(01)00375-0	http://dx.doi.org/10.1016/S0092-8674(01)00375-0			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	439NL	11389831	Bronze			2022-12-24	WOS:000169123200008
J	Guenin, LM				Guenin, LM			Essays on science and society - Morals and primordials	SCIENCE			English	Editorial Material									Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Guenin, LM (corresponding author), Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA.								0	17	17	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 1	2001	292	5522					1659	1660		10.1126/science.1062513	http://dx.doi.org/10.1126/science.1062513			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	438AP	11387460				2022-12-24	WOS:000169031800024
J	Hugot, JP; Chamaillard, M; Zouali, H; Lesage, S; Cezard, JP; Belaiche, J; Almer, S; Tysk, C; O'Morain, CA; Gassull, M; Binder, V; Finkel, Y; Cortot, A; Modigliani, R; Laurent-Puig, P; Gower-Rousseau, C; Macry, J; Colombel, JF; Sahbatou, M; Thomas, G				Hugot, JP; Chamaillard, M; Zouali, H; Lesage, S; Cezard, JP; Belaiche, J; Almer, S; Tysk, C; O'Morain, CA; Gassull, M; Binder, V; Finkel, Y; Cortot, A; Modigliani, R; Laurent-Puig, P; Gower-Rousseau, C; Macry, J; Colombel, JF; Sahbatou, M; Thomas, G			Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease	NATURE			English	Article							INFLAMMATORY-BOWEL-DISEASE; FACTOR-KAPPA-B; COMPLEX SEGREGATION ANALYSIS; LINKAGE DISEQUILIBRIUM; GENE; ACTIVATION; FAMILIES; C3H/HEJ; SEARCH; MICE	Crohn's disease(1,2) and ulcerative colitis, the two main types of chronic inflammatory bowel disease, are multifactorial conditions of unknown aetiology. A susceptibility locus for Crohn's disease has been mapped(3) to chromosome 16. Here we have used a positional-cloning strategy, based on linkage analysis followed by linkage disequilibrium mapping, to identify three independent associations for Crohn's disease: a frameshift variant and two missense variants of NOD2, encoding a member of the Apaf-1/Ced-4 superfamily of apoptosis regulators that is expressed in monocytes. These NOD2 variants alter the structure of either the leucine-rich repeat domain of the protein or the adjacent region. NOD2 activates nuclear factor NF-kB; this activating function is regulated by the carboxy-terminal leucine-rich repeat domain, which has an inhibitory role and also acts as an intracellular receptor for components of microbial pathogens. These observations suggest that the NOD2 gene product confers susceptibility to Crohn's disease by altering the recognition of these components and/or by over-activating NF-kB in monocytes, thus documenting a molecular model for the pathogenic mechanism of Crohn's disease that can now be further investigated.	Fdn Jean Dausset CEPH, F-75010 Paris, France; Hop Robert Debre, Dept Pediat Gastroenterol, PEWG IBD, F-75019 Paris, France; CHU Liege, GETAID, B-4000 Liege, Belgium; CHU Liege, Dept Gastroenterol, B-4000 Liege, Belgium; Linkoping Univ, IHM, Div Gastroenterol & Hepatol, SE-58185 Linkoping, Sweden; Orebro Med Ctr Hosp, Dept Gastroenterol, SE-70185 Orebro, Sweden; Adelaide & Meath Hosp, Dept Gastroenterol, Dublin 24, Ireland; Hosp Badalona Germans Trias & Pujol, Dept Gastroenterol, Badalona 08916, Spain; Herlev Hosp, Dept Gastroenterol, DK-2730 Herlev, Denmark; Astrid Lindgren Childrens Hosp, SE-16176 Stockholm, Sweden; Hop Calmette, Registre EPIMAD, F-59037 Lille, France; Hop St Louis, Dept Gastroenterol, F-75475 Paris, France; Hop Robert Debre, INSERM, U458, F-75019 Paris, France; Hop St Antoine, Dept Surg, F-75012 Paris, France	Foundation Jean Dausset-CEPH; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Liege; University of Liege; Linkoping University; Trinity College Dublin; Hospital Germans Trias i Pujol; University of Copenhagen; Herlev & Gentofte Hospital; Universite de Lille - ISITE; CHU Lille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite	Thomas, G (corresponding author), Fdn Jean Dausset CEPH, 27 Rue J Dodu, F-75010 Paris, France.	thomas@cephb.fr	Chamaillard, Mathias/L-6542-2013; Hugot, Jean-Pierre/F-6594-2012; Laurent-Puig, Pierre/K-3641-2019; CORTOT, ANTOINE/I-7739-2016; Gower-Rousseau, Corinne/I-2553-2018; laurent-puig, pierre/B-2226-2013; CORTOT, Antoine/I-5796-2015	Chamaillard, Mathias/0000-0002-0243-9717; Laurent-Puig, Pierre/0000-0001-8475-5459; CORTOT, ANTOINE/0000-0002-1067-8996; Gower-Rousseau, Corinne/0000-0002-3925-5364; laurent-puig, pierre/0000-0001-8475-5459; Almer, Sven/0000-0001-9334-1821; Hugot, Jean-Pierre/0000-0002-8446-6056				AUPHAN N, 1995, SCIENCE, V270, P286, DOI 10.1126/science.270.5234.286; Bertin J, 1999, J BIOL CHEM, V274, P12955, DOI 10.1074/jbc.274.19.12955; Calkins BM, 1995, INFLAMM BOWEL DIS, P31; Cavanaugh J, 2001, AM J HUM GENET, V68, P1165, DOI 10.1086/320119; Cho JH, 2000, HUM MOL GENET, V9, P1425, DOI 10.1093/hmg/9.9.1425; Colombel JF, 1996, GASTROENTEROLOGY, V111, P604, DOI 10.1053/gast.1996.v111.pm8780563; Duerr RH, 2000, AM J HUM GENET, V66, P1857, DOI 10.1086/302947; Hampe J, 1999, AM J HUM GENET, V65, P1647, DOI 10.1086/302677; Hugot JP, 1999, INT J COLORECTAL DIS, V14, P2, DOI 10.1007/s003840050175; Hugot JP, 1999, GASTROENTEROLOGY, V116, pA740; Hugot JP, 1996, NATURE, V379, P821, DOI 10.1038/379821a0; Inohara N, 2000, J BIOL CHEM, V275, P27823; Inohara N, 1999, J BIOL CHEM, V274, P14560, DOI 10.1074/jbc.274.21.14560; Inohara N, 2001, J BIOL CHEM, V276, P2551, DOI 10.1074/jbc.M009728200; KUSTER W, 1989, AM J MED GENET, V32, P105, DOI 10.1002/ajmg.1320320122; LENNARDJONES JE, 1989, SCAND J GASTROENTERO, V24, P2, DOI 10.3109/00365528909091339; Martin ER, 2000, AM J HUM GENET, V67, P146, DOI 10.1086/302957; McKay DM, 1999, CAN J GASTROENTEROL, V13, P509, DOI 10.1155/1999/680206; MONSEN U, 1990, ACTA CHIR SCAND    S, V559, P7; Ogura Y, 2001, J BIOL CHEM, V276, P4812, DOI 10.1074/jbc.M008072200; Olavesen MG, 2000, IMMUNOGENETICS, V51, P1, DOI 10.1007/s002510050001; ORHOLM M, 1993, BRIT MED J, V306, P20, DOI 10.1136/bmj.306.6869.20; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Rioux JD, 2000, AM J HUM GENET, V66, P1863, DOI 10.1086/302913; Satsangi J, 1996, NAT GENET, V14, P199, DOI 10.1038/ng1096-199; Schreiber S, 1998, GUT, V42, P477, DOI 10.1136/gut.42.4.477; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; SUNDBERG JP, 1994, GASTROENTEROLOGY, V107, P1726, DOI 10.1016/0016-5085(94)90813-3; Wahl C, 1998, J CLIN INVEST, V101, P1163, DOI 10.1172/JCI992; ZOUALI H, UNPUB EUR J HUM GENE	30	4219	4382	11	257	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 31	2001	411	6837					599	603		10.1038/35079107	http://dx.doi.org/10.1038/35079107			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437GE	11385576				2022-12-24	WOS:000168982500055
J	Elkayam, U; Tummala, PP; Rao, K; Akhter, MW; Karaalp, IS; Wani, OR; Hameed, A; Gviazda, I; Shotan, A				Elkayam, U; Tummala, PP; Rao, K; Akhter, MW; Karaalp, IS; Wani, OR; Hameed, A; Gviazda, I; Shotan, A			Maternal and fetal outcomes of subsequent pregnancies in women with peripartum cardiomyopathy.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LEFT-VENTRICULAR FUNCTION	Background: Peripartum cardiomyopathy is a rare but sometimes fatal form of heart failure. Little is known about the outcomes of subsequent pregnancies in women who have had the disorder. Methods: Through a survey of members of the American College of Cardiology, we identified 44 women who had had peripartum cardiomyopathy and had a total of 60 subsequent pregnancies. We then reviewed the medical records of these women and interviewed the women or their physicians. Results: Among the first subsequent pregnancies in the 44 women, 28 occurred in women in whom left ventricular function had returned to normal (group 1) and 16 occurred in women with persistent left ventricular dysfunction (group 2). The pregnancies were associated with a reduction in the mean (+/-SD) left ventricular ejection fraction both in the total cohort (from 49+/-12 percent to 42+/-13 percent, P<0.001) and in each group separately (from 56+/-7 percent to 49+/-10 percent in group 1, P=0.002; and from 36+/-9 percent to 32+/-11 percent in group 2, P=0.08). During these pregnancies, symptoms of heart failure occurred in 21 percent of the women in group 1 and 44 percent of those in group 2. The mortality rate was 0 percent in group 1 and 19 percent in group 2 (P=0.06). In addition, the frequency of premature delivery was higher in group 2 (37 percent vs. 11 percent), as was that of therapeutic abortions (25 percent vs. 4 percent). Conclusions: Subsequent pregnancy in women with a history of peripartum cardiomyopathy is associated with a significant decrease in left ventricular function and can result in clinical deterioration and even death. (N Engl J Med 2001;344:1567-71.) Copyright (C) 2001 Massachusetts Medical Society.	Univ So Calif, Sch Med, LAC USC Med Ctr, Dept Med,Div Cardiol,Sect Heart Failure, Los Angeles, CA 90033 USA; Univ So Calif, Sch Med, Dept Obstet & Gynecol, Los Angeles, CA 90033 USA	Los Angeles County+USC Medical Center; University of Southern California; University of Southern California	Elkayam, U (corresponding author), Univ So Calif, Sch Med, LAC USC Med Ctr, Dept Med,Div Cardiol,Sect Heart Failure, 2025 Zonal Ave,Rm 7621, Los Angeles, CA 90033 USA.		Wan Ahmad, Wan Azman/B-9879-2012					Ceci O, 1998, EUR J OBSTET GYN R B, V76, P29, DOI 10.1016/S0301-2115(97)00148-6; DEMAKIS JG, 1971, CIRCULATION, V44, P1053, DOI 10.1161/01.CIR.44.6.1053; ELKAYAM U, 1992, HEART DIS TXB CARDIO, P1790; FEIGENBAUM H, 1994, ECHOCARDIOGR-J CARD, P658; Felker GM, 2000, NEW ENGL J MED, V342, P1077, DOI 10.1056/NEJM200004133421502; Geva T, 1997, AM HEART J, V133, P53, DOI 10.1016/S0002-8703(97)70247-3; Heider A L, 1999, Obstet Gynecol Surv, V54, P526, DOI 10.1097/00006254-199908000-00023; Lampert MB, 1997, AM J OBSTET GYNECOL, V176, P189, DOI 10.1016/S0002-9378(97)80034-8; Lang R., 1998, CARDIAC PROBLEMS PRE, V3e, P87; OSTRZEGA E, 1995, CIRCULATION S1, V92, P333; Pearson GD, 2000, JAMA-J AM MED ASSOC, V283, P1183, DOI 10.1001/jama.283.9.1183; SUTTON MS, 1991, AM HEART J, V121, P1776; Witlin AG, 1997, AM J OBSTET GYNECOL, V176, P182, DOI 10.1016/S0002-9378(97)80033-6	13	272	284	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 24	2001	344	21					1567	1571		10.1056/NEJM200105243442101	http://dx.doi.org/10.1056/NEJM200105243442101			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	434RM	11372007				2022-12-24	WOS:000168829700001
J	Hopfner, KP; Karcher, A; Craig, L; Woo, TT; Carney, JP; Tainer, JA				Hopfner, KP; Karcher, A; Craig, L; Woo, TT; Carney, JP; Tainer, JA			Structural biochemistry and interaction architecture of the DNA double-strand break repair Mre11 nuclease and Rad50-ATPase	CELL			English	Article							CRYSTAL-STRUCTURE; CHROMOSOMES SMC; PROTEIN COMPLEX; RAD50; RECOMBINATION; MAINTENANCE; YEAST; MISMATCH; MUTANTS; BINDING	To clarify functions of the Mre11/Rad50 (MR) complex in DNA double-strand break repair, we report Pyrococcus furiosus Mre11 crystal structures, revealing a protein phosphatase-like, dimanganese binding domain capped by a unique domain controlling active site access. These structures unify Mre11's multiple nuclease activities in a single endo/exonuclease mechanism and reveal eukaryotic macromolecular interaction sites by mapping human and yeast Mre11 mutations. Furthermore, the structure of the P. furiosus Rad50 ABC-ATPase with its adjacent coiled-coil defines a compact Mre11/Rad50-ATPase complex and suggests that Rad50-ATP-driven conformational switching directly controls the Mre11 exonuclease. Electron microscopy, small angle X-ray scattering, and ultracentrifugation data of human and P. furiosus MR reveal a dual functional complex consisting of a (Mre11)(2)/(Rad50)(2) heterotetrameric DNA processing head and a double coiled-coil linker.	Scripps Res Inst, Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA; Univ Maryland, Sch Med, Marlene & Stewart Greenebaum Canc Ctr, Dept Radiat Oncol,Radiat Oncol Res Lab, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Mol & Cell Biol Grad Program, Baltimore, MD 21201 USA	Scripps Research Institute; Scripps Research Institute; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Tainer, JA (corresponding author), Scripps Res Inst, Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA.	jat@scripps.edu	Tainer, John/GWQ-4878-2022; Hopfner, Karl-Peter/B-6864-2014	Tainer, John/0000-0003-1659-2429; Hopfner, Karl-Peter/0000-0002-4528-8357; Craig, Lisa/0000-0001-8515-9915				ALANI E, 1990, CELL, V61, P419, DOI 10.1016/0092-8674(90)90524-I; Aravind L, 1999, NUCLEIC ACIDS RES, V27, P1223, DOI 10.1093/nar/27.5.1223; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bierne H, 1997, EMBO J, V16, P3332, DOI 10.1093/emboj/16.11.3332; Bressan DA, 1998, GENETICS, V150, P591; Bressan DA, 1999, MOL CELL BIOL, V19, P7681; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carney JP, 1998, CELL, V93, P477, DOI 10.1016/S0092-8674(00)81175-7; Chamankhah M, 2000, GENETICS, V155, P569; Connelly JC, 1997, J BIOL CHEM, V272, P19819, DOI 10.1074/jbc.272.32.19819; Connelly JC, 1998, P NATL ACAD SCI USA, V95, P7969, DOI 10.1073/pnas.95.14.7969; de Jager M, 2001, NUCLEIC ACIDS RES, V29, P1317, DOI 10.1093/nar/29.6.1317; Dolganov GM, 1996, MOL CELL BIOL, V16, P4832; Fishel R, 1997, CURR OPIN GENET DEV, V7, P105, DOI 10.1016/S0959-437X(97)80117-7; Furuse M, 1998, EMBO J, V17, P6412, DOI 10.1093/emboj/17.21.6412; GAME JC, 1993, SEMIN CANCER BIOL, V4, P73; Gellert M, 1997, ADV IMMUNOL, V64, P39, DOI 10.1016/S0065-2776(08)60886-X; GLUSKER JP, 1991, ADV PROTEIN CHEM, V42, P1; GRIFFITH JP, 1995, CELL, V82, P507, DOI 10.1016/0092-8674(95)90439-5; Haber JE, 1998, CELL, V95, P583, DOI 10.1016/S0092-8674(00)81626-8; Holland IB, 1999, J MOL BIOL, V293, P381, DOI 10.1006/jmbi.1999.2993; Hopfner KP, 2000, J BACTERIOL, V182, P6036, DOI 10.1128/JB.182.21.6036-6041.2000; Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9; Hung LW, 1998, NATURE, V396, P703, DOI 10.1038/25393; JOHZUKA K, 1995, GENETICS, V139, P1521; KADYK LC, 1992, GENETICS, V132, P387; Kolodner RD, 1999, CURR OPIN GENET DEV, V9, P89, DOI 10.1016/S0959-437X(99)80013-6; Lam WC, 1999, BIOCHEMISTRY-US, V38, P2661, DOI 10.1021/bi9820762; Lamers MH, 2000, NATURE, V407, P711, DOI 10.1038/35037523; LEACH DRF, 1996, GENETIC RECOMBINATIO; Luo GB, 1999, P NATL ACAD SCI USA, V96, P7376, DOI 10.1073/pnas.96.13.7376; Melby TE, 1998, J CELL BIOL, V142, P1595, DOI 10.1083/jcb.142.6.1595; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Michel B, 1997, EMBO J, V16, P430, DOI 10.1093/emboj/16.2.430; Mol CD, 2000, NATURE, V403, P451, DOI 10.1038/35000249; Nairz K, 1997, GENE DEV, V11, P2272, DOI 10.1101/gad.11.17.2272; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Obmolova G, 2000, NATURE, V407, P703, DOI 10.1038/35037509; OTWINOWSKI Z, 1993, DATA COLLECTION PROC; Paull TT, 1999, GENE DEV, V13, P1276, DOI 10.1101/gad.13.10.1276; Paull TT, 1998, MOL CELL, V1, P969, DOI 10.1016/S1097-2765(00)80097-0; Paull TT, 2000, P NATL ACAD SCI USA, V97, P6409, DOI 10.1073/pnas.110144297; Petrini J H, 1997, Semin Immunol, V9, P181, DOI 10.1006/smim.1997.0067; PHILLIPS JW, 1994, MOL CELL BIOL, V14, P5794, DOI 10.1128/MCB.14.9.5794; RAYMOND WE, 1993, NUCLEIC ACIDS RES, V21, P3851, DOI 10.1093/nar/21.16.3851; Roberts VA, 1999, J BIOL CHEM, V274, P38051, DOI 10.1074/jbc.274.53.38051; Roth D., 1988, GENETIC RECOMBINATIO, P621; RUSNACK F, 2000, METAL IONS BIOL SYST; Stewart GS, 1999, CELL, V99, P577, DOI 10.1016/S0092-8674(00)81547-0; SUN H, 1991, CELL, V64, P1155, DOI 10.1016/0092-8674(91)90270-9; SUN H, 1989, NATURE, V338, P87, DOI 10.1038/338087a0; SVERGUN DI, 1993, J APPL CRYSTALLOGR, V26, P258, DOI 10.1107/S0021889892011828; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Trujillo KM, 1998, J BIOL CHEM, V273, P21447, DOI 10.1074/jbc.273.34.21447; Tsubouchi H, 1998, MOL CELL BIOL, V18, P260, DOI 10.1128/MCB.18.1.260; Tsubouchi H, 2000, MOL BIOL CELL, V11, P2221, DOI 10.1091/mbc.11.7.2221; TURK D, 1992, THESIS TU MUNCHEN; Usui T, 1998, CELL, V95, P705, DOI 10.1016/S0092-8674(00)81640-2; Varon R, 1998, CELL, V93, P467, DOI 10.1016/S0092-8674(00)81174-5; WARD JF, 1988, PROG NUCLEIC ACID RE, V35, P95, DOI 10.1016/S0079-6603(08)60611-X; Yamaguchi-Iwai Y, 1999, EMBO J, V18, P6619, DOI 10.1093/emboj/18.23.6619; Zdzienicka MZ, 1996, CANCER SURV, V28, P281	63	392	406	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 18	2001	105	4					473	485		10.1016/S0092-8674(01)00335-X	http://dx.doi.org/10.1016/S0092-8674(01)00335-X			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	434XG	11371344	Bronze			2022-12-24	WOS:000168840700007
J	Narod, SA; Sun, P; Ghadirian, P; Lynch, H; Isaacs, C; Garber, J; Weber, B; Karlan, B; Fishman, D; Rosen, B; Tung, N; Neuhausen, SL				Narod, SA; Sun, P; Ghadirian, P; Lynch, H; Isaacs, C; Garber, J; Weber, B; Karlan, B; Fishman, D; Rosen, B; Tung, N; Neuhausen, SL		Hereditary Ovarian Canc Clinical	Tubal ligation and risk of ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control study	LANCET			English	Article							BREAST-CANCER; WOMEN; HYSTERECTOMY	Background In several case-control and prospective studies, tubal ligation has been associated with a decreased risk of invasive epithelial ovarian cancer. We aimed to assess the potential of tubal ligation in reducing the risk of ovarian cancer in women who carry predisposing mutations in the BRCA1 or BRCA2 genes. Methods We did a matched case-control study among women from Canada, the USA, and the UK who had undergone genetic testing and who carried a pathogenic mutation in BRCA1 or BRCA2. Cases were 232 women with a history of invasive ovarian cancer, and controls were 232 women without ovarian cancer, and who had both ovaries intact. Cases and controls were matched for year of birth, country of residence, and mutation (BRCA1 or BRCA2). The odds ratio for developing ovarian cancer was estimated for tubal ligation, adjusting for oral contraceptive use, parity, history of breast cancer, and ethnic group. Findings In an unadjusted analysis among BRCA1 carriers, significantly fewer cases than controls had ever had tubal ligation (30 of 173 [18%] vs 60 of 173 [35%], odds ratio 0.37 [95% CI 0.21-0.63]; p=0.0003). After adjustment for oral contraceptive use, parity, history of breast cancer and ethnic group, the odds ratio was 0.39 (p=0.002). Combination of tubal ligation and past use of an oral contraceptive was associated with an odds ratio of 0.28 (0.15-0.52). No protective effect of tubal ligation was seen among carriers of the BRCA2 mutation. Interpretation Tubal ligation is a feasible option to reduce the risk of ovarian cancer in women with BRCA1 mutations who have completed childbearing.	Univ Toronto, Ctr Res Womens Hlth, Toronto, ON M5G 1N8, Canada; Hotel Dieu, CHUM, Epidemiol Res Unit, Montreal, PQ, Canada; Creighton Univ, Sch Med, Dept Prevent Med & Publ Hlth, Omaha, NE USA; Georgetown Univ, Med Ctr, Lombardi Canc Ctr, Washington, DC 20007 USA; Dana Farber Canc Ctr, Boston, MA USA; Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA; Northwestern Univ, Chicago, IL 60611 USA; Univ Hlth Network, Dept Obstet & Gynecol, Toronto, ON, Canada; Beth Israel Deaconess Hosp, Boston, MA USA; Univ Utah, Dept Med Informat, Salt Lake City, UT 84112 USA	University of Toronto; Laval University; Universite de Montreal; Creighton University; Georgetown University; Harvard University; Dana-Farber Cancer Institute; University of Pennsylvania; Pennsylvania Medicine; Cedars Sinai Medical Center; Northwestern University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Harvard University; Beth Israel Deaconess Medical Center; Utah System of Higher Education; University of Utah	Narod, SA (corresponding author), Univ Toronto, Ctr Res Womens Hlth, 790 Bay St,Room 750, Toronto, ON M5G 1N8, Canada.		Narod, Steven A/AAA-6112-2022		NCI NIH HHS [CA74415, CA61231, CA 63678, CA 57601, 1RO1 CA 63682, N01-CN-67000] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA063678, R01CA061231, R01CA063682, R01CA057601, R01CA074415] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Brinton LA, 2000, BRIT J CANCER, V82, P1600; Brinton LA, 1997, AM J OBSTET GYNECOL, V176, P572, DOI 10.1016/S0002-9378(97)70550-7; Burke W, 1997, JAMA-J AM MED ASSOC, V277, P997, DOI 10.1001/jama.277.12.997; Cramer DW, 1998, FERTIL STERIL, V70, P371, DOI 10.1016/S0015-0282(98)00153-8; Cramer DW, 1998, LANCET, V351, P104, DOI 10.1016/S0140-6736(97)08064-1; Ford D, 1998, AM J HUM GENET, V62, P676, DOI 10.1086/301749; FORD D, 1994, LANCET, V343, P692, DOI 10.1016/S0140-6736(94)91578-4; Gertig DM, 2000, J NATL CANCER I, V92, P249, DOI 10.1093/jnci/92.3.249; Green A, 1997, AUST NZ J PUBL HEAL, V21, P337, DOI 10.1111/j.1467-842X.1997.tb01710.x; HANKINSON SE, 1993, JAMA-J AM MED ASSOC, V270, P2813, DOI 10.1001/jama.270.23.2813; Jacobs IJ, 1999, LANCET, V353, P1207, DOI 10.1016/S0140-6736(98)10261-1; Moslehi R, 2000, AM J HUM GENET, V66, P1259, DOI 10.1086/302853; Narod SA, 1998, NEW ENGL J MED, V339, P424, DOI 10.1056/NEJM199808133390702; Ness RB, 1999, JNCI-J NATL CANCER I, V91, P1459, DOI 10.1093/jnci/91.17.1459; Peterson HB, 2000, NEW ENGL J MED, V343, P1681, DOI 10.1056/NEJM200012073432303; RILMAN T, 1998, CLIN ENDOCRINOL, V49, P695; RISCH HA, 1995, CANCER EPIDEM BIOMAR, V4, P447; Risch HA, 2001, AM J HUM GENET, V68, P700, DOI 10.1086/318787; Rosenblatt KA, 1996, CANCER EPIDEM BIOMAR, V5, P933; Thompson D, 2001, AM J HUM GENET, V68, P410, DOI 10.1086/318181; WHITTEMORE AS, 1992, AM J EPIDEMIOL, V136, P1184, DOI 10.1093/oxfordjournals.aje.a116427	21	138	146	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 12	2001	357	9267					1467	1470		10.1016/S0140-6736(00)04642-0	http://dx.doi.org/10.1016/S0140-6736(00)04642-0			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	431CL	11377596				2022-12-24	WOS:000168614300008
J	Hoerauf, A; Mand, S; Adjei, O; Fleischer, B; Buttner, DW				Hoerauf, A; Mand, S; Adjei, O; Fleischer, B; Buttner, DW			Depletion of wolbachia endobacteria in Onchocerca volvulus by doxycycline and microfilaridermia after ivermectin treatment	LANCET			English	Article							CHEMOTHERAPY	Ivermectin is the drug used for mass chemotherapy of onchocerciasis within the WHO African Programme for Onchocerciasis Control. This approach aims to eliminate the disease as a public health problem but using one dose per year may not completely interrupt transmission since it does not suppress microfilaridermia thoroughly enough. Here we show that additional treatment with doxycycline, previously shown to sterilise adult female worms for a few months by depletion of symbiotic wolbachia endobacteria, significantly enhances ivermectin-induced suppression of microfilaridermia, rendering anti-wolbachia treatment a promising basis for blocking transmission by a drug-based approach.	Bernhard Nocht Inst Trop Med, D-20359 Hamburg, Germany; Univ Sci & Technol Kumasi, Kumasi, Ghana	Bernhard Nocht Institut fur Tropenmedizin; Kwame Nkrumah University Science & Technology	Hoerauf, A (corresponding author), Bernhard Nocht Inst Trop Med, Bernhard Nocht Str 74, D-20359 Hamburg, Germany.							Abiose A, 2000, LANCET, V356, P1523, DOI 10.1016/S0140-6736(05)73271-2; Awadzi K, 1995, TROP MED PARASITOL, V46, P213; Hoerauf A, 2000, LANCET, V355, P1242, DOI 10.1016/S0140-6736(00)02095-X; REMME J, 1986, B WORLD HEALTH ORGAN, V64, P667; Richards F, 2000, LANCET, V355, P1663, DOI 10.1016/S0140-6736(00)02235-2	5	183	189	0	15	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 5	2001	357	9266					1415	1416		10.1016/S0140-6736(00)04581-5	http://dx.doi.org/10.1016/S0140-6736(00)04581-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	428TW	11356444				2022-12-24	WOS:000168478200018
J	Kuroda, M; Ohta, T; Uchiyama, I; Baba, T; Yuzawa, H; Kobayashi, I; Cui, LZ; Oguchi, A; Aoki, K; Nagai, Y; Lian, JQ; Ito, T; Kanamori, M; Matsumaru, H; Maruyama, A; Murakami, H; Hosoyama, A; Mizutani-Ui, Y; Takahashi, NK; Sawano, T; Inoue, R; Kaito, C; Sekimizu, K; Hirakawa, H; Kuhara, S; Goto, S; Yabuzaki, J; Kanehisa, M; Yamashita, A; Oshima, K; Furuya, K; Yoshino, C; Shiba, T; Hattori, M; Ogasawara, N; Hayashi, H; Hiramatsu, K				Kuroda, M; Ohta, T; Uchiyama, I; Baba, T; Yuzawa, H; Kobayashi, I; Cui, LZ; Oguchi, A; Aoki, K; Nagai, Y; Lian, JQ; Ito, T; Kanamori, M; Matsumaru, H; Maruyama, A; Murakami, H; Hosoyama, A; Mizutani-Ui, Y; Takahashi, NK; Sawano, T; Inoue, R; Kaito, C; Sekimizu, K; Hirakawa, H; Kuhara, S; Goto, S; Yabuzaki, J; Kanehisa, M; Yamashita, A; Oshima, K; Furuya, K; Yoshino, C; Shiba, T; Hattori, M; Ogasawara, N; Hayashi, H; Hiramatsu, K			Whole genome sequencing of meticillin-resistant Staphylococcus aureus	LANCET			English	Article							PENICILLIN-BINDING PROTEINS; NUCLEOTIDE-SEQUENCE; GENE; CLONING; IDENTIFICATION; EXPRESSION; VIRULENCE; REGULATOR; ELEMENT; ENCODES	Background Staphylococcus aureus is one of the major causes of community-acquired and hospital-acquired infections. It produces numerous toxins including superantigens that cause unique disease entities such as toxic-shock syndrome and staphylococcal scarlet fever, and has acquired resistance to practically all antibiotics. Whole genome analysis is a necessary step towards future development of countermeasures against this organism. Methods Whole genome sequences of two related S aureus strains (N315 and Mu50) were determined by shot-gun random sequencing. N315 is a meticillin-resistant S aureus (MRSA) strain isolated in 1982, and Mu50 is an MRSA strain with vancomycin resistance isolated in 1997. The open reading frames were identified by use of GAMBLER and GLIMMER programs, and annotation of each was done with a BLAST homology search, motif analysis, and protein localisation prediction. Findings The Staphylococcus genome was composed of a complex mixture of genes, many of which seem to have been acquired by lateral gene transfer. Most of the antibiotic resistance genes were carried either by plasmids or by mobile genetic elements including a unique resistance island. Three classes of new pathogenicity islands were identified in the genome: a toxic-shock-syndrome toxin island family, exotoxin islands, and enterotoxin islands. in the latter two pathogenicity islands, clusters of exotoxin and enterotoxin genes were found closely linked with other gene clusters encoding putative pathogenic factors. The analysis also identified 70 candidates for new virulence factors. Interpretation The remarkable ability of S aureus to acquire useful genes from various organisms was revealed through the observation of genome complexity and evidence of lateral gene transfer. Repeated duplication of genes encoding superantigens explains why S aureus is capable of infecting humans of diverse genetic backgrounds, eliciting severe immune reactions. Investigation of many newly identified gene products, including the 70 putative virulence factors, will greatly improve our understanding of the biology of staphylococci and the processes of infectious diseases caused by S aureus.	Juntendo Univ, Dept Bacteriol, Bunkyo Ku, Tokyo 1138421, Japan; Univ Tsukuba, Coll Med Technol & Nursing, Tsukuba, Ibaraki 305, Japan; Okazaki Natl Res Inst, Res Ctr Computat Sci, Okazaki, Aichi, Japan; Univ Tokyo, Inst Med Sci, Div Basic Med Sci, Tokyo, Japan; Univ Tokyo, Grad Sch Pharmaceut Sci, Tokyo, Japan; Natl Inst Technol & Evaluat, Tokyo, Japan; Kyushu Univ, Fac Agr, Fukuoka 812, Japan; Kyoto Univ, Inst Chem Res, Kyoto 606, Japan; Kitasato Univ, Sch Sci, Kanagawa, Japan; RIKEN Genom Sci Ctr, Human Genome Res Grp, Kanagawa, Japan; Nara Inst Sci & Technol, Grad Sch Biol Sci, Nara, Japan; Univ Tsukuba, Inst Basic Med Sci, Tsukuba, Ibaraki 305, Japan	Juntendo University; University of Tsukuba; National Institutes of Natural Sciences (NINS) - Japan; Institute for Molecular Science (IMS); Okazaki Institute for Integrative Bioscience (OIIB); University of Tokyo; University of Tokyo; Kyushu University; Kyoto University; Kitasato University; RIKEN; Nara Institute of Science & Technology; University of Tsukuba	Hiramatsu, K (corresponding author), Juntendo Univ, Dept Bacteriol, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan.		Kaito, Chikara/W-1815-2019; Ogasawara, Naotake/B-7971-2011; Kaito, Chikara/G-1248-2017; Hattori, Masahira/C-6958-2016; Hattori, Masahira/AAD-3785-2019; Kanehisa, Minoru/R-3081-2018	Kaito, Chikara/0000-0002-2895-3386; Kaito, Chikara/0000-0002-2895-3386; Hattori, Masahira/0000-0001-9467-0344; cui (Cui), long zhu (Longzhu)/0000-0002-8909-3885; Uchiyama, Ikuo/0000-0002-9197-5000				ABE J, 1992, P NATL ACAD SCI USA, V89, P4066, DOI 10.1073/pnas.89.9.4066; AGATA N, 1995, MICROBIOL-UK, V141, P983, DOI 10.1099/13500872-141-4-983; Alm RA, 1999, NATURE, V397, P176, DOI 10.1038/16495; AMAKO K, 1979, MICROBIOL IMMUNOL, V23, P329, DOI 10.1111/j.1348-0421.1979.tb00470.x; BISSETT DL, 1974, J BACTERIOL, V119, P698, DOI 10.1128/JB.119.3.698-704.1974; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Chesney P.J., 1997, STAPHYLOCOCCI HUMAN, P509; CHEUNG AL, 1994, J BACTERIOL, V176, P4168, DOI 10.1128/JB.176.13.4168-4172.1994; Cramton SE, 2000, INFECT IMMUN, V68, P2344, DOI 10.1128/IAI.68.4.2344-2348.2000; Dinges MM, 2000, CLIN MICROBIOL REV, V13, P16, DOI 10.1128/CMR.13.1.16-34.2000; Fitzgerald JR, 2001, J BACTERIOL, V183, P63, DOI 10.1128/JB.183.1.63-70.2001; FLANNAGAN SE, 1994, PLASMID, V32, P350, DOI 10.1006/plas.1994.1077; FOSTER TJ, 1994, FEMS MICROBIOL LETT, V118, P199, DOI 10.1016/0378-1097(94)90504-5; Giraudo AT, 1999, FEMS MICROBIOL LETT, V177, P15, DOI 10.1016/S0378-1097(99)00282-7; HAYS JB, 1973, J BIOL CHEM, V248, P941; Hiramatsu K, 1999, BAILLIERE CLIN INF D, V5, P221; HIRAMATSU K, 1997, LANCET, V350, P1668; Ito T, 1999, ANTIMICROB AGENTS CH, V43, P1449, DOI 10.1128/AAC.43.6.1449; Jarraud S, 2001, J IMMUNOL, V166, P669, DOI 10.4049/jimmunol.166.1.669; JEVONS MP, 1961, BRIT MED J, V1, P124, DOI 10.1136/bmj.1.5219.124-a; JONSSON K, 1995, J BIOL CHEM, V270, P21457, DOI 10.1074/jbc.270.37.21457; Karlin S, 1998, MOL MICROBIOL, V29, P1341, DOI 10.1046/j.1365-2958.1998.01008.x; Katayama Y, 2000, ANTIMICROB AGENTS CH, V44, P1549, DOI 10.1128/AAC.44.6.1549-1555.2000; KIL KS, 1994, INFECT IMMUN, V62, P2440, DOI 10.1128/IAI.62.6.2440-2449.1994; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; Lindsay JA, 1998, MOL MICROBIOL, V29, P527, DOI 10.1046/j.1365-2958.1998.00947.x; Manganelli R, 1999, INFECT IMMUN, V67, P50, DOI 10.1128/IAI.67.1.50-56.1999; Manna A, 2001, INFECT IMMUN, V69, P885, DOI 10.1128/IAI.69.2.885-896.2001; MARSHALL JH, 1981, J BACTERIOL, V147, P900, DOI 10.1128/JB.147.3.900-913.1981; MARTIN C, 1992, J BACTERIOL, V174, P4517, DOI 10.1128/JB.174.13.4517-4523.1992; McNamara PJ, 2000, J BACTERIOL, V182, P3197, DOI 10.1128/JB.182.11.3197-3203.2000; NAITO T, 1995, SCIENCE, V267, P897, DOI 10.1126/science.7846533; PARK W, 1984, J BACTERIOL, V157, P538, DOI 10.1128/JB.157.2.538-544.1984; PENG HL, 1988, J BACTERIOL, V170, P4365, DOI 10.1128/jb.170.9.4365-4372.1988; PROJAN SJ, 1997, STAPHYLOCOCCI HUMAN, P55; Reed SB, 2001, INFECT IMMUN, V69, P1521, DOI 10.1128/IAI.69.3.1521-1527.2001; SCHNEEWIND O, 1992, CELL, V70, P267, DOI 10.1016/0092-8674(92)90101-H; Tegmark K, 2000, MOL MICROBIOL, V37, P398, DOI 10.1046/j.1365-2958.2000.02003.x; Tung HS, 2000, BIOCHEM J, V345, P611, DOI 10.1042/0264-6021:3450611; Wada A, 1998, J BACTERIOL, V180, P2759, DOI 10.1128/JB.180.10.2759-2765.1998; Williams RJ, 2000, INFECT IMMUN, V68, P4407, DOI 10.1128/IAI.68.8.4407-4415.2000; Yamaguchi T, 2000, MOL MICROBIOL, V38, P694, DOI 10.1046/j.1365-2958.2000.02169.x; Yarwood JM, 2001, J BACTERIOL, V183, P1113, DOI 10.1128/JB.183.4.1113-1123.2001	43	1510	3574	10	496	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 21	2001	357	9264					1225	1240		10.1016/S0140-6736(00)04403-2	http://dx.doi.org/10.1016/S0140-6736(00)04403-2			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	425YY	11418146				2022-12-24	WOS:000168323300008
J	Kim, M; Canio, W; Kessler, S; Sinha, N				Kim, M; Canio, W; Kessler, S; Sinha, N			Developmental changes due to long-distance movement of a homeobox fusion transcript in tomato	SCIENCE			English	Article							MESSENGER-RNA; VIRAL MOVEMENT; GENE; TRAFFICKING; PROTEIN; LEAF; PLASMODESMATA; LOCALIZATION; TRANSPORT; PLANTS	Long-distance movement of RNA through the phloem is known to occur, but the functional importance of these transported RNAs has remained unclear. Crafting experiments with a naturally occurring dominant gain-of-function Leaf mutation in tomato were used to demonstrate long-distance movement of mutant messenger RNA (mRNA) into wild-type scions. The stock-specific pattern of mRNA expression was graft transmissible, indicating that the mRNA accumulation pattern is inherent to the transcript and not attributable to the promoter. The translocated mRNA caused changes in Leaf morphology of the wild-type scions, suggesting that the translocated RNA is functional.	Univ Calif Davis, Div Biol Sci, Plant Biol Sect, Davis, CA 95616 USA	University of California System; University of California Davis	Sinha, N (corresponding author), Univ Calif Davis, Div Biol Sci, Plant Biol Sect, 1 Shields Ave, Davis, CA 95616 USA.		Kessler, Sharon A/T-4784-2017	Kessler, Sharon A/0000-0002-7964-0451; Sinha, Neelima/0000-0002-1494-7065				BERLETH T, 1988, EMBO J, V7, P1749, DOI 10.1002/j.1460-2075.1988.tb03004.x; Chen JJ, 1997, PLANT CELL, V9, P1289, DOI 10.1105/tpc.9.8.1289; Choi SB, 2000, NATURE, V407, P765, DOI 10.1038/35037633; EPHRUSSI A, 1991, CELL, V66, P37, DOI 10.1016/0092-8674(91)90137-N; FERRANDON D, 1994, CELL, V79, P1221, DOI 10.1016/0092-8674(94)90013-2; Gisel A, 1999, DEVELOPMENT, V126, P1879; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Janssen BJ, 1998, PLANT PHYSIOL, V117, P771, DOI 10.1104/pp.117.3.771; Kuehn Christina, 1997, Science (Washington D C), V275, P1298; LUCAS WJ, 1995, SCIENCE, V270, P1980, DOI 10.1126/science.270.5244.1980; LUCAS WJ, 1994, ANNU REV PHYTOPATHOL, V32, P387, DOI 10.1146/annurev.py.32.090194.002131; Parnis A, 1997, PLANT CELL, V9, P2143, DOI 10.1105/tpc.9.12.2143; Perbal MC, 1996, DEVELOPMENT, V122, P3433; Ratcliff F, 2001, PLANT J, V25, P237, DOI 10.1046/j.0960-7412.2000.00942.x; Ruiz-Medrano R, 1999, DEVELOPMENT, V126, P4405; Sessions A, 2000, SCIENCE, V289, P779, DOI 10.1126/science.289.5480.779; Xoconostle-Cazares B, 1999, SCIENCE, V283, P94, DOI 10.1126/science.283.5398.94	17	295	319	9	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 13	2001	293	5528					287	289		10.1126/science.1059805	http://dx.doi.org/10.1126/science.1059805			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	452TK	11452121				2022-12-24	WOS:000169875200055
J	Paris, F; Fuks, Z; Kang, A; Capodieci, P; Juan, G; Ehleiter, D; Haimovitz-Friedman, A; Cordon-Cardo, C; Kolesnick, R				Paris, F; Fuks, Z; Kang, A; Capodieci, P; Juan, G; Ehleiter, D; Haimovitz-Friedman, A; Cordon-Cardo, C; Kolesnick, R			Endothelial apoptosis as the primary lesion initiating intestinal radiation damage in mice	SCIENCE			English	Article							FIBROBLAST-GROWTH-FACTOR; STEM-CELL SURVIVAL; SPHINGOMYELINASE; IRRADIATION; EXPRESSION; TISSUES	Gastrointestinal (GI) tract damage by chemotherapy or radiation Limits their efficacy in cancer treatment. Radiation has been postulated to target epithelial stem cells within the crypts of Lieberkuhn to initiate the Lethal CII syndrome. Here, we show in mouse models that microvascular endothelial apoptosis is the primary Lesion Leading to stem cell dysfunction. Radiation-induced crypt damage, organ failure, and death from the CI syndrome were prevented when endothelial apoptosis was inhibited pharmacologically by intravenous basic fibroblast growth factor (bFGF) or genetically by deletion of the acid sphingomyelinase gene. Endothelial but not crypt, cells express FGF receptor transcripts, suggesting that the endothelial Lesion occurs before crypt stem cell damage in the evolution of the GI syndrome. This study provides a basis for new approaches to prevent radiation damage to the bowel.	Mem Sloan Kettering Canc Ctr, Lab Signal Transduct, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Kolesnick, R (corresponding author), Mem Sloan Kettering Canc Ctr, Lab Signal Transduct, 1275 York Ave, New York, NY 10021 USA.	r-kolesnick@ski.mskcc.org	Paris, francois E/L-4915-2015	Paris, francois E/0000-0002-0176-7348	NATIONAL CANCER INSTITUTE [R01CA085704] Funding Source: NIH RePORTER; NCI NIH HHS [CA85704, CA52462] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Booth C, 2000, J CLIN INVEST, V105, P1493, DOI 10.1172/JCI10229; Bronckers ALJJ, 2000, HISTOCHEM CELL BIOL, V113, P293, DOI 10.1007/s004180000137; Capodieci P, 1998, DIAGN MOL PATHOL, V7, P69, DOI 10.1097/00019606-199804000-00002; CORDONCARDO C, 1990, LAB INVEST, V63, P832; CORDONCARDO C, UNPUB; Dobrowsky RT, 2000, METHOD ENZYMOL, V311, P184; Fahimi HD, 1999, J HISTOCHEM CYTOCHEM, V47, P1219, DOI 10.1177/002215549904701001; FUKS Z, 1992, EUR J CANCER, V28A, P725, DOI 10.1016/0959-8049(92)90104-A; HaimovitzFriedman A, 1997, J EXP MED, V186, P1831, DOI 10.1084/jem.186.11.1831; Houchen CW, 1999, AM J PHYSIOL-GASTR L, V276, pG249, DOI 10.1152/ajpgi.1999.276.1.G249; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Khan WB, 1997, RADIAT RES, V148, P248, DOI 10.2307/3579609; MagiGalluzzi C, 1997, LAB INVEST, V76, P37; MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163; Marathe S, 1998, J BIOL CHEM, V273, P4081, DOI 10.1074/jbc.273.7.4081; Merritt AJ, 1997, ONCOGENE, V14, P2759, DOI 10.1038/sj.onc.1201126; Merritt Anita J., 1996, P269; Okunieff P, 1996, BRIT J CANCER, V74, pS105; Okunieff P, 1998, RADIAT RES, V150, P204, DOI 10.2307/3579856; Ornitz DM, 1996, J BIOL CHEM, V271, P15292, DOI 10.1074/jbc.271.25.15292; PARIS F, UNPUB; Pena LA, 2000, CANCER RES, V60, P321; POTTEN CS, 1990, INT J RADIAT BIOL, V58, P925, DOI 10.1080/09553009014552281; Potten CS, 1998, BRIT J CANCER, V78, P993, DOI 10.1038/bjc.1998.618; Potten CS, 1997, INT J EXP PATHOL, V78, P219, DOI 10.1046/j.1365-2613.1997.280362.x; Santana P, 1996, CELL, V86, P189, DOI 10.1016/S0092-8674(00)80091-4; Schissel SL, 1998, J BIOL CHEM, V273, P18250, DOI 10.1074/jbc.273.29.18250; TERRY NHA, 1989, INT J RADIAT ONCOL, V17, P569, DOI 10.1016/0360-3016(89)90108-9; [No title captured]	29	981	1036	2	70	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 13	2001	293	5528					293	297		10.1126/science.1060191	http://dx.doi.org/10.1126/science.1060191			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	452TK	11452123				2022-12-24	WOS:000169875200057
J	Bradstock, K				Bradstock, K			Wanderings of the bone-marrow stem cell	LANCET			English	Editorial Material							HEMATOPOIETIC PROGENITOR CELLS; CHEMOKINE SDF-1; PERIPHERAL-BLOOD; CD34(+) CELLS; MOBILIZATION; ENGRAFTMENT; MIGRATION		Westmead Hosp, Dept Haematol, Blood & Marrow Transplant Serv, Westmead, NSW 2145, Australia	University of Sydney	Bradstock, K (corresponding author), Westmead Hosp, Dept Haematol, Blood & Marrow Transplant Serv, Westmead, NSW 2145, Australia.	bradstok@icpmr.wsahs.nsw.gov.au						Aiuti A, 1997, J EXP MED, V185, P111, DOI 10.1084/jem.185.1.111; Gupta P, 1998, BLOOD, V91, P3724, DOI 10.1182/blood.V91.10.3724.3724_3724_3733; Kollet O, 2001, BLOOD, V97, P3283, DOI 10.1182/blood.V97.10.3283; Levesque JP, 2000, BLOOD, V96, p221A; LORD BI, 1975, BLOOD, V46, P65; Mohle R, 1998, BLOOD, V91, P4523, DOI 10.1182/blood.V91.12.4523.412k04_4523_4530; Nilsson SK, 2001, BLOOD, V97, P2293, DOI 10.1182/blood.V97.8.2293; PAPAYANNOPOULOU T, 1995, P NATL ACAD SCI USA, V92, P9647, DOI 10.1073/pnas.92.21.9647; Peled A, 2000, BLOOD, V95, P3289, DOI 10.1182/blood.V95.11.3289.011k33_3289_3296; Peled A, 1999, SCIENCE, V283, P845, DOI 10.1126/science.283.5403.845; Peled A, 1999, J CLIN INVEST, V104, P1199, DOI 10.1172/JCI7615; SHERIDAN WP, 1992, LANCET, V339, P640, DOI 10.1016/0140-6736(92)90795-5	12	2	3	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 7	2001	358	9275					5	6		10.1016/S0140-6736(00)05298-3	http://dx.doi.org/10.1016/S0140-6736(00)05298-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	449WV	11454366				2022-12-24	WOS:000169710900005
J	Dehnhardt, G; Mauck, B; Hanke, W; Bleckmann, H				Dehnhardt, G; Mauck, B; Hanke, W; Bleckmann, H			Hydrodynamic trail-following in harbor seals (Phoca vitulina)	SCIENCE			English	Article							FISH; WAKE	Marine mammals often forage in dark or turbid waters. Whereas dolphins use echolocation under such conditions, pinnipeds apparently lack this sensory ability. For seals hunting in the dark, one source of sensory information may consist of fish-generated water movements, which seals can detect with their highly sensitive whiskers. Water movements in the wake of fishes persist for several minutes. Here we show that blindfolded seals can use their whiskers to detect and accurately follow hydrodynamic trails generated by a miniature submarine. This shows that hydrodynamic information can be used for Long-distance prey location.	Univ Bonn, Inst Zool, D-53115 Bonn, Germany; Ruhr Univ Bochum, D-44780 Bochum, Germany	University of Bonn; Ruhr University Bochum	Dehnhardt, G (corresponding author), Univ Bonn, Inst Zool, Poppelsdorfer Schloss, D-53115 Bonn, Germany.							ADRIAN RJ, 1991, ANNU REV FLUID MECH, V23, P261, DOI 10.1146/annurev.fl.23.010191.001401; Au W. W., 1993, SONAR DOLPHINS; Bell W.J, 1991, SEARCHING BEHAV; BLECKMANN H, 1991, J COMP PHYSIOL A, V168, P749; Bleckmann H, 1994, RECEPTION HYDRODYNAM; BLICKHAN R, 1992, NATURWISSENSCHAFTEN, V79, P220, DOI 10.1007/BF01227131; COOMBS S, 1989, MECHANOSENSORY LATER; Davis RW, 1999, SCIENCE, V283, P993, DOI 10.1126/science.283.5404.993; Dehnhardt G, 1998, NATURE, V394, P235, DOI 10.1038/28303; Hanke W, 2000, J EXP BIOL, V203, P1193; Levenson DH, 1999, MAR MAMMAL SCI, V15, P1303, DOI 10.1111/j.1748-7692.1999.tb00892.x; Muller UK, 1997, J EXP BIOL, V200, P2893; Videler J. J, 1993, FISH SWIMMING, P1; Weissburg MJ, 1998, PHILOS T R SOC B, V353, P701, DOI 10.1098/rstb.1998.0236	14	234	241	2	99	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 6	2001	293	5527					102	104		10.1126/science.1060514	http://dx.doi.org/10.1126/science.1060514			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	451BB	11441183				2022-12-24	WOS:000169780300038
J	Changela, A; DiGate, RJ; Mondragon, A				Changela, A; DiGate, RJ; Mondragon, A			Crystal structure of a complex of a type IA DNA topoisomerase with a single-stranded DNA molecule	NATURE			English	Article							PROTEIN; DOMAIN; IDENTIFICATION; RESIDUES; INSIGHTS; PROGRAM; BINDING; TOPRIM	A variety of cellular processes, including DNA replication, transcription, and chromosome condensation, require enzymes that can regulate the ensuing topological changes occurring in DNA. Such enzymes-DNA topoisomerases-alter DNA topology by catalysing the cleavage of single-stranded DNA (ssDNA) or double-stranded DNA (dsDNA), the passage of DNA through the resulting break, and the rejoining of the broken phosphodiester backbone(1). DNA topoisomerase III from Escherichia coli belongs to the type IA family of DNA topoisomerases, which transiently cleave ssDNA via formation of a covalent 5' phosphotyrosine intermediate. Here we report the crystal structure, at 2.05 Angstrom resolution, of an inactive mutant of E. coli DNA topoisomerase III in a non-covalent complex with an 8-base ssDNA molecule. The enzyme undergoes a conformational change that allows the oligonucleotide to bind within a groove leading to the active site. We note that the ssDNA molecule adopts a conformation like that of B-DNA while bound to the enzyme. The position of the DNA within the realigned active site provides insight into the role of several highly conserved residues during catalysis. These findings confirm various aspects of the type IA topoisomerase mechanism while suggesting functional implications for other topoisomerases and proteins that perform DNA rearrangements.	Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA; Univ Maryland, Sch Med, Dept Pharmaceut Sci, Baltimore, MD 21201 USA	Northwestern University; University System of Maryland; University of Maryland Baltimore	Mondragon, A (corresponding author), Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, 2153 Sheridan Rd, Evanston, IL 60208 USA.	a-mondragon@northwestern.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051350] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM051350] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aravind L, 1998, NUCLEIC ACIDS RES, V26, P4205, DOI 10.1093/nar/26.18.4205; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Berger JM, 1996, NATURE, V379, P225, DOI 10.1038/379225a0; Berger JM, 1998, P NATL ACAD SCI USA, V95, P7876, DOI 10.1073/pnas.95.14.7876; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen SJ, 1998, J BIOL CHEM, V273, P6050, DOI 10.1074/jbc.273.11.6050; DOMANICO PL, 1991, J INORG BIOCHEM, V42, P87, DOI 10.1016/0162-0134(91)80035-G; EVANS SV, 1993, J MOL GRAPHICS, V11, P134, DOI 10.1016/0263-7855(93)87009-T; Fass D, 1999, NAT STRUCT BIOL, V6, P322; Harp JM, 1998, ACTA CRYSTALLOGR D, V54, P622, DOI 10.1107/S0907444997019008; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Keck JL, 2000, SCIENCE, V287, P2482, DOI 10.1126/science.287.5462.2482; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Li ZY, 2000, MOL MICROBIOL, V35, P888, DOI 10.1046/j.1365-2958.2000.01763.x; LIMA CD, 1994, NATURE, V367, P138, DOI 10.1038/367138a0; Liu QY, 1999, P NATL ACAD SCI USA, V96, P881, DOI 10.1073/pnas.96.3.881; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; Mondragon A, 1999, STRUCTURE, V7, P1373, DOI 10.1016/S0969-2126(00)80027-1; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Nichols MD, 1999, EMBO J, V18, P6177, DOI 10.1093/emboj/18.21.6177; Podobnik M, 2000, J MOL BIOL, V300, P353, DOI 10.1006/jmbi.2000.3844; Redinbo MR, 2000, BIOCHEMISTRY-US, V39, P6832, DOI 10.1021/bi992690t; Sherratt DJ, 1998, CELL, V93, P149, DOI 10.1016/S0092-8674(00)81566-4; WANG JC, 1971, J MOL BIOL, V55, P523, DOI 10.1016/0022-2836(71)90334-2; Wang JC, 1996, ANNU REV BIOCHEM, V65, P635, DOI 10.1146/annurev.bi.65.070196.003223; ZHANG HL, 1994, J BIOL CHEM, V269, P9052; ZHANG HL, 1995, J BIOL CHEM, V270, P23700, DOI 10.1074/jbc.270.40.23700; Zhu CX, 2000, J BIOL CHEM, V275, P5318, DOI 10.1074/jbc.275.8.5318; Zhu CX, 1998, J BIOL CHEM, V273, P8783, DOI 10.1074/jbc.273.15.8783	30	89	91	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 28	2001	411	6841					1077	1081		10.1038/35082615	http://dx.doi.org/10.1038/35082615			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	446TF	11429611				2022-12-24	WOS:000169528500054
J	Ferrari, G; Stornaiuolo, A; Mavilio, F				Ferrari, G; Stornaiuolo, A; Mavilio, F			Bone-marrow transplantation - Failure to correct murine muscular dystrophy	NATURE			English	Article							MUSCLE		H San Raffaele Telethon Inst Gene Therapy, I-20132 Milan, Italy; GeneEra SpA, I-20132 Milan, Italy; Univ Modena, Sch Med, Dept Biomed Sci, I-41100 Modena, Italy	Fondazione Telethon; San Raffaele Telethon Institute For Gene Therapy (Sr-Tiget); Universita di Modena e Reggio Emilia	Ferrari, G (corresponding author), H San Raffaele Telethon Inst Gene Therapy, Via Olgettina 58, I-20132 Milan, Italy.		Ferrari, Giuliana/AAB-5546-2019	Ferrari, Giuliana/0000-0003-0790-3133; Mavilio, Fulvio/0000-0003-0459-4320	Telethon [TGT00D01, TGT06S01] Funding Source: Medline	Telethon(Fondazione Telethon)		Bittner RE, 1999, ANAT EMBRYOL, V199, P391, DOI 10.1007/s004290050237; DANKO I, 1992, PEDIATR RES, V32, P128, DOI 10.1203/00006450-199207000-00025; Emery A.E.H., 1993, DUCHENNE MUSCULAR DY; Ferrari G, 1998, SCIENCE, V279, P1528, DOI 10.1126/science.279.5356.1528; Gussoni E, 1999, NATURE, V401, P390, DOI 10.1038/43919	5	124	133	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 28	2001	411	6841					1014	1015		10.1038/35082631	http://dx.doi.org/10.1038/35082631			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	446TF	11429592				2022-12-24	WOS:000169528500035
J	Fang, JY; Chen, AP; Peng, CH; Zhao, SQ; Ci, L				Fang, JY; Chen, AP; Peng, CH; Zhao, SQ; Ci, L			Changes in forest biomass carbon storage in China between 1949 and 1998	SCIENCE			English	Article							UNITED-STATES; BUDGET; CLIMATE; CO2	The Location and mechanisms responsible for the carbon sink in northern mid-latitude Lands are uncertain. Here, we used an improved estimation method of forest biomass and a 50-year national forest resource inventory in China to estimate changes in the storage of Living biomass between 1949 and 1998. Our results suggest that Chinese forests released about 0.68 petagram of carbon between 1949 and 1980, for an annual emission rate of 0.022 petagram of carbon. Carbon storage increased significantly after the Late 1970s from 4.38 to 4.75 petagram of carbon by 1998, for a mean accumulation rate of 0.021 petagram of carbon per year, mainly due to forest expansion and regrowth. Since the mid-1970s, planted forests (afforestation and reforestation) have sequestered 0.45 petagram of carbon, and their average carbon density increased from 15.3 to 31.1 megagrams per hectare, while natural forests have Lost an additional 0.14 petagram of carbon, suggesting that carbon sequestration through forest management practices addressed in the Kyoto Protocol could help offset industrial carbon dioxide emissions.	Peking Univ, Minist Educ, Dept Urban & Environm Sci, Beijing 100871, Peoples R China; Peking Univ, Minist Educ, Key Lab Earth Surface Proc, Beijing 100871, Peoples R China; Minist Nat Resources, Ontario Forest Res Inst, Sault Ste Marie, ON P6A 2E5, Canada; Lakehead Univ, Fac Forestry & Forest Environm, Thunder Bay, ON P7B 5E1, Canada; Chinese Acad Forestry, Inst Forest Ecol & Environm, Beijing 100091, Peoples R China	Peking University; Peking University; Ministry of Natural Resources & Forestry; Natural Resources Canada; Lakehead University; Chinese Academy of Forestry; Research Institute of Forest Ecology, Environment and Protection, CAF	Fang, JY (corresponding author), Peking Univ, Minist Educ, Dept Urban & Environm Sci, Beijing 100871, Peoples R China.	jyfang@urban.pku.edu.cn	Fang, Jingyun/A-4282-2009; Chen, Anping/H-9960-2014; Peng, Changhui/G-8248-2012	Chen, Anping/0000-0003-2085-3863; 				BIRDSEY RA, 1995, RM228 USDA FOR SERV, P1; BROWN S, 1992, INTERCIENCIA, V17, P8; Brown SL, 1999, ECOL APPL, V9, P968, DOI 10.1890/1051-0761(1999)009[0968:SPOAPA]2.0.CO;2; *CHIN MIN FOR, 1965, FOR RES STAT CHIN PE; *DEP FOR RES MAN C, 1996, FOR RES CHIN 1949 93; DIXON RK, 1994, SCIENCE, V263, P185, DOI 10.1126/science.263.5144.185; Fan S, 1998, SCIENCE, V282, P442, DOI 10.1126/science.282.5388.442; Fang JY, 1998, ECOL APPL, V8, P1084, DOI 10.2307/2640963; FANG JY, 2000, FOREST BIOMASS DATAB, P1; FANG JY, 1996, STUDIES EMISSIONS TH, P81; Field CB, 1999, SCIENCE, V285, P544, DOI 10.1126/science.285.5427.544; *FOR MIN CHIN, 1983, TECHN STAND FOR RES; Houghton RA, 1999, SCIENCE, V285, P574, DOI 10.1126/science.285.5427.574; Houghton RA, 2000, GLOBAL ECOL BIOGEOGR, V9, P125, DOI 10.1046/j.1365-2699.2000.00166.x; KAUPPI PE, 1992, SCIENCE, V256, P70, DOI 10.1126/science.256.5053.70; Kurz WA, 1999, ECOL APPL, V9, P526, DOI 10.1890/1051-0761(1999)009[0526:AYRAOC]2.0.CO;2; LI WH, 1996, RES FOREST RESOURCE; Peng CH, 1997, TELLUS B, V49, P393, DOI 10.1034/j.1600-0889.49.issue4.5.x; Potter S. C., 1999, SCIENCE, V283; Schimel D, 2000, SCIENCE, V287, P2004, DOI 10.1126/science.287.5460.2004; SCHLAMADINGER B, 2000, SPECIAL REPORT IPCC, P127; Schroeder P, 1997, FOREST SCI, V43, P424; Schulze ED, 2000, SCIENCE, V289, P2058, DOI 10.1126/science.289.5487.2058; Steffen W, 1998, SCIENCE, V280, P1393; TURNER DP, 1995, ECOL APPL, V5, P421, DOI 10.2307/1942033; WOFSY SC, 1993, SCIENCE, V260, P1314, DOI 10.1126/science.260.5112.1314; Zhang PC, 2000, SCIENCE, V288, P2135, DOI 10.1126/science.288.5474.2135	27	1022	1759	112	1093	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 22	2001	292	5525					2320	2322		10.1126/science.1058629	http://dx.doi.org/10.1126/science.1058629			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	445KD	11423660				2022-12-24	WOS:000169455900055
J	Pybus, OG; Charleston, MA; Gupta, S; Rambaut, A; Holmes, EC; Harvey, PH				Pybus, OG; Charleston, MA; Gupta, S; Rambaut, A; Holmes, EC; Harvey, PH			The epidemic behavior of the hepatitis C virus	SCIENCE			English	Article							MOLECULAR EPIDEMIOLOGY; RELATIVE PREVALENCE; POPULATION HISTORY; INFECTION; GENOTYPES; DIVERSITY; SUBTYPES; TRANSMISSION; RECIPIENTS; SEQUENCES	Hepatitis C virus (HCV) is a leading worldwide cause of liver disease. Here, we use a new model of HCV spread to investigate the epidemic behavior of the virus and to estimate its basic reproductive number from gene sequence data. We find significant differences in epidemic behavior among HCV subtypes and suggest that these differences are largely the result of subtype-specific transmission patterns. Our model builds a bridge between the disciplines of population genetics and mathematical epidemiology by using pathogen gene sequences to infer the population dynamic history of an infectious disease.	Univ Oxford, Dept Zool, Oxford OX1 3PS, England	University of Oxford	Pybus, OG (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.	oliver.pybus@zoo.ox.ac.uk	Charleston, Michael A/O-4903-2017; Holmes, Edward/GVR-9499-2022; Rambaut, Andrew/B-2481-2009; Pybus, Oliver G/B-2640-2012	Charleston, Michael A/0000-0001-8385-341X; Rambaut, Andrew/0000-0003-4337-3707; Pybus, Oliver G/0000-0002-8797-2667; Holmes, Edward/0000-0001-9596-3552				ANDERSON R M, 1991; *CDCP, 1998, MMWR-MORBID MORTAL W, V47, pRR19; Dubois F, 1997, HEPATOLOGY, V25, P1490, DOI 10.1002/hep.510250630; FARCI P, 1992, SCIENCE, V258, P135, DOI 10.1126/science.1279801; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; FORNS X, 1998, VIRAL HEPAT REV, V4, P1; Frank C, 2000, LANCET, V355, P887, DOI 10.1016/S0140-6736(99)06527-7; Garfein RS, 1996, AM J PUBLIC HEALTH, V86, P655, DOI 10.2105/AJPH.86.5.655; GRIFFITHS RC, 1994, PHILOS T ROY SOC B, V344, P403, DOI 10.1098/rstb.1994.0079; GUPTA S, 1994, SCIENCE, V263, P961, DOI 10.1126/science.8310293; Jeannel D, 1998, J MED VIROL, V55, P92, DOI 10.1002/(SICI)1096-9071(199806)55:2&lt;92::AID-JMV2&gt;3.0.CO;2-I; Kao JH, 2000, J GASTROEN HEPATOL, V15, pE91, DOI 10.1046/j.1440-1746.2000.02108.x; Kimura Y, 2000, J MED VIROL, V61, P37, DOI 10.1002/(SICI)1096-9071(200005)61:1&lt;37::AID-JMV6&gt;3.0.CO;2-E; Kingman JFC, 1982, J APPL PROB A, V19A, P27, DOI DOI 10.2307/3213548; MELLOR J, 1995, J GEN VIROL, V76, P2493, DOI 10.1099/0022-1317-76-10-2493; MILLER RH, 1990, P NATL ACAD SCI USA, V87, P2057, DOI 10.1073/pnas.87.6.2057; Morice Y, 2001, J GEN VIROL, V82, P1001, DOI 10.1099/0022-1317-82-5-1001; NEE S, 1995, PHILOS T ROY SOC B, V349, P25, DOI 10.1098/rstb.1995.0087; PAWLOTSKY JM, 1995, J INFECT DIS, V171, P1607, DOI 10.1093/infdis/171.6.1607; POL S, 1995, GASTROENTEROLOGY, V108, P581, DOI 10.1016/0016-5085(95)90088-8; POWER JP, 1995, LANCET, V345, P1211, DOI 10.1016/S0140-6736(95)91993-7; Prescott LE, 1997, J MED VIROL, V53, P237, DOI 10.1002/(SICI)1096-9071(199711)53:3<237::AID-JMV10>3.3.CO;2-P; Prescott LE, 1996, J MED VIROL, V50, P168, DOI 10.1002/(SICI)1096-9071(199610)50:2&lt;168::AID-JMV10&gt;3.0.CO;2-I; Pybus OG, 1999, MOL BIOL EVOL, V16, P953, DOI 10.1093/oxfordjournals.molbev.a026184; Pybus OG, 2000, GENETICS, V155, P1429; Rambaut A, 2000, BIOINFORMATICS, V16, P395, DOI 10.1093/bioinformatics/16.4.395; Rosen HR, 1999, AM J GASTROENTEROL, V94, P3015, DOI 10.1111/j.1572-0241.1999.01456.x; Seeff LB, 2000, ANN INTERN MED, V132, P105, DOI 10.7326/0003-4819-132-2-200001180-00003; SHERLOCK S, 1993, VIRAL HEPATITIS, P1; Shobokshi OA, 1999, J MED VIROL, V58, P44, DOI 10.1002/(SICI)1096-9071(199905)58:1&lt;44::AID-JMV6&gt;3.0.CO;2-U; SILINI E, 1995, J HEPATOL, V22, P691, DOI 10.1016/0168-8278(95)80225-8; SIMMONDS P, 1993, J GEN VIROL, V74, P2391, DOI 10.1099/0022-1317-74-11-2391; Smith DB, 1997, J GEN VIROL, V78, P321, DOI 10.1099/0022-1317-78-2-321; Smith DB, 1997, J MOL EVOL, V45, P238, DOI 10.1007/PL00006226; *WHO, 1997, WKLY EPIDEMIOL REC, V72, P65; Wong DA, 1998, EUR J EPIDEMIOL, V14, P421, DOI 10.1023/A:1007400304726	36	336	344	0	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 22	2001	292	5525					2323	2325		10.1126/science.1058321	http://dx.doi.org/10.1126/science.1058321			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	445KD	11423661				2022-12-24	WOS:000169455900056
J	Stokroos, I; Litinetsky, L; van der Want, JJL; Ishay, JS				Stokroos, I; Litinetsky, L; van der Want, JJL; Ishay, JS			Magnetic minerals - Keystone-like crystals in cells of hornet combs	NATURE			English	Article									Univ Groningen, Fac Med Sci, Dept Cell Biol, Grad Sch Brain Cognit & Neurosci, NL-9713 EZ Groningen, Netherlands; Tel Aviv Univ, Sackler Fac Med, Dept Physiol & Pharmacol, IL-69978 Ramat Aviv, Israel	University of Groningen; Tel Aviv University; Sackler Faculty of Medicine	Stokroos, I (corresponding author), Univ Groningen, Fac Med Sci, Dept Cell Biol, Grad Sch Brain Cognit & Neurosci, Oostersingel 69-2, NL-9713 EZ Groningen, Netherlands.	physio7@post.tau.ac.il	van der Want, Johannes/AAA-8058-2019	van der Want, Johannes/0000-0002-7485-4434				Ishay Jacob S., 1996, Scanning Microscopy, V10, P187; ISHAY JS, 1982, INSECT SOC, V29, P34, DOI 10.1007/BF02224526; Jongebloed WL, 1999, J ELECTRON MICROSC, V48, P63, DOI 10.1093/oxfordjournals.jmicro.a023652; SPRADBERY JP, 1973, WASPS; Welham NJ, 1998, J MATER SCI, V33, P1795, DOI 10.1023/A:1004388818110; Wilson GS, 1999, GEOL SOC SPEC PUBL, V151, P95, DOI 10.1144/GSL.SP.1999.151.01.10	6	16	16	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN	2001	411	6838					654	654		10.1038/35079679	http://dx.doi.org/10.1038/35079679			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439JC	11395756				2022-12-24	WOS:000169112500030
J	Todd, WTA				Todd, WTA			Prospects for the prevention of haemolytic-uraemic syndrome	LANCET			English	Editorial Material							HEMOLYTIC-UREMIC SYNDROME; ESCHERICHIA-COLI O157-H7; INFECTIONS; ANTIBODIES; STOOLS; TOXIN		Monklands Hosp, Lanarkshire Area Infect Dis Unit, Airdale ML6 0JS, Lanark, Scotland	Monklands Hospital	Todd, WTA (corresponding author), Monklands Hosp, Lanarkshire Area Infect Dis Unit, Airdale ML6 0JS, Lanark, Scotland.							CARTER AO, 1987, NEW ENGL J MED, V317, P1496, DOI 10.1056/NEJM198712103172403; Dundas S, 1999, LANCET, V354, P1327, DOI 10.1016/S0140-6736(99)01251-9; FITZPATRICK MM, 1991, BMJ-BRIT MED J, V303, P489, DOI 10.1136/bmj.303.6801.489; GRIFFIN PM, 1991, EPIDEMIOL REV, V13, P60, DOI 10.1093/oxfordjournals.epirev.a036079; KARMALI MA, 1983, LANCET, V1, P619, DOI 10.1016/s0140-6736(83)91795-6; Kimmitt PT, 1999, LANCET, V353, P1588, DOI 10.1016/S0140-6736(99)00621-2; Li YL, 2000, INFECT IMMUN, V68, P5090, DOI 10.1128/IAI.68.9.5090-5095.2000; Louie M, 1998, J CLIN MICROBIOL, V36, P3375, DOI 10.1128/JCM.36.11.3375-3377.1998; Manjarrez-Hernandez HA, 2000, INFECT IMMUN, V68, P5030, DOI 10.1128/IAI.68.9.5030-5036.2000; Martinez MB, 1999, J INFECT DIS, V179, P269, DOI 10.1086/314549; MONNENS L, 2000, INT S WORKSH SHIG TO; Nakao H, 1999, INFECT IMMUN, V67, P5717, DOI 10.1128/IAI.67.11.5717-5722.1999; Obrig Tom G., 1997, Frontiers in Bioscience, V2, pD635; PROULX F, 1992, J PEDIATR-US, V121, P299, DOI 10.1016/S0022-3476(05)81209-0; Takeda T, 1998, ESCHERICHIA COLI O15, P385; Wong CS, 2000, NEW ENGL J MED, V342, P1930, DOI 10.1056/NEJM200006293422601	16	3	3	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 26	2001	357	9269					1636	1638		10.1016/S0140-6736(00)04859-5	http://dx.doi.org/10.1016/S0140-6736(00)04859-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	435UY	11425363				2022-12-24	WOS:000168901600004
J	Shu, DG; Chen, L; Han, J; Zhang, XL				Shu, DG; Chen, L; Han, J; Zhang, XL			An early Cambrian tunicate from China	NATURE			English	Article							EVOLUTIONARY HISTORY; VERTEBRATES; FOSSIL	Like the Burgess Shales of Canada, the Chengjiang Lagerstatte from the Lower Cambrian of China is renowned for the detailed preservation as fossils of delicate, soft-bodied creatures(1-9), providing an insight into the Cambrian explosion. The fossils of possible hemichordate chordates(5-7) and vertebrates(9) have attracted particular attention. Tunicates, or urochordates, comprise the most basal chordate clade(10), and details of their evolution could be important in understanding the sequence of character acquisition that led to the emergence of chordates and vertebrates(11-18). However, definitive fossils of tunicates from the Cambrian are scarce or debatable(4,9,19-24). Here we report a probable tunicate Cheungkongella ancestralis from the Chengjiang fauna. It resembles the extant ascidian tunicate genus Styela whose morphology could be useful in understanding the origin of the vertebrates.	NW Univ Xian, Early Life Inst, Xian 710069, Peoples R China; NW Univ Xian, Dept Geol, Xian 710069, Peoples R China	Northwest University Xi'an; Northwest University Xi'an	Shu, DG (corresponding author), NW Univ Xian, Early Life Inst, Xian 710069, Peoples R China.	dgshu@sein.sxgb.com.cn						Berrill N.J., 1955, ORIGIN VERTEBRATES; Briggs D.E.G., 1994, FOSSILS BURGESS SHAL; Cameron CB, 2000, P NATL ACAD SCI USA, V97, P4469, DOI 10.1073/pnas.97.9.4469; CARTER GS, 1957, SYST ZOOL, V6, P187; CHEN JY, 1995, NATURE, V377, P720, DOI 10.1038/377720a0; Conway Morris S, 1982, ATLAS BURGESS SHALE, P26; Degan Shu, 1995, Beringeria Special Issue, V2, P203; Di Gregorio A, 1998, CURR OPIN GENET DEV, V8, P457, DOI 10.1016/S0959-437X(98)80118-4; GARSTANG WALTER, 1928, QUART JOUR MICROS SCI, V72, P51; Gee H., 1996, BACKBONE VIEWS ORIGI; Hou Xianguang, 1997, Fossils and Strata, V45, P1; JOLLIE M, 1982, ZOOL J LINN SOC-LOND, V75, P167, DOI 10.1111/j.1096-3642.1982.tb01946.x; Lehnert Oliver, 1999, Acta Universitatis Carolinae Geologica, V43, P447; LOHMANN H, 1922, MITT ZOOL MUS HAMBUR, V38, P69; MEGLITSCH PA, 1991, INVERTEBRATE ZOOLOGY, P576; MUELLER K J, 1977, Lethaia, V10, P107; Nielsen C., 1997, ANIMAL EVOLUTION INT; Ogasawara M, 1999, ZOOL SCI, V16, P559, DOI 10.2108/zsj.16.559; ROMER AS, 1971, VERTEBRATE STORY; Satoh N., 1994, DEV BIOL ASCIDIANS; Shu D, 1996, NATURE, V380, P428, DOI 10.1038/380428a0; Shu D, 1999, NATURE, V400, P746, DOI 10.1038/23445; Shu DG, 1995, ALCHERINGA, V19, P333, DOI 10.1080/03115519508619512; Shu DG, 1996, NATURE, V384, P157, DOI 10.1038/384157a0; Shu DG, 1999, NATURE, V402, P42, DOI 10.1038/46965; Swalla BJ, 2000, SYST BIOL, V49, P52, DOI 10.1080/10635150050207384; Wada H, 1998, MOL BIOL EVOL, V15, P1189, DOI 10.1093/oxfordjournals.molbev.a026026; WADA H, 1994, P NATL ACAD SCI USA, V91, P1801, DOI 10.1073/pnas.91.5.1801; ZHANG AY, 1987, SCI CHINA SER B, V30, P888; Zhang XL, 2001, J GEOL SOC LONDON, V158, P211, DOI 10.1144/jgs.158.2.211	30	83	100	2	26	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 24	2001	411	6836					472	473		10.1038/35078069	http://dx.doi.org/10.1038/35078069			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	435CB	11373678				2022-12-24	WOS:000168858700047
J	Johnston, WK; Unrau, PJ; Lawrence, MS; Glasner, ME; Bartel, DP				Johnston, WK; Unrau, PJ; Lawrence, MS; Glasner, ME; Bartel, DP			RNA-catalyzed RNA polymerization: Accurate and general RNA-templated primer extension	SCIENCE			English	Article							NONTEMPLATED NUCLEOTIDE ADDITION; FIDELITY; RIBOZYME; REPLICATION; ORIGIN; SITES	The RNA world hypothesis regarding the early evolution of Life relies on the premise that some RNA sequences can catalyze RNA replication. In support of this conjecture, we describe here an RNA molecule that catalyzes the type of polymerization needed for RNA replication. The ribozyme uses nucleoside triphosphates and the coding information of an RNA template to extend an RNA primer by the successive addition of up to 14 nucleotides-more than a complete turn of an RNA helix. Its polymerization activity is general in terms of the sequence and the Length of the primer and template RNAs, provided that the 3' terminus of the primer pairs with the template. Its polymerization is also quite accurate: when primers extended by 11 nucleotides were cloned and sequenced, 1088 of 1100 sequenced nucleotides matched the template.	MIT, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	Bartel, DP (corresponding author), MIT, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA.	dbartel@wi.mit.edu		Glasner, Margaret/0000-0003-1818-1965				Bartel D.P, 1999, RNA WORLD 2 NAT MOD, V37, P143; Bartel David P., 1999, Trends in Cell Biology, V9, pM9, DOI 10.1016/S0962-8924(99)01669-4; BARTEL DP, 1993, SCIENCE, V261, P1411, DOI 10.1126/science.7690155; BAUSCH JN, 1983, J BIOL CHEM, V258, P1978; Bergman NH, 2000, BIOCHEMISTRY-US, V39, P3115, DOI 10.1021/bi992654u; CECH TR, 1986, P NATL ACAD SCI USA, V83, P4360, DOI 10.1073/pnas.83.12.4360; CLARK JM, 1988, NUCLEIC ACIDS RES, V16, P9677, DOI 10.1093/nar/16.20.9677; DOUDNA JA, 1991, SCIENCE, V251, P1605, DOI 10.1126/science.1707185; DOUDNA JA, 1989, NATURE, V339, P519, DOI 10.1038/339519a0; ECHOLS H, 1991, ANNU REV BIOCHEM, V60, P477, DOI 10.1146/annurev.biochem.60.1.477; EKLAND EH, 1995, NUCLEIC ACIDS RES, V23, P3231, DOI 10.1093/nar/23.16.3231; EKLAND EH, 1995, SCIENCE, V269, P364, DOI 10.1126/science.7618102; Ekland EH, 1996, NATURE, V382, P373, DOI 10.1038/382373a0; Glasner ME, 2000, BIOCHEMISTRY-US, V39, P15556, DOI 10.1021/bi002174z; GREEN R, 1992, SCIENCE, V258, P1910, DOI 10.1126/science.1470913; Hager AJ, 1996, CHEM BIOL, V3, P717, DOI 10.1016/S1074-5521(96)90246-X; Joyce G. F., 1993, COLD SPRING HARB SYM, V24, P49; Kao C, 1999, RNA, V5, P1268, DOI 10.1017/S1355838299991033; KUNKEL TA, 1992, BIOESSAYS, V14, P303, DOI 10.1002/bies.950140503; LOEB LA, 1982, ANNU REV BIOCHEM, V51, P429, DOI 10.1146/annurev.bi.51.070182.002241; MOORE MJ, 1992, SCIENCE, V256, P992, DOI 10.1126/science.1589782; ORGEL LE, 1986, J THEOR BIOL, V123, P127, DOI 10.1016/S0022-5193(86)80149-7; PACE NR, 1985, ORIGINS LIFE EVOL B, V16, P97, DOI 10.1007/BF01809465; SHARP PA, 1985, CELL, V42, P397, DOI 10.1016/0092-8674(85)90092-3; STEINHAUER DA, 1986, J VIROL, V57, P219, DOI 10.1128/JVI.57.1.219-228.1986; Szostak JW, 2001, NATURE, V409, P387, DOI 10.1038/35053176; TUSCHL T, 1993, BIOCHEMISTRY-US, V32, P11658, DOI 10.1021/bi00094a023; Unrau PJ, 1998, NATURE, V395, P260, DOI 10.1038/26193; UNRAU PJ, UNPUB; WARD CD, 1992, J VIROL, V66, P3784, DOI 10.1128/JVI.66.6.3784-3793.1992; Washington MT, 1999, J BIOL CHEM, V274, P36835, DOI 10.1074/jbc.274.52.36835	31	436	457	4	115	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 18	2001	292	5520					1319	1325		10.1126/science.1060786	http://dx.doi.org/10.1126/science.1060786			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	435DV	11358999	Green Submitted			2022-12-24	WOS:000168862900032
J	Gillman, MW; Rifas-Shiman, SL; Camargo, CA; Berkey, CS; Frazier, AL; Rockett, HRH; Field, AE; Colditz, GA				Gillman, MW; Rifas-Shiman, SL; Camargo, CA; Berkey, CS; Frazier, AL; Rockett, HRH; Field, AE; Colditz, GA			Risk of overweight among adolescents who were breastfed as infants	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BODY-MASS INDEX; NUTRITION EXAMINATION SURVEYS; CHILDHOOD OBESITY; FOLLOW-UP; ENDOCRINE RESPONSES; FEEDING PRACTICES; YOUNG ADULTHOOD; NATIONAL-HEALTH; CHILDREN; GROWTH	Context Overweight during adolescence predicts short- and long-term morbidity as well as obesity in adulthood. The prevalence of overweight among adolescents is high and continues to increase. Physiological and behavioral mechanisms and preliminary epidemiologic data suggest that breastfeeding could lower the risk of subsequent obesity in adolescence. Objective To examine the extent to which overweight status among adolescents is associated with the type of infant feeding (breast milk vs infant formula) and duration of breastfeeding. Design, Setting, and Subjects Survey of 8186 girls and 7155 boys, aged 9 to 14 years, who are participants in the Growing Up Today Study, a nationwide cohort study of diet, activity, and growth. In the fall of 1996 we mailed a questionnaire to each of the subjects, and in the spring of 1997, we mailed a supplemental questionnaire to their mothers, who are participants in the Nurses' Health Study II. Main Outcome Measure Overweight status defined as body mass index exceeding the 95th percentile for age and sex from US national data. Results In the first 6 months of life, 9553 subjects (62%) were only or mostly fed breast milk, and 4744 (31%) were only or mostly fed infant formula. A total of 7186 subjects (48%) were breastfed for at least 7 months while 4613 (31%) were breastfed for 3 months or less. At ages 9 to 14 years, 404 girls (5%) and 635 boys (9%) were overweight. Among subjects who had been only or mostly fed breast milk, compared with those only or mostly fed formula, the odds ratio (OR) for being overweight was 0.78 (95% confidence interval [CI], 0.66-0.91), after adjustment for age, sex, sexual maturity, energy intake, time watching television, physical activity, mother's body mass index, and other variables reflecting social, economic, and lifestyle factors. Compared with subjects who had been breastfed for 3 months or less, those who had been breastfed for at least 7 months had an adjusted OR for being overweight of 0.80 (95% CI, 0.67-0.96). Timing of introduction of solid foods, infant formula, or cow's milk was not related to risk of being overweight, Conclusion Infants who were fed breast milk more than infant formula, or who were breastfed for longer periods, had a lower risk of being overweight during older childhood and adolescence.	Harvard Univ, Sch Med, Harvard Pilgrim Hlth Care, Dept Amulatory Care & Prevent, Boston, MA 02215 USA; Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA; Massachusetts Gen Hosp, Dept Emergency Med, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02215 USA; Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02215 USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02215 USA; Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02215 USA	Harvard Pilgrim Health Care; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Gillman, MW (corresponding author), Harvard Univ, Sch Med, Harvard Pilgrim Hlth Care, Dept Amulatory Care & Prevent, 126 Brookline Ave,Suite 200, Boston, MA 02215 USA.		Camargo, Carlos A./C-2145-2008; Colditz, Graham/A-3963-2009; Field, Alison/AAA-4508-2021	Camargo, Carlos A./0000-0002-5071-7654; Colditz, Graham/0000-0002-7307-0291; 	NCI NIH HHS [CA 50385] Funding Source: Medline; NIDDK NIH HHS [DK 46834] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA050385] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046834] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AGRAS WS, 1990, J PEDIATR-US, V116, P805, DOI 10.1016/S0022-3476(05)82677-0; Barker DJP, 1998, MOTHERS BABIES DIS L; Baughcum AE, 1998, ARCH PEDIAT ADOL MED, V152, P1010; Berkey CS, 2000, PEDIATRICS, V105, DOI 10.1542/peds.105.4.e56; Birch LL, 1998, PEDIATRICS, V101, P539; Butte NF, 1998, J NUTR, V128, p381S, DOI 10.1093/jn/128.2.381S; *CDC, 2001, CDC GROWTH CHARTS US; *COMM NUTR AM AC P, 1998, PED NUTR HDB; DEWEY KG, 1991, J PEDIATR-US, V119, P538, DOI 10.1016/S0022-3476(05)82401-1; DEWEY KG, 1995, PEDIATRICS, V96, P495; Elliott KG, 1997, OBES RES, V5, P538, DOI 10.1002/j.1550-8528.1997.tb00574.x; Ellis KJ, 1999, AM J EPIDEMIOL, V150, P939, DOI 10.1093/oxfordjournals.aje.a010102; FORD K, 1990, AM J CLIN NUTR, V52, P451, DOI 10.1093/ajcn/52.3.451; Freedman DS, 1999, PEDIATRICS, V103, P1175, DOI 10.1542/peds.103.6.1175; FRENCH SA, 1995, OBES RES, V3, P479, DOI 10.1002/j.1550-8528.1995.tb00179.x; Goodman E, 2000, PEDIATRICS, V106, P52, DOI 10.1542/peds.106.1.52; GORTMAKER SL, 1993, NEW ENGL J MED, V329, P1008, DOI 10.1056/NEJM199309303291406; Gunnell DJ, 1998, AM J CLIN NUTR, V67, P1111, DOI 10.1093/ajcn/67.6.1111; HAAGA JG, 1988, DEMOGRAPHY, V25, P307, DOI 10.2307/2061296; HAMOSH M, 1988, J PEDIATR GASTR NUTR, V7, P10, DOI 10.1097/00005176-198801000-00004; HAUNER H, 1995, EUR J CLIN INVEST, V25, P90, DOI 10.1111/j.1365-2362.1995.tb01532.x; Hilson JA, 1997, AM J CLIN NUTR, V66, P1371, DOI 10.1093/ajcn/66.6.1371; HIMES JH, 1994, AM J CLIN NUTR, V59, P307, DOI 10.1093/ajcn/59.2.307; Institute of Medicine, 1991, NUTR LACT; KARK JD, 1984, J EPIDEMIOL COMMUN H, V38, P218, DOI 10.1136/jech.38.3.218; KRAMER MS, 1981, J PEDIATR-US, V98, P883, DOI 10.1016/S0022-3476(81)80579-3; KUCZMARSKI RJ, 1994, JAMA-J AM MED ASSOC, V272, P205, DOI 10.1001/jama.272.3.205; LANTING CI, 1994, LANCET, V344, P1319, DOI 10.1016/S0140-6736(94)90692-0; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.2307/2336267; LUCAS A, 1980, LANCET, V1, P1267; LUCAS A, 1981, ACTA PAEDIATR SCAND, V70, P195, DOI 10.1111/j.1651-2227.1981.tb05541.x; MCGILL HC, 1996, NUTR REV, V54, P531; MUST A, 1992, NEW ENGL J MED, V327, P1350, DOI 10.1056/NEJM199211053271904; NEWCOMB PA, 1994, NEW ENGL J MED, V330, P81, DOI 10.1056/NEJM199401133300201; OCallaghan MJ, 1997, J PAEDIATR CHILD H, V33, P311, DOI 10.1111/j.1440-1754.1997.tb01607.x; RICHEDWARDS JW, 1994, AM J OBSTET GYNECOL, V171, P171, DOI 10.1016/0002-9378(94)90465-0; ROLLS BA, 1986, PHYSIOL BEHAV, V38, P185, DOI 10.1016/0031-9384(86)90153-8; RUTISHAUSER IHE, 1992, J EPIDEMIOL COMMUN H, V46, P559, DOI 10.1136/jech.46.6.559; SAMUELS SE, 1985, AM J CLIN NUTR, V42, P504, DOI 10.1093/ajcn/42.3.504; SHANNON B, 1991, J AM DIET ASSOC, V91, P675; Strauss RS, 1999, INT J OBESITY, V23, P904, DOI 10.1038/sj.ijo.0800971; Strbak V, 1991, Endocr Regul, V25, P53; Thorogood M, 1979, J R Coll Gen Pract, V29, P427; Tomeo CA, 1999, EPIDEMIOLOGY, V10, P774, DOI 10.1097/00001648-199911000-00022; Troiano RP, 1998, PEDIATRICS, V101, P497; TROIANO RP, 1995, ARCH PEDIAT ADOL MED, V149, P1085, DOI 10.1001/archpedi.1995.02170230039005; VOBECKY JS, 1988, J CLIN EPIDEMIOL, V41, P261, DOI 10.1016/0895-4356(88)90130-8; von Kries R, 1999, BRIT MED J, V319, P147, DOI 10.1136/bmj.319.7203.147; Whitaker RC, 1997, NEW ENGL J MED, V337, P869, DOI 10.1056/NEJM199709253371301; Whitaker RC, 1998, PEDIATRICS, V101, DOI 10.1542/peds.101.3.e5; Wilson AC, 1998, BMJ-BRIT MED J, V316, P21, DOI 10.1136/bmj.316.7124.21; ZIVE MM, 1992, AM J CLIN NUTR, V55, P1104, DOI 10.1093/ajcn/55.6.1104	52	482	509	3	48	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 16	2001	285	19					2461	2467		10.1001/jama.285.19.2461	http://dx.doi.org/10.1001/jama.285.19.2461			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	429ZC	11368698	Bronze			2022-12-24	WOS:000168547600027
J	Shimura, H; Schlossmacher, MC; Hattori, N; Frosch, MP; Trockenbacher, A; Schneider, R; Mizuno, Y; Kosik, KS; Selkoe, DJ				Shimura, H; Schlossmacher, MC; Hattori, N; Frosch, MP; Trockenbacher, A; Schneider, R; Mizuno, Y; Kosik, KS; Selkoe, DJ			Ubiquitination of a new form of alpha-synuclein by parkin from human brain: Implications for Parkinson's disease	SCIENCE			English	Article							RECESSIVE JUVENILE PARKINSONISM; PROTEIN LIGASE; SUBCELLULAR-LOCALIZATION; HIF-ALPHA; GENE; MUTATIONS; FIBRILLIZATION; HYDROXYLATION; FAMILIES; COMPLEX	Parkinson's disease (PD) is a common neurodegenerative disorder characterized by the progressive accumulation in selected neurons of protein inclusions containing alpha -synuclein and ubiquitin. Rare inherited forms of PD are caused by autosomal dominant mutations in alpha -synuclein or by autosomal recessive mutations in parkin, an E3 ubiquitin Ligase, We hypothesized that these two gene products interact functionally, namely, that parkin ubiquitinates alpha -synuclein normally and that this process is altered in autosomal recessive PD. We have now identified a protein complex in normal human brain that includes parkin as the E3 ubiquitin Ligase, UbcH7 as its associated E2 ubiquitin conjugating enzyme, and a new 22-kilodalton glycosylated form of alpha -synuclein (alpha Sp22) as its substrate. In contrast to normal parkin, mutant parkin associated with autosomal recessive PD failed to bind alpha Sp22. In an in vitro ubiquitination assay, alpha Sp22 Was modified by normal but not mutant parkin into polyubiquitinated, high molecular weight species. Accordingly, alpha Sp22 accumulated in a nonubiquitinated form in parkin-deficient PD brains. We conclude that alpha Sp22 is a substrate for parkin's ubiquitin Ligase activity in normal human brain and that Loss of parkin function causes pathological alpha Sp22 accumulation. These findings demonstrate a critical biochemical reaction between the two PD-Linked gene products and suggest that this reaction underlies the accumulation of ubiquitinated alpha -synuclein in conventional PD.	Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA; Juntendo Univ, Sch Med, Dept Neurol, Tokyo 113, Japan; Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Neurol, Boston, MA 02115 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pathol, Boston, MA 02115 USA; Univ Innsbruck, Inst Biochem, A-6020 Innsbruck, Austria	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Juntendo University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Innsbruck	Schlossmacher, MC (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA.	schloss@cnd.bwh.harvard.edu	Hattori, Nobutaka/ACR-0069-2022; Frosch, Matthew P/ABD-7456-2021; shimura, hideki/AAA-2864-2020	Frosch, Matthew P/0000-0002-3940-9861; Schlossmacher, Michael/0000-0002-0394-0300	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS038375] Funding Source: NIH RePORTER; NINDS NIH HHS [NS 38375, NS 02127] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Cummings CJ, 1999, NEURON, V24, P879, DOI 10.1016/S0896-6273(00)81035-1; Goldberg MS, 2000, NAT CELL BIOL, V2, pE115, DOI 10.1038/35017124; Hattori N, 1998, ANN NEUROL, V44, P935, DOI 10.1002/ana.410440612; Hattori N, 1998, BIOCHEM BIOPH RES CO, V249, P754, DOI 10.1006/bbrc.1998.9134; Hattori N, 2000, ADV RES NEURODEGENER, V8, P101; Hayashi S, 2000, MOVEMENT DISORD, V15, P884, DOI 10.1002/1531-8257(200009)15:5<884::AID-MDS1019>3.0.CO;2-8; Huynh DP, 2000, ANN NEUROL, V48, P737, DOI 10.1002/1531-8249(200011)48:5<737::AID-ANA7>3.3.CO;2-4; Imai Y, 2000, J BIOL CHEM, V275, P35661, DOI 10.1074/jbc.C000447200; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jiang YH, 1999, AM J HUM GENET, V65, P1, DOI 10.1086/302473; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; Kahle PJ, 2000, J NEUROSCI, V20, P6365, DOI 10.1523/JNEUROSCI.20-17-06365.2000; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lang AE, 1998, NEW ENGL J MED, V339, P1044, DOI 10.1056/NEJM199810083391506; Leroy E, 1998, NATURE, V395, P451, DOI 10.1038/26652; Lucking CB, 2000, NEW ENGL J MED, V342, P1560, DOI 10.1056/NEJM200005253422103; Mizuno Y, 1999, BIOMED PHARMACOTHER, V53, P109, DOI 10.1016/S0753-3322(99)80075-4; Mori H, 1998, NEUROLOGY, V51, P890, DOI 10.1212/WNL.51.3.890; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Rochet JC, 2000, BIOCHEMISTRY-US, V39, P10619, DOI 10.1021/bi001315u; SCHEFFNER M, 1993, CELL, V75, P495, DOI 10.1016/0092-8674(93)90384-3; SCHOSSMACHER MG, UNPUB; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Shimura H, 1999, ANN NEUROL, V45, P668, DOI 10.1002/1531-8249(199905)45:5<668::AID-ANA19>3.0.CO;2-Z; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; TAKAHASHI H, 1994, NEUROLOGY, V44, P437, DOI 10.1212/WNL.44.3_Part_1.437; Talis AL, 1998, J BIOL CHEM, V273, P6439, DOI 10.1074/jbc.273.11.6439; Tanaka K, 1998, MOL CELLS, V8, P503; Terreni L, 2001, NEUROLOGY, V56, P463, DOI 10.1212/WNL.56.4.463; TROJANOWSKI JQ, 1999, CELL DEATH DIFFER, V5, P823; van de Warrenburg BPC, 2001, NEUROLOGY, V56, P555, DOI 10.1212/WNL.56.4.555; Wells L, 2001, SCIENCE, V291, P2376, DOI 10.1126/science.1058714; Zhang Y, 2000, P NATL ACAD SCI USA, V97, P13354, DOI 10.1073/pnas.240347797	37	842	876	0	69	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 13	2001	293	5528					263	269		10.1126/science.1060627	http://dx.doi.org/10.1126/science.1060627			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	452TK	11431533				2022-12-24	WOS:000169875200048
J	Maas, R				Maas, R			Change of plasmid DNA structure, hypermethylation, and Lon-proteolysis as steps in a replicative cascade	CELL			English	Article							ESCHERICHIA-COLI; REPA1 PROTEIN; DAM METHYLTRANSFERASE; LEADER PEPTIDE; INITIATION; REPLICON; ORIR; RESOLUTION; INVITRO; BIOLOGY	I have defined conditions under which RepFIC plasmid DNA can be maintained in a state of lowered helical density. In exponentially growing cultures, the DNA of lowered helical density is present in small amounts but never totally absent, suggesting that it is; a normal variant of plasmid maintenance. It is fully methylated at frequent sites by dam-methyltransferase, some not previously recognized, further suggesting that the variant is a precursor of replication. The low-helical density plasmid is present in dam hosts, indicating that methylation is not essential for the change in helical density. The lowered helical density is stabilized in ion hosts, suggesting that Lon-protease may remove both the protein(s) that lower the helical density and the dam-methyltransferase after each round of replication.	NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA	New York University	Maas, R (corresponding author), NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA.				NIGMS NIH HHS [GM06048] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Berger I, 1996, P NATL ACAD SCI USA, V93, P12116, DOI 10.1073/pnas.93.22.12116; BLOMBERG P, 1992, EMBO J, V11, P2675, DOI 10.1002/j.1460-2075.1992.tb05333.x; BOYE E, 1990, CELL, V62, P981, DOI 10.1016/0092-8674(90)90272-G; CAMPBELL JL, 1990, CELL, V62, P967, DOI 10.1016/0092-8674(90)90271-F; Fu GK, 1997, J BIOL CHEM, V272, P534; JOHNSTON BH, 1985, CELL, V42, P713, DOI 10.1016/0092-8674(85)90268-5; Kornberg A., 1992, DNA REPLICATION; LU M, 1994, CELL, V77, P413, DOI 10.1016/0092-8674(94)90156-2; Maas R, 1997, J BACTERIOL, V179, P3823, DOI 10.1128/jb.179.12.3823-3827.1997; MAAS R, 1991, MOL MICROBIOL, V5, P927, DOI 10.1111/j.1365-2958.1991.tb00767.x; MAAS R, 1989, MOL GEN GENET, V218, P190, DOI 10.1007/BF00331268; Maas R, 1997, J BACTERIOL, V179, P2163, DOI 10.1128/jb.179.7.2163-2168.1997; MASAI H, 1989, J BIOL CHEM, V264, P8082; MASAI H, 1988, NUCLEIC ACIDS RES, V16, P6493, DOI 10.1093/nar/16.14.6493; MASAI H, 1983, P NATL ACAD SCI-BIOL, V80, P6814, DOI 10.1073/pnas.80.22.6814; Maxam A M, 1980, Methods Enzymol, V65, P499; PALMER BR, 1994, GENE, V143, P1, DOI 10.1016/0378-1119(94)90597-5; RICH A, 1984, ANNU REV BIOCHEM, V53, P791, DOI 10.1146/annurev.bi.53.070184.004043; SAADI S, 1987, J BACTERIOL, V169, P1836, DOI 10.1128/jb.169.5.1836-1846.1987; SCHELL MA, 1993, ANNU REV MICROBIOL, V47, P597, DOI 10.1146/annurev.micro.47.1.597; Stephens C, 1996, P NATL ACAD SCI USA, V93, P1210, DOI 10.1073/pnas.93.3.1210; WAGNER BM, 1987, J DRUG DEV S2, V1, P7; WANG AHJ, 1979, NATURE, V282, P680, DOI 10.1038/282680a0; WU RP, 1992, J BACTERIOL, V174, P7620, DOI 10.1128/JB.174.23.7620-7628.1992	24	12	13	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 29	2001	105	7					945	955		10.1016/S0092-8674(01)00402-0	http://dx.doi.org/10.1016/S0092-8674(01)00402-0			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	449BK	11439190	Bronze			2022-12-24	WOS:000169664300014
J	Coates, JD; Chakraborty, R; Lack, JG; O'Connor, SM; Cole, KA; Bender, KS; Achenbach, LA				Coates, JD; Chakraborty, R; Lack, JG; O'Connor, SM; Cole, KA; Bender, KS; Achenbach, LA			Anaerobic benzene oxidation coupled to nitrate reduction in pure culture by two strains of Dechloromonas	NATURE			English	Article							PETROLEUM-CONTAMINATED AQUIFER; POLYCYCLIC AROMATIC-HYDROCARBONS; SULFATE-REDUCING CONDITIONS; HARBOR SEDIMENTS; DEGRADATION; BIOREMEDIATION; TOLUENE; BIODEGRADATION; TRANSFORMATION; BACTERIUM	Benzene contamination is a significant problem. It is used in a wide range of manufacturing processes and is a primary component of petroleum-based fuels. Benzene is a hydrocarbon that is soluble, mobile, toxic and stable, especially in ground and surface waters. It is poorly biodegraded in the absence of oxygen. However, anaerobic benzene biodegradation has been documented under various conditions. Although benzene biomineralization has been demonstrated with nitrate(1), Fe(III)(2-5), sulphate(6,7) or CO28,9 as alternative electron acceptors, these studies were based on sediments or microbial enrichments. Until now there were no organisms in pure culture that degraded benzene anaerobically. Here we report two Dechloromonas strains, RCB and JJ, that can completely mineralize various mono-aromatic compounds including benzene to CO2 in the absence of O-2 with nitrate as the electron acceptor. This is the first example, to our knowledge, of an organism of any type that can oxidize benzene anaerobically, and we demonstrate the potential applicability of these organisms to the treatment of contaminated environments.	So Illinois Univ, Dept Microbiol, Carbondale, IL 62901 USA	Southern Illinois University System; Southern Illinois University	Coates, JD (corresponding author), So Illinois Univ, Dept Microbiol, Carbondale, IL 62901 USA.		Chakraborty, Romy/D-9230-2015	Chakraborty, Romy/0000-0001-9326-554X; Bender, Kelly/0000-0002-0025-2166				Achenbach LA, 2000, ASM NEWS, V66, P714; Achenbach LA, 2001, INT J SYST EVOL MICR, V51, P527, DOI 10.1099/00207713-51-2-527; Anderson R.T., 1999, BIOREMEDIAT J, V3, P121, DOI [DOI 10.1080/10889869991219271, 10.1080/10889869991219271]; Anderson RT, 2000, ENVIRON SCI TECHNOL, V34, P2261, DOI 10.1021/es991211a; Anderson RT, 1998, ENVIRON SCI TECHNOL, V32, P1222, DOI 10.1021/es9704949; Anderson RT, 1997, ADV MICROB ECOL, V15, P289; Bruce RA, 1999, ENVIRON MICROBIOL, V1, P319, DOI 10.1046/j.1462-2920.1999.00042.x; Burland SM, 1999, APPL ENVIRON MICROB, V65, P529; CHRISTENSEN TH, 1994, CRIT REV ENV SCI TEC, V24, P119, DOI 10.1080/10643389409388463; Coates J. D., 1999, BIOREMEDIAT J, V3, P323, DOI [10.1080/10889869991219415, DOI 10.1080/10889869991219415]; Coates JD, 1999, APPL ENVIRON MICROB, V65, P5234; Coates JD, 1996, APPL ENVIRON MICROB, V62, P1099, DOI 10.1128/AEM.62.3.1099-1101.1996; Coates JD, 1997, APPL ENVIRON MICROB, V63, P3589, DOI 10.1128/AEM.63.9.3589-3593.1997; Coates JD, 1996, APPL ENVIRON MICROB, V62, P1531, DOI 10.1128/AEM.62.5.1531-1536.1996; Coates JD, 1996, ENVIRON SCI TECHNOL, V30, P2784, DOI 10.1021/es9600441; Coates JD, 1998, NATURE, V396, P730, DOI 10.1038/25470; Galushko A, 1999, ENVIRON MICROBIOL, V1, P415; GRBICGALIC D, 1987, APPL ENVIRON MICROB, V53, P254; LOVLEY DR, 1994, NATURE, V370, P128, DOI 10.1038/370128a0; Lovley DR, 1997, J IND MICROBIOL BIOT, V18, P75, DOI 10.1038/sj.jim.2900246; Lovley DR, 1996, APPL ENVIRON MICROB, V62, P288, DOI 10.1128/AEM.62.1.288-291.1996; LOVLEY DR, 1995, APPL ENVIRON MICROB, V61, P953, DOI 10.1128/AEM.61.3.953-958.1995; LOVLEY DR, 1990, APPL ENVIRON MICROB, V56, P1858, DOI 10.1128/AEM.56.6.1858-1864.1990; Lovley DR, 1999, ENVIRON MICROBIOL, V1, P89, DOI 10.1046/j.1462-2920.1999.00009.x; RABUS R, 1993, APPL ENVIRON MICROB, V59, P1444, DOI 10.1128/AEM.59.5.1444-1451.1993; RIDGWAY HF, 1990, APPL ENVIRON MICROB, V56, P3565, DOI 10.1128/AEM.56.11.3565-3575.1990; Rooney-Varga JN, 1999, APPL ENVIRON MICROB, V65, P3056; VOGEL TM, 1986, APPL ENVIRON MICROB, V52, P200, DOI 10.1128/AEM.52.1.200-202.1986; Weiner JM, 1998, APPL ENVIRON MICROB, V64, P1937; Weiner JM, 1998, APPL ENVIRON MICROB, V64, P775	30	381	420	2	154	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 28	2001	411	6841					1039	1043		10.1038/35082545	http://dx.doi.org/10.1038/35082545			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	446TF	11429602				2022-12-24	WOS:000169528500045
J	Cheng, YZ; Endo, K; Wu, K; Rodan, AR; Heberlein, U; Davis, RL				Cheng, YZ; Endo, K; Wu, K; Rodan, AR; Heberlein, U; Davis, RL			Drosophila fasciclinII is required for the formation of odor memories and for normal sensitivity to alcohol	CELL			English	Article							CELL-ADHESION MOLECULES; LONG-TERM-MEMORY; GROWTH CONE GUIDANCE; DEPENDENT PROTEIN-KINASE; CAMP-RESPONSIVE ELEMENT; MUSHROOM BODIES; SYNAPTIC PLASTICITY; IMMUNOGLOBULIN SUPERFAMILY; PHARMACOLOGICAL EVIDENCE; PREFERENTIAL EXPRESSION	Drosophila fasciclinII (fasII) mutants perform poorly after olfactory conditioning due to a defect in encoding, stabilizing, or retrieving short-term memories. Performance was rescued by inducing the expression of a normal transgene just before training and immediate testing. Induction after training but before testing failed to rescue performance, showing that Fas II does not have an exclusive role in memory retrieval processes. The stability of odor memories in fasII mutants are indistinguishable from control animals when initial performance is normalized. Like several other muta nts deficient in odor learning, fasII mutants exhibit a heightened sensitivity to ethanol vapors. A combination of behavioral and genetic strategies have therefore revealed a role for Fas II in the molecular operations of encoding short-term odor memories and conferring alcohol sensitivity. The preferential expression of Fas II in the axons of mushroom body neurons furthermore suggests that short-term odor memories are formed in these neurites.	Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; Baylor Coll Med, Dept Psychiat & Behav Sci, Houston, TX 77030 USA; Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Program Biol Sci, San Francisco, CA 94143 USA	Baylor College of Medicine; Baylor College of Medicine; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Davis, RL (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.		Davis, Ronald/J-4998-2013	Davis, Ronald/0000-0002-5986-7608; Rodan, Aylin/0000-0001-9202-2378	NINDS NIH HHS [NS19904] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS019904, R01NS019904] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Bailey CH, 1996, P NATL ACAD SCI USA, V93, P13445, DOI 10.1073/pnas.93.24.13445; Beck CDO, 2000, J NEUROSCI, V20, P2944; Beggs HE, 1997, J BIOL CHEM, V272, P8310, DOI 10.1074/jbc.272.13.8310; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; Byrne JH, 1996, J NEUROSCI, V16, P425; CREMER H, 1994, NATURE, V367, P455, DOI 10.1038/367455a0; Crittenden JR, 1998, LEARN MEMORY, V5, P38; Crossin KL, 2000, DEV DYNAM, V218, P260, DOI 10.1002/(SICI)1097-0177(200006)218:2<260::AID-DVDY3>3.0.CO;2-9; DASH PK, 1990, NATURE, V345, P718, DOI 10.1038/345718a0; DAVIS RL, 1993, NEURON, V11, P1, DOI 10.1016/0896-6273(93)90266-T; DEBELLE JS, 1994, SCIENCE, V263, P692, DOI 10.1126/science.8303280; DOYLE E, 1992, J NEUROCHEM, V59, P1570, DOI 10.1111/j.1471-4159.1992.tb08477.x; DRAIN P, 1991, NEURON, V6, P71, DOI 10.1016/0896-6273(91)90123-H; GARCIAALONSO L, 1995, P NATL ACAD SCI USA, V92, P10501, DOI 10.1073/pnas.92.23.10501; GRENNINGLOH G, 1991, CELL, V67, P45, DOI 10.1016/0092-8674(91)90571-F; GRENNINGLOH G, 1990, COLD SPRING HARB SYM, V55, P323; Grotewiel MS, 1998, NATURE, V391, P455, DOI 10.1038/35079; Han PL, 1996, J NEUROBIOL, V31, P88, DOI 10.1002/(SICI)1097-4695(199609)31:1<88::AID-NEU8>3.0.CO;2-B; HAN PL, 1992, NEURON, V9, P619, DOI 10.1016/0896-6273(92)90026-A; HARRELSON AL, 1988, SCIENCE, V242, P700, DOI 10.1126/science.3187519; HARRIS RA, 1995, P NATL ACAD SCI USA, V92, P3658, DOI 10.1073/pnas.92.9.3658; Holmes AL, 1999, DEVELOPMENT, V126, P261; Holst BD, 1998, P NATL ACAD SCI USA, V95, P2597, DOI 10.1073/pnas.95.5.2597; Ito K, 1998, LEARN MEMORY, V5, P52; Lee T, 1999, DEVELOPMENT, V126, P4065; LEVIN LR, 1992, CELL, V68, P479, DOI 10.1016/0092-8674(92)90185-F; LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1; LIN DM, 1994, NEURON, V13, P1055, DOI 10.1016/0896-6273(94)90045-0; LUTHI A, 1994, NATURE, V372, P777, DOI 10.1038/372777a0; MALINOW R, 1988, NATURE, V335, P820, DOI 10.1038/335820a0; MALINOW R, 1989, SCIENCE, V245, P862, DOI 10.1126/science.2549638; Mansuy IM, 1998, CELL, V92, P39, DOI 10.1016/S0092-8674(00)80897-1; Mileusnic R, 1999, LEARN MEMORY, V6, P120; Moore MS, 1998, CELL, V93, P997, DOI 10.1016/S0092-8674(00)81205-2; Muller D, 1996, NEURON, V17, P413, DOI 10.1016/S0896-6273(00)80174-9; Murase S, 1999, CURR OPIN CELL BIOL, V11, P549, DOI 10.1016/S0955-0674(99)00019-8; NASSEL DR, 1992, CELL TISSUE RES, V267, P147, DOI 10.1007/BF00318701; Otmakhov N, 1997, J NEUROSCI, V17, P5357; Preat T, 1998, J NEUROSCI, V18, P8534; Riedel G, 1999, NAT NEUROSCI, V2, P898, DOI 10.1038/13202; ROMAN G, 2001, IN PRESS BIOESSAYS; ROSE SPR, 1995, TRENDS NEUROSCI, V18, P502, DOI 10.1016/0166-2236(95)92774-K; Schmid RS, 1999, J NEUROBIOL, V38, P542, DOI 10.1002/(SICI)1097-4695(199903)38:4<542::AID-NEU9>3.3.CO;2-T; SCHUCH U, 1989, NEURON, V3, P13, DOI 10.1016/0896-6273(89)90111-6; Schuster CM, 1996, NEURON, V17, P641, DOI 10.1016/S0896-6273(00)80197-X; Skoulakis EMC, 1996, NEURON, V17, P931, DOI 10.1016/S0896-6273(00)80224-X; SKOULAKIS EMC, 1993, NEURON, V11, P197, DOI 10.1016/0896-6273(93)90178-T; Waddell S, 2000, CELL, V103, P805, DOI 10.1016/S0092-8674(00)00183-5; WILSON C, 1989, GENE DEV, V3, P1301, DOI 10.1101/gad.3.9.1301; Winder DG, 1998, CELL, V92, P25, DOI 10.1016/S0092-8674(00)80896-X; Wright JW, 1999, DEVELOPMENT, V126, P3217; YIN JCP, 1994, CELL, V79, P49, DOI 10.1016/0092-8674(94)90399-9	53	105	108	1	11	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 15	2001	105	6					757	768		10.1016/S0092-8674(01)00386-5	http://dx.doi.org/10.1016/S0092-8674(01)00386-5			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	444AE	11440718	Bronze			2022-12-24	WOS:000169375100009
J	Kadotani, H; Kadotani, T; Young, T; Peppard, PE; Finn, L; Colrain, IM; Murphy, GM; Mignot, E				Kadotani, H; Kadotani, T; Young, T; Peppard, PE; Finn, L; Colrain, IM; Murphy, GM; Mignot, E			Association between apolipoprotein E epsilon 4 and sleep-disordered breathing in adults	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ALZHEIMERS-DISEASE; APNEA SYNDROME; HYPERTENSION	Context Apolipoprotein E epsilon4 (ApoE epsilon4) is a well-known risk factor for Alzheimer disease and cardiovascular disease. Sleep-disordered breathing occurs in Alzheimer disease patients and increases risks for cardiovascular disease. Complex interactions among sleep, brain pathology, and cardiovascular disease may occur in ApoE epsilon4 carriers, Objective To study whether genetic variation at the level of ApoE is associated with sleep-disordered breathing or sleep abnormalities in the general population. Design, Setting, and Participants Ongoing longitudinal cohort study of sleep disorders at a US university beginning in 1989, providing a population-based probability sample of 791 middle-aged adults (mean [SD] age, 49 [8] years; range, 32-68 years). Main Outcome Measure Nocturnal polysomnography to evaluate apnea-hypopnea index. Results The probability of moderate-to-severe sleep-disordered breathing (apnea-hypopnea index greater than or equal to 15%) was significantly higher in participants with epsilon4, independent of age, sex, body mass index, and ethnicity (12.0% vs 7.0%; P=.003). Mean (SEM) apnea-hypopnea index was also significantly higher in participants with ApoE epsilon4 (6.5 [0.6] vs 4.8 [0.3]; P=.01). These effects increased with the number of ApoE epsilon4 alleles carried. Conclusions A significant portion of sleep-disordered breathing is associated with ApoE epsilon4 in the general population.	Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Ctr Narcolepsy, Stanford, CA 94305 USA; Kobe Univ, Sch Med, Dept Pediat, Kobe, Hyogo 650, Japan; Univ Wisconsin, Dept Prevent Med, Madison, WI 53706 USA; Stanford Univ, Sleep Disorders Clin, Palo Alto, CA USA; Vet Affairs Sierra Pacific Mental Illness Res Edu, Palo Alto, CA USA	Stanford University; Kobe University; University of Wisconsin System; University of Wisconsin Madison; Stanford University	Mignot, E (corresponding author), Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Ctr Narcolepsy, Stanford, CA 94305 USA.		Kadotani, Hiroshi/A-7908-2015	Kadotani, Hiroshi/0000-0001-7474-3315	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR003186] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062252] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH040041] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS023724] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG014124, T32AG000164] Funding Source: NIH RePORTER; NCRR NIH HHS [M01 RR03186] Funding Source: Medline; NHLBI NIH HHS [R01HL62252] Funding Source: Medline; NIA NIH HHS [R01 AG14124, T32 AG00164] Funding Source: Medline; NIMH NIH HHS [P30 MH40041] Funding Source: Medline; NINDS NIH HHS [P50 NS23724] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Asada T, 2000, SLEEP, V23, P629; Bassetti C, 1999, SLEEP, V22, P217, DOI 10.1093/sleep/22.2.217; Engleman HM, 2000, SLEEP, V23, pS102; GUILLEMINAULT C, 1995, CHEST, V107, P1545, DOI 10.1378/chest.107.6.1545; Guilleminault C, 2000, NEUROLOGY, V54, P653, DOI 10.1212/WNL.54.3.653; Mahley RW, 1999, CURR OPIN LIPIDOL, V10, P207, DOI 10.1097/00041433-199906000-00003; MONTPLAISIR J, 1992, SLEEP, V15, pS17, DOI 10.1093/sleep/15.suppl_6.S17; Murphy GM, 1997, AM J PSYCHIAT, V154, P603; Nieto FJ, 2000, JAMA-J AM MED ASSOC, V283, P1829, DOI 10.1001/jama.283.14.1829; Peppard PE, 2000, JAMA-J AM MED ASSOC, V284, P3015, DOI 10.1001/jama.284.23.3015; Peppard PE, 2000, NEW ENGL J MED, V342, P1378, DOI 10.1056/NEJM200005113421901; PETIT D, 1993, NEUROBIOL AGING, V14, P141, DOI 10.1016/0197-4580(93)90089-T; PRINZ PN, 1982, J AM GERIATR SOC, V30, P86, DOI 10.1111/j.1532-5415.1982.tb01279.x; REDLINE S, 1995, AM J RESP CRIT CARE, V151, P682; Redline S, 1997, AM J RESP CRIT CARE, V155, P186, DOI 10.1164/ajrccm.155.1.9001310; Saarelainen S, 1998, CLIN GENET, V53, P147; SIEST G, 1995, CLIN CHEM, V41, P1068; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704; Young T, 2000, SLEEP, V23, pS122	19	173	182	0	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 13	2001	285	22					2888	2890		10.1001/jama.285.22.2888	http://dx.doi.org/10.1001/jama.285.22.2888			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	440BP	11401610	Bronze			2022-12-24	WOS:000169156300028
J	Sandalow, DB; Bowles, IA				Sandalow, DB; Bowles, IA			Climate change - Fundamentals of treaty-making on climate change	SCIENCE			English	Article									World Resources Inst, Washington, DC 20002 USA; Harvard Univ, John F Kennedy Sch Govt, Cambridge, MA 02138 USA; Conservat Int, Ctr Appl Biodivers Sci, Washington, DC 20036 USA	Harvard University; Conservation International	Sandalow, DB (corresponding author), World Resources Inst, 10 G St NE, Washington, DC 20002 USA.							AUSTIN D, 1998, CONTRIBUTIONS CLIMAT; CROWLEY T, 1991, SERIES GEOLOGY GEOPH, V18; *DOE, 2001, INT EN ANN 1999; Hansen J, 2000, P NATL ACAD SCI USA, V97, P9875, DOI 10.1073/pnas.170278997; HOUGHTON JT, 1990, SUMMARY POLICYMAKERS; *INT EN AG, 1998, EN STAT BAL OECD NON; IPCC, 2013, SUMM POL CLIM CHANG; ONEILL P, 1998, SPRING M AL ASS WASH; *UN, 1998, KYOT PROT UN FRAM CO; UN, 1992, FRAM CONV CLIM CHANG; United Nations, 1987, MONTR PROT SUBST DEP; US Department of Energy Energy Information Administration, 2001, INT EN OUTL 2001; Watson RT, 2000, LAND USE LAND USE CH	13	8	8	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 8	2001	292	5523					1839	1840		10.1126/science.1062174	http://dx.doi.org/10.1126/science.1062174			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	440WY	11397932				2022-12-24	WOS:000169200700025
J	Arp, G; Reimer, A; Reitner, J				Arp, G; Reimer, A; Reitner, J			Photosynthesis-induced biofilm calcification and calcium concentrations in phanerozoic oceans	SCIENCE			English	Article							ALKALINE SALT LAKES; CARBONATE MINERALOGY; SEAWATER CHEMISTRY; CYANOBACTERIA	Photosynthetic carbon assimilation is commonly invoked as the cause of calcium carbonate precipitation in cyanobacterial biofilms that results in the formation of calcareous stromatolites. However, biofilm calcification patterns in recent lakes and simulation of photosynthetically induced rise in calcium carbonate supersaturation demonstrate that this mechanism applies only in settings Low in dissolved inorganic carbon and high in calcium. Taking into account paleo-partial pressure curves for carbon dioxide, we show that Phanerozoic oceans sustaining calcified cyanobacteria must have had considerably higher calcium concentrations than oceans of today. In turn, the enigmatic lack of calcified cyanobacteria in stromatolite-bearing Precambrian sequences can now be explained as a result of high dissolved inorganic carbon concentrations.	Univ Gottingen, Gottinger Zentrum Geowissensch, Abt Geobiol, D-37077 Gottingen, Germany	University of Gottingen	Arp, G (corresponding author), Univ Gottingen, Gottinger Zentrum Geowissensch, Abt Geobiol, Goldschmidtstr 3, D-37077 Gottingen, Germany.	garp@gwdg.de						[Anonymous], 1994, EARLY LIFE EARTH; Arp G, 1999, SEDIMENT GEOL, V126, P159, DOI 10.1016/S0037-0738(99)00038-X; Arp G, 1999, EUR J PHYCOL, V34, P393, DOI 10.1017/S0967026299002292; Arp G, 1998, PALAIOS, V13, P581, DOI 10.2307/3515349; AWRAMIK SM, 1971, SCIENCE, V174, P825, DOI 10.1126/science.174.4011.825; Berner RA, 1998, PHILOS T ROY SOC B, V353, P75, DOI 10.1098/rstb.1998.0192; BERTRANDSARFATI J, 1981, PRECAMBRIAN RES, V15, P353, DOI 10.1016/0301-9268(81)90057-7; DECHO AW, 1990, OCEANOGR MAR BIOL, V28, P73; Ekart DD, 1999, AM J SCI, V299, P805, DOI 10.2475/ajs.299.10.805; Gebelein C. D., 1976, STROMATOLITES, P499; Grotzinger JP, 1996, NATURE, V383, P423, DOI 10.1038/383423a0; GROTZINGER JP, 1993, J GEOL, V101, P235, DOI 10.1086/648218; Hardie LA, 1996, GEOLOGY, V24, P279, DOI 10.1130/0091-7613(1996)024<0279:SVISCA>2.3.CO;2; Kempe Stephan, 1994, Bulletin de l'Institut Oceanographique Numero Special (Monaco), V13, P61; KNOLL AH, 1993, PALAIOS, V8, P512, DOI 10.2307/3515029; Knoll AH, 1992, EARLY ORGANIC EVOLUT, P450, DOI DOI 10.1007/978-3-642-76884-2_35; Laval B, 2000, NATURE, V407, P626, DOI 10.1038/35036579; Mann S., 1989, BIOMINERALIZATION CH; Merz M.U., 1992, FACIES, V26, P81, DOI [10.1007/BF02539795, DOI 10.1007/BF02539795]; PARKHURST D, 1990, 8096 US GEOL SURV; PENTECOST A, 1985, GEOMICROBIOL J, V4, P285, DOI 10.1080/01490458509385936; PENTECOST A, 1986, BIOMINERALIZATION LO, P73; RIDING R, 1992, J GEOL SOC LONDON, V149, P979, DOI 10.1144/gsjgs.149.6.0979; RIDING R, 1982, NATURE, V299, P814, DOI 10.1038/299814a0; RIDING R, 1977, Palaeontology (Oxford), V20, P33; Riding R., 1991, CALCAREOUS ALGAE STR, DOI DOI 10.1007/978-3-642-52335-9_2; RIDING R, 1994, EARLY LIFE EARTH, P426; SANDBERG PA, 1983, NATURE, V305, P19, DOI 10.1038/305019a0; Simkiss K, 1989, BIOMINERALIZATION CE; Stanley SM, 1998, PALAEOGEOGR PALAEOCL, V144, P3, DOI 10.1016/S0031-0182(98)00109-6; Stumm W, 1996, AQUATIC CHEM; Thompson JB, 1997, LIMNOL OCEANOGR, V42, P133	32	342	389	3	91	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 1	2001	292	5522					1701	1704		10.1126/science.1057204	http://dx.doi.org/10.1126/science.1057204			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	438AP	11387471				2022-12-24	WOS:000169031800040
J	Bence, NF; Sampat, RM; Kopito, RR				Bence, NF; Sampat, RM; Kopito, RR			Impairment of the ubiquitin-proteasome system by protein aggregation	SCIENCE			English	Article							MULTICATALYTIC PROTEINASE; GLUTAMINE REPEATS; DEGRADATION; NEURODEGENERATION; PROTEOLYSIS; INHIBITOR; DISEASE; ARREST; CELLS; SCA1	Intracellular deposition of aggregated and ubiquitylated proteins is a prominent cytopathological feature of most neurodegenerative disorders. Whether protein aggregates themselves are pathogenic or are the consequence of an underlying molecular lesion is unclear. Here, we report that protein aggregation directly impaired the function of the ubiquitin-proteasome system. Transient expression of two unrelated aggregation-prone proteins, a huntingtin fragment containing a pathogenic polyglutamine repeat and a folding mutant of cystic fibrosis transmembrane conductance regulator, caused nearly complete inhibition of the ubiquitin-proteasome system. Because of the central role of ubiquitin-dependent proteolysis in regulating fundamental cellular events such as cell division and apoptosis, our data suggest a potential mechanism Linking protein aggregation to cellular disregulation and cell death.	Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA	Stanford University	Kopito, RR (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.							Akopian TN, 1997, J BIOL CHEM, V272, P1791, DOI 10.1074/jbc.272.3.1791; Bercovich B, 1997, J BIOL CHEM, V272, P9002; Ciechanover A, 2000, BIOESSAYS, V22, P442, DOI 10.1002/(SICI)1521-1878(200005)22:5<442::AID-BIES6>3.0.CO;2-Q; Cummings CJ, 1999, NEURON, V24, P879, DOI 10.1016/S0896-6273(00)81035-1; Cummings CJ, 1998, NAT GENET, V19, P148, DOI 10.1038/502; Fernandez-Funez P, 2000, NATURE, V408, P101, DOI 10.1038/35040584; FINLEY D, 1984, CELL, V37, P43, DOI 10.1016/0092-8674(84)90299-X; Garcia-Mata R, 1999, J CELL BIOL, V146, P1239, DOI 10.1083/jcb.146.6.1239; Gilon T, 1998, EMBO J, V17, P2759, DOI 10.1093/emboj/17.10.2759; HOWARD M, 1995, AM J PHYSIOL, V269, pC1595; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Kopito Ron R., 1999, Physiological Reviews, V79, pS167; KWAK S, 1991, NEUROSCI LETT, V128, P21, DOI 10.1016/0304-3940(91)90751-E; Leroy E, 1998, NATURE, V395, P451, DOI 10.1038/26652; Mayer R J, 1989, Prog Clin Biol Res, V317, P809; PERUTZ MF, 1994, P NATL ACAD SCI USA, V91, P5355, DOI 10.1073/pnas.91.12.5355; Raina A K, 2000, Prog Cell Cycle Res, V4, P235; Saigoh K, 1999, NAT GENET, V23, P47, DOI 10.1038/12647; Schulz JB, 1999, CURR OPIN NEUROL, V12, P433, DOI 10.1097/00019052-199908000-00010; SHERWOOD SW, 1993, P NATL ACAD SCI USA, V90, P3353, DOI 10.1073/pnas.90.8.3353; Wigley WC, 1999, J CELL BIOL, V145, P481; Wojcik C, 1996, EUR J CELL BIOL, V70, P172; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	24	1704	1762	2	168	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 25	2001	292	5521					1552	1555		10.1126/science.292.5521.1552	http://dx.doi.org/10.1126/science.292.5521.1552			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YQ	11375494				2022-12-24	WOS:000168963800047
J	Elbashir, SM; Harborth, J; Lendeckel, W; Yalcin, A; Weber, K; Tuschl, T				Elbashir, SM; Harborth, J; Lendeckel, W; Yalcin, A; Weber, K; Tuschl, T			Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells	NATURE			English	Article							DOUBLE-STRANDED-RNA; DROSOPHILA CELLS; PROTEIN-KINASE; GENE; METHYLATION; INHIBITION	RNA interference (RNAi) is the process of sequence-specific, post-transcriptional gene silencing in animals and plants, initiated by double-stranded RNA (dsRNA) that is homologous in sequence to the silenced gene(1-4). The mediators of sequence-specific messenger RNA degradation are 21- and 22-nucleotide small interfering RNAs (siRNAs) generated by ribonuclease III cleavage from longer dsRNAs(5-9). Here we show that 21-nucleotide siRNA duplexes specifically suppress expression of endogenous and heterologous genes in different mammalian cell lines, including human embryonic kidney (293) and HeLa cells. Therefore, 21-nucleotide siRNA duplexes provide a new tool for studying gene function in mammalian cells and may eventually be used as gene-specific therapeutics.	Max Planck Inst Biophys Chem, Dept Cellular Biochem, D-37033 Gottingen, Germany; Max Planck Inst Biophys Chem, Dept Biochem & Cell Biol, D-37033 Gottingen, Germany	Max Planck Society; Max Planck Society	Tuschl, T (corresponding author), Max Planck Inst Biophys Chem, Dept Cellular Biochem, Fassberg 11, D-37033 Gottingen, Germany.		Yalcin, Abdullah/AAG-4175-2019; hu, jenny/AAK-8712-2020	Yalcin, Abdullah/0000-0001-8604-4749; 				Bahramian MB, 1999, MOL CELL BIOL, V19, P274; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Caplen NJ, 2000, GENE, V252, P95, DOI 10.1016/S0378-1119(00)00224-9; Clemens JC, 2000, P NATL ACAD SCI USA, V97, P6499, DOI 10.1073/pnas.110149597; CLEMENS MJ, 1978, CELL, V13, P565, DOI 10.1016/0092-8674(78)90329-X; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Fire A, 1999, TRENDS GENET, V15, P358, DOI 10.1016/S0168-9525(99)01818-1; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Hammond SM, 2001, NAT REV GENET, V2, P110, DOI 10.1038/35052556; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Harborth J, 1999, EMBO J, V18, P1689, DOI 10.1093/emboj/18.6.1689; Kehlenbach RH, 1998, J CELL BIOL, V141, P863, DOI 10.1083/jcb.141.4.863; KREIS T, 1999, GUIDEBOOK CYTOSKE 2B; KREIS T, 1999, GUIDEBOOK CYTOSKE 3A; Macejak DG, 2000, HEPATOLOGY, V31, P769, DOI 10.1002/hep.510310331; MANCHE L, 1992, MOL CELL BIOL, V12, P5238, DOI 10.1128/MCB.12.11.5238; Mette MF, 2000, EMBO J, V19, P5194, DOI 10.1093/emboj/19.19.5194; MINKS MA, 1979, J BIOL CHEM, V254, P180; Parrish S, 2000, MOL CELL, V6, P1077, DOI 10.1016/S1097-2765(00)00106-4; Razin A, 1998, EMBO J, V17, P4905, DOI 10.1093/emboj/17.17.4905; ROBER RA, 1990, EXP CELL RES, V190, P185, DOI 10.1016/0014-4827(90)90184-C; Sharp PA, 2001, GENE DEV, V15, P485, DOI 10.1101/gad.880001; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Sullivan T, 1999, J CELL BIOL, V147, P913, DOI 10.1083/jcb.147.5.913; Svoboda P, 2000, DEVELOPMENT, V127, P4147; Tuschl T, 2001, CHEMBIOCHEM, V2, P239, DOI 10.1002/1439-7633(20010401)2:4<239::AID-CBIC239>3.3.CO;2-I; Ui-Tei K, 2000, FEBS LETT, V479, P79, DOI 10.1016/S0014-5793(00)01883-4; Wang MB, 2001, RNA, V7, P16, DOI 10.1017/S1355838201001224; Wassenegger M, 2000, PLANT MOL BIOL, V43, P203, DOI 10.1023/A:1006479327881; Wianny F, 2000, NAT CELL BIOL, V2, P70, DOI 10.1038/35000016; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0	31	7404	9465	35	1109	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 24	2001	411	6836					494	498		10.1038/35078107	http://dx.doi.org/10.1038/35078107			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	435CB	11373684				2022-12-24	WOS:000168858700053
J	Brejc, K; van Dijk, WJ; Klaassen, RV; Schuurmans, M; van der Oost, J; Smit, AB; Sixma, TK				Brejc, K; van Dijk, WJ; Klaassen, RV; Schuurmans, M; van der Oost, J; Smit, AB; Sixma, TK			Crystal structure of an ACh-binding protein reveals the ligand-binding domain of nicotinic receptors	NATURE			English	Article							TORPEDO ACETYLCHOLINE-RECEPTOR; MAIN IMMUNOGENIC REGION; ALPHA-SUBUNIT; MOLECULAR DISSECTION; EXTRACELLULAR DOMAIN; IDENTIFICATION; SITE; RESIDUES; AGONIST; LOCATION	Pentameric ligand gated ion-channels, or Cys-loop receptors, mediate rapid chemical transmission of signals. This superfamily of allosteric transmembrane proteins includes the nicotinic acetylcholine (nAChR), serotonin 5-HT3, gamma -aminobutyric-acid (GABA(A) and GABA(C)) and glycine receptors. Biochemical and electrophysiological information on the prototypic nAChRs is abundant but structural data at atomic resolution have been missing. Here we present the crystal structure of molluscan acetylcholine-binding protein (AChBP), a structural and functional homologue of the amino-terminal ligand-binding domain of an nAChR alpha -subunit. In the AChBP homopentamer, the protomers have an immunoglobulin-like topology. Ligand-binding sites are located at each of five subunit interfaces and contain residues contributed by biochemically determined 'loops' A to F. The subunit interfaces are highly variable within the ion-channel family, whereas the conserved residues stabilize the protomer fold. This AChBP structure is relevant for the development of drugs against, for example, Alzheimer's disease and nicotine addiction.	Netherlands Canc Inst, Div Mol Carcinogenesis, NL-1066 CX Amsterdam, Netherlands; Free Univ Amsterdam, Fac Biol, Neurosci Res Inst, Dept Mol & Cellular Neurobiol, NL-1081 HV Amsterdam, Netherlands	Netherlands Cancer Institute; Vrije Universiteit Amsterdam	Sixma, TK (corresponding author), Netherlands Canc Inst, Div Mol Carcinogenesis, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	sixma@nki.nl	van+der+Oost, John/Y-2548-2019; Smit, August B/E-8410-2011	Sixma, Titia K/0000-0001-6180-0632				Alexeev T, 1999, EUR J BIOCHEM, V259, P310, DOI 10.1046/j.1432-1327.1999.00041.x; Arias HR, 2000, NEUROCHEM INT, V36, P595, DOI 10.1016/S0197-0186(99)00154-0; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BEROUKHIM R, 1995, NEURON, V15, P323, DOI 10.1016/0896-6273(95)90037-3; BORK P, 1994, J MOL BIOL, V242, P309, DOI 10.1006/jmbi.1994.1582; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Changeux JP, 1998, NEURON, V21, P959, DOI 10.1016/S0896-6273(00)80616-9; CORRINGER PJ, 1995, J BIOL CHEM, V270, P11749, DOI 10.1074/jbc.270.20.11749; Corringer PJ, 2000, ANNU REV PHARMACOL, V40, P431, DOI 10.1146/annurev.pharmtox.40.1.431; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; CZAJKOWSKI C, 1993, P NATL ACAD SCI USA, V90, P6285, DOI 10.1073/pnas.90.13.6285; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; DENNIS M, 1988, BIOCHEMISTRY-US, V27, P2346, DOI 10.1021/bi00407a016; Dougherty DA, 1996, SCIENCE, V271, P163, DOI 10.1126/science.271.5246.163; EISELE JL, 1993, NATURE, V366, P479, DOI 10.1038/366479a0; FU DX, 1994, J BIOL CHEM, V269, P26152; Galzi JL, 1996, EMBO J, V15, P5824, DOI 10.1002/j.1460-2075.1996.tb00969.x; GALZI JL, 1990, J BIOL CHEM, V265, P10430; Green WN, 1998, J NEUROSCI, V18, P5555; HAREL M, 1993, P NATL ACAD SCI USA, V90, P9031, DOI 10.1073/pnas.90.19.9031; HEMMINGSEN JM, 1994, PROTEIN SCI, V3, P1927, DOI 10.1002/pro.5560031104; Holm L, 1997, NUCLEIC ACIDS RES, V25, P231, DOI 10.1093/nar/25.1.231; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KAO PN, 1986, J BIOL CHEM, V261, P8085; Kleywegt GJ, 1994, 1 MAP FINAL MODEL, P59; Le Novere N, 1999, BIOPHYS J, V76, P2329, DOI 10.1016/S0006-3495(99)77390-X; Leslie AGW, 1999, ACTA CRYSTALLOGR D, V55, P1696, DOI 10.1107/S090744499900846X; MACHOLD J, 1995, EUR J BIOCHEM, V234, P427, DOI 10.1111/j.1432-1033.1995.427_b.x; Martin M, 1996, J BIOL CHEM, V271, P13497, DOI 10.1074/jbc.271.23.13497; MIDDLETON RE, 1991, BIOCHEMISTRY-US, V30, P6987, DOI 10.1021/bi00242a026; MISHINA M, 1985, NATURE, V313, P364, DOI 10.1038/313364a0; Miyazawa A, 1999, J MOL BIOL, V288, P765, DOI 10.1006/jmbi.1999.2721; OLEARY ME, 1994, AM J PHYSIOL, V266, pC648, DOI 10.1152/ajpcell.1994.266.3.C648; ORTELLS MO, 1995, TRENDS NEUROSCI, V18, P121, DOI 10.1016/0166-2236(95)93887-4; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paterson D, 2000, PROG NEUROBIOL, V61, P75, DOI 10.1016/S0301-0082(99)00045-3; Prince RJ, 1996, J BIOL CHEM, V271, P25770, DOI 10.1074/jbc.271.42.25770; Schrattenholz A, 1998, J BIOL CHEM, V273, P32393, DOI 10.1074/jbc.273.49.32393; SINE SM, 1995, NEURON, V15, P205, DOI 10.1016/0896-6273(95)90077-2; Smit AB, 2001, NATURE, V411, P261, DOI 10.1038/35077000; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tierney ML, 2000, J MOL BIOL, V303, P185, DOI 10.1006/jmbi.2000.4137; TZARTOS SJ, 1991, MOL NEUROBIOL, V5, P1, DOI 10.1007/BF02935610; UNWIN N, 1995, NATURE, V373, P37, DOI 10.1038/373037a0; UNWIN N, 1993, J MOL BIOL, V229, P1101, DOI 10.1006/jmbi.1993.1107; VALENZUELA CF, 1994, BIOPHYS J, V66, P674, DOI 10.1016/S0006-3495(94)80841-0; Wells GB, 1998, J BIOL CHEM, V273, P964, DOI 10.1074/jbc.273.2.964; West AP, 1997, J BIOL CHEM, V272, P25468, DOI 10.1074/jbc.272.41.25468; Zhong WG, 1998, P NATL ACAD SCI USA, V95, P12088, DOI 10.1073/pnas.95.21.12088	50	1527	1568	6	232	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 17	2001	411	6835					269	276		10.1038/35077011	http://dx.doi.org/10.1038/35077011			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432RT	11357122				2022-12-24	WOS:000168710000037
J	Goodman, S				Goodman, S			Battle to save beleaguered beluga	NATURE			English	News Item																			0	1	1	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 12	2001	412	6843					108	108		10.1038/35084355	http://dx.doi.org/10.1038/35084355			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	451AJ	11449227	Bronze			2022-12-24	WOS:000169778700009
J	Logothetis, NK; Pauls, J; Augath, M; Trinath, T; Oeltermann, A				Logothetis, NK; Pauls, J; Augath, M; Trinath, T; Oeltermann, A			Neurophysiological investigation of the basis of the fMRI signal	NATURE			English	Article							VISUAL-CORTEX; HUMAN BRAIN; NEURONAL-ACTIVITY; GLUCOSE-METABOLISM; BLOOD OXYGENATION; TEMPORAL BINDING; EEG; ACTIVATION; OSCILLATIONS; STIMULATION	Functional magnetic resonance imaging (fMRI) is widely used to study the operational organization of the human brain, but the exact relationship between the measured fMRI signal and the underlying neural activity is unclear. Here we present simultaneous intracortical recordings of neural signals and fMRI responses. We compared local field potentials (LFPs), single- and multi-unit spiking activity with highly spatio-temporally resolved blood-oxygen-level-dependent (BOLD) fMRI responses from the visual cortex of monkeys. The largest magnitude changes were observed in LFPs, which at recording sites characterized by transient responses were the only signal that significantly correlated with the haemodynamic response. Linear systems analysis on a trial-by-trial basis showed that the impulse response of the neurovascular system is both animal- and site-specific, and that LFPs yield a better estimate of BOLD responses than the multi-unit responses. These findings suggest that the BOLD contrast mechanism reflects the input and intracortical processing of a given area rather than its spiking output.	Max Planck Inst Biol Cybernet, D-72076 Tubingen, Germany	Max Planck Society	Logothetis, NK (corresponding author), Max Planck Inst Biol Cybernet, Spemannstr 38, D-72076 Tubingen, Germany.		Mandelkow, Hendrik/AAQ-2583-2021; anand, amit/A-7222-2009; Logothetis, Nikos/U-9282-2019	Mandelkow, Hendrik/0000-0003-0274-3599; 				BANDETTINI PA, 1992, MAGNET RESON MED, V25, P390, DOI 10.1002/mrm.1910250220; Bonhoeffer Tobias, 1996, P55; Bonmassar G, 1999, NEUROREPORT, V10, P1893, DOI 10.1097/00001756-199906230-00018; Boynton GM, 1999, VISION RES, V39, P257, DOI 10.1016/S0042-6989(98)00113-8; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Buxton RB, 1998, MAGNET RESON MED, V39, P855, DOI 10.1002/mrm.1910390602; Carandini M, 1997, J NEUROSCI, V17, P8621; Clarke DD, 1989, BASIC NEUROCHEMISTRY, P565; ECKHORN R, 1993, J NEUROSCI METH, V49, P175, DOI 10.1016/0165-0270(93)90121-7; ECKHORN R, 1988, BIOL CYBERN, V60, P121, DOI 10.1007/BF00202899; FRAHM J, 1992, JMRI-J MAGN RESON IM, V2, P501, DOI 10.1002/jmri.1880020505; Frahm J, 1996, MAGNET RESON MED, V35, P143, DOI 10.1002/mrm.1910350202; Freeman WJ, 1975, MASS ACTION NERVOUS; GRAY CM, 1989, P NATL ACAD SCI USA, V86, P1698, DOI 10.1073/pnas.86.5.1698; GRUETTER R, 1993, MAGNET RESON MED, V29, P804, DOI 10.1002/mrm.1910290613; HAASE A, 1986, J MAGN RESON, V67, P258, DOI 10.1016/0022-2364(86)90433-6; Hess A, 2000, J NEUROSCI, V20, P3328, DOI 10.1523/JNEUROSCI.20-09-03328.2000; Hu XP, 1997, MAGNET RESON MED, V37, P877, DOI 10.1002/mrm.1910370612; JOLIOT M, 1994, P NATL ACAD SCI USA, V91, P11748, DOI 10.1073/pnas.91.24.11748; Juergens E, 1999, EXP BRAIN RES, V129, P247, DOI 10.1007/s002210050895; Krakow K, 1999, BRAIN, V122, P1679, DOI 10.1093/brain/122.9.1679; Krakow K, 2000, HUM BRAIN MAPP, V10, P10, DOI 10.1002/(SICI)1097-0193(200005)10:1<10::AID-HBM20>3.0.CO;2-T; Kruger G, 1996, MAGNET RESON MED, V35, P797, DOI 10.1002/mrm.1910350602; KWONG KK, 1992, P NATL ACAD SCI USA, V89, P5675, DOI 10.1073/pnas.89.12.5675; LEGATT AD, 1980, J NEUROSCI METH, V2, P203, DOI 10.1016/0165-0270(80)90061-8; Logothetis NK, 1999, NAT NEUROSCI, V2, P555, DOI 10.1038/9210; Magistretti PJ, 1999, SCIENCE, V283, P496, DOI 10.1126/science.283.5401.496; Malonek D, 1996, SCIENCE, V272, P551, DOI 10.1126/science.272.5261.551; Mansfield P., 1977, J PHYS C SOLID STATE, V10, P55, DOI 10.1088/0022-3719/10/3/004; MENON RS, 1992, INVEST RADIOL S, V27, P53; Menon V, 1997, NEUROREPORT, V8, P3029, DOI 10.1097/00001756-199709290-00007; MITZDORF U, 1987, INT J NEUROSCI, V33, P33, DOI 10.3109/00207458708985928; MURTHY VN, 1992, P NATL ACAD SCI USA, V89, P5670, DOI 10.1073/pnas.89.12.5670; OGAWA S, 1990, MAGNET RESON MED, V16, P9, DOI 10.1002/mrm.1910160103; Pan JW, 2000, MAGNET RESON MED, V44, P673, DOI 10.1002/1522-2594(200011)44:5<673::AID-MRM3>3.0.CO;2-L; PELLERIN L, 1994, P NATL ACAD SCI USA, V91, P10625, DOI 10.1073/pnas.91.22.10625; Rainer G, 2001, CURR BIOL, V11, P846, DOI 10.1016/S0960-9822(01)00242-1; Rees G, 2000, NAT NEUROSCI, V3, P716, DOI 10.1038/76673; Rothman DL, 1999, PHILOS T R SOC B, V354, P1165, DOI 10.1098/rstb.1999.0472; Schmitt F., 1998, ECHO PLANAR IMAGING; SCLAR G, 1990, VISION RES, V30, P1, DOI 10.1016/0042-6989(90)90123-3; Shadlen MN, 1999, NEURON, V24, P67, DOI 10.1016/S0896-6273(00)80822-3; Shulman RG, 1998, P NATL ACAD SCI USA, V95, P11993, DOI 10.1073/pnas.95.20.11993; Sibson NR, 1998, P NATL ACAD SCI USA, V95, P316, DOI 10.1073/pnas.95.1.316; SINGER W, 1993, ANNU REV PHYSIOL, V55, P349, DOI 10.1146/annurev.physiol.55.1.349; Singer W, 1999, NEURON, V24, P49, DOI 10.1016/S0896-6273(00)80821-1; TAKAHASHI S, 1995, P NATL ACAD SCI USA, V92, P4616, DOI 10.1073/pnas.92.10.4616; TallonBaudry C, 1997, NEUROREPORT, V8, P1103, DOI 10.1097/00001756-199703240-00008; [No title captured]; [No title captured]	50	4299	4388	14	591	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 12	2001	412	6843					150	157		10.1038/35084005	http://dx.doi.org/10.1038/35084005			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	451AJ	11449264				2022-12-24	WOS:000169778700042
J	Zeki, S				Zeki, S			Artistic creativity and the Brain	SCIENCE			English	Article									UCL, Dept Cognit Neurol, London WC1E 6BT, England; Wellcome Dept Cognit Neurol, London, England	University of London; University College London; University of London; University College London	Zeki, S (corresponding author), UCL, Dept Cognit Neurol, Mortimer St, London WC1E 6BT, England.	zeki.pa@ucl.ac.uk	Zeki, Semir/AAA-1789-2020						0	97	104	2	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 6	2001	293	5527					51	52		10.1126/science.1062331	http://dx.doi.org/10.1126/science.1062331			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	451BB	11441167				2022-12-24	WOS:000169780300019
J	Schiermeier, Q				Schiermeier, Q			Imported stem cells deepen Germany's ethical divide	NATURE			English	News Item																			0	0	0	0	1	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 5	2001	412	6842					4	4		10.1038/35083712	http://dx.doi.org/10.1038/35083712			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448TB	11452264	Bronze			2022-12-24	WOS:000169644900004
J	Spelman, D				Spelman, D			Prevention of overwhelming sepsis in asplenic patients: could do better	LANCET			English	Editorial Material									Monash Univ, Alfred Hosp, Dept Microbiol & Infect Dis, Melbourne, Vic 3181, Australia	Florey Institute of Neuroscience & Mental Health; Monash University	Spelman, D (corresponding author), Monash Univ, Alfred Hosp, Dept Microbiol & Infect Dis, Melbourne, Vic 3181, Australia.	d.spelman@alfred.org.au						Cavill I, 1996, BRIT MED J, V312, P430; Hegarty P K, 2000, Hematol J, V1, P357, DOI 10.1038/sj.thj.6200056; Sarangi J, 1997, J PUBLIC HEALTH MED, V19, P208, DOI 10.1093/oxfordjournals.pubmed.a024611; Waghorn DJ, 2001, J CLIN PATHOL, V54, P214, DOI 10.1136/jcp.54.3.214	4	12	12	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 30	2001	357	9274					2072	2072		10.1016/S0140-6736(00)05227-2	http://dx.doi.org/10.1016/S0140-6736(00)05227-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	447RQ	11445096				2022-12-24	WOS:000169586600006
J	Young, BA; Anthony, LC; Gruber, TM; Arthur, TM; Heyduk, E; Lu, CZ; Sharp, MM; Heyduk, T; Burgess, RR; Gross, CA				Young, BA; Anthony, LC; Gruber, TM; Arthur, TM; Heyduk, E; Lu, CZ; Sharp, MM; Heyduk, T; Burgess, RR; Gross, CA			A coiled-coil from the RNA polymerase beta ' subunit allosterically induces selective nontemplate strand binding by sigma(70)	CELL			English	Article							PROMOTER RECOGNITION; CRYSTAL-STRUCTURE; AMINO-ACIDS; DNA; SEQUENCE; REGION; SITE; ORGANIZATION; MUTANT; DOMAIN	For transcription to initiate, RNA polymerase must recognize and melt promoters. Selective binding to the nontemplate strand of the -10 region of the promoter is central to this process. We show that a 48 amino acid (aa) coiled-coil from the beta' subunit (aa 262-309) induces sigma (70) to perform this function almost as efficiently as core RNA polymerase itself. We provide evidence that interaction between the beta' coiled-coil and region 2.2 of sigma (70) promotes an allosteric transition that allows om to selectively recognize the nontemplate strand. As the beta' 262-309 peptide can function with the previously crystallized portion of sigma (70), nontemplate recognition can be reconstituted with only 47 kDa, or 1/10 of holoenzyme.	Univ Calif San Francisco, Dept Stomatol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Microbiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Immunol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA; Univ Wisconsin, Dept Oncol, Madison, WI 53706 USA; St Louis Univ, Sch Med, EA Doisy Dept Biochem & Mol Biol, St Louis, MO 63128 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Saint Louis University	Gross, CA (corresponding author), Univ Calif San Francisco, Dept Stomatol, San Francisco, CA 94143 USA.	cgross@cgl.ucsf.edu		Burgess, Richard/0000-0001-9545-3165; Arthur, Terrance/0000-0001-9035-0474	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050514, R21GM050514, R01GM028575] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM50514, GM30477, GM28575] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arthur TM, 2000, J BIOL CHEM, V275, P23113, DOI 10.1074/jbc.M002040200; Arthur TM, 1998, J BIOL CHEM, V273, P31381, DOI 10.1074/jbc.273.47.31381; Callaci S, 1998, BIOCHEMISTRY-US, V37, P3312, DOI 10.1021/bi972041m; DANIELS D, 1990, P NATL ACAD SCI USA, V87, P8075, DOI 10.1073/pnas.87.20.8075; Dombroski AJ, 1997, J BIOL CHEM, V272, P3487; DOMBROSKI AJ, 1993, GENE DEV, V7, P2446, DOI 10.1101/gad.7.12a.2446; DOMBROSKI AJ, 1992, CELL, V70, P501, DOI 10.1016/0092-8674(92)90174-B; Ebright RH, 2000, J MOL BIOL, V304, P687, DOI 10.1006/jmbi.2000.4309; Fedoriw AM, 1998, BIOCHEMISTRY-US, V37, P11971, DOI 10.1021/bi980980o; Gross CA, 1998, COLD SPRING HARB SYM, V63, P141, DOI 10.1101/sqb.1998.63.141; GROSS CA, 1992, TRANSCRIPTIONAL REGU, P129; GRUBER TM, 2001, IN PRESS MOL CELL; Guo Y, 1998, P NATL ACAD SCI USA, V95, P11655, DOI 10.1073/pnas.95.20.11655; Heyduk E, 1999, J BIOL CHEM, V274, P3315, DOI 10.1074/jbc.274.6.3315; Huang H, 1997, PHYS WORLD, V10, P25; Joo DM, 1997, P NATL ACAD SCI USA, V94, P4907, DOI 10.1073/pnas.94.10.4907; KENNEY TJ, 1989, P NATL ACAD SCI USA, V86, P9109, DOI 10.1073/pnas.86.23.9109; Ko DC, 1998, GENE DEV, V12, P3276, DOI 10.1101/gad.12.20.3276; Korzheva N, 2000, SCIENCE, V289, P619, DOI 10.1126/science.289.5479.619; Kulbachinskiy A, 1999, FEBS LETT, V454, P71, DOI 10.1016/S0014-5793(99)00778-4; LONETTO M, 1992, J BACTERIOL, V174, P3843, DOI 10.1128/jb.174.12.3843-3849.1992; Malhotra A, 1996, CELL, V87, P127, DOI 10.1016/S0092-8674(00)81329-X; MARQUSEE S, 1989, P NATL ACAD SCI USA, V86, P5286, DOI 10.1073/pnas.86.14.5286; Marr MT, 1997, SCIENCE, V276, P1258, DOI 10.1126/science.276.5316.1258; Matlock DL, 2000, BIOCHEMISTRY-US, V39, P12274, DOI 10.1021/bi001433h; Minakhin L, 2001, P NATL ACAD SCI USA, V98, P892, DOI 10.1073/pnas.98.3.892; Naryshkin N, 2000, CELL, V101, P601, DOI 10.1016/S0092-8674(00)80872-7; Orphanides G, 1996, GENE DEV, V10, P2657, DOI 10.1101/gad.10.21.2657; Pace CN, 1989, PROTEIN STRUCTURE PR, P311; Record Jr MT, 1996, ESCHERICHIA COLI SAL, P792; RING BZ, 1994, CELL, V78, P317, DOI 10.1016/0092-8674(94)90300-X; Ring BZ, 1996, CELL, V86, P485, DOI 10.1016/S0092-8674(00)80121-X; Roberts CW, 1996, CELL, V86, P495; SENTENAC A, 1992, TRANSCRIPTIONAL REGU, P27; Severinov K, 1996, J BIOL CHEM, V271, P27969, DOI 10.1074/jbc.271.44.27969; SEVERINOV K, 1992, J BIOL CHEM, V267, P12813; Severinova E, 1996, J MOL BIOL, V263, P637, DOI 10.1006/jmbi.1996.0604; Sharp MM, 1999, GENE DEV, V13, P3015, DOI 10.1101/gad.13.22.3015; SIEGELE DA, 1989, J MOL BIOL, V206, P591, DOI 10.1016/0022-2836(89)90568-8; TAN RY, 1993, CELL, V73, P1031, DOI 10.1016/0092-8674(93)90280-4; Waldspurger J.-L., 1990, ISRAEL MATH C P, V2, P267; YOUNG RA, 1991, ANNU REV BIOCHEM, V60, P689, DOI 10.1146/annurev.bi.60.070191.003353; Zhang GY, 1999, CELL, V98, P811, DOI 10.1016/S0092-8674(00)81515-9	43	81	81	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 29	2001	105	7					935	944		10.1016/S0092-8674(01)00398-1	http://dx.doi.org/10.1016/S0092-8674(01)00398-1			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	449BK	11439189	Bronze			2022-12-24	WOS:000169664300013
J	Szulc, P; Meunier, PJ				Szulc, P; Meunier, PJ			Is vitamin K deficiency a risk factor for osteoporosis in Crohn's disease?	LANCET			English	Editorial Material							INFLAMMATORY-BOWEL-DISEASE; SERUM UNDERCARBOXYLATED OSTEOCALCIN; BONE-MINERAL DENSITY; ELDERLY WOMEN; HIP FRACTURE; MENATETRENONE; RESORPTION		Hop Edouard Herriot, INSERM, U403, F-69437 Lyon, France	CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm)	Meunier, PJ (corresponding author), Hop Edouard Herriot, INSERM, U403, F-69437 Lyon, France.		Szulc, Pawel/N-5238-2018	Szulc, Pawel/0000-0003-4168-6697				Bjarnason I, 1997, GUT, V40, P228, DOI 10.1136/gut.40.2.228; Caraballo PJ, 1999, ARCH INTERN MED, V159, P1750, DOI 10.1001/archinte.159.15.1750; CROUCHER PI, 1993, OSTEOPOROSIS INT, V3, P236, DOI 10.1007/BF01623826; HARA K, 1993, J BONE MINER RES, V8, P535; HARA K, 1995, BONE, V16, P179, DOI 10.1016/8756-3282(94)00027-W; HODGES SJ, 1993, J BONE MINER RES, V8, P1005; HODGES SJ, 1993, J BONE MINER RES, V8, P1241; MOTLEY RJ, 1993, BONE MINER, V23, P95, DOI 10.1016/S0169-6009(08)80046-3; NOTOYA K, 1995, BONE, V16, pS349, DOI 10.1016/8756-3282(94)00046-3; ROUX C, 1995, OSTEOPOROSIS INT, V5, P156, DOI 10.1007/BF02106094; Schoon EJ, 2001, GUT, V48, P473, DOI 10.1136/gut.48.4.473; Schulte CMS, 2000, GASTROENTEROLOGY, V119, P909, DOI 10.1053/gast.2000.18158; SHEARER MJ, 1995, LANCET, V345, P229, DOI 10.1016/S0140-6736(95)90227-9; Shiraki M, 2000, J BONE MINER RES, V15, P515, DOI 10.1359/jbmr.2000.15.3.515; Sokoll LJ, 1996, AM J CLIN NUTR, V63, P566, DOI 10.1093/ajcn/63.4.566; Stone KL, 1999, J BONE MINER RES, V14, pS263; SZULC P, 1994, J BONE MINER RES, V9, P1591; SZULC P, 1993, J CLIN INVEST, V91, P1769, DOI 10.1172/JCI116387	18	17	18	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 23	2001	357	9273					1995	1996		10.1016/S0140-6736(00)05135-7	http://dx.doi.org/10.1016/S0140-6736(00)05135-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	446JB	11438129				2022-12-24	WOS:000169509200006
J	Barker, PA; Street-Perrott, FA; Leng, MJ; Greenwood, PB; Swain, DL; Perrott, RA; Telford, RJ; Ficken, KJ				Barker, PA; Street-Perrott, FA; Leng, MJ; Greenwood, PB; Swain, DL; Perrott, RA; Telford, RJ; Ficken, KJ			A 14,000-year oxygen isotope record from diatom silica in two alpine lakes on Mt. Kenya	SCIENCE			English	Article							ATLANTIC-OCEAN; EAST-AFRICA; ICE; CLIMATE; FLUCTUATIONS; QUELCCAYA; EVENTS; IMPACT; BP	Oxygen isotopes are sensitive tracers of climate change in tropical regions. Abrupt shifts of up to 18 per mil in the oxygen isotope ratio of diatom silica have been found in a 14,000-year record from two alpine Lakes on Mt. Kenya. Interpretation of tropical-montane isotope records is controversial, especially concerning the relative roles of precipitation and temperature. Here, we argue that Holocene variations in delta O-18 are better explained by Lake moisture balance than by temperature-induced fractionation. Episodes of heavy convective precipitation dated similar to 11,100 to 8600, 6700 to 5600, 2900 to 1900, and <1300 years before the present were linked to enhanced soil erosion, neoglacial ice advances, and forest expansion on Mt. Kenya.	Univ Lancaster, Dept Geog, HYSED, Lancaster LA1 4YB, England; Univ Wales, Dept Geog, Trop Palaeoenvironm Res Grp, Swansea SA2 8PP, W Glam, Wales; NERC, Isotope Geosci Lab, Nottingham NG12 5GG, England	Lancaster University; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Geological Survey	Barker, PA (corresponding author), Univ Lancaster, Dept Geog, HYSED, Lancaster LA1 4YB, England.		Telford, Richard/C-1668-2008; Barker, Philip/J-5938-2012; Telford, Richard/AAD-2249-2019	Telford, Richard/0000-0001-9826-3076; Telford, Richard/0000-0001-9826-3076; Barker, Philip/0000-0002-5334-9201; Leng, Melanie/0000-0003-1115-5166				Brandriss ME, 1998, GEOCHIM COSMOCHIM AC, V62, P1119, DOI 10.1016/S0016-7037(98)00054-4; Darling W.G., 1996, THESIS OPEN U; DUPLESSY JC, 1980, NATURE, V286, P479, DOI 10.1038/286479a0; Flohn H., 1987, PALAEOECOL AFR, V18, P3; FONTES JC, 1993, ISOTOPE TECHNIQUES S, P231; GASSE F, 1994, EARTH PLANET SC LETT, V126, P435, DOI 10.1016/0012-821X(94)90123-6; Gatebe CK, 1999, J GEOPHYS RES-ATMOS, V104, P14237, DOI 10.1029/1998JD200103; GROOTES PM, 1989, J GEOPHYS RES-ATMOS, V94, P1187, DOI 10.1029/JD094iD01p01187; HASTENRATH S, 1981, GLACIERS EQUATORIAL; Hoffmann G, 1997, QUATERN INT, V37, P115, DOI 10.1016/1040-6182(96)00004-3; Jouzel J, 2000, QUATERNARY SCI REV, V19, P363, DOI 10.1016/S0277-3791(99)00069-4; Karlen W, 1999, AMBIO, V28, P409; KRISHNAMURTHY RV, 1985, NATURE, V317, P160, DOI 10.1038/317160a0; Ngecu WM, 1999, ENVIRON GEOL, V38, P277, DOI 10.1007/s002540050425; Nicholson S.E., 1996, LIMNOLOGY CLIMATOLOG, V1st ed., P25, DOI [DOI 10.1201/9780203748978-2, 10.1201/9780203748978-2]; Njitchoua R, 1999, J HYDROL, V223, P17, DOI 10.1016/S0022-1694(99)00087-6; Peyron O, 2000, QUATERNARY RES, V54, P90, DOI 10.1006/qres.2000.2136; Rietti-Shati M, 1998, SCIENCE, V281, P980, DOI 10.1126/science.281.5379.980; ROZANSKI K, 1996, LIMNOLOGY CLIMATOLOG, P79; Rozanski K., 1993, CLIMATE CHANGE CONTI, V78, P1, DOI DOI 10.1029/GM078P0001; Schmidt M, 2001, GEOCHIM COSMOCHIM AC, V65, P201, DOI 10.1016/S0016-7037(00)00534-2; Sonzogni C, 1998, QUATERNARY SCI REV, V17, P1185, DOI 10.1016/S0277-3791(97)00099-1; Stager JC, 1997, SCIENCE, V276, P1834, DOI 10.1126/science.276.5320.1834; STREETPERROTT FA, 1990, NATURE, V343, P607, DOI 10.1038/343607a0; StreetPerrott FA, 1997, SCIENCE, V278, P1422, DOI 10.1126/science.278.5342.1422; SWAIN DL, 1999, THESIS U WALES SWANS; Thompson LG, 1998, SCIENCE, V282, P1858, DOI 10.1126/science.282.5395.1858; THOMPSON LG, 1979, SCIENCE, V203, P1240, DOI 10.1126/science.203.4386.1240; Thompson LG, 2000, J QUATERNARY SCI, V15, P377, DOI 10.1002/1099-1417(200005)15:4<377::AID-JQS542>3.0.CO;2-L; THOMPSON LG, 1979, SEA LEVEL ICE CLIMAT, V131, P55; VYVERMAN W, 1995, J PALEOLIMNOL, V13, P65, DOI 10.1007/BF00678111	31	121	124	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 22	2001	292	5525					2307	2310		10.1126/science.1059612	http://dx.doi.org/10.1126/science.1059612			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	445KD	11423656				2022-12-24	WOS:000169455900051
J	Pacala, SW; Hurtt, GC; Baker, D; Peylin, P; Houghton, RA; Birdsey, RA; Heath, L; Sundquist, ET; Stallard, RF; Ciais, P; Moorcroft, P; Caspersen, JP; Shevliakova, E; Moore, B; Kohlmaier, G; Holland, E; Gloor, M; Harmon, ME; Fan, SM; Sarmiento, JL; Goodale, CL; Schimel, D; Field, CB				Pacala, SW; Hurtt, GC; Baker, D; Peylin, P; Houghton, RA; Birdsey, RA; Heath, L; Sundquist, ET; Stallard, RF; Ciais, P; Moorcroft, P; Caspersen, JP; Shevliakova, E; Moore, B; Kohlmaier, G; Holland, E; Gloor, M; Harmon, ME; Fan, SM; Sarmiento, JL; Goodale, CL; Schimel, D; Field, CB			Consistent land- and atmosphere-based US carbon sink estimates	SCIENCE			English	Article							WOOD PRODUCTS; UNITED-STATES; MODEL; CO2; STORAGE; TRANSPORT; FORESTS; FLUXES; BUDGET	For the period 1980-89, we estimate a carbon sink in the coterminous United States between 0.30 and 0.58 petagrams of carbon per year (petagrams of carbon = 10(15) grams of carbon). The net carbon flux from the atmosphere to the Land was higher, 0.37 to 0.71 petagrams of carbon per year, because a net flux of 0.07 to 0.13 petagrams of carbon per year was exported by rivers and commerce and returned to the atmosphere elsewhere. These Land-based estimates are Larger than those from previous studies (0.08 to 0.35 petagrams of carbon per year) because of the inclusion of additional processes and revised estimates of some component fluxes. Although component estimates are uncertain, about one-half of the total is outside the forest sector. We also estimated the sink using atmospheric models and the atmospheric concentration of carbon dioxide (the tracer-transport inversion method). The range of results from the atmosphere-based inversions contains the Land-based estimates. Atmosphere- and land-based estimates are thus consistent, within the Large ranges of uncertainty for both methods. Atmosphere-based results for 1980-89 are similar to those for 1985-89 and 1990-94, indicating a relatively stable U.S. sink throughout the period.	Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; Princeton Univ, Atmospher & Ocean Sci Program, Princeton, NJ 08544 USA; Univ New Hampshire, Inst Study Earth Oceans & Space, Complex Syst Res Ctr, Durham, NH 03824 USA; Woods Hole Res Ctr, Woods Hole, MA 02543 USA; UPMC, Biogeochim Isotop Lab, CNRS, INRA, Paris, France; US Forest Serv, USDA, Newtown Sq, PA 19073 USA; US Geol Survey, Woods Hole, MA 02543 USA; US Geol Survey, Div Water Resources, Boulder, CO 80303 USA; CEA Saclay, LSCE, F-91191 Gif Sur Yvette, France; Goethe Univ Frankfurt, Zentrum Umweltforsch, D-60325 Frankfurt, Germany; Max Planck Inst Biogeochem, D-07745 Jena, Germany; Oregon State Univ, Dept Forest Sci, Corvallis, OR 97331 USA; Carnegie Inst Sci, Dept Plant Biol, Stanford, CA 94305 USA	Princeton University; National Oceanic Atmospheric Admin (NOAA) - USA; Princeton University; University System Of New Hampshire; University of New Hampshire; Woods Hole Research Center; Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Sorbonne Universite; United States Department of Agriculture (USDA); United States Forest Service; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); Goethe University Frankfurt; Max Planck Society; Oregon State University; Carnegie Institution for Science	Pacala, SW (corresponding author), Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA.	Pacala@princeton.edu	Ciais, Philippe/A-6840-2011; Stallard, Robert F/H-2649-2013; Hurtt, George/A-8450-2012; Fan, Song-Miao/A-8004-2008; Noojipady, Praveen/B-2511-2010; Shevliakova, Elena/J-5770-2014	Ciais, Philippe/0000-0001-8560-4943; Stallard, Robert F/0000-0001-8209-7608; Hurtt, George/0000-0001-7278-202X; Fan, Song-Miao/0000-0001-8352-8035; Holland, Elisabeth Ann/0000-0002-3570-621X; Goodale, Christine/0000-0003-4317-3983; Peylin, Philippe/0000-0001-9335-6994				[Anonymous], GLOBAL ATMOSPHERIC T; Battle M, 2000, SCIENCE, V287, P2467, DOI 10.1126/science.287.5462.2467; Birdsey RA, 1992, WO59 USDA FOR SERV G; BIRDSEY RA, 1995, PRODUCTIVITY AM FORE, P56; Bousquet P, 2000, SCIENCE, V290, P1342, DOI 10.1126/science.290.5495.1342; Fan S, 1998, SCIENCE, V282, P442, DOI 10.1126/science.282.5388.442; *FED EM MAN AG ARM, 1993, WAT CONTR INFR NAT I; Gloor M, 1999, J GEOPHYS RES-ATMOS, V104, P14245, DOI 10.1029/1999JD900132; HEATH LS, 1993, WATER AIR SOIL POLL, V70, P279, DOI 10.1007/BF01105002; Houghton RA, 1999, SCIENCE, V285, P574, DOI 10.1126/science.285.5427.574; Houghton RA, 2000, GLOBAL ECOL BIOGEOGR, V9, P145, DOI 10.1046/j.1365-2699.2000.00164.x; Houghton RA, 2000, GLOBAL ECOL BIOGEOGR, V9, P125, DOI 10.1046/j.1365-2699.2000.00166.x; Kaminski T, 1999, J GEOPHYS RES-ATMOS, V104, P18555, DOI 10.1029/1999JD900146; MAHLMAN JD, 1978, J ATMOS SCI, V35, P1340, DOI 10.1175/1520-0469(1978)035<1340:TSUAGG>2.0.CO;2; MELILLO J, UNPUB; MOORCROFT P, IN PRESS ECOL MONOGR; Peylin P, 2000, GEOPH MONOG SERIES, V114, P295; PEYLIN P, UNPUB; POTTER CS, 1993, GLOBAL BIOGEOCHEM CY, V7, P811, DOI 10.1029/93GB02725; Rayner PJ, 1999, TELLUS B, V51, P213, DOI 10.1034/j.1600-0889.1999.t01-1-00008.x; Schimel D, 2000, SCIENCE, V287, P2004, DOI 10.1126/science.287.5460.2004; Skog KE, 1998, FOREST PROD J, V48, P75; TANS PP, 1990, SCIENCE, V247, P1431, DOI 10.1126/science.247.4949.1431; TURNER DP, 1995, ECOL APPL, V5, P421, DOI 10.2307/1942033; Winjum JK, 1998, FOREST SCI, V44, P272	25	634	721	13	197	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 22	2001	292	5525					2316	2320		10.1126/science.1057320	http://dx.doi.org/10.1126/science.1057320			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	445KD	11423659	Green Submitted			2022-12-24	WOS:000169455900054
J	Beltrami, AP; Urbanek, K; Kajstura, J; Yan, SM; Finato, N; Bussani, R; Nadal-Ginard, B; Silvestri, F; Leri, A; Beltrami, CA; Anversa, P				Beltrami, AP; Urbanek, K; Kajstura, J; Yan, SM; Finato, N; Bussani, R; Nadal-Ginard, B; Silvestri, F; Leri, A; Beltrami, CA; Anversa, P			Evidence that human cardiac myocytes divide after myocardial infarction (Publication with Expression of Concern. See vol. 379, pg. 1870, 2018)	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Publication with Expression of Concern							HEMATOPOIETIC STEM-CELLS; ISCHEMIC CARDIOMYOPATHY; DILATED CARDIOMYOPATHY; HEART-FAILURE; PROLIFERATION; DIFFERENTIATION; TRANSPLANTATION; HYPERTROPHY; INDUCTION; DIVISION	Background The scarring of the heart that results from myocardial infarction has been interpreted as evidence that the heart is composed of myocytes that are unable to divide. However, recent observations have provided evidence of proliferation of myocytes in the adult heart. Therefore, we studied the extent of mitosis among myocytes after myocardial infarction in humans. Methods Samples from the border of the infarct and from areas of the myocardium distant from the infarct were obtained from 13 patients who had died 4 to 12 days after infarction. Ten normal hearts were used as controls. Myocytes that had entered the cell cycle in preparation for cell division were measured by labeling of the nuclear antigen Ki-67, which is associated with cell division. The fraction of myocyte nuclei that were undergoing mitosis was determined, and the mitotic index (the ratio of the number of nuclei undergoing mitosis to the number not undergoing mitosis) was calculated. The presence of mitotic spindles, contractile rings, karyokinesis, and cytokinesis was also recorded. Results In the infarcted hearts, Ki-67 expression was detected in 4 percent of myocyte nuclei in the regions adjacent to the infarcts and in 1 percent of those in regions distant from the infarcts. The reentry of myocytes into the cell cycle resulted in mitotic indexes of 0.08 percent and 0.33 percent, respectively, in the zones adjacent to and distant from the infarcts. Events characteristic of cell division - the formation of the mitotic spindles, the formation of contractile rings, karyokinesis, and cytokinesis - were identified; these features demonstrated that there was myocyte proliferation after myocardial infarction. Conclusions Our results challenge the dogma that the adult heart is a postmitotic organ and raise the possibility that the regeneration of myocytes may contribute to the increase in muscle mass of the myocardium. (N Engl J Med 2001;344:1750-7.) Copyright (C) 2001 Massachusetts Medical Society.	New York Med Coll, Dept Med, Valhalla, NY 10595 USA; Univ Udine, Dept Pathol, I-33100 Udine, Italy; Univ Trieste, Dept Pathol, Trieste, Italy	New York Medical College; University of Udine; University of Trieste	Anversa, P (corresponding author), New York Med Coll, Dept Med, Vosburgh Pavil,Rm 302, Valhalla, NY 10595 USA.	piero_anversa@nymc.edu	Finato, Nicoletta/A-7351-2010; Beltrami, Antonio/C-5291-2008; beltrami, carlo a/A-8026-2008	Beltrami, Antonio/0000-0002-0679-2710; Yan, Shaomin/0000-0001-7642-3972; Bussani, Rossana/0000-0001-8241-9726	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL043023, R01HL038132, R01HL039902] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-38132, HL-43023, HL-39902] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Agah R, 1997, J CLIN INVEST, V100, P2722, DOI 10.1172/JCI119817; Antonio C, 2000, CELL, V102, P425, DOI 10.1016/S0092-8674(00)00048-9; ANVERSA P, 1990, PROG CARDIOVASC DIS, V33, P49, DOI 10.1016/0033-0620(90)90039-5; Anversa P, 2000, CIRC RES, V86, P121, DOI 10.1161/01.RES.86.2.121; Anversa P, 1998, CIRC RES, V83, P1, DOI 10.1161/01.RES.83.1.1; BELTRAMI CA, 1994, CIRCULATION, V89, P151, DOI 10.1161/01.CIR.89.1.151; BODINE DM, 1994, BLOOD, V84, P1482; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Fallon J, 2000, P NATL ACAD SCI USA, V97, P14686, DOI 10.1073/pnas.97.26.14686; GRATZNER HG, 1982, SCIENCE, V218, P474, DOI 10.1126/science.7123245; Guerra S, 1999, CIRC RES, V85, P856, DOI 10.1161/01.RES.85.9.856; HALL PA, 1990, CELL TISSUE KINET, V23, P505, DOI 10.1111/j.1365-2184.1990.tb01343.x; HALL PA, 1990, J CLIN PATHOL, V43, P184, DOI 10.1136/jcp.43.3.184; HALL PA, 1993, ONCOGENE, V8, P203; Horner PJ, 2000, NATURE, V407, P963, DOI 10.1038/35039559; KAJSTURA J, 1995, CIRCULATION, V92, P2306, DOI 10.1161/01.CIR.92.8.2306; KAJSTURA J, 1994, CIRC RES, V74, P383, DOI 10.1161/01.RES.74.3.383; Kajstura J, 1998, P NATL ACAD SCI USA, V95, P8801, DOI 10.1073/pnas.95.15.8801; Lagasse E, 2000, NAT MED, V6, P1229, DOI 10.1038/81326; Leor J, 1996, CIRCULATION, V94, P332; LINZBACH AJ, 1960, AM J CARDIOL, V5, P370, DOI 10.1016/0002-9149(60)90084-9; LOUD AV, 1984, LAB INVEST, V50, P250; MacCallum DE, 2000, J PATHOL, V191, P286; MacCallum DE, 2000, J PATHOL, V190, P537; Moreau V, 1999, CURR OPIN CELL BIOL, V11, P152, DOI 10.1016/S0955-0674(99)80019-2; Murry CE, 1996, J CLIN INVEST, V98, P2512, DOI 10.1172/JCI119070; Olivetti G, 1996, J MOL CELL CARDIOL, V28, P1463, DOI 10.1006/jmcc.1996.0137; OLIVETTI G, 1991, CIRC RES, V68, P1560, DOI 10.1161/01.RES.68.6.1560; Orlic D, 1998, BLOOD, V91, P3247, DOI 10.1182/blood.V91.9.3247.3247_3247_3254; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; PARODI O, 1993, CIRCULATION, V88, P509, DOI 10.1161/01.CIR.88.2.509; QUAINI F, 1994, CIRC RES, V75, P1050, DOI 10.1161/01.RES.75.6.1050; Reiss K, 1996, P NATL ACAD SCI USA, V93, P8630, DOI 10.1073/pnas.93.16.8630; RIEDER CL, 1982, INT REV CYTOL, V79, P1, DOI 10.1016/S0074-7696(08)61672-1; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; SKALLI O, 1988, AM J PATHOL, V130, P515; Soonpaa MH, 1998, CIRC RES, V83, P15, DOI 10.1161/01.RES.83.1.15; WALLENSTEIN S, 1980, CIRC RES, V47, P1, DOI 10.1161/01.RES.47.1.1; Wolf WA, 1999, CELL MOL LIFE SCI, V55, P108, DOI 10.1007/s000180050274; Zhang D, 2000, NAT MED, V6, P556, DOI 10.1038/75037	40	1044	1247	0	79	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 7	2001	344	23					1750	1757		10.1056/NEJM200106073442303	http://dx.doi.org/10.1056/NEJM200106073442303			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	439TL	11396441	Bronze			2022-12-24	WOS:000169133600003
J	Schwetz, BA				Schwetz, BA			Safety of aristolochic acid	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									US FDA, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Schwetz, BA (corresponding author), US FDA, Rockville, MD 20857 USA.								0	33	33	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 6	2001	285	21					2705	2705						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	437HG	11386912				2022-12-24	WOS:000168985800004
J	Engelhardt, KAM; Ritchie, ME				Engelhardt, KAM; Ritchie, ME			Effects of macrophyte species richness on wetland ecosystem functioning and services	NATURE			English	Article							PLANT DIVERSITY; BIODIVERSITY; PRODUCTIVITY; PHOSPHORUS; PATTERNS; DISTURBANCE; GRASSLANDS; EPIPHYTES; REGIMES; ALGAE	Wetlands provide many important ecosystem services to human society(1-5), which may depend on how plant diversity influences biomass production and nutrient retention(4,6-8). Vascular aquatic plant diversity may not necessarily enhance wetland ecosystem functioning, however, because competition among these plant species can be strong, often resulting in the local dominance of a single species(4,9). Here we have manipulated the species richness of rooted, submerged aquatic plant (macrophyte) communities in experimental wetland mesocosms. We found higher algal and total plant (algal plus macrophyte) biomass, as well as lower loss of total phosphorus, in mesocosms with a greater richness of macrophyte species. Greater plant biomass resulted from a sampling effect; that is, the increased chance in species mixtures that algal production would be facilitated by the presence of a less competitive species-in this case, crisped pondweed. Lower losses of total phosphorus resulted from the greater chance in species mixtures of a high algal biomass and the presence of sago pondweed, which physically filter particulate phosphorus from the water(2,10,11). These indirect and direct effects of macrophyte species richness on algal production, total plant biomass and phosphorus loss suggest that management practices that maintain macrophyte diversity may enhance the functioning and associated services of wetland ecosystems.	Utah State Univ, Dept Fisheries & Wildlife, Logan, UT 84322 USA; Utah State Univ, Ctr Ecol, Logan, UT 84322 USA	Utah System of Higher Education; Utah State University; Utah System of Higher Education; Utah State University	Engelhardt, KAM (corresponding author), Univ Maryland, Ctr Environm Sci, Appalachian Soil & Water Conservat Res Lab, 301 Braddock Rd, Frostburg, MD 21532 USA.		Engelhardt, Katharina AM/H-8755-2013					Bedford BL, 1999, ECOLOGY, V80, P2151, DOI 10.1890/0012-9658(1999)080[2151:PINAAP]2.0.CO;2; BUNN SE, 1993, OECOLOGIA, V96, P85, DOI 10.1007/BF00318034; BURKHOLDER JM, 1990, LIMNOL OCEANOGR, V35, P736, DOI 10.4319/lo.1990.35.3.0736; BURKHOLDER JM, 1989, J PHYCOL, V25, P55, DOI 10.1111/j.0022-3646.1989.00055.x; CARLSON RE, 1977, LIMNOL OCEANOGR, V22, P361, DOI 10.4319/lo.1977.22.2.0361; Chambers RM, 1999, AQUAT BOT, V64, P261, DOI 10.1016/S0304-3770(99)00055-8; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Fischer JM, 2000, ESTUARIES, V23, P565, DOI 10.2307/1353146; Grace James B., 1999, Perspectives in Plant Ecology Evolution and Systematics, V2, P1, DOI 10.1078/1433-8319-00063; HARGEBY A, 1994, HYDROBIOLOGIA, V279, P83, DOI 10.1007/BF00027843; Hector A, 1999, SCIENCE, V286, P1123, DOI 10.1126/science.286.5442.1123; Huston MA, 1997, OECOLOGIA, V110, P449, DOI 10.1007/s004420050180; Jeppesen E, 1999, HYDROBIOLOGIA, V395, P419, DOI 10.1023/A:1017071602549; Loreau M, 2000, OIKOS, V91, P3, DOI 10.1034/j.1600-0706.2000.910101.x; Mitsch W. J., 1993, WETLANDS; MITSCH WJ, 1995, ECOL APPL, V5, P830, DOI 10.2307/1941991; MOELLER RE, 1988, AQUAT BOT, V32, P261, DOI 10.1016/0304-3770(88)90120-9; NAEEM S, 1995, PHILOS T R SOC B, V347, P249, DOI 10.1098/rstb.1995.0025; Pollock MM, 1998, ECOLOGY, V79, P94; Robinson GGC, 1997, WETLANDS, V17, P182, DOI 10.1007/BF03161408; Symstad AJ, 1998, OIKOS, V81, P389, DOI 10.2307/3547058; Tilman D, 1997, P NATL ACAD SCI USA, V94, P1857, DOI 10.1073/pnas.94.5.1857; Tilman D, 1996, NATURE, V379, P718, DOI 10.1038/379718a0; Troumbis AY, 2000, OIKOS, V90, P549, DOI 10.1034/j.1600-0706.2000.900313.x; Ward JV, 1998, BIOL CONSERV, V83, P269, DOI 10.1016/S0006-3207(97)00083-9; Wardle DA, 1999, OIKOS, V87, P403, DOI 10.2307/3546757; Wetzel R. G, 1990, VERH INT VEREIN LIMN, V24, P6, DOI DOI 10.1080/03680770.1989.11898687; Wetzel R. G., 1991, LIMNOLOGICAL ANAL; Wilson MA, 1999, ECOL APPL, V9, P772, DOI 10.1890/1051-0761(1999)009[0772:EVOFES]2.0.CO;2; Wu XY, 1998, WETLANDS, V18, P9, DOI 10.1007/BF03161438	30	288	342	19	333	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN	2001	411	6838					687	689		10.1038/35079573	http://dx.doi.org/10.1038/35079573			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439JC	11395769				2022-12-24	WOS:000169112500043
J	Luo, ZX; Crompton, AW; Sun, AL				Luo, ZX; Crompton, AW; Sun, AL			A new mammaliaform from the Early Jurassic and evolution of mammalian characteristics	SCIENCE			English	Article							MORGANUCODON; DIVERSITY; ECOLOGY; SKULL	A fossil from the Early Jurassic (Sinemurian, similar to 195 million years ago) represents a new Lineage of mammaliaforms, the extinct groups more closely related to the living mammals than to nonmammaliaform cynodonts. it has an enlarged era nial cavity, but no postdentary trough on the mandible, indicating separation of the middle ear bones from the mandible. This extends the earliest record of these crucial mammalian features by some 45 million years and suggests that separation of the middle ear bones from the mandible and the expanded brain vault could be correlated. It shows that several key mammalian evolutionary innovations in the ear region, the temporomandibular joint, and the brain vault evolved incrementally through mammaliaform evolution and Long before the differentiation of the Living mammal groups. With an estimated body weight of only 2 grams, its coexistence with other Larger mammaliaforms with similar "triconodont-like" teeth for insectivory within the same fauna suggests a great trophic diversity within the mammaliaform insectivore feeding guild, as inferred from the range of body sizes.	Carnegie Museum Nat Hist, Sect Vertebrate Paleontol, Pittsburgh, PA 15213 USA; Harvard Univ, Museum Comparat Zool, Cambridge, MA 02138 USA; Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Beijing 100044, Peoples R China	Harvard University; Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS	Luo, ZX (corresponding author), Carnegie Museum Nat Hist, Sect Vertebrate Paleontol, Pittsburgh, PA 15213 USA.	Luoz@carnegiemuseums.org	Luo, Zhe-XI/AAU-2263-2021					ALLIN EF, 1992, EVOLUTIONARY BIOLOGY OF HEARING, P587; Alroy J, 1998, SCIENCE, V280, P731, DOI 10.1126/science.280.5364.731; [Anonymous], 1996, INDIA MIN; Bloch JI, 1998, J MAMMAL, V79, P804, DOI 10.2307/1383090; Cifelli RL, 1998, J VERTEBR PALEONTOL, V18, P237, DOI 10.1080/02724634.1998.10011048; Clemens W.A., 1980, Zitteliana, V5, P51; Crompton A.W., 1974, Bulletin Br Mus nat Hist (Geol), V24, P399; CROMPTON AW, 1993, MAMMAL PHYLOGENY, P30; Foote M, 1997, ANNU REV ECOL SYST, V28, P129, DOI 10.1146/annurev.ecolsys.28.1.129; FRASER NC, 1985, NATURE, V314, P161, DOI 10.1038/314161a0; Gingerich P.D., 1984, SIZE SCALING PRIMATE, P257; Hahn G., 1988, Palaeovertebrata (Montpellier), V18, P155; HERRING SW, 1993, AM ZOOL, V33, P472; Hopson J.A., 1986, P83; Hu YM, 1997, NATURE, V390, P137, DOI 10.1038/36505; JENKINS FA, 1983, SCIENCE, V222, P1233, DOI 10.1126/science.222.4629.1233; JENKINS FA, 1997, NATURE, V385, P315; Jerison HJ., 1973, EVOLUTION BRAIN INTE; Jernvall J, 1996, SCIENCE, V274, P1489, DOI 10.1126/science.274.5292.1489; Ji Q, 1999, NATURE, V398, P326; Kemp T.S., 1982, P1; KERMACK DORIS M., 1968, J LINN SOC LONDON ZOOL, V47, P407; KERMACK KA, 1981, ZOOL J LINN SOC-LOND, V71, P1, DOI 10.1111/j.1096-3642.1981.tb01127.x; KERMACK KA, 1973, ZOOL J LINN SOC-LOND, V53, P87, DOI 10.1111/j.1096-3642.1973.tb00786.x; KIELANJAWOROWSK.Z, 1997, LETHAIA, V29, P249; KielanJaworowska Z, 1997, ACTA PALAEONTOL POL, V42, P201; KIELBOWICZ RB, 1986, CRIT STUD MASS COMM, V3, P21, DOI 10.1080/15295038609366627; Kuhn H. J., 1971, Abh Senckenb Naturf Ges, V528, P1; Lillegraven J.A., 1991, Contributions to Geology University of Wyoming, V28, P39; Lucas Spencer G., 1993, Journal of Vertebrate Paleontology, V13, P309; LUO ZX, 1994, J VERTEBR PALEONTOL, V14, P341, DOI 10.1080/02724634.1994.10011564; LUO ZX, 1994, IN THE SHADOW OF THE DINOSAURS, P98; LUO ZX, 1995, J VERTEBR PALEONTOL, V15, P113, DOI 10.1080/02724634.1995.10011211; Musser AM, 1998, PHILOS T R SOC B, V353, P1063, DOI 10.1098/rstb.1998.0266; Nummela Sirpa, 1997, Comments on Theoretical Biology, V4, P387; PARRINGTON FR, 1978, PHILOS T ROY SOC B, V282, P177, DOI 10.1098/rstb.1978.0012; Rougier Guillermo W., 1996, American Museum Novitates, V3183, P1; Rowe T., 1988, Journal of Vertebrate Paleontology, V8, P241; Rowe T, 1996, SCIENCE, V273, P651, DOI 10.1126/science.273.5275.651; Sidor CA, 1998, PALEOBIOLOGY, V24, P254; Sigogneau-Russell Denise, 1995, Acta Palaeontologica Polonica, V40, P245; Smith KK, 1997, EVOLUTION, V51, P1663, DOI 10.1111/j.1558-5646.1997.tb01489.x; VANVALKENBURGH B, 1995, TRENDS ECOL EVOL, V10, P71, DOI 10.1016/S0169-5347(00)88980-6; VONMAIER W, 1989, Z ZOOL SYST EVOL, V27, P149; VONMAIER W, 1993, MAMMAL PHYLOGENY, P165; WIBLE JR, 1993, MAMMAL PHYLOGENY, P45; Zeller U., 1987, Mammalia Depicta, P17; Zeller U., 1989, ABHANDLUNGEN SENCKEN, V545, P1; Zeller U., 1993, MAMMAL PHYLOGENY, P95	49	172	180	5	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 25	2001	292	5521					1535	1540		10.1126/science.1058476	http://dx.doi.org/10.1126/science.1058476			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YQ	11375489				2022-12-24	WOS:000168963800042
J	Adam, D				Adam, D			Plans for GM livestock fail the poor	NATURE			English	News Item																		Reichhardt T, 2000, NATURE, V406, P10, DOI 10.1038/35017657; 2001, NATURE, V409, P749	2	0	0	0	2	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 24	2001	411	6836					403	403		10.1038/35078211	http://dx.doi.org/10.1038/35078211			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	435CB	11373634	Bronze			2022-12-24	WOS:000168858700007
J	Brockie, B				Brockie, B			GM cows face slaughter in multiple sclerosis experiment	NATURE			English	News Item																			0	1	1	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 24	2001	411	6836					402	402		10.1038/35078202	http://dx.doi.org/10.1038/35078202			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	435CB	11373631	Bronze			2022-12-24	WOS:000168858700004
J	Raoult, D; Fournier, PE; Fenollar, F; Jensenius, M; Prioe, T; de Pina, JJ; Caruso, G; Jones, N; Laferl, H; Rosenblatt, JE; Marrie, TJ				Raoult, D; Fournier, PE; Fenollar, F; Jensenius, M; Prioe, T; de Pina, JJ; Caruso, G; Jones, N; Laferl, H; Rosenblatt, JE; Marrie, TJ			Rickettsia africae, a tick-borne pathogen in travelers to sub-Saharan Africa.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MEDITERRANEAN SPOTTED-FEVER; BITE FEVER; EPIDEMIOLOGICAL FEATURES; PROTEIN ROMPA; INFECTIONS; CONORII; MICROIMMUNOFLUORESCENCE; SEROEPIDEMIOLOGY; DIFFERENTIATION; ANTIBODIES	Background: African tick-bite fever occurs after contact with ticks that carry Rickettsia africae and that parasitize cattle and game. Sporadic reports suggest that this infection has specific clinical and epidemiologic features. Methods: We studied patients who were tested for a rickettsial disease after returning from a visit to Africa or Guadeloupe. To assess the value of the microimmunofluorescence assay, Western blotting, and cross-adsorption assays, we compared the results of these tests in 39 patients in whom African tick-bite fever had been confirmed by the polymerase-chain-reaction assay, cell culture, or both; 50 patients with documented R. conorii infection; and 50 blood donors. These diagnostic criteria were then applied to 376 additional patients who had returned from southern Africa and 2 who had returned from Guadeloupe and whose serum was being tested for rickettsial disease. Results: In the 39 patients with direct evidence of R. africae infection, the combination of microimmunofluorescence assay, Western blotting, and cross-adsorption assays showing antibodies specific for R. africae had a sensitivity of 0.56; however, each test had a positive predictive value and a specificity of 1.0. An additional 80 patients were found to have an R. africae infection on the basis of these serologic criteria. Infections with R. africae were acquired by visitors to 11 African countries and Guadeloupe. The illness was generally mild and was characterized by a rash in 46 percent of the patients; the rash was usually maculopapular or vesicular and rarely purpuric. Ninety-five percent of patients had an inoculation eschar or eschars, and 54 percent of these patients had multiple eschars, a finding that is unusual in patients with rickettsial infection. Conclusions: In this series, R. africae was the cause of nearly all cases of tick-bite rickettsiosis in patients who became ill after a trip to sub-Saharan Africa. (N Engl J Med 2001;344:1504-10.) Copyright (C) 2001 Massachusetts Medical Society.	Univ Mediterranee, Fac Med, Unite Rickettsies, CNRS,UPRESA 6020, F-13385 Marseille 05, France; Aker Univ Hosp, Dept Internal Med, Oslo, Norway; Univ Copenhagen, Rigshosp, Dept Infect Dis, DK-2100 Copenhagen, Denmark; Hop Instruct Armees Laveran, Biol Lab, Marseille Armees, France; Osped Belluno, Div Malattie Infett, Belluno, Italy; John Radcliffe Hosp, Dept Microbiol & Infect Dis, Oxford OX3 9DU, England; Kaiser Franz Josef Hosp, Dept Med, Vienna, Austria; Mayo Clin, Div Clin Microbiol, Rochester, MN USA; Univ Alberta, Dept Med, Edmonton, AB, Canada	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; University of Oslo; Rigshospitalet; University of Copenhagen; ULSS 1 Dolomiti; Ospedale di Belluno; University of Oxford; Kaiser-Franz-Josef Hospital; Mayo Clinic; University of Alberta	Raoult, D (corresponding author), Univ Mediterranee, Fac Med, Unite Rickettsies, CNRS,UPRESA 6020, 27 Blvd Jean Moulin, F-13385 Marseille 05, France.		JONES, NICOLA/AAN-4246-2020; RAOULT, Didier/A-8434-2008; Fournier, Pierre-Edouard/AAC-6155-2021	RAOULT, Didier/0000-0002-0633-5974; Fournier, Pierre-Edouard/0000-0001-8463-8885; DE PINA, Jean Jacques/0000-0002-2081-3936				BABALIS T, 1993, AM J TROP MED HYG, V48, P784, DOI 10.4269/ajtmh.1993.48.784; Brouqui P, 1997, ARCH INTERN MED, V157, P119, DOI 10.1001/archinte.157.1.119; DEAN AD, 1991, EPI INFO VERSION 5 W; DUPONT HT, 1995, CLIN INFECT DIS, V21, P1126, DOI 10.1093/clinids/21.5.1126; Dupont HT, 1997, CLIN INFECT DIS, V25, P139, DOI 10.1086/514496; Fournier PE, 1998, CLIN INFECT DIS, V27, P316, DOI 10.1086/514664; Fournier PE, 1999, EMERG INFECT DIS, V5, P178, DOI 10.3201/eid0501.990127; Fournier PE, 1998, INT J SYST BACTERIOL, V48, P839, DOI 10.1099/00207713-48-3-839; GOLDWASSER RA, 1959, J IMMUNOL, V82, P373; HECHEMY KE, 1983, J CLIN MICROBIOL, V17, P445, DOI 10.1128/JCM.17.3.445-449.1983; HELMICK CG, 1984, J INFECT DIS, V150, P480, DOI 10.1093/infdis/150.4.480; HERREROHERRERO JI, 1993, EUR J EPIDEMIOL, V9, P59, DOI 10.1007/BF00463091; Jensenius M, 1999, SCAND J INFECT DIS, V31, P131, DOI 10.1080/003655499750006155; KELLY P, 1992, LANCET, V340, P982, DOI 10.1016/0140-6736(92)92878-J; KELLY PJ, 1994, J TROP MED HYG, V97, P129; Kelly PJ, 1996, INT J SYST BACTERIOL, V46, P611, DOI 10.1099/00207713-46-2-611; KELLY PJ, 1991, J TROP MED HYG, V94, P304; La Scola B, 2000, CLIN DIAGN LAB IMMUN, V7, P612, DOI 10.1128/CDLI.7.4.612-616.2000; NORVAL RAI, 1983, ZIMBABWE VET J, V13, P3; Parola P, 1998, NEW ENGL J MED, V338, P1391, DOI 10.1056/NEJM199805073381918; Pece S, 1996, MED SCI RES, V24, P435; Pijper A., 1936, Arch Inst Pasteur Tunis, V25, P388; Raoult D, 2000, P NATL ACAD SCI USA, V97, P12800, DOI 10.1073/pnas.220225197; RAOULT D, 1989, J CLIN MICROBIOL, V27, P2073, DOI 10.1128/JCM.27.9.2073-2079.1989; RAOULT D, 1986, AM J TROP MED HYG, V35, P845, DOI 10.4269/ajtmh.1986.35.845; Raoult D, 1997, CLIN MICROBIOL REV, V10, P694, DOI 10.1128/CMR.10.4.694; Rotz L, 1998, Del Med J, V70, P285; Roux V, 1996, J CLIN MICROBIOL, V34, P2058, DOI 10.1128/JCM.34.9.2058-2065.1996; Smoak BL, 1996, EMERG INFECT DIS, V2, P217, DOI 10.3201/eid0203.960309; SONENSHINE DE, 1993, BIOL TICKS, V2, P3; TEYSSEIRE N, 1992, J CLIN MICROBIOL, V30, P455, DOI 10.1128/JCM.30.2.455-460.1992; TROUP JM, 1938, LANCET, V2, P1183; WALKER D, 1998, HARRISONS PRINCIPLES, V1, P1045	33	210	214	0	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 17	2001	344	20					1504	1510		10.1056/NEJM200105173442003	http://dx.doi.org/10.1056/NEJM200105173442003			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	432DP	11357153	Bronze			2022-12-24	WOS:000168677200003
J	CHARIOT, P				CHARIOT, P			ZIDOVUDINE MYOPATHY	NEW ENGLAND JOURNAL OF MEDICINE			English	Note											CHARIOT, P (corresponding author), HOP HENRI MONDOR,F-94000 CRETEIL,FRANCE.		Chariot, Patrick/H-6384-2019	Chariot, Patrick/0000-0001-5556-8814					0	3	3	0	0	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 10	1993	328	23					1675	1675						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LF054	11407398				2022-12-24	WOS:A1993LF05400005
J	Iborra, FJ; Jackson, DA; Cook, PR				Iborra, FJ; Jackson, DA; Cook, PR			Coupled transcription and translation within nuclei of mammalian cells	SCIENCE			English	Article							MONOCLONAL-ANTIBODY; TRANSFER-RNAS; VISUALIZATION; POLYPEPTIDE; PROTEIN; EXPORT; DECAY; SITES	It is widely assumed that the vital processes of transcription and translation are spatially separated in eukaryotes and that no translation occurs in nuclei. We localized translation sites by incubating permeabilized mammalian cells with [H-3]lysine or lysyl-transfer RNA tagged with biotin or BODIPY; although most nascent polypeptides were cytoplasmic, some were found in discrete nuclear sites known as transcription "factories." Some of this nuclear translation also depends on concurrent transcription by RNA polymerase II. This coupling is simply explained if nuclear ribosomes translate nascent transcripts as those transcripts emerge from still-engaged RNA polymerases, much as they do in bacteria.	Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; Univ Manchester, Inst Sci & Technol, Dept Biomol Sci, Manchester M60 1QD, Lancs, England	University of Oxford; University of Manchester	Cook, PR (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.		iborra, francisco j/K-9313-2015; Iborra, Francisco J/A-2943-2009	iborra, francisco j/0000-0002-0692-3696; Cook, Peter/0000-0002-6639-188X				Arts GJ, 1998, EMBO J, V17, P7430, DOI 10.1093/emboj/17.24.7430; CHATTERJEE NK, 1977, ARCH BIOCHEM BIOPHYS, V183, P228, DOI 10.1016/0003-9861(77)90436-2; Cook PR, 1999, SCIENCE, V284, P1790, DOI 10.1126/science.284.5421.1790; EISINGER DP, 1997, MOL CELL BIOL, V17, P5135; ETCHISON D, 1987, J VIROL, V61, P2702, DOI 10.1128/JVI.61.9.2702-2710.1987; GOIDL JA, 1978, TRENDS BIOCHEM SCI, V3, pN225; GREBER UF, 1995, J CELL BIOL, V128, P5, DOI 10.1083/jcb.128.1.5; Hentze MW, 1999, CELL, V96, P307, DOI 10.1016/S0092-8674(00)80542-5; Hollinshead M, 1997, J HISTOCHEM CYTOCHEM, V45, P1053, DOI 10.1177/002215549704500803; IBORRA FJ, 1992, J HISTOCHEM CYTOCHEM, V40, P1865, DOI 10.1177/40.12.1453005; Iborra FJ, 1998, J CELL SCI, V111, P2269; Jackson DA, 2000, FASEB J, V14, P242, DOI 10.1096/fasebj.14.2.242; Jacobson A, 1996, ANNU REV BIOCHEM, V65, P693, DOI 10.1146/annurev.bi.65.070196.003401; LEJBKOWICZ F, 1992, P NATL ACAD SCI USA, V89, P9612, DOI 10.1073/pnas.89.20.9612; Lund E, 1998, SCIENCE, V282, P2082, DOI 10.1126/science.282.5396.2082; MILLER OL, 1970, SCIENCE, V169, P392, DOI 10.1126/science.169.3943.392; Neumann F, 1997, EXP CELL RES, V230, P252, DOI 10.1006/excr.1996.3417; Pederson T, 2000, J CELL BIOL, V148, P1091, DOI 10.1083/jcb.148.6.1091; Pombo A, 1999, EMBO J, V18, P2241, DOI 10.1093/emboj/18.8.2241; RAY MK, 1993, BIOCHEMISTRY-US, V32, P5151, DOI 10.1021/bi00070a026; ROTH MB, 1990, J CELL BIOL, V111, P2217, DOI 10.1083/jcb.111.6.2217; Yotov WV, 1998, MOL CELL BIOL, V18, P1303, DOI 10.1128/MCB.18.3.1303	22	300	311	0	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 10	2001	293	5532					1139	1142		10.1126/science.1061216	http://dx.doi.org/10.1126/science.1061216			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462RB	11423616				2022-12-24	WOS:000170432600061
J	Tishkoff, SA; Varkonyi, R; Cahinhinan, N; Abbes, S; Argyropoulos, G; Destro-Bisol, G; Drousiotou, A; Dangerfield, B; Lefranc, G; Loiselet, J; Piro, A; Stoneking, M; Tagarelli, A; Tagarelli, G; Touma, EH; Williams, SM; Clark, AG				Tishkoff, SA; Varkonyi, R; Cahinhinan, N; Abbes, S; Argyropoulos, G; Destro-Bisol, G; Drousiotou, A; Dangerfield, B; Lefranc, G; Loiselet, J; Piro, A; Stoneking, M; Tagarelli, A; Tagarelli, G; Touma, EH; Williams, SM; Clark, AG			Haplotype diversity and linkage disequilibrium at human G6PD: Recent origin of alleles that confer malarial resistance	SCIENCE			English	Article							GLUCOSE-6-PHOSPHATE-DEHYDROGENASE DEFICIENCY; LOCUS; POPULATION; EVOLUTION; GENE; POLYMORPHISM; SEQUENCE; SAMPLES; AFRICA	The frequencies of Low-activity alleles of glucose-6-phosphate dehydrogenase in humans are highly correlated with the prevalence of malaria. These "deficiency" alleles are thought to provide reduced risk from infection by the Plasmodium parasite and are maintained at high frequency despite the hemopathologies that they cause. Haplotype analysis of "A-" and "Med" mutations at this Locus indicates that they have evolved independently and have increased in frequency at a rate that is too rapid to be explained by random genetic drift. Statistical modeling indicates that the A- allele arose within the past 3840 to 11,760 years and the Med allele arose within the past 1600 to 6640 years. These results support the hypothesis that malaria has had a major impact on humans only since the introduction of agriculture within the past 10,000 years and provide a striking example of the signature of selection on the human genome.	Univ Maryland, Dept Biol, College Pk, MD 20742 USA; Penn State Univ, Dept Biol, Inst Evolutionary Genet, University Pk, PA 16802 USA; Fac Med, Tunis, Tunisia; Inst Pasteur, Tunis, Tunisia; Louisiana State Univ, Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA; Univ Roma La Sapienza, Dept Human & Anim Biol, Rome, Italy; Cyprus Inst Neurol & Genet, Dept Biochem Genet, Nicosia, Cyprus; Univ Witwatersrand, S African Inst Med Res, Dept Human Genet, Johannesburg, South Africa; Univ Sci, Montpellier, France; CNRS, Montpellier, France; Univ St Joseph, Beirut, Lebanon; CNR, Ist Med Sperimentale & Biotecnol, Mangone, Cosenza, Italy; Max Planck Inst Evolutionary Anthropol, Leipzig, Germany; Meharry Med Coll, Dept Microbiol, Nashville, TN 37208 USA	University System of Maryland; University of Maryland College Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Universite de Tunis-El-Manar; Faculte de Medecine de Tunis (FMT); Le Reseau International des Instituts Pasteur (RIIP); Universite de Tunis-El-Manar; Institut Pasteur Tunis; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Sapienza University Rome; University of Witwatersrand; Centre National de la Recherche Scientifique (CNRS); Saint Joseph University Beirut; Consiglio Nazionale delle Ricerche (CNR); Max Planck Society; Meharry Medical College	Tishkoff, SA (corresponding author), Univ Maryland, Dept Biol, Biol Psychol Bldg, College Pk, MD 20742 USA.	st130@umail.umd.edu	Williams, Scott/B-9491-2012; Tagarelli, Giuseppe/N-8140-2015; Williams, Scott/Q-4812-2019	Tagarelli, Giuseppe/0000-0002-4792-023X; Williams, Scott/0000-0002-4835-9544; Clark, Andrew/0000-0001-7159-8511; Destro Bisol, Giovanni/0000-0002-4232-9715	FIC NIH HHS [T37-TW00043] Funding Source: Medline; NCRR NIH HHS [G12-RR03032] Funding Source: Medline; NHLBI NIH HHS [HL03321] Funding Source: Medline; FOGARTY INTERNATIONAL CENTER [T37TW000043] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003032] Funding Source: NIH RePORTER	FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Argyropoulos G, 1998, J CLIN INVEST, V102, P1345, DOI 10.1172/JCI4115; BEUTLER E, 1989, BLOOD, V74, P2550; BEUTLER E, 1994, BLOOD, V84, P3613, DOI 10.1182/blood.V84.11.3613.bloodjournal84113613; BEUTLER E, 1990, AM J HUM GENET, V47, P1008; BEUTLER E, 1977, BLOOD, V49, P467; Brooks A., COMMUNICATION; Brooks A. S., 1990, WORLD 18000 BP, V2, P121; Cavalli-Sforza L. L., 1994, HIST GEOGRAPHY HUMAN; CLARK AG, 1990, MOL BIOL EVOL, V7, P111; Collins A, 1996, P NATL ACAD SCI USA, V93, P14771, DOI 10.1073/pnas.93.25.14771; Coluzzi M, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P277; DURANDO F, 1997, ANCIENT GREECE DAWN; FILOSA S, 1993, GENOMICS, V17, P6, DOI 10.1006/geno.1993.1276; *GENB, X55448 GENB; Gillespie JH, 2000, GENETICS, V155, P909; HAWLEY ME, 1995, J HERED, V86, P409, DOI 10.1093/oxfordjournals.jhered.a111613; HIRONO A, 1988, P NATL ACAD SCI USA, V85, P3951, DOI 10.1073/pnas.85.11.3951; Kidd JR, 2000, AM J HUM GENET, V66, P1882, DOI 10.1086/302952; LIVINGSTONE FB, 1971, ANNU REV GENET, V5, P33, DOI 10.1146/annurev.ge.05.120171.000341; LIVINGSTONE FB, 1958, AM ANTHROPOL, V60, P533, DOI 10.1525/aa.1958.60.3.02a00110; Luzzatto L, 2001, HEMATOLOGYONCOLOGY C, P4517, DOI [10.1016/j.hoc.2015.11.006, DOI 10.1016/J.HOC.2015.11.006]; Neuhauser C, 1997, GENETICS, V145, P519; PLATO CC, 1964, AM J HUM GENET, V16, P267; Rich SM, 2000, P NATL ACAD SCI USA, V97, P6994, DOI 10.1073/pnas.97.13.6994; Ruwende C, 1998, J MOL MED, V76, P581, DOI 10.1007/s001090050253; RUWENDE C, 1995, NATURE, V376, P246, DOI 10.1038/376246a0; SAUNDERS M, UNPUB; Sherman Irwin W., 1998, P3; Slatkin M, 2000, ANNU REV GENOM HUM G, V1, P225, DOI 10.1146/annurev.genom.1.1.225; Spedini G, 1999, AM J PHYS ANTHROPOL, V110, P143, DOI 10.1002/(SICI)1096-8644(199910)110:2<143::AID-AJPA3>3.3.CO;2-A; STONEKING M, 1990, GENETICS, V124, P717; Tagarelli A, 2000, FEBS LETT, V466, P139, DOI 10.1016/S0014-5793(99)01776-7; Tagarelli A, 1991, Gene Geogr, V5, P141; TAKIZAWA T, 1987, Genomics, V1, P228, DOI 10.1016/0888-7543(87)90048-6; Tishkoff SA, 2000, AM J HUM GENET, V67, P901, DOI 10.1086/303068; Tishkoff SA, 1998, AM J HUM GENET, V62, P1389, DOI 10.1086/301861; Tishkoff SA, 1996, SCIENCE, V271, P1380, DOI 10.1126/science.271.5254.1380; TOUMA E, 1997, 7 INT C INB ERR MET, P26; Verra F, 2000, MOL BIOCHEM PARASIT, V105, P149, DOI 10.1016/S0166-6851(99)00162-0; VERRELLI BC, UNPUB; VULLIAMY T, 1992, TRENDS GENET, V8, P138, DOI 10.1016/0168-9525(92)90372-B; VULLIAMY TJ, 1991, P NATL ACAD SCI USA, V88, P8568, DOI 10.1073/pnas.88.19.8568; WIESENFELD SL, 1967, SCIENCE, V157, P1134, DOI 10.1126/science.157.3793.1134; Williams SM, 2000, HYPERTENSION, V36, P2, DOI 10.1161/01.HYP.36.1.2; Yellen J.E., 1998, AFR ARCHAEOL REV, V15, P173, DOI [DOI 10.1023/, DOI 10.1023/A:1021659928822]	45	941	959	5	91	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 20	2001	293	5529					455	462		10.1126/science.1061573	http://dx.doi.org/10.1126/science.1061573			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	454HG	11423617				2022-12-24	WOS:000169966700037
J	Grimm, JW; Hope, BT; Wise, RA; Shaham, Y				Grimm, JW; Hope, BT; Wise, RA; Shaham, Y			Neuroadaptation - Incubation of cocaine craving after withdrawal	NATURE			English	Article							RELAPSE; SENSITIZATION; ABSTINENCE; ADDICTION; STRESS		NIDA, Behav Neurosci Branch, Intramural Res Program, NIH, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA)	Grimm, JW (corresponding author), NIDA, Behav Neurosci Branch, Intramural Res Program, NIH, 5500 Nathan Shock Dr, Baltimore, MD 21224 USA.		Hope, Bruce T/A-9223-2010; Wise, Roy A/A-6465-2012; shaham, yavin/G-1306-2014	Hope, Bruce T/0000-0001-5804-7061; 	Intramural NIH HHS [Z01 DA000434-08] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [Z01DA000434] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Childress AR, 1999, AM J PSYCHIAT, V156, P11, DOI 10.1176/ajp.156.1.11; deWit H, 1996, EXP CLIN PSYCHOPHARM, V4, P5, DOI 10.1037/1064-1297.4.1.5; GAWIN FH, 1986, ARCH GEN PSYCHIAT, V43, P107; Grimm JW, 2000, NEUROPSYCHOPHARMACOL, V22, P473, DOI 10.1016/S0893-133X(99)00157-8; Nestler EJ, 2001, NAT REV NEUROSCI, V2, P119, DOI 10.1038/35053570; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; SARNYAI Z, IN PRESS PHARM REV; SATEL SL, 1991, AM J PSYCHIAT, V148, P1712; Shaham Y, 2000, BRAIN RES REV, V33, P13, DOI 10.1016/S0165-0173(00)00024-2; Sinha R, 2000, PSYCHOPHARMACOLOGY, V152, P140, DOI 10.1007/s002130000499; STEWART J, 1983, PROG NEURO-PSYCHOPH, V7, P591, DOI 10.1016/0278-5846(83)90030-1; Vanderschuren LJMJ, 2000, PSYCHOPHARMACOLOGY, V151, P99, DOI 10.1007/s002130000493; White FJ, 1998, DRUG ALCOHOL DEPEN, V51, P141, DOI 10.1016/S0376-8716(98)00072-6	13	696	707	2	38	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 12	2001	412	6843					141	142		10.1038/35084134	http://dx.doi.org/10.1038/35084134			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	451AJ	11449260	Green Accepted			2022-12-24	WOS:000169778700038
J	Schoener, TW; Spiller, DA; Losos, JB				Schoener, TW; Spiller, DA; Losos, JB			Predators increase the risk of catastrophic extinction of prey populations	NATURE			English	Article							TROPHIC CASCADES; COMPETITION; DIVERSITY	There has been considerable research on both top-down effects(1,2) and on disturbances(3-5) in ecological communities; however, the interaction between the two, when the disturbance is catastrophic, has rarely been examined(6). Predators may increase the probability of prey extinction resulting from a catastrophic disturbance both by reducing prey population size(7,8) and by changing ecological traits of prey individuals such as habitat characteristics(8,9) in a way that increases the vulnerability of prey species to extinction. We show that a major hurricane in the Bahamas led to the extinction of lizard populations on most islands onto which a predator had been experimentally introduced, whereas no populations became extinct on control islands. Before the hurricane, the predator had reduced prey populations to about half of those on control islands. Two months after the hurricane, we found only recently hatched individuals-apparently lizards survived the inundating storm surge only as eggs. On predator-introduction islands, those hatchling populations were a smaller fraction of pre-hurricane populations than on control islands. Egg survival allowed rapid recovery of prey populations to pre-hurricane levels on all control islands but on only a third of predator-introduction islands-the other two-thirds lost their prey populations. Thus climatic disturbance compounded by predation brought prey populations to extinction.	Univ Calif Davis, Sect Ecol & Evolut, Davis, CA 95616 USA; Washington Univ, Dept Biol, St Louis, MO 63130 USA	University of California System; University of California Davis; Washington University (WUSTL)	Schoener, TW (corresponding author), Univ Calif Davis, Sect Ecol & Evolut, Davis, CA 95616 USA.	twschoener@ucdavis.edu						Abrams PA, 1996, AM NAT, V148, P211, DOI 10.1086/285920; Ackerman J., 2000, NAT GEOGR MAG    OCT, V198, P86; Andrewartha H.G., 1954, DISTRIBUTION ABUNDAN; DUNSON WA, 1991, AM NAT, V101, P97; EVANS EW, 1982, J NEW YORK ENTOMOL S, V90, P241; FIENBERG SE, 1972, BIOMETRIKA, V59, P591, DOI 10.2307/2334810; Gerber GP, 2000, OECOLOGIA, V124, P599, DOI 10.1007/s004420000414; HECKEL DG, 1979, ECOLOGY, V60, P966, DOI 10.2307/1936865; HOLT RD, 1994, ANNU REV ECOL SYST, V25, P495, DOI 10.1146/annurev.es.25.110194.002431; Kareiva P.M., 1993, BIOTIC INTERACTIONS; MENGE BA, 1976, AM NAT, V110, P351, DOI 10.1086/283073; Pace ML, 1999, TRENDS ECOL EVOL, V14, P483, DOI 10.1016/S0169-5347(99)01723-1; Pickett S. T. A., 1985, ECOLOGY NATURAL DIST; Power Mary E., 1996, P286; Roughgarden J, 1986, COMMUNITY ECOL, P333; Schmitz OJ, 1997, ECOLOGY, V78, P1388, DOI 10.1890/0012-9658(1997)078[1388:BMTCEO]2.0.CO;2; Schmitz OJ, 2000, AM NAT, V155, P141, DOI 10.1086/303311; Schoener T.W., 1987, P8; SCHOENER TW, 1968, ECOLOGY, V49, P704, DOI 10.2307/1935534; Schoener TW, 1996, NATURE, V381, P691, DOI 10.1038/381691a0; SCHOENER TW, 1975, ECOL MONOGR, V45, P233, DOI 10.2307/1942423; SCHOENER TW, 1982, OECOLOGIA, V53, P160, DOI 10.1007/BF00545659; SCHOENER TW, UNPUB ECOL MONOGR; SCHWARTZ A, 1991, AMPHIBIANS REPTILES, P424; Siegel S., 1988, NONPARAMETRIC STAT B, P128; SIH A, 1985, ANNU REV ECOL SYST, V16, P269, DOI 10.1146/annurev.es.16.110185.001413; SOUSA WP, 1984, ANNU REV ECOL SYST, V15, P353, DOI 10.1146/annurev.es.15.110184.002033; Spiller DA, 1998, SCIENCE, V281, P695, DOI 10.1126/science.281.5377.695; WIENS JA, 1977, AM SCI, V65, P590	29	75	81	0	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 12	2001	412	6843					183	186		10.1038/35084071	http://dx.doi.org/10.1038/35084071			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	451AJ	11449274				2022-12-24	WOS:000169778700052
J	Kuypers, MMM; Blokker, P; Erbacher, J; Kinkel, H; Pancost, RD; Schouten, S; Damste, JSS				Kuypers, MMM; Blokker, P; Erbacher, J; Kinkel, H; Pancost, RD; Schouten, S; Damste, JSS			Massive expansion of marine archaea during a mid-Cretaceous oceanic anoxic event	SCIENCE			English	Article							ORGANIC-CARBON; ETHER LIPIDS; SEDIMENTS; PRODUCTS; BIOMASS; EARTH; SEA	Biogeochemical and stable carbon isotopic analysis of black-share sequences deposited during an Albian oceanic anoxic event (similar to 112 million years ago) indicate that up to 80 weight percent of sedimentary organic carbon is derived from marine, nonthermophilic archaea, The carbon-13 content of archaeal molecular fossils indicates that these archaea were Living chemoautotrophically. Their massive expansion may have been a response to the strong stratification of the ocean during this anoxic event. Indeed, the sedimentary record of archaeal membrane lipids suggests that this anoxic event marks a time in Earth history at which certain hyperthermophilic archaea adapted to low-temperature environments.	Netherlands Inst Sea Res, Dept Biogeochem & Toxicol, NL-1790 AB Den Burg, Netherlands; Bundesanstalt Geowissensch & Rohstoffe, D-30655 Hannover, Germany	Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ)	Damste, JSS (corresponding author), Netherlands Inst Sea Res, Dept Biogeochem & Toxicol, POB 59, NL-1790 AB Den Burg, Netherlands.		Damste, Jaap S Sinninghe/F-6128-2011	Damste, Jaap S Sinninghe/0000-0002-8683-1854; Pancost, Richard/0000-0003-0298-4026; Erbacher, Jochen/0000-0003-2793-0307				ARTHUR MA, 1985, NATURE, V315, P216, DOI 10.1038/315216a0; ARTHUR MA, 1988, NATURE, V335, P714, DOI 10.1038/335714a0; ARTHUR MA, 1985, AM GEOPHYS UNION MON, V32, P504; Bralower TJ, 1997, GEOL SOC AM BULL, V109, P1421, DOI 10.1130/0016-7606(1997)109<1421:MCSISO>2.3.CO;2; BRALOWER TJ, 1987, GEOL SOC LOND SPEC P, V26, P345; Damste JSS, 1997, ORG GEOCHEM, V26, P517, DOI 10.1016/S0146-6380(97)00039-9; DeLong EF, 1998, APPL ENVIRON MICROB, V64, P1133; DEROSA M, 1988, PROG LIPID RES, V27, P153, DOI 10.1016/0163-7827(88)90011-2; Erbacher J, 2001, NATURE, V409, P325, DOI 10.1038/35053041; FUHRMAN JA, 1989, MAR ECOL PROG SER, V57, P207, DOI 10.3354/meps057207; Hoefs MJL, 1997, APPL ENVIRON MICROB, V63, P3090, DOI 10.1128/AEM.63.8.3090-3095.1997; Hold IM, 1998, ORG GEOCHEM, V28, P179, DOI 10.1016/S0146-6380(97)00130-7; Hopmans EC, 2000, RAPID COMMUN MASS SP, V14, P585, DOI 10.1002/(SICI)1097-0231(20000415)14:7<585::AID-RCM913>3.3.CO;2-E; Karner MB, 2001, NATURE, V409, P507, DOI 10.1038/35054051; Kuypers MMM, 1999, NATURE, V399, P342, DOI 10.1038/20659; KUYPERS MMM, UNPUB; LARSON RL, 1991, GEOLOGY, V19, P547, DOI 10.1130/0091-7613(1991)019<0547:LPOEEF>2.3.CO;2; OURISSON G, 1992, ACCOUNTS CHEM RES, V25, P398, DOI 10.1021/ar00021a003; PEARSON A, 2001, GEOCHIM COSMOCHIM AC, V196, P67; SCHLANGER S O, 1976, Geologie en Mijnbouw, V55, P179; Schouten S, 1997, ORG GEOCHEM, V26, P409, DOI 10.1016/S0146-6380(97)00011-9; Schouten S, 2000, P NATL ACAD SCI USA, V97, P14421, DOI 10.1073/pnas.97.26.14421; SCHOUTEN S, UNPUB; STETTER KO, 1998, EXTREMOPHILES MICROB, pCH1; VANDERMEER MTJ, IN PRESS FEMS MICROB; Vink A, 1998, GEOCHIM COSMOCHIM AC, V62, P965, DOI 10.1016/S0016-7037(98)00034-9; VOLKMAN JK, 1986, ORG GEOCHEM, V9, P83, DOI 10.1016/0146-6380(86)90089-6	27	188	210	3	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 6	2001	293	5527					92	94		10.1126/science.1058424	http://dx.doi.org/10.1126/science.1058424			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	451BB	11441180				2022-12-24	WOS:000169780300035
J	Lalvani, A; Pathan, AA; Durkan, H; Wilkinson, KA; Whelan, A; Deeks, JJ; Reece, WHH; Latif, M; Pasvol, G; Hill, AVS				Lalvani, A; Pathan, AA; Durkan, H; Wilkinson, KA; Whelan, A; Deeks, JJ; Reece, WHH; Latif, M; Pasvol, G; Hill, AVS			Enhanced contact tracing and spatial tracking of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells	LANCET			English	Article							ESAT-6 ANTIGEN; RESPONSES; EPIDEMIOLOGY; PROTEIN; DIAGNOSIS; BOVIS; BCG	Background Identification of individuals latently infected with Mycobacterium tuberculosis is an important part of tuberculosis control. The current method, the tuberculin shin test (TST), has poor specificity because of the antigenic cross-reactivity of purified protein derivative (PPD) with M bovis BCG vaccine and environmental mycobacteria. ESAT-6 is a secreted antigen that is highly specific for M tuberculosis complex, but is absent from M bovis BCG. With an enzyme-linked immunospot (ELISPOT) assay for interferon gamma, we have identified ESAT-6-specific T cells as an accurate marker of M tuberculosis infection. Methods We did a prospective, masked study of 50 healthy contacts, with varying but well defined degrees of exposure to M tuberculosis, who attended an urban contact-tracing clinic. We assessed and compared the efficacy of our assay and TST for detection of symptomless infected individuals by correlation of test results with the degree of exposure to an infectious index case. Findings The ESAT-6 ELISPOT assay results had a strong positive relation with increasing intensity of exposure (odds ratio=9.0 per unit increase in level of exposure [95% CI 2.6-31.6], p=0.001), whereas TST results had a weaker relation with exposure (1.9 [1.0-3.5], p=0.05). By contrast, ELISPOT results were not correlated with BCG vaccination status (p=0.7), whereas TST results were significantly more likely to be positive in BCG-vaccinated contacts (12.1 [1.3-115.7], p=0.03). Interpretation This new antigen-specific T cell-based assay could allow more accurate identification of symptom-free individuals recently exposed to M tuberculosis, and thereby help to improve tuberculosis control.	Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Med, Oxford OX3 9DU, England; Northwick Pk Hosp & Clin Res Ctr, Imperial Coll Sch Med, Wellcome Ctr Clin Trop Med, Harrow HA1 3UJ, Middx, England; Northwick Pk Hosp & Clin Res Ctr, TB Contact Tracing Clin, Harrow HA1 3UJ, Middx, England; Vet Labs Agcy, Dept Bacterial Dis, TB Res Grp, Weybridge, Surrey, England; Inst Hlth Sci, Ctr Stat Med, Oxford, England	University of Oxford; Imperial College London; Imperial College London; Veterinary Laboratories Agency; University of Oxford	Lalvani, A (corresponding author), Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Med, Oxford OX3 9DU, England.	ajit.lalvani@ndm.ox.ac.uk	Wilkinson, Katalin/AAQ-7713-2021; Pasvol, Geoffrey/B-7113-2009; Wilkinson, Katalin/AAF-6805-2020; Whelan, Adam O/C-9497-2011; Deeks, Jon/AAV-5745-2020; HILL, Adrian V>S>/C-1306-2008	Wilkinson, Katalin/0000-0002-9796-2040; Deeks, Jon/0000-0002-8850-1971; Lalvani, Ajit/0000-0002-2396-246X				Andersen P, 2000, LANCET, V356, P1099, DOI 10.1016/S0140-6736(00)02742-2; [Anonymous], 2000, MMWR Recomm Rep, V49, P1; Arend SM, 2000, INFECT IMMUN, V68, P3314, DOI 10.1128/IAI.68.6.3314-3321.2000; Arend SM, 2000, J INFECT DIS, V181, P1850, DOI 10.1086/315448; Barnes PF, 2001, AM J RESP CRIT CARE, V163, P807, DOI 10.1164/ajrccm.163.4.ed0201c; Behr MA, 1999, SCIENCE, V284, P1520, DOI 10.1126/science.284.5419.1520; Brandt L, 1996, J IMMUNOL, V157, P3527; COMSTOCK GW, 1975, AM J EPIDEMIOL, V101, P363, DOI 10.1093/oxfordjournals.aje.a112105; Dye C, 1999, JAMA-J AM MED ASSOC, V282, P677, DOI 10.1001/jama.282.7.677; Fine PEM, 1999, INT J TUBERC LUNG D, V3, P962; GRZYBOWSKI S, 1975, Bulletin of the International Union Against Tuberculosis, V50, P90; Harboe M, 1996, INFECT IMMUN, V64, P16, DOI 10.1128/IAI.64.1.16-22.1996; HMSO, 1996, IMM INF DIS; HOUK VN, 1968, ARCH ENVIRON HEALTH, V16, P26, DOI 10.1080/00039896.1968.10665011; HUEBNER RE, 1993, CLIN INFECT DIS, V17, P968, DOI 10.1093/clinids/17.6.968; Kenyon TA, 1996, NEW ENGL J MED, V334, P933, DOI 10.1056/NEJM199604113341501; KWAMANGA DO, 1995, E AFR MED J, V72, P222; LAIVANI A, 2001, J INFECT DIS, V183, P469; Lalvani A, 1997, J EXP MED, V186, P859, DOI 10.1084/jem.186.6.859; Lalvani A, 2001, AM J RESP CRIT CARE, V163, P824, DOI 10.1164/ajrccm.163.4.2009100; Lein AD, 1999, CLIN DIAGN LAB IMMUN, V6, P606, DOI 10.1128/CDLI.6.4.606-609.1999; Mahairas GG, 1996, J BACTERIOL, V178, P1274, DOI 10.1128/jb.178.5.1274-1282.1996; Ormerod P, 2000, THORAX, V55, P887; Ravn P, 1999, J INFECT DIS, V179, P637, DOI 10.1086/314640; SMALL PM, 1994, NEW ENGL J MED, V330, P1703, DOI 10.1056/NEJM199406163302402; SORENSEN AL, 1995, INFECT IMMUN, V63, P1710; STEAD WW, 1978, JAMA-J AM MED ASSOC, V240, P2544, DOI 10.1001/jama.240.23.2544; THOMPSON NJ, 1982, B WORLD HEALTH ORGAN, V60, P555; Ulrichs T, 1998, EUR J IMMUNOL, V28, P3949, DOI 10.1002/(SICI)1521-4141(199812)28:12<3949::AID-IMMU3949>3.3.CO;2-W; van Pinxteren LAH, 2000, CLIN DIAGN LAB IMMUN, V7, P155, DOI 10.1128/CDLI.7.2.155-160.2000	30	315	333	0	12	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 23	2001	357	9273					2017	2021		10.1016/S0140-6736(00)05115-1	http://dx.doi.org/10.1016/S0140-6736(00)05115-1			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	446JB	11438135				2022-12-24	WOS:000169509200012
J	Cassell, EJ; Leon, AC; Kaufman, SG				Cassell, EJ; Leon, AC; Kaufman, SG			Preliminary evidence of impaired thinking in sick patients	ANNALS OF INTERNAL MEDICINE			English	Article							MINI-MENTAL-STATE	Background: Earlier anecdotal observations suggested to us that certain aspects of judgment in sick adults approximate the thinking of children. Objective: To describe changes in judgment associated with serious illness in otherwise competent adults. Design: Cohort study. Setting: Urban acute-care hospital and senior citizen center. Participants: sicker (Karnofsky score less than or equal to 50; n = 24) and less sick (Karnofsky score > 50; n = 39) hospitalized patients were compared with controls (n = 28). Normal performance on the Mini-Mental State Examination (score greater than or equal to 24) was required for study entrance. Measurements: Seven Piagetian tasks of judgment designed to study childhood cognitive development. Degree of sickness was determined by using the Karnofsky scale of physical function. Results: Patients with Karnofsky scores of 50 or less responded correctly to fewer Piagetian tasks than controls (mean [+/- SD], 1.8 +/- 2.6 vs. 5.9 +/- 1.6; P < 0.001). Furthermore, a smaller proportion of sicker patients responded correctly to each of the seven tasks. Patients with Karnofsky scores greater than 50 did not perform differently than controls, Conclusion: In sicker hospitalized patients, performance on seven Piagetian tasks of judgment was similar to that among children younger than 10 years of age. This evidence of cognitive impairment warrants further investigation.	Cornell Univ, Joan & Sanford I Weill Coll Med, New York, NY USA; Lynbrook Publ Sch Syst, Lynbrook, NY USA	Cornell University	Cassell, EJ (corresponding author), 28 Old Fulton St, Brooklyn, NY 11201 USA.	ecassell@email.msn.com						Bond T. G, 1997, PIAGET VYGOTSKY, P167; BURKE LE, 1991, CHILD DEV; CASSELL EJ, 1985, HEALERS ART, P38; COCKRELL JR, 1988, PSYCHOPHARMACOL BULL, V24, P689; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GINSBURG H, 1969, PIAGETS THEORY INTEL, P168; Karnofsky DA, 1949, EVALUATION CHEMOTHER; Piaget J., 1967, CHILDS CONCEPT SPACE; Piaget J., 1969, PSYCHOL CHILD; Piaget J, 1950, PSYCHOL INTELLIGENCE	10	83	85	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 19	2001	134	12					1120	1123		10.7326/0003-4819-134-12-200106190-00012	http://dx.doi.org/10.7326/0003-4819-134-12-200106190-00012			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	442YU	11412052				2022-12-24	WOS:000169313200005
J	Martinek, S; Inonog, S; Manoukian, AS; Young, MW				Martinek, S; Inonog, S; Manoukian, AS; Young, MW			A role for the segment polarity gene shaggy/GSK-3 in the Drosophila circadian clock	CELL			English	Article							GLYCOGEN-SYNTHASE KINASE-3-BETA; KINASE-I-EPSILON; BEHAVIORAL RHYTHMS; PERIOD GENE; TEMPORAL EXPRESSION; WINGLESS SIGNAL; NERVOUS-SYSTEM; DOUBLE-TIME; PROTEIN; LIGHT	Tissue-specific overexpression of the glycogen synthase kinase-3 (GSK-3) ortholog shaggy (sgg) shortens the period of the Drosophila circadian locomotor activity cycle. The short period phenotype was attributed to premature nuclear translocation of the PERIOD/TIMELESS heterodimer. Reducing SGG/GSK-3 activity lengthens period, demonstrating an intrinsic role for the kinase in circadian rhythmicity. Lowered sgg activity decreased TIMELESS phosphorylation, and it was found that GSK-3 beta specifically phosphorylates TIMELESS in vitro. Overexpression of sgg in vivo converts hypophosphorylated TIMELESS to a hyperphosphorylated protein whose electrophoretic mobility, and light and phosphatase sensitivity, are indistinguishable from the rhythmically produced hyperphosphorylated TIMELESS of wild-type flies. Our results indicate a role for SGG/GSK-3 in TIMELESS phosphorylation and in the regulated nuclear translocation of the PERIOD/TIMELESS heterodimer.	Rockefeller Univ, Genet Lab, New York, NY 10021 USA; Rockefeller Univ, Natl Sci Fdn, Sci & Technol Ctr Biol Timing, New York, NY 10021 USA; Ontario Canc Inst, Div Cell & Mol Biol, Toronto, ON M5G 2M9, Canada	Rockefeller University; National Science Foundation (NSF); NSF - Center for Biological Timing; Rockefeller University; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Young, MW (corresponding author), Rockefeller Univ, Genet Lab, New York, NY 10021 USA.		, 机智的马小跳和机智的羊不愁/ABC-5169-2020		NIGMS NIH HHS [GM 54339] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM054339, R01GM054339] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ASCHOFF J, 1965, CIRCADIAN CLOCKS, P94; BAYLIES MK, 1987, NATURE, V326, P390, DOI 10.1038/326390a0; Blau J, 1999, CELL, V99, P661, DOI 10.1016/S0092-8674(00)81554-8; BOUROUIS M, 1990, EMBO J, V9, P2877, DOI 10.1002/j.1460-2075.1990.tb07477.x; Ceriani MF, 1999, SCIENCE, V285, P553, DOI 10.1126/science.285.5427.553; Cermakian N, 2000, NAT REV MOL CELL BIO, V1, P59, DOI 10.1038/35036078; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Edery I, 2000, PHYSIOL GENOMICS, V3, P59, DOI 10.1152/physiolgenomics.2000.3.2.59; Emery P, 2000, NEURON, V26, P493, DOI 10.1016/S0896-6273(00)81181-2; Emery P, 2000, NATURE, V404, P456, DOI 10.1038/35006558; Emery P, 1998, CELL, V95, P669, DOI 10.1016/S0092-8674(00)81637-2; EWER J, 1992, J NEUROSCI, V12, P3321; FRISCH B, 1994, NEURON, V12, P555, DOI 10.1016/0896-6273(94)90212-7; Giebultowicz JM, 2000, ANNU REV ENTOMOL, V45, P769, DOI 10.1146/annurev.ento.45.1.769; Hall JC, 2000, CURR OPIN NEUROBIOL, V10, P456, DOI 10.1016/S0959-4388(00)00117-3; Hardin PE, 1999, SCIENCE, V286, P2460, DOI 10.1126/science.286.5449.2460; Helfrich-Forster C, 2000, J NEUROSCI, V20, P3339, DOI 10.1523/JNEUROSCI.20-09-03339.2000; HunterEnsor M, 1996, CELL, V84, P677, DOI 10.1016/S0092-8674(00)81046-6; Kaneko M, 1997, J NEUROSCI, V17, P6745; King DP, 2000, ANNU REV NEUROSCI, V23, P713, DOI 10.1146/annurev.neuro.23.1.713; Kloss B, 1998, CELL, V94, P97, DOI 10.1016/S0092-8674(00)81225-8; KLOSS B, 2001, IN PRESS NEURON; KONOPKA RJ, 1971, P NATL ACAD SCI USA, V68, P2112, DOI 10.1073/pnas.68.9.2112; KONOPKA RJ, 1989, J NEUROGENET, V6, P1, DOI 10.3109/01677068909107096; Li C, 1999, MOL CELL, V3, P77, DOI 10.1016/S1097-2765(00)80176-8; LIU X, 1988, GENE DEV, V2, P228, DOI 10.1101/gad.2.2.228; McNeil GP, 1998, NEURON, V20, P297, DOI 10.1016/S0896-6273(00)80457-2; Myers MP, 1996, SCIENCE, V271, P1736, DOI 10.1126/science.271.5256.1736; Naidoo N, 1999, SCIENCE, V285, P1737, DOI 10.1126/science.285.5434.1737; NEWBY LM, 1993, GENETICS, V135, P1077; Park JH, 2000, P NATL ACAD SCI USA, V97, P3608, DOI 10.1073/pnas.070036197; PEIFER M, 1994, DEVELOPMENT, V120, P369; PEIFER M, 1994, DEV BIOL, V166, P543, DOI 10.1006/dbio.1994.1336; Peters JM, 1999, NATURE, V401, P345, DOI 10.1038/43830; Price JL, 1998, CELL, V94, P83, DOI 10.1016/S0092-8674(00)81224-6; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; Reppert SM, 2000, J BIOL RHYTHM, V15, P357, DOI 10.1177/074873000129001459; Rorth P, 1996, P NATL ACAD SCI USA, V93, P12418, DOI 10.1073/pnas.93.22.12418; Rothenfluh A, 2000, GENETICS, V156, P665; Rothenfluh A, 2000, NEURON, V26, P505, DOI 10.1016/S0896-6273(00)81182-4; RUEL L, 1993, NATURE, V362, P557, DOI 10.1038/362557a0; RUEL L, 1993, EMBO J, V12, P1657, DOI 10.1002/j.1460-2075.1993.tb05811.x; Saez L, 1996, NEURON, V17, P911, DOI 10.1016/S0896-6273(00)80222-6; Sakanaka C, 1999, P NATL ACAD SCI USA, V96, P12548, DOI 10.1073/pnas.96.22.12548; Scully AL, 2000, CELL, V100, P297, DOI 10.1016/S0092-8674(00)80665-0; SEHGAL A, 1992, P NATL ACAD SCI USA, V89, P1423, DOI 10.1073/pnas.89.4.1423; SEHGAL A, 1995, SCIENCE, V270, P808, DOI 10.1126/science.270.5237.808; SEHGAL A, 1994, SCIENCE, V263, P1603, DOI 10.1126/science.8128246; SIEGFRIED E, 1992, CELL, V71, P1167, DOI 10.1016/S0092-8674(05)80065-0; SIEGFRIED E, 1990, NATURE, V345, P825, DOI 10.1038/345825a0; SIEGFRIED E, 1994, NATURE, V367, P76, DOI 10.1038/367076a0; STAMBOLIC V, 1994, BIOCHEM J, V303, P701, DOI 10.1042/bj3030701; Stanewsky R, 1997, J NEUROSCI, V17, P676; Suri V, 2000, J NEUROSCI, V20, P7547; SUTHERLAND C, 1993, BIOCHEM J, V296, P15, DOI 10.1042/bj2960015; VOSSHALL LB, 1994, SCIENCE, V263, P1606, DOI 10.1126/science.8128247; Wager-Smith K, 2000, NAT GENET, V26, P23, DOI 10.1038/79134; Young MW, 2000, TRENDS BIOCHEM SCI, V25, P601, DOI 10.1016/S0968-0004(00)01695-9; Young MW, 1998, ANNU REV BIOCHEM, V67, P135, DOI 10.1146/annurev.biochem.67.1.135; Zeng HK, 1996, NATURE, V380, P129, DOI 10.1038/380129a0; ZENG HK, 1994, EMBO J, V13, P3590, DOI 10.1002/j.1460-2075.1994.tb06666.x	61	433	445	0	28	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 15	2001	105	6					769	779		10.1016/S0092-8674(01)00383-X	http://dx.doi.org/10.1016/S0092-8674(01)00383-X			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	444AE	11440719	Bronze			2022-12-24	WOS:000169375100010
J	Wenger, NS; Kanouse, DE; Collins, RL; Liu, HH; Schuster, MA; Gifford, AL; Bozzette, SA; Shapiro, MF				Wenger, NS; Kanouse, DE; Collins, RL; Liu, HH; Schuster, MA; Gifford, AL; Bozzette, SA; Shapiro, MF			End-of-life discussions and preferences among persons with HIV	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PHYSICIAN-ASSISTED SUICIDE; NATIONAL PROBABILITY SAMPLES; LOW-PREVALENCE DISEASES; ADVANCE DIRECTIVES; HOMOSEXUAL-MEN; CARE; COMMUNICATION; AIDS; ATTITUDES; BARRIERS	Context Deficits in advance care planning leave many patients and their physicians unprepared for decisions about end-of-life care. Even though the prognosis has im; proved for many persons with human immunodeficiency virus (HIV) infection, a need for planning remains. Objective To evaluate prevalence of end-of-life discussions, use of advance directives, and preferences concerning end-of-life care and their relationship with patient demographics, clinical status, psychosocial variables, and practitioner characteristics among HIV-infected persons. Design, Setting, and Patients Cross-sectional survey of a US probability sample of 2864, which represents 231 400 adults receiving care for HIV, conducted from January 1996 to April 1997. Main Outcome Measures Communication with physician regarding end-of-life issues, completion of an advance directive, preference for aggressiveness of care,and willingness to tolerate future permanent adverse health states. Results A total of 1432 patients (50%) discussed some aspect of end-of-life care with their practitioner and 1088 (38%) completed an advance directive. Patients were more likely to complete an advance directive after a physician discussion (odds ratio [OR], 5.82; 95% confidence interval [CI], 4.50-7.52). Practitioners discussed end-of-life care less with blacks (OR, 0.57; 95% CI, 0.39-0.83) and Latinos (OR, 0.74; 95% CI, 0.55-0.98) than with whites. Women (OR, 1.39; 95% CI, 1.05-1.84) and patients with children in the household (OR, 1.53; 95% CI, 1.12-2.10) communicated the most with practitioners about end-of-life issues. Patients infected with HIV via injection drug use (OR, 0.64; 95% CI, 0.45-0.89) and those with less education communicated the least with physicians about end-of-life issues. Less denial, greater trust in one's practitioner, and longer patient-practitioner relationship were associated with more advance care planning. Conclusions: Half of all persons infected with HIV are at risk of making end-of-life decisions without prior discussions with their health care practitioners. Blacks, Latinos, intravenous drug users, and less educated individuals need advance care planning interventions in clinical HIV programs.	Univ Calif Los Angeles, Dept Med, Div Gen Internal Med & Hlth Serv Res, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Pediat, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Hlth Serv, Los Angeles, CA 90095 USA; RAND Hlth, Santa Monica, CA USA; San Diego VA Healthcare Syst, Dept Med, La Jolla, CA USA; Univ Calif San Diego, La Jolla, CA 92093 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; RAND Corporation; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of California System; University of California San Diego	Wenger, NS (corresponding author), Univ Calif Los Angeles, Dept Med, Div Gen Internal Med & Hlth Serv Res, GIM HSR,911 Broxton Plaza, Los Angeles, CA 90095 USA.	nwenger@mednet.ucla.edu	Gifford, Allen L/D-9329-2016	Gifford, Allen L/0000-0001-6442-1128	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [U01HS008578] Funding Source: NIH RePORTER; AHRQ HHS [U-01HS08578] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		BERRY SH, 1999, MR1090AHCPR RAND; Bindels PJE, 1996, LANCET, V347, P499, DOI 10.1016/S0140-6736(96)91138-1; Bozzette SA, 1998, NEW ENGL J MED, V339, P1897, DOI 10.1056/NEJM199812243392606; Breitbart W, 1996, AM J PSYCHIAT, V153, P238; Cooper-Patrick L, 1999, JAMA-J AM MED ASSOC, V282, P583, DOI 10.1001/jama.282.6.583; COULTON CJ, 1990, J CLIN EPIDEMIOL, V43, pS51, DOI 10.1016/0895-4356(90)90219-F; Curtis JR, 1997, J GEN INTERN MED, V12, P736, DOI 10.1046/j.1525-1497.1997.07158.x; Curtis JR, 1999, AIDS, V13, P1123, DOI 10.1097/00002030-199906180-00017; Curtis JR, 2000, ARCH INTERN MED, V160, P1690, DOI 10.1001/archinte.160.11.1690; DUAN N, 1999, MR1060AHCPR RAND; Emanuel EJ, 1998, LANCET, V351, P21, DOI 10.1016/S0140-6736(98)90329-4; EMANUEL LL, 1995, J AM GERIATR SOC, V43, P440, DOI 10.1111/j.1532-5415.1995.tb05821.x; FOWLER FJ, 1995, MED DECIS MAKING, V15, P195, DOI 10.1177/0272989X9501500301; Frankel MR, 1999, HEALTH SERV RES, V34, P969; FRANKL D, 1989, AM J MED, V86, P645, DOI 10.1016/0002-9343(89)90436-1; HAAS JS, 1993, ARCH INTERN MED, V153, P1241, DOI 10.1001/archinte.153.10.1241; Hofmann JC, 1997, ANN INTERN MED, V127, P1, DOI 10.7326/0003-4819-127-1-199707010-00001; Kaldjian LC, 1998, AIDS, V12, P103, DOI 10.1097/00002030-199801000-00012; Kreuter MW, 2000, ARCH FAM MED, V9, P426, DOI 10.1001/archfami.9.5.426; Littrell J, 1996, SOC WORK HEALTH CARE, V23, P43, DOI 10.1300/J010v23n02_03; Loue S, 1995, J LEGAL MED, V16, P461, DOI 10.1080/01947649509510990; Shapiro MF, 1999, HEALTH SERV RES, V34, P951; Singer PA, 1999, JAMA-J AM MED ASSOC, V281, P163, DOI 10.1001/jama.281.2.163; SLOME L, 1992, J ACQ IMMUN DEF SYND, V5, P712; Slome LR, 1997, NEW ENGL J MED, V336, P417, DOI 10.1056/NEJM199702063360606; STEINBROOK R, 1986, NEW ENGL J MED, V314, P457, DOI 10.1056/NEJM198602133140730; TENO J, 1990, J GEN INTERN MED, V5, P490, DOI 10.1007/BF02600877; Tierney WM, 2001, J GEN INTERN MED, V16, P32, DOI 10.1111/j.1525-1497.2001.00215.x; WACHTER RM, 1993, CRIT CARE CLIN, V9, P125, DOI 10.1016/S0749-0704(18)30212-4; Wilson IB, 1997, J GEN INTERN MED, V12, P784, DOI 10.1046/j.1525-1497.1997.07166.x	30	53	54	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 13	2001	285	22					2880	2887		10.1001/jama.285.22.2880	http://dx.doi.org/10.1001/jama.285.22.2880			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	440BP	11401609				2022-12-24	WOS:000169156300027
J	Fischereder, M; Luckow, B; Hocher, B; Wuthrich, RP; Rothenpieler, U; Schneeberger, H; Panzer, U; Stahl, RAK; Hauser, IA; Budde, K; Neumayer, HH; Kramer, BK; Land, W; Schlondorff, D				Fischereder, M; Luckow, B; Hocher, B; Wuthrich, RP; Rothenpieler, U; Schneeberger, H; Panzer, U; Stahl, RAK; Hauser, IA; Budde, K; Neumayer, HH; Kramer, BK; Land, W; Schlondorff, D			CC chemokine receptor 5 and renal-transplant survival	LANCET			English	Article							HIV-1 INFECTION; FUNCTIONAL EXPRESSION; ALLOGRAFT-REJECTION; MOLECULAR-CLONING; DELETION ALLELE; RANTES; GENE; RESISTANCE; MIP-1-ALPHA; INDIVIDUALS	Background About 1% of white populations are homozygous carriers of an allele of the gene for the CC chemokine receptor 5 (CCR5) with a 32 bp deletion (CCR5 Delta 32), which leads to an inactive receptor. During acute and chronic transplant rejection, ligands for CCR5 are upregulated, and the graft is infiltrated by CCR5-positive mononuclear cells. We therefore investigated the influence of CCR5 Delta 32 on renal-transplant survival Methods Genomic DNA from peripheral-blood leucocytes of 1227 renal-transplant recipients was screened by PCR for the presence of CCR5 Delta 32. Demographic and clinical data were extracted from hospital records. Complete follow-up data were available for 576 recipients of first renal transplants. Graft survival was analysed by Fisher's exact test and Kaplan-Meier plots compared with a log-rank test. Findings PCR identified 21 patients homozygous for CCR5 Delta 32 (frequency 1.7%). One patient died with a functioning graft. Only one of the remaining patients lost transplant function during follow-up (median 7.2 years) compared with 78 of the 555 patients with a homozygous wild-type or heterozygous CCR5 Delta 32 genotype. Graft survival was significantly longer in the homozygous CCR5 Delta 32 group than in the control group (log-rank p=0.033; hazard ratio 0.367 [95% CI 0.157-0.859]). Interpretation Patients homozygous for CCR5 Delta 32; show longer survival of renal transplants than those with: other genotypes, suggesting a pathophysiological role for CCR5 in transplant Loss. This receptor may be a useful target for the prevention of transplant loss.	Univ Munchen Klinikum, Med Poliklin, D-80336 Munich, Germany; Humboldt Univ, Univ Klinikum, Charite, Berlin, Germany; Univ Spital Zurich, Zurich, Switzerland; Univ Munich, Klinikum Grosshadern, Abt Transplantat Chirurg, D-8000 Munich, Germany; Univ Hamburg, Med Klin & Poliklin, Abt Nephrol Osteol, Hamburg, Germany; Univ Regensburg Klinikum, Klin & Poliklin Innere Med 2, Regensburg, Germany; Univ Erlangen Nurnberg, Med Klin 4, Erlangen, Germany; Univ Frankfurt Klin, Med Klin 4, Funkt Bereich Nephrol, Frankfurt, Germany	University of Munich; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Zurich; University Zurich Hospital; University of Munich; University of Hamburg; University of Regensburg; University of Erlangen Nuremberg; Goethe University Frankfurt; Goethe University Frankfurt Hospital	Schlondorff, D (corresponding author), Univ Munchen Klinikum, Med Poliklin, Pettenkoferstr 8A, D-80336 Munich, Germany.		Budde, Klemens/AAD-2170-2020; Hocher, Berthold/AAC-3510-2020	Budde, Klemens/0000-0002-7929-5942; Land, Walter Gottlieb/0000-0002-0090-0629; Hocher, Berthold/0000-0001-8143-0579				Baggiolini M, 1998, NATURE, V392, P565, DOI 10.1038/33340; Belperio JA, 2000, J IMMUNOL, V165, P461, DOI 10.4049/jimmunol.165.1.461; Biti R, 1997, NAT MED, V3, P252, DOI 10.1038/nm0397-252; Blanpain C, 1999, BLOOD, V94, P1899; Combadiere C, 1996, J LEUKOCYTE BIOL, V60, P147, DOI 10.1002/jlb.60.1.147; Dean M, 1996, SCIENCE, V273, P1856, DOI 10.1126/science.273.5283.1856; Dekel B, 1999, INT IMMUNOL, V11, P1673, DOI 10.1093/intimm/11.10.1673; Fischereder M, 1998, TRANSPLANTATION, V65, P936, DOI 10.1097/00007890-199804150-00013; Gao W, 2000, J CLIN INVEST, V105, P35, DOI 10.1172/JCI8126; Garred P, 1998, J RHEUMATOL, V25, P1462; Gong WH, 1998, J BIOL CHEM, V273, P4289, DOI 10.1074/jbc.273.8.4289; Grone HJ, 1999, FASEB J, V13, P1371, DOI 10.1096/fasebj.13.11.1371; Hall IP, 1999, LANCET, V354, P1264, DOI 10.1016/S0140-6736(99)03425-X; Heidenreich S, 1998, J AM SOC NEPHROL, V9, P1309; Libert F, 1998, HUM MOL GENET, V7, P399, DOI 10.1093/hmg/7.3.399; Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5; Martinson JJ, 1997, NAT GENET, V16, P100, DOI 10.1038/ng0597-100; Murphy PM, 2000, PHARMACOL REV, V52, P145; NADEAU KC, 1995, P NATL ACAD SCI USA, V92, P8729, DOI 10.1073/pnas.92.19.8729; PATTISON J, 1994, LANCET, V343, P209, DOI 10.1016/S0140-6736(94)90992-X; Raport CJ, 1996, J BIOL CHEM, V271, P17161, DOI 10.1074/jbc.271.29.17161; Risch NJ, 2000, NATURE, V405, P847, DOI 10.1038/35015718; Robertson H, 1998, HISTOCHEM CELL BIOL, V110, P207, DOI 10.1007/s004180050283; Rossi D, 2000, ANNU REV IMMUNOL, V18, P217, DOI 10.1146/annurev.immunol.18.1.217; Samson M, 1996, NATURE, V382, P722, DOI 10.1038/382722a0; Samson M, 1996, BIOCHEMISTRY-US, V35, P3362, DOI 10.1021/bi952950g; Segerer S, 1999, KIDNEY INT, V56, P52, DOI 10.1046/j.1523-1755.1999.00544.x; Sellebjerg F, 2000, J NEUROIMMUNOL, V102, P98, DOI 10.1016/S0165-5728(99)00166-6; Stephens JC, 1998, AM J HUM GENET, V62, P1507, DOI 10.1086/301867	29	250	268	0	5	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 2	2001	357	9270					1758	1761		10.1016/S0140-6736(00)04898-4	http://dx.doi.org/10.1016/S0140-6736(00)04898-4			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	440BN	11403814				2022-12-24	WOS:000169156200015
J	Thomas, CD; Bodsworth, EJ; Wilson, RJ; Simmons, AD; Davies, ZG; Musche, M; Conradt, L				Thomas, CD; Bodsworth, EJ; Wilson, RJ; Simmons, AD; Davies, ZG; Musche, M; Conradt, L			Ecological and evolutionary processes at expanding range margins	NATURE			English	Article							BUTTERFLY HESPERIA-COMMA; METAPOPULATION MODELS; FRAGMENTED LANDSCAPES; FLIGHT MORPHOLOGY; CONSERVATION; DYNAMICS; HABITATS; BRITAIN; CLIMATE	Many animals are regarded as relatively sedentary and specialized in marginal parts of their geographical distributions(1,2). They are expected to be slow at colonizing new habitats. Despite this, the cool margins of many species' distributions have expanded rapidly in association with recent climate warming(3-10). We examined four insect species that have expanded their geographical ranges in Britain over the past 20 years. Here we report that two butterfly species have increased the variety of habitat types that they can colonize, and that two bush cricket species show increased fractions of longer-winged (dispersive) individuals in recently founded populations. Both ecological and evolutionary processes are probably responsible for these changes. Increased habitat breadth and dispersal tendencies have resulted in about 3- to 15-fold increases in expansion rates, allowing these insects to cross habitat disjunctions that would have represented major or complete barriers to dispersal before the expansions started. The emergence of dispersive phenotypes will increase the speed at which species invade new environments, and probably underlies the responses of many species to both past(11) and future climate change.	Univ Leeds, Sch Biol, Ctr Biodivers & Conservat, Leeds LS2 9JT, W Yorkshire, England	University of Leeds	Thomas, CD (corresponding author), Univ Leeds, Sch Biol, Ctr Biodivers & Conservat, Leeds LS2 9JT, W Yorkshire, England.		Thomas, Chris D/A-1894-2012; Musche, Martin/Z-5662-2019; Thomas, Chris D/A-1460-2014; Conradt, Larissa/H-6309-2011; Wilson, Robert J/I-8726-2014	Thomas, Chris D/0000-0003-2822-1334; Musche, Martin/0000-0002-9999-0838; Thomas, Chris D/0000-0003-2822-1334; Wilson, Robert J/0000-0003-4477-7068				Asher J, 2001, MILLENNIUM ATLAS BUT; BOURN NAD, 1993, BIOL CONSERV, V63, P67, DOI 10.1016/0006-3207(93)90075-C; Coope G. R., 1995, P55; CWYNAR LC, 1987, AM NAT, V129, P463, DOI 10.1086/284651; Doebeli M, 1997, EVOLUTION, V51, P1730, DOI 10.1111/j.1558-5646.1997.tb05097.x; Haes ECM, 1997, ATLAS GRASSHOPPERS C; HANSKI I, 1994, J ANIM ECOL, V63, P151, DOI 10.2307/5591; Heath J., 1984, ATLAS BUTTERFLIES BR; Hill JK, 1999, OECOLOGIA, V121, P165, DOI 10.1007/s004420050918; Hill JK, 1999, BIOL CONSERV, V87, P277, DOI 10.1016/S0006-3207(98)00091-3; Hill JK, 1999, P ROY SOC B-BIOL SCI, V266, P1197, DOI 10.1098/rspb.1999.0763; Hughes L, 2000, TRENDS ECOL EVOL, V15, P56, DOI 10.1016/S0169-5347(99)01764-4; Marshall JA, 1988, GRASSHOPPERS ALLIED; Moilanen A, 2000, J ANIM ECOL, V69, P143, DOI 10.1046/j.1365-2656.2000.00381.x; NIEMELA J, 1991, OIKOS, V62, P351, DOI 10.2307/3545500; Parmesan C, 1999, NATURE, V399, P579, DOI 10.1038/21181; Perring F.H., 1976, ATLAS BRIT FLORA; Ratnieks F.L.W., 1991, P119; THOMAS CD, 1992, OECOLOGIA, V92, P563, DOI 10.1007/BF00317850; Thomas CD, 1999, NATURE, V399, P213, DOI 10.1038/20335; THOMAS CD, 1993, J ANIM ECOL, V62, P472, DOI 10.2307/5196; Thomas Chris D., 1997, P359, DOI 10.1016/B978-012323445-2/50020-1; THOMAS JA, 1993, ECOGRAPHY, V16, P278, DOI 10.1111/j.1600-0587.1993.tb00217.x; THOMAS JA, 1986, J APPL ECOL, V23, P365, DOI 10.2307/2404023; Thomas V, 1999, J NURS CARE QUAL, V13, P1, DOI 10.1097/00001786-199906000-00003; Wahlberg N, 1996, SCIENCE, V273, P1536, DOI 10.1126/science.273.5281.1536; WIDGERY J, 2000, ORTHOPTERA RECORDING, P26; Williamson M, 1996, BIOL INVASIONS; WILSON RJ, 1999, SPATIOTEMPORAL DYNAM; Zera AJ, 1997, ANNU REV ENTOMOL, V42, P207, DOI 10.1146/annurev.ento.42.1.207	30	639	665	2	369	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 31	2001	411	6837					577	581		10.1038/35079066	http://dx.doi.org/10.1038/35079066			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437GE	11385570	Green Accepted			2022-12-24	WOS:000168982500049
J	Coulson, T; Catchpole, EA; Albon, SD; Morgan, BJT; Pemberton, JM; Clutton-Brock, TH; Crawley, MJ; Grenfell, BT				Coulson, T; Catchpole, EA; Albon, SD; Morgan, BJT; Pemberton, JM; Clutton-Brock, TH; Crawley, MJ; Grenfell, BT			Age, sex, density, winter weather, and population crashes in Soay sheep	SCIENCE			English	Article							DYNAMICS; TRENDS; CYCLES	Quantifying the impact of density, extrinsic climatic fluctuations, and demography on population fluctuations is a persistent challenge in ecology. We analyzed the effect of these processes on the irregular pattern of population crashes of Soay sheep on the St. Kilda archipelago, United Kingdom. Because the age and sex structure of the population fluctuates independently of population size, and because animals of different age and sex respond in different ways to density and weather, identical weather conditions can result in different dynamics in populations of equal size. In addition, the strength of density-dependent processes is a function of the distribution of weather events. Incorporating demographic heterogeneities into population models can influence dynamics and their response to climate change.	Zool Soc London, Inst Zool, London NW1 4RY, England; Univ New S Wales, Univ Coll, Australian Def Force Acad, Sch Math & Stat, Canberra, ACT 2600, Australia; Hill Brathens, Ctr Ecol & Hydrol, Banchory AB31 4BY, Kincardine, Scotland; Univ Kent, Inst Math & Stat, Canterbury CT2 7NF, Kent, England; Univ Edinburgh, Inst Cell Anim & Populat Biol, Edinburgh EH9 3JT, Midlothian, Scotland; Univ London Imperial Coll Sci Technol & Med, Ascot SL5 7PY, Berks, England; Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England	Zoological Society of London; Australian Defense Force Academy; University of New South Wales Sydney; UK Centre for Ecology & Hydrology (UKCEH); University of Kent; University of Edinburgh; Imperial College London; University of Cambridge	Coulson, T (corresponding author), Univ Cambridge, Dept Zool, Downing St, Cambridge CB2 3EJ, England.	tnc20@cam.ac.uk	ALBON, Stephen D/C-6304-2011; Coulson, Tim/AAL-8148-2021; Pemberton, Josephine M/F-3100-2010	ALBON, Stephen D/0000-0002-0811-1333; Coulson, Tim/0000-0001-9371-9003; 				Bjornstad ON, 1999, P NATL ACAD SCI USA, V96, P5066, DOI 10.1073/pnas.96.9.5066; Catchpole EA, 2000, J R STAT SOC C-APPL, V49, P453, DOI 10.1111/1467-9876.00205; Caughley G., 1977, ANAL VERTEBRATE POPU; Clutton-Brock TH, 1988, REPROD SUCCESS STUDI; Coulson T, 1999, J ANIM ECOL, V68, P658, DOI 10.1046/j.1365-2656.1999.00298.x; Gaillard JM, 2000, ANNU REV ECOL SYST, V31, P367, DOI 10.1146/annurev.ecolsys.31.1.367; Grenfell BT, 1998, NATURE, V394, P674, DOI 10.1038/29291; GRENFELL BT, 1992, NATURE, V355, P823, DOI 10.1038/355823a0; GULLAND FMD, 1992, PARASITOLOGY, V105, P493, DOI 10.1017/S0031182000074679; HASSELL MP, 1976, J ANIM ECOL, V45, P471, DOI 10.2307/3886; Hilborn Ray, 1997, V28; HURRELL JW, 1995, SCIENCE, V269, P676, DOI 10.1126/science.269.5224.676; Leirs H, 1997, NATURE, V389, P176, DOI 10.1038/38271; Milner JM, 1999, J ANIM ECOL, V68, P1235, DOI 10.1046/j.1365-2656.1999.00366.x; Stearns S.C., 1992, pi; Tuljapurkar S., 1997, STRUCTURED POPULATIO; [No title captured]	17	700	715	6	270	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 25	2001	292	5521					1528	1531		10.1126/science.292.5521.1528	http://dx.doi.org/10.1126/science.292.5521.1528			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YQ	11375487				2022-12-24	WOS:000168963800040
J	Baralle, D				Baralle, D			Chromosomal aberrations, subtelomeric defects, and mental retardation	LANCET			English	Editorial Material									Addenbrookes Hosp, Dept Med Genet, Cambridge CB2 5AQ, England	Addenbrooke's Hospital; University of Cambridge	Baralle, D (corresponding author), Addenbrookes Hosp, Dept Med Genet, Cambridge CB2 5AQ, England.			Baralle, Diana/0000-0003-3217-4833				Antonarakis SE, 2001, NAT GENET, V27, P230, DOI 10.1038/85769; Castellvi-Bel S, 2001, MOL GENET METAB, V72, P104, DOI 10.1006/mgme.2000.3128; De Vries BBA, 2001, J MED GENET, V38, P175, DOI 10.1136/jmg.38.3.175; de Vries BBA, 2001, J MED GENET, V38, P145, DOI 10.1136/jmg.38.3.145; Doheny KF, 1997, J MED GENET, V34, P640, DOI 10.1136/jmg.34.8.640; Hamerton JL, 1999, LANCET, V354, P1659, DOI 10.1016/S0140-6736(99)00246-9; Knight SJL, 1999, LANCET, V354, P1676, DOI 10.1016/S0140-6736(99)03070-6; Ning Y, 1996, NAT GENET, V14, P86, DOI 10.1038/ng0996-86; PHELAN MC, 1996, P GREENWOOD GENET CT, V15, P45; SACCONE S, 1992, P NATL ACAD SCI USA, V89, P4913, DOI 10.1073/pnas.89.11.4913; *WHO, 1968, 392 WHO; *WHO, 1986, WHO OFFS PUBL, V86; WINTER RM, 1998, LONDON DYSMORPHOLOGY	13	12	14	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 7	2001	358	9275					7	8		10.1016/S0140-6736(00)05300-9	http://dx.doi.org/10.1016/S0140-6736(00)05300-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	449WV	11454368				2022-12-24	WOS:000169710900007
J	Loreau, M; Hector, A				Loreau, M; Hector, A			Partitioning selection and complementarity in biodiversity experiments	NATURE			English	Article							GRASSLAND ECOSYSTEMS; SPECIES-DIVERSITY; PLANT DIVERSITY; PRODUCTIVITY; COVARIANCE	The impact of biodiversity loss on the functioning of ecosystems and their ability to provide ecological services has become a central issue in ecology. Several experiments have provided evidence that reduced species diversity may impair ecosystem processes such as plant biomass production(1-5). The interpretation of these experiments, however, has been controversial(6-12) because two types of mechanism may operate in combination(6,13-15). In the 'selection effect', dominance by species with particular traits affects ecosystem processes. In the 'complementarity effect', resource partitioning or positive interactions lead to increased total resource use. Here we present a new approach to separate the two effects on the basis of an additive partitioning analogous to the Price equation in evolutionary genetics(16-19). Applying this method to data from the pan-European BIODEPTH experiment(4) reveals that the selection effect is zero on average and varies from negative to positive in different localities, depending on whether species with lower- or higher-than-average biomass dominate communities. In contrast, the complementarity effect is positive overall, supporting the hypothesis that plant diversity influences primary production in European grasslands through niche differentiation or facilitation.	Ecole Normale Super, Ecol Lab, UMR 7625, F-75230 Paris 05, France; Imperial Coll, NERC, Ctr Populat Biol, Ascot SL5 7PY, Berks, England	UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Sorbonne Universite; Imperial College London; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC)	Loreau, M (corresponding author), Ecole Normale Super, Ecol Lab, UMR 7625, 46 Rue Ulm, F-75230 Paris 05, France.		Hector, Andrew/H-4199-2011	Hector, Andrew/0000-0002-1309-7716				Aarssen LW, 1997, OIKOS, V80, P183, DOI 10.2307/3546531; Frank SA, 1997, EVOLUTION, V51, P1712, DOI [10.2307/2410995, 10.1111/j.1558-5646.1997.tb05096.x]; FRANK SA, 1995, J THEOR BIOL, V175, P373, DOI 10.1006/jtbi.1995.0148; Garnier E, 1997, ACTA OECOL, V18, P657, DOI 10.1016/S1146-609X(97)80049-5; Hector A, 1999, SCIENCE, V286, P1123, DOI 10.1126/science.286.5442.1123; Hector A, 1998, OIKOS, V82, P597, DOI 10.2307/3546380; HECTOR A, 2000, SCIENCE, V289, P1255; Huston M A, 2000, Science, V289, P1255; Huston MA, 1997, OECOLOGIA, V110, P449, DOI 10.1007/s004420050180; Jolliffe PA, 2000, J ECOL, V88, P371, DOI 10.1046/j.1365-2745.2000.00470.x; Loreau M, 2000, OIKOS, V91, P3, DOI 10.1034/j.1600-0706.2000.910101.x; Loreau M, 1998, OIKOS, V82, P600, DOI 10.2307/3546381; Loreau M, 1998, P NATL ACAD SCI USA, V95, P5632, DOI 10.1073/pnas.95.10.5632; PRICE GR, 1995, J THEOR BIOL, V175, P389, DOI 10.1006/jtbi.1995.0149; PRICE GR, 1972, ANN HUM GENET, V35, P485, DOI 10.1111/j.1469-1809.1957.tb01874.x; PRICE GR, 1970, NATURE, V227, P520, DOI 10.1038/227520a0; Schlapfer F, 1999, ECOL APPL, V9, P893, DOI 10.1890/1051-0761(1999)009[0893:EEOBAC]2.0.CO;2; Tilman D, 1997, OIKOS, V80, P185, DOI 10.2307/3546532; Tilman D, 1997, SCIENCE, V277, P1300, DOI 10.1126/science.277.5330.1300; Tilman D, 1997, P NATL ACAD SCI USA, V94, P1857, DOI 10.1073/pnas.94.5.1857; Tilman D, 1996, NATURE, V379, P718, DOI 10.1038/379718a0; Troumbis AY, 2000, OIKOS, V90, P549, DOI 10.1034/j.1600-0706.2000.900313.x; van der Heijden MGA, 1999, OIKOS, V87, P408, DOI 10.2307/3546758; van der Heijden MGA, 1998, NATURE, V396, P69, DOI 10.1038/23932; Wardle DA, 1999, OIKOS, V87, P403, DOI 10.2307/3546757	25	1868	1948	68	1108	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 5	2001	412	6842					72	76		10.1038/35083573	http://dx.doi.org/10.1038/35083573			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448TB	11452308				2022-12-24	WOS:000169644900045
J	Holland, PC; Hancock, SW; Hodge, D; Thompson, D; Shires, S; Evans, S				Holland, PC; Hancock, SW; Hodge, D; Thompson, D; Shires, S; Evans, S			Degradation of albumin in meningococcal sepsis	LANCET			English	Article								We postulate that the proteolytic degradation of albumin into fragments could link the rapidity of the shock, rash, and hypocalcaemia associated with meningococcal sepsis, We examined urine of children with meningococcal disease and urine from control children with no sepsis and found albumin fragments of about 45 kDa, 25 kDa, and less than 20 kDa only in the urine of children with meningococcal sepsis and associated purpura, Exogenous or endogenous proteases, or both, may be released in severe meningococcal sepsis and, in association with an inadequate antiprotease response, result In albumin degradation. This may be a contributory factor to the rapid shock, hypocalcaemia, and rash seen in meningococcal sepsis.	Gen Infirm, Dept Paediat, Leeds LS2 9NS, W Yorkshire, England; Gen Infirm, Dept Clin Biochem & Immunol, Leeds LS2 9NS, W Yorkshire, England; Univ Leeds, Mol Epidemiol Unit, Leeds, W Yorkshire, England	Leeds General Infirmary; Leeds General Infirmary; University of Leeds	Holland, PC (corresponding author), Gen Infirm, Dept Paediat, Clarendon Wing, Leeds LS2 9NS, W Yorkshire, England.							Baines PB, 2000, ARCH DIS CHILD, V83, P510, DOI 10.1136/adc.83.6.510; KLEIN NJ, 1992, J CELL SCI, V102, P821; NETTER A, 1917, BRIT J CHILD DIS, V14, P101; Peters T., 1995, ALL ALBUMIN BIOCH GE, P9, DOI [10.1016/B978-012552110-9/50004-0, DOI 10.1016/B978-012552110-9/50004-0]; SELYE H, 1962, CALCIFYLAXIS	5	16	17	0	5	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 30	2001	357	9274					2102	2104		10.1016/S0140-6736(00)05200-4	http://dx.doi.org/10.1016/S0140-6736(00)05200-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	447RQ	11445107				2022-12-24	WOS:000169586600017
J	Kolber, ZS; Plumley, FG; Lang, AS; Beatty, JT; Blankenship, RE; VanDover, CL; Vetriani, C; Koblizek, M; Rathgeber, C; Falkowski, PG				Kolber, ZS; Plumley, FG; Lang, AS; Beatty, JT; Blankenship, RE; VanDover, CL; Vetriani, C; Koblizek, M; Rathgeber, C; Falkowski, PG			Contribution of aerobic photoheterotrophic bacteria to the carbon cycle in the ocean	SCIENCE			English	Article							ROSEOBACTER-DENITRIFICANS; BACTERIOCHLOROPHYLL ALPHA; PROTEIN COMPLEXES; ELECTRON-TRANSFER; CYTOCHROME; WATERS	The vertical distribution of bacteriochlorophyll a, the numbers of infrared fluorescent cells, and the variable fluorescence signal at 880 nanometers wavelength, all indicate that photosynthetically competent anoxygenic phototrophic bacteria are abundant in the upper open ocean and comprise at Least 11% of the total microbial community. These organisms are facultative photoheterotrophs, metabolizing organic carbon when available, but are capable of photosynthetic Light utilization when organic carbon is scarce. They are globally distributed in the euphotic zone and represent a hitherto unrecognized component of the marine microbial community that appears to be critical to the cycling of; both organic and inorganic carbon in the ocean.	Rutgers State Univ, Inst Marine & Coastal Sci, Environm Biophys & Mol Ecol Program, New Brunswick, NJ 08901 USA; Univ Alaska, Inst Marine Sci, Fairbanks, AK 99775 USA; Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z3, Canada; Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA; Coll William & Mary, Dept Biol, Williamsburg, VA 23187 USA; Univ Manitoba, Dept Microbiol, Winnipeg, MB R3T 2N2, Canada; Rutgers State Univ, Dept Geol, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; University of Alaska System; University of Alaska Fairbanks; University of British Columbia; Arizona State University; Arizona State University-Tempe; William & Mary; University of Manitoba; Rutgers State University New Brunswick	Kolber, ZS (corresponding author), Rutgers State Univ, Inst Marine & Coastal Sci, Environm Biophys & Mol Ecol Program, 71 Dudley Rd, New Brunswick, NJ 08901 USA.		Koblizek, Michal/H-2851-2014	Lang, Andrew/0000-0002-4510-7683				Cogdell R. J., 1995, ANOXYGENIC PHOTOSYNT, P315; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Garcia D, 1998, PHOTOSYNTH RES, V55, P331, DOI 10.1023/A:1005941031263; HARASHIMA K, 1980, PLANT CELL PHYSIOL, V21, P1283, DOI 10.1093/oxfordjournals.pcp.a076127; HICKS RE, 1992, APPL ENVIRON MICROB, V58, P158; KISHINO H, 1989, J MOL EVOL, V29, P170, DOI 10.1007/BF02100115; Kolber ZS, 2000, NATURE, V407, P177, DOI 10.1038/35025044; Kolber ZS, 1998, BBA-BIOENERGETICS, V1367, P88, DOI 10.1016/S0005-2728(98)00135-2; LARSEN N, 1993, NUCLEIC ACIDS RES, V21, P3021, DOI 10.1093/nar/21.13.3021; MOREL A, 1994, J PHYS OCEANOGR, V24, P1652, DOI 10.1175/1520-0485(1994)024<1652:HRWTUO>2.0.CO;2; NISHIMURA Y, 1989, ARCH MICROBIOL, V152, P1, DOI 10.1007/BF00447002; NOGUCHI T, 1992, PHOTOSYNTH RES, V31, P21, DOI 10.1007/BF00049533; PORTER KG, 1980, LIMNOL OCEANOGR, V25, P943, DOI 10.4319/lo.1980.25.5.0943; Schwarze C, 2000, EUR J BIOCHEM, V267, P422, DOI 10.1046/j.1432-1327.2000.01018.x; SHIBA T, 1991, APPL ENVIRON MICROB, V57, P295, DOI 10.1128/AEM.57.1.295-300.1991; SHIBA T, 1979, APPL ENVIRON MICROB, V38, P43, DOI 10.1128/AEM.38.1.43-45.1979; SHIBA T, 1984, J GEN APPL MICROBIOL, V30, P1313; Shimada K., 1995, ANOXYGENIC PHOTOSYNT, P105; TAKEMOTO J, 1977, J BACTERIOL, V129, P1102, DOI 10.1128/JB.129.2.1102-1109.1977; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; YURKOV V, 1994, INT J SYST BACTERIOL, V44, P427, DOI 10.1099/00207713-44-3-427; Yurkov VV, 1999, J BACTERIOL, V181, P4517, DOI 10.1128/JB.181.15.4517-4525.1999; YURKOV VV, 1993, ARCH MICROBIOL, V159, P84, DOI 10.1007/BF00244268; Yurkov VV, 1998, MICROBIOL MOL BIOL R, V62, P695, DOI 10.1128/MMBR.62.3.695-724.1998	25	323	360	3	79	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 29	2001	292	5526					2492	2495		10.1126/science.1059707	http://dx.doi.org/10.1126/science.1059707			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448YU	11431568				2022-12-24	WOS:000169658200042
J	O'Brien, SJ; Eizirik, E; Murphy, WJ				O'Brien, SJ; Eizirik, E; Murphy, WJ			Genomics - On choosing mammalian genomes for sequencing	SCIENCE			English	Editorial Material							PLACENTAL MAMMALS; PROJECT		NCI, Lab Genom Divers, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	O'Brien, SJ (corresponding author), NCI, Lab Genom Divers, Frederick, MD 21702 USA.	obrien@ncifcrf.gov	Eizirik, Eduardo/K-8034-2012; OBRIEN, STEPHEN/ABD-1346-2020	Eizirik, Eduardo/0000-0002-9658-0999; OBRIEN, STEPHEN/0000-0001-7857-0757				Cheung VG, 2001, NATURE, V409, P953, DOI 10.1038/35057192; Collins FS, 1998, SCIENCE, V282, P682, DOI 10.1126/science.282.5389.682; Eizirik E, 2001, J HERED, V92, P212, DOI 10.1093/jhered/92.2.212; Gibbons A, 2000, SCIENCE, V289, P1267; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Li W-H, 1997, MOL EVOLUTION; Madsen O, 2001, NATURE, V409, P610, DOI 10.1038/35054544; MAY RM, 1990, NATURE, V347, P129, DOI 10.1038/347129a0; McConkey EH, 2000, SCIENCE, V289, P1295; Murphy WJ, 2001, NATURE, V409, P614, DOI 10.1038/35054550; MURPHY WJ, IN PRESS GENOME BIOL; Nadeau JH, 2001, SCIENCE, V291, P1251, DOI 10.1126/science.1058244; O'Brien SJ, 1999, SCIENCE, V286, P458, DOI 10.1126/science.286.5439.458; Paabo S, 2001, SCIENCE, V291, P1219, DOI 10.1126/science.1056972; Pennisi E, 2000, SCIENCE, V287, P1179, DOI 10.1126/science.287.5456.1179; Pennisi E, 2001, SCIENCE, V291, P1204, DOI 10.1126/science.291.5507.1204; Rettie JC, 1951, CORONET, V29, P21; Rubin GM, 2001, NATURE, V409, P820, DOI 10.1038/35057277; Strausberg RL, 1999, SCIENCE, V286, P455, DOI 10.1126/science.286.5439.455; VandeBerg JL, 2000, SCIENCE, V290, P1504, DOI 10.1126/science.290.5496.1504; VANEWRIGHT RI, 1991, BIOL CONSERV, V55, P235, DOI 10.1016/0006-3207(91)90030-D; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040	22	46	49	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 22	2001	292	5525					2264	2266		10.1126/science.1059393	http://dx.doi.org/10.1126/science.1059393			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	445KD	11423643				2022-12-24	WOS:000169455900037
J	Picco, MF; Goodman, S; Reed, J; Bayless, TM				Picco, MF; Goodman, S; Reed, J; Bayless, TM			Methodologic pitfalls in the determination of genetic anticipation: The case of Crohn disease	ANNALS OF INTERNAL MEDICINE			English	Article							INFLAMMATORY-BOWEL-DISEASE; ONSET ANTICIPATION; AFFECTED PARENT; AGE; BIAS; PREVALENCE; DISORDER; COUNTY; COHORT	Background: The term genetic anticipation is used when genetically transmitted disease manifests at increasingly younger ages with each succeeding generation: that is, if the offspring of patients develop the disease, they will tend to do so at an earlier age than their parents. In some monogenetic disorders, genetic anticipation has a biological basis in expanded genetic triplet repeats; however, some have claimed that it occurs in polygenic disorders, such as Crohn disease, in which its mechanism cannot be explained. Objective: To show how apparent changes in age at diagnosis of Crohn disease between generations, which could suggest genetic anticipation, can be an artifact of inadequate analysis based on age at diagnosis in cohorts that have not been followed for a sufficiently long time. Design: Comparison of ages at diagnosis of Crohn disease among different birth cohorts, before and after adjustment for observation time. Setting: Meyerhoff Center for Inflammatory Bowel Disease, Johns Hopkins Hospital, Baltimore, Maryland. Patients: 928 consecutive outpatients with Crohn disease. Measurements: Trends in age at diagnosis of Crohn disease among birth cohorts were determined by calculating Pearson correlation coefficients and performing Kaplan-Meyer analysis before and after adjustment for observation time. Adjustment for observation time was performed by ensuring that the time during which all included patients were at risk for Crohn disease was equal and that all patients had developed disease by the end of the risk period. Results: Mean age at diagnosis decreased by approximately 5 years with each subsequent 10-year birth cohort on the basis of crude cross-sectional data that could suggest genetic anticipation between generations. However, after adjustment for observation time, the age at diagnosis decreased minimally, if at all, with each successive generation. Conclusions: Apparent genetic anticipation can be explained by observational biases without invoking any additional genetic influences. Claims for genetic anticipation must be based on methods that properly account for the duration of observation in all persons being studied.	Mayo Clin Jacksonville, Jacksonville, FL 32224 USA; Johns Hopkins Univ, Sch Med, Baltimore, MD 21287 USA; St Lukes Hosp, Res Inst, Bethlehem, PA 18105 USA	Mayo Clinic; Johns Hopkins University	Picco, MF (corresponding author), Mayo Clin Jacksonville, 4500 San Pablo Rd, Jacksonville, FL 32224 USA.							Ashley CT, 1995, ANNU REV GENET, V29, P703, DOI 10.1146/annurev.ge.29.120195.003415; BASSETT AS, 1994, AM J HUM GENET, V54, P864; Bayless TM, 1998, AM J GASTROENTEROL, V93, P2322, DOI 10.1111/j.1572-0241.1998.02322.x; BINDER V, 1982, GASTROENTEROLOGY, V83, P563; CHILDS B, 1986, PERSPECT BIOL MED, V29, P437; Fresko I, 1998, ANN RHEUM DIS, V57, P45, DOI 10.1136/ard.57.1.45; Frisch M, 1996, LANCET, V347, P1551, DOI 10.1016/S0140-6736(96)90703-5; Grandbastien B, 1998, GUT, V42, P170, DOI 10.1136/gut.42.2.170; Heiman GA, 1996, PSYCHIAT GENET, V6, P61, DOI 10.1097/00041444-199622000-00005; HODGE SE, 1995, PSYCHIATR GENET, V5, P43, DOI 10.1097/00041444-199521000-00007; HOLFORD TR, 1991, ANNU REV PUBL HEALTH, V12, P425, DOI 10.1146/annurev.pu.12.050191.002233; Inskip H, 1996, LANCET, V347, P1551; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; KILDEBO S, 1989, SCAND J GASTROENTERO, V24, P1265, DOI 10.3109/00365528909090797; Lashner B, 2000, INFLAMM BOWEL DIS, P305; Lee JCW, 1999, GUT, V44, P808, DOI 10.1136/gut.44.6.808; Loftus EV, 1998, GASTROENTEROLOGY, V114, P1161, DOI 10.1016/S0016-5085(98)70421-4; Marx G, 1999, CURR OPIN GASTROEN, V15, P322, DOI 10.1097/00001574-199907000-00008; McDermott E, 1996, ANN RHEUM DIS, V55, P475, DOI 10.1136/ard.55.7.475; MCINNIS MG, 1993, AM J HUM GENET, V53, P385; Munkholm P, 1997, DAN MED BULL, V44, P287; PETO R, 1977, BRIT J CANCER, V35, P1, DOI 10.1038/bjc.1977.1; PODOLSKY DK, 1991, NEW ENGL J MED, V325, P928, DOI 10.1056/NEJM199109263251306; Polito JMII, 1996, LANCET, V347, P798, DOI 10.1016/S0140-6736(96)90870-3; Post S, 1996, ANN SURG, V223, P253, DOI 10.1097/00000658-199603000-00005; Rabinowitz D, 1999, BIOMETRICS, V55, P834, DOI 10.1111/j.0006-341X.1999.00834.x; ROSE JDR, 1988, GUT, V29, P346, DOI 10.1136/gut.29.3.346; Rosner B., 2011, FUNDAMENTALS BIOSTAT, P352; Satsangi J, 1996, GUT, V38, P738, DOI 10.1136/gut.38.5.738; Tsai YY, 1997, GENET EPIDEMIOL, V14, P435, DOI 10.1002/(SICI)1098-2272(1997)14:4<435::AID-GEPI8>3.0.CO;2-1; YANG H, 1993, GUT, V34, P517, DOI 10.1136/gut.34.4.517	31	42	42	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 19	2001	134	12					1124	1129		10.7326/0003-4819-134-12-200106190-00013	http://dx.doi.org/10.7326/0003-4819-134-12-200106190-00013			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	442YU	11412053				2022-12-24	WOS:000169313200006
J	Lewis, S; Clarke, M				Lewis, S; Clarke, M			Forest plots: trying to see the wood and the trees	BMJ-BRITISH MEDICAL JOURNAL			English	Article							BETA		Univ Edinburgh, Western Gen Hosp, Dept Clin Neurosci, Neurosci Trials Unit, Edinburgh EH4 2XU, Midlothian, Scotland; UK Cochrane Ctr, NHS Res & Dev Programme, Oxford OX2 7LG, England	University of Edinburgh; Cochrane Centre	Lewis, S (corresponding author), Univ Edinburgh, Western Gen Hosp, Dept Clin Neurosci, Neurosci Trials Unit, Edinburgh EH4 2XU, Midlothian, Scotland.	steff.lewis@ed.ac.uk		Lewis, Steff/0000-0003-1210-2314				[Anonymous], 1988, BRIT MED J, V296, P320; BIJNENS L, 1996, P 4 COCHR C AD AUSTR; *COCHR COLL, 2001, COCHR LIB; DEMETS DL, 1987, STAT MED, V6, P341, DOI 10.1002/sim.4780060325; FREIMAN JA, 1978, NEW ENGL J MED, V299, P690, DOI 10.1056/NEJM197809282991304; GALBRAITH RF, 1988, STAT MED, V7, P889, DOI 10.1002/sim.4780070807; Lewis JA., 1982, PRIM CARDIOL, V1, P31; MCGILL R, 1978, AM STAT, V32, P12, DOI 10.2307/2683468; Sindhu F, 1996, J ADV NURS, V24, P1152, DOI 10.1111/j.1365-2648.1996.tb01020.x; YUSUF S, 1985, PROG CARDIOVASC DIS, V27, P335, DOI 10.1016/S0033-0620(85)80003-7	10	452	456	0	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 16	2001	322	7300					1479	1480		10.1136/bmj.322.7300.1479	http://dx.doi.org/10.1136/bmj.322.7300.1479			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	444FJ	11408310	Green Submitted, Green Published			2022-12-24	WOS:000169389200036
J	Ribo, JM; Crusats, J; Sagues, F; Claret, J; Rubires, R				Ribo, JM; Crusats, J; Sagues, F; Claret, J; Rubires, R			Chiral sign induction by vortices during the formation of mesophases in stirred solutions	SCIENCE			English	Article							ABSOLUTE ASYMMETRIC-SYNTHESIS; RESONANCE LIGHT-SCATTERING; SYMMETRY-BREAKING; PORPHYRIN; WATER	Achiral diprotonated porphyrins, forming homoassociates in aqueous solution, lead to spontaneous chiral symmetry breaking. The unexpected result is that the chirality sign of these homoassociates can be selected by vortex motion during the aggregation process. This result is confirmed by means of circular dichroism spectra. These experimental findings are rationalized in terms of the asymmetric influence of macroscopic forces on bifurcation scenarios and by considering the specific binding characteristics of the porphyrin units to form the homoassociates.	Univ Barcelona, Dept Organ Chem, E-08028 Barcelona, Catalonia, Spain; Univ Barcelona, Dept Phys Chem, E-08028 Barcelona, Catalonia, Spain	University of Barcelona; University of Barcelona	Ribo, JM (corresponding author), Univ Barcelona, Dept Organ Chem, Marti & Franques 1, E-08028 Barcelona, Catalonia, Spain.	jmr@qo.ub.es	Crusats, Joaquim/K-7367-2017; Ribó, Josep M./K-2052-2017; Sagues, Francesc/K-6414-2015	Ribó, Josep M./0000-0001-6258-1726; Sagues, Francesc/0000-0002-2956-5676; Crusats, Joaquim/0000-0003-3511-4676				Avalos M, 1998, CHEM REV, V98, P2391, DOI 10.1021/cr970096o; Avetisov V, 1996, P NATL ACAD SCI USA, V93, P11435, DOI 10.1073/pnas.93.21.11435; BARRON LD, 1986, CHEM SOC REV, V15, P189, DOI 10.1039/cs9861500189; Berlepsch H., 2000, J PHYS CHEM B, V104, P5255, DOI DOI 10.1021/JP000220Z; Bersuker G, 1999, J CHEM PHYS, V110, P10907, DOI 10.1063/1.479003; BUSTAMANTE C, 1983, P NATL ACAD SCI-BIOL, V80, P3568, DOI 10.1073/pnas.80.12.3568; Collings PJ, 1999, J PHYS CHEM B, V103, P8474, DOI 10.1021/jp991610s; Feringa BL, 1999, ANGEW CHEM INT EDIT, V38, P3419; Girard C, 1998, ANGEW CHEM INT EDIT, V37, P2923, DOI 10.1002/(SICI)1521-3773(19981116)37:21<2922::AID-ANIE2922>3.0.CO;2-1; Harada N., 1983, CIRCULAR DICHROISM S; HELMCHEN G, 1996, HOUBENWEYL METHODS O, V5; HELMCHEN G, 1996, HOUBENWEYL METHODS O, V1; HELMCHEN G, 1996, HOUBENWEYL METHODS O, V6; HELMCHEN G, 1996, HOUBENWEYL METHODS O, V2; HELMCHEN G, 1996, HOUBENWEYL METHODS O, V10; HELMCHEN G, 1996, HOUBENWEYL METHODS O, V7; HELMCHEN G, 1996, HOUBENWEYL METHODS O, V8; HELMCHEN G, 1996, HOUBENWEYL METHODS O, V9; HELMCHEN G, 1996, HOUBENWEYL METHODS O, V4; Jacques J., 1981, ENANTIOMERS RACEMATE; Katzenelson O, 1996, CHEM-EUR J, V2, P174, DOI 10.1002/chem.19960020209; Kondepudi DK, 1999, J AM CHEM SOC, V121, P1448, DOI 10.1021/ja983418u; KONDEPUDI DK, 1984, PHYSICA A, V125, P465, DOI 10.1016/0378-4371(84)90065-7; KONDEPUDI DK, 1993, J AM CHEM SOC, V115, P10211, DOI 10.1021/ja00075a041; KONDEPUDI DK, 1990, SCIENCE, V250, P975, DOI 10.1126/science.250.4983.975; KONDEPUDI DK, 1998, MODERN THERMODYNAMIC, P436; MASON SF, 1984, NATURE, V311, P19, DOI 10.1038/311019a0; Micali N, 2000, J PHYS CHEM B, V104, P5897, DOI 10.1021/jp991909a; Misawa K, 1999, J CHEM PHYS, V110, P5844, DOI 10.1063/1.478483; OHNO O, 1993, J CHEM PHYS, V99, P4128, DOI 10.1063/1.466109; PASTERNACK RF, 1995, SCIENCE, V269, P935, DOI 10.1126/science.7638615; QIU X, 1991, PHYS REV LETT, V67, P703, DOI 10.1103/PhysRevLett.67.703; Ribo JM, 2000, MAT SCI ENG C-BIO S, V11, P107, DOI 10.1016/S0928-4931(00)00147-8; Rubires R, 1999, NEW J CHEM, V23, P189, DOI 10.1039/a808943d; Rubires R, 2001, CHEM-EUR J, V7, P436, DOI 10.1002/1521-3765(20010119)7:2<436::AID-CHEM436>3.3.CO;2-9; SCHWARTZ DK, 1993, PHYS REV LETT, V70, P1267, DOI 10.1103/PhysRevLett.70.1267; Seddon J.M., 1995, HDB BIOL PHYS A&B, V1, P97	37	549	557	2	193	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 15	2001	292	5524					2063	2066		10.1126/science.1060835	http://dx.doi.org/10.1126/science.1060835			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442KP	11408653				2022-12-24	WOS:000169284700043
J	Wang, XQ; Ullah, H; Jones, AM; Assmann, SM				Wang, XQ; Ullah, H; Jones, AM; Assmann, SM			G protein regulation of ion channels and abscisic acid signaling in Arabidopsis guard cells	SCIENCE			English	Article							HETEROTRIMERIC G-PROTEIN; INWARD K+ CHANNEL; PLASMA-MEMBRANE; STOMATAL CLOSURE; ALPHA-SUBUNIT; CYTOPLASMIC CALCIUM; POTASSIUM CHANNELS; CYTOSOLIC CALCIUM; ANION CHANNELS; VICIA-FABA	The phytohormone abscisic acid (ABA) promotes plant water conservation by decreasing the apertures of stomatal pores in the epidermis through which water loss occurs. We found that Arabidopsis thaliana plants harboring transferred DNA insertional mutations in the sole prototypical heterotrimeric GTP-binding (G) protein a subunit gene, GPA1, lack both ABA inhibition of guard cell inward K+ channels and pH-independent ABA activation of anion channels. Stomatal opening in gpa1 plants is insensitive to inhibition by ABA, and the rate of water loss from gpa1 mutants is greater than that from wild-type plants. Manipulation of G protein status in guard cells may provide a mechanism for controlling plant water balance.	Penn State Univ, Dept Biol, Mueller Lab 208, University Pk, PA 16802 USA; Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of North Carolina; University of North Carolina Chapel Hill	Assmann, SM (corresponding author), Penn State Univ, Dept Biol, Mueller Lab 208, University Pk, PA 16802 USA.			Wang, Xi-Qing/0000-0003-4477-9557				Aharon GS, 1998, FEBS LETT, V424, P17, DOI 10.1016/S0014-5793(98)00129-X; Allen GJ, 1999, PLANT CELL, V11, P1785, DOI 10.1105/tpc.11.9.1785; ARMSTRONG F, 1995, PLANT J, V8, P187, DOI 10.1046/j.1365-313X.1995.08020187.x; ASSMANN SM, 1996, SIGNAL TRANSDUCTION, P39; BLATT MR, 1990, PLANTA, V180, P445, DOI 10.1007/BF00198799; BLATT MR, 1993, PLANTA, V191, P330, DOI 10.1007/BF00195690; BROWN AM, 1990, ANNU REV PHYSIOL, V52, P197, DOI 10.1146/annurev.ph.52.030190.001213; FAIRLEYGRENOT K, 1991, PLANT CELL, V3, P1037; Gelli A, 1997, PLANT PHYSIOL, V113, P269, DOI 10.1104/pp.113.1.269; GILROY S, 1990, NATURE, V346, P769, DOI 10.1038/346769a0; Grabov A, 1997, PLANT J, V12, P203, DOI 10.1046/j.1365-313X.1997.12010203.x; HEDRICH R, 1990, EMBO J, V9, P3889, DOI 10.1002/j.1460-2075.1990.tb07608.x; HEPLER JR, 1992, TRENDS BIOCHEM SCI, V17, P383, DOI 10.1016/0968-0004(92)90005-T; IRVING HR, 1992, P NATL ACAD SCI USA, V89, P1790, DOI 10.1073/pnas.89.5.1790; Jacob T, 1999, P NATL ACAD SCI USA, V96, P12192, DOI 10.1073/pnas.96.21.12192; KELLY WB, 1995, PLANT J, V8, P479, DOI 10.1046/j.1365-313X.1995.8040479.x; Krysan PJ, 1999, PLANT CELL, V11, P2283, DOI 10.1105/tpc.11.12.2283; Leckie CP, 1998, P NATL ACAD SCI USA, V95, P15837, DOI 10.1073/pnas.95.26.15837; LEE HJ, 1993, PLANT PHYSIOL, V102, P95, DOI 10.1104/pp.102.1.95; Lee YS, 1996, PLANT PHYSIOL, V110, P987, DOI 10.1104/pp.110.3.987; LEMTIRICHLIEH F, 1994, J MEMBRANE BIOL, V137, P99; Leung J, 1997, PLANT CELL, V9, P759, DOI 10.1105/tpc.9.5.759; Leymarie J, 1998, AUST J PLANT PHYSIOL, V25, P785, DOI 10.1071/PP98031; Li JX, 2000, SCIENCE, V287, P300, DOI 10.1126/science.287.5451.300; MA H, 1990, P NATL ACAD SCI USA, V87, P3821, DOI 10.1073/pnas.87.10.3821; MA H, 1994, PLANT MOL BIOL, V26, P1611, DOI 10.1007/BF00016493; MacRobbie EAC, 2000, P NATL ACAD SCI USA, V97, P12361, DOI 10.1073/pnas.220417197; MacRobbie EAC, 1997, J EXP BOT, V48, P515, DOI 10.1093/jxb/48.Special_Issue.515; MCAINSH MR, 1990, NATURE, V343, P186, DOI 10.1038/343186a0; Pei ZM, 1997, PLANT CELL, V9, P409, DOI 10.1105/tpc.9.3.409; Romano LA, 1998, PLANT CELL PHYSIOL, V39, P1133, DOI 10.1093/oxfordjournals.pcp.a029314; SCHROEDER JI, 1989, NATURE, V338, P427, DOI 10.1038/338427a0; SHEPHERD GM, 1991, CELL, V67, P845, DOI 10.1016/0092-8674(91)90358-6; Staxen I, 1999, P NATL ACAD SCI USA, V96, P1779, DOI 10.1073/pnas.96.4.1779; Ueguchi-Tanaka M, 2000, P NATL ACAD SCI USA, V97, P11638, DOI 10.1073/pnas.97.21.11638; Ullah H, 2001, SCIENCE, V292, P2066, DOI 10.1126/science.1059040; WANG X, UNPUB; Wang XQ, 1998, PLANT PHYSIOL, V118, P1421, DOI 10.1104/pp.118.4.1421; WARPEHA KMF, 1991, P NATL ACAD SCI USA, V88, P8925, DOI 10.1073/pnas.88.20.8925; WICKMAN K, 1995, PHYSIOL REV, V75, P865, DOI 10.1152/physrev.1995.75.4.865; WU WH, 1994, P NATL ACAD SCI USA, V91, P6310, DOI 10.1073/pnas.91.14.6310	41	376	437	5	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 15	2001	292	5524					2070	2072		10.1126/science.1059046	http://dx.doi.org/10.1126/science.1059046			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442KP	11408655	Green Submitted			2022-12-24	WOS:000169284700045
J	Schwetz, BA				Schwetz, BA			Oral therapy for CMV retinitis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									US FDA, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Schwetz, BA (corresponding author), US FDA, Rockville, MD 20857 USA.								0	33	33	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 6	2001	285	21					2705	2705						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	437HG	11386912				2022-12-24	WOS:000168985800005
J	Kang, JG; Yun, J; Kim, DH; Chung, KS; Fujioka, S; Kim, JI; Dae, HW; Yoshida, S; Takatsuto, S; Song, PS; Park, CM				Kang, JG; Yun, J; Kim, DH; Chung, KS; Fujioka, S; Kim, JI; Dae, HW; Yoshida, S; Takatsuto, S; Song, PS; Park, CM			Light and brassinosteroid signals are integrated via a dark-induced small G protein in etiolated seedling growth	CELL			English	Article							GTP-BINDING PROTEINS; DOWN-REGULATED EXPRESSION; YEAST EXPRESSION; TIP GROWTH; ARABIDOPSIS; BIOSYNTHESIS; PEA; IDENTIFICATION; PLANTS; FAMILY	Plant growth and development are regulated through coordinated interactions between light and phytohormones. Here, we demonstrate that a dark-induced small G protein, pea Pra2, regulates a variant cytochrome P450 that catalyzes C-2 hydroxylation in brassinosteroid biosynthesis. The cytochrome P450 is dark-induced and predominantly expressed in the rapidly elongating zone of etiolated pea epicotyls, where Pra2 is also most abundant. Transgenic plants with reduced Pra2 exhibit a dark-specific dwarfism, which is completely rescued by exogenous brassinolide. Overexpression of the cytochrome P450 results in enhanced hypocotyl growth even in the light, which phenocopies the etiolated hypocotyls. We therefore propose that Pra2 and its orthologs are molecular mediators for the cross-talk between light and brassinosteroids in the etiolation process in plants.	Kumho Life & Environm Sci Lab, Kwangju 500712, South Korea; RIKEN, Inst Phys & Chem Res, Wako, Saitama 3510198, Japan; Univ Nebraska, Dept Chem, Lincoln, NE 68588 USA; KJIST, Kwangju 500712, South Korea; Joetsu Univ Educ, Dept Chem, Joetsu, Niigata 9438512, Japan	RIKEN; University of Nebraska System; University of Nebraska Lincoln; Gwangju Institute of Science & Technology (GIST); Joetsu University Education	Park, CM (corresponding author), Kumho Life & Environm Sci Lab, Oryong Dong, Kwangju 500712, South Korea.	pssong@unlserve.unl.edu; cmpark@ksc.kumho.co.kr	Park, Chung-Mo/B-6175-2012		NIGMS NIH HHS [GM-36956] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036956] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Asami T, 1999, TRENDS PLANT SCI, V4, P348, DOI 10.1016/S1360-1385(99)01456-9; Bibikova TN, 1999, PLANT J, V17, P657, DOI 10.1046/j.1365-313X.1999.00415.x; Bishop GJ, 1999, P NATL ACAD SCI USA, V96, P1761, DOI 10.1073/pnas.96.4.1761; BRIGGS WR, 1965, PLANT PHYSIOL, V40, P934, DOI 10.1104/pp.40.5.934; Choe SW, 1998, PLANT CELL, V10, P231, DOI 10.1105/tpc.10.2.231; Clouse SD, 1998, ANNU REV PLANT PHYS, V49, P427, DOI 10.1146/annurev.arplant.49.1.427; COLEMAN DE, 1994, SCIENCE, V265, P1405, DOI 10.1126/science.8073283; Fujioka S, 2000, PHYTOCHEMISTRY, V53, P549, DOI 10.1016/S0031-9422(99)00582-8; Fujioka S, 1997, PHYSIOL PLANTARUM, V100, P710, DOI 10.1034/j.1399-3054.1997.1000335.x; Fujioka S, 1997, PLANT CELL, V9, P1951, DOI 10.1105/tpc.9.11.1951; HAIZEL T, 1995, PLANT PHYSIOL, V108, P59, DOI 10.1104/pp.108.1.59; HIGASHIJIMA T, 1987, J BIOL CHEM, V262, P757; Inaba T, 1999, PLANT PHYSIOL, V120, P491, DOI 10.1104/pp.120.2.491; Inaba T, 2000, J BIOL CHEM, V275, P19723, DOI 10.1074/jbc.M001337200; KIKUCHI A, 1995, METHOD ENZYMOL, V257, P57; Kost B, 1999, CURR OPIN PLANT BIOL, V2, P462, DOI 10.1016/S1369-5266(99)00024-2; Li H, 1999, PLANT CELL, V11, P1731, DOI 10.1105/tpc.11.9.1731; Li JM, 1996, SCIENCE, V272, P398, DOI 10.1126/science.272.5260.398; MA H, 1994, PLANT MOL BIOL, V26, P1611, DOI 10.1007/BF00016493; MATZKE MA, 1995, TRENDS GENET, V11, P1, DOI 10.1016/S0168-9525(00)88973-8; NAGANO Y, 1995, P NATL ACAD SCI USA, V92, P6314, DOI 10.1073/pnas.92.14.6314; Neff MM, 2000, GENE DEV, V14, P257; Neff MM, 1999, P NATL ACAD SCI USA, V96, P15316, DOI 10.1073/pnas.96.26.15316; Nisimoto Y, 1997, J BIOL CHEM, V272, P18834, DOI 10.1074/jbc.272.30.18834; Noguchi T, 1999, PLANT PHYSIOL, V121, P743, DOI 10.1104/pp.121.3.743; Pan JY, 1996, J BIOL CHEM, V271, P1322, DOI 10.1074/jbc.271.3.1322; Pompon D, 1996, METHOD ENZYMOL, V272, P51, DOI 10.1016/S0076-6879(96)72008-6; ROMERO LC, 1991, FEBS LETT, V282, P341, DOI 10.1016/0014-5793(91)80509-2; Schumacher K, 2000, CURR OPIN PLANT BIOL, V3, P79, DOI 10.1016/S1369-5266(99)00038-2; Szekeres M, 1996, CELL, V85, P171, DOI 10.1016/S0092-8674(00)81094-6; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Ueda T, 2000, PLANT J, V21, P341, DOI 10.1046/j.1365-313x.2000.00681.x; vonArnim A, 1996, ANNU REV PLANT PHYS, V47, P215, DOI 10.1146/annurev.arplant.47.1.215; WANG X, 2000, J BIOL CHEM, V275, P29198; WAXMAN DJ, 1991, METHOD ENZYMOL, V206, P462; YOSHIDA K, 1993, P NATL ACAD SCI USA, V90, P6636, DOI 10.1073/pnas.90.14.6636	36	136	154	1	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 1	2001	105	5					625	636		10.1016/S0092-8674(01)00370-1	http://dx.doi.org/10.1016/S0092-8674(01)00370-1			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	439NL	11389832	Bronze			2022-12-24	WOS:000169123200009
J	Sesti, F; Shih, TM; Nikolaeva, N; Goldstein, SAN				Sesti, F; Shih, TM; Nikolaeva, N; Goldstein, SAN			Immunity to K1 killer toxin: Internal TOK1 blockade	CELL			English	Article							DOUBLE-STRANDED-RNA; 2 PORE DOMAINS; SACCHAROMYCES-CEREVISIAE; K+ CHANNEL; FUNCTIONAL EXPRESSION; ENDOPLASMIC-RETICULUM; RETROGRADE TRANSPORT; POTASSIUM CHANNEL; YEAST K+; SECRETION	K1 killer strains of Saccharomyces cerevisiae harbor RNA viruses that mediate secretion of K1, a protein toxin that kills virus-free cells. Recently, external K1 toxin was shown to directly activate TOK1 channels in the plasma membranes of sensitive yeast cells, leading to excess potassium flux and cell death. Here, a mechanism by which killer cells resist their own toxin is shown: internal toxin inhibits TOK1 channels and suppresses activation by external toxin.	Yale Univ, Sch Med, Boyer Ctr Mol Med, Dept Pediat, New Haven, CT 06536 USA; Yale Univ, Sch Med, Boyer Ctr Mol Med, Dept Cellular & Mol Physiol, New Haven, CT 06536 USA	Yale University; Yale University	Goldstein, SAN (corresponding author), Yale Univ, Sch Med, Boyer Ctr Mol Med, Dept Pediat, 295 Congress Ave, New Haven, CT 06536 USA.	steve.goldstein@yale.edu	Goldstein, Steven A./E-9817-2015	Goldstein, Steven A./0000-0001-5207-5061				Ahmed A, 1999, CELL, V99, P283, DOI 10.1016/S0092-8674(00)81659-1; ALALDROOS K, 1978, CAN J MICROBIOL, V24, P228; ANDERSON JA, 1992, P NATL ACAD SCI USA, V89, P3736, DOI 10.1073/pnas.89.9.3736; BOONE C, 1990, J CELL BIOL, V110, P1833, DOI 10.1083/jcb.110.5.1833; BOONE C, 1986, CELL, V46, P105, DOI 10.1016/0092-8674(86)90864-0; BOSTIAN KA, 1984, CELL, V36, P741, DOI 10.1016/0092-8674(84)90354-4; BOSTIAN KA, 1980, CELL, V19, P403, DOI 10.1016/0092-8674(80)90514-0; BUSSEMAKERS MJG, 1991, PROGR UROLOGIE S, V1, P5; BUSSEY H, 1981, ADV MICROB PHYSIOL, V22, P93, DOI 10.1016/S0065-2911(08)60326-4; BUSSEY H, 1983, MOL CELL BIOL, V3, P1362, DOI 10.1128/MCB.3.8.1362; Eisfeld K, 2000, MOL MICROBIOL, V37, P926, DOI 10.1046/j.1365-2958.2000.02063.x; Fairman C, 1999, J MEMBRANE BIOL, V168, P149, DOI 10.1007/s002329900505; Goldstein SAN, 1996, P NATL ACAD SCI USA, V93, P13256, DOI 10.1073/pnas.93.23.13256; KETCHUM KA, 1995, NATURE, V376, P690, DOI 10.1038/376690a0; Kjeldsen T, 1999, J BIOTECHNOL, V75, P195, DOI 10.1016/S0168-1656(99)00159-5; KO CH, 1991, MOL CELL BIOL, V11, P4266, DOI 10.1128/MCB.11.8.4266; LOLLE S, 1984, EMBO J, V3, P1383, DOI 10.1002/j.1460-2075.1984.tb01981.x; Lord JM, 1998, J CELL BIOL, V140, P733; Loukin SH, 1997, EMBO J, V16, P4817, DOI 10.1093/emboj/16.16.4817; Magliani W, 1997, CLIN MICROBIOL REV, V10, P369, DOI 10.1128/CMR.10.3.369; Minor DL, 1999, CELL, V96, P879, DOI 10.1016/S0092-8674(00)80597-8; PETTOELLOMANTOVANI M, 1995, GASTROENTEROLOGY, V109, P1900, DOI 10.1016/0016-5085(95)90757-2; Plemper RK, 1999, J CELL SCI, V112, P4123; Plemper RK, 1999, FEBS LETT, V443, P241, DOI 10.1016/S0014-5793(98)01724-4; Schmitt MJ, 1995, ARCH MICROBIOL, V164, P435; Sesti F, 2000, P NATL ACAD SCI USA, V97, P10613, DOI 10.1073/pnas.180223197; SKIPPER N, 1984, EMBO J, V3, P107, DOI 10.1002/j.1460-2075.1984.tb01769.x; STARMER WT, 1987, CAN J MICROBIOL, V33, P783, DOI 10.1139/m87-134; STURLEY SL, 1986, EMBO J, V5, P3381, DOI 10.1002/j.1460-2075.1986.tb04654.x; TANG WM, 1995, MOL BIOL CELL, V6, P1231, DOI 10.1091/mbc.6.9.1231; THIELE DJ, 1982, NUCLEIC ACIDS RES, V10, P6903, DOI 10.1093/nar/10.21.6903; Vergani P, 1998, EMBO J, V17, P7190, DOI 10.1093/emboj/17.24.7190; Wesche J, 1999, J BIOL CHEM, V274, P34443, DOI 10.1074/jbc.274.48.34443; WICKNER RB, 1974, J BACTERIOL, V117, P1356, DOI 10.1128/JB.117.3.1356-1357.1974; Wickner RB, 1996, ANNU REV GENET, V30, P109, DOI 10.1146/annurev.genet.30.1.109; WICKNER RB, 1976, GENETICS, V82, P429; ZHOU XL, 1995, FEBS LETT, V373, P170, DOI 10.1016/0014-5793(95)01035-D; ZHU H, 1991, MOL CELL BIOL, V11, P175, DOI 10.1128/MCB.11.1.175	38	22	22	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 1	2001	105	5					637	644		10.1016/S0092-8674(01)00376-2	http://dx.doi.org/10.1016/S0092-8674(01)00376-2			8	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	439NL	11389833	Bronze			2022-12-24	WOS:000169123200010
J	Zeng, X; Goetz, JA; Suber, LM; Scott, WJ; Schreiner, CM; Robbins, DJ				Zeng, X; Goetz, JA; Suber, LM; Scott, WJ; Schreiner, CM; Robbins, DJ			A freely diffusible form of Sonic hedgehog mediates long-range signalling	NATURE			English	Article							LIMB-PATTERNING ACTIVITY; INDUCTION; PROTEIN; TRANSDUCTION; CYCLOPAMINE; INHIBITION; CLEAVAGE; PRODUCT; CELLS; CHICK	The secreted protein Sonic hedgehog (Shh) exerts many of its patterning effects through a combination of short- and long-range signalling(1-3). Three distinct mechanisms, which are not necessarily mutually exclusive, have been proposed to account for the long-range effects of Shh: simple diffusion of Shh, a relay mechanism in which Shh activates secondary signals, and direct delivery of Shh through cytoplasmic extensions, termed cytonemes. Although there is much data (using soluble recombinant Shh (ShhN)) to support the simple diffusion model of long-range Shh signalling(1,2), there has been little evidence to date for a native form of Shh that is freely diffusible and not membrane-associated. Here we provide evidence for a freely diffusible form of Shh (s-ShhNp) that is cholesterol modified, multimeric and biologically potent. We further demonstrate that the availability of s-ShhNp is regulated by two functional antagonists of the Shh pathway, Patched (Ptc) and Hedgehog-interacting protein (Hip)(4-6). Finally, we show a gradient of s-ShhNp across the anterior-posterior axis of the chick limb, demonstrating the physiological relevance of s-ShhNp.	Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45267 USA; Childrens Hosp Res Fdn, Div Dev Biol, Cincinnati, OH 45229 USA	University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation	Robbins, DJ (corresponding author), Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, 231 Albert Sabin Way, Cincinnati, OH 45267 USA.							Bell SM, 2000, METH MOL B, V136, P219; BUMCROT DA, 1995, MOL CELL BIOL, V15, P2294; Burke R, 1999, CELL, V99, P803, DOI 10.1016/S0092-8674(00)81677-3; CHANG DT, 1994, DEVELOPMENT, V120, P3339; Chen Y, 1996, CELL, V87, P553, DOI 10.1016/S0092-8674(00)81374-4; Chuang PT, 1999, NATURE, V397, P617, DOI 10.1038/17611; Chuang PT, 2000, CURR OPIN GENET DEV, V10, P515, DOI 10.1016/S0959-437X(00)00121-0; Cooper MK, 1998, SCIENCE, V280, P1603, DOI 10.1126/science.280.5369.1603; Ericson J, 1996, CELL, V87, P661, DOI 10.1016/S0092-8674(00)81386-0; Goodrich LV, 1999, DEV BIOL, V211, P323, DOI 10.1006/dbio.1999.9311; Guy RK, 2000, P NATL ACAD SCI USA, V97, P7307, DOI 10.1073/pnas.97.13.7307; Incardona JP, 1998, DEVELOPMENT, V125, P3553; JOHNSON RL, 1995, CELL, V81, P313, DOI 10.1016/0092-8674(95)90381-X; LOPEZMARTINEZ A, 1995, CURR BIOL, V5, P791, DOI 10.1016/S0960-9822(95)00156-4; MARTI E, 1995, DEVELOPMENT, V121, P2537; McMahon AP, 2000, CELL, V100, P185, DOI 10.1016/S0092-8674(00)81555-X; Nakamura T, 1997, BIOCHEM BIOPH RES CO, V237, P465, DOI 10.1006/bbrc.1997.7156; Pepinsky RB, 1998, J BIOL CHEM, V273, P14037, DOI 10.1074/jbc.273.22.14037; PORTER JA, 1995, NATURE, V374, P363, DOI 10.1038/374363a0; Porter JA, 1996, SCIENCE, V274, P255, DOI 10.1126/science.274.5285.255; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; Robbins DJ, 1997, CELL, V90, P225, DOI 10.1016/S0092-8674(00)80331-1; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; The I, 1999, MOL CELL, V4, P633, DOI 10.1016/S1097-2765(00)80214-2; Tickle C, 1999, SEMIN CELL DEV BIOL, V10, P345, DOI 10.1006/scdb.1999.0294; Wang BL, 2000, CELL, V100, P423, DOI 10.1016/S0092-8674(00)80678-9; WOLPERT L, 1969, J THEOR BIOL, V25, P1, DOI 10.1016/S0022-5193(69)80016-0; Yang Y, 1997, DEVELOPMENT, V124, P4393	28	354	364	0	12	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN	2001	411	6838					716	720		10.1038/35079648	http://dx.doi.org/10.1038/35079648			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439JC	11395778				2022-12-24	WOS:000169112500052
J	Farber, SA; Pack, M; Ho, SY; Johnson, LD; Wagner, DS; Dosch, R; Mullins, MC; Hendrickson, HS; Hendrickson, EK; Halpern, ME				Farber, SA; Pack, M; Ho, SY; Johnson, LD; Wagner, DS; Dosch, R; Mullins, MC; Hendrickson, HS; Hendrickson, EK; Halpern, ME			Genetic analysis of digestive physiology using fluorescent phospholipid reporters	SCIENCE			English	Article							ZEBRAFISH; A(2); CHOLESTEROL; ENZYMES; ASSAYS	Zebrafish are a valuable model for mammalian lipid metabolism; larvae process lipids similarly through the intestine and hepatobiliary system and respond to drugs that block cholesterol synthesis in humans. After ingestion of fluorescently quenched phospholipids, endogenous lipase activity and rapid transport of cleavage products results in intense gall bladder fluorescence. Genetic screening identifies zebrafish mutants, such as fat free, that show normal digestive organ morphology but severely reduced phospholipid and cholesterol processing. Thus, fluorescent lipids provide a sensitive readout of lipid metabolism and are a powerful tool for identifying genes that mediate vertebrate digestive physiology.	Carnegie Inst Washington, Dept Embryol, Baltimore, MD 21210 USA; Thomas Jefferson Univ, Kimmel Canc Ctr, Dept Microbiol & Immunol, Philadelphia, PA 19107 USA; Univ Penn, Dept Med, Philadelphia, PA 19104 USA; Univ Penn, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; Mol Probes Inc, Eugene, OR 97402 USA; Univ Washington, Dept Chem, Seattle, WA 98133 USA	Carnegie Institution for Science; Jefferson University; University of Pennsylvania; University of Pennsylvania; University of Washington; University of Washington Seattle	Farber, SA (corresponding author), Carnegie Inst Washington, Dept Embryol, 115 W Univ Pkwy, Baltimore, MD 21210 USA.		Wagner, Daniel S/C-9379-2009; Dosch, Roland/H-9633-2019; Farber, Steven A/G-5851-2012	Wagner, Daniel S/0000-0002-0595-2436; Dosch, Roland/0000-0001-9247-8586; Farber, Steven A/0000-0002-8037-7312	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054942] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 54942] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Cormier RT, 1997, NAT GENET, V17, P88, DOI 10.1038/ng0997-88; Dennis EA, 1997, TRENDS BIOCHEM SCI, V22, P1, DOI 10.1016/S0968-0004(96)20031-3; FARBER S, UNPUB; Farber SA, 1999, J BIOL CHEM, V274, P19338, DOI 10.1074/jbc.274.27.19338; Frolov A, 2000, J BIOL CHEM, V275, P12769, DOI 10.1074/jbc.275.17.12769; Goto T., 1997, Hepatology, V26, p295A; Hendrickson HS, 1999, ANAL BIOCHEM, V276, P27, DOI 10.1006/abio.1999.4280; HENDRICKSON HS, 1994, ANAL BIOCHEM, V219, P1, DOI 10.1006/abio.1994.1223; HOFMANN A, COMMUNICATION; HOMAN R, 2001, INTESTINAL LIPID MET, P81; Honkanen R.E., 1985, AM J PHYSIOL, V249, P399; MACPHEE M, 1995, CELL, V81, P957, DOI 10.1016/0092-8674(95)90015-2; MULLINS MC, 1994, CURR BIOL, V4, P189, DOI 10.1016/S0960-9822(00)00048-8; NAWROCKI JW, 1995, ARTERIOSCL THROM VAS, V15, P678, DOI 10.1161/01.ATV.15.5.678; Pack M, 1996, DEVELOPMENT, V123, P321; Rubin M, 1999, LIPIDS, V34, P571, DOI 10.1007/s11745-999-0400-x; Selvin PR, 2000, NAT STRUCT BIOL, V7, P730, DOI 10.1038/78948; SHERIDAN MA, 1988, COMP BIOCHEM PHYS B, V90, P679, DOI 10.1016/0305-0491(88)90322-7; STROBAND HWJ, 1979, HISTOCHEMISTRY, V64, P235, DOI 10.1007/BF00495024; Tocher Douglas R., 1995, Biochemistry and Molecular Biology of Fishes, V4, P119; WESTERFIELD M, 1995, ZEABRAFISH BOOK	21	249	258	2	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 18	2001	292	5520					1385	1388		10.1126/science.1060418	http://dx.doi.org/10.1126/science.1060418			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	435DV	11359013				2022-12-24	WOS:000168862900049
J	Lee, C; Murray, MF; Miron, PM; Marsden, D; Irons, M; Wilkins-Haug, LE; Morton, CC				Lee, C; Murray, MF; Miron, PM; Marsden, D; Irons, M; Wilkins-Haug, LE; Morton, CC			Clinical picture: multicolour karyotyping	LANCET			English	Editorial Material									Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Lee, C (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.								0	3	3	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 21	2001	357	9264					1240	1240		10.1016/S0140-6736(00)04472-X	http://dx.doi.org/10.1016/S0140-6736(00)04472-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	425YY	11458963	Bronze			2022-12-24	WOS:000168323300009
J	Baker, VR				Baker, VR			Water and the martian landscape	NATURE			English	Review							ORBITER LASER ALTIMETER; CHAOTIC OBLIQUITY; OUTFLOW CHANNELS; POLYGONAL TERRAIN; FLUVIAL VALLEYS; MARS; ICE; SURFACE; CRATER; CLIMATE	Over the past 30 years, the water-generated landforms and landscapes of Mars have been revealed in increasing detail by a succession of spacecraft missions. Recent data from the Mars Global Surveyor mission confirm the view that brief episodes of water-related activity, including glaciation, punctuated the geological history of Mars. The most recent of these episodes seems to have occurred within the past 10 million years. These new results are anomalous in regard to the prevailing view that the martian surface has been continuously extremely cold and dry, much as it is today, for the past 3.9 billion years. Interpretations of the new data are controversial, but explaining the anomalies in a consistent manner leads to potentially fruitful hypotheses for understanding the evolution of Mars in relation to Earth.	Univ Arizona, Dept Hydrol & Water Resources, Tucson, AZ 85721 USA	University of Arizona	Baker, VR (corresponding author), Univ Arizona, Dept Hydrol & Water Resources, Tucson, AZ 85721 USA.	baker@hwr.arizona.edu						Ackert RP, 1998, GEOGR ANN A, V80A, P267; ANDERSON RC, IN PRESS J GEOPHYS R; Baker V.R., 1992, CHANNELS VALLEY NETW, P493; Baker V.R., 1982, THE CHANNELS OF MARS, DOI [10.1029/EO063i045p00862, DOI 10.1029/EO063I045P00862]; BAKER VR, 1974, ICARUS, V23, P27, DOI 10.1016/0019-1035(74)90101-8; BAKER VR, 1991, NATURE, V352, P589, DOI 10.1038/352589a0; Baker VR, 1996, GEOMORPHOLOGY, V16, P197, DOI 10.1016/S0169-555X(96)80001-8; BAKER VR, 1986, J GEOPHYS RES-SOLID, V91, P3561, DOI 10.1029/JB091iB03p03561; BAKER VR, 1979, J GEOPHYS RES, V84, P7985, DOI 10.1029/JB084iB14p07985; Baker VR, 1996, BING SYMP G, P57; BAKER VR, FLOOD MEGAFLOOD DEPO; BAKER VR, 1993, RESOURCES NEAR EARTH, P765; Barlow NG, 2000, J GEOPHYS RES-PLANET, V105, P26733, DOI 10.1029/2000JE001258; Barsch D., 1996, ROCKGLACIERS; BROECKER WS, 1989, GEOCHIM COSMOCHIM AC, V53, P2465, DOI 10.1016/0016-7037(89)90123-3; BURR D, IN PRESS INT ASS SCI; BURR DM, UNPUB GEOPHYS RE LET; Cabrol NA, 1999, ICARUS, V142, P160, DOI 10.1006/icar.1999.6191; Cabrol NA, 2001, ICARUS, V149, P291, DOI 10.1006/icar.2000.6530; Cabrol NA, 1999, ICARUS, V139, P235, DOI 10.1006/icar.1999.6099; Carr M. H., 1977, Journal of Geophysical Research, V82, P4039, DOI 10.1029/JS082i028p04039; Carr M.H, 1996, WATER MARS; Carr MH, 1999, J GEOPHYS RES-PLANET, V104, P21897, DOI 10.1029/1999JE001048; CARR MH, 1981, ICARUS, V48, P91, DOI 10.1016/0019-1035(81)90156-1; CARR MH, 1990, ICARUS, V87, P210, DOI 10.1016/0019-1035(90)90031-4; Carr MH, 1997, J GEOPHYS RES-PLANET, V102, P9145, DOI 10.1029/97JE00113; Carr MH, 1996, PLANET SPACE SCI, V44, P1411, DOI 10.1016/S0032-0633(96)00053-0; Carr MH, 2000, ASTRON GEOPHYS, V41, P20, DOI 10.1046/j.1468-4004.2000.00320.x; Carr MH, 2000, ICARUS, V146, P366, DOI 10.1006/icar.2000.6428; CHAMBERLIN TC, 1904, POPULAR SCI MONTHLY, V66, P66; Chapman M.G., 2000, ENV EFFECTS VOLCANIC, P39, DOI DOI 10.1007/978-1-4615-4151-6_3; Clark DH, 1998, GEOGR ANN A, V80A, P175, DOI 10.1111/j.0435-3676.1998.00035.x; CLIFFORD SM, IN PRESS EVOLUTION M; Colaprete A, 1998, J GEOPHYS RES-PLANET, V103, P5897, DOI 10.1029/97JE03371; Costard F, 2001, GEOMORPHOLOGY, V37, P289, DOI 10.1016/S0169-555X(00)00088-X; COSTARD F, LUN PLAN SCI C, V32; CRADDOCK RA, 1993, J GEOPHYS RES-PLANET, V98, P3453, DOI 10.1029/92JE02508; CROWELL JC, 1999, GEOL SOC AM MEMOIR, V192; Davis WM, 1926, SCIENCE, V63, P463, DOI 10.1126/science.63.1636.463; Dohm JM, 2000, GEOPHYS RES LETT, V27, P3559, DOI 10.1029/2000GL011728; FRENCH HM, 1996, PERIGLACIAL ENV, V2nd; Gilbert G K, 1896, Science, V3, P1, DOI 10.1126/science.3.53.1; Golombek MP, 2000, J GEOPHYS RES-PLANET, V105, P1841, DOI 10.1029/1999JE001043; Greeley R., 1992, MARS, P730; Gulick VC, 1997, ICARUS, V130, P68, DOI 10.1006/icar.1997.5802; GULICK VC, 1989, NATURE, V341, P514, DOI 10.1038/341514a0; Gulick VC, 1998, J GEOPHYS RES-PLANET, V103, P19365, DOI 10.1029/98JE01321; Gulick VC, 2001, GEOMORPHOLOGY, V37, P241, DOI 10.1016/S0169-555X(00)00086-6; Hartmann WK, 2000, J GEOPHYS RES-PLANET, V105, P15011, DOI 10.1029/1999JE001189; HAYS JD, 1976, SCIENCE, V194, P1121, DOI 10.1126/science.194.4270.1121; Head JW, 1999, SCIENCE, V286, P2134, DOI 10.1126/science.286.5447.2134; HEAD JW, 2001, LUN PLAN SCI C, V32; HEAD JW, IN PRESS J GEOPHYS R; HEAD JW, 2001, LUNAR PLANET SCI, V32; Hiesinger H, 2000, J GEOPHYS RES-PLANET, V105, P11999, DOI 10.1029/1999JE001193; HODGES CA, 1979, J GEOPHYS RES, V84, P8061, DOI 10.1029/JB084iB14p08061; Hoffman N, 2000, ICARUS, V146, P326, DOI 10.1006/icar.2000.6398; Hoffman PF, 1998, SCIENCE, V281, P1342, DOI 10.1126/science.281.5381.1342; HOFFMAN PF, IN PRESS TERRA NOVA; Hynek BM, 2001, GEOLOGY, V29, P407, DOI 10.1130/0091-7613(2001)029<0407:EFEDOT>2.0.CO;2; Ivanov MA, 2001, J GEOPHYS RES-PLANET, V106, P3275, DOI 10.1029/2000JE001257; Jakosky B. M., 1992, MARS, P969; JAKOSKY BM, 1995, J GEOPHYS RES-PLANET, V100, P1579, DOI 10.1029/94JE02801; Jons H.-P, 1985, 16 LUNAR PLANET SCI, P414; KARGEL JS, 1995, J GEOPHYS RES-PLANET, V100, P5351, DOI 10.1029/94JE02447; KARGEL JS, 1992, GEOLOGY, V20, P3, DOI 10.1130/0091-7613(1992)020<0003:AGOM>2.3.CO;2; Keszthelyi L, 2000, J GEOPHYS RES-PLANET, V105, P15027, DOI 10.1029/1999JE001191; KOMAR PD, 1980, ICARUS, V42, P317, DOI 10.1016/0019-1035(80)90097-4; KOMATSU G, LUN PLAN SCI C, V31; LAITY JE, 1985, GEOL SOC AM BULL, V96, P203, DOI 10.1130/0016-7606(1985)96<203:SPATDO>2.0.CO;2; Lane MD, 2000, J GEOPHYS RES-PLANET, V105, P17617, DOI 10.1029/1999JE001197; LASKAR J, 1993, NATURE, V361, P608, DOI 10.1038/361608a0; LUCCHITTA BK, 1986, J GEOPHYS RES-SOLID, V91, pE166, DOI 10.1029/JB091iB13p0E166; Lucchitta BK, 2001, GEOPHYS RES LETT, V28, P403, DOI 10.1029/2000GL011924; LUCCHITTA BK, 1982, J GEOPHYS RES, V87, P9951, DOI 10.1029/JB087iB12p09951; LUCCHITTA BK, 1981, ICARUS, V45, P264, DOI 10.1016/0019-1035(81)90035-X; LUCCHITTA BK, 2001, LUNAR PLANET SCI, V32; Malin MC, 2000, SCIENCE, V290, P1927, DOI 10.1126/science.290.5498.1927; Malin MC, 2000, SCIENCE, V288, P2330, DOI 10.1126/science.288.5475.2330; Malin MC, 1998, SCIENCE, V279, P1681, DOI 10.1126/science.279.5357.1681; Malin MC, 1999, GEOPHYS RES LETT, V26, P3049, DOI 10.1029/1999GL002342; Mangold N, 2001, GEOPHYS RES LETT, V28, P407, DOI 10.1029/2000GL008491; MASURSKY H, 1973, J GEOPHYS RES, V78, P4009, DOI 10.1029/JB078i020p04009; Max MD, 2001, GEOPHYS RES LETT, V28, P1787, DOI 10.1029/2000GL011606; Max MD, 2000, J GEOPHYS RES-PLANET, V105, P4165, DOI 10.1029/1999JE001119; MOORE JG, 1989, J GEOPHYS RES-SOLID, V94, P17465, DOI 10.1029/JB094iB12p17465; MOUGINISMARK PJ, 1990, ICARUS, V84, P362, DOI 10.1016/0019-1035(90)90044-A; MOUGINISMARK PJ, 1993, LUNAR PLANET SCI, V24, P1021; Mulvaney R, 2000, GEOPHYS RES LETT, V27, P2673, DOI 10.1029/1999GL011254; Musselwhite DS, 2001, GEOPHYS RES LETT, V28, P1283, DOI 10.1029/2000GL012496; Nelson DM, 1999, J GEOPHYS RES-PLANET, V104, P8653, DOI 10.1029/98JE01900; NUMMEDAL D, 1981, ICARUS, V45, P77, DOI 10.1016/0019-1035(81)90007-5; Nummedal D., 1978, CHANNELED SCABLAND; Ori GG, 2000, J GEOPHYS RES-PLANET, V105, P17629, DOI 10.1029/1999JE001219; PARKER TJ, 1989, ICARUS, V82, P111, DOI 10.1016/0019-1035(89)90027-4; PARKER TJ, 1993, J GEOPHYS RES-PLANET, V98, P11061, DOI 10.1029/93JE00618; Phillips RJ, 2001, SCIENCE, V291, P2587, DOI 10.1126/science.1058701; PIERI DC, 1980, TM81979 NASA; POLLACK JB, 1987, ICARUS, V71, P203, DOI 10.1016/0019-1035(87)90147-3; RAYMO ME, 1992, NATURE, V359, P117, DOI 10.1038/359117a0; Rothschild LJ, 2001, NATURE, V409, P1092, DOI 10.1038/35059215; SCHULTZ PH, 1979, J GEOPHYS RES, V84, P7669, DOI 10.1029/JB084iB13p07669; Seibert NM, 2001, GEOPHYS RES LETT, V28, P899, DOI 10.1029/2000GL012093; SLEEP NH, IN PRESS P NATL ACAD; Smith DE, 1999, SCIENCE, V284, P1495, DOI 10.1126/science.284.5419.1495; Squyres S. W., 1992, MARS, P523; SQUYRES SW, 1989, ICARUS, V79, P229, DOI 10.1016/0019-1035(89)90078-X; Strom R.G., 1992, MARS, P383, DOI DOI 10.1016/S0032-0633(99)00016-1; SUGDEN DE, 1995, NATURE, V376, P412, DOI 10.1038/376412a0; Tanaka KL, 1999, J GEOPHYS RES-PLANET, V104, P8637, DOI 10.1029/98JE02552; TANAKA KL, 1990, J GEOPHYS RES-SOLID, V95, P14315, DOI 10.1029/JB095iB09p14315; TOUMA J, 1993, SCIENCE, V259, P1294, DOI 10.1126/science.259.5099.1294; WEITZ CM, 2001, LUNAR PLANET SCI, V32; Whewell W., 1847, PHILOS INDUCTIVE SCI; WILLIAMS GE, 1993, EARTH-SCI REV, V34, P1, DOI 10.1016/0012-8252(93)90004-Q; WILSON L, 1969, REV GEOGR PHYS GEOL, V11, P303; [No title captured]	117	424	434	3	100	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 12	2001	412	6843					228	236		10.1038/35084172	http://dx.doi.org/10.1038/35084172			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	451AJ	11449284	Bronze			2022-12-24	WOS:000169778700062
J	Hoeppner, DJ; Hengartner, MO; Schnabel, R				Hoeppner, DJ; Hengartner, MO; Schnabel, R			Engulfment genes cooperate with ced-3 to promote cell death in Caenorhabditis elegans	NATURE			English	Article							C-ELEGANS; APOPTOSIS; PROTEIN; GENETICS; NEMATODE; CORPSES	Genetic studies have identified over a dozen genes that function in programmed cell death (apoptosis) in the nematode Caenorhabditis elegans(1-3). Although the ultimate effects on cell survival or engulfment of mutations in each cell death gene have been extensively described, much less is known about how these mutations affect the kinetics of death and engulfment, or the interactions between these two processes. We have used four-dimensional-Nomarski time-lapse video microscopy to follow in detail how cell death genes regulate the extent and kinetics of apoptotic cell death and removal in the early C. elegans embryo. Here we show that blocking engulfment enhances cell survival when cells are subjected to weak pro-apoptotic signals. Thus, genes that mediate corpse removal can also function to actively kill cells.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; SUNY Stony Brook, Dept Mol Genet & Microbiol, Grad Program Genet, Stony Brook, NY 11794 USA; Tech Univ Braunschweig, Inst Genet, D-38106 Braunschweig, Germany	Cold Spring Harbor Laboratory; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Braunschweig University of Technology	Hengartner, MO (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.		Hengartner, Michael O/E-6235-2011; Hengartner, Michael O/A-7058-2008	Hengartner, Michael/0000-0002-7584-596X				BRENNER S, 1974, GENETICS, V77, P71; Chung SB, 2000, NAT CELL BIOL, V2, P931, DOI 10.1038/35046585; DiezRoux G, 1997, DEVELOPMENT, V124, P3633; Duffield JS, 2000, J IMMUNOL, V164, P2110, DOI 10.4049/jimmunol.164.4.2110; ELLIS RE, 1991, GENETICS, V129, P79; GUMIENNY TL, IN PRESS CELL DEATH; HENGARTNER MO, 1994, NATURE, V369, P318, DOI 10.1038/369318a0; HENGARTNER MO, 1992, NATURE, V356, P494, DOI 10.1038/356494a0; Hodgkin J, 1997, C ELEGANS, P881; Knepper-Nicolai B, 1998, J BIOL CHEM, V273, P30530, DOI 10.1074/jbc.273.46.30530; LANG R, 1994, DEVELOPMENT, V120, P3395; Liu QA, 1998, CELL, V93, P961, DOI 10.1016/S0092-8674(00)81202-7; Metzstein MM, 1998, TRENDS GENET, V14, P410, DOI 10.1016/S0168-9525(98)01573-X; Miller LK, 1999, TRENDS CELL BIOL, V9, P323, DOI 10.1016/S0962-8924(99)01609-8; ROBERTSON AMG, 1982, J EMBRYOL EXP MORPH, V67, P89; Schnabel R, 1997, DEV BIOL, V184, P234, DOI 10.1006/dbio.1997.8509; Shah A, 1999, AGING MENT HEALTH, V3, P153, DOI 10.1080/13607869956316; Stanfield GM, 2000, MOL CELL, V5, P423, DOI 10.1016/S1097-2765(00)80437-2; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; Wu YC, 1998, CELL, V93, P951, DOI 10.1016/S0092-8674(00)81201-5; XUE D, 1995, NATURE, V377, P248, DOI 10.1038/377248a0; [No title captured]	23	226	228	1	8	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 12	2001	412	6843					202	206		10.1038/35084103	http://dx.doi.org/10.1038/35084103			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	451AJ	11449279				2022-12-24	WOS:000169778700057
J	Super, H; Spekreijse, H; Lamme, VAF				Super, H; Spekreijse, H; Lamme, VAF			A neural correlate of working memory in the monkey primary visual cortex	SCIENCE			English	Article							PERSISTENCE; FIGURE; V1	The brain frequently needs to store information for short periods. In vision, this means that the perceptual correlate of a stimulus has to be maintained temporally once the stimulus has been removed from the visual scene. However, it is not known how the visual system transfers sensory information into a memory component. Here, we identify a neural correlate of working memory in the monkey primary visual cortex( V1). We propose that this component may Link sensory activity with memory activity.	Univ Amsterdam, Acad Med Ctr, Grad Sch Neurosci Amsterdam, Dept Visual Syst Anal, NL-1100 AA Amsterdam, Netherlands; Netherlands Ophthalm Res Inst, NL-1105 BA Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW)	Super, H (corresponding author), Univ Amsterdam, Acad Med Ctr, Grad Sch Neurosci Amsterdam, Dept Visual Syst Anal, POB 12011, NL-1100 AA Amsterdam, Netherlands.			Super, Hans/0000-0001-9328-0096				Courtney SM, 1997, NATURE, V386, P608, DOI 10.1038/386608a0; DILOLLO V, 1984, J EXP PSYCHOL HUMAN, V10, P144, DOI 10.1037/0096-1523.10.1.144; Fuster JM, 1997, TRENDS NEUROSCI, V20, P451, DOI 10.1016/S0166-2236(97)01128-4; GOLDMANRAKIC PS, 1990, PROGR BRAIN RES, P313; Hupe JM, 1998, NATURE, V394, P784, DOI 10.1038/29537; Lamme VAF, 1998, P NATL ACAD SCI USA, V95, P3263, DOI 10.1073/pnas.95.6.3263; Lamme VAF, 1998, CURR OPIN NEUROBIOL, V8, P529, DOI 10.1016/S0959-4388(98)80042-1; Lamme VAF, 2000, VISION RES, V40, P1507, DOI 10.1016/S0042-6989(99)00243-6; MIYASHITA Y, 1988, NATURE, V331, P68, DOI 10.1038/331068a0; Payne BR, 1996, TRENDS NEUROSCI, V19, P535, DOI 10.1016/S0166-2236(96)10061-8; SHIOIRI S, 1992, VISION RES, V32, P943, DOI 10.1016/0042-6989(92)90037-J; Super H, 2001, NAT NEUROSCI, V4, P304, DOI 10.1038/85170	12	190	191	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 6	2001	293	5527					120	124		10.1126/science.1060496	http://dx.doi.org/10.1126/science.1060496			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	451BB	11441187	Green Published			2022-12-24	WOS:000169780300042
J	Pichot, C; Maataoui, M; Raddi, S; Raddi, P				Pichot, C; Maataoui, M; Raddi, S; Raddi, P			Surrogate mother for endangered Cupressus	NATURE			English	Article									INRA, Unite Rech Forestieres Mediterraneennes, F-84000 Avignon, France; Fac Sci, Dept Biol, UMR INRA UAPV Ecol Invertebres, F-84000 Avignon, France; Univ Florence, DISTAF, I-50145 Florence, Italy; CNR, Inst Forest Tree Pathol, I-50144 Florence, Italy	INRAE; Avignon Universite; INRAE; University of Florence; Consiglio Nazionale delle Ricerche (CNR)	Pichot, C (corresponding author), INRA, Unite Rech Forestieres Mediterraneennes, Ave Vivaldi, F-84000 Avignon, France.		Raddi, Sabrina/U-5640-2019	Raddi, Sabrina/0000-0002-9796-1515				BARRY J P, 1970, Bulletin de la Societe d'Histoire Naturelle de l'Afrique du Nord, V61, P95; Den Nijs A. P. M., 1993, V1, P229; Frankham R, 1998, NATURE, V392, P441, DOI 10.1038/33022; GAUSSEN H., 1968, GYMNOSPERMES ACTUELL; Mogie M., 1992, EVOLUTION ASEXUAL RE; PAPAGEORGIOU AC, 1993, SILVAE GENET, V42, P109; Pichot C, 2000, ANN FOREST SCI, V57, P17; Pichot C, 2000, THEOR APPL GENET, V101, P574, DOI 10.1007/s001220051518; Pichot C, 1998, SEX PLANT REPROD, V11, P148, DOI 10.1007/s004970050132; Singh H., 1978, EMBRYOLOGY GYMNOSPER	10	59	66	2	18	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 5	2001	412	6842					39	39		10.1038/35083687	http://dx.doi.org/10.1038/35083687			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448TB	11452293	Bronze, Green Published			2022-12-24	WOS:000169644900030
J	Kleinert, S				Kleinert, S			Responding to the changing face of paediatric cardiology	LANCET			English	Editorial Material									The Lancet, London WC1X 8RR, England		Kleinert, S (corresponding author), The Lancet, London WC1X 8RR, England.							BLALOCK A, 1945, JAMA-J AM MED ASSOC, V128, P189, DOI 10.1001/jama.1945.02860200029009; de Leval MR, 2000, J THORAC CARDIOV SUR, V119, P661, DOI 10.1016/S0022-5223(00)70006-7; Ramsay S, 1998, LANCET, V351, P1935, DOI 10.1016/S0140-6736(98)23026-1; Shumway NE, 1999, ANN THORAC SURG, V68, pS34, DOI 10.1016/S0003-4975(99)00814-0; Somerville J, 2001, THORAC CARDIOV SURG, V49, P21, DOI 10.1055/s-2001-9911	5	1	1	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 30	2001	357	9274					2074	2074		10.1016/S0140-6736(00)05229-6	http://dx.doi.org/10.1016/S0140-6736(00)05229-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	447RQ	11445098				2022-12-24	WOS:000169586600008
J	Shann, F				Shann, F			Bacterial pneumonia: commoner than perceived	LANCET			English	Editorial Material							ANTIBIOTIC USE; CHILDREN		Royal Childrens Hosp, Intens Care Unit, Parkville, Vic 3052, Australia	Royal Children's Hospital Melbourne	Shann, F (corresponding author), Royal Childrens Hosp, Intens Care Unit, Flemington Rd, Parkville, Vic 3052, Australia.		Shann, Frank/C-9510-2011					Bullowa JGM, 1935, J AMER MED ASSOC, V105, P1512; CATALANO M, 1990, REV INFECT DIS, V12, pS998; CUNNINGHAM DG, 1983, J PEDIATR-US, V103, P747, DOI 10.1016/S0022-3476(83)80473-9; Drummond P, 2000, ARCH DIS CHILD, V83, P408, DOI 10.1136/adc.83.5.408; GHAFOOR A, 1990, REV INFECT DIS, V12, pS907; HORTAL M, 1990, REV INFECT DIS, V12, pS915; Liu YC, 1999, J CLIN EPIDEMIOL, V52, P539, DOI 10.1016/S0895-4356(99)00027-X; MIMICA I, 1971, AM J DIS CHILD, V122, P278, DOI 10.1001/archpedi.1971.02110040062002; NICHOL KP, 1967, NEW ENGL J MED, V277, P667, DOI 10.1056/NEJM196709282771301; Peters TR, 2000, J PEDIATR-US, V137, P416, DOI 10.1067/mpd.2000.109114; PUCZYNSKI MS, 1987, ANN EMERG MED, V16, P1359, DOI 10.1016/S0196-0644(87)80784-9; Shann F, 1999, LANCET, V354, P1488, DOI 10.1016/S0140-6736(99)00232-9; SHANN F, 1986, PEDIATR INFECT DIS J, V5, P247, DOI 10.1097/00006454-198603000-00017; Sombrero L, 1999, AM J TROP MED HYG, V60, P397, DOI 10.4269/ajtmh.1999.60.397; TAYLOR HG, 1988, EUR J CLIN PHARMACOL, V34, P84; TUPASI TE, 1990, REV INFECT DIS, V12, pS929; *WHO, 1994, WHOARI9434	17	24	27	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 30	2001	357	9274					2070	2072		10.1016/S0140-6736(00)05226-0	http://dx.doi.org/10.1016/S0140-6736(00)05226-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	447RQ	11445094				2022-12-24	WOS:000169586600005
J	Nestler, EJ				Nestler, EJ			Neurobiology - Total recall - The memory of addiction	SCIENCE			English	Editorial Material							NUCLEUS-ACCUMBENS; AMPHETAMINE; SYNAPSES		Univ Texas, SW Med Ctr, Dept Psychiat, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Ctr Basic Neurosci, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Nestler, EJ (corresponding author), Univ Texas, SW Med Ctr, Dept Psychiat, Dallas, TX 75390 USA.	eric.nestler@utsouthwestern.edu	Oka, Yoshitaka/C-9670-2010	Oka, Yoshitaka/0000-0002-3482-3051				Bell K, 2000, NEUROPSYCHOPHARMACOL, V23, P335, DOI 10.1016/S0893-133X(00)00100-7; Berke JD, 2000, NEURON, V25, P515, DOI 10.1016/S0896-6273(00)81056-9; Carlezon WA, 2000, J NEUROSCI, V20; Jones S, 2000, J NEUROSCI, V20, P5575, DOI 10.1523/JNEUROSCI.20-15-05575.2000; Kandel ER, 1997, J CELL PHYSIOL, V173, P124, DOI 10.1002/(SICI)1097-4652(199711)173:2<124::AID-JCP6>3.3.CO;2-5; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Nestler EJ, 2001, NAT REV NEUROSCI, V2, P119, DOI 10.1038/35053570; Nicola SM, 2000, ANNU REV NEUROSCI, V23, P185, DOI 10.1146/annurev.neuro.23.1.185; Robinson TE, 1997, J NEUROSCI, V17, P8491; Scannevin RH, 2000, NAT REV NEUROSCI, V1, P133, DOI 10.1038/35039075; Ungless MA, 2001, NATURE, V411, P583, DOI 10.1038/35079077; Wolf ME, 1998, PROG NEUROBIOL, V54, P679, DOI 10.1016/S0301-0082(97)00090-7	12	132	155	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 22	2001	292	5525					2266	2267		10.1126/science.1063024	http://dx.doi.org/10.1126/science.1063024			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	445KD	11423644				2022-12-24	WOS:000169455900038
J	Ango, F; Prezeau, L; Muller, T; Tu, JC; Xiao, B; Worley, PF; Pin, JP; Bockaert, J; Fagni, L				Ango, F; Prezeau, L; Muller, T; Tu, JC; Xiao, B; Worley, PF; Pin, JP; Bockaert, J; Fagni, L			Agonist-independent activation of metabotropic glutamate receptors by the intracellular protein Homer	NATURE			English	Article							CEREBELLAR GRANULE CELLS; CARBOXYL-TERMINAL DOMAIN; CONSTITUTIVE ACTIVITY; PHARMACOLOGICAL CHARACTERIZATION; PRIMARY CULTURES; SPLICE VARIANTS; K+ CHANNEL; GLUTAMATE-RECEPTOR-1; FAMILY; EXPRESSION	G-protein-coupled receptors (GPCRs) transduce signals from extracellular transmitters to the inside of the cell by activating G proteins. Mutation and overexpression of these receptors have revealed that they can reach their active state even in the absence of agonist, as a result of a natural shift in the equilibrium between their inactive and active conformations(1). Such agonist-independent (constitutive) activity has been observed for the glutamate GPCRs (the metabotropic glutamate receptors mGluR1a and mGluR5) when they are overexpressed in heterologous cells(2). Here we show that in neurons, the constitutive activity of these receptors is controlled by Homer proteins, which bind directly to the receptors' carboxy-terminal intracellular domains(3,4). Disruption of this interaction by mutagenesis or antisense strategies, or expression of endogenous Homer1a (H1a), induces constitutive activity in mGluR1a or mGluR5. Our results show that these glutamate GPCRs can be directly activated by intracellular proteins as well as by agonists.	CNRS, CCIPE, UPR 9023, F-34000 Montpellier, France; Bayer AG, Pharma Res, D-42096 Wuppertal, Germany; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA	Centre National de la Recherche Scientifique (CNRS); Bayer AG; Johns Hopkins University	Fagni, L (corresponding author), CNRS, CCIPE, UPR 9023, 141 Rue Cardonille, F-34000 Montpellier, France.		Pin, Jean-Philippe/Y-6668-2019	Pin, Jean-Philippe/0000-0002-1423-345X; Xiao, Bo/0000-0002-6161-9478; Ango, Fabrice/0000-0002-5548-209X				Ango F, 2000, J NEUROSCI, V20, P8710; Ango F, 1999, NEUROPHARMACOLOGY, V38, P793, DOI 10.1016/S0028-3908(99)00005-2; Brakeman PR, 1997, NATURE, V386, P284, DOI 10.1038/386284a0; Carroll FY, 2001, MOL PHARMACOL, V59, P965, DOI 10.1124/mol.59.5.965; Chavis P, 1998, EUR J NEUROSCI, V10, P2322, DOI 10.1046/j.1460-9568.1998.00243.x; Claeysen S, 1999, MOL PHARMACOL, V55, P910; Claeysen S, 2001, EMBO REP, V2, P61, DOI 10.1093/embo-reports/kve003; FAGNI L, 1991, EUR J NEUROSCI, V3, P778, DOI 10.1111/j.1460-9568.1991.tb01674.x; Galvez T, 2000, J BIOL CHEM, V275, P41166, DOI 10.1074/jbc.M007848200; Hasegawa H, 1996, J BIOL CHEM, V271, P1857, DOI 10.1074/jbc.271.4.1857; JOLY C, 1995, J NEUROSCI, V15, P3970; Kato A, 1997, FEBS LETT, V412, P183, DOI 10.1016/S0014-5793(97)00775-8; Kato A, 1998, J BIOL CHEM, V273, P23969, DOI 10.1074/jbc.273.37.23969; Kenakin T, 1997, TRENDS PHARMACOL SCI, V18, P416, DOI 10.1016/S0165-6147(97)01127-9; Litschig S, 1999, MOL PHARMACOL, V55, P453; Mary S, 1998, J BIOL CHEM, V273, P425, DOI 10.1074/jbc.273.1.425; MATUSLEIBOVITCH N, 1995, J BIOL CHEM, V270, P1041, DOI 10.1074/jbc.270.3.1041; NICOLETTI F, 1986, J NEUROCHEM, V46, P40, DOI 10.1111/j.1471-4159.1986.tb12922.x; Pagano A, 2000, J BIOL CHEM, V275, P33750, DOI 10.1074/jbc.M006230200; PARKER EM, 1991, J BIOL CHEM, V266, P9987; PREZEAU L, 1994, MOL PHARMACOL, V45, P570; Prezeau L, 1996, MOL PHARMACOL, V49, P422; Roche KW, 1999, J BIOL CHEM, V274, P25953, DOI 10.1074/jbc.274.36.25953; SLADECZEK F, 1985, NATURE, V317, P717, DOI 10.1038/317717a0; Tu JC, 1998, NEURON, V21, P717, DOI 10.1016/S0896-6273(00)80589-9; Tu JC, 1999, NEURON, V23, P583, DOI 10.1016/S0896-6273(00)80810-7; Xiao B, 1998, NEURON, V21, P707, DOI 10.1016/S0896-6273(00)80588-7	27	333	342	0	9	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 21	2001	411	6840					962	965		10.1038/35082096	http://dx.doi.org/10.1038/35082096			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	444EN	11418862				2022-12-24	WOS:000169386200048
J	Nash, D; Mostashari, F; Fine, A; Miller, J; O'Leary, D; Murray, K; Huang, A; Rosenberg, A; Greenberg, A; Sherman, M; Wong, S; Layton, M; Campbell, GL; Roehrig, JT; Gubler, DJ; Shieh, WJ; Zaki, S; Smith, P				Nash, D; Mostashari, F; Fine, A; Miller, J; O'Leary, D; Murray, K; Huang, A; Rosenberg, A; Greenberg, A; Sherman, M; Wong, S; Layton, M; Campbell, GL; Roehrig, JT; Gubler, DJ; Shieh, WJ; Zaki, S; Smith, P		1999 W Nile Outbreak Response Working	The outbreak of West Nile virus infection in the New York City area in 1999.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ENCEPHALITIS EPIDEMIC; PATHOLOGY; COUNTY; FEVER	Background: In late August 1999, an unusual cluster of cases of meningoencephalitis associated with muscle weakness was reported to the New York City Department of Health. The initial epidemiologic and environmental investigations suggested an arboviral cause. Methods: Active surveillance was implemented to identify patients hospitalized with viral encephalitis and meningitis. Cerebrospinal fluid, serum, and tissue specimens from patients with suspected cases underwent serologic and viral testing for evidence of arboviral infection. Results: Outbreak surveillance identified 59 patients who were hospitalized with West Nile virus infection in the New York City area during August and September of 1999. The median age of these patients was 71 years (range, 5 to 90). The overall attack rate of clinical West Nile virus infection was at least 6.5 cases per million population, and it increased sharply with age. Most of the patients (63 percent) had clinical signs of encephalitis; seven patients died (12 percent). Muscle weakness was documented in 27 percent of the patients and flaccid paralysis in 10 percent; in all of the latter, nerve conduction studies indicated an axonal polyneuropathy. An age of 75 years or older was an independent risk factor for death (relative risk adjusted for the presence or absence of diabetes mellitus, 8.5; 95 percent confidence interval, 1.2 to 59.1), as was the presence of diabetes mellitus (age-adjusted relative risk, 5.1; 95 percent confidence interval, 1.5 to 17.3). Conclusions: This outbreak of West Nile meningoencephalitis in the New York City metropolitan area represents the first time this virus has been detected in the Western Hemisphere. Given the subsequent rapid spread of the virus, physicians along the eastern seaboard of the United States should consider West Nile virus infection in the differential diagnosis of encephalitis and viral meningitis during the summer months, especially in older patients and in those with muscle weakness. (N Engl J Med 2001;344:1807-14.) Copyright (C) 2001 Massachusetts Medical Society.	New York City Dept Hlth, Communicable Dis Program, New York, NY 10013 USA; CDCP, Epidem Intelligence Serv, Epidemiol Program Off, Div Appl Publ Hlth Trainig,State Branch, Atlanta, GA USA; Ctr Dis Control & Prevent, Div Bioterrorism Preparedness, Atlanta, GA USA; Ctr Dis Control & Prevent, Div Vector Borne Infect Dis, Natl Ctr Infect Dis, Ft Collins, CO USA; Westchester Cty Dept Hlth, New Rochelle, NY USA; Nassau Cty Dept Hlth, Mineola, NY USA; New York State Dept Hlth, Albany, NY USA	New York City Department of Health & Mental Hygiene; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; State University of New York (SUNY) System	Nash, D (corresponding author), New York City Dept Hlth, HIV AIDS Surveillance Program, 346 Broadway,Rm 706, New York, NY 10013 USA.	dnash@health.nyc.gov	Nash, Denis/AFI-7485-2022	Roehrig, John/0000-0001-7581-0479; Nash, Denis/0000-0002-3280-5386	PHS HHS [U50/CCU212386-05] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Ahmed S, 2000, NEUROLOGY, V55, P144, DOI 10.1212/WNL.55.1.144; Asnis DS, 2000, CLIN INFECT DIS, V30, P841; Asnis DS, 2000, CLIN INFECT DIS, V30, P413, DOI 10.1086/313737; BENDER BS, 1986, J AM GERIATR SOC, V34, P649, DOI 10.1111/j.1532-5415.1986.tb04906.x; Briese T, 1999, LANCET, V354, P1650; Briese T, 1999, LANCET, V354, P1261, DOI 10.1016/S0140-6736(99)04576-6; CALISHER CH, 1989, J GEN VIROL, V70, P37, DOI 10.1099/0022-1317-70-1-37; Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P845; Han LL, 1999, J INFECT DIS, V179, P230, DOI 10.1086/314566; Hubalek Z, 1999, EMERG INFECT DIS, V5, P643, DOI 10.3201/eid0505.990505; Johnson AJ, 2000, J CLIN MICROBIOL, V38, P1827, DOI 10.1128/JCM.38.5.1827-1831.2000; Komar N, 2000, REV SCI TECH OIE, V19, P166, DOI 10.20506/rst.19.1.1201; KOMAR N, IN PRESS EMERG INFEC; Lanciotti RS, 2000, J CLIN MICROBIOL, V38, P4066, DOI 10.1128/JCM.38.11.4066-4071.2000; Lanciotti RS, 1999, SCIENCE, V286, P2333, DOI 10.1126/science.286.5448.2333; Lundstrom JO, 1999, J VECTOR ECOL, V24, P1; Lvov D. K., 2000, Voprosy Virusologii, V45, P37; Lvov D. K., 2000, Voprosy Virusologii, V45, P4; Lvov DK, 2000, EMERG INFECT DIS, V6, P373, DOI 10.3201/eid0604.000408; MARBERG K, 1956, AM J HYG, V64, P259, DOI 10.1093/oxfordjournals.aje.a119838; MARFIN AA, 1993, AM J TROP MED HYG, V49, P30, DOI 10.4269/ajtmh.1993.49.30; Martin DA, 2000, J CLIN MICROBIOL, V38, P1823, DOI 10.1128/JCM.38.5.1823-1826.2000; MCINTOSH BM, 1976, S AFR J SCI, V72, P295; MCINTOSH BM, 1994, CRC HDB SERIES ZOONO, P227; NASCI RS, IN PRESS EMERG INFEC; OLEJNIK E., 1952, Bulletin of the Research Council of Israel, V2, P210; POWERS DC, 1993, J INFECT DIS, V167, P584, DOI 10.1093/infdis/167.3.584; Richman DD, 1997, CLIN VIROLOGY; SALTZMAN RL, 1987, REV INFECT DIS, V9, P1127; Sampson BA, 2000, HUM PATHOL, V31, P527, DOI 10.1053/hp.2000.8047; *SAS I, 1990, SAS LANG REF VERS 6; SAS Institute, 1990, SAS PROC GUID VERS 6; Shieh WJ, 2000, EMERG INFECT DIS, V6, P370, DOI 10.3201/eid0604.000407; Steele KE, 2000, VET PATHOL, V37, P208, DOI 10.1354/vp.37-3-208; Szilak I, 2000, NEW ENGL J MED, V342, P59, DOI 10.1056/NEJM200001063420113; TSAI TE, 1994, CRC HDB SERIES ZOO B; Tsai TF, 1998, LANCET, V352, P767, DOI 10.1016/S0140-6736(98)03538-7; TSAI TF, 1988, J INFECT DIS, V157, P351, DOI 10.1093/infdis/157.2.351; WEISS D, IN PRESS EMERG INFEC; YOSHIKAWA TT, 1987, AGING CLIN PRACTICE; 1999, MMWR MORB MORTAL WKL, V48, P890; 2000, MMWR MORB MORTAL WKL, V49, P25; 1999, MMWR MORB MORTAL WKL, V48, P955; 1999, MMWR MORB MORTAL WKL, V48, P944; 2000, MMWR MORB MORTAL WKL, V49, P178	45	863	900	2	100	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 14	2001	344	24					1807	1814		10.1056/NEJM200106143442401	http://dx.doi.org/10.1056/NEJM200106143442401			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	441LC	11407341	Bronze, Green Published			2022-12-24	WOS:000169231000001
J	Hannaford, P				Hannaford, P			Postmarketing surveillance study of Norplant in developing countries	LANCET			English	Editorial Material							IMPLANTS		Univ Aberdeen, Foresterhill Hlth Ctr, Dept Gen Practice & Primary Care, Aberdeen AB25 2AY, Scotland	University of Aberdeen	Hannaford, P (corresponding author), Univ Aberdeen, Foresterhill Hlth Ctr, Dept Gen Practice & Primary Care, Aberdeen AB25 2AY, Scotland.		Hannaford, Philip C/B-7867-2012					Boonstra H, 2000, CONTRACEPTION, V61, P9, DOI 10.1016/S0010-7824(99)00121-3; Du MK, 2000, INT J GYNECOL OBSTET, V68, P249, DOI 10.1016/S0020-7292(99)00214-3; Entwistle VA, 2000, LANCET, V355, P1633, DOI 10.1016/S0140-6736(00)02226-1; Fraser IS, 1998, CONTRACEPTION, V57, P1, DOI 10.1016/S0010-7824(97)00200-X; Meirik O, 2001, OBSTET GYNECOL, V97, P539, DOI 10.1016/S0029-7844(00)01220-5; Sivin I, 1997, CONTRACEPTION, V55, P73, DOI 10.1016/S0010-7824(96)00275-2; Sivin I, 1998, OBSTET GYNECOL, V92, P337, DOI 10.1016/S0029-7844(98)00219-1; SMITH R, 1993, BRIT MED J, V306, P1285, DOI 10.1136/bmj.306.6888.1285; 2000, WORLD POPULATION PRO	9	2	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 9	2001	357	9271					1815	1816		10.1016/S0140-6736(00)05007-8	http://dx.doi.org/10.1016/S0140-6736(00)05007-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	440DN	11410183				2022-12-24	WOS:000169160800003
J	Chittka, L; Schurkens, S				Chittka, L; Schurkens, S			Successful invasion of a floral market - An exotic Asian plant has moved in on Europe's river-banks by bribing pollinators.	NATURE			English	Article							IMPATIENS-GLANDULIFERA; INSECT VISITS; COMPETITION; FLOWERS		Biozentrum, D-97074 Wurzburg, Germany	University of Wurzburg	Chittka, L (corresponding author), Biozentrum, D-97074 Wurzburg, Germany.	chittka@biozentrum.uni-wuerzburg.de	Chittka, Lars/C-3110-2012	Chittka, Lars/0000-0001-8153-1732				BEERLING DJ, 1993, J ECOL, V81, P367, DOI 10.2307/2261507; CAMPBELL DR, 1985, ECOLOGY, V66, P554, DOI 10.2307/1940404; Comba L, 1999, ANN BOT-LONDON, V83, P73, DOI 10.1006/anbo.1998.0798; Comba L, 1999, ANN BOT-LONDON, V83, P369, DOI 10.1006/anbo.1998.0835; Corbet SA, 2001, ANN BOT-LONDON, V87, P219, DOI 10.1006/anbo.2000.1322; PYSEK P, 1995, BIOL CONSERV, V74, P41, DOI 10.1016/0006-3207(95)00013-T; Schurkens S, 2001, ENTOMOL GEN, V25, P115; Toney JC, 1998, NORTHWEST SCI, V72, P198; Waser N.M., 1983, P277; WASER NM, 1978, ECOLOGY, V59, P934, DOI 10.2307/1938545	10	338	362	14	123	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN	2001	411	6838					653	653		10.1038/35079676	http://dx.doi.org/10.1038/35079676			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439JC	11395755				2022-12-24	WOS:000169112500029
J	Dye, MJ; Proudfoot, NJ				Dye, MJ; Proudfoot, NJ			Multiple transcript cleavage precedes polymerase release in termination by RNA polymerase II	CELL			English	Article							REPLICATION; ELONGATION; INITIATION; MECHANISM; PATHWAY; SIGNALS; SITES; HIV-1	The requirement of poly(A) signals to elicit transcription termination of RNA polymerase II (pol II) is firmly established. However, little else is known about the actual process of pol II transcription termination. Evidence presented in this paper, based on analysis of nascent transcripts of the human beta- and epsilon -globin genes, demonstrates that pol II transcription termination involves two distinct and temporally separate events. The first event, termed pretermination cleavage (PTC), is mediated by sequence tracts located downstream of the poly(A) site which appear to promote heterogeneous cleavage of the nascent transcript. The second event, in which pol II disengages from the DNA template, requires that polymerase has transcribed both a PTC sequence tract and a functional poly(A) site.	Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	University of Oxford	Proudfoot, NJ (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.	nicholas.proudfoot@path.ox.ac.uk		Proudfoot, Nicholas/0000-0001-8646-3222				Ashe HL, 1997, GENE DEV, V11, P2494, DOI 10.1101/gad.11.19.2494; Birse CE, 1997, EMBO J, V16, P3633, DOI 10.1093/emboj/16.12.3633; Bousquet-Antonelli C, 2000, CELL, V102, P765, DOI 10.1016/S0092-8674(00)00065-9; Chedin S, 1998, GENE DEV, V12, P3857, DOI 10.1101/gad.12.24.3857; Cook PR, 1999, SCIENCE, V284, P1790, DOI 10.1126/science.284.5421.1790; CULLEN BR, 1993, CELL, V73, P417, DOI 10.1016/0092-8674(93)90126-B; Dieci G, 1996, CELL, V84, P245, DOI 10.1016/S0092-8674(00)80979-4; Dye MJ, 1999, MOL CELL, V3, P371, DOI 10.1016/S1097-2765(00)80464-5; DYE MJ, 1999, THESIS OXFORD U OXFO; GIARDINA C, 1993, J BIOL CHEM, V268, P23806; Greger IH, 1998, EMBO J, V17, P4771, DOI 10.1093/emboj/17.16.4771; Hirose Y, 1998, NATURE, V395, P93, DOI 10.1038/25786; LABHART P, 1986, CELL, V45, P431, DOI 10.1016/0092-8674(86)90329-6; Mitchell P, 2000, CURR OPIN GENET DEV, V10, P193, DOI 10.1016/S0959-437X(00)00063-0; Paule MR, 2000, NUCLEIC ACIDS RES, V28, P1283, DOI 10.1093/nar/28.6.1283; Platt T, 1998, COLD SPRING HARBOR M, P541; PROUDFOOT NJ, 1992, NEW BIOL, V4, P369; PROUDFOOT NJ, 1989, TRENDS BIOCHEM SCI, V14, P105, DOI 10.1016/0968-0004(89)90132-1; PROUDFOOT NJ, 2000, TRENDS BIOCHEM SCI, V25, P105; REEDER RH, 1994, MOL MICROBIOL, V12, P11, DOI 10.1111/j.1365-2958.1994.tb00989.x; STROUBOULIS J, 1992, GENE DEV, V6, P1857, DOI 10.1101/gad.6.10.1857; TANTRAVAHI J, 1993, MOL CELL BIOL, V13, P578, DOI 10.1128/MCB.13.1.578; TREISMAN R, 1983, P NATL ACAD SCI-BIOL, V80, P7428, DOI 10.1073/pnas.80.24.7428; Uptain SM, 1997, ANNU REV BIOCHEM, V66, P117, DOI 10.1146/annurev.biochem.66.1.117; Wind M, 2000, BIOESSAYS, V22, P327, DOI 10.1002/(SICI)1521-1878(200004)22:4<327::AID-BIES3>3.0.CO;2-4; Yarnell WS, 1999, SCIENCE, V284, P611, DOI 10.1126/science.284.5414.611	26	89	92	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 1	2001	105	5					669	681		10.1016/S0092-8674(01)00372-5	http://dx.doi.org/10.1016/S0092-8674(01)00372-5			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	439NL	11389836	Bronze			2022-12-24	WOS:000169123200013
J	Reimann, JDR; Freed, E; Hsu, JY; Kramer, ER; Peters, JM; Jackson, PK				Reimann, JDR; Freed, E; Hsu, JY; Kramer, ER; Peters, JM; Jackson, PK			Emi1 is a mitotic regulator that interacts with Cdc20 and inhibits the anaphase promoting complex	CELL			English	Article							CHECKPOINT PROTEIN MAD2; F-BOX PROTEINS; SPINDLE CHECKPOINT; CELL-CYCLE; BUDDING YEAST; MITOSIS; PROTEOLYSIS; UBIQUITIN; FAMILY; PHOSPHORYLATION	We have discovered an early mitotic inhibitor, Emi1, which regulates mitosis by inhibiting the anaphase promoting complex/cyclosome (APC). Emi1 is a conserved F box protein containing a zinc binding region essential for APC inhibition. Emi1 accumulates before mitosis and is ubiquitylated and destroyed in mitosis, independent of the APC. Emi1 immunodepletion from cycling Xenopus extracts strongly delays cyclin B accumulation and mitotic entry, whereas nondestructible Emi1 stabilizes APC substrates and causes a mitotic block. Emi1 binds the APC activator Cdc20, and Cdc20 can rescue an Emi1-induced block to cyclin B destruction. Our results suggest that Emi1 regulates progression through early mitosis by preventing premature APC activation, and may help explain the well-known delay between cyclin B/Cdc2 activation and cyclin B destruction.	Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Canc Biol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Biophys, Stanford, CA 94305 USA; Res Inst Mol Pathol, A-1030 Vienna, Austria	Stanford University; Stanford University; Stanford University; Stanford University; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Jackson, PK (corresponding author), Stanford Univ, Sch Med, Dept Pathol, 300 Pasteur Dr, Stanford, CA 94305 USA.		Kramer, Edgar/A-9288-2012	Kramer, Edgar/0000-0002-4882-4143; Jackson, Peter/0000-0002-1742-2539	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054811, R01GM060439, T32GM007365] Funding Source: NIH RePORTER; NCI NIH HHS [CA09302] Funding Source: Medline; NIGMS NIH HHS [GM07365, GM54811, GM60439] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alexandru G, 1999, EMBO J, V18, P2707, DOI 10.1093/emboj/18.10.2707; Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; Cenciarelli C, 1999, CURR BIOL, V9, P1177, DOI 10.1016/S0960-9822(00)80020-2; Charles JF, 1998, CURR BIOL, V8, P497, DOI 10.1016/S0960-9822(98)70201-5; Clute P, 1999, NAT CELL BIOL, V1, P82, DOI 10.1038/10049; den Elzen N, 2001, J CELL BIOL, V153, P121, DOI 10.1083/jcb.153.1.121; Dong XZ, 1997, GENE DEV, V11, P94, DOI 10.1101/gad.11.1.94; Fang GW, 1998, GENE DEV, V12, P1871, DOI 10.1101/gad.12.12.1871; Fang GW, 1998, MOL CELL, V2, P163, DOI 10.1016/S1097-2765(00)80126-4; Freed E, 1999, GENE DEV, V13, P2242, DOI 10.1101/gad.13.17.2242; Geley S, 2001, J CELL BIOL, V153, P137, DOI 10.1083/jcb.153.1.137; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; Gmachl M, 2000, P NATL ACAD SCI USA, V97, P8973, DOI 10.1073/pnas.97.16.8973; Gorbsky GJ, 1998, J CELL BIOL, V141, P1193, DOI 10.1083/jcb.141.5.1193; HOLLOWAY SL, 1993, CELL, V73, P1393, DOI 10.1016/0092-8674(93)90364-V; Huang JY, 1999, EMBO J, V18, P2184, DOI 10.1093/emboj/18.8.2184; Hwang LH, 1998, SCIENCE, V279, P1041, DOI 10.1126/science.279.5353.1041; Jackson PK, 2000, TRENDS CELL BIOL, V10, P429, DOI 10.1016/S0962-8924(00)01834-1; JACKSON PK, 1995, J CELL BIOL, V130, P755, DOI 10.1083/jcb.130.4.755; Juang YL, 1997, SCIENCE, V275, P1311, DOI 10.1126/science.275.5304.1311; Kallio M, 1998, J CELL BIOL, V141, P1393, DOI 10.1083/jcb.141.6.1393; Kim SH, 1998, SCIENCE, V279, P1045, DOI 10.1126/science.279.5353.1045; KING RW, 1995, CELL, V81, P279, DOI 10.1016/0092-8674(95)90338-0; Kotani S, 1999, J CELL BIOL, V146, P791, DOI 10.1083/jcb.146.4.791; Kramer ER, 2000, MOL BIOL CELL, V11, P1555, DOI 10.1091/mbc.11.5.1555; Kramer ER, 1998, CURR BIOL, V8, P1207, DOI 10.1016/S0960-9822(07)00510-6; Li Y, 1997, P NATL ACAD SCI USA, V94, P12431, DOI 10.1073/pnas.94.23.12431; Lorca T, 1998, EMBO J, V17, P3565, DOI 10.1093/emboj/17.13.3565; MEIJER L, 1989, EMBO J, V8, P2275, DOI 10.1002/j.1460-2075.1989.tb08353.x; MINSHULL J, 1989, CELL, V56, P947, DOI 10.1016/0092-8674(89)90628-4; MURRAY AW, 1991, METHOD CELL BIOL, V36, P581; MURRAY AW, 1989, NATURE, V339, P275, DOI 10.1038/339275a0; Page AM, 1999, ANNU REV BIOCHEM, V68, P583, DOI 10.1146/annurev.biochem.68.1.583; Pfleger CM, 2000, GENE DEV, V14, P655; Regan-Reimann JD, 1999, CURR BIOL, V9, pR762, DOI 10.1016/S0960-9822(00)80006-8; Rudner AD, 2000, J CELL BIOL, V149, P1377, DOI 10.1083/jcb.149.7.1377; Schwab M, 1997, CELL, V90, P683, DOI 10.1016/S0092-8674(00)80529-2; Shirayama M, 1998, EMBO J, V17, P1336, DOI 10.1093/emboj/17.5.1336; Shteinberg M, 1999, BIOCHEM BIOPH RES CO, V260, P193, DOI 10.1006/bbrc.1999.0884; Straight AF, 1997, METHOD ENZYMOL, V283, P425; Taylor SS, 1997, CELL, V89, P727, DOI 10.1016/S0092-8674(00)80255-X; TUGENDREICH S, 1995, CELL, V81, P261, DOI 10.1016/0092-8674(95)90336-4; Van der Reijden BA, 1999, PROTEIN SCI, V8, P1557, DOI 10.1110/ps.8.7.1557; Visintin R, 1997, SCIENCE, V278, P460, DOI 10.1126/science.278.5337.460; Wassmann K, 1998, P NATL ACAD SCI USA, V95, P11193, DOI 10.1073/pnas.95.19.11193; Yu HT, 1998, SCIENCE, V279, P1219, DOI 10.1126/science.279.5354.1219; Zachariae W, 1999, GENE DEV, V13, P2039, DOI 10.1101/gad.13.16.2039; Zachariae W, 1998, SCIENCE, V282, P1721, DOI 10.1126/science.282.5394.1721	48	306	313	0	13	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 1	2001	105	5					645	655		10.1016/S0092-8674(01)00361-0	http://dx.doi.org/10.1016/S0092-8674(01)00361-0			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	439NL	11389834	Bronze			2022-12-24	WOS:000169123200011
J	Zhao, C; Takita, J; Tanaka, Y; Setou, M; Nakagawa, T; Takeda, S; Yang, HW; Terada, S; Nakata, T; Takei, Y; Saito, M; Tsuji, S; Hayashi, Y; Hirokawa, N				Zhao, C; Takita, J; Tanaka, Y; Setou, M; Nakagawa, T; Takeda, S; Yang, HW; Terada, S; Nakata, T; Takei, Y; Saito, M; Tsuji, S; Hayashi, Y; Hirokawa, N			Charcot-Marie-Tooth disease type 2A caused by mutation in a microtubule motor KIF1B beta	CELL			English	Article							LEFT-RIGHT ASYMMETRY; SYNAPTIC VESICLE; MONOMERIC MOTOR; NMDA RECEPTOR; KINESIN; PROTEIN; TRANSPORT; GENE; MICE; MITOCHONDRIA	The kinesin superfamily motor protein KIF1B has been shown to transport mitochondria. Here, we describe an isoform of KIF1B, KIF1B beta, that is distinct from KIF1B in its cargo binding domain. KIF1B knockout mice die at birth from apnea due to nervous system defects. Death of knockout neurons in culture can be rescued by expression of the beta isoform. The KIF1B heterozygotes have a defect in transporting synaptic vesicle precursors and suffer from progressive muscle weakness similar to human neuropathies. Charcot-Marie-Tooth disease type 2A was previously mapped to an interval containing KIF1B. We show that CMT2A patients contain a loss-of-function mutation in the motor domain of the KIF1B gene. This is clear indication that defects in axonal transport due to a mutated motor protein can underlie human peripheral neuropathy.	Univ Tokyo, Grad Sch Med, Dept Cell Biol & Anat, Tokyo 1130033, Japan; Univ Tokyo, Grad Sch Med, Dept Pediat, Tokyo 1130033, Japan; Niigata Univ, Brain Res Inst, Dept Neurol, Niigata 9518585, Japan	University of Tokyo; University of Tokyo; Niigata University	Hirokawa, N (corresponding author), Univ Tokyo, Grad Sch Med, Dept Cell Biol & Anat, Tokyo 1130033, Japan.		Takei, Yosuke/I-1828-2015; Takeda, Sen/I-8462-2012	Takei, Yosuke/0000-0002-5026-8027; Takeda, Sen/0000-0001-7090-2139; Tanaka, Yosuke/0000-0001-5376-5726				BENOTHMANE K, 1993, GENOMICS, V17, P370; Conforti L, 1999, MAMM GENOME, V10, P617, DOI 10.1007/s003359901056; Gong TWL, 1996, MAMM GENOME, V7, P790, DOI 10.1007/s003359900237; Gong TWL, 1999, GENE, V239, P117, DOI 10.1016/S0378-1119(99)00370-4; Goslin K., 1991, CULTURING NERVE CELL, P251; HARADA A, 1994, NATURE, V369, P488, DOI 10.1038/369488a0; HARDING AE, 1980, J MED GENET, V17, P329, DOI 10.1136/jmg.17.5.329; HIROKAWA N, 1990, J CELL BIOL, V111, P1027, DOI 10.1083/jcb.111.3.1027; Hirokawa N, 1998, SCIENCE, V279, P519, DOI 10.1126/science.279.5350.519; JONES BJ, 1968, J PHARM PHARMACOL, V20, P302, DOI 10.1111/j.2042-7158.1968.tb09743.x; Kadotani H, 1996, J NEUROSCI, V16, P7859; Kanai Y, 2000, J NEUROSCI, V20, P6374, DOI 10.1523/JNEUROSCI.20-17-06374.2000; Kukita Y, 1997, HUM MUTAT, V10, P400, DOI 10.1002/(SICI)1098-1004(1997)10:5<400::AID-HUMU11>3.3.CO;2-1; MAEDA K, 1992, MOL BIOL CELL, V3, P1181, DOI 10.1091/mbc.3.10.1181; Meyer O A, 1979, Neurobehav Toxicol, V1, P233; Nabeshima K, 1998, MOL BIOL CELL, V9, P3211, DOI 10.1091/mbc.9.11.3211; Nakagawa T, 1997, P NATL ACAD SCI USA, V94, P9654, DOI 10.1073/pnas.94.18.9654; Nakata T, 1998, J CELL BIOL, V140, P659, DOI 10.1083/jcb.140.3.659; NANGAKU M, 1994, CELL, V79, P1209, DOI 10.1016/0092-8674(94)90012-4; Nonaka S, 1998, CELL, V95, P829, DOI 10.1016/S0092-8674(00)81705-5; OKADA Y, 1995, CELL, V81, P769, DOI 10.1016/0092-8674(95)90538-3; ROBERTSON A, 1993, ACTA NEUROPATHOL, V86, P163, DOI 10.1007/BF00334883; Saito M, 1997, NEUROLOGY, V49, P1630, DOI 10.1212/WNL.49.6.1630; Setou M, 2000, SCIENCE, V288, P1796, DOI 10.1126/science.288.5472.1796; SHY ME, 1999, ANN NY ACAD SCI, V883, P34; Takeda S, 2000, J CELL BIOL, V148, P1255, DOI 10.1083/jcb.148.6.1255; Takeda S, 1999, J CELL BIOL, V145, P825, DOI 10.1083/jcb.145.4.825; Tanaka Y, 1998, CELL, V93, P1147, DOI 10.1016/S0092-8674(00)81459-2; Yonekawa Y, 1998, J CELL BIOL, V141, P431, DOI 10.1083/jcb.141.2.431	29	561	598	0	30	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 1	2001	105	5					587	597		10.1016/S0092-8674(01)00363-4	http://dx.doi.org/10.1016/S0092-8674(01)00363-4			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	439NL	11389829	Bronze			2022-12-24	WOS:000169123200006
J	Schlesinger, WH; Lichter, J				Schlesinger, WH; Lichter, J			Limited carbon storage in soil and litter of experimental forest plots under increased atmospheric CO2	NATURE			English	Article							C-13 NATURAL-ABUNDANCE; UNITED-STATES; PINE FOREST; US FORESTS; ENRICHMENT; ACCUMULATION; ECOSYSTEMS; TURNOVER; BIOMASS; CLIMATE	The current rise in atmospheric CO2 concentration is thought to be mitigated in part by carbon sequestration within forest ecosystems(1,2), where carbon can be stored in vegetation or soils. The storage of carbon in soils is determined by the fraction that is sequestered in persistent organic materials, such as humus. In experimental forest plots of loblolly pine (Pinus taeda) exposed to high CO2 concentrations(3,4), nearly half of the carbon uptake is allocated to short-lived tissues, largely foliage. These tissues fall to the ground and decompose, normally contributing only a small portion of their carbon content to refractory soil humic materials(5). Such findings call into question the role of soils as long-term carbon sinks, and show the need for a better understanding of carbon cycling in forest soils. Here we report a significant accumulation of carbon in the litter layer of experimental forest plots after three years of growth at increased CO2 concentrations (565 mul l(-1)). But fast turnover times of organic carbon in the litter layer (of about three years) appear to constrain the potential size of this carbon sink. Given the observation that carbon accumulation in the deeper mineral soil layers was absent, we suggest that significant, long-term net carbon sequestration in forest soils is unlikely.	Duke Univ, Nicholas Sch Environm & Earth Sci, Durham, NC 27708 USA; Bowdoin Coll, Dept Biol, Brunswick, ME 04011 USA; Bowdoin Coll, Environm Studies Program, Brunswick, ME 04011 USA	Duke University; Bowdoin College; Bowdoin College	Schlesinger, WH (corresponding author), Duke Univ, Nicholas Sch Environm & Earth Sci, Durham, NC 27708 USA.							ANDREWS JA, 1999, THESIS DUKE U; BALESDENT J, 1988, SOIL SCI SOC AM J, V52, P118, DOI 10.2136/sssaj1988.03615995005200010021x; Brown SL, 1999, ECOL APPL, V9, P968, DOI 10.1890/1051-0761(1999)009[0968:SPOAPA]2.0.CO;2; CAMBARDELLA CA, 1993, GEODERMA, V56, P449, DOI 10.1016/0016-7061(93)90126-6; Caspersen JP, 2000, SCIENCE, V290, P1148, DOI 10.1126/science.290.5494.1148; Ciais P, 2000, ECOL APPL, V10, P1574, DOI 10.1890/1051-0761(2000)010[1574:RBCFAI]2.0.CO;2; Cox PM, 2000, NATURE, V408, P184, DOI 10.1038/35041539; DELCOURT HR, 1980, SCIENCE, V210, P321, DOI 10.1126/science.210.4467.321; DeLucia EH, 1999, SCIENCE, V284, P1177, DOI 10.1126/science.284.5417.1177; Delucia EH, 1997, ANN BOT-LONDON, V79, P111, DOI 10.1006/anbo.1996.0320; Ellsworth DS, 1999, PLANT CELL ENVIRON, V22, P461, DOI 10.1046/j.1365-3040.1999.00433.x; Finzi AC, 2001, ECOLOGY, V82, P470, DOI 10.1890/0012-9658(2001)082[0470:FLPCAD]2.0.CO;2; FOX TR, 1990, SOIL SCI SOC AM J, V54, P1139, DOI 10.2136/sssaj1990.03615995005400040037x; Gill R, 1999, ECOSYSTEMS, V2, P226; HARRISON K, 1993, GLOBAL BIOGEOCHEM CY, V7, P69, DOI 10.1029/92GB02938; Hendrey GR, 1999, GLOBAL CHANGE BIOL, V5, P293, DOI 10.1046/j.1365-2486.1999.00228.x; Houghton RA, 1999, SCIENCE, V285, P574, DOI 10.1126/science.285.5427.574; Hungate BA, 1997, NATURE, V388, P576, DOI 10.1038/41550; Jastrow JD, 1996, SOIL SCI SOC AM J, V60, P801, DOI 10.2136/sssaj1996.03615995006000030017x; Jones TH, 1998, SCIENCE, V280, P441, DOI 10.1126/science.280.5362.441; JORGENSEN JR, 1980, SOIL SCI SOC AM J, V44, P1307, DOI 10.2136/sssaj1980.03615995004400060036x; Lichter J, 2000, BIOGEOCHEMISTRY, V50, P73, DOI 10.1023/A:1006337132631; Matamala R, 2000, GLOB CHANGE BIOL, V6, P967, DOI 10.1046/j.1365-2486.2000.00374.x; OLSON JS, 1963, ECOLOGY, V44, P322, DOI 10.2307/1932179; Richter DD, 1999, NATURE, V400, P56, DOI 10.1038/21867; SCHIFFMAN PM, 1989, CAN J FOREST RES, V19, P69, DOI 10.1139/x89-010; Schimel D, 2000, SCIENCE, V287, P2004, DOI 10.1126/science.287.5460.2004; SCHLESINGER WH, 1990, NATURE, V348, P232, DOI 10.1038/348232a0; Van Kessel C, 2000, GLOBAL CHANGE BIOL, V6, P435, DOI 10.1046/j.1365-2486.2000.00318.x; Weisberg S, 1985, APPL LINEAR REGRESSI, P114	30	376	437	7	180	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 24	2001	411	6836					466	469		10.1038/35078060	http://dx.doi.org/10.1038/35078060			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	435CB	11373676				2022-12-24	WOS:000168858700045
J	Jiggins, CD; Naisbit, RE; Coe, RL; Mallet, J				Jiggins, CD; Naisbit, RE; Coe, RL; Mallet, J			Reproductive isolation caused by colour pattern mimicry	NATURE			English	Article							HELICONIUS BUTTERFLIES; NATURAL-SELECTION; RACE FORMATION; WARNING-COLOR; SPECIATION; REINFORCEMENT; EVOLUTION; CONSEQUENCES; DIVERGENCE	Speciation is facilitated if ecological adaptation directly causes assortative mating(1), but few natural examples are known. Here we show that a shift in colour pattern mimicry was crucial in the origin of two butterfly species. The sister species Heliconius melpomene and Heliconius cydno recently diverged to mimic different model taxa, and our experiments show that their mimetic coloration is also important in choosing mates. Assortative mating between the sister species means that hybridization is rare in nature, and the few hybrids that are produced are nonmimetic, poorly adapted intermediates. Thus, the mimetic shift has caused both pre-mating and post-mating isolation. In addition, individuals from a population of H. melpomene allopatric to H. cydno court and mate with H. cydno more readily than those from a sympatric population. This suggests that assortative mating has been enhanced in sympatry.	UCL, Galton Lab, London NW1 2HE, England; Smithsonian Trop Res Inst, Balboa, Panama; Univ Cambridge Downing Coll, Cambridge CB2 1DQ, England	University of London; University College London; Smithsonian Institution; Smithsonian Tropical Research Institute; University of Cambridge	Jiggins, CD (corresponding author), UCL, Galton Lab, 4 Stephenson Way, London NW1 2HE, England.	jigginsc@naos.si.edu	Naisbit, Russell E/B-9658-2011; Jiggins, Chris/T-4296-2019; mallet, james L.B./B-5114-2008; Jiggins, Chris D/B-9960-2008	Naisbit, Russell E/0000-0003-0190-9323; Jiggins, Chris/0000-0002-7809-062X; Jiggins, Chris D/0000-0002-7809-062X; Mallet, James/0000-0002-3370-0367				Bates HW., 1862, T LINN SOC LOND, V1, P495, DOI DOI 10.1111/J.1096-3642.1860.TB00146.X; Brower AVZ, 1996, EVOLUTION, V50, P195, DOI 10.1111/j.1558-5646.1996.tb04486.x; BUTLIN R, 1987, TRENDS ECOL EVOL, V2, P8, DOI 10.1016/0169-5347(87)90193-5; CRAIG TP, 1993, EVOLUTION, V47, P1696, DOI 10.1111/j.1558-5646.1993.tb01262.x; Dieckmann U, 1999, NATURE, V400, P354, DOI 10.1038/22521; Dobzhansky T, 1940, AM NAT, V74, P312, DOI 10.1086/280899; EDWARDS Anthony William Fairbank, 1972, LIKELIHOOD; FEDER JL, 1994, P NATL ACAD SCI USA, V91, P7990, DOI 10.1073/pnas.91.17.7990; GILBERT LE, IN PRESS ECOLOGY EVO; Kirkpatrick M, 2000, P ROY SOC B-BIOL SCI, V267, P1649, DOI 10.1098/rspb.2000.1191; LINARES M, 1989, ADAPTIVE MICROEVOLUT; MALLET J, 1995, BIOL J LINN SOC, V55, P159, DOI 10.1006/bijl.1995.0034; Mallet J, 1999, ANNU REV ECOL SYST, V30, P201, DOI 10.1146/annurev.ecolsys.30.1.201; Mallet J, 1999, EVOL ECOL, V13, P777, DOI 10.1023/A:1011060330515; Mallet J, 1998, ENDLESS FORMS, P390; MALLET J, 1989, EVOLUTION, V43, P421, DOI 10.1111/j.1558-5646.1989.tb04237.x; MAYNARD SMITH J., 1966, AMER NATUR, V100, P637; McMillan WO, 1997, P NATL ACAD SCI USA, V94, P8628, DOI 10.1073/pnas.94.16.8628; Noor MAF, 1999, HEREDITY, V83, P503, DOI 10.1038/sj.hdy.6886320; Rundle HD, 2000, SCIENCE, V287, P306, DOI 10.1126/science.287.5451.306; TURNER JRG, 1981, ANNU REV ECOL SYST, V12, P99, DOI 10.1146/annurev.es.12.110181.000531; TURNER JRG, 1976, ZOOL J LINN SOC-LOND, V58, P297, DOI 10.1111/j.1096-3642.1976.tb01000.x; VANEWRIGHT RI, 1978, DIVERSITY INSECT FAU, P56	23	491	509	3	181	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 17	2001	411	6835					302	305		10.1038/35077075	http://dx.doi.org/10.1038/35077075			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432RT	11357131	Green Submitted			2022-12-24	WOS:000168710000046
J	Schellenberg, JRMA; Abdulla, S; Nathan, R; Mukasa, O; Marchant, TJ; Kikumbih, N; Mushi, AK; Mponda, H; Minja, H; Mshinda, H; Tanner, M; Lengeler, C				Schellenberg, JRMA; Abdulla, S; Nathan, R; Mukasa, O; Marchant, TJ; Kikumbih, N; Mushi, AK; Mponda, H; Minja, H; Mshinda, H; Tanner, M; Lengeler, C			Effect of large-scale social marketing of insecticide-treated nets on child survival in rural Tanzania	LANCET			English	Article							PLASMODIUM-FALCIPARUM TRANSMISSION; MALARIA MORBIDITY; MORTALITY; AFRICA; LIMITATIONS; POPULATION; PROGRAM; HEALTH; AREA	Background Insecticide-treated nets have proven efficacy as a malaria-control tool in Africa. However, the transition from efficacy to effectiveness cannot be taken for granted. We assessed coverage and the effect on child survival of a large-scale social marketing programme for insecticide-treated nets in two rural districts of southern Tanzania with high perennial malaria transmission. Methods Socially marketed insecticide-treated nets were introduced stepwise over a 2-year period from May, 1997, in a population of 480 000 people. Cross-sectional coverage surveys were done at baseline and after 1, 2, and 3 years. A demographic surveillance system (DSS) was set up in an area of 60 000 people to record population, births, and deaths. Within the DSS area, the effect of insecticide-treated nets on child survival was assessed by a case-control approach. Cases were deaths in children aged between 1 month and 4 years. Four controls for each case were chosen from the DSS database. Use of insecticide-treated nets and potential confounding factors were assessed by questionnaire. Individual effectiveness estimates from the case-control study were combined with coverage to estimate community effectiveness. Findings Insecticide-treated net coverage of infants in the DSS area rose from less than 10% at baseline to more than 50% 3 years later. Insecticide-treated nets were associated with a 27% increase in survival in children aged 1 month to 4 years (95% CI 3-45). Coverage in such children was higher in areas with longer access to the programme. The modest average coverage achieved by 1999 in the two districts (18% in children younger than 5 years) suggests that insecticide-treated nets prevented 1 in 20 child deaths at that time. Interpretation Social marketing of insecticide-treated nets has great potential for effective malaria control in rural African settings.	Ifakara Hlth Res & Dev Ctr, Ifakara, Tanzania; Swiss Trop Inst, CH-4002 Basel, Switzerland	Ifakara Health Institute; University of Basel; Swiss Tropical & Public Health Institute	Schellenberg, JRMA (corresponding author), Orchard Ground Cottage, Cublington LU7 0LJ, Beds, England.	dajobelo@aol.com		Marchant, Tanya/0000-0002-4228-4334; Schellenberg, Joanna/0000-0002-0708-3676				Abdulla S, 2001, BMJ-BRIT MED J, V322, P270, DOI 10.1136/bmj.322.7281.270; ANDREASEN AR, 1995, MARKETING SOCIAL CHA, P1; Binka FN, 1999, J BIOSOC SCI, V31, P375, DOI 10.1017/S0021932099003752; CHAVASSE D, 1999, INSECTICIDE TREATED, P1; DALESSANDRO U, 1995, LANCET, V345, P479, DOI 10.1016/S0140-6736(95)90582-0; Drakeley CJ, 1999, TROP MED INT HEALTH, V4, P639, DOI 10.1046/j.1365-3156.1999.00470.x; Habicht JP, 1999, INT J EPIDEMIOL, V28, P10, DOI 10.1093/ije/28.1.10; Hatz C, 1998, TROP MED INT HEALTH, V3, P498, DOI 10.1046/j.1365-3156.1998.00250.x; Hosmer D.W., 2004, APPL LOGISTIC REGRES, VSecond; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Langeler C, 1996, B WORLD HEALTH ORGAN, V74, P325; Lengeler C, 1999, TROP MED INT HEALTH, V4, P409, DOI 10.1046/j.1365-3156.1999.00422.x; LENGELER C, 2001, COCHRANE LIB; *MAL CONS, 1999, 2 INT C INS TREAT NE; Menendez C, 1997, LANCET, V350, P844, DOI 10.1016/S0140-6736(97)04229-3; MINJA H, 2001, THESIS U BASEL BASEL; MOLINEAUX L, 1985, HLTH POLICY SOCIAL P, P13; *NAT BUR STAT TANZ, 2000, TANZ REPR CHILD HLTH; PREGIBON D, 1981, ANN STAT, V9, P705, DOI 10.1214/aos/1176345513; Schellenberg D, 1999, AM J TROP MED HYG, V61, P431, DOI 10.4269/ajtmh.1999.61.431; SCHELLENBERG JRM, 2001, INDEPTH MONOGRAPH SE, V1; Schellenberg JRMA, 1999, T ROY SOC TROP MED H, V93, P225, DOI 10.1016/S0035-9203(99)90001-9; SMITH T, 1993, ACTA TROP, V54, P55, DOI 10.1016/0001-706X(93)90068-M; SNOW RW, 1992, LANCET, V340, P351, DOI 10.1016/0140-6736(92)91414-4; Snow RW, 1997, LANCET, V349, P1650, DOI 10.1016/S0140-6736(97)02038-2; Snow RW, 1999, B WORLD HEALTH ORGAN, V77, P624; TANNER M, 1992, DIS MORTALITY SUBSAH, P286; TODD JE, 1994, ANN TROP PAEDIATR, V14, P31, DOI 10.1080/02724936.1994.11747689; Trape JF, 1996, PARASITOL TODAY, V12, P236, DOI 10.1016/0169-4758(96)10015-6; WHO, 2000, AB DECL PLAN ACT EXT	30	215	216	2	23	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 21	2001	357	9264					1241	1247		10.1016/S0140-6736(00)04404-4	http://dx.doi.org/10.1016/S0140-6736(00)04404-4			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	425YY	11418148				2022-12-24	WOS:000168323300010
J	Humpherys, D; Eggan, K; Akutsu, H; Hochedlinger, K; Rideout, WM; Biniszkiewicz, D; Yanagimachi, R; Jaenisch, R				Humpherys, D; Eggan, K; Akutsu, H; Hochedlinger, K; Rideout, WM; Biniszkiewicz, D; Yanagimachi, R; Jaenisch, R			Epigenetic instability in ES cells and cloned mice	SCIENCE			English	Article							EMBRYONIC STEM-CELLS; NUCLEAR TRANSFER; SOMATIC-CELLS; H19 GENE; ADULT; METHYLATION; CLONING; MOUSE; FETAL; EXPRESSION	Cloning by nuclear transfer (NT) is an inefficient process in which most clones die before birth and survivors often display growth abnormalities. In an effort to correlate gene expression with survival and fetal overgrowth, we have examined imprinted gene expression in both mice cloned by nuclear transfer and in the embryonic stem (ES) cell donor populations from which they were derived. The epigenetic state of the ES cell genome was found to be extremely unstable. Similarly, variation in imprinted gene expression was observed in most cloned mice, even in those derived from ES cells of the same subclone. Many of the animals survived to adulthood despite widespread gene dysregulation, indicating that mammalian development may be rather tolerant to epigenetic aberrations of the genome. These data imply that even apparently normal cloned animals may have subtle abnormalities in gene expression.	MIT, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02142 USA; Univ Hawaii, John A Burns Sch Med, Dept Anat & Reprod Biol, Honolulu, HI 96822 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); University of Hawaii System	Jaenisch, R (corresponding author), MIT, Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.		Eggan, Kevin/P-7119-2018		NCI NIH HHS [R01-CA84198, 5-R35-CA44339] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R35CA044339, R01CA084198] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Baguisi A, 1999, NAT BIOTECHNOL, V17, P456, DOI 10.1038/8632; Bartolomei MS, 1997, ANNU REV GENET, V31, P493, DOI 10.1146/annurev.genet.31.1.493; Dean W, 1998, DEVELOPMENT, V125, P2273; Eggan K, 2001, P NATL ACAD SCI USA, V98, P6209, DOI 10.1073/pnas.101118898; Hill JR, 1999, THERIOGENOLOGY, V51, P1451, DOI 10.1016/S0093-691X(99)00089-8; Kato Y, 1998, SCIENCE, V282, P2095, DOI 10.1126/science.282.5396.2095; Kono T, 1998, REPROD FERT DEVELOP, V10, P593, DOI 10.1071/RD98056; LEIGHTON PA, 1995, NATURE, V375, P34, DOI 10.1038/375034a0; NAGY A, 1990, DEVELOPMENT, V110, P815; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Onishi A, 2000, SCIENCE, V289, P1188, DOI 10.1126/science.289.5482.1188; Ono Y, 2001, BIOL REPROD, V64, P44, DOI 10.1095/biolreprod64.1.44; Polejaeva IA, 2000, NATURE, V407, P86, DOI 10.1038/35024082; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Rideout WM, 2000, NAT GENET, V24, P109, DOI 10.1038/72753; TREMBLAY KD, 1995, NAT GENET, V9, P407, DOI 10.1038/ng0495-407; Tucker KL, 1996, GENE DEV, V10, P1008, DOI 10.1101/gad.10.8.1008; Wakayama T, 1998, NATURE, V394, P369, DOI 10.1038/28615; Wakayama T, 1999, P NATL ACAD SCI USA, V96, P14984, DOI 10.1073/pnas.96.26.14984; Wakayama T, 1999, NAT GENET, V22, P127, DOI 10.1038/9632; Wang ZQ, 1997, MECH DEVELOP, V62, P137, DOI 10.1016/S0925-4773(97)00655-2; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Young LE, 2000, THERIOGENOLOGY, V53, P627, DOI 10.1016/S0093-691X(99)00263-0; Young LE, 1998, REV REPROD, V3, P155, DOI 10.1530/ror.0.0030155	24	559	613	3	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 6	2001	293	5527					95	97		10.1126/science.1061402	http://dx.doi.org/10.1126/science.1061402			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	451BB	11441181				2022-12-24	WOS:000169780300036
J	Bicknell, AB; Lomthaisong, K; Woods, RJ; Hutchinson, EG; Bennett, HPJ; Gladwell, RT; Lowry, PJ				Bicknell, AB; Lomthaisong, K; Woods, RJ; Hutchinson, EG; Bennett, HPJ; Gladwell, RT; Lowry, PJ			Characterization of a serine protease that cleaves pro-gamma-melanotropin at the adrenal to stimulate growth	CELL			English	Article							PANCREATIC TRYPSIN-INHIBITOR; PROOPIOMELANOCORTIN PEPTIDES; UNILATERAL ADRENALECTOMY; CRYSTAL-STRUCTURE; RAT; EXPRESSION; CORTEX; ADRENOCORTICOTROPIN; DEXAMETHASONE; HYPERTROPHY	The adrenal gland requires stimuli from peptides derived from the ACTH precursor, pro-opiomelanocortin (POMC), to maintain its tonic state. Studies have proposed that a specific postsecretional cleavage of the nonmitogenic N-terminal 16 kDa fragment, also known as pro-gamma -melanotropin (pro-gamma -MSH), is required, releasing shorter fragments that promote adrenal growth. Here, we provide evidence for this hypothesis by the cloning and characterization of a serine protease that is upregulated during growth of the adrenal cortex. It is expressed exclusively in the outer adrenal cortex, the site of cell proliferation, and in the Y1 adrenal cell line. We also show that it is required for growth of Y1 cells, remains bound to the cell surface, and cleaves its substrate, pro-gamma -MSH, at a specific bond.	Univ Reading, Sch Anim & Microbial Sci, Reading RG6 6AJ, Berks, England; McGill Univ, Montreal, PQ, Canada	University of Reading; McGill University	Bicknell, AB (corresponding author), Univ Reading, Sch Anim & Microbial Sci, POB 228, Reading RG6 6AJ, Berks, England.	a.b.bicknell@rdg.ac.uk		Lomthaisong, Khomsorn/0000-0002-0645-5757				Bicknell AB, 2000, J NEUROENDOCRINOL, V12, P977, DOI 10.1046/j.1365-2826.2000.00543.x; BODE W, 1984, EUR J BIOCHEM, V144, P185, DOI 10.1111/j.1432-1033.1984.tb08447.x; BRANSOME ED, 1968, ENDOCRINOLOGY, V83, P956, DOI 10.1210/endo-83-5-956; BROWN JR, 1966, BIOCHEM J, V101, P933; DALLMAN MF, 1980, ENDOCRINOLOGY, V107, P1397, DOI 10.1210/endo-107-5-1397; DALLMAN MF, 1976, AM J PHYSIOL, V231, P408, DOI 10.1152/ajplegacy.1976.231.2.408; DUNLAP NE, 1984, ENDOCRINOLOGY, V114, P1490, DOI 10.1210/endo-114-5-1490; ESTIVARIZ FE, 1982, NATURE, V297, P419, DOI 10.1038/297419a0; ESTIVARIZ FE, 1992, ADRENAL GLAND, P43; HOLZWARTH M, 1988, INT CONGR SER, V799, P841; HORNSBY P J, 1984, Endocrine Research, V10, P259; JAMES S, 1985, J CHROMATOGR, V326, P329, DOI 10.1016/S0021-9673(01)87458-6; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; KRISTENSEN P, 1986, HISTOCHEMISTRY, V85, P431, DOI 10.1007/BF00982674; Lazure C, 1998, J BIOL CHEM, V273, P8572, DOI 10.1074/jbc.273.15.8572; LIPSCOMB HS, 1968, EXCERPTA MED, V222, P79; LOWRY PJ, 1983, NATURE, V306, P70, DOI 10.1038/306070a0; MIN HY, 1986, NUCLEIC ACIDS RES, V14, P8879; Morley SD, 1996, MOL ENDOCRINOL, V10, P585, DOI 10.1210/me.10.5.585; NAKAI K, 1992, GENOMICS, V14, P897, DOI 10.1016/S0888-7543(05)80111-9; NAKANISHI S, 1979, NATURE, V278, P423, DOI 10.1038/278423a0; PELLEGRINO C, 1963, EXP CELL RES, V31, P167, DOI 10.1016/0014-4827(63)90165-4; RAO AJ, 1978, ENDOCRINOLOGY, V102, P371, DOI 10.1210/endo-102-2-371; Ross JT, 2000, ENDOCRINOLOGY, V141, P2153, DOI 10.1210/en.141.6.2153; RUHLMANN A, 1973, J MOL BIOL, V77, P417, DOI 10.1016/0022-2836(73)90448-8; SAPHIER PW, 1993, ENDOCRINOLOGY, V133, P1459, DOI 10.1210/en.133.3.1459; Shutter JR, 1997, GENE DEV, V11, P593, DOI 10.1101/gad.11.5.593; VINSON GP, 1985, CELL BIOCHEM FUNCT, V3, P235, DOI 10.1002/cbf.290030402; WRIGHT NA, 1974, J ENDOCRINOL, V62, P527, DOI 10.1677/joe.0.0620527; Yamaoka K, 1998, J BIOL CHEM, V273, P11895, DOI 10.1074/jbc.273.19.11895; Yaswen L, 1999, NAT MED, V5, P1066, DOI 10.1038/12506	31	103	105	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 29	2001	105	7					903	912		10.1016/S0092-8674(01)00403-2	http://dx.doi.org/10.1016/S0092-8674(01)00403-2			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	449BK	11439186	Bronze			2022-12-24	WOS:000169664300010
J	Mayfield, JA; Fiebig, A; Johnstone, SE; Preuss, D				Mayfield, JA; Fiebig, A; Johnstone, SE; Preuss, D			Gene families from the Arabidopsis thaliana pollen coat proteome	SCIENCE			English	Article							INTRAGENIC RECOMBINATION; STIGMA INTERACTIONS; ALLELIC DIVERSITY; RAPID EVOLUTION; SELECTION; LOCUS; RESISTANCE; PROTEINS; REVEALS; GENOME	The pollen extracellular matrix contains proteins mediating species specificity and components needed for efficient pollination. We identified all proteins >10 kilodaltons in the Arabidopsis pollen coating and showed that most of the corresponding genes reside in two genomic clusters. One cluster encodes six Lipases, whereas the other contains six lipid-binding oleosin genes, including GRP17, a gene that promotes efficient pollination. Individual oleosins exhibit extensive divergence between eco types, but the entire cluster remains intact. Analysis of the syntenic region in Brassica oleracea revealed even greater divergence, but a similar clustering of the genes. Such allelic flexibility may promote speciation in plants.	Univ Chicago, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA; Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; Univ Chicago, Howard Hughes Med Inst, Chicago, IL 60637 USA	University of Chicago; University of Chicago; Howard Hughes Medical Institute; University of Chicago	Preuss, D (corresponding author), Univ Chicago, Dept Mol Genet & Cell Biol, 920 E 58Th St, Chicago, IL 60637 USA.	dpreuss@midway.uchicago.edu		Mayfield, Jacob/0000-0002-5762-6755; Fiebig, Aretha/0000-0002-0612-5029				Alonso-Blanco C, 1998, PLANT J, V14, P259, DOI 10.1046/j.1365-313X.1998.00115.x; Cavell AC, 1998, GENOME, V41, P62, DOI 10.1139/gen-41-1-62; DEOLIVEIRA DE, 1993, PLANT J, V3, P495, DOI 10.1046/j.1365-313X.1993.03040495.x; Dickinson HG, 2000, TRENDS GENET, V16, P373, DOI 10.1016/S0168-9525(00)02083-7; Ferris PJ, 1997, P NATL ACAD SCI USA, V94, P8634, DOI 10.1073/pnas.94.16.8634; Fiebig A, 2000, PLANT CELL, V12, P2001, DOI 10.1105/tpc.12.10.2001; HUGHES AL, 1988, NATURE, V335, P167, DOI 10.1038/335167a0; Kasahara M, 1997, TRENDS GENET, V13, P90, DOI 10.1016/S0168-9525(97)01065-2; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Mayfield JA, 2000, NAT CELL BIOL, V2, P128, DOI 10.1038/35000084; McDowell JM, 1998, PLANT CELL, V10, P1861, DOI 10.1105/tpc.10.11.1861; Michelmore RW, 1998, GENOME RES, V8, P1113, DOI 10.1101/gr.8.11.1113; Richman AD, 1996, SCIENCE, V273, P1212, DOI 10.1126/science.273.5279.1212; Ruiter RK, 1997, PLANT CELL, V9, P1621, DOI 10.1105/tpc.9.9.1621; SommerKnudsen J, 1997, SEX PLANT REPROD, V10, P253, DOI 10.1007/s004970050095; UPTON C, 1995, TRENDS BIOCHEM SCI, V20, P178, DOI 10.1016/S0968-0004(00)89002-7; Vacquier VD, 1998, SCIENCE, V281, P1995, DOI 10.1126/science.281.5385.1995; Wang X, 2001, PLANT PHYSIOL, V125, P1012, DOI 10.1104/pp.125.2.1012; Wolters-Arts M, 1998, NATURE, V392, P818, DOI 10.1038/33929; Wyckoff GJ, 2000, NATURE, V403, P304, DOI 10.1038/35002070; Zinkl GM, 2000, ANN BOT-LONDON, V85, P15, DOI 10.1006/anbo.1999.1066	22	163	194	1	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 29	2001	292	5526					2482	2485		10.1126/science.1060972	http://dx.doi.org/10.1126/science.1060972			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448YU	11431566				2022-12-24	WOS:000169658200039
J	Trimmer, BA; Aprille, JR; Dudzinski, DM; Lagace, CJ; Lewis, SM; Michel, T; Qazi, S; Zayas, RM				Trimmer, BA; Aprille, JR; Dudzinski, DM; Lagace, CJ; Lewis, SM; Michel, T; Qazi, S; Zayas, RM			Nitric oxide and the control of firefly flashing	SCIENCE			English	Article							MITOCHONDRIAL RESPIRATION; MANDUCA-SEXTA; OCTOPAMINE; DROSOPHILA; NEURONS; INHIBITION; SYNTHASE; OXYGEN	Bioluminescent flashing is essential for firefly reproduction, yet the specific molecular mechanisms that control Light production are not well understood. We report that Light production by fireflies can be stimulated by nitric oxide (NO) gas in the presence of oxygen and that NO scavengers block bioluminescence induced by the neurotransmitter octopamine, NO synthase is robustly expressed in the firefly Lantern in cells interposed between nerve endings and the light-producing photocytes, These results suggest that NO synthesis is a key determinant of flash control in fireflies.	Tufts Univ, Dept Biol, Medford, MA 02155 USA; Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA; Harvard Univ, Sch Med, Vet Affairs Boston Healthcare Syst, Boston, MA 02115 USA	Tufts University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Boston Healthcare System	Trimmer, BA (corresponding author), Tufts Univ, Dept Biol, Medford, MA 02155 USA.			Trimmer, Barry/0000-0003-1782-7373; Zayas, Ricardo M./0000-0002-6272-0519				Achenbach H, 1997, NEUROREPORT, V8, P3737, DOI 10.1097/00001756-199712010-00016; Bicker G, 1998, TRENDS NEUROSCI, V21, P349, DOI 10.1016/S0166-2236(98)01236-3; Borutaite V, 2000, BBA-BIOENERGETICS, V1459, P405, DOI 10.1016/S0005-2728(00)00178-X; Branham MA, 1996, NATURE, V381, P745, DOI 10.1038/381745b0; Brown GC, 1999, BBA-BIOENERGETICS, V1411, P351, DOI 10.1016/S0005-2728(99)00025-0; BUCK JB, 1948, ANN NY ACAD SCI, V49, P397, DOI 10.1111/j.1749-6632.1948.tb30944.x; Case J.F., 1978, P331; CHRISTENSEN TA, 1983, NEUROSCIENCE, V9, P183, DOI 10.1016/0306-4522(83)90055-6; CLEETER MWJ, 1994, FEBS LETT, V345, P50, DOI 10.1016/0014-5793(94)00424-2; Clementi E, 1999, P NATL ACAD SCI USA, V96, P1559, DOI 10.1073/pnas.96.4.1559; COPE FW, 1976, PHYSIOL CHEM PHYS M, V8, P343; DAWSON TM, 1991, P NATL ACAD SCI USA, V88, P7797, DOI 10.1073/pnas.88.17.7797; Ghiradella H, 1998, MICROSCOPIC ANATOMY OF INVERTEBRATES, VOL 11 A-C, P363; Gibbs SM, 1998, NEURON, V20, P83, DOI 10.1016/S0896-6273(00)80436-5; Grueber WB, 1999, J COMP NEUROL, V404, P127, DOI 10.1002/(SICI)1096-9861(19990201)404:1<127::AID-CNE10>3.0.CO;2-M; HASEMZADEH H, 1985, LIFE SCI, V37, P433; Lloyd J.E., 1979, P293; MULLER U, 1994, EUR J NEUROSCI, V6, P1362, DOI 10.1111/j.1460-9568.1994.tb00327.x; NATHANSON JA, 1979, SCIENCE, V203, P65, DOI 10.1126/science.214856; SMITH DS, 1963, J CELL BIOL, V16, P323, DOI 10.1083/jcb.16.2.323; VAUGHN M, 1998, AM J PHYSIOL, V274, P1705; Wilson T, 1998, ANNU REV CELL DEV BI, V14, P197, DOI 10.1146/annurev.cellbio.14.1.197; Wingrove JA, 1999, CELL, V98, P105, DOI 10.1016/S0092-8674(00)80610-8; WOOD J, 1994, NEUROPHARMACOLOGY, V33, P1235, DOI 10.1016/0028-3908(94)90022-1; Zayas RM, 2000, J COMP NEUROL, V419, P422	25	103	111	3	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 29	2001	292	5526					2486	2488		10.1126/science.1059833	http://dx.doi.org/10.1126/science.1059833			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448YU	11431567				2022-12-24	WOS:000169658200040
J	Yeh, JC; Hiraoka, N; Petryniak, B; Nakayama, J; Ellies, LG; Rabuka, D; Hindsgaul, O; Marth, JD; Lowe, JB; Fukuda, M				Yeh, JC; Hiraoka, N; Petryniak, B; Nakayama, J; Ellies, LG; Rabuka, D; Hindsgaul, O; Marth, JD; Lowe, JB; Fukuda, M			Novel sulfated lymphocyte homing receptors and their control by a core1 extension beta 1,3-N-acetylglucosaminyltransferase	CELL			English	Article							POLY-N-ACETYLLACTOSAMINE; HIGH ENDOTHELIAL VENULES; L-SELECTIN; MOLECULAR-CLONING; HEPARAN-SULFATE; FUNCTIONAL-CHARACTERIZATION; SULFOTRANSFERASE GENE; LEUKOCYTE TRAFFICKING; MONOCLONAL-ANTIBODY; EXPRESSION CLONING	L-selectin mediates lymphocyte homing by facilitating lymphocyte adhesion to addressins expressed in the high endothelial venules (HEV) of secondary lymphoid organs. Peripheral node addressin recognized by the MECA-79 antibody is apparently part of the L-selectin ligand, but its chemical nature has been undefined. We now identify a sulfated extended core1 mucin-type O-glycan, Gal beta1-->4(sulfo-->6)GlcNAc beta1-->3Gal beta1--> 3GalNAc, as the MECA-79 epitope. Molecular cloning of a HEV-expressed core1-beta1,3-N-acetylglucosaminyltransferase (Core1-beta 3GlcNAcT) enabled the construction of the 6-sulfo sialyl Lewis x on extended core1 O-glycans, recapitulating the potent L-selectin-mediated, shear-dependent adhesion observed with novel L-selectin ligands derived from core2 beta1,6-N-acetylglucosaminyltransferase-I null mice. These results identify Core1-beta 3GlcNAcT and its cognate extended core1 O-glycans as essential participants in the expression of the MECA-79-positive, HEV-specific L-selectin ligands required for lymphocyte homing.	Burnham Inst, Ctr Canc Res, Glycobiol Program, La Jolla, CA 92037 USA; Univ Michigan, Sch Med, Dept Pathol, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA; Shinshu Univ, Grad Sch Med, Inst Organ Transplants Reconstruct Med & Tissue E, Matsumoto, Nagano 3908621, Japan; Univ Calif San Diego, Howard Hughes Med Inst, Div Cellular & Mol Med, La Jolla, CA 92093 USA	Sanford Burnham Prebys Medical Discovery Institute; Howard Hughes Medical Institute; University of Michigan System; University of Michigan; Shinshu University; Howard Hughes Medical Institute; University of California System; University of California San Diego	Fukuda, M (corresponding author), Burnham Inst, Ctr Canc Res, Glycobiol Program, La Jolla, CA 92037 USA.				NATIONAL CANCER INSTITUTE [R01CA048737, F32CA079130] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK048247] Funding Source: NIH RePORTER; NCI NIH HHS [F32CA79130, CA48737, P01CA79132] Funding Source: Medline; NIDDK NIH HHS [DK48247] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Akama TO, 2000, NAT GENET, V26, P237, DOI 10.1038/79987; Angata K, 2001, J BIOL CHEM, V276, P15369, DOI 10.1074/jbc.M100576200; ARBONES ML, 1994, IMMUNITY, V1, P247, DOI 10.1016/1074-7613(94)90076-0; BARGATZE RF, 1995, IMMUNITY, V3, P99, DOI 10.1016/1074-7613(95)90162-0; BAUMHUETER S, 1993, SCIENCE, V262, P436, DOI 10.1126/science.7692600; BERG EL, 1993, NATURE, V366, P695, DOI 10.1038/366695a0; BIERHUIZEN MFA, 1992, P NATL ACAD SCI USA, V89, P9326, DOI 10.1073/pnas.89.19.9326; Bistrup A, 1999, J CELL BIOL, V145, P899, DOI 10.1083/jcb.145.4.899; Bruehl RE, 2000, J BIOL CHEM, V275, P32642, DOI 10.1074/jbc.M001703200; Bullock SL, 1998, GENE DEV, V12, P1894, DOI 10.1101/gad.12.12.1894; Butcher EC, 1996, SCIENCE, V272, P60, DOI 10.1126/science.272.5258.60; Capon C, 1997, J BIOL CHEM, V272, P31957, DOI 10.1074/jbc.272.51.31957; Clark RA, 1998, J CELL BIOL, V140, P721, DOI 10.1083/jcb.140.3.721; Constantin G, 2000, IMMUNITY, V13, P759, DOI 10.1016/S1074-7613(00)00074-1; DUIJVESTIJN AM, 1988, AM J PATHOL, V130, P147; Ellies LG, 1998, IMMUNITY, V9, P881, DOI 10.1016/S1074-7613(00)80653-6; FIETE D, 1991, CELL, V67, P1103, DOI 10.1016/0092-8674(91)90287-9; GIRARD JP, 1995, IMMUNITY, V2, P113, DOI 10.1016/1074-7613(95)90083-7; HEMMERICH S, 1994, J EXP MED, V180, P2219, DOI 10.1084/jem.180.6.2219; HEMMERICH S, 1995, J BIOL CHEM, V270, P12035, DOI 10.1074/jbc.270.20.12035; Hiraoka N, 2000, J BIOL CHEM, V275, P20188, DOI 10.1074/jbc.M002443200; Hiraoka N, 1999, IMMUNITY, V11, P79, DOI 10.1016/S1074-7613(00)80083-7; IMAI Y, 1993, NATURE, V361, P555; Kansas GS, 1996, BLOOD, V88, P3259, DOI 10.1182/blood.V88.9.3259.bloodjournal8893259; Kumamoto K, 1998, BIOCHEM BIOPH RES CO, V247, P514, DOI 10.1006/bbrc.1998.8824; LASKY LA, 1992, CELL, V69, P927, DOI 10.1016/0092-8674(92)90612-G; Lee JK, 1999, BIOCHEM BIOPH RES CO, V263, P543, DOI 10.1006/bbrc.1999.1324; LEE N, 1990, J BIOL CHEM, V265, P20476; Maly P, 1996, CELL, V86, P643, DOI 10.1016/S0092-8674(00)80137-3; MCEVER RP, 1995, J BIOL CHEM, V270, P11025, DOI 10.1074/jbc.270.19.11025; Misra AK, 2000, BIOORG MED CHEM LETT, V10, P1505, DOI 10.1016/S0960-894X(00)00207-9; Priatel JJ, 2000, IMMUNITY, V12, P273, DOI 10.1016/S1074-7613(00)80180-6; RAPRAEGER AC, 1991, SCIENCE, V252, P1705, DOI 10.1126/science.1646484; Rosen SD, 1999, AM J PATHOL, V155, P1013, DOI 10.1016/S0002-9440(10)65201-7; Sasaki K, 1997, P NATL ACAD SCI USA, V94, P14294, DOI 10.1073/pnas.94.26.14294; Sassetti C, 1998, J EXP MED, V187, P1965, DOI 10.1084/jem.187.12.1965; SCHACHTER H, 1994, MOL GLYCOBIOLOGY, P88; Schwientek T, 2000, J BIOL CHEM, V275, P11106, DOI 10.1074/jbc.275.15.11106; Shukla D, 1999, CELL, V99, P13, DOI 10.1016/S0092-8674(00)80058-6; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Stein JV, 1999, J EXP MED, V189, P37, DOI 10.1084/jem.189.1.37; STREETER PR, 1988, J CELL BIOL, V107, P1853, DOI 10.1083/jcb.107.5.1853; Suzuki A, 1996, BLOOD, V87, P3550, DOI 10.1182/blood.V87.9.3550.bloodjournal8793550; Tsuda M, 1999, NATURE, V400, P276, DOI 10.1038/22336; Uchimura K, 1998, J BIOL CHEM, V273, P22577, DOI 10.1074/jbc.273.35.22577; Ujita M, 2000, J BIOL CHEM, V275, P15868, DOI 10.1074/jbc.M001034200; USHIYAMA S, 1993, J BIOL CHEM, V268, P15229; WATANABE K, 1979, J BIOL CHEM, V254, P3221; YAYON A, 1991, CELL, V64, P841, DOI 10.1016/0092-8674(91)90512-W; Yeh JC, 1999, J BIOL CHEM, V274, P3215, DOI 10.1074/jbc.274.5.3215; Zhou DP, 1999, P NATL ACAD SCI USA, V96, P406, DOI 10.1073/pnas.96.2.406	51	283	297	0	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 29	2001	105	7					957	969		10.1016/S0092-8674(01)00394-4	http://dx.doi.org/10.1016/S0092-8674(01)00394-4			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	449BK	11439191	Bronze			2022-12-24	WOS:000169664300015
J	Brookfield, JFY				Brookfield, JFY			Predicting the future	NATURE			English	Editorial Material									Univ Nottingham, Inst Genet, Nottingham NG7 2UH, England	University of Nottingham	Brookfield, JFY (corresponding author), Univ Nottingham, Inst Genet, Nottingham NG7 2UH, England.							Maynard Smith, 1998, EVOL GENET	1	6	6	0	3	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 28	2001	411	6841					999	999		10.1038/35082701	http://dx.doi.org/10.1038/35082701			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	446TF	11429579				2022-12-24	WOS:000169528500024
J	Oliver, D; He, DZZ; Klocker, N; Ludwig, J; Schulte, U; Waldegger, S; Ruppersberg, JP; Dallos, P; Fakler, B				Oliver, D; He, DZZ; Klocker, N; Ludwig, J; Schulte, U; Waldegger, S; Ruppersberg, JP; Dallos, P; Fakler, B			Intracellular anions as the voltage sensor of prestin, the outer hair cell motor protein	SCIENCE			English	Article							CHANNELS; MOTILITY; CAPACITANCE; SALICYLATE; MECHANISM; COCHLEA	Outer hair cells (OHCs) of the mammalian cochlea actively change their cell Length in response to changes in membrane potential. This electromotility, thought to be the basis of cochlear amplification, is mediated by a voltage-sensitive motor molecule recently identified as the membrane protein prestin. Here, we show that voltage sensitivity is conferred to prestin by the intracellular anions chloride and bicarbonate. Removal of these anions abolished fast voltage-dependent motility, as well as the characteristic nonlinear charge movement ("gating currents") driving the underlying structural rearrangements of the protein. The results support a model in which anions act as extrinsic voltage sensors, which bind to the prestin molecule and thus trigger the conformational changes required for motility of OHCs.	Univ Tubingen, Dept Physiol 2, D-72074 Tubingen, Germany; Boys Town Natl Res Hosp, Omaha, NE 68131 USA; Univ Marburg, Ctr Pediat, D-35037 Marburg, Germany; Northwestern Univ, Dept Neurobiol & Physiol, Auditory Physiol Lab, Evanston, IL 60208 USA	Eberhard Karls University of Tubingen; Boys Town National Research Hospital; Philipps University Marburg; Northwestern University	Fakler, B (corresponding author), Univ Tubingen, Dept Physiol 2, D-72074 Tubingen, Germany.		Ludwig, Jost/K-3446-2017; Oliver, Dominik/F-5845-2013; Dallos, Peter/Q-9360-2019	Oliver, Dominik/0000-0002-8368-0923; Dallos, Peter/0000-0002-9731-6591; He (he zhi zhou), Zhi-Zhou/0000-0001-8383-9634	NIDCD NIH HHS [DC00089] Funding Source: Medline	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Ashmore J. F., 1989, MECH HEARING, P107; ASHMORE JF, 1987, J PHYSIOL-LONDON, V388, P323, DOI 10.1113/jphysiol.1987.sp016617; Belyantseva IA, 2000, J NEUROSCI, V20, part. no.; BROWNELL WE, 1985, SCIENCE, V227, P194, DOI 10.1126/science.3966153; DALLOS P, 1991, NATURE, V350, P155, DOI 10.1038/350155a0; DALLOS P, 1992, J NEUROSCI, V12, P4575; Fahlke C, 1997, J GEN PHYSIOL, V110, P551, DOI 10.1085/jgp.110.5.551; Frank G, 1999, P NATL ACAD SCI USA, V96, P4420, DOI 10.1073/pnas.96.8.4420; HE D, UNPUB; HE DZZ, 1994, HEARING RES, V78, P77, DOI 10.1016/0378-5955(94)90046-9; HERRINGTON JD, 1995, PULSE CONTROL V4 7; IWASA KH, 1994, J ACOUST SOC AM, V96, P2216, DOI 10.1121/1.410094; Kakehata S, 1996, J NEUROSCI, V16, P4881; KALINEC F, 1992, P NATL ACAD SCI USA, V89, P8671, DOI 10.1073/pnas.89.18.8671; Klocker N, 2001, MOL CELL NEUROSCI, V17, P514, DOI 10.1006/mcne.2000.0956; Ludwig J, 2001, P NATL ACAD SCI USA, V98, P4178, DOI 10.1073/pnas.071613498; Oliver D, 1999, J PHYSIOL-LONDON, V519, P791, DOI 10.1111/j.1469-7793.1999.0791n.x; Oliver D, 2000, NEURON, V26, P595, DOI 10.1016/S0896-6273(00)81197-6; OLIVER D, UNPUB; SANTOS-SACCHI J, 1991, J NEUROSCI, V11, P3096, DOI 10.1523/jneurosci.11-10-03096.1991; Santos-Sacchi J, 2001, J PHYSIOL-LONDON, V531, P661, DOI 10.1111/j.1469-7793.2001.0661h.x; Schulte U, 1999, P NATL ACAD SCI USA, V96, P15298, DOI 10.1073/pnas.96.26.15298; Scott DA, 2000, AM J PHYSIOL-CELL PH, V278, pC207, DOI 10.1152/ajpcell.2000.278.1.C207; TUNSTALL MJ, 1995, J PHYSIOL-LONDON, V485, P739, DOI 10.1113/jphysiol.1995.sp020765; Waldegger S, 2001, GENOMICS, V72, P43, DOI 10.1006/geno.2000.6445; Zheng J, 2000, NATURE, V405, P149, DOI 10.1038/35012009	26	341	356	1	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 22	2001	292	5525					2340	2343		10.1126/science.1060939	http://dx.doi.org/10.1126/science.1060939			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	445KD	11423665				2022-12-24	WOS:000169455900061
J	VanDemark, AP; Hofmann, RM; Tsui, C; Pickart, CM; Wolberger, C				VanDemark, AP; Hofmann, RM; Tsui, C; Pickart, CM; Wolberger, C			Molecular insights into polyubiquitin chain assembly: Crystal structure of the Mms2/Ubc13 heterodimer	CELL			English	Article							UBIQUITIN-CONJUGATING-ENZYME; RING FINGER PROTEINS; DNA-REPAIR; MULTIUBIQUITIN CHAIN; PROTEOLYSIS; COMPLEX; RAD6; GENE; INHIBITION; PROGRAM	While the signaling properties of ubiquitin depend on the topology of polyubiquitin chains, little is known concerning the molecular basis of specificity in chain assembly and recognition. UEV/Ubc complexes have been implicated in the assembly of Lys63-linked polyubiquitin chains that act as a novel signal in postreplicative DNA repair and I kappaB alpha kinase activation. The crystal structure of the Mms2/Ubc13 heterodimer shows the active site of Ubc13 at the intersection of two channels that are potential binding sites for the two substrate ubiquitins. Mutations that destabilize the heterodimer interface confer a marked UV sensitivity, providing direct evidence that the intact heterodimer is necessary for DNA repair. Selective mutations in the channels suggest a molecular model for specificity in the assembly of Lys63-linked polyubiquitin signals.	Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Publ Hlth, Dept Biochem, Baltimore, MD 21205 USA; Johns Hopkins Univ, Howard Hughes Med Inst, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University	Wolberger, C (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA.	cwolberg@jhmi.edu		VanDemark, Andrew/0000-0003-3424-4831; Wolberger, Cynthia/0000-0001-8578-2969	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060372] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM60372] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALANI E, 1987, GENETICS, V116, P541, DOI 10.1534/genetics.112.541.test; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Beal R, 1996, P NATL ACAD SCI USA, V93, P861, DOI 10.1073/pnas.93.2.861; Broomfield S, 1998, P NATL ACAD SCI USA, V95, P5678, DOI 10.1073/pnas.95.10.5678; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brusky J, 2000, CURR GENET, V37, P168, DOI 10.1007/s002940050515; Buschmann T, 2000, CELL, V101, P753, DOI 10.1016/S0092-8674(00)80887-9; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; Chen ZJ, 1996, CELL, V84, P853, DOI 10.1016/S0092-8674(00)81064-8; CHEN ZJ, 1991, J BIOL CHEM, V266, P15698; COOK WJ, 1992, J BIOL CHEM, V267, P15116; COOK WJ, 1993, BIOCHEMISTRY-US, V32, P13809, DOI 10.1021/bi00213a009; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; FINLEY D, 1994, MOL CELL BIOL, V14, P5501, DOI 10.1128/MCB.14.8.5501; Gabb HA, 1997, J MOL BIOL, V272, P106, DOI 10.1006/jmbi.1997.1203; Galan JM, 1997, EMBO J, V16, P5847, DOI 10.1093/emboj/16.19.5847; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hicke L, 1999, TRENDS CELL BIOL, V9, P107, DOI 10.1016/S0962-8924(98)01491-3; Hofmann RM, 1999, CELL, V96, P645, DOI 10.1016/S0092-8674(00)80575-9; Huang L, 1999, SCIENCE, V286, P1321, DOI 10.1126/science.286.5443.1321; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JENTSCH S, 1987, NATURE, V329, P131, DOI 10.1038/329131a0; Jiang F, 1999, BIOCHEMISTRY-US, V38, P6471, DOI 10.1021/bi9901329; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; JOHNSON RE, 1992, MOL CELL BIOL, V12, P3807, DOI 10.1128/MCB.12.9.3807; Kaiser P, 2000, CELL, V102, P303, DOI 10.1016/S0092-8674(00)00036-2; Koegl M, 1999, CELL, V96, P635, DOI 10.1016/S0092-8674(00)80574-7; Koepp DM, 1999, CELL, V97, P431, DOI 10.1016/S0092-8674(00)80753-9; Koonin EV, 1997, NAT GENET, V16, P330, DOI 10.1038/ng0897-330; LAMZIN VS, 1993, ACTA CRYSTALLOGR D, V49, P129, DOI 10.1107/S0907444992008886; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Miura T, 1999, J MOL BIOL, V290, P213, DOI 10.1006/jmbi.1999.2859; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Piotrowski J, 1997, J BIOL CHEM, V272, P23712, DOI 10.1074/jbc.272.38.23712; Rock KL, 1999, ANNU REV IMMUNOL, V17, P739, DOI 10.1146/annurev.immunol.17.1.739; Sancho E, 1998, MOL CELL BIOL, V18, P576, DOI 10.1128/MCB.18.1.576; SPENCE J, 1995, MOL CELL BIOL, V15, P1265; Spence J, 2000, CELL, V102, P67, DOI 10.1016/S0092-8674(00)00011-8; Thomson TM, 1998, FEBS LETT, V423, P49, DOI 10.1016/S0014-5793(98)00060-X; Ulrich HD, 2000, EMBO J, V19, P3388, DOI 10.1093/emboj/19.13.3388; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Worthylake DR, 1998, J BIOL CHEM, V273, P6271, DOI 10.1074/jbc.273.11.6271; Xiao W, 1998, NUCLEIC ACIDS RES, V26, P3908, DOI 10.1093/nar/26.17.3908; Xiao W, 2000, GENETICS, V155, P1633; You JX, 1999, BIOTECHNIQUES, V27, P950, DOI 10.2144/99275st01; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X	48	253	264	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 15	2001	105	6					711	720		10.1016/S0092-8674(01)00387-7	http://dx.doi.org/10.1016/S0092-8674(01)00387-7			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	444AE	11440714	Bronze			2022-12-24	WOS:000169375100005
J	Sacco, RL; Benson, RT; Kargman, DE; Boden-Albala, B; Tuck, C; Lin, IF; Cheng, JF; Paik, MC; Shea, S; Berglund, L				Sacco, RL; Benson, RT; Kargman, DE; Boden-Albala, B; Tuck, C; Lin, IF; Cheng, JF; Paik, MC; Shea, S; Berglund, L			High-density lipoprotein cholesterol and ischemic stroke in the elderly - The northern Manhattan stroke study	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY-HEART-DISEASE; RISK-FACTORS; CAROTID ATHEROSCLEROSIS; SERUM-CHOLESTEROL; CARDIOVASCULAR-DISEASE; CEREBRAL INFARCTION; HDL CHOLESTEROL; ARTERY-DISEASE; RACE-ETHNICITY; PLASMA-LIPIDS	Context Elevated high-density lipoprotein cholesterol (HDL-C) levels have been shown to be protective against cardiovascular disease. However, the association of specific lipoprotein classes and ischemic stroke has not been well defined, particularly in higher risk minority populations. Objective To evaluate the association between HDL-C and ischemic stroke in an elderly, racially or ethnically diverse population. Design Population-based, incident case-control study conducted July 1993 through June 1997. Setting A multiethnic community in northern Manhattan, New York, NY. Participants Cases (n = 539) of first ischemic stroke (67% aged greater than or equal to 65 years; 55% women; 53% Hispanic, 28% black, and 19% white) were enrolled and matched by age, sex, and race or ethnicity to stroke-free community residents (controls; n=905). Main Outcome Measure Independent association of fasting HDL-C levels, determined at enrollment, with ischemic stroke, including atherosclerotic and nonatherosclerotic ischemic stroke subtypes. Results After risk factor adjustment, a protective effect was observed for HDL-C levels of at least 35 mg/dL (0.91 mmol/L) (odds ratio [OR], 0.53; 95% confidence interval [CI], 0.39-0.72). A dose-response relationship was observed (OR, 0.65; 95% CI, 0.47-0.90 and OR, 0.31; 95% CI,0.21-0.46) for HDL-C levels of 35 to 49 mg/dL (0.91-1.28 mmol/L) and at least 50 mg/dL (1.29 mmol/L), respectively. The protective effect of a higher HDL-C level was significant among participants aged 75 years or older (OR, 0.51;95% CI,0.27-0.94), was more potent for the atherosclerotic stroke subtype (OR, 0.20; 95% CI, 0.08-0.50), and was present in all 3 racial or ethnic groups studied. Conclusions Increased HDL-C levels are associated with reduced risk of ischemic stroke in the elderly and among different racial or ethnic groups. These data add to the evidence relating lipids to stroke and support HDL-C as an important modifiable stroke risk factor.	Columbia Univ, Mailman Sch Publ Hlth, Dept Neurol, New York, NY USA; Columbia Univ, Mailman Sch Publ Hlth, Gertrude H Sergievsky Ctr, New York, NY USA; Columbia Univ, Mailman Sch Publ Hlth, Dept Med, Div Gen Med, New York, NY USA; Columbia Univ, Mailman Sch Publ Hlth, Dept Med, Div Prevent Med & Nutr, New York, NY USA; Columbia Univ, Mailman Sch Publ Hlth, Irving Ctr Clin Res, New York, NY USA; Columbia Univ, Mailman Sch Publ Hlth, Coll Phys & Surg, New York, NY USA; Columbia Univ, Mailman Sch Publ Hlth, Div Epidemiol, New York, NY USA; Columbia Univ, Mailman Sch Publ Hlth, Div Sociomed Sci, New York, NY USA; Columbia Univ, Mailman Sch Publ Hlth, Div Biostat, New York, NY USA	Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Columbia University	Sacco, RL (corresponding author), Neurol Inst, 710 W 168th St, New York, NY 10032 USA.	rsl1@columbia.edu	Albala, Bernadette Boden/J-5703-2013; Sacco, Ralph/Y-9278-2019	Albala, Bernadette Boden/0000-0001-5664-2342; Boden-Albala, Bernadette/0000-0002-3752-329X; Berglund, Lars/0000-0001-6705-1791	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000645] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS029993, T32NS007153, R01NS027517] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG015294] Funding Source: NIH RePORTER; NCRR NIH HHS [2 M01 RR00645] Funding Source: Medline; NIA NIH HHS [AG15294] Funding Source: Medline; NINDS NIH HHS [R01 NS29993, T32 NS07153, R01 NS27517] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ballantyne CM, 1999, CIRCULATION, V99, P736, DOI 10.1161/01.CIR.99.6.736; BENFANTE R, 1994, STROKE, V25, P814, DOI 10.1161/01.STR.25.4.814; BIHARIVARGA M, 1981, ATHEROSCLEROSIS, V40, P337, DOI 10.1016/0021-9150(81)90144-1; Blauw GJ, 1997, STROKE, V28, P946, DOI 10.1161/01.STR.28.5.946; Bureau of the Census, 1990, 1990 CENS POP HOUS; Casper ML, 1997, ANN EPIDEMIOL, V7, P146, DOI 10.1016/S1047-2797(96)00113-5; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; CORTI MC, 1995, JAMA-J AM MED ASSOC, V274, P539, DOI 10.1001/jama.274.7.539; Crouse JR, 1999, AM J CARDIOL, V83, P1476, DOI 10.1016/S0002-9149(99)00153-8; DEMPSEY RJ, 1990, NEUROSURGERY, V27, P343, DOI 10.1227/00006123-199009000-00001; FINEEDELSTEIN JS, 1994, NEUROLOGY, V44, P1046, DOI 10.1212/WNL.44.6.1046; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gan R, 1997, NEUROLOGY, V48, P1204, DOI 10.1212/WNL.48.5.1204; GENEST JJ, 1991, AM J CARDIOL, V67, P1185, DOI 10.1016/0002-9149(91)90924-A; GOLDBOURT U, 1977, AM J EPIDEMIOL, V105, P75, DOI 10.1093/oxfordjournals.aje.a112358; Goldbourt U, 1997, ARTERIOSCL THROM VAS, V17, P107, DOI 10.1161/01.ATV.17.1.107; GORDON DJ, 1989, CIRCULATION, V79, P8, DOI 10.1161/01.CIR.79.1.8; Gorelick PB, 1999, JAMA-J AM MED ASSOC, V281, P1112, DOI 10.1001/jama.281.12.1112; Gorelick PB, 1997, NEUROEPIDEMIOLOGY, V16, P107, DOI 10.1159/000109679; GRUNDY SM, 1993, JAMA-J AM MED ASSOC, V269, P3015, DOI 10.1001/jama.269.23.3015; Hebert PR, 1997, JAMA-J AM MED ASSOC, V278, P313, DOI 10.1001/jama.278.4.313; HEISS G, 1991, AM J EPIDEMIOL, V134, P250, DOI 10.1093/oxfordjournals.aje.a116078; HOWARD G, 1994, STROKE, V25, P2120, DOI 10.1161/01.STR.25.11.2120; ISO H, 1989, NEW ENGL J MED, V320, P904, DOI 10.1056/NEJM198904063201405; Kargman DE, 1998, ATHEROSCLEROSIS, V139, P391, DOI 10.1016/S0021-9150(98)00085-9; KITTNER SJ, 1990, JAMA-J AM MED ASSOC, V264, P1267, DOI 10.1001/jama.264.10.1267; KRONMAL RA, 1993, ARCH INTERN MED, V153, P1065, DOI 10.1001/archinte.153.9.1065; KRUMHOLZ HM, 1994, JAMA-J AM MED ASSOC, V272, P1335, DOI 10.1001/jama.272.17.1335; LINDENSTROM E, 1994, BMJ-BRIT MED J, V309, P11, DOI 10.1136/bmj.309.6946.11; MACKNESS MI, 1993, BIOCHEM J, V294, P829, DOI 10.1042/bj2940829; MENDEZ I, 1987, NEUROLOGY, V37, P507, DOI 10.1212/WNL.37.3.507; MILLER GJ, 1975, LANCET, V1, P16; MURAI A, 1981, STROKE, V12, P167, DOI 10.1161/01.STR.12.2.167; NUBIOLA AR, 1981, ARCH NEUROL-CHICAGO, V38, P468, DOI 10.1001/archneur.1981.00510070102026; OLEARY DH, 1992, STROKE, V23, P1752, DOI 10.1161/01.STR.23.12.1752; Packard CJ, 1998, CIRCULATION, V97, P1440; PEDERSEN TR, 1995, LANCET, V345, P1274; QIZILBASH N, 1991, BRIT MED J, V303, P605, DOI 10.1136/bmj.303.6803.605; Qizilbash N, 1995, LANCET, V346, P1647; QIZILBASH N, 1992, CEREBROVASC DIS, V2, P127, DOI 10.1159/000109004; Robins SJ, 2001, JAMA-J AM MED ASSOC, V285, P1585, DOI 10.1001/jama.285.12.1585; Rosenson RS, 1998, JAMA-J AM MED ASSOC, V279, P1643, DOI 10.1001/jama.279.20.1643; RUBINS HB, 1995, AM J CARDIOL, V75, P1196, DOI 10.1016/S0002-9149(99)80761-9; Rubins HB, 1999, NEW ENGL J MED, V341, P410, DOI 10.1056/NEJM199908053410604; Sacco RL, 1998, STROKE, V29, P380, DOI 10.1161/01.STR.29.2.380; SACCO RL, 1995, STROKE, V26, P14, DOI 10.1161/01.STR.26.1.14; Sacco RL, 1999, JAMA-J AM MED ASSOC, V281, P53, DOI 10.1001/jama.281.1.53; Sacco RL, 1997, STROKE, V28, P929, DOI 10.1161/01.STR.28.5.929; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; SAGIV M, 1994, INT J SPORTS MED, V15, P261, DOI 10.1055/s-2007-1021057; SALONEN R, 1988, ARTERIOSCLEROSIS, V8, P788, DOI 10.1161/01.ATV.8.6.788; SRIDHARAN R, 1992, NEUROEPIDEMIOLOGY, V11, P24, DOI 10.1159/000110903; Tanne David, 1997, Stroke, V28, P250; TASKINEN MR, 1987, AM HEART J, V113, P458, DOI 10.1016/0002-8703(87)90614-4; Tonkin A, 1998, NEW ENGL J MED, V339, P1349; White HD, 2000, NEW ENGL J MED, V343, P317, DOI 10.1056/NEJM200008033430502; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983; WOO J, 1990, STROKE, V21, P1407, DOI 10.1161/01.STR.21.10.1407; WOOD PD, 1988, NEW ENGL J MED, V319, P1173, DOI 10.1056/NEJM198811033191801; YAARI S, 1981, LANCET, V1, P1011; ZIMETBAUM P, 1992, ARTERIOSCLER THROMB, V12, P416, DOI 10.1161/01.ATV.12.4.416	61	211	223	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 6	2001	285	21					2729	2735		10.1001/jama.285.21.2729	http://dx.doi.org/10.1001/jama.285.21.2729			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	437HG	11386928	Bronze			2022-12-24	WOS:000168985800025
J	Liu, T; DeCostanzo, AJ; Liu, XX; Wang, HY; Hallagan, S; Moon, RT; Malbon, CC				Liu, T; DeCostanzo, AJ; Liu, XX; Wang, HY; Hallagan, S; Moon, RT; Malbon, CC			G protein signaling from activated rat Frizzled-1 to the beta-catenin-Lef-Tcf pathway	SCIENCE			English	Article							F9 TERATOCARCINOMA CELLS; ADRENERGIC RECEPTORS; WNT; DIFFERENTIATION; MEMBER; FAMILY; XWNT-8	The frizzled receptors, which mediate development and display seven hydrophobic, membrane-spanning segments, are cell membrane-localized. We constructed a chimeric receptor with the ligand-binding and transmembrane segments from the beta (2)-adrenergic receptor (beta (2)AR) and the cytoplasmic domains from rat Frizzled-1 (Rfz1). Stimulation of mouse F9 clones expressing the chimera (beta (2)AR-Rfz1) with the beta -adrenergic agonist isoproterenol stimulated stabilization of beta -catenin, activation. of a beta -catenin-sensitive promoter, and formation of primitive endoderm. The response was blocked by inactivation of pertussis toxin-sensitive, heterotrimeric guanine nucleotide-binding proteins (G proteins) and by depletion of G alphaq and G alphao. Thus, G proteins are elements of Wnt/Frizzled-1 signaling to the beta -catenin-lymphoid-enhancer factor (LEF)-T cell factor (Tcf) pathway.	SUNY Stony Brook, Univ Med Ctr, Dept Mol Pharmacol, Stony Brook, NY 11794 USA; SUNY Stony Brook, Univ Med Ctr, Dept Physiol, Diabet & Metab Dis Res Ctr, Stony Brook, NY 11794 USA; Univ Washington, Sch Med, Howard Hughes Med Inst, Dept Pharmacol, Seattle, WA 98195 USA; Univ Washington, Sch Med, Ctr Dev Biol, Seattle, WA 98195 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Stony Brook University Hospital; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Stony Brook University Hospital; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Malbon, CC (corresponding author), SUNY Stony Brook, Univ Med Ctr, Dept Mol Pharmacol, Stony Brook, NY 11794 USA.		malbon, craig/ABF-3604-2020; Moon, Randall/M-5605-2019; Moon, Randall T/B-1743-2014	Moon, Randall/0000-0002-9352-1408; Moon, Randall T/0000-0002-9352-1408				Bao J, UNPUB; Bhanot P, 1996, NATURE, V382, P225, DOI 10.1038/382225a0; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; CHAN SDH, 1992, J BIOL CHEM, V267, P25202; CHRISTIAN JL, 1991, DEVELOPMENT, V111, P1045; He X, 1997, SCIENCE, V275, P1652, DOI 10.1126/science.275.5306.1652; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Liu T, 1999, J BIOL CHEM, V274, P33539, DOI 10.1074/jbc.274.47.33539; Liu XX, 1999, P NATL ACAD SCI USA, V96, P14383, DOI 10.1073/pnas.96.25.14383; MAGUIRE ME, 1976, MOL PHARMACOL, V12, P335; MALBAN CC, UNPUB; MALBON CC, 1980, J BIOL CHEM, V255, P8692; Miller JR, 1999, ONCOGENE, V18, P7860, DOI 10.1038/sj.onc.1203245; MOON RT, 1993, DEVELOPMENT, V119, P97; Polakis P, 2000, GENE DEV, V14, P1837; ROS M, 1988, J BIOL CHEM, V263, P4362; Slusarski DC, 1997, NATURE, V390, P410, DOI 10.1038/37138; WANG HY, 1992, NATURE, V358, P334, DOI 10.1038/358334a0; Wu CL, 2000, DEVELOPMENT, V127, P2773; YangSnyder J, 1996, CURR BIOL, V6, P1302, DOI 10.1016/S0960-9822(02)70716-1	20	203	209	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 1	2001	292	5522					1718	1722		10.1126/science.1060100	http://dx.doi.org/10.1126/science.1060100			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	438AP	11387477				2022-12-24	WOS:000169031800046
J	Natelson, BH				Natelson, BH			Chronic fatigue syndrome	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							RANDOMIZED CONTROLLED TRIAL; COGNITIVE-BEHAVIOR THERAPY; ORTHOSTATIC INTOLERANCE; CEREBROSPINAL-FLUID; MULTIPLE-SCLEROSIS; SUBSTANCE-P; FIBROMYALGIA; DEPRESSION; HYPOTENSION; DEFINITION		Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Neurosci, Chron Fatigue Syndrome Cooperat Res Ctr, Newark, NJ 07103 USA; Vet Affairs Med Ctr, E Orange, NJ USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Natelson, BH (corresponding author), New Jersey Med Sch, Fatigue Res Ctr, 88 Ross St, E Orange, NJ 07018 USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI032246] Funding Source: NIH RePORTER; NIAID NIH HHS [AI32246] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BOUHOLAIGAH I, 1995, JAMA-J AM MED ASSOC, V274, P961, DOI 10.1001/jama.274.12.961; BUCHWALD D, 1994, ARCH INTERN MED, V154, P2049, DOI 10.1001/archinte.154.18.2049; Christodoulou C, 1998, J NEUROL NEUROSUR PS, V64, P431, DOI 10.1136/jnnp.64.4.431; Cook DB, 2001, INT J NEUROSCI, V107, P1, DOI 10.3109/00207450109149754; De Meirleir K, 2000, AM J MED, V108, P99, DOI 10.1016/S0002-9343(99)00300-9; Deale A, 1997, AM J PSYCHIAT, V154, P408; DELUCA J, 1995, J NEUROL NEUROSUR PS, V58, P38, DOI 10.1136/jnnp.58.1.38; DeLuca J, 1997, J NEUROL NEUROSUR PS, V62, P151, DOI 10.1136/jnnp.62.2.151; Evengard B, 1998, PAIN, V78, P153, DOI 10.1016/S0304-3959(98)00134-1; FRIEDBERG F, 1994, CLIN INFECT DIS, V18, pS105, DOI 10.1093/clinids/18.Supplement_1.S105; FRIEDBERG F, 2000, J CHRONIC FATIGUE SY, V5, P149; FUKUDA K, 1994, ANN INTERN MED, V121, P953, DOI 10.7326/0003-4819-121-12-199412150-00009; GOLD D, 1990, JAMA-J AM MED ASSOC, V264, P48, DOI 10.1001/jama.264.1.48; HICKIE I, 1995, PSYCHOL MED, V25, P925, DOI 10.1017/S0033291700037417; HOLMES GP, 1988, ANN INTERN MED, V108, P387, DOI 10.7326/0003-4819-108-3-387; Hotopf M, 1996, J NEUROL NEUROSUR PS, V60, P504, DOI 10.1136/jnnp.60.5.504; Jason LA, 1999, ARCH INTERN MED, V159, P2129, DOI 10.1001/archinte.159.18.2129; Johnson SK, 1996, PSYCHOSOM MED, V58, P50, DOI 10.1097/00006842-199601000-00008; Johnson SK, 1996, J AFFECT DISORDERS, V39, P21, DOI 10.1016/0165-0327(96)00015-8; JOHNSON SK, 1996, J PSYCHIAT RES, V31, P9; KATON W, 1992, ARCH INTERN MED, V152, P1604, DOI 10.1001/archinte.152.8.1604; Komaroff AL, 1996, AM J MED, V101, P281, DOI 10.1016/S0002-9343(96)00174-X; LaManca JJ, 1999, CLIN PHYSIOL, V19, P111; Lange G, 1999, J NEUROL SCI, V171, P3, DOI 10.1016/S0022-510X(99)00243-9; Lerner AM, 1997, INFECT DIS CLIN PRAC, V6, P327; LLOYD AR, 1993, AM J MED, V94, P197, DOI 10.1016/0002-9343(93)90183-P; Natelson BH, 1999, J AFFECT DISORDERS, V53, P179, DOI 10.1016/S0165-0327(98)00118-9; Natelson BH., 1998, FACING FIGHTING FATI; Parker J C, 1993, Arthritis Care Res, V6, P207, DOI 10.1002/art.1790060407; Poole J, 2000, ARCH INTERN MED, V160, P3461, DOI 10.1001/archinte.160.22.3461; Rowe PC, 2001, JAMA-J AM MED ASSOC, V285, P52, DOI 10.1001/jama.285.1.52; RUSSELL IJ, 1994, ARTHRITIS RHEUM-US, V37, P1593, DOI 10.1002/art.1780371106; Schondorf R, 1999, J AUTONOM NERV SYST, V75, P192, DOI 10.1016/S0165-1838(98)00177-5; Scott LV, 1999, FUNCT NEUROL, V14, P3; Sharpe M, 1996, BRIT MED J, V312, P22, DOI 10.1136/bmj.312.7022.22; Stewart JM, 1999, PEDIATRICS, V103, P116, DOI 10.1542/peds.103.1.116; STRAYER DR, 1994, CLIN INFECT DIS, V18, pS88, DOI 10.1093/clinids/18.Supplement_1.S88; Streeten D. H., 1998, J CHRONIC FATIGUE SY, V4, P3, DOI 10.1300/J092v04n01_02; Streeten DHP, 1998, CLIN AUTON RES, V8, P119, DOI 10.1007/BF02267822; STROBER W, 1994, CHRONIC FATIGUE SYND, P207; Thompson D, 1998, AM J PSYCHIAT, V155, P824; vonMikecz A, 1997, ARTHRITIS RHEUM-US, V40, P295; Wessely S, 1999, LANCET, V354, P936, DOI 10.1016/S0140-6736(98)08320-2; Wessely S, 1998, CHRONIC FATIGUE ITS; White PD, 1998, BRIT J PSYCHIAT, V173, P475, DOI 10.1192/bjp.173.6.475; Zhang QW, 1999, CLIN DIAGN LAB IMMUN, V6, P6, DOI 10.1128/CDLI.6.1.6-13.1999; Zhang QW, 2000, CHRONOBIOL INT, V17, P95, DOI 10.1081/CBI-100101035	47	23	26	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 23	2001	285	20					2557	2559		10.1001/jama.285.20.2557	http://dx.doi.org/10.1001/jama.285.20.2557			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	433LY	11368714				2022-12-24	WOS:000168761900002
J	Brown, DWG				Brown, DWG			Foot and mouth disease in human beings	LANCET			English	Editorial Material									Cent Publ Hlth Lab, Enter Resp & Neurol Virus Lab, London NW9 5HT, England	Public Health England	Brown, DWG (corresponding author), Cent Publ Hlth Lab, Enter Resp & Neurol Virus Lab, London NW9 5HT, England.							ARMSTRONG R, 1967, BMJ-BRIT MED J, V4, P529, DOI 10.1136/bmj.4.5578.529; BAUER K, 1997, ARCH VIROL, V13, P95; PILZ W, 1965, ZENTBL BAKTERIOLOG P, V198, P154; SELLERS R F, 1970, Journal of Hygiene, V68, P565; SELLERS RF, 1971, VET REC, V89, P447, DOI 10.1136/vr.89.16.447-a; 1967, LANCET, V1, P961; 2001, CDR WEEKLY      0503, P3	7	4	4	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 12	2001	357	9267					1463	1463		10.1016/S0140-6736(00)04670-5	http://dx.doi.org/10.1016/S0140-6736(00)04670-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	431CL	11377592				2022-12-24	WOS:000168614300004
J	Gillmore, JD; Lovat, LB; Persey, MR; Pepys, MB; Hawkins, PN				Gillmore, JD; Lovat, LB; Persey, MR; Pepys, MB; Hawkins, PN			Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein	LANCET			English	Article							P COMPONENT SCINTIGRAPHY; JUVENILE RHEUMATOID-ARTHRITIS; C-REACTIVE PROTEIN; SYSTEMIC AMYLOIDOSIS; LIVER-TRANSPLANTATION; ALZHEIMER-DISEASE; REGRESSION; DEPOSITS; IMMUNOASSAY; TURNOVER	Background Reactive systemic (AA, secondary) amyloidosis occurs in chronic inflammatory diseases, and most patients present with nephropathy. The amyloid fibrils are derived from the circulating acute-phase reactant serum amyloid A protein (SAA), but the relation between production of fib,il precursor protein, amyloid load, and clinical outcome in AA and other types of amyloidosis is unclear. Methods We studied amyloidotic organ function and survival prospectively for 12-117 months in 80 patients with systemic AA amyloidosis in whom serum SAA concentration was measured monthly and visceral amyloid deposits were assessed annually by serum amyloid P component scintigraphy. Underlying inflammatory diseases were treated as vigorously as possible. Findings Amyloid deposits regressed in 25 of 42 patients whose median SAA values were within the reference range (<10 mg/L) throughout follow-up, and amyloidotic organ function stabilised or improved in 39 of these cases. Outcome varied substantially among patients whose median SAA concentration exceeded 10 mg/L, but amyloid load increased and organ function deteriorated in most of those whose SAA was persistently above 50 mg/L, Estimated survival at 10 years was 90% in patients whose median SAA was under 10 mg/L, and 40% among those whose median SAA exceeded this value (p=0.0009). Interpretation Although isolated amyloid fibrils are stable in vitro, AA amyloid deposits exist in a state of dynamic turnover, and outcome is favourable in AA amyloidosis when the SAA concentration is maintained below 10 mg/L. The potential for amyloid to regress and for the function of amyloidotic organs to recover support therapeutic strategies to decrease the supply of amyloid fibril precursor proteins in amyloidosis generally.	UCL Royal Free & Univ Coll Med Sch, Dept Med, Ctr Amyloidosis & Acute Phase Prot, London NW3 2PF, England	University of London; University College London; UCL Medical School	Gillmore, JD (corresponding author), UCL Royal Free & Univ Coll Med Sch, Dept Med, Ctr Amyloidosis & Acute Phase Prot, Royal Free Campus, London NW3 2PF, England.	j.gillmore@rfc.ucl.ac.uk	Hawkins, Philip N/C-5573-2008; Lovat, Laurence/C-1986-2009	Lovat, Laurence/0000-0003-4542-3915				Akpolat T, 2000, AM J NEPHROL, V20, P68, DOI 10.1159/000013559; Baum J, 1977, ARTHRITIS RHEUM, V20, P253; BERGLUND K, 1993, J RHEUMATOL, V20, P2051; GERTZ MA, 1991, MEDICINE, V70, P246, DOI 10.1097/00005792-199107000-00002; Gillmore JD, 2000, QJM-INT J MED, V93, P269, DOI 10.1093/qjmed/93.5.269; Goldsmith DJA, 1996, NEPHRON, V74, P572, DOI 10.1159/000189454; HAWKINS PN, 1990, CLIN EXP IMMUNOL, V81, P325; HAWKINS PN, 1993, ARTHRITIS RHEUM, V36, P842, DOI 10.1002/art.1780360616; HAWKINS PN, 1988, J EXP MED, V167, P903, DOI 10.1084/jem.167.3.903; HAWKINS PN, 1988, LANCET, V1, P1413; HAWKINS PN, 1990, J CLIN INVEST, V86, P1862, DOI 10.1172/JCI114917; HAWKINS PN, 1993, Q J MED, V86, P365; HAWKINS PN, 1990, NEW ENGL J MED, V323, P508, DOI 10.1056/NEJM199008233230803; HAWKINS PN, 1995, MYELOMA, P477; HAZENBERG BPC, 1994, BAILLIERE CLIN RHEUM, V8, P661, DOI 10.1016/S0950-3579(05)80121-9; HOLMGREN G, 1993, LANCET, V341, P1113, DOI 10.1016/0140-6736(93)93127-M; Husby G, 1998, SCAND J RHEUMATOL, V27, P161, DOI 10.1080/030097498440750; HUTCHINSON WL, 1994, J CLIN INVEST, V94, P1390, DOI 10.1172/JCI117474; Jager PL, 1998, J NUCL MED, V39, P699; Kraul D., 1997, Clinical Chemistry, V43, pS150; Kyle RA, 1997, NEW ENGL J MED, V336, P1202, DOI 10.1056/NEJM199704243361702; Ledue TB, 1998, ANN CLIN BIOCHEM, V35, P745, DOI 10.1177/000456329803500607; Lovat LB, 1998, GUT, V42, P727, DOI 10.1136/gut.42.5.727; MORONI G, 1992, CLIN NEPHROL, V38, P81; Pepys MB, 1999, HORIZONS MED, P397; PEPYS MB, 1996, OXFORD TXB MED, P1512; Poole S, 1998, J IMMUNOL METHODS, V214, P1, DOI 10.1016/S0022-1759(98)00057-X; Rydh A, 1998, EUR J NUCL MED, V25, P709; SAVOLAINEN HA, 1993, J RHEUMATOL, V20, P1201; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; Schnitzer T J, 1977, Arthritis Rheum, V20, P245; Tan SY, 1996, KIDNEY INT, V50, P282, DOI 10.1038/ki.1996.313; TENNENT GA, 1995, P NATL ACAD SCI USA, V92, P4299, DOI 10.1073/pnas.92.10.4299; VIGUSHIN DM, 1994, AMYLOID AMYLOIDOSIS, P685; WILKINS J, 1994, CLIN CHEM, V40, P1284; YAMADA T, 1993, ANN CLIN BIOCHEM, V30, P72, DOI 10.1177/000456329303000112	36	407	432	0	15	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 7	2001	358	9275					24	29		10.1016/S0140-6736(00)05252-1	http://dx.doi.org/10.1016/S0140-6736(00)05252-1			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	449WV	11454373				2022-12-24	WOS:000169710900012
J	Weiss, R				Weiss, R			AIDS: unbeatable 20 years on	LANCET			English	Editorial Material									UCL, Dept Viral Oncol Immunol & Mol Pathol, London W1T 4JF, England	University of London; University College London	Weiss, R (corresponding author), UCL, Dept Viral Oncol Immunol & Mol Pathol, London W1T 4JF, England.	r.weiss@ucl.ac.uk						BARRESINOUSSI F, 1983, SCIENCE, V220, P868, DOI 10.1126/science.6189183; *CDCP, 1981, MMWR-MORBID MORTAL W, V30, P305; *CDCP, 1981, MMWR-MORBID MORTAL W, V30, P250; Cohen Jon, 2001, SHOTS DARK WAYWARD S; GOTTLIEB MS, 1981, NEW ENGL J MED, V305, P1425, DOI 10.1056/NEJM198112103052401; Piot P, 2001, NATURE, V410, P968, DOI 10.1038/35073639	6	6	5	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 30	2001	357	9274					2073	2074		10.1016/S0140-6736(00)05228-4	http://dx.doi.org/10.1016/S0140-6736(00)05228-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	447RQ	11445097				2022-12-24	WOS:000169586600007
J	Brennan, J; Lu, CC; Norris, DP; Rodriguez, TA; Beddington, RSP; Robertson, EJ				Brennan, J; Lu, CC; Norris, DP; Rodriguez, TA; Beddington, RSP; Robertson, EJ			Nodal signalling in the epiblast patterns the early mouse embryo	NATURE			English	Article							ANTERIOR PRIMITIVE ENDODERM; RIGHT ASYMMETRIC EXPRESSION; VISCERAL ENDODERM; TRANSCRIPTION FACTOR; POSTERIOR POLARITY; NEURAL PLATE; GASTRULATION; AXIS; SPECIFICATION; REQUIREMENT	Shortly after implantation the mouse embryo comprises three tissue layers. The founder tissue of the embryo proper, the epiblast, forms a radially symmetric cup of epithelial cells that grows in close apposition to the extra-embryonic ectoderm and the visceral endoderm. This simple cylindrical structure exhibits a distinct molecular pattern along its proximal-distal axis(1). The anterior-posterior axis of the embryo is positioned later by coordinated cell movements that rotate the pre-existing proximal-distal axis(2-5). The transforming growth factor-beta family member Nodal is known to be required for formation of the anterior-posterior axis(6). Here we show that signals from the epiblast are responsible for the initiation of proximal-distal polarity. Nodal acts to promote posterior cell fates in the epiblast and to maintain molecular pattern in the adjacent extra-embryonic ectoderm. Both of these functions are independent of Smad2. Moreover, Nodal signals from the epiblast also pattern the visceral endoderm by activating the Smad2-dependent pathway required for specification of anterior identity in overlying epiblast cells. Our experiments show that proximal-distal and subsequent anterior-posterior polarity of the pregastrulation embryo result from reciprocal cell-cell interactions between the epiblast and the two extra-embryonic tissues.	Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; Natl Inst Med Res, Div Mammalian Dev, London NW7 1AA, England	Harvard University; MRC National Institute for Medical Research	Robertson, EJ (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, 16 Divin Ave, Cambridge, MA 02138 USA.			Brennan, Jane/0000-0003-3222-5485; Rodriguez, Tristan/0000-0002-3415-8493				Acampora D, 1998, DEVELOPMENT, V125, P5091; Adachi H, 1999, GENE DEV, V13, P1589, DOI 10.1101/gad.13.12.1589; ANG SL, 1994, DEVELOPMENT, V120, P2979; Beddington RSP, 1999, CELL, V96, P195, DOI 10.1016/S0092-8674(00)80560-7; Belo JA, 1997, MECH DEVELOP, V68, P45, DOI 10.1016/S0925-4773(97)00125-1; BLUM M, 1992, CELL, V69, P1097, DOI 10.1016/0092-8674(92)90632-M; Collignon J, 1996, NATURE, V381, P155, DOI 10.1038/381155a0; CONLON FL, 1994, DEVELOPMENT, V120, P1919; Ding JX, 1998, NATURE, V395, P702, DOI 10.1038/27215; Gritsman K, 1999, CELL, V97, P121, DOI 10.1016/S0092-8674(00)80720-5; Kimura C, 2000, DEV BIOL, V225, P304, DOI 10.1006/dbio.2000.9835; Kumar A, 2001, J BIOL CHEM, V276, P656, DOI 10.1074/jbc.M004649200; Liu PT, 1999, NAT GENET, V22, P361, DOI 10.1038/11932; Meno C, 1999, MOL CELL, V4, P287, DOI 10.1016/S1097-2765(00)80331-7; Norris DP, 1999, GENE DEV, V13, P1575, DOI 10.1101/gad.13.12.1575; Perea-Gomez A, 1999, DEVELOPMENT, V126, P4499; POIRIER F, 1992, DEVELOPMENT, V115, P143; POIRIER F, 1991, DEVELOPMENT, V113, P1105; Rhinn M, 1998, DEVELOPMENT, V125, P845; ROSNER MH, 1990, NATURE, V345, P686, DOI 10.1038/345686a0; Russ AP, 2000, NATURE, V404, P95, DOI 10.1038/35003601; Saijoh Y, 2000, MOL CELL, V5, P35, DOI 10.1016/S1097-2765(00)80401-3; Schier AF, 2000, NATURE, V403, P385, DOI 10.1038/35000126; Thomas P, 1996, CURR BIOL, V6, P1487, DOI 10.1016/S0960-9822(96)00753-1; Thomas PQ, 1998, DEVELOPMENT, V125, P85; Tremblay KD, 2000, DEVELOPMENT, V127, P3079; Varlet I, 1997, DEVELOPMENT, V124, P1033; Waldrip WR, 1998, CELL, V92, P797, DOI 10.1016/S0092-8674(00)81407-5; Whitman M, 1998, GENE DEV, V12, P2445, DOI 10.1101/gad.12.16.2445; ZHOU XL, 1993, NATURE, V361, P543, DOI 10.1038/361543a0	30	382	399	0	15	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 21	2001	411	6840					965	969		10.1038/35082103	http://dx.doi.org/10.1038/35082103			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	444EN	11418863				2022-12-24	WOS:000169386200049
J	Smetacek, V				Smetacek, V			A watery arms race	NATURE			English	Editorial Material									Alfred Wegener Inst Polar & Marine Res, D-27570 Bremerhaven, Germany	Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research	Smetacek, V (corresponding author), Alfred Wegener Inst Polar & Marine Res, Handelshafen 12, D-27570 Bremerhaven, Germany.							Dawkins R., 1982, pi; MARGULI SL, 2000, ENV EVOLUTION; Raven JA, 1997, LIMNOL OCEANOGR, V42, P198, DOI 10.4319/lo.1997.42.1.0198; Verity PG, 1996, MAR ECOL PROG SER, V130, P277, DOI 10.3354/meps130277	4	148	158	0	44	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 14	2001	411	6839					745	745		10.1038/35081210	http://dx.doi.org/10.1038/35081210			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	441TV	11459035	Bronze			2022-12-24	WOS:000169246400024
J	Grupe, A; Germer, S; Usuka, J; Aud, D; Belknap, JK; Klein, RF; Ahluwalia, MK; Higuchi, R; Peltz, G				Grupe, A; Germer, S; Usuka, J; Aud, D; Belknap, JK; Klein, RF; Ahluwalia, MK; Higuchi, R; Peltz, G			In silico mapping of complex disease-related traits in mice	SCIENCE			English	Article							ALCOHOL PREFERENCE; ALLERGIC-ASTHMA; INBRED MICE; LOCI; MOUSE; GENES; IDENTIFICATION; DISCOVERY; DRINKING; MODELS	Experimental murine genetic models of complex human disease show great potential for understanding human disease pathogenesis. To reduce the time required for analysis of such models from many months down to milliseconds, a computational method for predicting chromosomal regions regulating phenotypic traits and a murine database of single nucleotide polymorphisms were developed. After entry of phenotypic information obtained from inbred mouse strains, the phenotypic and genotypic information is analyzed in silico to predict the chromosomal regions regulating the phenotypic trait.	Roche Biosci, Dept Genet & Genome, Palo Alto, CA 94303 USA; Roche Mol Syst, Alameda, CA 94501 USA; Stanford Univ, Dept Chem, Stanford, CA 94305 USA; Oregon Hlth Sci Univ, Portland, OR 97201 USA; Portland Vet Affairs Med Ctr, Portland, OR 97201 USA	Roche Holding; Roche Holding; Stanford University; Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Portland VA Medical Center; VA Portland Health Care System	Peltz, G (corresponding author), Roche Biosci, Dept Genet & Genome, Palo Alto, CA 94303 USA.				NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000044, R01HG002322] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044659] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P60AA010760] Funding Source: NIH RePORTER; NHGRI NIH HHS [1 R01 HG02322-01, T32HG-00044] Funding Source: Medline; NIAAA NIH HHS [P60 AA010760] Funding Source: Medline; NIAMS NIH HHS [R01 AR044659, R01 AR044659-07] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Beamer WG, 1999, MAMM GENOME, V10, P1043, DOI 10.1007/s003359901159; Belknap JK, 1997, BEHAV GENET, V27, P55, DOI 10.1023/A:1025615409383; Buck KJ, 1997, J NEUROSCI, V17, P3946; Darvasi A, 1998, NAT GENET, V18, P19, DOI 10.1038/ng0198-19; Dwyer-Nield LD, 2000, AM J PHYSIOL-LUNG C, V279, pL326, DOI 10.1152/ajplung.2000.279.2.L326; Ewart SL, 2000, AM J RESP CELL MOL, V23, P537, DOI 10.1165/ajrcmb.23.4.4199; Germer S, 2000, GENOME RES, V10, P258, DOI 10.1101/gr.10.2.258; Karp CL, 2000, NAT IMMUNOL, V1, P221, DOI 10.1038/79759; KLEIN RF, IN PRESS J BONE MINE; Lindblad-Toh K, 2000, NAT GENET, V24, P381, DOI 10.1038/74215; Melo JA, 1996, NAT GENET, V13, P147, DOI 10.1038/ng0696-147; MUCENSKI ML, 1986, MOL CELL BIOL, V6, P4236, DOI 10.1128/MCB.6.12.4236; Nadeau JH, 2000, NAT GENET, V25, P381, DOI 10.1038/78051; Phillips TJ, 1998, MAMM GENOME, V9, P936; PHILLIPS TJ, 1994, ALCOHOL CLIN EXP RES, V18, P931, DOI 10.1111/j.1530-0277.1994.tb00062.x; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Tarantino LM, 1998, ALCOHOL CLIN EXP RES, V22, P1099; Wielowieyski A, 1999, MAMM GENOME, V10, P623, DOI 10.1007/s003359901057; Williams RW, 1998, J NEUROSCI, V18, P138; Zhang YM, 1999, HUM MOL GENET, V8, P601, DOI 10.1093/hmg/8.4.601; Zhou G, 1999, INVEST OPHTH VIS SCI, V40, P817; 1998, JAX NOTES, V475	22	232	247	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 8	2001	292	5523					1915	1918		10.1126/science.1058889	http://dx.doi.org/10.1126/science.1058889			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	440WY	11397946				2022-12-24	WOS:000169200700050
J	Berkley, JA; Mwangi, I; Ngetsa, CJ; Mwarumba, S; Lowe, BS; Marsh, K; Newton, CRJC				Berkley, JA; Mwangi, I; Ngetsa, CJ; Mwarumba, S; Lowe, BS; Marsh, K; Newton, CRJC			Diagnosis of acute bacterial meningitis in children at a district hospital in sub-Saharan Africa	LANCET			English	Article							CEREBRAL MALARIA; REAGENT STRIPS	Background The diagnosis of acute bacterial meningitis in children is difficult in sub-Saharan Africa, because the clinical features overlap with those of other common diseases, and laboratory facilities are inadequate in many areas. We have assessed the value of non-laboratory tests and incomplete laboratory data in diagnosing childhood acute bacterial meningitis in this setting. Methods We prospectively studied 905 children undergoing lumbar puncture at a rural district hospital in Kenya over 1 year. We related microbiological findings and cerebrospinal-fluid (CSF) laboratory measurements to tests that would typically be available at such a hospital. Findings Acute bacterial meningitis was proven in 45 children (5.0% [95% CI 3.7-6.6]) and probable in 26 (2.9% [1.9-4.2]). 21 of the 71 cases of proven or probable acute bacterial meningitis had neither neck stiffness nor turbid CSF. In eight of 45 children with proven disease the CSF leucocyte count was less than 10x10(6)/L or leucocyte counting was not possible because of blood-staining. The presence of either a leucocyte count of 50x10(6)/L or more or a CSF/blood glucose ratio of 0.10 or less detected all but two of the 45 children with proven acute bacterial meningitis; these two samples were grossly blood-stained. Interpretation The diagnosis of childhood acute bacterial meningitis is likely to be missed in a third of cases at district hospitals in sub-Saharan Africa without adequate and reliable laboratory resources. CSF culture facilities are expensive and difficult to maintain, and greater gains could be achieved with facilities for accurate leucocyte counting and glucose measurement.	Ctr GEog Med Res Coast, Kilifi, Kenya; Univ Oxford, John Radcliffe Hosp, Nuffield Dept Med, Ctr Trop Med, Oxford OX3 9DU, England; Inst Child Hlth, Neurosci Unit, London, England	University of Oxford; University of London; University College London	Berkley, JA (corresponding author), Ctr GEog Med Res Coast, POB 230, Kilifi, Kenya.		Newton, Charles/C-6222-2009; Newton, Charles RJC/B-7578-2014; Newton, Charles/V-7872-2019	Newton, Charles RJC/0000-0002-6999-5507; Newton, Charles/0000-0002-6999-5507; Berkley, James/0000-0002-1236-849X				Berkley JA, 1999, QJM-INT J MED, V92, P151, DOI 10.1093/qjmed/92.3.151; BONADIO WA, 1992, PEDIATR INFECT DIS J, V11, P423, DOI 10.1097/00006454-199206000-00001; Bonev V, 1997, LANCET, V349, P287, DOI 10.1016/S0140-6736(05)64902-1; COMMEY JOO, 1994, E AFR MED J, V71, P113; FELGENHAUER K, 1985, J NEUROL, V232, P157, DOI 10.1007/BF00313892; FISHMAN RA, 1992, CEREBROSPINAL FLUID, P183; MARSH K, 1995, NEW ENGL J MED, V332, P1399, DOI 10.1056/NEJM199505253322102; Molyneux E, 1996, LANCET, V348, P1170, DOI 10.1016/S0140-6736(05)65304-4; Molyneux E, 1998, TROP MED INT HEALTH, V3, P610, DOI 10.1046/j.1365-3156.1998.00278.x; MOOSA AA, 1995, LANCET, V345, P1290, DOI 10.1016/S0140-6736(95)90931-1; NEWTON CRJC, 1991, LANCET, V337, P573, DOI 10.1016/0140-6736(91)91638-B; Palmer A, 1999, J TROP PEDIATRICS, V45, P51, DOI 10.1093/tropej/45.1.51; SCHIMDLEY JW, 1981, ANN NEUROL, V9, P81; Snow Robert W., 1994, Afr J Health Sci, V1, P71; *WHO, 1997, WHOCHD986; WRIGHT PW, 1993, PEDIATR INFECT DIS J, V12, P37, DOI 10.1097/00006454-199301000-00009	16	73	76	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 2	2001	357	9270					1753	1757		10.1016/S0140-6736(00)04897-2	http://dx.doi.org/10.1016/S0140-6736(00)04897-2			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	440BN	11403812				2022-12-24	WOS:000169156200013
J	Lecuit, M; Vandormael-Pournin, S; Lefort, J; Huerre, M; Gounon, P; Dupuy, C; Babinet, C; Cossart, P				Lecuit, M; Vandormael-Pournin, S; Lefort, J; Huerre, M; Gounon, P; Dupuy, C; Babinet, C; Cossart, P			A transgenic model for listeriosis: Role of internalin in crossing the intestinal barrier	SCIENCE			English	Article							CELL-ADHESION MOLECULES; E-CADHERIN; TYROSINE KINASE; SURFACE PROTEIN; L-MONOCYTOGENES; RECEPTOR; ENTRY; EXPRESSION; SYSTEM; GASTROENTERITIS	Listeria monocytogenes is responsible for severe food-borne infections, but the mechanisms by which bacteria cross the intestinal barrier are unknown. Listeria monocytogenes expresses a surface protein, internalin, that interacts with a host receptor, E-cadherin, to promote entry into human epithelial cells. Murine E-cadherin, in contrast to guinea pig E-cadherin, does not interact with internalin, excluding the mouse as a model for addressing internalin function in vivo. In guinea pigs and transgenic mice expressing human E-cadherin, internalin was found to mediate invasion of enterocytes and crossing of the intestinal barrier. These results illustrate how relevant animal models for human infections can be generated.	Inst Pasteur, Unite Interact Bacteries Cellules, CNRS, Unite Rech Associee 1960, F-75724 Paris 15, France; Inst Pasteur, Unite Biol Dev, CNRS, Unite Rech Associee 1960, F-75724 Paris, France; Inst Pasteur, Unite Pharmacol Cellulaire, F-75724 Paris 15, France; Inst Pasteur, Unite Histopathol, F-75724 Paris 15, France; Inst Pasteur, Stn Cent Microscopie Electron, F-75724 Paris 15, France	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Cossart, P (corresponding author), Inst Pasteur, Unite Interact Bacteries Cellules, CNRS, Unite Rech Associee 1960, F-75724 Paris 15, France.		Lecuit, Marc/J-4073-2013; Lecuit, Marc/M-4126-2019	Lecuit, Marc/0000-0002-4491-1063; Lecuit, Marc/0000-0002-4491-1063				Aureli P, 2000, NEW ENGL J MED, V342, P1236, DOI 10.1056/NEJM200004273421702; Birchmeier C, 1998, TRENDS CELL BIOL, V8, P404, DOI 10.1016/S0962-8924(98)01359-2; Cossart P, 1998, EMBO J, V17, P3797, DOI 10.1093/emboj/17.14.3797; Dalton CB, 1997, NEW ENGL J MED, V336, P100, DOI 10.1056/NEJM199701093360204; DRAMSI S, 1995, MOL MICROBIOL, V16, P251, DOI 10.1111/j.1365-2958.1995.tb02297.x; FIGARELLABRANGER D, 1995, ACTA NEUROPATHOL, V89, P248; GAILLARD JL, 1991, CELL, V65, P1127, DOI 10.1016/0092-8674(91)90009-N; Hermiston ML, 1996, GENE DEV, V10, P985, DOI 10.1101/gad.10.8.985; Lecuit M, 1999, EMBO J, V18, P3956, DOI 10.1093/emboj/18.14.3956; LORBER B, 1996, CLIN INFECT DIS, V24, P1; Marra A, 1997, INFECT IMMUN, V65, P3412, DOI 10.1128/IAI.65.8.3412-3421.1997; Mayhew TM, 1999, HISTOL HISTOPATHOL, V14, P257, DOI 10.14670/HH-14.257; Mengaud J, 1996, CELL, V84, P923, DOI 10.1016/S0092-8674(00)81070-3; Oldstone MBA, 1999, CELL, V98, P629, DOI 10.1016/S0092-8674(00)80050-1; Pron B, 1998, INFECT IMMUN, V66, P747, DOI 10.1128/IAI.66.2.747-755.1998; RACZ P, 1972, LAB INVEST, V26, P694; REN R, 1990, CELL, V63, P353, DOI 10.1016/0092-8674(90)90168-E; RUBIN LL, 1991, J CELL BIOL, V115, P1725, DOI 10.1083/jcb.115.6.1725; Schulte R, 2000, CELL MICROBIOL, V2, P173, DOI 10.1046/j.1462-5822.2000.00047.x; Shen Y, 2000, CELL, V103, P501, DOI 10.1016/S0092-8674(00)00141-0; SHIMOYAMA Y, 1989, CANCER RES, V49, P2128; Yap AS, 1997, ANNU REV CELL DEV BI, V13, P119, DOI 10.1146/annurev.cellbio.13.1.119	22	448	470	1	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 1	2001	292	5522					1722	1725		10.1126/science.1059852	http://dx.doi.org/10.1126/science.1059852			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	438AP	11387478				2022-12-24	WOS:000169031800047
J	Rizki, A; Lundblad, V				Rizki, A; Lundblad, V			Defects in mismatch repair promote telomerase-independent proliferation	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; HUMAN CANCER; RECOMBINATION; YEAST; MAINTENANCE; SENESCENCE; MUTATIONS; SEQUENCES; REMOVAL; HOMOLOG	Mismatch repair has a central role in maintaining genomic stability by repairing DNA replication errors and inhibiting recombination between non-identical (homeologous) sequences(1,2). Defects in mismatch repair have been linked to certain human cancers, including hereditary non-polyposis colorectal cancer (HNPCC) and sporadic tumours(3-5). A crucial requirement for tumour cell proliferation is the maintenance of telomere length(6), and most tumours achieve this by reactivating telomerase(7). In both yeast and human cells, however, telomerase-independent telomere maintenance can occur as a result of recombination-dependent exchanges between often imperfectly matched telomeric sequences(8-12). Here we show that loss of mismatch-repair function promotes cellular proliferation in the absence of telomerase. Defects in mismatch repair, including mutations that correspond to the same amino-acid changes recovered from HNPCC tumours(13), enhance telomerase-independent survival in both Saccharomyces cerevisiae and a related budding yeast with a degree of telomere sequence homology that is similar to human telomeres. These results indicate that enhanced telomeric recombination in human cells with mismatch-repair defects may contribute to cell immortalization and hence tumorigenesis.	Baylor Coll Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Lundblad, V (corresponding author), Baylor Coll Med, Dept Biochem & Mol Biol, 1 Baylor Plaza, Houston, TX 77030 USA.							ALLSHIRE RC, 1989, NUCLEIC ACIDS RES, V17, P4611, DOI 10.1093/nar/17.12.4611; Datta A, 2000, MOL CELL, V6, P593, DOI 10.1016/S1097-2765(00)00058-7; Dunham MA, 2000, NAT GENET, V26, P447, DOI 10.1038/82586; FISHEL R, 1993, CELL, V75, P1027, DOI 10.1016/0092-8674(93)90546-3; FISHMANLOBELL J, 1992, SCIENCE, V258, P480, DOI 10.1126/science.1411547; Flint J, 1997, HUM MOL GENET, V6, P1305, DOI 10.1093/hmg/6.8.1305; Hahn WC, 1999, NAT MED, V5, P1164, DOI 10.1038/13495; LEACH FS, 1993, CELL, V75, P1215, DOI 10.1016/0092-8674(93)90330-S; Lingner J, 1997, SCIENCE, V276, P561, DOI 10.1126/science.276.5312.561; LUNDBLAD V, 1989, CELL, V57, P633, DOI 10.1016/0092-8674(89)90132-3; LUNDBLAD V, 1993, CELL, V73, P347, DOI 10.1016/0092-8674(93)90234-H; MCEACHERN MJ, 1994, P NATL ACAD SCI USA, V91, P3453, DOI 10.1073/pnas.91.8.3453; McEachern MJ, 1996, GENE DEV, V10, P1822, DOI 10.1101/gad.10.14.1822; MODRICH P, 1994, SCIENCE, V266, P1959, DOI 10.1126/science.7801122; Modrich P, 1996, ANNU REV BIOCHEM, V65, P101, DOI 10.1146/annurev.bi.65.070196.000533; Nakamura TM, 1998, SCIENCE, V282, P493, DOI 10.1126/science.282.5388.493; Nicholson A, 2000, GENETICS, V154, P133; RAYSSIGUIER C, 1989, NATURE, V342, P389; SHAMPAY J, 1984, NATURE, V310, P154, DOI 10.1038/310154a0; Shay JW, 1997, EUR J CANCER, V33, P787, DOI 10.1016/S0959-8049(97)00062-2; Studamire B, 1999, MOL CELL BIOL, V19, P7558; Teng SC, 1999, MOL CELL BIOL, V19, P8083; Tran HT, 1999, MOL CELL BIOL, V19, P2000	23	106	107	0	5	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN	2001	411	6838					713	716		10.1038/35079641	http://dx.doi.org/10.1038/35079641			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439JC	11395777				2022-12-24	WOS:000169112500051
J	Birring, SS; Heartin, E; Williams, TJ; Brightling, CE; Pavord, ID				Birring, SS; Heartin, E; Williams, TJ; Brightling, CE; Pavord, ID			Peak expiratory flow sequence in acute exacerbations of asthma	BRITISH MEDICAL JOURNAL			English	Article							DEEP INHALATION		Gen Hosp Kettering, Dept Resp Med, Kettering NN16 8UZ, Northants, England; Univ Hosp Leicester NHS Trust, Dept Resp Med, Inst Lung Hlth, Leicester LE3 9QP, Leics, England	University Hospitals of Leicester NHS Trust; University of Leicester	Birring, SS (corresponding author), Gen Hosp Kettering, Dept Resp Med, Kettering NN16 8UZ, Northants, England.		Birring, Surinder/GWU-6967-2022	Pavord, Ian/0000-0002-4288-5973; brightling, chris/0000-0002-9345-4903				BURNS CB, 1985, J APPL PHYSIOL, V59, P1590, DOI 10.1152/jappl.1985.59.5.1590; LIM TK, 1987, AM REV RESPIR DIS, V135, P591; PELLEGRINO R, 1990, AM REV RESPIR DIS, V142, P822, DOI 10.1164/ajrccm/142.4.822	3	8	8	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 26	2001	322	7297					1281	1281		10.1136/bmj.322.7297.1281	http://dx.doi.org/10.1136/bmj.322.7297.1281			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	437YW	11375231	Green Submitted, Bronze, Green Published			2022-12-24	WOS:000169027800020
J	DeMaria, CD; Soong, TW; Alseikhan, BA; Alvania, RS; Yue, DT				DeMaria, CD; Soong, TW; Alseikhan, BA; Alvania, RS; Yue, DT			Calmodulin bifurcates the local Ca2+ signal that modulates P/Q-type Ca2+ channels	NATURE			English	Article							PRESYNAPTIC CALCIUM CURRENT; RAT BRAIN-STEM; CA2+-DEPENDENT INACTIVATION; TARGET SEQUENCE; FACILITATION; BINDING; ACTIVATION; DOMAINS; SYNAPSE; SUBUNIT	Acute modulation of P/Q-type (alpha (1A)) calcium channels by neuronal activity-dependent changes in intracellular Ca2+ concentration may contribute to short-term synaptic plasticity(1-3), potentially enriching the neurocomputational capabilities of the brain(4,5). An unconventional mechanism for such channel modulation has been proposed(6,7) in which calmodulin (CaM) may exert two opposing effects on individual channels, initially promoting ('facilitation') and then inhibiting ('inactivation') channel opening. Here we report that such dual regulation arises from surprising Ca2+-transduction capabilities of CaM. First, although facilitation and inactivation are two competing processes, both require Ca2+-CaM binding to a single 'IQ-like' domain on the carboxy tail of alpha (8)(1A); a previously identified 'CBD' CaM-binding site(6,7) has no detectable role. Second, expression of a CaM mutant with impairment of all four of its Ca2+-binding sites (CaM1234) eliminates both forms of modulation. This result confirms that CaM is the Ca2+ sensor for channel regulation, and indicates that CaM may associate with the channel even before local Ca2+ concentration rises. Finally, the bifunctional capability of CaM arises from bifurcation of Ca2+ signalling by the lobes of CaM: Ca2+ binding to the amino-terminal lobe selectively initiates channel inactivation, whereas Ca2+ sensing by the carboxy-terminal lobe induces facilitation. Such lobe-specific detection provides a compact means to decode local Ca2+ signals in two ways, and to separately initiate distinct actions on a single molecular complex.	Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Program Mol & Cellular Syst Physiol, Baltimore, MD 21205 USA; Natl Inst Neurosci, Singapore 308433, Singapore; Natl Univ Singapore, Dept Physiol, Singapore 117548, Singapore	Johns Hopkins University; Johns Hopkins University; National Neuroscience Institute (NNI); National University of Singapore	Yue, DT (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biomed Engn, 720 Rutland Ave, Baltimore, MD 21205 USA.	dyue@bme.jhu.edu		Alvania, Rebecca/0000-0002-3846-0702; Soong, Tuck Wah/0000-0002-0876-0325				Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; Barth A, 1998, J BIOL CHEM, V273, P2174, DOI 10.1074/jbc.273.4.2174; Borst JGG, 1998, J PHYSIOL-LONDON, V513, P149, DOI 10.1111/j.1469-7793.1998.149by.x; CHAO SH, 1984, MOL PHARMACOL, V26, P75; Colecraft HM, 2000, J GEN PHYSIOL, V115, P175, DOI 10.1085/jgp.115.2.175; Cuttle MF, 1998, J PHYSIOL-LONDON, V512, P723, DOI 10.1111/j.1469-7793.1998.723bd.x; Ehlers MD, 1996, CELL, V84, P745, DOI 10.1016/S0092-8674(00)81052-1; Elshorst B, 1999, BIOCHEMISTRY-US, V38, P12320, DOI 10.1021/bi9908235; Erickson MG, 2001, BIOPHYS J, V80, p196A; Fanger CM, 1999, J BIOL CHEM, V274, P5746, DOI 10.1074/jbc.274.9.5746; Forsythe ID, 1998, NEURON, V20, P797, DOI 10.1016/S0896-6273(00)81017-X; HOUDUSSE A, 1995, P NATL ACAD SCI USA, V92, P10644, DOI 10.1073/pnas.92.23.10644; Keen JE, 1999, J NEUROSCI, V19, P8830, DOI 10.1523/JNEUROSCI.19-20-08830.1999; KINCAID RL, 1988, METHOD ENZYMOL, V159, P605; KINK JA, 1990, CELL, V62, P165, DOI 10.1016/0092-8674(90)90250-I; Lee A, 2000, J NEUROSCI, V20, P6830, DOI 10.1523/JNEUROSCI.20-18-06830.2000; Lee A, 1999, NATURE, V399, P155, DOI 10.1038/20194; Mori M, 2000, BIOCHEMISTRY-US, V39, P1316, DOI 10.1021/bi9912600; OHYA Y, 1994, SCIENCE, V263, P963, DOI 10.1126/science.8310294; Patil PG, 1998, NEURON, V20, P1027, DOI 10.1016/S0896-6273(00)80483-3; Peterson BZ, 2000, BIOPHYS J, V78, P1906, DOI 10.1016/S0006-3495(00)76739-7; Peterson BZ, 1999, NEURON, V22, P549, DOI 10.1016/S0896-6273(00)80709-6; PUTKEY JA, 1989, J BIOL CHEM, V264, P12370; Qin N, 1999, P NATL ACAD SCI USA, V96, P2435, DOI 10.1073/pnas.96.5.2435; Rodney GG, 2001, J BIOL CHEM, V276, P2069, DOI 10.1074/jbc.M008891200; Song LS, 1998, J PHYSIOL-LONDON, V512, P677, DOI 10.1111/j.1469-7793.1998.677bd.x; Sutton R, 1999, BAKKEN RES, V1, P401; Tsodyks MV, 1997, P NATL ACAD SCI USA, V94, P719, DOI 10.1073/pnas.94.2.719; Zuhlke RD, 2000, J BIOL CHEM, V275, P21121, DOI 10.1074/jbc.M002986200; Zuhlke RD, 1999, NATURE, V399, P159, DOI 10.1038/20200	30	323	334	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 24	2001	411	6836					484	489		10.1038/35078091	http://dx.doi.org/10.1038/35078091			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	435CB	11373682				2022-12-24	WOS:000168858700051
J	Huelsken, J; Vogel, R; Erdmann, B; Cotsarelis, G; Birchmeier, W				Huelsken, J; Vogel, R; Erdmann, B; Cotsarelis, G; Birchmeier, W			beta-catenin controls hair follicle morphogenesis and stem cell differentiation in the skin	CELL			English	Article							EPITHELIAL-MESENCHYMAL INTERACTIONS; HYPOHIDROTIC ECTODERMAL DYSPLASIA; ANTERIOR-POSTERIOR AXIS; ALPHA-CATENIN; MICE LACKING; FUNCTIONAL INTERACTION; EMBRYONIC HEART; COLON-CARCINOMA; HUMAN HOMOLOG; FEATHER BUDS	beta -Catenin is an essential molecule in Wnt/wingless signaling, which controls decisive steps in embryogenesis. To study the role of beta -catenin in skin development, we introduced a conditional mutation of the gene in the epidermis and hair follicles using Cre/loxP technology. When beta -catenin is mutated during embryogenesis, formation of placodes that generate hair follicles is blocked. We show that beta -catenin is required genetically downstream of tabby/downless and upstream of bmp and shh in placode formation. If beta -catenin is deleted after hair follicles have formed, hair is completely lost after the first hair cycle. Further analysis demonstrates that beta -catenin is essential for fate decisions of skin stem cells: in the absence of beta -catenin, stem cells rail to differentiate into follicular keratinocytes, but instead adopt an epidermal fate.	Max Delbrueck Ctr Mol Med, D-13092 Berlin, Germany; Univ Penn, Dept Dermatol, Philadelphia, PA 19104 USA	Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Pennsylvania	Birchmeier, W (corresponding author), Max Delbrueck Ctr Mol Med, Robert Roessle Str 10, D-13092 Berlin, Germany.	wbirch@mdc-berlin.de	Huelsken, Joerg/AAC-9581-2021	Huelsken, Joerg/0000-0003-3105-9606				Aberle H, 1996, J BIOL CHEM, V271, P1520, DOI 10.1074/jbc.271.3.1520; Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Akiyama M, 2000, J INVEST DERMATOL, V114, P321, DOI 10.1046/j.1523-1747.2000.00857.x; Barker N, 2000, ADV CANCER RES, V77, P1; Barsh G, 1999, NAT GENET, V22, P315, DOI 10.1038/11876; Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Ben-Ze'ev A, 1998, CURR OPIN CELL BIOL, V10, P629, DOI 10.1016/S0955-0674(98)80039-2; Bierkamp C, 1996, DEV BIOL, V180, P780, DOI 10.1006/dbio.1996.0346; Botchkarev VA, 1999, NAT CELL BIOL, V1, P158, DOI 10.1038/11078; Chan EF, 1999, NAT GENET, V21, P410, DOI 10.1038/7747; Chen CWJ, 1997, DEV BIOL, V188, P181, DOI 10.1006/dbio.1997.8643; Chiang C, 1999, DEV BIOL, V205, P1, DOI 10.1006/dbio.1998.9103; Chuong CM, 1996, J INVEST DERMATOL, V107, P639, DOI 10.1111/1523-1747.ep12584254; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; Cotsarelis G, 1999, EXP DERMATOL, V8, P80, DOI 10.1111/j.1600-0625.1999.tb00351.x; Crowe R, 1998, DEVELOPMENT, V125, P767; DasGupta R, 1999, DEVELOPMENT, V126, P4557; Dowling J, 1996, J CELL BIOL, V134, P559, DOI 10.1083/jcb.134.2.559; Dymecki SM, 1996, P NATL ACAD SCI USA, V93, P6191, DOI 10.1073/pnas.93.12.6191; Fuchs E, 2000, CELL, V100, P143, DOI 10.1016/S0092-8674(00)81691-8; Fuchs E, 1995, ANNU REV CELL DEV BI, V11, P123, DOI 10.1146/annurev.cb.11.110195.001011; Fuchs E, 1998, SCIENCE, V279, P514, DOI 10.1126/science.279.5350.514; Gat U, 1998, CELL, V95, P605, DOI 10.1016/S0092-8674(00)81631-1; GU H, 1993, CELL, V73, P1155, DOI 10.1016/0092-8674(93)90644-6; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Headon DJ, 1999, NAT GENET, V22, P370, DOI 10.1038/11943; HEID HW, 1988, DIFFERENTIATION, V37, P137, DOI 10.1111/j.1432-0436.1988.tb00805.x; Huelsken J, 2000, J CELL BIOL, V148, P567, DOI 10.1083/jcb.148.3.567; Hulsken J, 2000, J CELL SCI, V113, P3545; HULSKEN J, 1994, J CELL BIOL, V127, P2061, DOI 10.1083/jcb.127.6.2061; JONES PH, 1993, CELL, V73, P713, DOI 10.1016/0092-8674(93)90251-K; Jung HS, 1998, DEV BIOL, V196, P11, DOI 10.1006/dbio.1998.8850; Kere J, 1996, NAT GENET, V13, P409, DOI 10.1038/ng0895-409; Kishimoto J, 2000, GENE DEV, V14, P1181; Koch PJ, 1997, J CELL BIOL, V137, P1091, DOI 10.1083/jcb.137.5.1091; Kofron M, 1997, DEVELOPMENT, V124, P1553; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; Kratochwil K, 1996, GENE DEV, V10, P1382, DOI 10.1101/gad.10.11.1382; Langbein L, 1999, J BIOL CHEM, V274, P19874, DOI 10.1074/jbc.274.28.19874; Lavker RM, 2000, P NATL ACAD SCI USA, V97, P13473, DOI 10.1073/pnas.250380097; Lyle S, 1998, J CELL SCI, V111, P3179; McGowan KM, 1998, J CELL BIOL, V143, P469, DOI 10.1083/jcb.143.2.469; McGrath JA, 1997, NAT GENET, V17, P240, DOI 10.1038/ng1097-240; McKoy G, 2000, LANCET, V355, P2119, DOI 10.1016/S0140-6736(00)02379-5; Millar SE, 1999, DEV BIOL, V207, P133, DOI 10.1006/dbio.1998.9140; Miller JR, 1997, J CELL BIOL, V139, P229, DOI 10.1083/jcb.139.1.229; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Monreal AW, 1999, NAT GENET, V22, P366, DOI 10.1038/11937; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Nieset JE, 1997, J CELL SCI, V110, P1013; NOCKA K, 1990, EMBO J, V9, P3287, DOI 10.1002/j.1460-2075.1990.tb07528.x; Noramly S, 1999, DEVELOPMENT, V126, P3509; NUSSE R, 1992, CELL, V69, P1073, DOI 10.1016/0092-8674(92)90630-U; Nusse R, 1999, TRENDS GENET, V15, P1, DOI 10.1016/S0168-9525(98)01634-5; Oro AE, 1998, CELL, V95, P575, DOI 10.1016/S0092-8674(00)81624-4; Oshima H, 2001, CELL, V104, P233, DOI 10.1016/S0092-8674(01)00208-2; Palka HL, 1997, J CELL SCI, V110, P2359; Panteleyev AA, 1999, AM J PATHOL, V155, P159, DOI 10.1016/S0002-9440(10)65110-3; Paus R, 1999, J INVEST DERMATOL, V113, P523, DOI 10.1046/j.1523-1747.1999.00740.x; Paus R, 1999, NEW ENGL J MED, V341, P491, DOI 10.1056/NEJM199908123410706; Polakis P, 2000, GENE DEV, V14, P1837; Rubinfeld B, 1997, SCIENCE, V275, P1790, DOI 10.1126/science.275.5307.1790; Rubinfeld B, 1996, SCIENCE, V272, P1023, DOI 10.1126/science.272.5264.1023; Ruiz P, 1996, J CELL BIOL, V135, P215, DOI 10.1083/jcb.135.1.215; Saitoh A, 1998, EXP CELL RES, V243, P150, DOI 10.1006/excr.1998.4152; SNAITH MR, 1995, GENE, V166, P173, DOI 10.1016/0378-1119(95)00579-8; Song HK, 1996, P NATL ACAD SCI USA, V93, P10246, DOI 10.1073/pnas.93.19.10246; Srivastava AK, 1997, P NATL ACAD SCI USA, V94, P13069, DOI 10.1073/pnas.94.24.13069; St-Jacques B, 1998, CURR BIOL, V8, P1058, DOI 10.1016/S0960-9822(98)70443-9; TANDA N, 1995, BIOCHEM BIOPH RES CO, V211, P123, DOI 10.1006/bbrc.1995.1786; Taylor G, 2000, CELL, V102, P451, DOI 10.1016/S0092-8674(00)00050-7; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Thorey IS, 1998, MOL CELL BIOL, V18, P3081, DOI 10.1128/MCB.18.5.3081; TOKSOZ D, 1992, P NATL ACAD SCI USA, V89, P7350, DOI 10.1073/pnas.89.16.7350; TSAI FY, 1994, NATURE, V371, P221, DOI 10.1038/371221a0; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X; VANGENDEREN C, 1994, GENE DEV, V8, P2691, DOI 10.1101/gad.8.22.2691; Vasioukhin V, 2001, CELL, V104, P605, DOI 10.1016/S0092-8674(01)00246-X; Wang JW, 1996, ONCOGENE, V13, P1537; Watt FM, 2000, SCIENCE, V287, P1427, DOI 10.1126/science.287.5457.1427; WEISS MJ, 1995, P NATL ACAD SCI USA, V92, P9623, DOI 10.1073/pnas.92.21.9623; Widelitz RB, 2000, DEV BIOL, V219, P98, DOI 10.1006/dbio.1999.9580; Widelitz RB, 1999, DEVELOPMENT, V126, P2577; Wilson N, 1999, Exp Dermatol, V8, P367; Winter H, 1998, J INVEST DERMATOL, V111, P955, DOI 10.1046/j.1523-1747.1998.00456.x; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539	90	1049	1129	10	110	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 18	2001	105	4					533	545		10.1016/S0092-8674(01)00336-1	http://dx.doi.org/10.1016/S0092-8674(01)00336-1			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	434XG	11371349	Bronze			2022-12-24	WOS:000168840700012
J	Koenig, F; Knittel, J; Stepp, H				Koenig, F; Knittel, J; Stepp, H			Diagnosing cancer in vivo	SCIENCE			English	Article							5-AMINOLEVULINIC ACID; CONFOCAL MICROSCOPE; BLADDER-CARCINOMA; OPTICAL BIOPSY; FLUORESCENCE		Humboldt Univ, Charite Med Sch, Dept Urol, D-1086 Berlin, Germany; Univ Tubingen, Dept Minimally Invas Surg, D-72074 Tubingen, Germany; Univ Munich Grosshadern, Dept Urol, Laser Forschungslab, Munich, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Eberhard Karls University of Tubingen; University of Munich	Koenig, F (corresponding author), Humboldt Univ, Charite Med Sch, Dept Urol, D-1086 Berlin, Germany.	frank.koenig@charite.de	Knittel, Joachim/C-5854-2009; Stepp, Herbert/E-1990-2013					Abulafia O, 1999, Obstet Gynecol Surv, V54, P253, DOI 10.1097/00006254-199904000-00022; Benaron DA, 1997, SCIENCE, V276, P2002, DOI 10.1126/science.276.5321.2002; Bom N, 1998, Eur J Ultrasound, V7, P9, DOI 10.1016/S0929-8266(98)00007-X; DABBS T, 1992, APPL OPTICS, V31, P3030, DOI 10.1364/AO.31.003030; Dickensheets DL, 1996, OPT LETT, V21, P764, DOI 10.1364/OL.21.000764; Dickensheets DL, 1998, J MICROELECTROMECH S, V7, P38, DOI 10.1109/84.661382; Dijkstra J, 1999, INT J CARDIAC IMAG, V15, P513, DOI 10.1023/A:1006334517720; GMITRO AF, 1993, OPT LETT, V18, P565, DOI 10.1364/OL.18.000565; Hamilton PW, 1998, ANAL QUANT CYTOL, V20, P443; Ikeda N, 1998, LUNG CANCER-J IASLC, V19, P161, DOI 10.1016/S0169-5002(97)00095-0; Jichlinski P, 1997, LASER SURG MED, V20, P402, DOI 10.1002/(SICI)1096-9101(1997)20:4<402::AID-LSM5>3.0.CO;2-U; KIEMENEY LALM, 1993, J UROLOGY, V150, P60, DOI 10.1016/S0022-5347(17)35397-1; Knittel J, 2001, OPT COMMUN, V188, P267, DOI 10.1016/S0030-4018(00)01164-0; Koenig F, 1999, BJU INT, V83, P129, DOI 10.1046/j.1464-410X.1999.00917.x; Koenig F, 1999, UROLOGY, V53, P853, DOI 10.1016/S0090-4295(98)00628-1; KORAITIM M, 1995, J UROLOGY, V154, P375, DOI 10.1016/S0022-5347(01)67051-4; Kriegmair M, 1996, J UROLOGY, V155, P105, DOI 10.1016/S0022-5347(01)66559-5; RAJADHYAKSHA M, 1995, J INVEST DERMATOL, V104, P946, DOI 10.1111/1523-1747.ep12606215; Spitzer M, 1998, AM J OBSTET GYNECOL, V179, P544, DOI 10.1016/S0002-9378(98)70393-X; Stepp H, 1995, P SOC PHOTO-OPT INS, V2627, P13, DOI 10.1117/12.228884; Tearney GJ, 1998, OPT LETT, V23, P1152, DOI 10.1364/OL.23.001152; Tearney GJ, 1997, J UROLOGY, V157, P1915, DOI 10.1016/S0022-5347(01)64900-0; Tearney GJ, 1997, SCIENCE, V276, P2037, DOI 10.1126/science.276.5321.2037; Uchida K, 1998, Endoscopy, V30 Suppl 1, pA14, DOI 10.1055/s-2007-1001457	24	57	58	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 18	2001	292	5520					1401	+		10.1126/science.292.5520.1401	http://dx.doi.org/10.1126/science.292.5520.1401			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	435DV	11360991				2022-12-24	WOS:000168862900052
J	Greenspan, D; Canchoia, AJ; MacPhail, LA; Cheikh, B; Greenspan, JS				Greenspan, D; Canchoia, AJ; MacPhail, LA; Cheikh, B; Greenspan, JS			Effect of highly active antiretroviral therapy on frequency of oral warts	LANCET			English	Article							MANIFESTATIONS	To investigate changes in the pattern of oral disease associated with highly active antiretroviral therapy (HAART), we assessed the frequency of these lesions in our clinic over 9 years. We retrospectively studied 1280 patients seen between Jury, 1990, and June, 1999, and related oral findings to medication use, immune function, and viral load. We found significant decreases in oral candidosis, hairy leucoplakia, and Kaposi's sarcoma over time, but no change in the occurrence of aphthous ulcers. There was an increase in salivary-gland disease and a striking Increase in warts: three-fold for patients an antiretroviral therapy and six-fold for those an HAART (p = 0.01). This pattern of oral disease in a referral clinic suggests that an increase in oral warts could be occurring as a complication of HAART.	Univ Calif San Francisco, Dept Stomatol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Oral AIDS Ctr, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Greenspan, D (corresponding author), Univ Calif San Francisco, Dept Stomatol, San Francisco, CA 94143 USA.		Greenspan, John/AAE-9321-2020		NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [P01DE007946] Funding Source: NIH RePORTER; NIDCR NIH HHS [P0 1 DE 07946] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Greenspan D, 1996, LANCET, V348, P729, DOI 10.1016/S0140-6736(96)02308-2; GREENSPAN JS, 1992, ORAL SURG ORAL MED O, V73, P142, DOI 10.1016/0030-4220(92)90185-S; Ledergerber B, 1999, JAMA-J AM MED ASSOC, V282, P2220, DOI 10.1001/jama.282.23.2220; Leigh IM, 1999, J ACQ IMMUN DEF SYND, V21, pS49; Patton LL, 2000, ORAL SURG ORAL MED O, V89, P299, DOI 10.1016/S1079-2104(00)70092-8	5	149	158	0	5	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 5	2001	357	9266					1411	1412		10.1016/S0140-6736(00)04578-5	http://dx.doi.org/10.1016/S0140-6736(00)04578-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	428TW	11356441				2022-12-24	WOS:000168478200015
J	Binder, GK; Griffin, DE				Binder, GK; Griffin, DE			Interferon-gamma-mediated site-specific clearance of alphavirus from CNS neurons	SCIENCE			English	Article							CENTRAL-NERVOUS-SYSTEM; VIRAL-INFECTIONS; VIRUS-INFECTION; EXPRESSION; MICE; NEUROVIRULENCE; ENCEPHALITIS; CYTOKINES; MOUSE	Recovery from viral encephalomyelitis requires immune-mediated noncytolytic clearance from neurons by mechanisms assumed to be the same for all neurons. In alphavirus encephalomyelitis, antibody clears infectious virus from neurons in all regions of the central nervous system (CNS), but CD8 T cells contribute to elimination of viral RNA. To understand the role of T cells in clearance, we infected antibody knockout mice with Sindbis virus. Virus was cleared from spinal cord and brain stem neurons, but not from cortical neurons, and required both CD4 and CD8 T cells. Infection with cytokine-expressing recombinant viruses suggested that T cells used interferon-gamma, but not tumor necrosis factor alpha, in clearing virus and that populations of neurons differ in responsiveness to this effector pathway.	Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Griffin, DE (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA.				NINDS NIH HHS [R01 NS038932] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038932] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BINDER GK, UNPUB; Cheng EHY, 1996, NATURE, V379, P554, DOI 10.1038/379554a0; GRIFFIN DE, 1977, J IMMUNOL, V118, P1070; Guidotti LG, 2000, VIROLOGY, V273, P221, DOI 10.1006/viro.2000.0442; Guidotti LG, 1996, IMMUNITY, V4, P25, DOI 10.1016/S1074-7613(00)80295-2; Guidotti LG, 1999, SCIENCE, V284, P825, DOI 10.1126/science.284.5415.825; JACKSON AC, 1988, LAB INVEST, V58, P503; JOLY E, 1991, SCIENCE, V253, P1283, DOI 10.1126/science.1891717; Kelly J. P., 1991, PRINCIPLES NEURAL SC, P273; Kelly JP., 1991, PRINC NEURAL SCI, V1, P283; Kimura T, 2000, J VIROL, V74, P6117, DOI 10.1128/JVI.74.13.6117-6125.2000; KITAMURA D, 1991, NATURE, V350, P423, DOI 10.1038/350423a0; KUNDIG TM, 1993, J IMMUNOL, V150, P2316; LEVINE B, 1991, SCIENCE, V254, P856, DOI 10.1126/science.1658936; Lin MT, 1998, ADV EXP MED BIOL, V440, P431; McCluskey LP, 2000, J NEUROPATH EXP NEUR, V59, P177, DOI 10.1093/jnen/59.3.177; OLDSTONE MBA, 1986, NATURE, V321, P239, DOI 10.1038/321239a0; PEARCE BD, 1994, J VIROL, V68, P5483, DOI 10.1128/JVI.68.9.5483-5495.1994; RAMSAY AJ, 1993, IMMUNOL TODAY, V14, P155, DOI 10.1016/0167-5699(93)90277-R; Ramshaw IA, 1997, IMMUNOL REV, V159, P119, DOI 10.1111/j.1600-065X.1997.tb01011.x; Schnell L, 1999, EUR J NEUROSCI, V11, P3648, DOI 10.1046/j.1460-9568.1999.00792.x; TUCKER PC, 1991, J VIROL, V65, P1551, DOI 10.1128/JVI.65.3.1551-1557.1991; WESSELINGH SL, 1994, J IMMUNOL, V152, P1289; Will A, 1996, J IMMUNOL, V157, P4576; ZINKERNA.RM, 1974, NATURE, V248, P701, DOI 10.1038/248701a0	25	200	204	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 13	2001	293	5528					303	306		10.1126/science.1059742	http://dx.doi.org/10.1126/science.1059742			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	452TK	11452126				2022-12-24	WOS:000169875200060
J	Bao, SW; Chan, WT; Merzenich, MM				Bao, SW; Chan, WT; Merzenich, MM			Cortical remodelling induced by activity of ventral tegmental dopamine neurons	NATURE			English	Article							AUDITORY-CORTEX; SOMATOSENSORY CORTEX; BASAL FOREBRAIN; CEREBRAL-CORTEX; PLASTICITY; RECEPTORS; SYSTEMS; REORGANIZATION; PREDICTION; INDUCTION	Representations of sensory stimuli in the cerebral cortex can undergo progressive remodelling according to the behavioural importance of the stimuli(1,2). The cortex receives widespread projections from dopamine neurons in the ventral tegmental area (VTA)(3-5), which are activated by new stimuli or unpredicted rewards(6,7), and are believed to provide a reinforcement signal for such learning-related cortical reorganization(8). In the primary auditory cortex (AI) dopamine release has been observed during auditory learning that remodels the sound-frequency representations(9,10). Furthermore, dopamine modulates longterm potentiation(11,12), a putative cellular mechanism underlying plasticity(13). Here we show that stimulating the VTA together with an auditory stimulus of a particular tone increases the cortical area and selectivity of the neural responses to that sound stimulus in AI. Conversely, the AI representations of nearby sound frequencies are selectively decreased. Strong, sharply tuned responses to the paired tones also emerge in a second cortical area, whereas the same stimuli evoke only poor or non-selective responses in this second cortical field in naive animals. In addition, we found that strong long-range coherence of neuronal discharge emerges between AI and this secondary auditory cortical area.	Univ Calif San Francisco, Keck Ctr Integrat Neurosci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Merzenich, MM (corresponding author), Univ Calif San Francisco, Keck Ctr Integrat Neurosci, San Francisco, CA 94143 USA.	merz@phy.ucsf.edu						Bakin JS, 1996, BEHAV NEUROSCI, V110, P905, DOI 10.1037/0735-7044.110.5.905; Bakin JS, 1996, P NATL ACAD SCI USA, V93, P11219, DOI 10.1073/pnas.93.20.11219; Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; DIAMOND DM, 1986, BRAIN RES, V372, P357, DOI 10.1016/0006-8993(86)91144-3; ENGEL AK, 1991, SCIENCE, V252, P1177, DOI 10.1126/science.252.5009.1177; FOOTE SL, 1987, ANNU REV NEUROSCI, V10, P67, DOI 10.1146/annurev.ne.10.030187.000435; Goldsmith SK, 1996, NEUROSCIENCE, V74, P435, DOI 10.1016/0306-4522(96)00132-7; Gurden H, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-22-j0003.2000; HARING JH, 1986, BRAIN RES, V366, P152, DOI 10.1016/0006-8993(86)91290-4; Hollerman JR, 1998, NAT NEUROSCI, V1, P304, DOI 10.1038/1124; JENKINS WM, 1990, J NEUROPHYSIOL, V63, P82, DOI 10.1152/jn.1990.63.1.82; Kilgard MP, 1998, SCIENCE, V279, P1714, DOI 10.1126/science.279.5357.1714; Kilgard MP, 1998, NAT NEUROSCI, V1, P727, DOI 10.1038/3729; LIDOW MS, 1991, NEUROSCIENCE, V40, P657, DOI 10.1016/0306-4522(91)90003-7; Montague PR, 1996, J NEUROSCI, V16, P1936, DOI 10.1523/jneurosci.16-05-01936.1996; Nudo RJ, 1996, SCIENCE, V272, P1791, DOI 10.1126/science.272.5269.1791; OADES RD, 1987, BRAIN RES REV, V12, P117, DOI 10.1016/0165-0173(87)90011-7; Otmakhova NA, 1998, J NEUROSCI, V18, P1270; PANDYA DN, 1982, TRENDS NEUROSCI, V5, P386, DOI 10.1016/0166-2236(82)90219-3; RECANZONE GH, 1993, J NEUROSCI, V13, P87; Rioult-Pedotti MS, 2000, SCIENCE, V290, P533, DOI 10.1126/science.290.5491.533; Sachdev RNS, 1998, J NEUROPHYSIOL, V79, P3216, DOI 10.1152/jn.1998.79.6.3216; Sanes JN, 2000, ANNU REV NEUROSCI, V23, P393, DOI 10.1146/annurev.neuro.23.1.393; Schultz W, 2000, ANNU REV NEUROSCI, V23, P473, DOI 10.1146/annurev.neuro.23.1.473; Singer W, 1999, NEURON, V24, P49, DOI 10.1016/S0896-6273(00)80821-1; Stark H, 1997, J NEUROCHEM, V68, P691; Traub RD, 1996, NATURE, V383, P621, DOI 10.1038/383621a0; TREMBLAY N, 1990, J NEUROPHYSIOL, V64, P1212, DOI 10.1152/jn.1990.64.4.1212; VANESSEN DC, 1992, SCIENCE, V255, P419, DOI 10.1126/science.1734518; ZILLES K, 1990, CEREBRAL CORTEX RAT, P77	30	426	447	0	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 5	2001	412	6842					79	83		10.1038/35083586	http://dx.doi.org/10.1038/35083586			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448TB	11452310				2022-12-24	WOS:000169644900047
J	Koivisto, UM; Hubbard, AL; Mellman, R				Koivisto, UM; Hubbard, AL; Mellman, R			A novel cellular phenotype for familial hypercholesterolemia due to a defect in polarized targeting of LDL receptor	CELL			English	Article							DENSITY-LIPOPROTEIN RECEPTOR; PLASMA-MEMBRANE PROTEINS; MDCK CELLS; EPITHELIAL-CELLS; MONOCLONAL-ANTIBODIES; DOMAIN; GENE; ENDOCYTOSIS; TRAFFICKING; GOLGI	Basolateral targeting of membrane proteins in polarized epithelial cells typically requires cytoplasmic domain sorting signals. In the familial hypercholesterolemia (FH)-Turku LDL receptor allele, a mutation of glycine 823 residue affects the signal required for basolateral targeting in MDCK cells. We show that the mutant receptor is mistargeted to the apical surface in both MDCK and hepatic epithelial cells, resulting in reduced endocytosis of LDL from the basolateral/sinusoidal surface. Consequently, virally encoded mutant receptor fails to mediate cholesterol clearance in LDL receptor-deficient mice, suggesting that a defect in polarized LDL receptor expression in hepatocytes underlies the hypercholesterolemia in patients harboring this allele. This evidence directly links the pathogenesis of a human disease to defects in basolateral targeting signals, providing a genetic confirmation of these signals in maintaining epithelial cell polarity.	Yale Univ, Sch Med, Ludwig Inst Canc Res, Dept Cell Biol, New Haven, CT 06520 USA; Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA	Ludwig Institute for Cancer Research; Yale University; Johns Hopkins University	Mellman, R (corresponding author), Yale Univ, Sch Med, Ludwig Inst Canc Res, Dept Cell Biol, 333 Cedar St,POB 208002, New Haven, CT 06520 USA.				NIDDK NIH HHS [DK44375] Funding Source: Medline; NIGMS NIH HHS [GM28765] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK044375] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ameen NA, 2000, TRAFFIC, V1, P76, DOI 10.1034/j.1600-0854.2000.010111.x; APODACA G, 1994, J CELL BIOL, V125, P67, DOI 10.1083/jcb.125.1.67; BARTLES JR, 1987, J CELL BIOL, V105, P1241, DOI 10.1083/jcb.105.3.1241; BEISIEGEL U, 1981, J BIOL CHEM, V256, P1923; Bonifacino JS, 1999, J CELL BIOL, V145, P923, DOI 10.1083/jcb.145.5.923; Charron AJ, 2000, J CELL BIOL, V149, P111, DOI 10.1083/jcb.149.1.111; DAVIS CG, 1986, CELL, V45, P15, DOI 10.1016/0092-8674(86)90533-7; DAVIS CG, 1987, J BIOL CHEM, V262, P4075; Diaz E, 1998, CELL, V93, P433, DOI 10.1016/S0092-8674(00)81171-X; Drubin DG, 1996, CELL, V84, P335, DOI 10.1016/S0092-8674(00)81278-7; Folsch H, 1999, CELL, V99, P189, DOI 10.1016/S0092-8674(00)81650-5; Folsch H, 2001, J CELL BIOL, V152, P595, DOI 10.1083/jcb.152.3.595; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; HERZ J, 1993, P NATL ACAD SCI USA, V90, P2812, DOI 10.1073/pnas.90.7.2812; Hobbs Helen H., 1992, Human Mutation, V1, P445, DOI 10.1002/humu.1380010602; HUETTINGER M, 1984, J CLIN INVEST, V74, P1017, DOI 10.1172/JCI111469; HUNZIKER W, 1991, CELL, V66, P907, DOI 10.1016/0092-8674(91)90437-4; Ihrke G, 1998, J CELL BIOL, V141, P115, DOI 10.1083/jcb.141.1.115; IHRKE G, 1993, J CELL BIOL, V123, P1761, DOI 10.1083/jcb.123.6.1761; ISHIBASHI S, 1993, J CLIN INVEST, V92, P883, DOI 10.1172/JCI116663; Keller P, 1997, J CELL SCI, V110, P3001; Kipp H, 2000, J BIOL CHEM, V275, P15917, DOI 10.1074/jbc.M909875199; KNIGHT A, 1995, MOL BIOL CELL, V6, P597, DOI 10.1091/mbc.6.5.597; KOIVISTO UM, 1995, AM J HUM GENET, V57, P789; Kroschewski R, 1999, NAT CELL BIOL, V1, P8, DOI 10.1038/8977; Marmorstein AD, 2000, P NATL ACAD SCI USA, V97, P3248, DOI 10.1073/pnas.070049497; MATTER K, 1994, CURR OPIN CELL BIOL, V6, P545, DOI 10.1016/0955-0674(94)90075-2; MATTER K, 1993, CELL, V74, P1053, DOI 10.1016/0092-8674(93)90727-8; MATTER K, 1994, J CELL BIOL, V126, P991, DOI 10.1083/jcb.126.4.991; MATTER K, 1992, CELL, V71, P741, DOI 10.1016/0092-8674(92)90551-M; MOSTOV K, 1992, J CELL BIOL, V116, P577, DOI 10.1083/jcb.116.3.577; MOSTOV KE, 1994, ANNU REV IMMUNOL, V12, P63, DOI 10.1146/annurev.immunol.12.1.63; Moyer BD, 1999, J CLIN INVEST, V104, P1353, DOI 10.1172/JCI7453; Ohno H, 1999, FEBS LETT, V449, P215, DOI 10.1016/S0014-5793(99)00432-9; Powell-Braxton L, 1998, NAT MED, V4, P934, DOI 10.1038/nm0898-934; Sheff DR, 1999, J CELL BIOL, V145, P123, DOI 10.1083/jcb.145.1.123; Tuma PL, 1999, J CELL BIOL, V145, P1089, DOI 10.1083/jcb.145.5.1089; VANDRIEL IR, 1987, J BIOL CHEM, V262, P17443; Wan L, 1998, CELL, V94, P205, DOI 10.1016/S0092-8674(00)81420-8; YOKODE M, 1992, J CELL BIOL, V117, P39, DOI 10.1083/jcb.117.1.39; Yu Q, 2000, J CLIN INVEST, V105, P741, DOI 10.1172/JCI7997	41	76	78	1	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 1	2001	105	5					575	585		10.1016/S0092-8674(01)00371-3	http://dx.doi.org/10.1016/S0092-8674(01)00371-3			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	439NL	11389828	Bronze			2022-12-24	WOS:000169123200005
J	Esch, HE; Zhang, SW; Srinivasan, MV; Tautz, J				Esch, HE; Zhang, SW; Srinivasan, MV; Tautz, J			Honeybee dances communicate distances measured by optic flow	NATURE			English	Article								In honeybees, employed foragers recruit unemployed hive mates to food sources by dances from which a human observer can read the distance and direction of the food source(1). When foragers collect food in a short, narrow tunnel, they dance as if the food source were much farther away. Dancers gauge distance by retinal image flow on the way to their destination. Their visually driven odometer misreads distance because the close tunnel walls increase optic flow(2). We examined how hive mates interpret these dances. Here we show that recruited bees search outside in the direction of the tunnel at exaggerated distances and not inside the tunnel where the foragers come from. Thus, dances must convey information about the direction of the food source and the total amount of image motion en route to the food source, but they do not convey information about absolute distances. We also found that perceived distances on various outdoor routes from the same hive could be considerably different. Navigational errors are avoided as recruits and dancers tend to fly in the same direction. Reported racial differences in honeybee dances(1) could have arisen merely from differences in the environments in which these bees flew.	Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA; Australian Natl Univ, Res Sch Biol Sci, Ctr Visual Sci, Canberra, ACT 2601, Australia; Univ Wurzburg, Biozentrum, D-97074 Wurzburg, Germany	University of Notre Dame; Australian National University; University of Wurzburg	Esch, HE (corresponding author), Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA.		Srinivasan, Mandyam V/G-5571-2010; Zhang, Shaowu/C-9139-2009	Zhang, Shaowu/0000-0002-3551-5587				Esch HE, 1996, J EXP BIOL, V199, P155; HERAN H, 1959, Z VERGL PHYSIOL, V42, P103, DOI 10.1007/BF00298733; Srinivasan MV, 2000, SCIENCE, V287, P851, DOI 10.1126/science.287.5454.851; von Frisch K, 1969, DANCE LANGUAGE ORIEN	4	184	190	1	71	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 31	2001	411	6837					581	583		10.1038/35079072	http://dx.doi.org/10.1038/35079072			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437GE	11385571				2022-12-24	WOS:000168982500050
J	Nemergut, ME; Mizzen, CA; Stukenberg, T; Allis, CD; Macara, IG				Nemergut, ME; Mizzen, CA; Stukenberg, T; Allis, CD; Macara, IG			Chromatin docking and exchange activity enhancement of RCC1 by histones H2A and H2B	SCIENCE			English	Article							XENOPUS EGG EXTRACTS; DNA-REPLICATION; RAN; NUCLEOPLASMIN; CYTOPLASM; RANGAP1; MITOSIS; PROTEIN; GTPASE	The Ran guanosine triphosphatase (GTPase) controls nucleocytoplasmic transport, mitotic spindle formation, and nuclear envelope assembly. These functions rely on the association of the Ran-specific exchange factor, RCC1 (regulator of chromosome condensation 1), with chromatin. We find that RCC1 binds directly to mononucleosomes and to histones H2A and H2B. RCC1 utilizes these histones to bind Xenopus sperm chromatin, and the binding of RCC1 to nucleosomes or histones stimulates the catalytic activity-of RCC1, We propose that the docking of RCC1 to H2A/H2B establishes the polarity of the Ran-CTP gradient that drives nuclear envelope assembly, nuclear transport, and other nuclear events.	Univ Virginia, Ctr Cell Signaling, Charlottesville, VA 22908 USA; Univ Virginia, Dept Microbiol, Charlottesville, VA 22908 USA; Univ Virginia, Dept Pharmacol, Charlottesville, VA 22908 USA; Univ Virginia, Dept Biochem, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia; University of Virginia; University of Virginia	Nemergut, ME (corresponding author), Univ Virginia, Ctr Cell Signaling, Hosp W RM 7191,POB 800577 HSC, Charlottesville, VA 22908 USA.			Stukenberg, Todd/0000-0002-6788-2111; Nemergut, Michael/0000-0002-6803-1765	NIGMS NIH HHS [GM-50526] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050526] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BISCHOFF FR, 1994, P NATL ACAD SCI USA, V91, P2587, DOI 10.1073/pnas.91.7.2587; Cheung P, 2000, CELL, V103, P263, DOI 10.1016/S0092-8674(00)00118-5; DASSO M, 1992, MOL CELL BIOL, V12, P3337, DOI 10.1128/MCB.12.8.3337; Dasso M, 2001, CELL, V104, P321, DOI 10.1016/S0092-8674(01)00218-5; de la Barre AE, 2000, EMBO J, V19, P379, DOI 10.1093/emboj/19.3.379; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Hetzer M, 2000, MOL CELL, V5, P1013, DOI 10.1016/S1097-2765(00)80266-X; Karantza V, 1996, BIOCHEMISTRY-US, V35, P2037, DOI 10.1021/bi9518858; KLEBE C, 1995, BIOCHEMISTRY-US, V34, P12543, DOI 10.1021/bi00039a008; KLEBE C, 1995, BIOCHEMISTRY-US, V34, P639, DOI 10.1021/bi00002a031; Leno GH, 1998, METHOD CELL BIOL, V53, P497; Mizzen CA, 1999, METHOD ENZYMOL, V304, P675; MURRAY AW, 1991, METHOD CELL BIOL, V36, P581; Nemergut ME, 2000, J CELL BIOL, V149, P835, DOI 10.1083/jcb.149.4.835; NEMERGUT ME, UNPUB; PHILPOTT A, 1992, CELL, V69, P759, DOI 10.1016/0092-8674(92)90288-N; PHILPOTT A, 1991, CELL, V65, P569, DOI 10.1016/0092-8674(91)90089-H; RICH G, 1995, VENEREOLOGY, V8, P270; SEINO H, 1992, J CELL SCI, V102, P393; Zhang CM, 2000, SCIENCE, V288, P1429, DOI 10.1126/science.288.5470.1429	20	180	186	1	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 25	2001	292	5521					1540	1543		10.1126/science.292.5521.1540	http://dx.doi.org/10.1126/science.292.5521.1540			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YQ	11375490				2022-12-24	WOS:000168963800043
J	Ohki, I; Shimotake, N; Fujita, N; Jee, JG; Ikegami, T; Nakao, M; Shirakawa, M				Ohki, I; Shimotake, N; Fujita, N; Jee, JG; Ikegami, T; Nakao, M; Shirakawa, M			Solution structure of the methyl-CpG binding domain of human MBD1 in complex with methylated DNA	CELL			English	Article							TRANSCRIPTIONAL REPRESSOR MECP2; HISTONE DEACETYLASE COMPLEX; RETT-SYNDROME MUTATIONS; PROTEIN MBD1; ASSOCIATION; NUCLEOSOME; GENE; NMR; METHYLTRANSFERASE; CHROMATIN	In vertebrates, the biological consequences of DNA methylation are often mediated by protein factors containing conserved methyl-CpG binding domains (MBDs). Mutations in the MBD protein MeCP2 cause the neurodevelopmental disease Rett syndrome. We report here the solution structure of the MBD of the human methylation-dependent transcriptional regulator MBD1 bound to methylated BRA. DNA binding causes a loop in MBD1 to fold into a major and novel DNA binding interface. Recognition of the methyl groups and CG sequence at the methylation site is due to five highly conserved residues that form a hydrophobic patch. The structure indicates how MBD may access nucleosomal DNA without encountering steric interference from core histones, and provides a basis to interpret mutations linked to Rett syndrome in MeCP2.	Nara Inst Sci & Technol, Grad Sch Biol Sci, Nara 6300101, Japan; Yokohama City Univ, Grad Sch Integrated Sci, Kanagawa 2300045, Japan; Kumamoto Univ, Sch Med, Dept Tumor Genet & Biol, Kumamoto 8600811, Japan	Nara Institute of Science & Technology; Yokohama City University; Kumamoto University	Shirakawa, M (corresponding author), Nara Inst Sci & Technol, Grad Sch Biol Sci, 8916-5 Takayama, Nara 6300101, Japan.		Ikegami, Takahisa/I-9626-2017; Ohki, Izuru/C-7883-2013; Ohki, Izuru/O-4816-2019	Ikegami, Takahisa/0000-0002-1429-1844; Ohki, Izuru/0000-0002-0667-5936				Allen MD, 1998, EMBO J, V17, P5484, DOI 10.1093/emboj/17.18.5484; Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Ballabio A, 1992, CURR OPIN GENET DEV, V2, P439, DOI 10.1016/S0959-437X(05)80155-8; Ballestar E, 2000, BIOCHEMISTRY-US, V39, P7100, DOI 10.1021/bi0001271; Ballestar E, 2001, EUR J BIOCHEM, V268, P1, DOI 10.1046/j.1432-1327.2001.01869.x; Baylin SB, 1998, ADV CANCER RES, V72, P141; Bird AP, 1999, CELL, V99, P451, DOI 10.1016/S0092-8674(00)81532-9; BRUENGER AT, 1993, XPLOR 3 1 SYSTEM XRA; Cavanagh J., 1996, PROTEIN NMR SPECTROS; Chandler SP, 1999, BIOCHEMISTRY-US, V38, P7008, DOI 10.1021/bi990224y; Chen RZ, 1998, NATURE, V395, P89, DOI 10.1038/25779; Connolly KM, 2000, J MOL BIOL, V300, P841, DOI 10.1006/jmbi.2000.3888; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Costello JF, 2000, NAT GENET, V24, P132, DOI 10.1038/72785; Cross SH, 1997, NAT GENET, V16, P256, DOI 10.1038/ng0797-256; Dragich J, 2000, HUM MOL GENET, V9, P2365, DOI 10.1093/hmg/9.16.2365; Free A, 2001, J BIOL CHEM, V276, P3353, DOI 10.1074/jbc.M007224200; Fujita N, 2000, MOL CELL BIOL, V20, P5107, DOI 10.1128/MCB.20.14.5107-5118.2000; Fujita N, 1999, MOL CELL BIOL, V19, P6415; Guschin D, 1998, BIOCHEMISTRY-US, V37, P8629, DOI 10.1021/bi9805846; Hendrich B, 1998, MOL CELL BIOL, V18, P6538, DOI 10.1128/MCB.18.11.6538; Hendrich B, 1999, NATURE, V401, P301, DOI 10.1038/45843; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Jones S, 1999, J MOL BIOL, V287, P877, DOI 10.1006/jmbi.1999.2659; Katoh E, 1999, J AM CHEM SOC, V121, P2607, DOI 10.1021/ja984041v; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lee KM, 1998, BIOCHEMISTRY-US, V37, P8622, DOI 10.1021/bi980499y; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; MEEHAN RR, 1989, CELL, V69, P905; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Ng HH, 2000, MOL CELL BIOL, V20, P1394, DOI 10.1128/MCB.20.4.1394-1406.2000; Ng HH, 1999, NAT GENET, V23, P58, DOI 10.1038/12659; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Ohki I, 1999, EMBO J, V18, P6653, DOI 10.1093/emboj/18.23.6653; Omichinski JG, 1997, NAT STRUCT BIOL, V4, P122, DOI 10.1038/nsb0297-122; Robertson KD, 2000, NAT REV GENET, V1, P11, DOI 10.1038/35049533; Surani MA, 1998, CELL, V93, P309, DOI 10.1016/S0092-8674(00)81156-3; SUTCLIFFE JS, 1994, NAT GENET, V8, P52, DOI 10.1038/ng0994-52; Van den Veyver IB, 2000, CURR OPIN GENET DEV, V10, P275, DOI 10.1016/S0959-437X(00)00083-6; VUISTER GW, 1998, BIOL MAGN RESON, P195; Wade PA, 1999, NAT GENET, V23, P62, DOI 10.1038/12664; Wakefield RID, 1999, J MOL BIOL, V291, P1055, DOI 10.1006/jmbi.1999.3023; Wojciak JM, 1999, NAT STRUCT BIOL, V6, P366; Xu GL, 1999, NATURE, V402, P187, DOI 10.1038/46052; YAMAZAKI T, 1995, J AM CHEM SOC, V117, P3556, DOI 10.1021/ja00117a025; Yusufzai TM, 2000, NUCLEIC ACIDS RES, V28, P4172, DOI 10.1093/nar/28.21.4172; Zhang Y, 1999, GENE DEV, V13, P1924, DOI 10.1101/gad.13.15.1924	48	238	249	2	26	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 18	2001	105	4					487	497		10.1016/S0092-8674(01)00324-5	http://dx.doi.org/10.1016/S0092-8674(01)00324-5			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	434XG	11371345	Bronze			2022-12-24	WOS:000168840700008
J	Turner, BL; Haygarth, PM				Turner, BL; Haygarth, PM			Biogeochemistry - Phosphorus solubilization in rewetted soils	NATURE			English	Article									Inst Grassland & Environm Res, Soil Sci Grp, Okehampton EX20 2SB, Devon, England		Turner, BL (corresponding author), ARS, USDA, NW Irrigat & Soils Res Lab, Kimberly, ID 83341 USA.		Haygarth, Philip Matthew/F-6790-2014; Turner, Benjamin L/E-5940-2011	Turner, Benjamin L/0000-0002-6585-0722				BIRCH H. F., 1960, Plant and Soil, V12, P81, DOI 10.1007/BF01377763; BROOKES PC, 1982, SOIL BIOL BIOCHEM, V14, P319, DOI 10.1016/0038-0717(82)90001-3; HOUGHTON JT, 1992, CLIMATE CHANGE IPCC; Pote DH, 1999, J ENVIRON QUAL, V28, P170, DOI 10.2134/jeq1999.00472425002800010020x; SALEMA MP, 1982, SOIL BIOL BIOCHEM, V14, P15, DOI 10.1016/0038-0717(82)90071-2; Turner BL, 2000, SOIL SCI SOC AM J, V64, P1090, DOI 10.2136/sssaj2000.6431090x	6	309	326	12	165	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 17	2001	411	6835					258	258		10.1038/35077146	http://dx.doi.org/10.1038/35077146			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432RT	11357117				2022-12-24	WOS:000168710000032
J	Sam, M; Vora, S; Malnic, B; Ma, WD; Novotny, MV; Buck, LB				Sam, M; Vora, S; Malnic, B; Ma, WD; Novotny, MV; Buck, LB			Neuropharmacology - Odorants may arouse instinctive behaviours	NATURE			English	Article							NEURONS; ODORS		Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Neurobiol, Boston, MA 02115 USA; Indiana Univ, Dept Chem, Inst Pheromone Res, Bloomington, IN 47405 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Indiana University System; Indiana University Bloomington	Sam, M (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Neurobiol, Boston, MA 02115 USA.	lbuck@hms.harvard.edu	Malnic, Bettina/A-4905-2008	Malnic, Bettina/0000-0002-5877-4784				BINDER BF, 1995, J CHEM ECOL, V21, P1315, DOI 10.1007/BF02027564; Buck LB, 2000, CELL, V100, P611, DOI 10.1016/S0092-8674(00)80698-4; Dobson HEM, 1996, AM J BOT, V83, P877, DOI 10.2307/2446264; HALPERN M, 1987, ANNU REV NEUROSCI, V10, P325, DOI 10.1146/annurev.ne.10.030187.001545; Kielty JP, 1996, J INSECT BEHAV, V9, P237, DOI 10.1007/BF02213868; Leinders-Zufall T, 2000, NATURE, V405, P792, DOI 10.1038/35015572; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; NOVOTNY M, 1990, CHEM SIGNAL, V5, P1; SATO T, 1994, J NEUROPHYSIOL, V72, P2980, DOI 10.1152/jn.1994.72.6.2980; Wysocki C.J., 1987, P125	10	182	188	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 12	2001	412	6843					142	142		10.1038/35084137	http://dx.doi.org/10.1038/35084137			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	451AJ	11449261	Bronze			2022-12-24	WOS:000169778700039
J	Yamaguchi, Y; Filipovska, J; Yano, K; Furuya, A; Inukai, N; Narita, T; Wada, T; Sugimoto, S; Konarska, MM; Handa, H				Yamaguchi, Y; Filipovska, J; Yano, K; Furuya, A; Inukai, N; Narita, T; Wada, T; Sugimoto, S; Konarska, MM; Handa, H			Stimulation of RNA polymerase II elongation by hepatitis delta antigen	SCIENCE			English	Article							TRANSCRIPTION ELONGATION; VIRUS; DSIF; REPLICATION; INITIATION; GENOME; SPT4; GENE	Transcription elongation by RNA polymerase II (RNAPII) is negatively regulated by the human factors DRB-sensitivity inducing factor (DSIF) and negative elongation factor (NELF). A 66-kilodalton subunit of NELF (NELF-A) shows limited sequence similarity to hepatitis delta antigen (HDAg), the viral protein required for replication of hepatitis delta virus (HDV). The host RNAPII has been implicated in HDV replication, but the detailed mechanism and the role of HDAg in this process are not understood. We show that HDAg binds RNAPII directly and stimulates transcription by displacing NELF and promoting RNAPII elongation. These results suggest that HDAg may regulate RNAPII elongation during both cellular messenger RNA synthesis and HDV RNA replication.	Tokyo Inst Technol, Frontier Collaborat Res Ctr, Yokohama, Kanagawa 2268503, Japan; Rockefeller Univ, New York, NY 10021 USA; Tokyo Res Labs, Tokyo 1948533, Japan	Tokyo Institute of Technology; Rockefeller University	Handa, H (corresponding author), Tokyo Inst Technol, Frontier Collaborat Res Ctr, 4259 Nagatsuta, Yokohama, Kanagawa 2268503, Japan.	hhanda@bio.titech.ac.jp	Filipovska, Julija/AAI-5306-2021; Konarska, Maria/ABG-6405-2020; Yamaguchi, Yuki/B-9390-2015; Konarska, Maria M./AAT-2572-2021	Yamaguchi, Yuki/0000-0002-0197-614X; Konarska, Maria M./0000-0001-9235-1702				Bichko VV, 1996, J VIROL, V70, P8064, DOI 10.1128/JVI.70.11.8064-8070.1996; Brazas R, 1996, SCIENCE, V274, P90, DOI 10.1126/science.274.5284.90; CASEY JL, 1993, P NATL ACAD SCI USA, V90, P9016, DOI 10.1073/pnas.90.19.9016; CHANG FL, 1991, P NATL ACAD SCI USA, V88, P8490, DOI 10.1073/pnas.88.19.8490; Conaway JW, 2000, TRENDS BIOCHEM SCI, V25, P375, DOI 10.1016/S0968-0004(00)01615-7; Corpet F, 1998, NUCLEIC ACIDS RES, V26, P323, DOI 10.1093/nar/26.1.323; Filipovska J, 2000, RNA, V6, P41, DOI 10.1017/S1355838200991167; Garber ME, 1999, CURR OPIN IMMUNOL, V11, P460, DOI 10.1016/S0952-7915(99)80077-6; Hartzog GA, 1998, GENE DEV, V12, P357, DOI 10.1101/gad.12.3.357; Kim JB, 2001, J BIOL CHEM, V276, P12317, DOI 10.1074/jbc.M010908200; KUO MYP, 1989, J VIROL, V63, P1945, DOI 10.1128/JVI.63.5.1945-1950.1989; LAI MMC, 1995, ANNU REV BIOCHEM, V64, P259, DOI 10.1146/annurev.bi.64.070195.001355; Lo K, 1998, VIROLOGY, V247, P178, DOI 10.1006/viro.1998.9253; Modahl LE, 2000, J VIROL, V74, P7375, DOI 10.1128/JVI.74.16.7375-7380.2000; Robertson HD, 1996, SCIENCE, V274, P66, DOI 10.1126/science.274.5284.66; ROST B, 1993, J MOL BIOL, V232, P584, DOI 10.1006/jmbi.1993.1413; TAYLOR WR, 1986, J THEOR BIOL, V119, P205, DOI 10.1016/S0022-5193(86)80075-3; Wada T, 1998, EMBO J, V17, P7395, DOI 10.1093/emboj/17.24.7395; Wada T, 1998, GENE DEV, V12, P343, DOI 10.1101/gad.12.3.343; Wei Y, 1998, J VIROL, V72, P2089, DOI 10.1128/JVI.72.3.2089-2096.1998; Wright TJ, 1999, GENOMICS, V59, P203, DOI 10.1006/geno.1999.5871; Yamaguchi Y, 1999, CELL, V97, P41, DOI 10.1016/S0092-8674(00)80713-8; Yamaguchi Y, 1998, GENES CELLS, V3, P9, DOI 10.1046/j.1365-2443.1998.00162.x	23	117	122	1	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 6	2001	293	5527					124	127		10.1126/science.1057925	http://dx.doi.org/10.1126/science.1057925			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	451BB	11387440				2022-12-24	WOS:000169780300043
J	Broza, M; Halpern, M				Broza, M; Halpern, M			Pathogen reservoirs - Chironomid egg masses and Vibrio cholerae	NATURE			English	Article							CLIMATE		Univ Haifa, Fac Sci & Sci Educ, Dept Biol, IL-36006 Tivon, Israel	University of Haifa	Broza, M (corresponding author), Univ Haifa, Fac Sci & Sci Educ, Dept Biol, IL-36006 Tivon, Israel.	broza@research.haifa.ac.il	Halpern, Malka/AAH-1498-2019	Halpern, Malka/0000-0002-3407-2198				Armitage P.D., 1995, THE CHIRONOMIDAE; Broza M, 2000, WATER SCI TECHNOL, V42, P71, DOI 10.2166/wst.2000.0293; Colwell Rita R., 1994, P117; Colwell RR, 1996, SCIENCE, V274, P2025, DOI 10.1126/science.274.5295.2025; Colwell RR, 1999, J APPL MICROBIOL, V85, p134S, DOI 10.1111/j.1365-2672.1998.tb05292.x; ECHOLS H, 1961, J MOL BIOL, V3, P425, DOI 10.1016/S0022-2836(61)80055-7; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; Heidelberg JF, 2000, NATURE, V406, P477, DOI 10.1038/35020000; Lewin S. M., 1996, P228; NOLTE U, 1993, ENT SCAND S, V43, P5; ROSZAK DB, 1987, MICROBIOL REV, V51, P365, DOI 10.1128/MMBR.51.3.365-379.1987	11	93	100	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 5	2001	412	6842					40	40		10.1038/35083691	http://dx.doi.org/10.1038/35083691			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448TB	11452294	Bronze			2022-12-24	WOS:000169644900031
J	Corten, GP; Veldkamp, HF				Corten, GP; Veldkamp, HF			Aerodynamics - Insects can halve wind-turbine power	NATURE			English	Article									Energy Ctr Netherlands, Unit Wind Energy, NL-1755 ZG Petten, Netherlands; NEG Micon AS, DK-8900 Randers, Denmark	Vestas Wind Systems	Corten, GP (corresponding author), Energy Ctr Netherlands, Unit Wind Energy, POB 1, NL-1755 ZG Petten, Netherlands.							Bak C., 1999, WIND ENERGY, V2, P195; Corten G. P, 1999, 13 IEA EXP M AER WIN; Corten GP., 2001, THESIS U UTRECHT; DYRMOSE SZ, 1998, DOUBLE STALL PHENOME; Madsen H. A., 1991, AERODYNAMICS HORIZON; Snel H., 1999, PROGR JOULE PROJECT	6	75	83	2	43	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 5	2001	412	6842					41	42		10.1038/35083698	http://dx.doi.org/10.1038/35083698			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448TB	11452297				2022-12-24	WOS:000169644900034
J	Goldie, SJ; Kuhn, L; Denny, L; Pollack, A; Wright, TC				Goldie, SJ; Kuhn, L; Denny, L; Pollack, A; Wright, TC			Policy analysis of cervical cancer screening strategies in low-resource settings - Clinical benefits and cost-effectiveness	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HUMAN-PAPILLOMAVIRUS INFECTION; SQUAMOUS INTRAEPITHELIAL LESIONS; HUMAN-IMMUNODEFICIENCY-VIRUS; NATURAL-HISTORY; HIGH-RISK; HIV-INFECTION; SOUTH-AFRICA; DEVELOPING-COUNTRIES; VISUAL INSPECTION; UTERINE CERVIX	Context Cervical cancer is a leading cause of cancer-related death among women in developing countries. In such low-resource settings, cytology-based screening is difficult to implement, and less complex strategies may offer additional options. Objective To assess the cost-effectiveness of several cervical cancer screening strategies using population-specific data. Design and Setting Cost-effectiveness analysis using a mathematical model and a hypothetical cohort of previously unscreened 30-year-old black South African women. Screening tests included direct visual inspection (DVI) of the cervix, cytologic methods, and testing for high-risk types of human papillomavirus (HPV) DNA, Strategies differed by number of clinical visits, screening frequency, and response to a positive test result. Data sources included a South African screening study, national surveys and fee schedules, and published literature. Main Outcome Measures Years of life saved (YLS), lifetime costs in US dollars, and incremental cost-effectiveness ratios (cost per YLS). Results When analyzing all strategies performed as a single lifetime screen at age 35 years compared with no screening, HPV testing followed by treatment of screen-positive women at a second visit, cost $39/YLS (27% cancer incidence reduction); DVI, coupled with immediate treatment of screen-positive women at the first visit was next most effective (26% cancer incidence reduction) and was cost saving; cytology, followed by treatment of screen-positive women at a second visit was least effective (19% cancer incidence reduction) at a cost of $81/YLS, For any given screening frequency, when strategies were compared incrementally, HPV DNA testing generally was more effective but also more costly than DVI, and always was more effective and less costly than cytology. When comparing all strategies simultaneously across screening frequencies, DVI was the nondominated strategy up to a frequency of every 3 years (incremental cost-effectiveness ratio, $460/YLS), and HPV testing every 3 years (incremental cost-effectiveness ratio, $11 500/YLS) was the most effective strategy. Conclusion Cervical cancer screening strategies that incorporate DVI or HPV DNA testing and eliminate colposcopy may offer attractive alternatives to cytology-based screening programs in low-resource settings.	Harvard Univ, Sch Publ Hlth, Ctr Risk Anal, Dept Hlth Policy & Management, Boston, MA 02115 USA; Univ Cape Town, Dept Obstet & Gynecol, ZA-7925 Cape Town, South Africa; Columbia Univ, Joseph L Mailman Sch Publ Hlth, Div Epidemiol, New York, NY USA; Columbia Univ, Coll Phys & Surg, Gertrude H Sergievsky Ctr, New York, NY USA; EngenderHlth, New York, NY USA; Columbia Univ, Coll Phys & Surg, Dept Pathol, New York, NY USA	Harvard University; Harvard T.H. Chan School of Public Health; University of Cape Town; Columbia University; Columbia University; Columbia University	Goldie, SJ (corresponding author), Harvard Univ, Sch Publ Hlth, Ctr Risk Anal, Dept Hlth Policy & Management, 718 Huntington Ave,Suite 2, Boston, MA 02115 USA.							ANDERSEN ES, 1992, GYNECOL ONCOL, V45, P240, DOI 10.1016/0090-8258(92)90297-V; [Anonymous], 1997, CONFR AIDS PUBL PRIO; Bailie RS, 1996, INT J EPIDEMIOL, V25, P488, DOI 10.1093/ije/25.3.488; BALLEGOOLJEN M, 1992, EUR J CANCER, V28, P1703; *CENTR STAT SERV, 1997, S AFR LIV STAND DEV; *CENTR STAT SERV, 1997, 1994 HOUS SURV; *CENTR STAT SERV, 1997, CONS PRIC IND; Clavel C, 1999, BRIT J CANCER, V80, P1306, DOI 10.1038/sj.bjc.6690523; CREASMAN WT, 1984, OBSTET GYNECOL, V63, P145; Cuzick J, 1999, BRIT J CANCER, V81, P554, DOI 10.1038/sj.bjc.6690730; CUZICK J, 1999, HEALTH TECHNOL ASSES, V3, P1; Denny L, 2000, AM J OBSTET GYNECOL, V183, P383, DOI 10.1067/mob.2000.105871; Denny L, 2000, CANCER-AM CANCER SOC, V89, P826, DOI 10.1002/1097-0142(20000815)89:4&lt;826::AID-CNCR15&gt;3.0.CO;2-5; DENNY L, 2000, THESIS U CAPE TOWN; DORRINGTON R, 1999, ESTIMATES LEVEL SHAP; Ellerbrock TV, 2000, JAMA-J AM MED ASSOC, V283, P1031, DOI 10.1001/jama.283.8.1031; Enger C, 1996, JAMA-J AM MED ASSOC, V275, P1329, DOI 10.1001/jama.275.17.1329; FAHEY MT, 1995, AM J EPIDEMIOL, V141, P680, DOI 10.1093/oxfordjournals.aje.a117485; Freedberg KA, 1998, JAMA-J AM MED ASSOC, V279, P130, DOI 10.1001/jama.279.2.130; Gaffikin L, 1999, LANCET, V353, P869; Gilson L, 1997, LANCET, V350, P1805, DOI 10.1016/S0140-6736(97)08222-6; Gold MR, 1996, COST EFFECTIVENESS H; Goldie SJ, 1999, ANN INTERN MED, V130, P97, DOI 10.7326/0003-4819-130-2-199901190-00003; Grant A D, 1997, AIDS, V11 Suppl B, pS43; Harper DM, 1999, J FAM PRACTICE, V48, P531; Herrero R, 2000, JNCI-J NATL CANCER I, V92, P464, DOI 10.1093/jnci/92.6.464; HILDESHEIM A, 1994, J INFECT DIS, V169, P235, DOI 10.1093/infdis/169.2.235; Hillemanns P, 1999, LANCET, V354, P1970, DOI 10.1016/S0140-6736(99)04110-0; HO GYF, 1995, JNCI-J NATL CANCER I, V87, P1365, DOI 10.1093/jnci/87.18.1365; Ho GYF, 1998, NEW ENGL J MED, V338, P423, DOI 10.1056/NEJM199802123380703; Holowaty P, 1999, JNCI-J NATL CANCER I, V91, P252, DOI 10.1093/jnci/91.3.252; *INT AG RES CANC, 1995, IARC MON EV CARC RIS, V64; Jenkins D, 1996, INT J CANCER, V65, P768; Kitchener HC, 1999, LANCET, V353, P856, DOI 10.1016/S0140-6736(98)00417-6; KOUTSKY LA, 1992, NEW ENGL J MED, V327, P1272, DOI 10.1056/NEJM199210293271804; Kuhn L, 2000, JNCI-J NATL CANCER I, V92, P818, DOI 10.1093/jnci/92.10.818; Londesborough P, 1996, INT J CANCER, V69, P364; LONGINI IM, 1989, STAT MED, V8, P831, DOI 10.1002/sim.4780080708; LOPEZ A, 2001, LIFETABLES 191 COUNT; Mandelblatt JS, 1997, J GEN INTERN MED, V12, P551, DOI 10.1046/j.1525-1497.1997.07107.x; MATHERS C, 2001, 16 WHO GLOB PROGR EV; MCCRORY D, 1999, AHCPR PUB; *MED ASS S AFR, 1999, 1999 GUID FEES MED S; Mitchell MF, 1998, OBSTET GYNECOL, V92, P737, DOI 10.1097/00006250-199811000-00001; Moscicki AB, 1998, J PEDIATR-US, V132, P277, DOI 10.1016/S0022-3476(98)70445-7; Myers ER, 2000, AM J EPIDEMIOL, V151, P1158, DOI 10.1093/oxfordjournals.aje.a010166; Nanda K, 2000, ANN INTERN MED, V132, P810, DOI 10.7326/0003-4819-132-10-200005160-00009; Nene BM, 1996, INT J CANCER, V68, P770, DOI 10.1002/(SICI)1097-0215(19961211)68:6<770::AID-IJC14>3.0.CO;2-4; Nobbenhuis MAE, 1999, LANCET, V354, P20, DOI 10.1016/S0140-6736(98)12490-X; OLATUNBOSUN OA, 1992, INT J GYNECOL OBSTET, V38, P305, DOI 10.1016/0020-7292(92)91023-H; OSTOR AG, 1993, INT J GYNECOL PATHOL, V12, P186; Palefsky JM, 1999, JNCI-J NATL CANCER I, V91, P226, DOI 10.1093/jnci/91.3.226; Parkin DM, 1999, INT J CANCER, V80, P827, DOI 10.1002/(SICI)1097-0215(19990315)80:6&lt;827::AID-IJC6&gt;3.0.CO;2-P; Parkin DM, 1999, AIDS, V13, P2563, DOI 10.1097/00002030-199912240-00010; Pecorelli S, 1999, INT J GYNECOL OBSTET, V65, P243, DOI 10.1016/S0020-7292(99)00070-3; Peters DH, 2000, B WORLD HEALTH ORGAN, V78, P761; PETTERSSON F, 1985, INT J EPIDEMIOL, V14, P521, DOI 10.1093/ije/14.4.521; Pisani P, 1999, INT J CANCER, V83, P18, DOI 10.1002/(SICI)1097-0215(19990924)83:1&lt;18::AID-IJC5&gt;3.0.CO;2-M; PONTEN J, 1995, INT J CANCER, V60, P1, DOI 10.1002/ijc.2910600102; REMMINK AJ, 1995, INT J CANCER, V61, P306, DOI 10.1002/ijc.2910610305; ROGO KO, 1990, INT J GYNECOL OBSTET, V33, P249, DOI 10.1016/0020-7292(90)90010-I; Rozendaal L, 1996, INT J CANCER, V68, P766, DOI 10.1002/(SICI)1097-0215(19961211)68:6<766::AID-IJC13>3.0.CO;2-Z; Sankaranarayanan R, 1998, IARC Sci Publ, P135; Sankaranarayanan R, 1998, CANCER-AM CANCER SOC, V83, P2150, DOI 10.1002/(SICI)1097-0142(19981115)83:10<2150::AID-CNCR13>3.3.CO;2-S; SCHIFFMAN M, 2000, JAMA-J AM MED ASSOC, V28, P2525; Sellors JW, 2000, CAN MED ASSOC J, V163, P513; Serwadda D, 1999, J INFECT DIS, V180, P1316, DOI 10.1086/315026; SherlawJohnson C, 1997, INT J CANCER, V72, P210, DOI 10.1002/(SICI)1097-0215(19970717)72:2&lt;210::AID-IJC2&gt;3.0.CO;2-U; Sitas F, 1997, BRIT J CANCER, V75, P1704, DOI 10.1038/bjc.1997.290; SITAS F, 1994, S AFR MED J, V84, P344; SOLOMON D, 1989, JAMA-J AM MED ASSOC, V262, P931; Sun XW, 1997, NEW ENGL J MED, V337, P1343, DOI 10.1056/NEJM199711063371903; SYRJANEN K, 1992, OBSTET GYNECOL, V79, P675; *U CAP TOWN, 1993, COST COMP STUD SEV M; *US DHHS, 2001, CANC STAT REV; Wallin KL, 1999, NEW ENGL J MED, V341, P1633, DOI 10.1056/NEJM199911253412201; Womack SD, 2000, INT J CANCER, V85, P206, DOI 10.1002/(SICI)1097-0215(20000115)85:2%3C206::AID-; *WORLD BANK AIDS E, 2000, PUBL PRIOR GLOB EP C; Wright TC, 2000, JAMA-J AM MED ASSOC, V283, P81, DOI 10.1001/jama.283.1.81	79	229	242	0	19	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 27	2001	285	24					3107	3115		10.1001/jama.285.24.3107	http://dx.doi.org/10.1001/jama.285.24.3107			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	444FF	11427139	Bronze			2022-12-24	WOS:000169388900024
J	Galarreta, M; Hestrin, S				Galarreta, M; Hestrin, S			Spike transmission and synchrony detection in networks of GABAergic interneurons	SCIENCE			English	Article							CAT VISUAL-CORTEX; LAYER-V NEURONS; SOMATOSENSORY CORTEX; PYRAMIDAL NEURONS; NEOCORTICAL NEURONS; PRINCIPAL NEURONS; CORTICAL-NEURONS; RAT HIPPOCAMPUS; SYNAPSES; RECEPTORS	The temporal pattern and relative timing of action potentials among neocortical neurons may carry important information. However, how cortical circuits detect or generate coherent activity remains unclear. Using paired recordings in rat neocortical slices, we found that the firing of fast-spiking cells can reflect the spiking pattern of single-axon pyramidal inputs. Moreover, this property allowed groups of fast-spiking cells interconnected by electrical and gamma -aminobutyric acid (GABA)-releasing (GABAergic) synapses to detect the relative timing of their excitatory inputs. These results indicate that networks of fast-spiking cells may play a role in the detection and promotion of synchronous activity within the neocortex.	Stanford Univ, Sch Med, Dept Comparat Med, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA	Stanford University; Stanford University	Galarreta, M (corresponding author), Stanford Univ, Sch Med, Dept Comparat Med, Stanford, CA 94305 USA.		Hestrin, Shaul/F-4410-2010		NEI NIH HHS [EY09120, EY12114] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY009120, R01EY012114] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Angulo MC, 1999, J NEUROPHYSIOL, V82, P1295, DOI 10.1152/jn.1999.82.3.1295; Azouz R, 2000, P NATL ACAD SCI USA, V97, P8110, DOI 10.1073/pnas.130200797; Buhl EH, 1997, J PHYSIOL-LONDON, V500, P689, DOI 10.1113/jphysiol.1997.sp022053; BUZSAKI G, 1995, CURR OPIN NEUROBIOL, V5, P504, DOI 10.1016/0959-4388(95)80012-3; Chow A, 1999, J NEUROSCI, V19, P9332; COPE TC, 1987, J PHYSIOL-LONDON, V390, P161, DOI 10.1113/jphysiol.1987.sp016692; Csicsvari J, 1998, NEURON, V21, P179, DOI 10.1016/S0896-6273(00)80525-5; Fricker D, 2000, NEURON, V28, P559, DOI 10.1016/S0896-6273(00)00133-1; Galarreta M, 1998, NAT NEUROSCI, V1, P587, DOI 10.1038/2822; Galarreta M, 1999, NATURE, V402, P72, DOI 10.1038/47029; Geiger JRP, 1997, NEURON, V18, P1009, DOI 10.1016/S0896-6273(00)80339-6; GEIGER JRP, 1995, NEURON, V15, P193, DOI 10.1016/0896-6273(95)90076-4; Gibson JR, 1999, NATURE, V402, P75, DOI 10.1038/47035; GRAY CM, 1989, P NATL ACAD SCI USA, V86, P1698, DOI 10.1073/pnas.86.5.1698; Gupta A, 2000, SCIENCE, V287, P273, DOI 10.1126/science.287.5451.273; Jefferys JGR, 1996, TRENDS NEUROSCI, V19, P202, DOI 10.1016/S0166-2236(96)10023-0; Jones MS, 2000, J NEUROPHYSIOL, V84, P1505, DOI 10.1152/jn.2000.84.3.1505; Kawaguchi Y, 1997, CEREB CORTEX, V7, P476, DOI 10.1093/cercor/7.6.476; Lambolez B, 1996, P NATL ACAD SCI USA, V93, P1797, DOI 10.1073/pnas.93.5.1797; MAINEN ZF, 1995, SCIENCE, V268, P1503, DOI 10.1126/science.7770778; Martina M, 1997, J PHYSIOL-LONDON, V505, P593, DOI 10.1111/j.1469-7793.1997.593ba.x; Martina M, 1998, J NEUROSCI, V18, P8111; Martina M, 2000, SCIENCE, V287, P295, DOI 10.1126/science.287.5451.295; MILES R, 1990, J PHYSIOL-LONDON, V428, P61, DOI 10.1113/jphysiol.1990.sp018200; Reyes A, 1998, NAT NEUROSCI, V1, P279, DOI 10.1038/1092; Shadlen MN, 1998, J NEUROSCI, V18, P3870; Singer W, 1999, NEURON, V24, P49, DOI 10.1016/S0896-6273(00)80821-1; STAFSTROM CE, 1984, J NEUROPHYSIOL, V52, P244, DOI 10.1152/jn.1984.52.2.244; STAFSTROM CE, 1985, J NEUROPHYSIOL, V53, P153, DOI 10.1152/jn.1985.53.1.153; Steinmetz PN, 2000, NATURE, V404, P187, DOI 10.1038/35004588; STUART G, 1995, NEURON, V15, P1065, DOI 10.1016/0896-6273(95)90095-0; Swadlow HA, 1998, J NEUROPHYSIOL, V79, P567, DOI 10.1152/jn.1998.79.2.567; Tamas G, 2000, NAT NEUROSCI, V3, P366, DOI 10.1038/73936; Tamas G, 1997, J PHYSIOL-LONDON, V500, P715, DOI 10.1113/jphysiol.1997.sp022054; Tamas G, 1998, J NEUROSCI, V18, P4255; THOMSON AM, 1988, J NEUROPHYSIOL, V60, P1896, DOI 10.1152/jn.1988.60.6.1896; Thomson AM, 1996, J PHYSIOL-LONDON, V496, P81, DOI 10.1113/jphysiol.1996.sp021667; Timofeev I, 2001, P NATL ACAD SCI USA, V98, P1924, DOI 10.1073/pnas.041430398; VAADIA E, 1995, NATURE, V373, P515, DOI 10.1038/373515a0; Venance L, 2000, P NATL ACAD SCI USA, V97, P10260, DOI 10.1073/pnas.160037097	40	287	290	1	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 22	2001	292	5525					2295	2299		10.1126/science.1061395	http://dx.doi.org/10.1126/science.1061395			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	445KD	11423653				2022-12-24	WOS:000169455900047
J	Hampe, J; Cuthbert, A; Croucher, PJP; Mirza, MM; Mascheretti, S; Fisher, S; Frenzel, H; King, K; Hasselmeyer, A; MacPherson, AJS; Bridger, S; van Deventer, S; Forbes, A; Nikolaus, S; Lennard-Jones, JE; Foelsch, UR; Krawczak, M; Lewis, C; Schreiber, S; Mathew, CG				Hampe, J; Cuthbert, A; Croucher, PJP; Mirza, MM; Mascheretti, S; Fisher, S; Frenzel, H; King, K; Hasselmeyer, A; MacPherson, AJS; Bridger, S; van Deventer, S; Forbes, A; Nikolaus, S; Lennard-Jones, JE; Foelsch, UR; Krawczak, M; Lewis, C; Schreiber, S; Mathew, CG			Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations	LANCET			English	Article							INFLAMMATORY-BOWEL-DISEASE; LARGE EUROPEAN COHORT; FACTOR KAPPA-B; SUPPORTS LINKAGE; CHROMOSOME-16; ACTIVATION; FAMILIES; COLITIS; LOCUS; CELLS	Background Genetic predisposition to inflammatory bowel disease (IBD) has been shown by epidemiological and linkage studies. Genetic linkage of IBD to chromosome 16 has been previously observed and replicated in independent populations. The recently identified NOD2 gene is a good positional and functional candidate gene since it is located in the region of linkage on chromosome 16q12, and activates nuclear factor (NF) KB in response to bacterial lipopolysaccharides. Methods We sequenced the coding region of the NOD2 gene and genotyped an insertion polymorphism affecting the leucine-rich region of the protein product in 512 individuals with IBD from 309 German or British families, 369 German trios (ie, German patients with sporadic IBD and their unaffected parents), and 272 normal controls. We then tested for association with Crohn's disease and ulcerative colitis. Findings Family-based association analyses were consistently positive in 95 British and 99 German affected sibling pairs with Crohn's disease (combined p<0.0001); the association was confirmed in the 304 German trios with Crohn's disease. No association was seen in the 115 sibling pairs and 65 trios with ulcerative colitis. The genotype-specific disease risks conferred by heterozygous and homozygous mutant genotypes were 2.6 (95% CI 1.5-4.5)and 42.1(4.3-<infinity>), respectively. Interpretation The insertion mutation in the NOD2 gene confers a substantially increased susceptibility to Crohn's disease but not to ulcerative colitis.	Univ Kiel, Dept Gen Internal Med, Kiel, Germany; Guys Kings & St Thomas Sch Med, Div Med & Mol Genet, London, England; Guys Kings & St Thomas Sch Med, Div Med, London, England; AMC Amsterdam, Dept Gastroenterol, Amsterdam, Netherlands; St Marks Hosp, Harrow, Middx, England; Cardiff Univ, Inst Med Genet, Cardiff CF4 4XN, S Glam, Wales	University of Kiel; University of London; King's College London; University of London; King's College London; University of Amsterdam; Academic Medical Center Amsterdam; Imperial College London; Cardiff University	Schreiber, S (corresponding author), Univ Kiel, Dept Med 1, Schittenhelmstr 12, D-24105 Kiel, Germany.	S.Schreiber@mucosa.de	Mathew, Christopher G/G-3434-2015; Lewis, Cathryn M/A-5225-2010; Lewis, Cathryn/M-8766-2019; Hampe, Jochen/A-2555-2010; Krawczak, Michael/A-8964-2010	Mathew, Christopher G/0000-0003-4178-1838; Lewis, Cathryn M/0000-0002-8249-8476; Lewis, Cathryn/0000-0002-8249-8476; Hampe, Jochen/0000-0002-2421-6127; Krawczak, Michael/0000-0003-2603-1502; Forbes, Alastair/0000-0001-7416-9843	MRC [G9800001] Funding Source: UKRI; Medical Research Council [G9800001] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Annese V, 1999, EUR J HUM GENET, V7, P567, DOI 10.1038/sj.ejhg.5200328; Brant SR, 1998, GASTROENTEROLOGY, V115, P1056, DOI 10.1016/S0016-5085(98)70073-3; Cavanaugh J, 2001, AM J HUM GENET, V68, P1165, DOI 10.1086/320119; Clayton D, 1999, AM J HUM GENET, V65, P1170, DOI 10.1086/302577; Clayton D, 1999, AM J HUM GENET, V65, P1161, DOI 10.1086/302566; Curran ME, 1998, GASTROENTEROLOGY, V115, P1066, DOI 10.1016/S0016-5085(98)70075-7; Fleiss J. L., 1981, STAT METHODS RATES P, V2; Hampe J, 1999, AM J HUM GENET, V64, P808, DOI 10.1086/302294; Hampe J, 1998, INT J COLORECTAL DIS, V13, P260, DOI 10.1007/s003840050173; HAMPE J, IN PRESS BIOINFORMAT; HENNEKENS CH, 1987, EPIDEMIOLOGY MED, P77; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Hugot JP, 1996, NATURE, V379, P821, DOI 10.1038/379821a0; Inohara N, 2000, J BIOL CHEM, V275, P27823; INOHARA N, 2000, J BIOL CHEM, V31, P31; LENNARDJONES JE, 1989, SCAND J GASTROENTERO, V24, P2, DOI 10.3109/00365528909091339; Neurath MF, 1996, NAT MED, V2, P998, DOI 10.1038/nm0996-998; Nikolaus S, 2000, LANCET, V356, P1475, DOI 10.1016/S0140-6736(00)02871-3; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Ogura Y, 2001, J BIOL CHEM, V276, P4812, DOI 10.1074/jbc.M008072200; Olavesen MG, 2000, IMMUNOGENETICS, V51, P1, DOI 10.1007/s002510050001; ORHOLM M, 1991, NEW ENGL J MED, V324, P84, DOI 10.1056/NEJM199101103240203; Rogler G, 1998, GASTROENTEROLOGY, V115, P357, DOI 10.1016/S0016-5085(98)70202-1; Schreiber S, 1998, GUT, V42, P477, DOI 10.1136/gut.42.4.477; SCHREIBER S, 1991, GASTROENTEROLOGY, V101, P1020, DOI 10.1016/0016-5085(91)90729-5; Shivananda S, 1996, GUT, V39, P690, DOI 10.1136/gut.39.5.690; Targan SR, 1997, NEW ENGL J MED, V337, P1029, DOI 10.1056/NEJM199710093371502; Thompson NP, 1996, BRIT MED J, V312, P95; TRUELOVE SC, 1976, GUT, V17, P192, DOI 10.1136/gut.17.3.192; TYSK C, 1988, GUT, V29, P990, DOI 10.1136/gut.29.7.990	30	905	947	2	30	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 16	2001	357	9272					1925	1928		10.1016/S0140-6736(00)05063-7	http://dx.doi.org/10.1016/S0140-6736(00)05063-7			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	444YZ	11425413				2022-12-24	WOS:000169431000011
J	Tranel, D				Tranel, D			Combs, ducks, and the brain	LANCET			English	Editorial Material							RETRIEVAL; NOUNS; VERBS; SYSTEMS; KNOWLEDGE		Univ Iowa Hosp & Clin, Dept Neurol, Div Behav Neurol & Cognit Neurosci, Iowa City, IA 52242 USA	University of Iowa	Tranel, D (corresponding author), Univ Iowa Hosp & Clin, Dept Neurol, Div Behav Neurol & Cognit Neurosci, Iowa City, IA 52242 USA.			Tranel, Daniel/0000-0002-1338-1389				CARAMAZZA A, 1991, NATURE, V349, P788, DOI 10.1038/349788a0; Caramazza A, 1998, J COGNITIVE NEUROSCI, V10, P1, DOI 10.1162/089892998563752; DAMASIO AR, 1993, P NATL ACAD SCI USA, V90, P4957, DOI 10.1073/pnas.90.11.4957; Damasio H, 2001, NEUROIMAGE, V13, P1053, DOI 10.1006/nimg.2001.0775; Federmeier KD, 2000, BRAIN, V123, P2552, DOI 10.1093/brain/123.12.2552; GOODGLASS H, 1994, NEUROPSYCHOLOGY, V8, P598, DOI DOI 10.1037/0894-4105.8.4.598; HILLIS AE, 1995, J COGNITIVE NEUROSCI, V7, P396, DOI 10.1162/jocn.1995.7.3.396; HUMPHREYS GW, IN PRESS BEHAV BRAIN; James LE, 2000, J EXP PSYCHOL LEARN, V26, P1378, DOI 10.1037//0278-7393.26.6.1378; MCCARTHY R, 1985, NEUROPSYCHOLOGIA, V23, P709, DOI 10.1016/0028-3932(85)90079-X; Pulvermuller F, 1999, CEREB CORTEX, V9, P497, DOI 10.1093/cercor/9.5.497; TRANEL D, 1991, BRAIN COGNITION, V15, P187, DOI 10.1016/0278-2626(91)90025-4; Tranel D, 1997, NEUROPSYCHOLOGIA, V35, P1319, DOI 10.1016/S0028-3932(97)00085-7; TRANEL D, IN PRESS COGN NEUROP; WARRINGTON EK, 1994, NEUROPSYCHOLOGIA, V32, P1465, DOI 10.1016/0028-3932(94)90118-X; ZINGESER LB, 1990, BRAIN LANG, V39, P14, DOI 10.1016/0093-934X(90)90002-X	16	7	7	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 9	2001	357	9271					1818	1819		10.1016/S0140-6736(00)05010-8	http://dx.doi.org/10.1016/S0140-6736(00)05010-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	440DN	11410186				2022-12-24	WOS:000169160800006
J	Walter, LC; Covinsky, KE				Walter, LC; Covinsky, KE			Cancer screening in elderly patients - A framework for individualized decision making	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							FECAL-OCCULT-BLOOD; QUALITY-OF-LIFE; CARCINOMA IN-SITU; BREAST-CANCER; COLORECTAL-CANCER; COST-EFFECTIVENESS; CONTROLLED TRIAL; CERVICAL-CANCER; OLDER WOMEN; FOLLOW-UP	Considerable uncertainty exists about the use of cancer screening tests in older people, as illustrated by the different age cutoffs recommended by various guideline panels. We suggest that a framework to guide individualized cancer screening decisions in older patients may be more useful to the practicing clinician than age guidelines, Like many medical decisions, cancer screening decisions require weighing quantitative information, such as risk of cancer death and likelihood of beneficial and adverse screening outcomes, as well as qualitative factors, such as individual patients' values and preferences, Our framework first anchors decisions through quantitative estimates of life expectancy, risk of cancer death, and screening outcomes based on published data. Potential benefits of screening are presented as the number needed to screen to prevent 1 cancer-specific death, based on the estimated life expectancy during which a patient will be screened. Estimates reveal substantial variability in the likelihood of benefit for patients of similar ages with varying life expectancies. In fact, patients with life expectancies of less than 5 years are unlikely to derive any survival benefit from cancer screening. We also consider the likelihood of potential harm from screening according to patient factors and test characteristics. Some of the greatest harms of screening occur by detecting cancers that would never have become clinically significant. This becomes more likely as life expectancy decreases. Finally, since many cancer screening decisions in older adults cannot be answered solely by quantitative estimates of benefits and harms, considering the estimated outcomes according to the patient's own values and preferences is the final step for making informed screening decisions.	Vet Affairs Med Ctr, Div Geriatr, San Francisco, CA 94121 USA; Univ Calif San Francisco, San Francisco, CA 94143 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California San Francisco	Walter, LC (corresponding author), Vet Affairs Med Ctr, Div Geriatr, 111G,4150 Clement St, San Francisco, CA 94121 USA.				AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K02HS000006] Funding Source: NIH RePORTER; AHRQ HHS [K02HS00006-01] Funding Source: Medline; PHS HHS [T-32] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Barratt A, 1999, JAMA-J AM MED ASSOC, V281, P2029, DOI 10.1001/jama.281.21.2029; Bennahum DA, 1997, CLIN GERIATR MED, V13, P33; Bergstrom R, 1999, BRIT J CANCER, V81, P159, DOI 10.1038/sj.bjc.6690666; Bogardus ST, 1999, JAMA-J AM MED ASSOC, V281, P1037, DOI 10.1001/jama.281.11.1037; CASSEL CK, 1992, J GERONTOL, V47, P126; COSTANZA ME, 1994, CANCER-AM CANCER SOC, V74, P2046, DOI 10.1002/1097-0142(19941001)74:7+<2046::AID-CNCR2820741710>3.0.CO;2-U; Covinsky KE, 1997, J GEN INTERN MED, V12, P203, DOI 10.1007/s11606-006-5041-5; Cruickshank ME, 1997, BRIT J OBSTET GYNAEC, V104, P586, DOI 10.1111/j.1471-0528.1997.tb11537.x; Degner LF, 1997, JAMA-J AM MED ASSOC, V277, P1485, DOI 10.1001/jama.277.18.1485; DIXON JM, 1988, BRIT J SURG, V75, P918, DOI 10.1002/bjs.1800750931; EDDY DM, 1990, JAMA-J AM MED ASSOC, V263, P2493, DOI 10.1001/jama.263.18.2493; EDDY DM, 1990, ANN INTERN MED, V113, P214, DOI 10.7326/0003-4819-113-3-214; Ernster VL, 1996, JAMA-J AM MED ASSOC, V275, P913, DOI 10.1001/jama.275.12.913; Essink-Bot ML, 1998, J NATL CANCER I, V90, P925, DOI 10.1093/jnci/90.12.925; EUSEBI V, 1989, SEMIN DIAGN PATHOL, V6, P165; FISCHHOFF B, 1999, MONOGR NAT CANC I, V25, P7; Fonseca R, 1997, ANN INTERN MED, V127, P1013, DOI 10.7326/0003-4819-127-11-199712010-00013; Fried LP, 1998, JAMA-J AM MED ASSOC, V279, P585, DOI 10.1001/jama.279.8.585; Gonzales R, 1999, JAMA-J AM MED ASSOC, V281, P1512, DOI 10.1001/jama.281.16.1512; Hardcastle JD, 1996, LANCET, V348, P1472, DOI 10.1016/S0140-6736(96)03386-7; HARRIS R, 1995, ANN INTERN MED, V122, P539, DOI 10.7326/0003-4819-122-7-199504010-00011; HUGHES JE, 1987, CANCER SURV, V6, P455; Inouye SK, 1998, JAMA-J AM MED ASSOC, V279, P1187, DOI 10.1001/jama.279.15.1187; Kerlikowske K, 2000, ANN INTERN MED, V133, P855, DOI 10.7326/0003-4819-133-11-200012050-00009; Kerlikowske K, 1999, JAMA-J AM MED ASSOC, V282, P2156, DOI 10.1001/jama.282.22.2156; KERLIKOWSKE K, 1995, JAMA-J AM MED ASSOC, V273, P149, DOI 10.1001/jama.273.2.149; Kronborg O, 1996, LANCET, V348, P1467, DOI 10.1016/S0140-6736(96)03430-7; LAARA E, 1987, LANCET, V1, P1247; LERMAN C, 1991, ANN INTERN MED, V114, P657, DOI 10.7326/0003-4819-114-8-657; Lurie JD, 1999, J NATL CANCER I, V91, P1641, DOI 10.1093/jnci/91.19.1641; MALENKA DJ, 1992, J GEN INTERN MED, V92, P121; MANDEL JS, 1993, NEW ENGL J MED, V328, P1365, DOI 10.1056/NEJM199305133281901; Marshall KG, 1996, CAN MED ASSOC J, V155, P169; MAZUR DJ, 1993, J GEN INTERN MED, V8, P374, DOI 10.1007/BF02600076; McQuay HJ, 1997, ANN INTERN MED, V126, P712, DOI 10.7326/0003-4819-126-9-199705010-00007; MOSKOWITZ M, 1986, RADIOLOGY, V161, P37, DOI 10.1148/radiology.161.1.3532183; *NAT CTR HLTH STAT, 2000, LIF TABL US 1997; National Hospice Organization, 1996, MED GUID DET PROGN S; PAGE DL, 1982, CANCER, V49, P751, DOI 10.1002/1097-0142(19820215)49:4<751::AID-CNCR2820490426>3.0.CO;2-Y; Pignone M, 2000, ANN INTERN MED, V133, P761, DOI 10.7326/0003-4819-133-10-200011210-00008; Pignone M, 1999, J GEN INTERN MED, V14, P432, DOI 10.1046/j.1525-1497.1999.00018.x; Prevost TC, 1998, AM J EPIDEMIOL, V148, P609; Ransohoff DF, 1997, ANN INTERN MED, V127, P1029, DOI 10.7326/0003-4819-127-11-199712010-00016; Ransohoff DF, 1997, ANN INTERN MED, V126, P811, DOI 10.7326/0003-4819-126-10-199705150-00014; REDELMEIER DA, 1993, JAMA-J AM MED ASSOC, V270, P72, DOI 10.1001/jama.270.1.72; Ries L. A. G., 1999, SEER CANC STAT REV 1; Robinson B, 1997, CLIN GERIATR MED, V13, P97; Sackett DL, 1991, CLIN EPIDEMIOLOGY BA, V2nd; Salzmann P, 1997, ANN INTERN MED, V127, P955, DOI 10.7326/0003-4819-127-11-199712010-00001; SATARIANO WA, 1994, ANN INTERN MED, V120, P104, DOI 10.7326/0003-4819-120-2-199401150-00002; Schwartz LM, 1997, ANN INTERN MED, V127, P966, DOI 10.7326/0003-4819-127-11-199712010-00003; SELBY JV, 1992, NEW ENGL J MED, V326, P653, DOI 10.1056/NEJM199203053261001; Smith RA, 2000, CA-CANCER J CLIN, V50, P34, DOI 10.3322/canjclin.50.1.34; Sox HC, 1998, J GEN INTERN MED, V13, P424, DOI 10.1046/j.1525-1497.1998.00126.x; TABAR L, 1992, RADIOL CLIN N AM, V30, P187; TABAR L, 1995, CANCER, V75, P2507, DOI 10.1002/1097-0142(19950515)75:10<2507::AID-CNCR2820751017>3.0.CO;2-H; US Preventive Services Task Force, 1996, GUID CLIN PREV SERV, P18; WARDLE J, 1992, J PSYCHOSOM RES, V36, P609, DOI 10.1016/0022-3999(92)90051-3; WARREN R, 1988, BRIT MED J, V297, P969, DOI 10.1136/bmj.297.6654.969; Weingarten S, 1999, ANN INTERN MED, V130, P454, DOI 10.7326/0003-4819-130-5-199903020-00023; Welch HG, 1996, ANN INTERN MED, V124, P577, DOI 10.7326/0003-4819-124-6-199603150-00007; Welch HG, 1998, J NATL CANCER I, V90, P1389, DOI 10.1093/jnci/90.18.1389; Winawer SJ, 1997, GASTROENTEROLOGY, V112, P594, DOI 10.1053/gast.1997.v112.agast970594; YANCIK R, 1994, CANCER, V74, P1995, DOI 10.1002/1097-0142(19941001)74:7+<1995::AID-CNCR2820741702>3.0.CO;2-Y	64	664	670	0	23	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 6	2001	285	21					2750	2756		10.1001/jama.285.21.2750	http://dx.doi.org/10.1001/jama.285.21.2750			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	437HG	11386931				2022-12-24	WOS:000168985800028
J	Zheng, BH; Albrecht, U; Kaasik, K; Sage, M; Lu, WQ; Vaishnav, S; Li, Q; Sun, ZS; Eichele, G; Bradley, A; Lee, CC				Zheng, BH; Albrecht, U; Kaasik, K; Sage, M; Lu, WQ; Vaishnav, S; Li, Q; Sun, ZS; Eichele, G; Bradley, A; Lee, CC			Nonredundant roles of the mPer1 and mPer2 genes in the mammalian circadian clock	CELL			English	Article							DELTA-AMINOLEVULINATE SYNTHASE; DROSOPHILA-PERIOD; POSITIONAL CLONING; PROTEIN; HEME; EXPRESSION; TRANSCRIPTION; PACEMAKER; COMPONENT; ORTHOLOG	Mice carrying a null mutation in the Period 1 (mPer1) gene were generated using embryonic stem cell technology. Homozygous mPer1 mutants display a shorter circadian period with reduced precision and stability. Mice deficient in both mPer1 and mPer2 do not express circadian rhythms. While mPER2 regulates clock gene expression at the transcriptional level, mPER1 is dispensable for the rhythmic RNA expression of mPer1 and mPer2 and may instead regulate mPER2 at a posttranscriptional level. Studies of clock-controlled genes (CCGs) reveal a complex pattern of regulation by mPER1 and mPER2, suggesting independent controls by the two proteins over some output pathways. Genes encoding key enzymes in heme biosynthesis are under circadian control and are regulated by mPER1 and mPER2. Together, our studies show that mPER1 and mPER2 have distinct and complementary roles in the mouse clock mechanism.	Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Verna & Marrs Mclean Dept Biochem, Houston, TX 77030 USA; Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute	Bradley, A (corresponding author), Sanger Ctr, Wellcome Trust Genome Campus, Cambridge CB10 1SA, England.	abradley@sanger.ac.uk; ching@bcm.tmc.edu	Sun, Zhongsheng/AAS-4883-2020; Albrecht, Urs/A-9831-2011; Jansen, Heiko T./A-5770-2008	Sun, Zhongsheng/0000-0002-7640-5026; Albrecht, Urs/0000-0002-0663-8676; Jansen, Heiko T./0000-0003-0178-396X; Bradley, Allan/0000-0002-2349-8839				Albrecht U, 2001, J BIOL RHYTHM, V16, P100, DOI 10.1177/074873001129001791; Albrecht U, 1997, CELL, V91, P1055, DOI 10.1016/S0092-8674(00)80495-X; Albrecht U, 1997, MOL CELLULAR METHODS, P23; Allada R, 1998, CELL, V93, P791, DOI 10.1016/S0092-8674(00)81440-3; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; BARGIELLO TA, 1984, NATURE, V312, P752, DOI 10.1038/312752a0; Blau J, 1999, CELL, V99, P661, DOI 10.1016/S0092-8674(00)81554-8; Bracewell R. N., 1986, HARTLEY TRANSFORM; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Chang AL, 2001, BIOCHEMISTRY-US, V40, P3420, DOI 10.1021/bi0100236; Cheung VG, 1999, NAT GENET, V21, P15, DOI 10.1038/4439; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; Clayton JD, 2001, NATURE, V409, P829, DOI 10.1038/35057006; Darlington TK, 1998, SCIENCE, V280, P1599, DOI 10.1126/science.280.5369.1599; Delgado-Nixon VM, 2000, BIOCHEMISTRY-US, V39, P2685, DOI 10.1021/bi991911s; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Festing MFW, 1999, MAMM GENOME, V10, P836, DOI 10.1007/s003359901099; Field MD, 2000, NEURON, V25, P437, DOI 10.1016/S0896-6273(00)80906-X; Garcia JA, 2000, SCIENCE, V288, P2226, DOI 10.1126/science.288.5474.2226; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Ghyselinck NB, 1999, EMBO J, V18, P4903, DOI 10.1093/emboj/18.18.4903; Gong WM, 1998, P NATL ACAD SCI USA, V95, P15177, DOI 10.1073/pnas.95.26.15177; Griffin EA, 1999, SCIENCE, V286, P768, DOI 10.1126/science.286.5440.768; HAMILTON JW, 1991, ARCH BIOCHEM BIOPHYS, V289, P387, DOI 10.1016/0003-9861(91)90428-L; KAPPAS A, 1968, Seminars in Hematology, V5, P323; KIKUCHI G, 1981, MOL CELL BIOCHEM, V37, P27, DOI 10.1007/BF02355885; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; Kloss B, 1998, CELL, V94, P97, DOI 10.1016/S0092-8674(00)81225-8; KONOPKA RJ, 1971, P NATL ACAD SCI USA, V68, P2112, DOI 10.1073/pnas.68.9.2112; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Lowrey PL, 2000, ANNU REV GENET, V34, P533, DOI 10.1146/annurev.genet.34.1.533; Lowrey PL, 2000, SCIENCE, V288, P483, DOI 10.1126/science.288.5465.483; Lucas KA, 2000, PHARMACOL REV, V52, P375; Miyamoto Y, 1998, P NATL ACAD SCI USA, V95, P6097, DOI 10.1073/pnas.95.11.6097; MYERS MP, 1995, SCIENCE, V270, P805, DOI 10.1126/science.270.5237.805; Pellequer JL, 1999, CURR BIOL, V9, pR416, DOI 10.1016/S0960-9822(99)80257-7; Pellequer JL, 1998, P NATL ACAD SCI USA, V95, P5884, DOI 10.1073/pnas.95.11.5884; Ponka P, 1999, AM J MED SCI, V318, P241, DOI 10.1097/00000441-199910000-00004; RAMIREZSOLIS R, 1993, METHOD ENZYMOL, V225, P855; RIDDLE RD, 1989, P NATL ACAD SCI USA, V86, P792, DOI 10.1073/pnas.86.3.792; Rutila JE, 1998, CELL, V93, P805, DOI 10.1016/S0092-8674(00)81441-5; Sangoram AM, 1998, NEURON, V21, P1101, DOI 10.1016/S0896-6273(00)80627-3; Shearman LP, 2000, MOL CELL BIOL, V20, P6269, DOI 10.1128/MCB.20.17.6269-6275.2000; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; SOKOLOVE PG, 1978, J THEOR BIOL, V72, P131, DOI 10.1016/0022-5193(78)90022-X; Stuehr DJ, 1997, ANNU REV PHARMACOL, V37, P339, DOI 10.1146/annurev.pharmtox.37.1.339; Sun ZS, 1997, CELL, V90, P1003, DOI 10.1016/S0092-8674(00)80366-9; Tei H, 1997, NATURE, V389, P512, DOI 10.1038/39086; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; VITATERNA MH, 1994, SCIENCE, V264, P719, DOI 10.1126/science.8171325; Young MW, 2000, SCI AM, V282, P64, DOI 10.1038/scientificamerican0300-64; Zheng BH, 1999, NATURE, V400, P169, DOI 10.1038/22118; Zylka MJ, 1998, NEURON, V20, P1103, DOI 10.1016/S0896-6273(00)80492-4	53	660	693	2	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 1	2001	105	5					683	694		10.1016/S0092-8674(01)00380-4	http://dx.doi.org/10.1016/S0092-8674(01)00380-4			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	439NL	11389837	Bronze			2022-12-24	WOS:000169123200014
J	Annas, GJ				Annas, GJ			Testing poor pregnant women for cocaine - Physicians as police investigators.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Boston Univ, Sch Publ Hlth, Hlth Law Dept, Boston, MA 02215 USA	Boston University	Annas, GJ (corresponding author), Boston Univ, Sch Publ Hlth, Hlth Law Dept, Boston, MA 02215 USA.			Annas, George/0000-0001-5836-7831				ANNAS GJ, 1991, NEW ENGL J MED, V325, P740, DOI 10.1056/NEJM199109053251020; Annas GJ, 2001, NEW ENGL J MED, V344, P152, DOI 10.1056/NEJM200101113440220; ANNAS GJ, 1989, HASTINGS CENT REP, V19, P1935; Chavkin W, 2001, JAMA-J AM MED ASSOC, V285, P1626, DOI 10.1001/jama.285.12.1626; Frank DA, 2001, JAMA-J AM MED ASSOC, V285, P1613, DOI 10.1001/jama.285.12.1613; GANTZ LH, 1989, AM J PUBLIC HEALTH, V79, P1427; GREEN V, 1993, DOPED UP KNOCKED UP; Mariner Wendy K, 1990, Crim Justice Ethics, V9, P30; Paltrow Lynn M, 1990, Crim Justice Ethics, V9, P41; Roberts Dorothy, 1999, J HLTH CARE LAW POLI, V3, P72; SIEGEL B, 1994, LA TIMES        0807, P14	11	17	17	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 31	2001	344	22					1729	1732		10.1056/NEJM200105313442219	http://dx.doi.org/10.1056/NEJM200105313442219			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	436YG	11386286	Green Published			2022-12-24	WOS:000168963000028
J	Nadler, MJS; Hermosura, MC; Inabe, K; Perraud, AL; Zhu, QQ; Stokes, AJ; Kurosaki, T; Kinet, JP; Penner, R; Scharenberg, AM; Fleig, A				Nadler, MJS; Hermosura, MC; Inabe, K; Perraud, AL; Zhu, QQ; Stokes, AJ; Kurosaki, T; Kinet, JP; Penner, R; Scharenberg, AM; Fleig, A			LTRPC7 is a Mg center dot ATP-regulated divalent cation channel required for cell viability	NATURE			English	Article								The molecular mechanisms that regulate basal or background entry of divalent cations into mammalian cells are poorly understood. Here we describe the cloning and functional characterization of a Ca2+ - and Mg2+-permeable divalent cation channel, LTRPC7 (nomenclature compatible with that proposed in ref. 1), a new member of the LTRPC family of putative ion channels. Targeted deletion of LTRPC7 in DT-40 B cells was lethal, indicating that LTRPC7 has a fundamental and nonredundant role in cellular physiology. Electrophysiological analysis of HEK-293 cells overexpressing recombinant LTRPC7 showed large currents regulated by millimolar levels of intracellular Mg.ATP and Mg.GTP with the permeation properties of a voltage-independent divalent cation influx pathway. Analysis of several cultured cell types demonstrated small magnesium-nucleotide-regulated metal ion currents (MagNuM) with regulation and permeation properties essentially identical to the large currents observed in cells expressing recombinant LTRPC7. Our data indicate that LTRPC7, by virtue of its sensitivity to physiological Mg.ATP levels, may be involved in a fundamental process that adjusts plasma membrane divalent cation fluxes according to the metabolic state of the cell.	Harvard Univ, Sch Med, Boston, MA 02215 USA; Univ Hawaii, Queens Med Ctr, Biomed Res Ctr, Lab Cell & Mol Signaling, Honolulu, HI 96813 USA; Univ Hawaii, John A Burns Sch Med, Honolulu, HI 96813 USA; Kansai Med Univ, Inst Liver Res, Dept Mol Genet, Osaka 5708506, Japan; Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA	Harvard University; Harvard Medical School; The Queen's Medical Center; University of Hawaii System; University of Hawaii System; Kansai Medical University; Harvard University; Beth Israel Deaconess Medical Center	Scharenberg, AM (corresponding author), Univ Washington, Dept Pediat & Immunol, Seattle, WA 98195 USA.		Kurosaki, Tomohiro/D-1306-2009; Stokes, Alexander/B-1086-2015	Kurosaki, Tomohiro/0000-0002-6352-304X; Stokes, Alexander/0000-0002-3526-4685; Fleig, Andrea/0000-0001-8396-7249; Penner, Reinhold/0000-0002-5366-1537				Harteneck C, 2000, TRENDS NEUROSCI, V23, P159, DOI 10.1016/S0166-2236(99)01532-5; Luthi D, 1999, EXP PHYSIOL, V84, P231, DOI 10.1111/j.1469-445X.1999.01799.x; Romani AMP, 2000, FRONT BIOSCI, V5, pD720, DOI 10.2741/Romani; Runnels LW, 2001, SCIENCE, V291, P1043, DOI 10.1126/science.1058519; Ryazanov AG, 1997, P NATL ACAD SCI USA, V94, P4884, DOI 10.1073/pnas.94.10.4884	5	736	768	2	44	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 31	2001	411	6837					590	595		10.1038/35079092	http://dx.doi.org/10.1038/35079092			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437GE	11385574				2022-12-24	WOS:000168982500053
J	Jallepalli, PV; Waizenegger, IC; Bunz, F; Langer, S; Speicher, MR; Peters, JM; Kinzler, KW; Vogelstein, B; Lengauer, C				Jallepalli, PV; Waizenegger, IC; Bunz, F; Langer, S; Speicher, MR; Peters, JM; Kinzler, KW; Vogelstein, B; Lengauer, C			Securin is required for chromosomal stability in human cells	CELL			English	Article							SISTER-CHROMATID SEPARATION; MITOTIC CHECKPOINT GENES; KINETOCHORE LOCALIZATION; SPINDLE CHECKPOINT; HUMAN HOMOLOG; ANAPHASE; PROTEIN; LACKING; COHESIN; INHIBITOR	Abnormalities of chromosome number are the most common genetic aberrations in cancer. The mechanisms regulating the fidelity of mitotic chromosome transmission in mammalian cells are therefore of great interest. Here we show that human cells without an hSecurin gene lose chromosomes at a high frequency. This loss was linked to abnormal anaphases during which cells underwent repetitive unsuccessful attempts to segregate their chromosomes. The abnormal mitoses were associated with biochemical defects in the activation of separin, the sister-separating protease, rendering it unable to cleave the cohesin subunit Scc1 efficiently. These results illuminate the function of mammalian securin and show that it is essential for the maintenance of euploidy.	Johns Hopkins Oncol Ctr, Baltimore, MD 21231 USA; Howard Hughes Med Inst, Baltimore, MD 21231 USA; Res Inst Mol Pathol, A-1030 Vienna, Austria; Univ Munich, Inst Anthropol & Human Genet, D-80333 Munich, Germany	Johns Hopkins University; Johns Hopkins Medicine; Howard Hughes Medical Institute; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); University of Munich	Lengauer, C (corresponding author), Johns Hopkins Oncol Ctr, 1650 Orleans St, Baltimore, MD 21231 USA.	lengauer@jhmi.edu	Speicher, Michael R/B-5362-2013	Speicher, Michael R/0000-0003-0105-955X	NCI NIH HHS [CA 62924, CA 57345, CA 43460] Funding Source: Medline; NIGMS NIH HHS [GM 41690, GM07309] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA057345, P50CA062924, R01CA043460, R37CA057345, R37CA043460] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Amon A, 1999, CURR OPIN GENET DEV, V9, P69, DOI 10.1016/S0959-437X(99)80010-0; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Cahill DP, 1999, TRENDS CELL BIOL, V9, pM57, DOI 10.1016/S0962-8924(99)01661-X; Cahill DP, 1998, NATURE, V392, P300, DOI 10.1038/32688; Chan TA, 1999, NATURE, V401, P616, DOI 10.1038/44188; Chen RH, 1996, SCIENCE, V274, P242, DOI 10.1126/science.274.5285.242; Ciosk R, 1998, CELL, V93, P1067, DOI 10.1016/S0092-8674(00)81211-8; CohenFix O, 1996, GENE DEV, V10, P3081, DOI 10.1101/gad.10.24.3081; Dobles M, 2000, CELL, V101, P635, DOI 10.1016/S0092-8674(00)80875-2; Dominguez A, 1998, ONCOGENE, V17, P2187, DOI 10.1038/sj.onc.1202140; Duesberg P, 1999, ANTICANCER RES, V19, P4887; Fang GW, 1998, GENE DEV, V12, P1871, DOI 10.1101/gad.12.12.1871; Funabiki H, 1996, EMBO J, V15, P6617, DOI 10.1002/j.1460-2075.1996.tb01052.x; Funabiki H, 1996, NATURE, V381, P438, DOI 10.1038/381438a0; Gardner RD, 2000, TRENDS CELL BIOL, V10, P154, DOI 10.1016/S0962-8924(00)01727-X; Gemma A, 2000, GENE CHROMOSOME CANC, V29, P213, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1027>3.0.CO;2-G; Glotzer M, 1999, CURR BIOL, V9, pR531, DOI 10.1016/S0960-9822(99)80329-7; Heaney AP, 2000, LANCET, V355, P716, DOI 10.1016/S0140-6736(99)10238-1; Imai Y, 1999, JPN J CANCER RES, V90, P837, DOI 10.1111/j.1349-7006.1999.tb00824.x; Kalitsis P, 2000, GENE DEV, V14, P2277, DOI 10.1101/gad.827500; Kanda T, 1998, CURR BIOL, V8, P377, DOI 10.1016/S0960-9822(98)70156-3; King RW, 1996, SCIENCE, V274, P1652, DOI 10.1126/science.274.5293.1652; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Lee H, 1999, MOL CELL, V4, P1, DOI 10.1016/S1097-2765(00)80182-3; Leismann O, 2000, GENE DEV, V14, P2192, DOI 10.1101/gad.176700; Lengauer C, 1997, NATURE, V386, P623, DOI 10.1038/386623a0; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Li Y, 1996, SCIENCE, V274, P246, DOI 10.1126/science.274.5285.246; LOEB LA, 1991, CANCER RES, V51, P3075; Losada A, 1998, GENE DEV, V12, P1986, DOI 10.1101/gad.12.13.1986; Martinez-Exposito MJ, 1999, P NATL ACAD SCI USA, V96, P8493, DOI 10.1073/pnas.96.15.8493; Masramon L, 2000, CANCER GENET CYTOGEN, V121, P17, DOI 10.1016/S0165-4608(00)00219-3; Michel LS, 2001, NATURE, V409, P355, DOI 10.1038/35053094; Morgan DO, 1999, NAT CELL BIOL, V1, pE47, DOI 10.1038/10039; Nasmyth K, 2000, SCIENCE, V288, P1379, DOI 10.1126/science.288.5470.1379; Peters JM, 1999, EXP CELL RES, V248, P339, DOI 10.1006/excr.1999.4443; Rhee I, 2000, NATURE, V404, P1003, DOI 10.1038/35010000; Saez C, 1999, ONCOGENE, V18, P5473, DOI 10.1038/sj.onc.1202914; Speicher MR, 1996, NAT GENET, V12, P368, DOI 10.1038/ng0496-368; Stennicke HR, 2000, BBA-PROTEIN STRUCT M, V1477, P299, DOI 10.1016/S0167-4838(99)00281-2; Stratmann R, 1996, CELL, V84, P25, DOI 10.1016/S0092-8674(00)80990-3; Sumara I, 2000, J CELL BIOL, V151, P749, DOI 10.1083/jcb.151.4.749; Taylor SS, 1997, CELL, V89, P727, DOI 10.1016/S0092-8674(00)80255-X; Taylor SS, 1998, J CELL BIOL, V142, P1, DOI 10.1083/jcb.142.1.1; Uhlmann F, 1999, NATURE, V400, P37, DOI 10.1038/21831; Uhlmann F, 2000, CELL, V103, P375, DOI 10.1016/S0092-8674(00)00130-6; Waizenegger IC, 2000, CELL, V103, P399, DOI 10.1016/S0092-8674(00)00132-X; Waldman T, 1996, NATURE, V381, P713, DOI 10.1038/381713a0; Yamamoto A, 1996, J CELL BIOL, V133, P99, DOI 10.1083/jcb.133.1.99; Yamamoto A, 1996, J CELL BIOL, V133, P85, DOI 10.1083/jcb.133.1.85; Yanagida M, 2000, GENES CELLS, V5, P1, DOI 10.1046/j.1365-2443.2000.00306.x; Zou H, 1999, SCIENCE, V285, P418, DOI 10.1126/science.285.5426.418	52	336	360	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 18	2001	105	4					445	457		10.1016/S0092-8674(01)00340-3	http://dx.doi.org/10.1016/S0092-8674(01)00340-3			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	434XG	11371342	Bronze			2022-12-24	WOS:000168840700005
J	Mao, BY; Wu, W; Li, Y; Hoppe, D; Stannek, P; Glinka, A; Niehrs, C				Mao, BY; Wu, W; Li, Y; Hoppe, D; Stannek, P; Glinka, A; Niehrs, C			LDL-receptor-related protein 6 is a receptor for Dickkopf proteins	NATURE			English	Article							SPEMANN ORGANIZER; SIGNAL-TRANSDUCTION; SECRETED PROTEINS; HEAD INDUCTION; WNT; XENOPUS; ACTIVATION; EXPRESSION; ANTAGONIST; CERBERUS	Wnt glycoproteins have been implicated in diverse processes during embryonic patterning in metazoa. They signal through frizzled-type seven-transmembrane-domain receptors to stabilize beta -catenin(1,2). Wnt signalling is antagonized by the extracellular Wnt inhibitor dickkopf1 (dkk1), which is a member of a multigene family(3). dkk1 was initially identified as a head inducer in Xenopus embryos but the mechanism by which it blocks Wnt signalling is unknown. LDL-receptor-related protein 6 (LRP6) is required during Wnt/beta -catenin signalling in Drosophila, Xenopus and mouse, possibly acting as a co-receptor for Wnt(4-6). Here we show that LRP6 (ref. 7) is a specific, high-affinity receptor for Dkk1 and Dkk2. Dkk1 blocks LRP6-mediated Wnt/beta -catenin signalling by interacting with domains that are distinct from those required for Wnt/Frizzled interaction. dkk1 and LRP6 interact antagonistically during embryonic head induction in Xenopus where LRP6 promotes the posteriorizing role of Wnt/beta -catenin signalling. Thus, DKKs inhibit Wnt co-receptor function, exemplifying the modulation of LRP signalling by antagonists.	Deutsch Krebsforschungszentrum, Div Mol Embryol, D-69120 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ)	Niehrs, C (corresponding author), Deutsch Krebsforschungszentrum, Div Mol Embryol, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.		Mao, Bingyu/L-9955-2014	Mao, Bingyu/0000-0002-7993-3158				Bouwmeester T, 1996, NATURE, V382, P595, DOI 10.1038/382595a0; Brannon M, 1996, DEV BIOL, V180, P344, DOI 10.1006/dbio.1996.0306; Brown SP, 1998, J AGING PHYS ACTIV, V6, P248, DOI 10.1123/japa.6.3.248; Carnac G, 1996, DEVELOPMENT, V122, P3055; CHEN G, 1994, BIOL CONTROL, V4, P157, DOI 10.1006/bcon.1994.1025; CHENG HJ, 1995, CELL, V82, P371, DOI 10.1016/0092-8674(95)90426-3; CHRISTIAN JL, 1993, GENE DEV, V7, P13, DOI 10.1101/gad.7.1.13; Gawantka V, 1995, EMBO J, V14, P6268, DOI 10.1002/j.1460-2075.1995.tb00317.x; Glinka A, 1998, NATURE, V391, P357, DOI 10.1038/34848; Glinka A, 1997, NATURE, V389, P517, DOI 10.1038/39092; Hsieh JC, 1999, NATURE, V398, P431, DOI 10.1038/18899; Hsieh JC, 1999, P NATL ACAD SCI USA, V96, P3546, DOI 10.1073/pnas.96.7.3546; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Leyns L, 1997, CELL, V88, P747, DOI 10.1016/S0092-8674(00)81921-2; Miller JR, 1999, ONCOGENE, V18, P7860, DOI 10.1038/sj.onc.1203245; Monaghan AP, 1999, MECH DEVELOP, V87, P45, DOI 10.1016/S0925-4773(99)00138-0; Niehrs C, 1999, TRENDS GENET, V15, P314, DOI 10.1016/S0168-9525(99)01767-9; Piccolo S, 1999, NATURE, V397, P707, DOI 10.1038/17820; Pinson KI, 2000, NATURE, V407, P535, DOI 10.1038/35035124; Rattner A, 1997, P NATL ACAD SCI USA, V94, P2859, DOI 10.1073/pnas.94.7.2859; SMITH WC, 1992, CELL, V70, P829, DOI 10.1016/0092-8674(92)90316-5; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; Wehrli M, 2000, NATURE, V407, P527, DOI 10.1038/35035110; Willnow TE, 1999, NAT CELL BIOL, V1, pE157, DOI 10.1038/14109; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Wu W, 2000, CURR BIOL, V10, P1611, DOI 10.1016/S0960-9822(00)00868-X	26	834	897	4	45	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 17	2001	411	6835					321	325		10.1038/35077108	http://dx.doi.org/10.1038/35077108			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432RT	11357136				2022-12-24	WOS:000168710000051
J	Metz, JG; Roessler, P; Facciotti, D; Levering, C; Dittrich, F; Lassner, M; Valentine, R; Lardizabal, K; Domergue, F; Yamada, A; Yazawa, K; Knauf, V; Browse, J				Metz, JG; Roessler, P; Facciotti, D; Levering, C; Dittrich, F; Lassner, M; Valentine, R; Lardizabal, K; Domergue, F; Yamada, A; Yazawa, K; Knauf, V; Browse, J			Production of polyunsaturated fatty acids by polyketide synthases in both prokaryotes and eukaryotes	SCIENCE			English	Article							EICOSAPENTAENOIC ACID; ESCHERICHIA-COLI; BIOSYNTHESIS; DESATURATION; ELONGATION; BACTERIUM; MICROORGANISMS; ARABIDOPSIS; INITIATION; ENZYME	Polyunsaturated fatty acids (PUFAs) are essential membrane components in higher eukaryotes and are the precursors of many lipid-derived signaling molecules. Here, pathways for PUFA synthesis are described that do not require desaturation and elongation of saturated fatty acids. These pathways are catalyzed by polyketide synthases (PKSs) that are distinct from previously recognized PKSs in both structure and mechanism. Generation of cis double bonds probably involves position-specific isomerases; such enzymes might be useful in the production of new families of antibiotics. it is Likely that PUFA synthesis in cold marine ecosystems is accomplished in part by these PKS enzymes.	Omega Tech, Boulder, CO 80301 USA; Monsanto Co, Davis, CA 95616 USA; Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA; Sagami Chem Res Ctr, Kanagawa 229, Japan	Monsanto; Washington State University	Metz, JG (corresponding author), Omega Tech, 4909 Nautilus Court N, Boulder, CO 80301 USA.			Domergue, Frederic/0000-0002-0183-7000; Browse, John/0000-0002-2554-2821				Allen EE, 1999, APPL ENVIRON MICROB, V65, P1710; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BARCLAY WR, 1994, J APPL PHYCOL, V6, P123, DOI 10.1007/BF02186066; Bentley R, 1999, ANNU REV MICROBIOL, V53, P411, DOI 10.1146/annurev.micro.53.1.411; Bisang C, 1999, NATURE, V401, P502, DOI 10.1038/46829; Creelman RA, 1997, ANNU REV PLANT PHYS, V48, P355, DOI 10.1146/annurev.arplant.48.1.355; DELONG EF, 1986, APPL ENVIRON MICROB, V51, P730, DOI 10.1128/AEM.51.4.730-737.1986; GELLERMAN JL, 1979, BIOCHIM BIOPHYS ACTA, V573, P23, DOI 10.1016/0005-2760(79)90169-3; Heath RJ, 2000, NATURE, V406, P145, DOI 10.1038/35018162; Heath RJ, 1996, J BIOL CHEM, V271, P27795, DOI 10.1074/jbc.271.44.27795; Heller A, 1998, DRUGS, V55, P487, DOI 10.2165/00003495-199855040-00001; HOPWOOD DA, 1990, ANNU REV GENET, V24, P37, DOI 10.1146/annurev.ge.24.120190.000345; Keating TA, 1999, CURR OPIN CHEM BIOL, V3, P598, DOI 10.1016/S1367-5931(99)00015-0; Lauritzen L, 2001, PROG LIPID RES, V40, P1, DOI 10.1016/S0163-7827(00)00017-5; MAGNUSON K, 1993, MICROBIOL REV, V57, P522, DOI 10.1128/MMBR.57.3.522-542.1993; McConn M, 1998, PLANT J, V15, P521, DOI 10.1046/j.1365-313X.1998.00229.x; MIQUEL M, 1992, J BIOL CHEM, V267, P1502; Muller-Navarra DC, 2000, NATURE, V403, P74, DOI 10.1038/47469; Nichols D, 1999, CURR OPIN BIOTECH, V10, P240, DOI 10.1016/S0958-1669(99)80042-1; Parker-Barnes JM, 2000, P NATL ACAD SCI USA, V97, P8284, DOI 10.1073/pnas.97.15.8284; Pearson W R, 2000, Methods Mol Biol, V132, P185; Shanklin J, 1998, ANNU REV PLANT PHYS, V49, P611, DOI 10.1146/annurev.arplant.49.1.611; Sprecher H, 1999, Curr Opin Clin Nutr Metab Care, V2, P135, DOI 10.1097/00075197-199903000-00007; Tanaka M, 1999, BIOTECHNOL LETT, V21, P939, DOI 10.1023/A:1005601606929; Watanabe K, 1997, J BIOCHEM-TOKYO, V122, P467; Yazawa K, 1996, LIPIDS, V31, pS297, DOI 10.1007/BF02637095	26	517	610	8	187	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 13	2001	293	5528					290	293		10.1126/science.1059593	http://dx.doi.org/10.1126/science.1059593			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	452TK	11452122				2022-12-24	WOS:000169875200056
J	Jakosky, BM; Phillips, RJ				Jakosky, BM; Phillips, RJ			Mars' volatile and climate history	NATURE			English	Review							MARTIAN ATMOSPHERIC ARGON; ORBITER LASER ALTIMETER; CARBON-DIOXIDE CLOUDS; CHAOTIC OBLIQUITY; WATER RESERVOIRS; NORTHERN PLAINS; IMPACT EROSION; EVOLUTION; METEORITE; SURFACE	There is substantial evidence that the martian volatile inventory and climate have changed markedly throughout the planet's history. Clues come from areas as disparate as the history and properties of the deep interior, the composition of the crust and regolith, the morphology of the surface, composition of the present-day atmosphere, and the nature of the interactions between the upper atmosphere and the solar wind. We piece together the relevant observations into a coherent view of the evolution of the martian climate, focusing in particular on the observations that provide the strongest constraints.	Univ Colorado, Atmospher & Space Phys Lab, Boulder, CO 80309 USA; Univ Colorado, Dept Geol Sci, Boulder, CO 80309 USA; Washington Univ, McDonnell Ctr Space Sci, St Louis, MO 63130 USA; Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63130 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; Washington University (WUSTL); Washington University (WUSTL)	Jakosky, BM (corresponding author), Univ Colorado, Atmospher & Space Phys Lab, Boulder, CO 80309 USA.	bruce.jakosky@lasp.colorado.edu; phillips@wustite.wustl.edu						Acuna MH, 1999, SCIENCE, V284, P790, DOI 10.1126/science.284.5415.790; Aharonson O, 1998, GEOPHYS RES LETT, V25, P4413, DOI 10.1029/1998GL900057; ANDERSON RC, IN PRESS J GEOPHYS R; Ayres TR, 1997, J GEOPHYS RES-PLANET, V102, P1641, DOI 10.1029/96JE03306; Baker V.R., 1982, THE CHANNELS OF MARS, DOI [10.1029/EO063i045p00862, DOI 10.1029/EO063I045P00862]; BAKER VR, 1986, J GEOPHYS RES-SOLID, V91, P3561, DOI 10.1029/JB091iB03p03561; Bjoraker G. L., 1989, B AM ASTRON SOC, V21, P991; Brain DA, 1998, J GEOPHYS RES-PLANET, V103, P22689, DOI 10.1029/98JE02074; BRASS GW, 1980, ICARUS, V42, P20, DOI 10.1016/0019-1035(80)90237-7; Cabrol NA, 1999, ICARUS, V142, P160, DOI 10.1006/icar.1999.6191; Carr M.H, 1996, WATER MARS; CARR MH, 1986, ICARUS, V68, P187, DOI 10.1016/0019-1035(86)90019-9; CARR MH, 1981, ICARUS, V48, P91, DOI 10.1016/0019-1035(81)90156-1; Carr MH, 1997, J GEOPHYS RES-PLANET, V102, P9145, DOI 10.1029/97JE00113; CARR MH, 1979, J GEOPHYS RES, V84, P2995, DOI 10.1029/JB084iB06p02995; Carr MH, 2000, ICARUS, V146, P366, DOI 10.1006/icar.2000.6428; CHAPMAN CR, 1977, ANNU REV EARTH PL SC, V5, P515, DOI 10.1146/annurev.ea.05.050177.002503; Christensen PR, 2000, J GEOPHYS RES-PLANET, V105, P9623, DOI 10.1029/1999JE001093; CHRISTENSEN PR, IN PRESS J GEOPHYS R; Chyba C.F., 1994, HAZARDS DUE COMETS A, P9; Connerney JEP, 1999, SCIENCE, V284, P794, DOI 10.1126/science.284.5415.794; Craddock RA, 1997, J GEOPHYS RES-PLANET, V102, P13321, DOI 10.1029/97JE01084; CRADDOCK RA, 1993, J GEOPHYS RES-PLANET, V98, P3453, DOI 10.1029/92JE02508; DONAHUE TM, 1995, NATURE, V374, P432, DOI 10.1038/374432a0; Forget F, 1997, SCIENCE, V278, P1273, DOI 10.1126/science.278.5341.1273; FREY HV, 2001, LUN PLAN SCI C, V32; GOLDSPIEL JM, 1991, ICARUS, V89, P392, DOI 10.1016/0019-1035(91)90186-W; Golombek MP, 2000, J GEOPHYS RES-PLANET, V105, P1841, DOI 10.1029/1999JE001043; GOODING JL, 1988, GEOCHIM COSMOCHIM AC, V52, P909, DOI 10.1016/0016-7037(88)90361-4; GREELEY R, IN PRESS MARS EXPLOR; Haberle RM, 1998, J GEOPHYS RES-PLANET, V103, P28467, DOI 10.1029/98JE01396; HARRISON KP, LUN PLAN SCI C, V32; Hartmann W.K., 1981, BASALTIC VOLCANISM T, P1049; Hartmann WK, 2000, J GEOPHYS RES-PLANET, V105, P15011, DOI 10.1029/1999JE001189; HARTMANN WK, IN PRESS SPACE SCI R; Head JW, 1999, SCIENCE, V286, P2134, DOI 10.1126/science.286.5447.2134; Head JW, 1998, GEOPHYS RES LETT, V25, P4401, DOI 10.1029/1998GL900116; HEAD JW, 2001, LUN PLAN SCI C, V32; Hiesinger H, 2000, J GEOPHYS RES-PLANET, V105, P11999, DOI 10.1029/1999JE001193; Hoffman N, 2000, ICARUS, V146, P326, DOI 10.1006/icar.2000.6398; Hutchins KS, 1996, J GEOPHYS RES-PLANET, V101, P14933, DOI 10.1029/96JE00860; Hutchins KS, 1997, J GEOPHYS RES-PLANET, V102, P9183, DOI 10.1029/96JE03838; Hynek BM, 2001, GEOLOGY, V29, P407, DOI 10.1130/0091-7613(2001)029<0407:EFEDOT>2.0.CO;2; Jakosky B. M., 1992, MARS, P969; Jakosky BM, 1997, REV GEOPHYS, V35, P1, DOI 10.1029/96RG02903; JAKOSKY BM, 1994, ICARUS, V111, P271, DOI 10.1006/icar.1994.1145; JAKOSKY BM, 1995, J GEOPHYS RES-PLANET, V100, P1579, DOI 10.1029/94JE02801; JAKOSKY BM, AM GEOPH UN SPRING M; JAKOSKY BM, 2000, WATER MANY MYSTERIES; Kasting J.F., 1991, SUN TIME, P447; KASTING JF, 1991, ICARUS, V94, P1, DOI 10.1016/0019-1035(91)90137-I; Kieffer H. H., 1992, MARS, P1180; KOMAR PD, 1980, ICARUS, V42, P317, DOI 10.1016/0019-1035(80)90097-4; Krasnopolsky V, 2000, ICARUS, V148, P597, DOI 10.1006/icar.2000.6534; Krasnopolsky VA, 1997, J GEOPHYS RES-PLANET, V102, P6525, DOI 10.1029/96JE03766; Lane MD, 2000, J GEOPHYS RES-PLANET, V105, P17617, DOI 10.1029/1999JE001197; Leshin LA, 2000, GEOPHYS RES LETT, V27, P2017, DOI 10.1029/1999GL008455; LIU SC, 1976, ICARUS, V28, P231, DOI 10.1016/0019-1035(76)90035-X; Lucchitta BK, 2001, GEOPHYS RES LETT, V28, P403, DOI 10.1029/2000GL011924; LUHMANN JG, 1992, GEOPHYS RES LETT, V19, P2151, DOI 10.1029/92GL02485; Malin MC, 2000, SCIENCE, V290, P1927, DOI 10.1126/science.290.5498.1927; Malin MC, 2000, SCIENCE, V288, P2330, DOI 10.1126/science.288.5475.2330; Malin MC, 1999, GEOPHYS RES LETT, V26, P3049, DOI 10.1029/1999GL002342; Marti K, 2000, GEOPHYS RES LETT, V27, P1463, DOI 10.1029/1999GL011064; Mathew KJ, 2001, J GEOPHYS RES-PLANET, V106, P1401, DOI 10.1029/2000JE001255; MCELROY MB, 1976, PLANET SPACE SCI, V24, P1107, DOI 10.1016/0032-0633(76)90148-3; MCSWEEN HY, 1985, REV GEOPHYS, V23, P391, DOI 10.1029/RG023i004p00391; MCSWEEN HY, 1994, METEORITICS, V29, P757, DOI 10.1111/j.1945-5100.1994.tb01092.x; McSween HY, 2001, NATURE, V409, P487, DOI 10.1038/35054011; MELLON MT, IN PRESS J GEOPHYS R; MELOSH HJ, 1989, NATURE, V338, P487, DOI 10.1038/338487a0; Mischna MA, 2000, ICARUS, V145, P546, DOI 10.1006/icar.2000.6380; MITCHELL DL, 2000, CRUSTAL MAGNETOCYLIN; Musselwhite DS, 2001, GEOPHYS RES LETT, V28, P1283, DOI 10.1029/2000GL012496; NEWMAN MJ, 1977, SCIENCE, V198, P1035, DOI 10.1126/science.198.4321.1035; OWEN T, 1995, ICARUS, V116, P215, DOI 10.1006/icar.1995.1122; OWEN T, 1988, SCIENCE, V240, P1767, DOI 10.1126/science.240.4860.1767; Owen T., 1992, COMPOSITION EARLY HI, P818; PARKER TJ, 1989, ICARUS, V82, P111, DOI 10.1016/0019-1035(89)90027-4; PARKER TJ, 1993, J GEOPHYS RES-PLANET, V98, P11061, DOI 10.1029/93JE00618; PARKER TJ, 2000, LUN PLAN SCI C, V31; PECHMANN JC, 1980, ICARUS, V42, P185, DOI 10.1016/0019-1035(80)90071-8; PEPIN RO, 1994, ICARUS, V111, P289, DOI 10.1006/icar.1994.1146; Phillips RJ, 2001, SCIENCE, V291, P2587, DOI 10.1126/science.1058701; POLLACK JB, 1987, ICARUS, V71, P203, DOI 10.1016/0019-1035(87)90147-3; POLLACK JB, 1990, J GEOPHYS RES-SOLID, V95, P14595, DOI 10.1029/JB095iB09p14595; Purucker M, 2000, GEOPHYS RES LETT, V27, P2449, DOI 10.1029/2000GL000072; ROMANEK CS, 1994, NATURE, V372, P655, DOI 10.1038/372655a0; Schubert G, 2000, NATURE, V408, P666, DOI 10.1038/35047163; Smith DE, 1999, SCIENCE, V284, P1495, DOI 10.1126/science.284.5419.1495; SQUYRES SW, 1994, SCIENCE, V265, P744, DOI 10.1126/science.265.5173.744; STEWART ST, UNPUB J GEOPHYS RES; Swindle TD, 2000, METEORIT PLANET SCI, V35, P107, DOI 10.1111/j.1945-5100.2000.tb01978.x; TANAKA K, 2000, GSA ABSTR PROGR, V32; Tanaka KL, 1999, J GEOPHYS RES-PLANET, V104, P8637, DOI 10.1029/98JE02552; TANAKA KL, 1986, J GEOPHYS RES-SOLID, V91, pE139, DOI 10.1029/JB091iB13p0E139; Tanaka KL, 1998, J GEOPHYS RES-PLANET, V103, P31407, DOI 10.1029/98JE01599; TOUMA J, 1993, SCIENCE, V259, P1294, DOI 10.1126/science.259.5099.1294; TREIMAN AH, 1993, METEORITICS, V28, P86, DOI 10.1111/j.1945-5100.1993.tb00251.x; Turner G, 1997, GEOCHIM COSMOCHIM AC, V61, P3835, DOI 10.1016/S0016-7037(97)00285-8; WARD WR, 1974, J GEOPHYS RES, V79, P3375, DOI 10.1029/JC079i024p03375; WATSON LL, 1994, SCIENCE, V265, P86, DOI 10.1126/science.265.5168.86; WEISS BP, 2001, LUN PLAN SCI C, V32; Withers P, 2001, NATURE, V410, P651, DOI 10.1038/35070640; YUNG YL, 1988, ICARUS, V76, P146, DOI 10.1016/0019-1035(88)90147-9; Zuber MT, 2000, SCIENCE, V287, P1788, DOI 10.1126/science.287.5459.1788	106	321	324	2	81	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 12	2001	412	6843					237	244		10.1038/35084184	http://dx.doi.org/10.1038/35084184			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	451AJ	11449285	Bronze			2022-12-24	WOS:000169778700063
J	Pethe, K; Alonso, S; Biet, F; Delogu, G; Brennan, MJ; Locht, C; Menozzi, FD				Pethe, K; Alonso, S; Biet, F; Delogu, G; Brennan, MJ; Locht, C; Menozzi, FD			The heparin-binding haemagglutinin of M-tuberculosis is required for extrapulmonary dissemination	NATURE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; HEMAGGLUTININ; GENE; IDENTIFICATION; MACROPHAGES; VIRULENCE; SURVIVAL; COMPLEX; ADHESIN; MICE	Tuberculosis remains the world's leading cause of death due to a single infectious agent, Mycobacterium tuberculosis, with 3 million deaths and 10 million new cases per year(1). The infection initiates in the lungs and can then spread rapidly to other tissues(2). The availability of the entire M. tuberculosis genome sequence(3) and advances in gene disruption technologies(4) have led to the identification of several mycobacterial determinants involved in virulence(5-8). However, no virulence factor specifically involved in the extrapulmonary dissemination of M. tuberculosis has been identified to date. Here we show that the disruption of the M. tuberculosis or Mycobacterium bovis Bacille Calmette-Guerin (BCG) hbhA gene encoding the heparin-binding haemagglutinin adhesin (HBHA) markedly affects mycobacterial interactions with epithelial cells, but not with macrophage-like cells. When nasally administered to mice, the mutant strains were severely impaired in spleen colonization, but not in lung colonization. Coating wild-type mycobacteria with anti-HBHA antibodies also impaired dissemination after intranasal infection. These results provide evidence that adhesins such as HBHA are required for extrapulmonary dissemination, and that interactions with non-phagocytic cells have an important role in the pathogenesis of tuberculosis. They also suggest that antibody responses to HBHA may add to immune protection against tuberculosis.	Inst Pasteur Lille, INSERM, U447, F-59019 Lille, France; US FDA, Ctr Biol Evaluat & Res, Lab Mycobacterial Dis, Bethesda, MD 20892 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; US Food & Drug Administration (FDA)	Locht, C (corresponding author), Inst Pasteur Lille, INSERM, U447, 1 Rue Prof Calmette, F-59019 Lille, France.		Pethe, Kevin/F-9495-2015; Delogu, Giovanni/I-3701-2012; Biet, Franck/ABA-4151-2021; Pethe, Kevin/L-1199-2013; Pethe, Kevin/D-4505-2011; Locht, Camille/L-3516-2018	Delogu, Giovanni/0000-0003-0182-8267; Biet, Franck/0000-0001-8425-6158; Pethe, Kevin/0000-0003-0297-0150; Pethe, Kevin/0000-0003-0916-8873				BALASUBRAMANIAN V, 1994, TUBERCLE LUNG DIS, V75, P168, DOI 10.1016/0962-8479(94)90002-7; Berthet FX, 1998, SCIENCE, V282, P759, DOI 10.1126/science.282.5389.759; Camacho LR, 1999, MOL MICROBIOL, V34, P257, DOI 10.1046/j.1365-2958.1999.01593.x; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Cox JS, 1999, NATURE, V402, P79, DOI 10.1038/47042; Delogu G, 1999, J BACTERIOL, V181, P7464, DOI 10.1128/JB.181.24.7464-7469.1999; Dye C, 1999, JAMA-J AM MED ASSOC, V282, P677, DOI 10.1001/jama.282.7.677; HENDERSON HJ, 1963, J IMMUNOL, V90, P553; McKinney JD, 2000, NATURE, V406, P735, DOI 10.1038/35021074; Menozzi FD, 1996, J EXP MED, V184, P993, DOI 10.1084/jem.184.3.993; Menozzi FD, 1998, P NATL ACAD SCI USA, V95, P12625, DOI 10.1073/pnas.95.21.12625; Pavelka MS, 1996, J BACTERIOL, V178, P6496, DOI 10.1128/jb.178.22.6496-6507.1996; Pelicic V, 1997, P NATL ACAD SCI USA, V94, P10955, DOI 10.1073/pnas.94.20.10955; Pethe K, 2001, MOL MICROBIOL, V39, P89, DOI 10.1046/j.1365-2958.2001.02206.x; Pethe K, 2000, J BIOL CHEM, V275, P14273, DOI 10.1074/jbc.275.19.14273; QUANDT J, 1993, GENE, V127, P15, DOI 10.1016/0378-1119(93)90611-6; Reddy VM, 2000, J INFECT DIS, V181, P1189, DOI 10.1086/315327; Teitelbaum R, 1998, P NATL ACAD SCI USA, V95, P15688, DOI 10.1073/pnas.95.26.15688; Teitelbaum R, 1999, IMMUNITY, V10, P641, DOI 10.1016/S1074-7613(00)80063-1; Wei J, 2000, J BACTERIOL, V182, P377, DOI 10.1128/JB.182.2.377-384.2000	20	347	370	0	24	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 12	2001	412	6843					190	194		10.1038/35084083	http://dx.doi.org/10.1038/35084083			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	451AJ	11449276				2022-12-24	WOS:000169778700054
J	Graef, IA; Chen, F; Chen, L; Kuo, A; Crabtree, GR				Graef, IA; Chen, F; Chen, L; Kuo, A; Crabtree, GR			Signals transduced by Ca2+/calcineurin and NFATc3/c4 pattern the developing vasculature	CELL			English	Article							BLOOD-VESSEL FORMATION; RECEPTOR TYROSINE KINASE; TRANSCRIPTION FACTOR MEF2C; CARDIAC DEVELOPMENT; CARDIOVASCULAR DEVELOPMENT; NEUREGULIN RECEPTOR; ENDOTHELIAL-CELLS; DEFICIENT MICE; CYCLOSPORINE-A; NF-ATC	Vascular development requires an orderly exchange of signals between growing vessels and their supporting tissues, but little is known of the intracellular signaling pathways underlying this communication. We find that mice with disruptions of both NFATc4 and the related NFATc3 genes die around E11 with generalized defects in vessel assembly as well as excessive and disorganized growth of vessels into the neural tube and somites. Since calcineurin is thought to control nuclear localization of NFATc proteins, we introduced a mutation into the calcineurin a gene that prevents phosphatase activation by Ca2+ signals. These CnB mutant mice exhibit vascular developmental abnormalities similar to the NFATc3/c4 null mice. We show that calcineurin function is transiently required between E7.5 and E8.5. Hence, early calcineurin/NFAT signaling initiates the later cross-talk between vessels and surrounding tissues that pattern the vasculature.	Stanford Univ, Howard Hughes Med Inst, Dept Dev Biol, Stanford, CA 94305 USA; Stanford Univ, Howard Hughes Med Inst, Dept Pathol, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University; Howard Hughes Medical Institute; Stanford University	Crabtree, GR (corresponding author), Stanford Univ, Howard Hughes Med Inst, Dept Dev Biol, Stanford, CA 94305 USA.							Adams RH, 2001, CELL, V104, P57, DOI 10.1016/S0092-8674(01)00191-X; Adams RH, 1999, GENE DEV, V13, P295, DOI 10.1101/gad.13.3.295; Bi WZ, 1999, DEV BIOL, V211, P255, DOI 10.1006/dbio.1999.9307; Carmeliet P, 1996, NATURE, V383, P73, DOI 10.1038/383073a0; Carmeliet P, 1999, CELL, V98, P147, DOI 10.1016/S0092-8674(00)81010-7; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; CLIPSTONE NA, 1992, NATURE, V357, P695, DOI 10.1038/357695a0; Crabtree GR, 1999, CELL, V96, P611, DOI 10.1016/S0092-8674(00)80571-1; de la Pompa JL, 1998, NATURE, V392, P182, DOI 10.1038/32419; DICKSON MC, 1995, DEVELOPMENT, V121, P1845; Dumont DJ, 1998, SCIENCE, V282, P946, DOI 10.1126/science.282.5390.946; DUMONT DJ, 1994, GENE DEV, V8, P1897, DOI 10.1101/gad.8.16.1897; Erickson SL, 1997, DEVELOPMENT, V124, P4999; Esser S, 1998, J CELL SCI, V111, P1853; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; FLANAGAN WM, 1991, NATURE, V352, P803, DOI 10.1038/352803a0; Folkman J, 1996, CELL, V87, P1153, DOI 10.1016/S0092-8674(00)81810-3; FONG GH, 1995, NATURE, V376, P66, DOI 10.1038/376066a0; GASSMANN M, 1995, NATURE, V378, P390, DOI 10.1038/378390a0; Gerety SS, 1999, MOL CELL, V4, P403, DOI 10.1016/S1097-2765(00)80342-1; Graef IA, 2001, P NATL ACAD SCI USA, V98, P5740, DOI 10.1073/pnas.101602398; GRIFFITH JP, 1995, CELL, V82, P507, DOI 10.1016/0092-8674(95)90439-5; Hellstrom M, 1999, DEVELOPMENT, V126, P3047; KLEE CB, 1979, P NATL ACAD SCI USA, V76, P6270, DOI 10.1073/pnas.76.12.6270; Klee CB, 1998, J BIOL CHEM, V273, P13367, DOI 10.1074/jbc.273.22.13367; LEE KF, 1995, NATURE, V378, P394, DOI 10.1038/378394a0; Lin Q, 1998, DEVELOPMENT, V125, P4565; Lin Q, 1997, SCIENCE, V276, P1404, DOI 10.1126/science.276.5317.1404; Lindahl P, 1997, SCIENCE, V277, P242, DOI 10.1126/science.277.5323.242; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; MEYER D, 1995, NATURE, V378, P386, DOI 10.1038/378386a0; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Oh SP, 2000, P NATL ACAD SCI USA, V97, P2626, DOI 10.1073/pnas.97.6.2626; Olson EN, 2000, CELL, V101, P689, DOI 10.1016/S0092-8674(00)80880-6; Oukka M, 1998, IMMUNITY, V9, P295, DOI 10.1016/S1074-7613(00)80612-3; PURI MC, 1995, EMBO J, V14, P5884, DOI 10.1002/j.1460-2075.1995.tb00276.x; Ranger AM, 1998, NATURE, V392, P186, DOI 10.1038/32426; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; SATO TN, 1995, NATURE, V376, P70, DOI 10.1038/376070a0; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Suri C, 1996, CELL, V87, P1171, DOI 10.1016/S0092-8674(00)81813-9; UMESS LD, 2000, NAT GENET, V26, P328; Wang HU, 1998, CELL, V93, P741, DOI 10.1016/S0092-8674(00)81436-1; Yancopoulos GD, 2000, NATURE, V407, P242, DOI 10.1038/35025215; Yang X, 1999, DEVELOPMENT, V126, P1571	45	341	364	2	17	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 29	2001	105	7					863	875		10.1016/S0092-8674(01)00396-8	http://dx.doi.org/10.1016/S0092-8674(01)00396-8			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	449BK	11439183	Bronze			2022-12-24	WOS:000169664300007
J	Wang, DZ; Chang, PS; Wang, ZG; Sutherland, L; Richardson, JA; Small, E; Krieg, PA; Olson, EN				Wang, DZ; Chang, PS; Wang, ZG; Sutherland, L; Richardson, JA; Small, E; Krieg, PA; Olson, EN			Activation of cardiac gene expression by myocardin, a transcriptional cofactor for serum response factor	CELL			English	Article							ALPHA-ACTIN GENE; TINMAN-RELATED GENES; C-FOS PROMOTER; TERNARY COMPLEX; SMOOTH-MUSCLE; ELEMENT; SKELETAL; CELLS; DNA; SM22-ALPHA	Serum response factor (SRF) regulates transcription of numerous muscle and growth factor-inducible genes. Because SRF is not muscle specific, It has been postulated to activate muscle genes by recruiting myogenic accessory factors. Using a bioinformatics-based screen for unknown cardiac-specific genes, we identified a novel and highly potent transcription factor, named myocardin, that is expressed in cardiac and smooth muscle cells. Myocardin belongs to the SAP domain family of nuclear proteins and activates cardiac muscle promoters by associating with SRF. Expression of a dominant negative mutant of myocardin in Xenopus embryos interferes with myocardial cell differentiation. Myocardin is the founding member of a class of muscle transcription factors and provides a mechanism whereby SRF can convey myogenic activity to cardiac muscle genes.	Univ Texas, SW Med Ctr, Dept Mol Biol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Pathol, Dallas, TX 75390 USA; Univ Arizona, Coll Med, Dept Cell Biol & Anat, Tucson, AZ 85724 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Arizona	Olson, EN (corresponding author), Univ Texas, SW Med Ctr, Dept Mol Biol, 6000 Harry Hines Blvd, Dallas, TX 75390 USA.		Wang, Zhigao/ABE-9411-2021	Wang, Zhigao/0000-0002-6544-4302	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL063926, R01HL053351] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL63926, R01 HL053351] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Aravind L, 2000, TRENDS BIOCHEM SCI, V25, P112, DOI 10.1016/S0968-0004(99)01537-6; Belaguli NS, 2000, MOL CELL BIOL, V20, P7550, DOI 10.1128/MCB.20.20.7550-7558.2000; Black BL, 1998, ANNU REV CELL DEV BI, V14, P167, DOI 10.1146/annurev.cellbio.14.1.167; Chang PS, 2001, J BIOL CHEM, V276, P17206, DOI 10.1074/jbc.M010983200; Chen CY, 1996, MOL CELL BIOL, V16, P6372; CHOW KL, 1990, MOL CELL BIOL, V10, P528, DOI 10.1128/MCB.10.2.528; Cleaver OB, 1996, DEVELOPMENT, V122, P3549; Croissant JD, 1996, DEV BIOL, V177, P250, DOI 10.1006/dbio.1996.0160; Faber J., 1994, NORMAL TABLE XENOPUS, P2; Fu YC, 1998, DEVELOPMENT, V125, P4439; GILLE H, 1992, NATURE, V358, P414, DOI 10.1038/358414a0; GILMAN MZ, 1986, MOL CELL BIOL, V6, P4305, DOI 10.1128/MCB.6.12.4305; Grow MW, 1998, DEV BIOL, V204, P187, DOI 10.1006/dbio.1998.9080; HARLAND RM, 1991, METHOD CELL BIOL, V36, P685; HAUSCHKA SD, 1994, MYOLOGY, P3; Hines WA, 1999, MOL CELL BIOL, V19, P1841; Kim S, 1997, MOL CELL BIOL, V17, P2266, DOI 10.1128/MCB.17.4.2266; Kipp M, 2000, MOL CELL BIOL, V20, P7480, DOI 10.1128/MCB.20.20.7480-7489.2000; LEE TC, 1991, MOL CELL BIOL, V11, P5090, DOI 10.1128/MCB.11.10.5090; Li L, 1996, CIRC RES, V78, P188, DOI 10.1161/01.RES.78.2.188; Li L, 1997, DEV BIOL, V187, P311, DOI 10.1006/dbio.1997.8621; Lien CL, 1999, DEVELOPMENT, V126, P75; LINTS TJ, 1993, DEVELOPMENT, V119, P419; Lu JR, 1999, MOL CELL BIOL, V19, P4495; Mack CP, 1999, CIRC RES, V84, P852; MARAIS R, 1993, CELL, V73, P381, DOI 10.1016/0092-8674(93)90237-K; McFadden DG, 2000, DEVELOPMENT, V127, P5331; Morin S, 2001, MOL CELL BIOL, V21, P1036, DOI 10.1128/MCB.21.4.1036-1044.2001; Nakagawa O, 2000, P NATL ACAD SCI USA, V97, P13655, DOI 10.1073/pnas.250485597; NORMAN C, 1988, CELL, V55, P989, DOI 10.1016/0092-8674(88)90244-9; Paradis P, 1996, J BIOL CHEM, V271, P10827, DOI 10.1074/jbc.271.18.10827; PRYWES R, 1992, NUCLEIC ACIDS RES, V20, P513, DOI 10.1093/nar/20.3.513; PTASHNE M, 1988, NATURE, V335, P683, DOI 10.1038/335683a0; REECY J, 1998, HEART DEV, P273; Santelli E, 2000, J MOL BIOL, V297, P437, DOI 10.1006/jmbi.2000.3568; SHAW PE, 1989, CELL, V56, P563, DOI 10.1016/0092-8674(89)90579-5; SHORE P, 1995, EUR J BIOCHEM, V229, P1, DOI 10.1111/j.1432-1033.1995.tb20430.x; Sotiropoulos A, 1999, CELL, V98, P159, DOI 10.1016/S0092-8674(00)81011-9; SPRENKLE AB, 1995, CIRC RES, V77, P1060, DOI 10.1161/01.RES.77.6.1060; TREISMAN R, 1994, CURR OPIN GENET DEV, V4, P96, DOI 10.1016/0959-437X(94)90097-3; Wang DZ, 1999, DEVELOPMENT, V126, P1281; ZHU H, 1991, MOL CELL BIOL, V11, P2273, DOI 10.1128/MCB.11.4.2273	42	721	765	1	31	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 29	2001	105	7					851	862		10.1016/S0092-8674(01)00404-4	http://dx.doi.org/10.1016/S0092-8674(01)00404-4			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	449BK	11439182	Bronze			2022-12-24	WOS:000169664300006
J	Myung, K; Chen, C; Kolodner, RD				Myung, K; Chen, C; Kolodner, RD			Multiple pathways cooperate in the suppression of genome instability in Saccharomyces cerevisiae	NATURE			English	Article							STRAND-BREAK REPAIR; CHROMOSOMAL REARRANGEMENTS; DNA HELICASE; YEAST; RECOMBINATION; MAINTENANCE; TELOMERASE; ENDS; REPLICATION; MUTANTS	Gross chromosome rearrangements (GCRs), such as translocations, deletion of a chromosome arm, interstitial deletions and inversions, are often observed in cancer cells(1-3). Spontaneous GCRs are rare in Saccharomyces cerevisiae; however, the existence of mutator mutants with increased genome instability suggests that GCRs are actively suppressed(4,5). Here we show by genetic analysis that these genome rearrangements probably result from DNA replication errors and are suppressed by at least three interacting pathways or groups of proteins: S-phase checkpoint functions 5, recombination proteins(4) and proteins that prevent de novo addition of telomeres at double-strand breaks (DSBs). Mutations that inactivate these pathways cause high rates of GCRs and show synergistic interactions, indicating that the pathways that suppress GCRs all compete for the same DNA substrates.	Univ Calif San Diego, Sch Med, Ctr Canc, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92093 USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego	Kolodner, RD (corresponding author), Univ Calif San Diego, Sch Med, Ctr Canc, Ludwig Inst Canc Res, La Jolla, CA 92093 USA.		Chen, Clark C/C-8714-2013	Chen, Clark C/0000-0001-6258-9277				Bai Y, 1996, GENE DEV, V10, P2025, DOI 10.1101/gad.10.16.2025; Boulton SJ, 1996, EMBO J, V15, P5093, DOI 10.1002/j.1460-2075.1996.tb00890.x; Bryan TM, 1999, CURR OPIN CELL BIOL, V11, P318, DOI 10.1016/S0955-0674(99)80043-X; Chen C, 1998, MOL CELL, V2, P9, DOI 10.1016/S1097-2765(00)80109-4; Chen C, 1999, NAT GENET, V23, P81, DOI 10.1038/12687; Chen QJ, 2001, MOL CELL BIOL, V21, P1819, DOI 10.1128/MCB.21.5.1819-1827.2001; Diede SJ, 1999, CELL, V99, P723, DOI 10.1016/S0092-8674(00)81670-0; Grandin N, 1997, GENE DEV, V11, P512, DOI 10.1101/gad.11.4.512; HABER J E, 1992, Current Opinion in Cell Biology, V4, P401, DOI 10.1016/0955-0674(92)90005-W; Herrmann G, 1998, EMBO J, V17, P4188, DOI 10.1093/emboj/17.14.4188; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; LAHAYE A, 1991, EMBO J, V10, P997, DOI 10.1002/j.1460-2075.1991.tb08034.x; Lee SE, 1998, CELL, V94, P399, DOI 10.1016/S0092-8674(00)81482-8; Lee SE, 1999, CURR BIOL, V9, P767, DOI 10.1016/S0960-9822(99)80339-X; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Lewis LK, 2000, MUTAT RES-FUND MOL M, V451, P71, DOI 10.1016/S0027-5107(00)00041-5; Lundblad V, 2000, MUTAT RES-FUND MOL M, V451, P227, DOI 10.1016/S0027-5107(00)00052-X; Michel B, 2000, TRENDS BIOCHEM SCI, V25, P173, DOI 10.1016/S0968-0004(00)01560-7; MITELMAN F, 1991, CATALOG CHROMOSOME A; Moore JK, 1996, MOL CELL BIOL, V16, P2164, DOI 10.1128/mcb.16.5.2164; Myung KJ, 2001, CELL, V104, P397, DOI 10.1016/S0092-8674(01)00227-6; Nugent CI, 1996, SCIENCE, V274, P249, DOI 10.1126/science.274.5285.249; Padilla-Nash HM, 1999, GENE CHROMOSOME CANC, V25, P53, DOI 10.1002/(SICI)1098-2264(199905)25:1<53::AID-GCC8>3.0.CO;2-T; Pennock E, 2001, CELL, V104, P387, DOI 10.1016/S0092-8674(01)00226-4; Petrini JHJ, 2000, CURR OPIN CELL BIOL, V12, P293, DOI 10.1016/S0955-0674(00)00091-0; SCHULZ VP, 1994, CELL, V76, P145, DOI 10.1016/0092-8674(94)90179-1; Signon L, 2001, MOL CELL BIOL, V21, P2048, DOI 10.1128/MCB.21.6.2048-2056.2001; Teo SH, 1997, EMBO J, V16, P4788, DOI 10.1093/emboj/16.15.4788; Vessey CJ, 2000, PROG NUCLEIC ACID RE, V63, P189, DOI 10.1016/S0079-6603(08)60723-0; Zhou JQ, 2000, SCIENCE, V289, P771, DOI 10.1126/science.289.5480.771	30	292	294	0	11	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 28	2001	411	6841					1073	1076		10.1038/35082608	http://dx.doi.org/10.1038/35082608			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	446TF	11429610				2022-12-24	WOS:000169528500053
J	Schulz, R; Beach, SR; Lind, B; Martire, LM; Zdaniuk, B; Hirsch, C; Jackson, S; Burton, L				Schulz, R; Beach, SR; Lind, B; Martire, LM; Zdaniuk, B; Hirsch, C; Jackson, S; Burton, L			Involvement in caregiving and adjustment to death of a spouse - Findings from the caregiver health effects study	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BEREAVEMENT; DEPRESSION; PREDICTORS	Context Most deaths in the United States occur among older persons who have 1 or more disabling conditions. As a result, many deaths are preceded by an extended period during which family members provide care to their disabled relative. Objective To better understand the effect of bereavement on family caregivers by examining predeath vs postdeath changes in self-reported and objective health outcomes among elderly persons providing varying levels of care prior to their spouse's death. Design and Setting Prospective, population-based cohort study conducted in 4 US communities between 1993 and 1998. Participants One hundred twenty-nine individuals aged 66 to 96 years whose spouse died during an average 4-year follow-up. Individuals were classified as noncaregivers (n=40), caregivers who reported no strain (n=37), or strained caregivers (n=52). Main Outcome Measures Changes in depression symptoms (assessed by the 10-item Center for Epidemiological Studies-Depression [CES-D] scale), antidepressant medication use, 6 health risk behaviors, and weight among the 3 groups of participants. Results Controlling for age, sex, race, education, prevalent cardiovascular disease at baseline, and interval between predeath and postdeath assessments, CES-D scores remained high but did not change among strained caregivers (9.44 vs 9.19; P=.76), while these scores increased for both noncaregivers (4.74 vs 8.25; F-1,F-116=14.33; P<.001) and nonstrained caregivers (4.94 vs 7.13; F-1,F-116=4.35; P= .04) Noncaregivers were significantly more likely to be using nontricyclic antidepressant medications following the death than the nonstrained caregiver group (odds ratio [OR], 12.85; 95% confidence interval [Cl], 1.02-162.13; P=.05). The strained caregiver group experienced significant improvement in health risk behaviors following the death of their spouse (1.47 vs 0.66 behaviors; F-1,F-118=20.23; P<.001), while the noncaregiver and nonstrained caregiver groups showed little change (0.27 vs 0.27 [P=.99] and 0.46 vs 0.27 [P=.39] behaviors, respectively). Noncaregivers experienced significant weight loss following the death (149.1 vs 145.3 lb [67.1 vs 65.4 kg]; F-1,F-101=8.12; P=.005), while the strained and nonstrained caregiving groups did not show significant weight change (156.2 vs 155.2 lb [70.3 vs 69.8 kg] [P= 41] and 156.2 vs 154.0 lb [70.3 vs 69.3 kg] [P=.12], respectively). Conclusions These data indicate that the impact of losing one's spouse among older persons Varies as a function of the caregiving experiences that precede the death. Among individuals who are already strained prior to the death of their spouse, the death itself does not increase their level of distress. Instead, they show reductions in health risk behaviors. Among noncaregivers, losing one's spouse results in increased depression and weight loss.	Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Univ Ctr Social & Urban Res, Pittsburgh, PA 15260 USA; Univ Washington, Dept Biostat, Seattle, WA 98195 USA; Univ Calif Davis, Davis Med Ctr, Div Gen Med, Davis, CA USA; Wake Forest Univ, Sch Med, Dept Publ Hlth Sci, Epidemiol Sect, Winston Salem, NC 27109 USA; Johns Hopkins Univ, Sch Hyg & Publ Hlth, Hlth Serv & Dev Ctr, Baltimore, MD USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Washington; University of Washington Seattle; University of California System; University of California Davis; Wake Forest University; Johns Hopkins University	Schulz, R (corresponding author), Univ Pittsburgh, Dept Psychiat, 121 Univ Pl, Pittsburgh, PA 15260 USA.				DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC085086, N01HC085079] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL065111, P50HL065112] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH052247, R01MH046015, T32MH019986] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U01AG013305] Funding Source: NIH RePORTER; NHLBI NIH HHS [N01-HC-85086, HL65111, HL65112, N01-HC-85079] Funding Source: Medline; NIA NIH HHS [AG13305, AG01532] Funding Source: Medline; NIMH NIH HHS [R01 MH52247, T32 MH19986, R01 MH46015] Funding Source: Medline	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BODNAR JC, 1994, PSYCHOL AGING, V9, P372; Emanuel EJ, 1999, NEW ENGL J MED, V341, P956, DOI 10.1056/NEJM199909233411306; Emanuel EJ, 2000, ANN INTERN MED, V132, P451, DOI 10.7326/0003-4819-132-6-200003210-00005; Fried Linda P., 1991, Annals of Epidemiology, V1, P263; Kurtz ME, 1997, SUPPORT CARE CANCER, V5, P53, DOI 10.1007/BF01681962; MCHORNEY CA, 1988, MED CARE, V26, P882, DOI 10.1097/00005650-198809000-00007; Park CL, 1997, J PERS, V65, P421, DOI 10.1111/j.1467-6494.1997.tb00960.x; Psaty Bruce M., 1995, Annals of Epidemiology, V5, P270, DOI 10.1016/1047-2797(94)00092-8; SCHULZ R, 1995, GERONTOLOGIST, V35, P771, DOI 10.1093/geront/35.6.771; Schulz R, 1997, ANN BEHAV MED, V19, P110, DOI 10.1007/BF02883327; Schulz R, 1997, AGING MENT HEALTH, V1, P269, DOI 10.1080/13607869757173; Schulz R, 1999, JAMA-J AM MED ASSOC, V282, P2215, DOI 10.1001/jama.282.23.2215; SHROUT PE, 1989, J CLIN EPIDEMIOL, V42, P69, DOI 10.1016/0895-4356(89)90027-9; Tell G S, 1993, Ann Epidemiol, V3, P358, DOI 10.1016/1047-2797(93)90062-9	14	179	182	1	15	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 27	2001	285	24					3123	3129		10.1001/jama.285.24.3123	http://dx.doi.org/10.1001/jama.285.24.3123			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	444FF	11427141				2022-12-24	WOS:000169388900026
J	Kivipelto, M; Helkala, EL; Laakso, MP; Hanninen, T; Hallikainen, M; Alhainen, K; Soininen, H; Tuomilehto, J; Nissien, A				Kivipelto, M; Helkala, EL; Laakso, MP; Hanninen, T; Hallikainen, M; Alhainen, K; Soininen, H; Tuomilehto, J; Nissien, A			Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							APOLIPOPROTEIN-E; BLOOD-PRESSURE; DEMENTIA; ATHEROSCLEROSIS; HYPERTENSION	Objective To examine the relation of midlife raised blood pressure and serum cholesterol concentrations to Alzheimer's disease in later life. Design Prospective, population based study. Setting Populations of Kuopio and Joensuu, eastern Finland. Participants Participants were derived from random, population based samples previously studied in a survey carried out in 1972, 1977, 1982, or 1987. After an average of 21 years' follow up, a total of 1449 (73%) participants aged 65-79 took part in the re-examination in 1998. Main outcome measures Midlife blood pressure and cholesterol concentrations and development of Alzheimer's disease in later life. Results People with raised systolic blood pressure (greater than or equal to 160 mm Hg) or high serum cholesterol concentration (greater than or equal to6.5 mmol/l) in midlife had a significantly higher risk of Alzheimer's disease in later life, even after adjustment for age, body mass index, education, vascular events, smoking status, and alcohol consumption, than those with normal systolic blood pressure (odds ratio 2.3, 95% confidence interval 1.0 to 5.5) or serum cholesterol (odds ratio 2.1, 1.0 to 4.4). Participants with both of these risk factors in midlife had a significantly higher risk of developing Alzheimer's disease than those with either of the risk factors alone (odds ratio 3.5, 1.6 to 7.9). Diastolic blood pressure in midlife had no significant effect on the risk of Alzheimer's disease. Conclusion Raised systolic blood pressure and high serum cholesterol concentration, and in particular the combination of these risks, in midlife increase the risk of Alzheimer's disease in later life.	Univ Kuopio, Dept Neurol & Neurosci, FIN-70211 Kuopio, Finland; Univ Kuopio, Dept Publ Hlth & Gen Practice, FIN-70211 Kuopio, Finland; Dept Clin Radiol, Kuopio 70211, Finland; Kuopio Univ Hosp, Dept Neurol, SF-70210 Kuopio, Finland; N Karelia Cent Hosp, Joensuu 80210, Finland; Natl Publ Hlth Inst, SF-00300 Helsinki, Finland	University of Eastern Finland; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; Finland National Institute for Health & Welfare	Kivipelto, M (corresponding author), Univ Kuopio, Dept Neurol & Neurosci, POB 1627, FIN-70211 Kuopio, Finland.	miia.kivipelto@uku.fi	Kivipelto, Miia/AAS-3557-2021; Laakso, Mikko/AHB-7022-2022	Laakso, Mikko/0000-0003-1250-3425; Kivipelto, Miia/0000-0003-0992-3875				American Psychological Association, 1994, DIAGN STAT MAN MENT, V4th; APPLEGATE WB, 1989, ANN INTERN MED, V110, P901, DOI 10.7326/0003-4819-110-11-901; Braak E, 1999, EUR ARCH PSY CLIN N, V249, P14; Brookmeyer R, 1998, AM J PUBLIC HEALTH, V88, P1337, DOI 10.2105/AJPH.88.9.1337; DAVIGNON J, 1988, ARTERIOSCLEROSIS, V8, P1, DOI 10.1161/01.ATV.8.1.1; Forette F, 1998, LANCET, V352, P1347, DOI 10.1016/S0140-6736(98)03086-4; HACHINSKI VC, 1975, ARCH NEUROL-CHICAGO, V32, P632, DOI 10.1001/archneur.1975.00490510088009; Hofman A, 1997, LANCET, V349, P151, DOI 10.1016/S0140-6736(96)09328-2; Klungel OH, 2000, STROKE, V31, P420, DOI 10.1161/01.STR.31.2.420; Kosunen O, 1996, ACTA NEUROPATHOL, V91, P185, DOI 10.1007/s004010050412; Launer LJ, 2000, NEUROBIOL AGING, V21, P49, DOI 10.1016/S0197-4580(00)00096-8; LAUNER LJ, 1994, AM J EPIDEMIOL, V139, P803, DOI 10.1093/oxfordjournals.aje.a117077; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Notkola IL, 1998, NEUROEPIDEMIOLOGY, V17, P14, DOI 10.1159/000026149; Skoog I, 1999, ALZ DIS ASSOC DIS, V13, pS106, DOI 10.1097/00002093-199912003-00016; Skoog I, 1996, LANCET, V347, P1141, DOI 10.1016/S0140-6736(96)90608-X; VARTIAINEN E, 1994, INT J EPIDEMIOL, V23, P495, DOI 10.1093/ije/23.3.495	17	1146	1188	1	63	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 16	2001	322	7300					1447	1451		10.1136/bmj.322.7300.1447	http://dx.doi.org/10.1136/bmj.322.7300.1447			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	444FJ	11408299	Green Published, Green Submitted, Bronze			2022-12-24	WOS:000169389200022
J	Rowbotham, DJ				Rowbotham, DJ			Endogenous opioids, placebo response, and pain	LANCET			English	Editorial Material							ANALGESIA; MORPHINE; RECEPTOR; PHARMACOKINETICS; NOCICEPTIN		Leicester Royal Infirm, Leicester Warwick Med Sch, Dept Anaesthesia & Pain Management, Leicester LE1 5WW, Leics, England	University of Leicester	Rowbotham, DJ (corresponding author), Leicester Royal Infirm, Leicester Warwick Med Sch, Dept Anaesthesia & Pain Management, Leicester LE1 5WW, Leics, England.							Amanzio M, 2001, PAIN, V90, P205, DOI 10.1016/S0304-3959(00)00486-3; BAILLIE SP, 1989, AGE AGEING, V18, P258, DOI 10.1093/ageing/18.4.258; Calo' G, 2000, BRIT J PHARMACOL, V129, P1183, DOI 10.1038/sj.bjp.0703169; Calo G, 2000, BRIT J PHARMACOL, V129, P1261, DOI 10.1038/sj.bjp.0703219; Darland T, 1998, TRENDS NEUROSCI, V21, P215, DOI 10.1016/S0166-2236(97)01204-6; Gear RW, 1996, NAT MED, V2, P1248, DOI 10.1038/nm1196-1248; GLARE PA, 1991, THER DRUG MONIT, V13, P1, DOI 10.1097/00007691-199101000-00001; Horvath G, 2000, PHARMACOL THERAPEUT, V88, P437, DOI 10.1016/S0163-7258(00)00100-5; Hrobjartsson A, 2001, NEW ENGL J MED, V344, P1594, DOI 10.1056/NEJM200105243442106; LEVINE JD, 1978, LANCET, V2, P654, DOI 10.1016/S0140-6736(78)92762-9; MANSOUR A, 1988, TRENDS NEUROSCI, V11, P308, DOI 10.1016/0166-2236(88)90093-8; Picard PR, 1997, PAIN, V72, P309, DOI 10.1016/S0304-3959(97)00040-7; PLEUVRY BJ, 1991, BRIT J ANAESTH, V66, P370, DOI 10.1093/bja/66.3.370; PORTENOY RK, 1990, PAIN, V43, P273, DOI 10.1016/0304-3959(90)90025-9; Price DD, 1999, PAIN, V83, P147, DOI 10.1016/S0304-3959(99)00081-0; Stein C, 1997, PAIN, V71, P119, DOI 10.1097/00006396-199706000-00001; ter Riet G, 1998, PAIN, V76, P273, DOI 10.1016/S0304-3959(98)00057-8; YAKSH TL, 1978, PAIN, V4, P299, DOI 10.1016/0304-3959(77)90145-2; Zadina JE, 1997, NATURE, V386, P499, DOI 10.1038/386499a0	19	15	15	1	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 16	2001	357	9272					1901	1902		10.1016/S0140-6736(00)05090-X	http://dx.doi.org/10.1016/S0140-6736(00)05090-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	444YZ	11425407				2022-12-24	WOS:000169431000005
J	Franklin, MC; Wang, JM; Steitz, TA				Franklin, MC; Wang, JM; Steitz, TA			Structure of the replicating complex of a pol alpha family DNA polymerase	CELL			English	Article							I KLENOW FRAGMENT; CRYSTAL-STRUCTURE; KINETIC CHARACTERIZATION; ACTIVE-SITE; REVERSE-TRANSCRIPTASE; ANGSTROM RESOLUTION; MUTATIONAL ANALYSIS; TERNARY COMPLEXES; B-DNA; BACTERIOPHAGE-T4	We describe the 2.6 Angstrom resolution crystal structure of RB69 DNA polymerase with primer-template DNA and dTTP, capturing the step just before primer extension. This ternary complex structure in the human DNA polymerase alpha family shows a 60 degrees rotation of the fingers domain relative to the ape-protein structure, similar to the fingers movement in pol I family polymerases. Minor groove interactions near the primer 3' terminus suggest a common fidelity mechanism for pol I and pol alpha family polymerases. The duplex product DNA orientation differs by 40 degrees between the polymerizing mode and editing mode structures. The role of the thumb in this DNA motion provides a model for editing in the pol alpha family.	Yale Univ, Dept Mol Biophys & Biochem, POB 6666, New Haven, CT 06511 USA; Yale Univ, Dept Chem, New Haven, CT 06511 USA; Yale Univ, Howard Hughes Med Inst, New Haven, CT 06511 USA	Yale University; Yale University; Howard Hughes Medical Institute; Yale University	Steitz, TA (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, POB 6666, New Haven, CT 06511 USA.	eatherton@csb.yale.edu	Steitz, Thomas A./C-6559-2009		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057510] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM57510] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Astatke M, 1998, P NATL ACAD SCI USA, V95, P3402, DOI 10.1073/pnas.95.7.3402; Bankier A T, 1983, Mol Biol Med, V1, P21; BEESE LS, 1993, BIOCHEMISTRY-US, V32, P14095, DOI 10.1021/bi00214a004; BEESE LS, 1993, SCIENCE, V260, P352, DOI 10.1126/science.8469987; Berdis AJ, 1996, P NATL ACAD SCI USA, V93, P12822, DOI 10.1073/pnas.93.23.12822; BHAT TN, 1988, J APPL CRYSTALLOGR, V21, P279, DOI 10.1107/S0021889887012755; BLASCO MA, 1995, J BIOL CHEM, V270, P2735, DOI 10.1074/jbc.270.6.2735; Bonnin A, 1999, J MOL BIOL, V290, P241, DOI 10.1006/jmbi.1999.2900; BRAITHWAITE DK, 1993, NUCLEIC ACIDS RES, V21, P787, DOI 10.1093/nar/21.4.787; Brautigam CA, 1998, CURR OPIN STRUC BIOL, V8, P54, DOI 10.1016/S0959-440X(98)80010-9; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CAPSON TL, 1992, BIOCHEMISTRY-US, V31, P10984, DOI 10.1021/bi00160a007; COPELAND WC, 1993, J BIOL CHEM, V268, P11028; COWART M, 1989, BIOCHEMISTRY-US, V28, P1975, DOI 10.1021/bi00431a004; DAHLBERG ME, 1991, BIOCHEMISTRY-US, V30, P4835, DOI 10.1021/bi00234a002; DELARUE M, 1990, PROTEIN ENG, V3, P461, DOI 10.1093/protein/3.6.461; DONLIN MJ, 1991, BIOCHEMISTRY-US, V30, P538, DOI 10.1021/bi00216a031; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; Doublie S, 1999, STRUCTURE, V7, pR31, DOI 10.1016/S0969-2126(99)80017-3; DRAKE JW, 1991, P NATL ACAD SCI USA, V88, P7160, DOI 10.1073/pnas.88.16.7160; Dressman HK, 1997, P NATL ACAD SCI USA, V94, P8042, DOI 10.1073/pnas.94.15.8042; Eom SH, 1996, NATURE, V382, P278, DOI 10.1038/382278a0; EPSTEIN RH, 1963, COLD SPRING HARB SYM, V28, P375, DOI 10.1101/SQB.1963.028.01.053; Frey B, 1995, BIOCHEMICA, V2, P34; Gao GX, 1997, P NATL ACAD SCI USA, V94, P407, DOI 10.1073/pnas.94.2.407; Gardner AF, 1999, NUCLEIC ACIDS RES, V27, P2545, DOI 10.1093/nar/27.12.2545; Hopfner KP, 1999, P NATL ACAD SCI USA, V96, P3600, DOI 10.1073/pnas.96.7.3600; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; HUGHES MB, 1987, GENETICS, V115, P393; HUNTER WN, 1987, NUCLEIC ACIDS RES, V15, P6589, DOI 10.1093/nar/15.16.6589; HUNTER WN, 1987, J BIOL CHEM, V262, P9962; JACOBOMOLINA A, 1993, P NATL ACAD SCI USA, V90, P6320, DOI 10.1073/pnas.90.13.6320; Jang SB, 1998, BIOCHEMISTRY-US, V37, P11726, DOI 10.1021/bi980758j; JOHNSON KA, 1993, ANNU REV BIOCHEM, V62, P685, DOI 10.1146/annurev.bi.62.070193.003345; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Karam JD, 2000, PROG NUCLEIC ACID RE, V64, P65, DOI 10.1016/S0079-6603(00)64002-3; Kiefer JR, 1998, NATURE, V391, P304, DOI 10.1038/34693; Kool ET, 1998, BIOPOLYMERS, V48, P3, DOI 10.1002/(SICI)1097-0282(1998)48:1<3::AID-BIP2>3.0.CO;2-7; KUCHTA RD, 1987, BIOCHEMISTRY-US, V26, P8410, DOI 10.1021/bi00399a057; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li Y, 1998, EMBO J, V17, P7514, DOI 10.1093/emboj/17.24.7514; LIN TC, 1994, J BIOL CHEM, V269, P19286; Minnick DT, 1999, J BIOL CHEM, V274, P3067, DOI 10.1074/jbc.274.5.3067; OLLIS DL, 1985, NATURE, V313, P762, DOI 10.1038/313762a0; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pan BC, 1999, BIOCHEMISTRY-US, V38, P2826, DOI 10.1021/bi982122y; PATEL SS, 1991, BIOCHEMISTRY-US, V30, P511, DOI 10.1021/bi00216a029; Pavlov AR, 2000, NUCLEIC ACIDS RES, V28, P4657, DOI 10.1093/nar/28.23.4657; PELLETIER H, 1994, SCIENCE, V264, P1891, DOI 10.1126/science.7516580; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; REHAKRANTZ LJ, 1989, J VIROL, V63, P4762, DOI 10.1128/JVI.63.11.4762-4766.1989; RICE LM, 1994, PROTEINS, V19, P277, DOI 10.1002/prot.340190403; Rodriguez AC, 2000, J MOL BIOL, V299, P447, DOI 10.1006/jmbi.2000.3728; Saturno J, 1995, J BIOL CHEM, V270, P31235, DOI 10.1074/jbc.270.52.31235; Saturno J, 1998, J MOL BIOL, V283, P633, DOI 10.1006/jmbi.1998.2121; Sawaya MR, 1997, BIOCHEMISTRY-US, V36, P11205, DOI 10.1021/bi9703812; Schultz J, 2000, NUCLEIC ACIDS RES, V28, P231, DOI 10.1093/nar/28.1.231; SEEMAN NC, 1976, P NATL ACAD SCI USA, V73, P804, DOI 10.1073/pnas.73.3.804; Shamoo Y, 1999, CELL, V99, P155, DOI 10.1016/S0092-8674(00)81647-5; STOCKI SA, 1995, J MOL BIOL, V254, P15, DOI 10.1006/jmbi.1995.0595; TUERK C, 1990, J MOL BIOL, V213, P749, DOI 10.1016/S0022-2836(05)80261-X; WANG CC, 1995, J BIOL CHEM, V270, P26558, DOI 10.1074/jbc.270.44.26558; Wang J, 1997, CELL, V89, P1087, DOI 10.1016/S0092-8674(00)80296-2; WONG I, 1991, BIOCHEMISTRY-US, V30, P526, DOI 10.1021/bi00216a030; Wu P, 1998, BIOCHEMISTRY-US, V37, P14748, DOI 10.1021/bi980835a; Yang GW, 1999, BIOCHEMISTRY-US, V38, P8094, DOI 10.1021/bi990653w; Zhao YX, 1999, STRUCTURE, V7, P1189, DOI 10.1016/S0969-2126(00)80053-2; [No title captured]	69	470	482	1	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 1	2001	105	5					657	667		10.1016/S0092-8674(01)00367-1	http://dx.doi.org/10.1016/S0092-8674(01)00367-1			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	439NL	11389835	Bronze			2022-12-24	WOS:000169123200012
J	Schliekelman, P; Garner, C; Slatkin, M				Schliekelman, P; Garner, C; Slatkin, M			Natural selection and resistance to HIV	NATURE			English	Article							HAPLOTYPES; PREVALENCE		Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Schliekelman, P (corresponding author), Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA.							ALLISON AC, 1954, BRIT MED J, V1, P290, DOI 10.1136/bmj.1.4857.290; Charlesworth B., 1980, EVOLUTION AGE STRUCT; Gonzalez E, 1999, P NATL ACAD SCI USA, V96, P12004, DOI 10.1073/pnas.96.21.12004; Gregson S, 1996, AIDS, V10, P1689, DOI 10.1097/00002030-199612000-00014; Stephens JC, 1998, AM J HUM GENET, V62, P1507, DOI 10.1086/301867; *UN, 2000, JOINT UN PROGR HIV A; United States Census Bureau, 2000, CENS; Wilkinson D, 2000, J ACQ IMMUN DEF SYND, V23, P405	8	49	51	0	10	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 31	2001	411	6837					545	546		10.1038/35079176	http://dx.doi.org/10.1038/35079176			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437GE	11385558				2022-12-24	WOS:000168982500037
J	He, S; MacLeod, DIA				He, S; MacLeod, DIA			Orientation-selective adaptation and tilt after-effect from invisible patterns	NATURE			English	Article							PRIMARY VISUAL-CORTEX; GRATINGS; VISION	Exposure to visual patterns of high contrast (for example, gratings formed by alternating white and black bars) creates after-effects in perception. We become temporarily insensitive to faint test patterns that resemble the pre-exposed pattern (such as gratings of the same orientation), and we require more contrast to detect them(1). Moreover, if the test pattern is slightly tilted relative to the pre-exposed one, this tilt may be perceptually exaggerated: we experience a tilt after-effect(2,3). Here we show that these visual after-effects occur even if the pre-exposed grating is too fine to be perceptually resolved. After looking at a very fine grating, so high in spatial frequency that it was perceptually indistinguishable from a uniform field, observers required more contrast to detect a test grating presented at the same orientation than one presented at the orthogonal orientation. They also experienced a tilt aftereffect that depended on the relation of the test pattern's tilt to the unseen orientation of the pre-exposed pattern. Because these after-effects are due to changes in orientation-sensitive mechanisms in visual cortex(4-6), our observations imply that extremely fine details, even those too fine to be seen, can penetrate the visual system as far as the cortex, where they are represented neurally without conscious awareness.	Univ Minnesota, Dept Psychol, Minneapolis, MN 55455 USA; Univ Calif San Diego, Dept Psychol, La Jolla, CA 92093 USA	University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California San Diego	He, S (corresponding author), Univ Minnesota, Dept Psychol, 75 E River Rd, Minneapolis, MN 55455 USA.							Barlow H B, 1972, Perception, V1, P371, DOI 10.1068/p010371; BLAKEMORE C, 1969, J PHYSIOL-LONDON, V200, pP11; CAMPBELL FW, 1966, J PHYSIOL-LONDON, V186, P558, DOI 10.1113/jphysiol.1966.sp008056; Carandini M, 1998, NEUROPHARMACOLOGY, V37, P501, DOI 10.1016/S0028-3908(98)00069-0; COLTHEART M, 1971, PSYCHOL REV, V78, P114, DOI 10.1037/h0030639; CRICK F, 1995, NATURE, V375, P121, DOI 10.1038/375121a0; Gibson JJ, 1937, J EXP PSYCHOL, V20, P453, DOI 10.1037/h0059826; He S, 1996, J OPT SOC AM A, V13, P1139, DOI 10.1364/JOSAA.13.001139; HUBEL DH, 1977, PROC R SOC SER B-BIO, V198, P1, DOI 10.1098/rspb.1977.0085; LEGRAND Y, 1937, REV OPT, V16, P201; LEVI DM, 1979, SCIENCE, V206, P852, DOI 10.1126/science.493988; MAFFEI L, 1973, SCIENCE, V182, P1036, DOI 10.1126/science.182.4116.1036; McMahon MJ, 2000, J NEUROSCI, V20, P2043; MOVSHON JA, 1979, NATURE, V278, P850, DOI 10.1038/278850a0; RATLIFF F, 1965, MACH BANDS QUANTITAT, P1; REID RC, 1995, NATURE, V378, P281, DOI 10.1038/378281a0; SEKIGUCHI N, 1993, J OPT SOC AM A, V10, P2118, DOI 10.1364/JOSAA.10.002118; Smallman HS, 1996, J NEUROSCI, V16, P1852; WOLFE JM, 1984, VISION RES, V24, P1959, DOI 10.1016/0042-6989(84)90030-0	19	119	123	0	24	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 24	2001	411	6836					473	476		10.1038/35078072	http://dx.doi.org/10.1038/35078072			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	435CB	11373679				2022-12-24	WOS:000168858700048
J	Oren, R; Ellsworth, DS; Johnsen, KH; Phillips, N; Ewers, BE; Maier, C; Schafer, KVR; McCarthy, H; Hendrey, G; McNulty, SG; Katul, GG				Oren, R; Ellsworth, DS; Johnsen, KH; Phillips, N; Ewers, BE; Maier, C; Schafer, KVR; McCarthy, H; Hendrey, G; McNulty, SG; Katul, GG			Soil fertility limits carbon sequestration by forest ecosystems in a CO2-enriched atmosphere	NATURE			English	Article							TERRESTRIAL ECOSYSTEMS; NITROGEN LIMITATION; ELEVATED CO2; GROWTH; AIR; ENRICHMENT; FEEDBACKS; BIOSPHERE; BALANCE; BUDGET	Northern mid-latitude forests are a large terrestrial carbon sink(1-4). Ignoring nutrient limitations, large increases in carbon sequestration from carbon dioxide (CO2) fertilization are expected in these forests(5). Yet, forests are usually relegated to sites of moderate to poor fertility, where tree growth is often limited by nutrient supply, in particular nitrogen(6,7). Here we present evidence that estimates of increases in carbon sequestration of forests, which is expected to partially compensate for increasing CO2 in the atmosphere, are unduly optimistic(8). In two forest experiments on maturing pines exposed to elevated atmospheric CO2, the CO2-induced biomass carbon increment without added nutrients was undetectable at a nutritionally poor site, and the stimulation at a nutritionally moderate site was transient, stabilizing at a marginal gain after three years. However, a large synergistic gain from higher CO2 and nutrients was detected with nutrients added. This gain was even larger at the poor site (threefold higher than the expected additive effect) than at the moderate site (twofold higher). Thus, fertility can restrain the response of wood carbon sequestration to increased atmospheric CO2. Assessment of future carbon sequestration should consider the limitations imposed by soil fertility, as well as interactions with nitrogen deposition.	Duke Univ, Nicholas Sch Environm & Earth Sci, Durham, NC 27708 USA; Univ Michigan, Sch Nat Resources & Environm, Ann Arbor, MI 48109 USA; Brookhaven Natl Lab, Dept Environm Sci, Upton, NY 11973 USA; US Forest Serv, So Res Stn, Res Triangle Pk, NC 27709 USA; Boston Univ, Dept Geog, Boston, MA 02215 USA; US Forest Serv, So Global Climate Change Program, Raleigh, NC 27606 USA	Duke University; University of Michigan System; University of Michigan; United States Department of Energy (DOE); Brookhaven National Laboratory; United States Department of Agriculture (USDA); United States Forest Service; Boston University; United States Department of Agriculture (USDA); United States Forest Service	Oren, R (corresponding author), Duke Univ, Nicholas Sch Environm & Earth Sci, Durham, NC 27708 USA.	ramoren@duke.edu	McCarthy, Heather/Q-9347-2019; Katul, Gabriel G/A-7210-2008; Oren, Ram/AAC-5326-2019; Ewers, Brent E/A-9696-2008	Katul, Gabriel G/0000-0001-9768-3693; Oren, Ram/0000-0002-5654-1733; McNulty, Steven/0000-0003-4518-5646; McCarthy, Heather R/0000-0002-2219-5182; Ewers, Brent/0000-0001-6647-7475; Ellsworth, David/0000-0002-9699-2272				Aber J, 1998, BIOSCIENCE, V48, P921, DOI 10.2307/1313296; Albaugh TJ, 1998, FOREST SCI, V44, P317; BAZZAZ FA, 1993, OECOLOGIA, V96, P478, DOI 10.1007/BF00320504; Berntson GM, 1996, PLANT SOIL, V187, P119, DOI 10.1007/BF00017085; Bolin B, 1999, SCIENCE, V285, P1851; CIAIS P, 1995, SCIENCE, V269, P1098, DOI 10.1126/science.269.5227.1098; COMINS HN, 1993, ECOL APPL, V3, P666, DOI 10.2307/1942099; DeLucia EH, 1999, SCIENCE, V284, P1177, DOI 10.1126/science.284.5417.1177; ELLSWORTH DS, 1995, OECOLOGIA, V104, P139, DOI 10.1007/BF00328578; Field CB, 1999, SCIENCE, V285, P544, DOI 10.1126/science.285.5427.544; Hendrey GR, 1999, GLOBAL CHANGE BIOL, V5, P293, DOI 10.1046/j.1365-2486.1999.00228.x; Houghton RA, 1999, SCIENCE, V285, P574, DOI 10.1126/science.285.5427.574; Houghton RA, 1998, GLOBAL BIOGEOCHEM CY, V12, P25, DOI 10.1029/97GB02729; Hu S, 2001, NATURE, V409, P188, DOI 10.1038/35051576; IDSO SB, 1993, GLOBAL BIOGEOCHEM CY, V7, P537, DOI 10.1029/93GB01164; Kicklighter DW, 1999, TELLUS B, V51, P343, DOI 10.1034/j.1600-0889.1999.00017.x; KORNER C, 1995, PLANT CELL ENVIRON, V18, P1101, DOI 10.1111/j.1365-3040.1995.tb00622.x; Linder S, 1995, ECOL B COPENHAGEN, V44, P178, DOI DOI 10.2307/20113161; Nadelhoffer KJ, 1999, NATURE, V398, P145, DOI 10.1038/18205; Naidu SL, 1998, CAN J FOREST RES, V28, P1116, DOI 10.1139/cjfr-28-8-1116; Norby RJ, 1998, NATURE, V396, P17, DOI 10.1038/23812; Oren R, 1998, ECOL APPL, V8, P990, DOI 10.1890/1051-0761(1998)008[0990:WBDTSL]2.0.CO;2; Oren R., 1996, P75; SCHIMEL DS, 1995, GLOBAL CHANGE BIOL, V1, P77, DOI 10.1111/j.1365-2486.1995.tb00008.x; Sokal Robert R., 1969, BIOMETRY; Tans PP, 1998, SCIENCE, V281, P183, DOI 10.1126/science.281.5374.183; Tissue DT, 1996, TREE PHYSIOL, V16, P49; VITOUSEK PM, 1991, BIOGEOCHEMISTRY, V13, P87; VITOUSEK PM, 1994, ECOLOGY, V75, P1861, DOI 10.2307/1941591; Wullschleger S., 1995, BIOTIC FEEDBACKS GLO, P85	30	795	844	8	425	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 24	2001	411	6836					469	472		10.1038/35078064	http://dx.doi.org/10.1038/35078064			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	435CB	11373677	Green Published			2022-12-24	WOS:000168858700046
J	Bradley, EH; Holmboe, ES; Mattera, JA; Roumanis, SA; Radford, MJ; Krumholz, HM				Bradley, EH; Holmboe, ES; Mattera, JA; Roumanis, SA; Radford, MJ; Krumholz, HM			A qualitative study of increasing beta-blocker use after myocardial infarction - Why do some hospitals succeed?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PRACTICE GUIDELINES; OF-CARE; MEDICARE PATIENTS; MANAGEMENT; IMPROVEMENT; IMPACT; OUTCOMES	Context Based on evidence that beta -blockers can reduce mortality in patients with acute myocardial infarction (AMI), many hospitals have initiated performance improvement efforts to increase prescription of beta -blockers at discharge, Determination of the factors associated with such improvements may provide guidance to hospitals that have been less successful in increasing beta -blocker use, Objectives To identify factors that may influence the success of improvement efforts to increase beta -blocker use after AMI and to develop a taxonomy for classifying such efforts. Design, Setting, and Participants Qualitative study in which data were gathered from in-depth interviews conducted in March-June 2000 with 45 key physician, nursing, quality management, and administrative participants at 8 US hospitals chosen to represent a range of hospital sizes, geographic regions, and changes in beta -blocker use rates between October 1996 and September 1999. Main Outcome Measures initiatives, strategies, and approaches to improve care for patients with AMI. Results The interviews revealed 6 broad factors that characterized hospital-based improvement efforts: goals of the efforts, administrative support, support among clinicians, design and implementation of improvement initiatives, use of data, and modifying variables. Hospitals with greater improvements in beta -blocker use over time demonstrated 4 characteristics not found in hospitals with less or no improvement: shared goals for improvement, substantial administrative support, strong physician leadership advocating beta -blocker use, and use of credible data feedback, Conclusions This study provides a context for understanding efforts to improve care in the hospital setting by describing a taxonomy for classifying and evaluating such efforts. In addition, the study suggests possible elements of successful efforts to increase beta -blocker use for patients with AMI.	Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Med, Sect Cardiovasc Med, New Haven, CT 06520 USA; Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, New Haven, CT 06504 USA	Yale University; Yale University; Yale University	Krumholz, HM (corresponding author), Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, 333 Cedar St,POB 208025, New Haven, CT 06520 USA.		, Harlan/AAI-2875-2020	Radford, Martha/0000-0001-7503-9557	AHRQ HHS [R01 HS10407] Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS010407] Funding Source: NIH RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		AGUSTI A, 1994, EUR J CLIN PHARMACOL, V46, P95; AUDET AM, 1990, ANN INTERN MED, V113, P709, DOI 10.7326/0003-4819-113-9-709; Berwick D. M, 1990, CURING HLTH CARE NEW; Blumenthal D, 1998, MILBANK Q, V76, P625, DOI 10.1111/1468-0009.00108; BLUMENTHAL D, 1995, IMPROVING CLIN PRACT; Bogardus ST, 1998, J GEN INTERN MED, V13, P675, DOI 10.1046/j.1525-1497.1998.00203.x; BRAND DA, 1995, J AM COLL CARDIOL, V26, P1432, DOI 10.1016/0735-1097(95)00362-2; Carman JM, 1996, HEALTH CARE MANAGE R, V21, P48; CONSTAS MA, 1992, AM EDUC RES J, V29, P253, DOI 10.3102/00028312029002253; Crabtree BF., 1999, DOING QUALITATIVE RE, V2nd ed; CRECO PJ, 1993, NEW ENGL J MED, V329, P1271; CROCKETT SE, 1998, BETA BLOCKER PROPHYL; DAVIS DA, 1992, JAMA-J AM MED ASSOC, V268, P1111, DOI 10.1001/jama.268.9.1111; ELLERBECK EF, 1995, JAMA-J AM MED ASSOC, V273, P1509, DOI 10.1001/jama.273.19.1509; French WJ, 2000, AM J CARDIOL, V85, p5B; Glaser B. G., 1978, AWARENESS DYING; GURWITZ JH, 1992, AM J MED, V93, P605, DOI 10.1016/0002-9343(92)90192-E; KARLSON BW, 1994, CLIN CARDIOL, V17, P311, DOI 10.1002/clc.4960170608; KOSECOFF J, 1987, JAMA-J AM MED ASSOC, V258, P2708, DOI 10.1001/jama.258.19.2708; Krumholz HM, 1998, JAMA-J AM MED ASSOC, V280, P623, DOI 10.1001/jama.280.7.623; LOMAS J, 1989, NEW ENGL J MED, V321, P1306, DOI 10.1056/NEJM198911093211906; Marciniak TA, 1998, JAMA-J AM MED ASSOC, V279, P1351, DOI 10.1001/jama.279.17.1351; McCracken G., 1988, LONG INTERVIEW; Miles M., 1994, QUALITATIVE DATA ANA; Ryan TJ, 1996, J AM COLL CARDIOL, V28, P1328; Shortell SM, 2000, MED CARE, V38, P207, DOI 10.1097/00005650-200002000-00010; Shortell SM, 1998, MILBANK Q, V76, P593, DOI 10.1111/1468-0009.00107; SIAL SH, 1994, J GEN INTERN MED, V9, P599, DOI 10.1007/BF02600301; Soumerai SB, 1998, JAMA-J AM MED ASSOC, V279, P1358, DOI 10.1001/jama.279.17.1358; Soumeral SB, 1997, JAMA-J AM MED ASSOC, V277, P115, DOI 10.1001/jama.277.2.115; Weiner BJ, 1997, HEALTH SERV RES, V32, P491; Weiner BJ, 1996, MED CARE RES REV, V53, P397, DOI 10.1177/107755879605300402; WHITFORD DL, 1994, BMJ-BRIT MED J, V309, P1268, DOI 10.1136/bmj.309.6964.1268; YUSUF S, 1985, PROG CARDIOVASC DIS, V27, P335, DOI 10.1016/S0033-0620(85)80003-7	35	226	227	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 23	2001	285	20					2604	2611		10.1001/jama.285.20.2604	http://dx.doi.org/10.1001/jama.285.20.2604			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	433LY	11368734	Bronze			2022-12-24	WOS:000168761900027
J	Grohskopf, LA; Roth, VR; Feikin, DR; Arduino, MJ; Carson, LA; Tokars, JI; Holt, SC; Jensen, BJ; Hoffman, RE; Jarvis, WR				Grohskopf, LA; Roth, VR; Feikin, DR; Arduino, MJ; Carson, LA; Tokars, JI; Holt, SC; Jensen, BJ; Hoffman, RE; Jarvis, WR			Serratia liquefaciens bloodstream infections from contamination of epoetin alfa at a hemodialysis center.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BACTERIAL-CONTAMINATION; TRANSFUSION; BLOOD; SEPSIS	Background: In one month, 10 Serratia liquefaciens bloodstream infections and 6 pyrogenic reactions occurred in outpatients at a hemodialysis center. Methods: We performed a cohort study of all hemodialysis sessions on days that staff members reported S. liquefaciens bloodstream infections or pyrogenic reactions. We reviewed procedures and cultured samples of water, medications, soaps, and hand lotions and swabs from the hands of personnel. Results: We analyzed 208 sessions involving 48 patients. In 12 sessions, patients had S. liquefaciens bloodstream infections, and in 8, patients had pyrogenic reactions without bloodstream infection. Sessions with infections or reactions were associated with higher median doses of epoetin alfa than the 188 other sessions (6500 vs. 4000 U, P = 0.03) and were more common during afternoon or evening shifts than morning shifts (P = 0.03). Sessions with infections or reactions were associated with doses of epoetin alfa of more than 4000 U (multivariate odds ratio, 4.0; 95 percent confidence interval, 1.3 to 12.3). A review of procedures revealed that preservative-free, single-use vials of epoetin alfa were punctured multiple times, and residual epoetin alfa from multiple vials was pooled and administered to patients. S. liquefaciens was isolated from pooled epoetin alfa, empty vials of epoetin alfa, antibacterial soap, and hand lotion. All the isolates were identical by pulsed-field gel electrophoresis. After the practice of pooling epoetin alfa was discontinued and the contaminated soap and lotion were replaced, no further S. liquefaciens bloodstream infections or pyrogenic reactions occurred at this hemodialysis facility. Conclusions: Puncturing single-use vials multiple times and pooling preservative-free epoetin alfa caused this outbreak of bloodstream infections in a hemodialysis unit. To prevent similar outbreaks, dialysis units should use medication vials containing the doses most appropriate to their clinical needs. (N Engl J Med 2001;344:1491-7.) Copyright (C) 2001 Massachusetts Medical Society.	CDCP, Hosp Infect Program, Atlanta, GA 30333 USA; CDCP, Epidem Intelligence Serv, Div Appl Publ Hlth Training, Epidemiol Program Off, Atlanta, GA 30333 USA; CDCP, Prevent Med Residency, Div Appl Publ Hlth Training, Epidemiol Program Off, Atlanta, GA 30333 USA; Colorado Dept Publ Hlth & Environm, Denver, CO USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Colorado Department of Public Health & Environment	Grohskopf, LA (corresponding author), CDCP, Hosp Infect Program, 1600 Clifton Rd NE,Mailstop E-69, Atlanta, GA 30333 USA.		Arduino, Matthew/C-1461-2012	Arduino, Matthew/0000-0001-7072-538X				Association for the Advancement of Medical Instrumentation, 1992, AM NAT STAND HEM SYS; Boulton FE, 1998, TRANSFUSION MED, V8, P15; *DHHS, 1997, A019700509 DHHS; DUNCAN KL, 1994, TRANSFUSION, V34, P738, DOI 10.1046/j.1537-2995.1994.34894353473.x; FAVERO FS, 1998, HOSP INFECT, P357; Garg PP, 1999, NEW ENGL J MED, V341, P1653, DOI 10.1056/NEJM199911253412205; GRIMONT PAD, 1978, ANNU REV MICROBIOL, V32, P221, DOI 10.1146/annurev.mi.32.100178.001253; *HLTH CAR FIN ADM, 1999, PROGR MEM INT; JEPPSSON B, 1984, ACTA CHIR SCAND, V150, P489; Maslow Joel N., 1993, P563; PETERSEN NJ, 1973, HEALTH LAB SCI, V10, P18; PUCKETT A, 1986, MED LAB SCI, V43, P252; *REN DAT SUST, 1994, SRDS 1994 ANN DAT RE; *REN DAT SYST, 1999, USRDS 199 ANN DAT RE; Roth VR, 2000, TRANSFUSION, V40, P931, DOI 10.1046/j.1537-2995.2000.40080931.x; SERRUYSSCHOUTENS E, 1984, EUR J CLIN MICROBIOL, V3, P316, DOI 10.1007/BF01977480; Tenover FC, 1997, INFECT CONT HOSP EP, V18, P426; WOLF CFW, 1993, TRANSFUSION S, V33, pS151; WOODFIELD DG, 1991, NEW ZEAL MED J, V104, P141	19	96	97	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 17	2001	344	20					1491	1497		10.1056/NEJM200105173442001	http://dx.doi.org/10.1056/NEJM200105173442001			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	432DP	11357151				2022-12-24	WOS:000168677200001
J	Ford, WCL				Ford, WCL			Biological mechanisms of male infertility	LANCET			English	Editorial Material							VITAMIN-E; IN-VITRO; SPERMATOZOA; MOTILITY; MEN		St Michaels Hosp, Univ Div Obstet & Gynaecol, Bristol BS2 8EG, Avon, England		Ford, WCL (corresponding author), St Michaels Hosp, Univ Div Obstet & Gynaecol, Bristol BS2 8EG, Avon, England.	chris.ford@bristol.ac.uk						AITKEN RJ, 1991, AM J OBSTET GYNECOL, V164, P542, DOI 10.1016/S0002-9378(11)80017-7; Bronson RA, 1999, J REPROD IMMUNOL, V45, P159; De Kretser DM, 2000, INT J ANDROL, V23, P30; LILFORD R, 1994, BMJ-BRIT MED J, V309, P570, DOI 10.1136/bmj.309.6954.570; Mallidis KMC, 2000, EUR J ENDOCRINOL, V142, P418, DOI 10.1530/eje.0.1420418; Oosterhuis GJE, 2000, FERTIL STERIL, V74, P245, DOI 10.1016/S0015-0282(00)00623-3; Rolf C, 1999, HUM REPROD, V14, P1028, DOI 10.1093/humrep/14.4.1028; Ruiz-Pesini E, 2000, AM J HUM GENET, V67, P682, DOI 10.1086/303040; Sakkas D, 1999, EXP CELL RES, V251, P350, DOI 10.1006/excr.1999.4586; Sharma RK, 1999, HUM REPROD, V14, P2801, DOI 10.1093/humrep/14.11.2801; Shetty J, 1999, BIOL REPROD, V61, P61, DOI 10.1095/biolreprod61.1.61; SUKCHAROEN N, 1995, FERTIL STERIL, V63, P1293, DOI 10.1016/S0015-0282(16)57614-6; Suleiman SA, 1996, J ANDROL, V17, P530; Tesarik J, 1999, FERTIL STERIL, V72, P809, DOI 10.1016/S0015-0282(99)00379-9	14	11	11	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 21	2001	357	9264					1223	1224		10.1016/S0140-6736(00)04452-4	http://dx.doi.org/10.1016/S0140-6736(00)04452-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	425YY	11418145				2022-12-24	WOS:000168323300007
J	Horton, R				Horton, R			Euthanasia and assisted suicide: what does the Dutch vote mean?	LANCET			English	Editorial Material							OF-LIFE CARE; END		Lancet, London WC1X 8RR, England		Horton, R (corresponding author), Lancet, London WC1X 8RR, England.							Asch DA, 1997, SOC SCI MED, V45, P1661, DOI 10.1016/S0277-9536(97)00125-1; Bolmsjo I, 2000, J PALLIAT CARE, V16, P20, DOI 10.1177/082585970001600204; Carron A T, 1999, Ann Intern Med, V130, P82; Dworkin R, 1997, NEW YORK REV BOOKS, V44, P41; Ferrand E, 2001, LANCET, V357, P9, DOI 10.1016/S0140-6736(00)03564-9; Ganzini L, 2000, NEW ENGL J MED, V343, P151; Ganzini L, 2000, NEW ENGL J MED, V342, P557, DOI 10.1056/NEJM200002243420806; Groenewoud JH, 2000, NEW ENGL J MED, V342, P551, DOI 10.1056/NEJM200002243420805; HORTON R, 2000, NEW YORK REV    0810, P30; Kohlwes RJ, 2001, ARCH INTERN MED, V161, P657, DOI 10.1001/archinte.161.5.657; Prendergast TJ, 1998, AM J RESP CRIT CARE, V158, P1163, DOI 10.1164/ajrccm.158.4.9801108; Rabow MW, 2000, JAMA-J AM MED ASSOC, V283, P771, DOI 10.1001/jama.283.6.771; Roscoe LA, 2000, NEW ENGL J MED, V343, P1735, DOI 10.1056/NEJM200012073432315; Singer PA, 1999, JAMA-J AM MED ASSOC, V281, P163, DOI 10.1001/jama.281.2.163; Sullivan AD, 2001, NEW ENGL J MED, V344, P605, DOI 10.1056/NEJM200102223440811; Weber W, 2001, LANCET, V357, P1189, DOI 10.1016/S0140-6736(00)04400-7	16	12	12	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 21	2001	357	9264					1221	1222		10.1016/S0140-6736(00)04450-0	http://dx.doi.org/10.1016/S0140-6736(00)04450-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	425YY	11418143				2022-12-24	WOS:000168323300005
J	Lindgren, E; Gustafson, R				Lindgren, E; Gustafson, R			Tick-borne encephalitis in Sweden and climate change	LANCET			English	Article							IXODES-SCAPULARIS ACARI; TEMPERATURE; IXODIDAE; DISEASE; RICINUS	Background The incidence of tick-borne encephalitis (TBE) in Sweden has substantially increased since the mid-1980s. During the same period the climate has become milder and ticks have become more abundant. We investigated whether there is a link between the change in climate and the increase in incidence of TEE. Methods Since the late 1950s all cases of encephalitis admitted in Stockholm County have been serologically tested for TEE. We analysed the period 1960-98 with multiple regressions. The number of days per season with temperatures of known importance for tick prevalence and pathogen transmission were studied. 2 years of temperature data were related to each TEE incidence rate to account for the tick's long life-span. Findings Increases in disease incidence was significantly related (R-2=0.58; p<0.0001) to a combination of two consecutive mild winters, temperatures favouring spring development (8-10<degrees>C) and extended autumn activity (5-8 degreesC) in the year prior to the incidence year, and temperatures allowing tick activity (5-8 degreesC) early in the incidence year. Interpretations The findings indicate that the increase in TBE incidence since the mid-1980s is related to the period's change towards milder winters and early arrival of spring. Other factors may have influenced TBE incidence such as more people in endemic locations, and increases in host animal populations; factors which are partly climate related. Access to TBE vaccination since 1986 and increased awareness of ticks might have caused an underestimation of the links found. Our findings also suggest that the incidence of other tick-borne zoonoses might have been affected by the milder climate.	Stockholm Univ, Dept Syst Ecol Nat Resources Management, SE-10691 Stockholm, Sweden; Huddinge Univ Hosp, Karolinska Inst, Div Clin Immunol, Dept Immunol Microbiol Pathol & Infect Dis, Stockholm, Sweden	Stockholm University; Karolinska Institutet	Lindgren, E (corresponding author), Stockholm Univ, Dept Syst Ecol Nat Resources Management, SE-10691 Stockholm, Sweden.							Balashov Y.S., 1972, MISC PIB ENTOMOL SOC, V8, P161; BERGLUND J, 1995, NEW ENGL J MED, V333, P1319, DOI 10.1056/NEJM199511163332004; Berry MO, 1981, HDB SNOW, P32; Bjoersdorff A, 1999, SCAND J INFECT DIS, V31, P51, DOI 10.1080/00365549950161880; DANIEL M, 1993, ACAROLOGIA, V34, P105; DUFFY DC, 1994, J MED ENTOMOL, V31, P178, DOI 10.1093/jmedent/31.1.178; FUJIMOTO K, 1994, JPN J SANIT ZOOL, V1, P333; GUSTAFSON R, 1994, SCAND J INFECT DI S1, V24, pS181; KAISER R, 1995, LANCET, V345, P463, DOI 10.1016/S0140-6736(95)90452-2; Lindblom U, 1998, EUR J PAIN-LONDON, V2, P1, DOI 10.1016/S1090-3801(98)90040-4; Lindgren E, 2000, ENVIRON HEALTH PERSP, V108, P119, DOI 10.2307/3454509; LINDSAY LR, 1995, J MED ENTOMOL, V32, P143, DOI 10.1093/jmedent/32.2.143; Mann ME, 1998, NATURE, V392, P779, DOI 10.1038/33859; *WORLD MET ORG, 1999, STAT STAT GLOB CLIM; Zinyovera MC, 1998, IPCC REGIONAL IMPACA, P149	15	251	262	1	57	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 7	2001	358	9275					16	18		10.1016/S0140-6736(00)05250-8	http://dx.doi.org/10.1016/S0140-6736(00)05250-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	449WV	11454371				2022-12-24	WOS:000169710900010
J	Li, LY; Luo, L; Wang, XD				Li, LY; Luo, L; Wang, XD			Endonuclease G is an apoptotic DNase when released from mitochondria	NATURE			English	Article							CYTOCHROME-C RELEASE; CELL-DEATH; CASPASE ACTIVATION; MICE LACKING; PROTEIN; FRAGMENTATION; BAX; PATHWAYS; BINDING; BRAIN	Nucleosomal fragmentation of DNA is a hallmark of apoptosis (programmed cell death)(1), and results from the activation of nucleases in cells undergoing apoptosis. One such nuclease, DNA fragmentation factor (DFF, a caspase-activated deoxyribonuclease (CAD) and its inhibitor (ICAD)), is capable of inducing DNA fragmentation and chromatin condensation after cleavage by caspase-3 (refs 2-4). However, although transgenic mice lacking DFF45 or its caspase cleavage site have significantly reduced DNA fragmentation(5,6), these mice still show residual DNA fragmentation and are phenotypically normal(5-7). Here we report the identification and characterization of another nuclease that is specifically activated by apoptotic stimuli and is able to induce nucleosomal fragmentation of DNA in fibroblast cells from embryonic mice lacking DFF. This nuclease is endonuclease G (endoG), a mitochondrion-specific nuclease that translocates to the nucleus during apoptosis. Once released from mitochondria, endoG cleaves chromatin DNA into nucleosomal fragments independently of caspases. Therefore, endoG represents a caspase-independent apoptotic pathway initiated from the mitochondria.	Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75390 USA	Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Wang, XD (corresponding author), Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dallas, TX 75390 USA.	xwang@biochem.swmed.edu		Wang, Xiaodong/0000-0001-9885-356X				Cecconi F, 1998, CELL, V94, P727, DOI 10.1016/S0092-8674(00)81732-8; Chautan M, 1999, CURR BIOL, V9, P967, DOI 10.1016/S0960-9822(99)80425-4; Chou JJ, 1999, CELL, V96, P615, DOI 10.1016/S0092-8674(00)80572-3; COTE J, 1993, SCIENCE, V261, P765, DOI 10.1126/science.7688144; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Enari M, 1998, NATURE, V391, P43, DOI 10.1038/34112; Gross A, 1999, J BIOL CHEM, V274, P1156, DOI 10.1074/jbc.274.2.1156; Hakem R, 1998, CELL, V94, P339, DOI 10.1016/S0092-8674(00)81477-4; Honarpour N, 2000, DEV BIOL, V218, P248, DOI 10.1006/dbio.1999.9585; Ikeda S, 1997, BIOCHEM BIOPH RES CO, V235, P291, DOI 10.1006/bbrc.1997.6786; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; Krammer PH, 2000, NATURE, V407, P789, DOI 10.1038/35037728; Kuida K, 1998, CELL, V94, P325, DOI 10.1016/S0092-8674(00)81476-2; Kuida K, 1996, NATURE, V384, P368, DOI 10.1038/384368a0; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; Liu XS, 1998, P NATL ACAD SCI USA, V95, P8461, DOI 10.1073/pnas.95.15.8461; Liu XS, 1997, CELL, V89, P175, DOI 10.1016/S0092-8674(00)80197-X; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; McIlroy D, 2000, GENE DEV, V14, P549; Puthalakath H, 1999, MOL CELL, V3, P287, DOI 10.1016/S1097-2765(00)80456-6; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; TIRANTI V, 1995, GENOMICS, V25, P559, DOI 10.1016/0888-7543(95)80058-T; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; von Ahsen O, 2000, J CELL BIOL, V150, P1027, DOI 10.1083/jcb.150.5.1027; WYLLIE AH, 1980, NATURE, V284, P555, DOI 10.1038/284555a0; Xiang JL, 1996, P NATL ACAD SCI USA, V93, P14559, DOI 10.1073/pnas.93.25.14559; Yoshida H, 1998, CELL, V94, P739, DOI 10.1016/S0092-8674(00)81733-X; Zhang JH, 2000, CELL RES, V10, P205, DOI 10.1038/sj.cr.7290049; Zhang JH, 1998, P NATL ACAD SCI USA, V95, P12480, DOI 10.1073/pnas.95.21.12480; Zou H, 1999, J BIOL CHEM, V274, P11549, DOI 10.1074/jbc.274.17.11549	30	1273	1349	11	84	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 5	2001	412	6842					95	99		10.1038/35083620	http://dx.doi.org/10.1038/35083620			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448TB	11452314				2022-12-24	WOS:000169644900051
J	Ergon, T; Lambin, X; Stenseth, NC				Ergon, T; Lambin, X; Stenseth, NC			Life-history traits of voles in a fluctuating population respond to the immediate environment	NATURE			English	Article							DENSITY-DEPENDENCE; SMALL MAMMALS; IN-FIELD; CYCLES; PREDATION; DYNAMICS; PATTERNS	Life-history traits relating to growth and reproduction vary greatly among species and populations(1,2) and among individuals within populations(3). In vole populations, body size and age at maturation may vary considerably among locations and among years within the same location(4-8). Individuals in increasing populations are typically larger and start reproduction earlier in the spring than those in declining populations(6-8). The cause of such life-history variation within populations has been subject of much discussion(7,9,10). Much of the controversy concerns whether the memory of past conditions, leading to delayed effects on life-history traits, resides in the environment (for example, predators(11,12), pathogens(13) or food(14,15)) or intrinsically within populations or individuals (age distribution(16,17), physiological state(3), genetic(18) or maternal effects(19,20)). Here we report from an extensive field transplant experiment in which voles were moved before the breeding season between sites that differed in average overwintering body mass. Transplanted voles did not retain the characteristics of their source population, and we demonstrate an over-riding role of the immediate environment in shaping life-history traits of small rodents.	Univ Oslo, Dept Biol, Div Zool, N-0316 Oslo, Norway; Univ Aberdeen, Dept Zool, Aberdeen AB24 2TZ, Scotland	University of Oslo; University of Aberdeen	Stenseth, NC (corresponding author), Univ Oslo, Dept Biol, Div Zool, POB 1050 Blindern, N-0316 Oslo, Norway.	x.lambin@abdn.ac.uk; n.c.stenseth@bio.uio.no	Lambin, Xavier/E-8284-2011; Stenseth, Nils Chr./G-5212-2016	Lambin, Xavier/0000-0003-4643-2653; Stenseth, Nils Chr./0000-0002-1591-5399				AGRELL J, 1995, P ROY SOC B-BIOL SCI, V262, P65, DOI 10.1098/rspb.1995.0177; AGRELL J, 1992, CAN J ZOOL, V70, P494, DOI 10.1139/z92-074; Batzli G.O., 1992, WILDLIFE 2001 POPULA; BOONSTRA R, 1994, EVOL ECOL, V8, P196, DOI 10.1007/BF01238250; BOONSTRA R, 1987, EVOLUTION, V41, P929, DOI 10.1111/j.1558-5646.1987.tb05868.x; Burnham K.P., 1998, MODEL SELECTION INFE; CHITTY D, 1952, PHILOS T ROY SOC B, V236, P505, DOI 10.1098/rstb.1952.0009; Chitty D., 1967, Proceedings of the Ecological Society of Australia, V2, P51; Inchausti P, 1998, J ANIM ECOL, V67, P180, DOI 10.1046/j.1365-2656.1998.00189.x; KENDALL WL, 1995, BIOMETRICS, V51, P293, DOI 10.2307/2533335; Korpimaki E, 1996, BIOSCIENCE, V46, P754, DOI 10.2307/1312851; Krebs C.J., 1974, ADV ECOL RES, V8, P267, DOI DOI 10.1016/S0065-2504(08)60280-9; Krebs CJ, 1996, J MAMMAL, V77, P8, DOI 10.2307/1382705; Lambin X, 2000, J ANIM ECOL, V69, P106, DOI 10.1046/j.1365-2656.2000.00380.x; Lambin X, 1998, P ROY SOC B-BIOL SCI, V265, P1491, DOI 10.1098/rspb.1998.0462; LEBRETON JD, 1992, ECOL MONOGR, V62, P67, DOI 10.2307/2937171; Littell R. C, 1996, SAS SYSTEM MIXED MOD; Mappes T, 1998, OIKOS, V82, P365, DOI 10.2307/3546977; McNamara JM, 1996, NATURE, V380, P215, DOI 10.1038/380215a0; NELSON RJ, 1987, AM NAT, V130, P350, DOI 10.1086/284715; NICHOLS JD, 1992, BIOSCIENCE, V42, P94, DOI 10.2307/1311650; Roff Derek A., 1992; Soveri T, 2000, COMP IMMUNOL MICROB, V23, P73, DOI 10.1016/S0147-9571(99)00057-0; Stearns S.C., 1992, pi; Stenseth NC, 1999, OIKOS, V87, P427, DOI 10.2307/3546809; TAST J, 1984, WINTER ECOLOGY SMALL, P59; Tkadlec E, 1998, EVOL ECOL, V12, P191, DOI 10.1023/A:1006583713042; [No title captured], DOI DOI 10.1016/J.FORECO.2007.08.005	28	98	100	1	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 28	2001	411	6841					1043	1045		10.1038/35082553	http://dx.doi.org/10.1038/35082553			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	446TF	11429603				2022-12-24	WOS:000169528500046
J	Ochsenbein, AF; Sierro, S; Odermatt, B; Pericin, M; Karrer, U; Hermans, IF; Hemmi, S; Hengartner, H; Zinkernagel, RM				Ochsenbein, AF; Sierro, S; Odermatt, B; Pericin, M; Karrer, U; Hermans, IF; Hemmi, S; Hengartner, H; Zinkernagel, RM			Roles of tumour localization, second signals and cross priming in cytotoxic T-cell induction	NATURE			English	Article							ANTIGEN-PRESENTING CELLS; IMMUNE-RESPONSES; LYMPHOID ORGANS; BONE-MARROW; IN-VIVO; LYMPHOCYTES; COSTIMULATION; MICE; REJECTION; MATURATION	The vertebrate immune system has evolved to protect against infections that threaten survival before reproduction. Clinically manifest tumours mostly arise after the reproductive years and somatic mutations allow even otherwise antigenic tumours to evade the attention of the immune system(1-3). Moreover, the lack of immunological co-stimulatory molecules on solid tumours could result in T-cell tolerance(4-8); that is, the failure of T cells to respond. However, this may not generally apply(9,10). Here we report several important findings regarding the immune response to tumours, on the basis of studies of several tumour types. First, tumour-specific induction of protective cytotoxic T cells (CTLs) depends on sufficient tumour cells reaching secondary lymphatic organs early and for a long enough duration. Second, diffusely invading systemic tumours delete CTLs. Third, tumours that stay strictly outside secondary lymphatic organs, or that are within these organs but separated from T cells by barriers, are ignored by T cells but do not delete them. Fourth, co-stimulatory molecules on tumour cells do not influence CTL priming but enhance primed CTL responses in peripheral solid tumours. Last, cross priming of CTLs by tumour antigens, mediated by major histocompatibility complex (MHC) class I molecules of antigen-presenting host cells, is inefficient and not protective. These rules of T-cell induction and maintenance not only change previous views but also rationales for anti-tumour immunotherapy(1,2).	Univ Zurich Hosp, Inst Expt Immunol, CH-8091 Zurich, Switzerland; Univ Zurich, Inst Mol Biol, CH-8057 Zurich, Switzerland; Malaghan Inst Med Res, Wellington, New Zealand	University of Zurich; University Zurich Hospital; University of Zurich; Malaghan Institute; Victoria University Wellington	Zinkernagel, RM (corresponding author), Univ Zurich Hosp, Inst Expt Immunol, CH-8091 Zurich, Switzerland.	adrian.ochsenbein@insel.ch; rolf.zinkernagel@pty.usz.ch	Hermans, Ian/I-3961-2013	Ochsenbein, Adrian/0000-0003-1773-5436				BEVAN MJ, 1976, J EXP MED, V143, P1283, DOI 10.1084/jem.143.5.1283; BOON T, 1994, ANNU REV IMMUNOL, V12, P337, DOI 10.1146/annurev.immunol.12.1.337; Braun S, 2000, NEW ENGL J MED, V342, P525, DOI 10.1056/NEJM200002243420801; Carbone FR, 1998, IMMUNOL TODAY, V19, P368, DOI 10.1016/S0167-5699(98)01301-2; CHEN YM, 1993, MOL CRYST LIQ CRYS B, V4, P71; HAHN H, 1981, REV INFECT DIS, V3, P1221; HARLAN DM, 1994, P NATL ACAD SCI USA, V91, P3137, DOI 10.1073/pnas.91.8.3137; HELLSTROM KE, 1995, IMMUNOL REV, V145, P123, DOI 10.1111/j.1600-065X.1995.tb00079.x; Hermans IF, 1998, CANCER RES, V58, P3909; HUANG AYC, 1994, SCIENCE, V264, P961, DOI 10.1126/science.7513904; Jeannin P, 2000, NAT IMMUNOL, V1, P502, DOI 10.1038/82751; Karrer U, 1997, J EXP MED, V185, P2157, DOI 10.1084/jem.185.12.2157; KUNDIG TM, 1995, SCIENCE, V268, P1343, DOI 10.1126/science.7761853; Lu ZB, 2000, J EXP MED, V191, P541, DOI 10.1084/jem.191.3.541; Maric M, 1998, CANCER RES, V58, P3376; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.immunol.12.1.991; Ochsenbein AF, 1999, P NATL ACAD SCI USA, V96, P2233, DOI 10.1073/pnas.96.5.2233; OEHEN SU, 1994, CELL IMMUNOL, V158, P342, DOI 10.1006/cimm.1994.1281; OLD LJ, 1992, CURR OPIN IMMUNOL, V4, P603, DOI 10.1016/0952-7915(92)90034-C; Ossendorp F, 1998, J EXP MED, V187, P693, DOI 10.1084/jem.187.5.693; Oxenius A, 1998, EUR J IMMUNOL, V28, P390, DOI 10.1002/(SICI)1521-4141(199801)28:01<390::AID-IMMU390>3.0.CO;2-O; Prevost-Blondel A, 1998, J IMMUNOL, V161, P2187; RAMARATHINAM L, 1994, J EXP MED, V179, P1205, DOI 10.1084/jem.179.4.1205; SCHWARTZ RH, 1992, CELL, V71, P1065, DOI 10.1016/S0092-8674(05)80055-8; SHAHINIAN A, 1993, SCIENCE, V261, P609, DOI 10.1126/science.7688139; Staveley-O'Carroll K, 1998, P NATL ACAD SCI USA, V95, P1178, DOI 10.1073/pnas.95.3.1178; Toes REM, 1996, CANCER RES, V56, P3782; TOWNSEND SE, 1993, SCIENCE, V259, P368, DOI 10.1126/science.7678351; WU TC, 1995, J EXP MED, V182, P1415, DOI 10.1084/jem.182.5.1415; Yewdell JW, 1999, ADV IMMUNOL, V73, P1, DOI 10.1016/S0065-2776(08)60785-3	30	420	449	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 28	2001	411	6841					1058	1064		10.1038/35082583	http://dx.doi.org/10.1038/35082583			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	446TF	11429607				2022-12-24	WOS:000169528500050
J	Yu, QY; Geng, Y; Sicinski, P				Yu, QY; Geng, Y; Sicinski, P			Specific protection against breast cancers by cyclin D1 ablation	NATURE			English	Article							TRANSGENIC MICE; CELL-PROLIFERATION; SIGNALING PATHWAY; NEU ONCOGENE; EXPRESSION; RAS; OVEREXPRESSION; TRANSFORMATION; PROGRESSION; GENE	Breast cancer is the most common malignancy among women. Most of these cancers overexpress cyclin D1, a component of the core cell-cycle machinery. We previously generated mice lacking cyclin D1 using gene targeting. Here we report that these cyclin D1-deficient mice are resistant to breast cancers induced by the neu and ras oncogenes. However, animals lacking cyclin D1 remain fully sensitive to other oncogenic pathways of the mammary epithelium, such as those driven by c-myc or Wnt-1. Our analyses revealed that, in mammary epithelial cells, the Neu-Ras pathway is connected to the cell-cycle machinery by cyclin D1, explaining the absolute dependency on cyclin D1 for malignant transformation in this tissue. Our results suggest that an anti-cyclin D1 therapy might be highly specific in treating human breast cancers with activated Neu-Ras pathways.	Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Sicinski, P (corresponding author), Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA.							ALBANESE C, 1995, J BIOL CHEM, V270, P23589, DOI 10.1074/jbc.270.40.23589; Alevizopoulos K, 1997, EMBO J, V16, P5322, DOI 10.1093/emboj/16.17.5322; BALL RK, 1988, EMBO J, V7, P2089, DOI 10.1002/j.1460-2075.1988.tb03048.x; BARGMANN CI, 1986, CELL, V45, P649, DOI 10.1016/0092-8674(86)90779-8; BARTKOVA J, 1994, INT J CANCER, V57, P353, DOI 10.1002/ijc.2910570311; BIECHE I, 1995, GENE CHROMOSOME CANC, V14, P227, DOI 10.1002/gcc.2870140402; DICKINSON AJ, 1990, OPHTHALMIC PAED GEN, V11, P1, DOI 10.3109/13816819009012942; FANTL V, 1995, GENE DEV, V9, P2364, DOI 10.1101/gad.9.19.2364; FILMUS J, 1994, ONCOGENE, V9, P3627; Geng Y, 1999, CELL, V97, P767, DOI 10.1016/S0092-8674(00)80788-6; Gillett C, 1996, INT J CANCER, V69, P92, DOI 10.1002/(SICI)1097-0215(19960422)69:2<92::AID-IJC4>3.3.CO;2-I; GILLETT C, 1994, CANCER RES, V54, P1812; JANES PW, 1994, ONCOGENE, V9, P3601; Lavoie JN, 1996, J BIOL CHEM, V271, P20608, DOI 10.1074/jbc.271.34.20608; Lee RJ, 2000, MOL CELL BIOL, V20, P672, DOI 10.1128/MCB.20.2.672-683.2000; LIU JJ, 1995, MOL CELL BIOL, V15, P3654; LUKAS J, 1995, ONCOGENE, V10, P2125; MCINTOSH GG, 1995, ONCOGENE, V11, P885; MULLER WJ, 1988, CELL, V54, P105, DOI 10.1016/0092-8674(88)90184-5; Rimerman RA, 2000, J BIOL CHEM, V275, P14736, DOI 10.1074/jbc.M910241199; Robles AI, 1998, GENE DEV, V12, P2469, DOI 10.1101/gad.12.16.2469; Santoni-Rugiu E, 2000, MOL CELL BIOL, V20, P3497, DOI 10.1128/MCB.20.10.3497-3509.2000; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; SICINSKI P, 1995, CELL, V82, P621, DOI 10.1016/0092-8674(95)90034-9; Sicinski P, 1996, NATURE, V384, P470, DOI 10.1038/384470a0; SINN E, 1987, CELL, V49, P465, DOI 10.1016/0092-8674(87)90449-1; STEWART TA, 1984, CELL, V38, P627, DOI 10.1016/0092-8674(84)90257-5; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; TSUKAMOTO AS, 1988, CELL, V55, P619, DOI 10.1016/0092-8674(88)90220-6; WANG TC, 1994, NATURE, V369, P669, DOI 10.1038/369669a0; WEINSTATSASLOW D, 1995, NAT MED, V1, P1257, DOI 10.1038/nm1295-1257	31	783	819	0	29	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 28	2001	411	6841					1017	1021		10.1038/35082500	http://dx.doi.org/10.1038/35082500			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	446TF	11429595				2022-12-24	WOS:000169528500038
J	Brown, CE; Howe, L; Sousa, K; Alley, SC; Carrozza, MJ; Tan, S; Workman, JL				Brown, CE; Howe, L; Sousa, K; Alley, SC; Carrozza, MJ; Tan, S; Workman, JL			Recruitment of HAT complexes by direct activator interactions with the ATM-related tra1 subunit	SCIENCE			English	Article							HISTONE ACETYLTRANSFERASE COMPLEXES; IN-VIVO; TRANSCRIPTIONAL ADAPTER; BASAL TRANSCRIPTION; ESSENTIAL COFACTOR; C-MYC; YEAST; PROTEIN; DOMAIN; BINDING	Promoter-specific recruitment of histone acetyltransferase activity is often critical for transcriptional activation. We present a detailed study of the interaction between the histone acetyltransferase complexes SAGA and NuA4, and transcription activators. We demonstrate by affinity chromatography and photo-cross-linking Label transfer that acidic activators directly interact with Tra1p, a shared subunit of SAGA and NUA4. Mutations within the COOH-terminus of Tra1p disrupted its interaction with activators and resulted in gene-specific transcriptional defects that correlated with Lowered promoter-specific histone acetylation. These data demonstrate that the essential Tra1 protein serves as a common target for activators in both SAGA and NuA4 acetyltransferases.	Penn State Univ, Howard Hughes Med Inst, Althouse Lab 306, University Pk, PA 16802 USA; Penn State Univ, Dept Biochem & Mol Biol, Althouse Lab 306, University Pk, PA 16802 USA; Penn State Univ, Dept Chem, Althouse Lab 306, University Pk, PA 16802 USA	Howard Hughes Medical Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Workman, JL (corresponding author), Penn State Univ, Howard Hughes Med Inst, Althouse Lab 306, University Pk, PA 16802 USA.			Brown, Christine/0000-0003-4915-8207	NIGMS NIH HHS [GM19492] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM019492] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allard S, 1999, EMBO J, V18, P5108, DOI 10.1093/emboj/18.18.5108; Alley SC, 2000, J AM CHEM SOC, V122, P6126, DOI 10.1021/ja000591t; BALASUBRAMANIAN R, UNPUB; BARLEV NA, 1995, J BIOL CHEM, V270, P19337, DOI 10.1074/jbc.270.33.19337; BERGER SL, 1990, CELL, V61, P1199, DOI 10.1016/0092-8674(90)90684-7; BERGER SL, 1992, CELL, V70, P251, DOI 10.1016/0092-8674(92)90100-Q; Brown CE, 2000, TRENDS BIOCHEM SCI, V25, P15, DOI 10.1016/S0968-0004(99)01516-9; BROWN CM, UNPUB; Candau R, 1997, EMBO J, V16, P555, DOI 10.1093/emboj/16.3.555; Candau R, 1996, J BIOL CHEM, V271, P5237; DRYSDALE CM, 1995, MOL CELL BIOL, V15, P1220, DOI 10.1128/MCB.15.3.1220; Eberharter A, 1998, METHODS, V15, P315, DOI 10.1006/meth.1998.0635; Galarneau L, 2000, MOL CELL, V5, P927, DOI 10.1016/S1097-2765(00)80258-0; GOODRICH JA, 1993, CELL, V75, P519, DOI 10.1016/0092-8674(93)90386-5; Grant PA, 1998, MOL CELL, V2, P863, DOI 10.1016/S1097-2765(00)80300-7; Gregory PD, 1999, EMBO J, V18, P6407, DOI 10.1093/emboj/18.22.6407; Henriksson A, 1997, MOL CELL BIOL, V17, P3065, DOI 10.1128/MCB.17.6.3065; Ikeda K, 1999, MOL CELL BIOL, V19, P855; Jia MH, 2000, PHYSIOL GENOMICS, V3, P83, DOI 10.1152/physiolgenomics.2000.3.2.83; Kuo MH, 1998, GENE DEV, V12, P627, DOI 10.1101/gad.12.5.627; LU H, 1995, P NATL ACAD SCI USA, V92, P5154, DOI 10.1073/pnas.92.11.5154; McMahon SB, 1998, CELL, V94, P363, DOI 10.1016/S0092-8674(00)81479-8; McMahon SB, 2000, MOL CELL BIOL, V20, P556, DOI 10.1128/MCB.20.2.556-562.2000; Saleh A, 1998, J BIOL CHEM, V273, P26559, DOI 10.1074/jbc.273.41.26559; SELLECK W, IN PRESS NATURE STRU; SELLECK W, UNPUB; Sil AK, 1999, MOL CELL BIOL, V19, P7828; THUT CJ, 1995, SCIENCE, V267, P100, DOI 10.1126/science.7809597; Uesugi M, 1997, SCIENCE, V277, P1310, DOI 10.1126/science.277.5330.1310; Utley RT, 1998, NATURE, V394, P498, DOI 10.1038/28886; Vignali M, 2000, EMBO J, V19, P2629, DOI 10.1093/emboj/19.11.2629; Workman JL, 1998, ANNU REV BIOCHEM, V67, P545, DOI 10.1146/annurev.biochem.67.1.545	32	285	289	1	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 22	2001	292	5525					2333	2337		10.1126/science.1060214	http://dx.doi.org/10.1126/science.1060214			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	445KD	11423663				2022-12-24	WOS:000169455900059
J	Ullah, H; Chen, JG; Young, JC; Im, KH; Sussman, MR; Jones, AM				Ullah, H; Chen, JG; Young, JC; Im, KH; Sussman, MR; Jones, AM			Modulation of cell proliferation by heterotrimeric G protein in Arabidopsis	SCIENCE			English	Article							SIGNAL-TRANSDUCTION; COUPLED RECEPTORS; CRYSTAL-STRUCTURE; ALPHA-SUBUNIT; EXPANSION; THALIANA; PATHWAYS; DIVISION; GROWTH; LEAVES	The alpha subunit of a prototypical heterotrimeric GTP-binding protein (G protein), which is encoded by a single gene (GPA 1) in Arabidopsis, is a modulator of plant cell proliferation. gpa1 null mutants have reduced cell division in aerial tissues throughout development. Inducible overexpression of GPA1 in Arabidopsis confers inducible ectopic cell division. GPA1 overexpression in synchronized BY-2 cells causes premature advance of the nuclear cycle and the premature appearance of a division wall, Results from loss of function and ectopic expression and activation of GPA1 indicate that this subunit is a positive modulator of cell division in plants.	Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; Univ Wisconsin, Cell & Mol Biol Program, Madison, WI 53706 USA; Univ Wisconsin, Dept Hort, Madison, WI 53706 USA	University of North Carolina; University of North Carolina Chapel Hill; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Jones, AM (corresponding author), Univ N Carolina, Dept Biol, CB 3280, Chapel Hill, NC 27599 USA.	alan_jones@unc.edu	Chen, Jin-Gui/A-4773-2011; Chen, Jin-Gui/AFV-6337-2022	Chen, Jin-Gui/0000-0002-1752-4201; Chen, Jin-Gui/0000-0002-1752-4201				Ashikari M, 1999, P NATL ACAD SCI USA, V96, P10284, DOI 10.1073/pnas.96.18.10284; Dhanasekaran N., 1995, Endocrine Reviews, V16, P259; Dhanasekaran N, 1998, ONCOGENE, V17, P1383, DOI 10.1038/sj.onc.1202242; Donnelly PM, 1999, DEV BIOL, V215, P407, DOI 10.1006/dbio.1999.9443; FRANCIS D, 1998, PORTLAND PRESS RES M; Gendreau E, 1997, PLANT PHYSIOL, V114, P295, DOI 10.1104/pp.114.1.295; Gutkind JS, 1998, J BIOL CHEM, V273, P1839, DOI 10.1074/jbc.273.4.1839; HABER AH, 1962, AM J BOT, V49, P583, DOI 10.2307/2439715; HEMERLY A, 1995, EMBO J, V14, P3925, DOI 10.1002/j.1460-2075.1995.tb00064.x; Jelacic TM, 2000, J BIOL CHEM, V275, P36211, DOI 10.1074/jbc.M007087200; Jones AM, 1998, SCIENCE, V282, P1114, DOI 10.1126/science.282.5391.1114; Kim GT, 1999, P NATL ACAD SCI USA, V96, P9433, DOI 10.1073/pnas.96.16.9433; Kovtun Y, 1998, NATURE, V395, P716, DOI 10.1038/27240; Krysan PJ, 1999, PLANT CELL, V11, P2283, DOI 10.1105/tpc.11.12.2283; Lambright DG, 1996, NATURE, V379, P311, DOI 10.1038/379311a0; LAMORTE VJ, 1992, J BIOL CHEM, V267, P691; Liebmann C, 2000, CURR MED CHEM, V7, P911, DOI 10.2174/0929867003374589; Lopez I, 2001, J BIOL CHEM, V276, P2758, DOI 10.1074/jbc.M008119200; MA H, 1994, PLANT MOL BIOL, V26, P1611, DOI 10.1007/BF00016493; Nishida M, 2000, NATURE, V408, P492, DOI 10.1038/35044120; Selbie LA, 1998, TRENDS PHARMACOL SCI, V19, P87, DOI 10.1016/S0165-6147(97)01166-8; Sondek J, 1996, NATURE, V379, P369, DOI 10.1038/379369a0; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; Tsuge T, 1996, DEVELOPMENT, V122, P1589; Vernoux T, 2000, PLANT CELL, V12, P97, DOI 10.1105/tpc.12.1.97; Wang XQ, 2001, SCIENCE, V292, P2070, DOI 10.1126/science.1059046; WATKINS DC, 1992, SCIENCE, V258, P1373, DOI 10.1126/science.1455234; Weiss CA, 1997, FEBS LETT, V407, P361, DOI 10.1016/S0014-5793(97)00378-5	28	277	311	3	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 15	2001	292	5524					2066	2069		10.1126/science.1059040	http://dx.doi.org/10.1126/science.1059040			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442KP	11408654	Green Submitted			2022-12-24	WOS:000169284700044
J	Yoo, BC; Lubec, G				Yoo, BC; Lubec, G			Neurobiology - p25 protein in neurodegeneration	NATURE			English	Article							ALZHEIMERS-DISEASE; P35; ACTIVATOR; CALPAIN; CDK5; CLEAVAGE		Univ Vienna, Dept Pediat, A-1090 Vienna, Austria	University of Vienna	Yoo, BC (corresponding author), Univ Vienna, Dept Pediat, A-1090 Vienna, Austria.			Lubec, Gert/0000-0002-6333-9461				Ahlijanian MK, 2000, P NATL ACAD SCI USA, V97, P2910, DOI 10.1073/pnas.040577797; Kusakawa G, 2000, J BIOL CHEM, V275, P17166, DOI 10.1074/jbc.M907757199; Lee MS, 2000, NATURE, V405, P360, DOI 10.1038/35012636; MIRRA SS, 1991, NEUROLOGY, V41, P479, DOI 10.1212/WNL.41.4.479; Nath R, 2000, BIOCHEM BIOPH RES CO, V274, P16, DOI 10.1006/bbrc.2000.3070; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; TIERNEY MC, 1988, NEUROLOGY, V38, P359, DOI 10.1212/WNL.38.3.359	7	74	80	0	3	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 14	2001	411	6839					763	764		10.1038/35081146	http://dx.doi.org/10.1038/35081146			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	441TV	11459045				2022-12-24	WOS:000169246400034
J	Pell, JP; Sirel, JM; Marsden, AK; Ford, I; Cobbe, SM				Pell, JP; Sirel, JM; Marsden, AK; Ford, I; Cobbe, SM			Effect of reducing ambulance response times on deaths from out of hospital cardiac arrest: cohort study	BRITISH MEDICAL JOURNAL			English	Article							AUTOMATED EXTERNAL DEFIBRILLATORS; EMERGENCY MEDICAL TECHNICIANS; AMERICAN-HEART-ASSOCIATION; HEALTH-PROFESSIONALS; CLINICAL-EXPERIENCE; UTSTEIN STYLE; MANAGEMENT; STATEMENT; SCOTLAND; EFFICACY	Objectives To determine the association between ambulance response time and survival from out of hospital cardiopulmonary arrest and to estimate the effect of reducing response times. Design Cohort study. Setting Scottish Ambulance Service. Subjects All out of hospital cardiopulmonary arrests due to cardiac disease attended by the Scottish Ambulance Service during May 1991 to March 1998. Main outcome measures Survival rate to hospital discharge and potential improvement from reducing response times. Results Of 13 822 arrests not witnessed by ambulance crews but attended by them within 15 minutes, complete data were available for 10 554 (76%). Of these patients, 653 (6%) survived to hospital discharge. After other significant covariates were adjusted for, shorter response time was significantly associated with increased probability of receiving defibrillation and survival to discharge among those defibrillated. Reducing the 90th centile for response time to 8 minutes increased the predicted survival to 8%, and reducing it to 5 minutes increased survival to 10-11% (depending on the model used). Conclusions Reducing ambulance response times to 5 minutes could almost double the survival rate for cardiac arrests not witnessed by ambulance crews.	Univ Glasgow, Glasgow Royal Infirm, Dept Med Cardiol, Glasgow G31 2ER, Lanark, Scotland; Scottish Ambulance Serv Headquarters, Edinburgh, Midlothian, Scotland; Univ Glasgow, Robertson Ctr Biostat, Glasgow G12 8QQ, Lanark, Scotland	University of Glasgow; University of Glasgow	Cobbe, SM (corresponding author), Univ Glasgow, Glasgow Royal Infirm, Dept Med Cardiol, Glasgow G31 2ER, Lanark, Scotland.		Ford, Ian/ABE-6145-2020	Pell, Jill/0000-0002-8898-7035				BEAGLEHOLE R, 1986, BMJ-BRIT MED J, V292, P33, DOI 10.1136/bmj.292.6512.33; COBB LA, 1992, CIRCULATION, V85, P98; COBBE SM, 1991, BRIT MED J, V302, P1517, DOI 10.1136/bmj.302.6791.1517; CUMMINS RO, 1987, JAMA-J AM MED ASSOC, V257, P1605, DOI 10.1001/jama.257.12.1605; CUMMINS RO, 1991, CIRCULATION, V84, P960, DOI 10.1161/01.CIR.84.2.960; CUMMINS RO, 1991, CIRCULATION, V83, P1832, DOI 10.1161/01.CIR.83.5.1832; CUMMINS RO, 1989, ANN EMERG MED, V18, P1269, DOI 10.1016/S0196-0644(89)80257-4; Dracup K, 1997, ANN INTERN MED, V126, P645, DOI 10.7326/0003-4819-126-8-199704150-00010; Evans T, 1998, BMJ-BRIT MED J, V316, P1031; Kuisma M, 1996, HEART, V76, P18, DOI 10.1136/hrt.76.1.18; *NHS, 1996, REV AMB PERF STAND F; Nichol G, 1996, ANN EMERG MED, V27, P711, DOI 10.1016/S0196-0644(96)70188-9; Norris RM, 1998, BMJ-BRIT MED J, V316, P1065; Rayner M, 1998, CORONARY HEART DIS S; SEDGWICK ML, 1992, RESUSCITATION, V24, P73, DOI 10.1016/0300-9572(92)90175-C; STULTS KR, 1986, CIRCULATION, V73, P701, DOI 10.1161/01.CIR.73.4.701; STULTS KR, 1984, NEW ENGL J MED, V310, P219, DOI 10.1056/NEJM198401263100403; WEAVER WD, 1986, AM J CARDIOL, V57, P1017, DOI 10.1016/0002-9149(86)90667-3; WEAVER WD, 1988, NEW ENGL J MED, V319, P661, DOI 10.1056/NEJM198809153191101	19	164	165	0	9	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 9	2001	322	7299					1385	1388		10.1136/bmj.322.7299.1385	http://dx.doi.org/10.1136/bmj.322.7299.1385			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	442KN	11397740	Green Submitted, Bronze, Green Accepted, Green Published			2022-12-24	WOS:000169284600014
J	Salzberg, SL; White, O; Peterson, J; Eisen, JA				Salzberg, SL; White, O; Peterson, J; Eisen, JA			Microbial genes in the human genome: Lateral transfer or gene loss?	SCIENCE			English	Article							SEQUENCE; EVOLUTION; BACTERIA	The human genome was analyzed for evidence that genes had been Laterally transferred into the genome from prokaryotic organisms. Protein sequence comparisons of the proteomes of human, fruit fly, nematode worm, yeast, mustard weed, eukaryotic parasites, and all completed prokaryote genomes were performed, and all genes shared between human and each of the other groups of organisms were collected. About 40 genes were found to be exclusively shared by humans and bacteria and are candidate examples of horizontal transfer from bacteria to vertebrates. Gene Loss combined with sample size effects and evolutionary rate variation provide an alternative, more biologically plausible explanation.	Inst Genome Res, Rockville, MD 20850 USA	J. Craig Venter Institute	Salzberg, SL (corresponding author), Inst Genome Res, 9712 Med Ctr Dr, Rockville, MD 20850 USA.	salzberg@tigr.org	Salzberg, Steven L/F-6162-2011; Eisen, Jonathan A./H-2706-2019; Salzberg, Steven/Q-6514-2019	Salzberg, Steven L/0000-0002-8859-7432; Eisen, Jonathan A./0000-0002-0159-2197; Salzberg, Steven/0000-0002-8859-7432	NATIONAL LIBRARY OF MEDICINE [R01LM006845] Funding Source: NIH RePORTER	NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; ALTSCHUL SF, 1993, J MOL EVOL, V36, P290, DOI 10.1007/BF00160485; Andersson SGE, 1998, NATURE, V396, P133, DOI 10.1038/24094; Arabidopsis Genome Initiative, 2000, Nature (London), V408, P796, DOI 10.1038/35048692; Braun EL, 2000, GENOME RES, V10, P416, DOI 10.1101/gr.10.4.416; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Doolittle WF, 1999, SCIENCE, V284, P2124, DOI 10.1126/science.284.5423.2124; Doolittle WF, 1999, TRENDS CELL BIOL, V9, pM5, DOI 10.1016/S0962-8924(99)01664-5; Eisen JA, 1998, GENOME RES, V8, P163, DOI 10.1101/gr.8.3.163; Eisen JA, 2000, CURR OPIN GENET DEV, V10, P606, DOI 10.1016/S0959-437X(00)00143-X; Felsenstein J, 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; GISH W, 1993, NAT GENET, V3, P266, DOI 10.1038/ng0393-266; Goffeau A, 1996, SCIENCE, V274, P546, DOI 10.1126/science.274.5287.546; Gogarten JP, 1999, BIOL BULL, V196, P359, DOI 10.2307/1542970; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Li W-H, 1997, MOL EVOLUTION; Lin XY, 1999, NATURE, V402, P761, DOI 10.1038/45471; Martin W, 1998, NATURE, V393, P162, DOI 10.1038/30234; Nelson KE, 2000, NAT BIOTECHNOL, V18, P1049, DOI 10.1038/80235; Nelson KE, 1999, NATURE, V399, P323, DOI 10.1038/20601; Palmer JD, 2000, P NATL ACAD SCI USA, V97, P6960, DOI 10.1073/pnas.97.13.6960; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040	23	199	208	1	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 8	2001	292	5523					1903	1906		10.1126/science.1061036	http://dx.doi.org/10.1126/science.1061036			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	440WY	11358996				2022-12-24	WOS:000169200700047
J	Nirenberg, S; Carcieri, SM; Jacobs, AL; Latham, PE				Nirenberg, S; Carcieri, SM; Jacobs, AL; Latham, PE			Retinal ganglion cells act largely as independent encoders	NATURE			English	Article							VISUAL INFORMATION; X-CELL; Y-CELL; HYPOTHESIS; POPULATION; LIGHT	Correlated firing among neurons is widespread in the visual system. Neighbouring neurons, in areas from retina to cortex, tend to fire together more often than would be expected by chance. The importance of this correlated firing for encoding visual information is unclear and controversial(1-5). Here we examine its importance in the retina. We present the retina with natural stimuli and record the responses of its output cells, the ganglion cells. We then use information theoretic techniques to measure the amount of information about the stimuli that can be obtained from the cells under two conditions: when their correlated firing is taken into account, and when their correlated firing is ignored. We rnd that more than 90% of the information about the stimuli can be obtained from the cells when their correlated firing is ignored. This indicates that ganglion cells act largely independently to encode information, which greatly simplifies the problem of decoding their activity.	Univ Calif Los Angeles, Dept Neurobiol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Nirenberg, S (corresponding author), Univ Calif Los Angeles, Dept Neurobiol, 10833 Le Conte Ave, Los Angeles, CA 90095 USA.	sheilan@ucla.edu						Alonso JM, 1996, NATURE, V383, P815, DOI 10.1038/383815a0; BIALEK W, 1991, SCIENCE, V252, P1854, DOI 10.1126/science.2063199; CARTERDAWSON LD, 1979, J COMP NEUROL, V188, P245, DOI 10.1002/cne.901880204; Chichilnisky E. J., 1999, Society for Neuroscience Abstracts, V25, P1042; Cover T.M., 2006, ELEMENTS INFORM THEO, DOI [10.1002/047174882X, DOI 10.1002/047174882X]; DeVries SH, 1999, J NEUROPHYSIOL, V81, P908, DOI 10.1152/jn.1999.81.2.908; DODD RL, 1988, PROGRAM NEUROSCIENCE, P153; Gray CM, 1999, NEURON, V24, P31, DOI 10.1016/S0896-6273(00)80820-X; MASTRONARDE DN, 1983, J NEUROPHYSIOL, V49, P303, DOI 10.1152/jn.1983.49.2.303; MASTRONARDE DN, 1983, J NEUROPHYSIOL, V49, P325, DOI 10.1152/jn.1983.49.2.325; MEISTER M, 1994, J NEUROSCI METH, V51, P95, DOI 10.1016/0165-0270(94)90030-2; MEISTER M, 1995, SCIENCE, V270, P1207, DOI 10.1126/science.270.5239.1207; Meister M, 1996, P NATL ACAD SCI USA, V93, P609, DOI 10.1073/pnas.93.2.609; Nirenberg S, 1997, NEURON, V18, P637, DOI 10.1016/S0896-6273(00)80304-9; Nirenberg S, 1998, CURR OPIN NEUROBIOL, V8, P488, DOI 10.1016/S0959-4388(98)80036-6; Panzeri S, 1999, P ROY SOC B-BIOL SCI, V266, P1001, DOI 10.1098/rspb.1999.0736; PENN JS, 1984, VISION RES, V24, P1673, DOI 10.1016/0042-6989(84)90325-0; PERKEL DH, 1967, BIOPHYS J, V7, P419, DOI 10.1016/S0006-3495(67)86597-4; Reinagel P, 2000, J NEUROSCI, V20, P5392, DOI 10.1523/JNEUROSCI.20-14-05392.2000; RODIECK RW, 1967, J NEUROPHYSIOL, V30, P1043, DOI 10.1152/jn.1967.30.5.1043; RUDERMAN DL, 1994, PHYS REV LETT, V73, P814, DOI 10.1103/PhysRevLett.73.814; Shadlen MN, 1999, NEURON, V24, P67, DOI 10.1016/S0896-6273(00)80822-3; Shannon C. E., 1949, MATH THEORY INFORM; Soucy E, 1998, NEURON, V21, P481, DOI 10.1016/S0896-6273(00)80560-7; Strong SP, 1998, PHYS REV LETT, V80, P197, DOI 10.1103/PhysRevLett.80.197; Warland DK, 1997, J NEUROPHYSIOL, V78, P2336, DOI 10.1152/jn.1997.78.5.2336	26	217	226	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN	2001	411	6838					698	701		10.1038/35079612	http://dx.doi.org/10.1038/35079612			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439JC	11395773				2022-12-24	WOS:000169112500047
J	Siller, S				Siller, S			Sexual selection and the maintenance of sex	NATURE			English	Article							DELETERIOUS MUTATIONS; AFFECTING FITNESS; EVOLUTION; ADVANTAGE; EPISTASIS; PLANTS	Sex is expensive. A population of females that reproduce asexually should prima facie have twice the growth rate of an otherwise equivalent anisogamous sexual population lacking paternal care, or a population with modes of paternal care that can be co-opted by parthenogenetic females(1-6). The two leading theories for the maintenance of sex require either synergistic interactions between deleterious mutations, or antagonistic epistasis between beneficial mutations(5). Current evidence is equivocal as to whether the required levels of epistasis exist(6-10). Here I show that a third factor, differential male mating success (or, more generally, higher variance in male than in female fitness), can drastically reduce mutational load in sexual populations with or without any form of epistasis. Differential mating success has the further advantage of being ubiquitous, and is likely to have preceded or evolved concurrently with anisogamy(11).	Univ Oxford, Dept Zool, Oxford OX1 3PS, England	University of Oxford	Siller, S (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.	steven.siller@zoo.ox.ac.uk						ARNOLD SJ, 1994, AM NAT, V144, pS1, DOI 10.1086/285650; ATMAR W, 1991, ANIM BEHAV, V41, P195, DOI 10.1016/S0003-3472(05)80471-3; Barton NH, 1998, SCIENCE, V281, P1986, DOI 10.1126/science.281.5385.1986; Bell G, 1982, MASTERPIECE NATURE E; DALE S, 1992, BEHAV ECOL SOCIOBIOL, V30, P165, DOI 10.1007/BF00166699; de Visser JAGM, 1998, GENET RES, V71, P39, DOI 10.1017/S0016672397003091; Elena SF, 1997, NATURE, V390, P395, DOI 10.1038/37108; Fisher R. A., 1930, GENETICAL THEORY NAT, DOI 10.5962/bhl.title.27468; Holland B, 1999, P NATL ACAD SCI USA, V96, P5083, DOI 10.1073/pnas.96.9.5083; Hurst Laurence D., 1996, Trends in Ecology and Evolution, V11, P46, DOI 10.1016/0169-5347(96)81041-X; Keightley PD, 2000, SCIENCE, V290, P331, DOI 10.1126/science.290.5490.331; Keightley PD, 1999, GENETICS, V153, P515; Kodric-Brown A, 1987, EVOL ECOL, V1, P95, DOI 10.1007/BF02067393; KOESLAG PD, 1994, J THEOR BIOL, V166, P251, DOI 10.1006/jtbi.1994.1023; KONDRASHOV AS, 1988, NATURE, V336, P435, DOI 10.1038/336435a0; KONDRASHOV AS, 1988, GENETICS, V120, P853; Kondrashov AS, 2001, TRENDS GENET, V17, P75, DOI 10.1016/S0168-9525(00)02188-0; KONDRASHOV AS, 1993, J HERED, V84, P372, DOI 10.1093/oxfordjournals.jhered.a111358; Lenski RE, 1999, NATURE, V400, P661, DOI 10.1038/23245; Lynch M, 1999, EVOLUTION, V53, P645, DOI 10.1111/j.1558-5646.1999.tb05361.x; MANNING JT, 1984, J THEOR BIOL, V108, P215, DOI 10.1016/S0022-5193(84)80067-3; Maynard Smith J., 1971, GROUP SELECTION, P163; PETRIE M, 1991, ANIM BEHAV, V41, P323, DOI 10.1016/S0003-3472(05)80484-1; Rohlf F. J., 1994, STAT TABLES; SIMMONS MJ, 1977, ANNU REV GENET, V11, P49, DOI 10.1146/annurev.ge.11.120177.000405; TRIVERS RL, 1976, EVOLUTION, V30, P253, DOI 10.1111/j.1558-5646.1976.tb00908.x; West SA, 1998, GENETICS, V149, P435; West SA, 1999, J EVOLUTION BIOL, V12, P1003	28	179	179	0	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN	2001	411	6838					689	692		10.1038/35079578	http://dx.doi.org/10.1038/35079578			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439JC	11395770				2022-12-24	WOS:000169112500044
J	Chavis, P; Westbrook, G				Chavis, P; Westbrook, G			Integrins mediate functional pre- and postsynaptic maturation at a hippocampal synapse	NATURE			English	Article							LONG-TERM POTENTIATION; CELL-ADHESION MOLECULES; D-ASPARTATE RECEPTOR; TYROSINE PHOSPHORYLATION; TRANSMITTER RELEASE; EXCITATORY SYNAPSES; NMDA RECEPTORS; ALPHA-IIB-BETA-3; ALPHA-V-BETA-3; ALPHA-5-BETA-1	Coordinated signalling between presynaptic terminals and their postsynaptic targets is essential for the development and function of central synapses. In addition to diffusible molecules(1), this bidirectional flow of information could involve direct interactions through cell-adhesion molecules(2,3). Here, we show that one class of cell-adhesion molecule, the integrins, are required for the functional maturation of hippocampal synapses in vitro. At immature synapses, a high probability of glutamate release (P-r) was correlated with the expression of postsynaptic NMDA (N-methyl-D-aspartate) receptors containing the NR2B subunit. The activity-dependent reduction in P-r and a switch in the subunit composition of synaptic NMDA receptors was prevented by chronic blockade with peptides containing the integrin-binding site Arg-Gly-Asp (RGD), or by a functional antibody against the beta3 integrin subunit. Active synapses, monitored by the uptake of antibodies against the intraluminal domain of synaptotagmin I, also had beta3 subunit immunoreactivity. Our results provide evidence that integrin-mediated signalling is essential for the orchestrated maturation of central excitatory synapses.	Univ Portland, Vollum Inst Oregon Hlth Sci, Portland, OR 97201 USA	University of Portland	Chavis, P (corresponding author), CNRS, UPR 9023, 141 Rue Cardonille, F-34094 Montpellier, France.		Chavis, Pascale/M-8312-2016	Chavis, Pascale/0000-0002-3038-1014				Aplin AE, 1998, PHARMACOL REV, V50, P197; Blaess S, 1998, J NEUROCHEM, V71, P2615, DOI 10.1046/j.1471-4159.1998.71062615.x; BOLSHAKOV VY, 1995, SCIENCE, V269, P1730, DOI 10.1126/science.7569903; Boyer C, 1998, J NEUROSCI, V18, P5294, DOI 10.1523/JNEUROSCI.18-14-05294.1998; Chavis P, 1998, NEURON, V20, P773, DOI 10.1016/S0896-6273(00)81015-6; CHAVIS P, 1998, SOC NEUR ABS; Fitzsimonds RM, 1998, PHYSIOL REV, V78, P143, DOI 10.1152/physrev.1998.78.1.143; Grotewiel MS, 1998, NATURE, V391, P455, DOI 10.1038/35079; HESSLER NA, 1993, NATURE, V366, P569, DOI 10.1038/366569a0; Kohmura N, 1998, NEURON, V20, P1137, DOI 10.1016/S0896-6273(00)80495-X; LAU LF, 1995, J BIOL CHEM, V270, P20036, DOI 10.1074/jbc.270.34.20036; LUTHI A, 1994, NATURE, V372, P777, DOI 10.1038/372777a0; Murthy VN, 1997, NEURON, V18, P599, DOI 10.1016/S0896-6273(00)80301-3; PFAFF M, 1994, CELL ADHES COMMUN, V2, P491, DOI 10.3109/15419069409014213; Pinkstaff JK, 1999, J NEUROSCI, V19, P1541; ROSENMUND C, 1993, SCIENCE, V262, P754, DOI 10.1126/science.7901909; Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Schikorski T, 1997, J NEUROSCI, V17, P5858; Schlaepfer DD, 1998, TRENDS CELL BIOL, V8, P151, DOI 10.1016/S0962-8924(97)01172-0; Song JY, 1999, P NATL ACAD SCI USA, V96, P1100, DOI 10.1073/pnas.96.3.1100; Staubli U, 1998, J NEUROSCI, V18, P3460; Tang LX, 1998, NEURON, V20, P1165, DOI 10.1016/S0896-6273(00)80497-3; Tovar KR, 1999, J NEUROSCI, V19, P4180; Vicini S, 1998, J NEUROPHYSIOL, V79, P555, DOI 10.1152/jn.1998.79.2.555; WILLIAMS K, 1993, NEURON, V10, P267, DOI 10.1016/0896-6273(93)90317-K; WILLIAMS K, 1993, MOL PHARMACOL, V44, P851	27	248	255	0	19	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 17	2001	411	6835					317	321		10.1038/35077101	http://dx.doi.org/10.1038/35077101			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432RT	11357135				2022-12-24	WOS:000168710000050
J	Hutvagner, G; McLachlan, J; Pasquinelli, AE; Balint, E; Tuschl, T; Zamore, PD				Hutvagner, G; McLachlan, J; Pasquinelli, AE; Balint, E; Tuschl, T; Zamore, PD			A cellular function for the RNA-interference enzyme Dicer in the maturation of the let-7 small temporal RNA	SCIENCE			English	Article							DOUBLE-STRANDED-RNA; CAENORHABDITIS-ELEGANS; C-ELEGANS; REGULATORY RNA; MESSENGER-RNA; GENE; LIN-14; ARABIDOPSIS; DROSOPHILA; SEQUENCE	The 21-nucleotide small temporal RNA (stRNA) let-7 regulates developmental timing in Caenorhabditis elegans and probably in other bilateral animals. We present in vivo and in vitro evidence that in Drosophila melanogaster a developmentally regulated precursor RNA is cleaved by an RNA interference-like mechanism to produce mature let-7 stRNA. Targeted destruction in cultured human cells of the messenger RNA encoding the enzyme Dicer, which acts in the RNA interference pathway, leads to accumulation of the let-7 precursor. Thus, the RNA interference and stRNA pathways intersect. Both pathways require the RNA-processing enzyme Dicer to produce the active small-RNA component that represses gene expression.	Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01655 USA; Univ Massachusetts, Sch Med, Dept Cell Biol, Worcester, MA 01655 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; Max Planck Inst Biophys Chem, Dept Cellular Biochem, D-37077 Gottingen, Germany	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Max Planck Society	Hutvagner, G (corresponding author), Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01655 USA.	phillip.zamore@umassmed.edu	Zamore, Phillip D/A-8941-2013	Zamore, Phillip/0000-0002-4505-9618; Hutvagner, Gyorgy/0000-0002-7231-9446	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062862, R37GM062862] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM62862-01] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alefelder S, 1998, NUCLEIC ACIDS RES, V26, P4983, DOI 10.1093/nar/26.21.4983; ARASU P, 1991, GENE DEV, V5, P1825, DOI 10.1101/gad.5.10.1825; Bass BL, 2000, CELL, V101, P235, DOI 10.1016/S0092-8674(02)71133-1; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; CHELLADURAI B, 1993, BIOCHEMISTRY-US, V32, P7549, DOI 10.1021/bi00080a029; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Filippov V, 2000, GENE, V245, P213, DOI 10.1016/S0378-1119(99)00571-5; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Ha I, 1996, GENE DEV, V10, P3041, DOI 10.1101/gad.10.23.3041; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Jacobsen SE, 1999, DEVELOPMENT, V126, P5231; Lam G, 2000, CURR BIOL, V10, P957, DOI 10.1016/S0960-9822(00)00631-X; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; Matsuda S, 2000, BBA-GENE STRUCT EXPR, V1490, P163, DOI 10.1016/S0167-4781(99)00221-3; Moss EG, 2000, CURR BIOL, V10, pR436, DOI 10.1016/S0960-9822(00)00528-5; Moss EG, 1997, CELL, V88, P637, DOI 10.1016/S0092-8674(00)81906-6; Nicholson AW, 1999, FEMS MICROBIOL REV, V23, P371, DOI 10.1016/S0168-6445(99)00013-3; NYKANEN A, UNPUB; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; Parrish S, 2000, MOL CELL, V6, P1077, DOI 10.1016/S1097-2765(00)00106-4; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; PASQUINELLI AE, UNPUB; Ray A, 1996, DEVELOPMENT, V122, P2631; Ray S, 1996, DEV BIOL, V180, P365, DOI 10.1006/dbio.1996.0309; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; RUVKUN G, 1991, DEVELOPMENT, P47; Slack FJ, 2000, MOL CELL, V5, P659, DOI 10.1016/S1097-2765(00)80245-2; Tuschl T, 1999, GENE DEV, V13, P3191, DOI 10.1101/gad.13.24.3191; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; WIGHTMAN B, 1991, GENE DEV, V5, P1813, DOI 10.1101/gad.5.10.1813; Yang D, 2000, CURR BIOL, V10, P1191, DOI 10.1016/S0960-9822(00)00732-6; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0; ZUKER M, 1999, PRACTICAL GUIDE RNA	36	2046	2332	5	174	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 3	2001	293	5531					834	838		10.1126/science.1062961	http://dx.doi.org/10.1126/science.1062961			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459FU	11452083				2022-12-24	WOS:000170241000037
J	Li, J; Stein, D; McMullan, C; Branton, D; Aziz, MJ; Golovchenko, JA				Li, J; Stein, D; McMullan, C; Branton, D; Aziz, MJ; Golovchenko, JA			Ion-beam sculpting at nanometre length scales	NATURE			English	Article							POLYNUCLEOTIDE MOLECULES; BOMBARDED SI(001); DISCRIMINATION; CHANNEL; SIO2	Manipulating matter at the nanometre scale is important for many electronic, chemical and biological advances(1-3), but present solid-state fabrication methods do not reproducibly achieve dimensional control at the nanometre scale. Here we report a means of fashioning matter at these dimensions that uses low-energy ion beams and reveals surprising atomic transport phenomena that occur in a variety of materials and geometries. The method is implemented in a feedback-controlled sputtering system that provides fine control over ion beam exposure and sample temperature. We call the method "ion-beam sculpting'', and apply it to the problem of fabricating a molecular-scale hole, or nanopore, in a thin insulating solid-state membrane. Such pores can serve to localize molecular-scale electrical junctions and switches(4-6) and function as masks(7) to create other small-scale structures. Nanopores also function as membrane channels in all living systems, where they serve as extremely sensitive electro-mechanical devices that regulate electric potential, ionic flow, and molecular transport across cellular membranes(8). We show that ion-beam sculpting can be used to fashion an analogous solid-state device: a robust electronic detector consisting of a single nanopore in a Si(3)N(4) membrane, capable of registering single DNA molecules in aqueous solution.	Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; Harvard Univ, Div Engn & Appl Sci, Cambridge, MA 02138 USA; Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University; Harvard University; Harvard University	Golovchenko, JA (corresponding author), Harvard Univ, Dept Phys, Cambridge, MA 02138 USA.	golovchenko@physics.harvard.edu	Aziz, Michael/AAK-4866-2020; Stein, Derek/AAV-4959-2020	Aziz, Michael/0000-0001-9657-9456; Stein, Derek/0000-0001-5917-4986				Akeson M, 1999, BIOPHYS J, V77, P3227, DOI 10.1016/S0006-3495(99)77153-5; Bezrukov SM, 2000, J MEMBRANE BIOL, V174, P1, DOI 10.1007/s002320001026; BEZRUKOV SM, 1994, NATURE, V370, P279, DOI 10.1038/370279a0; Brongersma ML, 2000, J APPL PHYS, V88, P59, DOI 10.1063/1.373624; Carter G, 1997, SURF INTERFACE ANAL, V25, P952, DOI 10.1002/(SICI)1096-9918(199711)25:12<952::AID-SIA333>3.0.CO;2-F; Deshmukh MM, 1999, APPL PHYS LETT, V75, P1631, DOI 10.1063/1.124777; Erlebacher J, 1999, PHYS REV LETT, V82, P2330, DOI 10.1103/PhysRevLett.82.2330; Erlebacher J, 2000, J VAC SCI TECHNOL A, V18, P115, DOI 10.1116/1.582127; GNASET H, 1999, ION IRRADIATION SOLI; Gu LQ, 1999, NATURE, V398, P686, DOI 10.1038/19491; HAMMILL OP, 1981, PFLUGERS ARCH, V391, P85; Hille B., 1992, IONIC CHANNELS EXCIT; Ito T, 2000, NATURE, V406, P1027, DOI 10.1038/35023233; Joachim C, 2000, NATURE, V408, P541, DOI 10.1038/35046000; JOHNSON RE, 1993, KONG DANSK VIDENSK, P403; Kasianowicz JJ, 1996, P NATL ACAD SCI USA, V93, P13770, DOI 10.1073/pnas.93.24.13770; MAYER TM, 1994, J APPL PHYS, V76, P1633, DOI 10.1063/1.357748; Meller A, 2000, P NATL ACAD SCI USA, V97, P1079, DOI 10.1073/pnas.97.3.1079; NENADOVIC T, 1990, NUCL INSTRUM METH B, V48, P538, DOI 10.1016/0168-583X(90)90178-W; RAICHOUDHURY P, 1997, HDB MICROLITHOGRAPHY, P41; RALLS KS, 1989, APPL PHYS LETT, V55, P2459, DOI 10.1063/1.102001; RALPH DC, 1995, PHYS REV LETT, V74, P3241, DOI 10.1103/PhysRevLett.74.3241; Reed MA, 1998, ANN NY ACAD SCI, V852, P133, DOI 10.1111/j.1749-6632.1998.tb09868.x; SIGMUND P, 1993, DANSKE VIDENSK SELSK, V43, P7; Stupp SI, 1997, SCIENCE, V277, P1242, DOI 10.1126/science.277.5330.1242; WOLF S, 2000, SILICON PROCESSING V, P149; Zhou C, 1997, APPL PHYS LETT, V71, P611, DOI 10.1063/1.120195	27	1378	1537	28	545	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 12	2001	412	6843					166	169		10.1038/35084037	http://dx.doi.org/10.1038/35084037			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	451AJ	11449268	Green Submitted			2022-12-24	WOS:000169778700046
J	Havlir, DV; Bassett, R; Levitan, D; Gilbert, P; Tebas, P; Collier, AC; Hirsch, MS; Ignacio, C; Condra, J; Gunthard, HF; Richman, DD; Wong, JK				Havlir, DV; Bassett, R; Levitan, D; Gilbert, P; Tebas, P; Collier, AC; Hirsch, MS; Ignacio, C; Condra, J; Gunthard, HF; Richman, DD; Wong, JK			Prevalence and predictive value of intermittent viremia with combination HIV therapy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ACTIVE ANTIRETROVIRAL THERAPY; PROTEASE INHIBITOR THERAPY; TRIPLE-DRUG THERAPY; VIROLOGICAL RESPONSE; VIRAL REPLICATION; INDUCTION THERAPY; GENETIC-VARIATION; PERIPHERAL-BLOOD; IN-VIVO	Context In HIV-infected patients having virologic suppression (plasma HIV RNA <50 copies/mL) with antiretroviral therapy, intermittent episodes of low-level viremia have been correlated with slower decay rates of latently infected cells and increased levels of viral evolution, but the clinical significance of these episodes is unknown. Objective To determine if HIV-infected patients with intermittent viremia have a higher risk of virologic failure (confirmed HIV RNA >200 copies/mL). Design and Setting Retrospective analysis of subjects in well-characterized cohorts, the AIDS Clinical Trials Group (ACTG) 343 trial of induction-maintenance therapy (August 1997 to November 1998) and the Merck 035 trial (ongoing since March 1995). Patients Two hundred forty-one ACTG 343 patients, of whom 101 received triple-drug therapy throughout the study, and a small group of 13 patients from Merck 035 having virologic suppression after 6 months of indinavir-zidovudine-lamivudine. Main Outcome Measures Association of intermittent viremia (plasma HIV RNA >50 copies/mL) with a subsequent measure (50 copies/mL) with virologic failure (2 consecutive plasma HIV RNA measures >200 copies/mL) in both study groups; evidence of drug resistance in 7 patients from the small (n=13) study group with long-term follow-up. Results Intermittent viremia occurred in 96 (40%) of the 241 ACTG 343 patients of whom 32 (13%) had 2 consecutive HIV RNA values >50 copies/mL. during the median 84 weeks of observation (median duration of observation after first intermittent viremia episode was 46 weeks). Of the 101 individuals receiving triple-drug therapy throughout, 29% had intermittent viremia; the proportion of episodes occurring during the maintenance period was 64% for the entire cohort and 68% for the group not receiving triple-drug therapy throughout vs 55% for those who did (P=.25), Intermittent viremia did not predict virologic failure: 10 (10.4%) of 96 patients with and 20 (13.8%) of 145 patients without intermittent viremia had virologic failure (relative risk, 0.76; 95% confidence interval [CI], 0.29-1.72). In a Cox proportional hazards model, the risk for virologic failure was not significantly greater in the ACTG 343 patients with intermittent viremia (hazard ratio, 1.28; 95% CI, 0.59-2.79). Median Viral load in 10 ACTG 343 patients assessed between 24 and 60 weeks of therapy using an ultrasensitive 2.5-copies/mL detection level assay was 23 copies/mL in those with intermittent viremia vs <2.5 copies/mL in those without (P=.15). intermittent viremia occurred in 6 of 13 patients from the small study group assessed after 76 to 260 weeks of therapy (using the 2.5-copies/mL detection level assay) and was associated with a higher steady state of viral replication (P=.03), but not virologic failure over 4.5 years of observation. Viral DNA sequences from 7 patients did not show evolution of drug resistance. Conclusions Intermittent viremia occurred frequently and was associated with higher levels of replication (Merck 035), but was not associated with virologic failure in patients receiving initial combination therapy of indinavir-zidovudine-lamivudine (ACTG 343 and Merck 035). In this population, treatment changes may not be necessary to maintain long-term virologic suppression with low-level or intermittent viremia.	Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA; Univ Calif San Diego, Dept Pathol, San Diego, CA 92103 USA; San Diego VA Healthcare Syst, San Diego, CA USA; Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; Harvard Univ, Dept Med, Infect Dis Unit, Boston, MA 02115 USA; Washington Univ, Dept Internal Med, St Louis, MO USA; Univ Washington, Sch Med, Dept Allergy & Infect Dis, Seattle, WA 98195 USA; Merck Res Lab, W Point, PA USA; Univ Zurich, Dept Med, Div Infect Dis & Hosp Epidemiol, Zurich, Switzerland	University of California System; University of California San Diego; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Washington University (WUSTL); University of Washington; University of Washington Seattle; Merck & Company; University of Zurich	Havlir, DV (corresponding author), Univ Calif San Diego, Dept Med, 150 W Washington,Suite 100, San Diego, CA 92103 USA.		Tebas, Pablo/A-7061-2008; gunthard, huldrych f/F-1724-2011	gunthard, huldrych f/0000-0002-1142-6723; Tebas, Pablo/0000-0001-5345-7942	NIAID NIH HHS [AI38858, AI43752, AI27670, AI29164, AI36214, AI38855] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI029164, U01AI027670, R37AI029164, P30AI036214, U01AI038855, R01AI043752, U01AI038858] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ACOSTA EP, 2000, 7 C RETR OPP INF SAN, P162; Carpenter CCJ, 2000, JAMA-J AM MED ASSOC, V283, P381, DOI 10.1001/jama.283.3.381; CLAVEL F, 1989, J VIROL, V63, P1455, DOI 10.1128/JVI.63.3.1455-1459.1989; COFFIN JM, 1992, CURR TOP MICROBIOL, V176, P143; COFFIN JM, 1995, SCIENCE, V267, P483, DOI 10.1126/science.7824947; Dornadula G, 1999, JAMA-J AM MED ASSOC, V282, P1627, DOI 10.1001/jama.282.17.1627; Drusano GL, 1998, J INFECT DIS, V178, P360, DOI 10.1086/515631; Furtado MR, 1999, NEW ENGL J MED, V340, P1614, DOI 10.1056/NEJM199905273402102; Grabar S, 2000, AIDS, V14, P141, DOI 10.1097/00002030-200001280-00009; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Grossman Z, 1999, NAT MED, V5, P1099, DOI 10.1038/13410; Grossman Z, 1998, P NATL ACAD SCI USA, V95, P6314, DOI 10.1073/pnas.95.11.6314; Gulick RM, 1997, NEW ENGL J MED, V337, P734, DOI 10.1056/NEJM199709113371102; Gunthard HF, 1999, J VIROL, V73, P9404; Haslett PAJ, 2000, J INFECT DIS, V181, P1264, DOI 10.1086/315381; Havlir DV, 1998, NEW ENGL J MED, V339, P1261, DOI 10.1056/NEJM199810293391801; Kempf DJ, 1998, AIDS, V12, pF9, DOI 10.1097/00002030-199805000-00001; Martinez-Picado J, 2000, P NATL ACAD SCI USA, V97, P10948, DOI 10.1073/pnas.97.20.10948; Mocroft A, 1998, AIDS, V12, P2161, DOI 10.1097/00002030-199816000-00011; O'Brien TR, 2000, AIDS, V14, P821, DOI 10.1097/00002030-200005050-00008; OBRIEN WA, 1995, BLOOD, V86, P1082; Paredes R, 2000, ARCH INTERN MED, V160, P1123, DOI 10.1001/archinte.160.8.1123; Paris D, 1999, AIDS RES HUM RETROV, V15, P1631, DOI 10.1089/088922299309676; Paterson DL, 2000, ANN INTERN MED, V133, P21, DOI 10.7326/0003-4819-133-1-200007040-00004; Pialoux G, 1998, NEW ENGL J MED, V339, P1269, DOI 10.1056/NEJM199810293391802; Pilcher CD, 1999, AIDS, V13, P1337, DOI 10.1097/00002030-199907300-00010; Powderly WG, 1999, AIDS, V13, P1873, DOI 10.1097/00002030-199910010-00009; Raboud JM, 1999, J INFECT DIS, V180, P1347, DOI 10.1086/314998; Raboud JM, 1998, AIDS, V12, P1619, DOI 10.1097/00002030-199813000-00008; Ramratnam B, 2000, NAT MED, V6, P82, DOI 10.1038/71577; Reijers MHE, 1998, LANCET, V352, P185, DOI 10.1016/S0140-6736(98)06193-5; TEMIN HM, 1993, P NATL ACAD SCI USA, V90, P6900, DOI 10.1073/pnas.90.15.6900; US Department of Health and Human Services, 2001, GUID US ANT AG HIV I; Wit FWNM, 1999, J INFECT DIS, V179, P790, DOI 10.1086/314675; Yerly S, 2000, AIDS, V14, P243, DOI 10.1097/00002030-200002180-00006; Zennou V, 1998, J VIROL, V72, P3300, DOI 10.1128/JVI.72.4.3300-3306.1998; Zhang LQ, 1999, NEW ENGL J MED, V340, P1605, DOI 10.1056/NEJM199905273402101	37	288	289	1	10	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 11	2001	286	2					171	179		10.1001/jama.286.2.171	http://dx.doi.org/10.1001/jama.286.2.171			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	451JJ	11448280	Bronze			2022-12-24	WOS:000169798700022
J	Wadman, M				Wadman, M			US blood ban underlines CJD fears	NATURE			English	News Item																		Wadman M, 2001, NATURE, V409, P441, DOI 10.1038/35054193	1	0	0	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 5	2001	412	6842					7	7		10.1038/35083730	http://dx.doi.org/10.1038/35083730			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448TB	11452271	Bronze			2022-12-24	WOS:000169644900010
J	Mochizuki, N; Yamashita, S; Kurokawa, K; Ohba, Y; Nagai, T; Miyawaki, A; Matsuda, M				Mochizuki, N; Yamashita, S; Kurokawa, K; Ohba, Y; Nagai, T; Miyawaki, A; Matsuda, M			Spatio-temporal images of growth-factor-induced activation of Ras and Rap1	NATURE			English	Article							GREEN FLUORESCENT PROTEIN; SIGNAL-REGULATED KINASE; DEPENDENT ACTIVATION; MOLECULAR SWITCH; PHOSPHORYLATION; PATHWAYS; GENE; CREB	G proteins of the Ras family function as molecular switches in many signalling cascades(1-3); however, little is known about where they become activated in living cells. Here we use FRET (fluorescent resonance energy transfer)-based sensors to report on the spatio-temporal images of growth-factor-induced activation of Ras and Rap1. Epidermal growth factor activated Ras at the peripheral plasma membrane and Rap1 at the intracellular perinuclear region of COS-1 cells. In PC12 cells, nerve growth factor-induced activation of Ras was initiated at the plasma membrane and transmitted to the whole cell body. After three hours, high Ras activity was observed at the extending neurites. By using the FRAP (fluorescence recovery after photobleaching) technique, we found that Ras at the neurites turned over rapidly; therefore, the sustained Ras activity at neurites was due to high GTP/GDP exchange rate and/or low GTPase activity, but not to the retention of the active Ras. These observations may resolve long-standing questions as to how Ras and Rap1 induce different cellular responses(4) and how the signals for differentiation and survival are distinguished by neuronal cells(5).	Natl Cardiovasc Ctr, Res Inst, Dept Struct Anal, Suita, Osaka 5658565, Japan; Int Med Ctr Japan, Res Inst, Dept Pathol, Shinjuku Ku, Tokyo 1628655, Japan; Osaka Univ, Inst Microbial Dis, Dept Tumor Virol, Suita, Osaka 5650871, Japan; RIKEN, Brain Sci Inst, Lab Cell Funct & Dynam, Wako, Saitama 3510198, Japan	National Cerebral & Cardiovascular Center - Japan; National Center for Global Health & Medicine - Japan; Osaka University; RIKEN	Matsuda, M (corresponding author), Natl Cardiovasc Ctr, Res Inst, Dept Struct Anal, 5-7-1 Fujishirodai, Suita, Osaka 5658565, Japan.		Kurokawa, Kazuo/E-9130-2013; Miyawaki, Atsushi/K-3569-2014; Ohba, Yusuke/E-7944-2011	Kurokawa, Kazuo/0000-0003-3549-4795; Miyawaki, Atsushi/0000-0002-2329-3235; Matsuda, Michiyuki/0000-0002-5876-9969; Nagai, Takeharu/0000-0003-2650-9895				BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; Bos JL, 1998, EMBO J, V17, P6776, DOI 10.1093/emboj/17.23.6776; COOK SJ, 1993, EMBO J, V12, P3475, DOI 10.1002/j.1460-2075.1993.tb06022.x; FEIG LA, 1988, MOL CELL BIOL, V8, P3235, DOI 10.1128/MCB.8.8.3235; HOSHINO M, 1988, MOL CELL BIOL, V8, P4169, DOI 10.1128/MCB.8.10.4169; Hu CD, 1997, J BIOL CHEM, V272, P11702, DOI 10.1074/jbc.272.18.11702; Ichiba T, 1999, J BIOL CHEM, V274, P14376, DOI 10.1074/jbc.274.20.14376; KITAYAMA H, 1989, CELL, V56, P77, DOI 10.1016/0092-8674(89)90985-9; Lippincott-Schwartz J, 1999, METHOD CELL BIOL, V58, P261; LOWY DR, 1993, ANNU REV BIOCHEM, V62, P851, DOI 10.1146/annurev.bi.62.070193.004223; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Miyawaki A, 1999, P NATL ACAD SCI USA, V96, P2135, DOI 10.1073/pnas.96.5.2135; Miyawaki A, 2000, METHOD ENZYMOL, V327, P472, DOI 10.1016/S0076-6879(00)27297-2; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Mochizuki N, 1999, NATURE, V400, P891, DOI 10.1038/23738; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Ohba Y, 2000, MOL CELL BIOL, V20, P6074, DOI 10.1128/MCB.20.16.6074-6083.2000; Riccio A, 1997, SCIENCE, V277, P1097, DOI 10.1126/science.277.5329.1097; RodriguezViciana P, 1997, CELL, V89, P457, DOI 10.1016/S0092-8674(00)80226-3; SATOH T, 1992, J BIOL CHEM, V267, P24149; SCHELL DL, 1994, J SOC GYNECOL INVEST, V1, P269, DOI 10.1177/107155769400100405; SCHLESSINGER J, 1994, COLD SPRING HARB SYM, V59, P173, DOI 10.1101/SQB.1994.059.01.021; Vojtek AB, 1998, J BIOL CHEM, V273, P19925, DOI 10.1074/jbc.273.32.19925; Xing J, 1998, MOL CELL BIOL, V18, P1946, DOI 10.1128/MCB.18.4.1946; Zhang YZ, 2000, J NEUROSCI, V20, P5671, DOI 10.1523/JNEUROSCI.20-15-05671.2000	25	475	496	1	69	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 28	2001	411	6841					1065	1068		10.1038/35082594	http://dx.doi.org/10.1038/35082594			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	446TF	11429608				2022-12-24	WOS:000169528500051
J	Watkins, RE; Wisely, GB; Moore, LB; Collins, JL; Lambert, MH; Williams, SP; Willson, TM; Kliewer, SA; Redinbo, MR				Watkins, RE; Wisely, GB; Moore, LB; Collins, JL; Lambert, MH; Williams, SP; Willson, TM; Kliewer, SA; Redinbo, MR			The human nuclear xenobiotic receptor PXR: Structural determinants of directed promiscuity	SCIENCE			English	Article							PREGNANE-X-RECEPTOR; LIGAND-BINDING DOMAIN; CRYSTAL-STRUCTURE; JOHNS-WORT; SIGNALING PATHWAY; MOLECULAR-BASIS; CHOLESTEROL; COACTIVATOR; ANTAGONISM; ACTIVATION	The human nuclear pregnane X receptor (hPXR) activates cytochrome P450-3A expression in response to a wide variety of xenobiotics and plays a critical role in mediating dangerous drug-drug interactions. We present the crystal structures of the ligand-binding domain of hPXR both alone and in complex with the cholesterol-lowering drug SR12813 at resolutions of 2.5 and 2.75 angstroms, respectively. The hydrophobic ligand-binding cavity of hPXR contains a small number of polar residues, permitting SR12813 to bind in three distinct orientations. The position and nature of these polar residues were found to be critical for establishing the precise pharmacologic activation profile of PXR. Our findings provide important insights into how hPXR detects xenobiotics and may prove useful in predicting and avoiding drug-drug interactions.	Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA; Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; GlaxoSmithKline, Nucl Receptor Discovery Res, Res Triangle Pk, NC 27709 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; GlaxoSmithKline	Redinbo, MR (corresponding author), Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA.		feinstein, doug/M-9414-2019	Williams, Shawn/0000-0001-8311-2638				Berkhout TA, 1996, J BIOL CHEM, V271, P14376, DOI 10.1074/jbc.271.24.14376; Berkhout TA, 1997, ATHEROSCLEROSIS, V133, P203, DOI 10.1016/S0021-9150(97)00131-7; Bertilsson G, 1998, P NATL ACAD SCI USA, V95, P12208, DOI 10.1073/pnas.95.21.12208; Blumberg B, 1998, GENE DEV, V12, P3195, DOI 10.1101/gad.12.20.3195; BOURGUET W, 1995, NATURE, V375, P377, DOI 10.1038/375377a0; BRUNGER AT, 1993, ACTA CRYSTALLOGR D, V49, P24, DOI 10.1107/S0907444992007352; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brzozowski AM, 1997, NATURE, V389, P753, DOI 10.1038/39645; Gampe RT, 2000, MOL CELL, V5, P545, DOI 10.1016/S1097-2765(00)80448-7; Goodwin B, 1999, MOL PHARMACOL, V56, P1329, DOI 10.1124/mol.56.6.1329; Jones SA, 2000, MOL ENDOCRINOL, V14, P27, DOI 10.1210/me.14.1.27; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kliewer SA, 1998, CELL, V92, P73, DOI 10.1016/S0092-8674(00)80900-9; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Lehmann JM, 1998, J CLIN INVEST, V102, P1016, DOI 10.1172/JCI3703; MAUREL P, 1996, CYTOCHROMES P450 MET, P241; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Moore LB, 2000, P NATL ACAD SCI USA, V97, P7500, DOI 10.1073/pnas.130155097; Moore LB, 2000, J BIOL CHEM, V275, P15122, DOI 10.1074/jbc.M001215200; Moras D, 1998, CURR OPIN CELL BIOL, V10, P384, DOI 10.1016/S0955-0674(98)80015-X; Navaza J, 1997, METHOD ENZYMOL, V276, P581, DOI 10.1016/S0076-6879(97)76079-8; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Nolte RT, 1998, NATURE, V395, P137, DOI 10.1038/25931; ONATE SA, 1995, SCIENCE, V270, P1354; Piscitelli SC, 2000, LANCET, V355, P547, DOI 10.1016/S0140-6736(99)05712-8; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; RENAUD JP, 1995, NATURE, V378, P681, DOI 10.1038/378681a0; Rochel N, 2000, MOL CELL, V5, P173, DOI 10.1016/S1097-2765(00)80413-X; Ruschitzka F, 2000, LANCET, V355, P548, DOI 10.1016/S0140-6736(99)05467-7; Savas U, 2000, DRUG METAB DISPOS, V28, P529; Shiau AK, 1998, CELL, V95, P927, DOI 10.1016/S0092-8674(00)81717-1; Weatherman RV, 1999, ANNU REV BIOCHEM, V68, P559, DOI 10.1146/annurev.biochem.68.1.559; Wentworth JM, 2000, J ENDOCRINOL, V166, pR11, DOI 10.1677/joe.0.166R011; Williams SP, 1998, NATURE, V393, P392, DOI 10.1038/30775; Xie W, 2000, NATURE, V406, P435, DOI 10.1038/35019116	35	635	661	1	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 22	2001	292	5525					2329	2333		10.1126/science.1060762	http://dx.doi.org/10.1126/science.1060762			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	445KD	11408620				2022-12-24	WOS:000169455900058
J	Chuang, HH; Prescott, ED; Kong, HY; Shields, S; Jordt, SE; Basbaum, AI; Chao, MV; Julius, D				Chuang, HH; Prescott, ED; Kong, HY; Shields, S; Jordt, SE; Basbaum, AI; Chao, MV; Julius, D			Bradykinin and nerve growth factor release the capsaicin receptor from PtdIns(4,5)P-2-mediated inhibition	NATURE			English	Article							SENSORY NEURONS; SIGNALING COMPLEX; DIRECT ACTIVATION; MICE LACKING; PAIN; HYPERALGESIA; CHANNELS; PHOTOTRANSDUCTION; SENSITIZATION; RESPONSES	Tissue injury generates endogenous factors that heighten our sense of pain by increasing the response of sensory nerve endings to noxious stimuli(1,2). Bradykinin and nerve growth factor (NGF) are two such pro-algesic agents that activate G-protein-coupled (BK2) and tyrosine kinase (TrkA) receptors, respectively, to stimulate phospholipase C (PLC) signalling pathways in primary afferent neurons(3,4). How these actions produce sensitization to physical or chemical stimuli has not been elucidated at the molecular level. Here, we show that bradykinin- or NGF-mediated potentiation of thermal sensitivity in vivo requires expression of VR1, a heat-activated ion channel on sensory neurons. Diminution of plasma membrane phosphatidylinositol-4,5-bisphosphate (PtdIns(4,5)P-2) levels through antibody sequestration or PLC-mediated hydrolysis mimics the potentiating effects of bradykinin or NGF at the cellular level. Moreover, recruitment of PLC-gamma to TrkA is essential for NGF-mediated potentiation of channel activity, and biochemical studies suggest that VR1 associates with this complex. These studies delineate a biochemical mechanism through which bradykinin and NGF produce hypersensitivity and might explain how the activation of PLC signalling systems regulates other members of the TRP channel family.	Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA; NYU, Sch Med, Skirball Inst Biomol Med, Mol Neurobiol Program, New York, NY 10016 USA; Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, WM Keck Ctr Neurosci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; New York University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Julius, D (corresponding author), Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA.	julius@socrates.ucsf.edu	Jordt, Sven-Eric/ABE-6517-2020	Jordt, Sven-Eric/0000-0001-6171-5622; Chao, Moses/0000-0002-6969-3744; Shields, Shannon/0000-0002-8006-7103				Bergmann I, 1998, NEUROSCI LETT, V255, P87, DOI 10.1016/S0304-3940(98)00713-7; Bevan S., 1999, TXB PAIN, P85; BURGESS GM, 1989, J NEUROSCI, V9, P3314; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Cesare P, 1999, NEURON, V23, P617, DOI 10.1016/S0896-6273(00)80813-2; Chevesich J, 1997, NEURON, V18, P95, DOI 10.1016/S0896-6273(01)80049-0; Davis JB, 2000, NATURE, V405, P183, DOI 10.1038/35012076; Estacion M, 2001, J PHYSIOL-LONDON, V530, P1, DOI 10.1111/j.1469-7793.2001.0001m.x; Ganju P, 1998, EUR J NEUROSCI, V10, P1995, DOI 10.1046/j.1460-9568.1998.00209.x; Harteneck C, 2000, TRENDS NEUROSCI, V23, P159, DOI 10.1016/S0166-2236(99)01532-5; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; Huang CL, 1998, NATURE, V391, P803, DOI 10.1038/35882; Jordt SE, 2000, P NATL ACAD SCI USA, V97, P8134, DOI 10.1073/pnas.100129497; Koltzenburg M, 1999, PAIN, pS93, DOI 10.1016/S0304-3959(99)00142-6; Koltzenburg M, 1999, EUR J NEUROSCI, V11, P1698, DOI 10.1046/j.1460-9568.1999.00590.x; Li HS, 1999, NEURON, V24, P261, DOI 10.1016/S0896-6273(00)80838-7; MCMAHON SB, 1999, TXB PAIN, P105; Nicholas RS, 1999, NEUROSCIENCE, V91, P1425, DOI 10.1016/S0306-4522(98)00706-4; Premkumar LS, 2000, NATURE, V408, P985, DOI 10.1038/35050121; Scott K, 1998, NATURE, V395, P805, DOI 10.1038/27448; Shu XQ, 1999, NEUROSCI LETT, V274, P159, DOI 10.1016/S0304-3940(99)00701-6; Shu XQ, 1999, P NATL ACAD SCI USA, V96, P7693, DOI 10.1073/pnas.96.14.7693; STEPHENS RM, 1994, NEURON, V12, P691, DOI 10.1016/0896-6273(94)90223-2; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Womack KB, 2000, J NEUROSCI, V20, P2792; Woolf CJ, 1996, PHILOS T ROY SOC B, V351, P441, DOI 10.1098/rstb.1996.0040; Woolf CJ, 2000, SCIENCE, V288, P1765, DOI 10.1126/science.288.5472.1765; ZHANG Z, 1983, CHINESE ANN MATH B, V4, P1; Zygmunt PM, 1999, NATURE, V400, P452, DOI 10.1038/22761	30	943	1005	1	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 21	2001	411	6840					957	962		10.1038/35082088	http://dx.doi.org/10.1038/35082088			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	444EN	11418861				2022-12-24	WOS:000169386200047
J	Joshipura, KJ; Hu, FB; Manson, JE; Stampfer, MJ; Rimm, EB; Speizer, FE; Colditz, G; Ascherio, A; Rosner, B; Spiegelman, D; Willett, WC				Joshipura, KJ; Hu, FB; Manson, JE; Stampfer, MJ; Rimm, EB; Speizer, FE; Colditz, G; Ascherio, A; Rosner, B; Spiegelman, D; Willett, WC			The effect of fruit and vegetable intake on risk for coronary heart disease	ANNALS OF INTERNAL MEDICINE			English	Article							FOOD FREQUENCY QUESTIONNAIRE; VITAMIN-E CONSUMPTION; DIETARY PATTERNS; CLINICAL-TRIAL; MEN; MORTALITY; WOMEN; STROKE; HEALTH; FIBER	Background: Many constituents of fruits and vegetables may reduce the risk for coronary heart disease, but data on the relationship between fruit and vegetable consumption and risk for coronary heart disease are sparse. Objective: To evaluate the association of fruit and vegetable consumption with risk for coronary heart disease. Design: Prospective cohort study. Setting: The Nurses' Health Study and the Health Professionals' Follow-Up Study. Participants: 84 251 women 34 to 59 years of age who were followed for 14 years and 42 148 men 40 to 75 years who were followed for 8 years. All were free of diagnosed cardiovascular disease, cancer, and diabetes at baseline. Measurements: The main outcome measure was incidence of nonfatal myocardial infarction or fatal coronary heart disease (1127 cases in women and 1063 cases in men). Diet was assessed by using food-frequency questionnaires. Results: After adjustment for standard cardiovascular risk factors, persons in the highest quintile of fruit and vegetable intake had a relative risk for coronary heart disease of 0.80 (95% CI, 0.69 to 0.93) compared with those in the lowest quintile of intake. Each 1-serving/d increase in intake of fruits or vegetables was associated with a 4% lower risk for coronary heart disease (relative risk, 0.96 [CI, 0.94 to 0.99]; P = 0.01, test for trend). Green leafy vegetables (relative risk with 1-serving/d increase, 0.77 [CI, 0.64 to 0.93]), and vitamin C-rich fruits and vegetables (relative risk with 1-serving/d increase, 0.94 [CI, 0.88 to 0.99]) contributed most to the apparent protective effect of total fruit and vegetable intake. Conclusions: Consumption of fruits and vegetables, particularly green leafy vegetables and vitamin C-rich fruits and vegetables, appears to have a protective effect against coronary heart disease.	Harvard Univ, Sch Dent Med, Dept Oral Hlth Policy & Epidemiol, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; Brigham & Womens Hosp, Channing Lab, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Harvard School of Dental Medicine; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Joshipura, KJ (corresponding author), Harvard Univ, Sch Dent Med, Dept Oral Hlth Policy & Epidemiol, 188 Longwood Ave, Boston, MA 02115 USA.		Hu, Frank/C-1919-2013; Joshipura, Kaumudi J/AAA-3852-2020; Colditz, Graham/A-3963-2009	Colditz, Graham/0000-0002-7307-0291; Joshipura, Kaumudi/0000-0003-1964-7579	NATIONAL CANCER INSTITUTE [R01CA040356, R37CA040356] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL034595, R01HL035464] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE012102] Funding Source: NIH RePORTER; NCI NIH HHS [CA40356, CA55075] Funding Source: Medline; NHLBI NIH HHS [HL35464, HL34595] Funding Source: Medline; NIDCR NIH HHS [DE12102] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Appel LJ, 1997, NEW ENGL J MED, V336, P1117, DOI 10.1056/NEJM199704173361601; ASCHERIO A, 1992, CIRCULATION, V86, P1475, DOI 10.1161/01.CIR.86.5.1475; Ascherio A, 1998, CIRCULATION, V98, P1198, DOI 10.1161/01.CIR.98.12.1198; CAAN B, 1991, EPIDEMIOLOGY, V2, P430, DOI 10.1097/00001648-199111000-00007; Chatellier G, 1996, BRIT MED J, V312, P426; DAGOSTINO RB, 1990, STAT MED, V9, P1501, DOI 10.1002/sim.4780091214; de Lorgeril M, 1999, CIRCULATION, V99, P779, DOI 10.1161/01.CIR.99.6.779; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; FESKANICH D, 1993, J AM DIET ASSOC, V93, P790, DOI 10.1016/0002-8223(93)91754-E; FRASER GE, 1992, ARCH INTERN MED, V152, P1416, DOI 10.1001/archinte.152.7.1416; GABH Rose, 1982, WHO MONOGRAPH SERIES; GILLMAN MW, 1995, JAMA-J AM MED ASSOC, V273, P1113, DOI 10.1001/jama.273.14.1113; Hirayama T, 1986, Prog Clin Biol Res, V206, P299; Hu FB, 1999, AM J EPIDEMIOL, V149, P531, DOI 10.1093/oxfordjournals.aje.a009849; Hu FB, 1997, NEW ENGL J MED, V337, P1491, DOI 10.1056/NEJM199711203372102; Joshipura KJ, 1999, JAMA-J AM MED ASSOC, V282, P1233, DOI 10.1001/jama.282.13.1233; KHAW KT, 1987, AM J EPIDEMIOL, V126, P1093, DOI 10.1093/oxfordjournals.aje.a114748; KHAW KT, 1987, NEW ENGL J MED, V316, P235, DOI 10.1056/NEJM198701293160502; Knekt P, 1996, BRIT MED J, V312, P478, DOI 10.1136/bmj.312.7029.478; KNEKT P, 1994, AM J EPIDEMIOL, V139, P1180, DOI 10.1093/oxfordjournals.aje.a116964; Kushi LH, 1996, NEW ENGL J MED, V334, P1156, DOI 10.1056/NEJM199605023341803; KUSHI LH, 1985, NEW ENGL J MED, V312, P811, DOI 10.1056/NEJM198503283121302; Miller ER, 1998, CIRCULATION, V98, P2390, DOI 10.1161/01.CIR.98.22.2390; MORRIS JN, 1977, BMJ-BRIT MED J, V2, P1307, DOI 10.1136/bmj.2.6098.1307; Ness AR, 1997, INT J EPIDEMIOL, V26, P1, DOI 10.1093/ije/26.1.1; RIMM EB, 1992, AM J EPIDEMIOL, V135, P1114, DOI 10.1093/oxfordjournals.aje.a116211; Rimm EB, 1998, JAMA-J AM MED ASSOC, V279, P359, DOI 10.1001/jama.279.5.359; Rimm EB, 1996, JAMA-J AM MED ASSOC, V275, P447, DOI 10.1001/jama.275.6.447; RIMM EB, 1993, NEW ENGL J MED, V328, P1450, DOI 10.1056/NEJM199305203282004; SALVINI S, 1989, INT J EPIDEMIOL, V18, P858, DOI 10.1093/ije/18.4.858; STAMPFER MJ, 1984, AM J EPIDEMIOL, V119, P837, DOI 10.1093/oxfordjournals.aje.a113804; STAMPFER MJ, 1993, NEW ENGL J MED, V328, P1444, DOI 10.1056/NEJM199305203282003; STEINMETZ KA, 1993, CANCER RES, V53, P536; Willett W., 2012, NUTR EPIDEMIOLOGY	34	980	1026	0	128	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 19	2001	134	12					1106	1114		10.7326/0003-4819-134-12-200106190-00010	http://dx.doi.org/10.7326/0003-4819-134-12-200106190-00010			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	442YU	11412050	Green Published			2022-12-24	WOS:000169313200003
J	Kalir, S; McClure, J; Pabbaraju, K; Southward, C; Ronen, M; Leibler, S; Surette, MG; Alon, U				Kalir, S; McClure, J; Pabbaraju, K; Southward, C; Ronen, M; Leibler, S; Surette, MG; Alon, U			Ordering genes in a flagella pathway by analysis of expression kinetics from living bacteria	SCIENCE			English	Article							ESCHERICHIA-COLI; SACCHAROMYCES-CEREVISIAE; SALMONELLA-TYPHIMURIUM; MUTANTS; REGULON; UNITS	The recent advances in large-scale monitoring of gene expression raise the challenge of mapping systems on the basis of kinetic expression data in living cells. To address this, we measured promoter activity in the flagellar system of Escherichia coli at high accuracy and temporal resolution by means of reporter plasmids. The genes in the pathway were ordered by analysis algorithms without dependence on mutant strains. The observed temporal program of transcription was much more detailed than was previously thought and was associated with multiple steps of flagella assembly.	Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel; Weizmann Inst Sci, Dept Phys Complex Syst, IL-76100 Rehovot, Israel; Univ Calgary, Dept Microbiol & Infect Dis, Calgary, AB T2N 4N1, Canada; Princeton Univ, Dept Mol Biol, Howard Hughes Med Inst, Princeton, NJ 08544 USA; Princeton Univ, Dept Phys, Princeton, NJ 08544 USA	Weizmann Institute of Science; Weizmann Institute of Science; University of Calgary; Howard Hughes Medical Institute; Princeton University; Princeton University	Alon, U (corresponding author), Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel.	urialon@weizmann.ac.il	Surette, Michael G/AAE-8825-2020; Rosa, Bruce/F-6393-2010	McClure, JoAnn/0000-0003-4165-744X				Alon U, 1999, NATURE, V397, P168, DOI 10.1038/16483; AMSLER CD, 1993, J BACTERIOL, V175, P6238, DOI 10.1128/JB.175.19.6238-6244.1993; BLAIR DF, 1988, SCIENCE, V242, P1678, DOI 10.1126/science.2849208; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; BLOCK SM, 1984, NATURE, V309, P470, DOI 10.1038/309470a0; Chilcott GS, 2000, MICROBIOL MOL BIOL R, V64, P694, DOI 10.1128/MMBR.64.4.694-708.2000; Chu S, 1998, SCIENCE, V282, P699, DOI 10.1126/science.282.5389.699; Cluzel P, 2000, SCIENCE, V287, P1652, DOI 10.1126/science.287.5458.1652; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Dimster-Denk D, 1999, J LIPID RES, V40, P850; Duda R. O., 1973, PATTERN CLASSIFICATI; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; HUGHES KT, 1993, SCIENCE, V262, P1277, DOI 10.1126/science.8235660; Karlinsey JE, 2000, MOL MICROBIOL, V37, P1220, DOI 10.1046/j.1365-2958.2000.02081.x; KOMEDA Y, 1980, GENETICS, V94, P277; KOMEDA Y, 1982, J BACTERIOL, V150, P16, DOI 10.1128/JB.150.1.16-26.1982; KOMEDA Y, 1986, J BACTERIOL, V168, P1315, DOI 10.1128/jb.168.3.1315-1318.1986; KUTSUKAKE K, 1990, J BACTERIOL, V172, P741, DOI 10.1128/jb.172.2.741-747.1990; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; Macnab R., 1996, ESCHERICHIA COLI SAL, V2nd ed, P119; OHNISHI K, 1992, MOL MICROBIOL, V6, P3149, DOI 10.1111/j.1365-2958.1992.tb01771.x; PARKINSON JS, 1982, J BACTERIOL, V151, P106, DOI 10.1128/JB.151.1.106-113.1982; Pruss BM, 1997, J BACTERIOL, V179, P5602; Reid BG, 1997, BIOCHEMISTRY-US, V36, P6786, DOI 10.1021/bi970281w; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Waldo GS, 1999, NAT BIOTECHNOL, V17, P691, DOI 10.1038/10904; Zhao RB, 2000, GENE DEV, V14, P981	27	269	276	2	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 15	2001	292	5524					2080	2083		10.1126/science.1058758	http://dx.doi.org/10.1126/science.1058758			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442KP	11408658				2022-12-24	WOS:000169284700049
J	Smith, JB; Lamanna, MC; Lacovara, KJ; Dodson, P; Smith, JR; Poole, JC; Giegengack, R; Attia, Y				Smith, JB; Lamanna, MC; Lacovara, KJ; Dodson, P; Smith, JR; Poole, JC; Giegengack, R; Attia, Y			A giant sauropod dinosaur from an Upper Cretaceous mangrove deposit in Egypt	SCIENCE			English	Article							PREDATORY DINOSAUR; SAHARA	We describe a giant titanosaurid sauropod dinosaur discovered in coastal deposits in the Upper Cretaceous Bahariya Formation of Egypt, a unit that has produced three Tyrannosaurus-sized theropods and numerous other vertebrate taxa, Paralititan stromeri is the first tetrapod reported from Bahariya since 1935. Its 1.69-meter-long humerus is Longer than that of any known Cretaceous sauropod. The autochthonous scavenged skeleton was preserved in mangrove deposits, raising the possibility that titanosaurids and their predators habitually entered such environments.	Univ Penn, Dept Earth & Environm Sci, Philadelphia, PA 19104 USA; Drexel Univ, Philadelphia, PA 19104 USA; Univ Penn, Sch Vet Med, Dept Anim Biol, Philadelphia, PA 19104 USA; Acad Nat Sci Philadelphia, Philadelphia, PA 19103 USA; Egyptian Geol Survey & Min Author, Egyptian Geol Museum, Cairo, Egypt	University of Pennsylvania; Drexel University; University of Pennsylvania; Drexel University	Smith, JB (corresponding author), Univ Penn, Dept Earth & Environm Sci, 240 S 33rd St, Philadelphia, PA 19104 USA.	smithjb@sas.upenn.edu	Dodson, Peter/A-9544-2009					Andrejeko M.J., 1983, TASKS VEGETATION SCI; Boureau E., 1951, CR SOMM SEANCES SOC, V7, P107; Cridland A.A., 1964, PALAEONTOLOGY, V7, P186; CURTICE BD, 1996, CONTINENTAL JURASSIC, P87; DAVIS RA, 1992, QUATERNARY COASTS US, P193; Dominik W, 1985, BERLINER GEOWISSENSC, V62, P1; Duke N.C., 1992, TROPICAL MANGROVE EC, V41, P63, DOI [10.1029/ce041p0063, DOI 10.1029/CE041P0063]; Ellison AM, 1999, GLOBAL ECOL BIOGEOGR, V8, P95, DOI 10.1046/j.1365-2699.1999.00126.x; Fassell ML, 1999, GEOL S AM S, P121; HAQ BU, 1987, SCIENCE, V235, P1156, DOI 10.1126/science.235.4793.1156; Jain SL, 1997, J VERTEBR PALEONTOL, V17, P114, DOI 10.1080/02724634.1997.10010958; Jianu CM, 1999, GEOL MIJNBOUW, V78, P335, DOI 10.1023/A:1003855416962; Krause DW, 1997, NATURE, V390, P504, DOI 10.1038/37343; Lavocat R., 1954, C GEOLOGIQUE INT ALG, V15, P65; Lydekker R., 1893, ANALES MUSEO LA PLAT, V2, P1; Paul Gregory S., 1997, P129; Russell Dale A., 1996, Bulletin du Museum National d'Histoire Naturelle Section C Sciences de la Terre Paleontologie Geologie Mineralogie, V18, P349; Salgado Leonardo, 1997, Ameghiniana, V34, P3; Salgado Leonardo, 1993, Ameghiniana, V30, P265; Salgado Leonardo, 1996, Ameghiniana, V33, P355; Sampson SD, 1998, SCIENCE, V280, P1048, DOI 10.1126/science.280.5366.1048; Sampson SD, 2001, NATURE, V409, P504, DOI 10.1038/35054046; Sanz Jose Luis, 1999, Estudios del Museo de Ciencias Naturales de Alava, V14, P235; Sereno PC, 1999, SCIENCE, V286, P1342, DOI 10.1126/science.286.5443.1342; Sereno PC, 1996, SCIENCE, V272, P986, DOI 10.1126/science.272.5264.986; Shinaq R., 1998, FREIBERGER FORSCH, V6, P39; Stromer E., 1932, ABHANDLUNGEN BAYERIS, V10, P1; STROMER E, 1936, ABH BAYER AKAD WISS, V33, P1; Taquet P, 1998, CR ACAD SCI II A, V327, P347, DOI 10.1016/S1251-8050(98)80054-2; THANIKAIMONI G, 1987, MANGROVE PALYNOLOGY, P1; Upchurch P, 1998, ZOOL J LINN SOC-LOND, V124, P43, DOI 10.1111/j.1096-3642.1998.tb00569.x; Wilson JA, 1998, J VERTEBR PALEONTOL, V18, P1, DOI 10.1080/02724634.1998.10011115	32	114	118	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 1	2001	292	5522					1704	1706		10.1126/science.1060561	http://dx.doi.org/10.1126/science.1060561			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	438AP	11387472	Green Submitted			2022-12-24	WOS:000169031800041
J	Szakonyi, G; Guthridge, JM; Li, DW; Young, K; Holers, VM; Chen, XJS				Szakonyi, G; Guthridge, JM; Li, DW; Young, K; Holers, VM; Chen, XJS			Structure of complement receptor 2 in complex with its C3d ligand	SCIENCE			English	Article							EPSTEIN-BARR-VIRUS; CRYSTAL-STRUCTURE; LYMPHOCYTES-B; BINDING-SITE; IMMUNE-RESPONSE; CR-2; CD21; ANTIGEN; CELLS; INFECTION	Complement receptor 2 (CR2/CD21) is an important receptor that amplifies B lymphocyte activation by bridging the innate and adaptive immune systems. CR2 Ligands include complement C3d and Epstein-Barr virus glycoprotein 350/ 220. We describe the x-ray structure of this CR2 domain in complex with C3d at 2.0 angstroms, The structure reveals extensive main chain interactions between C3d and only one short consensus repeat (SCR) of CR2 and substantial SCR side-side packing, These results provide a detailed understanding of receptor-ligand interactions in this protein family and reveal potential target sites for molecular drug design.	Univ Colorado, Hlth Sci Ctr, Sch Med, Dept Biochem & Mol Genet, Denver, CO 80262 USA; Univ Colorado, Hlth Sci Ctr, Sch Med, Dept Med, Denver, CO 80262 USA; Univ Colorado, Hlth Sci Ctr, Sch Med, Dept Immunol, Denver, CO 80262 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Chen, XJS (corresponding author), Univ Colorado, Hlth Sci Ctr, Sch Med, Dept Biochem & Mol Genet, Denver, CO 80262 USA.		Li, Dawei/I-8751-2016	Li, Dawei/0000-0003-4133-1263; Guthridge, Joel/0000-0002-9308-237X	NCI NIH HHS [R0-1 CA53615] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA053615] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ahearn JM, 1996, IMMUNITY, V4, P251, DOI 10.1016/S1074-7613(00)80433-1; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; AUBRY JP, 1992, NATURE, V358, P505, DOI 10.1038/358505a0; BARLOW PN, 1993, J MOL BIOL, V232, P268, DOI 10.1006/jmbi.1993.1381; BJORKMAN PJ, 1987, NATURE, V329, P512, DOI 10.1038/329512a0; BRANDEN C, 1999, INTRO PROTEIN STRUCT, P16; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CAREL JC, 1990, J BIOL CHEM, V265, P12293; CARTER RH, 1992, SCIENCE, V256, P105, DOI 10.1126/science.1373518; Casasnovas JM, 1999, EMBO J, V18, P2911, DOI 10.1093/emboj/18.11.2911; Clemenza L, 2000, J IMMUNOL, V165, P3839, DOI 10.4049/jimmunol.165.7.3839; Fearon DT, 1998, SEMIN IMMUNOL, V10, P355, DOI 10.1006/smim.1998.0137; FINGEROTH JD, 1984, P NATL ACAD SCI-BIOL, V81, P4510, DOI 10.1073/pnas.81.14.4510; GUTHRIDGE JM, IN PRESS BIOCHEMISTR; HEBELL T, 1991, SCIENCE, V254, P102, DOI 10.1126/science.1718035; KALLI KR, 1991, J IMMUNOL, V147, P590; LAW SKA, 1995, FOCUS SERIES; LOWELL CA, 1989, J EXP MED, V170, P1931, DOI 10.1084/jem.170.6.1931; MARTIN DR, 1994, J VIROL, V68, P4716, DOI 10.1128/JVI.68.8.4716-4726.1994; Moir S, 2000, J EXP MED, V192, P637, DOI 10.1084/jem.192.5.637; Molina H, 1996, P NATL ACAD SCI USA, V93, P3357, DOI 10.1073/pnas.93.8.3357; MOLINA H, 1995, J IMMUNOL, V154, P5426; Nagar B, 1998, SCIENCE, V280, P1277, DOI 10.1126/science.280.5367.1277; POZNANSKY MC, 1989, J IMMUNOL, V143, P1254; Prodeus AP, 1998, IMMUNITY, V9, P721, DOI 10.1016/S1074-7613(00)80669-X; Prodinger WM, 1998, J IMMUNOL, V161, P4604; RAO PE, 1985, CELL IMMUNOL, V93, P549, DOI 10.1016/0008-8749(85)90159-5; Schwarzenbacher R, 1999, EMBO J, V18, P6228, DOI 10.1093/emboj/18.22.6228; Wiles AP, 1997, J MOL BIOL, V272, P253, DOI 10.1006/jmbi.1997.1241	29	126	145	1	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 1	2001	292	5522					1725	1728		10.1126/science.1059118	http://dx.doi.org/10.1126/science.1059118			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	438AP	11387479				2022-12-24	WOS:000169031800048
J	Turecek, R; Trussell, LO				Turecek, R; Trussell, LO			Presynaptic glycine receptors enhance transmitter release at a mammalian central synapse	NATURE			English	Article							GAMMA-AMINOBUTYRIC ACID; RAT BRAIN-STEM; CALCIUM CURRENTS; GABA(B) RECEPTOR; BIPOLAR CELLS; NEURONS; NEUROTRANSMITTER; FACILITATION; INHIBITION; MODULATION	Glycine and GABA(A) (gamma -aminobutyric acid A) receptors are inhibitory neurotransmitter-gated Cl- channels localized in postsynaptic membranes. In some cases, GABA(A) receptors are also found presynaptically, but they retain their inhibitory effect as their activation reduces excitatory transmitter release(1-4). Here we report evidence for presynaptic ionotropic glycine receptors, using pre- and postsynaptic recordings of a calyceal synapse in the medial nucleus of the trapezoid body (MNTB). Unlike the classical action of glycine, presynaptic glycine receptors triggered a weakly depolarizing Cl- current in the nerve terminal. The depolarization enhanced transmitter release by activating Ca2+ channels and increasing resting intraterminal Ca2+ concentrations. Repetitive activation of glycinergic synapses on MNTB neurons also enhanced glutamatergic synaptic currents, indicating that presynaptic glycine receptors are activated by glycine spillover. These results reveal a novel site of action of the transmitter glycine, and indicate that under certain conditions presynaptic Cl- channels may increase transmitter release.	Oregon Hearing Res Ctr & Vollum Inst, Portland, OR 97201 USA		Trussell, LO (corresponding author), Oregon Hearing Res Ctr & Vollum Inst, L-335A,3181 SW Sam Jackson Pk Rd, Portland, OR 97201 USA.		Turecek, Rostislav/AAL-3523-2020; Turecek, Rostislav/H-2706-2014	Turecek, Rostislav/0000-0003-4978-7556; 				Akaike N, 1996, PROG BIOPHYS MOL BIO, V65, P251, DOI 10.1016/S0079-6107(96)00013-2; Atluri PP, 1998, J NEUROSCI, V18, P8214; BANKS MI, 1992, J NEUROSCI, V12, P2819; Bollmann JH, 2000, SCIENCE, V289, P953, DOI 10.1126/science.289.5481.953; BORMANN J, 1987, J PHYSIOL-LONDON, V385, P243, DOI 10.1113/jphysiol.1987.sp016493; Borst JGG, 1998, J PHYSIOL-LONDON, V513, P149, DOI 10.1111/j.1469-7793.1998.149by.x; Borst JGG, 1996, NATURE, V383, P431, DOI 10.1038/383431a0; Cuttle MF, 1998, J PHYSIOL-LONDON, V512, P723, DOI 10.1111/j.1469-7793.1998.723bd.x; Dittman JS, 1997, J NEUROSCI, V17, P9048; ECCLES JC, 1963, J PHYSIOL-LONDON, V168, P500, DOI 10.1113/jphysiol.1963.sp007205; FORSYTHE ID, 1993, P ROY SOC B-BIOL SCI, V251, P151, DOI 10.1098/rspb.1993.0022; Funabiki K, 1998, J PHYSIOL-LONDON, V508, P851, DOI 10.1111/j.1469-7793.1998.851bp.x; GROTHE B, 1994, J NEUROSCI, V14, P1701, DOI 10.1523/JNEUROSCI.14-03-01701.1994; Isaacson JS, 1998, J NEUROPHYSIOL, V80, P1571, DOI 10.1152/jn.1998.80.3.1571; ISAACSON JS, 1993, NEURON, V10, P165, DOI 10.1016/0896-6273(93)90308-E; Martin AR, 1977, HDB PHYSL 1, V1, P329, DOI 10.1002/cphy.cp010110; Min MY, 1998, NEURON, V21, P561, DOI 10.1016/S0896-6273(00)80566-8; Mitchell SJ, 2000, NATURE, V404, P498, DOI 10.1038/35006649; Pouzat C, 1999, J NEUROSCI, V19, P1675; Schneggenburger R, 2000, NATURE, V406, P889, DOI 10.1038/35022702; TACHIBANA M, 1987, P NATL ACAD SCI USA, V84, P3501, DOI 10.1073/pnas.84.10.3501; TACHIBANA M, 1993, J NEUROSCI, V13, P2898; Takahashi T, 1998, J NEUROSCI, V18, P3138; Taschenberger H, 2000, J NEUROSCI, V20, P9162; Wang LY, 1998, NATURE, V394, P384, DOI 10.1038/28645; WU SH, 1992, J NEUROSCI, V12, P3084, DOI 10.1523/JNEUROSCI.12-08-03084.1992; ZHANG SLJ, 1995, J PHYSIOL-LONDON, V483, P583, DOI 10.1113/jphysiol.1995.sp020608	27	231	239	0	11	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 31	2001	411	6837					587	590		10.1038/35079084	http://dx.doi.org/10.1038/35079084			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437GE	11385573				2022-12-24	WOS:000168982500052
J	Staessen, JA; Nawrot, T; Den Hond, E; Thijs, L; Fagard, R; Hoppenbrouwers, K; Koppen, G; Nelen, V; Schoeters, G; Vanderschueren, D; Van Hecke, E; Verschaeve, L; Vlietinck, R; Roels, HA				Staessen, JA; Nawrot, T; Den Hond, E; Thijs, L; Fagard, R; Hoppenbrouwers, K; Koppen, G; Nelen, V; Schoeters, G; Vanderschueren, D; Van Hecke, E; Verschaeve, L; Vlietinck, R; Roels, HA		Environm Hlth Study Grp	Renal function, cytogenetic measurements, and sexual development in adolescents in relation to environmental pollutants: a feasibility study of biomarkers	LANCET			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; GENERAL-POPULATION; PUBERTAL CHANGES; TOBACCO-SMOKE; LEAD SMELTER; EXPOSURE; HEALTH; CHILDREN; DIOXIN; PCBS	Background Human exposure to chemicals is normally monitored by measurement of environmental pollutants in external media. We investigated whether biomarkers in adolescents can show exposure to, and health effects of, common environmental pollutants. Methods We recruited 200 17-year-old adolescents (120 girls) from a rural control area and from two suburbs polluted by a lead smelter and two waste incinerators. We measured biomarkers of exposure and of effect in blood and urine samples, and obtained questionnaire data. School doctors measured testicular volume and staged sexual maturation. Findings Internal exposure was mostly within current standards, Concentrations of lead and cadmium in blood, PCBs (polychlorinated biphenyls) and dioxin-like compounds In serum samples, and metabolites of VOCs (volatile organic compounds) in urine were higher in one or both suburbs than in the control area, Children who lived near the waste incinerators matured sexually at an older age than others, and testicular volume was smaller in boys from the suburbs than in controls. Biomarkers of glomerular or tubular renal dysfunction in individuals were positively correlated with blood lead. Biomarkers of DNA damage were positively correlated with urinary metabolites of PAHs (polycyclic aromatic hydrocarbons) and VOCs, Interpretation Biomarkers can be used to detect environmental exposure to pollutants and measure their biological effects before overt disease develops. Our findings suggest that current environmental standards are insufficient to avoid measurable biological effects.	Katholieke Univ Leuven, Studiecoordinatiectr Hypertensie & Cardiovasc Rev, Dept Mol & Cardiovasc Onderzoek, Louvain, Belgium; Katholieke Univ Leuven, Dienst Jeugdgezondheidszorg, Dept Maatschappelijke Gezondheidszorg, Louvain, Belgium; Katholieke Univ Leuven, Afdeling Expt Geneeskunde, Dept Ontwikkelingsbiol, Louvain, Belgium; Katholieke Univ Leuven, Inst Sociale & Econ Geog, Louvain, Belgium; Katholieke Univ Leuven, Afdeling Genet Epidemiol, Ctr Menselijke Erfelijkheid, Dept Med Celbiol, Louvain, Belgium; Vlaamse Instelling Technol Onderzoek, Afdeling Leefmillieu, Onderzoekseenheid Milieutoxicol, Mol, Belgium; Prov Inst Hyg, Antwerp, Belgium; Catholic Univ Louvain, Unite Toxicol Ind & Med Travail, B-1200 Brussels, Belgium	KU Leuven; KU Leuven; KU Leuven; KU Leuven; KU Leuven; VITO; Universite Catholique Louvain	Staessen, JA (corresponding author), Studiecoordinatiectr, Lab Hypertensie, Campus Gasthuisberg,Gebouw Onderwijs Navorsing,He, B-3000 Louvain, Belgium.	jan.staessen@med.kuleuven.ac.be	Nawrot, Tim/AAA-4531-2019; Koppen, Gudrun/Q-4011-2018; Staessen, Jan A/A-1065-2011	Staessen, Jan A/0000-0002-3026-1637; Thijs, Lutgarde/0000-0002-8108-2356; Schoeters, Greta/0000-0002-6556-4814; vanderschueren, dirk/0000-0003-1395-0104; Nawrot, Tim/0000-0002-3583-3593				ABDULLA M, 1990, BIOL TRACE ELEM RES, V23, P25, DOI 10.1007/BF02917176; AELVOET W, 1997, GEZONDHEIDSINDICATOR, P130; AERTS JMM, 1996, ORGANOHALOGEN COMP, V27, P285; [Anonymous], [No title captured]; Arai T, 1998, INT J FERTIL WOMEN M, V43, P40; Bernard A, 1999, NATURE, V401, P231, DOI 10.1038/45717; BERNARD AM, 1995, ENVIRON RES, V68, P91, DOI 10.1006/enrs.1995.1012; Bertazzi PA, 1998, ENVIRON HEALTH PERSP, V106, P625, DOI 10.2307/3433813; Bokenkamp A, 1998, PEDIATRICS, V101, P875, DOI 10.1542/peds.101.5.875; BREEDVELD BC, 1996, NEDERLANDSE VOEDINGS; Brouwer A, 1999, ENVIRON HEALTH PERSP, V107, P639, DOI 10.2307/3434557; BROUWER A, 1995, EUR J PHARM-ENVIRON, V293, P1; BUCHET JP, 1990, LANCET, V336, P699, DOI 10.1016/0140-6736(90)92201-R; CLAEYS F, 1992, CADMIUM HUMAN ENV TO, P83; Clapp R, 2000, LANCET, V355, P1838, DOI 10.1016/S0140-6736(00)02280-7; Davis DL, 1998, JAMA-J AM MED ASSOC, V279, P1018, DOI 10.1001/jama.279.13.1018; DORNBERGER V, 1987, ANDROLOGIA, V19, P487; Duarte-Davidson R, 2001, OCCUP ENVIRON MED, V58, P2, DOI 10.1136/oem.58.1.2; Elinder CG., 1985, CADMIUM HLTH TOXICOL, P23; Faustman EM, 2000, ENVIRON HEALTH PERSP, V108, P13, DOI 10.2307/3454629; FLOYD RA, 1990, CARCINOGENESIS, V11, P1147; Golub MS, 2000, ENVIRON HEALTH PERSP, V108, P355, DOI 10.2307/3454355; Hagmar L, 1998, CANCER RES, V58, P4117; Hansen LG, 1998, ENVIRON HEALTH PERSP, V106, P171, DOI 10.2307/3433919; Haufroid V, 1998, INT ARCH OCC ENV HEA, V71, P162, DOI 10.1007/s004200050266; Hotz P, 1997, INT ARCH OCC ENV HEA, V70, P29, DOI 10.1007/s004200050183; KIMBROUGH RD, 1995, CRIT REV TOXICOL, V25, P133, DOI 10.3109/10408449509021611; KOOPMANESSEBOOM C, 1994, CHEMOSPHERE, V28, P1721, DOI 10.1016/0045-6535(94)90428-6; MARSHALL WA, 1969, ARCH DIS CHILD, V44, P291, DOI 10.1136/adc.44.235.291; MARSHALL WA, 1970, ARCH DIS CHILD, V45, P13, DOI 10.1136/adc.45.239.13; Mocarelli P, 2000, LANCET, V355, P1858, DOI 10.1016/S0140-6736(00)02290-X; ORTH JM, 1988, ENDOCRINOLOGY, V122, P787, DOI 10.1210/endo-122-3-787; Pauwels A, 2000, ENVIRON HEALTH PERSP, V108, P553, DOI 10.1289/ehp.00108553; Persons DL, 1998, CANCER GENET CYTOGEN, V106, P11, DOI 10.1016/S0165-4608(98)00036-3; Phillips DH, 1999, MUTAT RES-GEN TOX EN, V443, P139, DOI 10.1016/S1383-5742(99)00016-2; Pierce CH, 1998, INT ARCH OCC ENV HEA, V71, P433, DOI 10.1007/s004200050303; ROELS HA, 1980, ENVIRON RES, V22, P81, DOI 10.1016/0013-9351(80)90121-8; ROELS HA, 1978, ENVIRON RES, V15, P290, DOI 10.1016/0013-9351(78)90105-6; SCHOETERS G, 1998, 1998TOXR0097 DEP GEZ; SCHWARTZ GG, 1990, BIOL MARKERS EPIDEMI, P147; SHARPE RM, 1993, LANCET, V341, P1392, DOI 10.1016/0140-6736(93)90953-E; Siegel S., 1988, NONPARAMETRIC STAT B, P284; Staessen J A, 1996, J Cardiovasc Risk, V3, P26, DOI 10.1097/00043798-199602000-00005; STAESSEN JA, 1994, AM J HYPERTENS, V7, P685, DOI 10.1093/ajh/7.8.685; STAESSEN JA, 1992, NEW ENGL J MED, V327, P151, DOI 10.1056/NEJM199207163270303; Tagesson C, 1993, Pol J Occup Med Environ Health, V6, P357; Timbrell J.A., 1996, BIOMARKERS, V1, P1; van Zeeland AA, 1999, MUTAT RES-GEN TOX EN, V439, P249, DOI 10.1016/S1383-5718(98)00192-2; VanGoethem F, 1997, MUTAT RES-GEN TOX EN, V392, P31, DOI 10.1016/S0165-1218(97)00043-8; VANHUMMELEN P, 1993, MUTAT RES, V300, P231, DOI 10.1016/0165-1218(93)90055-I; VANROOIJ JGM, 1994, INT ARCH OCC ENV HEA, V66, P55, DOI 10.1007/BF00386580; *VLAAMS MIL, 2000, STAT NIEUWS MEETR DI; *WOLT ATL PROD, 1997, WOLT KLEIN WER, P1	53	168	171	3	32	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 26	2001	357	9269					1660	1669		10.1016/S0140-6736(00)04822-4	http://dx.doi.org/10.1016/S0140-6736(00)04822-4			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	435UY	11425371				2022-12-24	WOS:000168901600012
J	Amara, RR; Villinger, F; Altman, JD; Lydy, SL; O'Neil, SP; Staprans, SI; Montefiori, DC; Xu, Y; Herndon, JG; Wyatt, LS; Candido, MA; Kozyr, NL; Earl, PL; Smith, JM; Ma, HL; Grimm, BD; Hulsey, ML; Miller, J; McClure, HM; McNicholl, JM; Moss, B; Robinson, HL				Amara, RR; Villinger, F; Altman, JD; Lydy, SL; O'Neil, SP; Staprans, SI; Montefiori, DC; Xu, Y; Herndon, JG; Wyatt, LS; Candido, MA; Kozyr, NL; Earl, PL; Smith, JM; Ma, HL; Grimm, BD; Hulsey, ML; Miller, J; McClure, HM; McNicholl, JM; Moss, B; Robinson, HL			Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine	SCIENCE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; RHESUS-MONKEYS; NEUTRALIZING ANTIBODIES; ENVELOPE GLYCOPROTEINS; PATHOGENIC SIV; INFECTION; REPLICATION; RESPONSES; TYPE-1; ASSAY	Heterologous prime/boost regimens have the potential for raising high Levels of immune responses. Here we report that DNA priming followed by a recombinant modified vaccinia Ankara (rMVA) booster controlled a highly pathogenic immunodeficiency virus challenge in a rhesus macaque model. Both the DNA and rMVA components of the vaccine expressed multiple immunodeficiency virus proteins. Two DNA inoculations at 0 and 8 weeks and a single rMVA booster at 24 weeks effectively controlled an intrarectal challenge administered 7 months after the booster. These findings provide hope that a relatively simple multiprotein DNA/MVA vaccine can help to control the acquired immune deficiency syndrome epidemic.	Emory Univ, Vaccine Res Ctr, Atlanta, GA 30329 USA; Emory Univ, Yerkes Reg Primate Res Ctr, Atlanta, GA 30329 USA; Emory Univ, Sch Med, Vaccine Res Ctr, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA; NIAID, Viral Dis Lab, NIH, Bethesda, MD 20892 USA; Emory Univ, Sch Med, Dept Med, Div Infect Dis, Atlanta, GA 30322 USA; Ctr Dis Control & Prevent, Div AIDS STD & TB Lab Res, Natl Ctr Infect Dis, Atlanta, GA 30330 USA	Emory University; Emory University; Emory University; Emory University; Emory University; Duke University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Emory University; Centers for Disease Control & Prevention - USA	Robinson, HL (corresponding author), Emory Univ, Vaccine Res Ctr, Atlanta, GA 30329 USA.	hrobins@rmy.emory.edu	Amara, Rama/AAO-8136-2021	Moss, Bernard/0000-0002-2154-8564	NCRR NIH HHS [P51 RR000165] Funding Source: Medline; NIAID NIH HHS [P01 AI 43045] Funding Source: Medline; NIDA NIH HHS [P30 DA 12121] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000416, ZIAAI000416, P01AI043045] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA012121] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Allen TM, 2000, J IMMUNOL, V164, P4968, DOI 10.4049/jimmunol.164.9.4968; Barouch DH, 2000, SCIENCE, V290, P486, DOI 10.1126/science.290.5491.486; Egan MA, 2000, J VIROL, V74, P7485, DOI 10.1128/JVI.74.16.7485-7495.2000; Gorelick RJ, 1999, VIROLOGY, V253, P259, DOI 10.1006/viro.1998.9513; Goulder PJR, 1999, AIDS, V13, pS121; Hofmann-Lehmann R, 2000, AIDS RES HUM RETROV, V16, P1247, DOI 10.1089/08892220050117014; Karlsson GB, 1997, J VIROL, V71, P4218, DOI 10.1128/JVI.71.6.4218-4225.1997; Lechner F, 2000, J EXP MED, V191, P1499, DOI 10.1084/jem.191.9.1499; Mellors JW, 1996, SCIENCE, V272, P1167, DOI 10.1126/science.272.5265.1167; MONTEFIORI DC, 1988, J CLIN MICROBIOL, V26, P231, DOI 10.1128/JCM.26.2.231-235.1988; Montefiori DC, 1998, J VIROL, V72, P3427, DOI 10.1128/JVI.72.4.3427-3431.1998; Ourmanov I, 2000, J VIROL, V74, P2740, DOI 10.1128/JVI.74.6.2740-2751.2000; Power CA, 1999, J IMMUNOL METHODS, V227, P99, DOI 10.1016/S0022-1759(99)00074-5; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Robinson HL, 1999, NAT MED, V5, P526, DOI 10.1038/8406; Robinson R, 2000, J GEOPHYS RES-SOL EA, V105, P16139, DOI 10.1029/2000JB900012; Sauter MM, 1996, J CELL BIOL, V132, P795, DOI 10.1083/jcb.132.5.795; Staprans Silvija I., 1996, P167; Waldrop SL, 1997, J CLIN INVEST, V99, P1739, DOI 10.1172/JCI119338	19	972	1039	2	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 6	2001	292	5514					69	74		10.1126/science.1058915	http://dx.doi.org/10.1126/science.1058915			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420FU	11393868				2022-12-24	WOS:000167995200037
J	Luecke, H; Schobert, B; Lanyi, JK; Spudich, EN; Spudich, JL				Luecke, H; Schobert, B; Lanyi, JK; Spudich, EN; Spudich, JL			Crystal structure of sensory rhodopsin II at 2.4 angstroms: Insights into color tuning and transducer interaction	SCIENCE			English	Article							MOLECULAR-MECHANISM; NATRONOBACTERIUM-PHARAONIS; PROTON TRANSLOCATION; BACTERIORHODOPSIN; PROTEIN; PHOBORHODOPSIN; PHOTOCYCLE; RECEPTOR; MODEL; TEMPERATURE	We report an atomic-resolution structure for a sensory member of the microbial rhodopsin family, the phototaxis receptor sensory rhodopsin II (NpSRII), which mediates blue-light avoidance by the haloarchaeon Natronobacterium pharaonis. The 2.4 angstrom structure reveals features responsible for the 70- to 80-nanometer blue shift of its absorption maximum relative to those of haloarchaeal transport rhodopsins, as well as structural differences due to its sensory, as opposed to transport, function. Multiple factors appear to account for the spectral tuning difference with respect to bacteriorhodopsin: (i) repositioning of the guanidinium group of arginine 72, a residue that interacts with the counterion to the retinylidene protonated Schiff base; (ii) rearrangement of the protein near the retinal ring; and (iii) changes in tilt and slant of the retinal polyene chain. Inspection of the surface topography reveals an exposed polar residue, tyrosine 199, not present in bacteriorhodopsin, in the middle of the membrane bilayer. We propose that this residue interacts with the adjacent helices of the cognate NpSRII transducer NpHtrII.	Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92697 USA; Univ Texas, Sch Med, Dept Microbiol & Mol Genet, Houston, TX 77030 USA; Univ Texas, Sch Med, Struct Biol Ctr, Houston, TX 77030 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of Texas System; University of Texas System	Luecke, H (corresponding author), Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA.	hudel@uci.edu; jlanyi@orion.oac.uci.edu; john.l.spudich@uth.tmc.edu	Luecke, Hartmut/F-4712-2012; Lanyi, Janos/C-3808-2011	Luecke, Hartmut/0000-0002-4938-0775; 	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029498, R01GM027750, R01GM059970] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM027750, R01 GM029498, R01-GM27750, R01 GM059970, R01-GM29498, R01-GM59970] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Balashov SP, 1996, BIOPHYS J, V70, P473, DOI 10.1016/S0006-3495(96)79591-7; Beja O, 2000, SCIENCE, V289, P1902, DOI 10.1126/science.289.5486.1902; Belrhali H, 1999, STRUCTURE, V7, P909, DOI 10.1016/S0969-2126(99)80118-X; Bieszke JA, 1999, BIOCHEMISTRY-US, V38, P14138, DOI 10.1021/bi9916170; BOGOMOLNI RA, 1994, P NATL ACAD SCI USA, V91, P10188, DOI 10.1073/pnas.91.21.10188; Brown LS, 1998, BIOPHYS J, V75, P1455, DOI 10.1016/S0006-3495(98)74064-0; Brown LS, 1998, BIOCHEMISTRY-US, V37, P3982, DOI 10.1021/bi9728396; Brunger A. T., 1992, XPLOR VERSION 3 1 SY; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chizhov I, 1998, BIOPHYS J, V75, P999, DOI 10.1016/S0006-3495(98)77588-5; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; HIRAYAMA J, 1992, BIOCHEMISTRY-US, V31, P2093, DOI 10.1021/bi00122a029; Hoff WD, 1997, ANNU REV BIOPH BIOM, V26, P223, DOI 10.1146/annurev.biophys.26.1.223; KAMO N, IN PRESS BIOCHEMISTR; Kolbe M, 2000, SCIENCE, V288, P1390, DOI 10.1126/science.288.5470.1390; Kunji ERS, 2001, J MOL BIOL, V308, P279, DOI 10.1006/jmbi.2001.4565; Landau EM, 1996, P NATL ACAD SCI USA, V93, P14532, DOI 10.1073/pnas.93.25.14532; Lanyi JK, 2000, J PHYS CHEM B, V104, P11441, DOI 10.1021/jp0023718; Luecke H, 1998, SCIENCE, V280, P1934, DOI 10.1126/science.280.5371.1934; Luecke H, 1999, J MOL BIOL, V291, P899, DOI 10.1006/jmbi.1999.3027; MILLER A, 1990, BIOCHIM BIOPHYS ACTA, V1020, P57, DOI 10.1016/0005-2728(90)90093-J; NAKANISHI K, 1979, PHOTOCHEM PHOTOBIOL, V29, P657, DOI 10.1111/j.1751-1097.1979.tb07745.x; Oesterhelt D, 1998, CURR OPIN STRUC BIOL, V8, P489, DOI 10.1016/S0959-440X(98)80128-0; Otwinowski Z., 1993, DATA COLLECTION PROC, P56; Rammelsberg R, 1998, BIOCHEMISTRY-US, V37, P5001, DOI 10.1021/bi971701k; Richter HT, 1996, BIOCHEMISTRY-US, V35, P4054, DOI 10.1021/bi952883q; SACK JS, 1988, J MOL GRAPHICS, V6, P224, DOI 10.1016/S0263-7855(98)80040-4; Sasaki J, 1999, BIOPHYS J, V77, P2145, DOI 10.1016/S0006-3495(99)77055-4; Schmies G, 2000, BIOPHYS J, V78, P967, DOI 10.1016/S0006-3495(00)76654-9; Schmies G, 2001, P NATL ACAD SCI USA, V98, P1555, DOI 10.1073/pnas.031562298; SEIDEL R, 1995, P NATL ACAD SCI USA, V92, P3036, DOI 10.1073/pnas.92.7.3036; Shimono K, 2000, PHOTOCHEM PHOTOBIOL, V72, P141; SPUDICH JL, 1986, BIOPHYS J, V49, P479, DOI 10.1016/S0006-3495(86)83657-8; Spudich JL, 2000, ANNU REV CELL DEV BI, V16, P365, DOI 10.1146/annurev.cellbio.16.1.365; Subramaniam S, 2000, NATURE, V406, P653, DOI 10.1038/35020614; Sudo Y, 2001, BIOPHYS J, V80, P916, DOI 10.1016/S0006-3495(01)76070-5; SUDO Y, 2000, BIOPHYS J, V78, P959; TAKAHASHI T, 1990, BIOCHEMISTRY-US, V29, P8467, DOI 10.1021/bi00488a038; Wegener AA, 2000, J MOL BIOL, V301, P881, DOI 10.1006/jmbi.2000.4008; YAN B, 1995, J BIOL CHEM, V270, P29668; YAO VJ, 1992, P NATL ACAD SCI USA, V89, P11915, DOI 10.1073/pnas.89.24.11915; Zhang WS, 1996, P NATL ACAD SCI USA, V93, P8230, DOI 10.1073/pnas.93.16.8230; Zhang XN, 1999, P NATL ACAD SCI USA, V96, P857, DOI 10.1073/pnas.96.3.857	43	311	321	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 24	2001	293	5534					1499	1503		10.1126/science.1062977	http://dx.doi.org/10.1126/science.1062977			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465XV	11452084	Green Accepted			2022-12-24	WOS:000170616000047
J	Cook-Deegan, RM; McCormack, SJ				Cook-Deegan, RM; McCormack, SJ			Intellectual property - Patents, secrecy, and DNA	SCIENCE			English	Editorial Material							ACADEMIC RESEARCH; TECHNOLOGY		Georgetown Univ, Kennedy Inst Eth, Washington, DC 20057 USA; Stanford Washington Program, Washington, DC 20008 USA; AlleCure Corp, Valencia, CA 91355 USA	Georgetown University; Stanford University	Cook-Deegan, RM (corresponding author), Georgetown Univ, Kennedy Inst Eth, Washington, DC 20057 USA.			Cook-Deegan, Robert/0000-0002-8251-4237				Cockburn I, 1996, P NATL ACAD SCI USA, V93, P12725, DOI 10.1073/pnas.93.23.12725; Gambardella A., 1995, SCI INNOVATION US PH; HASELTINE W, 1994, WORKSH OFF TECHN ASS; Henderson R, 1998, REV ECON STAT, V80, P119, DOI 10.1162/003465398557221; *INT COMM INT PROP, 1999, TRAD KNOWL FOLKL, P10; JACOBS P, 2000, LA TIMES        0228, pA1; JORDA KF, 1999, INTELLECTUAL PROPERT; MANSFIELD E, 1991, RES POLICY, V20, P1, DOI 10.1016/0048-7333(91)90080-A; MANSFIELD E, 1995, REV ECON STAT, V77, P55, DOI 10.2307/2109992; NARIN F, 1992, RES POLICY, V21, P237, DOI 10.1016/0048-7333(92)90018-Y; NARIN F, 1988, RES POLICY, V17, P139, DOI 10.1016/0048-7333(88)90039-X; National Academy of Engineering, 1992, TIME HORIZONS TECHNO; *OTA, 1988, MAPP OUR GEN GEN PRO, P167; *USPTO, 2000, FED REGISTER, V65, P57024; 2000, Patent No. 6025154	15	25	25	1	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 13	2001	293	5528					217	217		10.1126/science.1058032	http://dx.doi.org/10.1126/science.1058032			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	452TK	11452101				2022-12-24	WOS:000169875200027
J	Dupuis, S; Dargemont, C; Fieschi, C; Thomassin, N; Rosenzweig, S; Harris, J; Holland, SM; Schreiber, RD; Casanova, JL				Dupuis, S; Dargemont, C; Fieschi, C; Thomassin, N; Rosenzweig, S; Harris, J; Holland, SM; Schreiber, RD; Casanova, JL			Impairment od mycobacterial but not viral immunity by a germline human STAT1 mutation	SCIENCE			English	Article							INTERFERON-GAMMA-RECEPTOR; CALMETTE-GUERIN INFECTION; TARGETED DISRUPTION; DEFICIENCY; SUSCEPTIBILITY; MICE; GENE; DEFENSE; CHILD; CHAIN	Interferons (IFN) alpha/beta and gamma induce the formation of two transcriptional activators: gamma-activating factor (CAF) and interferon-stimulated gamma factor 3 (ISGF3). We report a natural heterozygous germline STAT1 mutation associated with susceptibility to mycobacterial but not viral disease. This mutation causes a loss of CAF and ISGF3 activation but is dominant for one cellular phenotype and recessive for the other. It impairs the nuclear accumulation of GAF but not of ISGF3 in heterozygous cells stimulated by IFNs. Thus, the antimycobacterial, but not the antiviral, effects of human IFNs are principally mediated by GAF.	Univ Paris 05, Fac Med Necker Enfants Malad, INSERM,UMR550, Lab Genet Humaine Malad Infect, F-75015 Paris, France; Hop Necker Enfants Malad, INSERM, U429, F-75015 Paris, France; Univ Paris 06, CNRS, Inst Jacques Monod, F-75005 Paris, France; Univ Paris 07, CNRS, UMR 7592, F-75005 Paris, France; Ctr Hosp Gen, F-58000 Nevers, France; NIAID, Host Def Lab, Bethesda, MD 20892 USA; Univ San Francisco, Dept Pediat, San Francisco, CA 94117 USA; Washington Univ, Dept Pathol, St Louis, MO 63110 USA; Hop Necker Enfants Malad, Unite Hematol Immunol Pediat, F-75015 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of San Francisco; Washington University (WUSTL); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Casanova, JL (corresponding author), Univ Paris 05, Fac Med Necker Enfants Malad, INSERM,UMR550, Lab Genet Humaine Malad Infect, F-75015 Paris, France.		Boisson-Dupuis, Stéphanie/I-2040-2017; Schreiber, Robert/Q-7550-2019; Casanova, Jean-Laurent/I-3418-2017; Boisson-Dupuis, Stephanie/AAF-5066-2021; Schreiber, Robert D/A-1276-2013	Boisson-Dupuis, Stéphanie/0000-0002-7115-116X; Schreiber, Robert D/0000-0001-6311-0432; Casanova, Jean-Laurent/0000-0002-7782-4169; Schreiber, Robert/0000-0003-1590-2341	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000647, Z01AI000647] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Altare F, 1998, J CLIN INVEST, V102, P2035, DOI 10.1172/JCI4950; Altare F, 1998, SCIENCE, V280, P1432, DOI 10.1126/science.280.5368.1432; Casanova JL, 1996, PEDIATRICS, V98, P774; Chen XM, 1998, CELL, V93, P827, DOI 10.1016/S0092-8674(00)81443-9; de Jong R, 1998, SCIENCE, V280, P1435; Doffinger R, 2000, J INFECT DIS, V181, P379, DOI 10.1086/315197; Dorman SE, 1998, J CLIN INVEST, V101, P2364, DOI 10.1172/JCI2901; Durbin JE, 1996, CELL, V84, P443, DOI 10.1016/S0092-8674(00)81289-1; Gil MP, 2001, P NATL ACAD SCI USA, V98, P6680, DOI 10.1073/pnas.111163898; Jouanguy E, 1997, J CLIN INVEST, V100, P2658, DOI 10.1172/JCI119810; Jouanguy E, 1996, NEW ENGL J MED, V335, P1956, DOI 10.1056/NEJM199612263352604; Jouanguy E, 1999, NAT GENET, V21, P370, DOI 10.1038/7701; KAMIJO R, 1993, J EXP MED, V178, P1435, DOI 10.1084/jem.178.4.1435; LEVIN M, 1995, LANCET, V345, P79, DOI 10.1016/S0140-6736(95)90059-4; Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Newport MJ, 1996, NEW ENGL J MED, V335, P1941, DOI 10.1056/NEJM199612263352602; Park C, 1999, NUCLEIC ACIDS RES, V27, P4191, DOI 10.1093/nar/27.21.4191; Park C, 2000, IMMUNITY, V13, P795, DOI 10.1016/S1074-7613(00)00077-7; Qureshi SA, 1996, MOL CELL BIOL, V16, P288; Ramana CV, 2000, ONCOGENE, V19, P2619, DOI 10.1038/sj.onc.1203525; Takaoka A, 2000, SCIENCE, V288, P2357, DOI 10.1126/science.288.5475.2357; vandenBroek MF, 1995, IMMUNOL REV, V148, P5; VERLIAC F, 1972, INFECT OSSEUSES BACT	24	359	367	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 13	2001	293	5528					300	303		10.1126/science.1061154	http://dx.doi.org/10.1126/science.1061154			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	452TK	11452125				2022-12-24	WOS:000169875200059
J	Carr, MH; Garvin, J				Carr, MH; Garvin, J			Mars exploration	NATURE			English	Editorial Material								An international flotilla of spacecraft are to be sent to Mars over the next decade in an effort to understand the planet's geology and climate history, and to determine whether some form of life ever started there. At least two spacecraft will be sent at each launch opportunity, and at times up to four spacecraft may be operating simultaneously at the planet.	US Geol Survey, Menlo Park, CA 94025 USA; NASA Headquarters, Washington, DC 20546 USA	United States Department of the Interior; United States Geological Survey; National Aeronautics & Space Administration (NASA)	Carr, MH (corresponding author), US Geol Survey, 345 Middlefield Rd, Menlo Park, CA 94025 USA.			Garvin, James/0000-0003-1606-5645				Acuna MH, 1998, SCIENCE, V279, P1676, DOI 10.1126/science.279.5357.1676; Christensen PR, 2000, J GEOPHYS RES-PLANET, V105, P9609, DOI 10.1029/1999JE001127; Gladman BJ, 1996, SCIENCE, V271, P1387, DOI 10.1126/science.271.5254.1387; Haberle RM, 1998, J GEOPHYS RES-PLANET, V103, P28467, DOI 10.1029/98JE01396; McKay C.P., 1992, MARS, P1234; McKay DS, 1996, SCIENCE, V273, P924, DOI 10.1126/science.273.5277.924; Smith DE, 1999, SCIENCE, V284, P1495, DOI 10.1126/science.284.5419.1495; STEVENS TO, 1995, SCIENCE, V270, P450, DOI 10.1126/science.270.5235.450; Zuber MT, 2000, SCIENCE, V287, P1788, DOI 10.1126/science.287.5459.1788	9	6	7	0	4	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 12	2001	412	6843					250	253		10.1038/35084200	http://dx.doi.org/10.1038/35084200			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	451AJ	11449287				2022-12-24	WOS:000169778700065
J	Lorenz, MC; Fink, GR				Lorenz, MC; Fink, GR			The glyoxylate cycle is required for fungal virulence	NATURE			English	Article							YEAST YARROWIA-LIPOLYTICA; CANDIDA-ALBICANS; SACCHAROMYCES-CEREVISIAE; MYCOBACTERIUM-TUBERCULOSIS; ISOCITRATE LYASE; GENE; EXPRESSION; DISRUPTION; MUTATIONS; CLONING	Candida albicans, a normal component of the mammalian gastrointestinal flora, is responsible for most fungal infections in immunosuppressed patients. Candida is normally phagocytosed by macrophages and neutrophils, which secrete cytokines and induce hyphal development in this fungus(1,2). Neutropenic patients, deficient in these immune cells, are particularly susceptible to systemic candidiasis(3,4). Here we use genome-wide expression profiles of the related yeast Saccharomyces cerevisiae to obtain a signature of the events that take place in the fungus on ingestion by a mammalian macrophage. Live S. cerevisiae cells isolated from the phagolysosome are induced for genes of the glyoxylate cycle, a metabolic pathway that permits the use of two-carbon compounds as carbon sources. In C. albicans, phagocytosis also upregulates the principal enzymes of the glyoxylate cycle, isocitrate lyase (ICL1) and malate synthase (MLS1). Candida albicans mutants lacking ICL1 are markedly less virulent in mice than the wild type. These findings in fungi, in conjunction with reports that isocitrate lyase is both upregulated and required for the virulence of Mycobacterium tuberculosis(5,6), demonstrate the wide-ranging significance of the glyoxylate cycle in microbial pathogenesis.	Whitehead Inst Biomed Res, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute	Fink, GR (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	fink@wi.mit.edu		Lorenz, Michael/0000-0002-7881-8027				ASHMAN RB, 1995, MICROBIOL REV, V59, P646, DOI 10.1128/MMBR.59.4.646-672.1995; Bentrup KHZ, 1999, J BACTERIOL, V181, P7161; BODEY G, 1992, EUR J CLIN MICROBIOL, V11, P99, DOI 10.1007/BF01967060; Braun BR, 1997, SCIENCE, V277, P105, DOI 10.1126/science.277.5322.105; CANNON RD, 1992, MOL GEN GENET, V235, P453, DOI 10.1007/BF00279393; FONZI WA, 1993, GENETICS, V134, P717; GILLUM AM, 1984, MOL GEN GENET, V198, P179, DOI 10.1007/BF00328721; KUJAU M, 1992, YEAST, V8, P193, DOI 10.1002/yea.320080305; Lo HJ, 1997, CELL, V90, P939, DOI 10.1016/S0092-8674(00)80358-X; McKinney JD, 2000, NATURE, V406, P735, DOI 10.1038/35021074; MINARD KI, 1991, MOL CELL BIOL, V11, P370, DOI 10.1128/MCB.11.1.370; MORTIMER RK, 1986, GENETICS, V113, P35; SEDIVY JM, 1985, J MOL BIOL, V186, P307, DOI 10.1016/0022-2836(85)90107-X; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Tzschoppe K, 1999, YEAST, V15, P1645, DOI 10.1002/(SICI)1097-0061(199911)15:15<1645::AID-YEA491>3.0.CO;2-G; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; Wodicka L, 1997, NAT BIOTECHNOL, V15, P1359, DOI 10.1038/nbt1297-1359; Wright WL, 1997, INFECT DIS CLIN N AM, V11, P411, DOI 10.1016/S0891-5520(05)70363-9	18	559	580	1	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 5	2001	412	6842					83	86		10.1038/35083594	http://dx.doi.org/10.1038/35083594			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448TB	11452311				2022-12-24	WOS:000169644900048
J	Navarro-Gonzalez, R; McKay, CP; Mvondo, DN				Navarro-Gonzalez, R; McKay, CP; Mvondo, DN			A possible nitrogen crisis for Archaean life due to reduced nitrogen fixation by lightning	NATURE			English	Article							EARTHS EARLY ATMOSPHERE; NITRIC-OXIDE; EVOLUTION; CARBON; ENERGY; OXYGEN	Nitrogen is an essential element for life and is often the limiting nutrient for terrestrial ecosystems(1,2). As most nitrogen is locked in the kinetically stable form(3), N-2, in the Earth's atmosphere, processes that can fix N-2 into biologically available forms-such as nitrate and ammonia-control the supply of nitrogen for organisms. On the early Earth, nitrogen is thought to have been fixed abiotically, as nitric oxide formed during lightning discharge(4-6). The advent of biological nitrogen fixation suggests that at some point the demand for fixed nitrogen exceeded the supply from abiotic sources, but the timing and causes of the onset of biological nitrogen fixation remain unclear(7-11). Here we report an experimental simulation of nitrogen fixation by lightning over a range of Hadean (4.5-3.8 Gyr ago) and Archaean (3.8-2.5 Gyr ago) atmospheric compositions, from predominantly carbon dioxide to predominantly dinitrogen (but always without oxygen). We infer that, as atmospheric CO2 decreased over the Archaean period, the production of nitric oxide from lightning discharge decreased by two orders of magnitude until about 2.2 Gyr. After this time, the rise in oxygen (or methane) concentrations probably initiated other abiotic sources of nitrogen. Although the temporary reduction in nitric oxide production may have lasted for only 100 Myr or less, this was potentially long enough to cause an ecological crisis that triggered the development of biological nitrogen fixation.	Univ Nacl Autonoma Mexico, Inst Ciencias Nucl, Lab Quim Plasmas & Estud Planetarios, Mexico City 04510, DF, Mexico; NASA, Ames Res Ctr, Div Space Sci, Moffett Field, CA 94035 USA	Universidad Nacional Autonoma de Mexico; National Aeronautics & Space Administration (NASA); NASA Ames Research Center	Navarro-Gonzalez, R (corresponding author), Univ Nacl Autonoma Mexico, Inst Ciencias Nucl, Lab Quim Plasmas & Estud Planetarios, Circuito Exterior,Ciudad Univ,Apartado Postal 70-, Mexico City 04510, DF, Mexico.		Navarro-González, Rafael/D-1748-2009	Navarro-González, Rafael/0000-0002-6078-7621; NNA MVONDO, Delphine/0000-0001-7107-4988				Beaumont V, 1999, PRECAMBRIAN RES, V96, P63, DOI 10.1016/S0301-9268(99)00005-4; Brocks JJ, 1999, SCIENCE, V285, P1033, DOI 10.1126/science.285.5430.1033; CHAMEIDES WL, 1981, ORIGINS LIFE EVOL B, V11, P291, DOI 10.1007/BF00931483; CHYBA C, 1991, ORIGINS LIFE EVOL B, V21, P3, DOI 10.1007/BF01809509; CLOUD PE, 1968, SCIENCE, V160, P729, DOI 10.1126/science.160.3829.729; Golubic S, 1995, LETHAIA, V28, P285, DOI 10.1111/j.1502-3931.1995.tb01817.x; Howard JB, 1996, CHEM REV, V96, P2965, DOI 10.1021/cr9500545; JEBENS DS, 1992, GEOPHYS RES LETT, V19, P273, DOI 10.1029/91GL02937; KASTING JF, 1990, ORIGINS LIFE EVOL B, V20, P199, DOI 10.1007/BF01808105; Kasting JF, 2001, ORIGINS LIFE EVOL B, V31, P271, DOI 10.1023/A:1010600401718; KASTING JF, 1981, J GEOPHYS RES-OCEANS, V86, P1147, DOI 10.1029/JC086iC02p01147; KNIPOVICH OM, 1988, RUSS J PHYS CHEM, V62, P867; LEVINE JS, 1982, GEOPHYS RES LETT, V9, P893, DOI 10.1029/GL009i008p00893; MANCINELLI RL, 1988, ORIGINS LIFE EVOL B, V18, P311, DOI 10.1007/BF01808213; Pavlov AA, 2000, J GEOPHYS RES-PLANET, V105, P11981, DOI 10.1029/1999JE001134; POSTGATE J, 1987, NITROGEN FIXATION, P73; Raven JA, 1998, NEW PHYTOL, V139, P205, DOI 10.1046/j.1469-8137.1998.00168.x; Rosswall T., 1981, SOME PERSPECTIVES MA; RYE R, 1995, NATURE, V378, P603, DOI 10.1038/378603a0; Rye R, 1998, AM J SCI, V298, P621, DOI 10.2475/ajs.298.8.621; SCHOPF JW, 1987, SCIENCE, V237, P70, DOI 10.1126/science.11539686; Schopf JW, 2000, PROKARYOTIC DEVELOPMENT, P105; Schopf JW, 1983, EARTHS EARLIEST BIOS; The National Institute of Standards and Technology, NIST STAND REF DAT 1; Walker, 1977, EVOLUTION ATMOSPHERE, V32, P71; Wang Y, 1998, J GEOPHYS RES-ATMOS, V103, P19149, DOI 10.1029/98JD01356; Young J. P. W., 1992, BIOL NITROGEN FIXATI, V1544, P43; YUNG YL, 1984, ASTROPHYS J SUPPL S, V55, P465, DOI 10.1086/190963; YUNG YL, 1979, SCIENCE, V203, P1002, DOI 10.1126/science.203.4384.1002; ZAHNLE KJ, 1986, J GEOPHYS RES-ATMOS, V91, P2819, DOI 10.1029/JD091iD02p02819	30	181	185	5	92	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 5	2001	412	6842					61	64		10.1038/35083537	http://dx.doi.org/10.1038/35083537			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448TB	11452304	Green Submitted			2022-12-24	WOS:000169644900041
J	Weeks, AR; Marec, F; Breeuwer, JAJ				Weeks, AR; Marec, F; Breeuwer, JAJ			A mite species that consists entirely of haploid females	SCIENCE			English	Article							RIBOSOMAL DNA; NO EVIDENCE; EVOLUTION; REPRODUCTION; ARTHROPODS; DIPLOIDY	The dominance of the diploid state in higher organisms, with haploidy generally confined to the gametic phase, has Led to the perception that diploidy is favored by selection. This view is highlighted by the fact that no known female organism within the Metazoa exists exclusively (or even for a prolonged period) in a haploid state. We used fluorescence microscopy and variation at nine microsatellite Loci to show that the false spider mite, Brevipalpus phoenicis, consists of haploid female parthenogens. We show that this reproductive anomaly is caused by infection by an undescribed endosymbiotic bacterium, which results in feminization of haploid genetic males.	Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Sect Populat Biol, NL-1098 SM Amsterdam, Netherlands; Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Sect Evolutionary Biol, NL-1098 SM Amsterdam, Netherlands; Acad Sci Czech Republ, Inst Entomol, CZ-37005 Ceske Budejovice, Czech Republic	University of Amsterdam; University of Amsterdam; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences	Weeks, AR (corresponding author), Monash Univ, Dept Biol Sci, Ctr Environm Stress & Adaptat Res, Clayton, Vic 3168, Australia.		Weeks, Andrew/ABC-3048-2020; Marec, Frantisek/G-7943-2014	Marec, Frantisek/0000-0002-6745-5603; Weeks, Andrew/0000-0003-3081-135X				Blackman RL, 1996, CHROMOSOME RES, V4, P314, DOI 10.1007/BF02263684; Bordenstein SR, 2001, NATURE, V409, P707, DOI 10.1038/35055543; *GENB, AF350221 GENB; Grasso DA, 2000, ETHOL ECOL EVOL, V12, P309; HELLE W, 1980, GENETICA, V54, P45, DOI 10.1007/BF00122407; HELLE W, 1972, EXPERIENTIA, V28, P707, DOI 10.1007/BF01944992; Kennedy JS, 1996, J APPL ENTOMOL, V120, P493, DOI 10.1111/j.1439-0418.1996.tb01641.x; KONDRASHOV AS, 1991, NATURE, V351, P314, DOI 10.1038/351314a0; Kurtti TJ, 1996, J INVERTEBR PATHOL, V67, P318, DOI 10.1006/jipa.1996.0050; Mable BK, 1998, BIOESSAYS, V20, P453, DOI 10.1002/(SICI)1521-1878(199806)20:6<453::AID-BIES3>3.0.CO;2-N; MARTIN G, 1990, GEN COMP ENDOCR, V80, P349, DOI 10.1016/0016-6480(90)90183-M; Norton Roy A., 1993, P8; ORR HA, 1995, GENETICS, V139, P1441; PerrotMinnot MJ, 1997, CAN ENTOMOL, V129, P691, DOI 10.4039/Ent129691-4; PIJNACKER LP, 1980, GENETICA, V51, P211, DOI 10.1007/BF00121613; PIJNACKER LP, 1981, ACAROLOGIA, V22, P157; Rigaud T, 1997, BIOESSAYS, V19, P409, DOI 10.1002/bies.950190508; ROUSSET F, 1992, P ROY SOC B-BIOL SCI, V250, P91, DOI 10.1098/rspb.1992.0135; Sahara K, 1999, CHROMOSOME RES, V7, P449, DOI 10.1023/A:1009297729547; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Stouthamer R, 1999, ANNU REV MICROBIOL, V53, P71, DOI 10.1146/annurev.micro.53.1.71; Suomalainen E., 1987, CYTOLOGY EVOLUTION P; Weeks AR, 2000, EXP APPL ACAROL, V24, P775, DOI 10.1023/A:1006486400800; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Welch DM, 2000, SCIENCE, V288, P1211, DOI 10.1126/science.288.5469.1211; Wenseleers T, 2000, J EVOLUTION BIOL, V13, P277, DOI 10.1046/j.1420-9101.2000.00168.x; Wenseleers T, 1998, P ROY SOC B-BIOL SCI, V265, P1447, DOI 10.1098/rspb.1998.0456; Wrensch Dana L., 1994, P282; ZCHORIFEIN E, COMMUNICATION	29	201	216	0	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 29	2001	292	5526					2479	2482		10.1126/science.1060411	http://dx.doi.org/10.1126/science.1060411			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448YU	11431565				2022-12-24	WOS:000169658200038
J	Thomas, GL; Thorne, RE				Thomas, GL; Thorne, RE			Night-time predation by Steller sea lions	NATURE			English	Article									Prince William Sound Sci Ctr, Cordova, AK 99574 USA		Thomas, GL (corresponding author), Prince William Sound Sci Ctr, POB 705, Cordova, AK 99574 USA.							CASTELLINI M, 1993, AKSG9301, P4; Loughlin TR., 1998, BIOSPH CONSER NAT WI, V1, P91, DOI [10.20798/biospherecons.1.2_91, DOI 10.20798/BIOSPHERECONS.1.2_91]; MacLennan D.N., 1992, SPRINGER SCI BUS MED; Mantua NJ, 1997, B AM METEOROL SOC, V78, P1069, DOI 10.1175/1520-0477(1997)078<1069:APICOW>2.0.CO;2; Merrick RL, 1997, CAN J FISH AQUAT SCI, V54, P1342, DOI 10.1139/cjfas-54-6-1342; MERRICK RL, 1994, POLAR RES, V13, P105, DOI 10.1111/j.1751-8369.1994.tb00441.x; National Research Council, 1996, BER SEA EC; Thomas G. L., 1997, DEV SUSTAINING WORLD, P606; THORNE RE, 1983, FAO FISH REP, V300, P217	9	53	53	2	8	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 28	2001	411	6841					1013	1013		10.1038/35082745	http://dx.doi.org/10.1038/35082745			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	446TF	11429591				2022-12-24	WOS:000169528500033
J	Bernhardt, TG; Wang, IN; Struck, DK; Young, R				Bernhardt, TG; Wang, IN; Struck, DK; Young, R			A protein antibiotic in the phage Q beta virion: Diversity in lysis targets	SCIENCE			English	Article							ESCHERICHIA-COLI; CELL-LYSIS; ELEMENTS; STRAINS	A(2), a capsid protein of RNA phage Q beta, is also responsible for host Lysis. A(2) blocked synthesis of murein precursors in vivo by inhibiting MurA, the catalyst of the committed step of murein biosynthesis. An A(2)-resistance mutation mapped to an exposed surface near the substrate-binding cleft of MurA. Moreover, purified Q beta virions inhibited wild-type MurA, but not the mutant MurA, in vitro. Thus, the two small phages characterized for their Lysis strategy, Q beta and the small DNA phage phi X174, effect host Lysis by targeting different enzymes in the multistep, universally conserved pathway of cell wall biosynthesis.	Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA; Texas A&M Univ, Hlth Sci Ctr, Dept Med Biochem & Genet, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Young, R (corresponding author), Texas A&M Univ, Dept Biochem & Biophys, 2128 TAMU, College Stn, TX 77843 USA.			Young, Ry/0000-0001-8001-2914	NIGMS NIH HHS [R01 GM027099] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Berlyn MKB, 1998, MICROBIOL MOL BIOL R, V62, P814, DOI 10.1128/MMBR.62.3.814-984.1998; Bernhardt TG, 2000, P NATL ACAD SCI USA, V97, P4297, DOI 10.1073/pnas.97.8.4297; Bernhardt TG, 2001, J BIOL CHEM, V276, P6093, DOI 10.1074/jbc.M007638200; BERNHARDT TM, UNPUB; Chaplin MF, 1986, CARBOHYDRATE ANAL PR; KOZAK M, 1971, NATURE-NEW BIOL, V234, P209, DOI 10.1038/newbio234209a0; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; MARQUARDT JL, 1992, J BACTERIOL, V174, P5748, DOI 10.1128/JB.174.17.5748-5752.1992; Miller J.H., 1972, EXPT MOL GENETICS; PARANCHYCH W, 1975, RNA PHAGES, pCH4; ROOF W, UNPUB; Sektas M, 1999, BIOTECHNIQUES, V27, P911, DOI 10.2144/99275bm07; SINGER M, 1989, MICROBIOL REV, V53, P1; STRAUSS JH, 1963, J MOL BIOL, V7, P43, DOI 10.1016/S0022-2836(63)80017-0; VANDUIN J, 1988, BACTERIOPHAGES, V1, pCH4; WANG IC, UNPUB; Wang IN, 2000, ANNU REV MICROBIOL, V54, P799, DOI 10.1146/annurev.micro.54.1.799; WINTER RB, 1983, CELL, V33, P877, DOI 10.1016/0092-8674(83)90030-2; WITTE A, 1990, BIOCHIMIE, V72, P191, DOI 10.1016/0300-9084(90)90145-7; Young R, 2000, TRENDS MICROBIOL, V8, P120, DOI 10.1016/S0966-842X(00)01705-4	20	100	108	1	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 22	2001	292	5525					2326	2329		10.1126/science.1058289	http://dx.doi.org/10.1126/science.1058289			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	445KD	11423662				2022-12-24	WOS:000169455900057
J	Hines, PJ; Marx, J				Hines, PJ; Marx, J			The endless race between plant and pathogen	SCIENCE			English	Editorial Material																			0	4	4	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 22	2001	292	5525					2269	2269		10.1126/science.292.5525.2269	http://dx.doi.org/10.1126/science.292.5525.2269			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	445KD	11423645				2022-12-24	WOS:000169455900039
J	Honein, MA; Paulozzi, LJ; Mathews, TJ; Erickson, JD; Wong, LYC				Honein, MA; Paulozzi, LJ; Mathews, TJ; Erickson, JD; Wong, LYC			Impact of folic acid fortification of the US food supply on the occurrence of neural tube defects	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PRENATAL-DIAGNOSIS; BIRTH-DEFECTS; ELECTIVE TERMINATION; FOLATE LEVELS; PREVENTION; PREVALENCE; CERTIFICATES; HOMOCYSTEINE; DECISION; GRAIN	Context Daily consumption of 400 mug of folic acid before conception and during early pregnancy dramatically reduces the occurrence of neural tube defects (NTDs), Before food fortification, however, only an estimated 29% of US reproductive-aged women were taking a supplement containing 400 mug of folic acid daily. The US Food and Drug Administration authorized addition of folic acid to enriched grain products in March 1996, with compliance mandatory by January 1998. Objective To evaluate the impact of food fortification with folic acid on NTD birth prevalence. Design, Setting, and Population National study of birth certificate data for live births to women in 45 US states and Washington, DC, between January 1990 and December 1999, Main Outcome Measure Birth certificate reports of spina bifida and anencephaly before fortification (October 1995 through December 1996) compared with after mandatory fortification (October 1998 through December 1999). Results The birth prevalence of NTDs reported on birth certificates decreased from 37.8 per 100000 live births before fortification to 30.5 per 100000 live births conceived after mandatory folic acid fortification, representing a 19% decline (prevalence ratio [PR], 0.81; 95% confidence interval [CI], 0.75-0.87), During the same period, NTD birth prevalence declined from 53.4 per 100000 to 46.5 per 100000 (PR, 0.87; 95% CI, 0.64-1.18) for women who received only third-trimester or no prenatal care. Conclusions A 19% reduction in NTD birth prevalence occurred following folic acid fortification of the US food supply. However, factors other than fortification may have contributed to this decline.	Ctr Dis Control & Prevent, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA 30341 USA; Ctr Dis Control & Prevent, Natl Ctr Hlth Stat, Div Vital Stat, Atlanta, GA 30341 USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; CDC National Center for Health Statistics (NCHS)	Honein, MA (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Birth Defects & Dev Disabil, Mailstop F-45,4770 Buford Hwy NE, Atlanta, GA 30341 USA.	MHonein@cdc.gov						Adams T, 1996, AM J PUBLIC HEALTH, V86, P593, DOI 10.2105/AJPH.86.4.593; Allen WP, 1996, PRENATAL DIAG, V16, P531, DOI 10.1002/(SICI)1097-0223(199606)16:6<531::AID-PD914>3.0.CO;2-1; [Anonymous], 1991, Lancet, V338, P131, DOI 10.1016/0140-6736(91)90133-A; [Anonymous], 1992, MMWR Recomm Rep, V41, P1; *CDC, 2000, TRENDS SPIN BIF AN U; *CDC, 2000, MMWR-MORBID MORTAL W, V49, P962; Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P325; COHEN SA, 1998, GUTTMACHER REP PUBLI, V1, P6; Committee on Medical Aspects of Food and Nutrition Policy, 2000, FOL AC PREV DIS; Cornel MC, 1997, TERATOLOGY, V55, P134; CROWDER SV, 1987, J QUAL TECHNOL, V19, P161, DOI 10.1080/00224065.1987.11979055; CZEIZEL AE, 1992, NEW ENGL J MED, V327, P1832, DOI 10.1056/NEJM199212243272602; DALY LE, 1995, JAMA-J AM MED ASSOC, V274, P1698, DOI 10.1001/jama.274.21.1698; Daly S, 1997, LANCET, V350, P1666, DOI 10.1016/S0140-6736(97)07247-4; Daly S, 1998, CURR OPIN OBSTET GYN, V10, P85, DOI 10.1097/00001703-199804000-00002; Forrester MB, 1998, AM J EPIDEMIOL, V148, P1206; FREEDMAN MA, 1988, AM J PUBLIC HEALTH, V78, P168, DOI 10.2105/AJPH.78.2.168; Freire WB, 2000, EUR J PEDIATR SURG, V10, P42; Gregory JF, 1997, EUR J CLIN NUTR, V51, pS54; GREVENGOOD C, 1994, FETAL DIAGN THER, V9, P273, DOI 10.1159/000263947; Hook EB, 1997, LANCET, V350, P513, DOI 10.1016/S0140-6736(97)01342-1; Jacques PF, 1999, NEW ENGL J MED, V340, P1449, DOI 10.1056/NEJM199905133401901; Lawrence JM, 1999, LANCET, V354, P915, DOI 10.1016/S0140-6736(99)03227-4; Mulinare J, 1997, TERATOLOGY, V56, P17, DOI 10.1002/(SICI)1096-9926(199707/08)56:1/2<17::AID-TERA5>3.0.CO;2-Z; Nelen WLDM, 2000, OBSTET GYNECOL, V95, P519, DOI 10.1016/S0029-7844(99)00610-9; Olsen CL, 1996, PAEDIATR PERINAT EP, V10, P161, DOI 10.1111/j.1365-3016.1996.tb00040.x; PIPER JM, 1993, AM J EPIDEMIOL, V137, P758, DOI 10.1093/oxfordjournals.aje.a116736; PRYDE PG, 1992, OBSTET GYNECOL, V80, P52; Rader JI, 2000, FOOD CHEM, V70, P275, DOI 10.1016/S0308-8146(00)00116-3; ROBERTS HE, 1995, PEDIATRICS, V96, P880; ROMANO PS, 1995, AM J PUBLIC HEALTH, V85, P667, DOI 10.2105/AJPH.85.5.667; ROSENFIELD A, 1993, AM J OBSTET GYNECOL, V169, P128, DOI 10.1016/0002-9378(93)90146-A; Skeaff M, 1998, NEW ZEAL MED J, V111, P417; TAFFEL SM, 1989, BIRTH-ISS PERINAT C, V16, P188, DOI 10.1111/j.1523-536X.1989.tb00896.x; TOLSON GC, 1991, VITAL HLTH STAT 4, V28, P1; Turner LA, 1998, CAN MED ASSOC J, V158, P773; Velie EM, 1996, AM J EPIDEMIOL, V144, P473; Ventura SJ., 2000, BIRTHS FINAL DATA 19, V48; Wald NJ, 1998, LANCET, V351, P834, DOI 10.1016/S0140-6736(05)78966-2; Wald NJ, 2001, AM J MED GENET, V98, P204, DOI 10.1002/1096-8628(20010115)98:2<204::AID-AJMG1032>3.0.CO;2-D; Watkins ML, 1996, AM J PUBLIC HEALTH, V86, P731, DOI 10.2105/AJPH.86.5.731; Watkins ML, 1999, NEW ENGL J MED, V341, P923; Wynn Margaret, 1998, Nutrition and Health (Bicester), V12, P147; 1996, FED REG, V61, P8781	44	710	731	2	57	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 20	2001	285	23					2981	2986		10.1001/jama.285.23.2981	http://dx.doi.org/10.1001/jama.285.23.2981			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	442AR	11410096				2022-12-24	WOS:000169263200020
J	Roper, NA; Bilous, RW; Kelly, WF; Unwin, NC; Connolly, VM				Roper, NA; Bilous, RW; Kelly, WF; Unwin, NC; Connolly, VM			Excess mortality in a population with diabetes and the impact of material deprivation: longitudinal, population based study	BRITISH MEDICAL JOURNAL			English	Article							ALL-CAUSE MORTALITY; SOCIOECONOMIC-STATUS; SOCIAL DEPRIVATION; RISK-FACTORS; MELLITUS; COHORT; PEOPLE; PREVALENCE; DISEASE; ADULTS	Objectives To establish the age and sex specific mortality for people with diabetes in comparison with local and national background populations; to investigate the relationship between mortality and material deprivation in an unselected population with diabetes. Design Longitudinal study, using a population based district diabetes register. Setting South Tees, United Kingdom. Participants All people known to have diabetes living in Middlesbrough and Redcar and Cleveland local authorities on 1 January 1994. Main outcome measure Death, from any cause, between 1 January 1994 and 31 December 1999. Results Over the six years of the study 1205 (24.9%) of 4842 participants died. All cause standardised mortality ratios for type 1 diabetes were 641 (95% confidence interval 406 to 962) in women and 294 (200 to 418) in men, and those for type 2 diabetes were 160 (147 to 174) in women and 141 (130 to 152) in men. Cause specific standardised mortality ratios were increased for ischaemic heart disease, cerebrovascular disease, and renal disease; no reductions in mortality from other causes were seen. The risk of premature death increased significantly with increasing material deprivation (P < 0.001). Conclusions Diabetes is associated with excess mortality, even in an area with high background death rates from cardiovascular disease. This excess mortality is evident in all age groups, most pronounced in young people with type 1 diabetes, and exacerbated by material deprivation. Aggressive approaches to the management of cardiovascular risk factors could reduce the excess mortality in people with diabetes.	Middlesbrough Gen Hosp, Diabet Care Ctr, Middlesbrough TS5 5AZ, Cleveland, England; Univ Newcastle Upon Tyne, Sch Clin Med Sci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; Univ Newcastle Upon Tyne, Dept Diabet & Epidemiol, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; Univ Newcastle Upon Tyne, Dept Publ Hlth, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK; Newcastle University - UK	Roper, NA (corresponding author), Middlesbrough Gen Hosp, Diabet Care Ctr, Middlesbrough TS5 5AZ, Cleveland, England.			Unwin, Nigel/0000-0002-1368-1648				Chaturvedi N, 1998, BMJ-BRIT MED J, V316, P100; Connolly VM, 1996, DIABETES CARE, V19, P419, DOI 10.2337/diacare.19.5.419; CROXSON SCM, 1994, DIABETIC MED, V11, P250, DOI 10.1111/j.1464-5491.1994.tb00267.x; *DEP HLTH, 2000, NAT SERV FRAM COR HE; Devis T, 1990, POPUL TRENDS, V60, P23; Diabetes care and research in Europe, 1990, DIABETIC MED, V7, P360; *DOC GEIG, 1970, SCI TABL; Evans JMM, 2000, DIABETIC MED, V17, P478, DOI 10.1046/j.1464-5491.2000.00309.x; Gatling W, 1997, DIABETIC MED, V14, P316, DOI 10.1002/(SICI)1096-9136(199704)14:4<316::AID-DIA328>3.0.CO;2-0; Gu K, 1998, DIABETES CARE, V21, P1138, DOI 10.2337/diacare.21.7.1138; Jones ME, 1998, AM J EPIDEMIOL, V148, P1012; KELLY WF, 1993, BRIT MED J, V307, P1115, DOI 10.1136/bmj.307.6912.1115; Koskinen SVP, 1998, AM J PUBLIC HEALTH, V88, P765, DOI 10.2105/AJPH.88.5.765; Laing SP, 1999, DIABETIC MED, V16, P459, DOI 10.1046/j.1464-5491.1999.00075.x; MOSS SE, 1991, AM J PUBLIC HEALTH, V81, P1158, DOI 10.2105/AJPH.81.9.1158; MUGGEO M, 1995, DIABETOLOGIA, V38, P318, DOI 10.1007/s001250050288; *OFF POP CENS SURV, 1994, SER DH2, V2126; *OFF POP CENS SURV, 1994, SER DH1, V2730; PHILLIMORE P, 1994, BRIT MED J, V308, P1125, DOI 10.1136/bmj.308.6937.1125; Raymond NT, 1995, J EPIDEMIOL COMMUN H, V49, P570, DOI 10.1136/jech.49.6.570; Robinson N, 1998, DIABETIC MED, V15, P205, DOI 10.1002/(SICI)1096-9136(199803)15:3<205::AID-DIA519>3.0.CO;2-#; Townsend PP., 1988, HLTH DEPRIVATION INE; Unwin N, 1996, DIABETIC MED, V13, P72, DOI 10.1002/(SICI)1096-9136(199601)13:1<72::AID-DIA21>3.3.CO;2-K; WAUGH NR, 1989, DIABETOLOGIA, V32, P103, DOI 10.1007/BF00505181; WONG JSK, 1991, DIABETIC MED, V8, P135, DOI 10.1111/j.1464-5491.1991.tb01559.x	25	231	234	1	6	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 9	2001	322	7299					1389	1393		10.1136/bmj.322.7299.1389	http://dx.doi.org/10.1136/bmj.322.7299.1389			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	442KN	11397742	Bronze, Green Published, Green Submitted			2022-12-24	WOS:000169284600015
J	Rybczynski, N; Reisz, RR				Rybczynski, N; Reisz, RR			Earliest evidence for efficient oral processing in a terrestrial herbivore	NATURE			English	Article							EVOLUTION	Herbivores can increase their digestion rate by mechanically reducing particle size through oral trituration(1). Groups of terrestrial vertebrates with the greatest capacity to reduce tough plant foods orally are also the most abundant and diverse, as exemplified by ornithopod dinosaurs during the Mesozoic and extant artiodactyl and perissodactyl mammals(2). Thus, the effective oral processing of high-fibre plant material seems to represent an evolutionary innovation of both functional and macroevolutionary significance. However, evidence for oral processing is poorly documented in the fossil record, especially during the initial stages of terrestrial vertebrate diversification(3,4). Here we report on the basal anomodont Suminia getmanovi, the only known Palaeozoic vertebrate in which unequivocal specializations in its cranium and teeth for high-fibre herbivory are well preserved. We propose that the capacity to comminute tough plant foods was critical to the diversification of anomodonts, the most diverse, widely dispersed and abundant group of Palaeozoic terrestrial vertebrates, and to the onset of modern terrestrial ecosystems.	Univ Toronto, Dept Zool, Mississauga, ON L5L 1C6, Canada; Duke Univ, Dept Biol Anthropol & Anat, Durham, NC 27708 USA	University of Toronto; University Toronto Mississauga; Duke University	Reisz, RR (corresponding author), Univ Toronto, Dept Zool, 3359 Mississauga Rd, Mississauga, ON L5L 1C6, Canada.							BJORNDAL KA, 1990, PHYSIOL ZOOL, V63, P710, DOI 10.1086/physzool.63.4.30158172; COSTA RL, 1981, J PALEONTOL, V55, P635; Dimichele William A., 1992, P205; Galton P.M., 1986, P203; Hotton N. III, 1986, P71; Hotton Nicholas III, 1997, P207; IVACHNENKO MF, 1994, PALEONTOLOG J, V28, P96; King G.M., 1996, REPTILES HERBIVORY; KING GM, 1994, J ZOOL, V232, P651, DOI 10.1111/j.1469-7998.1994.tb04620.x; NORMAN DB, 1985, AM NAT, V126, P151, DOI 10.1086/284406; Popowics TE, 1997, ANN ZOOL FENN, V34, P73; Reisz Robert R., 2000, P9, DOI 10.1017/CBO9780511549717.003; RENSBERGER JM, 1973, J PALEONTOL, V47, P515; RENSBERGER JM, 1975, J PALEONTOL, V49, P10; Rybczynski N, 2000, ZOOL J LINN SOC-LOND, V130, P329, DOI 10.1006/zjls.1999.0218; Sues HD, 1998, TRENDS ECOL EVOL, V13, P141, DOI 10.1016/S0169-5347(97)01257-3; THROCKMORTON GS, 1976, J MORPHOL, V148, P363, DOI 10.1002/jmor.1051480307	17	40	41	0	16	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN	2001	411	6838					684	687		10.1038/35079567	http://dx.doi.org/10.1038/35079567			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439JC	11395768				2022-12-24	WOS:000169112500042
J	Bartolazzi, A; Gasbarri, A; Papotti, M; Bussolati, G; Lucante, T; Khan, A; Inohara, H; Marandino, F; Orlandi, F; Nardi, F; Vecchione, A; Tecce, R; Larsson, O				Bartolazzi, A; Gasbarri, A; Papotti, M; Bussolati, G; Lucante, T; Khan, A; Inohara, H; Marandino, F; Orlandi, F; Nardi, F; Vecchione, A; Tecce, R; Larsson, O		Thyroid Canc Study Grp	Application of an immunodiagnostic method for improving preoperative diagnosis of nodular thyroid lesions	LANCET			English	Article							FINE-NEEDLE-ASPIRATION; HASHIMOTO THYROIDITIS; EXPRESSION; GALECTIN-3; CD44; CARCINOMA; MARKER; CYTOLOGY; FUSION; TUMORS	Background Thyroid cancer is the most common endocrine malignant disease, but preoperative diagnosis remains a challenge. Fine-needle aspiration cytology has greatly improved the clinical management of thyroid nodules, but the preoperative characterisation of follicular lesions is very difficult. Many patients are thus referred to surgery more for diagnosis than for therapeutic necessity. We undertook an international multicentre study to assess the usefulness of immunohistocytochemical staining for two potential markers of malignant thyrocytes. Methods Expression of galectin-3 and CD44v6 was tested on 1009 thyroid lesions (tissue specimens and cytological cell-blocks) and 226 fresh cytological samples obtained preoperatively by ultrasound-guided fine-needle aspiration of thyroid nodules (prospective analysis). The test used monoclonal antibodies specific for CD44v6 and galectin-3, the indirect avidin-biotin complex immunoperoxidase method, and 3-amino-9-ethylcarbazole as substrate. Findings The sensitivity, specificity, positive predictive value, and diagnostic accuracy of this test method (for coexpression of the two markers) in the prospective analysis were 88%, 98%, 91%, and 97%, respectively. The sensitivity and specificity of galectin-3 immunodetection alone in discriminating benign from malignant thyroid lesions were more than 99% and 98% respectively, and the positive predictive value and diagnostic accuracy were 92% and 99%. Interpretation The integration of galectin-3 immunostaining with conventional cytomorphological and clinical diagnostic procedures represents a sensitive and reliable diagnostic approach for preoperative identification of thyroid carcinomas. This test method improves the diagnostic accuracy of conventional cytology and provides the molecular basis for a new nosological assignation of the not yet classified thyroid neoplasms of indeterminate malignant behaviour.	Karolinska Hosp, Canc Ctr Karolinska, Dept Oncol Pathol Cellular & Mol Tumor Pathol, S-17176 Stockholm, Sweden; Regina Elena Inst Canc Res, Dept Pathol, Rome, Italy; Regina Elena Inst Canc Res, Dept Immunol, Rome, Italy; Univ Turin, Dept Biomed Sci & Human Oncol, I-10124 Turin, Italy; Univ Turin, Dept Biol & Clin Sci, I-10124 Turin, Italy; Univ Roma La Sapienza, Policlin Umberto I, Dept Pathol & Expt Med, I-00161 Rome, Italy; Univ Roma La Sapienza, Policlin Umberto I, Dept Cytopathol, I-00161 Rome, Italy; Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01605 USA; Univ Massachusetts, Sch Med, Div Anat Pathol, Worcester, MA 01605 USA; Osaka Univ, Grad Sch Med, Dept Otolaryngol, Osaka, Japan; Osaka Univ, Grad Sch Med, Dept Sensory Organ Surg, Osaka, Japan	Karolinska Institutet; Karolinska University Hospital; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; University of Turin; University of Turin; Sapienza University Rome; University Hospital Sapienza Rome; Sapienza University Rome; University Hospital Sapienza Rome; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Osaka University; Osaka University	Bartolazzi, A (corresponding author), Karolinska Hosp, Canc Ctr Karolinska, Dept Oncol Pathol Cellular & Mol Tumor Pathol, S-17176 Stockholm, Sweden.	Armando.Bartolazzi@cck.ki.se	MARANDINO, FERDINANDO/AAB-2537-2019; Bartolazzi, Armando/K-9708-2016	Bartolazzi, Armando/0000-0001-7820-5127				Baloch ZW, 1998, THYROID, V8, P565, DOI 10.1089/thy.1998.8.565; Bartolazzi A, 2000, LANCET, V355, P1661, DOI 10.1016/S0140-6736(00)02233-9; CARAWAY NP, 1993, DIAGN CYTOPATHOL, V9, P345, DOI 10.1002/dc.2840090320; CHIARIOTTI L, 1992, ONCOGENE, V7, P2507; EISENBERG BL, 1989, ARCH SURG-CHICAGO, V124, P1045; ERMAK G, 1995, CANCER RES, V55, P4594; Fernandez PL, 1997, J PATHOL, V181, P80; Gasbarri A, 1999, J CLIN ONCOL, V17, P3494, DOI 10.1200/JCO.1999.17.11.3494; Gu J, 1998, PATHOL INT, V48, P184, DOI 10.1111/j.1440-1827.1998.tb03891.x; GUNTHERT U, 1991, CELL, V65, P13, DOI 10.1016/0092-8674(91)90403-L; HALL TL, 1989, CANCER, V63, P718, DOI 10.1002/1097-0142(19890215)63:4<718::AID-CNCR2820630420>3.0.CO;2-N; HEDINGER CE, 1993, SCHWEIZ MED WSCHR, V123, P1673; Inohara H, 1999, CANCER, V85, P2475, DOI 10.1002/(SICI)1097-0142(19990601)85:11<2475::AID-CNCR25>3.3.CO;2-T; Kini SR, 1987, GUIDE CLIN ASPIRATIO, V3; Kroll TG, 2000, SCIENCE, V289, P1357, DOI 10.1126/science.289.5483.1357; Naor D, 1997, ADV CANCER RES, V71, P241, DOI 10.1016/S0065-230X(08)60101-3; NUNEZ C, 1989, PATHOL ANNU, V24, P161; Orlandi F, 1998, CANCER RES, V58, P3015; Ponta H., 1998, FRONT BIOSCI, V3, P650; Raber W, 1997, WIEN KLIN WOCHENSCHR, V109, P116; Rosai J., 1992, ATLAS TUMOR PATHOL, P1; Schlinkert RT, 1997, MAYO CLIN PROC, V72, P913, DOI 10.1016/S0025-6196(11)63360-0; SCLAFANI AP, 1993, LARYNGOSCOPE, V103, P845; SCREATON GR, 1992, P NATL ACAD SCI USA, V89, P12160, DOI 10.1073/pnas.89.24.12160; Sidawy MK, 1997, CANCER CYTOPATHOL, V81, P253, DOI 10.1002/(SICI)1097-0142(19970825)81:4<253::AID-CNCR7>3.0.CO;2-Q; SILVERMAN JF, 1986, CANCER-AM CANCER SOC, V57, P1164, DOI 10.1002/1097-0142(19860315)57:6<1164::AID-CNCR2820570617>3.0.CO;2-S; TAKASHIMA S, 1992, RADIOLOGY, V185, P125, DOI 10.1148/radiology.185.1.1523294; Tuttle RM, 1998, THYROID, V8, P377, DOI 10.1089/thy.1998.8.377; Wirtschafter A, 1997, LARYNGOSCOPE, V107, P95, DOI 10.1097/00005537-199701000-00019; XU XC, 1995, AM J PATHOL, V147, P815	30	318	346	0	17	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 26	2001	357	9269					1644	1650		10.1016/S0140-6736(00)04817-0	http://dx.doi.org/10.1016/S0140-6736(00)04817-0			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	435UY	11425367				2022-12-24	WOS:000168901600008
J	Vicsek, T				Vicsek, T			A question of scale	NATURE			English	Article									Eotvos Lorand Univ, Dept Biol Phys, H-1117 Budapest, Hungary	Eotvos Lorand University	Vicsek, T (corresponding author), Eotvos Lorand Univ, Dept Biol Phys, Pazmany P Stny 1A, H-1117 Budapest, Hungary.		Vicsek, Tamas/A-3305-2009					Coleman J.S., 1990, FDN SOCIAL THEORY; Huang K, 1987, STAT MECH; VICSEK T, 2001, SCALING FLUCTUATIONS	3	93	102	2	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 24	2001	411	6836					421	421		10.1038/35078161	http://dx.doi.org/10.1038/35078161			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	435CB	11373653	Green Submitted			2022-12-24	WOS:000168858700024
J	Gu, HH; Saito, K; Klaman, LD; Shen, JQ; Fleming, T; Wang, YP; Pratt, JC; Lin, GS; Lim, B; Kinet, JP; Neel, BG				Gu, HH; Saito, K; Klaman, LD; Shen, JQ; Fleming, T; Wang, YP; Pratt, JC; Lin, GS; Lim, B; Kinet, JP; Neel, BG			Essential role for Gab2 in the allergic response	NATURE			English	Article							PHOSPHOLIPASE C-GAMMA; GROWTH-FACTOR RECEPTORS; PHOSPHATIDYLINOSITOL 3-KINASE; SIGNAL-TRANSDUCTION; MAST-CELLS; ACTIVATION; PROTEIN; KINASE; CYTOKINE; PATHWAY	Dos/Gab family scaffolding adapters (Dos, Gab1, Gab2) bind several signal relay molecules, including the protein-tyrosine phosphatase Shp-2 and phosphatidylinositol-3-OH kinase (PI(3)K); they are also implicated in growth factor, cytokine and antigen receptor signal transduction(1). Mice lacking Gab1 die during embryogenesis and show defective responses to several stimuli(2,3). Here we report that Gab2(-/-) mice are viable and generally healthy; however, the response (for example, degranulation and cytokine gene expression) of Gab2(-/-) mast cells to stimulation of the high affinity immunoglobulin-epsilon (IgE) receptor Fc epsilon RI is defective. Accordingly, allergic reactions such as passive cutaneous and systemic anaphylaxis are markedly impaired in Gab2(-/-) mice. Biochemical analyses reveal that signalling pathways dependent on PI(3)K, a critical component of Fc epsilon RI signalling, are defective in Gab2(-/-) mast cells. Our data identify Gab2 as the principal activator of PI(3)K in response to FceRI activation, thereby providing genetic evidence that Dos/Gab family scaffolds regulate the PI(3)K pathway in vivo. Gab2 and/or its associated signalling molecules may be new targets for developing drugs to treat allergy.	Beth Israel Deaconess Med Ctr, Div Hematol & Oncol, Canc Biol Program, Boston, MA 02215 USA; Beth Israel Deaconess Med Ctr, Dept Med, Div Expt Pathol, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA 02215 USA; Franklin W Olin Coll Engn, Needham, MA 02492 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Franklin W. Olin College of Engineering	Gu, HH (corresponding author), Beth Israel Deaconess Med Ctr, Div Hematol & Oncol, Canc Biol Program, Boston, MA 02215 USA.	hgu@caregroup.harvard.edu						Bae YS, 1998, J BIOL CHEM, V273, P4465, DOI 10.1074/jbc.273.8.4465; Barker SA, 1999, J LEUKOCYTE BIOL, V65, P321, DOI 10.1002/jlb.65.3.321; Barkley R., 1995, ADHD REPORT, V3, P5; Craddock BL, 1999, J BIOL CHEM, V274, P10633, DOI 10.1074/jbc.274.15.10633; Dombrowicz D, 1997, J CLIN INVEST, V99, P915, DOI 10.1172/JCI119256; Falasca M, 1998, EMBO J, V17, P414, DOI 10.1093/emboj/17.2.414; Franke TF, 1997, SCIENCE, V275, P665, DOI 10.1126/science.275.5300.665; Galli SJ, 2000, CURR OPIN HEMATOL, V7, P32, DOI 10.1097/00062752-200001000-00007; Gommerman JL, 2000, J IMMUNOL, V165, P6915, DOI 10.4049/jimmunol.165.12.6915; Gu HH, 2000, MOL CELL BIOL, V20, P7109, DOI 10.1128/MCB.20.19.7109-7120.2000; Gu HH, 1998, MOL CELL, V2, P729, DOI 10.1016/S1097-2765(00)80288-9; Hibi M, 2000, LEUKEMIA LYMPHOMA, V37, P299, DOI 10.3109/10428190009089430; Ishizuka T, 1999, J IMMUNOL, V162, P2087; Itoh M, 2000, MOL CELL BIOL, V20, P3695, DOI 10.1128/MCB.20.10.3695-3704.2000; Kawakami Y, 1998, J IMMUNOL, V161, P1795; Liu YC, 1998, CELL SIGNAL, V10, P377, DOI 10.1016/S0898-6568(97)00179-4; Lu-Kuo JM, 2000, J BIOL CHEM, V275, P6022, DOI 10.1074/jbc.275.8.6022; NAKANISHI S, 1995, CELL SIGNAL, V7, P545, DOI 10.1016/0898-6568(95)00033-L; Nishida K, 1999, BLOOD, V93, P1809, DOI 10.1182/blood.V93.6.1809.406k35_1809_1816; Pratt JC, 2000, J IMMUNOL, V165, P4158, DOI 10.4049/jimmunol.165.8.4158; Raabe T, 1996, CELL, V85, P911, DOI 10.1016/S0092-8674(00)81274-X; Rameh LE, 1998, J BIOL CHEM, V273, P23750, DOI 10.1074/jbc.273.37.23750; Rameh LE, 1997, J BIOL CHEM, V272, P22059, DOI 10.1074/jbc.272.35.22059; Sachs M, 2000, J CELL BIOL, V150, P1375, DOI 10.1083/jcb.150.6.1375; Saitoh S, 2000, IMMUNITY, V12, P525, DOI 10.1016/S1074-7613(00)80204-6; Scharenberg AM, 1998, EMBO J, V17, P1961, DOI 10.1093/emboj/17.7.1961; Schwaller J, 1998, EMBO J, V17, P5321, DOI 10.1093/emboj/17.18.5321; Turner H, 1999, NATURE, V402, pB24, DOI 10.1038/35037021; Yang FC, 2000, IMMUNITY, V12, P557, DOI 10.1016/S1074-7613(00)80207-1	29	266	276	1	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 12	2001	412	6843					186	190		10.1038/35084076	http://dx.doi.org/10.1038/35084076			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	451AJ	11449275				2022-12-24	WOS:000169778700053
J	Haile-Selassie, Y				Haile-Selassie, Y			Late Miocene hominids from the Middle Awash, Ethiopia	NATURE			English	Article							AUSTRALOPITHECUS-AFARENSIS; HOMINOIDS; LOTHAGAM; SEQUENCE; RIFT	Molecular studies suggest that the lineages leading to humans and chimpanzees diverged approximately 6.5-5.5 million years (Myr) ago, in the Late Miocene(1-3). Hominid fossils from this interval, however, are fragmentary and of uncertain phylogenetic status, age, or both(4-6). Here I report new hominid specimens from the Middle Awash area of Ethiopia that date to 5.2-5.8 Myr and are associated with a wooded palaeoenvironment(7). These Late Miocene fossils are assigned to the hominid genus Ardipithecus and represent the earliest definitive evidence of the hominid clade. Derived dental characters are shared exclusively with all younger hominids. This indicates that the fossils probably represent a hominid taxon that postdated the divergence of lineages leading to modern chimpanzees and humans. However, the persistence of primitive dental and postcranial characters in these new fossils indicates that Ardipithecus was phylogenetically close to the common ancestor of chimpanzees and humans. These new findings raise additional questions about the claimed hominid status of Orrorin tugenensis(8), recently described from Kenya and dated to similar to6 Myr(9).	Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Human Evolut Studies Lab, Museum Vertebrate Zool, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Haile-Selassie, Y (corresponding author), Univ Calif Berkeley, Dept Integrat Biol, 3060 VLSB, Berkeley, CA 94720 USA.							Chen FC, 2001, AM J HUM GENET, V68, P444, DOI 10.1086/318206; DAY MH, 1969, NATURE, V47, P230; Hill A., 1994, INTEGRATIVE PATHS PA, P123; HORAI S, 1995, P NATL ACAD SCI USA, V92, P532, DOI 10.1073/pnas.92.2.532; LATIMER B, 1990, AM J PHYS ANTHROPOL, V83, P13, DOI 10.1002/ajpa.1330830103; LATIMER BM, 1982, AM J PHYS ANTHROPOL, V57, P701, DOI 10.1002/ajpa.1330570412; Leakey MG, 1996, J VERTEBR PALEONTOL, V16, P556, DOI 10.1080/02724634.1996.10011339; McDougall I, 1999, J GEOL SOC LONDON, V156, P731, DOI 10.1144/gsjgs.156.4.0731; Ohman JC, 1997, AM J PHYS ANTHROPOL, V104, P117, DOI 10.1002/(SICI)1096-8644(199709)104:1<117::AID-AJPA8>3.0.CO;2-O; Pickford M, 2001, CR ACAD SCI II A, V332, P145, DOI 10.1016/S1251-8050(01)01528-2; Renne PR, 1999, GEOL SOC AM BULL, V111, P869, DOI 10.1130/0016-7606(1999)111<0869:COTMPS>2.3.CO;2; Ruvolo M, 1997, MOL BIOL EVOL, V14, P248, DOI 10.1093/oxfordjournals.molbev.a025761; Senut B, 2001, CR ACAD SCI II A, V332, P137, DOI 10.1016/S1251-8050(01)01529-4; WHITE TD, 1994, NATURE, V371, P306, DOI 10.1038/371306a0; WoldeGabriel G, 2001, NATURE, V412, P175, DOI 10.1038/35084058	15	279	291	4	65	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 12	2001	412	6843					178	181		10.1038/35084063	http://dx.doi.org/10.1038/35084063			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	451AJ	11449272				2022-12-24	WOS:000169778700050
J	Phillips, PS; Nolan, JP				Phillips, PS; Nolan, JP			Training in basic and advanced life support in UK medical schools: questionnaire survey	BRITISH MEDICAL JOURNAL			English	Article							CARDIOPULMONARY RESUSCITATION		Univ Southampton, Southampton Gen Hosp, Fac Med, Southampton SO16 6YD, Hants, England; Royal United Hosp, Dept Anaesthesia & Intens Care Med, Bath BA1 3NG, Avon, England	University of Southampton	Phillips, PS (corresponding author), Univ Southampton, Southampton Gen Hosp, Fac Med, Southampton SO16 6YD, Hants, England.		Nolan, Jerry P./ABF-2561-2020	Nolan, Jerry/0000-0003-3141-3812				CASEY WF, 1984, J ROY SOC MED, V77, P921, DOI 10.1177/014107688407701105; *GEN MED COUNC, 1997, NEW DOCT REC GEN CLI; Perkins GD, 1999, RESUSCITATION, V41, P19, DOI 10.1016/S0300-9572(99)00037-4; SKINNER DV, 1985, BRIT MED J, V290, P1549, DOI 10.1136/bmj.290.6481.1549; The Royal College of Physicians of London, 1987, J ROY COLL PHYS LOND, V21, P175	5	53	53	1	4	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 7	2001	323	7303					22	23		10.1136/bmj.323.7303.22	http://dx.doi.org/10.1136/bmj.323.7303.22			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	451WA	11440938	Green Published, Bronze			2022-12-24	WOS:000169824300019
J	Pockley, P				Pockley, P			Gene screens for nuclear veterans	NATURE			English	News Item																			0	0	0	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 5	2001	412	6842					5	5		10.1038/35083721	http://dx.doi.org/10.1038/35083721			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448TB	11452267	Bronze			2022-12-24	WOS:000169644900006
J	Schwartlander, B; Stover, J; Walker, N; Bollinger, L; Gutierrez, JP; McGreevey, M; Opuni, M; Forsythe, S; Kumaranayake, L; Watts, C; Bertozzi, S				Schwartlander, B; Stover, J; Walker, N; Bollinger, L; Gutierrez, JP; McGreevey, M; Opuni, M; Forsythe, S; Kumaranayake, L; Watts, C; Bertozzi, S			AIDS - Resource needs for HIV/AIDS	SCIENCE			English	Editorial Material									UNAIDS, Joint United Nations Programme HIV AIDS, Geneva, Switzerland; Futures Grp Int, Washington, DC 20036 USA; Natl Inst Publ Hlth, Cuernavaca, Morelos, Mexico; London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, London WC1, England	UNAIDS; Instituto Nacional de Salud Publica; University of London; London School of Hygiene & Tropical Medicine	Schwartlander, B (corresponding author), UNAIDS, Joint United Nations Programme HIV AIDS, Geneva, Switzerland.		Forsythe, Steven/AAL-7558-2020; Gutierrez, Juan Pablo/A-4253-2010	Forsythe, Steven/0000-0002-4409-5991; Gutierrez, Juan Pablo/0000-0002-0557-5562; Bertozzi, Stefano M/0000-0002-1723-7085; Opuni, Marjorie/0000-0002-0939-7695				BOLLINGER L, UNIT COSTS HIV AIDS; Bonnel R, 2000, COSTS SCALING HIV PR; Cantor CH, 1997, ARCH SUICIDE RES, V3, P5, DOI 10.1023/A:1009699126206; FORSYTHE S, 2001, UNPUB CURRENT SPENDI; FOSTER S, 2000, FEDERAL HIV AIDS SPE; KUMARANAYAKE L, 2001, 5 WHO COMM MACR HLTH; Merson MH, 2000, AIDS, V14, pS68; *UNAIDS, 2000, REP GLOB HIV AIDS EP; World Bank, 2000, WORLD DEV REP 1999 2	9	116	118	1	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 29	2001	292	5526					2434	2436		10.1126/science.1062876	http://dx.doi.org/10.1126/science.1062876			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448YU	11423619				2022-12-24	WOS:000169658200022
J	Weston, CR; Davis, RJ				Weston, CR; Davis, RJ			Signal transduction - Signaling specificity - a complex affair	SCIENCE			English	Editorial Material							GLYCOGEN-SYNTHASE KINASE-3; SUBSTRATE-SPECIFICITY; MAP KINASES; TRANSCRIPTION; INSULIN; 3-BETA; GSK3		Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester	Weston, CR (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA.	roger.davis@umassmed.edu						Coghlan MP, 2000, CHEM BIOL, V7, P793, DOI 10.1016/S1074-5521(00)00025-9; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Dajani R, 2001, CELL, V105, P721, DOI 10.1016/S0092-8674(01)00374-9; Ding VW, 2000, J BIOL CHEM, V275, P32475, DOI 10.1074/jbc.M005342200; Frame S, 2001, MOL CELL, V7, P1321, DOI 10.1016/S1097-2765(01)00253-2; Kim L, 2000, CURR OPIN GENET DEV, V10, P508, DOI 10.1016/S0959-437X(00)00120-9; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Tanoue T, 2001, EMBO J, V20, P466, DOI 10.1093/emboj/20.3.466; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Williams RSB, 2000, TRENDS PHARMACOL SCI, V21, P61, DOI 10.1016/S0165-6147(99)01428-5; WOODGETT JR, 1990, EMBO J, V9, P2431, DOI 10.1002/j.1460-2075.1990.tb07419.x; Yang SH, 1998, EMBO J, V17, P1740, DOI 10.1093/emboj/17.6.1740	12	56	60	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 29	2001	292	5526					2439	2440		10.1126/science.1063279	http://dx.doi.org/10.1126/science.1063279			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448YU	11431552				2022-12-24	WOS:000169658200024
J	Hirsh, AE; Fraser, HB				Hirsh, AE; Fraser, HB			Protein dispensability and rate of evolution	NATURE			English	Article							SUBSTITUTION RATE; GENES EVOLVE; GENOME; YEAST; CONSTRAINTS; REGION; SITES; TIME	If protein evolution is due in large part to slightly deleterious amino acid substitutions(1,2), then the rate of evolution should be greater in proteins that contribute less to individual fitness. The rationale for this prediction is that relatively dispensable proteins should be subject to weaker purifying selection, and should therefore accumulate mildly deleterious substitutions more rapidly. Although this argument was presented(3) over twenty years ago, and is fundamental to many applications of evolutionary theory(4), the prediction has proved difficult to confirm. In fact, a recent study showed that essential mouse genes do not evolve more slowly than non-essential ones(5). Thus, although a variety of factors influencing the rate of protein evolution have been supported by extensive sequence analysis(6-12), the relationship between protein dispensability and evolutionary rate has remained unconfirmed. Here we use the results from a highly parallel growth assay of single gene deletions in yeast(13) to assess protein dispensability, which we relate to evolutionary rate estimates that are based on comparisons of sequences drawn from twenty-one fully annotated genomes. Our analysis reveals a highly significant relationship between protein dispensability and evolutionary rate, and explains why this relationship is not detectable by categorical comparison of essential versus nonessential proteins. The relationship is highly conserved, so that protein dispensability in yeast is also predictive of evolutionary rate in a nematode worm.	Stanford Univ, Ctr Computat Genet & Biol Molding, Dept Biol Sci, Stanford, CA 94305 USA	Stanford University	Hirsh, AE (corresponding author), Stanford Univ, Ctr Computat Genet & Biol Molding, Dept Biol Sci, Stanford, CA 94305 USA.							Ashburner M, 1999, GENETICS, V153, P179; Chervitz SA, 1998, SCIENCE, V282, P2022, DOI 10.1126/science.282.5396.2022; Ewens W.J., 1979, MATH POPULATION GENE; Feng DF, 1997, J MOL EVOL, V44, P361, DOI 10.1007/PL00006155; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; GRISHIN NV, 1995, J MOL EVOL, V41, P675; Grishin NV, 2000, GENOME RES, V10, P991, DOI 10.1101/gr.10.7.991; Hughes AL, 1997, MOL BIOL EVOL, V14, P1, DOI 10.1093/oxfordjournals.molbev.a025694; Hurst LD, 1999, CURR BIOL, V9, P747, DOI 10.1016/S0960-9822(99)80334-0; Huynen MA, 1998, P NATL ACAD SCI USA, V95, P5849, DOI 10.1073/pnas.95.11.5849; KIMURA M, 1962, GENETICS, V47, P713; KUMA K, 1995, MOL BIOL EVOL, V12, P123, DOI 10.1093/oxfordjournals.molbev.a040181; Makalowski W, 1998, J MOL EVOL, V47, P119, DOI 10.1007/PL00006367; OHTA T, 1992, ANNU REV ECOL SYST, V23, P263, DOI 10.1146/annurev.es.23.110192.001403; OHTA T, 1973, NATURE, V246, P96, DOI 10.1038/246096a0; Rivera MC, 1998, P NATL ACAD SCI USA, V95, P6239, DOI 10.1073/pnas.95.11.6239; Robinson M, 1998, MOL BIOL EVOL, V15, P1091, DOI 10.1093/oxfordjournals.molbev.a026016; SARICH VM, 1973, SCIENCE, V179, P1144, DOI 10.1126/science.179.4078.1144; Smith V, 1996, SCIENCE, V274, P2069, DOI 10.1126/science.274.5295.2069; Stockbauer KE, 1998, P NATL ACAD SCI USA, V95, P3128, DOI 10.1073/pnas.95.6.3128; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Tourasse NJ, 2000, MOL BIOL EVOL, V17, P656, DOI 10.1093/oxfordjournals.molbev.a026344; Wagner A, 2000, NAT GENET, V24, P355, DOI 10.1038/74174; Williams EJB, 2000, NATURE, V407, P900, DOI 10.1038/35038066; WILSON AC, 1977, ANNU REV BIOCHEM, V46, P573, DOI 10.1146/annurev.bi.46.070177.003041; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; WU CI, 1985, P NATL ACAD SCI USA, V82, P1741, DOI 10.1073/pnas.82.6.1741; Yamaguchi Y, 1997, P NATL ACAD SCI USA, V94, P1264, DOI 10.1073/pnas.94.4.1264; Zhang JZ, 1998, GENETICS, V149, P1615	29	315	320	0	25	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 28	2001	411	6841					1046	1049		10.1038/35082561	http://dx.doi.org/10.1038/35082561			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	446TF	11429604				2022-12-24	WOS:000169528500047
J	Wilhelms, A; Larter, SR; Head, I; Farrimond, P; di-Primio, R; Zwach, C				Wilhelms, A; Larter, SR; Head, I; Farrimond, P; di-Primio, R; Zwach, C			Biodegradation of oil in uplifted basins prevented by deep-burial sterilization	NATURE			English	Article							NORTH-SEA; ARCHAEA; LIFE; BIOSPHERE; RATES; FIELD	Biodegradation of crude oil by bacterial activity-which has occurred in the majority of the Earth's oil reserves(1)-is known to reduce greatly the quality of petroleum in reservoirs(2). For economically successful prospecting for oil, it is therefore important to understand the processes and conditions in geological formations that lead to oil biodegradation. Although recent studies speculate that bacterial activity can potentially occur up to temperatures as high as 150 degreesC (refs 3, 4), it is generally accepted that effective petroleum biodegradation over geological timescales generally occurs in reservoirs with temperatures below 80 degreesC (ref. 2). This appears, however, to be at odds with the observation that non-degraded oils can still be found in reservoirs below this temperature. Here we compile data regarding the extent of oil biodegradation in several oil reservoirs, and rnd that the extensive occurrence of non-biodegraded oil in shallow, cool basins is restricted to those that have been uplifted from deeper, hotter regions of the Earth. We suggest that these petroleum reservoirs were sterilized by heating to a temperature around 80-90 degreesC during deep burial, inactivating hydrocarbon-degrading organisms that occur in the deep biosphere. Even when such reservoirs are subsequently uplifted to much cooler regions and filled with oil, degradation does not occur, implying that the sterilized sediments are not recolonized by hydrocarbon-degrading bacteria.	Univ Newcastle, Fossil Fuels & Environm Geochem Postgrad Inst, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; Norsk Hydro AS, N-5020 Bergen, Norway	Newcastle University - UK; Norsk Hydro ASA	Larter, SR (corresponding author), Univ Newcastle, Fossil Fuels & Environm Geochem Postgrad Inst, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	Steve.Larter@ncl.ac.uk	Abu Laban, Nidal/E-5809-2011	, Zeinab/0000-0001-7975-7943; Head, Ian/0000-0002-5373-162X; Larter, Stephen/0000-0001-7195-1477				BARNARD PC, 1991, GEOLOGICAL SOC SPECI, V59, P167; Blochl E, 1997, EXTREMOPHILES, V1, P14; Bray RJ, 1998, GEOL SOC SPEC PUBL, V133, P199, DOI 10.1144/GSL.SP.1998.133.01.09; Cannan J, 1984, ADV PETROLEUM GEOCHE, P299, DOI DOI 10.1016/B978-0-12-032001-1.50011-0; CHAPELLE FH, 1990, APPL ENVIRON MICROB, V56, P1865, DOI 10.1128/AEM.56.6.1865-1874.1990; CORNFORD C, 1988, ORG GEOCHEM, V13, P399, DOI 10.1016/0146-6380(88)90062-9; CORNFORD C, 1990, INTRO PETROLEUM GEOL, P294; Daniel RM, 2000, CELL MOL LIFE SCI, V57, P250, DOI 10.1007/PL00000688; Evans J, 1998, GEOL SOC SPEC PUBL, V133, P407, DOI 10.1144/GSL.SP.1998.133.01.22; FREDRICKSON JK, 1995, MOL ECOL, V4, P619, DOI 10.1111/j.1365-294X.1995.tb00262.x; Grassia GS, 1996, FEMS MICROBIOL ECOL, V21, P47; Horstad I, 1997, AAPG BULL, V81, P222; JOBSON A, 1972, APPL MICROBIOL, V23, P1082, DOI 10.1128/AEM.23.6.1082-1089.1972; LARTER SR, 2000, P GEOC 2000 CSPG GAC, P1; LHARIDON S, 1995, NATURE, V377, P223, DOI 10.1038/377223a0; LINJORDET A, 1992, AAPG MEMOIR, V54, P349; Murphy EM, 1998, GEOCHIM COSMOCHIM AC, V62, P3395, DOI 10.1016/S0016-7037(98)00254-3; Nilsen RK, 1996, APPL ENVIRON MICROB, V62, P1793, DOI 10.1128/AEM.62.5.1793-1798.1996; ORPHAN VJ, 1999, APPL ENVIRON MICROB, V65, P700; PARKES RJ, 1994, NATURE, V371, P410, DOI 10.1038/371410a0; Pedersen K, 2000, FEMS MICROBIOL LETT, V185, P9, DOI 10.1016/S0378-1097(00)00061-6; Roadifer R.E., 1987, AAPG STUDIES GEOLOGY, V23, P3; RUETER P, 1994, NATURE, V372, P455, DOI 10.1038/372455a0; SCHROEDER FW, 1993, NPF SPECIAL PUBLICAT, V3, P469; STETTER KO, 1990, FEMS MICROBIOL LETT, V75, P117, DOI 10.1111/j.1574-6968.1990.tb04089.x; STETTER KO, 1993, NATURE, V365, P743, DOI 10.1038/365743a0; Stetter KO, 1996, FEMS MICROBIOL REV, V18, P149, DOI 10.1111/j.1574-6976.1996.tb00233.x; Takahata Y, 2000, APPL ENVIRON MICROB, V66, P73, DOI 10.1128/AEM.66.1.73-79.2000; THEIS NJ, 1993, NPF SPECIAL PUBLICAT, V3, P433; Zengler K, 1999, NATURE, V401, P266, DOI 10.1038/45777; ZOBELL CE, 1945, SCIENCE, V102, P364, DOI 10.1126/science.102.2650.364	31	219	236	0	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 28	2001	411	6841					1034	1037		10.1038/35082535	http://dx.doi.org/10.1038/35082535			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	446TF	11429600				2022-12-24	WOS:000169528500043
J	Jordan, P; Fromme, P; Witt, HT; Klukas, O; Saenger, W; Krauss, N				Jordan, P; Fromme, P; Witt, HT; Klukas, O; Saenger, W; Krauss, N			Three-dimensional structure of cyanobacterial photosystem I at 2.5 angstrom resolution	NATURE			English	Article							PHOTOSYNTHETIC REACTION CENTERS; ELECTRON-TRANSFER; SYNECHOCOCCUS SP; 4-ANGSTROM RESOLUTION; 2 PHYLLOQUINONES; CHLOROPHYLL-A; ACCEPTOR; COMPLEX; PROTEIN; MODEL	Life on Earth depends on photosynthesis, the conversion of light energy from the Sun to chemical energy. In plants, green algae and cyanobacteria, this process is driven by the cooperation of two large protein-cofactor complexes, photosystems I and II, which are located in the thylakoid photosynthetic membranes. The crystal structure of photosystem I from the thermophilic cyanobacterium Synechococcus elongatus described here provides a picture at atomic detail of 12 protein subunits and 127 cofactors comprising 96 chlorophylls, 2 phylloquinones, 3 Fe4S4 clusters, 22 carotenoids, 4 lipids, a putative Ca2+ ion and 201 water molecules. The structural information on the proteins and cofactors and their interactions provides a basis for understanding how the high efficiency of photosystem I in light capturing and electron transfer is achieved.	Tech Univ Berlin, Max Volmer Lab Biophys Chem, Inst Chem, Fak 2, D-10623 Berlin, Germany; Free Univ Berlin, Inst Chem Kristallog, D-14195 Berlin, Germany	Technical University of Berlin; Free University of Berlin	Fromme, P (corresponding author), Tech Univ Berlin, Max Volmer Lab Biophys Chem, Inst Chem, Fak 2, Str 17,Juni 135, D-10623 Berlin, Germany.			Fromme, Petra/0000-0003-0953-4909; Krauss, Norbert/0000-0002-7128-4632				ADMAN ET, 1973, J BIOL CHEM, V248, P3987; Artz K, 1997, P NATL ACAD SCI USA, V94, P13582, DOI 10.1073/pnas.94.25.13582; ASHIKAWA I, 1986, BIOCHEMISTRY-US, V25, P6154, DOI 10.1021/bi00368a049; Bittl R, 1997, BIOCHEMISTRY-US, V36, P12001, DOI 10.1021/bi971645n; BOEKEMA EJ, 1987, FEBS LETT, V217, P283, DOI 10.1016/0014-5793(87)80679-8; Brettel K, 1997, BBA-BIOENERGETICS, V1318, P322, DOI 10.1016/S0005-2728(96)00112-0; CHAMOROVSKY SK, 1982, PHOTOBIOCH PHOTOBIOP, V4, P195; COGDELL RJ, 1985, PURE APPL CHEM, V57, P723, DOI 10.1351/pac198557050723; COUFAL J, 1989, PHOTOSYNTHETICA, V23, P603; DEISENHOFER J, 1995, J MOL BIOL, V246, P429, DOI 10.1006/jmbi.1994.0097; FALZONE CJ, 1994, BIOCHEMISTRY-US, V33, P6052, DOI 10.1021/bi00186a004; FISH LE, 1985, J BIOL CHEM, V260, P1413; Fleming GR, 1997, CURR OPIN STRUC BIOL, V7, P738, DOI 10.1016/S0959-440X(97)80086-3; Foerster T., 1948, ANN PHYS, V2, P55; FROMME P, 1994, BBA-BIOENERGETICS, V1187, P99, DOI 10.1016/0005-2728(94)90092-2; Fromme P, 1998, BBA-BIOENERGETICS, V1365, P175, DOI 10.1016/S0005-2728(98)00059-0; Golbeck JH, 1999, PHOTOSYNTH RES, V61, P107, DOI 10.1023/A:1006281802710; GOLBECK JH, 1994, ADV PHOTOSYNTHESIS M, P319; Guergova-Kuras M, 2001, P NATL ACAD SCI USA, V98, P4437, DOI 10.1073/pnas.081078898; Hippler M, 1999, J BIOL CHEM, V274, P4180, DOI 10.1074/jbc.274.7.4180; IKEUCHI M, 1991, FEBS LETT, V287, P5, DOI 10.1016/0014-5793(91)80003-L; IWAKI M, 1991, BIOCHEMISTRY-US, V30, P5347, DOI 10.1021/bi00236a004; Joliot P, 1999, BIOCHEMISTRY-US, V38, P11130, DOI 10.1021/bi990857c; Kamlowski A, 1998, J PHYS CHEM B, V102, P8278, DOI 10.1021/jp9824611; Karapetyan NV, 1999, FEBS LETT, V460, P395, DOI 10.1016/S0014-5793(99)01352-6; Kass H, 2001, J PHYS CHEM B, V105, P1225, DOI 10.1021/jp0032311; Klukas O, 1999, J BIOL CHEM, V274, P7361, DOI 10.1074/jbc.274.11.7361; KOIKE H, 1989, FEBS LETT, V253, P257, DOI 10.1016/0014-5793(89)80971-8; KRATKY C, 1977, J MOL BIOL, V113, P431, DOI 10.1016/0022-2836(77)90151-6; Krauss N, 1996, NAT STRUCT BIOL, V3, P965, DOI 10.1038/nsb1196-965; Lancaster CRD, 2000, J BIOL CHEM, V275, P39364, DOI 10.1074/jbc.M008225200; Makewicz A, 1996, Z NATURFORSCH C, V51, P319; Makewicz Anja, 1995, P156; Mayer KL, 1999, BIOCHEMISTRY-US, V38, P13736, DOI 10.1021/bi9910373; MOSER CC, 1992, BIOCHIM BIOPHYS ACTA, V1101, P171, DOI 10.1016/S0005-2728(05)80012-X; Muhlenhoff U, 1996, EMBO J, V15, P488, DOI 10.1002/j.1460-2075.1996.tb00381.x; MUHLENHOFF U, 1993, GENE, V127, P71, DOI 10.1016/0378-1119(93)90618-D; NITSCHKE W, 1991, TRENDS BIOCHEM SCI, V16, P241, DOI 10.1016/0968-0004(91)90095-D; Palsson LO, 1998, BIOPHYS J, V74, P2611, DOI 10.1016/S0006-3495(98)77967-6; Scheer H., 1991, CHLOROPHYLLS; Schlodder E, 1998, BIOCHEMISTRY-US, V37, P9466, DOI 10.1021/bi973182r; Schubert WD, 1998, J MOL BIOL, V280, P297, DOI 10.1006/jmbi.1998.1824; Sun J, 1999, J BIOL CHEM, V274, P19048, DOI 10.1074/jbc.274.27.19048; VALKUNAS L, 1995, PHOTOSYNTH RES, V43, P149, DOI 10.1007/BF00042972; WATANABE T, 1985, FEBS LETT, V191, P252, DOI 10.1016/0014-5793(85)80019-3; Webber AN, 1996, BIOCHEMISTRY-US, V35, P12857, DOI 10.1021/bi961198w; XU QA, 1994, J BIOL CHEM, V269, P3205; Yang F, 1998, J PHYS CHEM B, V102, P8288, DOI 10.1021/jp981952i; ZHAO JD, 1992, BIOCHEMISTRY-US, V31, P5093, DOI 10.1021/bi00137a001; Zouni A, 2001, NATURE, V409, P739, DOI 10.1038/35055589	50	1967	2097	7	420	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 21	2001	411	6840					909	917		10.1038/35082000	http://dx.doi.org/10.1038/35082000			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	444EN	11418848				2022-12-24	WOS:000169386200034
J	Lenhard, M; Bohnert, A; Jurgens, G; Laux, T				Lenhard, M; Bohnert, A; Jurgens, G; Laux, T			Termination of stem cell maintenance in Arabidopsis floral meristems by interactions between WUSCHEL and AGAMOUS	CELL			English	Article							HOMEOTIC GENE; FLOWER DEVELOPMENT; NEGATIVE REGULATION; ORGAN IDENTITY; EXPRESSION; SHOOT; ACTIVATION; THALIANA; PLANTS; SEPARATION	Floral meristems and shoot apical meristems (SAMs) are homologous, self-maintaining stem cell systems. Unlike SAMs, floral meristems are determinate, and stem cell maintenance is abolished once all floral organs are initiated. to investigate the underlying regulatory mechanisms, we analyzed the interactions between WUSCHEL (WUS), which specifies stem cell identity, and AGAMOUS (AG), which is required for floral determinacy. Our results show that repression of WUS by AG is essential for terminating the floral meristem and that WUS can induce AG expression in developing flowers. Together, this suggests that floral determinacy depends on a negative autoregulatory mechanism involving WUS and AG, which terminates stem cell maintenance.	Univ Tubingen, ZMBP Entwicklungsgenet, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen	Laux, T (corresponding author), Univ Freiburg, Inst Biol 3, Schanzlestr 1, D-79104 Freiburg, Germany.		Lenhard, Michael/J-1554-2015					BARTON MK, 1993, DEVELOPMENT, V119, P823; BECKER D, 1992, PLANT MOL BIOL, V20, P1195, DOI 10.1007/BF00028908; Bowman J., 1994, ARABIDOPSIS ATLAS MO, V102, P117; BOWMAN JL, 1991, PLANT CELL, V3, P749, DOI 10.1105/tpc.3.8.749; BOWMAN JL, 1989, PLANT CELL, V1, P37, DOI 10.1105/tpc.1.1.37; Brand U, 2000, SCIENCE, V289, P617, DOI 10.1126/science.289.5479.617; Busch MA, 1999, SCIENCE, V285, P585, DOI 10.1126/science.285.5427.585; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Deyholos MK, 2000, PLANT CELL, V12, P1799, DOI 10.1105/tpc.12.10.1799; DREWS GN, 1991, CELL, V65, P991, DOI 10.1016/0092-8674(91)90551-9; Endrizzi K, 1996, PLANT J, V10, P967, DOI 10.1046/j.1365-313X.1996.10060967.x; GUSTAFSONBROWN C, 1994, CELL, V76, P131, DOI 10.1016/0092-8674(94)90178-3; IRISH VF, 1990, PLANT CELL, V2, P741, DOI 10.1105/tpc.2.8.741; JACK T, 1992, CELL, V68, P683, DOI 10.1016/0092-8674(92)90144-2; Jack T, 1997, PLANT J, V11, P825, DOI 10.1046/j.1365-313X.1997.11040825.x; KONCZ C, 1986, MOL GEN GENET, V204, P383, DOI 10.1007/BF00331014; Laux T, 1996, DEVELOPMENT, V122, P87; Mayer KFX, 1998, CELL, V95, P805, DOI 10.1016/S0092-8674(00)81703-1; MIZUKAMI Y, 1992, CELL, V71, P119, DOI 10.1016/0092-8674(92)90271-D; MIZUKAMI Y, 1995, PLANT MOL BIOL, V28, P767, DOI 10.1007/BF00042064; Mizukami Y, 1997, PLANT CELL, V9, P393, DOI 10.1105/tpc.9.3.393; Moore I, 1998, P NATL ACAD SCI USA, V95, P376, DOI 10.1073/pnas.95.1.376; Schoof H, 2000, CELL, V100, P635, DOI 10.1016/S0092-8674(00)80700-X; SCHULTZ EA, 1991, PLANT CELL, V3, P771, DOI 10.1105/tpc.3.8.771; Sieburth LE, 1997, PLANT CELL, V9, P355, DOI 10.1105/tpc.9.3.355; Sieburth LE, 1998, DEVELOPMENT, V125, P4303; SIEBURTH LE, 1995, PLANT CELL, V7, P1249, DOI 10.1105/tpc.7.8.1249; Steeves T.A., 1989, PATTERNS PLANT DEV, DOI 10.1017/CBO9780511626227; WEIGEL D, 1993, SCIENCE, V261, P1723, DOI 10.1126/science.261.5129.1723; WEIGEL D, 1992, CELL, V69, P843, DOI 10.1016/0092-8674(92)90295-N; WEIGEL D, 1995, NATURE, V377, P495, DOI 10.1038/377495a0; YANOFSKY MF, 1990, NATURE, V346, P35, DOI 10.1038/346035a0	32	405	443	6	78	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 15	2001	105	6					805	814		10.1016/S0092-8674(01)00390-7	http://dx.doi.org/10.1016/S0092-8674(01)00390-7			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	444AE	11440722	Bronze			2022-12-24	WOS:000169375100013
J	Santagata, S; Boggon, TJ; Baird, CL; Gomez, CA; Zhao, J; Shan, WS; Myszka, DG; Shapiro, L				Santagata, S; Boggon, TJ; Baird, CL; Gomez, CA; Zhao, J; Shan, WS; Myszka, DG; Shapiro, L			G-protein signaling through tubby proteins	SCIENCE			English	Article							MOLECULAR CHARACTERIZATION; PLASMA-MEMBRANE; RECESSIVE MUTATIONS; STRUCTURAL BASIS; PHOSPHOLIPASE-C; GENE FAMILY; OBESITY; MOUSE; MICE; SEROTONIN	Dysfunction of the tubby protein results in maturity-onset obesity in mice. Tubby has been implicated as a transcription regulator, but details of the molecular mechanism underlying its function remain unclear. Here we show that tubby functions in signal transduction from heterotrimeric GTP-binding protein (G protein)-coupled receptors. Tubby Localizes to the plasma membrane by binding phosphatidylinositol 4,5-bisphosphate through its carboxyl terminal "tubby domain." X-ray crystallography reveals the atomic-level basis of this interaction and implicates tubby domains as phosphorylated-phosphatidylinositol binding factors. Receptor-mediated activation of G protein alpha (q) (G alpha (q)) releases tubby from the plasma membrane through the action of phospholipase C-beta, triggering translocation of tubby to the cell nucleus. The localization of tubby-like protein 3 (TULP3) is similarly regulated. These data suggest that tubby proteins function as membrane-bound transcription regulators that translocate to the nucleus in response to phosphoinositide hydrolysis, providing a direct link between G-protein signaling and the regulation of gene expression.	NYU, Mt Sinai Sch Med, Struct Biol Program, New York, NY 10029 USA; NYU, Mt Sinai Sch Med, Ruttenberg Canc Ctr, New York, NY 10029 USA; NYU, Mt Sinai Sch Med, Dept Biochem & Mol Biol, New York, NY 10029 USA; Univ Utah, Ctr Biomol Interact Anal, Salt Lake City, UT 84132 USA	Icahn School of Medicine at Mount Sinai; New York University; Icahn School of Medicine at Mount Sinai; New York University; Icahn School of Medicine at Mount Sinai; New York University; Utah System of Higher Education; University of Utah	Shapiro, L (corresponding author), NYU, Mt Sinai Sch Med, Struct Biol Program, Room 16-20,1425 Madison Ave, New York, NY 10029 USA.	shapiro@inka.mssm.edu	Baird, Cheryl L/F-6569-2011; Baird, Cheryl/AGM-0065-2022; Santagata, Sandro/A-7714-2009	Santagata, Sandro/0000-0002-7528-9668				Aronheim A, 1997, MOL CELL BIOL, V17, P3094, DOI 10.1128/MCB.17.6.3094; Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; Banerjee P, 1998, NAT GENET, V18, P177, DOI 10.1038/ng0298-177; Boggon TJ, 1999, SCIENCE, V286, P2119, DOI 10.1126/science.286.5447.2119; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BRUNGER AT, 1992, XPLOR VRSION 3 1 SYS; Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501; Chen AS, 2000, NAT GENET, V26, P97, DOI 10.1038/79254; COLEMAN DL, 1990, J HERED, V81, P424, DOI 10.1093/oxfordjournals.jhered.a111019; CRABTREE GR, 1994, ANNU REV BIOCHEM, V63, P1045, DOI 10.1146/annurev.bi.63.070194.005145; Dowler S, 1999, BIOCHEM J, V342, P7, DOI 10.1042/0264-6021:3420007; Erickson JC, 1996, NATURE, V381, P415, DOI 10.1038/381415a0; EVANS SV, 1993, J MOL GRAPHICS, V11, P134, DOI 10.1016/0263-7855(93)87009-T; Ferguson KM, 2000, MOL CELL, V6, P373, DOI 10.1016/S1097-2765(00)00037-X; Flier JS, 1998, CELL, V92, P437, DOI 10.1016/S0092-8674(00)80937-X; Ford MGJ, 2001, SCIENCE, V291, P1051, DOI 10.1126/science.291.5506.1051; Hagstrom SA, 1998, NAT GENET, V18, P174, DOI 10.1038/ng0298-174; Hartman JL, 1996, J BIOL CHEM, V271, P22591, DOI 10.1074/jbc.271.37.22591; He W, 2000, MOL BRAIN RES, V81, P109, DOI 10.1016/S0169-328X(00)00164-9; Horvath CM, 1997, CURR OPIN CELL BIOL, V9, P233, DOI 10.1016/S0955-0674(97)80067-1; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; Jian XY, 1999, J BIOL CHEM, V274, P11573, DOI 10.1074/jbc.274.17.11573; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; JULIUS D, 1988, SCIENCE, V241, P558, DOI 10.1126/science.3399891; Kapeller R, 1999, J BIOL CHEM, V274, P24980, DOI 10.1074/jbc.274.35.24980; Kleyn PW, 1996, CELL, V85, P281, DOI 10.1016/S0092-8674(00)81104-6; Kobrinsky E, 2000, NAT CELL BIOL, V2, P507, DOI 10.1038/35019544; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Kretzschmar M, 2000, BREAST CANCER RES, V2, P107, DOI 10.1186/bcr42; Kutateladze T, 2001, SCIENCE, V291, P1793, DOI 10.1126/science.291.5509.1793; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Leibowitz SF, 1998, BIOL PSYCHIAT, V44, P851, DOI 10.1016/S0006-3223(98)00186-3; Lietzke SE, 2000, MOL CELL, V6, P385, DOI 10.1016/S1097-2765(00)00038-1; Mehrotra B, 2000, BIOCHEMISTRY-US, V39, P9679, DOI 10.1021/bi000487o; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; NISHINA PM, 1994, METABOLISM, V43, P549, DOI 10.1016/0026-0495(94)90194-5; Nishina PM, 1998, GENOMICS, V54, P215, DOI 10.1006/geno.1998.5567; NobenTrauth K, 1996, NATURE, V380, P534, DOI 10.1038/380534a0; Nonogaki K, 1998, NAT MED, V4, P1152, DOI 10.1038/2647; North MA, 1997, P NATL ACAD SCI USA, V94, P3128, DOI 10.1073/pnas.94.7.3128; Offermanns S, 1998, EMBO J, V17, P4304, DOI 10.1093/emboj/17.15.4304; OhkiHamazaki H, 1997, NATURE, V390, P165, DOI 10.1038/36568; Raucher D, 2000, CELL, V100, P221, DOI 10.1016/S0092-8674(00)81560-3; Roth BL, 1998, PHARMACOL THERAPEUT, V79, P231, DOI 10.1016/S0163-7258(98)00019-9; Saito Y, 1999, NATURE, V400, P265, DOI 10.1038/22321; Sargent PA, 1997, PSYCHOPHARMACOLOGY, V133, P309, DOI 10.1007/s002130050407; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Stauffer TP, 1998, CURR BIOL, V8, P343, DOI 10.1016/S0960-9822(98)70135-6; STERNWEIS PC, 1992, TRENDS BIOCHEM SCI, V17, P502, DOI 10.1016/0968-0004(92)90340-F; Stevens J, 2000, NUTR REV, V58, P129, DOI 10.1111/j.1753-4887.2000.tb01847.x; Stubdal H, 2000, MOL CELL BIOL, V20, P878, DOI 10.1128/MCB.20.3.878-882.2000; Szczypka MS, 1999, P NATL ACAD SCI USA, V96, P12138, DOI 10.1073/pnas.96.21.12138; TECOTT LH, 1995, NATURE, V374, P542, DOI 10.1038/374542a0; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; VICKERS JD, 1993, J PHARMACOL EXP THER, V266, P1156; Wang HY, 1995, MOL PHARMACOL, V48, P988; WHO Consultation, 2000, WHO TECH REP SER, V894, P1	58	271	281	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 15	2001	292	5524					2041	2050		10.1126/science.1061233	http://dx.doi.org/10.1126/science.1061233			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442KP	11375483				2022-12-24	WOS:000169284700038
J	Hannan, EL; Magaziner, J; Wang, JJ; Eastwood, EA; Silberzweig, SB; Gilbert, M; Morrison, RS; McLaughlin, MN; Orosz, GM; Siu, AL				Hannan, EL; Magaziner, J; Wang, JJ; Eastwood, EA; Silberzweig, SB; Gilbert, M; Morrison, RS; McLaughlin, MN; Orosz, GM; Siu, AL			Mortality and locomotion 6 months after hospitalization for hip fracture - Risk factors and risk-adjusted hospital outcomes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							FUNCTIONAL STATUS; PROXIMAL FEMUR; SURVIVAL; WOMEN; OLDER; CARE; EXPERIENCE; PREDICTORS; MOBILITY; RECOVERY	Context Hip fracture is a common clinical problem that leads to considerable mortality and disability. A need exists for a practical means to monitor and improve outcomes, including function, for patients with hip fracture, Objectives To identify and compare the importance of significant prefracture predictors of functional status and mortality at 6 months for patients hospitalized with hip fracture and to compare risk-adjusted outcomes for hospitals providing initial care. Design Prospective study with data obtained from medical records and through structured interviews with patients and proxies. Setting and Participants A total of 571 adults aged 50 years or older with hip fracture who were admitted to 4 New York, NY, metropolitan hospitals between August 1997 and August 1998. Main Outcome Measures In-hospital and 6-month mortality; locomotion at 6 months; and adverse outcomes at 6 months, defined as death or needing assistance to ambulate, compared by hospital, adjusting for patient risk factors. Results The in-hospital mortality rate was 1.6%. At 6 months, the mortality rate was 13.5%, and another 12.8% needed total assistance to ambulate. Laboratory values were strong predictors of mortality but were not significantly associated with locomotion. Age and prefracture residence at a nursing home were significant predictors of locomotion (P=.02 for both) but were not significantly associated with mortality. Adjustment for baseline characteristics either substantially augmented or diminished interhospital differences in outcomes. Two hospitals had 1 outcome (functional status or mortality) that was significantly worse than the overall mean while the other outcome was nonsignificantly better than average. Conclusions Mortality and functional status ideally should be considered both together and individually to distinguish effects limited to one or the other outcome. Hospital performance for these 2 measures may differ substantially after adjustment, probably because different processes of care are important to each outcome.	SUNY Albany, Dept Hlth Policy Management & Behav, Sch Publ Hlth, Rensselaer, NY 12144 USA; Univ Maryland, Sch Med, Dept Epidemiol & Prevent Med, Baltimore, MD 21201 USA; Mt Sinai Sch Med, Dept Hlth Policy, New York, NY USA; Mt Sinai Sch Med, Dept Rehabil Med, New York, NY USA; Mt Sinai Sch Med, Dept Orthopaed, New York, NY USA; Mt Sinai Sch Med, Dept Geriatr & Adult Dev, New York, NY USA; Mt Sinai Sch Med, Dept Med, New York, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Albany; University System of Maryland; University of Maryland Baltimore; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Hannan, EL (corresponding author), SUNY Albany, Dept Hlth Policy Management & Behav, Sch Publ Hlth, 1 Univ Pl, Rensselaer, NY 12144 USA.				AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [U18HS009459] Funding Source: NIH RePORTER; AHRQ HHS [U18HS09459-0] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		*AG HLTH CAR POL R, 1999, AHCPR PUBL; APPLEGATE WB, 1990, NEW ENGL J MED, V322, P1572, DOI 10.1056/NEJM199005313222205; Carson JL, 1998, JAMA-J AM MED ASSOC, V279, P199, DOI 10.1001/jama.279.3.199; CEDER L, 1980, CLIN ORTHOP RELAT R, P173; COBEY JC, 1976, CLIN ORTHOP RELAT R, P258; Diamond TH, 1997, MED J AUSTRALIA, V167, P412, DOI 10.5694/j.1326-5377.1997.tb126646.x; DOLK T, 1989, UPSALA J MED SCI, V94, P209, DOI 10.3109/03009738909178565; FINSEN V, 1995, ANN CHIR GYNAECOL FE, V84, P291; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; HOLT EM, 1994, INJURY, V25, P91, DOI 10.1016/0020-1383(94)90109-0; Hosmer D.W., 2004, APPL LOGISTIC REGRES, VSecond; JENSEN JS, 1984, INJURY, V15, P411; JETTE AM, 1987, ARCH PHYS MED REHAB, V68, P735; Kane RL, 1998, J AM GERIATR SOC, V46, P1525, DOI 10.1111/j.1532-5415.1998.tb01537.x; Kane RL, 1996, J AM GERIATR SOC, V44, P242, DOI 10.1111/j.1532-5415.1996.tb00909.x; KENNIE DC, 1988, BRIT MED J, V297, P1083, DOI 10.1136/bmj.297.6656.1083; KENZORA JE, 1984, CLIN ORTHOP RELAT R, P45; Koval KJ, 1998, CLIN ORTHOP RELAT R, P22; KOVAL KJ, 1995, CLIN ORTHOP RELAT R, P150; Koval KJ, 1996, J ORTHOP TRAUMA, V10, P531, DOI 10.1097/00005131-199611000-00004; KYO T, 1993, CLIN ORTHOP RELAT R, P215; LUYAO GL, 1994, AM J PUBLIC HEALTH, V84, P1287, DOI 10.2105/AJPH.84.8.1287; Lyons Anthony R., 1997, American Journal of Medicine, V103, p51S, DOI 10.1016/S0002-9343(97)90027-9; Magaziner J, 1997, AM J EPIDEMIOL, V146, P418, DOI 10.1093/oxfordjournals.aje.a009295; Magaziner J, 1997, AM J PUBLIC HEALTH, V87, P1630, DOI 10.2105/AJPH.87.10.1630; Magaziner J, 1996, AM J EPIDEMIOL, V143, P283; MAGAZINER J, 1988, J CLIN EPIDEMIOL, V41, P1065, DOI 10.1016/0895-4356(88)90076-5; MAGAZINER J, 1989, AM J PUBLIC HEALTH, V79, P274, DOI 10.2105/AJPH.79.3.274; Magaziner J, 1990, J GERONTOL, V45, P101; MAROTTOLI RA, 1994, AM J PUBLIC HEALTH, V84, P1807, DOI 10.2105/AJPH.84.11.1807; Morrison RS, 1998, ANN INTERN MED, V128, P1010, DOI 10.7326/0003-4819-128-12_Part_1-199806150-00010; MULLEN JO, 1992, CLIN ORTHOP RELAT R, P214; Nettleman MD, 1996, J GEN INTERN MED, V11, P765, DOI 10.1007/BF02598997; PITTO RP, 1994, INT ORTHOP, V18, P109, DOI 10.1007/BF02484420; Svensson O, 1996, J BONE JOINT SURG BR, V78B, P115, DOI 10.1302/0301-620X.78B1.0780115; TODD CJ, 1995, BRIT MED J, V310, P904, DOI 10.1136/bmj.310.6984.904; TURCOTTE R, 1990, CLIN ORTHOP RELAT R, P132; WEATHERALL M, 1994, NEW ZEAL MED J, V107, P308; Young Y, 1997, J AM GERIATR SOC, V45, P288, DOI 10.1111/j.1532-5415.1997.tb00942.x	39	317	335	1	13	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 6	2001	285	21					2736	2742		10.1001/jama.285.21.2736	http://dx.doi.org/10.1001/jama.285.21.2736			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	437HG	11386929	Bronze			2022-12-24	WOS:000168985800026
J	Lewis, PM; Dunn, MP; McMahon, JA; Logan, M; Martin, JF; St-Jacques, B; McMahon, AP				Lewis, PM; Dunn, MP; McMahon, JA; Logan, M; Martin, JF; St-Jacques, B; McMahon, AP			Cholesterol modification of sonic hedgehog is required for long-range signaling activity and effective modulation of signaling by Ptc1	CELL			English	Article							DEVELOPING CHICK LIMB; MOUSE PATCHED GENE; VERTEBRATE LIMB; FEEDBACK LOOP; TRANSDUCING HEDGEHOG; POLARIZING ACTIVITY; PATTERNING ACTIVITY; HEPARAN-SULFATE; NEURAL-TUBE; TOUT-VELU	Sonic hedgehog (Shh) signaling from the posterior zone of polarizing activity (ZPA) is the primary determinant of anterior-posterior polarity in the vertebrate limb field. An active signal is produced by an autoprocessing reaction that covalently links cholesterol to the N-terminal signaling moiety (N-Shh(p)), tethering N-Shh(p) to the cell membrane. We have addressed the role played by this lipophilic modification in Shh-mediated patterning of mouse digits. Both the distribution and activity of N-Shh(p) indicate that N-Shh(p) acts directly over a few hundred microns. In contrast, N-Shh, a form that lacks cholesterol, retains similar biological activity to N-Shh(p), but signaling is posteriorly restricted. Thus, cholesterol modification is essential for the normal range of signaling. It also appears to be necessary for appropriate modulation of signaling by the Shh receptor, Ptc1.	Harvard Univ, Dept Mol & Cellular Biol, Biolabs, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Univ Texas, SW Med Ctr, Dept Mol Biol, Dallas, TX 75235 USA	Harvard University; Harvard University; Harvard Medical School; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	McMahon, AP (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Biolabs, 16 Divin Ave, Cambridge, MA 02138 USA.		McMahon, Andrew P/ABE-7520-2020	Dunn, Matthew/0000-0002-1320-4235	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS033642, R01NS033642] Funding Source: NIH RePORTER; NINDS NIH HHS [NS 33642] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BASLER K, 1994, NATURE, V368, P208, DOI 10.1038/368208a0; Bellaiche Y, 1998, NATURE, V394, P85, DOI 10.1038/27932; BUMCROT DA, 1995, MOL CELL BIOL, V15, P2294; Burke R, 1999, CELL, V99, P803, DOI 10.1016/S0092-8674(00)81677-3; Buscher D, 1997, MECH DEVELOP, V62, P175, DOI 10.1016/S0925-4773(97)00656-4; CAPDEVILA J, 1994, EMBO J, V13, P4459, DOI 10.1002/j.1460-2075.1994.tb06768.x; Charite J, 2000, DEVELOPMENT, V127, P2461; Chen Y, 1996, CELL, V87, P553, DOI 10.1016/S0092-8674(00)81374-4; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Chiang C, 1999, DEV BIOL, V205, P1, DOI 10.1006/dbio.1998.9103; Dassule HR, 2000, DEVELOPMENT, V127, P4775; Drossopoulou G, 2000, DEVELOPMENT, V127, P1337; Duprez DM, 1996, DEVELOPMENT, V122, P1821; ECHELARD Y, 1993, CELL, V75, P1417, DOI 10.1016/0092-8674(93)90627-3; Goodrich LV, 1996, GENE DEV, V10, P301, DOI 10.1101/gad.10.3.301; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Gruneberg H, 1963, PATHOLOGY DEV; Hammerschmidt M, 1997, TRENDS GENET, V13, P14, DOI 10.1016/S0168-9525(96)10051-2; HINCHLIFFE JR, 1983, DEV EVOLUTION, P99; Hogan BLM, 1996, CURR OPIN GENET DEV, V6, P432, DOI 10.1016/S0959-437X(96)80064-5; HONIG LS, 1981, NATURE, V291, P72, DOI 10.1038/291072a0; Ingham PW, 1998, EMBO J, V17, P3505, DOI 10.1093/emboj/17.13.3505; Karp SJ, 2000, DEVELOPMENT, V127, P543; Kraus P, 2001, MECH DEVELOP, V100, P45, DOI 10.1016/S0925-4773(00)00492-5; LAUFER E, 1994, CELL, V79, P993, DOI 10.1016/0092-8674(94)90030-2; Lee J, 1997, DEVELOPMENT, V124, P2537; LEE JJ, 1994, SCIENCE, V266, P1528, DOI 10.1126/science.7985023; Lin X, 1998, BIOCHEM BIOPH RES CO, V248, P738, DOI 10.1006/bbrc.1998.9050; LOPEZMARTINEZ A, 1995, CURR BIOL, V5, P791, DOI 10.1016/S0960-9822(95)00156-4; Marigo V, 1996, NATURE, V384, P176, DOI 10.1038/384176a0; Marigo V, 1996, P NATL ACAD SCI USA, V93, P9346, DOI 10.1073/pnas.93.18.9346; Marigo V, 1996, DEV BIOL, V180, P273, DOI 10.1006/dbio.1996.0300; MARTI E, 1995, DEVELOPMENT, V121, P2537; Martin JF, 2000, GENESIS, V26, P225, DOI 10.1002/(SICI)1526-968X(200004)26:4<225::AID-GENE10>3.0.CO;2-F; McCormick C, 1998, NAT GENET, V19, P158, DOI 10.1038/514; Motoyama J, 1998, NAT GENET, V20, P54, DOI 10.1038/1711; Motoyama J, 1998, NAT GENET, V18, P104, DOI 10.1038/ng0298-104; Nieto MA, 1996, METHOD CELL BIOL, V51, P219, DOI 10.1016/S0091-679X(08)60630-5; NISWANDER L, 1994, NATURE, V371, P609, DOI 10.1038/371609a0; Osborne TF, 1998, CURR OPIN LIPIDOL, V9, P137, DOI 10.1097/00041433-199804000-00010; Pearse RV, 1998, J EXP ZOOL, V282, P677, DOI 10.1002/(SICI)1097-010X(19981215)282:6<677::AID-JEZ4>3.0.CO;2-F; Pepicelli CV, 1998, CURR BIOL, V8, P1083, DOI 10.1016/S0960-9822(98)70446-4; Pepinsky RB, 1998, J BIOL CHEM, V273, P14037, DOI 10.1074/jbc.273.22.14037; PORTER JA, 1995, NATURE, V374, P363, DOI 10.1038/374363a0; Porter JA, 1996, SCIENCE, V274, P255, DOI 10.1126/science.274.5285.255; Porter JA, 1996, CELL, V86, P21, DOI 10.1016/S0092-8674(00)80074-4; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; Rietveld A, 1999, J BIOL CHEM, V274, P12049, DOI 10.1074/jbc.274.17.12049; Selleck SB, 2000, TRENDS GENET, V16, P206, DOI 10.1016/S0168-9525(00)01997-1; SMITH JC, 1978, NATURE, V272, P612, DOI 10.1038/272612a0; St-Jacques B, 1998, CURR BIOL, V8, P1058, DOI 10.1016/S0960-9822(98)70443-9; Stickens D, 1997, BIOCHEM MOL MED, V61, P16, DOI 10.1006/bmme.1997.2588; Stone DM, 1996, NATURE, V384, P129, DOI 10.1038/384129a0; Sun X, 1999, GENE DEV, V13, P1834, DOI 10.1101/gad.13.14.1834; TABATA T, 1994, CELL, V76, P89, DOI 10.1016/0092-8674(94)90175-9; TABATA T, 1992, GENE DEV, V6, P2635, DOI 10.1101/gad.6.12b.2635; Tabin CJ, 1997, TRENDS CELL BIOL, V7, P442, DOI 10.1016/S0962-8924(97)01159-8; TAYLOR AM, 1993, MECH DEVELOP, V42, P89, DOI 10.1016/0925-4773(93)90101-3; The I, 1999, MOL CELL, V4, P633, DOI 10.1016/S1097-2765(00)80214-2; Theil T, 1999, CELL TISSUE RES, V296, P75, DOI 10.1007/s004410051268; TICKLE C, 1981, NATURE, V289, P295, DOI 10.1038/289295a0; TICKLE C, 1975, NATURE, V254, P199, DOI 10.1038/254199a0; Vervoort M, 2000, BIOESSAYS, V22, P460, DOI 10.1002/(SICI)1521-1878(200005)22:5&lt;460::AID-BIES8&gt;3.0.CO;2-G; Wang BL, 2000, CELL, V100, P423, DOI 10.1016/S0092-8674(00)80678-9; WILKINSON DG, 1992, IN SITU HYBRIDIZATIO, P75; WOLPERT L, 1989, CELL TO CELL SIGNALLING : FROM EXPERIMENTS TO THEORETICAL MODELS, P133; Yang Y, 1997, DEVELOPMENT, V124, P4393; Zakany J, 1999, CELL TISSUE RES, V296, P19, DOI 10.1007/s004410051262; Zuniga A, 1999, NATURE, V401, P598, DOI 10.1038/44157	69	387	400	0	15	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 1	2001	105	5					599	612		10.1016/S0092-8674(01)00369-5	http://dx.doi.org/10.1016/S0092-8674(01)00369-5			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	439NL	11389830	Bronze			2022-12-24	WOS:000169123200007
J	Carroll, KS; Hanna, J; Simon, I; Krise, J; Barbero, P; Pfeffer, SR				Carroll, KS; Hanna, J; Simon, I; Krise, J; Barbero, P; Pfeffer, SR			Role of Rab9 GTPase in facilitating receptor recruitment by TIP47	SCIENCE			English	Article							ENDOSOMES; BIOGENESIS; TRANSPORT	Mannose 6-phosphate receptors (MPRs) deliver lysosomal hydrolases from the Golgi to endosomes and then return to the Golgi complex. TIP47 recognizes the cytoplasmic domains of MPRs and is required for endosome-to-Golgi transport. Here we show that TIP47 also bound directly to the Rab9 guanosine triphosphatase (GTPase) in its active, GTP-bound conformation. Moreover, Rab9 increased the affinity of TIP47 for its cargo. A functional Rab9 binding site was required for TIP47 stimulation of MPR transport in vivo. Thus, a cytosolic cargo selection device may be selectively recruited onto a specific organelle, and vesicle budding might be coupled to the presence of an active Rab GTPase.	Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA	Stanford University	Pfeffer, SR (corresponding author), Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA.	pfeffer@cmgm.stanford.edu		Carroll, Kate/0000-0002-7624-9617	NIDDK NIH HHS [DK37332] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK037332, R56DK037332, R37DK037332] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		CHAVRIER P, 1990, MOL CELL BIOL, V10, P6578, DOI 10.1128/MCB.10.12.6578; Diaz E, 1998, CELL, V93, P433, DOI 10.1016/S0092-8674(00)81171-X; FENG Y, 1995, J CELL BIOL, V131, P1435, DOI 10.1083/jcb.131.6.1435; Itin C, 1997, J BIOL CHEM, V272, P27737, DOI 10.1074/jbc.272.44.27737; Jedd G, 1997, J CELL BIOL, V137, P563, DOI 10.1083/jcb.137.3.563; KORNFELD S, 1992, ANNU REV BIOCHEM, V61, P307, DOI 10.1146/annurev.bi.61.070192.001515; KORNFELD S, 1989, ANNU REV CELL BIOL, V5, P483, DOI 10.1146/annurev.cb.05.110189.002411; Krise JP, 2000, J BIOL CHEM, V275, P25188, DOI 10.1074/jbc.M001138200; LOMBARDI D, 1993, EMBO J, V12, P677, DOI 10.1002/j.1460-2075.1993.tb05701.x; McLauchlan H, 1998, CURR BIOL, V8, P34, DOI 10.1016/S0960-9822(98)70018-1; Novick P, 1997, CURR OPIN CELL BIOL, V9, P496, DOI 10.1016/S0955-0674(97)80025-7; Pfeffer SR, 1999, NAT CELL BIOL, V1, pE17, DOI 10.1038/8967; RIEDERER MA, 1994, J CELL BIOL, V125, P573, DOI 10.1083/jcb.125.3.573; Schimmoller F, 1998, J BIOL CHEM, V273, P22161, DOI 10.1074/jbc.273.35.22161; SOLDATI T, 1993, MOL BIOL CELL, V4, P425, DOI 10.1091/mbc.4.4.425	15	192	200	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 18	2001	292	5520					1373	1376		10.1126/science.1056791	http://dx.doi.org/10.1126/science.1056791			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	435DV	11359012				2022-12-24	WOS:000168862900045
J	Szathmary, E; Jordan, F; Pal, C				Szathmary, E; Jordan, F; Pal, C			Molecular biology and evolution - Can genes explain biological complexity?	SCIENCE			English	Editorial Material									Coll Budapest, Inst Adv Study, H-1014 Budapest, Hungary		Szathmary, E (corresponding author), Coll Budapest, Inst Adv Study, 2 Szentharomsag, H-1014 Budapest, Hungary.		Szathmáry, Eörs/A-5007-2011; Szathmary, Eors/AAS-1202-2021; Jordan, Ferenc/A-9940-2009	Szathmary, Eors/0000-0001-5227-2997; Jordan, Ferenc/0000-0002-0224-6472				ATLAN H, 1990, B MATH BIOL, V52, P335, DOI 10.1007/BF02458575; BIRD AP, 1995, TRENDS GENET, V11, P94, DOI 10.1016/S0168-9525(00)89009-5; Bork P, 2001, NATURE, V409, P818, DOI 10.1038/35057274; Carroll SB, 2001, NATURE, V409, P1102, DOI 10.1038/35059227; Claverie JM, 2001, SCIENCE, V291, P1255, DOI 10.1126/science.1058969; Gerhart J, 1997, CELLS EMBRYOS EVOLUT; Graveley BR, 2001, TRENDS GENET, V17, P100, DOI 10.1016/S0168-9525(00)02176-4; Harary F., 1994, GRAPH THEORY; HIGASHI M, 1991, THEORETICAL STUDIES; Pichersky E, 2000, TRENDS PLANT SCI, V5, P439, DOI 10.1016/S1360-1385(00)01741-6; Riechmann JL, 2000, SCIENCE, V290, P2105, DOI 10.1126/science.290.5499.2105; Smith J. M., 1995, MAJOR TRANSITIONS EV; Thieffry D, 1998, BIOESSAYS, V20, P433, DOI 10.1002/(SICI)1521-1878(199805)20:5<433::AID-BIES10>3.0.CO;2-2; Tupler R, 2001, NATURE, V409, P832, DOI 10.1038/35057011	14	87	91	1	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 18	2001	292	5520					1315	1316		10.1126/science.1060852	http://dx.doi.org/10.1126/science.1060852			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	435DV	11360989				2022-12-24	WOS:000168862900030
J	Krishnan, B; Levine, JD; Lynch, MKS; Dowse, HB; Funes, P; Hall, JC; Hardin, PE; Dryer, SE				Krishnan, B; Levine, JD; Lynch, MKS; Dowse, HB; Funes, P; Hall, JC; Hardin, PE; Dryer, SE			A new role for cryptochrome in a Drosophila circadian oscillator	NATURE			English	Article							LIGHT; CLOCK; PHOTORECEPTOR; RHYTHMS; CRY; TRANSCRIPTION; MELANOGASTER; MUTATION	Cryptochromes are flavin/pterin-containing proteins that are involved in circadian clock function in Drosophila and mice. In mice, the cryptochromes Cry1 and Cry2 are integral components of the circadian oscillator within the brain(1-6) and contribute to circadian photoreception in the retina(7). In Drosophila, cryptochrome (CRY) acts as a photoreceptor that mediates light input to circadian oscillators in both brain and peripheral tissue(8-12). A Drosophila cry mutant, cry(b), leaves circadian oscillator function intact in central circadian pacemaker neurons but renders peripheral circadian oscillators largely arrhythmic. Although this arrhythmicity could be caused by a loss of light entrainment, it is also consistent with a role for CRY in the oscillator. A peripheral oscillator drives circadian olfactory responses in Drosophila antennae(13). Here we show that CRY contributes to oscillator function and physiological output rhythms in the antenna during and after entrainment to light-dark cycles and after photic input is eliminated by entraining flies to temperature cycles. These results demonstrate a photoreceptor-independent role for CRY in the periphery and imply fundamental differences between central and peripheral oscillator mechanisms in Drosophila.	Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA; Univ Houston, Biol Clocks Program, Houston, TX 77204 USA; Brandeis Univ, Dept Biol, Waltham, MA 02454 USA; Brandeis Univ, NSF, Ctr Biol Timing, Waltham, MA 02454 USA; Univ Maine, Dept Biol Sci, Orono, ME 04469 USA	University of Houston System; University of Houston; University of Houston System; University of Houston; Brandeis University; Brandeis University; National Science Foundation (NSF); NSF - Center for Biological Timing; University of Maine System; University of Maine Orono	Hardin, PE (corresponding author), Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA.		Krishnan, Balaji/M-9914-2019; Krishnan, Balaji/C-7572-2009	Krishnan, Balaji/0000-0003-2074-4165; Hardin, Paul/0000-0002-3370-9011				Brandes C, 1996, NEURON, V16, P687, DOI 10.1016/S0896-6273(00)80088-4; Ceriani MF, 1999, SCIENCE, V285, P553, DOI 10.1126/science.285.5427.553; Chatfield C., 1999, ANAL TIME SERIES; Dowse H, 1995, J NEUROGENET, V10, P153, DOI 10.3109/01677069509083461; DOWSE HB, 1991, J THEOR BIOL, V148, P139, DOI 10.1016/S0022-5193(05)80468-0; DOWSE HB, 1989, J THEOR BIOL, V139, P487, DOI 10.1016/S0022-5193(89)80067-0; Emery P, 2000, NEURON, V26, P493, DOI 10.1016/S0896-6273(00)81181-2; Emery P, 2000, NATURE, V404, P456, DOI 10.1038/35006558; Emery P, 1998, CELL, V95, P669, DOI 10.1016/S0092-8674(00)81637-2; Field MD, 2000, NEURON, V25, P437, DOI 10.1016/S0896-6273(00)80906-X; Griffin EA, 1999, SCIENCE, V286, P768, DOI 10.1126/science.286.5440.768; Ishikawa T, 1999, GENES CELLS, V4, P57, DOI 10.1046/j.1365-2443.1999.00237.x; Johnson E, 1998, J NEUROGENET, V12, P1, DOI 10.3109/01677069809108552; Krishnan B, 1999, NATURE, V400, P375, DOI 10.1038/22566; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Okamura H, 1999, SCIENCE, V286, P2531, DOI 10.1126/science.286.5449.2531; Plautz JD, 1997, J BIOL RHYTHM, V12, P204, DOI 10.1177/074873049701200302; Plautz JD, 1997, SCIENCE, V278, P1632, DOI 10.1126/science.278.5343.1632; POWER J, 1995, J NEUROGENET, V9, P227, DOI 10.3109/01677069509084159; Selby CP, 2000, P NATL ACAD SCI USA, V97, P14697, DOI 10.1073/pnas.260498597; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; Stanewsky R, 1998, CELL, V95, P681, DOI 10.1016/S0092-8674(00)81638-4; Stanewsky R, 1997, EMBO J, V16, P5006, DOI 10.1093/emboj/16.16.5006; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; Vitaterna MH, 1999, P NATL ACAD SCI USA, V96, P12114, DOI 10.1073/pnas.96.21.12114; WHEELER DA, 1993, J BIOL RHYTHM, V8, P67, DOI 10.1177/074873049300800106	26	185	195	1	26	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 17	2001	411	6835					313	317		10.1038/35077094	http://dx.doi.org/10.1038/35077094			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432RT	11357134				2022-12-24	WOS:000168710000049
J	Kondro, W				Kondro, W			Canada needs better drug reporting, says inquest	LANCET			English	News Item																			0	4	4	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 5	2001	357	9266					1424	1424		10.1016/S0140-6736(00)04637-7	http://dx.doi.org/10.1016/S0140-6736(00)04637-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	428TW	11356458				2022-12-24	WOS:000168478200031
J	Montaner, J; Hill, A; Acosta, E				Montaner, J; Hill, A; Acosta, E			Practical implications for the interpretation of minimum plasma concentration/inhibitory concentration ratios	LANCET			English	Editorial Material							HUMAN-IMMUNODEFICIENCY-VIRUS; PROTEASE INHIBITORS; ANTIVIRAL ACTIVITY; DRUG-RESISTANCE; THERAPY; PHARMACOKINETICS; ADULTS		Univ British Columbia, St Pauls Hosp, Vancouver, BC V6Z 1Y6, Canada; Roche Prod Ltd, Welwyn Garden City AL7 3AY, Herts, England; Univ Alabama, Birmingham, AL USA	St. Paul's Hospital; University of British Columbia; University of Saskatchewan; Roche Holding; University of Alabama System; University of Alabama Birmingham	Montaner, J (corresponding author), Univ British Columbia, St Pauls Hosp, Vancouver, BC V6Z 1Y6, Canada.							Barry M, 1997, CLIN PHARMACOKINET, V32, P194, DOI 10.2165/00003088-199732030-00003; Condra JH, 2000, J INFECT DIS, V182, P758, DOI 10.1086/315782; Cooper D, 1999, LANCET, V353, P2061, DOI 10.1016/S0140-6736(98)10391-4; Drusano GL, 1998, ANTIMICROB AGENTS CH, V42, P2153, DOI 10.1128/AAC.42.9.2153; Durant J, 2000, AIDS, V14, P1333, DOI 10.1097/00002030-200007070-00005; Falloon J, 2000, CLIN INFECT DIS, V30, P313, DOI 10.1086/313667; Gieschke R, 1999, CLIN PHARMACOKINET, V37, P75, DOI 10.2165/00003088-199937010-00005; Hennessy M, 2000, AIDS, V14, pS97; Hirsch MS, 1998, JAMA-J AM MED ASSOC, V279, P1984, DOI 10.1001/jama.279.24.1984; HSU A, 2000, 40 INT C ANT AG CHEM; HSYU PH, 2000, 13 INT AIDS C DURB; Kilby JM, 2000, ANTIMICROB AGENTS CH, V44, P2672, DOI 10.1128/AAC.44.10.2672-2678.2000; Levison ME, 2000, INFECT DIS CLIN N AM, V14, P281, DOI 10.1016/S0891-5520(05)70248-8; Molla A, 1998, VIROLOGY, V250, P255, DOI 10.1006/viro.1998.9383; Nascimbeni M, 1999, ANTIMICROB AGENTS CH, V43, P2629, DOI 10.1128/AAC.43.11.2629; OBRIEN WA, 1999, 39 INT C ANT AG CHEM; SAAH A, 1999, 6 C RETR OPP INF CHI; SADLER BM, 2000, 7 C RETR OPP INF JAN; ZHANG K, 1997, 6 EUR ISSX M GOTH SW	19	20	20	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 5	2001	357	9266					1438	1440		10.1016/S0140-6736(00)04577-3	http://dx.doi.org/10.1016/S0140-6736(00)04577-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	428TW	11356471				2022-12-24	WOS:000168478200043
J	BRAUN, HA; WISSING, H; SCHAFER, K; HIRSCH, MC				BRAUN, HA; WISSING, H; SCHAFER, K; HIRSCH, MC			OSCILLATION AND NOISE DETERMINE SIGNAL-TRANSDUCTION IN SHARK MULTIMODAL SENSORY CELLS	NATURE			English	Article							NEURONS; TRANSMISSION; INFORMATION	OSCILLATING membrane potentials that generate rhythmic impulse patterns are considered to be of particular significance for neuronal information processing1-4. In contrast, noise is usually seen as a disturbance which limits the accuracy of information transfer5-8. We show here, however, that noise in combination with intrinsic oscillations can provide neurons with particular encoding properties, a discovery we made when recording from single electro-sensory afferents of a fish. The temporal sequence of the impulse trains indicates oscillations that operate near the spike-triggering threshold. The oscillation frequency determines the basic rhythm of impulse generation, but whether or not an impulse is actually triggered essentially depends on superimposed noise. The probability of impulse generation can be altered considerably by minor modifications of oscillation baseline and amplitude, which may underlie the exquisite sensitivity of these receptors to thermal and electrical stimuli. Additionally, thermal, but not electrical, stimuli alter the oscillation frequency, allowing dual sensory messages to be conveyed in a single spike train. These findings demonstrate novel properties of sensory transduction which may be relevant for neuronal signalling in general.			BRAUN, HA (corresponding author), UNIV MARBURG,INST PHYSIOL,DEUTSCHHAUSSTR 2,D-35037 MARBURG,GERMANY.							Akoev G.N., 1981, Advances in Physiological Sciences, V31, P57; ALDENHOFF JB, 1989, PHARMACOPSYCHIATRY, V22, P227, DOI 10.1055/s-2007-1014606; ALONSO A, 1993, J NEUROPHYSIOL, V70, P128, DOI 10.1152/jn.1993.70.1.128; BIALEK W, 1992, TRENDS NEUROSCI, V15, P428, DOI 10.1016/0166-2236(92)90005-S; BRAUN HA, 1980, PFLUG ARCH EUR J PHY, V386, P1, DOI 10.1007/BF00584180; BRAUN HA, 1990, THERMORECEPTION AND TEMPERATURE REGULATION, P19; BRAUN HA, 1984, SENSORY RECEPTOR MEC, P147; BRINK F, 1946, ANN NY ACAD SCI, V47, P457; BROMM B, 1975, EXPERIENTIA, V31, P615, DOI 10.1007/BF01932490; BULLER AJ, 1953, J PHYSIOL-LONDON, V122, P409, DOI 10.1113/jphysiol.1953.sp005011; BULLOCK TH, 1970, J GEN PHSL, V5, P565; CONNORS BW, 1990, TRENDS NEUROSCI, V13, P99, DOI 10.1016/0166-2236(90)90185-D; DOUGLASS JK, 1993, NATURE, V365, P337, DOI 10.1038/365337a0; DYKES RW, 1975, BRAIN RES, V98, P485, DOI 10.1016/0006-8993(75)90368-6; FITZHUGH R, 1958, J GEN PHYSIOL, V40, P675; FOHLMEISTER JF, 1974, J NEUROPHYSIOL, V37, P1213, DOI 10.1152/jn.1974.37.6.1213; HENSEL H, 1955, Z VERGL PHYSIOL, V37, P509, DOI 10.1007/BF00341377; IGGO A, 1969, J PYSL LOND, V200, P391; KALMIJN AJ, 1966, NATURE, V212, P1232, DOI 10.1038/2121232b0; KNIGHT BW, 1972, J GEN PHYSIOL, V59, P734, DOI 10.1085/jgp.59.6.734; LLINAS RR, 1988, SCIENCE, V242, P1654, DOI 10.1126/science.3059497; LONGTIN A, 1991, PHYS REV LETT, V67, P656, DOI 10.1103/PhysRevLett.67.656; LONGTIN A, 1993, J STAT PHYS, V70, P309, DOI 10.1007/BF01053970; MADDOX J, 1991, NATURE, V325, P469; MCGORMICK DA, 1990, NEUROSCIENCE, V39, P103; SCHAFER K, 1990, EXPERIENTIA, V47, P47; SCHAFER K, 1991, PFLUGERS ARCH, V417, P91; SCHREINER RC, 1978, J NEUROPHYSIOL, V41, P338, DOI 10.1152/jn.1978.41.2.338; SOKABE M, 1993, J NEUROPHYSIOL, V70, P275, DOI 10.1152/jn.1993.70.1.275; WALTMAN BERNARD, 1966, ACTA PHYSIOL SCAND, V66, P1	30	340	360	0	18	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	JAN 20	1994	367	6460					270	273		10.1038/367270a0	http://dx.doi.org/10.1038/367270a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MR494	11407413				2022-12-24	WOS:A1994MR49400056
J	Rutter, J; Reick, M; Wu, LC; McKnight, SL				Rutter, J; Reick, M; Wu, LC; McKnight, SL			Regulation of clock and NPAS2 DNA binding by the redox state of NAD cofactors	SCIENCE			English	Article							NICOTINAMIDE-ADENINE DINUCLEOTIDE; SUPRACHIASMATIC NUCLEUS; CIRCADIAN CLOCK; ANTICIPATORY ACTIVITY; AEROBIC GLYCOLYSIS; EXPRESSION; LACTATE; BRAIN; ORGANIZATION; ENTRAINMENT	Clock:BMAL1 and NPAS2:BMAL1 are heterodimeric transcription factors that control gene expression as a function of the Light-dark cycle. Although built to fluctuate at or near a 24-hour cycle, the clock can be entrained by Light, activity, or food. Here we show that the DNA-binding activity of the Clock:BMAL1 and NPAS2:BMAL1 heterodimers is regulated by the redox state of nicotinamide adenine dinucleotide (NAD) cofactors in a purified system. The reduced forms of the redox cofactors, NAD(H) and NADP(H), strongly enhance DNA binding of the Clock:BMAL1 and NPAS2:BMAL1 heterodimers, whereas the oxidized forms inhibit. These observations raise the possibility that food, neuronal activity, or both may entrain the circadian clock by direct modulation of cellular redox state.	Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	McKnight, SL (corresponding author), Univ Texas, SW Med Ctr, Dept Biochem, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	smckni@biochem.swmed.edu	Jansen, Heiko T./A-5770-2008	Jansen, Heiko T./0000-0003-0178-396X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008291] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059388] Funding Source: NIH RePORTER; NIGMS NIH HHS [NIH5-T32-GM08-291-12] Funding Source: Medline; NIMH NIH HHS [1RO1MH59388] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Abe H, 1998, NEUROSCI LETT, V258, P93, DOI 10.1016/S0304-3940(98)00877-5; Bergmeyer H.U., 1974, METHODS ENZYMATIC AN, V4; CAO ZD, 1991, GENE DEV, V5, P1538, DOI 10.1101/gad.5.9.1538; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Garcia JA, 2000, SCIENCE, V288, P2226, DOI 10.1126/science.288.5474.2226; GAROFALO O, 1988, J NEUROCHEM, V51, P172, DOI 10.1111/j.1471-4159.1988.tb04851.x; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Gerich JE, 2000, DIABETES OBES METAB, V2, P345, DOI 10.1046/j.1463-1326.2000.00085.x; Griffin EA, 1999, SCIENCE, V286, P768, DOI 10.1126/science.286.5440.768; Hogenesch JB, 1998, P NATL ACAD SCI USA, V95, P5474, DOI 10.1073/pnas.95.10.5474; INOUYE ST, 1979, P NATL ACAD SCI USA, V76, P5962, DOI 10.1073/pnas.76.11.5962; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; KONOPKA RJ, 1971, P NATL ACAD SCI USA, V68, P2112, DOI 10.1073/pnas.68.9.2112; Kopperschlager G, 1996, J CHROMATOGR B, V684, P25, DOI 10.1016/0378-4347(96)00133-8; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; MAGISTRETTI PJ, COMMUNICATION; MISTLBERGER RE, 1994, NEUROSCI BIOBEHAV R, V18, P171, DOI 10.1016/0149-7634(94)90023-X; MOORE RY, 1995, CIBA F SYMP, V183, P88; Pellerin L, 1998, P NATL ACAD SCI USA, V95, P3990, DOI 10.1073/pnas.95.7.3990; Pellerin L, 1996, DEV NEUROSCI-BASEL, V18, P336, DOI 10.1159/000111426; PELLERIN L, 1994, P NATL ACAD SCI USA, V91, P10625, DOI 10.1073/pnas.91.22.10625; Peters A, 1991, FINE STRUCTURE NERVO; PHELPS ME, 1979, ANN NEUROL, V6, P371, DOI 10.1002/ana.410060502; PITTENDRIGH CS, 1993, ANNU REV PHYSIOL, V55, P16; Reick M, 2001, SCIENCE, V293, P506, DOI 10.1126/science.1060699; REICK M, UNPUB; RUTTER J, UNPUB; Schurr A, 1999, J NEUROSCI, V19, P34, DOI 10.1523/JNEUROSCI.19-01-00034.1999; SCHURR A, 1988, SCIENCE, V240, P1326, DOI 10.1126/science.3375817; SCHWARTZ WJ, 1977, SCIENCE, V197, P1089, DOI 10.1126/science.887940; Sheffield P, 1999, PROTEIN EXPRES PURIF, V15, P34, DOI 10.1006/prep.1998.1003; SOKOLOFF L, 1977, J NEUROCHEM, V28, P897, DOI 10.1111/j.1471-4159.1977.tb10649.x; STEPHAN FK, 1979, BEHAV NEURAL BIOL, V25, P545, DOI 10.1016/S0163-1047(79)90332-7; Stokkan KA, 2001, SCIENCE, V291, P490, DOI 10.1126/science.291.5503.490; TAKAHASHI JS, 1995, ANNU REV NEUROSCI, V18, P531, DOI 10.1146/annurev.neuro.18.1.531; TAKAHASHI S, 1995, P NATL ACAD SCI USA, V92, P4616, DOI 10.1073/pnas.92.10.4616; VEECH RL, 1969, BIOCHEM J, V115, P609, DOI 10.1042/bj1150609a; Wakamatsu H, 2001, EUR J NEUROSCI, V13, P1190, DOI 10.1046/j.0953-816x.2001.01483.x; WILLIAMSON DH, 1967, BIOCHEM J, V103, P514, DOI 10.1042/bj1030514; Yamazaki S, 1998, J NEUROSCI, V18, P10709; Zhou YD, 1997, P NATL ACAD SCI USA, V94, P713, DOI 10.1073/pnas.94.2.713	42	718	742	0	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 20	2001	293	5529					510	514		10.1126/science.1060698	http://dx.doi.org/10.1126/science.1060698			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	454HG	11441146				2022-12-24	WOS:000169966700051
J	Zuccato, C; Ciammola, A; Rigamonti, D; Leavitt, BR; Goffredo, D; Conti, L; MacDonald, ME; Friedlander, RM; Silani, V; Hayden, MR; Timmusk, T; Sipione, S; Cattaneo, E				Zuccato, C; Ciammola, A; Rigamonti, D; Leavitt, BR; Goffredo, D; Conti, L; MacDonald, ME; Friedlander, RM; Silani, V; Hayden, MR; Timmusk, T; Sipione, S; Cattaneo, E			Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease	SCIENCE			English	Article							NEUROTROPHIC FACTOR; MOUSE MODEL; CELLULAR-LOCALIZATION; TARGETED DISRUPTION; GABAERGIC NEURONS; TRANSGENIC MICE; MESSENGER-RNA; RAT-BRAIN; IN-VITRO; EXPRESSION	Huntingtin is a 350-kilodalton protein of unknown function that is mutated in Huntington's disease (HD), a neurodegenerative disorder. The mutant protein is presumed to acquire a toxic gain of function that is detrimental to striatal neurons in the brain. However, Loss of a beneficial activity of wild-type huntingtin may also cause the death of striatal neurons. Here we demonstrate that wild-type huntingtin up-regulates transcription of brain-derived neurotrophic factor (BDNF), a pro-survival factor produced by cortical neurons that is necessary for survival of striatal neurons in the brain. We show that this beneficial activity of huntingtin is Lost when the protein becomes mutated, resulting in decreased production of cortical BDNF. This Leads to insufficient neurotrophic support for striatal neurons, which then die. Restoring wild-type huntingtin activity and increasing BDNF production may be therapeutic approaches for treating HD.	Univ Milan, Dept Pharmacol Sci, I-20133 Milan, Italy; Univ Milan, Ctr Excellance Neurodegenerat Dis, I-20133 Milan, Italy; Univ Milan, IRCCS Osped Maggiore, Sch Med, Ctr Dino Ferrari,Dept Neurol Sci, I-20133 Milan, Italy; Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada; Massachusetts Gen Hosp, Mol Neurogenet Unit, Charlestown, MA 02129 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Neurosurg, Boston, MA 02115 USA; Univ Helsinki, Inst Biotechnol, Program Mol Neurosci, Helsinki, Finland; Uppsala Univ, Ctr Biomed, Dept Dev Neurosci, Uppsala, Sweden	University of Milan; University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; University of British Columbia; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Helsinki; Uppsala University	Cattaneo, E (corresponding author), Univ Milan, Dept Pharmacol Sci, Via Balzaretti 9, I-20133 Milan, Italy.	elena.cattaneo@unimi.it	Conti, Luciano/H-4184-2012; Friedlander, Robert M/A-2845-2016; Leavitt, Blair R/G-1934-2012; Silani, Vincenzo/P-4421-2017; Hayden, Michael R/D-8581-2011; Timmusk, Tonis/H-4889-2015	Conti, Luciano/0000-0002-2050-9846; Friedlander, Robert M/0000-0003-4423-9219; Silani, Vincenzo/0000-0002-7698-3854; Hayden, Michael R/0000-0001-5159-1419; Timmusk, Tonis/0000-0002-1015-3348; leavitt, Blair/0000-0002-4532-766X; CATTANEO, ELENA/0000-0002-0755-4917; ZUCCATO, CHIARA/0000-0003-1771-3392	Telethon [E.0840] Funding Source: Medline	Telethon(Fondazione Telethon)		Altar CA, 1997, NATURE, V389, P856, DOI 10.1038/39885; Bachoud-Levi A, 2000, LANCET, V356, P1975, DOI 10.1016/S0140-6736(00)03310-9; Canals JM, 2001, J NEUROSCI, V21, P117, DOI 10.1523/JNEUROSCI.21-01-00117.2001; Cattaneo E, 2001, TRENDS NEUROSCI, V24, P182, DOI 10.1016/S0166-2236(00)01721-5; Cha JHJ, 1998, P NATL ACAD SCI USA, V95, P6480, DOI 10.1073/pnas.95.11.6480; Cha JHJ, 2000, TRENDS NEUROSCI, V23, P387, DOI 10.1016/S0166-2236(00)01609-X; Conner JM, 1997, J NEUROSCI, V17, P2295; Dragatsis I, 2000, NAT GENET, V26, P300, DOI 10.1038/81593; DUYAO MP, 1995, SCIENCE, V269, P407, DOI 10.1126/science.7618107; Fusco FR, 1999, J NEUROSCI, V19, P1189; HARPER PS, 1996, HUNTINGTONS DIS, P317; HAYDEN MR, 1981, HUNTINGTONS CHOREA, P140; Hilditch-Maguire P, 2000, HUM MOL GENET, V9, P2789, DOI 10.1093/hmg/9.19.2789; Hodgson JG, 1999, NEURON, V23, P181, DOI 10.1016/S0896-6273(00)80764-3; HOFER M, 1990, EMBO J, V9, P2459, DOI 10.1002/j.1460-2075.1990.tb07423.x; Ivkovic S, 1999, J NEUROSCI, V19, P5409; Kegel KB, 2000, J NEUROSCI, V20, P7268, DOI 10.1523/jneurosci.20-19-07268.2000; Leavitt BR, 2001, AM J HUM GENET, V68, P313, DOI 10.1086/318207; LIU ZQ, 1995, CHEM RES CHINESE U, V11, P155; Luthi-Carter R, 2000, HUM MOL GENET, V9, P1259, DOI 10.1093/hmg/9.9.1259; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; METSIS M, 1993, P NATL ACAD SCI USA, V90, P8802, DOI 10.1073/pnas.90.19.8802; MIZUNO K, 1994, DEV BIOL, V165, P243, DOI 10.1006/dbio.1994.1250; NASIR J, 1995, CELL, V81, P811, DOI 10.1016/0092-8674(95)90542-1; O'Kusky JR, 1999, BRAIN RES, V818, P468, DOI 10.1016/S0006-8993(98)01312-2; Ona VO, 1999, NATURE, V399, P263, DOI 10.1038/20446; Rigamonti D, 2000, J NEUROSCI, V20, P3705, DOI 10.1523/JNEUROSCI.20-10-03705.2000; SHARP AH, 1995, NEURON, V14, P1065, DOI 10.1016/0896-6273(95)90345-3; TIMMUSK T, 1995, J CELL BIOL, V128, P185, DOI 10.1083/jcb.128.1.185; TIMMUSK T, 1994, NEUROSCIENCE, V60, P287, DOI 10.1016/0306-4522(94)90242-9; TIMMUSK T, 1993, NEURON, V10, P475, DOI 10.1016/0896-6273(93)90335-O; Trettel F, 2000, HUM MOL GENET, V9, P2799, DOI 10.1093/hmg/9.19.2799; TROTTIER Y, 1995, NAT GENET, V10, P104, DOI 10.1038/ng0595-104; Velier J, 1998, EXP NEUROL, V152, P34, DOI 10.1006/exnr.1998.6832; VENTIMIGLIA R, 1995, EUR J NEUROSCI, V7, P213, DOI 10.1111/j.1460-9568.1995.tb01057.x; Wheeler VC, 1999, HUM MOL GENET, V8, P115, DOI 10.1093/hmg/8.1.115; White JK, 1997, NAT GENET, V17, P404, DOI 10.1038/ng1297-404	37	955	994	2	80	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 20	2001	293	5529					493	498		10.1126/science.1059581	http://dx.doi.org/10.1126/science.1059581			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	454HG	11408619				2022-12-24	WOS:000169966700048
J	Pardini, AT; Jones, CS; Noble, LR; Kreiser, B; Malcolm, H; Bruce, BD; Stevens, JD; Cliff, G; Scholl, MC; Francis, M; Duffy, CAJ; Martin, AP				Pardini, AT; Jones, CS; Noble, LR; Kreiser, B; Malcolm, H; Bruce, BD; Stevens, JD; Cliff, G; Scholl, MC; Francis, M; Duffy, CAJ; Martin, AP			Sex-biased dispersal of great white sharks - In some respects, these sharks behave more like whales and dolphins than other fish.	NATURE			English	Article							MITOCHONDRIAL		Univ Aberdeen, Dept Zool, Aberdeen AB24 2TZ, Scotland; Univ So Mississippi, Dept Biol Sci, Hattiesburg, MS 39406 USA; Univ Colorado, Dept Environm Populat & Organism Biol, Boulder, CO 80309 USA; CSIRO, Marine Res Labs, Hobart, Tas 7000, Australia; Natal Sharks Board, ZA-4320 Umhlanga Rocks, South Africa; Natl Inst Water & Atmospher Res, Wellington, New Zealand	University of Aberdeen; University of Southern Mississippi; University of Colorado System; University of Colorado Boulder; Commonwealth Scientific & Industrial Research Organisation (CSIRO); National Institute of Water & Atmospheric Research (NIWA) - New Zealand	Pardini, AT (corresponding author), Univ Aberdeen, Dept Zool, Tillydrone Ave, Aberdeen AB24 2TZ, Scotland.	am@stripe.colorado.edu	Scholl, Michael Christoph/ABF-5665-2021	Cliff, Geremy/0000-0003-1790-6055; Noble, leslie/0000-0003-3076-0759				BASS J, 1978, SENSORY BIOL SHARKS, P545; Cliff G, 1996, GREAT WHITE SHARKS, P393, DOI 10.1016/B978-012415031-7/50037-9; Compagno LJV, 1997, ENVIRON BIOL FISH, V50, P61, DOI 10.1023/A:1007308406137; Economakis AE, 1998, ENVIRON BIOL FISH, V51, P129, DOI 10.1023/A:1007416813214; Escorza-Trevino S, 2000, MOL ECOL, V9, P1049, DOI 10.1046/j.1365-294x.2000.00959.x; Goodman SJ, 1997, MOL ECOL, V6, P881, DOI 10.1046/j.1365-294X.1997.00260.x; GREENWOOD PJ, 1980, ANIM BEHAV, V28, P1140, DOI 10.1016/S0003-3472(80)80103-5; Klimley A.P., 1985, Memoirs of the Southern California Academy of Sciences, V9, P15; KLIMLEY AP, 1987, ENVIRON BIOL FISH, V18, P27, DOI 10.1007/BF00002325; Lyrholm T, 1999, P ROY SOC B-BIOL SCI, V266, P347, DOI 10.1098/rspb.1999.0644; Pardini AT, 2000, MOL ECOL, V9, P1176, DOI 10.1046/j.1365-294x.2000.00954-4.x; Strong WR, 1996, GREAT WHITE SHARKS, P401, DOI 10.1016/B978-012415031-7/50038-0; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]	13	236	242	5	112	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 12	2001	412	6843					139	140		10.1038/35084125	http://dx.doi.org/10.1038/35084125			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	451AJ	11449258				2022-12-24	WOS:000169778700036
J	Sjogren, M				Sjogren, M			EDRF transcripts and diagnosis of variant Creutzfeldt-Jakob disease	LANCET			English	Editorial Material									Univ Gothenburg, Inst Clin Neurosci, SE-43180 Molndal, Sweden	University of Gothenburg	Sjogren, M (corresponding author), Univ Gothenburg, Inst Clin Neurosci, SE-43180 Molndal, Sweden.		Sjogren, Magnus/M-2668-2015	Sjogren, Magnus/0000-0003-2060-1914				Hill AF, 1999, LANCET, V353, P183, DOI 10.1016/S0140-6736(98)12075-5; Ironside JW, 2000, LANCET, V355, P1693, DOI 10.1016/S0140-6736(00)02243-1; Miele G, 2001, NAT MED, V7, P361, DOI 10.1038/85515; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363	4	3	3	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 30	2001	357	9274					2069	2070		10.1016/S0140-6736(00)05224-7	http://dx.doi.org/10.1016/S0140-6736(00)05224-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	447RQ	11445093				2022-12-24	WOS:000169586600003
J	Allen, GJ; Chu, SP; Harrington, CL; Schumacher, K; Hoffman, T; Tang, YY; Grill, E; Schroeder, JI				Allen, GJ; Chu, SP; Harrington, CL; Schumacher, K; Hoffman, T; Tang, YY; Grill, E; Schroeder, JI			A defined range of guard cell calcium oscillation parameters encodes stomatal movements	NATURE			English	Article							CYTOSOLIC-FREE CALCIUM; ABSCISIC-ACID; SIGNAL-TRANSDUCTION; GENE-EXPRESSION; ANION CHANNELS; ARABIDOPSIS; FREQUENCY; GROWTH; SPECIFICITY; INCREASES	Oscillations in cytosolic calcium concentration ([Ca2+](cyt)) are central regulators of signal transduction cascades(1), although the roles of individual [Ca2+](cyt) oscillation parameters in regulating downstream physiological responses remain largely unknown. In plants, guard cells integrate environmental and endogenous signals to regulate the aperture of stomatal pores(2) and [Ca2+](cyt) oscillations are a fundamental component of stomatal closure(3,4). Here we systematically vary [Ca2+](cyt) oscillation parameters in Arabidopsis guard cells using a 'calcium clamp'(3,5-7) and show that [Ca2+](cyt) controls stomatal closure by two mechanisms. Shortterm 'calcium-reactive' closure occurred rapidly when [Ca2+](cyt) was elevated, whereas the degree of long-term steady-state closure was 'calcium programmed' by [Ca2+](cyt) oscillations within a defined range of frequency, transient number, duration and amplitude. Furthermore, in guard cells of the gca2 mutant(8), [Ca2+](cyt) oscillations induced by abscisic acid and extracellular calcium had increased frequencies and reduced transient duration, and steady-state stomatal closure was abolished. Experimentally imposing [Ca2+](cyt) oscillations with parameters that elicited closure in the wild type restored long-term closure in gca2 stomata. These data show that a defined window of guard cell [Ca2+](cyt) oscillation parameters programs changes in steady-state stomatal aperture.	Univ Calif San Diego, Div Biol, Cell & Dev Biol Sect, La Jolla, CA 92093 USA; Univ Calif San Diego, Ctr Mol Genet, La Jolla, CA 92093 USA; Univ Tubingen, ZMBP Pflanzenphysiol, D-72076 Tubingen, Germany; Tech Univ, Lehrstuhl Bot, D-85350 Freising Weihenstephan, Germany	University of California System; University of California San Diego; University of California System; University of California San Diego; Eberhard Karls University of Tubingen	Schroeder, JI (corresponding author), Univ Calif San Diego, Div Biol, Cell & Dev Biol Sect, La Jolla, CA 92093 USA.		Schumacher, Karin/E-8500-2014	Schumacher, Karin/0000-0001-6484-8105				Allen GJ, 1999, PLANT J, V19, P735, DOI 10.1046/j.1365-313x.1999.00574.x; Allen GJ, 2000, SCIENCE, V289, P2338, DOI 10.1126/science.289.5488.2338; Berridge MJ, 1997, NATURE, V386, P759, DOI 10.1038/386759a0; Blatt MR, 2000, CURR OPIN PLANT BIOL, V3, P196, DOI 10.1016/S1369-5266(00)00064-9; CAMACHO P, 1993, SCIENCE, V260, P226, DOI 10.1126/science.8385800; Cutler S, 1996, SCIENCE, V273, P1239, DOI 10.1126/science.273.5279.1239; Dal Santo P, 1999, CELL, V98, P757, DOI 10.1016/S0092-8674(00)81510-X; De Koninck P, 1998, SCIENCE, V279, P227, DOI 10.1126/science.279.5348.227; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; Ehrhardt DW, 1996, CELL, V85, P673, DOI 10.1016/S0092-8674(00)81234-9; FELLE H, 1988, PLANTA, V174, P495, DOI 10.1007/BF00634478; GILROY S, 1991, PLANT CELL, V3, P333, DOI 10.1105/tpc.3.4.333; Gomez TM, 1999, NATURE, V397, P350, DOI 10.1038/16927; Grabov A, 1998, P NATL ACAD SCI USA, V95, P4778, DOI 10.1073/pnas.95.8.4778; GU XN, 1995, NATURE, V375, P784, DOI 10.1038/375784a0; Hamilton DWA, 2000, P NATL ACAD SCI USA, V97, P4967, DOI 10.1073/pnas.080068897; Himmelbach A, 1998, PHILOS T R SOC B, V353, P1439, DOI 10.1098/rstb.1998.0299; HoldawayClarke TL, 1997, PLANT CELL, V9, P1999, DOI 10.1105/tpc.9.11.1999; KOORNNEEF M, 1984, PHYSIOL PLANTARUM, V61, P377, DOI 10.1111/j.1399-3054.1984.tb06343.x; Li WH, 1998, NATURE, V392, P936, DOI 10.1038/31965; MacRobbie EAC, 1997, J EXP BOT, V48, P515, DOI 10.1093/jxb/48.Special_Issue.515; MCAINSH MR, 1995, PLANT CELL, V7, P1207, DOI 10.1105/tpc.7.8.1207; McAinsh MR, 1998, TRENDS PLANT SCI, V3, P32, DOI 10.1016/S1360-1385(97)01150-3; Miyawaki A, 1999, P NATL ACAD SCI USA, V96, P2135, DOI 10.1073/pnas.96.5.2135; Pei ZM, 2000, NATURE, V406, P731, DOI 10.1038/35021067; Pei ZM, 1997, PLANT CELL, V9, P409, DOI 10.1105/tpc.9.3.409; Pei ZM, 1998, SCIENCE, V282, P287, DOI 10.1126/science.282.5387.287; SCHROEDER JI, 1990, P NATL ACAD SCI USA, V87, P9305, DOI 10.1073/pnas.87.23.9305; Staxen I, 1999, P NATL ACAD SCI USA, V96, P1779, DOI 10.1073/pnas.96.4.1779; Trewavas AJ, 1998, CURR OPIN PLANT BIOL, V1, P428, DOI 10.1016/S1369-5266(98)80268-9	30	411	455	6	117	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 28	2001	411	6841					1053	1057		10.1038/35082575	http://dx.doi.org/10.1038/35082575			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	446TF	11429606				2022-12-24	WOS:000169528500049
J	Jones, PL				Jones, PL			Extracellular matrix and tenascin-C in pathogenesis of breast cancer	LANCET			English	Editorial Material							MALIGNANT GLIOMAS; PHASE-I; CARCINOGENESIS; EXPRESSION; INVASION; RECEPTOR; 81C6		Univ Colorado, Hlth Sci Ctr, Dept Pediat, Denver, CO 80262 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Jones, PL (corresponding author), Univ Colorado, Hlth Sci Ctr, Dept Pediat, Denver, CO 80262 USA.			Jones, Peter Lloyd/0000-0003-1445-4081				Bergers G, 2000, NAT CELL BIOL, V2, P737, DOI 10.1038/35036374; BIGNER DD, 1995, J NEURO-ONCOL, V24, P109, DOI 10.1007/BF01052668; Cokgor I, 2000, J CLIN ONCOL, V18, P3862, DOI 10.1200/JCO.2000.18.22.3862; Goepel C, 2000, GYNECOL ONCOL, V79, P372, DOI 10.1006/gyno.2000.5978; Hansen RK, 2000, ENDOCR-RELAT CANCER, V7, P95, DOI 10.1677/erc.0.0070095; Jahkola T, 1998, BRIT J CANCER, V78, P1507, DOI 10.1038/bjc.1998.714; Jahkola T, 1998, EUR J CANCER, V34, P1687, DOI 10.1016/S0959-8049(98)00215-9; Jones FS, 2000, DEV DYNAM, V218, P235, DOI 10.1002/(SICI)1097-0177(200006)218:2<235::AID-DVDY2>3.3.CO;2-7; Jones PL, 2000, MATRIX BIOL, V19, P581, DOI 10.1016/S0945-053X(00)00106-2; Kuukasjarvi T, 1996, J CLIN ONCOL, V14, P2584, DOI 10.1200/JCO.1996.14.9.2584; LEMAISTRE CF, 1994, BREAST CANCER RES TR, V32, P97, DOI 10.1007/BF00666210; Silletti S, 2001, P NATL ACAD SCI USA, V98, P119, DOI 10.1073/pnas.011343298; Sternlicht MD, 1999, CELL, V98, P137, DOI 10.1016/S0092-8674(00)81009-0; Wang F, 1998, P NATL ACAD SCI USA, V95, P14821, DOI 10.1073/pnas.95.25.14821; Woodward TL, 2000, ENDOCRINOLOGY, V141, P2814, DOI 10.1210/en.141.8.2814	15	20	20	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 23	2001	357	9273					1992	1994		10.1016/S0140-6736(00)05133-3	http://dx.doi.org/10.1016/S0140-6736(00)05133-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	446JB	11438127				2022-12-24	WOS:000169509200004
J	Gopfert, MC; Robert, D				Gopfert, MC; Robert, D			Turning the key on Drosophila audition	NATURE			English	Article							MECHANOSENSORY TRANSDUCTION; MUTATIONS		Univ Zurich, Inst Zool, CH-8057 Zurich, Switzerland	University of Zurich	Gopfert, MC (corresponding author), Univ Zurich, Inst Zool, Winterthurerstr 190, CH-8057 Zurich, Switzerland.			Gopfert, Martin/0000-0001-8201-5334				BENNETCLARK HC, 1971, NATURE, V234, P255, DOI 10.1038/234255a0; Carlson JR, 1996, TRENDS GENET, V12, P175, DOI 10.1016/0168-9525(96)10015-9; Eberl DF, 1997, P NATL ACAD SCI USA, V94, P14837, DOI 10.1073/pnas.94.26.14837; Eberl DF, 2000, J NEUROSCI, V20, P5981, DOI 10.1523/JNEUROSCI.20-16-05981.2000; Gopfert MC, 2000, P ROY SOC B-BIOL SCI, V267, P453, DOI 10.1098/rspb.2000.1021; HALL JC, 1994, SCIENCE, V264, P1702, DOI 10.1126/science.8209251; KERNAN M, 1994, NEURON, V12, P1195, DOI 10.1016/0896-6273(94)90437-5; *RYB CONS, 1999, NUCLEIC ACIDS RES, V28, P85; Walker RG, 2000, SCIENCE, V287, P2229, DOI 10.1126/science.287.5461.2229; Yager DD, 1999, MICROSC RES TECHNIQ, V47, P380, DOI 10.1002/(SICI)1097-0029(19991215)47:6<380::AID-JEMT3>3.0.CO;2-P	10	78	81	0	11	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 21	2001	411	6840					908	908		10.1038/35082144	http://dx.doi.org/10.1038/35082144			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	444EN	11418847	Bronze			2022-12-24	WOS:000169386200033
J	May, R				May, R			Risk and uncertainty	NATURE			English	Editorial Material									Royal Soc, London SW1Y 5AG, England		May, R (corresponding author), Royal Soc, Carlton House Terrace, London SW1Y 5AG, England.								0	13	13	1	13	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 21	2001	411	6840					891	891		10.1038/35082158	http://dx.doi.org/10.1038/35082158			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	444EN	11418834	Bronze			2022-12-24	WOS:000169386200022
J	Zhang, CY; Baffy, G; Perret, P; Krauss, S; Peroni, O; Grujic, D; Hagen, T; Vidal-Puig, AJ; Boss, O; Kim, YB; Zheng, XX; Wheeler, MB; Shulman, GI; Chan, CB; Lowell, BB				Zhang, CY; Baffy, G; Perret, P; Krauss, S; Peroni, O; Grujic, D; Hagen, T; Vidal-Puig, AJ; Boss, O; Kim, YB; Zheng, XX; Wheeler, MB; Shulman, GI; Chan, CB; Lowell, BB			Uncoupling protein-2 negatively regulates insulin secretion and is a major link between obesity, beta cell dysfunction, and type 2 diabetes	CELL			English	Article							SENSITIVE K+ CHANNELS; BROWN ADIPOSE-TISSUE; FATTY-ACIDS; CARBOHYDRATE-METABOLISM; PANCREATIC-ISLETS; THYROID-HORMONE; RECEPTOR GENE; KNOCKOUT MICE; NORMAL MEN; EXPRESSION	B cells sense glucose through its metabolism and the resulting increase in ATP, which subsequently stimulates insulin secretion. Uncoupling protein-2 (UCP2) mediates mitochondrial proton leak, decreasing ATP production. In the present study, we assessed UCP2's role in regulating insulin secretion. UCP2-deficient mice had higher islet ATP levels and increased glucose-stimulated insulin secretion, establishing that UCP2 negatively regulates insulin secretion. Of pathophysiologic significance, UCP2 was markedly upregulated in islets of ob/ob mice, a model of obesity-induced diabetes. Importantly, ob/ob mice lacking UCP2 had restored first-phase insulin secretion, increased serum insulin levels, and greatly decreased levels of glycemia. These results establish UCP2 as a key component of beta cell glucose sensing, and as a critical link between obesity, B cell dysfunction, and type 2 diabetes.	Beth Israel Deaconess Med Ctr, Div Endocrinol, Boston, MA 02215 USA; Beth Israel Deaconess Med Ctr, Dept Med, Div Immunol, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA 02215 USA; Brigham & Womens Hosp, Dept Med, Div Gastroenterol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06520 USA; Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA; Univ Toronto, Fac Med, Dept Med & Physiol, Toronto, ON M5F 1A8, Canada; Univ Prince Edward Isl, Atlantic Vet Coll, Dept Anat & Physiol, Charlottetown, PE C1A 4P3, Canada	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Yale University; Howard Hughes Medical Institute; Yale University; University of Toronto; University of Prince Edward Island	Lowell, BB (corresponding author), Beth Israel Deaconess Med Ctr, Div Endocrinol, 99 Brookline Ave, Boston, MA 02215 USA.	blowell@caregroup.harvard.edu	Baffy, Gyorgy/P-7986-2018; Perret, Pascale/M-3911-2014; Perret, pascale/O-7382-2019; Chan, Catherine/C-1162-2011; Shulman, Gerald I./P-7176-2019	Baffy, Gyorgy/0000-0002-8334-0400; Perret, Pascale/0000-0003-0804-8247; Perret, pascale/0000-0003-0804-8247; Chan, Catherine/0000-0003-3882-0592; Shulman, Gerald I./0000-0003-1529-5668; Wheeler, Michael B./0000-0002-7480-7267; Vidal-Puig, Antonio/0000-0003-4220-9577	NIDDK NIH HHS [T32 DK07533, DK57521, R37 DK053477, R01 DK040936, R01-DK53477, DK46200] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK040936, R37DK053477, R01DK053477, T32DK007533, P30DK046200, P30DK057521] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ADRA CN, 1987, GENE, V60, P65, DOI 10.1016/0378-1119(87)90214-9; Arsenijevic D, 2000, NAT GENET, V26, P435, DOI 10.1038/82565; Ashcroft FM, 1999, DIABETOLOGIA, V42, P903, DOI 10.1007/s001250051247; BELOFFCHAIN A, 1975, HORM METAB RES, V7, P374, DOI 10.1055/s-0028-1093730; BODEN G, 1991, DIABETES, V40, P686, DOI 10.2337/diabetes.40.6.686; BODEN G, 1991, J CLIN INVEST, V88, P960, DOI 10.1172/JCI115399; Boss O, 1997, FEBS LETT, V408, P39, DOI 10.1016/S0014-5793(97)00384-0; BRICHARD SM, 1990, DIABETES, V39, P1326, DOI 10.2337/diabetes.39.11.1326; Brun T, 1997, DIABETES, V46, P393, DOI 10.2337/diabetes.46.3.393; CAWTHORN EG, 1991, MOL CELL ENDOCRINOL, V75, P197, DOI 10.1016/0303-7207(91)90161-K; Chan CB, 1999, DIABETES, V48, P1482, DOI 10.2337/diabetes.48.7.1482; CHAN CB, 2001, IN PRESS DIABETES; Chao L, 2000, J CLIN INVEST, V106, P1221, DOI 10.1172/JCI11245; Chung WK, 1997, OBES RES, V5, P183, DOI 10.1002/j.1550-8528.1997.tb00291.x; COLEMAN DL, 1982, DIABETES, V31, P1; Cortez-Pinto H, 1999, GASTROENTEROLOGY, V116, P1184, DOI 10.1016/S0016-5085(99)70022-3; DEFRONZO RA, 1988, DIABETES, V37, P667, DOI 10.2337/diab.37.6.667; Echtay KS, 2001, P NATL ACAD SCI USA, V98, P1416, DOI 10.1073/pnas.98.4.1416; Enerback S, 1997, NATURE, V387, P90, DOI 10.1038/387090a0; Fleury C, 1997, NAT GENET, V15, P269, DOI 10.1038/ng0397-269; GEMBAL M, 1993, J CLIN INVEST, V91, P871, DOI 10.1172/JCI116308; GEPTS W, 1960, DIABETES, V9, P63, DOI 10.2337/diab.9.1.63; Gimeno RE, 1997, DIABETES, V46, P900, DOI 10.2337/diabetes.46.5.900; Gong DW, 1997, J BIOL CHEM, V272, P24129, DOI 10.1074/jbc.272.39.24129; Gong DW, 2000, J BIOL CHEM, V275, P16251, DOI 10.1074/jbc.M910177199; HELLMAN B, 1961, ACTA ENDOCRINOL-COP, V36, P606; HIMMSHAGEN J, 1989, PROG LIPID RES, V28, P67, DOI 10.1016/0163-7827(89)90009-X; Hinz W, 1999, FEBS LETT, V448, P57, DOI 10.1016/S0014-5793(99)00331-2; Hong Y, 2001, ENDOCRINOLOGY, V142, P249, DOI 10.1210/en.142.1.249; Jaburek M, 1999, J BIOL CHEM, V274, P26003, DOI 10.1074/jbc.274.37.26003; Kahn Steven E., 2000, American Journal of Medicine, V108, p2S, DOI 10.1016/S0002-9343(00)00336-3; Kim JK, 2000, J CLIN INVEST, V105, P1791, DOI 10.1172/JCI8305; Klingenberg M, 1999, BBA-BIOMEMBRANES, V1415, P271, DOI 10.1016/S0005-2736(98)00232-6; Lameloise N, 2001, DIABETES, V50, P803, DOI 10.2337/diabetes.50.4.803; LI E, 1993, P NATL ACAD SCI USA, V90, P1590, DOI 10.1073/pnas.90.4.1590; Matschinsky FM, 1998, DIABETES, V47, P307, DOI 10.2337/diabetes.47.3.307; Miki T, 1998, P NATL ACAD SCI USA, V95, P10402, DOI 10.1073/pnas.95.18.10402; Pick A, 1998, DIABETES, V47, P358, DOI 10.2337/diabetes.47.3.358; Poitout V, 1996, ANNU REV MED, V47, P69; Reilly JM, 2000, BIOCHEM BIOPH RES CO, V277, P541, DOI 10.1006/bbrc.2000.3705; Rial E, 1999, EMBO J, V18, P5827, DOI 10.1093/emboj/18.21.5827; Ronner P, 1999, ANAL BIOCHEM, V275, P208, DOI 10.1006/abio.1999.4317; SAKO Y, 1990, ENDOCRINOLOGY, V127, P1580, DOI 10.1210/endo-127-4-1580; Schaff er I. E., 1999, MITOCHONDRIA, P141; Segall L, 1999, AM J PHYSIOL-ENDOC M, V277, pE521, DOI 10.1152/ajpendo.1999.277.3.E521; Seghers V, 2000, J BIOL CHEM, V275, P9270, DOI 10.1074/jbc.275.13.9270; Shulman GI, 2000, J CLIN INVEST, V106, P171, DOI 10.1172/JCI10583; Skulachev VP, 1998, BBA-BIOENERGETICS, V1363, P100, DOI 10.1016/S0005-2728(97)00091-1; TAYLOR SI, 1992, DIABETES, V41, P1473, DOI 10.2337/diabetes.41.11.1473; UNGER RH, 1995, DIABETES, V44, P863, DOI 10.2337/diabetes.44.8.863; Vidal-Puig AJ, 2000, J BIOL CHEM, V275, P16258, DOI 10.1074/jbc.M910179199; VidalPuig A, 1997, BIOCHEM BIOPH RES CO, V235, P79, DOI 10.1006/bbrc.1997.6740; Wang MY, 1999, DIABETES, V48, P1020, DOI 10.2337/diabetes.48.5.1020; ZAVARONI I, 1987, J CLIN ENDOCR METAB, V65, P494, DOI 10.1210/jcem-65-3-494; Zhang CY, 1999, FEBS LETT, V449, P129, DOI 10.1016/S0014-5793(99)00441-X; ZHOU YP, 1995, J CLIN ENDOCR METAB, V80, P1584, DOI 10.1210/jc.80.5.1584	56	717	749	0	46	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 15	2001	105	6					745	755		10.1016/S0092-8674(01)00378-6	http://dx.doi.org/10.1016/S0092-8674(01)00378-6			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	444AE	11440717	Bronze			2022-12-24	WOS:000169375100008
J	Niemann, T; Nielsen, TT; Thorsgaard, N; Lous, J				Niemann, T; Nielsen, TT; Thorsgaard, N; Lous, J			Differences in therapeutic consequences of exercise testing between a rural and an urban Danish county: population based study	BRITISH MEDICAL JOURNAL			English	Article							ACUTE MYOCARDIAL-INFARCTION; CORONARY ANGIOGRAPHY		Med Res Unit Ringkobing, DK-6950 Ringkobing, Denmark; Aarhus Univ Hosp, Dept Cardiol, DK-8200 Aarhus N, Denmark; Herning Cent Hosp, Dept Med, DK-7400 Herning, Denmark; Aarhus Univ, Inst Gen Practice, DK-8000 Aarhus C, Denmark; Aarhus Univ, Res Unit Gen Practice, DK-8000 Aarhus C, Denmark	Aarhus University; Aarhus University; Aarhus University; Aarhus University	Niemann, T (corresponding author), Finsensgade 26, DK-7400 Herning, Denmark.							EVERY NR, 1993, NEW ENGL J MED, V329, P546, DOI 10.1056/NEJM199308193290807; GRAY D, 1994, BRIT HEART J, V71, P474; Niemann T, 2000, SCAND CARDIOVASC J, V34, P286, DOI 10.1080/713783124; PILOTE L, 1995, NEW ENGL J MED, V333, P565, DOI 10.1056/NEJM199508313330907	4	4	4	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 9	2001	322	7299					1394	1395		10.1136/bmj.322.7299.1394	http://dx.doi.org/10.1136/bmj.322.7299.1394			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	442KN	11397744	Green Submitted, Green Published, Bronze			2022-12-24	WOS:000169284600017
J	MacKenzie, IZ; Cooke, I				MacKenzie, IZ; Cooke, I			Prospective 12 month study of 30 minute decision to delivery intervals for "emergency" caesarean section	BRITISH MEDICAL JOURNAL			English	Article									Univ Oxford, John Radcliffe Hosp, Nuffield Dept Obstet & Gynaecol, Oxford OX3 9DU, England	University of Oxford	MacKenzie, IZ (corresponding author), Univ Oxford, John Radcliffe Hosp, Nuffield Dept Obstet & Gynaecol, Oxford OX3 9DU, England.							[Anonymous], 2000, 7 MAT CHILD HLTH RES, P41; DENNIS J, 1989, AM J OBSTET GYNECOL, V161, P213, DOI 10.1016/0002-9378(89)90269-X; DUNPHY, 1991, J OBSTET GYNAECOL, V11, P241; HANNAH WJ, 1986, CAN MED ASSOC J, V134, P1348; Okunwobi-Smith Y, 2000, BRIT J OBSTET GYNAEC, V107, P467, DOI 10.1111/j.1471-0528.2000.tb13263.x	5	48	48	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 2	2001	322	7298					1334	1335		10.1136/bmj.322.7298.1334	http://dx.doi.org/10.1136/bmj.322.7298.1334			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	440GQ	11387178	Green Published, Bronze, Green Submitted			2022-12-24	WOS:000169167900017
J	Cho, H; Mu, J; Kim, JK; Thorvaldsen, JL; Chu, QW; Crenshaw, EB; Kaestner, KH; Bartolomei, MS; Shulman, GI; Birnbaum, MJ				Cho, H; Mu, J; Kim, JK; Thorvaldsen, JL; Chu, QW; Crenshaw, EB; Kaestner, KH; Bartolomei, MS; Shulman, GI; Birnbaum, MJ			Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta)	SCIENCE			English	Article							PHOSPHOENOLPYRUVATE CARBOXYKINASE GENE; GLUT4 TRANSLOCATION; 3T3-L1 ADIPOCYTES; GLUCOSE-UPTAKE; C-LAMBDA; EXPRESSION; ACTIVATION; TRANSCRIPTION; HEPATOCYTES; INHIBITION	Glucose homeostasis depends on insulin responsiveness in target tissues, most importantly, muscle and Liver. The critical initial steps in insulin action include phosphorylation of scaffolding proteins and activation of phosphatidylinositol 3-kinase. These early events Lead to activation of the serine-threonine protein kinase Akt, also known as protein kinase B. We show that mice deficient in Akt2 are impaired in the ability of insulin to Lower blood glucose because of defects in the action of the hormone on Liver and skeletal muscle. These data establish Akt2 as an essential gene in the maintenance of normal glucose homeostasis.	Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Neurosci, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA; Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06520 USA; Univ Penn, Dept Biol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Yale University; University of Pennsylvania	Birnbaum, MJ (corresponding author), Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA.		Shulman, Gerald I./P-7176-2019	Shulman, Gerald I./0000-0003-1529-5668; Kim, Jason/0000-0002-7185-042X	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK050306, R01DK040936, R01DK056886] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007229] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK040936, P30 DK50306, R01 DK56886] Funding Source: Medline; NIGMS NIH HHS [GM07229] Funding Source: Medline; PHS HHS [P30 19525] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Abel ED, 2001, NATURE, V409, P729, DOI 10.1038/35055575; Accili D, 1996, NAT GENET, V12, P106, DOI 10.1038/ng0196-106; Agati JM, 1998, J BIOL CHEM, V273, P18751, DOI 10.1074/jbc.273.30.18751; Altomare DA, 1996, CYTOGENET CELL GENET, V74, P248, DOI 10.1159/000134426; ARAKI E, 1994, NATURE, V372, P186, DOI 10.1038/372186a0; BELLACOSA A, 1993, ONCOGENE, V8, P745; BIRNBAUM MJ, 1992, INT REV CYTOL, V137A, P239; BIRNBAUM MJ, 1989, CELL, V57, P305, DOI 10.1016/0092-8674(89)90968-9; Brozinick JT, 1998, J BIOL CHEM, V273, P14679, DOI 10.1074/jbc.273.24.14679; Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0; Bruning JC, 1997, CELL, V88, P561, DOI 10.1016/S0092-8674(00)81896-6; Calera MR, 1998, J BIOL CHEM, V273, P7201, DOI 10.1074/jbc.273.13.7201; Cherrington AD, 1998, DIABETOLOGIA, V41, P987, DOI 10.1007/s001250051021; Cho H.-G., UNPUB; Hill MM, 1999, MOL CELL BIOL, V19, P7771; Iynedjian PB, 2000, BIOCHEM J, V351, P621, DOI 10.1042/0264-6021:3510621; Kadowaki T, 2000, J CLIN INVEST, V106, P459, DOI 10.1172/JCI10830; Kim JK, 2000, J BIOL CHEM, V275, P8456, DOI 10.1074/jbc.275.12.8456; Kohn AD, 1996, J BIOL CHEM, V271, P31372, DOI 10.1074/jbc.271.49.31372; Kohn AD, 1998, J BIOL CHEM, V273, P11937, DOI 10.1074/jbc.273.19.11937; Kotani K, 1999, J BIOL CHEM, V274, P21305, DOI 10.1074/jbc.274.30.21305; Kotani K, 1998, MOL CELL BIOL, V18, P6971, DOI 10.1128/MCB.18.12.6971; Liao JF, 1998, J BIOL CHEM, V273, P27320, DOI 10.1074/jbc.273.42.27320; Matthaei S, 2000, ENDOCR REV, V21, P585, DOI 10.1210/er.21.6.585; Michael MD, 2000, MOL CELL, V6, P87, DOI 10.1016/S1097-2765(00)00010-1; Murthy SS, 2000, CYTOGENET CELL GENET, V88, P38, DOI 10.1159/000015481; Phippard D, 1999, J NEUROSCI, V19, P5980, DOI 10.1523/JNEUROSCI.19-14-05980.1999; Sauer B, 1998, METHODS, V14, P381, DOI 10.1006/meth.1998.0593; Summers SA, 1999, J BIOL CHEM, V274, P23858, DOI 10.1074/jbc.274.34.23858; TAMEMOTO H, 1994, NATURE, V372, P182, DOI 10.1038/372182a0; Ueki K, 1998, J BIOL CHEM, V273, P5315, DOI 10.1074/jbc.273.9.5315; Wang QH, 1999, MOL CELL BIOL, V19, P4008; Withers DJ, 1998, NATURE, V391, P900, DOI 10.1038/36116	33	1444	1523	6	134	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 1	2001	292	5522					1728	1731		10.1126/science.292.5522.1728	http://dx.doi.org/10.1126/science.292.5522.1728			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	438AP	11387480				2022-12-24	WOS:000169031800049
J	Dubois, M; Deme, B; Gulik-Krzywicki, T; Dedieu, JC; Vautrin, C; Desert, S; Perez, E; Zemb, T				Dubois, M; Deme, B; Gulik-Krzywicki, T; Dedieu, JC; Vautrin, C; Desert, S; Perez, E; Zemb, T			Self-assembly of regular hollow icosahedra in salt-free catanionic solutions	NATURE			English	Article							VESICLES	Self-assembled structures having a regular hollow icosahedral form (such as those observed for proteins of virus capsids) can occur as a result of biomineralization processes(1), but are extremely rare in mineral crystallites(2). Compact icosahedra made from a boron oxide have been reported(3), but equivalent structures made of synthetic organic components such as surfactants have not hitherto been observed. It is, however, well known that lipids, as well as mixtures of anionic and cationic single chain surfactants, can readily form bilayers(4,5) that can adopt a variety of distinct geometric forms: they can fold into soft vesicles or random bilayers (the so-called sponge phase) or form ordered stacks of flat or undulating membranes(6). Here we show that in salt-free mixtures of anionic and cationic surfactants, such bilayers can self-assemble into hollow aggregates with a regular icosahedral shape. These aggregates are stabilized by the presence of pores located at the vertices of the icosahedra. The resulting structures have a size of about one micrometre and mass of about 10(10) daltons, making them larger than any known icosahedral protein assembly(7) or virus capsid(8). We expect the combination of wall rigidity and holes at vertices of these icosahedral aggregates to be of practical value for controlled drug or DNA release.	CEA Saclay, Serv Chim Mol, F-91191 Gif Sur Yvette, France; Inst Max Von Laue Paul Langevin, F-38042 Grenoble 09, France; CNRS, Ctr Genet Mol, F-91198 Gif Sur Yvette, France; IMRCP, CNRS, URA 470, F-31062 Toulouse, France	CEA; UDICE-French Research Universities; Universite Paris Saclay; Institut Laue-Langevin (ILL); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS)	Dubois, M (corresponding author), CEA Saclay, Serv Chim Mol, F-91191 Gif Sur Yvette, France.	duboism@scm.saclay.cea.fr	ZEMB, Thomas N/E-5958-2010; Demé, Bruno/AAG-1620-2021	Demé, Bruno/0000-0002-9523-7662				CRICK FHC, 1956, NATURE, V177, P473, DOI 10.1038/177473a0; Donath E, 1998, ANGEW CHEM INT EDIT, V37, P2202, DOI 10.1002/(SICI)1521-3773(19980904)37:16<2201::AID-ANIE2201>3.0.CO;2-E; Dubois M, 2000, PROG COLL POL SCI S, V115, P238; Dubois M, 1998, CR ACAD SCI II C, V1, P567, DOI 10.1016/S1387-1609(98)80012-1; Dubois M, 2000, CURR OPIN COLLOID IN, V5, P27, DOI 10.1016/S1359-0294(00)00032-7; Fogden A, 1997, J PHYS II, V7, P229, DOI 10.1051/jp2:1997121; Fogden A, 1997, COLLOID SURFACE A, V129, P157, DOI 10.1016/S0927-7757(97)00034-4; GRACIAA A, 1989, J PHYS CHEM-US, V93, P4167, DOI 10.1021/j100347a055; Hubert H, 1998, NATURE, V391, P376, DOI 10.1038/34885; Hyde ST, 1997, COLLOID SURFACE A, V129, P207, DOI 10.1016/S0927-7757(97)00038-1; KALER EW, 1989, SCIENCE, V245, P1371, DOI 10.1126/science.2781283; KIMOTO K, 1966, J APPL PHYS, V16, P941; KLUG A, 1959, BIOCHIM BIOPHYS ACTA, V32, P203, DOI 10.1016/0006-3002(59)90570-0; KLUG A., 1960, ADVANCES IN VIRUS RES, V7, P225; NELSON DR, 1989, SOLID STATE PHYS, V42, P1; PARENTE RA, 1985, BIOCHIM BIOPHYS ACTA, V812, P493, DOI 10.1016/0005-2736(85)90324-4; Radtchenko IL, 2000, J COLLOID INTERF SCI, V230, P272, DOI 10.1006/jcis.2000.7068; Regev O, 1999, LANGMUIR, V15, P642, DOI 10.1021/la9803474; SACKMANN E, 1995, HDB BIOL PHYSICS B, V1; SCAMEHORN JF, 1989, SURFACTANT SCI SERIE, V33, pCH10; SCHNUR JM, 1993, SCIENCE, V262, P1669, DOI 10.1126/science.262.5140.1669; Spector MS, 1996, LANGMUIR, V12, P4704, DOI 10.1021/la960218s; THOMAS BN, 1995, SCIENCE, V267, P1635, DOI 10.1126/science.267.5204.1635; Thompson D.W., 1961, GROWTH FORM; WALS J, 1997, MOL CELL, V1, P59; Zemb T, 1999, SCIENCE, V283, P816, DOI 10.1126/science.283.5403.816	26	302	311	4	119	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN	2001	411	6838					672	675		10.1038/35079541	http://dx.doi.org/10.1038/35079541			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439JC	11395764				2022-12-24	WOS:000169112500038
J	McConnell, JR; Emery, J; Eshed, Y; Bao, N; Bowman, J; Barton, MK				McConnell, JR; Emery, J; Eshed, Y; Bao, N; Bowman, J; Barton, MK			Role of PHABULOSA and PHAVOLUTA in determining radial patterning in shoots	NATURE			English	Article							HD-ZIP; GENE; ARABIDOPSIS; MERISTEM; ENCODES; MEMBERS; LEAVES	The upper side of the angiosperm leaf is specialized for efficient capture of sunlight whereas the lower side is specialized for gas exchange. In Arabidopsis, the establishment of polarity in the leaf probably requires the generation and perception of positional information along the radial (adaxial versus abaxial or central versus peripheral) dimension of the plant. This is because the future upper (adaxial) side of the leaf develops from cells closer to the centre of the shoot, whereas the future under (abaxial) side develops from cells located more peripherally. Here we implicate the Arabidopsis PHABULOSA and PHAVOLUTA genes in the perception of radial positional information in the leaf primordium. Dominant phabulosa (phb)(1) and phavoluta (phv) mutations cause a dramatic transformation of abaxial leaf fates into adaxial leaf fates. They do so by altering the predicted sterol/lipid-binding domains of ATHB14 and ATHB9, proteins of previously unknown function that also contain DNA-binding motifs. This change probably renders the protein constitutively active, implicating this domain as a central regulator of protein function and the PHB and PHV proteins as receptors for an adaxializing signal.	Univ Wisconsin, Dept Genet, Madison, WI 53706 USA; Univ Wisconsin, Mol & Cellular Biol Program, Madison, WI 53706 USA; Univ Wisconsin, Program Plant Breeding & Plant Genet, Madison, WI 53706 USA; Univ Calif Davis, Plant Biol Sect, Davis, CA 95616 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of California System; University of California Davis	Barton, MK (corresponding author), Univ Wisconsin, Dept Genet, 445 Henry Mall, Madison, WI 53706 USA.	mkbarton@facstaff.wisc.edu		Bowman, John/0000-0001-7347-3691; Eshed, Yuval/0000-0001-8290-0018				BENFEY PN, 1990, EMBO J, V9, P1677, DOI 10.1002/j.1460-2075.1990.tb08291.x; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Long J, 2000, DEV BIOL, V218, P341, DOI 10.1006/dbio.1999.9572; Lynn K, 1999, DEVELOPMENT, V126, P469; McConnell JR, 1998, DEVELOPMENT, V125, P2935; Ponting CP, 1999, TRENDS BIOCHEM SCI, V24, P130, DOI 10.1016/S0968-0004(99)01362-6; Ratcliffe OJ, 2000, PLANT CELL, V12, P315, DOI 10.1105/tpc.12.3.315; Sawa S, 1999, GENE DEV, V13, P1079, DOI 10.1101/gad.13.9.1079; Sessa G, 1998, PLANT MOL BIOL, V38, P609, DOI 10.1023/A:1006016319613; Siegfried KR, 1999, DEVELOPMENT, V126, P4117; SNOW M, 1959, NEW PHYTOL, V8, P188; SUSSEX I. M., 1955, PHYTOMORPHOLOGY [DELHI], V5, P286; TALBERT PB, 1995, DEVELOPMENT, V121, P2723; WAITES R, 1995, DEVELOPMENT, V121, P2143; Zhong RQ, 1999, PLANT CELL, V11, P2139, DOI 10.1105/tpc.11.11.2139	15	828	1056	6	102	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN	2001	411	6838					709	713		10.1038/35079635	http://dx.doi.org/10.1038/35079635			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439JC	11395776				2022-12-24	WOS:000169112500050
J	Sturm, M; Racine, C; Tape, K				Sturm, M; Racine, C; Tape, K			Climate change - Increasing shrub abundance in the Arctic	NATURE			English	Article									USA, Cold Reg Res & Engn Lab, Ft Wainwright, AK 99703 USA; USA, Cold Reg Res & Engn Lab, Hanover, NH 03755 USA; Univ Alaska Fairbanks, Inst Geophys, Fairbanks, AK 99775 USA	United States Department of Defense; United States Army; U.S. Army Corps of Engineers; U.S. Army Engineer Research & Development Center (ERDC); Cold Regions Research & Engineering Laboratory (CRREL); United States Department of Defense; United States Army; U.S. Army Corps of Engineers; U.S. Army Engineer Research & Development Center (ERDC); Cold Regions Research & Engineering Laboratory (CRREL); University of Alaska System; University of Alaska Fairbanks	Sturm, M (corresponding author), USA, Cold Reg Res & Engn Lab, POB 35170, Ft Wainwright, AK 99703 USA.		Sturm, Matthew/GXF-6926-2022					Anderson Patricia M., 1993, P386; BILLINGS WD, 1987, QUATERNARY SCI REV, V6, P155; BLISS L C, 1992, P59; CHAPIN FS, 1995, ECOLOGY, V76, P694, DOI 10.2307/1939337; Chapin FS, 2000, J CLIMATE, V13, P2002, DOI 10.1175/1520-0442(2000)013<2002:SDAAEI>2.0.CO;2; Epstein HE, 2000, ECOL APPL, V10, P824, DOI 10.1890/1051-0761(2000)010[0824:ATNBMO]2.0.CO;2; McGuire AD, 2000, GLOBAL CHANGE BIOL, V6, P141, DOI 10.1046/j.1365-2486.2000.06017.x; Myneni RB, 1997, NATURE, V386, P698, DOI 10.1038/386698a0; Oechel WC, 2000, NATURE, V406, P978, DOI 10.1038/35023137; Overpeck J, 1997, SCIENCE, V278, P1251, DOI 10.1126/science.278.5341.1251; REED JC, 1958, 302 US GEOL SURV; Serreze MC, 2000, CLIMATIC CHANGE, V46, P159, DOI 10.1023/A:1005504031923; Sturm M, 2001, J CLIMATE, V14, P336, DOI 10.1175/1520-0442(2001)014<0336:SSIIAT>2.0.CO;2	13	954	1012	10	356	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 31	2001	411	6837					546	547		10.1038/35079180	http://dx.doi.org/10.1038/35079180			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437GE	11385559				2022-12-24	WOS:000168982500038
J	Cowley, MA; Smart, JL; Rubinstein, M; Cordan, MG; Diano, S; Horvath, TL; Cone, RD; Low, MJ				Cowley, MA; Smart, JL; Rubinstein, M; Cordan, MG; Diano, S; Horvath, TL; Cone, RD; Low, MJ			Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus	NATURE			English	Article							CENTRAL MELANOCORTIN SYSTEM; NEUROPEPTIDE-Y RECEPTOR; HYPOTHALAMIC NEURONS; OBESE GENE; MOUSE; MICE; INNERVATION; CHANNELS; RATS; AREA	The administration of leptin(1) to leptin-deficient humans, and the analogous Lep(ob)/Lep(ob) mice, effectively reduces hyperphagia and obesity(2,3). But common obesity is associated with elevated leptin, which suggests that obese humans are resistant to this adipocyte hormone. In addition to regulating long-term energy balance, leptin also rapidly affects neuronal activity(4-6). Proopiomelanocortin (POMC) and neuropeptide-Y types of neurons in the arcuate nucleus of the hypothalamus(7) are both principal sites of leptin receptor expression and the source of potent neuropeptide modulators, melanocortins and neuropeptide Y, which exert opposing effects on feeding and metabolism(8,9). These neurons are therefore ideal for characterizing leptin action and the mechanism of leptin resistance; however, their diffuse distribution makes them difficult to study. Here we report electrophysiological recordings on POMC neurons, which we identified by targeted expression of green fluorescent protein in transgenic mice. Leptin increases the frequency of action potentials in the anorexigenic POMC neurons by two mechanisms: depolarization through a nonspecific cation channel; and reduced inhibition by local orexigenic neuropeptide-Y/GABA (gamma -aminobutyric acid) neurons. Furthermore, we show that melanocortin peptides have an autoinhibitory effect on this circuit. On the basis of our results, we propose an integrated model of leptin action and neuronal architecture in the arcuate nucleus of the hypothalamus.	Oregon Hlth Sci Univ, Vollum Inst, Portland, OR 97201 USA; Univ Buenos Aires, Sch Sci, Dept Biol, RA-1428 Buenos Aires, DF, Argentina; CONICET, Inst Invest Ingn Genet & Biol Mol, RA-1428 Buenos Aires, DF, Argentina; Yale Univ, Sch Med, Dept Obstet & Gynecol, Reprod Neurosci Unit, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06520 USA	Oregon Health & Science University; University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Yale University; Yale University	Cone, RD (corresponding author), Oregon Hlth Sci Univ, Vollum Inst, L474, Portland, OR 97201 USA.		Cowley, Michael A/B-9428-2008	Cowley, Michael A/0000-0001-7811-134X; Low, Malcolm/0000-0002-9900-3708				BAGNOL D, 1999, J NEUROSCI      0825; Broberger C, 1997, NEUROENDOCRINOLOGY, V66, P393, DOI 10.1159/000127265; Butler AA, 2000, ENDOCRINOLOGY, V141, P3518, DOI 10.1210/en.141.9.3518; CAMPFIELD LA, 1995, SCIENCE, V269, P546, DOI 10.1126/science.7624778; Cone RD, 1999, TRENDS ENDOCRIN MET, V10, P211, DOI 10.1016/S1043-2760(99)00153-8; Cowley MA, 1999, NEURON, V24, P155, DOI 10.1016/S0896-6273(00)80829-6; CSIFFARY A, 1990, BRAIN RES, V506, P215, DOI 10.1016/0006-8993(90)91253-D; Elias CF, 1999, NEURON, V23, P775, DOI 10.1016/S0896-6273(01)80035-0; Farooqi IS, 1999, NEW ENGL J MED, V341, P879, DOI 10.1056/NEJM199909163411204; Franklin KBJ, 2008, MOUSE BRAIN STEREOTA, V3rd; Glaum SR, 1996, MOL PHARMACOL, V50, P230; Grieco P, 2000, J MED CHEM, V43, P4998, DOI 10.1021/jm000211e; Hakansson ML, 1998, J NEUROSCI, V18, P559; Halaas JL, 1997, P NATL ACAD SCI USA, V94, P8878, DOI 10.1073/pnas.94.16.8878; Haynes WG, 1997, J CLIN INVEST, V100, P270, DOI 10.1172/JCI119532; Haynes WG, 1999, HYPERTENSION, V33, P542, DOI 10.1161/01.HYP.33.1.542; Horvath TL, 1997, BRAIN RES, V756, P283, DOI 10.1016/S0006-8993(97)00184-4; HORVATH TL, 1992, NEUROSCIENCE, V51, P391, DOI 10.1016/0306-4522(92)90323-T; Kalra SP, 1999, ENDOCR REV, V20, P68, DOI 10.1210/er.20.1.68; KELLY MJ, 1990, NEUROENDOCRINOLOGY, V52, P268, DOI 10.1159/000125597; Kim MS, 2000, J CLIN INVEST, V105, P1005, DOI 10.1172/JCI8857; King PJ, 1999, J NEUROCHEM, V73, P641, DOI 10.1046/j.1471-4159.1999.0730641.x; Lee K, 1999, J PHYSIOL-LONDON, V515, P439, DOI 10.1111/j.1469-7793.1999.439ac.x; Powis JE, 1998, AM J PHYSIOL-REG I, V274, pR1468, DOI 10.1152/ajpregu.1998.274.5.R1468; Shiraishi T, 1999, NUTRITION, V15, P576, DOI 10.1016/S0899-9007(99)00088-X; Slugg RM, 2000, NEUROENDOCRINOLOGY, V72, P208, DOI 10.1159/000054589; Spanswick D, 1997, NATURE, V390, P521, DOI 10.1038/37379; Young JI, 1998, J NEUROSCI, V18, P6631; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	29	1660	1704	1	143	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 24	2001	411	6836					480	484		10.1038/35078085	http://dx.doi.org/10.1038/35078085			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	435CB	11373681	Green Submitted, Green Published			2022-12-24	WOS:000168858700050
J	Alexandru, G; Uhlmann, F; Mechtler, K; Poupart, MA; Nasmyth, K				Alexandru, G; Uhlmann, F; Mechtler, K; Poupart, MA; Nasmyth, K			Phosphorylation of the cohesin subunit Scc1 by Polo/Cdc5 kinase regulates sister chromatid separation in yeast	CELL			English	Article							CELL-CYCLE REGULATION; POLO-LIKE KINASES; SACCHAROMYCES-CEREVISIAE; BUDDING YEAST; PROTEOLYTIC CLEAVAGE; DNA-REPLICATION; PROTEIN-KINASES; ANAPHASE; CHROMOSOME; METAPHASE	At the onset of anaphase, a caspase-related protease (separase) destroys the link between sister chromatids by cleaving the cohesin subunit Scc1. During most of the cell cycle, separase is kept inactive by binding to an inhibitory protein called securin. Separase activation requires proteolysis of securin, which is mediated by an ubiquitin protein ligase called the anaphase-promoting complex. Cells regulate anaphase entry by delaying securin ubiquitination until all chromosomes have attached to the mitotic spindle. Though no longer regulated by this mitotic surveillance mechanism, sister separation remains tightly cell cycle regulated in yeast mutants lacking securin. We show here that the Polo/Cdc5 kinase phosphorylates serine residues adjacent to Scc1 cleavage sites and strongly enhances their cleavage. Phosphorylation of separase recognition sites may be highly conserved and regulates sister chromatid separation independently of securin.	Res Inst Mol Pathol, A-1030 Vienna, Austria; Boehringer Ingelheim Canada Ltd, Laval, PQ H7S 2G5, Canada	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Boehringer Ingelheim	Nasmyth, K (corresponding author), Res Inst Mol Pathol, Dr Bohr Gasse 7, A-1030 Vienna, Austria.	nasmyth@nt.imp.univie.ac.at	Mechtler, Karl/AAF-2717-2019	Mechtler, Karl/0000-0002-3392-9946; Alexandru, Gabriela/0000-0002-7058-5644; Nasmyth, Kim/0000-0001-7030-4403; Uhlmann, Frank/0000-0002-3527-6619				Alexandru G, 1999, EMBO J, V18, P2707, DOI 10.1093/emboj/18.10.2707; AMON A, 1993, CELL, V74, P993, DOI 10.1016/0092-8674(93)90722-3; Bae SS, 2000, FASEB J, V14, P1083, DOI 10.1096/fasebj.14.9.1083; Barkett M, 1997, J BIOL CHEM, V272, P29419, DOI 10.1074/jbc.272.47.29419; Buonomo SBC, 2000, CELL, V103, P387, DOI 10.1016/S0092-8674(00)00131-8; Cahill DP, 1998, NATURE, V392, P300, DOI 10.1038/32688; Charles JF, 1998, CURR BIOL, V8, P497, DOI 10.1016/S0960-9822(98)70201-5; Cheng L, 1998, MOL CELL BIOL, V18, P7360, DOI 10.1128/MCB.18.12.7360; Ciosk R, 1998, CELL, V93, P1067, DOI 10.1016/S0092-8674(00)81211-8; CohenFix O, 1996, GENE DEV, V10, P3081, DOI 10.1101/gad.10.24.3081; Craig KL, 1999, PROG BIOPHYS MOL BIO, V72, P299, DOI 10.1016/S0079-6107(99)00010-3; Darwiche N, 1999, GENE, V233, P39, DOI 10.1016/S0378-1119(99)00160-2; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; EPSTEIN CB, 1992, GENE DEV, V6, P1695, DOI 10.1101/gad.6.9.1695; Fuchs SY, 1998, ONCOGENE, V17, P1483, DOI 10.1038/sj.onc.1202184; Funabiki H, 1996, EMBO J, V15, P6617, DOI 10.1002/j.1460-2075.1996.tb01052.x; Funabiki H, 1996, NATURE, V381, P438, DOI 10.1038/381438a0; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Glover DM, 1998, GENE DEV, V12, P3777, DOI 10.1101/gad.12.24.3777; Goshima G, 2000, CELL, V100, P619, DOI 10.1016/S0092-8674(00)80699-6; He XW, 2000, CELL, V101, P763, DOI 10.1016/S0092-8674(00)80888-0; Hoque MT, 2001, J BIOL CHEM, V276, P5059, DOI 10.1074/jbc.M007809200; Jallepalli PV, 2001, CELL, V105, P445, DOI 10.1016/S0092-8674(01)00340-3; Klein F, 1999, CELL, V98, P91, DOI 10.1016/S0092-8674(00)80609-1; Kumada K, 1998, CURR BIOL, V8, P633, DOI 10.1016/S0960-9822(98)70250-7; Lee KS, 1997, MOL CELL BIOL, V17, P3408, DOI 10.1128/MCB.17.6.3408; Leismann O, 2000, GENE DEV, V14, P2192, DOI 10.1101/gad.176700; Losada A, 1998, GENE DEV, V12, P1986, DOI 10.1101/gad.12.13.1986; Losada A, 2000, J CELL BIOL, V150, P405, DOI 10.1083/jcb.150.3.405; Mayor T, 1999, FEBS LETT, V452, P92, DOI 10.1016/S0014-5793(99)00534-7; Michaelis C, 1997, CELL, V91, P35, DOI 10.1016/S0092-8674(01)80007-6; Nasmyth K, 2000, SCIENCE, V288, P1379, DOI 10.1126/science.288.5470.1379; Nasmyth K, 1996, TRENDS GENET, V12, P405, DOI 10.1016/0168-9525(96)10041-X; Nigg EA, 1998, CURR OPIN CELL BIOL, V10, P776, DOI 10.1016/S0955-0674(98)80121-X; Piatti S, 1996, GENE DEV, V10, P1516, DOI 10.1101/gad.10.12.1516; PRINGLE JR, 1981, MOL BIOL YEAST SACCH; Rao H, 2001, NATURE, V410, P955, DOI 10.1038/35073627; Salvesen GS, 1999, P NATL ACAD SCI USA, V96, P10964, DOI 10.1073/pnas.96.20.10964; Sanchez Y, 1999, SCIENCE, V286, P1166, DOI 10.1126/science.286.5442.1166; SCHWOB E, 1993, GENE DEV, V7, P1160, DOI 10.1101/gad.7.7a.1160; Shirayama M, 1998, EMBO J, V17, P1336, DOI 10.1093/emboj/17.5.1336; Smits VAJ, 2000, NAT CELL BIOL, V2, P672, DOI 10.1038/35023629; Stratmann R, 1996, CELL, V84, P25, DOI 10.1016/S0092-8674(00)80990-3; Sumara I, 2000, J CELL BIOL, V151, P749, DOI 10.1083/jcb.151.4.749; Tanaka TU, 2000, NAT CELL BIOL, V2, P492, DOI 10.1038/35019529; Toczyski DP, 1997, CELL, V90, P1097, DOI 10.1016/S0092-8674(00)80375-X; Tomonaga T, 2000, GENE DEV, V14, P2757, DOI 10.1101/gad.832000; Uhlmann F, 1999, NATURE, V400, P37, DOI 10.1038/21831; Uhlmann F, 2000, CELL, V103, P375, DOI 10.1016/S0092-8674(00)00130-6; Waizenegger IC, 2000, CELL, V103, P399, DOI 10.1016/S0092-8674(00)00132-X; Yamamoto A, 1996, J CELL BIOL, V133, P99, DOI 10.1083/jcb.133.1.99; Yamamoto A, 1996, J CELL BIOL, V133, P85, DOI 10.1083/jcb.133.1.85; Zachariae W, 1999, GENE DEV, V13, P2039, DOI 10.1101/gad.13.16.2039; Zou H, 1999, SCIENCE, V285, P418, DOI 10.1126/science.285.5426.418	54	306	312	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 18	2001	105	4					459	472		10.1016/S0092-8674(01)00362-2	http://dx.doi.org/10.1016/S0092-8674(01)00362-2			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	434XG	11371343	Bronze			2022-12-24	WOS:000168840700006
J	Ganguly, K; Schinder, AF; Wong, ST; Poo, M				Ganguly, K; Schinder, AF; Wong, ST; Poo, M			GABA itself promotes the developmental switch of neuronal GABAergic responses from excitation to inhibition	CELL			English	Article							K-CL COTRANSPORTER; CA3 HIPPOCAMPAL-NEURONS; POSTNATAL RAT BRAINS; DORSAL HORN NEURONS; IN-VITRO; CREB PHOSPHORYLATION; CALCIUM CURRENTS; SENSORY NEURONS; ACTIVATION; EXPRESSION	GABA is the main inhibitory neurotransmitter in the adult brain. Early in development, however, GABAergic synaptic transmission is excitatory and can exert widespread trophic effects. During the postnatal period, GABAergic responses undergo a switch from being excitatory to inhibitory. Here, we show that the switch is delayed by chronic blockade of GABA(A) receptors, and accelerated by increased GABA(A) receptor activation. In contrast, blockade of glutamatergic transmission or action potentials has no effect. Furthermore, GABAergic activity modulated the mRNA levels of KCC2, a K+-Cl- cotransporter whose expression correlates with the switch. Finally, we report that GABA can alter the properties of depolarization-induced Ca2+ influx. Thus, GABA acts as a self-limiting trophic factor during neural development.	Univ Calif San Diego, Program Neurosci, La Jolla, CA 92093 USA; Univ Calif San Diego, Div Biol, Neurobiol Sect, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Poo, M (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Div Neurobiol, Berkeley, CA 94720 USA.		Jansen, Heiko T./A-5770-2008	Jansen, Heiko T./0000-0003-0178-396X; Schinder, Alejandro/0000-0003-4863-8348	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037831, R01NS036999] Funding Source: NIH RePORTER; NINDS NIH HHS [NS 37831, NS 36999] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BenAri Y, 1997, TRENDS NEUROSCI, V20, P523, DOI 10.1016/S0166-2236(97)01147-8; BENARI Y, 1989, J PHYSIOL-LONDON, V416, P303, DOI 10.1113/jphysiol.1989.sp017762; BERNINGER B, 1995, DEVELOPMENT, V121, P2327; Boukhaddaoui H, 2000, EUR J NEUROSCI, V12, P2068, DOI 10.1046/j.1460-9568.2000.00105.x; Caillard O, 1999, J PHYSIOL-LONDON, V518, P109, DOI 10.1111/j.1469-7793.1999.0109r.x; Chameu P, 1999, NEUROSCIENCE, V90, P383, DOI 10.1016/S0306-4522(98)00457-6; Chen G, 1996, J PHYSIOL-LONDON, V494, P451, DOI 10.1113/jphysiol.1996.sp021505; CHERUBINI E, 1991, TRENDS NEUROSCI, V14, P515, DOI 10.1016/0166-2236(91)90003-D; CHERUBINI E, 1990, INT J DEV NEUROSCI, V8, P481, DOI 10.1016/0736-5748(90)90080-L; CONNOR JA, 1987, J NEUROSCI, V7, P1384; Deisseroth K, 1996, NEURON, V16, P89, DOI 10.1016/S0896-6273(00)80026-4; Deisseroth K, 1998, NATURE, V392, P198, DOI 10.1038/32448; Desmadryl G, 1998, EUR J NEUROSCI, V10, P545, DOI 10.1046/j.1460-9568.1998.00055.x; Garaschuk O, 2000, NAT NEUROSCI, V3, P452, DOI 10.1038/74823; GRUOL DL, 1992, J NEUROSCI, V12, P2838; Hilaire C, 1996, NEUROSCIENCE, V75, P1219, DOI 10.1016/0306-4522(96)00347-8; Hsia AY, 1998, J NEUROPHYSIOL, V79, P2013, DOI 10.1152/jn.1998.79.4.2013; Ikeda Y, 1997, DEV BRAIN RES, V98, P253, DOI 10.1016/S0165-3806(96)00183-6; Jarolimek W, 1999, J NEUROSCI, V19, P4695; Kakazu Y, 1999, J NEUROSCI, V19, P2843; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Khazipov R, 1997, J PHYSIOL-LONDON, V498, P763, DOI 10.1113/jphysiol.1997.sp021900; Kirsch J, 1998, NATURE, V392, P717, DOI 10.1038/33694; Kneussel M, 2000, TRENDS NEUROSCI, V23, P429, DOI 10.1016/S0166-2236(00)01627-1; Koester HJ, 1998, P NATL ACAD SCI USA, V95, P9596, DOI 10.1073/pnas.95.16.9596; Lamsa K, 2000, J NEUROPHYSIOL, V83, P359, DOI 10.1152/jn.2000.83.1.359; LEE JJ, 1987, METHOD ENZYMOL, V152, P633; LEINEKUGEL X, 1995, J PHYSIOL-LONDON, V487, P319, DOI 10.1113/jphysiol.1995.sp020882; Li YX, 1998, J PHYSIOL-LONDON, V509, P847, DOI 10.1111/j.1469-7793.1998.847bm.x; LoTurco JJ, 1995, NEURON, V15, P1287, DOI 10.1016/0896-6273(95)90008-X; Lu J, 1999, J NEUROBIOL, V39, P558, DOI 10.1002/(SICI)1097-4695(19990615)39:4<558::AID-NEU9>3.0.CO;2-5; LUHMANN HJ, 1991, J NEUROPHYSIOL, V65, P247, DOI 10.1152/jn.1991.65.2.247; Marty S, 1996, NEURON, V16, P565, DOI 10.1016/S0896-6273(00)80075-6; MUELLER AL, 1984, J NEUROSCI, V4, P860; MURPHY TH, 1991, NEURON, V7, P625, DOI 10.1016/0896-6273(91)90375-A; Obrietan K, 1997, J NEUROSCI, V17, P4785; OBRIETAN K, 1995, J NEUROSCI, V15, P5065; Owens DF, 1996, J NEUROSCI, V16, P6414; Palva JM, 2000, J NEUROSCI, V20, P1170, DOI 10.1523/JNEUROSCI.20-03-01170.2000; Payne JA, 1996, J BIOL CHEM, V271, P16245, DOI 10.1074/jbc.271.27.16245; Plotkin MD, 1997, J NEUROBIOL, V33, P781, DOI 10.1002/(SICI)1097-4695(19971120)33:6<781::AID-NEU6>3.0.CO;2-5; REICHLING DB, 1994, J PHYSIOL-LONDON, V476, P411, DOI 10.1113/jphysiol.1994.sp020142; Rivera C, 1999, NATURE, V397, P251, DOI 10.1038/16697; Rosenstein JM, 1998, CELL TRANSPLANT, V7, P121, DOI 10.1016/S0963-6897(98)00006-2; Schierle GS, 1997, CEREB CORTEX, V7, P130, DOI 10.1093/cercor/7.2.130; STALEY KJ, 1995, SCIENCE, V269, P977, DOI 10.1126/science.7638623; Ullian EM, 2001, SCIENCE, V291, P657, DOI 10.1126/science.291.5504.657; van den Pol AN, 1998, J NEUROSCI, V18, P10749; Vu TQ, 2000, J NEUROSCI, V20, P1414; WANG J, 1994, EUR J NEUROSCI, V6, P1275, DOI 10.1111/j.1460-9568.1994.tb00317.x; YUSTE R, 1991, NEURON, V6, P334	51	516	529	0	21	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 18	2001	105	4					521	532		10.1016/S0092-8674(01)00341-5	http://dx.doi.org/10.1016/S0092-8674(01)00341-5			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	434XG	11371348	Bronze			2022-12-24	WOS:000168840700011
J	McGuire, SE; Le, PT; Davis, RL				McGuire, SE; Le, PT; Davis, RL			The role of Drosophila mushroom body signaling in olfactory memory	SCIENCE			English	Article							SYNAPTIC VESICLE MEMBRANE; MUTANT DROSOPHILA; SHIBIRE; BODIES; DYNAMIN; MELANOGASTER; SENSITIVITY; EXPRESSION; DEFICIENT; MUTATIONS	The mushroom bodies of the Drosophila brain are important for olfactory learning and memory. To investigate the requirement for mushroom body signaling during the different phases of memory processing, we transiently inactivated neurotransmission through this region of the brain by expressing a temperature-sensitive allele of the shibire dynamin guanosine triphosphatase, which is required for synaptic transmission. Inactivation of mushroom body signaling through alpha/beta neurons during different phases of memory processing revealed a requirement for mushroom body signaling during memory retrieval, but not during acquisition or consolidation.	Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; Baylor Coll Med, Dept Psychiat & Behav Sci, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Davis, RL (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.	rdavis@bcm.tmc.edu	Davis, Ronald/J-4998-2013; Oka, Yoshitaka/C-9670-2010	Davis, Ronald/0000-0002-5986-7608; Oka, Yoshitaka/0000-0002-3482-3051	NINDS NIH HHS [NS19904] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS019904, R37NS019904] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Armstrong JD, 1998, LEARN MEMORY, V5, P102; Beck CDO, 2000, J NEUROSCI, V20, P2944; BRAND AH, 1993, DEVELOPMENT, V118, P401; CHEN MS, 1991, NATURE, V351, P583, DOI 10.1038/351583a0; Cheng YZ, 2001, CELL, V105, P757, DOI 10.1016/S0092-8674(01)00386-5; Connolly JB, 1996, SCIENCE, V274, P2104, DOI 10.1126/science.274.5295.2104; Crittenden JR, 1998, LEARN MEMORY, V5, P38; DAVIS RL, 1993, NEURON, V11, P1, DOI 10.1016/0896-6273(93)90266-T; DEBELLE JS, 1994, SCIENCE, V263, P692, DOI 10.1126/science.8303280; Dubnau J, 2001, NATURE, V411, P476, DOI 10.1038/35078077; FOLKERS E, 1993, P NATL ACAD SCI USA, V90, P8123, DOI 10.1073/pnas.90.17.8123; Grant D, 1998, GENETICS, V149, P1019; GRIGLIATTI TA, 1973, MOL GEN GENET, V120, P107, DOI 10.1007/BF00267238; HEISENBERG M, 1985, J NEUROGENET, V2, P1, DOI 10.3109/01677068509100140; Heisenberg M, 1998, LEARN MEMORY, V5, P1; Ito K, 1998, LEARN MEMORY, V5, P52; Kawasaki F, 2000, NAT NEUROSCI, V3, P859, DOI 10.1038/78753; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; KOENIG JH, 1989, J NEUROSCI, V9, P3844; Lee T, 1999, DEVELOPMENT, V126, P4065; MCGUIRE SE, UNPUB; ROMAN G, IN PRESS BIOESSAYS; Sokal RR, 1981, BIOMETRY PRINCIPLES; STOCKER RF, 1994, CELL TISSUE RES, V275, P3, DOI 10.1007/BF00305372; TULLY T, 1985, J COMP PHYSIOL A, V157, P263, DOI 10.1007/BF01350033; VANDERBLIEK AM, 1991, NATURE, V351, P411, DOI 10.1038/351411a0; Waddell S, 2000, CELL, V103, P805, DOI 10.1016/S0092-8674(00)00183-5; Zars T, 2000, SCIENCE, V288, P672, DOI 10.1126/science.288.5466.672	28	333	342	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 17	2001	293	5533					1330	1333		10.1126/science.1062622	http://dx.doi.org/10.1126/science.1062622			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	463TD	11397912				2022-12-24	WOS:000170492600044
J	Baudouin-Cornu, P; Surdin-Kerjan, Y; Marliere, P; Thomas, D				Baudouin-Cornu, P; Surdin-Kerjan, Y; Marliere, P; Thomas, D			Molecular evolution of protein atomic composition	SCIENCE			English	Article							AMINO-ACID-COMPOSITION; SACCHAROMYCES-CEREVISIAE; METABOLISM; CYSTEINE	Living organisms encounter various growth conditions in their habitats, raising the question of whether ecological fluctuations could alter biological macromolecules. The advent of complete genome sequences and the characterization of whole metabolic pathways allowed us to search for such ecological imprints. Significant correlations between atomic composition and metabolic function were found in sulfur- and carbon-assimilatory enzymes, which appear depleted in sulfur and carbon, respectively, in both the bacterium Escherichia coli and the eukaryote Saccharomyces cerevisiae, In addition to genetic instructions, genomic data thus also provide paleontological records of environmental nutrient availability and of metabolic costs.	CNRS, Ctr Genet Mol, F-91198 Gif Sur Yvette, France; Evol SA, F-91000 Evry, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Thomas, D (corresponding author), CNRS, Ctr Genet Mol, F-91198 Gif Sur Yvette, France.			Baudouin-Cornu, Peggy/0000-0001-7296-099X				CHEREST H, 1993, J BACTERIOL, V175, P5366, DOI 10.1128/JB.175.17.5366-5374.1993; Creighton TE, 1983, PROTEINS STRUCTURES; Fraenkel D., 1996, ESCHERICHIA COLI SAL, P189; GRIFFITH OW, 1987, METHOD ENZYMOL, V143, P366; JOHNSTON M, 1992, MOL CELLULAR BIOL YE, P193; KARLIN S, 1992, PROTEIN ENG, V5, P729, DOI 10.1093/protein/5.8.729; KARLIN S, 1992, SCIENCE, V257, P39, DOI 10.1126/science.1621093; Kimura M, 1985, NEUTRAL THEORY MOL E; KREDICH NM, 1996, ESCHERICHIA COLI SAL, P419; KRUGER WD, 1994, P NATL ACAD SCI USA, V91, P6614, DOI 10.1073/pnas.91.14.6614; LEYH TS, 1992, J BIOL CHEM, V267, P542; LI WH, 1997, MOL EVOLUTOIN; MAGASANIK B, 1992, MOL CELLULAR BIOL YE, V2, P283; MAZEL D, 1989, NATURE, V341, P245, DOI 10.1038/341245a0; Nei M, 1987, MOL EVOLUTIONARY GEN; Singer GAC, 2000, MOL BIOL EVOL, V17, P1581, DOI 10.1093/oxfordjournals.molbev.a026257; SUEKOA N, 1961, COLD SPRING HARB SYM, V26, P35; Thomas D, 1997, MICROBIOL MOL BIOL R, V61, P503, DOI 10.1128/.61.4.503-532.1997; Tourasse NJ, 2000, MOL BIOL EVOL, V17, P656, DOI 10.1093/oxfordjournals.molbev.a026344	19	102	108	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 13	2001	293	5528					297	300		10.1126/science.1061052	http://dx.doi.org/10.1126/science.1061052			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	452TK	11452124				2022-12-24	WOS:000169875200058
J	Richardson, JE; Weitz, FM; Fay, MF; Cronk, QCB; Linder, HP; Reeves, G; Chase, MW				Richardson, JE; Weitz, FM; Fay, MF; Cronk, QCB; Linder, HP; Reeves, G; Chase, MW			Rapid and recent origin of species richness in the Cape flora of South Africa	NATURE			English	Article							DNA; EVOLUTION	The Cape flora of South Africa grows in a continental area with many diverse and endemic species(1-4). We need to understand the evolutionary origins and ages of such 'hotspots' to conserve them effectively(5). In volcanic islands the timing of diversification can be precisely measured with potassium-argon dating. In contrast, the history of these continental species is based upon an incomplete fossil record and relatively imprecise isotopic palaeotemperature signatures. Here we use molecular phylogenetics and precise dating of two island species within the same clade as the continental taxa to show recent speciation in a species-rich genus characteristic of the Cape flora. The results indicate that diversification began approximately(7-8) Myr ago, coincident with extensive aridification caused by changes in ocean currents. The recent origin of endemic species diversity in the Cape flora shows that large continental bursts of speciation can occur rapidly over timescales comparable to those previously associated with oceanic island radiations(6,7).	Royal Bot Gardens, Jodrell Lab, Richmond TW9 3DS, Surrey, England; Univ Western Cape, Dept Bot, ZA-7535 Bellville, Cape Province, South Africa; Univ Cape Town, Bolus Herbarium, Dept Bot, ZA-7700 Rondebosch, South Africa; Univ Edinburgh, Inst Cell & Mol Biol, Edinburgh EH9 3JR, Midlothian, Scotland; Royal Bot Garden, Edinburgh EH3 5LR, Midlothian, Scotland	Royal Botanic Gardens, Kew; University of the Western Cape; University of Cape Town; University of Edinburgh	Richardson, JE (corresponding author), Univ Calif Santa Cruz, Dept Ecol & Evolut Biol, Santa Cruz, CA 95064 USA.	jamesr@darwin.ucsc.edu	Chase, Mark W/A-6642-2011; Fay, Michael F/G-4741-2010; Richardson, James-Edward/L-2768-2016; Linder, Hans Peter/F-5316-2010; Fay, Michael/AAU-5861-2021	Fay, Michael F/0000-0003-3491-9093; Richardson, James-Edward/0000-0001-9014-4865; Cronk, Quentin/0000-0002-4027-7368				Axelrod D. I., 1978, Biogeography and ecology of Southern Africa. Vol.1., P77; Baldwin Bruce G., 1995, P259; COETZEE J A, 1983, Bothalia, V14, P345; Coetzee J. A., 1978, ANTARCTIC GLACIAL HI, P115; CRONK QCB, 2000, ENDEMIC FLORA ST HEL, P23; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; FITCH WM, 1971, SYST ZOOL, V20, P406, DOI 10.2307/2412116; Givnish Thomas J., 1995, P288; GOLDBLATT P, 1978, ANN MO BOT GARD, V65, P369, DOI 10.2307/2398858; GOOD R, 1974, GEOGRAPHY FLOWERING, P190; HODGES SA, 1994, P NATL ACAD SCI USA, V91, P5129, DOI 10.1073/pnas.91.11.5129; Johnson SD, 1996, TAXON, V45, P59, DOI 10.2307/1222585; KENNETT JP, 1980, PALAEOGEOGR PALAEOCL, V31, P123, DOI 10.1016/0031-0182(80)90017-6; Linder H.P., 1992, P113; Linder HP, 1998, BOT J LINN SOC, V128, P319; LINDER HP, 1985, TRANSVAAL MUSEUM MON, V4, P53; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; RAMBAUT A, 2000, TREEEDIT VERSION 1 0; Richardson JE, 2000, AM J BOT, V87, P1309, DOI 10.2307/2656724; Sanderson MJ, 1997, MOL BIOL EVOL, V14, P1218, DOI 10.1093/oxfordjournals.molbev.a025731; SWOFFORD DL, 1998, PAUPSTAR4 0 B2 PHYLO; TAKHTAJAN A, 1986, FLORISTIC REGIONS WO, P263; Wojciechowski MF, 1999, SYST BOT, V24, P409, DOI 10.2307/2419698	24	213	218	4	25	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 12	2001	412	6843					181	183		10.1038/35084067	http://dx.doi.org/10.1038/35084067			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	451AJ	11449273				2022-12-24	WOS:000169778700051
J	WoldeGabriel, G; Haile-Selassie, Y; Renne, PR; Hart, WK; Ambrose, SH; Asfaw, B; Heiken, G; White, T				WoldeGabriel, G; Haile-Selassie, Y; Renne, PR; Hart, WK; Ambrose, SH; Asfaw, B; Heiken, G; White, T			Geology and palaeontology of the Late Miocene Middle Awash valley, Afar rift, Ethiopia	NATURE			English	Article							EARLY HOMINID; AUSTRALOPITHECUS; CLIMATE; CARBON; AFRICA; ARAMIS	The Middle Awash study area of Ethiopia's Afar rift has yielded abundant vertebrate fossils (approximate to 10,000), including several hominid taxa(1-4). The study area contains a long sedimentary record spanning Late Miocene (5.3-11.2 Myr ago) to Holocene times. Exposed in a unique tectonic and volcanic transition zone between the main Ethiopian rift (MER) and the Afar rift, sediments along the western Afar rift margin in the Middle Awash provide a unique window on the Late Miocene of Ethiopia. These deposits have now yielded the earliest hominids, described in an accompanying paper(5) and dated here to between 5.54 and 5.77 Myr. These geological and palaeobiological data from the Middle Awash provide fresh perspectives on hominid origins and early evolution. Here we show that these earliest hominids derive from relatively wet and wooded environments that were modulated by tectonic, volcanic, climatic and geomorphic processes. A similar wooded habitat also has been suggested for the 6.0 Myr hominoid fossils recently recovered from Lukeino, Kenya(6). These findings require fundamental reassessment of models that invoke a significant role for global climatic change and/or savannah habitat in the origin of hominids.	Univ Calif Los Alamos Natl Lab, Inst Geophys & Planetary Phys, Los Alamos, NM 87545 USA; Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Human Evolut Studies Lab, Museum Vertebrate Zool, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94709 USA; Berkeley Geochronol Ctr, Berkeley, CA 94709 USA; Miami Univ, Dept Geol, Oxford, OH 45056 USA; Univ Illinois, Dept Anthropol, Urbana, IL 61801 USA; Rift Valley Res Serv, Addis Ababa, Ethiopia	United States Department of Energy (DOE); Los Alamos National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Berkeley Geochronolgy Center; University System of Ohio; Miami University; University of Illinois System; University of Illinois Urbana-Champaign	WoldeGabriel, G (corresponding author), Univ Calif Los Alamos Natl Lab, Inst Geophys & Planetary Phys, EES-6-MS D462, Los Alamos, NM 87545 USA.			Renne, Paul/0000-0003-1769-5235				Asfaw B, 1999, SCIENCE, V284, P629, DOI 10.1126/science.284.5414.629; CANDE SC, 1995, J GEOPHYS RES-SOL EA, V100, P6093, DOI 10.1029/94JB03098; CERLING TE, 1989, NATURE, V341, P138, DOI 10.1038/341138a0; CONROY GC, 1978, NATURE, V275, P67; DEMENOCAL PB, 1995, SCIENCE, V270, P53, DOI 10.1126/science.270.5233.53; Griffin DL, 1999, J GEOL SOC LONDON, V156, P817, DOI 10.1144/gsjgs.156.4.0817; Haile-Selassie Y, 2001, NATURE, V412, P178, DOI 10.1038/35084063; Harland W.B., 1990, GEOLOGIC TIME SCALE; HEDBERG H. D., 1976, INT STRATIGRAPHIC GU; Kalb J.E., 1982, Newsletters on Stratigraphy, V11, P95; KALB JE, 1993, NEWSL STRATIGR, V29, P21; KINGDOM J, 1974, E AFRICAN MAMMALS B, V2; Leakey MG, 1996, J VERTEBR PALEONTOL, V16, P556, DOI 10.1080/02724634.1996.10011339; MOHR P, 1983, TECTONOPHYSICS, V94, P509, DOI 10.1016/0040-1951(83)90032-X; MORLEY CK, 1990, AAPG BULL, V74, P1234; MORTON WH, 1975, AFAR DEPRESSION ETHI, P55; Pickford M, 2001, CR ACAD SCI II A, V332, P145, DOI 10.1016/S1251-8050(01)01528-2; QUADE J, 1989, GEOL SOC AM BULL, V101, P464, DOI 10.1130/0016-7606(1989)101&lt;0464:SVITCA&gt;2.3.CO;2; Renne PR, 1999, GEOL SOC AM BULL, V111, P869, DOI 10.1130/0016-7606(1999)111<0869:COTMPS>2.3.CO;2; Ruddiman W., 1989, P OCEAN DRILLING PG, V108, P463, DOI DOI 10.2973/0DP.PR0C.SR.108.173.1989; TIERCELIN JJ, 1980, ACCAD NAZ LINCEI ROM, V47, P491; Van Campo E., 1991, P OCEAN DRILLING PRO, V117, P277; WHITE TD, 1994, NATURE, V371, P306, DOI 10.1038/371306a0; WHITE TD, 1993, NATURE, V366, P261, DOI 10.1038/366261a0; WOLDEGABRIEL G, 1994, NATURE, V371, P330, DOI 10.1038/371330a0; YEMANE K, 1985, NATURE, V318, P653, DOI 10.1038/318653a0	26	141	147	1	32	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 12	2001	412	6843					175	178		10.1038/35084058	http://dx.doi.org/10.1038/35084058			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	451AJ	11449271				2022-12-24	WOS:000169778700049
J	Langer, R				Langer, R			Perspectives: Drug delivery - Drugs on target	SCIENCE			English	Editorial Material									MIT, Dept Chem Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Langer, R (corresponding author), MIT, Dept Chem Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.							Affleck DG, 2001, GENE THER, V8, P349, DOI 10.1038/sj.gt.3301395; Carino GP, 1999, ADV DRUG DELIVER REV, V35, P249, DOI 10.1016/S0169-409X(98)00075-1; Daugherty AL, 1999, PHARM SCI TECHNOL TO, V2, P144, DOI 10.1016/S1461-5347(99)00142-X; de Lima MCP, 2001, ADV DRUG DELIVER REV, V47, P277, DOI 10.1016/S0169-409X(01)00110-7; EDWARDS DA, 1999, ENCY CONTROLLED DRUG, V2, P936; Hwang SJ, 2001, CURR OPIN MOL THER, V3, P183; Hwang SJ, 2001, BIOCONJUGATE CHEM, V12, P280, DOI 10.1021/bc0001084; Langer R, 1998, NATURE, V392, P5; Luo D, 2000, NAT BIOTECHNOL, V18, P33, DOI 10.1038/71889; SANTINI JT, 2000, ANGEW CHEM INT EDIT, V39, P2396	10	478	515	2	137	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 6	2001	293	5527					58	59		10.1126/science.1063273	http://dx.doi.org/10.1126/science.1063273			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	451BB	11441170				2022-12-24	WOS:000169780300024
J	White, LE; Coppola, DM; Fitzpatrick, D				White, LE; Coppola, DM; Fitzpatrick, D			The contribution of sensory experience to the maturation of orientation selectivity in ferret visual cortex	NATURE			English	Article							SHREW STRIATE CORTEX; DARK-REARED KITTENS; HORIZONTAL CONNECTIONS; CORTICOCORTICAL CONNECTIONS; CAT; MAPS; SPECIFICITY; ARRANGEMENT; DEPRIVATION; PREFERENCE	Sensory experience begins when neural circuits in the cerebral cortex are still immature; however, the contribution of experience to cortical maturation remains unclear. In the visual cortex, the selectivity of neurons for oriented stimuli at the time of eye opening is poor(1-5) and increases dramatically after the onset of visual experience(3-8). Here we investigate whether visual experience has a significant role in the maturation of orientation selectivity and underlying cortical circuits(9-12) using two forms of deprivation: dark rearing, which completely eliminates experience, and binocular lid suture, which alters the pattern of sensory driven activity(13). Orientation maps were present in dark-reared ferrets, but fully mature levels of tuning were never attained. In contrast, only rudimentary levels of orientation selectivity were observed in lid-sutured ferrets. Despite these differences, horizontal connections in both groups were less extensive and less clustered than normal, suggesting that long-range cortical processing is not essential for the expression of orientation selectivity, but may be needed for the full maturation of tuning. Thus, experience is beneficial or highly detrimental to cortical maturation, depending on the pattern of sensory driven activity.	Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Community & Family Med, Div Phys Therapy, Durham, NC 27710 USA; Centenary Coll Louisiana, Dept Biol, Shreveport, LA 71134 USA	Duke University; Duke University	White, LE (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA.	white033@mc.duke.edu						BLAKEMORE C, 1975, J PHYSIOL-LONDON, V248, P663, DOI 10.1113/jphysiol.1975.sp010995; Bonhoeffer Tobias, 1996, P55; Bosking WH, 1997, J NEUROSCI, V17, P2112; Bosking WH, 2000, J NEUROSCI, V20, P2346; CALLAWAY EM, 1991, P NATL ACAD SCI USA, V88, P745, DOI 10.1073/pnas.88.3.745; CHAPMAN B, 1993, J NEUROSCI, V13, P5251, DOI 10.1523/JNEUROSCI.13-12-05251.1993; Chapman B, 2000, J NEUROSCI, V20, P1922; Chapman B, 1996, J NEUROSCI, V16, P6443; Chapman B, 1999, J NEUROBIOL, V41, P18, DOI 10.1002/(SICI)1097-4695(199910)41:1<18::AID-NEU4>3.0.CO;2-V; Crair MC, 1998, SCIENCE, V279, P566, DOI 10.1126/science.279.5350.566; DAW N, 1995, VISUAL DEV; Durack JC, 1996, CEREB CORTEX, V6, P178, DOI 10.1093/cercor/6.2.178; FREGNAC Y, 1978, J PHYSIOL-LONDON, V278, P27, DOI 10.1113/jphysiol.1978.sp012290; FREGNAC Y, 1984, PHYSIOL REV, V64, P325, DOI 10.1152/physrev.1984.64.1.325; GILBERT CD, 1989, J NEUROSCI, V9, P2432; Godecke I, 1997, EUR J NEUROSCI, V9, P1754; HUBEL DH, 1963, J NEUROPHYSIOL, V26, P994, DOI 10.1152/jn.1963.26.6.994; Krug K, 2001, J NEUROPHYSIOL, V85, P1436, DOI 10.1152/jn.2001.85.4.1436; LUBKE J, 1992, J COMP NEUROL, V323, P42, DOI 10.1002/cne.903230105; Miller KD, 1999, J NEUROBIOL, V41, P44, DOI 10.1002/(SICI)1097-4695(199910)41:1<44::AID-NEU7>3.0.CO;2-V; MOWER GD, 1981, BRAIN RES, V220, P255, DOI 10.1016/0006-8993(81)91216-6; Ruthazer ES, 1996, J NEUROSCI, V16, P7253; Sengpiel F, 1999, NAT NEUROSCI, V2, P727, DOI 10.1038/11192; SHERMAN SM, 1982, PHYSIOL REV, V62, P738, DOI 10.1152/physrev.1982.62.2.738; Shouval HZ, 2000, J NEUROSCI, V20, P1119, DOI 10.1523/JNEUROSCI.20-03-01119.2000; Weliky M, 1997, NATURE, V386, P680, DOI 10.1038/386680a0; WIESEL TN, 1974, J COMP NEUROL, V158, P307, DOI 10.1002/cne.901580306; Wong ROL, 1996, NEURON, V16, P1087, DOI 10.1016/S0896-6273(00)80135-X; Zufferey PD, 1999, EUR J NEUROSCI, V11, P2669, DOI 10.1046/j.1460-9568.1999.00683.x	29	161	163	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 28	2001	411	6841					1049	1052		10.1038/35082568	http://dx.doi.org/10.1038/35082568			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	446TF	11429605				2022-12-24	WOS:000169528500048
J	Brady, AJB; Oliver, MA; Pittard, JB				Brady, AJB; Oliver, MA; Pittard, JB			Secondary prevention in 24,431 patients with coronary heart disease: survey in primary care	BMJ-BRITISH MEDICAL JOURNAL			English	Article									Univ Glasgow, Glasgow Royal Infirm, Dept Med Cardiol, Glasgow G31 2ER, Lanark, Scotland; Merck Sharp & Dohme Ltd, Hoddesdon EN11 9BU, Herts, England; Staines & Thameside Med, Staines TW18 3JH, Surrey, England	University of Glasgow; Merck & Company	Brady, AJB (corresponding author), Univ Glasgow, Glasgow Royal Infirm, Dept Med Cardiol, Glasgow G31 2ER, Lanark, Scotland.	a.j.brady@clinmed.gla.ac.uk						Bowker TJ, 1996, HEART, V75, P334, DOI 10.1136/hrt.75.4.334; Campbell NC, 1998, BMJ-BRIT MED J, V316, P1430, DOI 10.1136/bmj.316.7142.1430; *DEP HLTH, 2000, NAT SERV FRAM COR HE; Flanagan DEH, 1999, QJM-INT J MED, V92, P245, DOI 10.1093/qjmed/92.5.245	4	57	57	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 16	2001	322	7300					1463	1463		10.1136/bmj.322.7300.1463	http://dx.doi.org/10.1136/bmj.322.7300.1463			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	444FJ	11408303	Green Accepted, Green Published, Bronze, Green Submitted			2022-12-24	WOS:000169389200030
J	Adams, H; Ashworth, E; Breault, GA; Guo, J; Hunter, CA; Mayers, PC				Adams, H; Ashworth, E; Breault, GA; Guo, J; Hunter, CA; Mayers, PC			Knot tied around an octahedral metal centre	NATURE			English	Article							MOLECULAR TREFOIL KNOT; TOPOLOGY		Univ Sheffield, Dept Chem, Krebs Inst Biomolec Sci, Ctr Chem Biol, Sheffield S3 7HF, S Yorkshire, England; AstraZeneca, Macclesfield SK10 4TG, Cheshire, England	University of Sheffield; AstraZeneca	Adams, H (corresponding author), Univ Sheffield, Dept Chem, Krebs Inst Biomolec Sci, Ctr Chem Biol, Sheffield S3 7HF, S Yorkshire, England.		Hunter, Christopher Alexander/AFS-7239-2022	Hunter, Christopher Alexander/0000-0002-5182-1859				Arai Y, 1999, NATURE, V399, P446, DOI 10.1038/20894; Ashton PR, 1997, LIEBIGS ANN-RECL, P2485; Breault GA, 1999, TETRAHEDRON, V55, P5265, DOI 10.1016/S0040-4020(99)00282-3; Breault GA, 1998, J AM CHEM SOC, V120, P3402, DOI 10.1021/ja973938+; Carina RF, 1996, J AM CHEM SOC, V118, P9110, DOI 10.1021/ja961459p; Dietrich-Buchecker C., 1999, MOL CATENANES ROTAXA, P107; DIETRICHBUCHECKER CO, 1989, ANGEW CHEM INT EDIT, V28, P189, DOI 10.1002/anie.198901891; Safarowsky O, 2000, ANGEW CHEM INT EDIT, V39, P1616, DOI 10.1002/(SICI)1521-3773(20000502)39:9<1616::AID-ANIE1616>3.0.CO;2-Y; Seeman NC, 1998, ANGEW CHEM INT EDIT, V37, P3220, DOI 10.1002/(SICI)1521-3773(19981217)37:23<3220::AID-ANIE3220>3.0.CO;2-C; Sokolov V. I., 1973, RUSS CHEM REV, V42, P452, DOI DOI 10.1070/RC1973V042N06ABEH002636; Wang H, 1996, P NATL ACAD SCI USA, V93, P9477, DOI 10.1073/pnas.93.18.9477	11	89	89	1	17	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 14	2001	411	6839					763	763		10.1038/35081143	http://dx.doi.org/10.1038/35081143			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	441TV	11459044				2022-12-24	WOS:000169246400033
J	Woodman, CBJ; Collins, S; Winter, H; Bailey, A; Ellis, J; Prior, P; Yates, M; Rollason, TP; Young, LS				Woodman, CBJ; Collins, S; Winter, H; Bailey, A; Ellis, J; Prior, P; Yates, M; Rollason, TP; Young, LS			Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study	LANCET			English	Article							INTRAEPITHELIAL NEOPLASIA; HIGH-GRADE; RISK-FACTOR; LESIONS; TYPE-16; PROGRESSION; SMEARS; DNA	Background Laboratory and epidemiological research suggests an association between human papillomavirus (HPV) and cervical intraepithelial neoplasia (CIN). We studied the natural history of incident cervical HPV infection and its relation to the development of CIN. Methods We recruited 2011 women aged 15-19 years who had recently become sexually active. We took a cervical smear every 6 months and stored samples for virological analysis. We immediately referred all women with any cytological abnormality for colposcopic assessment, out postponed treatment until there was histological evidence of progression to high-grade CIN. Findings IN 1075 women who were cytologically normal and HPV negative at recruitment, the cumulative risk at 3 years of any HPV infection was 44% (95% CI 40-48): HPV 16 was the most common type. The cumulative risk at 3 years of detecting an HPV type not present in the first positive sample was 26% (20-32). 246 women had an abnormal smear during follow-up, of whom 28 progressed to high-grade CIN. The risk of high-grade CIN was greatest in women who tested positive for HPV 16 (risk ratio 8.5 [3.7-19.2]); this risk was maximum 6-12 months after first detection of HPV 16. All HPV types under consideration were associated with cytologically abnormal smears. Although abnormality was significantly less likely to be associated with low-viral-load samples, the cumulative risk at 3 years of a high-viral-load sample after a low-viral-load sample was 45% (95% CI 35-56). Five women who progressed to high-grade CIN consistently tested negative for HPV. Interpretation Our findings suggest that attempts to exploit the association between cervical neoplasia and HPV infection to improve effectiveness of cervical screening programmes might be undermined by the limited inferences that can be drawn from the characterisation of a woman's HPV status at a single point in time, and the short lead time gained by its detection.	Univ Manchester, Ctr Canc Epidemiol, Manchester M20 4QL, Lancs, England; Cent Manchester Healthcare Trust, Dept Clin Virol, Manchester, Lancs, England; Univ Birmingham, Dept Publ Hlth, Birmingham B15 2TT, W Midlands, England; Univ Birmingham, CRC, Inst Canc Studies, Birmingham B15 2TT, W Midlands, England; Birmingham Womens Hosp, Dept Pathol, Birmingham, W Midlands, England; Birmingham Womens Hosp, Acad Dept Obstet & Gynaecol, Birmingham, W Midlands, England	University of Manchester; University of Birmingham; University of Birmingham; Birmingham Women's Hospital; Birmingham Women's Hospital	Woodman, CBJ (corresponding author), Univ Manchester, Ctr Canc Epidemiol, Manchester M20 4QL, Lancs, England.	ciaran.woodman@cce.man.ac.uk	Young, Lawrence S/B-7213-2009	Young, Lawrence S/0000-0003-3919-4298				Bauer HM, 1992, DIAGNOSTIC MOL PATHO, P131; BERNARD HU, 1994, J INFECT DIS, V170, P1077, DOI 10.1093/infdis/170.5.1077; Burger MPM, 1996, BRIT J CANCER, V73, P831, DOI 10.1038/bjc.1996.146; Chenoy R, 1996, BRIT J OBSTET GYNAEC, V103, P457, DOI 10.1111/j.1471-0528.1996.tb09773.x; DOWNEY GP, 1994, LANCET, V344, P432, DOI 10.1016/S0140-6736(94)91768-X; FLANNELLY G, 1995, J MED VIROL, V47, P6, DOI 10.1002/jmv.1890470103; Herrington CS, 1999, J PATHOL, V189, P1; HILDESHEIM A, 1994, J INFECT DIS, V169, P235, DOI 10.1093/infdis/169.2.235; HIPPELAINEN MI, 1994, SEX TRANSM DIS, V21, P76, DOI 10.1097/00007435-199403000-00004; HO GYF, 1995, JNCI-J NATL CANCER I, V87, P1365, DOI 10.1093/jnci/87.18.1365; Ho GYF, 1998, INT J CANCER, V78, P594, DOI 10.1002/(SICI)1097-0215(19981123)78:5&lt;594::AID-IJC11&gt;3.0.CO;2-B; Ho GYF, 1998, NEW ENGL J MED, V338, P423, DOI 10.1056/NEJM199802123380703; HUSMAN AMDR, 1995, J GEN VIROL, V76, P1057; Kjellberg L, 1999, J GEN VIROL, V80, P391, DOI 10.1099/0022-1317-80-2-391; KOUTSKY LA, 1992, NEW ENGL J MED, V327, P1272, DOI 10.1056/NEJM199210293271804; Kruger-Kjaer S, 1998, INT J CANCER, V76, P613, DOI 10.1002/(SICI)1097-0215(19980529)76:5&lt;613::AID-IJC1&gt;3.0.CO;2-T; Liaw KL, 1999, J NATL CANCER I, V91, P954, DOI 10.1093/jnci/91.11.954; Luostarinen T, 1999, INT J CANCER, V80, P818, DOI 10.1002/(SICI)1097-0215(19990315)80:6&lt;818::AID-IJC4&gt;3.0.CO;2-T; Nobbenhuis MAE, 1999, LANCET, V354, P20, DOI 10.1016/S0140-6736(98)12490-X; Park JJ, 1998, GYNECOL ONCOL, V70, P386, DOI 10.1006/gyno.1998.5100; RAFFLE AE, 1995, LANCET, V345, P1469, DOI 10.1016/S0140-6736(95)91036-0; RICHART RM, 1969, AM J OBSTET GYNECOL, V105, P386, DOI 10.1016/0002-9378(69)90268-3; Shah KV, 1996, INT J GYNECOL PATHOL, V15, P127, DOI 10.1097/00004347-199604000-00006; Silins I, 1999, J GEN VIROL, V80, P2931, DOI 10.1099/0022-1317-80-11-2931; SOLER C, 1991, J VIROL METHODS, V35, P143, DOI 10.1016/0166-0934(91)90130-R; Swan DC, 1999, J CLIN MICROBIOL, V37, P1030, DOI 10.1128/JCM.37.4.1030-1034.1999; Tabrizi SN, 1999, BRIT J OBSTET GYNAEC, V106, P252, DOI 10.1111/j.1471-0528.1999.tb08239.x; VANDENBRULE AJC, 1990, J CLIN MICROBIOL, V28, P2739, DOI 10.1128/JCM.28.12.2739-2743.1990; VANDENVELDE C, 1992, J MED VIROL, V36, P279, DOI 10.1002/jmv.1890360409; Vonka V, 1999, INT J CANCER, V80, P365, DOI 10.1002/(SICI)1097-0215(19990129)80:3&lt;365::AID-IJC5&gt;3.0.CO;2-C; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Wideroff L, 1999, J INFECT DIS, V180, P1424, DOI 10.1086/315055; 1997, REVISED GUIDELINES C; 1995, HUMAN PAPILLOMAVIRUS, V64	34	590	649	0	26	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 9	2001	357	9271					1831	1836		10.1016/S0140-6736(00)04956-4	http://dx.doi.org/10.1016/S0140-6736(00)04956-4			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	440DN	11410191				2022-12-24	WOS:000169160800011
J	Tuffnell, DJ; Wilkinson, K; Beresford, N				Tuffnell, DJ; Wilkinson, K; Beresford, N			Interval between decision and delivery by caesarean section - are current standards achievable? Observational case series	BRITISH MEDICAL JOURNAL			English	Article							ANESTHESIA	Objectives To audit interval from decision to delivery in urgent caesarean section to determine whether the current standard of 30 minutes is achievable routinely; to determine whether delay leads to an excess of admissions to special care. Design Three audit cycles over four years followed by a continuous audit over 32 months. Setting Large district general hospital delivering 5500 women each year. Participants All women delivered by urgent caesarean section for abnormal fetal heart rate patterns, cord prolapse, failed instrumental delivery, or suspected placental abruption. Main outcome measures Proportion of women delivered within 30 and 40 minutes of decision. Admission rates to special care by length of interval between decision and delivery Results In the continuous audit 478 of 721 (66.3%) women were delivered in 30 minutes and 637 (88.3%) within 40 minutes; 29 (4.0%) were undelivered at 50 minutes. If the woman was taken to theatre in 10 minutes, 409 of 500 (81.8%) were delivered in 30 minutes and 495 (97%) in 40 minutes. There was no significant difference in the proportion of babies born at 36 weeks or later who were admitted to special care, when analysed by interval from decision to delivery. 36/449 (8%) babies with an interval, from decision to delivery of less than 30 minutes were admitted to special care and 3/23 (13%) with an interval of more than 50 minutes were admitted. Conclusions The current recommendations for the interval between decision and delivery are not being achieved in routine practice. Failure to meet the recommendations does not seem to increase neonatal morbidity.	Bradford NHS Trust, Matern Unit, Bradford BD9 6RJ, W Yorkshire, England		Tuffnell, DJ (corresponding author), Bradford NHS Trust, Matern Unit, Bradford BD9 6RJ, W Yorkshire, England.							*ASS AN GREAT BRIT, 1998, GUID OBST AN SERV; Brown G W, 1995, Int J Obstet Anesth, V4, P214, DOI 10.1016/0959-289X(95)82913-U; CHADWICK HS, 1991, ANESTHESIOLOGY, V74, P242, DOI 10.1097/00000542-199102000-00009; *CLIN NEGL SCHEM T, 1999, CLIN RISK MAN STAND; DWYER JP, 1999, 4 INT SCI M ROYAL CO, P13; *FOC GROUP, 2000, CONF ENQ STILLB DEAT, P41; Hawkins JL, 1997, ANESTHESIOLOGY, V86, P277, DOI 10.1097/00000542-199702000-00002; Johnson RV, 2000, ANAESTHESIA, V55, P179, DOI 10.1046/j.1365-2044.2000.055002179.x; Lucas DN, 2000, J ROY SOC MED, V93, P346, DOI 10.1177/014107680009300703; MacLennan A, 1999, BMJ-BRIT MED J, V319, P1054, DOI 10.1136/bmj.319.7216.1054; Madej T H, 1993, Qual Health Care, V2, P31, DOI 10.1136/qshc.2.1.31; *OYAL COLL OBST GY, 1995, ORG STAND MAT SERV, P36; *ROYAL COLL OBST G, 1999, SAF CHILDB, P17; 1997, WHY MOTHERS DIE CONF, P91	14	96	98	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 2	2001	322	7298					1330	1333		10.1136/bmj.322.7298.1330	http://dx.doi.org/10.1136/bmj.322.7298.1330			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	440GQ	11387177	Green Submitted, Bronze, Green Published			2022-12-24	WOS:000169167900016
J	Frankel, MS; Chapman, AR				Frankel, MS; Chapman, AR			Genetic technologies - Facing inheritable genetic modifications	SCIENCE			English	Article									Amer Assoc Advancement Sci, Sci Program, Washington, DC 20005 USA; Amer Assoc Advancement Sci, Policy Program, Washington, DC 20005 USA; Amer Assoc Advancement Sci, Sci Freedom Responsibil & Law, Washington, DC 20005 USA; Amer Assoc Advancement Sci, Dialogue Sci Eth & Relig Program, Washington, DC 20005 USA; Amer Assoc Advancement Sci, Sci & Human Rights Program, Washington, DC 20005 USA		Frankel, MS (corresponding author), Amer Assoc Advancement Sci, Sci Program, Washington, DC 20005 USA.							Barritt JA, 2001, HUM REPROD, V16, P513, DOI 10.1093/humrep/16.3.513; Couzin J, 1998, SCIENCE, V282, P27, DOI 10.1126/science.282.5386.27; Frankel MS., 2000, HUMAN INHERITABLE GE; *NIH, 1995, FED REG         0427, V60, P20737; *NY STAT TASK FORC, 1998, LAW ASS REPR TECHN A; Parens E, 2001, SCIENCE, V292, P397, DOI 10.1126/science.292.5516.397; 1994, GENE TECHNOLOGY 0712	7	7	7	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 18	2001	292	5520					1303	1303		10.1126/science.1057712	http://dx.doi.org/10.1126/science.1057712			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	435DV	11360984				2022-12-24	WOS:000168862900022
J	Smit, AB; Syed, NI; Schaap, D; van Minnen, J; Klumperman, J; Kits, KS; Lodder, H; van der Schors, RC; van Elk, R; Sorgedrager, B; Brejc, K; Sixma, TK; Geraerts, WPM				Smit, AB; Syed, NI; Schaap, D; van Minnen, J; Klumperman, J; Kits, KS; Lodder, H; van der Schors, RC; van Elk, R; Sorgedrager, B; Brejc, K; Sixma, TK; Geraerts, WPM			A glia-derived acetylcholine-binding protein that modulates synaptic transmission	NATURE			English	Article							IDENTIFIED LYMNAEA NEURONS; CULTURED HIPPOCAMPAL-NEURONS; FROG NEUROMUSCULAR-JUNCTION; PERISYNAPTIC SCHWANN-CELLS; ASTROCYTES IN-SITU; INTRACELLULAR CALCIUM; NICOTINIC RECEPTORS; SUBUNIT; SYNAPTOGENESIS; COMMUNICATION	There is accumulating evidence that glial cells actively modulate neuronal synaptic transmission. We identified a glia-derived soluble acetylcholine-binding protein (AChBP), which is a naturally occurring analogue of the ligand-binding domains of the nicotinic acetylcholine receptors (nAChRs). Like the nAChRs, it assembles into a homopentamer with ligand-binding characteristics that are typical for a nicotinic receptor; unlike the nAChRs, however, it lacks the domains to form a transmembrane ion channel. Presynaptic release of acetylcholine induces the secretion of AChBP through the glial secretory pathway. We describe a molecular and cellular mechanism by which glial cells release AChBP in the synaptic cleft, and propose a model for how they actively regulate cholinergic transmission between neurons in the central nervous system.	Free Univ Amsterdam, Fac Biol, Neurosci Res Inst, Dept Mol & Cellular Neurobiol, NL-1081 HV Amsterdam, Netherlands; Netherlands Canc Inst, Div Mol Carcinogenesis, NL-1066 CX Amsterdam, Netherlands; Univ Calgary, Dept Cell Biol & Anat, Calgary, AB T2N 4N1, Canada; Univ Utrecht, Med Ctr, Dept Cell Biol, Inst Biomembranes, NL-3584 CX Utrecht, Netherlands; Ctr Biogenet, NL-3584 CX Utrecht, Netherlands; Organon Teknika BV, Biosci Res Unit, Boxtel, Netherlands	Vrije Universiteit Amsterdam; Netherlands Cancer Institute; University of Calgary; Utrecht University	Smit, AB (corresponding author), Free Univ Amsterdam, Fac Biol, Neurosci Res Inst, Dept Mol & Cellular Neurobiol, De Boelelaan 1087, NL-1081 HV Amsterdam, Netherlands.	absmit@bio.vu.nl	Smit, August B/E-8410-2011	Sixma, Titia K/0000-0001-6180-0632				Araque A, 1999, TRENDS NEUROSCI, V22, P208, DOI 10.1016/S0166-2236(98)01349-6; Araque A, 1998, J NEUROSCI, V18, P6822; Araque A, 1998, EUR J NEUROSCI, V10, P2129, DOI 10.1046/j.1460-9568.1998.00221.x; BADIO B, 1994, MOL PHARMACOL, V45, P563; Betz H, 1999, ANN NY ACAD SCI, V868, P667, DOI 10.1111/j.1749-6632.1999.tb11343.x; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Calegari F, 1999, J BIOL CHEM, V274, P22539, DOI 10.1074/jbc.274.32.22539; CORNELLBELL AH, 1990, SCIENCE, V247, P470, DOI 10.1126/science.1967852; Corringer PJ, 1998, J NEUROSCI, V18, P648; Corringer PJ, 2000, ANNU REV PHARMACOL, V40, P431, DOI 10.1146/annurev.pharmtox.40.1.431; DANI JW, 1992, NEURON, V8, P429, DOI 10.1016/0896-6273(92)90271-E; DEVILLERSTHIERY A, 1993, J MEMBRANE BIOL, V136, P97, DOI 10.1007/BF02505755; Drisdel RC, 2000, J NEUROSCI, V20, P133, DOI 10.1523/JNEUROSCI.20-01-00133.2000; Edelstein SJ, 1997, J MOL BIOL, V267, P10, DOI 10.1006/jmbi.1996.0861; Feng ZP, 1997, J NEUROSCI, V17, P7839; GARDNER D, 1977, J NEUROPHYSIOL, V40, P349, DOI 10.1152/jn.1977.40.2.349; Green WN, 1999, J GEN PHYSIOL, V113, P163, DOI 10.1085/jgp.113.2.163; GROEBE DR, 1995, J BIOL CHEM, V270, P281, DOI 10.1074/jbc.270.1.281; Hamakawa T, 1999, J NEUROSCI, V19, P9306; JAHROMI BS, 1992, NEURON, V8, P1069, DOI 10.1016/0896-6273(92)90128-Z; Kang J, 1998, NAT NEUROSCI, V1, P683, DOI 10.1038/3684; Karlin A, 1995, NEURON, V15, P1231, DOI 10.1016/0896-6273(95)90004-7; KATZ B, 1973, J PHYSIOL-LONDON, V231, P549, DOI 10.1113/jphysiol.1973.sp010248; KUFFLER SW, 1975, J PHYSL, V1, P465; LENOVERE N, 1995, J MOL EVOL, V40, P155, DOI 10.1007/BF00167110; Mehta AK, 1999, BRAIN RES REV, V29, P196, DOI 10.1016/S0165-0173(98)00052-6; MURPHY TH, 1993, J NEUROSCI, V13, P2672, DOI 10.1523/JNEUROSCI.13-06-02672.1993; NEDERGAARD M, 1994, SCIENCE, V263, P1768, DOI 10.1126/science.8134839; Newman EA, 1998, J NEUROSCI, V18, P4022; OrrUrtreger A, 1997, J NEUROSCI, V17, P9165; PARPURA V, 1994, NATURE, V369, P744, DOI 10.1038/369744a0; PASTI L, 1995, J BIOL CHEM, V270, P15203, DOI 10.1074/jbc.270.25.15203; Pasti L, 1997, J NEUROSCI, V17, P7817; Porter JT, 1996, J NEUROSCI, V16, P5073; Robitaille R, 1997, J PHYSIOL-LONDON, V504, P337, DOI 10.1111/j.1469-7793.1997.337be.x; Robitaille R, 1998, NEURON, V21, P847, DOI 10.1016/S0896-6273(00)80600-5; SLOT JW, 1988, METHOD MICROBIOL, V20, P211, DOI 10.1016/S0580-9517(08)70053-9; SMITH SJ, 1992, PROG BRAIN RES, V94, P119; SYED NI, 1990, SCIENCE, V250, P282, DOI 10.1126/science.2218532; THEODOSIS DT, 1993, NEUROSCIENCE, V57, P501, DOI 10.1016/0306-4522(93)90002-W; VANMINNEN J, 1988, CELL TISSUE RES, V251, P477, DOI 10.1007/BF00215857; Verbitsky M, 2000, NEUROPHARMACOLOGY, V39, P2515, DOI 10.1016/S0028-3908(00)00124-6; VERRALL S, 1992, CELL, V68, P23, DOI 10.1016/0092-8674(92)90203-O; Wang ZZ, 1996, J BIOL CHEM, V271, P27575, DOI 10.1074/jbc.271.44.27575; WATHEY JC, 1979, BIOPHYS J, V27, P145, DOI 10.1016/S0006-3495(79)85208-X; Wells GB, 1998, J BIOL CHEM, V273, P964, DOI 10.1074/jbc.273.2.964; Woodin MA, 1999, LEARN MEMORY, V6, P307; YEOMAN MS, 1993, J NEUROPHYSIOL, V70, P37, DOI 10.1152/jn.1993.70.1.37; Zwart R, 1997, MOL PHARMACOL, V52, P886, DOI 10.1124/mol.52.5.886	50	435	456	2	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 17	2001	411	6835					261	268		10.1038/35077000	http://dx.doi.org/10.1038/35077000			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432RT	11357121				2022-12-24	WOS:000168710000036
J	Wilson, SI; Rydstrom, A; Trimborn, T; Willert, K; Nusse, R; Jessell, TM; Edlund, T				Wilson, SI; Rydstrom, A; Trimborn, T; Willert, K; Nusse, R; Jessell, TM; Edlund, T			The status of Wnt signalling regulates neural and epidermal fates in the chick embryo	NATURE			English	Article							BETA-CATENIN; NONNEURAL ECTODERM; SOX3 GENES; INDUCTION; EXPRESSION; XENOPUS; CELLS; FGF; GASTRULATION; REQUIREMENT	The acquisition of neural fate by embryonic ectodermal cells is a fundamental step in the formation of the vertebrate nervous system. Neural induction seems to involve signalling by fibroblast growth factors (FGFs) and attenuation of the activity of bone morphogenetic protein (BMP)(1-4). But FGFs, either alone or in combination with BMP antagonists, are not sufficient to induce neural fate in prospective epidermal ectoderm of amniote embryos(1,3,4). These findings suggest that additional signals are involved in the specification of neural fate. Here we show that the state of Wnt signalling is a critical determinant of neural and epidermal fates in the chick embryo. Continual Wnt signalling blocks the response of epiblast cells to FGF signals, permitting the expression and signalling of BMP to direct an epidermal fate. Conversely, a lack of exposure of epiblast cells to Wnt signals permits FGFs to induce a neural fate.	Umea Univ, Dept Microbiol, S-90187 Umea, Sweden; Stanford Univ, Beckman Ctr, Howard Hughes Med Inst, Dept Dev Biol, Stanford, CA 94305 USA; Columbia Univ, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, New York, NY 10032 USA	Umea University; Howard Hughes Medical Institute; Stanford University; Columbia University; Howard Hughes Medical Institute	Edlund, T (corresponding author), Umea Univ, Dept Microbiol, S-90187 Umea, Sweden.			Rydstrom, Anna/0000-0002-3404-7195				Dufort D, 1998, DEVELOPMENT, V125, P3015; EYALGILADI H, 1976, DEV BIOL, V49, P321, DOI 10.1016/0012-1606(76)90178-0; GUGER KA, 1995, DEV BIOL, V172, P115, DOI 10.1006/dbio.1995.0009; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Harland R, 2000, CURR OPIN GENET DEV, V10, P357, DOI 10.1016/S0959-437X(00)00096-4; Hsieh JC, 1999, P NATL ACAD SCI USA, V96, P3546, DOI 10.1073/pnas.96.7.3546; KELLY GM, 1995, MECH DEVELOP, V53, P261, DOI 10.1016/0925-4773(95)00442-4; Kishi M, 2000, DEVELOPMENT, V127, P791; KOENIG BB, 1994, MOL CELL BIOL, V14, P5961, DOI 10.1128/MCB.14.9.5961; Mallamaci A, 1996, MECH DEVELOP, V58, P165, DOI 10.1016/S0925-4773(96)00571-0; Mohammadi M, 1997, SCIENCE, V276, P955, DOI 10.1126/science.276.5314.955; NEW DAT, 1955, J EMBRYOL EXP MORPH, V3, P320; NOORDERMEER J, 1994, NATURE, V367, P80, DOI 10.1038/367080a0; Pera E, 1999, DEVELOPMENT, V126, P63; Pevny LH, 1998, DEVELOPMENT, V125, P1967; Read EM, 1998, INT J DEV BIOL, V42, P763; Rex M, 1997, DEV DYNAM, V209, P323, DOI 10.1002/(SICI)1097-0177(199707)209:3<323::AID-AJA7>3.0.CO;2-K; Roeser T, 1999, DEVELOPMENT, V126, P2955; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Sheng GJ, 1999, MECH DEVELOP, V87, P213, DOI 10.1016/S0925-4773(99)00150-1; Shibamoto S, 1998, GENES CELLS, V3, P659; Shimizu H, 1997, CELL GROWTH DIFFER, V8, P1349; Streit A, 2000, NATURE, V406, P74, DOI 10.1038/35017617; Streit A, 1999, MECH DEVELOP, V82, P51, DOI 10.1016/S0925-4773(99)00013-1; TENDIJKE P, 1994, SCIENCE, V264, P101, DOI 10.1126/science.8140412; WILSON PA, 1995, NATURE, V376, P331, DOI 10.1038/376331a0; Wilson SI, 2000, CURR BIOL, V10, P421, DOI 10.1016/S0960-9822(00)00431-0; Wood HB, 1999, MECH DEVELOP, V86, P197, DOI 10.1016/S0925-4773(99)00116-1; Zorn AM, 1999, MOL CELL, V4, P487, DOI 10.1016/S1097-2765(00)80200-2	29	215	223	0	15	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 17	2001	411	6835					325	330		10.1038/35077115	http://dx.doi.org/10.1038/35077115			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432RT	11357137				2022-12-24	WOS:000168710000052
J	Schwetz, BA				Schwetz, BA			New treatment for chronic myelogenous leukemia	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									US FDA, Off Commissioner, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Schwetz, BA (corresponding author), US FDA, Off Commissioner, HF-1,Room 14-71,5600 Fishers Ln, Rockville, MD 20857 USA.							Stephenson J, 2001, JAMA-J AM MED ASSOC, V285, P2841, DOI 10.1001/jama.285.22.2841	1	8	8	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 4	2001	286	1					35	35		10.1001/jama.286.1.35	http://dx.doi.org/10.1001/jama.286.1.35			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	449GR	11434814				2022-12-24	WOS:000169676400005
J	Sheng, M; Lee, SH				Sheng, M; Lee, SH			AMPA receptor trafficking and the control of synaptic transmission	CELL			English	Review							LONG-TERM POTENTIATION; PLASTICITY; SYNAPSES; MEMBRANE; LTP		Massachusetts Gen Hosp, Dept Neurobiol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Howard Hughes Med Inst, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; Harvard University; Harvard Medical School	Sheng, M (corresponding author), MIT, Ctr Learning & Memory, 77 Massachusetts Ave, Cambridge, MA 02139 USA.			Sheng, Morgan/0000-0002-8703-5366				Beattie EC, 2000, NAT NEUROSCI, V3, P1291, DOI 10.1038/81823; Carroll RC, 2001, NAT REV NEUROSCI, V2, P315, DOI 10.1038/35072500; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Lin JW, 2000, NAT NEUROSCI, V3, P1282, DOI 10.1038/81814; Lledo PM, 1998, SCIENCE, V279, P399, DOI 10.1126/science.279.5349.399; Luscher C, 2000, NAT NEUROSCI, V3, P545, DOI 10.1038/75714; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; LYNCH G, 1984, SCIENCE, V224, P1057, DOI 10.1126/science.6144182; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Malinow R, 2000, CURR OPIN NEUROBIOL, V10, P352, DOI 10.1016/S0959-4388(00)00099-4; Man HY, 2000, NEURON, V25, P649, DOI 10.1016/S0896-6273(00)81067-3; Nusser Z, 2000, CURR OPIN NEUROBIOL, V10, P337, DOI 10.1016/S0959-4388(00)00086-6; Scannevin RH, 2000, NAT REV NEUROSCI, V1, P133, DOI 10.1038/35039075; Sheng M, 2000, ANNU REV PHYSIOL, V62, P755, DOI 10.1146/annurev.physiol.62.1.755; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Wenthold RJ, 1996, J NEUROSCI, V16, P1982; Zhu JJ, 2000, NAT NEUROSCI, V3, P1098, DOI 10.1038/80614	20	160	163	0	11	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 29	2001	105	7					825	828		10.1016/S0092-8674(01)00406-8	http://dx.doi.org/10.1016/S0092-8674(01)00406-8			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	449BK	11439178	Bronze			2022-12-24	WOS:000169664300003
J	Stanhope, MJ; Lupas, A; Italia, MJ; Koretke, KK; Volker, C; Brown, JR				Stanhope, MJ; Lupas, A; Italia, MJ; Koretke, KK; Volker, C; Brown, JR			Phylogenetic analyses do not support horizontal gene transfers from bacteria to vertebrates	NATURE			English	Article							MONOAMINE-OXIDASE; GENOME SEQUENCE; BEHAVIOR; ARCHAEA	Horizontal gene transfer (HGT) has long been recognized as a principal force in the evolution of genomes(1). Genome sequences of Archaea and Bacteria have revealed the existence of genes whose similarity to loci in distantly related organisms is explained most parsimoniously by HGT events(2-4). In most multicellular organisms, such genetic fixation can occur only in the germ line. Therefore, it is notable that the publication of the human genome reports 113 incidents of direct HGT between bacteria and vertebrates(5), without any apparent occurrence in evolutionary intermediates, that is, non-vertebrate eukaryotes. Phylogenetic analysis arguably provides the most objective approach for determining the occurrence and directionality of HGT(6,7). Here we report a phylogenetic analysis of 28 proposed HGT genes, whose presence in the human genome had been confirmed by polymerase chain reaction (PCR)(5). The results indicate that most putative HGT genes are present in more anciently derived eukaryotes (many such sequences available in non-vertebrate EST databases) and can be explained in terms of descent through common ancestry. They are, therefore, unlikely to be examples of direct HGT from bacteria to vertebrates.	GlaxoSmithKline Inc, Bioinformat, Collegeville, PA 19426 USA	GlaxoSmithKline	Stanhope, MJ (corresponding author), GlaxoSmithKline Inc, Bioinformat, 1250 S Collegeville Rd,UP1345, Collegeville, PA 19426 USA.	Michael_J_Stanhope@sbphrd.com; James_R_Brown@sbphrd.com		Italia, Michael/0000-0002-6941-6181				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Brown JR, 1997, MICROBIOL MOL BIOL R, V61, P456, DOI 10.1128/.61.4.456-502.1997; BRUNNER HG, 1993, SCIENCE, V262, P578, DOI 10.1126/science.8211186; CASES O, 1995, SCIENCE, V268, P1763, DOI 10.1126/science.7792602; Deckert J, 1999, HUM MOL GENET, V8, P621, DOI 10.1093/hmg/8.4.621; Doolittle WF, 1999, SCIENCE, V284, P2124, DOI 10.1126/science.284.5423.2124; Eisen JA, 1998, GENOME RES, V8, P163, DOI 10.1101/gr.8.3.163; FELSENSTEIN J, 2000, PHYLIP PHYLOGENY INT; GRAY MW, 1992, INT REV CYTOL, V141, P233, DOI 10.1016/S0074-7696(08)62068-9; Kyrpides NC, 1999, TRENDS GENET, V15, P298, DOI 10.1016/S0168-9525(99)01811-9; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Logsdon JM, 1999, CURR BIOL, V9, pR747, DOI 10.1016/S0960-9822(99)80474-6; Nelson KE, 1999, NATURE, V399, P323, DOI 10.1038/20601; Ruepp A, 2000, NATURE, V407, P508, DOI 10.1038/35035069; SMITH MW, 1992, TRENDS BIOCHEM SCI, V17, P489, DOI 10.1016/0968-0004(92)90335-7; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673	16	157	164	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 21	2001	411	6840					940	944		10.1038/35082058	http://dx.doi.org/10.1038/35082058			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	444EN	11418856				2022-12-24	WOS:000169386200042
J	Lamont, EB; Christakis, NA				Lamont, EB; Christakis, NA			Prognostic disclosure to patients with cancer near the end of life	ANNALS OF INTERNAL MEDICINE			English	Article							INFORMATION NEEDS; ODDS RATIOS; SURVIVAL; PREFERENCES; PREDICTIONS; ATTITUDES; SUPPORT	Background: Patients' understanding of their prognosis informs numerous medical and nonmedical decisions, but patients with cancer and their physicians often have disparate prognostic expectations. Objective: To determine whether physician behavior might contribute to the disparity between patients' and physicians' prognostic expectations. Design: Prospective cohort study. Setting: Five hospices in Chicago, Illinois. Patients: 326 patients with cancer. Intervention: Physicians formulated survival estimates and also indicated the survival estimates that they would communicate to their patients if the patients insisted. Measurements: Comparison of the formulated and communicated prognoses. Results: For 300 of 311 evaluable patients (96.5%), physicians were able to formulate prognoses. Physicians reported that they would not communicate any survival estimate 22.7% (95% CI, 17.9% to 27.4%) of the time, would communicate the same survival estimate they formulated 37% (CI, 31.5% to 42.5%) of the time, and would communicate a survival estimate different from the one they formulated 40.3% (CI, 34.8% to 45.9%) of the time. Of the discrepant survival estimates, most (70.2%) were optimistically discrepant. Multivariate analysis revealed that older patients were more likely to receive frank survival estimates, that the most experienced physicians and the physicians who were least confident about their prognoses were more likely to favor no disclosure over frank disclosure, and that female physicians were less likely to favor frank disclosure over pessimistically discrepant disclosure. Conclusions: Physicians reported that even if patients with cancer requested survival estimates, they would provide a frank estimate only 37% of the time and would provide no estimate, a conscious overestimate, or a conscious underestimate most of the time (63%). This pattern may contribute to the observed disparities between physicians' and patients' estimates of survival.	Univ Chicago, Med Ctr, Chicago, IL 60637 USA	University of Chicago; University of Chicago Medical Center	Christakis, NA (corresponding author), Univ Chicago, Med Ctr, 5841 S Maryland Ave,MC 2007, Chicago, IL 60637 USA.	nchrista@medicine.bsd.uchicago.edu	Christakis, Nicholas A/C-3205-2009; Christakis, Nicholas A/B-6690-2008	Lamont, Elizabeth/0000-0001-6604-678X	NIA NIH HHS [K12 AG-0048-09] Funding Source: Medline	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		AGRESTI A, 1990, CATEGORICAL DATA ANA, P125; Altman DG, 1998, BRIT MED J, V317, P1318, DOI 10.1136/bmj.317.7168.1318; [Anonymous], 1999, DEATH FORETOLD PROPH; Asch DA, 1997, J CLIN EPIDEMIOL, V50, P1129, DOI 10.1016/S0895-4356(97)00126-1; BILLINGS JA, 1985, OUTPATIENT MANAGEMEN; BLANCHARD CG, 1988, SOC SCI MED, V27, P1139, DOI 10.1016/0277-9536(88)90343-7; Buckman R., 1992, BREAK BAD NEWS GUIDE; Christakis NA, 1996, NEW ENGL J MED, V335, P172, DOI 10.1056/NEJM199607183350306; Christakis NA, 1998, ARCH INTERN MED, V158, P2389, DOI 10.1001/archinte.158.21.2389; Christakis NA, 2000, MED CARE, V38, P528, DOI 10.1097/00005650-200005000-00009; Christakis NA, 2000, BRIT MED J, V320, P469, DOI 10.1136/bmj.320.7233.469; CONNORS AF, 1992, MED DECIS MAKING, V12, P336; Davies HTO, 1998, BRIT MED J, V316, P989, DOI 10.1136/bmj.316.7136.989; Davison B J, 1995, Oncol Nurs Forum, V22, P1401; Degner LF, 1997, JAMA-J AM MED ASSOC, V277, P1485, DOI 10.1001/jama.277.18.1485; EIDINGER RN, 1984, CANCER, V53, P2736, DOI 10.1002/1097-0142(19840615)53:12<2736::AID-CNCR2820531233>3.0.CO;2-W; EVANS C, 1985, LANCET, V1, P1204; FIREBAUGH G, 1985, AM SOCIOL REV, V50, P713, DOI 10.2307/2095384; FITTS WT, 1953, JAMA-J AM MED ASSOC, V153, P901, DOI 10.1001/jama.1953.02940270007002; FORSTER LE, 1988, ARCH INTERN MED, V148, P2540, DOI 10.1001/archinte.148.12.2540; FRANKL D, 1989, AM J MED, V86, P645, DOI 10.1016/0002-9343(89)90436-1; Hobcraft J., 1985, COHORT ANAL SOCIAL R, P89; KNAUS WA, 1995, ANN INTERN MED, V122, P191, DOI 10.7326/0003-4819-122-3-199502010-00007; Kutner JS, 1999, SOC SCI MED, V48, P1341, DOI 10.1016/S0277-9536(98)00453-5; MACKILLOP WJ, 1988, BRIT J CANCER, V58, P355, DOI 10.1038/bjc.1988.218; MCCULLAGH P, 1999, GEN LINEAR MODELS, P125; MURPHY DJ, 1994, NEW ENGL J MED, V330, P545, DOI 10.1056/NEJM199402243300807; NOVACK DH, 1979, JAMA-J AM MED ASSOC, V241, P897, DOI 10.1001/jama.241.9.897; OKEN D, 1961, JAMA-J AM MED ASSOC, V175, P1120, DOI 10.1001/jama.1961.03040130004002; PARKES CM, 1972, BRIT MED J, V2, P29, DOI 10.1136/bmj.2.5804.29; POSES RM, 1990, ARCH INTERN MED, V150, P1874, DOI 10.1001/archinte.150.9.1874; STEIHAUSER KE, 2000, ANN INTERN MED, V132, P5825; Steinhauser AE, 2000, JAMA-J AM MED ASSOC, V284, P2476, DOI 10.1001/jama.284.19.2476; Weeks JC, 1998, JAMA-J AM MED ASSOC, V279, P1709, DOI 10.1001/jama.279.21.1709; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690; Zubrod C.G., 1960, J CHRON DIS, V11, P7	36	364	368	0	13	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 19	2001	134	12					1096	1105		10.7326/0003-4819-134-12-200106190-00009	http://dx.doi.org/10.7326/0003-4819-134-12-200106190-00009			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	442YU	11412049				2022-12-24	WOS:000169313200002
J	Gollob, MH; Green, MS; Tang, ASL; Gollob, T; Karibe, A; Roberts, R; Ahmad, F; Lozado, R; Shah, G; Fananapazir, L; Bachinski, LL; Roberts, R; Tapscott, T; Gonzales, O; Begley, D; Mohiddin, S				Gollob, MH; Green, MS; Tang, ASL; Gollob, T; Karibe, A; Roberts, R; Ahmad, F; Lozado, R; Shah, G; Fananapazir, L; Bachinski, LL; Roberts, R; Tapscott, T; Gonzales, O; Begley, D; Mohiddin, S			Identification of a gene responsible for familial Wolff-Parkinson-White syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Proceedings Paper	22nd Annual Meeting of the North-American-Society-of-Pacing-and-Electrophysiology	MAY 02-05, 2001	BOSTON, MA	N Amer Soc Pacing & Electrophysiol			ACTIVATED PROTEIN-KINASE; ATRIAL-FIBRILLATION; CARDIAC-ARREST; PATTERNS; SUBUNIT; YOUNG	Background The Wolff Parkinson White syndrome, with a prevalence in Western countries of 1.5 to 3.1 per 1000 persons, causes considerable morbidity and may cause sudden death. We identified two families in which the Wolff Parkinson White syndrome segregated as an autosomal dominant disorder. Methods We studied 70 members of the two families (57 in Family 1 and 13 in Family 2). The subjects underwent 12-lead electrocardiography and two-dimensional echocardiography. Genotyping mapped the gene responsible to 7q34-q36, a locus previously identified to be responsible for an inherited form of Wolff Parkinson White syndrome. Candidate genes were identified, sequenced, and analyzed in normal and affected family members to identify the disease-causing gene. Results A total of 31 members (23 from Family 1 and 8 from Family 2) had the Wolff Parkinson White syndrome. Affected members of both families had ventricular preexcitation with conduction abnormalities and cardiac hypertrophy. The maximal combined two-point lod score was 9.82 at a distance of 5 cM from marker D7S636, which confirmed the linkage of the gene in both families to 7q34-q36. Haplotype analysis indicated that there were no alleles in common in the two families at this locus, suggesting that the two families do not have a common founder. We identified a missense mutation in the gene that encodes the gamma2 regulatory subunit of AMP-activated protein kinase (PRKAG2). The mutation results in the substitution of glutamine for arginine at residue 302 in the protein. Conclusions The identification of this genetic defect has important implications for elucidating the pathogenesis of ventricular preexcitation. Further understanding of how this molecular defect leads to supraventricular arrhythmias could influence the development of specific therapies for other forms of supraventricular arrhythmia. (N Engl J Med 2001;344:1823-31.) Copyright (C) 2001 Massachusetts Medical Society.	Baylor Coll Med, Dept Med, Cardiol Sect, Houston, TX 77030 USA; Univ Ottawa, Inst Heart, Ottawa, ON, Canada; NHLBI, Inherited Heart Dis Sect, NIH, Bethesda, MD 20892 USA	Baylor College of Medicine; University of Ottawa; University of Ottawa Heart Institute; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Roberts, R (corresponding author), Baylor Coll Med, Dept Med, Cardiol Sect, 6550 Fannin,MS SM 677, Houston, TX 77030 USA.	rroberts@bcm.tmc.edu	Tang, Anthony S/E-6203-2014	Ahmad, Ferhaan/0000-0003-2877-4641; Gollob, Michael/0000-0003-0242-5208	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [Z01HL005058] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Al-Khatib SM, 1999, AM HEART J, V138, P403, DOI 10.1016/S0002-8703(99)70140-7; Aliot E, 1998, EUR HEART J, V19, pE25; BAUERNFEIND RA, 1981, AM J CARDIOL, V47, P562, DOI 10.1016/0002-9149(81)90539-7; BENSON DW, 1983, AM J CARDIOL, V52, P65, DOI 10.1016/0002-9149(83)90070-X; CAMPBELL RWF, 1977, AM J CARDIOL, V40, P514, DOI 10.1016/0002-9149(77)90065-0; Cheung PCF, 2000, BIOCHEM J, V346, P659, DOI 10.1042/0264-6021:3460659; COOPER DN, 1990, HUM GENET, V85, P55; Crute BE, 1998, J BIOL CHEM, V273, P35347, DOI 10.1074/jbc.273.52.35347; Dunnigan A., 1986, CARDIAC PREEXCITATIO, P21; FURLANELLO F, 1992, PACE, V15, P1403; GUIZE L, 1985, ANN MED INTERNE, V136, P474; HEJTMANCIK MR, 1957, AM HEART J, V54, P708, DOI 10.1016/0002-8703(57)90425-8; JACKMAN WM, 1991, NEW ENGL J MED, V324, P1605, DOI 10.1056/NEJM199106063242301; Kastor J A, 1974, Cardiovasc Clin, V6, P111; KLEIN GJ, 1988, J AM COLL CARDIOL, V11, P1035, DOI 10.1016/S0735-1097(98)90063-8; Leclerc I, 1998, FEBS LETT, V431, P180, DOI 10.1016/S0014-5793(98)00745-5; MACRAE CA, 1995, J CLIN INVEST, V96, P1216, DOI 10.1172/JCI118154; Moule SK, 1998, FEBS LETT, V439, P287, DOI 10.1016/S0014-5793(98)01392-1; NEITZEL H, 1986, HUM GENET, V73, P320, DOI 10.1007/BF00279094; Ott J., 1991, ANAL HUMAN GENETIC L; PACKARD JM, 1954, CIRCULATION, V10, P384, DOI 10.1161/01.CIR.10.3.384; Rosenblum BB, 1997, NUCLEIC ACIDS RES, V25, P4500, DOI 10.1093/nar/25.22.4500; Thompson MW, 1991, THOMPSON THOMPSON GE; TOPAZ O, 1989, AM HEART J, V118, P281, DOI 10.1016/0002-8703(89)90186-5; WAN Q, 1992, CHINESE MED J-PEKING, V105, P284; Winder WW, 2000, J APPL PHYSIOL, V88, P2219, DOI 10.1152/jappl.2000.88.6.2219; Woods A, 1996, J BIOL CHEM, V271, P10282, DOI 10.1074/jbc.271.17.10282	27	425	451	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 14	2001	344	24					1823	1831		10.1056/NEJM200106143442403	http://dx.doi.org/10.1056/NEJM200106143442403			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	441LC	11407343	Bronze			2022-12-24	WOS:000169231000003
J	Ziv, E; Cauley, J; Morin, PA; Saiz, R; Browner, WS				Ziv, E; Cauley, J; Morin, PA; Saiz, R; Browner, WS			Association between the T29 -> C polymorphism in the transforming growth factor beta 1 gene and breast cancer among elderly white women the study of osteoporotic fractures	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BONE-MINERAL DENSITY; GROWTH-FACTOR-BETA-1 GENE; MYOCARDIAL-INFARCTION; CIGARETTE-SMOKING; RISK; SUSCEPTIBILITY; FREQUENCY; CYP17; BRCA1	Context Transgenic animal experiments suggest that increased expression of transforming growth factor beta1 (TGF-beta1) is protective against early tumor development, particularly in breast cancer. A T -->C (thymine to cytosine) transition in the 29th nucleotide in the coding sequence results in a leucine to proline substitution at the 10th amino acid and is associated with increased serum levels of TGF-beta1. Objective To determine whether an association exists between this TGF-beta1 polymorphism and breast cancer risk. Design, Setting, and Participants The Study of Osteoporotic Fractures, a prospective cohort study of white, community-dwelling women aged 65 years or older who were recruited at 4 US centers between 1986 and 1988. Three thousand seventy-five women who provided sufficient clinical information, buffy coat samples, and adequate consent for genotyping are included in this analysis. Main Outcome Measure Breast cancer cases during a mean (SD) follow-up of 9.3 (1.9) years, verified by medical chart review and compared by genotype. Results Risk of breast cancer was similar in the 1124 women with the T/T genotype (56 cases; 5.4 per 1000 person-years) and the 1493 women with the T/C genotype (80 cases; 5.8 per 1000 person-years) but was significantly lower (P=.01) in the 458 women with the C/C genotype (10 cases; 2.3 per 1000 person-years). In analyses that adjusted for age, age at menarche, age at menopause, estrogen use, parity, body mass index, and bone mineral density, women with the C/C genotype had a significantly lower risk of developing breast cancer compared with women with the T/T or T/C genotype (hazard ratio [HR], 0.36; 95% confidence interval [CI], 0.17-0.75). There was no significant difference between the risk for women with the T/C genotype compared with women with the T/T genotype (adjusted HR, 1.04; 95% CI, 0.73-1.48). Conclusions Our findings suggest that TGF-beta1 genotype is associated with risk of breast cancer in white women aged 65 years or older. Because the T allele is the common variant and confers an increased risk, it may be associated with a large proportion of breast cancer cases.	Vet Affairs Med Ctr, Div Gen Internal Med, San Francisco, CA 94122 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA USA; Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA USA; Axys Pharmaceut Inc, La Jolla, CA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California San Francisco; University of California System; University of California San Francisco; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Ziv, E (corresponding author), Vet Affairs Med Ctr, Div Gen Internal Med, Box 111-A1,4150 Clement St, San Francisco, CA 94122 USA.	eziv@itsa.ucsf.edu	Morin, Phillip A/E-9515-2010; Cauley, Jane A/N-4836-2015; Ziv, Elad/L-5396-2014	Cauley, Jane A/0000-0003-0752-4408; Morin, Phillip/0000-0002-3279-1519	NIAMS NIH HHS [AR35582, AR355833, AR35584] Funding Source: Medline; NIA NIH HHS [AG05349, AG05407] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR035582, R01AR035584] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Ambrosone CB, 1996, JAMA-J AM MED ASSOC, V276, P1494, DOI 10.1001/jama.276.18.1494; Armstrong K, 2000, NEW ENGL J MED, V342, P564, DOI 10.1056/NEJM200002243420807; Arteaga CL, 1996, BREAST CANCER RES TR, V38, P49, DOI 10.1007/BF01803783; Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807; Cambien F, 1996, HYPERTENSION, V28, P881, DOI 10.1161/01.HYP.28.5.881; Cauley JA, 1996, JAMA-J AM MED ASSOC, V276, P1404, DOI 10.1001/jama.276.17.1404; Coughlin SS, 1999, CANCER EPIDEM BIOMAR, V8, P1023; Dunning AM, 1998, BRIT J CANCER, V77, P2045, DOI 10.1038/bjc.1998.340; Dunning AM, 1999, CANCER EPIDEM BIOMAR, V8, P843; Feigelson HS, 1997, CANCER RES, V57, P1063; FORD D, 1995, AM J HUM GENET, V57, P1457; Grainger DJ, 1999, HUM MOL GENET, V8, P93, DOI 10.1093/hmg/8.1.93; Millikan RC, 1998, CANCER EPIDEM BIOMAR, V7, P371; Morin PA, 1999, BIOTECHNIQUES, V27, P538, DOI 10.2144/99273rr02; Newman B, 1998, JAMA-J AM MED ASSOC, V279, P915, DOI 10.1001/jama.279.12.915; Pasche B, 1999, CANCER RES, V59, P5678; PIERCE DF, 1995, P NATL ACAD SCI USA, V92, P4254, DOI 10.1073/pnas.92.10.4254; Rebbeck TR, 1999, CANCER-AM CANCER SOC, V86, P2493, DOI 10.1002/(SICI)1097-0142(19991201)86:11+<2493::AID-CNCR6>3.0.CO;2-Z; Reiss M, 1997, BREAST CANCER RES TR, V45, P81, DOI 10.1023/A:1005865812918; Tang BW, 1998, NAT MED, V4, P802, DOI 10.1038/nm0798-802; Yamada Y, 1999, AM J MED, V106, P477, DOI 10.1016/S0002-9343(99)00043-1; Yamada Y, 1998, J BONE MINER RES, V13, P1569, DOI 10.1359/jbmr.1998.13.10.1569; Yokota M, 2000, CIRCULATION, V101, P2783, DOI 10.1161/01.CIR.101.24.2783; Zhang YQ, 1997, NEW ENGL J MED, V336, P611, DOI 10.1056/NEJM199702273360903	24	105	112	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 13	2001	285	22					2859	2863		10.1001/jama.285.22.2859	http://dx.doi.org/10.1001/jama.285.22.2859			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	440BP	11401606	Bronze			2022-12-24	WOS:000169156300024
J	Zhang, YP; Xiong, Y				Zhang, YP; Xiong, Y			A p53 amino-terminal nuclear export signal inhibited by DNA damage-induced phosphorylation	SCIENCE			English	Article							RING-FINGER DOMAIN; STABILIZES P53; MDM2; DEGRADATION; PROTEIN; HDM2; TRANSACTIVATION; LOCALIZATION; PROMOTES; PATHWAY	The p53 protein is present in low amounts in normally growing cells and is activated in response to physiological insults. MDM2 regulates p53 either through inhibiting p53's transactivating function in the nucleus or by targeting p53 degradation in the cytoplasm. We identified a previously unknown nuclear export signal (NES) in the amino terminus of p53, spanning residues 11 to 27 and containing two serine residues phosphorylated after DNA damage, which was required for p53 nuclear export in colloboration with the carboxyl-terminal NES, Serine-15-phosphorylated p53 induced by ultraviolet irradiation was not exported. Thus, DNA damage-induced phosphorylation may achieve optimal p53 activation by inhibiting both MDM2 binding to, and the nuclear export of, p53.	Univ N Carolina, Dept Biochem & Biophys, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; Univ N Carolina, Program Mol Biol & Biotechnol, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Xiong, Y (corresponding author), Univ N Carolina, Dept Biochem & Biophys, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.			Zhang, Yi/0000-0002-2789-0811	NATIONAL CANCER INSTITUTE [R01CA065572, K01CA087580] Funding Source: NIH RePORTER; NCI NIH HHS [CA65572, K01 CA087580] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Boyd SD, 2000, NAT CELL BIOL, V2, P563, DOI 10.1038/35023500; Chao C, 2000, EMBO J, V19, P4967, DOI 10.1093/emboj/19.18.4967; Chao C, 2000, P NATL ACAD SCI USA, V97, P11936, DOI 10.1073/pnas.220252297; Chehab NH, 2000, GENE DEV, V14, P278; Freedman DA, 1998, MOL CELL BIOL, V18, P7288, DOI 10.1128/MCB.18.12.7288; Geyer RK, 2000, NAT CELL BIOL, V2, P569, DOI 10.1038/35023507; Giaccia AJ, 1998, GENE DEV, V12, P2973, DOI 10.1101/gad.12.19.2973; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Jimenez GS, 2000, NAT GENET, V26, P37, DOI 10.1038/79152; Ko LJ, 1996, GENE DEV, V10, P1054, DOI 10.1101/gad.10.9.1054; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; LIN JY, 1994, GENE DEV, V8, P1235, DOI 10.1101/gad.8.10.1235; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; Oren M, 1999, J BIOL CHEM, V274, P36031, DOI 10.1074/jbc.274.51.36031; Prives C, 1998, CELL, V95, P5, DOI 10.1016/S0092-8674(00)81774-2; Roth J, 1998, EMBO J, V17, P554, DOI 10.1093/emboj/17.2.554; Sherr CJ, 1998, GENE DEV, V12, P2984, DOI 10.1101/gad.12.19.2984; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Stommel JM, 1999, EMBO J, V18, P1660, DOI 10.1093/emboj/18.6.1660; Tao WK, 1999, P NATL ACAD SCI USA, V96, P6937, DOI 10.1073/pnas.96.12.6937; Tao WK, 1999, P NATL ACAD SCI USA, V96, P3077, DOI 10.1073/pnas.96.6.3077; Thut CJ, 1997, GENE DEV, V11, P1974, DOI 10.1101/gad.11.15.1974; WEN W, 1995, CELL, V82, P463, DOI 10.1016/0092-8674(95)90435-2; Zhang YP, 2001, CELL GROWTH DIFFER, V12, P175; Zhang YP, 1998, CELL, V92, P725, DOI 10.1016/S0092-8674(00)81401-4; Zhang YP, 1999, MOL CELL, V3, P579, DOI 10.1016/S1097-2765(00)80351-2	28	300	311	1	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 8	2001	292	5523					1910	1915		10.1126/science.1058637	http://dx.doi.org/10.1126/science.1058637			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	440WY	11397945				2022-12-24	WOS:000169200700049
J	Zhu, YX; Doray, B; Poussu, A; Lehto, VP; Kornfeld, S				Zhu, YX; Doray, B; Poussu, A; Lehto, VP; Kornfeld, S			Binding of GGA2 to the lysosomal enzyme sorting motif of the mannose 6-phosphate receptor	SCIENCE			English	Article							FACTOR-II RECEPTOR; GAMMA-ADAPTIN; MUTATIONAL ANALYSIS; CYTOPLASMIC DOMAIN; TRANS-GOLGI; PROTEINS; FAMILY; VHS	The GGAs are a multidomain protein family implicated in protein trafficking between the Golgi and endosomes. Here, the VHS domain of GGA2 was shown to bind to the acidic cluster-dileucine motif in the cytoplasmic tail of the cation-independent mannose 6-phosphate receptor (CI-MPR). Receptors with mutations in this motif were defective in lysosomal enzyme sorting. The hinge domain of GGA2 bound clathrin, suggesting that GGA2 could be a link between cargo molecules and clathrin-coated vesicle assembly. Thus, GGA2 binding to the Cl-MPR is important for lysosomal enzyme targeting.	Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA; Univ Oulu, Dept Pathol, FIN-90410 Oulu, Finland	Washington University (WUSTL); University of Oulu	Kornfeld, S (corresponding author), Washington Univ, Sch Med, Dept Internal Med, 660 S Euclid Ave, St Louis, MO 63110 USA.			Doray, Balraj/0000-0003-3347-5013	NATIONAL CANCER INSTITUTE [R01CA008759] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA-08759] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Black MW, 2000, J CELL BIOL, V151, P587, DOI 10.1083/jcb.151.3.587; Boman AL, 2000, MOL BIOL CELL, V11, P1241, DOI 10.1091/mbc.11.4.1241; CHEN HJ, 1993, J BIOL CHEM, V268, P22338; Chen HJ, 1997, J BIOL CHEM, V272, P7003, DOI 10.1074/jbc.272.11.7003; Dell'Angelica EC, 2000, J CELL BIOL, V149, P81, DOI 10.1083/jcb.149.1.81; DORAY B, IN PRESS MOL BIOL CE; Hirst J, 2000, J CELL BIOL, V149, P67, DOI 10.1083/jcb.149.1.67; JOHNSON KF, 1992, J CELL BIOL, V119, P249, DOI 10.1083/jcb.119.2.249; KLUMPERMAN J, 1993, J CELL BIOL, V121, P997, DOI 10.1083/jcb.121.5.997; KORNFELD S, 1992, ANNU REV BIOCHEM, V61, P307, DOI 10.1146/annurev.bi.61.070192.001515; LOBEL P, 1989, CELL, V57, P787, DOI 10.1016/0092-8674(89)90793-9; Poussu A, 2000, J BIOL CHEM, V275, P7176, DOI 10.1074/jbc.275.10.7176; Takatsu H, 2000, BIOCHEM BIOPH RES CO, V271, P719, DOI 10.1006/bbrc.2000.2700; Traub LM, 1999, P NATL ACAD SCI USA, V96, P8907, DOI 10.1073/pnas.96.16.8907; York SJ, 1999, J BIOL CHEM, V274, P1164, DOI 10.1074/jbc.274.2.1164; Zhdankina O, 2001, YEAST, V18, P1, DOI 10.1002/1097-0061(200101)18:1<1::AID-YEA644>3.0.CO;2-5	16	224	230	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 1	2001	292	5522					1716	1718		10.1126/science.1060896	http://dx.doi.org/10.1126/science.1060896			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	438AP	11387476				2022-12-24	WOS:000169031800045
J	Cronin, TW; Caldwell, RL; Marshall, J				Cronin, TW; Caldwell, RL; Marshall, J			Sensory adaptation - Tunable colour vision in a mantis shrimp	NATURE			English	Article							SYSTEM		Univ Maryland Baltimore Cty, Dept Biol Sci, Baltimore, MD 21250 USA; Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; Univ Queensland, Vis Touch & Hearing Res Ctr, Brisbane, Qld 4072, Australia	University System of Maryland; University of Maryland Baltimore County; University of California System; University of California Berkeley; University of Queensland	Cronin, TW (corresponding author), Univ Maryland Baltimore Cty, Dept Biol Sci, Baltimore, MD 21250 USA.			Marshall, Justin/0000-0001-9006-6713				CRONIN TW, 1994, VISION RES, V34, P2639, DOI 10.1016/0042-6989(94)90221-6; Cronin TW, 2000, PHILOS T ROY SOC B, V355, P1263, DOI 10.1098/rstb.2000.0680; CRONIN TW, 1989, NATURE, V339, P137, DOI 10.1038/339137a0; CRONIN TW, 1994, VISION RES, V34, P279, DOI 10.1016/0042-6989(94)90087-6; HAWRYSHYN CW, 1989, VISUAL NEUROSCI, V2, P247, DOI 10.1017/S0952523800001164; Marshall J, 1999, NATURE, V401, P873, DOI 10.1038/44751; MARSHALL NJ, 1988, NATURE, V333, P557, DOI 10.1038/333557a0; MCFARLAND WN, 1975, VISION RES, V15, P1063, DOI 10.1016/0042-6989(75)90002-4; SUZUKI T, 1985, ZOOL SCI, V2, P455; TSIN ATC, 1977, SCIENCE, V195, P1358, DOI 10.1126/science.841335	10	60	65	24	101	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 31	2001	411	6837					547	548		10.1038/35079184	http://dx.doi.org/10.1038/35079184			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437GE	11385560				2022-12-24	WOS:000168982500039
J	Ohtaki, T; Shintani, Y; Honda, S; Matsumoto, H; Hori, A; Kanehashi, K; Terao, Y; Kumano, S; Takatsu, Y; Masuda, Y; Ishibashi, Y; Watanabe, T; Asada, M; Yamada, T; Suenaga, M; Kitada, C; Usuki, S; Kurokawa, T; Onda, H; Nishimura, O; Fujino, M				Ohtaki, T; Shintani, Y; Honda, S; Matsumoto, H; Hori, A; Kanehashi, K; Terao, Y; Kumano, S; Takatsu, Y; Masuda, Y; Ishibashi, Y; Watanabe, T; Asada, M; Yamada, T; Suenaga, M; Kitada, C; Usuki, S; Kurokawa, T; Onda, H; Nishimura, O; Fujino, M			Metastasis suppressor gene KiSS-1 encodes peptide ligand of a G-protein-coupled receptor	NATURE			English	Article							IDENTIFICATION; CELLS; MOTILITY; CLONING; BINDING; SITES	Metastasis is a major cause of death in cancer patients and involves a multistep process including detachment of cancer cells from a primary cancer, invasion of surrounding tissue, spread through circulation, re-invasion and proliferation in distant organs. KiSS-1 is a human metastasis suppressor gene(1), that suppresses metastases of human melanomas(2) and breast carcinomas(3) without affecting tumorigenicity. However, its gene product and functional mechanisms have not been elucidated. Here we show that KiSS-1 (refs 1, 4) encodes a carboxy-terminally amidated peptide with 54 amino-acid residues, which we have isolated from human placenta as the endogenous ligand of an orphan G-protein-coupled receptor (hOT7T175) and have named 'metastin'. Metastin inhibits chemotaxis and invasion of hOT7T175-transfected CHO cells in vitro and attenuates pulmonary metastasis of hOT7T175-transfected B16-BL6 melanomas in vivo. The results suggest possible mechanisms of action for KiSS-1 and a potential new therapeutic approach.	Takeda Chem Ind Ltd, Pharmaceut Discovery Res Div, Tsukuba, Ibaraki 3004293, Japan; Univ Tsukuba, Inst Clin Med, Dept Obstet & Gynecol, Tsukuba, Ibaraki 3058575, Japan	Takeda Chemical Industries; University of Tsukuba	Ohtaki, T (corresponding author), Takeda Chem Ind Ltd, Pharmaceut Discovery Res Div, Wadai 10, Tsukuba, Ibaraki 3004293, Japan.		Oka, Yoshitaka/C-9670-2010	Oka, Yoshitaka/0000-0002-3482-3051				Bischof P, 2000, PLACENTA, V21, pS55, DOI 10.1053/plac.2000.0521; Bloomquist BT, 1998, BIOCHEM BIOPH RES CO, V243, P474, DOI 10.1006/bbrc.1998.8133; Fujii R, 2000, J BIOL CHEM, V275, P21068, DOI 10.1074/jbc.M001546200; Lee DK, 1999, FEBS LETT, V446, P103, DOI 10.1016/S0014-5793(99)00009-5; Lee JH, 1997, CANCER RES, V57, P2384; Lee JH, 1997, INT J CANCER, V71, P1035, DOI 10.1002/(SICI)1097-0215(19970611)71:6<1035::AID-IJC20>3.3.CO;2-T; Lee JH, 1996, JNCI-J NATL CANCER I, V88, P1731, DOI 10.1093/jnci/88.23.1731; LEE JH, 1997, J NATL CANCER I, V89, P1549; LINDEN J, 1982, J CYCLIC NUCL PROT, V8, P163; Masuda Y, 1996, J PHARMACOL EXP THER, V279, P675; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Nishimura O, 1998, CHEM PHARM BULL, V46, P1490; Ohtaki T, 1999, J BIOL CHEM, V274, P37041, DOI 10.1074/jbc.274.52.37041; ROUILLE Y, 1995, FRONT NEUROENDOCRIN, V16, P322, DOI 10.1006/frne.1995.1012; SADAHIRA Y, 1992, P NATL ACAD SCI USA, V89, P9686, DOI 10.1073/pnas.89.20.9686; Turner CE, 2000, NAT CELL BIOL, V2, pE231, DOI 10.1038/35046659; West A, 1998, GENOMICS, V54, P145, DOI 10.1006/geno.1998.5566; Yamamura S, 2000, ANN NY ACAD SCI, V905, P301	18	1109	1210	1	60	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 31	2001	411	6837					613	617		10.1038/35079135	http://dx.doi.org/10.1038/35079135			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437GE	11385580				2022-12-24	WOS:000168982500059
J	Perraud, AL; Fleig, A; Dunn, CA; Bagley, LA; Launay, P; Schmitz, C; Stokes, AJ; Zhu, QQ; Bessman, MJ; Penner, R; Kinet, JP; Scharenberg, AM				Perraud, AL; Fleig, A; Dunn, CA; Bagley, LA; Launay, P; Schmitz, C; Stokes, AJ; Zhu, QQ; Bessman, MJ; Penner, R; Kinet, JP; Scharenberg, AM			ADP-ribose gating of the calcium-permeable LTRPC2 channel revealed by Nudix motif homology	NATURE			English	Article							MITOCHONDRIA; ENZYMES	Free ADP-ribose (ADPR), a product of NAD hydrolysis and a breakdown product of the calcium-release second messenger cyclic ADPR (cADPR), has no defined role as an intracellular signalling molecule in vertebrate systems. Here we show that a 350-amino-acid protein (designated NUDT9) and a homologous domain (NUDT9 homology domain) near the carboxy terminus of the LTRPC2/TrpC7 putative cation channel(1) both function as specific ADPR pyrophosphatases. Whole-cell and single-channel analysis of HEK-293 cells expressing LTRPC2 show that LTRPC2 functions as a calcium-permeable cation channel that is specifically gated by free ADPR. The expression of native LTRPC2 transcripts is detectable in many tissues including the U937 monocyte cell line, in which ADPR induces large cation currents (designated I-ADPR) that closely match those mediated by recombinant LTRPC2. These results indicate that intracellular ADPR regulates calcium entry into cells that express LTRPC2.	Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA 02215 USA; Univ Hawaii, Queens Med Ctr, Biomed Res Ctr, Lab Cell & Mol Signaling, Honolulu, HI 96813 USA; Univ Hawaii, John A Burns Sch Med, Honolulu, HI 96813 USA; Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; The Queen's Medical Center; University of Hawaii System; University of Hawaii System; Johns Hopkins University	Scharenberg, AM (corresponding author), Univ Washington, Dept Pediat & Immunol, Seattle, WA 98195 USA.		Stokes, Alexander/B-1086-2015; Launay, Pierre/AAH-7076-2019	Stokes, Alexander/0000-0002-3526-4685; Dunn, Christopher/0000-0001-7899-0110; Penner, Reinhold/0000-0002-5366-1537; Fleig, Andrea/0000-0001-8396-7249				AMES BN, 1960, J BIOL CHEM, V235, P769; Bessman MJ, 1996, J BIOL CHEM, V271, P25059, DOI 10.1074/jbc.271.41.25059; Chakraborti T, 1999, CELL SIGNAL, V11, P77, DOI 10.1016/S0898-6568(98)00025-4; Dousa TP, 1996, AM J PHYSIOL-CELL PH, V271, pC1007, DOI 10.1152/ajpcell.1996.271.4.C1007; Guse AH, 2000, J MOL MED, V78, P26, DOI 10.1007/s001090000076; Harteneck C, 2000, TRENDS NEUROSCI, V23, P159, DOI 10.1016/S0166-2236(99)01532-5; HILLYARD D, 1981, J BIOL CHEM, V256, P8491; KochNolte F, 1997, ADV EXP MED BIOL, V419, P1; Liang M, 1999, ARCH BIOCHEM BIOPHYS, V371, P317, DOI 10.1006/abbi.1999.1463; McConkey DJ, 1996, STEM CELLS, V14, P619, DOI 10.1002/stem.140619; Nagamine K, 1998, GENOMICS, V54, P124, DOI 10.1006/geno.1998.5551; Okazaki IJ, 1998, J BIOL CHEM, V273, P23617, DOI 10.1074/jbc.273.37.23617; Wilding M, 1998, AM J PHYSIOL-CELL PH, V275, pC1277, DOI 10.1152/ajpcell.1998.275.5.C1277	13	694	725	0	26	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 31	2001	411	6837					595	599		10.1038/35079100	http://dx.doi.org/10.1038/35079100			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437GE	11385575				2022-12-24	WOS:000168982500054
J	Dubnau, J; Grady, L; Kitamoto, T; Tully, T				Dubnau, J; Grady, L; Kitamoto, T; Tully, T			Disruption of neurotransmission in Drosophila mushroom body blocks retrieval but not acquisition of memory	NATURE			English	Article							EXPRESSION; DYNAMIN; SHIBIRE; MELANOGASTER; NEURONS; BODIES; BRAIN; ORGANIZATION; MUTATIONS; ANATOMY	Surgical, pharmacological and genetic lesion studies have revealed distinct anatomical sites involved with different forms of learning. Studies of patients with localized brain damage and work in rodent model systems, for example, have shown that the hippocampal formation participates in acquisition of declarative tasks but is not the site of their long-term storage(1,2). Such lesions are usually irreversible, however, which has limited their use for dissecting the temporal processes of acquisition, storage and retrieval of memories(3,4). Studies in bees and flies have similarly revealed a distinct anatomical region of the insect brain, the mushroom body, that is involved specifically in olfactory associative learning(5,6). We have used a temperature-sensitive dynamin transgene, which disrupts synaptic transmission reversibly and on the time-scale of minutes(7), to investigate the temporal requirements for ongoing neural activity during memory formation. Here we show that synaptic transmission from mushroom body neurons is required during memory retrieval but not during acquisition or storage. We propose that the hebbian processes underlying olfactory associative learning reside in mushroom body dendrites or upstream of the mushroom body and that the resulting alterations in synaptic strength modulate mushroom body output during memory retrieval.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; City Hope Natl Med Ctr, Beckman Res Inst, Div Neurosci, Duarte, CA 91010 USA	Cold Spring Harbor Laboratory; City of Hope; Beckman Research Institute of City of Hope	Dubnau, J (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	dubnau@cshl.org		Dubnau, Josh/0000-0002-9285-7444; Kitamoto, Toshihiro/0000-0003-0863-8466				BENZER S, 1967, P NATL ACAD SCI USA, V58, P1112, DOI 10.1073/pnas.58.3.1112; BRAND AH, 1993, DEVELOPMENT, V118, P401; Carroll RC, 1999, P NATL ACAD SCI USA, V96, P14112, DOI 10.1073/pnas.96.24.14112; CHEN MS, 1991, NATURE, V351, P583, DOI 10.1038/351583a0; Connolly JB, 1996, SCIENCE, V274, P2104, DOI 10.1126/science.274.5295.2104; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; DEBELLE JS, 1994, SCIENCE, V263, P692, DOI 10.1126/science.8303280; Dubnau J, 2001, CURR BIOL, V11, pR240, DOI 10.1016/S0960-9822(01)00115-4; DUDAI Y, 1988, J COMP PHYSIOL A, V162, P101, DOI 10.1007/BF01342707; Grant D, 1998, GENETICS, V149, P1019; Hammer M, 1998, LEARN MEMORY, V5, P146; Ito K, 1998, LEARN MEMORY, V5, P52; Joiner MLA, 1999, LEARN MEMORY, V6, P177; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; KOENIG JH, 1989, J NEUROSCI, V9, P3844; Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678; Milner B, 1998, NEURON, V20, P445, DOI 10.1016/S0896-6273(00)80987-3; POODRY CA, 1979, J CELL BIOL, V81, P520, DOI 10.1083/jcb.81.3.520; POODRY CA, 1973, DEV BIOL, V32, P373, DOI 10.1016/0012-1606(73)90248-0; RAMASWAMI M, 1993, J NEUROGENET, V9, P73, DOI 10.3109/01677069309083451; RYBAK J, 1993, J COMP NEUROL, V334, P444, DOI 10.1002/cne.903340309; Scoville WB, 2000, J NEUROPSYCH CLIN N, V12, P103; Shimizu E, 2000, SCIENCE, V290, P1170, DOI 10.1126/science.290.5494.1170; Strausfeld NJ, 1999, J COMP NEUROL, V409, P603; TULLY T, 1994, CELL, V79, P35, DOI 10.1016/0092-8674(94)90398-0; VANDERBLIEK AM, 1991, NATURE, V351, P411, DOI 10.1038/351411a0; Waddell S, 2000, CELL, V103, P805, DOI 10.1016/S0092-8674(00)00183-5; Wang YT, 2000, NEURON, V25, P635, DOI 10.1016/S0896-6273(00)81066-1; YANG MY, 1995, NEURON, V15, P45; Zars T, 2000, SCIENCE, V288, P672, DOI 10.1126/science.288.5466.672	30	316	327	0	24	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 24	2001	411	6836					476	480		10.1038/35078077	http://dx.doi.org/10.1038/35078077			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	435CB	11373680				2022-12-24	WOS:000168858700049
J	O'Connell, KF; Caron, C; Kopish, KR; Hurd, DD; Kemphues, KJ; Li, YJ; White, JG				O'Connell, KF; Caron, C; Kopish, KR; Hurd, DD; Kemphues, KJ; Li, YJ; White, JG			The C-elegans zyg-1 gene encodes a regulator of centrosome duplication with distinct maternal and paternal roles in the embryo	CELL			English	Article							XENOPUS EGG EXTRACTS; HAMSTER OVARY CELLS; CAENORHABDITIS-ELEGANS; PROTEIN-SYNTHESIS; BODY DUPLICATION; MITOTIC SPINDLE; CYCLIN-E; REPRODUCTION; KINASE; MICROTUBULES	Centrosome duplication is a critical step in assembly of the bipolar mitotic spindle, but the molecular mechanisms regulating this process during the cell cycle and during animal development are poorly understood. Here, we report that the zyg-1 gene of Caenorhabditis elegans is an essential regulator of centrosome duplication. ZYG-1 is a protein kinase specifically required for daughter centriole formation that localizes transiently to centrosomes and acts at least one cell cycle prior to each spindle assembly event. In the embryo, ZYG-1 participates in a unique regulatory scheme whereby paternal ZYG-1 regulates duplication and bipolar spindle assembly during the first cell cycle, and maternal ZYG-1 regulates these processes thereafter. ZYG-1 is therefore a key molecular component of the centrosome/centriole duplication process.	Univ Wisconsin, Mol Biol Lab, Madison, WI 53706 USA; Univ Wisconsin, Dept Anat, Madison, WI 53706 USA; Univ Wisconsin, Howard Hughes Med Inst, Madison, WI 53706 USA; Cornell Univ, Genet & Dev Sect, Ithaca, NY 14853 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Howard Hughes Medical Institute; University of Wisconsin System; University of Wisconsin Madison; Cornell University	O'Connell, KF (corresponding author), Univ Wisconsin, Mol Biol Lab, Madison, WI 53706 USA.	kfoconne@facstaff.wisc.edu		O'Connell, Kevin/0000-0002-9789-288X	NIGMS NIH HHS [GM-54454] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALBERTSON DG, 1984, DEV BIOL, V101, P61, DOI 10.1016/0012-1606(84)90117-9; Albertson DG, 1993, CHROMOSOME RES, V1, P15, DOI 10.1007/BF00710603; BALCZON R, 1995, J CELL BIOL, V130, P105, DOI 10.1083/jcb.130.1.105; BLUMENTHAL T, 1995, TRENDS GENET, V11, P132, DOI 10.1016/S0168-9525(00)89026-5; BRENNER S, 1974, GENETICS, V77, P71; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Freed E, 1999, GENE DEV, V13, P2242, DOI 10.1101/gad.13.17.2242; Fry AM, 1998, J CELL BIOL, V141, P1563, DOI 10.1083/jcb.141.7.1563; Fry AM, 1998, EMBO J, V17, P470, DOI 10.1093/emboj/17.2.470; GARD DL, 1990, J CELL BIOL, V110, P2033, DOI 10.1083/jcb.110.6.2033; Heald R, 1996, NATURE, V382, P420, DOI 10.1038/382420a0; Hinchcliffe EH, 1999, SCIENCE, V283, P851, DOI 10.1126/science.283.5403.851; JACKSON PK, 1995, J CELL BIOL, V130, P755, DOI 10.1083/jcb.130.4.755; KEMPHUES KJ, 1988, GENETICS, V120, P977; Khodjakov A, 2000, CURR BIOL, V10, P59, DOI 10.1016/S0960-9822(99)00276-6; Kimble J, 1988, NEMATODE CAENORHABDI, P191; KURIYAMA R, 1981, J CELL BIOL, V91, P814, DOI 10.1083/jcb.91.3.814; Lacey KR, 1999, P NATL ACAD SCI USA, V96, P2817, DOI 10.1073/pnas.96.6.2817; Matsumoto Y, 1999, CURR BIOL, V9, P429, DOI 10.1016/S0960-9822(99)80191-2; MAZIA D, 1960, J BIOPHYS BIOCHEM CY, V7, P1, DOI 10.1083/jcb.7.1.1; Mello C, 1995, METHOD CELL BIOL, V48, P451; Meraldi P, 1999, NAT CELL BIOL, V1, P88, DOI 10.1038/10054; Middendorp S, 2000, J CELL BIOL, V148, P405, DOI 10.1083/jcb.148.3.405; Mountain V, 1999, J CELL BIOL, V147, P351, DOI 10.1083/jcb.147.2.351; O'Connell KF, 2000, DEV BIOL, V222, P55, DOI 10.1006/dbio.2000.9714; O'Connell KF, 1998, GENETICS, V149, P1303; Okuda M, 2000, CELL, V103, P127, DOI 10.1016/S0092-8674(00)00093-3; Peters JM, 1998, CURR OPIN CELL BIOL, V10, P759, DOI 10.1016/S0955-0674(98)80119-1; PHILLIPS SG, 1976, J CELL BIOL, V70, P9, DOI 10.1083/jcb.70.1.9; Ruiz F, 1999, CURR BIOL, V9, P43, DOI 10.1016/S0960-9822(99)80045-1; SCHATTEN G, 1994, DEV BIOL, V165, P299, DOI 10.1006/dbio.1994.1256; SLUDER G, 1990, J CELL BIOL, V110, P2025, DOI 10.1083/jcb.110.6.2025; SLUDER G, 1985, J CELL BIOL, V100, P887, DOI 10.1083/jcb.100.3.887; Sluder G, 1999, BIOL CELL, V91, P413, DOI 10.1016/S0248-4900(99)80083-5; Sluder G, 1997, J CELL SCI, V110, P421; STJOHNSTON D, 1992, CELL, V68, P201; Strausfeld UP, 1996, J CELL SCI, V109, P1555; SWOFFORD DL, 1998, PAUP ASTERISK PHYLOG; Tabara H, 1999, DEVELOPMENT, V126, P1; Urbani L, 1999, CURR BIOL, V9, pR315, DOI 10.1016/S0960-9822(99)80201-2; WINEY M, 1991, J CELL BIOL, V114, P745, DOI 10.1083/jcb.114.4.745; WOLF N, 1978, J ULTRA MOL STRUCT R, V63, P155, DOI 10.1016/S0022-5320(78)80071-9; WOOD WB, 1980, DEV BIOL, V74, P446, DOI 10.1016/0012-1606(80)90445-5; WOOD WB, 1994, TRENDS GENET, V10, P49, DOI 10.1016/0168-9525(94)90148-1; Wu XY, 1999, P NATL ACAD SCI USA, V96, P1397, DOI 10.1073/pnas.96.4.1397	46	232	240	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 18	2001	105	4					547	558		10.1016/S0092-8674(01)00338-5	http://dx.doi.org/10.1016/S0092-8674(01)00338-5			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	434XG	11371350	Bronze			2022-12-24	WOS:000168840700013
J	Dubilier, N; Mulders, C; Ferdelman, T; de Beer, D; Pernthaler, A; Klein, M; Wagner, M; Erseus, C; Thiermann, F; Krieger, J; Giere, O; Amann, R				Dubilier, N; Mulders, C; Ferdelman, T; de Beer, D; Pernthaler, A; Klein, M; Wagner, M; Erseus, C; Thiermann, F; Krieger, J; Giere, O; Amann, R			Endosymbiotic sulphate-reducing and sulphide-oxidizing bacteria in an oligochaete worm	NATURE			English	Article							SULFATE REDUCTION; SEDIMENTS; ANNELIDA; SULFUR; TUBIFICIDAE; DIVERSITY; SYMBIONTS; ECOLOGY; OXYGEN; COAST	Stable associations of more than one species of symbiont within a single host cell or tissue are assumed to be rare in metazoans because competition for space and resources between symbionts can be detrimental to the host(1). In animals with multiple endosymbionts, such as mussels from deep-sea hydrothermal vents(2) and reef-building corals(3), the costs of competition between the symbionts are outweighed by the ecological and physiological flexibility gained by the hosts. A further option for the coexistence of multiple symbionts within a host is if these benefit directly from one another, but such symbioses have not been previously described. Here we show that in the gutless marine oligochaete Olavius algarvensis, endosymbiotic sulphate-reducing bacteria produce sulphide that can serve as an energy source for sulphide-oxidizing symbionts of the host. Thus, these symbionts do not compete for resources but rather share a mutalistic relationship with each other in an endosymbiotic sulphur cycle, in addition to their symbiotic relationship with the oligochaete host.	Max Planck Inst Marine Microbiol, D-28359 Bremen, Germany; Tech Univ Munich, Dept Microbiol, D-85350 Freising, Germany; Swedish Museum Nat Hist, Dept Invertebrate Zool, S-10405 Stockholm, Sweden; Univ Hamburg, Inst Zool, D-20146 Hamburg, Germany; Univ Hamburg, Museum Zool, D-20146 Hamburg, Germany	Max Planck Society; Technical University of Munich; Swedish Museum of Natural History; University of Hamburg; University of Hamburg	Dubilier, N (corresponding author), Max Planck Inst Marine Microbiol, Celsiusstr 1, D-28359 Bremen, Germany.		Wagner, Michael/A-7801-2011; Amann, Rudolf I/C-6534-2014; de Beer, Dirk/L-4840-2013; Dubilier, Nicole/I-8203-2018; Ferdelman, Timothy G/A-3758-2013	Wagner, Michael/0000-0002-9778-7684; Amann, Rudolf I/0000-0002-0846-7372; de Beer, Dirk/0000-0001-5274-1781; Dubilier, Nicole/0000-0002-9394-825X; Ferdelman, Timothy G/0000-0002-9701-3793				Barton LL., 1995, SULFATE REDUCING BAC; BUSSMANN I, 1991, MAR ECOL PROG SER, V78, P97, DOI 10.3354/meps078097; CANFIELD DE, 1993, GEOCHIM COSMOCHIM AC, V57, P3971, DOI 10.1016/0016-7037(93)90347-Y; CLINE JD, 1969, LIMNOL OCEANOGR, V14, P454, DOI 10.4319/lo.1969.14.3.0454; Cottrell MT, 1999, APPL ENVIRON MICROB, V65, P1127; Crank J., 1975, MATH DIFFUSION; DISTEL DL, 1995, P NATL ACAD SCI USA, V92, P9598, DOI 10.1073/pnas.92.21.9598; DUBILIER N, 1995, AM ZOOL, V35, P163; DUBILIER N, 1995, APPL ENVIRON MICROB, V61, P2346, DOI 10.1128/AEM.61.6.2346-2350.1995; Dubilier N, 1999, MAR ECOL PROG SER, V178, P271, DOI 10.3354/meps178271; FENCHEL T, 1992, ARCH MICROBIOL, V158, P394; Ferdelman TG, 1997, GEOCHIM COSMOCHIM AC, V61, P3065, DOI 10.1016/S0016-7037(97)00158-0; FOSSING H, 1989, BIOGEOCHEMISTRY, V8, P205; GIERE O, 1987, MAR BIOL, V93, P641, DOI 10.1007/BF00392801; GIERE O, 1991, MAR ECOL PROG SER, V68, P287; Giere O, 1998, ZOOL ANZ, V237, P209; GIERE O, 1995, ACTA ZOOL-STOCKHOLM, V76, P281, DOI 10.1111/j.1463-6395.1995.tb01000.x; Grieshaber M K, 1994, Rev Physiol Biochem Pharmacol, V125, P43, DOI 10.1007/BFb0030909; JORGENSEN BB, 1978, GEOMICROBIOL J, V1, P49; Krieger J, 2000, MAR BIOL, V137, P239, DOI 10.1007/s002270000355; Kuhnigk T, 1996, SYST APPL MICROBIOL, V19, P139, DOI 10.1016/S0723-2020(96)80039-7; Morvan B, 1996, CURR MICROBIOL, V32, P129, DOI 10.1007/s002849900023; Rowan R, 1997, NATURE, V388, P265, DOI 10.1038/40843; Sahm K, 1999, ENVIRON MICROBIOL, V1, P65, DOI 10.1046/j.1462-2920.1999.00007.x; Smith J. M., 1995, MAJOR TRANSITIONS EV; vandenEnde FP, 1997, FEMS MICROBIOL ECOL, V23, P65, DOI 10.1016/S0168-6496(97)00014-7; Vetter RD, 1998, MAR BIOL, V132, P453, DOI 10.1007/s002270050411; Wagner M, 1998, J BACTERIOL, V180, P2975, DOI 10.1128/JB.180.11.2975-2982.1998	28	160	165	1	56	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 17	2001	411	6835					298	302		10.1038/35077067	http://dx.doi.org/10.1038/35077067			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432RT	11357130				2022-12-24	WOS:000168710000045
J	Wittmann, CW; Wszolek, MF; Shulman, JM; Salvaterra, PM; Lewis, J; Hutton, M; Feany, MB				Wittmann, CW; Wszolek, MF; Shulman, JM; Salvaterra, PM; Lewis, J; Hutton, M; Feany, MB			Tauopathy in Drosophila: Neurodegeneration without neurofibrillary tangles	SCIENCE			English	Article							PAIRED HELICAL FILAMENTS; HUMAN TAU; ALZHEIMERS-DISEASE; BRAIN DEGENERATION; GENE-EXPRESSION; MUTANT; PHOSPHORYLATION; DEMENTIA; PROTEINS; NEURONS	The microtubule-binding protein tau has been implicated in the pathogenesis of Alzheimer's disease and related disorders. However, the mechanisms underlying tau-mediated neurotoxicity remain unclear. We created a genetic model of tau-related neurodegenerative disease by expressing wild-type and mutant forms of human tau in the fruit fly Drosophila melanogaster. Transgenic flies showed key features of the human disorders: adult onset, progressive neurodegeneration, early death, enhanced toxicity of mutant tau, accumulation of abnormal tau, and relative anatomic selectivity. However, neurodegeneration occurred without the neurofibrillary tangle formation that is seen in human disease and some rodent tauopathy models. This fly model may allow a genetic analysis of the cellular mechanisms underlying tau neurotoxicity.	Brigham & Womens Hosp, Dept Pathol, Div Neuropathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; City Hope Natl Med Ctr, Beckman Res Inst, Div Neurosci, Duarte, CA 91010 USA; Mayo Clin Jacksonville, Jacksonville, FL 32224 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; City of Hope; Beckman Research Institute of City of Hope; Mayo Clinic	Feany, MB (corresponding author), Brigham & Womens Hosp, Dept Pathol, Div Neuropathol, 221 Longwood Ave,Room 514, Boston, MA 02115 USA.			Feany, Mel/0000-0003-0315-7970				Bird TD, 1999, BRAIN, V122, P741, DOI 10.1093/brain/122.4.741; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brion JP, 1999, AM J PATHOL, V154, P255, DOI 10.1016/S0002-9440(10)65272-8; BUCHANAN RL, 1993, NEURON, V10, P839, DOI 10.1016/0896-6273(93)90200-B; COOMBE PE, 1986, J NEUROGENET, V3, P135, DOI 10.3109/01677068609106845; Feany MB, 2000, J NEUROPATH EXP NEUR, V59, P847, DOI 10.1093/jnen/59.10.847; Feany MB, 2000, NATURE, V404, P394, DOI 10.1038/35006074; Feany MB, 1996, ANN NEUROL, V40, P139, DOI 10.1002/ana.410400204; Fernandez-Funez P, 2000, NATURE, V408, P101, DOI 10.1038/35040584; GEDDES JF, 1993, BRAIN, V116, P281, DOI 10.1093/brain/116.1.281; GOEDERT M, 1992, NEURON, V8, P159, DOI 10.1016/0896-6273(92)90117-V; GREENBERG SG, 1990, P NATL ACAD SCI USA, V87, P5827, DOI 10.1073/pnas.87.15.5827; Hall GF, 1997, P NATL ACAD SCI USA, V94, P4733, DOI 10.1073/pnas.94.9.4733; Hutton M, 2000, ANN NY ACAD SCI, V920, P63; Ishihara T, 1999, NEURON, V24, P751, DOI 10.1016/S0896-6273(00)81127-7; Ishihara T, 2001, AM J PATHOL, V158, P555, DOI 10.1016/S0002-9440(10)63997-1; Jicha GA, 1997, J NEUROSCI RES, V48, P128, DOI 10.1002/(SICI)1097-4547(19970415)48:2<128::AID-JNR5>3.0.CO;2-E; Jicha GA, 1999, J NEUROSCI RES, V55, P713, DOI 10.1002/(SICI)1097-4547(19990315)55:6<713::AID-JNR6>3.0.CO;2-G; Kretzschmar D, 1997, J NEUROSCI, V17, P7425; Lewis J, 2000, NAT GENET, V25, P402, DOI 10.1038/78078; Warrick JM, 1999, NAT GENET, V23, P425, DOI 10.1038/70532; Yasuyama K, 1999, MICROSC RES TECHNIQ, V45, P65, DOI 10.1002/(SICI)1097-0029(19990415)45:2<65::AID-JEMT2>3.0.CO;2-0; YEH E, 1995, P NATL ACAD SCI USA, V92, P7036, DOI 10.1073/pnas.92.15.7036; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	25	663	686	1	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 27	2001	293	5530					711	714		10.1126/science.1062382	http://dx.doi.org/10.1126/science.1062382			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458PW	11408621				2022-12-24	WOS:000170204600059
J	Reick, M; Garcia, JA; Dudley, C; McKnight, SL				Reick, M; Garcia, JA; Dudley, C; McKnight, SL			NPAS2: An analog of clock operative in the mammalian forebrain	SCIENCE			English	Article							CIRCADIAN CLOCK; GENE-EXPRESSION; DOUBLE-TIME; PROTEIN; MPER1; RHYTHMICITY; ORTHOLOG; CLONING; LOOP	Neuronal PAS domain protein 2 (NPAS2) is a transcription factor expressed primarily in the mammalian forebrain. NPAS2 is highly related in primary amino acid sequence to Clock, a transcription factor expressed in the suprachiasmatic nucleus that heterodimerizes with BMAL1 and regulates circadian rhythm. To investigate the biological role of NPAS2, we prepared a neuroblastoma cell Line capable of conditional induction of the NPAS2:BMAL1 heterodimer and identified putative target genes by representational difference analysis, DNA microarrays, and Northern blotting. Coinduction of NPAS2 and BMAL1 activated transcription of the endogenous Per1, Per2, and Cry1 genes, which encode negatively activating components of the circadian regulatory apparatus, and repressed transcription of the endogenous BMAL1 gene. Analysis of the frontal cortex of wild-type mice kept in a 24-hour Light-dark cycle revealed that Per1, Per2, and Cry1 mRNA Levels were elevated during darkness and reduced during Light, whereas BMAL1 mRNA displayed the opposite pattern. In situ hybridization assays of mice kept in constant darkness revealed that Per2 mRNA abundance did not oscillate as a function of the circadian cycle in NPAS2-deficient mice. Thus, NPAS2 likely functions as part of a molecular clock operative in the mammalian forebrain.	Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Internal Med, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	McKnight, SL (corresponding author), Univ Texas, SW Med Ctr, Dept Biochem, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	smckni@biochem.swmed.edu	Jansen, Heiko T./A-5770-2008	Jansen, Heiko T./0000-0003-0178-396X; Garcia, Joseph/0000-0002-5621-7538	NIMH NIH HHS [1RO1MH59388] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059388] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Albrecht U, 1997, CELL, V91, P1055, DOI 10.1016/S0092-8674(00)80495-X; Bae K, 2001, NEURON, V30, P525, DOI 10.1016/S0896-6273(01)00302-6; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; BIEDLER JL, 1988, ADV NEUROBLASTOMA RE, V2, P265; Bruick RK, 2000, P NATL ACAD SCI USA, V97, P9082, DOI 10.1073/pnas.97.16.9082; DECOURSEY PJ, 1989, BRAIN RES, V500, P263, DOI 10.1016/0006-8993(89)90322-3; DRUCKERCOLIN R, 1984, BRAIN RES, V311, P353, DOI 10.1016/0006-8993(84)90099-4; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Franklin KBJ, 2008, MOUSE BRAIN STEREOTA, V3rd; Garcia JA, 2000, SCIENCE, V288, P2226, DOI 10.1126/science.288.5474.2226; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Hogenesch JB, 1998, P NATL ACAD SCI USA, V95, P5474, DOI 10.1073/pnas.95.10.5474; Hughes TR, 2001, NAT BIOTECHNOL, V19, P342, DOI 10.1038/86730; Jin XW, 1999, CELL, V96, P57, DOI 10.1016/S0092-8674(00)80959-9; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; Klein D.C., 1991, SUPRACHIASMATIC NUCL; Kloss B, 1998, CELL, V94, P97, DOI 10.1016/S0092-8674(00)81225-8; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Lowrey PL, 2000, SCIENCE, V288, P483, DOI 10.1126/science.288.5465.483; No D, 1996, P NATL ACAD SCI USA, V93, P3346, DOI 10.1073/pnas.93.8.3346; Price JL, 1998, CELL, V94, P83, DOI 10.1016/S0092-8674(00)81224-6; REICK M, UNPUB; Sangoram AM, 1998, NEURON, V21, P1101, DOI 10.1016/S0896-6273(00)80627-3; Sun ZS, 1997, CELL, V90, P1003, DOI 10.1016/S0092-8674(00)80366-9; Thresher RJ, 1998, SCIENCE, V282, P1490, DOI 10.1126/science.282.5393.1490; Tosini G, 1996, SCIENCE, V272, P419, DOI 10.1126/science.272.5260.419; Vitaterna MH, 1999, P NATL ACAD SCI USA, V96, P12114, DOI 10.1073/pnas.96.21.12114; Zhou YD, 1997, P NATL ACAD SCI USA, V94, P713, DOI 10.1073/pnas.94.2.713; Zylka MJ, 1998, NEURON, V20, P1103, DOI 10.1016/S0896-6273(00)80492-4	29	435	452	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 20	2001	293	5529					506	509		10.1126/science.1060699	http://dx.doi.org/10.1126/science.1060699			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	454HG	11441147				2022-12-24	WOS:000169966700050
J	Roux, AVD; Merkin, SS; Arnett, D; Chambless, L; Massing, M; Nieto, FJ; Sorlie, P; Szklo, M; Tyroler, HA; Watson, RL				Roux, AVD; Merkin, SS; Arnett, D; Chambless, L; Massing, M; Nieto, FJ; Sorlie, P; Szklo, M; Tyroler, HA; Watson, RL			Neighborhood of residence and incidence of coronary heart disease.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ALAMEDA-COUNTY; CARDIOVASCULAR-DISEASE; ATHEROSCLEROSIS RISK; SOCIOECONOMIC-STATUS; MULTILEVEL ANALYSIS; PHYSICAL-ACTIVITY; UNITED-STATES; SOCIAL-CLASS; HEALTH; MORTALITY	Background: Where a person lives is not usually thought of as an independent predictor of his or her health, although physical and social features of places of residence may affect health and health-related behavior. Methods: Using data from the Atherosclerosis Risk in Communities Study, we examined the relation between characteristics of neighborhoods and the incidence of coronary heart disease. Participants were 45 to 64 years of age at base line and were sampled from four study sites in the United States: Forsyth County, North Carolina; Jackson, Mississippi; the northwestern suburbs of Minneapolis; and Washington County, Maryland. As proxies for neighborhoods, we used block groups containing an average of 1000 people, as defined by the U.S. Census. We constructed a summary score for the socioeconomic environment of each neighborhood that included information about wealth and income, education, and occupation. Results: During a median of 9.1 years of follow-up, 615 coronary events occurred in 13,009 participants. Residents of disadvantaged neighborhoods (those with lower summary scores) had a higher risk of disease than residents of advantaged neighborhoods, even after we controlled for personal income, education, and occupation. Hazard ratios for coronary heart disease among low-income persons living in the most disadvantaged neighborhoods, as compared with high-income persons in the most advantaged neighborhoods, were 3.1 among whites (95 percent confidence interval, 2.1 to 4.8) and 2.5 among blacks (95 percent confidence interval, 1.4 to 4.5). These associations remained unchanged after adjustment for established risk factors for coronary heart disease. Conclusions: Even after controlling for personal income, education, and occupation, we found that living in a disadvantaged neighborhood is associated with an increased incidence of coronary heart disease. (N Engl J Med 2001;345:99-106.) Copyright (C) 2001 Massachusetts Medical Society.	Columbia Univ, Columbia Coll Phys & Surg, Div Gen Med, New York, NY USA; Columbia Univ, Joseph T Mailman Sch Publ Hlth, Div Epidemiol, New York, NY USA; Univ Minnesota, Sch Publ Hlth, Div Epidemiol, Minneapolis, MN 55455 USA; Univ N Carolina, Dept Biostat, Chapel Hill, NC USA; Univ N Carolina, Collaborat Studies Coordinating Ctr, Chapel Hill, NC USA; Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA; Johns Hopkins Univ, Sch Hyg & Publ Hlth, Dept Epidemiol, Baltimore, MD USA; NHLBI, Div Epidemiol & Clin Applicat, Bethesda, MD 20892 USA; Univ Mississippi, Med Ctr, Dept Prevent Med, Jackson, MS 39216 USA	Columbia University; Columbia University; University of Minnesota System; University of Minnesota Twin Cities; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Mississippi; University of Mississippi Medical Center	Roux, AVD (corresponding author), Columbia Presbyterian Med Ctr, Div Gen Med, 622 W 168th St,PH9 E,Rm 105, New York, NY 10032 USA.			Szklo, Moyses/0000-0001-9433-6266	NHLBI NIH HHS [N01-HC-55015, N01-HC-55016, R29 HL59386] Funding Source: Medline; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC055016, N01HC055015] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL059386] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ANDERSON JT, 1979, PREV MED, V8, P525, DOI 10.1016/0091-7435(79)90328-1; Anderson RT, 1997, EPIDEMIOLOGY, V8, P42, DOI 10.1097/00001648-199701000-00007; [Anonymous], [No title captured]; BAECKE JAH, 1982, AM J CLIN NUTR, V36, P936; *BUR CENS, 1982, 1980 CENS POP; CHEADLE A, 1991, PREV MED, V20, P250, DOI 10.1016/0091-7435(91)90024-X; COX DR, 1972, J R STAT SOC B, V34, P187; Diez-Roux AV, 1999, J EPIDEMIOL COMMUN H, V53, P55, DOI 10.1136/jech.53.1.55; DiezRoux AV, 1997, AM J EPIDEMIOL, V146, P48, DOI 10.1093/oxfordjournals.aje.a009191; Duncan C, 1999, SOC SCI MED, V48, P497, DOI 10.1016/S0277-9536(98)00360-8; ELFORD J, 1989, LANCET, V1, P343; FABSITZ R, 1980, AM J EPIDEMIOL, V111, P315, DOI 10.1093/oxfordjournals.aje.a112903; GREEN M, 1991, POOR PAY MORE LESS 1; HAAN M, 1987, AM J EPIDEMIOL, V125, P989, DOI 10.1093/oxfordjournals.aje.a114637; HACKBARTH DP, 1995, J PUBLIC HEALTH POL, V16, P213, DOI 10.2307/3342593; Hart C, 1997, SOC SCI MED, V45, P893, DOI 10.1016/S0277-9536(96)00431-5; HENRY JP, 1986, POSTGRAD MED J, V62, P687, DOI 10.1136/pgmj.62.729.687; Jargowsky PA, 1996, AM SOCIOL REV, V61, P984, DOI 10.2307/2096304; Kahn HA, 1989, STAT METHODS EPIDEMI; KAPLAN GA, 1993, CIRCULATION, V88, P1973, DOI 10.1161/01.CIR.88.4.1973; Kaplan GA, 1996, INT J HEALTH SERV, V26, P507, DOI 10.2190/4CUU-7B3G-G4XR-0K0B; KING AC, 1992, MED SCI SPORTS EXERC, V24, P221; Kleinschmidt I, 1995, J EPIDEMIOL COMMUN H, V49, pS72, DOI 10.1136/jech.49.Suppl_2.S72; MACINTYRE S, 1993, J SOC POLICY, V22, P213, DOI 10.1017/S0047279400019310; Massey DS, 1996, DEMOGRAPHY, V33, P395, DOI 10.2307/2061773; Mooney C., 1990, Journal of Human Nutrition and Dietetics, V3, P111, DOI 10.1111/j.1365-277X.1990.tb00058.x; Pucci LG, 1998, AM J PREV MED, V15, P155, DOI 10.1016/S0749-3797(98)00034-8; RAUTAHARJU PM, 1981, CIRCULATION, V64, P249, DOI 10.1161/01.CIR.64.2.249; Robert SA, 1999, ANNU REV SOCIOL, V25, P489, DOI 10.1146/annurev.soc.25.1.489; Robert SA, 1998, J HEALTH SOC BEHAV, V39, P18, DOI 10.2307/2676387; ROBINS JM, 1992, EPIDEMIOLOGY, V3, P143, DOI 10.1097/00001648-199203000-00013; Shah BV, 1997, SUDAAN USERS MANUAL; Shumaker SA, 1994, SOCIAL SUPPORT CARDI; Smith GD, 1998, J EPIDEMIOL COMMUN H, V52, P399, DOI 10.1136/jech.52.6.399; SZKKO M, 2000, EPIDEMIOLOGY BASICS; TROUTT DD, 1993, THIN RED LINE POOR S; Waitzman NJ, 1998, AM J PUBLIC HEALTH, V88, P1122; White AD, 1996, J CLIN EPIDEMIOL, V49, P223, DOI 10.1016/0895-4356(95)00041-0; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184; WING S, 1987, LANCET, V2, P1067; WING S, 1988, AM J PUBLIC HEALTH, V78, P923, DOI 10.2105/AJPH.78.8.923; Yen IH, 1998, AM J PUBLIC HEALTH, V88, P1709, DOI 10.2105/AJPH.88.11.1709; Yen IH, 1999, AM J EPIDEMIOL, V149, P898; 1999, MMWR MORB MORTAL WKL, V48, P143	44	1253	1266	0	55	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 12	2001	345	2					99	106		10.1056/NEJM200107123450205	http://dx.doi.org/10.1056/NEJM200107123450205			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	451AH	11450679	Green Published			2022-12-24	WOS:000169776900005
J	Richter, JD; Theurkauf, WE				Richter, JD; Theurkauf, WE			Development - The message is in the translation	SCIENCE			English	Editorial Material							MESSENGER-RNA; NANOS; DROSOPHILA; PUMILIO; PHOSPHORYLATION; RECRUITMENT; INTERACTS; CPEB		Univ Massachusetts, Sch Med, Dept Mol Genet & Microbiol, Worcester, MA 01605 USA; Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Richter, JD (corresponding author), Univ Massachusetts, Sch Med, Dept Mol Genet & Microbiol, Worcester, MA 01605 USA.	joel.richter@umassmed.edu; william.theurkauf@umassmed.edu		Theurkauf, William/0000-0001-7342-1912				Asaoka-Taguchi M, 1999, NAT CELL BIOL, V1, P431, DOI 10.1038/15666; DALBY B, 1993, EMBO J, V12, P1219, DOI 10.1002/j.1460-2075.1993.tb05763.x; Groisman I, 2000, CELL, V103, P435, DOI 10.1016/S0092-8674(00)00135-5; King RW, 1996, SCIENCE, V274, P1652, DOI 10.1126/science.274.5293.1652; Mendez R, 2000, MOL CELL, V6, P1253, DOI 10.1016/S1097-2765(00)00121-0; Mendez R, 2000, NATURE, V404, P302, DOI 10.1038/35005126; Nakahata S, 2001, J BIOL CHEM, V276, P20945, DOI 10.1074/jbc.M010528200; RICHTER JD, 2000, TRANSLATIONAL CONTRO, pCH27; Sonoda J, 1999, GENE DEV, V13, P2704, DOI 10.1101/gad.13.20.2704; Sonoda J, 2001, GENE DEV, V15, P762, DOI 10.1101/gad.870801; Stebbins-Boaz B, 1999, MOL CELL, V4, P1017, DOI 10.1016/S1097-2765(00)80230-0; Wreden C, 1997, DEVELOPMENT, V124, P3015	12	31	32	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 6	2001	293	5527					60	62		10.1126/science.1062237	http://dx.doi.org/10.1126/science.1062237			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	451BB	11441171				2022-12-24	WOS:000169780300026
J	Knight, J				Knight, J			Meet the Herod bug	NATURE			English	News Item							MALE-KILLING WOLBACHIA; ARMADILLIDIUM-VULGARE LATR; CYTOPLASMIC INCOMPATIBILITY; MOLECULAR-IDENTIFICATION; DROSOPHILA; ENDOSYMBIONT; HYMENOPTERA; SEQUENCES; SEX											Bordenstein SR, 2001, NATURE, V409, P707, DOI 10.1038/35055543; BROWER JH, 1976, ANN ENTOMOL SOC AM, V69, P1011, DOI 10.1093/aesa/69.6.1011; Campbell B.C., 1993, Insect Molecular Biology, V2, P225; Cole ST, 2001, NATURE, V409, P1007, DOI 10.1038/35059006; Fialho RF, 2000, P ROY SOC B-BIOL SCI, V267, P1469, DOI 10.1098/rspb.2000.1166; HOFFMANN AA, 1986, EVOLUTION, V40, P692, DOI 10.1111/j.1558-5646.1986.tb00531.x; Hoffmann AA, 1998, GENETICS, V148, P221; Hurst GDD, 1999, P ROY SOC B-BIOL SCI, V266, P735, DOI 10.1098/rspb.1999.0698; Hurst GDD, 2000, GENETICS, V156, P699; Jeyaprakash A, 2000, INSECT MOL BIOL, V9, P393, DOI 10.1046/j.1365-2583.2000.00203.x; Jiggins FM, 2001, P ROY SOC B-BIOL SCI, V268, P1123, DOI 10.1098/rspb.2001.1632; Majerus TMO, 1999, INSECT MOL BIOL, V8, P551, DOI 10.1046/j.1365-2583.1999.00151.x; Masui S, 2000, J MOL EVOL, V51, P491, DOI 10.1007/s002390010112; RICHARDSON PM, 1987, J INVERTEBR PATHOL, V50, P176, DOI 10.1016/0022-2011(87)90080-2; RIGAUD T, 1993, GENETICS, V133, P247; RIGAUD T, 1991, ENDOCYTOBIOSIS CELL, V7, P259; STOUTHAMER R, 1993, NATURE, V361, P66, DOI 10.1038/361066a0; STOUTHAMER R, 1990, P NATL ACAD SCI USA, V87, P2424, DOI 10.1073/pnas.87.7.2424; Stouthamer R, 2001, P ROY SOC B-BIOL SCI, V268, P617, DOI 10.1098/rspb.2000.1404; Taylor MJ, 2000, PARASITOL TODAY, V16, P179, DOI 10.1016/S0169-4758(00)01661-6; Van Opijnen T, 1999, EXP APPL ACAROL, V23, P871, DOI 10.1023/A:1006363604916; WADE MJ, 1985, SCIENCE, V227, P527, DOI 10.1126/science.3966160; Werren J.H., 1995, P ROY SOC LOND B BIO, V262, P147; YEN JH, 1971, NATURE, V232, P657, DOI 10.1038/232657a0	24	13	14	0	14	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 5	2001	412	6842					12	14		10.1038/35083744	http://dx.doi.org/10.1038/35083744			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448TB	11452274	Bronze			2022-12-24	WOS:000169644900012
J	Sutcliffe, AG; Taylor, B; Saunders, K; Thornton, S; Lieberman, BA; Grudzinskas, JG				Sutcliffe, AG; Taylor, B; Saunders, K; Thornton, S; Lieberman, BA; Grudzinskas, JG			Outcome in the second year of life after in-vitro fertilisation by intracytoplasmic sperm injection: a UK case-control study	LANCET			English	Article							CHILDREN BORN; FOLLOW-UP; PREGNANCIES; DISEASES; RISK	Background There have been reports suggesting that children born after in-vitro fertilisation by intracytoplasmic sperm injection (ICSI) are at increased risk of neurodevelopmental delay. We have undertaken a case-control study of this issue. Methods We studied 208 singleton children conceived by ICSI and a control group of 221 normally conceived singleton children. Children were recruited from 22 fertility centres and local nurseries throughout the UK. Controls were selected to match cases as closely as possible for social class, maternal educational attainment, region, sex, and race. The primary outcome measure was neurodevelopmental scoring; secondary measures were perinatal outcomes, postnatal health, and congenital abnormalities. A single examiner assessed all the children. Findings A follow-up rate of 90% for the ICSI group was achieved at a mean age of 17 months. No difference between the study children and controls was found in mean neurodevelopmental scores (98.08 [SD 10.93] vs 98.69 [9.99]) or any subscales on the Griffiths' scales of mental development. Perinatal outcome was similar apart from a higher rate of caesarean section (73 [35.1%] vs 53 [24.0%], p=0.015) and a lower mean birthweight (3163 [SD 642] vs 3341 [606] g, p=0.013) in the study group. Rates of major congenital abnormality were also similar overall (ten [4.8%] study vs ten [4.5%] control), although there were significantly more congenital anomalies among children born to fathers with oligozoospermia than in other children. Interpretation This population study did not show any significant difference between children conceived after ICSI and their naturally conceived peers in terms of physical health and development.	UCL Royal Free & Univ Coll Med Sch, Dept Paediat & Child Hlth, London NW3 2PF, England; Monash Univ, Monash Med Ctr, Dept Paediat, Melbourne, Vic 3004, Australia; Pk Hosp, CARE, Nottingham, England; St Marys Hosp, Dept Reprod Med, Manchester M13 0JH, Lancs, England; BUPA Hosp, Manchester Fertil Serv, Manchester, Lancs, England; St Bartholomews & Royal London Sch Med & Dent, Dept Obstet & Gynaecol, London, England	University of London; University College London; UCL Medical School; Monash University; University of Manchester; University of London; Queen Mary University London	Sutcliffe, AG (corresponding author), UCL Royal Free & Univ Coll Med Sch, Dept Paediat & Child Hlth, Royal Free Campus, London NW3 2PF, England.	icsi@rfc.ucl.ac.uk		Sutcliffe, Alastair/0000-0001-8542-6155				Bergh T, 1999, LANCET, V354, P1579, DOI 10.1016/S0140-6736(99)04345-7; Bonduelle M, 1999, HUM REPROD, V14, P243, DOI 10.1093/humrep/14.suppl_1.243; Bonduelle M, 1998, LANCET, V351, P1553, DOI 10.1016/S0140-6736(98)24021-9; Bowen JR, 1998, LANCET, V351, P1529, DOI 10.1016/S0140-6736(98)10168-X; Hawkins MM, 1999, LANCET, V354, P1906, DOI 10.1016/S0140-6736(05)76874-4; Kent-First MG, 1996, MOL HUM REPROD, V2, P943, DOI 10.1093/molehr/2.12.943; Kurinczuk JJ, 1997, BRIT MED J, V315, P1260, DOI 10.1136/bmj.315.7118.1260; Loft A, 1999, HUM REPROD, V14, P2143, DOI 10.1093/humrep/14.8.2143; PALERMO G, 1992, LANCET, V340, P17, DOI 10.1016/0140-6736(92)92425-F; Palermo GD, 1996, JAMA-J AM MED ASSOC, V276, P1893, DOI 10.1001/jama.276.23.1893; Stuppia L, 1998, HUM GENET, V102, P566, DOI 10.1007/s004390050741; Sutcliffe AG, 1999, BMJ-BRIT MED J, V318, P704; Sutcliffe AG, 1998, LANCET, V352, P578, DOI 10.1016/S0140-6736(05)79291-6; SUTCLIFFE AG, 2001, INT COLLABORATIVE ST; Vogt PH, 1999, LANCET, V354, P611, DOI 10.1016/S0140-6736(99)80147-0; Wennerholm UB, 1996, HUM REPROD, V11, P1113; Wennerholm UB, 2000, HUM REPROD, V15, P944, DOI 10.1093/humrep/15.4.944; World Health Organization, 1999, WHO LAB MANUAL EXAMI, V4th	18	179	185	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 30	2001	357	9274					2080	2084		10.1016/S0140-6736(00)05180-1	http://dx.doi.org/10.1016/S0140-6736(00)05180-1			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	447RQ	11445100				2022-12-24	WOS:000169586600010
J	Mungai, M; Tegtmeier, G; Chamberland, M; Parise, M				Mungai, M; Tegtmeier, G; Chamberland, M; Parise, M			Transfusion-transmitted malaria in the United States from 1963 through 1999	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BLOOD-DONOR SELECTION; COLLECTION; COMPONENTS; TRANSMISSION	Background: Transfusion-transmitted malaria is uncommon in the United States. After the report of three cases of complicated Plasmodium falciparum infection acquired by transfusion, we reviewed all cases of transfusion-transmitted malaria reported to the Centers for Disease Control and Prevention (CDC) from 1963 through 1999. Methods: Information on the patients was from surveillance reports sent to the CDC. Information about the implicated blood donors came from the National Malaria Surveillance System. To determine whether donors should have been excluded from donating blood, we compared their characteristics with the exclusion guidelines of the Food and Drug Administration and the American Association of Blood Banks. Results: Of 93 cases of transfusion-transmitted malaria reported in 28 states, 33 (35 percent) were due to P. falciparum, 25 (27 percent) were due to P. vivax, 25 (27 percent) were due to P. malariae, 5 (5 percent) were due to P. ovale, 3 (3 percent) were mixed infections, and 2 (2 percent) were due to unidentified species. Ten of the 93 patients (11 percent) died. There were potentially 91 donors (in two cases, two patients received blood from the same donor), 67 of whom (74 percent) could be identified as infective. Of 64 implicated donors whose country of origin was reported, 38 (59 percent) were foreign born. Among those for whom complete information was available, 37 of 60 donors (62 percent) would have been excluded from donating according to current guidelines (in place since 1994), and 30 of 48 donors (62 percent) should have been excluded under the guidelines in place at the time of donation. Conclusions: Careful screening of donors according to the recommended exclusion guidelines remains the best way to prevent transfusion-transmitted malaria. (N Engl J Med 2001;344:1973-8.) Copyright (C) 2001 Massachusetts Medical Society.	Ctr Dis Control & Prevent, Div Parasit Dis, Natl Ctr Infect Dis, Atlanta, GA 30341 USA; Ctr Dis Control & Prevent, Div Viral & Rickettsial Dis, Natl Ctr Infect Dis, Atlanta, GA 30341 USA; Publ Hlth Serv, US Dept HHS, Washington, DC USA; Community Blood Ctr Greater Kansas City, Kansas City, MO USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; United States Public Health Service	Parise, M (corresponding author), Ctr Dis Control & Prevent, Div Parasit Dis, Natl Ctr Infect Dis, Mailstop F-22,4770 Buford Hwy, Atlanta, GA 30341 USA.	mcp0@cdc.gov						*AM ASS BLOOD BANK, 1999, ASS B, V9910; *AM ASS BLOOD BANK, 1999, STAND BLOOD BANKS TR; BEADLE C, 1994, LANCET, V343, P564, DOI 10.1016/S0140-6736(94)91520-2; BESSON P, 1976, REV FR TRANSFUS IMMU, V19, P369, DOI 10.1016/S0338-4535(76)80076-1; BRASSEUR P, 1981, HEMATOLOGIE, V24, P597; BRUCECHW.LJ, 1974, B WORLD HEALTH ORGAN, V50, P337; Busch MP, 2000, VOX SANG, V78, P253; Chiodini PL, 1997, VOX SANG, V73, P143, DOI 10.1046/j.1423-0410.1997.7330143.x; CHWATT LJB, 1982, TROP DIS B, V79, P827; *GEN ACC OFF, 1997, GAOPEMD972; Gilles HM, 1993, ESSENTIAL MALARIOLOG, P124; Goodnough LT, 1999, NEW ENGL J MED, V340, P438, DOI 10.1056/NEJM199902113400606; GUERRERO IC, 1983, ANN INTERN MED, V99, P221, DOI 10.7326/0003-4819-99-2-221; HANG VTT, 1995, T ROY SOC TROP MED H, V89, P44, DOI 10.1016/0035-9203(95)90652-5; KACHUR SP, 1998, LAST PUBLIC HLTH PRE, P313; Linden JV, 2000, TRANSFUSION, V40, P285, DOI 10.1046/j.1537-2995.2000.40030285.x; LOPEZ CE, 1977, J INFECT DIS, V135, P875, DOI 10.1093/infdis/135.5.875; McQuiston JH, 2000, TRANSFUSION, V40, P274, DOI 10.1046/j.1537-2995.2000.40030274.x; MILLER LH, 1975, TRANSMISSIBLE DISEAS, P241; NAHLEN BL, 1991, TRANSFUSION, V31, P798, DOI 10.1046/j.1537-2995.1991.31992094665.x; Piper R, 1999, AM J TROP MED HYG, V60, P109, DOI 10.4269/ajtmh.1999.60.109; SHULMAN IA, 1994, ARCH PATHOL LAB MED, V118, P366; SULZER AJ, 1971, B WORLD HEALTH ORGAN, V45, P375; SURGENOR DM, 1990, NEW ENGL J MED, V322, P1646, DOI 10.1056/NEJM199006073222306; Talib V H, 1996, Indian J Pathol Microbiol, V39, P493; TURC JM, 1990, EMERGING GLOBAL PATTERNS IN TRANSFUSION-TRANSMITTED INFECTIONS, P31; VAMVAKAS EC, 1994, TRANSFUSION, V34, P464, DOI 10.1046/j.1537-2995.1994.34694295059.x; Wallace EL, 1998, TRANSFUSION, V38, P625, DOI 10.1046/j.1537-2995.1998.38798346630.x; WALLACE EL, 1995, TRANSFUSION, V35, P802, DOI 10.1046/j.1537-2995.1995.351096026360.x; WALLACE EL, 1993, TRANSFUSION, V33, P139, DOI 10.1046/j.1537-2995.1993.33293158046.x; WILLIAMSON W. C., 1848, ANN MAG NAT HIST, V1, P1, DOI 10.1080/03745485809494465; Zoon K, 1994, RECOMMENDATIONS DEFE, P64; 2000, FED REG, V65, P36452; 1999, MMWR MORB MORTAL WKL, V48, P253	34	179	196	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 28	2001	344	26					1973	1978		10.1056/NEJM200106283442603	http://dx.doi.org/10.1056/NEJM200106283442603			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	446HQ	11430326				2022-12-24	WOS:000169508200003
J	Roelofs, J; Van Haastert, PJM				Roelofs, J; Van Haastert, PJM			Genomics - Genes lost during evolution	NATURE			English	Article									Univ Groningen, Dept Biochem, NL-9747 AG Groningen, Netherlands	University of Groningen	Roelofs, J (corresponding author), Univ Groningen, Dept Biochem, Nijenborgh 4, NL-9747 AG Groningen, Netherlands.	p.j.m.van.haastert@chem.rug.nl	Roelofs, Jeroen/AAC-5119-2021	Roelofs, Jeroen/0000-0003-0944-2465				Baldauf SL, 2000, SCIENCE, V290, P972, DOI 10.1126/science.290.5493.972; Kay RR, 1999, TRENDS GENET, V15, P294, DOI 10.1016/S0168-9525(99)01770-9; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Roelofs J, 2001, BIOCHEM J, V354, P697, DOI 10.1042/0264-6021:3540697	4	58	59	2	9	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 28	2001	411	6841					1013	1014		10.1038/35082627	http://dx.doi.org/10.1038/35082627			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	446TF	11429590	Green Submitted, Green Published			2022-12-24	WOS:000169528500034
J	Moulin, L; Munive, A; Dreyfus, B; Boivin-Masson, C				Moulin, L; Munive, A; Dreyfus, B; Boivin-Masson, C			Nodulation of legumes by members of the beta-subclass of Proteobacteria	NATURE			English	Article							HOST-SPECIFICITY	Members of the Leguminosae form the largest plant family on Earth, with around 18,000 species. The success of legumes can largely be attributed to their ability to form a nitrogen-fixing symbiosis with specific bacteria known as rhizobia, manifested by the development of nodules on the plant roots in which the bacteria rx atmospheric nitrogen, a major contributor to the global nitrogen cycle. Rhizobia described so far belong exclusively to the a-subclass of Proteobacteria, where they are distributed in four distinct phylogenetic branches(1,2). Although nitrogen-fixing bacteria exist in other proteobacterial subclasses, for example Herbaspirillum and Azoarcus from the phylogenetically distant beta -subclass, none has been found to harbour the nod genes essential for establishing rhizobial symbiosis(3,4). Here we report the identification of proteobacteria from the b-subclass that nodulate legumes. This finding shows that the ability to establish a symbiosis with legumes is more widespread in bacteria than anticipated to date.	IRD INRA CIRAD ENSAM Baillarguet, Lab Symbioses Trop & Mediterraneennes, F-34398 Montpellier 5, France	Arts et Metiers Institute of Technology; CIRAD; INRAE; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Boivin-Masson, C (corresponding author), IRD INRA CIRAD ENSAM Baillarguet, Lab Symbioses Trop & Mediterraneennes, PB 5035, F-34398 Montpellier 5, France.	Catherine.Boivin@mpl.ird.fr	Munive, José-Antonio/P-4379-2018; Moulin, Lionel/C-2921-2008	Munive, José-Antonio/0000-0003-4509-6563; Moulin, Lionel/0000-0001-9068-6912				Boone CM, 1999, CARBOHYD RES, V317, P155, DOI 10.1016/S0008-6215(99)00083-X; Denarie J, 1996, ANNU REV BIOCHEM, V65, P503, DOI 10.1146/annurev.bi.65.070196.002443; DESCHODT C C, 1976, Phytophylactica, V8, P103; KOKOTEK W, 1989, GENE, V84, P467, DOI 10.1016/0378-1119(89)90522-2; LEROUGE P, 1990, NATURE, V344, P781, DOI 10.1038/344781a0; Perret X, 2000, MICROBIOL MOL BIOL R, V64, P180, DOI 10.1128/MMBR.64.1.180-201.2000; Polhill R.M., 1981, ADV LEGUME SYSTEMATI, P191; QUANDT J, 1993, GENE, V127, P15, DOI 10.1016/0378-1119(93)90611-6; SPAINK HP, 1991, NATURE, V354, P125, DOI 10.1038/354125a0; SWOFFORD D.L., 2003, PAUP PHYLOGENETIC AN; Sy A, 2001, J BACTERIOL, V183, P214, DOI 10.1128/JB.183.1.214-220.2001; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; van Berkum P, 1998, RHIZOBIACEAE MOL BIO, P124; Young JPW, 1996, NEW PHYTOL, V133, P87, DOI 10.1111/j.1469-8137.1996.tb04344.x; Zhang XX, 2000, APPL ENVIRON MICROB, V66, P2988, DOI 10.1128/AEM.66.7.2988-2995.2000	15	473	511	0	77	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 21	2001	411	6840					948	950		10.1038/35082070	http://dx.doi.org/10.1038/35082070			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	444EN	11418858				2022-12-24	WOS:000169386200044
J	Chyba, CF; Hand, KP				Chyba, CF; Hand, KP			Planetary science - Life without photosynthesis	SCIENCE			English	Editorial Material							EUROPA; OCEAN; EARTH; MARS; ICE		SETI Inst, Ctr Study Life Universe, Mt View, CA 94404 USA; Stanford Univ, Ctr Int Secur & Cooperat, Stanford, CA 94305 USA; Stanford Univ, Dept Geol & Environm Sci, Stanford, CA 94305 USA; Stanford Univ, Dept Mech Engn, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Chyba, CF (corresponding author), SETI Inst, Ctr Study Life Universe, Mt View, CA 94404 USA.		Hand, Kevin Peter/I-8246-2018	Hand, Kevin Peter/0000-0002-3225-9426				Chyba CF, 2001, P NATL ACAD SCI USA, V98, P801, DOI 10.1073/pnas.98.3.801; COLBURN DS, 1985, ICARUS, V63, P39, DOI 10.1016/0019-1035(85)90019-3; Cooper JF, 2001, ICARUS, V149, P133, DOI 10.1006/icar.2000.6498; DRAGANIC IG, 1991, PRECAMBRIAN RES, V52, P337, DOI 10.1016/0301-9268(91)90087-Q; FREDRIKSSON K, 1988, METEORITICS, V23, P35, DOI 10.1111/j.1945-5100.1988.tb00894.x; Gaidos EJ, 1999, SCIENCE, V284, P1631, DOI 10.1126/science.284.5420.1631; Jakosky BM, 1998, J GEOPHYS RES-PLANET, V103, P19359, DOI 10.1029/98JE01892; Kargel JS, 2000, ICARUS, V148, P226, DOI 10.1006/icar.2000.6471; Kivelson MG, 2000, SCIENCE, V289, P1340, DOI 10.1126/science.289.5483.1340; McCollom TM, 1999, J GEOPHYS RES-PLANET, V104, P30729, DOI 10.1029/1999JE001126; McCord TB, 1999, J GEOPHYS RES-PLANET, V104, P11827, DOI 10.1029/1999JE900005; MOORE JC, 1994, J GEOPHYS RES-OCEANS, V99, P5171, DOI 10.1029/93JC02832; Nealson KH, 1997, J GEOPHYS RES-PLANET, V102, P23675, DOI 10.1029/97JE01996; WALKER JCG, 1977, EVOLUTION ATMOSPHERE, P93; ZOLOTOV MY, 2000, LUNAR PLANET SCI, V31	15	72	73	1	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 15	2001	292	5524					2026	2027		10.1126/science.1060081	http://dx.doi.org/10.1126/science.1060081			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442KP	11408649				2022-12-24	WOS:000169284700036
J	Kuehni, CE; Davis, A; Brooke, AM; Silverman, M				Kuehni, CE; Davis, A; Brooke, AM; Silverman, M			Are all wheezing disorders in very young: (preschool) children increasing in prevalence?	LANCET			English	Article							RESPIRATORY SYMPTOMS; NATURAL-HISTORY; ASTHMA; CHILDHOOD; RISK; ADULTS; TRENDS; ATOPY	Background Distinct wheezing disorders co-exist in young (preschool) children, some of which (early transient wheeze and viral wheeze) are thought to be unrelated to atopy. Investigation of changes in prevalence of wheezing disorders in preschool children could provide important clues about underlying mechanisms responsible for increasing prevalence of asthma in schoolchildren. Methods Repeated population surveys of the prevalence of respiratory symptoms were done by parent-completed postal questionnaires in random samples of 1650 (1990) and 2600 (1998) caucasian children aged 1-5 years living in the county of Leicestershire, UK. Findings The response rates were 86% (1422 of 1650) in 1990 and 84% (2127 of 2522) in 1998. Between 1990 and 1998, there was a significant increase in the prevalence of reported wheeze ever (16% to 29%, p<0.0001), current wheeze (12% to 26%, p<0.0001), diagnosis of asthma (11% to 19%, p<0.0001), treatment for wheeze (15% to 26%, p<0.0001), and admission for wheeze or other chest trouble (6% to 10%, p<0.0001). The increase occurred both in children with viral wheeze (9% to 19%) and in those with the classic asthma pattern of wheezing with multiple triggers (6% to 10%). There was also an increase in transient early wheezers (3% to 5%), persistent wheezers (5% to 13%), and late-onset wheezers (6% to 8%), and in all severity groups. The increase could not be accounted for by putative household risk factors because these declined between the 2 years. Interpretation The fact that all preschool wheezing disorders increased (including viral wheeze) makes it probable that factors unrelated to atopy are implicated in the changing epidemiology of wheeze in childhood.	Univ Bern, Inselspital, Dept Paediat, CH-3010 Bern, Switzerland; Univ Leicester, Leicester Royal Infirm, Dept Child Hlth, Leicester, Leics, England; Leicestershire & Rutland Healthcare Trust, Childrens Directorate, Leicester LE1 7RG, Leics, England	University of Bern; University Hospital of Bern; University of Leicester	Kuehni, CE (corresponding author), Univ Bern, Inselspital, Dept Paediat, CH-3010 Bern, Switzerland.	claudia.kuehni@insel.ch		Kuehni, Claudia E./0000-0001-8957-2002				ANDERSON HR, 1994, BRIT MED J, V308, P1600, DOI 10.1136/bmj.308.6944.1600; ANDERSON HR, 1986, J EPIDEMIOL COMMUN H, V40, P121, DOI 10.1136/jech.40.2.121; BROOKE AM, 1995, AM J RESP CRIT CARE, V152, P1872, DOI 10.1164/ajrccm.152.6.8520749; Cane RS, 2000, ARCH DIS CHILD, V82, P327, DOI 10.1136/adc.82.4.327; Fleming DM, 2000, THORAX, V55, P657, DOI 10.1136/thorax.55.8.657; KELLY WJW, 1987, BRIT MED J, V294, P1059, DOI 10.1136/bmj.294.6579.1059; Kuehni CE, 2000, EUR RESPIR J, V16, P81, DOI 10.1034/j.1399-3003.2000.16a14.x; *LUNG ASTHM INF AG, 1996, 962 STGE HOSP MED SC; LUYT DK, 1994, ARCH DIS CHILD, V71, P24, DOI 10.1136/adc.71.1.24; LUYT DK, 1993, BMJ-BRIT MED J, V306, P1386, DOI 10.1136/bmj.306.6889.1386; LUYT DK, 1995, EUR RESPIR J, V8, P1736, DOI 10.1183/09031936.95.08101736; Magnus P, 1997, BRIT MED J, V314, P1795, DOI 10.1136/bmj.314.7097.1795; Martinez FD, 1998, EUR RESPIR J, V12, p3S; NINAN TK, 1992, BRIT MED J, V304, P873, DOI 10.1136/bmj.304.6831.873; Nystad W, 1998, EUR J EPIDEMIOL, V14, P247, DOI 10.1023/A:1007453322547; PARK ES, 1986, ARCH DIS CHILD, V61, P642, DOI 10.1136/adc.61.7.642; Pearce N, 1999, THORAX, V54, P268, DOI 10.1136/thx.54.3.268; PEAT JK, 1994, BMJ-BRIT MED J, V308, P1591, DOI 10.1136/bmj.308.6944.1591; Rusconi F, 1999, AM J RESP CRIT CARE, V160, P1617, DOI 10.1164/ajrccm.160.5.9811002; Russell G, 1997, BRIT MED J, V315, P1014, DOI 10.1136/bmj.315.7114.1014; Shaheen SO, 2000, THORAX, V55, P266, DOI 10.1136/thorax.55.4.266; Shaheen SO, 1999, THORAX, V54, P396, DOI 10.1136/thx.54.5.396; SILVERMAN M, 1993, THORAX, V48, P1200, DOI 10.1136/thx.48.12.1200; Silverman M, 1997, ARCH DIS CHILD, V77, P62, DOI 10.1136/adc.77.1.62; Stein RT, 1997, THORAX, V52, P946, DOI 10.1136/thx.52.11.946; Weiss ST, 1997, CIBA F SYMP, V206, P244	26	190	192	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 9	2001	357	9271					1821	1825		10.1016/S0140-6736(00)04958-8	http://dx.doi.org/10.1016/S0140-6736(00)04958-8			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	440DN	11410189				2022-12-24	WOS:000169160800009
J	Schwetz, BA				Schwetz, BA			Labeling changes for Orlaam	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									US FDA, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Schwetz, BA (corresponding author), US FDA, Rockville, MD 20857 USA.								0	33	33	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 6	2001	285	21					2705	2705						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	437HG	11386912				2022-12-24	WOS:000168985800006
J	Lee, AL; Wand, AJ				Lee, AL; Wand, AJ			Microscopic origins of entropy, heat capacity and the glass transition in proteins	NATURE			English	Article							INELASTIC NEUTRON-SCATTERING; SIDE-CHAIN DYNAMICS; ORDER PARAMETERS; RIBONUCLEASE-A; NMR; RELAXATION; MYOGLOBIN; BINDING; H-2; MOTIONS	Internal motion is central to protein folding(1), to protein stability through the resulting residual entropy(2), and to protein function(1,3-7). Despite its importance, the precise nature of the internal motions of protein macromolecules remains a mystery. Here we report a survey of the temperature dependence of the fast dynamics of methyl-bearing side chains in a calmodulin-peptide complex using site-specific deuterium NMR relaxation methods. The amplitudes of motion had a markedly heterogeneous spectrum and segregated into three largely distinct classes. Other proteins studied at single temperatures tend to segregate similarly. Furthermore, a large variability in the degree of thermal activation of the dynamics in the calmodulin complex indicates a heterogeneous distribution of residual entropy and hence reveals the microscopic origins of heat capacity in proteins. These observations also point to an unexpected explanation for the low-temperature 'glass transition' of proteins. It is this transition that has been ascribed to the creation of protein motional modes that are responsible for biological activity(5-7).	Univ Penn, Johnson Res Fdn, Philadelphia, PA 19104 USA; Univ Penn, Dept Biochem & Biophys, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Wand, AJ (corresponding author), Univ N Carolina, Sch Pharm, Div Med Chem & Nat Prod, Chapel Hill, NC 27599 USA.		Lee, Andrew/GVU-2817-2022					AUSTIN RH, 1975, BIOCHEMISTRY-US, V14, P5355, DOI 10.1021/bi00695a021; Constantine KL, 1998, BIOCHEMISTRY-US, V37, P7965, DOI 10.1021/bi980203o; Diehl M, 1997, BIOPHYS J, V73, P2726, DOI 10.1016/S0006-3495(97)78301-2; DOSTER W, 1989, NATURE, V337, P754, DOI 10.1038/337754a0; Feher VA, 1999, NATURE, V400, P289, DOI 10.1038/22357; FRAUENFELDER H, 1991, SCIENCE, V254, P1598, DOI 10.1126/science.1749933; FRAUENFELDER H, 1985, SCIENCE, V229, P337, DOI 10.1126/science.4012322; HARTMANN H, 1982, P NATL ACAD SCI-BIOL, V79, P4967, DOI 10.1073/pnas.79.16.4967; KARPLUS M, 1987, BIOPHYS J, V52, P1083, DOI 10.1016/S0006-3495(87)83303-9; Kay LE, 1996, BIOCHEMISTRY-US, V35, P361, DOI 10.1021/bi9522312; Lee AL, 1999, J AM CHEM SOC, V121, P2891, DOI 10.1021/ja983758f; Lee AL, 2000, NAT STRUCT BIOL, V7, P72; LeMaster DM, 1999, J AM CHEM SOC, V121, P1726, DOI 10.1021/ja982988r; Li ZG, 1996, PROTEIN SCI, V5, P2647, DOI 10.1002/pro.5560051228; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; Mittermaier A, 1999, J BIOMOL NMR, V13, P181, DOI 10.1023/A:1008387715167; MUHANDIRAM DR, 1995, J AM CHEM SOC, V117, P11536, DOI 10.1021/ja00151a018; NICHOLSON LK, 1992, BIOCHEMISTRY-US, V31, P5253, DOI 10.1021/bi00138a003; Onuchic JN, 1997, ANNU REV PHYS CHEM, V48, P545, DOI 10.1146/annurev.physchem.48.1.545; Palmer AG, 1997, CURR OPIN STRUC BIOL, V7, P732, DOI 10.1016/S0959-440X(97)80085-1; RASMUSSEN BF, 1992, NATURE, V357, P423, DOI 10.1038/357423a0; Reat V, 2000, P NATL ACAD SCI USA, V97, P9961, DOI 10.1073/pnas.97.18.9961; Sokolov AP, 1996, SCIENCE, V273, P1675, DOI 10.1126/science.273.5282.1675; TILTON RF, 1992, BIOCHEMISTRY-US, V31, P2469, DOI 10.1021/bi00124a006; Wand AJ, 1996, BIOCHEMISTRY-US, V35, P6116, DOI 10.1021/bi9530144; Yang DW, 1996, J MOL BIOL, V263, P369, DOI 10.1006/jmbi.1996.0581; Yang DW, 1998, J MOL BIOL, V276, P939, DOI 10.1006/jmbi.1997.1588; Zavodszky P, 1998, P NATL ACAD SCI USA, V95, P7406, DOI 10.1073/pnas.95.13.7406	28	267	268	0	85	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 24	2001	411	6836					501	504		10.1038/35078119	http://dx.doi.org/10.1038/35078119			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	435CB	11373686				2022-12-24	WOS:000168858700055
J	Olson, A; Stenlid, J				Olson, A; Stenlid, J			Plant pathogens - Mitochondrial control of fungal hybrid virulence	NATURE			English	Article							HETEROBASIDION-ANNOSUM; M-MEDUSAE; HYBRIDIZATION		Swedish Univ Agr Sci, Dept Forest Mycol & Pathol, SE-75007 Uppsala, Sweden	Swedish University of Agricultural Sciences	Olson, A (corresponding author), Swedish Univ Agr Sci, Dept Forest Mycol & Pathol, SE-75007 Uppsala, Sweden.	ake.olson@mykopat.slu.se	Stenlid, Jan/K-5909-2019					Brasier C, 2000, NATURE, V405, P134, DOI 10.1038/35012193; Brasier CM, 1999, P NATL ACAD SCI USA, V96, P5878, DOI 10.1073/pnas.96.10.5878; Brasier CM, 1998, MYCOL RES, V102, P45, DOI 10.1017/S0953756297004541; ERESK T, 1995, PHYTOPATHOLOGY, V85, P1343; Garbelotto M, 1996, PHYTOPATHOLOGY, V86, P543, DOI 10.1094/Phyto-86-543; GARBELOTTO M, 1996, PHYTOPATHOLOGY S, V86, P28; Garbelotto MM, 1997, MYCOLOGIA, V89, P92, DOI 10.2307/3761177; Korhonen K, 1998, HETEROBASIDION ANNOSUM: BIOLOGY, ECOLOGY, IMPACT AND CONTROL, P43; Newcombe G, 2000, MYCOL RES, V104, P261, DOI 10.1017/S0953756299001665; SHARMA P, 1993, PHYSIOL MOL PLANT P, V43, P57, DOI 10.1006/pmpp.1993.1040; SPIERS AG, 1994, MYCOL RES, V98, P889, DOI 10.1016/S0953-7562(09)80260-8; t Veld VAMI, 1998, PHYTOPATHOLOGY, V88, P922, DOI 10.1094/PHYTO.1998.88.9.922	12	70	70	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 24	2001	411	6836					438	438		10.1038/35078147	http://dx.doi.org/10.1038/35078147			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	435CB	11373666	Bronze			2022-12-24	WOS:000168858700035
J	Beier, M				Beier, M			Visiting the sadness	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	1	1	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 16	2001	285	19					2425	2426		10.1001/jama.285.19.2425	http://dx.doi.org/10.1001/jama.285.19.2425			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	429ZC	11368675				2022-12-24	WOS:000168547600001
J	Sasieni, P; Adams, J				Sasieni, P; Adams, J			Changing rates of adenocarcinoma and adenosquamous carcinoma of the cervix in England	LANCET			English	Article							CANCER MORTALITY; CELL CARCINOMAS; TRENDS; WALES; RISK	Background A recent analysis showed little or no effect of screening on the incidence of adenocarcinoma of the cervix between 1971 and 1992. We have used additional data on cancers diagnosed in 1993-94 in England and up to 1997 in five English cancer registries to investigate more recent trends. Methods After imputing the number of adenocarcinomas in women with unknown histology, we fitted an age-cohort model to 8062 adenocarcinomas of the cervix diagnosed in England between 1971 and 1987. Predictions from this model were applied to the more recent data on 5854 cases. Residual effects were plotted against year of diagnosis in each of four age-groups. Findings We estimated the underlying risk of cervical adenocarcinoma to be 14 times (95% CI 11-19) greater in women born in the early 1960s than in cohorts born before 1935. An age-cohort model fitted the data for England well up to 1987, but substantially overestimated the numbers of adenocarcinomas in young women from 1990 onwards. In 1996-97 the incidence rate in women aged 25-54 years was less than 40% of that predicted from the age-cohort model. Interpretation The substantial increase in cervical adenocarcinoma in recent years is largely a birth-cohort effect presumably associated with greater exposure to human papillomavirus after the sexual revolution in the 1960s. The relative decline in younger women observed in more recent years suggests an effect of cervical screening.	Imperial Canc Res Fund, Dept Math Stat & Epidemiol, London WC2A 3PX, England	Cancer Research UK	Sasieni, P (corresponding author), Imperial Canc Res Fund, Dept Math Stat & Epidemiol, 61 Lincolns Inn Fields, London WC2A 3PX, England.	p.sasieni@icrf.icnet.uk		Sasieni, Peter/0000-0003-1509-8744				BERAL V, 1974, LANCET, V1, P1037; Bergstrom R, 1999, BRIT J CANCER, V81, P159, DOI 10.1038/sj.bjc.6690666; BOSCH FX, 1995, JNCI-J NATL CANCER I, V87, P796, DOI 10.1093/jnci/87.11.796; *INT AG RES CANC, 1995, IARC MON EV CARC RIS; Lacey JV, 1999, CANCER EPIDEM BIOMAR, V8, P1079; McCann J, 1998, J MED SCREEN, V5, P42, DOI 10.1136/jms.5.1.42; MCCULLAGH P, 1989, GEN LINEAR MODELS, P324; *OFF NAT STAT, 1999, SERIES MBI, V26; *OFF NAT STAT, 2000, STAT B; PARKIN DM, 1985, BRIT J OBSTET GYNAEC, V92, P150, DOI 10.1111/j.1471-0528.1985.tb01067.x; Sasieni P, 1999, BRIT MED J, V318, P1244; Sasieni PD, 2000, J ROY STAT SOC A STA, V163, P191, DOI 10.1111/1467-985X.00165; Sasieni PD, 1999, AM J EPIDEMIOL, V149, P869; URSIN G, 1994, LANCET, V344, P1390, DOI 10.1016/S0140-6736(94)90567-3; Vizcaino AP, 1998, INT J CANCER, V75, P536, DOI 10.1002/(SICI)1097-0215(19980209)75:4<536::AID-IJC8>3.0.CO;2-U	15	138	143	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 12	2001	357	9267					1490	1493		10.1016/S0140-6736(00)04646-8	http://dx.doi.org/10.1016/S0140-6736(00)04646-8			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	431CL	11377601				2022-12-24	WOS:000168614300013
J	Hermankova, M; Ray, SC; Ruff, C; Powell-Davis, M; Ingersoll, R; D'Aquila, RT; Quinn, TC; Siliciano, RF; Persaud, D				Hermankova, M; Ray, SC; Ruff, C; Powell-Davis, M; Ingersoll, R; D'Aquila, RT; Quinn, TC; Siliciano, RF; Persaud, D			HIV-1 drug resistance profiles in children and adults with viral load of < 50 copies/mL receiving combination therapy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; ACTIVE ANTIRETROVIRAL THERAPY; REVERSE-TRANSCRIPTASE; LATENT RESERVOIR; GENOTYPIC RESISTANCE; PROTEASE INHIBITOR; CONFERS RESISTANCE; INFECTED PATIENTS; PLASMA VIREMIA; IN-VIVO	Context The continued release of human immunodeficiency virus type 1 (HIV-1) into plasma at very low levels during highly active antiretroviral therapy (HAART) can be detected using specialized techniques, but the nature and significance of this low-level viremia, especially as related to acquisition of drug resistance mutations, are unclear. Objective To determine genetic resistance profiles of low-level plasma HIV-1 in patients with prolonged viral suppression (<50 copies/mL of plasma HIV-1 RNA) while receiving HAART. Design and Setting Cross-sectional study conducted at a US academic hospital from November 1999 to February 2001 using a novel method for amplification of low levels of viral genomes in plasma. Patients Eighteen HIV-1-infected patients (7 children and 11 adults), enrolled in a longitudinal study of HIV-1 reservoirs, who had suppression of viral replication while receiving protease inhibitor-containing combination therapy. Two patients (1 adult and 1 child) with less optimal suppression of viral replication were included to assess virus predominating when plasma HIV-1 RNA levels are low but detectable (<1000 copies/mL). Follow-up analyses were conducted in 3 patients. Main Outcome Measure Detection of drug resistance mutations in clones amplified from low-level plasma virus. Results Viral sequences were amplified from 8 of the 18 patients with simultaneous plasma HIV-1 measurements of less than 50 copies/mL and from 2 patients with 231 and 50 copies/mL. Clones from 3 treatment-naive patients with less than 50 copies/mL of plasma HIV-1 RNA showed continued release, for as long as 42 months, of wild-type drug-sensitive virus. The 7 patients with prior nonsuppressive therapy, with viral loads below 50 copies/mL and during "blips" to 231 and 64 copies/mL, had only resistance mutations consistent with pre-HAART therapy (although reverse transcriptase inhibitor mutations may have continued to occur), New HAART-related mutations were seen in a control patient with prior viral load levels of about 400 to 1000 copies/mL. For phylogenetic analysis, sequences were available for both resting CD4(+) T cells and plasma HIV for 7 of 10 patients and showed patient-specific clustering of sequences and a close relationship between virus in the plasma and the latent reservoir. Conclusions Based on the samples that could be amplified, low-level viremia in children and adults receiving HAART with prolonged suppression of viremia to less than 50 copies/mL of HIV-1 RNA may result primarily from archival, pre-HAART virus, reflecting earlier treatment conditions, and does not appear to require development of new, HAART-selected mutations reflecting partial resistance to therapy. Low-level viremia below 50 copies/mL may represent less of a concern regarding impending drug failure of current HAART regimens, However, the archival drug-resistant virus may be relevant regarding future treatment strategies.	Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21287 USA; Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Inst Genet, Baltimore, MD USA; Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA USA; NIAID, NIH, Bethesda, MD 20892 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Persaud, D (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pediat, 600 N Wolfe St,256 Pk Bldg, Baltimore, MD 21287 USA.		Quinn, Thomas/A-2494-2010; Ray, Stuart C./B-7527-2008	Ray, Stuart C./0000-0002-1051-7260; , Roxann/0000-0002-4266-613X	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P30HD027799] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000361, R01AI043222, R01AI029193] Funding Source: NIH RePORTER; NIAID NIH HHS [AI43222, AI29193] Funding Source: Medline; NICHD NIH HHS [P30HD27799] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Atkinson B, 2000, J INFECT DIS, V182, P420, DOI 10.1086/315726; Brown AJL, 1997, NAT MED, V3, P268, DOI 10.1038/nm0397-268; Chun TW, 2000, NAT MED, V6, P757, DOI 10.1038/77481; CHUN TW, 1995, NAT MED, V1, P1284, DOI 10.1038/nm1295-1284; Chun TW, 1997, NATURE, V387, P183, DOI 10.1038/387183a0; Chun TW, 1997, P NATL ACAD SCI USA, V94, P13193, DOI 10.1073/pnas.94.24.13193; de Mendoza C, 2000, J ACQ IMMUN DEF SYND, V23, P279; Demeter LM, 2000, ANTIMICROB AGENTS CH, V44, P794, DOI 10.1128/AAC.44.3.794-797.2000; Descamps D, 2000, JAMA-J AM MED ASSOC, V283, P205, DOI 10.1001/jama.283.2.205; Dornadula G, 1999, JAMA-J AM MED ASSOC, V282, P1627, DOI 10.1001/jama.282.17.1627; Felsenstein J., 1985, EVOLUTION 1985, V39, P783; Finzi D, 1999, NAT MED, V5, P512, DOI 10.1038/8394; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; Furtado MR, 1999, NEW ENGL J MED, V340, P1614, DOI 10.1056/NEJM199905273402102; Grossman Z, 1998, IMMUNOL TODAY, V19, P528, DOI 10.1016/S0167-5699(98)01353-X; Gulick RM, 1997, NEW ENGL J MED, V337, P734, DOI 10.1056/NEJM199709113371102; Gunthard HF, 1999, J VIROL, V73, P9404; Gunthard HF, 1998, J VIROL, V72, P2422; Hammer SM, 1997, NEW ENGL J MED, V337, P725, DOI 10.1056/NEJM199709113371101; Havlir DV, 2000, JAMA-J AM MED ASSOC, V283, P229, DOI 10.1001/jama.283.2.229; Hertogs K, 2000, ANTIMICROB AGENTS CH, V44, P568, DOI 10.1128/AAC.44.3.568-573.2000; Hirsch MS, 2000, JAMA-J AM MED ASSOC, V283, P2417, DOI 10.1001/jama.283.18.2417; Ho DD, 2000, NAT MED, V6, P736, DOI 10.1038/77447; Imamichi H, 2001, J INFECT DIS, V183, P36, DOI 10.1086/317641; Learn GH, 1996, J VIROL, V70, P5720, DOI 10.1128/JVI.70.8.5720-5730.1996; Luzuriaga K, 1999, J VIROL, V73, P362, DOI 10.1128/JVI.73.1.362-367.1999; Luzuriaga K, 1997, NEW ENGL J MED, V336, P1343, DOI 10.1056/NEJM199705083361902; MARKOWITZ M, 1995, J VIROL, V69, P701, DOI 10.1128/JVI.69.2.701-706.1995; Martinez-Picado J, 2000, P NATL ACAD SCI USA, V97, P10948, DOI 10.1073/pnas.97.20.10948; Melvin AJ, 1999, J ACQ IMMUN DEF SYND, V20, P468, DOI 10.1097/00042560-199904150-00009; Molla A, 1996, NAT MED, V2, P760, DOI 10.1038/nm0796-760; Patick AK, 1998, ANTIMICROB AGENTS CH, V42, P2637, DOI 10.1128/AAC.42.10.2637; Perelson AS, 1997, NATURE, V387, P188, DOI 10.1038/387188a0; Persaud D, 2000, J CLIN INVEST, V105, P995, DOI 10.1172/JCI9006; Ramratnam B, 2000, NAT MED, V6, P82, DOI 10.1038/71577; RICHMAN DD, 1994, J VIROL, V68, P1660, DOI 10.1128/JVI.68.3.1660-1666.1994; Rouzine IM, 1999, P NATL ACAD SCI USA, V96, P10758, DOI 10.1073/pnas.96.19.10758; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SCHINAZI RF, 1993, ANTIMICROB AGENTS CH, V37, P875, DOI 10.1128/AAC.37.4.875; Sharkey ME, 2000, NAT MED, V6, P76, DOI 10.1038/71569; Smith DB, 1997, J GEN VIROL, V78, P1511, DOI 10.1099/0022-1317-78-7-1511; SWOFFORD DL, 2000, PAUP ASTERISK PHYLOG; TISDALE M, 1993, P NATL ACAD SCI USA, V90, P5653, DOI 10.1073/pnas.90.12.5653; Winters MA, 1998, J CLIN INVEST, V102, P1769, DOI 10.1172/JCI4948; Wong JK, 1997, SCIENCE, V278, P1291, DOI 10.1126/science.278.5341.1291; Yerly S, 2000, AIDS, V14, P243, DOI 10.1097/00002030-200002180-00006; Zhang LQ, 1999, NEW ENGL J MED, V340, P1605, DOI 10.1056/NEJM199905273402101	47	178	184	0	6	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 11	2001	286	2					196	207		10.1001/jama.286.2.196	http://dx.doi.org/10.1001/jama.286.2.196			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	451JJ	11448283	Bronze			2022-12-24	WOS:000169798700025
J	Lowenfels, AB; Maisonneuve, P; Whitcomb, DC; Lerch, MM; DiMagno, EP				Lowenfels, AB; Maisonneuve, P; Whitcomb, DC; Lerch, MM; DiMagno, EP			Cigarette smoking as a risk factor for pancreatic cancer in patients with hereditary pancreatitis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									New York Med Coll, Dept Surg & Community & Prevent Med, Valhalla, NY 10595 USA; European Inst Oncol, Div Epidemiol & Biostat, Milan, Italy; Univ Pittsburgh, Dept Med, Div Gastroenterol Hepatol & Nutr, Pittsburgh, PA USA; Univ Pittsburgh, Ctr Genom Sci, Pittsburgh, PA USA; Univ Munster, Dept Med B, D-4400 Munster, Germany; Mayo Clin & Mayo Fdn, Gastroenterol Res Unit, Rochester, MN 55905 USA	New York Medical College; IRCCS European Institute of Oncology (IEO); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Munster; Mayo Clinic	Lowenfels, AB (corresponding author), New York Med Coll, Dept Surg & Community & Prevent Med, Valhalla, NY 10595 USA.		Lowenfels, Albert/ABD-8388-2021; Maisonneuve, Patrick/U-9789-2018; Lerch, Markus M./E-2206-2016	Maisonneuve, Patrick/0000-0002-5309-4704; Lerch, Markus M./0000-0002-9643-8263	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054709] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK54709] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		DEMESQUITA HBB, 1991, INT J CANCER, V49, P816, DOI 10.1002/ijc.2910490604; Efthimiou E, 2001, GUT, V48, P143, DOI 10.1136/gut.48.2.143; Lowenfels AB, 1997, J NATL CANCER I, V89, P442, DOI 10.1093/jnci/89.6.442; Schenk M, 2001, JNCI-J NATL CANCER I, V93, P640, DOI 10.1093/jnci/93.8.640; Whitcomb DC, 1996, NAT GENET, V14, P141, DOI 10.1038/ng1096-141	5	206	220	0	6	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 11	2001	286	2					169	170		10.1001/jama.286.2.169	http://dx.doi.org/10.1001/jama.286.2.169			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	451JJ	11448279				2022-12-24	WOS:000169798700020
J	McNamara, P; Seo, SB; Rudic, RD; Sehgal, A; Chakravarti, D; FitzGerald, GA				McNamara, P; Seo, SB; Rudic, RD; Sehgal, A; Chakravarti, D; FitzGerald, GA			Regulation of CLOCK and MOP4 by nuclear hormone receptors in the vasculature: A humoral mechanism to reset a peripheral clock	CELL			English	Article							CIRCADIAN CLOCK; SUPRACHIASMATIC NUCLEUS; DIURNAL-VARIATION; RETINOIC ACID; MESSENGER-RNA; EXPRESSION; LOOP; TISSUES; TRANSCRIPTION; OSCILLATORS	Circadian clock genes are expressed in the suprachiasmatic nucleus and in peripheral tissues to regulate cyclically physiological processes. Synchronization of peripheral oscillators is thought to involve humoral signals, but the mechanisms by which these are mediated and integrated are poorly understood. We report a hormone-dependent interaction of the nuclear receptors, RAR alpha and RXR alpha, with CLOCK and MOP4. These interactions negatively regulate CLOCK/MOP4: BMAL1-mediated transcriptional activation of clock gene expression in vascular cells. MOP4 exhibits a robust rhythm in the vasculature, and retinoic acid can phase shift Per2 mRNA rhythmicity in vivo and in serum-induced smooth muscle cells in vitro, providing a molecular mechanism for hormonal central of clock gene expression. We propose that circadian or periodic availability of nuclear hormones may play a critical role in resetting a peripheral vascular clock.	Univ Penn, Sch Med, Ctr Expt Therapeut, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Howard Hughes Med Inst, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Neurosci, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; Howard Hughes Medical Institute; University of Pennsylvania; University of Pennsylvania	FitzGerald, GA (corresponding author), Univ Penn, Sch Med, Ctr Expt Therapeut, Philadelphia, PA 19104 USA.	garret@spirit.gcrc.upenn.edu	FitzGerald, Garret A/A-4222-2010; Rudic, Dan/B-3432-2016	Rudic, Dan/0000-0001-9122-3127; Chakravarti, Debabrata/0000-0001-8446-8599	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL062250, P50HL054500] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK057079] Funding Source: NIH RePORTER; NHLBI NIH HHS [1P50HL54500, P01 HL62250-01] Funding Source: Medline; NIDDK NIH HHS [R01 DK057079, R01-DK57079-01A1] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Akashi M, 2000, GENE DEV, V14, P645; Amir S, 1998, NEUROSCIENCE, V86, P345, DOI 10.1016/S0306-4522(98)00172-9; Andre E, 1998, EMBO J, V17, P3867, DOI 10.1093/emboj/17.14.3867; Balsalobre A, 2000, SCIENCE, V289, P2344, DOI 10.1126/science.289.5488.2344; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Czeisler CA, 1999, RECENT PROG HORM RES, V54, P97; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; Darlington TK, 1998, SCIENCE, V280, P1599, DOI 10.1126/science.280.5369.1599; ESTOJAK J, 1995, MOL CELL BIOL, V15, P5820; FORMAN BM, 1995, CELL, V81, P541, DOI 10.1016/0092-8674(95)90075-6; Garcia JA, 2000, SCIENCE, V288, P2226, DOI 10.1126/science.288.5474.2226; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Glass CK, 2000, GENE DEV, V14, P121; HEYMAN RA, 1992, CELL, V68, P397, DOI 10.1016/0092-8674(92)90479-V; Hogenesch JB, 1997, J BIOL CHEM, V272, P8581, DOI 10.1074/jbc.272.13.8581; Hogenesch JB, 1998, P NATL ACAD SCI USA, V95, P5474, DOI 10.1073/pnas.95.10.5474; HOSSMANN V, 1980, CARDIOVASC RES, V14, P125, DOI 10.1093/cvr/14.3.125; Ishida N, 1999, P NATL ACAD SCI USA, V96, P8819, DOI 10.1073/pnas.96.16.8819; Jin XW, 1999, CELL, V96, P57, DOI 10.1016/S0092-8674(00)80959-9; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Lee C, 1999, MOL CELL BIOL, V19, P5316; Liu C, 1997, CELL, V91, P855, DOI 10.1016/S0092-8674(00)80473-0; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; MARSHALL J, 1977, STROKE, V8, P230, DOI 10.1161/01.STR.8.2.230; Miano JM, 1996, CIRCULATION, V93, P1886, DOI 10.1161/01.CIR.93.10.1886; MILLARCRAIG MW, 1978, LANCET, V1, P795; Muller JE, 1999, AM J HYPERTENS, V12, p35S, DOI 10.1016/S0895-7061(98)00278-7; Oishi K, 1998, BIOCHEM BIOPH RES CO, V253, P199, DOI 10.1006/bbrc.1998.9779; PANZA JA, 1991, NEW ENGL J MED, V325, P986, DOI 10.1056/NEJM199110033251402; Perlmann T, 1997, CELL, V90, P391, DOI 10.1016/S0092-8674(00)80498-5; Rajendran RR, 1996, J EXP BIOL, V199, P2775; Reppert SM, 2001, ANNU REV PHYSIOL, V63, P647, DOI 10.1146/annurev.physiol.63.1.647; RIDKER PM, 1990, CIRCULATION, V82, P897, DOI 10.1161/01.CIR.82.3.897; Sakamoto K, 1998, J BIOL CHEM, V273, P27039, DOI 10.1074/jbc.273.42.27039; Sarov-Blat L, 2000, CELL, V101, P647, DOI 10.1016/S0092-8674(00)80876-4; Schulman IG, 1996, MOL CELL BIOL, V16, P3807; Seo SB, 2001, CELL, V104, P119, DOI 10.1016/S0092-8674(01)00196-9; Shearman LP, 1999, NEUROSCIENCE, V89, P387, DOI 10.1016/S0306-4522(98)00325-X; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; Stokkan KA, 2001, SCIENCE, V291, P490, DOI 10.1126/science.291.5503.490; Tronche F, 1998, CURR OPIN GENET DEV, V8, P532, DOI 10.1016/S0959-437X(98)80007-5; TSEMENTZIS SA, 1985, NEUROSURGERY, V17, P901, DOI 10.1227/00006123-198512000-00005; WELSH DK, 1995, NEURON, V14, P697, DOI 10.1016/0896-6273(95)90214-7; Westin S, 2000, ADV PHARMACOL, V47, P89; Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682; Zheng BH, 2001, CELL, V105, P683, DOI 10.1016/S0092-8674(01)00380-4; Zhou YD, 1997, P NATL ACAD SCI USA, V94, P713, DOI 10.1073/pnas.94.2.713; Zylka MJ, 1998, NEURON, V20, P1103, DOI 10.1016/S0896-6273(00)80492-4	49	364	376	2	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 29	2001	105	7					877	889		10.1016/S0092-8674(01)00401-9	http://dx.doi.org/10.1016/S0092-8674(01)00401-9			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	449BK	11439184	Bronze			2022-12-24	WOS:000169664300008
J	Takayama, S; Ostuni, E; LeDuc, P; Naruse, K; Ingber, DE; Whitesides, GM				Takayama, S; Ostuni, E; LeDuc, P; Naruse, K; Ingber, DE; Whitesides, GM			Laminar flows - Subcellular positioning of small molecules	NATURE			English	Article									Childrens Hosp, Dept Pathol, Boston, MA 02115 USA; Childrens Hosp, Dept Surg, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University	Takayama, S (corresponding author), Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA.	gwhitesides@gmwgroup.harvard.edu	Ingber, Donald E/AAC-5894-2019; NARUSE, Keiji/B-1620-2011; Sokabe, Masahiro/I-1565-2012	naruse, keiji/0000-0003-4100-6444				Ayscough K, 1998, METHOD ENZYMOL, V298, P18, DOI 10.1016/S0076-6879(98)98004-1; BALL EH, 1982, P NATL ACAD SCI-BIOL, V79, P123, DOI 10.1073/pnas.79.1.123; Bradke F, 1999, SCIENCE, V283, P1931, DOI 10.1126/science.283.5409.1931; Duffy DC, 1998, ANAL CHEM, V70, P4974, DOI 10.1021/ac980656z; Huang S, 1999, NAT CELL BIOL, V1, pE131, DOI 10.1038/13043; Kenis PJA, 1999, SCIENCE, V285, P83, DOI 10.1126/science.285.5424.83; Takayama S, 1999, P NATL ACAD SCI USA, V96, P5545, DOI 10.1073/pnas.96.10.5545; WANG N, 1993, SCIENCE, V260, P1124, DOI 10.1126/science.7684161; Weigl BH, 1999, SCIENCE, V283, P346, DOI 10.1126/science.283.5400.346; Xia YN, 1998, ANGEW CHEM INT EDIT, V37, P550, DOI 10.1002/(SICI)1521-3773(19980316)37:5<550::AID-ANIE550>3.0.CO;2-G	10	428	455	4	99	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 28	2001	411	6841					1016	1016		10.1038/35082637	http://dx.doi.org/10.1038/35082637			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	446TF	11429594	Green Published, Bronze			2022-12-24	WOS:000169528500037
J	Pearson, DL; Dawling, S; Walsh, WF; Haines, JL; Christman, BW; Bazyk, A; Scott, N; Summar, ML				Pearson, DL; Dawling, S; Walsh, WF; Haines, JL; Christman, BW; Bazyk, A; Scott, N; Summar, ML			Neonatal pulmonary hypertension - Urea-cycle intermediates, nitric oxide production, and carbamoyl-phosphate synthetase function	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HYALINE-MEMBRANE DISEASE; L-ARGININE; RELAXING FACTOR; BIOLOGICAL-FLUIDS; VASCULAR TONE; END-PRODUCTS; NEWBORN; NITRATE; ENDOTHELIN-1; CIRCULATION	Background: Endogenous production of nitric oxide is vital for the decrease in pulmonary vascular resistance that normally occurs after birth. The precursor of nitric oxide is arginine, a urea-cycle intermediate. We hypothesized that low concentrations of arginine would correlate with the presence of persistent pulmonary hypertension in newborns and that the supply of this precursor would be affected by a functional polymorphism (the substitution of asparagine for threonine at position 1405 [T1405N]) in carbamoyl-phosphate synthetase, which controls the rate-limiting step of the urea cycle. Methods: Plasma concentrations of amino acids and genotypes of the carbamoyl-phosphate synthetase variants were determined in 65 near-term neonates with respiratory distress. Plasma nitric oxide metabolites were measured in a subgroup of 10 patients. The results in infants with pulmonary hypertension, as assessed by echocardiography, were compared with those in infants without pulmonary hypertension. The frequencies of the carbamoyl-phosphate synthetase genotypes in the study population were assessed for Hardy-Weinberg equilibrium. Results: As compared with infants without pulmonary hypertension, infants with pulmonary hypertension had lower mean (+/-SD) plasma concentrations of arginine (20.2+/-8.8 vs. 39.8+/-17.0 micromol per liter, P<0.001) and nitric oxide metabolites (18.8+/-12.7 vs. 47.2+/-11.2 micromol per liter, P = 0.05). As compared with the general population, the infants in the study had a significantly skewed distribution of the genotypes for the carbamoyl-phosphate synthetase variants at position 1405 (P<0.005). None of the infants with pulmonary hypertension were homozygous for the T1405N polymorphism. Conclusions: Infants with persistent pulmonary hypertension have low plasma concentrations of arginine and nitric oxide metabolites. The simultaneous presence of diminished concentrations of precursors and breakdown products suggests that inadequate production of nitric oxide is involved in the pathogenesis of neonatal pulmonary hypertension. Our preliminary observations suggest that the genetically predetermined capacity of the urea cycle - in particular, the efficiency of carbamoyl-phosphate synthetase - may contribute to the availability of precursors for nitric oxide synthesis. (N Engl J Med 2001;344:1832-8.) Copyright (C) 2001 Massachusetts Medical Society.	Vanderbilt Univ, Med Ctr, Div Med Genet, Dept Pediat, Nashville, TN 37232 USA; Vanderbilt Univ, Med Ctr, Dept Pediat, Div Neonatol, Nashville, TN 37232 USA; Vanderbilt Univ, Med Ctr, Dept Internal Med, Div Pulm Med, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Summar, ML (corresponding author), Vanderbilt Univ, Med Ctr, Div Med Genet, Dept Pediat, DD 2205 Med Ctr N, Nashville, TN 37232 USA.	marshall.summar@mcmail.vanderbilt.edu	Haines, Jonathan/C-3374-2012	Haines, Jonathan/0000-0002-4351-4728; Summar, Marshall/0000-0001-8920-0110	NIEHS NIH HHS [R01 ES-09915] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES009915] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		ABMAN SH, 1990, AM J PHYSIOL, V259, pH1921, DOI 10.1152/ajpheart.1990.259.6.H1921; [Anonymous], 1997, NEW ENGL J MED, V337, P434; BAIG MMA, 1992, PEDIATR RES, V31, P143, DOI 10.1203/00006450-199202000-00010; CASTILLO L, 1995, PEDIATR RES, V38, P17, DOI 10.1203/00006450-199507000-00004; Christou H, 1997, J PEDIATR-US, V130, P603, DOI 10.1016/S0022-3476(97)70245-2; Clark RH, 2000, NEW ENGL J MED, V342, P469, DOI 10.1056/NEJM200002173420704; CORNFIELD DN, 1992, AM J PHYSIOL, V262, pH1474, DOI 10.1152/ajpheart.1992.262.5.H1474; Diaz J, 1998, CLIN BIOCHEM, V31, P513, DOI 10.1016/S0009-9120(98)00051-4; DOLLBERG S, 1995, PEDIATR RES, V37, P31, DOI 10.1203/00006450-199501000-00007; Endo A, 1996, BIOL NEONATE, V70, P15; EVANS NJ, 1991, ARCH DIS CHILD-FETAL, V66, P6, DOI 10.1136/adc.66.1_Spec_No.6; FINEMAN JR, 1994, J CLIN INVEST, V93, P2675, DOI 10.1172/JCI117281; FINEMAN JR, 1995, ANNU REV PHYSIOL, V57, P115; GRANGER DL, 1990, J CLIN INVEST, V85, P264, DOI 10.1172/JCI114422; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Guevara I, 1998, CLIN CHIM ACTA, V274, P177, DOI 10.1016/S0009-8981(98)00060-6; HECKER M, 1990, P NATL ACAD SCI USA, V87, P8612, DOI 10.1073/pnas.87.21.8612; Lepage N, 1997, CLIN CHEM, V43, P2397; Lipsitz EC, 1996, J PEDIATR SURG, V31, P137, DOI 10.1016/S0022-3468(96)90336-X; Marzinzig M, 1997, NITRIC OXIDE-BIOL CH, V1, P177, DOI 10.1006/niox.1997.0116; MONCADA S, 1993, NEW ENGL J MED, V329, P2002; NELIN LD, 1994, PEDIATR RES, V35, P20, DOI 10.1203/00006450-199401000-00006; PALMER RMJ, 1988, BIOCHEM BIOPH RES CO, V153, P1251, DOI 10.1016/S0006-291X(88)81362-7; RAIHA NCR, 1968, ACTA PAEDIATR SCAND, V57, P121, DOI 10.1111/j.1651-2227.1968.tb04663.x; RIVERA A, 1989, J PEDIATR-US, V115, P465, DOI 10.1016/S0022-3476(89)80858-3; Roberts JD, 1997, NEW ENGL J MED, V336, P605, DOI 10.1056/NEJM199702273360902; SHAUL PW, 1992, AM J PHYSIOL, V262, pH355, DOI 10.1152/ajpheart.1992.262.2.H355; SKINNER JR, 1992, ARCH DIS CHILD-FETAL, V67, P366, DOI 10.1136/adc.67.4_Spec_No.366; Stork E, 1997, NEW ENGL J MED, V336, P597; Summar ML, 1999, AM J HUM GENET, V65, pA25; VOSATKA RJ, 1994, BIOL NEONATE, V66, P65; Walsh-Sukys MC, 2000, PEDIATRICS, V105, P14, DOI 10.1542/peds.105.1.14; Xie LJ, 2000, SEMIN PERINATOL, V24, P42, DOI 10.1016/S0146-0005(00)80054-3	33	159	170	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 14	2001	344	24					1832	1838		10.1056/NEJM200106143442404	http://dx.doi.org/10.1056/NEJM200106143442404			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	441LC	11407344				2022-12-24	WOS:000169231000004
J	Levy, JB; Turner, AN; Rees, AJ; Pusey, CD				Levy, JB; Turner, AN; Rees, AJ; Pusey, CD			Long-term outcome of anti-glomerular basement membrane antibody disease treated with plasma exchange and immunosuppression	ANNALS OF INTERNAL MEDICINE			English	Article							RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS; GOODPASTURES-SYNDROME; MEDIATED DISEASE; NEPHRITIS; DIAGNOSIS; PROGNOSIS; COLLAGEN; THERAPY; ANTIGEN; CHAIN	Background: Anti-glomerular basement membrane (GBM) antibody disease is an autoantibody-mediated disorder that usually presents as rapidly progressive glomerulonephritis, often with pulmonary hemorrhage (the Goodpasture syndrome). It is reported that patients with severe renal failure do not generally recover renal function. Objective: To examine the long-term outcome of severe anti-GBM antibody disease. Design: Retrospective review of patients treated for confirmed anti-GBM antibody disease over 25 years. Setting: A tertiary referral center in the United Kingdom. Patients: 71 treated patients with anti-GBM antibody disease. Intervention: All patients received plasma exchange, prednisolone, and cyclophosphamide, Measurements: Patient and renal survival, renal histology, and antibody levels. Results: Patients who presented with a creatinine concentration less than 500 mu mol/L (5.7 mg/dL) (n = 19) had 100% patient survival and 95% renal survival at 1 year and 84% patient survival and 74% renal survival at last follow-up. In patients who presented with a creatinine concentration of 500 mu mol/L or more (greater than or equal to5.7 mg/dL) (n = 13) but did not require immediate dialysis, patient and renal survival were 83% and 82% at 1 year and 62% and 69% at last follow-up. In patients who presented with dialysis-dependent renal failure (n = 39), patient and renal survival were 65% and 8% at 1 year and 36% and 5% at last follow-up. All patients who required immediate dialysis and had 100% crescents on renal biopsy remained dialysis dependent. Conclusions: Patients with the Goodpasture syndrome and severe renal failure should be considered for urgent immunosuppression therapy, including plasma exchange, to maximize the chance of renal recovery. Patients needing immediate dialysis are less likely to recover.	Hammersmith Hosp, Imperial Coll Sch Med, Renal Sect, London W12 0NN, England; Univ Edinburgh, Royal Infirm, Edinburgh EH3 9YW, Midlothian, Scotland; Univ Aberdeen, Inst Med Sci, Aberdeen, Scotland	Imperial College London; Royal Infirmary of Edinburgh; University of Edinburgh; University of Aberdeen	Levy, JB (corresponding author), Hammersmith Hosp, Imperial Coll Sch Med, Renal Sect, Ducane Rd, London W12 0NN, England.			Turner, Neil/0000-0003-4547-873X				ANDREWS PA, 1995, CLIN NEPHROL, V44, P262; BOLTON WK, 1989, AM J NEPHROL, V9, P368; Bolton WK, 1996, KIDNEY INT, V50, P1753, DOI 10.1038/ki.1996.495; BOUGET J, 1990, ANN MED INTERNE, V141, P409; BRIGGS WA, 1979, MEDICINE, V58, P348, DOI 10.1097/00005792-197909000-00002; Daly C, 1996, RENAL FAILURE, V18, P105, DOI 10.3109/08860229609052780; EWAN PW, 1976, NEW ENGL J MED, V295, P1391, DOI 10.1056/NEJM197612162952502; Hellmark T, 1999, J BIOL CHEM, V274, P25862, DOI 10.1074/jbc.274.36.25862; HERODY M, 1993, CLIN NEPHROL, V40, P249; JOHNSON JP, 1985, MEDICINE, V64, P219, DOI 10.1097/00005792-198507000-00003; Katbamna I, 1995, J Clin Lab Immunol, V47, P11; LERNER RA, 1967, J EXP MED, V126, P989, DOI 10.1084/jem.126.6.989; Levy JB, 1996, AM J KIDNEY DIS, V27, P573, DOI 10.1016/S0272-6386(96)90169-9; LEVY JB, 2000, COMPREHENSIVE CLIN N; LEVY JB, 1997, NEPHROLOGY, P599; LOCKWOOD CM, 1976, LANCET, V1, P711; LOCKWOOD CM, 1975, BRIT MED J, V2, P252, DOI 10.1136/bmj.2.5965.252; MERKEL F, 1994, NEPHROL DIAL TRANSPL, V9, P372; PETERS DK, 1982, TRANSPLANT P, V14, P513; REES AJ, 1977, BMJ-BRIT MED J, V2, P723, DOI 10.1136/bmj.2.6089.723; SAUS J, 1988, J BIOL CHEM, V263, P13374; SAVAGE COS, 1986, BRIT MED J, V292, P301, DOI 10.1136/bmj.292.6516.301; SIMPSON IJ, 1982, AM J NEPHROL, V2, P301, DOI 10.1159/000166666; TURNER N, 1992, J CLIN INVEST, V89, P592, DOI 10.1172/JCI115625; WALKER RG, 1985, Q J MED, V54, P75; WILSON CB, 1973, KIDNEY INT, V3, P74, DOI 10.1038/ki.1973.14	26	345	359	1	15	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 5	2001	134	11					1033	1042		10.7326/0003-4819-134-11-200106050-00009	http://dx.doi.org/10.7326/0003-4819-134-11-200106050-00009			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	436YL	11388816				2022-12-24	WOS:000168963400003
J	Rushton, DH; Dover, R; Sainsbury, AW; Norris, MJ; Gilkes, JJH; Ramsay, ID				Rushton, DH; Dover, R; Sainsbury, AW; Norris, MJ; Gilkes, JJH; Ramsay, ID			Why should women have lower reference limits for haemoglobin and ferritin concentrations than men?	BMJ-BRITISH MEDICAL JOURNAL			English	Article							IRON-DEFICIENCY; SERUM FERRITIN; UNITED-STATES; POPULATION; ABSORPTION; STORES		Univ Portsmouth, Sch Pharm & Biomed Sci, Portsmouth PO1 2DT, Hants, England; Imperial Canc Res Fund, London WC2A 3PX, England; Zool Soc London, Inst Zool, London NW1 4RY, England; Lister Hosp, London SW1W 8RH, England	University of Portsmouth; Cancer Research UK; Zoological Society of London; Lister Hospital	Rushton, DH (corresponding author), Univ Portsmouth, Sch Pharm & Biomed Sci, Portsmouth PO1 2DT, Hants, England.	rushton@btinternet.com	Rushton, D Hugh/AAE-8491-2020					Andrews NC, 1999, NEW ENGL J MED, V341, P1986, DOI 10.1056/NEJM199912233412607; BOTHWELL TH, 1979, IRON METABOLISM MAN, P7; Bruner AB, 1996, LANCET, V348, P992, DOI 10.1016/S0140-6736(96)02341-0; COOK JD, 1986, BLOOD, V68, P726; COOK JD, 1976, BLOOD, V48, P449; DALLMAN PR, 1986, ANNU REV NUTR, V6, P13, DOI 10.1146/annurev.nu.06.070186.000305; DILLMANN E, 1979, AM J PHYSIOL, V237, pR337; FRASSINELLIGUNDERSON EP, 1985, AM J CLIN NUTR, V41, P703, DOI 10.1093/ajcn/41.4.703; Hallberg L, 1997, AM J CLIN NUTR, V66, P347, DOI 10.1093/ajcn/66.2.347; HALLBERG L, 1966, ACTA OBSTET GYN SCAN, V45, P320, DOI 10.3109/00016346609158455; HALLBERG L, 1982, HUM NUTR-CLIN NUTR, V36, P259; Hallberg L., 1993, HUMAN NUTR DIETETICS; HALLGREN B, 1958, J NEUROCHEM, V3, P41, DOI 10.1111/j.1471-4159.1958.tb12607.x; HARD S, 1963, ACTA DERM-VENEREOL, V43, P562; Hoffbrand AV, 1993, ESSENTIAL HAEMATOLOG, P419; Jain NC, 1993, ESSENTIALS VET HEMAT; JI G, 1987, J REPROD MED, V32, P822; Looker AC, 1997, JAMA-J AM MED ASSOC, V277, P973, DOI 10.1001/jama.277.12.973; Lynx, 2000, LYNX HAEM BIOCH DAT; *MIN AGR, 1994, DIET NUTR SURV BRIT, P72; MYERS AM, 1968, LANCET, V2, P261; NELSON M, 1999, 1 HOUS COMM ED EMPL; RUSHTON DH, 1992, CLIN ENDOCRINOL, V36, P421; SCRIMSHAW NS, 1984, J NUTR SCI VITAMINOL, V30, P47, DOI 10.3177/jnsv.30.47; SIMON TL, 1981, JAMA-J AM MED ASSOC, V245, P2038, DOI 10.1001/jama.245.20.2038; VALBERG LS, 1976, CAN MED ASSOC J, V114, P417; VITERI FE, 1972, BRIT J HAEMATOL, V23, P189, DOI 10.1111/j.1365-2141.1972.tb03472.x; WALKER ML, 1995, AM J PRIMATOL, V35, P59, DOI 10.1002/ajp.1350350106	28	71	75	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 2	2001	322	7298					1355	1357		10.1136/bmj.322.7298.1355	http://dx.doi.org/10.1136/bmj.322.7298.1355			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	440GQ	11387188	Green Published			2022-12-24	WOS:000169167900024
J	Coulter, DM; Bate, A; Meyboom, RHB; Lindquist, M; Edwards, IR				Coulter, DM; Bate, A; Meyboom, RHB; Lindquist, M; Edwards, IR			Antipsychotic drugs and heart muscle disorder in international pharmacovigilance: data mining study	BMJ-BRITISH MEDICAL JOURNAL			English	Article								Objectives To examine die relation between antipsychotic drugs and myocarditis and cardiomyopathy. Design Data mining using bayesian statistics implemented in a neural network architecture. Setting International database on adverse drug reactions run by the World Health Organization programme for international drug monitoring. Main outcome measures Reports mentioning antipsychotic drugs, cardiomyopathy or myocarditis. Results A strong signal existed for an association between clozapine and cardiomyopathy and myocarditis. An association was also seen with other antipsychotics as a group. The association was based on sufficient cases with adequate documentation and apparent lack of confounding to constitute a signal. Associations between myocarditis or cardiomyopathy and lithium, chlorpromazine, fluphenazine, haloperidol, and risperidone need further investigation. Conclusions Some antipsychotic drugs seem to be linked to cardiomyopathy and myocarditis, The study shows the potential of bayesian neural networks in analysing data on drug safety.	Uppsala Monitoring Ctr, WHO, Collaborating Ctr Int Drug Monitoring, S-75320 Uppsala, Sweden; Univ Otago, Dept Prevent & Social Med, Intens Med Monitoring Programme, Dunedin, New Zealand; Univ Otago, Ctr Adverse React Monitoring, Dunedin, New Zealand	World Health Organization; University of Otago; University of Otago	Edwards, IR (corresponding author), Uppsala Monitoring Ctr, WHO, Collaborating Ctr Int Drug Monitoring, S-75320 Uppsala, Sweden.	ralph.edwards@who-umc.org	Bate, Andrew/J-3799-2019					Bate A, 1998, EUR J CLIN PHARMACOL, V54, P315, DOI 10.1007/s002280050466; Edwards IR, 1997, BRIT MED J, V315, P500, DOI 10.1136/bmj.315.7107.500; EDWARDS IR, 1990, LANCET, V336, P156, DOI 10.1016/0140-6736(90)91669-2; Geddes J, 2000, BRIT MED J, V321, P1371, DOI 10.1136/bmj.321.7273.1371; Hand D., 1999, SIGKDD EXPLORATIONS, V1, P16, DOI [10.1145/846170.846171, DOI 10.1145/846170.846171]; Honigfeld G, 1998, J CLIN PSYCHIAT, V59, P3; Jensen V E, 1994, Ugeskr Laeger, V156, P4151; Kilian JG, 1999, LANCET, V354, P1841, DOI 10.1016/S0140-6736(99)10385-4; Olsson S, 1998, DRUG SAFETY, V19, P1, DOI 10.2165/00002018-199819010-00001	9	147	159	0	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 19	2001	322	7296					1207	1209		10.1136/bmj.322.7296.1207	http://dx.doi.org/10.1136/bmj.322.7296.1207			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	435UV	11358771	Green Published, Bronze, Green Submitted			2022-12-24	WOS:000168900700023
J	Sandercock, P				Sandercock, P			Statins for stroke prevention?	LANCET			English	Editorial Material							SERUM-CHOLESTEROL; TRIALS; RISK		Univ Edinburgh, Western Gen Hosp, Dept Clin Neurosci, Edinburgh EH4 2XU, Midlothian, Scotland	University of Edinburgh	Sandercock, P (corresponding author), Univ Edinburgh, Western Gen Hosp, Dept Clin Neurosci, Edinburgh EH4 2XU, Midlothian, Scotland.		sandercock, peter/GQI-3167-2022	sandercock, peter/0000-0001-8484-0135				Bandyopadhyay S, 2001, QJM-INT J MED, V94, P127, DOI 10.1093/qjmed/94.3.127; Byington RP, 2001, CIRCULATION, V103, P387; *DEP HLTH, 2000, NAT SERV FRAM COR HE; Di Mascio R, 2000, CEREBROVASC DIS, V10, P85, DOI 10.1159/000016035; DOWNS JR, 1995, AM J CARDIOL, V75, P1130; HEBERT PR, 1995, ARCH INTERN MED, V155, P50, DOI 10.1001/archinte.155.1.50; ISO H, 1989, NEW ENGL J MED, V320, P904, DOI 10.1056/NEJM198904063201405; Kelly J, 2000, BMJ-BRIT MED J, V320, P1278, DOI 10.1136/bmj.320.7244.1278; LAW MR, 1994, BRIT MED J, V308, P373, DOI 10.1136/bmj.308.6925.373; Meade T, 1999, EUR HEART J, V20, P725; Oliver MF, 2000, BMJ-BRIT MED J, V320, P459, DOI 10.1136/bmj.320.7233.459; PICKIN DM, 1999, P ROYAL COLL PHYSICI, V29, P31; Qizilbash N, 1995, LANCET, V346, P1647; Rodgers A, 1998, LANCET, V352, P1801; Smith GD, 1999, LANCET, V353, P1097, DOI 10.1016/S0140-6736(05)76452-7; WADE DT, 2000, NATL CLIN GUIDELINES	16	19	20	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 19	2001	357	9268					1548	1549		10.1016/S0140-6736(00)04779-6	http://dx.doi.org/10.1016/S0140-6736(00)04779-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	434RR	11377639				2022-12-24	WOS:000168830100005
J	Anderson, AK; Phelps, EA				Anderson, AK; Phelps, EA			Lesions of the human amygdala impair enhanced perception of emotionally salient events	NATURE			English	Article							MEDIAL TEMPORAL-LOBE; ATTENTIONAL BLINK; MEMORY; RECOGNITION; SUPPRESSION; RESPONSES; FEAR	Commensurate with the importance of rapidly and efficiently evaluating motivationally significant stimuli, humans are probably endowed with distinct faculties(1,2) and maintain specialized neural structures to enhance their detection. Here we consider that a critical function of the human amygdala(3,4) is to enhance the perception of stimuli that have emotional significance. Under conditions of limited attention for normal perceptual awareness-that is, the attentional blink(5,6)-we show that healthy observers demonstrate robust benefits for the perception of verbal stimuli of aversive content compared with stimuli of neutral content. In contrast, a patient with bilateral amygdala damage has no enhanced perception for such aversive stimulus events. Examination of patients with either left or right amygdala resections shows that the enhanced perception of aversive words depends specifically on the left amygdala. All patients comprehend normally the affective meaning of the stimulus events, despite the lack of evidence for enhanced perceptual encoding of these events in patients with left amygdala lesions. Our results reveal a neural substrate for affective influences on perception, indicating that similar neural mechanisms may underlie the affective modulation of both recollective(7-9) and perceptual experience.	Yale Univ, Dept Psychol, New Haven, CT 06520 USA; NYU, Dept Psychol, New York, NY 10003 USA	Yale University; New York University	Anderson, AK (corresponding author), Yale Univ, Dept Psychol, New Haven, CT 06520 USA.	adam.k.anderson@stanford.edu						Adolphs R, 2000, J NEUROSCI, V20, P2683; ADOLPHS R, 1995, J NEUROSCI, V15, P5879; Adolphs R., 2000, AMYGDALA FUNCTIONAL, P587; AMARAL D G, 1992, P1; Amaral DG, 1992, AMYGDALA NEUROBIOLOG, P465; Anderson AK, 2000, PSYCHOL SCI, V11, P106, DOI 10.1111/1467-9280.00224; Anderson AK, 2000, NEUROPSYCHOLOGY, V14, P526, DOI 10.1037/0894-4105.14.4.526; ANDERSON AK, UNPUB J EXP PSYCHOL; BRUNER JS, 1947, J PERS, V16, P69, DOI 10.1111/j.1467-6494.1947.tb01076.x; Cahill L, 1996, P NATL ACAD SCI USA, V93, P8016, DOI 10.1073/pnas.93.15.8016; CAHILL L, 1995, NATURE, V377, P295, DOI 10.1038/377295a0; Canli T, 2000, J NEUROSCI, V20; CHUN MM, 1995, J EXP PSYCHOL HUMAN, V21, P109; Derryberry D, 1994, HEARTS EYE EMOTIONAL, P166; FUNAYAMA ES, IN PRESS J COGN NEUR; Hamann SB, 1999, NAT NEUROSCI, V2, P289, DOI 10.1038/6404; Isenberg N, 1999, P NATL ACAD SCI USA, V96, P10456, DOI 10.1073/pnas.96.18.10456; KAPP BS, 1990, NEUROCOMPUTATION LEA, P53; LaBar KS, 1998, PSYCHOL SCI, V9, P490, DOI 10.1111/1467-9280.00090; LeDoux J.E., 1992, EMOTIONAL BRAIN; Morris JS, 1998, BRAIN, V121, P47, DOI 10.1093/brain/121.1.47; Morris JS, 1998, P ROY SOC B-BIOL SCI, V265, P649, DOI 10.1098/rspb.1998.0343; NISHIJO H, 1988, J NEUROSCI, V8, P3570; Phelps EA, 1998, NEUROCASE, V4, P527, DOI 10.1080/13554799808410645; RAYMOND JE, 1992, J EXP PSYCHOL HUMAN, V18, P849, DOI 10.1037/0096-1523.18.3.849; SPENCER DD, 1984, NEUROSURGERY, V15, P667, DOI 10.1227/00006123-198411000-00005; Strange BA, 2000, NEUROIMAGE, V12, P425, DOI 10.1006/nimg.2000.0637; Vogel EK, 1998, J EXP PSYCHOL HUMAN, V24, P1656, DOI 10.1037/0096-1523.24.6.1656; Weinberger Norman M., 1995, P1071; Whalen PJ, 1998, CURR DIR PSYCHOL SCI, V7, P177, DOI 10.1111/1467-8721.ep10836912	30	930	953	5	106	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 17	2001	411	6835					305	309		10.1038/35077083	http://dx.doi.org/10.1038/35077083			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	432RT	11357132				2022-12-24	WOS:000168710000047
J	Frankland, PW; O'Brien, C; Ohno, M; Kirkwood, A; Silva, AJ				Frankland, PW; O'Brien, C; Ohno, M; Kirkwood, A; Silva, AJ			alpha-CaMKII-dependent plasticity in the cortex is required for permanent memory	NATURE			English	Article							CALMODULIN KINASE-II; LONG-TERM-MEMORY; RETROGRADE-AMNESIA; HIPPOCAMPAL-FORMATION; MUTANT MICE; VISUAL-CORTEX; CONSOLIDATION; PROTEIN; LESIONS; NEOCORTEX	Cortical plasticity seems to be critical for the establishment of permanent memory traces(1-3). Little is known, however, about the molecular and cellular processes that support consolidation of memories in cortical networks(4,5). Here we show that mice heterozygous for a null mutation of a-calcium-calmodulin kinase II (alpha -CaMKII+/-) show normal learning and memory 1-3 days after training in two hippocampus-dependent tasks. However, their memory is severely impaired at longer retention delays (10-50 days). Consistent with this, we found that alpha -CaMKII+/- mice have impaired cortical, but not hippocampal, long-term potentiation. Our results represent a first step in unveiling the molecular and cellular mechanisms underlying the establishment of permanent memories, and they indicate that alpha -CaMKII may modulate the synaptic events required for the consolidation of memory traces in cortical networks.	Johns Hopkins Univ, Dept Neurosci, Baltimore, MD 21218 USA; Johns Hopkins Univ, Mid Brain Inst, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins University	Silva, AJ (corresponding author), Johns Hopkins Univ, Dept Neurosci, Baltimore, MD 21218 USA.		Silva, Alcino/ABD-7684-2021	Silva, Alcino/0000-0002-1587-4558; Silva, Alcino/0000-0001-5525-0494				Anagnostaras SG, 2000, LEARN MEMORY, V7, P58, DOI 10.1101/lm.7.1.58; Bontempi B, 1999, NATURE, V400, P671, DOI 10.1038/23270; Bourtchouladze R, 1998, LEARN MEMORY, V5, P365; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; CHO YH, 1993, J NEUROSCI, V13, P1759; Dudai Y, 1996, NEURON, V17, P367, DOI 10.1016/S0896-6273(00)80168-3; Frankland PW, 1998, BEHAV NEUROSCI, V112, P863, DOI 10.1037/0735-7044.112.4.863; Giese KP, 1998, SCIENCE, V279, P870, DOI 10.1126/science.279.5352.870; Glazewski S, 1996, SCIENCE, V272, P421, DOI 10.1126/science.272.5260.421; Glazewski S, 2000, NAT NEUROSCI, V3, P911, DOI 10.1038/78820; Gordon JA, 1996, NEURON, V17, P491, DOI 10.1016/S0896-6273(00)80181-6; Graham KS, 1999, CURR OPIN NEUROBIOL, V9, P245, DOI 10.1016/S0959-4388(99)80035-X; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; Kirkwood A, 1997, P NATL ACAD SCI USA, V94, P3380, DOI 10.1073/pnas.94.7.3380; KIRKWOOD A, 1994, J NEUROSCI, V14, P1634, DOI 10.1523/JNEUROSCI.14-03-01634.1994; Knowlton BJ, 1998, CURR OPIN NEUROBIOL, V8, P293, DOI 10.1016/S0959-4388(98)80154-2; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Mumby DG, 1999, BEHAV BRAIN RES, V106, P97, DOI 10.1016/S0166-4328(99)00097-2; Nadel L, 1997, CURR OPIN NEUROBIOL, V7, P217, DOI 10.1016/S0959-4388(97)80010-4; RempelClower NL, 1996, J NEUROSCI, V16, P5233; Riedel G, 1999, NAT NEUROSCI, V2, P898, DOI 10.1038/13202; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; Shimizu E, 2000, SCIENCE, V290, P1170, DOI 10.1126/science.290.5494.1170; SILVA AJ, 1992, SCIENCE, V257, P206, DOI 10.1126/science.1321493; Silva AJ, 1996, CURR BIOL, V6, P1509, DOI 10.1016/S0960-9822(96)00756-7; SQUIRE LR, 1995, CURR OPIN NEUROBIOL, V5, P169, DOI 10.1016/0959-4388(95)80023-9; Whishaw IQ, 1997, CURR OPIN NEUROBIOL, V7, P228, DOI 10.1016/S0959-4388(97)80011-6; ZOLAMORGAN SM, 1990, SCIENCE, V250, P288, DOI 10.1126/science.2218534	30	319	332	0	30	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 17	2001	411	6835					309	313		10.1038/35077089	http://dx.doi.org/10.1038/35077089			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432RT	11357133				2022-12-24	WOS:000168710000048
J	Wang, HB; Huang, ZQ; Xia, L; Feng, Q; Erdjument-Bromage, H; Strahl, BD; Briggs, SD; Allis, CD; Wong, JM; Tempst, P; Zhang, Y				Wang, HB; Huang, ZQ; Xia, L; Feng, Q; Erdjument-Bromage, H; Strahl, BD; Briggs, SD; Allis, CD; Wong, JM; Tempst, P; Zhang, Y			Methylation of histone H4 at arginine 3 facilitating transcriptional activation by nuclear hormone receptor	SCIENCE			English	Article							METHYLTRANSFERASES; CELLS; YEAST; H3	Acetylation of core histone tails plays a fundamental role in transcription regulation. In addition to acetylation, other posttranslational modifications, such as phosphorylation and methylation, occur in core histone tails. Here, we report the purification, molecular identification, and functional characterization of a histone H4-specific methyltransferase PRMT1, a protein arginine methyltransferase. PRMT1 specifically methylates arginine 3 (Arg 3) of H4 in vitro and in vivo. Methylation of Arg 3 by PRMT1 facilitates subsequent acetylation of H4 tails by p300. However, acetylation of H4 inhibits its methylation by PRMT1. Most important, a mutation in the S-adenosyl-L-methionine-binding site of PRMT1 substantially crippled its nuclear receptor coactivator activity. Our finding reveals Arg 3 of H4 as a novel methylation site by PRMT1 and indicates that Arg 3 methylation plays an important role in transcriptional regulation.	Univ N Carolina, Dept Biochem & Biophys, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10021 USA; Univ Virginia, Hlth Sci Ctr, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA	University of North Carolina; University of North Carolina Chapel Hill; Baylor College of Medicine; Memorial Sloan Kettering Cancer Center; University of Virginia	Zhang, Y (corresponding author), Univ N Carolina, Dept Biochem & Biophys, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.		Strahl, Brian/C-7601-2012	Strahl, Brian/0000-0002-4947-6259; Zhang, Yi/0000-0002-2789-0811; Briggs, Scott D/0000-0003-2852-3594; Wong, Jiemin/0000-0002-5311-842X; Erdjument-Bromage, Hediye/0000-0003-0224-3594; Tempst, Paul/0000-0002-6680-3987	NCI NIH HHS [P30 CA08748] Funding Source: Medline; NIGMS NIH HHS [GM63067-01] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063067] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANNUNZIATO AT, 1995, BIOCHEMISTRY-US, V34, P2916, DOI 10.1021/bi00009a023; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Bao J, UNPUB; Chen DG, 1999, SCIENCE, V284, P2174, DOI 10.1126/science.284.5423.2174; Chen DG, 2000, J BIOL CHEM, V275, P40810, DOI 10.1074/jbc.M005459200; Gary JD, 1998, PROG NUCLEIC ACID RE, V61, P65, DOI 10.1016/S0079-6603(08)60825-9; Koh SS, 2001, J BIOL CHEM, V276, P1089, DOI 10.1074/jbc.M004228200; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Luger K, 1999, METHOD ENZYMOL, V304, P3; McBride AE, 2000, J BIOL CHEM, V275, P3128, DOI 10.1074/jbc.275.5.3128; MURRAY K, 1964, BIOCHEMISTRY-US, V3, P10, DOI 10.1021/bi00889a003; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Pawlak MR, 2000, MOL CELL BIOL, V20, P4859, DOI 10.1128/MCB.20.13.4859-4869.2000; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Scott HS, 1998, GENOMICS, V48, P330, DOI 10.1006/geno.1997.5190; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Strahl BD, 1999, P NATL ACAD SCI USA, V96, P14967, DOI 10.1073/pnas.96.26.14967; WONG JM, 1995, GENE DEV, V9, P2696, DOI 10.1101/gad.9.21.2696; Zhang Y, 1998, MOL CELL, V1, P1021, DOI 10.1016/S1097-2765(00)80102-1	19	547	576	2	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 3	2001	293	5531					853	857		10.1126/science.1060781	http://dx.doi.org/10.1126/science.1060781			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459FU	11387442				2022-12-24	WOS:000170241000042
J	Bostom, AG; Selhub, J; Jacques, PF; Rosenberg, IH				Bostom, AG; Selhub, J; Jacques, PF; Rosenberg, IH			Power shortage: Clinical trials testing the "homocysteine hypothesis" against a background of folic acid-fortified cereal grain flour	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							CONVERTING ENZYME-INHIBITION; METAANALYSIS	Large randomized, controlled trials of total homocysteine-lowering therapy for the potential reduction of cardiovascular disease outcomes are ongoing in the United States and Canada, These trials are the Vitamin Intervention for Stroke Prevention (VISP) trial, the Women's Antioxidant Cardiovascular Disease Study (WACS), and the Heart Outcomes Prevention Evaluation (HOPE-2). However, the dramatic effect of policies mandating fortification of cereal grain flour products with folic acid may reduce the statistical power of these trials. All three trials assume that the active treatment groups will achieve the same mean effects of total homocysteine-lowering therapy as those reported in the absence of folic acid-fortified cereal grain flour. This paper examines this assumption using data from studies of total homocysteine-lowering therapy in U.S. and Canadian patients with cardiovascular disease who were exposed to products made with folic acid-fortified cereal grain flour, These data showed that the VISP trial, HOPE-2, and WACS will probably achieve only approximately 20% to 25% of the projected treatment effects of mean total homocysteine-lowering therapy (1.0 to 1.5 mu mol/L vs. 4.0 to 6.0 mu mol/L). As a result, all three trials will be substantially underpowered to test the specific hypotheses of total homocysteine- lowering therapy identified a priori. In contrast, renal transplant recipients have a persistent excess prevalence of hyperhomocysteinemia in the era of fortification but remain very responsive to supraphysiologic doses of folic acid-based supplementation (mean reduction in total homocysteine level, 5.0 to 6.0 mu mol/L). Therefore, unlike other populations with normal renal function that are at high risk for cardiovascular disease but are profoundly affected by fortification efforts, renal transplant recipients continue to merit serious consideration for a controlled trial of the "homocysteine hypothesis.".	Univ Colorado, Hlth Sci Ctr, Denver, CO 80262 USA; Denver Hlth, Denver, CO 80204 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Denver Health Medical Center	Bostom, AG (corresponding author), Univ Colorado, Hlth Sci Ctr, 4200 E 9th Ave,Room 6403, Denver, CO 80262 USA.	abostom@loa.com						GANSEVOORT RT, 1995, NEPHROL DIAL TRANSPL, V10, P1963; Jafar TH, 2001, ANN INTERN MED, V135, P73, DOI 10.7326/0003-4819-135-2-200107170-00007; KASISKE BL, 1993, ANN INTERN MED, V118, P129, DOI 10.7326/0003-4819-118-2-199301150-00009; LEWIS EJ, 1993, NEW ENGL J MED, V329, P1456, DOI 10.1056/NEJM199311113292004; Mosconi L, 1996, KIDNEY INT, pS91; Ravid M, 1996, ARCH INTERN MED, V156, P286, DOI 10.1001/archinte.156.3.286; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; WEIDMANN P, 1995, NEPHROL DIAL TRANSPL, V10, P39	9	81	82	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 17	2001	135	2					133	139		10.7326/0003-4819-135-2-200107170-00014	http://dx.doi.org/10.7326/0003-4819-135-2-200107170-00014			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	452DR	11453713				2022-12-24	WOS:000169842300007
J	Gundersen, L				Gundersen, L			Physician burnout	ANNALS OF INTERNAL MEDICINE			English	Article																			0	175	184	0	17	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 17	2001	135	2					145	148		10.7326/0003-4819-135-2-200107170-00023	http://dx.doi.org/10.7326/0003-4819-135-2-200107170-00023			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	452DR	11453722				2022-12-24	WOS:000169842300013
J	Sakuta, H; Suzuki, R; Takahashi, H; Kato, A; Shintani, T; Iemura, S; Yamamoto, TS; Ueno, N; Noda, M				Sakuta, H; Suzuki, R; Takahashi, H; Kato, A; Shintani, T; Iemura, S; Yamamoto, TS; Ueno, N; Noda, M			Ventroptin: A BMP-4 antagonist expressed in a double-gradient pattern in the retina	SCIENCE			English	Article							GANGLION-CELL AXONS; RETINOTECTAL PROJECTION; EPHRINA LIGANDS; CHICK; MAP; ELF-1	In the visual system, the establishment of the anteroposterior and dorsoventral axes in the retina ana tectum during development is important for topographic retinotectal projection. We identified chick Ventroptin, an antagonist of bone morphogenetic protein 4 (BMP-4), which is mainly expressed in the ventral retina, not only with a ventral high-dorsal low gradient but also with a nasal high-temporal Low gradient at later stages, Misexpression of Ventroptin altered expression patterns of several topographic genes in the retina and projection of the retinal axons to the tectum along both axes. Thus, the topographic retinotectal projection appears to be specified by the double-gradient molecule Ventroptin along the two axes.	Grad Univ Adv Studies, Natl Inst Basic Biol, Div Mol Neurobiol, Okazaki, Aichi 4448585, Japan; Grad Univ Adv Studies, Natl Inst Basic Biol, Div Morphogenesis, Okazaki, Aichi 4448585, Japan; Grad Univ Adv Studies, Dept Mol Biomech, Okazaki, Aichi 4448585, Japan	Graduate University for Advanced Studies - Japan; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Graduate University for Advanced Studies - Japan; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Graduate University for Advanced Studies - Japan	Noda, M (corresponding author), Grad Univ Adv Studies, Natl Inst Basic Biol, Div Mol Neurobiol, 38 Nishigonaka, Okazaki, Aichi 4448585, Japan.		Noda, Masaharu/D-7146-2016	Noda, Masaharu/0000-0002-3796-524X; Sakuta, Hiraki/0000-0003-2375-0528; Ueno, Naoto/0000-0002-8375-2317; Shintani, Takafumi/0000-0002-6165-2307				Blitz IL, 2000, DEV BIOL, V223, P120, DOI 10.1006/dbio.2000.9740; CHENG HJ, 1995, CELL, V82, P371, DOI 10.1016/0092-8674(95)90426-3; CROSSLAND WJ, 1974, J COMP NEUROL, V155, P127, DOI 10.1002/cne.901550202; CROSSLAND WJ, 1975, BRAIN RES, V91, P1, DOI 10.1016/0006-8993(75)90463-1; Dudley AT, 1997, DEV DYNAM, V208, P349; Dutting D, 1999, DEV BIOL, V216, P297, DOI 10.1006/dbio.1999.9489; Fainsod A, 1997, MECH DEVELOP, V63, P39, DOI 10.1016/S0925-4773(97)00673-4; Hornberger MR, 1999, NEURON, V22, P731, DOI 10.1016/S0896-6273(00)80732-1; Hyatt GA, 1996, DEVELOPMENT, V122, P195; KAHN AJ, 1974, DEV BIOL, V38, P30, DOI 10.1016/0012-1606(74)90256-5; Koshiba-Takeuchi K, 2000, SCIENCE, V287, P134, DOI 10.1126/science.287.5450.134; MATSUNO T, 1992, NEUROSCI RES, V15, P96, DOI 10.1016/0168-0102(92)90022-5; Monschau B, 1997, EMBO J, V16, P1258, DOI 10.1093/emboj/16.6.1258; Schulte D, 1999, NEURON, V24, P541, DOI 10.1016/S0896-6273(00)81111-3; Schulte D, 2000, DEVELOPMENT, V127, P5033; Smith WC, 1999, TRENDS GENET, V15, P3, DOI 10.1016/S0168-9525(98)01641-2; SPERRY RW, 1963, P NATL ACAD SCI USA, V50, P703, DOI 10.1073/pnas.50.4.703; Suzuki H, 1996, NUCLEIC ACIDS RES, V24, P289, DOI 10.1093/nar/24.2.289; Suzuki R, 2000, MECH DEVELOP, V98, P37, DOI 10.1016/S0925-4773(00)00450-0; Yuasa J, 1996, NATURE, V382, P632, DOI 10.1038/382632a0	20	157	167	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 6	2001	293	5527					111	115		10.1126/science.1058379	http://dx.doi.org/10.1126/science.1058379			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	451BB	11441185				2022-12-24	WOS:000169780300040
J	Javaux, EJ; Knoll, AH; Walter, MR				Javaux, EJ; Knoll, AH; Walter, MR			Morphological and ecological complexity in early eukaryotic ecosystems	NATURE			English	Article							ROCKS; MICROFOSSILS; EXAMPLE; FOSSILS; BASIN	Molecular phylogeny and biogeochemistry indicate that eukaryotes differentiated early in Earth history. Sequence comparisons of small-subunit ribosomal RNA genes suggest a deep evolutionary divergence of Eukarya and Archaea(1); C-27-C-29 steranes (derived from sterols synthesized by eukaryotes) and strong depletion of C-13 (a biogeochemical signature of methanogenic Archaea) in 2,700 Myr old kerogens independently place a minimum age on this split(2,3). Steranes, large spheroidal microfossils, and rare macrofossils of possible eukaryotic origin occur in Palaeoproterozoic rocks(4-6). Until now, however, evidence for morphological and taxonomic diversification within the domain has generally been restricted to very late Mesoproterozoic and Neoproterozoic successions(7). Here we show that the cytoskeletal and ecological prerequisites for eukaryotic diversification were already established in eukaryotic microorganisms fossilized nearly 1,500 Myr ago in shales of the early Mesoproterozoic Roper Group in northern Australia.	Harvard Univ, Bot Museum, Cambridge, MA 02138 USA; Macquarie Univ, Australian Ctr Astrobiol, Dept Earth & Planetary Sci, Sydney, NSW 2109, Australia	Harvard University; Macquarie University	Knoll, AH (corresponding author), Harvard Univ, Bot Museum, Cambridge, MA 02138 USA.	aknoll@oeb.harvard.edu						Abbott ST, 2000, AUST J EARTH SCI, V47, P637, DOI 10.1046/j.1440-0952.2000.00795.x; ANBAR AD, 1999, 1999 AM GEOPH UN FAL; Brocks JJ, 1999, SCIENCE, V285, P1033, DOI 10.1126/science.285.5430.1033; Butterfield Nicholas J., 1994, Fossils and Strata, V34, P1; BUTTERFIELD NJ, 1992, PALAEONTOLOGY, V35, P943; Canfield DE, 1998, NATURE, V396, P450, DOI 10.1038/24839; GERMAN TN, 1990, ORGANIC WORLD 1 BILL, P1; HAN TM, 1992, SCIENCE, V257, P232, DOI 10.1126/science.1631544; Hayes J.M., 1994, EARLY LIFE EARTH, V84, P220; Jackson M.J., 1999, INTEGRATED BASIN ANA; JACKSON MJ, 1991, PRECAMBRIAN RES, V54, P81, DOI 10.1016/0301-9268(91)90070-Q; JACOBSON SR, 1979, J PALEONTOL, V53, P1197; JANKAUSKAS TV, 1989, PRECAMBRIAN MICROFOS, P5; Jansen RP, 1999, FASEB J, V13, P455, DOI 10.1096/fasebj.13.3.455; Knoll A.H., 1996, PALYNOLOGY PRINCIPLE, V1, P51; KRALIK M, 1982, PRECAMBRIAN RES, V18, P157, DOI 10.1016/0301-9268(82)90044-4; PEAT C J, 1978, BMR (Bureau of Mineral Resources) Journal of Australian Geology and Geophysics, V3, P1; PETROV PY, 1995, STRATIGR GEO CORREL+, V3, P435; Samuelsson J, 1999, PRECAMBRIAN RES, V96, P1, DOI 10.1016/S0301-9268(98)00123-5; Schmidt A, 1998, ANNU REV CELL DEV BI, V14, P305, DOI 10.1146/annurev.cellbio.14.1.305; SUMMONS RE, 1987, GEOCHIM COSMOCHIM AC, V51, P3075, DOI 10.1016/0016-7037(87)90381-4; VEIS AF, 1992, IZV AN SSSR GEOL, V8, P114; VIDAL G, 1990, AM J SCI, V290A, P170; WOESE CR, 1990, P NATL ACAD SCI USA, V87, P4576, DOI 10.1073/pnas.87.12.4576; Xiao SH, 1997, PRECAMBRIAN RES, V84, P197, DOI 10.1016/S0301-9268(97)00029-6; Yin LM, 1997, REV PALAEOBOT PALYNO, V98, P15, DOI 10.1016/S0034-6667(97)00022-5; Zhang Zhongying, 1986, Journal of Micropalaeontology, V5, P9; ZHOU H, 1999, SEQUENCE STRATIGRAPH, P5	28	284	321	0	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 5	2001	412	6842					66	69		10.1038/35083562	http://dx.doi.org/10.1038/35083562			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448TB	11452306				2022-12-24	WOS:000169644900043
J	Rhode, SC; Pawlowski, M; Tollrian, R				Rhode, SC; Pawlowski, M; Tollrian, R			The impact of ultraviolet radiation on the vertical distribution of zooplankton of the genus Daphnia	NATURE			English	Article							SOLAR UV-RADIATION; ADAPTIVE SIGNIFICANCE; MIGRATION; EXPOSURE; MAGNA	The vertical migration of zooplankton into lower and darker water strata by day is generally explained by the avoidance of visually orienting predators, mainly fish(1-4); however, it is unclear why daily zooplankton migration has been maintained in fishless areas(5). In addition to predation, ultraviolet radiation-a hazardous factor for zooplankton in the surface layers of marine and freshwater environments(6-8) - has been suspected as a possible cause of daytime downward migration(9). Here we test this hypothesis by studying several Daphnia species, both in a controlled laboratory system and under natural sunlight in an outdoor system. We selected Daphnia species that differed in their pigmentation as both melanin and carotenoids have been shown to protect Daphnia from ultraviolet light(10,11). All Daphnia species escaped into significantly deeper water layers under ultraviolet radiation. The extent to which the daphnids responded to this radiation was inversely linked to their pigmentation, which reduced ultraviolet transmission. These results suggest that ultraviolet avoidance is an additional factor in explaining daytime downward migration. Synergistic benefits might have shaped the evolution of this complex behaviour.	Univ Munich, Dept Ecol, Inst Zool, D-80333 Munich, Germany	University of Munich	Tollrian, R (corresponding author), Univ Munich, Dept Ecol, Inst Zool, Karlstr 25, D-80333 Munich, Germany.	ralph.tollrian@lrz.uni-muenchen.de						BOLLENS SM, 1994, J PLANKTON RES, V16, P555, DOI 10.1093/plankt/16.5.555; CALKINS J, 1980, NATURE, V283, P563, DOI 10.1038/283563a0; CONFER JL, 1978, OIKOS, V31, P27, DOI 10.2307/3543380; DAMKAER DM, 1982, ROLE SOLAR ULTRAVIOL, P701; De Meester L, 1998, ECOLOGY AND EVOLUTION OF INDUCIBLE DEFENSES, P160; DEMEESTER L, 1995, NATURE, V378, P483; DODSON S, 1990, LIMNOL OCEANOGR, V35, P1195, DOI 10.4319/lo.1990.35.5.1195; FLEISCHMANN EM, 1989, LIMNOL OCEANOGR, V34, P1623, DOI 10.4319/lo.1989.34.8.1623; HAIRSTON NG, 1976, P NATL ACAD SCI USA, V73, P971, DOI 10.1073/pnas.73.3.971; HEBERT PDN, 1990, FUNCT ECOL, V4, P703; HESSEN DO, 1994, ARCH HYDROBIOL BEIH, V43, P85; Kerfoot W.C., 1985, Contributions in Marine Science, V27, P91; LAMPERT W, 1989, FUNCT ECOL, V3, P21, DOI 10.2307/2389671; Leech DM, 2001, LIMNOL OCEANOGR, V46, P416, DOI 10.4319/lo.2001.46.2.0416; LOOSE CJ, 1994, ECOLOGY, V75, P2255, DOI 10.2307/1940881; MADRONICH S, 1995, AMBIO, V24, P143; Merker E., 1930, Zoologische Jahrbuecher Jena Allgemeine Zoologie, V48, P277; Morris DP, 1995, LIMNOL OCEANOGR, V40, P1381, DOI 10.4319/lo.1995.40.8.1381; NEILL WE, 1990, NATURE, V345, P524, DOI 10.1038/345524a0; Ringelberg J., 1964, Netherlands Journal of Sea Research, V2, P319, DOI 10.1016/0077-7579(64)90001-8; Siebeck O., 1994, Advances in Limnology, V43, P197; SMITH KC, 1990, J COMP PHYSIOL A, V166, P597; SMITH RC, 1981, APPL OPTICS, V20, P177, DOI 10.1364/AO.20.000177; STICH HB, 1981, NATURE, V293, P396, DOI 10.1038/293396a0; Storz UC, 1998, J COMP PHYSIOL A, V183, P709, DOI 10.1007/s003590050293; VINYARD GL, 1976, J FISH RES BOARD CAN, V33, P2845, DOI 10.1139/f76-342; WILLIAMSON CE, 1994, J PLANKTON RES, V16, P205, DOI 10.1093/plankt/16.3.205; WILLIAMSON CE, IN PRESS ECOLOGY; ZARET TM, 1976, LIMNOL OCEANOGR, V21, P804, DOI 10.4319/lo.1976.21.6.0804	29	184	199	6	77	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 5	2001	412	6842					69	72		10.1038/35083567	http://dx.doi.org/10.1038/35083567			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448TB	11452307				2022-12-24	WOS:000169644900044
J	Taylor, RB; Shakoor, O; Behrens, RH; Everard, M; Low, AS; Wangboonskul, J; Raid, RG; Kolawole, JA				Taylor, RB; Shakoor, O; Behrens, RH; Everard, M; Low, AS; Wangboonskul, J; Raid, RG; Kolawole, JA			Pharmacopoeial quality of drugs supplied by Nigerian pharmacies	LANCET			English	Article							SUBSTANDARD DRUGS	Background The quality of medicines available in some less-developed countries is inadequate in terms of content of active ingredient. Reasons for the poor quality of drugs include widespread counterfeiting of medicines in less-developed countries, excessive decomposition of active ingredient as a result of high temperature and humidity, and poor quality assurance during the manufacture of medicinal products. Our aim was to investigate the quality of different drugs obtained from retail pharmacies in two urban areas of Nigeria, and, in instances of poor quality, to ascertain the reason why. Methods We randomly collected 581 samples of 27 different drugs from 35 pharmacies in Lagos and Abuja in Nigeria. We analysed the medicines for drug content by validated chromatographic methods, and compared our results with pharmacopoeial requirements. Findings 279 (48%) samples did not comply with set pharmacopoeial limits, and this proportion was uniform for the various types of drugs tested. Although some preparations contained no active ingredient, most had amounts just outside the pharmacopoeial limits. We identified samples with both too much and too little active drug content. Interpretation The most probable cause of the poor quality of drugs is absence of adequate quality assurance during manufacture. Substandard drugs sold in the pharmacies of less-developed countries could contribute to global microbial resistance and therapeutic failure of infectious diseases.	Robert Gordon Univ, Sch Pharm, Aberdeen AB10 1FR, Scotland; London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1, England; Khon Kaen Univ, Fac Pharmaceut Sci, Khon Kaen, Thailand; Univ Jos, Dept Pharm, Jos, Nigeria	Robert Gordon University; University of London; London School of Hygiene & Tropical Medicine; Khon Kaen University; University of Jos	Taylor, RB (corresponding author), Robert Gordon Univ, Sch Pharm, Aberdeen AB10 1FR, Scotland.			Behrens, Ron/0000-0002-8166-2633				ABDI YA, 1995, LANCET, V346, P1161, DOI 10.1016/S0140-6736(95)91834-5; [Anonymous], 1990, ACUTE RESP INFECT CH; Arya S C, 1995, World Health Forum, V16, P269; CAMPBELL H, 1995, ARCH DIS CHILD, V73, P281, DOI 10.1136/adc.73.4.281; Dye C, 1999, JAMA-J AM MED ASSOC, V282, P677, DOI 10.1001/jama.282.7.677; HOGERZEIL HV, 1991, LANCET, V338, P754, DOI 10.1016/0140-6736(91)91470-F; KELLY JC, 1990, ANN EMERG MED, V19, P47, DOI 10.1016/S0196-0644(05)82141-9; KIBWAGE IO, 1992, E AFR MED J, V69, P577; Low AS, 1999, ANALYST, V124, P1589, DOI 10.1039/a907400g; PETRALANDA I, 1995, LANCET, V345, P1433, DOI 10.1016/S0140-6736(95)92620-8; Roy J, 1994, World Health Forum, V15, P406; Shakoor O, 1997, TROP MED INT HEALTH, V2, P839, DOI 10.1046/j.1365-3156.1997.d01-403.x; TENHAM M, 1992, ADVERSE DRUG REACT T, V11, P59; WONDEMAGEGNEHU E, 1995, COUNTERFEIT SUBSTAND; 1999, WORLD HLTH REPORT 19, P49	15	139	142	0	17	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 16	2001	357	9272					1933	1936		10.1016/S0140-6736(00)05065-0	http://dx.doi.org/10.1016/S0140-6736(00)05065-0			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	444YZ	11425415				2022-12-24	WOS:000169431000013
J	Dajani, R; Fraser, E; Roe, SM; Young, N; Good, V; Dale, TC; Pearl, LH				Dajani, R; Fraser, E; Roe, SM; Young, N; Good, V; Dale, TC; Pearl, LH			Crystal structure of glycogen synthase kinase 3 beta: Structural basis for phosphate-primed substrate specificity and autoinhibition	CELL			English	Article							BETA-CATENIN; PHOSPHORYLASE-KINASE; GSK-3-BETA-DEPENDENT PHOSPHORYLATION; 3-DIMENSIONAL STRUCTURE; CATALYTIC DOMAIN; AXIN; PEPTIDE; IDENTIFICATION; ACTIVATION; GSK-3	Glycogen synthase kinase 3 beta (GSK3 beta) plays a key role in insulin and Wnt signaling, phosphorylating downstream targets by default, and becoming inhibited following the extracellular signaling event. The crystal structure of human GSK3 beta shows a catalytically active conformation in the absence of activation-segment phosphorylation, with the sulphonate of a buffer molecule bridging the activation-segment and N-terminal domain in the same way as the phosphate group of the activation-segment phospho-Ser/Thr in other kinases. The location of this oxyanion binding site in the substrate binding cleft indicates direct coupling of P+4 phosphate-primed substrate binding and catalytic activation, explains the ability of GSK3 beta to processively hyperphosphorylate substrates with Ser/Thr pentad-repeats, and suggests a mechanism for autoinhibition in which the phosphorylated N terminus binds as a competitive pseudosubstrate with phospho-Ser 9 occupying the P+4 site.	Inst Canc Res, Chester Beatty Labs, Sect Struct Biol, London SW3 6JB, England; Inst Canc Res, Chester Beatty Labs, CRC, Ctr Cell & Mol Biol, London SW3 6JB, England	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Pearl, LH (corresponding author), Inst Canc Res, Chester Beatty Labs, Sect Struct Biol, 237 Fulham Rd, London SW3 6JB, England.	laurence@icr.ac.uk	Dale, Trevor C/D-3749-2009; Fraser, Elizabeth/M-7049-2015	Dale, Trevor C/0000-0002-4880-9963; Fraser, Elizabeth/0000-0001-8420-3208; Roe, Mark/0000-0002-7371-9855; Pearl, Laurence/0000-0002-6910-1809				Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Canagarajah BJ, 1997, CELL, V90, P859, DOI 10.1016/S0092-8674(00)80351-7; Chen P, 2000, CELL, V100, P681, DOI 10.1016/S0092-8674(00)80704-7; Cobb MH, 2000, TRENDS BIOCHEM SCI, V25, P7, DOI 10.1016/S0968-0004(99)01508-X; Cohen P, 1999, PHILOS T R SOC B, V354, P485, DOI 10.1098/rstb.1999.0399; COX S, 1992, PROTEIN ENG, V5, P811, DOI 10.1093/protein/5.8.811; DEBONDT HL, 1993, NATURE, V363, P595, DOI 10.1038/363595a0; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; Farr GH, 2000, J CELL BIOL, V148, P691, DOI 10.1083/jcb.148.4.691; FIOL CJ, 1990, J BIOL CHEM, V265, P6061; FIOL CJ, 1988, ARCH BIOCHEM BIOPHYS, V267, P797, DOI 10.1016/0003-9861(88)90089-6; FLOTOW H, 1990, J BIOL CHEM, V265, P14264; GRODEN J, 1991, CELL, V66, P589, DOI 10.1016/0092-8674(81)90021-0; Hart MJ, 1998, CURR BIOL, V8, P573, DOI 10.1016/S0960-9822(98)70226-X; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; HUBBARD SR, 1994, NATURE, V372, P746, DOI 10.1038/372746a0; HUGHES K, 1993, EMBO J, V12, P803, DOI 10.1002/j.1460-2075.1993.tb05715.x; Ikeda S, 1998, EMBO J, V17, P1371, DOI 10.1093/emboj/17.5.1371; Ikeda S, 2000, ONCOGENE, V19, P537, DOI 10.1038/sj.onc.1203359; Itoh K, 1995, DEVELOPMENT, V121, P3979; Johnson LN, 1996, CELL, V85, P149, DOI 10.1016/S0092-8674(00)81092-2; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kim L, 1999, CELL, V99, P399, DOI 10.1016/S0092-8674(00)81526-3; KINZLER KW, 1991, SCIENCE, V253, P661, DOI 10.1126/science.1651562; KNIGHTON DR, 1991, SCIENCE, V253, P407, DOI 10.1126/science.1862342; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LESLIE A, 1995, MOSFLM USERS GUIDE; Li L, 1999, EMBO J, V18, P4233, DOI 10.1093/emboj/18.15.4233; Longenecker KL, 1996, J MOL BIOL, V257, P618, DOI 10.1006/jmbi.1996.0189; Lowe ED, 1997, EMBO J, V16, P6646, DOI 10.1093/emboj/16.22.6646; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; Murai H, 1996, FEBS LETT, V392, P153, DOI 10.1016/0014-5793(96)00806-X; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; NICHOLLS A, 1993, BIOPHYS J, V64, pA166; OWEN DJ, 1995, STRUCTURE, V3, P467, DOI 10.1016/S0969-2126(01)00180-0; PLYTE SE, 1992, BIOCHIM BIOPHYS ACTA, V1114, P147, DOI 10.1016/0304-419X(92)90012-N; Polakis P, 1999, CURR OPIN GENET DEV, V9, P15, DOI 10.1016/S0959-437X(99)80003-3; Polakis P, 2000, GENE DEV, V14, P1837; ROBBINS DJ, 1993, J BIOL CHEM, V268, P5097; Ross SE, 1999, MOL CELL BIOL, V19, P8433; Russo AA, 1996, NAT STRUCT BIOL, V3, P696, DOI 10.1038/nsb0896-696; Ryves WJ, 1998, ANAL BIOCHEM, V264, P124, DOI 10.1006/abio.1998.2832; Sicheri F, 1997, NATURE, V385, P602, DOI 10.1038/385602a0; Stambolic V, 1996, CURR BIOL, V6, P1664, DOI 10.1016/S0960-9822(02)70790-2; Thomas GM, 1999, FEBS LETT, V458, P247, DOI 10.1016/S0014-5793(99)01161-8; WANG YH, 1993, J BIOL CHEM, V268, P23876; Wang ZL, 1997, P NATL ACAD SCI USA, V94, P2327, DOI 10.1073/pnas.94.6.2327; Williams RSB, 2000, TRENDS PHARMACOL SCI, V21, P61, DOI 10.1016/S0165-6147(99)01428-5; XU RM, 1995, EMBO J, V14, P1015, DOI 10.1002/j.1460-2075.1995.tb07082.x; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0; Yost C, 1998, CELL, V93, P1031, DOI 10.1016/S0092-8674(00)81208-8; ZHANG FM, 1994, NATURE, V367, P704, DOI 10.1038/367704a0; ZHANG JD, 1995, STRUCTURE, V3, P299, DOI 10.1016/S0969-2126(01)00160-5	55	542	576	1	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 15	2001	105	6					721	732		10.1016/S0092-8674(01)00374-9	http://dx.doi.org/10.1016/S0092-8674(01)00374-9			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	444AE	11440715	Bronze			2022-12-24	WOS:000169375100006
J	Dodson, KW; Pinkner, JS; Rose, T; Magnusson, G; Hultgren, SJ; Waksman, G				Dodson, KW; Pinkner, JS; Rose, T; Magnusson, G; Hultgren, SJ; Waksman, G			Structural basis of the interaction of the pyelonephritic E. coli adhesin to its human kidney receptor	CELL			English	Article							UROPATHOGENIC ESCHERICHIA-COLI; SIALOSYL GALACTOSYL GLOBOSIDE; PREFERRED BINDING-RECEPTOR; URINARY-TRACT-INFECTION; CYTOKINE RESPONSES; GLYCOLIPID RECEPTOR; BACTERIAL INVASION; COMMON THEMES; PAPG ADHESIN; P-FIMBRIAE	PapG is the adhesin at the tip of the P pilus that mediates attachment of uropathogenic Escherichia coli to the uroepithelium of the human kidney. The human specific allele of PapG binds to globoside (GbO4), which consists of the tetrasaccharide GalNAc beta1-3Gal alpha1-4Gal beta1-4Glc linked to ceramide. Here, we present the crystal structures of a binary complex of the PapG receptor binding domain bound to GbO4 as well as the unbound form of the adhesin. The biological importance of each of the residues involved in binding was investigated by site-directed mutagenesis. These studies provide a molecular snapshot of a host-pathogen interaction that determines the tropism of uropathogenic E. coli for the human kidney and is critical to the pathogenesis of pyelonephritis.	Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA; Lund Univ, Lund, Sweden	Washington University (WUSTL); Washington University (WUSTL); Lund University	Hultgren, SJ (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.	hultgren@borcim.wustl.edu; waksman@biochem.wustl.edu		ROSE, Thierry/0000-0001-8863-0207; Pinkner, Jerome/0000-0002-7389-7440	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049950, R01AI048689, R37AI029549, R01AI029549] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051406] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054033] Funding Source: NIH RePORTER; NIAID NIH HHS [AI49950, AI48689, AI29549] Funding Source: Medline; NIDDK NIH HHS [DK51406] Funding Source: Medline; NIGMS NIH HHS [GM54033] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; BRUNGER AT, 1987, SCIENCE, V235, P458, DOI 10.1126/science.235.4787.458; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BULLITT E, 1995, NATURE, V373, P164, DOI 10.1038/373164a0; Choudhury D, 1999, SCIENCE, V285, P1061, DOI 10.1126/science.285.5430.1061; CLEGG S, 1982, INFECT IMMUN, V38, P739, DOI 10.1128/IAI.38.2.739-744.1982; Finlay BB, 1997, MICROBIOL MOL BIOL R, V61, P136, DOI 10.1128/.61.2.136-169.1997; FOXMAN B, 1990, AM J PUBLIC HEALTH, V80, P331, DOI 10.2105/AJPH.80.3.331; Guex N, 1999, TRENDS BIOCHEM SCI, V24, P364, DOI 10.1016/S0968-0004(99)01427-9; Hedlund M, 1999, MOL MICROBIOL, V33, P693, DOI 10.1046/j.1365-2958.1999.01513.x; Hedlund M, 1996, J EXP MED, V183, P1037, DOI 10.1084/jem.183.3.1037; Hooton TM, 1997, INFECT DIS CLIN N AM, V11, P551, DOI 10.1016/S0891-5520(05)70373-1; HULTGREN SJ, 1989, P NATL ACAD SCI USA, V86, P4357, DOI 10.1073/pnas.86.12.4357; HULTGREN SJ, 1990, MOL MICROBIOL, V4, P1311, DOI 10.1111/j.1365-2958.1990.tb00710.x; JACOBDUBUISSON F, 1993, EMBO J, V12, P837, DOI 10.1002/j.1460-2075.1993.tb05724.x; Johnson JR, 1998, J INFECT DIS, V177, P97, DOI 10.1086/513824; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KIHLBERG J, 1989, J AM CHEM SOC, V111, P6364, DOI 10.1021/ja00198a056; KLANN AG, 1994, J BACTERIOL, V176, P2312, DOI 10.1128/JB.176.8.2312-2317.1994; KUEHN MJ, 1992, NATURE, V356, P252, DOI 10.1038/356252a0; LEFFLER H, 1980, FEMS MICROBIOL LETT, V8, P127, DOI 10.1111/j.1574-6968.1980.tb05064.x; LEMASTER DM, 1985, BIOCHEMISTRY-US, V24, P7263, DOI 10.1021/bi00346a036; LUND B, 1987, P NATL ACAD SCI USA, V84, P5898, DOI 10.1073/pnas.84.16.5898; Martinez JJ, 2000, EMBO J, V19, P2803, DOI 10.1093/emboj/19.12.2803; NICHOLLS A, 1991, J COMPUT CHEM, V12, P435, DOI 10.1002/jcc.540120405; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PASCHER I, 1992, BIOCHIM BIOPHYS ACTA, V1113, P339, DOI 10.1016/0304-4157(92)90006-V; PATTON JP, 1991, MED CLIN N AM, V75, P495, DOI 10.1016/S0025-7125(16)30466-7; Pernestig AK, 2000, ADV EXP MED BIOL, V485, P137; ROBERTS JA, 1994, P NATL ACAD SCI USA, V91, P11889, DOI 10.1073/pnas.91.25.11889; RONALD AR, 1991, MED CLIN N AM, V75, P299, DOI 10.1016/S0025-7125(16)30455-2; Roussel A, 1991, SILICON GRAPHICS GEO, P86; Sauer FG, 1999, SCIENCE, V285, P1058, DOI 10.1126/science.285.5430.1058; Sauer FG, 2000, SEMIN CELL DEV BIOL, V11, P27, DOI 10.1006/scdb.1999.0348; Schilling JD, 2001, J IMMUNOL, V166, P1148, DOI 10.4049/jimmunol.166.2.1148; Soto GE, 1999, J BACTERIOL, V181, P1059, DOI 10.1128/JB.181.4.1059-1071.1999; Stapleton AE, 1998, INFECT IMMUN, V66, P3856, DOI 10.1128/IAI.66.8.3856-3861.1998; STRIKER R, 1995, MOL MICROBIOL, V16, P1021, DOI 10.1111/j.1365-2958.1995.tb02327.x; STROMBERG N, 1990, EMBO J, V9, P2001, DOI 10.1002/j.1460-2075.1990.tb08328.x; STROMBERG N, 1991, P NATL ACAD SCI USA, V88, P9340, DOI 10.1073/pnas.88.20.9340; Stroud MR, 1998, BIOCHEMISTRY-US, V37, P17420, DOI 10.1021/bi9814639; Svanborg C, 1996, ANN NY ACAD SCI, V797, P177, DOI 10.1111/j.1749-6632.1996.tb52959.x; Svanborg C, 1997, INFECT DIS CLIN N AM, V11, P513, DOI 10.1016/S0891-5520(05)70371-8; TERWILLIGER TC, 1994, ACTA CRYSTALLOGR D, V50, P17, DOI 10.1107/S0907444993008236; Thanassi DG, 2000, METHODS, V20, P111, DOI 10.1006/meth.1999.0910; Warren John W., 1996, P3; Zhang JP, 1996, SCIENCE, V273, P1234, DOI 10.1126/science.273.5279.1234	48	197	205	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 15	2001	105	6					733	743		10.1016/S0092-8674(01)00388-9	http://dx.doi.org/10.1016/S0092-8674(01)00388-9			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	444AE	11440716	Bronze			2022-12-24	WOS:000169375100007
J	Orme, CA; Noy, A; Wierzbicki, A; McBride, MT; Grantham, M; Teng, HH; Dove, PM; DeYoreo, JJ				Orme, CA; Noy, A; Wierzbicki, A; McBride, MT; Grantham, M; Teng, HH; Dove, PM; DeYoreo, JJ			Formation of chiral morphologies through selective binding of amino acids to calcite surface steps	NATURE			English	Article							FREE-ENERGIES; ELECTROSTATIC POTENTIALS; CRYSTAL NUCLEATION; AQUEOUS-SOLUTION; GROWTH; CRYSTALLIZATION; INTERFACES; SOLVATION; MODEL; DIFFRACTION	Many living organisms contain biominerals and composites with finely tuned properties, reflecting a remarkable level of control over the nucleation, growth and shape of the constituent crystals(1-6). Peptides and proteins play an important role in achieving this control(1,7,8). But the general view that organic molecules affect mineralization through stereochemical recognition, where geometrical and chemical constraints dictate their binding to a mineral, seems difficult to reconcile(4) with a mechanistic understanding, where crystallization is controlled by thermodynamic and kinetic factors(9). Indeed, traditional crystal growth models emphasize the inhibiting effect of so-called 'modifiers' on surface-step growth, rather than stereochemical matching to newly expressed crystal facets. Here we report in situ atomic force microscope observations and molecular modelling studies of calcite growth in the presence of chiral amino acids that reconcile these two seemingly divergent views. We rnd that enantiomer-specific binding of the amino acids to those surface-step edges that offer the best geometric and chemical rt changes the step-edge free energies, which in turn results in macroscopic crystal shape modifications. Our results emphasize that the mechanism underlying crystal modification through organic molecules is best understood by considering both stereochemical recognition and the effects of binding on the interfacial energies of the growing crystal.	Lawrence Livermore Natl Lab, Dept Chem & Mat Sci, Livermore, CA 94551 USA; Univ S Alabama, Dept Chem, Mobile, AL 36688 USA; Virginia Polytech Inst & State Univ, Dept Geol Sci, Blacksburg, VA 24061 USA; George Washington Univ, Dept Earth & Environm Sci, Washington, DC 20052 USA	United States Department of Energy (DOE); Lawrence Livermore National Laboratory; University of South Alabama; Virginia Polytechnic Institute & State University; George Washington University	Orme, CA (corresponding author), Lawrence Livermore Natl Lab, Dept Chem & Mat Sci, Livermore, CA 94551 USA.	orme1@llnl.gov	Dove, Patricia M/A-7911-2010; Orme, Christine A/A-4109-2009	Orme, Christine A/0000-0003-3652-3367; Noy, Aleksandr/0000-0003-4924-2652				ADDADI L, 1986, TOP STEREOCHEM, V16, P1, DOI 10.1002/9780470147252.ch1; ADDADI L, 1987, P NATL ACAD SCI USA, V84, P2732, DOI 10.1073/pnas.84.9.2732; Aizenberg J, 1999, NATURE, V398, P495, DOI 10.1038/19047; AIZENBERG J, 1995, CHEM-EUR J, V1, P414, DOI 10.1002/chem.19950010705; ALBECK S, 1993, J AM CHEM SOC, V115, P11691, DOI 10.1021/ja00078a005; Belcher AM, 1996, NATURE, V381, P56, DOI 10.1038/381056a0; BERMAN A, 1993, SCIENCE, V259, P776, DOI 10.1126/science.259.5096.776; BERMAN A, 1988, NATURE, V331, P546, DOI 10.1038/331546a0; BRENEMAN CM, 1990, J COMPUT CHEM, V11, P361, DOI 10.1002/jcc.540110311; BURTON WK, 1951, PHILOS T R SOC S-A, V243, P299, DOI 10.1098/rsta.1951.0006; CHIRLIAN LE, 1987, J COMPUT CHEM, V8, P894, DOI 10.1002/jcc.540080616; CRAMER CJ, 1991, J AM CHEM SOC, V113, P8305, DOI 10.1021/ja00022a017; CRAMER CJ, 1992, J COMPUT AID MOL DES, V6, P629, DOI 10.1007/BF00126219; CRAMER CJ, 1992, SCIENCE, V256, P213, DOI 10.1126/science.256.5054.213; Davis KJ, 2000, SCIENCE, V290, P1134, DOI 10.1126/science.290.5494.1134; Didymus J.M., 1991, P267; DIDYMUS JM, 1994, P ROY SOC B-BIOL SCI, V258, P237, DOI 10.1098/rspb.1994.0168; FEIDENHANSL R, 1989, SURF SCI REP, V10, P105, DOI 10.1016/0167-5729(89)90002-2; Fenter P, 2000, GEOCHIM COSMOCHIM AC, V64, P1221, DOI 10.1016/S0016-7037(99)00403-2; HONESS AP, 1937, 35 PENNS STAT COLL M, P667; Land TA, 1999, NATURE, V399, P442, DOI 10.1038/20886; MADURA JD, 1994, J AM CHEM SOC, V116, P417, DOI 10.1021/ja00080a066; MANN S, 1993, SCIENCE, V261, P1286, DOI 10.1126/science.261.5126.1286; MANN S, 1990, J CHEM SOC FARADAY T, V86, P1873, DOI 10.1039/ft9908601873; MANN S, 1987, PROC R SOC SER B-BIO, V231, P477, DOI 10.1098/rspb.1987.0056; REEDER RJ, 1983, CARBONATES MINERALOG, V2, P1; Robinson IK, 1998, ACTA CRYSTALLOGR A, V54, P772, DOI 10.1107/S0108767398008125; SIKES CS, 1991, ACS SYM SER, V444, P50; STEWART JJP, 1989, J COMPUT CHEM, V10, P221, DOI 10.1002/jcc.540100209; STIPP SL, 1991, GEOCHIM COSMOCHIM AC, V55, P1723, DOI 10.1016/0016-7037(91)90142-R; Teng HH, 1998, SCIENCE, V282, P724, DOI 10.1126/science.282.5389.724; WEISSBUCH I, 1991, SCIENCE, V253, P637, DOI 10.1126/science.253.5020.637; Wulff G, 1901, Z KRYSTALLOGR MINERA, V34, P449, DOI 10.1524/zkri.1901.34.1.449; Zhao XY, 2000, LANGMUIR, V16, P9812, DOI 10.1021/la000378a	34	550	562	16	303	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 14	2001	411	6839					775	779		10.1038/35081034	http://dx.doi.org/10.1038/35081034			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	441TV	11459051				2022-12-24	WOS:000169246400042
J	Beguin, P; Nagashima, K; Gonoi, T; Shibasaki, T; Takahashi, K; Kashima, Y; Ozaki, N; Geering, T; Iwanaga, T; Seino, S				Beguin, P; Nagashima, K; Gonoi, T; Shibasaki, T; Takahashi, K; Kashima, Y; Ozaki, N; Geering, T; Iwanaga, T; Seino, S			Regulation of Ca2+ channel expression at the cell surface by the small G-protein kir/Gem	NATURE			English	Article							RAS-LIKE GTPASE; CALCIUM CHANNELS; BETA-SUBUNIT; FUNCTIONAL-CHARACTERIZATION; N-TYPE; FACILITATION; BINDING; ROLES; ACTIVATION; SIGNAL	Voltage-dependent calcium (Ca2+) channels are involved in many specialized cellular functions(1-3), and are controlled by intracellular signals such as heterotrimeric G-proteins(4), protein kinases(5,6) and calmodulin (CaM)(7,8). However, the direct role of small G-proteins in the regulation of Ca2+ channels is unclear. We report here that the GTP-bound form of kir/Gem, identified originally as a Ras-related small G-protein that binds CaM9-11, inhibits high-voltage-activated Ca2+ channel activities by interacting directly with the beta -subunit. The reduced channel activities are due to a decrease in alpha (1)-subunit expression at the plasma membrane. The binding of Ca2+/CaM to kir/Gem is required for this inhibitory effect by promoting the cytoplasmic localization of kir/Gem. Inhibition of L-type Ca2+ channels by kir/Gem prevents Ca2+ triggered exocytosis in hormone-secreting cells. We propose that the small G-protein kir/Gem, interacting with beta -subunits, regulates Ca2+ channel expression at the cell surface.	Chiba Univ, Grad Sch Med, Dept Cellular & Mol Med, Chuo Ku, Chiba 2608670, Japan; Univ Lausanne, Inst Pharmacol & Toxicol, CH-1005 Lausanne, Switzerland; Chiba Univ, Pathogen Fungi & Microbial Toxicoses Res Ctr, Chuo Ku, Chiba 2608673, Japan; Chiba Univ, Grad Sch Med, Dept Mol Immunol,CREST, Chuo Ku, Chiba 2608670, Japan; Hokkaido Univ, Grad Sch Vet Med, Lab Anat, Sapporo, Hokkaido 0600818, Japan	Chiba University; University of Lausanne; Chiba University; Chiba University; Japan Science & Technology Agency (JST); Hokkaido University	Seino, S (corresponding author), Chiba Univ, Grad Sch Med, Dept Cellular & Mol Med, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan.		gonoi, tohru/AAC-5181-2021; , gonoi/GRS-0648-2022	gonoi, tohru/0000-0003-3655-7911; , gonoi/0000-0003-3655-7911				ARTALEJO CR, 1994, NATURE, V367, P72, DOI 10.1038/367072a0; Beguin P, 1999, EMBO J, V18, P4722, DOI 10.1093/emboj/18.17.4722; Berridge MJ, 1998, NATURE, V395, P645, DOI 10.1038/27094; Bichet D, 2000, NEURON, V25, P177, DOI 10.1016/S0896-6273(00)80881-8; Brice NL, 1997, EUR J NEUROSCI, V9, P749, DOI 10.1111/j.1460-9568.1997.tb01423.x; Cherfils J, 1999, TRENDS BIOCHEM SCI, V24, P306, DOI 10.1016/S0968-0004(99)01429-2; CHIEN AJ, 1995, J BIOL CHEM, V270, P30036; COHEN L, 1994, P NATL ACAD SCI USA, V91, P12448, DOI 10.1073/pnas.91.26.12448; Dolphin AC, 1996, TRENDS NEUROSCI, V19, P35, DOI 10.1016/0166-2236(96)81865-0; Dolphin AC, 1998, J PHYSIOL-LONDON, V506, P3, DOI 10.1111/j.1469-7793.1998.003bx.x; Dzhura I, 2000, NAT CELL BIOL, V2, P173, DOI 10.1038/35004052; Ertel EA, 2000, NEURON, V25, P533, DOI 10.1016/S0896-6273(00)81057-0; Fischer R, 1996, J BIOL CHEM, V271, P25067, DOI 10.1074/jbc.271.41.25067; Hardingham GE, 1997, NATURE, V385, P260, DOI 10.1038/385260a0; IHARA Y, 1995, MOL ENDOCRINOL, V9, P121, DOI 10.1210/me.9.1.121; ISOM LL, 1994, NEURON, V12, P1183, DOI 10.1016/0896-6273(94)90436-7; Kawaki J, 1999, DIABETES, V48, P2001, DOI 10.2337/diabetes.48.10.2001; Lee A, 1999, NATURE, V399, P155, DOI 10.1038/20194; MAGUIRE J, 1994, SCIENCE, V265, P241, DOI 10.1126/science.7912851; MIKAMI A, 1989, NATURE, V340, P230, DOI 10.1038/340230a0; NIIDOME T, 1994, BIOCHEM BIOPH RES CO, V203, P1821, DOI 10.1006/bbrc.1994.2399; Ozaki N, 2000, NAT CELL BIOL, V2, P805, DOI 10.1038/35041046; PLUMMER MR, 1989, NEURON, V2, P1453, DOI 10.1016/0896-6273(89)90191-8; Wakamori M, 1998, J NEUROPHYSIOL, V79, P622, DOI 10.1152/jn.1998.79.2.622; Walker D, 1998, TRENDS NEUROSCI, V21, P148, DOI 10.1016/S0166-2236(97)01200-9; Wes PD, 1996, EMBO J, V15, P5839, DOI 10.1002/j.1460-2075.1996.tb00971.x; WHEELER DB, 1994, SCIENCE, V264, P107, DOI 10.1126/science.7832825; WILLIAMS ME, 1992, NEURON, V8, P71, DOI 10.1016/0896-6273(92)90109-Q; Zuhlke RD, 1999, NATURE, V399, P159, DOI 10.1038/20200	29	223	232	0	8	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN	2001	411	6838					701	706		10.1038/35079621	http://dx.doi.org/10.1038/35079621			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439JC	11395774				2022-12-24	WOS:000169112500048
J	Ogura, Y; Bonen, DK; Inohara, N; Nicolae, DL; Chen, FF; Ramos, R; Britton, H; Moran, T; Karaliuskas, R; Duerr, RH; Achkar, JP; Brant, SR; Bayless, TM; Kirschner, BS; Hanauer, SB; Nunez, G; Cho, JH				Ogura, Y; Bonen, DK; Inohara, N; Nicolae, DL; Chen, FF; Ramos, R; Britton, H; Moran, T; Karaliuskas, R; Duerr, RH; Achkar, JP; Brant, SR; Bayless, TM; Kirschner, BS; Hanauer, SB; Nunez, G; Cho, JH			A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease	NATURE			English	Article							INFLAMMATORY-BOWEL-DISEASE; SUPPORTS LINKAGE; GENETIC-ANALYSIS; CHROMOSOME-16; LOCUS; IDENTIFICATION; TOMATO; IBD1	Crohn's disease is a chronic inflammatory disorder of the gastrointestinal tract, which is thought to result from the effect of environmental factors in a genetically predisposed host. A gene location in the pericentromeric region of chromosome 16, IBD1, that contributes to susceptibility to Crohn's disease has been established through multiple linkage studies(1-6), but the specific gene(s) has not been identified. NOD2, a gene that encodes a protein with homology to plant disease resistance gene products is located in the peak region of linkage on chromosome 16 (ref. 7). Here we show, by using the transmission disequilibium test and case-control analysis, that a frameshift mutation caused by a cytosine insertion, 3020insC, which is expected to encode a truncated NOD2 protein, is associated with Crohn's disease. Wild-type NOD2 activates nuclear factor NF-kappaB, making it responsive to bacterial lipopolysaccharides; however, this induction was deficient in mutant NOD2. These results implicate NOD2 in susceptibility to Crohn's disease, and suggest a link between an innate immune response to bacterial components and development of disease.	Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA; Univ Chicago Hosp, Dept Med, Gastroenterol Sect, Martin Boyer Labs, Chicago, IL 60637 USA; Univ Chicago, Dept Pediat, Chicago, IL 60637 USA; Univ Chicago, Dept Stat, Chicago, IL 60637 USA; Univ Pittsburgh, Dept Med, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Ctr Genom Sci, Pittsburgh, PA 15260 USA; Cleveland Clin Fdn, Dept Gastroenterol, Cleveland, OH 44195 USA; Johns Hopkins Univ, Sch Med, Dept Med, Harvey M & Lyn P Meyerhoff Inflammatory Bowel Dis, Baltimore, MD 21205 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Chicago; University of Illinois System; University of Chicago; University of Chicago; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Cleveland Clinic Foundation; Johns Hopkins University	Nunez, G (corresponding author), Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA.	bclx@umich.edu	Duerr, Richard H/B-4188-2009; Nuñez, Gabriel/A-7160-2014	Duerr, Richard H/0000-0001-6586-3905; Nicolae, Dan/0000-0002-0918-4630; Kirschner, Barbara/0000-0003-4640-2438				Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; Annese V, 1999, EUR J HUM GENET, V7, P567, DOI 10.1038/sj.ejhg.5200328; Arbour NC, 2000, NAT GENET, V25, P187, DOI 10.1038/76048; Berg DJ, 1996, J CLIN INVEST, V98, P1010, DOI 10.1172/JCI118861; Binder V, 1998, DIGEST DIS, V16, P351, DOI 10.1159/000016891; Cavanaugh JA, 1998, ANN HUM GENET, V62, P291, DOI 10.1046/j.1469-1809.1998.6240291.x; Cho JH, 1998, P NATL ACAD SCI USA, V95, P7502, DOI 10.1073/pnas.95.13.7502; Curran ME, 1998, GASTROENTEROLOGY, V115, P1066, DOI 10.1016/S0016-5085(98)70075-7; Dixon MS, 2000, P NATL ACAD SCI USA, V97, P8807, DOI 10.1073/pnas.97.16.8807; Ellis JG, 1999, PLANT CELL, V11, P495, DOI 10.1105/tpc.11.3.495; Fiocchi C, 1998, GASTROENTEROLOGY, V115, P182, DOI 10.1016/S0016-5085(98)70381-6; Han CS, 2000, GENOME RES, V10, P714, DOI 10.1101/gr.10.5.714; Hugot JP, 1996, NATURE, V379, P821, DOI 10.1038/379821a0; Inohara N, 2001, J BIOL CHEM, V276, P2551, DOI 10.1074/jbc.M009728200; KYLE J, 1992, GASTROENTEROLOGY, V103, P392, DOI 10.1016/0016-5085(92)90826-K; Loftus EV, 1998, GASTROENTEROLOGY, V114, P1161, DOI 10.1016/S0016-5085(98)70421-4; MOORE KW, 1993, ANNU REV IMMUNOL, V11, P165, DOI 10.1146/annurev.immunol.11.1.165; Ogura Y, 2001, J BIOL CHEM, V276, P4812, DOI 10.1074/jbc.M008072200; Ohmen JD, 1996, HUM MOL GENET, V5, P1679, DOI 10.1093/hmg/5.10.1679; Parniske M, 1997, CELL, V91, P821, DOI 10.1016/S0092-8674(00)80470-5; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Spielman RS, 1996, AM J HUM GENET, V59, P983	22	3763	3913	5	201	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 31	2001	411	6837					603	606		10.1038/35079114	http://dx.doi.org/10.1038/35079114			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437GE	11385577				2022-12-24	WOS:000168982500056
J	Lower, SK; Hochella, MF; Beveridge, TJ				Lower, SK; Hochella, MF; Beveridge, TJ			Bacterial recognition of mineral surfaces: Nanoscale interactions between Shewanella and alpha-FeOOH	SCIENCE			English	Article							CRYSTALLINE IRON(III) OXIDES; ATOMIC-FORCE MICROSCOPY; PUTREFACIENS MR-1; OUTER-MEMBRANE; MICROBIAL REDUCTION; DISSIMILATORY REDUCTION; MN(IV) REDUCTION; CYTOCHROME-C; IRON; FE(III)	Force microscopy has been used to quantitatively measure the infinitesimal forces that characterize interactions between Shewanella oneidensis (a dissimilatory metal-reducing bacterium) and goethite (alpha -FeOOH), both commonly found in Earth near-surface environments. Force measurements with subnano-newton resolution were made in real time with living cells under aerobic and anaerobic solutions as a function of the distance, in nanometers, between a cell and the mineral surface. Energy values [in attojoules (10(-18) joules)] derived from these measurements show that the affinity between S. oneidensis and goethite rapidly increases by two to five times under anaerobic conditions in which electron transfer from bacterium to mineral is expected. Specific signatures in the force curves suggest that a 150-kilodalton putative iron reductase is mobilized within the outer membrane of S. oneidensis and specifically interacts with the goethite surface to facilitate the electron transfer process.	Virginia Polytech Inst & State Univ, Dept Geol Sci, Nanogeosci & Technol Lab, Blacksburg, VA 24061 USA; Univ Guelph, Coll Biol Sci, Dept Microbiol, Guelph, ON N1G 2W1, Canada	Virginia Polytechnic Institute & State University; University of Guelph	Lower, SK (corresponding author), Univ Maryland, Dept Geol, College Pk, MD 20742 USA.		Lower, Steven/A-2440-2008	Lower, Steven/0000-0001-9796-0830				ARNOLD RG, 1990, APPL ENVIRON MICROB, V56, P2811, DOI 10.1128/AEM.56.9.2811-2817.1990; ARNOLD RG, 1988, BIOTECHNOL BIOENG, V32, P1081, DOI 10.1002/bit.260320902; Beliaev AS, 1998, J BACTERIOL, V180, P6292; Beveridge TJ, 1999, J BACTERIOL, V181, P4725, DOI 10.1128/JB.181.16.4725-4733.1999; Bloemberg GV, 1997, APPL ENVIRON MICROB, V63, P4543, DOI 10.1128/AEM.63.11.4543-4551.1997; BROWN S, 1992, P NATL ACAD SCI USA, V89, P8651, DOI 10.1073/pnas.89.18.8651; Caccavo F, 1997, APPL ENVIRON MICROB, V63, P3837, DOI 10.1128/AEM.63.10.3837-3843.1997; CLEVELAND JP, 1993, REV SCI INSTRUM, V64, P403, DOI 10.1063/1.1144209; DCOSTA NP, 1995, REV SCI INSTRUM, V66, P5096, DOI 10.1063/1.1146135; DICHRISTINA TJ, 1994, J BACTERIOL, V176, P1468, DOI 10.1128/jb.176.5.1468-1474.1994; DUCKER WA, 1992, LANGMUIR, V8, P1831, DOI 10.1021/la00043a024; Flory P. J., 1989, STAT MECH CHAIN MOL, P401; Fredrickson JK, 1998, GEOCHIM COSMOCHIM AC, V62, P3239, DOI 10.1016/S0016-7037(98)00243-9; KARLSSON JJ, 1996, PROTEIN FOLDS DISTAN, P56; KORENEVSKY A, UNPUB; LOVLEY DR, 1991, MICROBIOL REV, V55, P259, DOI 10.1128/MMBR.55.2.259-287.1991; LOVLEY DR, 1988, APPL ENVIRON MICROB, V54, P1472, DOI 10.1128/AEM.54.6.1472-1480.1988; LOVLEY DR, 1986, APPL ENVIRON MICROB, V52, P751, DOI 10.1128/AEM.52.4.751-757.1986; Lower SK, 2000, GEOCHIM COSMOCHIM AC, V64, P3133, DOI 10.1016/S0016-7037(00)00430-0; Lower SK, 2001, GEOMICROBIOL J, V18, P63, DOI 10.1080/01490450151079798; Mueller H, 1999, BIOPHYS J, V76, P1072, DOI 10.1016/S0006-3495(99)77272-3; Muller DJ, 1999, P NATL ACAD SCI USA, V96, P13170, DOI 10.1073/pnas.96.23.13170; MYERS CR, 1992, J BACTERIOL, V174, P3429, DOI 10.1128/JB.174.11.3429-3438.1992; Myers CR, 1997, BBA-BIOMEMBRANES, V1326, P307, DOI 10.1016/S0005-2736(97)00034-5; MYERS CR, 1993, FEMS MICROBIOL LETT, V108, P15; Myers CR, 1997, J BACTERIOL, V179, P1143, DOI 10.1128/jb.179.4.1143-1152.1997; MYERS CR, 1990, J BACTERIOL, V172, P6232, DOI 10.1128/jb.172.11.6232-6238.1990; Myers JM, 1998, BBA-BIOMEMBRANES, V1373, P237, DOI 10.1016/S0005-2736(98)00111-4; Myers JM, 2001, APPL ENVIRON MICROB, V67, P260, DOI 10.1128/AEM.67.1.260-269.2001; Myers JM, 2000, J BACTERIOL, V182, P67, DOI 10.1128/JB.182.1.67-75.2000; NEALSON KH, 1994, ANNU REV MICROBIOL, V48, P311, DOI 10.1146/annurev.mi.48.100194.001523; Newman DK, 2000, NATURE, V405, P94, DOI 10.1038/35011098; OHMURA N, 1993, APPL ENVIRON MICROB, V59, P4044, DOI 10.1128/AEM.59.12.4044-4050.1993; Rief M, 1997, SCIENCE, V276, P1109, DOI 10.1126/science.276.5315.1109; Roden EE, 1996, ENVIRON SCI TECHNOL, V30, P1618, DOI 10.1021/es9506216; Sokolov I, 2001, ENVIRON SCI TECHNOL, V35, P341, DOI 10.1021/es001258s; STUMM W, 1996, AQUAT CHEM, P534; Urrutia MM, 1999, ENVIRON SCI TECHNOL, V33, P4022, DOI 10.1021/es990447b; Venkateswaran K, 1999, INT J SYST BACTERIOL, V49, P705, DOI 10.1099/00207713-49-2-705; Zachara JM, 1998, AM MINERAL, V83, P1426, DOI 10.2138/am-1998-11-1232	40	344	363	4	221	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 18	2001	292	5520					1360	1363		10.1126/science.1059567	http://dx.doi.org/10.1126/science.1059567			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	435DV	11359008				2022-12-24	WOS:000168862900041
J	Wang, YM; Zhang, WG; Jin, Y; Johansen, J; Johansen, KM				Wang, YM; Zhang, WG; Jin, Y; Johansen, J; Johansen, KM			The JIL-1 tandem kinase mediates histone H3 phosphorylation and is required for maintenance of chromatin structure in Drosophila	CELL			English	Article							MITOTIC CHROMOSOME CONDENSATION; DOSAGE COMPENSATION; X-CHROMOSOMES; GENE; ACETYLATION; MELANOGASTER; NUCLEOSOMES; ACTIVATION; SERINE-10; MITOSIS	To analyze the function of the chromosomal kinase JIL-1, we generated an allelic series of hypomorphic and null mutations. JIL-1 is an essential kinase for viability, and reduced levels of JIL-1 kinase activity lead to a global change in chromatin structure. in JIL-1 hypomorphs, euchromatic regions of polytene chromosomes are severely reduced and the chromosome arms condensed. This is correlated with decreased levels of histone H3 Ser10 phosphorylation. These levels can be restored by a JIL-1 transgene placing JIL-1 directly in the pathway mediating histone H3 phosphorylation. We propose a model where JIL-1 kinase activity is required for maintaining the structure of the more open chromatin regions that facilitate gene transcription.	Iowa State Univ, Dept Zool & Genet, Ames, IA 50011 USA	Iowa State University	Johansen, KM (corresponding author), Iowa State Univ, Dept Zool & Genet, 3154 Mol Biol Bldg, Ames, IA 50011 USA.			Zhang, Weiguo/0000-0002-3045-0569; Wang, Yanming/0000-0002-0710-043X	NIGMS NIH HHS [GM62916] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062916] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akhtar A, 2000, MOL CELL, V5, P367, DOI 10.1016/S1097-2765(00)80431-1; BAKER BS, 1994, ANNU REV GENET, V28, P491, DOI 10.1146/annurev.ge.28.120194.002423; BONE JR, 1994, GENE DEV, V8, P96, DOI 10.1101/gad.8.1.96; Cheung P, 2000, MOL CELL, V5, P905, DOI 10.1016/S1097-2765(00)80256-7; Cheung P, 2000, CELL, V103, P263, DOI 10.1016/S0092-8674(00)00118-5; Clayton AL, 2000, EMBO J, V19, P3714, DOI 10.1093/emboj/19.14.3714; De Souza CPC, 2000, CELL, V102, P293, DOI 10.1016/S0092-8674(00)00035-0; Giet R, 2001, J CELL BIOL, V152, P669, DOI 10.1083/jcb.152.4.669; Goto H, 1999, J BIOL CHEM, V274, P25543, DOI 10.1074/jbc.274.36.25543; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; Hsu JY, 2000, CELL, V102, P279, DOI 10.1016/S0092-8674(00)00034-9; Jin Y, 2000, J CELL BIOL, V149, P1005, DOI 10.1083/jcb.149.5.1005; Jin Y, 1999, MOL CELL, V4, P129, DOI 10.1016/S1097-2765(00)80195-1; Johansen KM, 1996, J CELL BIOCHEM, V63, P268, DOI 10.1002/(SICI)1097-4644(19961201)63:3<268::AID-JCB2>3.3.CO;2-H; Kaszas E, 2000, J CELL SCI, V113, P3217; KELLEY RL, 1995, CELL, V81, P867, DOI 10.1016/0092-8674(95)90007-1; KELLEY RL, 1995, SCIENCE, V270, P1607, DOI 10.1126/science.270.5242.1607; Lindsley D.L., 1992, GENOME DROSOPHILA ME, Veighth; Lo WS, 2000, MOL CELL, V5, P917, DOI 10.1016/S1097-2765(00)80257-9; Lucchesi JC, 1998, CURR OPIN GENET DEV, V8, P179, DOI 10.1016/S0959-437X(98)80139-1; MAHADEVAN LC, 1991, CELL, V65, P775, DOI 10.1016/0092-8674(91)90385-C; MITCHISON TJ, 1983, DEV BIOL, V99, P261, DOI 10.1016/0012-1606(83)90275-0; Nowak SJ, 2000, GENE DEV, V14, P3003, DOI 10.1101/gad.848800; Pimpinelli S., 2000, DROSOPHILA PROTOCOLS, P3; Preston CR, 1996, GENETICS, V144, P1611; Roberts D. B, 1986, DROSOPHILA PRACTICAL; ROBERTSON HM, 1988, GENETICS, V118, P461; Rorth P, 1998, DEVELOPMENT, V125, P1049; RYKOWSKI MC, 1988, CELL, V54, P461, DOI 10.1016/0092-8674(88)90067-0; Sassone-Corsi P, 1999, SCIENCE, V285, P886, DOI 10.1126/science.285.5429.886; Smith ER, 2000, MOL CELL BIOL, V20, P312, DOI 10.1128/MCB.20.1.312-318.2000; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Thomson S, 1999, SEMIN CELL DEV BIOL, V10, P205, DOI 10.1006/scdb.1999.0302; TURNER BM, 1992, CELL, V69, P375, DOI 10.1016/0092-8674(92)90417-B; Turner BM, 2000, BIOESSAYS, V22, P836, DOI 10.1002/1521-1878(200009)22:9<836::AID-BIES9>3.0.CO;2-X; Wei Y, 1998, P NATL ACAD SCI USA, V95, P7480, DOI 10.1073/pnas.95.13.7480; Wei Y, 1999, CELL, V97, P99, DOI 10.1016/S0092-8674(00)80718-7; ZHOU SB, 1995, EMBO J, V14, P2884, DOI 10.1002/j.1460-2075.1995.tb07288.x; ZINK B, 1989, NATURE, V337, P468, DOI 10.1038/337468a0	39	166	173	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 18	2001	105	4					433	443		10.1016/S0092-8674(01)00325-7	http://dx.doi.org/10.1016/S0092-8674(01)00325-7			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	434XG	11371341	Bronze			2022-12-24	WOS:000168840700004
J	Kearon, C; Ginsberg, JS; Douketis, J; Crowther, M; Brill-Edwards, P; Weitz, JI; Hirsh, J				Kearon, C; Ginsberg, JS; Douketis, J; Crowther, M; Brill-Edwards, P; Weitz, JI; Hirsh, J			Management of suspected deep venous thrombosis in outpatients by using clinical assessment and D-dimer testing	ANNALS OF INTERNAL MEDICINE			English	Article							WHOLE-BLOOD ASSAY; SIMPLIRED-D-DIMER; VEIN THROMBOSIS; PULMONARY-EMBOLISM; NONINVASIVE DIAGNOSIS; THROMBOEMBOLISM; SCORE; MODEL	Background: When deep venous thrombosis is suspected, objective testing is required to confirm or refute the diagnosis. Objective: To determine whether the combination of a low clinical suspicion and a normal D-dimer result rules out deep venous thrombosis. Design: Prospective cohort study. Setting: Three tertiary care hospitals in Canada. Patients: 445 outpatients with a suspected first episode of deep venous thrombosis. Interventions: Patients were categorized as having low, moderate, or high pretest probability of thrombosis and underwent whole-blood D-dimer testing. Patients with a low pretest probability and a negative result on the D-dimer test had no further diagnostic testing and received no anticoagulant therapy. Additional diagnostic testing was done in all other patients. Measurements: Venous thromboembolic events during 3-month follow-up. Results: 177 (40%) patients had both a low pretest probability and a negative D-dimer result. One of these patients had deep venous thrombosis during follow-up (negative predictive value, 99.4% [95% CI, 96.9% to 100%]). Conclusion: The combination of a low pretest probability of deep venous thrombosis and a negative result on a whole-blood D-dimer test rules out deep venous thrombosis in a large proportion of symptomatic outpatients.	Hamilton Civ Hosp, Res Ctr, Hamilton, ON, Canada; McMaster Univ, Hamilton, ON L8S 4L8, Canada	McMaster University; McMaster University	Kearon, C (corresponding author), McMaster Univ, Henderson Gen Hosp, Room 401,711 Concess St, Hamilton, ON L8V 1C3, Canada.		Weitz, Jeffrey/AAD-1929-2019; Douketis, James/AAO-5659-2021; ginsberg, jeffrey s/ABC-1065-2020	Weitz, Jeffrey/0000-0002-1092-7550; 				Anand SS, 1998, JAMA-J AM MED ASSOC, V279, P1094, DOI 10.1001/jama.279.14.1094; Becker DM, 1996, ARCH INTERN MED, V156, P939, DOI 10.1001/archinte.156.9.939; Bigaroni A, 2000, THROMB HAEMOSTASIS, V83, P788, DOI 10.1055/s-0037-1613912; BOUNAMEAUX H, 1994, THROMB HAEMOSTASIS, V71, P1; Ginsberg JS, 1997, ARCH INTERN MED, V157, P1077, DOI 10.1001/archinte.157.10.1077; Ginsberg JS, 1998, ANN INTERN MED, V129, P1006, DOI 10.7326/0003-4819-129-12-199812150-00003; JOHN MA, 1990, THROMB RES, V58, P273, DOI 10.1016/0049-3848(90)90097-V; Kearon C, 1998, ANN INTERN MED, V128, P663, DOI 10.7326/0003-4819-128-8-199804150-00011; KEARON C, 1995, HAEMOSTASIS, V25, P72; Lee AYY, 1998, BAILLIERE CLIN HAEM, V11, P587, DOI 10.1016/S0950-3536(98)80084-X; Miron MJ, 2000, J INTERN MED, V247, P249, DOI 10.1046/j.1365-2796.2000.00605.x; Perrier A, 1999, LANCET, V353, P190, DOI 10.1016/S0140-6736(98)05248-9; van der Graaf F, 2000, THROMB HAEMOSTASIS, V83, P191; Wells PS, 1998, J INTERN MED, V243, P15; Wells PS, 1998, ANN INTERN MED, V129, P997, DOI 10.7326/0003-4819-129-12-199812150-00002; WELLS PS, 1995, LANCET, V345, P1326, DOI 10.1016/S0140-6736(95)92535-X; WELLS PS, 1995, CIRCULATION, V91, P2184, DOI 10.1161/01.CIR.91.8.2184; Wells PS, 1998, LANCET, V351, P1405, DOI 10.1016/S0140-6736(05)79444-7	18	149	155	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 17	2001	135	2					108	111		10.7326/0003-4819-135-2-200107170-00011	http://dx.doi.org/10.7326/0003-4819-135-2-200107170-00011			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	452DR	11453710				2022-12-24	WOS:000169842300004
J	Grimm, PC; Nickerson, P; Jeffery, J; Savani, RC; Gough, J; McKenna, RM; Stern, E; Rush, DN				Grimm, PC; Nickerson, P; Jeffery, J; Savani, RC; Gough, J; McKenna, RM; Stern, E; Rush, DN			Neointimal and tubulointerstitial infiltration by recipient mesenchymal cells in chronic renal-allograft rejection.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SMOOTH-MUSCLE CELLS; CHRONIC TRANSPLANT REJECTION; INTERNATIONAL STANDARDIZATION; MYOFIBROBLAST INVOLVEMENT; SUBCLINICAL REJECTION; HISTOLOGIC DIAGNOSIS; INJURY; HYALURONAN; DIFFERENTIATION; VASCULOPATHY	Background: Tissue remodeling depends on mesenchymal cells (fibroblasts and myofibroblasts) and is a prominent feature of chronic renal-transplant rejection. It is not known whether the mesenchymal cells that participate in remodeling originate locally or from circulating precursor cells. Methods: We obtained biopsy specimens of renal allografts from six male recipients of an allograft from a female donor, four female recipients of an allograft from a male donor, two male recipients of an allograft from a male donor, and two female recipients of an allograft from a female donor. All the allografts were undergoing chronic rejection. We used immunohistochemical methods to identify mesenchymal cells with smooth-muscle alpha- actin and in situ hybridization to identify mesenchymal cells with Y-chromosome DNA. Results: No Y-chromosome bodies were identified in the case of the two renal-allograft specimens in which both the donor and the recipient were female. In the case of the two renal-allograft specimens in which both the donor and the recipient were male, approximately 40 percent of mesenchymal cells contained a Y-chromosome body. In the case of the six specimens in which the donor was female and the recipient was male, a mean (+/-SD) of 34+/-16 percent of mesenchymal cells in the neointima, 38+/-12 percent of such cells in the adventitia, and 30+/-7 percent of such cells in the interstitium contained the Y-chromosomal marker, indicating that they originated from the recipient rather than the donor. In the case of the four renal-allograft specimens in which the donor was male and the recipient was female, the respective values were 24+/-15 percent, 33+/-9 percent, and 23+/-8 percent, indicating a persistent population of donor mesenchymal cells. Conclusions: The presence of mesenchymal cells of host origin in the vascular and interstitial compartments of renal allografts undergoing chronic rejection provides evidence that a circulating mesenchymal precursor cell has the potential to migrate to areas of inflammation. (N Engl J Med 2001;345:93-7.) Copyright (C) 2001 Massachusetts Medical Society.	Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; Univ Manitoba, Dept Internal Med, Winnipeg, MB, Canada; Univ Manitoba, Dept Pathol, Winnipeg, MB, Canada; Univ Penn, Dept Pediat, Philadelphia, PA 19104 USA	University of California System; University of California San Diego; University of Manitoba; University of Manitoba; University of Pennsylvania	Grimm, PC (corresponding author), Univ Calif San Diego, Dept Pediat, 9500 Gilman Dr,MC 0831, La Jolla, CA 92093 USA.		Rashmin C. Savani, MBChB/AAG-2041-2021	Rashmin C. Savani, MBChB/0000-0002-9533-5422; Nickerson, Peter/0000-0002-7393-7799; Grimm, Paul/0000-0001-7870-8592	NIAID NIH HHS [R01-AI43655-02] Funding Source: Medline; NIDDK NIH HHS [R21 DK53610-01] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK053610] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Akyurek LM, 1996, TRANSPLANTATION, V62, P1526; ANDERSEN CB, 1991, APMIS, V99, P645, DOI 10.1111/j.1699-0463.1991.tb01240.x; Brazelton T. R., 1997, Journal of Heart and Lung Transplantation, V16, P72; Brazelton TR, 1999, INFLAMM RES, V48, pS134; BUCALA R, 1994, MOL MED, V1, P71, DOI 10.1007/bf03403533; COOKE HJ, 1982, CHROMOSOMA, V87, P491, DOI 10.1007/BF00333470; Elias JA, 1999, J CLIN INVEST, V104, P1001, DOI 10.1172/JCI8124; Geraghty JG, 1996, TRANSPLANTATION, V62, P502, DOI 10.1097/00007890-199608270-00013; Gizycki MJ, 1997, AM J RESP CELL MOL, V16, P664, DOI 10.1165/ajrcmb.16.6.9191468; GRIMM PC, 1995, TRANSPLANTATION, V59, P579; Grimm PC, 1999, J AM SOC NEPHROL, V10, P1582; Horwitz EM, 1999, NAT MED, V5, P309, DOI 10.1038/6529; Huynh T, 1999, NAT BIOTECHNOL, V17, P1083, DOI 10.1038/15062; Jain M, 1996, J CLIN INVEST, V97, P596, DOI 10.1172/JCI118455; Katoh Y, 1996, TRENDS CARDIOVAS MED, V6, P100, DOI 10.1016/1050-1738(96)00014-X; LI J, 1995, EXP HEMATOL, V23, P133; Ng YY, 1998, KIDNEY INT, V54, P864, DOI 10.1046/j.1523-1755.1998.00076.x; Pedagogos E, 1997, TRANSPLANTATION, V64, P1192, DOI 10.1097/00007890-199710270-00019; Pethig K, 1998, AM HEART J, V135, P628, DOI 10.1016/S0002-8703(98)70278-9; PLISSONNIER D, 1995, TRANSPLANTATION, V60, P414, DOI 10.1097/00007890-199509000-00003; Routledge MW, 1997, TRANSPLANT P, V29, P2603, DOI 10.1016/S0041-1345(97)00525-3; Rush D, 1998, J AM SOC NEPHROL, V9, P2129; RUSH DN, 1994, TRANSPLANTATION, V57, P208, DOI 10.1097/00007890-199401001-00009; SALOMON RN, 1991, AM J PATHOL, V138, P791; SAVANI RC, 1995, J CLIN INVEST, V95, P1158, DOI 10.1172/JCI117764; SAVANI RC, 1995, P W PHARMACOL SOC, V38, P131; Shi Y, 1996, CIRCULATION, V93, P340, DOI 10.1161/01.CIR.93.2.340; SKALLI O, 1987, DIFFERENTIATION, V33, P232, DOI 10.1111/j.1432-0436.1987.tb01562.x; SOLEZ K, 1994, CLIN TRANSPLANT, V8, P345; SOLEZ K, 1993, KIDNEY INT, V44, P411, DOI 10.1038/ki.1993.259	30	215	225	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 12	2001	345	2					93	97		10.1056/NEJM200107123450203	http://dx.doi.org/10.1056/NEJM200107123450203			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	451AH	11450677	Bronze			2022-12-24	WOS:000169776900003
J	Leovy, C				Leovy, C			Weather and climate on Mars	NATURE			English	Review							THERMAL INFRARED PROPERTIES; MARTIAN ATMOSPHERE; INTERANNUAL VARIABILITY; DUST STORMS; TEMPERATURES; SIMULATION; TIDES; TES	Imagine a planet very much like the Earth, with similar size, rotation rate and inclination of rotation axis, possessing an atmosphere and a solid surface, but lacking oceans and dense clouds of liquid water. We might expect such a desert planet to be dominated by large variations in day-night and winter-summer weather. Dust storms would be common. Observations and simulations of martian climate confirm these expectations and provide a wealth of detail that can help resolve problems of climate evolution.	Univ Washington, Dept Atmospher Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Leovy, C (corresponding author), Univ Washington, Dept Atmospher Sci, Box 351640, Seattle, WA 98195 USA.	conway@atmos.washington.edu						ANDERSON E, 1978, J ATMOS SCI, V35, P723, DOI 10.1175/1520-0469(1978)035<0723:MTLOOD>2.0.CO;2; Anderson FS, 1999, J GEOPHYS RES-PLANET, V104, P18991, DOI 10.1029/1999JE900024; ARVIDSON RE, 1983, SCIENCE, V222, P463, DOI 10.1126/science.222.4623.463; BARNES JR, 1984, J ATMOS SCI, V41, P1536, DOI 10.1175/1520-0469(1984)041<1536:LBIITM>2.0.CO;2; BARNES JR, 1981, J ATMOS SCI, V38, P225, DOI 10.1175/1520-0469(1981)038<0225:MDITMA>2.0.CO;2; BRIGGS G, 1972, B AM METEOROL SOC, V55, P278; CANTOR B, IN PRESS J GEOPHYS R, V106; Clancy RT, 2000, J GEOPHYS RES-PLANET, V105, P9553, DOI 10.1029/1999JE001089; CONRATH B, 1999, J GEOPHYS RES, V104, P9509; CONRATH BJ, 1981, ICARUS, V48, P246, DOI 10.1016/0019-1035(81)90107-X; Forget F, 1999, J GEOPHYS RES-PLANET, V104, P24155, DOI 10.1029/1999JE001025; GIERASCH P, 1979, GEOPHYS RES LETT, V6, P405, DOI 10.1029/GL006i005p00405; GIERASCH PJ, 1972, J ATMOS SCI, V29, P400, DOI 10.1175/1520-0469(1972)029<0400:TEODOT>2.0.CO;2; GREELEY R, 1993, J GEOPHYS RES-PLANET, V98, P3183, DOI 10.1029/92JE02580; GREELEY R, 1992, MARS, P835; HABERLE RM, 1986, SCIENCE, V234, P459, DOI 10.1126/science.234.4775.459; Haberle RM, 1997, J GEOPHYS RES-PLANET, V102, P13301, DOI 10.1029/97JE01334; Hartmann DL, 1994, GLOBAL PHYSICAL CLIM, P140; HINSON D, IN PRESS J GEOPHYS R, V106; Hinson DP, 1999, J GEOPHYS RES-PLANET, V104, P26997, DOI 10.1029/1999JE001069; Hollingsworth JL, 1996, J ATMOS SCI, V53, P428, DOI 10.1175/1520-0469(1996)053<0428:FSPWIM>2.0.CO;2; Hollingsworth JL, 1996, NATURE, V380, P413, DOI 10.1038/380413a0; James PB, 1999, ICARUS, V138, P64, DOI 10.1006/icar.1998.6060; JAMES PB, 1992, MARS, P934; JOSHI MM, 1994, NATURE, V367, P548, DOI 10.1038/367548a0; Kahn R. A., 1992, MARS, P1017; KEATING G, 2000, B AM ASTRON SOC, V32; Leovy C. B., 1985, Recent Advances in Planetary Meteorology. Seymour Hess Memorial Symposium at the 1983 IUGG General Assembly, P69; LEOVY CB, 1973, J ATMOS SCI, V30, P749, DOI 10.1175/1520-0469(1973)030<0749:MFMDS>2.0.CO;2; Lewis SR, 1999, J GEOPHYS RES-PLANET, V104, P24177, DOI 10.1029/1999JE001024; MARTIN TZ, 1979, J GEOPHYS RES, V84, P2843, DOI 10.1029/JB084iB06p02843; Murphy JR, 1995, J GEOPHYS RES-PLANET, V100, P26357, DOI 10.1029/95JE02984; MURPHY JR, 1990, J GEOPHYS RES-SOLID, V95, P14555, DOI 10.1029/JB095iB09p14555; PETERFREUND AR, 1979, J GEOPHYS RES, V84, P2853, DOI 10.1029/JB084iB06p02853; RYAN JA, 1970, J GEOPHYS RES, V75, P531, DOI 10.1029/JC075i003p00531; RYAN JA, 1981, GEOPHYS RES LETT, V8, P899, DOI 10.1029/GL008i008p00899; SANTEE M, 1993, J GEOPHYS RES-PLANET, V98, P3261, DOI 10.1029/92JE01896; Schofield JT, 1997, SCIENCE, V278, P1752, DOI 10.1126/science.278.5344.1752; Seiff A., 1977, Journal of Geophysical Research, V82, P4364, DOI 10.1029/JS082i028p04364; SMITH M, IN PRESS J GEOPHYS R, V106; Smith MD, 2000, J GEOPHYS RES-PLANET, V105, P9539, DOI 10.1029/1999JE001097; THOMAS P, 1985, SCIENCE, V230, P175, DOI 10.1126/science.230.4722.175; THOMAS PG, 1984, ICARUS, V58, P396, DOI 10.1016/0019-1035(84)90085-X; TILLMAN JE, 1988, J GEOPHYS RES-ATMOS, V93, P9433, DOI 10.1029/JD093iD08p09433; TILLMAN JE, 1993, J GEOPHYS RES-PLANET, V98, P10963, DOI 10.1029/93JE01084; Wilson RJ, 2000, ICARUS, V145, P555, DOI 10.1006/icar.2000.6378; Wilson RJ, 1996, J ATMOS SCI, V53, P1290, DOI 10.1175/1520-0469(1996)053<1290:CMSOTT>2.0.CO;2; Zurek R.W., 1992, MARS, P835; ZUREK RW, 1981, SCIENCE, V213, P437, DOI 10.1126/science.213.4506.437; ZUREK RW, 1976, J ATMOS SCI, V33, P321, DOI 10.1175/1520-0469(1976)033<0321:DTITMA>2.0.CO;2; ZUREK RW, 1993, J GEOPHYS RES-PLANET, V98, P3247, DOI 10.1029/92JE02936; ZUREK RW, 1988, J ATMOS SCI, V45, P2469, DOI 10.1175/1520-0469(1988)045<2469:ZSRTAT>2.0.CO;2; [No title captured]	53	87	89	5	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 12	2001	412	6843					245	249		10.1038/35084192	http://dx.doi.org/10.1038/35084192			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	451AJ	11449286				2022-12-24	WOS:000169778700064
J	Johnston, AM; Raven, JA; Beardall, J; Leegood, RC				Johnston, AM; Raven, JA; Beardall, J; Leegood, RC			Carbon fixation - Photosynthesis in a marine diatom	NATURE			English	Article							INORGANIC CARBON; ACQUISITION		Scottish Crop Res Inst, Dundee DD2 5DA, Scotland; Univ Dundee, Inst Biol Sci, Dundee DD1 4HN, Scotland; Monash Univ, Dept Biol Sci, Clayton, Vic 3800, Australia; Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England	James Hutton Institute; University of Dundee; Monash University; University of Sheffield	Johnston, AM (corresponding author), Scottish Crop Res Inst, Dundee DD2 5DA, Scotland.	ajohn@scri.sari.ac.uk	Beardall, John/A-1250-2008; Beardall, John/L-5262-2019	Beardall, John/0000-0001-7684-446X; Beardall, John/0000-0001-7684-446X				Badger Murray R., 2000, Advances in Photosynthesis, V9, P369; BEARDALL J, 1976, J PHYCOL, V12, P409; BEARDALL J, 1989, AQUAT BOT, V34, P105, DOI 10.1016/0304-3770(89)90052-1; JOHNSTON AM, 1991, CAN J BOT, V69, P1123, DOI 10.1139/b91-144; JOHNSTON AM, 1987, PHYCOLOGIA, V26, P159, DOI 10.2216/i0031-8884-26-2-159.1; JOHNSTON AM, 1992, MARINE ECOL PROG SER, V87, P517; Raven JA, 1997, ADV BOT RES, V27, P85; Reinfelder JR, 2000, NATURE, V407, P996, DOI 10.1038/35039612; Riebesell U, 2000, NATURE, V407, P959, DOI 10.1038/35039665; Sage R. F., 1999, C4 PLANT BIOL, P596	10	35	38	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 5	2001	412	6842					40	41		10.1038/35083694	http://dx.doi.org/10.1038/35083694			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448TB	11452295				2022-12-24	WOS:000169644900032
J	Grodstein, F; Manson, JE; Stampfer, MJ				Grodstein, F; Manson, JE; Stampfer, MJ			Postmenopausal hormone use and secondary prevention of coronary events in the nurses' health study - A prospective, observational study	ANNALS OF INTERNAL MEDICINE			English	Article							ESTROGEN REPLACEMENT THERAPY; ARTERY-DISEASE; HEART-DISEASE; WOMEN; RISK; REPRODUCIBILITY; PROGESTIN; MORTALITY; VALIDITY; TRIAL	Background: The Heart and Estrogen/progestin Replacement Study (HERS) was the first randomized clinical trial of combined hormone therapy and secondary prevention of coronary events. The trial had overall null results but reported an unexpected increased risk for recurrent events in the initial year, followed by a decrease during the final years. Objective: To provide additional data on a time trend in risk for recurrent heart disease. Design: A prospective, observational cohort study of secondary prevention of coronary heart disease. Setting: Nurses' Health Study. Patients: 2489 postmenopausal women with previous myocardial infarction or documented atherosclerosis; 213 cases of recurrent nonfatal myocardial infarction or coronary death were identified from 1976 through 1996. Measurements: Information on hormone status and on recurrent disease was collected by using biennial questionnaires. Multi-variable-adjusted relative risks and 95% CIs were calculated from logistic regression models. Results: A trend of decreasing risk for recurrent major coronary heart disease events with increasing duration of hormone use was observed (P for trend = 0.002). For short-term current users, the multivariate-adjusted relative risk for major coronary heart disease was 1.25 (95% CI, 0.78 to 2.00) compared with never-users. However, after longer-term hormone use, the rate of second events was lower in current users than in never-users (relative risk, 0.38 [CI, 0.22 to 0.66]). No clear differences emerged between users of estrogen alone and users of estrogen combined with progestin. Overall, with up to 20 years of follow-up, the relative risk for a second event among current users of hormone therapy was 0.65 (CI, 0.45 to 0.95) compared with never-users. Conclusions: The risk for recurrent major coronary events seems to increase among short-term hormone users with previous coronary disease but to decrease with longer-term use.	Harvard Univ, Sch Med, Brigham & Womens Hosp, Channing Lab, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Grodstein, F (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Channing Lab, 181 Longwood Ave, Boston, MA 02115 USA.				NCI NIH HHS [CA40356] Funding Source: Medline; NHLBI NIH HHS [HL34594] Funding Source: Medline; NIA NIH HHS [AG13482] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R37CA040356, R01CA040356] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL034594] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R29AG013482] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BARRETTCONNOR E, 1991, ANN INTERN MED, V115, P455, DOI 10.7326/0003-4819-115-6-455; BUSH TL, 1987, CIRCULATION, V75, P1102, DOI 10.1161/01.CIR.75.6.1102; COLDITZ GA, 1987, AM J EPIDEMIOL, V126, P319, DOI 10.1093/aje/126.2.319; CUPPLES LA, 1988, STAT MED, V7, P205, DOI 10.1002/sim.4780070122; Cushman M, 1999, CIRCULATION, V100, P717, DOI 10.1161/01.CIR.100.7.717; DAGOSTINO RB, 1990, STAT MED, V9, P1501, DOI 10.1002/sim.4780091214; Daly E, 1996, LANCET, V348, P977, DOI 10.1016/S0140-6736(96)07113-9; GREENLAND S, 1985, AM J EPIDEMIOL, V122, P495, DOI 10.1093/oxfordjournals.aje.a114131; GRODSTEIN F, 1994, OBSTET GYNECOL, V83, P5; GRODSTEIN F, 1995, PROG CARDIOVASC DIS, V38, P199, DOI 10.1016/S0033-0620(95)80012-3; Grodstein F, 1996, NEW ENGL J MED, V335, P453, DOI 10.1056/NEJM199608153350701; Grodstein F, 1996, LANCET, V348, P983, DOI 10.1016/S0140-6736(96)07308-4; HENDERSON BE, 1991, ARCH INTERN MED, V151, P75, DOI 10.1001/archinte.151.1.75; Herrington DM, 2000, NEW ENGL J MED, V343, P522, DOI 10.1056/NEJM200008243430801; Herrington DM, 1999, ANN INTERN MED, V131, P463, DOI 10.7326/0003-4819-131-6-199909210-00012; Hodis HN, 2000, CIRCULATION, V102, P837; Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605; Khan MA, 2000, AM J CARDIOL, V86, P330, DOI 10.1016/S0002-9149(00)00926-7; KIM SC, 1995, CIRCULATION S1, V92, P674; Matthews KA, 1996, AM J EPIDEMIOL, V143, P971; NEWTON KM, 1997, AM J EPIDEMIOL, V145, P69; OKeefe JH, 1997, J AM COLL CARDIOL, V29, P1; *ORG WH, 1971, ID REG REP 5 WORK GR; Rimm E B, 1990, Epidemiology, V1, P466, DOI 10.1097/00001648-199011000-00009; ROSANO GMC, 1993, LANCET, V342, P133, DOI 10.1016/0140-6736(93)91343-K; Rothman K, 1986, MODERN EPIDEMIOLOGY; Rothman KJ, 1979, NIH PUBLICATION, V79-1649, P31; STAMPFER MJ, 1984, AM J EPIDEMIOL, V119, P837, DOI 10.1093/oxfordjournals.aje.a113804; SULLIVAN JM, 1990, ARCH INTERN MED, V150, P2557, DOI 10.1001/archinte.150.12.2557; SULLIVAN JM, 1994, J AM COLL CARDIOL, V23, pA49; WILLETT W, 1983, AM J EPIDEMIOL, V117, P651, DOI 10.1093/oxfordjournals.aje.a113598; WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086	32	218	232	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 3	2001	135	1					1	8		10.7326/0003-4819-135-1-200107030-00003	http://dx.doi.org/10.7326/0003-4819-135-1-200107030-00003			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	449JC	11434726	Green Published, Green Submitted			2022-12-24	WOS:000169680500001
J	Boughman, JW				Boughman, JW			Divergent sexual selection enhances reproductive isolation in sticklebacks	NATURE			English	Article							SYMPATRIC STICKLEBACKS; INTRASPECIFIC VARIATION; GASTEROSTEUS-ACULEATUS; NATURAL-SELECTION; BRITISH-COLUMBIA; SPECIES-PAIR; SPECIATION; EVOLUTION; TRAITS; COMPETITION	Sexual selection may facilitate speciation because it can cause rapid evolutionary diversification of male mating signals and female preferences. Divergence in these traits can then contribute to reproductive isolation(1-3). The sensory drive hypothesis predicts that three mechanisms underlie divergence in sexually selected traits(4): (1) habitat-specific transmission of male signals(5-7); (2) adaptation of female perceptual sensitivity to local ecological conditions(8); and (3) matching of male signals to female perceptual sensitivity(4,9). I test these mechanisms in threespine sticklebacks (Gasterosteus spp.) that live in different light environments. Here I show that female perceptual sensitivity to red light varies with the extent of redshift in the light environment, and contributes to divergent preferences. Male nuptial colour varies with environment and is tuned to female perceptual sensitivity. The extent of divergence among populations in both male signal colour and female preference for red is correlated with the extent of reproductive isolation in these recently diverged species. These results demonstrate that divergent sexual selection generated by sensory drive contributes to speciation.	Univ British Columbia, Dept Zool, Vancouver, BC V6T 1Z4, Canada	University of British Columbia	Boughman, JW (corresponding author), Univ British Columbia, Dept Zool, 6270 Univ Blvd, Vancouver, BC V6T 1Z4, Canada.			Boughman, Janette/0000-0002-5731-7389				CRONLYDILLON J, 1968, J EXP BIOL, V49, P679; Endler J. A., 1992, AM NAT, V139, pS125; ENDLER JA, 1991, VISION RES, V31, P587, DOI 10.1016/0042-6989(91)90109-I; Fisher R. A., 1930, GENETICAL THEORY NAT, DOI 10.5962/bhl.title.27468; Higashi M, 1999, NATURE, V402, P523, DOI 10.1038/990087; Klump G.M., 1995, METHODS COMP PSYCHOA; KODRICBROWN A, 1984, AM NAT, V124, P309, DOI 10.1086/284275; LANDE R, 1981, P NATL ACAD SCI-BIOL, V78, P3721, DOI 10.1073/pnas.78.6.3721; LANDE R, 1988, J THEOR BIOL, V133, P85, DOI 10.1016/S0022-5193(88)80026-2; LEVINE JS, 1979, SENS PROCESS, V3, P95; LUTHGOSE JN, 1979, ECOLOGY VISION; MARCHETTI K, 1993, NATURE, V362, P149, DOI 10.1038/362149a0; Martins EP, 1997, AM NAT, V149, P646, DOI 10.1086/286013; MCDONALD CG, 1995, J COMP PHYSIOL A, V176, P255; MCFARLAND WN, 1975, VISION RES, V15, P1071, DOI 10.1016/0042-6989(75)90003-6; McPhail J.D., 1994, P399; MCPHAIL JD, 1984, CAN J ZOOL, V62, P1402, DOI 10.1139/z84-201; MCPHAIL JD, 1992, CAN J ZOOL, V70, P361, DOI 10.1139/z92-054; Nagel L, 1998, EVOLUTION, V52, P209, DOI 10.1111/j.1558-5646.1998.tb05154.x; Podos J, 2001, NATURE, V409, P185, DOI 10.1038/35051570; REIMCHEN TE, 1989, EVOLUTION, V43, P450, DOI 10.1111/j.1558-5646.1989.tb04239.x; Rundle HD, 2000, SCIENCE, V287, P306, DOI 10.1126/science.287.5451.306; RYAN M.J., 1990, OXFORD SURV EVOL BIO, V7, P156; RYAN MJ, 1991, BIOL J LINN SOC, V44, P249, DOI 10.1111/j.1095-8312.1991.tb00619.x; SCHLUTER D, 1993, P ROY SOC B-BIOL SCI, V253, P117, DOI 10.1098/rspb.1993.0089; SCHLUTER D, 1994, SCIENCE, V266, P798, DOI 10.1126/science.266.5186.798; Schluter D, 1998, ENDLESS FORMS, P114; Seehausen O, 1997, SCIENCE, V277, P1808, DOI 10.1126/science.277.5333.1808; TAYLOR EB, 2000, GASTROSTEUS P R SO B, V267, P2375, DOI DOI 10.1098/RSPB.2000.1294; WESTEBERHARD MJ, 1983, Q REV BIOL, V58, P155, DOI 10.1086/413215	30	513	520	1	215	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 21	2001	411	6840					944	948		10.1038/35082064	http://dx.doi.org/10.1038/35082064			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	444EN	11418857				2022-12-24	WOS:000169386200043
J	McDonald, JJ; Teder-Salejarvi, WA; Ward, LM				McDonald, JJ; Teder-Salejarvi, WA; Ward, LM			Multisensory integration and crossmodal attention effects in the human brain	SCIENCE			English	Editorial Material							SPATIAL ATTENTION; AUDITORY-CORTEX; SPEECH		Simon Fraser Univ, Dept Psychol, Burnaby, BC V5A 1S6, Canada; Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; Univ British Columbia, Dept Psychol, Vancouver, BC V6T 1Z4, Canada	Simon Fraser University; University of California System; University of California San Diego; University of British Columbia	McDonald, JJ (corresponding author), Simon Fraser Univ, Dept Psychol, 8888 Univ Dr, Burnaby, BC V5A 1S6, Canada.	jmcd@sfu.ca; wat@sdepl.ucsd.edu; lward@cortex.psych.ubc.ca		Ward, Lawrence/0000-0003-4431-5015				Bertelson P, 2000, PERCEPT PSYCHOPHYS, V62, P321, DOI 10.3758/BF03205552; Bertelson P., 1999, COGNITIVE CONTRIBUTI, P347, DOI DOI 10.1016/S0166-4115(99)80034-X; Calvert GA, 1997, SCIENCE, V276, P593, DOI 10.1126/science.276.5312.593; de Gelder B, 2000, SCIENCE, V289, P1148; Driver J, 1996, NATURE, V381, P66, DOI 10.1038/381066a0; FOLK CL, 1992, J EXP PSYCHOL HUMAN, V18, P1030, DOI 10.1037/0096-1523.18.4.1030; JACK CE, 1973, PERCEPT MOTOR SKILL, V37, P967, DOI 10.2466/pms.1973.37.3.967; KENNETT S, IN PRESS J COGNIT NE; Macaluso E, 2000, SCIENCE, V289, P1206, DOI 10.1126/science.289.5482.1206; McDonald JJ, 2000, NATURE, V407, P906, DOI 10.1038/35038085; McDonald JJ, 2000, PSYCHOL SCI, V11, P167, DOI 10.1111/1467-9280.00233; MCDONALD JJ, 1999, THESIS U BRIT COLUMB; MEREDITH MA, 1987, J NEUROSCI, V7, P3125; RICHARD C, 1999, THESIS U BRIT COLUMB; SAMS M, 1991, NEUROSCI LETT, V127, P141, DOI 10.1016/0304-3940(91)90914-F; Stein BE., 1993, MERGING SENSES; TASSINARI G, 1994, VISION RES, V34, P179, DOI 10.1016/0042-6989(94)90330-1; VROOMEN J, IN PRESS PERCEPT PSY; Ward LM, 2000, PERCEPT PSYCHOPHYS, V62, P1258, DOI 10.3758/BF03212127; WELCH RB, 1986, HDB PERCEPTION HUMAN, V1, pCH25	20	71	73	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 8	2001	292	5523												2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	440WY	11397913				2022-12-24	WOS:000169200700051
J	Kerstetter, RA; Bollman, K; Taylor, RA; Bomblies, K; Poethig, RS				Kerstetter, RA; Bollman, K; Taylor, RA; Bomblies, K; Poethig, RS			KANADI regulates organ polarity in Arabidopsis	NATURE			English	Article							RESPONSE REGULATORS; NUCLEAR-LOCALIZATION; ASP PHOSPHORELAY; THALIANA; PROTEIN; GENE; LEAF; MERISTEM; EXPRESSION; ENCODES	Leaves and floral organs are polarized along their adaxial-abaxial (dorsal-ventral) axis. In Arabidopsis, this difference is particularly obvious in the first two rosette leaves, which possess trichomes (leaf hairs) on their adaxial surface but not their abaxial surface(1-3). Mutant alleles of KANADI (KAN) were identified in a screen for mutants that produce abaxial trichomes on these first two leaves. kan mutations were originally identified as enhancers of the mutant floral phenotype of crabs claw (crc), a gene that specifies abaxial identity in carpels(4,5). Here we show that KAN is required for abaxial identity in both leaves and carpels, and encodes a nuclear-localized protein in the GARP family of putative transcription factors. The expression pattern of KAN messenger RNA and the effect of ectopically expressing KAN under the regulation of the cauliflower mosaic virus (CAMV) 35S promoter indicate that KAN may also specify peripheral identity in the developing embryo.	Univ Penn, Dept Biol, Inst Plant Sci, Philadelphia, PA 19104 USA	University of Pennsylvania	Poethig, RS (corresponding author), Univ Penn, Dept Biol, Inst Plant Sci, Philadelphia, PA 19104 USA.		Poethig, R. Scott/J-7009-2015	Poethig, R. Scott/0000-0001-6592-5862; Bomblies, Kirsten/0000-0002-2434-3863				BARTON MK, 1993, DEVELOPMENT, V119, P823; Behringer FJ, 1992, PLANT MOL BIOL REP, V10, P190, DOI 10.1007/BF02668346; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Bowman JL, 1999, DEVELOPMENT, V126, P2387; Chien JC, 1996, PLANT PHYSIOL, V111, P1321, DOI 10.1104/pp.111.4.1321; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Eshed Y, 1999, CELL, V99, P199, DOI 10.1016/S0092-8674(00)81651-7; Hall LN, 1998, PLANT CELL, V10, P925, DOI 10.1105/tpc.10.6.925; Imamura A, 1999, PLANT CELL PHYSIOL, V40, P733, DOI 10.1093/oxfordjournals.pcp.a029600; KIEBER JJ, 1993, CELL, V72, P427, DOI 10.1016/0092-8674(93)90119-B; KONCZ C, 1986, MOL GEN GENET, V204, P383, DOI 10.1007/BF00331014; LINCOLN C, 1994, PLANT CELL, V6, P1859, DOI 10.1105/tpc.6.12.1859; Lohrmann J, 1999, PLANT BIOLOGY, V1, P495, DOI 10.1111/j.1438-8677.1999.tb00775.x; Lynn K, 1999, DEVELOPMENT, V126, P469; Makino S, 2000, PLANT CELL PHYSIOL, V41, P791, DOI 10.1093/pcp/41.6.791; McConnell JR, 1998, DEVELOPMENT, V125, P2935; Patharkar OR, 2000, PLANT J, V24, P679, DOI 10.1046/j.1365-313x.2000.00912.x; Riechmann JL, 2000, SCIENCE, V290, P2105, DOI 10.1126/science.290.5499.2105; Roberts C, 1997, PCAMBIA VECTOR RELEA; Sakai H, 1998, PLANT CELL PHYSIOL, V39, P1232, DOI 10.1093/oxfordjournals.pcp.a029325; Sakai H, 2000, PLANT J, V24, P703, DOI 10.1046/j.1365-313x.2000.00909.x; Telfer A, 1997, DEVELOPMENT, V124, P645; Telfer A, 1994, ARABIDOPSIS, P379, DOI DOI 10.1083/JCB.201205114; VARAGONA MJ, 1992, PLANT CELL, V4, P1213, DOI 10.1105/tpc.4.10.1213; Wykoff DD, 1999, P NATL ACAD SCI USA, V96, P15336, DOI 10.1073/pnas.96.26.15336	25	444	470	4	71	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN	2001	411	6838					706	709		10.1038/35079629	http://dx.doi.org/10.1038/35079629			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439JC	11395775				2022-12-24	WOS:000169112500049
J	Whittington, AT; Vugrek, O; Wei, KJ; Hasenbein, NG; Sugimoto, K; Rashbrooke, MC; Wasteneys, GO				Whittington, AT; Vugrek, O; Wei, KJ; Hasenbein, NG; Sugimoto, K; Rashbrooke, MC; Wasteneys, GO			MOR1 is essential for organizing cortical microtubules in plants	NATURE			English	Article							MITOTIC SPINDLE; HEAT REPEATS; LIVING CELLS; PROTEIN; XMAP215; ORGANIZATION; CYTOSKELETON; MUTATIONS; COMPONENT; DYNAMICS	Microtubules orchestrate cell division and morphogenesis, but how they disassemble and reappear at different subcellular locations is unknown. Microtubule organizing centres are thought to have an important role, but in higher plants microtubules assemble in ordered configurations even though microtubule organizing centres are inconspicuous or absent. Plant cells generate highly organized microtubule arrays that coordinate mitosis, cytokinesis and expansion. Inhibiting microtubule assembly prevents chromosome separation(1), blocks cell division(2) and impairs growth polarity(3). Microtubules are essential for the formation of cell walls, through an array of plasma-membrane-associated cortical microtubules whose control mechanisms are unknown. Using a genetic strategy to identify microtubule organizing factors in Arabidopsis thaliana, we isolated temperature-sensitive mutant alleles of the MICROTUBULE ORGANIZATION 1 (MOR1) gene. Here we show that MOR1 is the plant version of an ancient family of microtubule-associated proteins(4). Point mutations that substitute single amino-acid residues in an amino-terminal HEAT repeat impart reversible temperature-dependent cortical microtubule disruption, showing that MOR1 is essential for cortical microtubule organization.	Australian Natl Univ, Res Sch Biol Sci, Plant Cell Biol Grp, Canberra, ACT 2601, Australia	Australian National University	Wasteneys, GO (corresponding author), Australian Natl Univ, Res Sch Biol Sci, Plant Cell Biol Grp, GPO Box 475, Canberra, ACT 2601, Australia.	geoffw@rsbs.anu.edu.au	Sugimoto, Keiko/B-3368-2010; Wasteneys, Geoffrey/AGQ-5388-2022	Sugimoto, Keiko/0000-0002-9209-8230; Wasteneys, Geoffrey/0000-0002-8746-7994				Andersen SSL, 1998, CELL MOTIL CYTOSKEL, V41, P202, DOI 10.1002/(SICI)1097-0169(1998)41:3<202::AID-CM2>3.0.CO;2-X; Andrade MA, 2000, J MOL BIOL, V298, P521, DOI 10.1006/jmbi.2000.3684; ANDRADE MA, 1995, NAT GENET, V11, P115, DOI 10.1038/ng1095-115; BASKIN TI, 1994, PLANT CELL PHYSIOL, V35, P935; BASKIN TI, 1990, ANNU REV PLANT PHYS, V41, P277, DOI 10.1146/annurev.pp.41.060190.001425; Charrasse S, 1998, J CELL SCI, V111, P1371; Charrasse S, 2000, EXP CELL RES, V254, P249, DOI 10.1006/excr.1999.4740; Cullen CF, 1999, J CELL BIOL, V146, P1005, DOI 10.1083/jcb.146.5.1005; GARD DL, 1987, J CELL BIOL, V105, P2203, DOI 10.1083/jcb.105.5.2203; Graf R, 2000, J CELL SCI, V113, P1747; Hall TA, 1999, NUCL ACIDS S SERIES, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; KENNELLY PJ, 1991, J BIOL CHEM, V266, P15555; KONIECZNY A, 1993, PLANT J, V4, P403, DOI 10.1046/j.1365-313X.1993.04020403.x; Kunz J, 2000, J BIOL CHEM, V275, P37011, DOI 10.1074/jbc.M007296200; Lloyd C, 2001, NAT REV MOL CELL BIO, V2, P40, DOI 10.1038/35048005; Matthews LR, 1998, J CELL BIOL, V141, P1159, DOI 10.1083/jcb.141.5.1159; Mayer U, 1999, EUR J CELL BIOL, V78, P100, DOI 10.1016/S0171-9335(99)80011-9; NABESHIMA K, 1995, GENE DEV, V9, P1572, DOI 10.1101/gad.9.13.1572; Smertenko A, 2000, NAT CELL BIOL, V2, P750, DOI 10.1038/35036390; Spittle C, 2000, J BIOL CHEM, V275, P20748, DOI 10.1074/jbc.M002597200; Sugimoto K, 2000, PLANT PHYSIOL, V124, P1493, DOI 10.1104/pp.124.4.1493; Tournebize R, 2000, NAT CELL BIOL, V2, P13, DOI 10.1038/71330; Ueda K, 2000, PROTOPLASMA, V213, P28, DOI 10.1007/BF01280502; Ueda K, 1999, PROTOPLASMA, V206, P201, DOI 10.1007/BF01279267; Vasquez RJ, 1999, CELL MOTIL CYTOSKEL, V43, P310, DOI 10.1002/(SICI)1097-0169(1999)43:4<310::AID-CM4>3.3.CO;2-A; Wang PJJ, 1997, J CELL BIOL, V139, P1271, DOI 10.1083/jcb.139.5.1271; Wasteneys GO, 2000, CURR OPIN PLANT BIOL, V3, P503, DOI 10.1016/S1369-5266(00)00120-5; Wasteneys GO, 1997, J MICROSC-OXFORD, V188, P51, DOI 10.1046/j.1365-2818.1977.2390796.x; Wick S, 2000, NAT CELL BIOL, V2, pE204, DOI 10.1038/35041129	29	342	368	7	47	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 31	2001	411	6837					610	613		10.1038/35079128	http://dx.doi.org/10.1038/35079128			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437GE	11385579				2022-12-24	WOS:000168982500058
J	Iwata, N; Tsubuki, S; Takaki, Y; Shirotani, K; Lu, B; Gerard, NP; Gerard, C; Hama, E; Lee, HJ; Saido, TC				Iwata, N; Tsubuki, S; Takaki, Y; Shirotani, K; Lu, B; Gerard, NP; Gerard, C; Hama, E; Lee, HJ; Saido, TC			Metabolic regulation of brain A beta by neprilysin	SCIENCE			English	Article							ALZHEIMERS-DISEASE; IDENTIFICATION; PROTEIN; GENE; DEGRADATION; CATABOLISM; PRESENILIN; REGION; MICE	Amyloid beta peptide (A beta) the pathogenic agent of Alzheimer's disease (AD), is a physiological metabolite in the brain. We examined the role of neprilysin, a candidate A beta -degrading peptidase, in the metabolism using neprilysin gene-disrupted mice. Neprilysin deficiency resulted in defects both in the degradation of exogenously administered A beta and in the metabolic suppression of the endogenous A beta Levels in a gene dose-dependent manner. The regional Levels of A beta in the neprilysin-deficient mouse brain were in the distinct order of hippocampus, cortex, thalamus/striatum, and cerebellum, where hippocampus has the highest Level and cerebellum the lowest, correlating with the vulnerability to A beta deposition in brains of humans with AD. Our observations suggest that even partial down-regulation of neprilysin activity, which could be caused by aging, can contribute to AD development by promoting A beta accumulation.	RIKEN, Brain Sci Inst, Lab Proteolyt Neurosci, Wako, Saitama 3510198, Japan; Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA	RIKEN; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Saido, TC (corresponding author), RIKEN, Brain Sci Inst, Lab Proteolyt Neurosci, Wako, Saitama 3510198, Japan.	saido@brain.riken.go.jp	Sado, Takaomi/AAN-2759-2021; Saido, Takaomi C/N-5472-2015	Sado, Takaomi/0000-0003-1970-6903; Saido, Takaomi C/0000-0003-1970-6903				Borchelt DR, 1996, NEURON, V17, P1005, DOI 10.1016/S0896-6273(00)80230-5; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Duff K, 1996, NATURE, V383, P710, DOI 10.1038/383710a0; Fratiglioni L, 1997, NEUROLOGY, V48, P132, DOI 10.1212/WNL.48.1.132; HAOUAS H, 1995, BIOCHEM BIOPH RES CO, V207, P933, DOI 10.1006/bbrc.1995.1275; Hardy J, 1997, TRENDS NEUROSCI, V20, P154, DOI 10.1016/S0166-2236(96)01030-2; Ikeda K, 1999, J BIOL CHEM, V274, P32469, DOI 10.1074/jbc.274.45.32469; Iwata N, 2000, NAT MED, V6, P143, DOI 10.1038/72237; IWATSUBO T, 1994, NEURON, V13, P45, DOI 10.1016/0896-6273(94)90458-8; Kiryu-Seo S, 2000, P NATL ACAD SCI USA, V97, P4345, DOI 10.1073/pnas.070509897; LI CW, 1995, J BIOL CHEM, V270, P5723, DOI 10.1074/jbc.270.11.5723; Li CW, 1998, ARCH BIOCHEM BIOPHYS, V358, P189, DOI 10.1006/abbi.1998.0855; LU B, 1995, J EXP MED, V181, P2271, DOI 10.1084/jem.181.6.2271; Nakano Y, 1999, EUR J NEUROSCI, V11, P2577, DOI 10.1046/j.1460-9568.1999.00698.x; Perez A, 2000, NEUROCHEM RES, V25, P247, DOI 10.1023/A:1007527721160; Poduslo SE, 1999, HUM GENET, V105, P32, DOI 10.1007/s004390051060; Saido T.C., 2000, NEUROSCI NEWS, V5, P52; Saido TC, 1998, NEUROBIOL AGING, V19, pS69, DOI 10.1016/S0197-4580(98)00033-5; Saria A, 1997, NEUROSCI LETT, V234, P27, DOI 10.1016/S0304-3940(97)00660-5; Sawamura N, 2000, J BIOL CHEM, V275, P27901; Selkoe DJ, 1998, TRENDS CELL BIOL, V8, P447, DOI 10.1016/S0962-8924(98)01363-4; SELKOE DJ, 1993, TRENDS NEUROSCI, V16, P403, DOI 10.1016/0166-2236(93)90008-A; Shen RQ, 2000, MOL CELL ENDOCRINOL, V170, P131, DOI 10.1016/S0303-7207(00)00326-9; SHIROTANI K, IN PRESS J BIOL CHEM; Takaki Y, 2000, J BIOCHEM-TOKYO, V128, P897, DOI 10.1093/oxfordjournals.jbchem.a022839; Tanzi RE, 1996, NEUROBIOL DIS, V3, P159, DOI 10.1006/nbdi.1996.0016; Tucker HM, 2000, J NEUROSCI, V20, P3937; Vekrellis K, 2000, J NEUROSCI, V20, P1657; Yasojima K, 2001, NEUROSCI LETT, V297, P97, DOI 10.1016/S0304-3940(00)01675-X	29	784	833	1	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 25	2001	292	5521					1550	1552		10.1126/science.1059946	http://dx.doi.org/10.1126/science.1059946			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YQ	11375493				2022-12-24	WOS:000168963800046
J	Kawane, K; Fukuyama, H; Kondoh, G; Takeda, J; Ohsawa, Y; Uchiyama, Y; Nagata, S				Kawane, K; Fukuyama, H; Kondoh, G; Takeda, J; Ohsawa, Y; Uchiyama, Y; Nagata, S			Requirement of DNase II for definitive erythropoiesis in the mouse fetal liver	SCIENCE			English	Article							TRANSCRIPTION FACTOR PU.1; DEOXYRIBONUCLEASE-II; MOLECULAR-CLONING; APOPTOTIC CELLS; TGF-BETA; GENE; MACROPHAGES; DIFFERENTIATION; FRAGMENTATION; ABSENCE	Mature erythrocytes in mammals have no nuclei, although they differentiate from nucleated precursor cells. The mechanism by which enucleation occurs is not well understood. Here we show that deoxyribonuclease II (DNase II) is indispensable for definitive erythropoiesis in mouse fetal liver. No live DNase Ii-null mice were born, owing to severe anemia. When mutant fetal liver cells were transferred into Lethally irradiated wild-type mice, mature red blood cells were generated from the mutant cells, suggesting that DNase II functions in a non-cell-autonomous manner. Histochemical analyses indicated that the critical cellular sources of DNase II are macrophages present at the site of definitive erythropoiesis in the fetal Liver. Thus, DNase II in macrophages appears to be responsible for destroying the nuclear DNA expelled from erythroid precursor cells.	Osaka Univ, Sch Med, Dept Genet, Suita, Osaka 5650871, Japan; Japan Sci & Technol Corp, Core Res Evolut Sci & Technol, Suita, Osaka 5650871, Japan; Osaka Univ, Sch Med, Dept Social & Environm Med, Suita, Osaka 5650871, Japan; Osaka Univ, Sch Med, Dept Cell Biol & Anat, Suita, Osaka 5650871, Japan	Osaka University; Japan Science & Technology Agency (JST); Osaka University; Osaka University	Nagata, S (corresponding author), Osaka Univ, Sch Med, Dept Genet, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.		Nagata, Shigekazu/AAG-3203-2019; Fukuyama, Hidehiro/AAY-6256-2021; Fukuyama, Hidehiro/N-5276-2018	Nagata, Shigekazu/0000-0001-9758-8426; Fukuyama, Hidehiro/0000-0002-6457-0630; Fukuyama, Hidehiro/0000-0002-6457-0630; Kawane, Kohki/0000-0003-1125-9483				ALTER BP, 1982, HEMOGLOBIN, V6, P517, DOI 10.3109/03630268209083764; Appierto V, 1997, GENE, V188, P119, DOI 10.1016/S0378-1119(96)00794-9; AUSTYN JM, 1981, EUR J IMMUNOL, V11, P805, DOI 10.1002/eji.1830111013; Baker KP, 1998, GENE, V215, P281, DOI 10.1016/S0378-1119(98)00280-7; CECCHINI MG, 1994, DEVELOPMENT, V120, P1357; CROCKER PR, 1985, J EXP MED, V162, P993, DOI 10.1084/jem.162.3.993; DYBEDAL I, 1995, BLOOD, V86, P949; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Kondoh G, 1999, J BIOCHEM BIOPH METH, V39, P137, DOI 10.1016/S0165-022X(99)00008-1; Krieser RJ, 2000, GENE, V252, P155, DOI 10.1016/S0378-1119(00)00209-2; Lichanska AM, 1999, BLOOD, V94, P127, DOI 10.1182/blood.V94.1.127.413k07_127_138; McCall K, 1998, SCIENCE, V279, P230, DOI 10.1126/science.279.5348.230; McIlroy D, 2000, GENE DEV, V14, P549; Nagata S, 2000, EXP CELL RES, V256, P12, DOI 10.1006/excr.2000.4834; NUEZ B, 1995, NATURE, V375, P316, DOI 10.1038/375316a0; PERKINS AC, 1995, NATURE, V375, P318; Platt N, 1998, TRENDS CELL BIOL, V8, P365, DOI 10.1016/S0962-8924(98)01329-4; RUSSELL ES, 1974, ANN NY ACAD SCI, V241, P25, DOI 10.1111/j.1749-6632.1974.tb21864.x; SCOTT EW, 1994, SCIENCE, V265, P1573, DOI 10.1126/science.8079170; Shiokawa D, 1999, NUCLEIC ACIDS RES, V27, P4083, DOI 10.1093/nar/27.20.4083; TORRIGLIA A, 1995, J BIOL CHEM, V270, P28579, DOI 10.1074/jbc.270.48.28579; WIKTORJEDRZEJCZAK W, 1990, P NATL ACAD SCI USA, V87, P4828, DOI 10.1073/pnas.87.12.4828; Wu YC, 2000, GENE DEV, V14, P536; Yasuda T, 1998, J BIOL CHEM, V273, P2610, DOI 10.1074/jbc.273.5.2610; YOSHIDA H, 1990, NATURE, V345, P442, DOI 10.1038/345442a0	25	283	296	1	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 25	2001	292	5521					1546	1549		10.1126/science.292.5521.1546	http://dx.doi.org/10.1126/science.292.5521.1546			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YQ	11375492				2022-12-24	WOS:000168963800045
J	Yamada, K; Ji, JJ; Yuan, HJ; Miki, T; Sato, S; Horimoto, N; Shimizu, T; Seino, S; Inagaki, N				Yamada, K; Ji, JJ; Yuan, HJ; Miki, T; Sato, S; Horimoto, N; Shimizu, T; Seino, S; Inagaki, N			Protective role ob ATP-sensitive potassium channels in hypoxia-induced generalized seizure	SCIENCE			English	Article							NIGRA PARS-RETICULATA; RAT SUBSTANTIA-NIGRA; SULFONYLUREA RECEPTOR; BINDING-SITES; K+ CHANNELS; NEURONS; LOCALIZATION; CONDUCTANCE; DOPAMINE; ANOXIA	Adenosine triphosphate (ATP)-sensitive potassium (K-ATP) channels are activated by various metabolic stresses, including hypoxia. The substantia nigra pars reticulata (SNr), the area with the highest expression of K-ATP channels in the brain, plays a pivotal role in the control of seizures. Mutant mice lacking the Kir6.2 subunit of K-ATP channels [knockout (KO) mice] were susceptible to generalized seizures after brief hypoxia. In normal mice, SNr neuron activity was inactivated during hypoxia by the opening of the postsynaptic K-ATP channels, whereas in KO mice, the activity of these neurons was enhanced. K-ATP channels exert a depressant effect on SNr neuronal activity during hypoxia and may be involved in the nigral protection mechanism against generalized seizures.	Akita Univ, Sch Med, Dept Physiol, Akita 0108543, Japan; Akita Univ, Sch Med, Dept Psychiat, Akita 0108543, Japan; Japan Sci & Technol Corp, CREST, Akita 0108543, Japan; Chiba Univ, Grad Sch Med, Dept Cellular & Mol Biol, Chuo Ku, Chiba 2608670, Japan	Akita University; Akita University; Japan Science & Technology Agency (JST); Chiba University	Inagaki, N (corresponding author), Akita Univ, Sch Med, Dept Physiol, 1-1-1 Hondo, Akita 0108543, Japan.	inagaki@med.akita-u.ac.jp	MIKI, Takashi/ABD-3995-2020	MIKI, Takashi/0000-0001-5741-1626; Inagaki, Nobuya/0000-0001-8261-2593; Yuan, Hongjie/0000-0002-8127-7145				AMOROSO S, 1990, SCIENCE, V247, P852, DOI 10.1126/science.2305257; ASHCROFT FM, 1988, ANNU REV NEUROSCI, V11, P97, DOI 10.1146/annurev.neuro.11.1.97; CHUN J, 1991, BRAIN RES, V568, P159, DOI 10.1016/0006-8993(91)91392-E; DEPAULIS A, 1994, PROG NEUROBIOL, V42, P33, DOI 10.1016/0301-0082(94)90020-5; DESARRO G, 1984, EUR J PHARMACOL, V106, P175, DOI 10.1016/0014-2999(84)90692-7; Dugan Laura L., 1999, P711; FISCH BJ, 1999, FISCH SPEHLMANS EEG, P301; HANSEN AJ, 1982, ACTA PHYSIOL SCAND, V115, P301, DOI 10.1111/j.1748-1716.1982.tb07082.x; HICKS GA, 1994, NEUROSCIENCE, V61, P285, DOI 10.1016/0306-4522(94)90231-3; IADAROLA MJ, 1982, SCIENCE, V218, P1237, DOI 10.1126/science.7146907; INAGAKI N, 1995, SCIENCE, V270, P1166, DOI 10.1126/science.270.5239.1166; Lamensdorf I, 1999, BRAIN RES, V818, P275, DOI 10.1016/S0006-8993(98)01290-6; Liss B, 1999, EMBO J, V18, P833, DOI 10.1093/emboj/18.4.833; Miki T, 1998, P NATL ACAD SCI USA, V95, P10402, DOI 10.1073/pnas.95.18.10402; MOURRE C, 1989, BRAIN RES, V486, P159, DOI 10.1016/0006-8993(89)91288-2; NOMA A, 1983, NATURE, V305, P147, DOI 10.1038/305147a0; OERTEL WH, 1982, BRAIN RES BULL, V9, P463, DOI 10.1016/0361-9230(82)90155-1; Richards CD, 1997, NEUROSCIENCE, V80, P545, DOI 10.1016/S0306-4522(97)00093-6; SCHWANSTECHER C, 1993, N-S ARCH PHARMACOL, V348, P113, DOI 10.1007/BF00168546; Seino S, 1999, ANNU REV PHYSIOL, V61, P337, DOI 10.1146/annurev.physiol.61.1.337; Stanford IM, 1996, NEUROSCIENCE, V74, P499, DOI 10.1016/0306-4522(96)00151-0; TURSKI L, 1990, BRAIN RES, V520, P232, DOI 10.1016/0006-8993(90)91710-X; Wu CW, 1996, NEUROREPORT, V7, P2513, DOI 10.1097/00001756-199611040-00022; Yamada K., UNPUB	24	273	285	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 25	2001	292	5521					1543	1546		10.1126/science.1059829	http://dx.doi.org/10.1126/science.1059829			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YQ	11375491				2022-12-24	WOS:000168963800044
J	Polacek, N; Gaynor, M; Yassin, A; Mankin, AS				Polacek, N; Gaynor, M; Yassin, A; Mankin, AS			Ribosomal peptidyl transferase can withstand mutations at the putative catalytic nucleotide	NATURE			English	Article							TRANSFER-RNA; DOMAIN-V; A-SITES; P-SITES; POSITIONS; BASE; RECONSTITUTION; RESISTANCE	Peptide bond formation is the principal reaction of protein synthesis. It takes place in the peptidyl transferase centre of the large (50S) ribosomal subunit. In the course of the reaction, the polypeptide is transferred from peptidyl transfer RNA to the alpha -amino group of amino acyl-tRNA. The crystallographic structure of the 50S subunit showed no proteins within 18 Angstrom E from the active site, revealing peptidyl transferase as an RNA enzyme(1). Reported unique structural and biochemical features of the universally conserved adenine residue A2451 in 23S ribosomal RNA (Escherichia coli numbering) led to the proposal of a mechanism of rRNA catalysis that implicates this nucleotide as the principal catalytic residue(2,3). In vitro genetics allowed us to test the importance of A2451 for the overall rate of peptide bond formation. Here we report that large ribosomal subunits with mutated A2451 showed significant peptidyl transferase activity in several independent assays. Mutations at another nucleotide, G2447, which is essential to render catalytic properties to A2451 (refs 2, 3), also did not dramatically change the transpeptidation activity. As alterations of the putative catalytic residues do not severely affect the rate of peptidyl transfer the ribosome apparently promotes transpeptidation not through chemical catalysis, but by properly positioning the substrates of protein synthesis.	Univ Illinois, Ctr Pharmaceut Biotechnol MC 870, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Mankin, AS (corresponding author), Univ Illinois, Ctr Pharmaceut Biotechnol MC 870, 900 S Ashland Ave, Chicago, IL 60607 USA.		Polacek, Norbert/AAV-7346-2020; Yassin, Aymen/N-8490-2016	Polacek, Norbert/0000-0001-5317-3990; Yassin, Aymen/0000-0002-4423-164X				Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Barta A., 2001, SCIENCE, V291, p203a, DOI [10.1126/science.291.5502.203a, DOI 10.1126/SCIENCE.291.5502.203A]; Blaha G, 2000, METHOD ENZYMOL, V317, P292; Bocchetta M, 1998, P NATL ACAD SCI USA, V95, P3525, DOI 10.1073/pnas.95.7.3525; CRICK FHC, 1976, ORIGINS LIFE EVOL B, V7, P389, DOI 10.1007/BF00927934; Green J, 1996, AEROSPACE, V23, P2; Green R, 1997, J MOL BIOL, V266, P40, DOI 10.1006/jmbi.1996.0780; Green R, 1999, BIOCHEMISTRY-US, V38, P1772, DOI 10.1021/bi982246a; HART HE, 1979, MOL IMMUNOL, V16, P265, DOI 10.1016/0161-5890(79)90065-8; KEARSEY SE, 1981, NATURE, V290, P607, DOI 10.1038/290607a0; Khaitovich P, 2000, RIBOSOME: STRUCTURE, FUNCTION, ANTIBIOTICS, AND CELLULAR INTERACTIONS, P229; Khaitovich P, 1999, BIOCHEMISTRY-US, V38, P1780, DOI 10.1021/bi9822473; Khaitovich P, 1999, RNA, V5, P605, DOI 10.1017/S1355838299990295; Kim DF, 1999, MOL CELL, V4, P859, DOI 10.1016/S1097-2765(00)80395-0; Krayevsky A A, 1979, Prog Nucleic Acid Res Mol Biol, V23, P1; MOAZED D, 1989, CELL, V57, P585, DOI 10.1016/0092-8674(89)90128-1; MONRO RE, 1967, J MOL BIOL, V25, P347, DOI 10.1016/0022-2836(67)90146-5; Muth GW, 2000, SCIENCE, V289, P947, DOI 10.1126/science.289.5481.947; Nakano S, 2000, SCIENCE, V287, P1493, DOI 10.1126/science.287.5457.1493; Nierhaus K., 1990, RIBOSOMES PROTEIN SY, P161; NIERHAUS KH, 1980, BIOCHEM INT, V1, P185; Nissen P, 2000, SCIENCE, V289, P920, DOI 10.1126/science.289.5481.920; OCONNOR M, 1993, P NATL ACAD SCI USA, V90, P9214, DOI 10.1073/pnas.90.19.9214; PORSE BT, 1995, J MOL BIOL, V249, P1, DOI 10.1006/jmbi.1995.0276; SAMAHA RR, 1995, NATURE, V377, P309, DOI 10.1038/377309a0; STEINER G, 1988, EMBO J, V7, P3949, DOI 10.1002/j.1460-2075.1988.tb03281.x; SWANEY SM, 1998, 38 INT C ANT AG CHEM, pC104; Xiong LQ, 2000, J BACTERIOL, V182, P5325, DOI 10.1128/JB.182.19.5325-5331.2000; Yean SL, 2000, NATURE, V408, P881, DOI 10.1038/35048617; Zhang BL, 1997, NATURE, V390, P96, DOI 10.1038/36375	30	154	165	0	7	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 24	2001	411	6836					498	501		10.1038/35078113	http://dx.doi.org/10.1038/35078113			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	435CB	11373685				2022-12-24	WOS:000168858700054
J	Plaster, NM; Tawil, R; Tristani-Firouzi, M; Canun, S; Bendahhou, S; Tsunoda, A; Donaldson, MR; Iannaccone, ST; Brunt, E; Barohn, R; Clark, J; Deymeer, F; George, AL; Fish, FA; Hahn, A; Nitu, A; Ozdemir, C; Serdaroglu, P; Subramony, SH; Wolfe, G; Fu, YH; Ptacek, LJ				Plaster, NM; Tawil, R; Tristani-Firouzi, M; Canun, S; Bendahhou, S; Tsunoda, A; Donaldson, MR; Iannaccone, ST; Brunt, E; Barohn, R; Clark, J; Deymeer, F; George, AL; Fish, FA; Hahn, A; Nitu, A; Ozdemir, C; Serdaroglu, P; Subramony, SH; Wolfe, G; Fu, YH; Ptacek, LJ			Mutations in Kir2.1 cause the developmental and episodic electrical phenotypes of Andersen's syndrome	CELL			English	Article							HYPOKALEMIC PERIODIC PARALYSIS; RECTIFIER POTASSIUM CHANNEL; LONG QT SYNDROME; FUNCTIONAL EXPRESSION; K+ CHANNEL; CARDIAC-ARRHYTHMIA; MOLECULAR-CLONING; GENE; INACTIVATION; SUBUNITS	Andersen's syndrome is characterized by periodic paralysis, cardiac arrhythmias, and dysmorphic features. We have mapped an Andersen's locus to chromosome 17q23 (maximum LOD = 3.23 at theta = 0) near the inward rectifying potassium channel gene KCNJ2. A missense mutation in KCNJ2 (encoding D71V) was identified in the linked family. Eight additional mutations were identified in unrelated patients. Expression of two of these mutations in Xenopus oocytes revealed loss of function and a dominant negative effect in Kir2.1 current as assayed by voltage-clamp. We conclude that mutations in Kir2.1 cause Andersen's syndrome. These findings suggest that Kir2.1 plays an important role in developmental signaling in addition to its previously recognized function in controlling cell excitability in skeletal muscle and heart.	Univ Utah, Dept Human Genet, Salt Lake City, UT 84112 USA; Univ Utah, Howard Hughes Med Inst, Salt Lake City, UT 84112 USA; Univ Utah, Dept Neurol, Salt Lake City, UT 84112 USA; Univ Utah, Dept Neurobiol & Anat, Salt Lake City, UT 84112 USA; Univ Utah, Dept Pediat, Salt Lake City, UT 84112 USA; Univ Rochester, Sch Med, Rochester, NY 14642 USA; Hosp Gen Dr Manuel Gea Gonzalez, Dept Genet, Mexico City 14000, DF, Mexico; Texas Scottish Rite Hosp Children, Dept Neurol, Dallas, TX 75219 USA; Univ Groningen, Univ Med Ctr Groningen, Acad Ziekenhuis Groningen, Neurol Klin, NL-9700 RB Groningen, Netherlands; Univ Kansas, Med Ctr, Dept Neurol, Kansas City, KS 66160 USA; Childrens Hosp, Med Ctr, Akron, OH 44308 USA; Istanbul Univ, Tip Fak, Noroloji Anabilim, TR-34390 Istanbul, Turkey; Vanderbilt Univ, Med Ctr, Nashville, TN 37232 USA; London Hlth Sci Ctr, Dept Clin & Neurol Sci, London, ON N6A 4GA, Canada; Indiana Univ, Med Ctr, Dept Neurol, Indianapolis, IN 46202 USA; Univ Texas, SW Med Ctr, Dallas, TX 75390 USA	Utah System of Higher Education; University of Utah; Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; University of Rochester; Texas Scottish Rite Hospital for Children; University of Groningen; University of Kansas; University of Kansas Medical Center; Akron Children's Hospital; Istanbul University; Vanderbilt University; London Health Sciences Centre; Indiana University System; Indiana University-Purdue University Indianapolis; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Ptacek, LJ (corresponding author), Univ Utah, Dept Human Genet, Salt Lake City, UT 84112 USA.	ptacek@genetics.utah.edu	Wolfe, Gil/AAO-2786-2020	, Piraye/0000-0001-8202-5313	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038616] Funding Source: NIH RePORTER; NCRR NIH HHS [M01-RR00064] Funding Source: Medline; NINDS NIH HHS [NS38616] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abbott GW, 2001, CELL, V104, P217, DOI 10.1016/S0092-8674(01)00207-0; Canun S, 1999, AM J MED GENET, V85, P147, DOI 10.1002/(SICI)1096-8628(19990716)85:2<147::AID-AJMG9>3.0.CO;2-0; CURRAN ME, 1995, CELL, V80, P795, DOI 10.1016/0092-8674(95)90358-5; Derst C, 1997, BIOCHEM BIOPH RES CO, V230, P641, DOI 10.1006/bbrc.1996.6024; DOUPNIK CA, 1995, CURR OPIN NEUROBIOL, V5, P268, DOI 10.1016/0959-4388(95)80038-7; Fouad G, 1997, NEUROMUSCULAR DISORD, V7, P33, DOI 10.1016/S0960-8966(96)00401-4; HOROWICZ P, 1994, MYOLOGY BASIC CLIN, P405; Jan LY, 1997, J PHYSIOL-LONDON, V505, P267, DOI 10.1111/j.1469-7793.1997.267bb.x; JANUARY CT, 1989, CIRC RES, V64, P977, DOI 10.1161/01.RES.64.5.977; JEN J, 2001, METABOLIC MOL BASES, P5223; Jurkat-Rott K, 2000, P NATL ACAD SCI USA, V97, P9549, DOI 10.1073/pnas.97.17.9549; KANNEL WB, 1987, AM HEART J, V113, P799, DOI 10.1016/0002-8703(87)90722-8; Karschin C, 1997, MOL CELL NEUROSCI, V10, P131, DOI 10.1006/mcne.1997.0655; Keating MT, 2001, CELL, V104, P569, DOI 10.1016/S0092-8674(01)00243-4; KUBO Y, 1993, NATURE, V362, P127, DOI 10.1038/362127a0; LATHROP GM, 1985, AM J HUM GENET, V37, P482; MARTIN AB, 1995, AM J CARDIOL, V75, P950, DOI 10.1016/S0002-9149(99)80697-3; MCMANIS PG, 1986, MUSCLE NERVE, V9, P704, DOI 10.1002/mus.880090805; MORISHIGE KI, 1994, FEBS LETT, V346, P251, DOI 10.1016/0014-5793(94)00483-8; Nakamura TY, 1998, AM J PHYSIOL-HEART C, V274, pH892, DOI 10.1152/ajpheart.1998.274.3.H892; Nichols CG, 1997, ANNU REV PHYSIOL, V59, P171, DOI 10.1146/annurev.physiol.59.1.171; PATIL N, 1995, NAT GENET, V11, P126, DOI 10.1038/ng1095-126; PTACEK LJ, 1991, CELL, V67, P1021; PTACEK LJ, 1994, CELL, V77, P863; RAABGRAHAM KF, 1994, NEUROREPORT, V5, P2501, DOI 10.1097/00001756-199412000-00024; ROJAS CV, 1991, NATURE, V354, P387, DOI 10.1038/354387a0; Ruff RL, 2000, P NATL ACAD SCI USA, V97, P9832, DOI 10.1073/pnas.170293197; Ruff RL, 1999, NEUROLOGY, V53, P1556, DOI 10.1212/WNL.53.7.1556; Ruff RL, 2000, NEUROLOGY, V54, P2191, DOI 10.1212/WNL.54.11.2191; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; Sanguinetti MC, 2000, CARDIAC ELECTROPHYSI, P79; Sansone V, 1997, ANN NEUROL, V42, P305, DOI 10.1002/ana.410420306; SCHWARTZ PJ, 1993, CIRCULATION, V88, P782, DOI 10.1161/01.CIR.88.2.782; Simon DB, 1996, NAT GENET, V14, P152, DOI 10.1038/ng1096-152; Splawski I, 1997, NAT GENET, V17, P338, DOI 10.1038/ng1197-338; TAKAHASHI N, 1994, J BIOL CHEM, V269, P23274; TAWIL R, 1994, ANN NEUROL, V35, P326, DOI 10.1002/ana.410350313; Tinker A, 1996, CELL, V87, P857, DOI 10.1016/S0092-8674(00)81993-5; Topert C, 1998, J NEUROSCI, V18, P4096; Tricarico D, 1999, J CLIN INVEST, V103, P675, DOI 10.1172/JCI4552; Tristani-Firouzi M, 1998, J PHYSIOL-LONDON, V510, P37, DOI 10.1111/j.1469-7793.1998.037bz.x; Tucker SJ, 1999, J BIOL CHEM, V274, P33393, DOI 10.1074/jbc.274.47.33393; WANG Q, 1995, CELL, V80, P805, DOI 10.1016/0092-8674(95)90359-3; Wang Q, 1996, NAT GENET, V12, P17, DOI 10.1038/ng0196-17; WIBLE BA, 1995, CIRC RES, V76, P343, DOI 10.1161/01.RES.76.3.343; WILLICH SN, 1987, AM J CARDIOL, V60, P801, DOI 10.1016/0002-9149(87)91027-7; Yang J, 1995, NEURON, V15, P1441, DOI 10.1016/0896-6273(95)90021-7; Zaritsky JJ, 2000, CIRC RES, V87, P160, DOI 10.1161/01.RES.87.2.160	48	687	724	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 18	2001	105	4					511	519		10.1016/S0092-8674(01)00342-7	http://dx.doi.org/10.1016/S0092-8674(01)00342-7			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	434XG	11371347	Bronze			2022-12-24	WOS:000168840700010
J	Zhang, XM; Ramalho-Santos, M; McMahon, AP				Zhang, XM; Ramalho-Santos, M; McMahon, AP			Smoothened mutants reveal redundant roles for Shh and Ihh signaling including regulation of L/R asymmetry by the mouse node	CELL			English	Article							LEFT-RIGHT AXIS; SONIC-HEDGEHOG; SCLEROTOME INDUCTION; INDIAN HEDGEHOG; CARTILAGE DIFFERENTIATION; VERTEBRATE DEVELOPMENT; MAMMALIAN TOOTH; GENE; EXPRESSION; PROLIFERATION	Genetic analyses in Drosophila have demonstrated that the multipass membrane protein Smoothened (Smo) is essential for all Hedgehog signaling. We show that Smo acts epistatic to Ptc1 to mediate Shh and Ihh signaling in the early mouse embryo. Smo and Shh/Ihh compound mutants have identical phenotypes: embryos fail to turn, arresting at somite stages with a small, linear heart tube, an open gut and cyclopia. The absence of visible left/right (L/R) asymmetry led us to examine the pathways controlling L/R situs. We present evidence consistent with a model in which Hedgehog signaling within the node is required for activation of Gdf1, and induction of left-side determinants. Further, we demonstrate an absolute requirement for Hedgehog signaling in sclerotomal development and a role in cardiac morphogenesis.	Harvard Univ, Dept Mol & Cellular Biol, Biolabs, Cambridge, MA 02138 USA	Harvard University	McMahon, AP (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Biolabs, 16 Divin Ave, Cambridge, MA 02138 USA.		McMahon, Andrew P/ABE-7520-2020; Ramalho-Santos, Miguel/L-9092-2018	Ramalho-Santos, Miguel/0000-0003-0177-5556	NINDS NIH HHS [NS33642] Funding Source: Medline	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Akiyama H, 1997, BIOCHEM BIOPH RES CO, V235, P142, DOI 10.1006/bbrc.1997.6750; Alcedo J, 2000, MOL CELL, V6, P457, DOI 10.1016/S1097-2765(00)00044-7; Apelqvist A, 1997, CURR BIOL, V7, P801, DOI 10.1016/S0960-9822(06)00340-X; Barresi MJF, 2000, DEVELOPMENT, V127, P2189; Bitgood MJ, 1996, CURR BIOL, V6, P298, DOI 10.1016/S0960-9822(02)00480-3; BITGOOD MJ, 1995, DEV BIOL, V172, P126, DOI 10.1006/dbio.1995.0010; Borycki AG, 2000, CURR TOP DEV BIOL, V48, P165; Borycki AG, 1999, DEVELOPMENT, V126, P4053; Borycki AG, 1998, DEVELOPMENT, V125, P777; Burdine RD, 2000, GENE DEV, V14, P763; Capdevila J, 2000, CELL, V101, P9, DOI 10.1016/S0092-8674(00)80619-4; Carpenter D, 1998, P NATL ACAD SCI USA, V95, P13630, DOI 10.1073/pnas.95.23.13630; Chen Y, 1996, CELL, V87, P553, DOI 10.1016/S0092-8674(00)81374-4; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Chiang C, 1999, DEV BIOL, V205, P1, DOI 10.1006/dbio.1998.9103; Collignon J, 1996, NATURE, V381, P155, DOI 10.1038/381155a0; Cossu G, 1999, EMBO J, V18, P6867, DOI 10.1093/emboj/18.24.6867; Dassule HR, 2000, DEVELOPMENT, V127, P4775; Dassule HR, 1998, DEV BIOL, V202, P215, DOI 10.1006/dbio.1998.8992; Denef N, 2000, CELL, V102, P521, DOI 10.1016/S0092-8674(00)00056-8; Dockter JL, 2000, CURR TOP DEV BIOL, V48, P77; Dutton R, 1999, J NEUROSCI, V19, P2601; ECHELARD Y, 1993, CELL, V75, P1417, DOI 10.1016/0092-8674(93)90627-3; FAN CM, 1994, CELL, V79, P1175, DOI 10.1016/0092-8674(94)90009-4; FAN CM, 1995, CELL, V81, P457, DOI 10.1016/0092-8674(95)90398-4; Gaio U, 1999, CURR BIOL, V9, P1339, DOI 10.1016/S0960-9822(00)80059-7; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Hammerschmidt M, 1997, TRENDS GENET, V13, P14, DOI 10.1016/S0168-9525(96)10051-2; Hebrok M, 2000, DEVELOPMENT, V127, P4905; Hynes M, 2000, NAT NEUROSCI, V3, P41, DOI 10.1038/71114; Ingham PW, 2000, CURR BIOL, V10, P1315, DOI 10.1016/S0960-9822(00)00755-7; Karp SJ, 2000, DEVELOPMENT, V127, P543; Kos L, 1998, MECH DEVELOP, V70, P25, DOI 10.1016/S0925-4773(97)00168-8; Lassar AB, 1996, CURR OPIN NEUROBIOL, V6, P57, DOI 10.1016/S0959-4388(96)80009-2; LEVIN M, 1995, CELL, V82, P803, DOI 10.1016/0092-8674(95)90477-8; Litingtung Y, 1998, NAT GENET, V20, P58, DOI 10.1038/1717; Liu AM, 1998, MECH DEVELOP, V75, P107, DOI 10.1016/S0925-4773(98)00090-2; Lyons GE, 1996, CURR OPIN GENET DEV, V6, P454, DOI 10.1016/S0959-437X(96)80067-0; LYONS I, 1995, GENE DEV, V9, P1654, DOI 10.1101/gad.9.13.1654; Marcelle C, 1999, DEV BIOL, V214, P277, DOI 10.1006/dbio.1999.9389; Marigo V, 1996, NATURE, V384, P176, DOI 10.1038/384176a0; MASUYA H, 1995, GENE DEV, V9, P1645, DOI 10.1101/gad.9.13.1645; Meno C, 1997, GENES CELLS, V2, P513, DOI 10.1046/j.1365-2443.1997.1400338.x; Meno C, 1998, CELL, V94, P287, DOI 10.1016/S0092-8674(00)81472-5; Meyers EN, 1999, SCIENCE, V285, P403, DOI 10.1126/science.285.5426.403; Monkley SJ, 1996, DEVELOPMENT, V122, P3343; Murtaugh LC, 1999, GENE DEV, V13, P225, DOI 10.1101/gad.13.2.225; Nonaka S, 1998, CELL, V95, P829, DOI 10.1016/S0092-8674(00)81705-5; OBRIEN TX, 1993, P NATL ACAD SCI USA, V90, P5157, DOI 10.1073/pnas.90.11.5157; Parmantier E, 1999, NEURON, V23, P713, DOI 10.1016/S0896-6273(01)80030-1; PARR BA, 1995, NATURE, V374, P350, DOI 10.1038/374350a0; Pepicelli CV, 1998, CURR BIOL, V8, P1083, DOI 10.1016/S0960-9822(98)70446-4; Piedra ME, 1998, CELL, V94, P319, DOI 10.1016/S0092-8674(00)81475-0; Quirk J, 1997, COLD SPRING HARB SYM, V62, P217; Ramalho-Santos M, 2000, DEVELOPMENT, V127, P2763; Ramirez-Weber FA, 2000, MOL CELL, V6, P479, DOI 10.1016/S1097-2765(00)00046-0; Rankin CT, 2000, NAT GENET, V24, P262, DOI 10.1038/73472; Rowitch DH, 1999, J NEUROSCI, V19, P8954, DOI 10.1523/JNEUROSCI.19-20-08954.1999; Ryan AK, 1998, NATURE, V394, P545, DOI 10.1038/29004; Sarkar L, 2000, P NATL ACAD SCI USA, V97, P4520, DOI 10.1073/pnas.97.9.4520; Sato N, 1999, J CLIN INVEST, V104, P855, DOI 10.1172/JCI7691; Shen MM, 2000, TRENDS GENET, V16, P303, DOI 10.1016/S0168-9525(00)02006-0; St-Jacques B, 1998, CURR BIOL, V8, P1058, DOI 10.1016/S0960-9822(98)70443-9; St-Jacques B, 1999, GENE DEV, V13, P2072, DOI 10.1101/gad.13.16.2072; Stone DM, 1996, NATURE, V384, P129, DOI 10.1038/384129a0; Strutt H, 2001, CURR BIOL, V11, P608, DOI 10.1016/S0960-9822(01)00179-8; Teillet MA, 1998, DEVELOPMENT, V125, P2019; Tsukui T, 1999, P NATL ACAD SCI USA, V96, P11376, DOI 10.1073/pnas.96.20.11376; Vortkamp A, 1996, SCIENCE, V273, P613, DOI 10.1126/science.273.5275.613; Wallace VA, 1999, CURR BIOL, V9, P445, DOI 10.1016/S0960-9822(99)80195-X; Wechsler-Reya RJ, 1999, NEURON, V22, P103, DOI 10.1016/S0896-6273(00)80682-0; WHITING J, 1991, GENE DEV, V5, P2048, DOI 10.1101/gad.5.11.2048; Xie JW, 1998, NATURE, V391, P90, DOI 10.1038/34201; Yan YT, 1999, GENE DEV, V13, P2527, DOI 10.1101/gad.13.19.2527; Ye WL, 1998, CELL, V93, P755, DOI 10.1016/S0092-8674(00)81437-3; Yoshioka H, 1998, CELL, V94, P299, DOI 10.1016/S0092-8674(00)81473-7; Zhang YD, 2000, DEVELOPMENT, V127, P1431; Zuniga A, 1999, NATURE, V401, P598, DOI 10.1038/44157	78	458	472	1	14	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 15	2001	105	6					781	792		10.1016/S0092-8674(01)00385-3	http://dx.doi.org/10.1016/S0092-8674(01)00385-3			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	444AE	11440720	Bronze			2022-12-24	WOS:000169375100011
